{"nbformat":4,"nbformat_minor":0,"metadata":{"colab":{"name":"5-Grants Enrichment Part 3-Enriching-Grants-With-Patents-and-ClinicalTrials-Information.ipynb","provenance":[{"file_id":"1SWGjQ1Yok_o0n5u1TxH107OM4ymsY_9t","timestamp":1573074008320}],"collapsed_sections":[],"toc_visible":true},"kernelspec":{"name":"python3","display_name":"Python 3"}},"cells":[{"cell_type":"markdown","metadata":{"colab_type":"text","id":"B8WH5Xmt8-pJ"},"source":["# Enriching Grants part 3: adding related Patents and Clinical Trials data\n","\n","In this third and final final part of the grants enrichment tutorial we are going to extract from Dimensions all Patents and Clinical Trials information linked to our *vaccines* grants datasets.  \n","\n","This tutorial builds on the previous one, *Enriching Grants with Publications Information from Dimensions*, and it assumes that our grants list already includes Dimensions IDs as well as publications counts for each grant. \n","\n","The enriched grants list we are starting from can be [downloaded here](http://static.michelepasin.org/dsl/grants_enriched_pubs.csv). "]},{"cell_type":"markdown","metadata":{"colab_type":"text","id":"Jtv99rG58-pR"},"source":["## Load libraries and login\n","Click the 'play' button on the left (or shift+enter) to run this cell."]},{"cell_type":"code","metadata":{"colab_type":"code","cellView":"both","outputId":"9acac4c6-faf4-4d14-abf2-f2a86eb482a3","executionInfo":{"status":"ok","timestamp":1573585890677,"user_tz":0,"elapsed":6574,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"id":"9PDUgx1c8-pS","colab":{"base_uri":"https://localhost:8080/","height":51}},"source":["username = \"\"  #@param {type: \"string\"}\n","password = \"\"  #@param {type: \"string\"}\n","endpoint = \"https://app.dimensions.ai\"  #@param {type: \"string\"}\n","\n","#\n","!pip install dimcli plotly_express -U --quiet \n","# !dimcli --init\n","import dimcli\n","dimcli.login(username, password, endpoint)\n","dsl = dimcli.Dsl()\n","\n","#\n","# load common libraries\n","import pandas as pd\n","import time\n","import json\n","from tqdm import tqdm_notebook as progressbar"],"execution_count":0,"outputs":[{"output_type":"stream","text":["\u001b[?25l\r\u001b[K     |██▉                             | 10kB 19.4MB/s eta 0:00:01\r\u001b[K     |█████▊                          | 20kB 3.5MB/s eta 0:00:01\r\u001b[K     |████████▌                       | 30kB 5.0MB/s eta 0:00:01\r\u001b[K     |███████████▍                    | 40kB 3.1MB/s eta 0:00:01\r\u001b[K     |██████████████▎                 | 51kB 3.8MB/s eta 0:00:01\r\u001b[K     |█████████████████               | 61kB 4.5MB/s eta 0:00:01\r\u001b[K     |████████████████████            | 71kB 5.2MB/s eta 0:00:01\r\u001b[K     |██████████████████████▉         | 81kB 5.8MB/s eta 0:00:01\r\u001b[K     |█████████████████████████▋      | 92kB 6.5MB/s eta 0:00:01\r\u001b[K     |████████████████████████████▌   | 102kB 5.1MB/s eta 0:00:01\r\u001b[K     |███████████████████████████████▍| 112kB 5.1MB/s eta 0:00:01\r\u001b[K     |████████████████████████████████| 122kB 5.1MB/s \n","\u001b[?25hDimCli v0.6.1 - Succesfully connected to <https://app.dimensions.ai> (method: manual login)\n"],"name":"stdout"}]},{"cell_type":"markdown","metadata":{"id":"uK8MAnLKnz24","colab_type":"text"},"source":["## Uploading the enriched grants data from part-2\n","\n","First make sure you have downloaded the file [\"grants_enriched_pubs.csv\"](http://static.michelepasin.org/dsl/grants_enriched_pubs.csv). \n","\n","> If you are using Google Colab, you also want to open up the left sidebar / Files menu (Apple/Ctrl + B) and drag and drop the file in there so that it can be seen by the notebook. "]},{"cell_type":"code","metadata":{"id":"JjAprcJSaToK","colab_type":"code","colab":{}},"source":["grants = pd.read_csv(\"grants_enriched_pubs.csv\")\n","grantsids = list(grants['Grant ID']) "],"execution_count":0,"outputs":[]},{"cell_type":"markdown","metadata":{"id":"0aoFtg-qI9ij","colab_type":"text"},"source":["This file contains 5k recent grants records on the topic of vaccines. Now we can preview the contents of the file."]},{"cell_type":"code","metadata":{"id":"OeywaSG7bnyR","colab_type":"code","outputId":"dd87136b-d3e4-47ca-c542-0081d94b61b9","executionInfo":{"status":"ok","timestamp":1573587763347,"user_tz":0,"elapsed":516,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"colab":{"base_uri":"https://localhost:8080/","height":634}},"source":["grants.head(10)"],"execution_count":0,"outputs":[{"output_type":"execute_result","data":{"application/vnd.google.colaboratory.module+javascript":"\n      import \"https://ssl.gstatic.com/colaboratory/data_table/9e554b27bdd509f3/data_table.js\";\n\n      window.createDataTable({\n        data: [[{\n            'v': 0,\n            'f': \"0\",\n        },\n\"grant.8172033\",\n\"30410203277\",\n\"\\u75ab\\u82d7\\uff0d\\u6574\\u4f53\\u65b9\\u6848\",\n{\n            'v': 1208,\n            'f': \"1208\",\n        },\n\"2004-11-30\",\n{\n            'v': 2004.0,\n            'f': \"2004.0\",\n        },\n\"2004-12-31\",\n{\n            'v': 2004,\n            'f': \"2004\",\n        },\n\"Sichuan University\",\n\"grid.13291.38\",\n\"China\",\n\"National Natural Science Foundation of China\",\n\"China\",\n{\n            'v': 0,\n            'f': \"0\",\n        }],\n [{\n            'v': 1,\n            'f': \"1\",\n        },\n\"grant.7715379\",\n\"620792\",\n\"Engineering Inhalable Vaccines\",\n{\n            'v': 26956,\n            'f': \"26956\",\n        },\n\"2017-04-01\",\n{\n            'v': 2017.0,\n            'f': \"2017.0\",\n        },\n\"2018-03-31\",\n{\n            'v': 2018,\n            'f': \"2018\",\n        },\n\"University of Alberta\",\n\"grid.17089.37\",\n\"Canada\",\n\"Natural Sciences and Engineering Research Council\",\n\"Canada\",\n{\n            'v': 0,\n            'f': \"0\",\n        }],\n [{\n            'v': 2,\n            'f': \"2\",\n        },\n\"grant.6962629\",\n\"599115\",\n\"Engineering Inhalable Vaccines\",\n{\n            'v': 26403,\n            'f': \"26403\",\n        },\n\"2016-04-01\",\n{\n            'v': 2016.0,\n            'f': \"2016.0\",\n        },\n\"2017-03-31\",\n{\n            'v': 2017,\n            'f': \"2017\",\n        },\n\"University of Alberta\",\n\"grid.17089.37\",\n\"Canada\",\n\"Natural Sciences and Engineering Research Council\",\n\"Canada\",\n{\n            'v': 0,\n            'f': \"0\",\n        }],\n [{\n            'v': 3,\n            'f': \"3\",\n        },\n\"grant.6723913\",\n\"251564\",\n\"HIV Vaccine research\",\n{\n            'v': 442366,\n            'f': \"442366\",\n        },\n\"2003-01-01\",\n{\n            'v': 2003.0,\n            'f': \"2003.0\",\n        },\n\"2007-12-31\",\n{\n            'v': 2007,\n            'f': \"2007\",\n        },\n\"University of Melbourne\",\n\"grid.1008.9\",\n\"Australia\",\n\"National Health and Medical Research Council\",\n\"Australia\",\n{\n            'v': 0,\n            'f': \"0\",\n        }],\n [{\n            'v': 4,\n            'f': \"4\",\n        },\n\"grant.6722306\",\n\"334174\",\n\"HIV Vaccine Development\",\n{\n            'v': 236067,\n            'f': \"236067\",\n        },\n\"2005-01-01\",\n{\n            'v': 2005.0,\n            'f': \"2005.0\",\n        },\n\"2009-12-31\",\n{\n            'v': 2009,\n            'f': \"2009\",\n        },\n\"Monash University\",\n\"grid.1002.3\",\n\"Australia\",\n\"National Health and Medical Research Council\",\n\"Australia\",\n{\n            'v': 1,\n            'f': \"1\",\n        }],\n [{\n            'v': 5,\n            'f': \"5\",\n        },\n\"grant.6716312\",\n\"910292\",\n\"Dengue virus vaccine.\",\n{\n            'v': 130890,\n            'f': \"130890\",\n        },\n\"1991-01-01\",\n{\n            'v': 1991.0,\n            'f': \"1991.0\",\n        },\n\"1993-12-31\",\n{\n            'v': 1993,\n            'f': \"1993\",\n        },\n\"Royal Children's Hospital\",\n\"grid.416107.5\",\n\"Australia\",\n\"National Health and Medical Research Council\",\n\"Australia\",\n{\n            'v': 0,\n            'f': \"0\",\n        }],\n [{\n            'v': 6,\n            'f': \"6\",\n        },\n\"grant.5526688\",\n\"578221\",\n\"Engineering Inhalable Vaccines\",\n{\n            'v': 27386,\n            'f': \"27386\",\n        },\n\"2015-04-01\",\n{\n            'v': 2015.0,\n            'f': \"2015.0\",\n        },\n\"2016-03-31\",\n{\n            'v': 2016,\n            'f': \"2016\",\n        },\n\"University of Alberta\",\n\"grid.17089.37\",\n\"Canada\",\n\"Natural Sciences and Engineering Research Council\",\n\"Canada\",\n{\n            'v': 0,\n            'f': \"0\",\n        }],\n [{\n            'v': 7,\n            'f': \"7\",\n        },\n\"grant.3733803\",\n\"IC18980360\",\n\"Schistosomiasis Vaccine Network.\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"1998-11-01\",\n{\n            'v': 1998.0,\n            'f': \"1998.0\",\n        },\n\"2000-10-31\",\n{\n            'v': 2000,\n            'f': \"2000\",\n        },\n\"Pasteur Institute of Lille; University of Edinburgh; Kenya Medical Research Institute; Ghent University; University of York; Centre de Recherche M\\u00e9dicale et Sanitaire; Oswaldo Cruz Foundation; Institute of Tropical Medicine Antwerp\",\n\"grid.8970.6; grid.4305.2; grid.33058.3d; grid.5342.0; grid.5685.e; grid.452260.7; grid.418068.3; grid.11505.30\",\n\"France; United Kingdom; Kenya; Belgium; United Kingdom; Niger; Brazil; Belgium\",\n\"European Commission\",\n\"Belgium\",\n{\n            'v': 0,\n            'f': \"0\",\n        }],\n [{\n            'v': 8,\n            'f': \"8\",\n        },\n\"grant.3274273\",\n\"7621798\",\n\"Pneumococcal Ribosomal Vaccines\",\n{\n            'v': 46000,\n            'f': \"46000\",\n        },\n\"1977-08-01\",\n{\n            'v': 1977.0,\n            'f': \"1977.0\",\n        },\n\"1980-01-31\",\n{\n            'v': 1980,\n            'f': \"1980\",\n        },\n\"University of Iowa\",\n\"grid.214572.7\",\n\"United States\",\n\"Directorate for Biological Sciences\",\n\"United States\",\n{\n            'v': 0,\n            'f': \"0\",\n        }],\n [{\n            'v': 9,\n            'f': \"9\",\n        },\n\"grant.2936015\",\n\"255890\",\n\"Rational vaccine design\",\n{\n            'v': 7138,\n            'f': \"7138\",\n        },\n\"2003-04-01\",\n{\n            'v': 2003.0,\n            'f': \"2003.0\",\n        },\n\"2004-03-31\",\n{\n            'v': 2004,\n            'f': \"2004\",\n        },\nNaN,\nNaN,\nNaN,\n\"Natural Sciences and Engineering Research Council\",\n\"Canada\",\n{\n            'v': 0,\n            'f': \"0\",\n        }]],\n        columns: [[\"number\", \"index\"], [\"string\", \"Grant ID\"], [\"string\", \"Grant Number\"], [\"string\", \"Title\"], [\"number\", \"Funding Amount in USD\"], [\"string\", \"Start Date\"], [\"number\", \"Start Year\"], [\"string\", \"End Date\"], [\"number\", \"End Year\"], [\"string\", \"Research Organization - standardized\"], [\"string\", \"GRID ID\"], [\"string\", \"Country of Research organization\"], [\"string\", \"Funder\"], [\"string\", \"Funder Country\"], [\"number\", \"pubs\"]],\n        columnOptions: [{\"width\": \"1px\", \"className\": \"index_column\"}],\n        rowsPerPage: 25,\n        helpUrl: \"https://colab.research.google.com/notebooks/data_table.ipynb\",\n      });\n    ","text/html":["<div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>Grant ID</th>\n","      <th>Grant Number</th>\n","      <th>Title</th>\n","      <th>Funding Amount in USD</th>\n","      <th>Start Date</th>\n","      <th>Start Year</th>\n","      <th>End Date</th>\n","      <th>End Year</th>\n","      <th>Research Organization - standardized</th>\n","      <th>GRID ID</th>\n","      <th>Country of Research organization</th>\n","      <th>Funder</th>\n","      <th>Funder Country</th>\n","      <th>pubs</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>grant.8172033</td>\n","      <td>30410203277</td>\n","      <td>疫苗－整体方案</td>\n","      <td>1208</td>\n","      <td>2004-11-30</td>\n","      <td>2004.0</td>\n","      <td>2004-12-31</td>\n","      <td>2004</td>\n","      <td>Sichuan University</td>\n","      <td>grid.13291.38</td>\n","      <td>China</td>\n","      <td>National Natural Science Foundation of China</td>\n","      <td>China</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>grant.7715379</td>\n","      <td>620792</td>\n","      <td>Engineering Inhalable Vaccines</td>\n","      <td>26956</td>\n","      <td>2017-04-01</td>\n","      <td>2017.0</td>\n","      <td>2018-03-31</td>\n","      <td>2018</td>\n","      <td>University of Alberta</td>\n","      <td>grid.17089.37</td>\n","      <td>Canada</td>\n","      <td>Natural Sciences and Engineering Research Council</td>\n","      <td>Canada</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>grant.6962629</td>\n","      <td>599115</td>\n","      <td>Engineering Inhalable Vaccines</td>\n","      <td>26403</td>\n","      <td>2016-04-01</td>\n","      <td>2016.0</td>\n","      <td>2017-03-31</td>\n","      <td>2017</td>\n","      <td>University of Alberta</td>\n","      <td>grid.17089.37</td>\n","      <td>Canada</td>\n","      <td>Natural Sciences and Engineering Research Council</td>\n","      <td>Canada</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>grant.6723913</td>\n","      <td>251564</td>\n","      <td>HIV Vaccine research</td>\n","      <td>442366</td>\n","      <td>2003-01-01</td>\n","      <td>2003.0</td>\n","      <td>2007-12-31</td>\n","      <td>2007</td>\n","      <td>University of Melbourne</td>\n","      <td>grid.1008.9</td>\n","      <td>Australia</td>\n","      <td>National Health and Medical Research Council</td>\n","      <td>Australia</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>grant.6722306</td>\n","      <td>334174</td>\n","      <td>HIV Vaccine Development</td>\n","      <td>236067</td>\n","      <td>2005-01-01</td>\n","      <td>2005.0</td>\n","      <td>2009-12-31</td>\n","      <td>2009</td>\n","      <td>Monash University</td>\n","      <td>grid.1002.3</td>\n","      <td>Australia</td>\n","      <td>National Health and Medical Research Council</td>\n","      <td>Australia</td>\n","      <td>1</td>\n","    </tr>\n","    <tr>\n","      <th>5</th>\n","      <td>grant.6716312</td>\n","      <td>910292</td>\n","      <td>Dengue virus vaccine.</td>\n","      <td>130890</td>\n","      <td>1991-01-01</td>\n","      <td>1991.0</td>\n","      <td>1993-12-31</td>\n","      <td>1993</td>\n","      <td>Royal Children's Hospital</td>\n","      <td>grid.416107.5</td>\n","      <td>Australia</td>\n","      <td>National Health and Medical Research Council</td>\n","      <td>Australia</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>6</th>\n","      <td>grant.5526688</td>\n","      <td>578221</td>\n","      <td>Engineering Inhalable Vaccines</td>\n","      <td>27386</td>\n","      <td>2015-04-01</td>\n","      <td>2015.0</td>\n","      <td>2016-03-31</td>\n","      <td>2016</td>\n","      <td>University of Alberta</td>\n","      <td>grid.17089.37</td>\n","      <td>Canada</td>\n","      <td>Natural Sciences and Engineering Research Council</td>\n","      <td>Canada</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>7</th>\n","      <td>grant.3733803</td>\n","      <td>IC18980360</td>\n","      <td>Schistosomiasis Vaccine Network.</td>\n","      <td>0</td>\n","      <td>1998-11-01</td>\n","      <td>1998.0</td>\n","      <td>2000-10-31</td>\n","      <td>2000</td>\n","      <td>Pasteur Institute of Lille; University of Edin...</td>\n","      <td>grid.8970.6; grid.4305.2; grid.33058.3d; grid....</td>\n","      <td>France; United Kingdom; Kenya; Belgium; United...</td>\n","      <td>European Commission</td>\n","      <td>Belgium</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>8</th>\n","      <td>grant.3274273</td>\n","      <td>7621798</td>\n","      <td>Pneumococcal Ribosomal Vaccines</td>\n","      <td>46000</td>\n","      <td>1977-08-01</td>\n","      <td>1977.0</td>\n","      <td>1980-01-31</td>\n","      <td>1980</td>\n","      <td>University of Iowa</td>\n","      <td>grid.214572.7</td>\n","      <td>United States</td>\n","      <td>Directorate for Biological Sciences</td>\n","      <td>United States</td>\n","      <td>0</td>\n","    </tr>\n","    <tr>\n","      <th>9</th>\n","      <td>grant.2936015</td>\n","      <td>255890</td>\n","      <td>Rational vaccine design</td>\n","      <td>7138</td>\n","      <td>2003-04-01</td>\n","      <td>2003.0</td>\n","      <td>2004-03-31</td>\n","      <td>2004</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>Natural Sciences and Engineering Research Council</td>\n","      <td>Canada</td>\n","      <td>0</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>"],"text/plain":["        Grant ID Grant Number  ... Funder Country  pubs\n","0  grant.8172033  30410203277  ...          China     0\n","1  grant.7715379       620792  ...         Canada     0\n","2  grant.6962629       599115  ...         Canada     0\n","3  grant.6723913       251564  ...      Australia     0\n","4  grant.6722306       334174  ...      Australia     1\n","5  grant.6716312       910292  ...      Australia     0\n","6  grant.5526688       578221  ...         Canada     0\n","7  grant.3733803   IC18980360  ...        Belgium     0\n","8  grant.3274273      7621798  ...  United States     0\n","9  grant.2936015       255890  ...         Canada     0\n","\n","[10 rows x 14 columns]"]},"metadata":{"tags":[]},"execution_count":6}]},{"cell_type":"markdown","metadata":{"colab_type":"text","id":"Lyesh4yLs3QJ"},"source":["## Extracting linked Patents data\n","\n","Using a similar methodology as with publications, we can easily extract all patents linked to each grant in two steps. \n","\n","* retrieve all the relevant patents records using the `associated_grant_ids` field (see also the [data model](https://docs.dimensions.ai/dsl/data-model.html) and the  [patents fields](https://docs.dimensions.ai/dsl/data-sources.html#patents))\n","* group patents by grant ID in so that we can have a single count per record \n","\n","Note: in this case we can iterate 400 grants at a time cause in general there are much less associated patents per grant (compared to publications)."]},{"cell_type":"code","metadata":{"colab_type":"code","outputId":"73691672-93e7-4aeb-d8f7-bc78ecb71102","executionInfo":{"status":"ok","timestamp":1573588105638,"user_tz":0,"elapsed":48152,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"id":"EFbX0SoUs3QM","colab":{"resources":{"http://localhost:8080/nbextensions/google.colab/colabwidgets/controls.css":{"data":"/* Copyright (c) Jupyter Development Team.
 * Distributed under the terms of the Modified BSD License.
 */

 /* We import all of these together in a single css file because the Webpack
loader sees only one file at a time. This allows postcss to see the variable
definitions when they are used. */

 /*-----------------------------------------------------------------------------
| Copyright (c) Jupyter Development Team.
| Distributed under the terms of the Modified BSD License.
|----------------------------------------------------------------------------*/

 /*
This file is copied from the JupyterLab project to define default styling for
when the widget styling is compiled down to eliminate CSS variables. We make one
change - we comment out the font import below.
*/

 /**
 * The material design colors are adapted from google-material-color v1.2.6
 * https://github.com/danlevan/google-material-color
 * https://github.com/danlevan/google-material-color/blob/f67ca5f4028b2f1b34862f64b0ca67323f91b088/dist/palette.var.css
 *
 * The license for the material design color CSS variables is as follows (see
 * https://github.com/danlevan/google-material-color/blob/f67ca5f4028b2f1b34862f64b0ca67323f91b088/LICENSE)
 *
 * The MIT License (MIT)
 *
 * Copyright (c) 2014 Dan Le Van
 *
 * Permission is hereby granted, free of charge, to any person obtaining a copy
 * of this software and associated documentation files (the "Software"), to deal
 * in the Software without restriction, including without limitation the rights
 * to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
 * copies of the Software, and to permit persons to whom the Software is
 * furnished to do so, subject to the following conditions:
 *
 * The above copyright notice and this permission notice shall be included in
 * all copies or substantial portions of the Software.
 *
 * THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
 * IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
 * FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
 * AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
 * LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
 * OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
 * SOFTWARE.
 */

 /*
The following CSS variables define the main, public API for styling JupyterLab.
These variables should be used by all plugins wherever possible. In other
words, plugins should not define custom colors, sizes, etc unless absolutely
necessary. This enables users to change the visual theme of JupyterLab
by changing these variables.

Many variables appear in an ordered sequence (0,1,2,3). These sequences
are designed to work well together, so for example, `--jp-border-color1` should
be used with `--jp-layout-color1`. The numbers have the following meanings:

* 0: super-primary, reserved for special emphasis
* 1: primary, most important under normal situations
* 2: secondary, next most important under normal situations
* 3: tertiary, next most important under normal situations

Throughout JupyterLab, we are mostly following principles from Google's
Material Design when selecting colors. We are not, however, following
all of MD as it is not optimized for dense, information rich UIs.
*/

 /*
 * Optional monospace font for input/output prompt.
 */

 /* Commented out in ipywidgets since we don't need it. */

 /* @import url('https://fonts.googleapis.com/css?family=Roboto+Mono'); */

 /*
 * Added for compabitility with output area
 */

 :root {

  /* Borders

  The following variables, specify the visual styling of borders in JupyterLab.
   */

  /* UI Fonts

  The UI font CSS variables are used for the typography all of the JupyterLab
  user interface elements that are not directly user generated content.
  */ /* Base font size */ /* Ensures px perfect FontAwesome icons */

  /* Use these font colors against the corresponding main layout colors.
     In a light theme, these go from dark to light.
  */

  /* Use these against the brand/accent/warn/error colors.
     These will typically go from light to darker, in both a dark and light theme
   */

  /* Content Fonts

  Content font variables are used for typography of user generated content.
  */ /* Base font size */


  /* Layout

  The following are the main layout colors use in JupyterLab. In a light
  theme these would go from light to dark.
  */

  /* Brand/accent */

  /* State colors (warn, error, success, info) */

  /* Cell specific styles */
  /* A custom blend of MD grey and blue 600
   * See https://meyerweb.com/eric/tools/color-blend/#546E7A:1E88E5:5:hex */
  /* A custom blend of MD grey and orange 600
   * https://meyerweb.com/eric/tools/color-blend/#546E7A:F4511E:5:hex */

  /* Notebook specific styles */

  /* Console specific styles */

  /* Toolbar specific styles */
}

 /* Copyright (c) Jupyter Development Team.
 * Distributed under the terms of the Modified BSD License.
 */

 /*
 * We assume that the CSS variables in
 * https://github.com/jupyterlab/jupyterlab/blob/master/src/default-theme/variables.css
 * have been defined.
 */

 /* This file has code derived from PhosphorJS CSS files, as noted below. The license for this PhosphorJS code is:

Copyright (c) 2014-2017, PhosphorJS Contributors
All rights reserved.

Redistribution and use in source and binary forms, with or without
modification, are permitted provided that the following conditions are met:

* Redistributions of source code must retain the above copyright notice, this
  list of conditions and the following disclaimer.

* Redistributions in binary form must reproduce the above copyright notice,
  this list of conditions and the following disclaimer in the documentation
  and/or other materials provided with the distribution.

* Neither the name of the copyright holder nor the names of its
  contributors may be used to endorse or promote products derived from
  this software without specific prior written permission.

THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS "AS IS"
AND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE
IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE ARE
DISCLAIMED. IN NO EVENT SHALL THE COPYRIGHT HOLDER OR CONTRIBUTORS BE LIABLE
FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL
DAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR
SERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS INTERRUPTION) HOWEVER
CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY,
OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE
OF THIS SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.

*/

 /*
 * The following section is derived from https://github.com/phosphorjs/phosphor/blob/23b9d075ebc5b73ab148b6ebfc20af97f85714c4/packages/widgets/style/tabbar.css 
 * We've scoped the rules so that they are consistent with exactly our code.
 */

 .jupyter-widgets.widget-tab > .p-TabBar {
  display: -webkit-box;
  display: -ms-flexbox;
  display: flex;
  -webkit-user-select: none;
  -moz-user-select: none;
  -ms-user-select: none;
  user-select: none;
}

 .jupyter-widgets.widget-tab > .p-TabBar[data-orientation='horizontal'] {
  -webkit-box-orient: horizontal;
  -webkit-box-direction: normal;
      -ms-flex-direction: row;
          flex-direction: row;
}

 .jupyter-widgets.widget-tab > .p-TabBar[data-orientation='vertical'] {
  -webkit-box-orient: vertical;
  -webkit-box-direction: normal;
      -ms-flex-direction: column;
          flex-direction: column;
}

 .jupyter-widgets.widget-tab > .p-TabBar > .p-TabBar-content {
  margin: 0;
  padding: 0;
  display: -webkit-box;
  display: -ms-flexbox;
  display: flex;
  -webkit-box-flex: 1;
      -ms-flex: 1 1 auto;
          flex: 1 1 auto;
  list-style-type: none;
}

 .jupyter-widgets.widget-tab > .p-TabBar[data-orientation='horizontal'] > .p-TabBar-content {
  -webkit-box-orient: horizontal;
  -webkit-box-direction: normal;
      -ms-flex-direction: row;
          flex-direction: row;
}

 .jupyter-widgets.widget-tab > .p-TabBar[data-orientation='vertical'] > .p-TabBar-content {
  -webkit-box-orient: vertical;
  -webkit-box-direction: normal;
      -ms-flex-direction: column;
          flex-direction: column;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab {
  display: -webkit-box;
  display: -ms-flexbox;
  display: flex;
  -webkit-box-orient: horizontal;
  -webkit-box-direction: normal;
      -ms-flex-direction: row;
          flex-direction: row;
  -webkit-box-sizing: border-box;
          box-sizing: border-box;
  overflow: hidden;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabIcon,
.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabCloseIcon {
  -webkit-box-flex: 0;
      -ms-flex: 0 0 auto;
          flex: 0 0 auto;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabLabel {
  -webkit-box-flex: 1;
      -ms-flex: 1 1 auto;
          flex: 1 1 auto;
  overflow: hidden;
  white-space: nowrap;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab.p-mod-hidden {
  display: none !important;
}

 .jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging .p-TabBar-tab {
  position: relative;
}

 .jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging[data-orientation='horizontal'] .p-TabBar-tab {
  left: 0;
  -webkit-transition: left 150ms ease;
  transition: left 150ms ease;
}

 .jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging[data-orientation='vertical'] .p-TabBar-tab {
  top: 0;
  -webkit-transition: top 150ms ease;
  transition: top 150ms ease;
}

 .jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging .p-TabBar-tab.p-mod-dragging {
  -webkit-transition: none;
  transition: none;
}

 /* End tabbar.css */

 :root { /* margin between inline elements */

    /* From Material Design Lite */
}

 .jupyter-widgets {
    margin: 2px;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    color: black;
    overflow: visible;
}

 .jupyter-widgets.jupyter-widgets-disconnected::before {
    line-height: 28px;
    height: 28px;
}

 .jp-Output-result > .jupyter-widgets {
    margin-left: 0;
    margin-right: 0;
}

 /* vbox and hbox */

 .widget-inline-hbox {
    /* Horizontal widgets */
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: horizontal;
    -webkit-box-direction: normal;
        -ms-flex-direction: row;
            flex-direction: row;
    -webkit-box-align: baseline;
        -ms-flex-align: baseline;
            align-items: baseline;
}

 .widget-inline-vbox {
    /* Vertical Widgets */
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
    -webkit-box-align: center;
        -ms-flex-align: center;
            align-items: center;
}

 .widget-box {
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    margin: 0;
    overflow: auto;
}

 .widget-gridbox {
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    display: grid;
    margin: 0;
    overflow: auto;
}

 .widget-hbox {
    -webkit-box-orient: horizontal;
    -webkit-box-direction: normal;
        -ms-flex-direction: row;
            flex-direction: row;
}

 .widget-vbox {
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
}

 /* General Button Styling */

 .jupyter-button {
    padding-left: 10px;
    padding-right: 10px;
    padding-top: 0px;
    padding-bottom: 0px;
    display: inline-block;
    white-space: nowrap;
    overflow: hidden;
    text-overflow: ellipsis;
    text-align: center;
    font-size: 13px;
    cursor: pointer;

    height: 28px;
    border: 0px solid;
    line-height: 28px;
    -webkit-box-shadow: none;
            box-shadow: none;

    color: rgba(0, 0, 0, .8);
    background-color: #EEEEEE;
    border-color: #E0E0E0;
    border: none;
}

 .jupyter-button i.fa {
    margin-right: 4px;
    pointer-events: none;
}

 .jupyter-button:empty:before {
    content: "\200b"; /* zero-width space */
}

 .jupyter-widgets.jupyter-button:disabled {
    opacity: 0.6;
}

 .jupyter-button i.fa.center {
    margin-right: 0;
}

 .jupyter-button:hover:enabled, .jupyter-button:focus:enabled {
    /* MD Lite 2dp shadow */
    -webkit-box-shadow: 0 2px 2px 0 rgba(0, 0, 0, .14),
                0 3px 1px -2px rgba(0, 0, 0, .2),
                0 1px 5px 0 rgba(0, 0, 0, .12);
            box-shadow: 0 2px 2px 0 rgba(0, 0, 0, .14),
                0 3px 1px -2px rgba(0, 0, 0, .2),
                0 1px 5px 0 rgba(0, 0, 0, .12);
}

 .jupyter-button:active, .jupyter-button.mod-active {
    /* MD Lite 4dp shadow */
    -webkit-box-shadow: 0 4px 5px 0 rgba(0, 0, 0, .14),
                0 1px 10px 0 rgba(0, 0, 0, .12),
                0 2px 4px -1px rgba(0, 0, 0, .2);
            box-shadow: 0 4px 5px 0 rgba(0, 0, 0, .14),
                0 1px 10px 0 rgba(0, 0, 0, .12),
                0 2px 4px -1px rgba(0, 0, 0, .2);
    color: rgba(0, 0, 0, .8);
    background-color: #BDBDBD;
}

 .jupyter-button:focus:enabled {
    outline: 1px solid #64B5F6;
}

 /* Button "Primary" Styling */

 .jupyter-button.mod-primary {
    color: rgba(255, 255, 255, 1.0);
    background-color: #2196F3;
}

 .jupyter-button.mod-primary.mod-active {
    color: rgba(255, 255, 255, 1);
    background-color: #1976D2;
}

 .jupyter-button.mod-primary:active {
    color: rgba(255, 255, 255, 1);
    background-color: #1976D2;
}

 /* Button "Success" Styling */

 .jupyter-button.mod-success {
    color: rgba(255, 255, 255, 1.0);
    background-color: #4CAF50;
}

 .jupyter-button.mod-success.mod-active {
    color: rgba(255, 255, 255, 1);
    background-color: #388E3C;
 }

 .jupyter-button.mod-success:active {
    color: rgba(255, 255, 255, 1);
    background-color: #388E3C;
 }

 /* Button "Info" Styling */

 .jupyter-button.mod-info {
    color: rgba(255, 255, 255, 1.0);
    background-color: #00BCD4;
}

 .jupyter-button.mod-info.mod-active {
    color: rgba(255, 255, 255, 1);
    background-color: #0097A7;
}

 .jupyter-button.mod-info:active {
    color: rgba(255, 255, 255, 1);
    background-color: #0097A7;
}

 /* Button "Warning" Styling */

 .jupyter-button.mod-warning {
    color: rgba(255, 255, 255, 1.0);
    background-color: #FF9800;
}

 .jupyter-button.mod-warning.mod-active {
    color: rgba(255, 255, 255, 1);
    background-color: #F57C00;
}

 .jupyter-button.mod-warning:active {
    color: rgba(255, 255, 255, 1);
    background-color: #F57C00;
}

 /* Button "Danger" Styling */

 .jupyter-button.mod-danger {
    color: rgba(255, 255, 255, 1.0);
    background-color: #F44336;
}

 .jupyter-button.mod-danger.mod-active {
    color: rgba(255, 255, 255, 1);
    background-color: #D32F2F;
}

 .jupyter-button.mod-danger:active {
    color: rgba(255, 255, 255, 1);
    background-color: #D32F2F;
}

 /* Widget Button*/

 .widget-button, .widget-toggle-button {
    width: 148px;
}

 /* Widget Label Styling */

 /* Override Bootstrap label css */

 .jupyter-widgets label {
    margin-bottom: 0;
    margin-bottom: initial;
}

 .widget-label-basic {
    /* Basic Label */
    color: black;
    font-size: 13px;
    overflow: hidden;
    text-overflow: ellipsis;
    white-space: nowrap;
    line-height: 28px;
}

 .widget-label {
    /* Label */
    color: black;
    font-size: 13px;
    overflow: hidden;
    text-overflow: ellipsis;
    white-space: nowrap;
    line-height: 28px;
}

 .widget-inline-hbox .widget-label {
    /* Horizontal Widget Label */
    color: black;
    text-align: right;
    margin-right: 8px;
    width: 80px;
    -ms-flex-negative: 0;
        flex-shrink: 0;
}

 .widget-inline-vbox .widget-label {
    /* Vertical Widget Label */
    color: black;
    text-align: center;
    line-height: 28px;
}

 /* Widget Readout Styling */

 .widget-readout {
    color: black;
    font-size: 13px;
    height: 28px;
    line-height: 28px;
    overflow: hidden;
    white-space: nowrap;
    text-align: center;
}

 .widget-readout.overflow {
    /* Overflowing Readout */

    /* From Material Design Lite
        shadow-key-umbra-opacity: 0.2;
        shadow-key-penumbra-opacity: 0.14;
        shadow-ambient-shadow-opacity: 0.12;
     */
    -webkit-box-shadow: 0 2px 2px 0 rgba(0, 0, 0, .2),
                        0 3px 1px -2px rgba(0, 0, 0, .14),
                        0 1px 5px 0 rgba(0, 0, 0, .12);

    box-shadow: 0 2px 2px 0 rgba(0, 0, 0, .2),
                0 3px 1px -2px rgba(0, 0, 0, .14),
                0 1px 5px 0 rgba(0, 0, 0, .12);
}

 .widget-inline-hbox .widget-readout {
    /* Horizontal Readout */
    text-align: center;
    max-width: 148px;
    min-width: 72px;
    margin-left: 4px;
}

 .widget-inline-vbox .widget-readout {
    /* Vertical Readout */
    margin-top: 4px;
    /* as wide as the widget */
    width: inherit;
}

 /* Widget Checkbox Styling */

 .widget-checkbox {
    width: 300px;
    height: 28px;
    line-height: 28px;
}

 .widget-checkbox input[type="checkbox"] {
    margin: 0px 8px 0px 0px;
    line-height: 28px;
    font-size: large;
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    -ms-flex-negative: 0;
        flex-shrink: 0;
    -ms-flex-item-align: center;
        align-self: center;
}

 /* Widget Valid Styling */

 .widget-valid {
    height: 28px;
    line-height: 28px;
    width: 148px;
    font-size: 13px;
}

 .widget-valid i:before {
    line-height: 28px;
    margin-right: 4px;
    margin-left: 4px;

    /* from the fa class in FontAwesome: https://github.com/FortAwesome/Font-Awesome/blob/49100c7c3a7b58d50baa71efef11af41a66b03d3/css/font-awesome.css#L14 */
    display: inline-block;
    font: normal normal normal 14px/1 FontAwesome;
    font-size: inherit;
    text-rendering: auto;
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
}

 .widget-valid.mod-valid i:before {
    content: "\f00c";
    color: green;
}

 .widget-valid.mod-invalid i:before {
    content: "\f00d";
    color: red;
}

 .widget-valid.mod-valid .widget-valid-readout {
    display: none;
}

 /* Widget Text and TextArea Stying */

 .widget-textarea, .widget-text {
    width: 300px;
}

 .widget-text input[type="text"], .widget-text input[type="number"]{
    height: 28px;
    line-height: 28px;
}

 .widget-text input[type="text"]:disabled, .widget-text input[type="number"]:disabled, .widget-textarea textarea:disabled {
    opacity: 0.6;
}

 .widget-text input[type="text"], .widget-text input[type="number"], .widget-textarea textarea {
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    border: 1px solid #9E9E9E;
    background-color: white;
    color: rgba(0, 0, 0, .8);
    font-size: 13px;
    padding: 4px 8px;
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    min-width: 0; /* This makes it possible for the flexbox to shrink this input */
    -ms-flex-negative: 1;
        flex-shrink: 1;
    outline: none !important;
}

 .widget-textarea textarea {
    height: inherit;
    width: inherit;
}

 .widget-text input:focus, .widget-textarea textarea:focus {
    border-color: #64B5F6;
}

 /* Widget Slider */

 .widget-slider .ui-slider {
    /* Slider Track */
    border: 1px solid #BDBDBD;
    background: #BDBDBD;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    position: relative;
    border-radius: 0px;
}

 .widget-slider .ui-slider .ui-slider-handle {
    /* Slider Handle */
    outline: none !important; /* focused slider handles are colored - see below */
    position: absolute;
    background-color: white;
    border: 1px solid #9E9E9E;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    z-index: 1;
    background-image: none; /* Override jquery-ui */
}

 /* Override jquery-ui */

 .widget-slider .ui-slider .ui-slider-handle:hover, .widget-slider .ui-slider .ui-slider-handle:focus {
    background-color: #2196F3;
    border: 1px solid #2196F3;
}

 .widget-slider .ui-slider .ui-slider-handle:active {
    background-color: #2196F3;
    border-color: #2196F3;
    z-index: 2;
    -webkit-transform: scale(1.2);
            transform: scale(1.2);
}

 .widget-slider  .ui-slider .ui-slider-range {
    /* Interval between the two specified value of a double slider */
    position: absolute;
    background: #2196F3;
    z-index: 0;
}

 /* Shapes of Slider Handles */

 .widget-hslider .ui-slider .ui-slider-handle {
    width: 16px;
    height: 16px;
    margin-top: -7px;
    margin-left: -7px;
    border-radius: 50%;
    top: 0;
}

 .widget-vslider .ui-slider .ui-slider-handle {
    width: 16px;
    height: 16px;
    margin-bottom: -7px;
    margin-left: -7px;
    border-radius: 50%;
    left: 0;
}

 .widget-hslider .ui-slider .ui-slider-range {
    height: 8px;
    margin-top: -3px;
}

 .widget-vslider .ui-slider .ui-slider-range {
    width: 8px;
    margin-left: -3px;
}

 /* Horizontal Slider */

 .widget-hslider {
    width: 300px;
    height: 28px;
    line-height: 28px;

    /* Override the align-items baseline. This way, the description and readout
    still seem to align their baseline properly, and we don't have to have
    align-self: stretch in the .slider-container. */
    -webkit-box-align: center;
        -ms-flex-align: center;
            align-items: center;
}

 .widgets-slider .slider-container {
    overflow: visible;
}

 .widget-hslider .slider-container {
    height: 28px;
    margin-left: 6px;
    margin-right: 6px;
    -webkit-box-flex: 1;
        -ms-flex: 1 1 148px;
            flex: 1 1 148px;
}

 .widget-hslider .ui-slider {
    /* Inner, invisible slide div */
    height: 4px;
    margin-top: 12px;
    width: 100%;
}

 /* Vertical Slider */

 .widget-vbox .widget-label {
    height: 28px;
    line-height: 28px;
}

 .widget-vslider {
    /* Vertical Slider */
    height: 200px;
    width: 72px;
}

 .widget-vslider .slider-container {
    -webkit-box-flex: 1;
        -ms-flex: 1 1 148px;
            flex: 1 1 148px;
    margin-left: auto;
    margin-right: auto;
    margin-bottom: 6px;
    margin-top: 6px;
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
}

 .widget-vslider .ui-slider-vertical {
    /* Inner, invisible slide div */
    width: 4px;
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    margin-left: auto;
    margin-right: auto;
}

 /* Widget Progress Styling */

 .progress-bar {
    -webkit-transition: none;
    transition: none;
}

 .progress-bar {
    height: 28px;
}

 .progress-bar {
    background-color: #2196F3;
}

 .progress-bar-success {
    background-color: #4CAF50;
}

 .progress-bar-info {
    background-color: #00BCD4;
}

 .progress-bar-warning {
    background-color: #FF9800;
}

 .progress-bar-danger {
    background-color: #F44336;
}

 .progress {
    background-color: #EEEEEE;
    border: none;
    -webkit-box-shadow: none;
            box-shadow: none;
}

 /* Horisontal Progress */

 .widget-hprogress {
    /* Progress Bar */
    height: 28px;
    line-height: 28px;
    width: 300px;
    -webkit-box-align: center;
        -ms-flex-align: center;
            align-items: center;

}

 .widget-hprogress .progress {
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    margin-top: 4px;
    margin-bottom: 4px;
    -ms-flex-item-align: stretch;
        align-self: stretch;
    /* Override bootstrap style */
    height: auto;
    height: initial;
}

 /* Vertical Progress */

 .widget-vprogress {
    height: 200px;
    width: 72px;
}

 .widget-vprogress .progress {
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    width: 20px;
    margin-left: auto;
    margin-right: auto;
    margin-bottom: 0;
}

 /* Select Widget Styling */

 .widget-dropdown {
    height: 28px;
    width: 300px;
    line-height: 28px;
}

 .widget-dropdown > select {
    padding-right: 20px;
    border: 1px solid #9E9E9E;
    border-radius: 0;
    height: inherit;
    -webkit-box-flex: 1;
        -ms-flex: 1 1 148px;
            flex: 1 1 148px;
    min-width: 0; /* This makes it possible for the flexbox to shrink this input */
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    outline: none !important;
    -webkit-box-shadow: none;
            box-shadow: none;
    background-color: white;
    color: rgba(0, 0, 0, .8);
    font-size: 13px;
    vertical-align: top;
    padding-left: 8px;
	appearance: none;
	-webkit-appearance: none;
	-moz-appearance: none;
    background-repeat: no-repeat;
	background-size: 20px;
	background-position: right center;
    background-image: url("data:image/svg+xml;base64,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");
}

 .widget-dropdown > select:focus {
    border-color: #64B5F6;
}

 .widget-dropdown > select:disabled {
    opacity: 0.6;
}

 /* To disable the dotted border in Firefox around select controls.
   See http://stackoverflow.com/a/18853002 */

 .widget-dropdown > select:-moz-focusring {
    color: transparent;
    text-shadow: 0 0 0 #000;
}

 /* Select and SelectMultiple */

 .widget-select {
    width: 300px;
    line-height: 28px;

    /* Because Firefox defines the baseline of a select as the bottom of the
    control, we align the entire control to the top and add padding to the
    select to get an approximate first line baseline alignment. */
    -webkit-box-align: start;
        -ms-flex-align: start;
            align-items: flex-start;
}

 .widget-select > select {
    border: 1px solid #9E9E9E;
    background-color: white;
    color: rgba(0, 0, 0, .8);
    font-size: 13px;
    -webkit-box-flex: 1;
        -ms-flex: 1 1 148px;
            flex: 1 1 148px;
    outline: none !important;
    overflow: auto;
    height: inherit;

    /* Because Firefox defines the baseline of a select as the bottom of the
    control, we align the entire control to the top and add padding to the
    select to get an approximate first line baseline alignment. */
    padding-top: 5px;
}

 .widget-select > select:focus {
    border-color: #64B5F6;
}

 .wiget-select > select > option {
    padding-left: 4px;
    line-height: 28px;
    /* line-height doesn't work on some browsers for select options */
    padding-top: calc(28px - var(--jp-widgets-font-size) / 2);
    padding-bottom: calc(28px - var(--jp-widgets-font-size) / 2);
}

 /* Toggle Buttons Styling */

 .widget-toggle-buttons {
    line-height: 28px;
}

 .widget-toggle-buttons .widget-toggle-button {
    margin-left: 2px;
    margin-right: 2px;
}

 .widget-toggle-buttons .jupyter-button:disabled {
    opacity: 0.6;
}

 /* Radio Buttons Styling */

 .widget-radio {
    width: 300px;
    line-height: 28px;
}

 .widget-radio-box {
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
    -webkit-box-align: stretch;
        -ms-flex-align: stretch;
            align-items: stretch;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    margin-bottom: 8px;
}

 .widget-radio-box label {
    height: 20px;
    line-height: 20px;
    font-size: 13px;
}

 .widget-radio-box input {
    height: 20px;
    line-height: 20px;
    margin: 0 8px 0 1px;
    float: left;
}

 /* Color Picker Styling */

 .widget-colorpicker {
    width: 300px;
    height: 28px;
    line-height: 28px;
}

 .widget-colorpicker > .widget-colorpicker-input {
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    -ms-flex-negative: 1;
        flex-shrink: 1;
    min-width: 72px;
}

 .widget-colorpicker input[type="color"] {
    width: 28px;
    height: 28px;
    padding: 0 2px; /* make the color square actually square on Chrome on OS X */
    background: white;
    color: rgba(0, 0, 0, .8);
    border: 1px solid #9E9E9E;
    border-left: none;
    -webkit-box-flex: 0;
        -ms-flex-positive: 0;
            flex-grow: 0;
    -ms-flex-negative: 0;
        flex-shrink: 0;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    -ms-flex-item-align: stretch;
        align-self: stretch;
    outline: none !important;
}

 .widget-colorpicker.concise input[type="color"] {
    border-left: 1px solid #9E9E9E;
}

 .widget-colorpicker input[type="color"]:focus, .widget-colorpicker input[type="text"]:focus {
    border-color: #64B5F6;
}

 .widget-colorpicker input[type="text"] {
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    outline: none !important;
    height: 28px;
    line-height: 28px;
    background: white;
    color: rgba(0, 0, 0, .8);
    border: 1px solid #9E9E9E;
    font-size: 13px;
    padding: 4px 8px;
    min-width: 0; /* This makes it possible for the flexbox to shrink this input */
    -ms-flex-negative: 1;
        flex-shrink: 1;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
}

 .widget-colorpicker input[type="text"]:disabled {
    opacity: 0.6;
}

 /* Date Picker Styling */

 .widget-datepicker {
    width: 300px;
    height: 28px;
    line-height: 28px;
}

 .widget-datepicker input[type="date"] {
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    -ms-flex-negative: 1;
        flex-shrink: 1;
    min-width: 0; /* This makes it possible for the flexbox to shrink this input */
    outline: none !important;
    height: 28px;
    border: 1px solid #9E9E9E;
    background-color: white;
    color: rgba(0, 0, 0, .8);
    font-size: 13px;
    padding: 4px 8px;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
}

 .widget-datepicker input[type="date"]:focus {
    border-color: #64B5F6;
}

 .widget-datepicker input[type="date"]:invalid {
    border-color: #FF9800;
}

 .widget-datepicker input[type="date"]:disabled {
    opacity: 0.6;
}

 /* Play Widget */

 .widget-play {
    width: 148px;
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-align: stretch;
        -ms-flex-align: stretch;
            align-items: stretch;
}

 .widget-play .jupyter-button {
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    height: auto;
}

 .widget-play .jupyter-button:disabled {
    opacity: 0.6;
}

 /* Tab Widget */

 .jupyter-widgets.widget-tab {
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
}

 .jupyter-widgets.widget-tab > .p-TabBar {
    /* Necessary so that a tab can be shifted down to overlay the border of the box below. */
    overflow-x: visible;
    overflow-y: visible;
}

 .jupyter-widgets.widget-tab > .p-TabBar > .p-TabBar-content {
    /* Make sure that the tab grows from bottom up */
    -webkit-box-align: end;
        -ms-flex-align: end;
            align-items: flex-end;
    min-width: 0;
    min-height: 0;
}

 .jupyter-widgets.widget-tab > .widget-tab-contents {
    width: 100%;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    margin: 0;
    background: white;
    color: rgba(0, 0, 0, .8);
    border: 1px solid #9E9E9E;
    padding: 15px;
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    overflow: auto;
}

 .jupyter-widgets.widget-tab > .p-TabBar {
    font: 13px Helvetica, Arial, sans-serif;
    min-height: 25px;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab {
    -webkit-box-flex: 0;
        -ms-flex: 0 1 144px;
            flex: 0 1 144px;
    min-width: 35px;
    min-height: 25px;
    line-height: 24px;
    margin-left: -1px;
    padding: 0px 10px;
    background: #EEEEEE;
    color: rgba(0, 0, 0, .5);
    border: 1px solid #9E9E9E;
    border-bottom: none;
    position: relative;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab.p-mod-current {
    color: rgba(0, 0, 0, 1.0);
    /* We want the background to match the tab content background */
    background: white;
    min-height: 26px;
    -webkit-transform: translateY(1px);
            transform: translateY(1px);
    overflow: visible;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab.p-mod-current:before {
    position: absolute;
    top: -1px;
    left: -1px;
    content: '';
    height: 2px;
    width: calc(100% + 2px);
    background: #2196F3;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab:first-child {
    margin-left: 0;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab:hover:not(.p-mod-current) {
    background: white;
    color: rgba(0, 0, 0, .8);
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-mod-closable > .p-TabBar-tabCloseIcon {
    margin-left: 4px;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-mod-closable > .p-TabBar-tabCloseIcon:before {
    font-family: FontAwesome;
    content: '\f00d'; /* close */
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabIcon,
.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabLabel,
.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabCloseIcon {
    line-height: 24px;
}

 /* Accordion Widget */

 .p-Collapse {
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
    -webkit-box-align: stretch;
        -ms-flex-align: stretch;
            align-items: stretch;
}

 .p-Collapse-header {
    padding: 4px;
    cursor: pointer;
    color: rgba(0, 0, 0, .5);
    background-color: #EEEEEE;
    border: 1px solid #9E9E9E;
    padding: 10px 15px;
    font-weight: bold;
}

 .p-Collapse-header:hover {
    background-color: white;
    color: rgba(0, 0, 0, .8);
}

 .p-Collapse-open > .p-Collapse-header {
    background-color: white;
    color: rgba(0, 0, 0, 1.0);
    cursor: default;
    border-bottom: none;
}

 .p-Collapse .p-Collapse-header::before {
    content: '\f0da\00A0';  /* caret-right, non-breaking space */
    display: inline-block;
    font: normal normal normal 14px/1 FontAwesome;
    font-size: inherit;
    text-rendering: auto;
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
}

 .p-Collapse-open > .p-Collapse-header::before {
    content: '\f0d7\00A0'; /* caret-down, non-breaking space */
}

 .p-Collapse-contents {
    padding: 15px;
    background-color: white;
    color: rgba(0, 0, 0, .8);
    border-left: 1px solid #9E9E9E;
    border-right: 1px solid #9E9E9E;
    border-bottom: 1px solid #9E9E9E;
    overflow: auto;
}

 .p-Accordion {
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
    -webkit-box-align: stretch;
        -ms-flex-align: stretch;
            align-items: stretch;
}

 .p-Accordion .p-Collapse {
    margin-bottom: 0;
}

 .p-Accordion .p-Collapse + .p-Collapse {
    margin-top: 4px;
}

 /* HTML widget */

 .widget-html, .widget-htmlmath {
    font-size: 13px;
}

 .widget-html > .widget-html-content, .widget-htmlmath > .widget-html-content {
    /* Fill out the area in the HTML widget */
    -ms-flex-item-align: stretch;
        align-self: stretch;
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    -ms-flex-negative: 1;
        flex-shrink: 1;
    /* Makes sure the baseline is still aligned with other elements */
    line-height: 28px;
    /* Make it possible to have absolutely-positioned elements in the html */
    position: relative;
}

/*# sourceMappingURL=data:application/json;base64,{"version":3,"sources":["../node_modules/@jupyter-widgets/controls/css/widgets.css","../node_modules/@jupyter-widgets/controls/css/labvariables.css","../node_modules/@jupyter-widgets/controls/css/materialcolors.css","../node_modules/@jupyter-widgets/controls/css/widgets-base.css","../node_modules/@jupyter-widgets/controls/css/phosphor.css"],"names":[],"mappings":"AAAA;;GAEG;;CAEF;;kCAEiC;;CCNlC;;;+EAG+E;;CAE/E;;;;EAIE;;CCTF;;;;;;;;;;;;;;;;;;;;;;;;;;;;;GA6BG;;CDhBH;;;;;;;;;;;;;;;;;;;EAmBE;;CAGF;;GAEG;;CACF,yDAAyD;;CAC1D,yEAAyE;;CAEzE;;GAEG;;CAOH;;EAEE;;;KAGG;;EAQH;;;;IAIE,CAIwB,oBAAoB,CAGhB,0CAA0C;;EAGxE;;IAEE;;EAOF;;KAEG;;EAOH;;;IAGE,CAWwB,oBAAoB;;;EAU9C;;;;IAIE;;EAOF,kBAAkB;;EAYlB,+CAA+C;;EAsB/C,0BAA0B;EAa1B;4EAC0E;EAE1E;wEACsE;;EAGtE,8BAA8B;;EAK9B,6BAA6B;;EAI7B,6BAA6B;CAQ9B;;CEzMD;;GAEG;;CAEH;;;;GAIG;;CCRH;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;EA8BE;;CAEF;;;GAGG;;CAEH;EACE,qBAAc;EAAd,qBAAc;EAAd,cAAc;EACd,0BAA0B;EAC1B,uBAAuB;EACvB,sBAAsB;EACtB,kBAAkB;CACnB;;CAGD;EACE,+BAAoB;EAApB,8BAAoB;MAApB,wBAAoB;UAApB,oBAAoB;CACrB;;CAGD;EACE,6BAAuB;EAAvB,8BAAuB;MAAvB,2BAAuB;UAAvB,uBAAuB;CACxB;;CAGD;EACE,UAAU;EACV,WAAW;EACX,qBAAc;EAAd,qBAAc;EAAd,cAAc;EACd,oBAAe;MAAf,mBAAe;UAAf,eAAe;EACf,sBAAsB;CACvB;;CAGD;EACE,+BAAoB;EAApB,8BAAoB;MAApB,wBAAoB;UAApB,oBAAoB;CACrB;;CAGD;EACE,6BAAuB;EAAvB,8BAAuB;MAAvB,2BAAuB;UAAvB,uBAAuB;CACxB;;CAGD;EACE,qBAAc;EAAd,qBAAc;EAAd,cAAc;EACd,+BAAoB;EAApB,8BAAoB;MAApB,wBAAoB;UAApB,oBAAoB;EACpB,+BAAuB;UAAvB,uBAAuB;EACvB,iBAAiB;CAClB;;CAGD;;EAEE,oBAAe;MAAf,mBAAe;UAAf,eAAe;CAChB;;CAGD;EACE,oBAAe;MAAf,mBAAe;UAAf,eAAe;EACf,iBAAiB;EACjB,oBAAoB;CACrB;;CAGD;EACE,yBAAyB;CAC1B;;CAGD;EACE,mBAAmB;CACpB;;CAGD;EACE,QAAQ;EACR,oCAA4B;EAA5B,4BAA4B;CAC7B;;CAGD;EACE,OAAO;EACP,mCAA2B;EAA3B,2BAA2B;CAC5B;;CAGD;EACE,yBAAiB;EAAjB,iBAAiB;CAClB;;CAED,oBAAoB;;CD9GpB,QAUqC,oCAAoC;;IA2BrE,+BAA+B;CAIlC;;CAED;IACI,YAAiC;IACjC,+BAAuB;YAAvB,uBAAuB;IACvB,aAA+B;IAC/B,kBAAkB;CACrB;;CAED;IACI,kBAA6C;IAC7C,aAAwC;CAC3C;;CAED;IACI,eAAe;IACf,gBAAgB;CACnB;;CAED,mBAAmB;;CAEnB;IACI,wBAAwB;IACxB,+BAAuB;YAAvB,uBAAuB;IACvB,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,+BAAoB;IAApB,8BAAoB;QAApB,wBAAoB;YAApB,oBAAoB;IACpB,4BAAsB;QAAtB,yBAAsB;YAAtB,sBAAsB;CACzB;;CAED;IACI,sBAAsB;IACtB,+BAAuB;YAAvB,uBAAuB;IACvB,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;IACvB,0BAAoB;QAApB,uBAAoB;YAApB,oBAAoB;CACvB;;CAED;IACI,+BAAuB;YAAvB,uBAAuB;IACvB,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,UAAU;IACV,eAAe;CAClB;;CAED;IACI,+BAAuB;YAAvB,uBAAuB;IACvB,cAAc;IACd,UAAU;IACV,eAAe;CAClB;;CAED;IACI,+BAAoB;IAApB,8BAAoB;QAApB,wBAAoB;YAApB,oBAAoB;CACvB;;CAED;IACI,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;CAC1B;;CAED,4BAA4B;;CAE5B;IACI,mBAAmB;IACnB,oBAAoB;IACpB,iBAAiB;IACjB,oBAAoB;IACpB,sBAAsB;IACtB,oBAAoB;IACpB,iBAAiB;IACjB,wBAAwB;IACxB,mBAAmB;IACnB,gBAAuC;IACvC,gBAAgB;;IAEhB,aAAwC;IACxC,kBAAkB;IAClB,kBAA6C;IAC7C,yBAAiB;YAAjB,iBAAiB;;IAEjB,yBAAgC;IAChC,0BAA0C;IAC1C,sBAAsC;IACtC,aAAa;CAChB;;CAED;IACI,kBAA8C;IAC9C,qBAAqB;CACxB;;CAED;IACI,iBAAiB,CAAC,sBAAsB;CAC3C;;CAED;IACI,aAA4C;CAC/C;;CAED;IACI,gBAAgB;CACnB;;CAED;IACI,wBAAwB;IACxB;;+CAE+E;YAF/E;;+CAE+E;CAClF;;CAED;IACI,wBAAwB;IACxB;;iDAE6E;YAF7E;;iDAE6E;IAC7E,yBAAgC;IAChC,0BAA0C;CAC7C;;CAED;IACI,2BAA8D;CACjE;;CAED,8BAA8B;;CAE9B;IACI,gCAAwC;IACxC,0BAAyC;CAC5C;;CAED;IACI,8BAAwC;IACxC,0BAAyC;CAC5C;;CAED;IACI,8BAAwC;IACxC,0BAAyC;CAC5C;;CAED,8BAA8B;;CAE9B;IACI,gCAAwC;IACxC,0BAA2C;CAC9C;;CAED;IACI,8BAAwC;IACxC,0BAA2C;EAC7C;;CAEF;IACI,8BAAwC;IACxC,0BAA2C;EAC7C;;CAED,2BAA2B;;CAE5B;IACI,gCAAwC;IACxC,0BAAwC;CAC3C;;CAED;IACI,8BAAwC;IACxC,0BAAwC;CAC3C;;CAED;IACI,8BAAwC;IACxC,0BAAwC;CAC3C;;CAED,8BAA8B;;CAE9B;IACI,gCAAwC;IACxC,0BAAwC;CAC3C;;CAED;IACI,8BAAwC;IACxC,0BAAwC;CAC3C;;CAED;IACI,8BAAwC;IACxC,0BAAwC;CAC3C;;CAED,6BAA6B;;CAE7B;IACI,gCAAwC;IACxC,0BAAyC;CAC5C;;CAED;IACI,8BAAwC;IACxC,0BAAyC;CAC5C;;CAED;IACI,8BAAwC;IACxC,0BAAyC;CAC5C;;CAED,kBAAkB;;CAElB;IACI,aAA4C;CAC/C;;CAED,0BAA0B;;CAE1B,kCAAkC;;CAClC;IACI,iBAAuB;IAAvB,uBAAuB;CAC1B;;CAED;IACI,iBAAiB;IACjB,aAAqC;IACrC,gBAAuC;IACvC,iBAAiB;IACjB,wBAAwB;IACxB,oBAAoB;IACpB,kBAA6C;CAChD;;CAED;IACI,WAAW;IACX,aAAqC;IACrC,gBAAuC;IACvC,iBAAiB;IACjB,wBAAwB;IACxB,oBAAoB;IACpB,kBAA6C;CAChD;;CAED;IACI,6BAA6B;IAC7B,aAAqC;IACrC,kBAAkB;IAClB,kBAA0D;IAC1D,YAA4C;IAC5C,qBAAe;QAAf,eAAe;CAClB;;CAED;IACI,2BAA2B;IAC3B,aAAqC;IACrC,mBAAmB;IACnB,kBAA6C;CAChD;;CAED,4BAA4B;;CAE5B;IACI,aAAuC;IACvC,gBAAuC;IACvC,aAAwC;IACxC,kBAA6C;IAC7C,iBAAiB;IACjB,oBAAoB;IACpB,mBAAmB;CACtB;;CAED;IACI,yBAAyB;;IAEzB;;;;OAIG;IACH;;uDAEoD;;IAMpD;;+CAE4C;CAC/C;;CAED;IACI,wBAAwB;IACxB,mBAAmB;IACnB,iBAAgD;IAChD,gBAA+C;IAC/C,iBAA6C;CAChD;;CAED;IACI,sBAAsB;IACtB,gBAA4C;IAC5C,2BAA2B;IAC3B,eAAe;CAClB;;CAED,6BAA6B;;CAE7B;IACI,aAAsC;IACtC,aAAwC;IACxC,kBAA6C;CAChD;;CAED;IACI,wBAAgE;IAChE,kBAA6C;IAC7C,iBAAiB;IACjB,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,qBAAe;QAAf,eAAe;IACf,4BAAmB;QAAnB,mBAAmB;CACtB;;CAED,0BAA0B;;CAE1B;IACI,aAAwC;IACxC,kBAA6C;IAC7C,aAA4C;IAC5C,gBAAuC;CAC1C;;CAED;IACI,kBAA6C;IAC7C,kBAA8C;IAC9C,iBAA6C;;IAE7C,0JAA0J;IAC1J,sBAAsB;IACtB,8CAA8C;IAC9C,mBAAmB;IACnB,qBAAqB;IACrB,oCAAoC;IACpC,mCAAmC;CACtC;;CAED;IACI,iBAAiB;IACjB,aAAa;CAChB;;CAED;IACI,iBAAiB;IACjB,WAAW;CACd;;CAED;IACI,cAAc;CACjB;;CAED,qCAAqC;;CAErC;IACI,aAAsC;CACzC;;CAED;IACI,aAAwC;IACxC,kBAA6C;CAChD;;CAED;IACI,aAA4C;CAC/C;;CAED;IACI,+BAAuB;YAAvB,uBAAuB;IACvB,0BAAwF;IACxF,wBAA2D;IAC3D,yBAAqC;IACrC,gBAAuC;IACvC,iBAAsF;IACtF,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,aAAa,CAAC,iEAAiE;IAC/E,qBAAe;QAAf,eAAe;IACf,yBAAyB;CAC5B;;CAED;IACI,gBAAgB;IAChB,eAAe;CAClB;;CAED;IACI,sBAAyD;CAC5D;;CAED,mBAAmB;;CAEnB;IACI,kBAAkB;IAClB,0BAA4E;IAC5E,oBAAoC;IACpC,+BAAuB;YAAvB,uBAAuB;IACvB,mBAAmB;IACnB,mBAAmB;CACtB;;CAED;IACI,mBAAmB;IACnB,yBAAyB,CAAC,oDAAoD;IAC9E,mBAAmB;IACnB,wBAAmE;IACnE,0BAAiG;IACjG,+BAAuB;YAAvB,uBAAuB;IACvB,WAAW;IACX,uBAAuB,CAAC,wBAAwB;CACnD;;CAED,wBAAwB;;CACxB;IACI,0BAA+D;IAC/D,0BAAiG;CACpG;;CAED;IACI,0BAA+D;IAC/D,sBAA2D;IAC3D,WAAW;IACX,8BAAsB;YAAtB,sBAAsB;CACzB;;CAED;IACI,iEAAiE;IACjE,mBAAmB;IACnB,oBAAyD;IACzD,WAAW;CACd;;CAED,8BAA8B;;CAE9B;IACI,YAA4C;IAC5C,aAA6C;IAC7C,iBAAgJ;IAChJ,kBAAqG;IACrG,mBAAmB;IACnB,OAAO;CACV;;CAED;IACI,YAA4C;IAC5C,aAA6C;IAC7C,oBAAuG;IACvG,kBAAiJ;IACjJ,mBAAmB;IACnB,QAAQ;CACX;;CAED;IACI,YAA6D;IAC7D,iBAAyJ;CAC5J;;CAED;IACI,WAA4D;IAC5D,kBAA0J;CAC7J;;CAED,uBAAuB;;CAEvB;IACI,aAAsC;IACtC,aAAwC;IACxC,kBAA6C;;IAE7C;;oDAEgD;IAChD,0BAAoB;QAApB,uBAAoB;YAApB,oBAAoB;CACvB;;CAED;IACI,kBAAkB;CACrB;;CAED;IACI,aAAwC;IACxC,iBAAwG;IACxG,kBAAyG;IACzG,oBAA+C;QAA/C,oBAA+C;YAA/C,gBAA+C;CAClD;;CAED;IACI,gCAAgC;IAChC,YAAiD;IACjD,iBAAmG;IACnG,YAAY;CACf;;CAED,qBAAqB;;CAErB;IACI,aAAwC;IACxC,kBAA6C;CAChD;;CAED;IACI,qBAAqB;IACrB,cAA0C;IAC1C,YAA2C;CAC9C;;CAED;IACI,oBAA+C;QAA/C,oBAA+C;YAA/C,gBAA+C;IAC/C,kBAAkB;IAClB,mBAAmB;IACnB,mBAA0G;IAC1G,gBAAuG;IACvG,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;CAC1B;;CAED;IACI,gCAAgC;IAChC,WAAgD;IAChD,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,kBAAkB;IAClB,mBAAmB;CACtB;;CAED,6BAA6B;;CAE7B;IACI,yBAAyB;IAIzB,iBAAiB;CACpB;;CAED;IACI,aAAwC;CAC3C;;CAED;IACI,0BAAyC;CAC5C;;CAED;IACI,0BAA2C;CAC9C;;CAED;IACI,0BAAwC;CAC3C;;CAED;IACI,0BAAwC;CAC3C;;CAED;IACI,0BAAyC;CAC5C;;CAED;IACI,0BAA0C;IAC1C,aAAa;IACb,yBAAiB;YAAjB,iBAAiB;CACpB;;CAED,yBAAyB;;CAEzB;IACI,kBAAkB;IAClB,aAAwC;IACxC,kBAA6C;IAC7C,aAAsC;IACtC,0BAAoB;QAApB,uBAAoB;YAApB,oBAAoB;;CAEvB;;CAED;IACI,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,gBAA4C;IAC5C,mBAA+C;IAC/C,6BAAoB;QAApB,oBAAoB;IACpB,8BAA8B;IAC9B,aAAgB;IAAhB,gBAAgB;CACnB;;CAED,uBAAuB;;CAEvB;IACI,cAA0C;IAC1C,YAA2C;CAC9C;;CAED;IACI,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,YAA4C;IAC5C,kBAAkB;IAClB,mBAAmB;IACnB,iBAAiB;CACpB;;CAED,2BAA2B;;CAE3B;IACI,aAAwC;IACxC,aAAsC;IACtC,kBAA6C;CAChD;;CAED;IACI,oBAAoB;IACpB,0BAAwF;IACxF,iBAAiB;IACjB,gBAAgB;IAChB,oBAA+C;QAA/C,oBAA+C;YAA/C,gBAA+C;IAC/C,aAAa,CAAC,iEAAiE;IAC/E,+BAAuB;YAAvB,uBAAuB;IACvB,yBAAyB;IACzB,yBAAiB;YAAjB,iBAAiB;IACjB,wBAA2D;IAC3D,yBAAqC;IACrC,gBAAuC;IACvC,oBAAoB;IACpB,kBAAyD;CAC5D,iBAAiB;CACjB,yBAAyB;CACzB,sBAAsB;IACnB,6BAA6B;CAChC,sBAAsB;CACtB,kCAAkC;IAC/B,kuBAAmD;CACtD;;CACD;IACI,sBAAyD;CAC5D;;CAED;IACI,aAA4C;CAC/C;;CAED;6CAC6C;;CAC7C;IACI,mBAAmB;IACnB,wBAAwB;CAC3B;;CAED,+BAA+B;;CAE/B;IACI,aAAsC;IACtC,kBAA6C;;IAE7C;;kEAE8D;IAC9D,yBAAwB;QAAxB,sBAAwB;YAAxB,wBAAwB;CAC3B;;CAED;IACI,0BAAwF;IACxF,wBAA2D;IAC3D,yBAAqC;IACrC,gBAAuC;IACvC,oBAA+C;QAA/C,oBAA+C;YAA/C,gBAA+C;IAC/C,yBAAyB;IACzB,eAAe;IACf,gBAAgB;;IAEhB;;kEAE8D;IAC9D,iBAAiB;CACpB;;CAED;IACI,sBAAyD;CAC5D;;CAED;IACI,kBAA8C;IAC9C,kBAA6C;IAC7C,kEAAkE;IAClE,0DAAiF;IACjF,6DAAoF;CACvF;;CAID,4BAA4B;;CAE5B;IACI,kBAA6C;CAChD;;CAED;IACI,iBAAsC;IACtC,kBAAuC;CAC1C;;CAED;IACI,aAA4C;CAC/C;;CAED,2BAA2B;;CAE3B;IACI,aAAsC;IACtC,kBAA6C;CAChD;;CAED;IACI,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;IACvB,2BAAqB;QAArB,wBAAqB;YAArB,qBAAqB;IACrB,+BAAuB;YAAvB,uBAAuB;IACvB,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,mBAA8D;CACjE;;CAED;IACI,aAA4C;IAC5C,kBAAiD;IACjD,gBAAuC;CAC1C;;CAED;IACI,aAA4C;IAC5C,kBAAiD;IACjD,oBAA4D;IAC5D,YAAY;CACf;;CAED,0BAA0B;;CAE1B;IACI,aAAsC;IACtC,aAAwC;IACxC,kBAA6C;CAChD;;CAED;IACI,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,qBAAe;QAAf,eAAe;IACf,gBAA+C;CAClD;;CAED;IACI,YAAuC;IACvC,aAAwC;IACxC,eAAe,CAAC,6DAA6D;IAC7E,kBAAqD;IACrD,yBAAqC;IACrC,0BAAwF;IACxF,kBAAkB;IAClB,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,qBAAe;QAAf,eAAe;IACf,+BAAuB;YAAvB,uBAAuB;IACvB,6BAAoB;QAApB,oBAAoB;IACpB,yBAAyB;CAC5B;;CAED;IACI,+BAA6F;CAChG;;CAED;IACI,sBAAyD;CAC5D;;CAED;IACI,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,yBAAyB;IACzB,aAAwC;IACxC,kBAA6C;IAC7C,kBAAqD;IACrD,yBAAqC;IACrC,0BAAwF;IACxF,gBAAuC;IACvC,iBAAsF;IACtF,aAAa,CAAC,iEAAiE;IAC/E,qBAAe;QAAf,eAAe;IACf,+BAAuB;YAAvB,uBAAuB;CAC1B;;CAED;IACI,aAA4C;CAC/C;;CAED,yBAAyB;;CAEzB;IACI,aAAsC;IACtC,aAAwC;IACxC,kBAA6C;CAChD;;CAED;IACI,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,qBAAe;QAAf,eAAe;IACf,aAAa,CAAC,iEAAiE;IAC/E,yBAAyB;IACzB,aAAwC;IACxC,0BAAwF;IACxF,wBAA2D;IAC3D,yBAAqC;IACrC,gBAAuC;IACvC,iBAAsF;IACtF,+BAAuB;YAAvB,uBAAuB;CAC1B;;CAED;IACI,sBAAyD;CAC5D;;CAED;IACI,sBAAoC;CACvC;;CAED;IACI,aAA4C;CAC/C;;CAED,iBAAiB;;CAEjB;IACI,aAA4C;IAC5C,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,2BAAqB;QAArB,wBAAqB;YAArB,qBAAqB;CACxB;;CAED;IACI,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,aAAa;CAChB;;CAED;IACI,aAA4C;CAC/C;;CAED,gBAAgB;;CAEhB;IACI,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;CAC1B;;CAED;IACI,yFAAyF;IACzF,oBAAoB;IACpB,oBAAoB;CACvB;;CAED;IACI,iDAAiD;IACjD,uBAAsB;QAAtB,oBAAsB;YAAtB,sBAAsB;IACtB,aAAa;IACb,cAAc;CACjB;;CAED;IACI,YAAY;IACZ,+BAAuB;YAAvB,uBAAuB;IACvB,UAAU;IACV,kBAAoC;IACpC,yBAAgC;IAChC,0BAA6D;IAC7D,cAA6C;IAC7C,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,eAAe;CAClB;;CAED;IACI,wCAA+D;IAC/D,iBAAmF;CACtF;;CAED;IACI,oBAAiD;QAAjD,oBAAiD;YAAjD,gBAAiD;IACjD,gBAAgB;IAChB,iBAAmF;IACnF,kBAAqD;IACrD,kBAA+C;IAC/C,kBAAkB;IAClB,oBAAoC;IACpC,yBAAgC;IAChC,0BAA6D;IAC7D,oBAAoB;IACpB,mBAAmB;CACtB;;CAED;IACI,0BAAgC;IAChC,gEAAgE;IAChE,kBAAoC;IACpC,iBAAuF;IACvF,mCAA8C;YAA9C,2BAA8C;IAC9C,kBAAkB;CACrB;;CAED;IACI,mBAAmB;IACnB,UAAuC;IACvC,WAAwC;IACxC,YAAY;IACZ,YAAoD;IACpD,wBAA+C;IAC/C,oBAAmC;CACtC;;CAED;IACI,eAAe;CAClB;;CAED;IACI,kBAAoC;IACpC,yBAAgC;CACnC;;CAED;IACI,iBAAiB;CACpB;;CAED;IACI,yBAAyB;IACzB,iBAAiB,CAAC,WAAW;CAChC;;CAED;;;IAGI,kBAAqD;CACxD;;CAED,sBAAsB;;CAEtB;IACI,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;IACvB,2BAAqB;QAArB,wBAAqB;YAArB,qBAAqB;CACxB;;CAED;IACI,aAAyC;IACzC,gBAAgB;IAChB,yBAAgC;IAChC,0BAA0C;IAC1C,0BAAqE;IACrE,mBAA+F;IAC/F,kBAAkB;CACrB;;CAED;IACI,wBAA0C;IAC1C,yBAAgC;CACnC;;CAED;IACI,wBAA0C;IAC1C,0BAAgC;IAChC,gBAAgB;IAChB,oBAAoB;CACvB;;CAED;IACI,sBAAsB,EAAE,qCAAqC;IAC7D,sBAAsB;IACtB,8CAA8C;IAC9C,mBAAmB;IACnB,qBAAqB;IACrB,oCAAoC;IACpC,mCAAmC;CACtC;;CAED;IACI,sBAAsB,CAAC,oCAAoC;CAC9D;;CAED;IACI,cAA6C;IAC7C,wBAA0C;IAC1C,yBAAgC;IAChC,+BAA0E;IAC1E,gCAA2E;IAC3E,iCAA4E;IAC5E,eAAe;CAClB;;CAED;IACI,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;IACvB,2BAAqB;QAArB,wBAAqB;YAArB,qBAAqB;CACxB;;CAED;IACI,iBAAiB;CACpB;;CAED;IACI,gBAAgB;CACnB;;CAID,iBAAiB;;CAEjB;IACI,gBAAuC;CAC1C;;CAED;IACI,0CAA0C;IAC1C,6BAAoB;QAApB,oBAAoB;IACpB,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,qBAAe;QAAf,eAAe;IACf,kEAAkE;IAClE,kBAA6C;IAC7C,yEAAyE;IACzE,mBAAmB;CACtB","file":"controls.css","sourcesContent":["/* Copyright (c) Jupyter Development Team.\n * Distributed under the terms of the Modified BSD License.\n */\n\n /* We import all of these together in a single css file because the Webpack\nloader sees only one file at a time. This allows postcss to see the variable\ndefinitions when they are used. */\n\n@import \"./labvariables.css\";\n@import \"./widgets-base.css\";\n","/*-----------------------------------------------------------------------------\n| Copyright (c) Jupyter Development Team.\n| Distributed under the terms of the Modified BSD License.\n|----------------------------------------------------------------------------*/\n\n/*\nThis file is copied from the JupyterLab project to define default styling for\nwhen the widget styling is compiled down to eliminate CSS variables. We make one\nchange - we comment out the font import below.\n*/\n\n@import \"./materialcolors.css\";\n\n/*\nThe following CSS variables define the main, public API for styling JupyterLab.\nThese variables should be used by all plugins wherever possible. In other\nwords, plugins should not define custom colors, sizes, etc unless absolutely\nnecessary. This enables users to change the visual theme of JupyterLab\nby changing these variables.\n\nMany variables appear in an ordered sequence (0,1,2,3). These sequences\nare designed to work well together, so for example, `--jp-border-color1` should\nbe used with `--jp-layout-color1`. The numbers have the following meanings:\n\n* 0: super-primary, reserved for special emphasis\n* 1: primary, most important under normal situations\n* 2: secondary, next most important under normal situations\n* 3: tertiary, next most important under normal situations\n\nThroughout JupyterLab, we are mostly following principles from Google's\nMaterial Design when selecting colors. We are not, however, following\nall of MD as it is not optimized for dense, information rich UIs.\n*/\n\n\n/*\n * Optional monospace font for input/output prompt.\n */\n /* Commented out in ipywidgets since we don't need it. */\n/* @import url('https://fonts.googleapis.com/css?family=Roboto+Mono'); */\n\n/*\n * Added for compabitility with output area\n */\n:root {\n  --jp-icon-search: none;\n  --jp-ui-select-caret: none;\n}\n\n\n:root {\n\n  /* Borders\n\n  The following variables, specify the visual styling of borders in JupyterLab.\n   */\n\n  --jp-border-width: 1px;\n  --jp-border-color0: var(--md-grey-700);\n  --jp-border-color1: var(--md-grey-500);\n  --jp-border-color2: var(--md-grey-300);\n  --jp-border-color3: var(--md-grey-100);\n\n  /* UI Fonts\n\n  The UI font CSS variables are used for the typography all of the JupyterLab\n  user interface elements that are not directly user generated content.\n  */\n\n  --jp-ui-font-scale-factor: 1.2;\n  --jp-ui-font-size0: calc(var(--jp-ui-font-size1)/var(--jp-ui-font-scale-factor));\n  --jp-ui-font-size1: 13px; /* Base font size */\n  --jp-ui-font-size2: calc(var(--jp-ui-font-size1)*var(--jp-ui-font-scale-factor));\n  --jp-ui-font-size3: calc(var(--jp-ui-font-size2)*var(--jp-ui-font-scale-factor));\n  --jp-ui-icon-font-size: 14px; /* Ensures px perfect FontAwesome icons */\n  --jp-ui-font-family: \"Helvetica Neue\", Helvetica, Arial, sans-serif;\n\n  /* Use these font colors against the corresponding main layout colors.\n     In a light theme, these go from dark to light.\n  */\n\n  --jp-ui-font-color0: rgba(0,0,0,1.0);\n  --jp-ui-font-color1: rgba(0,0,0,0.8);\n  --jp-ui-font-color2: rgba(0,0,0,0.5);\n  --jp-ui-font-color3: rgba(0,0,0,0.3);\n\n  /* Use these against the brand/accent/warn/error colors.\n     These will typically go from light to darker, in both a dark and light theme\n   */\n\n  --jp-inverse-ui-font-color0: rgba(255,255,255,1);\n  --jp-inverse-ui-font-color1: rgba(255,255,255,1.0);\n  --jp-inverse-ui-font-color2: rgba(255,255,255,0.7);\n  --jp-inverse-ui-font-color3: rgba(255,255,255,0.5);\n\n  /* Content Fonts\n\n  Content font variables are used for typography of user generated content.\n  */\n\n  --jp-content-font-size: 13px;\n  --jp-content-line-height: 1.5;\n  --jp-content-font-color0: black;\n  --jp-content-font-color1: black;\n  --jp-content-font-color2: var(--md-grey-700);\n  --jp-content-font-color3: var(--md-grey-500);\n\n  --jp-ui-font-scale-factor: 1.2;\n  --jp-ui-font-size0: calc(var(--jp-ui-font-size1)/var(--jp-ui-font-scale-factor));\n  --jp-ui-font-size1: 13px; /* Base font size */\n  --jp-ui-font-size2: calc(var(--jp-ui-font-size1)*var(--jp-ui-font-scale-factor));\n  --jp-ui-font-size3: calc(var(--jp-ui-font-size2)*var(--jp-ui-font-scale-factor));\n\n  --jp-code-font-size: 13px;\n  --jp-code-line-height: 1.307;\n  --jp-code-padding: 5px;\n  --jp-code-font-family: monospace;\n\n\n  /* Layout\n\n  The following are the main layout colors use in JupyterLab. In a light\n  theme these would go from light to dark.\n  */\n\n  --jp-layout-color0: white;\n  --jp-layout-color1: white;\n  --jp-layout-color2: var(--md-grey-200);\n  --jp-layout-color3: var(--md-grey-400);\n\n  /* Brand/accent */\n\n  --jp-brand-color0: var(--md-blue-700);\n  --jp-brand-color1: var(--md-blue-500);\n  --jp-brand-color2: var(--md-blue-300);\n  --jp-brand-color3: var(--md-blue-100);\n\n  --jp-accent-color0: var(--md-green-700);\n  --jp-accent-color1: var(--md-green-500);\n  --jp-accent-color2: var(--md-green-300);\n  --jp-accent-color3: var(--md-green-100);\n\n  /* State colors (warn, error, success, info) */\n\n  --jp-warn-color0: var(--md-orange-700);\n  --jp-warn-color1: var(--md-orange-500);\n  --jp-warn-color2: var(--md-orange-300);\n  --jp-warn-color3: var(--md-orange-100);\n\n  --jp-error-color0: var(--md-red-700);\n  --jp-error-color1: var(--md-red-500);\n  --jp-error-color2: var(--md-red-300);\n  --jp-error-color3: var(--md-red-100);\n\n  --jp-success-color0: var(--md-green-700);\n  --jp-success-color1: var(--md-green-500);\n  --jp-success-color2: var(--md-green-300);\n  --jp-success-color3: var(--md-green-100);\n\n  --jp-info-color0: var(--md-cyan-700);\n  --jp-info-color1: var(--md-cyan-500);\n  --jp-info-color2: var(--md-cyan-300);\n  --jp-info-color3: var(--md-cyan-100);\n\n  /* Cell specific styles */\n\n  --jp-cell-padding: 5px;\n  --jp-cell-editor-background: #f7f7f7;\n  --jp-cell-editor-border-color: #cfcfcf;\n  --jp-cell-editor-background-edit: var(--jp-ui-layout-color1);\n  --jp-cell-editor-border-color-edit: var(--jp-brand-color1);\n  --jp-cell-prompt-width: 100px;\n  --jp-cell-prompt-font-family: 'Roboto Mono', monospace;\n  --jp-cell-prompt-letter-spacing: 0px;\n  --jp-cell-prompt-opacity: 1.0;\n  --jp-cell-prompt-opacity-not-active: 0.4;\n  --jp-cell-prompt-font-color-not-active: var(--md-grey-700);\n  /* A custom blend of MD grey and blue 600\n   * See https://meyerweb.com/eric/tools/color-blend/#546E7A:1E88E5:5:hex */\n  --jp-cell-inprompt-font-color: #307FC1;\n  /* A custom blend of MD grey and orange 600\n   * https://meyerweb.com/eric/tools/color-blend/#546E7A:F4511E:5:hex */\n  --jp-cell-outprompt-font-color: #BF5B3D;\n\n  /* Notebook specific styles */\n\n  --jp-notebook-padding: 10px;\n  --jp-notebook-scroll-padding: 100px;\n\n  /* Console specific styles */\n\n  --jp-console-background: var(--md-grey-100);\n\n  /* Toolbar specific styles */\n\n  --jp-toolbar-border-color: var(--md-grey-400);\n  --jp-toolbar-micro-height: 8px;\n  --jp-toolbar-background: var(--jp-layout-color0);\n  --jp-toolbar-box-shadow: 0px 0px 2px 0px rgba(0,0,0,0.24);\n  --jp-toolbar-header-margin: 4px 4px 0px 4px;\n  --jp-toolbar-active-background: var(--md-grey-300);\n}\n","/**\n * The material design colors are adapted from google-material-color v1.2.6\n * https://github.com/danlevan/google-material-color\n * https://github.com/danlevan/google-material-color/blob/f67ca5f4028b2f1b34862f64b0ca67323f91b088/dist/palette.var.css\n *\n * The license for the material design color CSS variables is as follows (see\n * https://github.com/danlevan/google-material-color/blob/f67ca5f4028b2f1b34862f64b0ca67323f91b088/LICENSE)\n *\n * The MIT License (MIT)\n *\n * Copyright (c) 2014 Dan Le Van\n *\n * Permission is hereby granted, free of charge, to any person obtaining a copy\n * of this software and associated documentation files (the \"Software\"), to deal\n * in the Software without restriction, including without limitation the rights\n * to use, copy, modify, merge, publish, distribute, sublicense, and/or sell\n * copies of the Software, and to permit persons to whom the Software is\n * furnished to do so, subject to the following conditions:\n *\n * The above copyright notice and this permission notice shall be included in\n * all copies or substantial portions of the Software.\n *\n * THE SOFTWARE IS PROVIDED \"AS IS\", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR\n * IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,\n * FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE\n * AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER\n * LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,\n * OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE\n * SOFTWARE.\n */\n:root {\n  --md-red-50: #FFEBEE;\n  --md-red-100: #FFCDD2;\n  --md-red-200: #EF9A9A;\n  --md-red-300: #E57373;\n  --md-red-400: #EF5350;\n  --md-red-500: #F44336;\n  --md-red-600: #E53935;\n  --md-red-700: #D32F2F;\n  --md-red-800: #C62828;\n  --md-red-900: #B71C1C;\n  --md-red-A100: #FF8A80;\n  --md-red-A200: #FF5252;\n  --md-red-A400: #FF1744;\n  --md-red-A700: #D50000;\n\n  --md-pink-50: #FCE4EC;\n  --md-pink-100: #F8BBD0;\n  --md-pink-200: #F48FB1;\n  --md-pink-300: #F06292;\n  --md-pink-400: #EC407A;\n  --md-pink-500: #E91E63;\n  --md-pink-600: #D81B60;\n  --md-pink-700: #C2185B;\n  --md-pink-800: #AD1457;\n  --md-pink-900: #880E4F;\n  --md-pink-A100: #FF80AB;\n  --md-pink-A200: #FF4081;\n  --md-pink-A400: #F50057;\n  --md-pink-A700: #C51162;\n\n  --md-purple-50: #F3E5F5;\n  --md-purple-100: #E1BEE7;\n  --md-purple-200: #CE93D8;\n  --md-purple-300: #BA68C8;\n  --md-purple-400: #AB47BC;\n  --md-purple-500: #9C27B0;\n  --md-purple-600: #8E24AA;\n  --md-purple-700: #7B1FA2;\n  --md-purple-800: #6A1B9A;\n  --md-purple-900: #4A148C;\n  --md-purple-A100: #EA80FC;\n  --md-purple-A200: #E040FB;\n  --md-purple-A400: #D500F9;\n  --md-purple-A700: #AA00FF;\n\n  --md-deep-purple-50: #EDE7F6;\n  --md-deep-purple-100: #D1C4E9;\n  --md-deep-purple-200: #B39DDB;\n  --md-deep-purple-300: #9575CD;\n  --md-deep-purple-400: #7E57C2;\n  --md-deep-purple-500: #673AB7;\n  --md-deep-purple-600: #5E35B1;\n  --md-deep-purple-700: #512DA8;\n  --md-deep-purple-800: #4527A0;\n  --md-deep-purple-900: #311B92;\n  --md-deep-purple-A100: #B388FF;\n  --md-deep-purple-A200: #7C4DFF;\n  --md-deep-purple-A400: #651FFF;\n  --md-deep-purple-A700: #6200EA;\n\n  --md-indigo-50: #E8EAF6;\n  --md-indigo-100: #C5CAE9;\n  --md-indigo-200: #9FA8DA;\n  --md-indigo-300: #7986CB;\n  --md-indigo-400: #5C6BC0;\n  --md-indigo-500: #3F51B5;\n  --md-indigo-600: #3949AB;\n  --md-indigo-700: #303F9F;\n  --md-indigo-800: #283593;\n  --md-indigo-900: #1A237E;\n  --md-indigo-A100: #8C9EFF;\n  --md-indigo-A200: #536DFE;\n  --md-indigo-A400: #3D5AFE;\n  --md-indigo-A700: #304FFE;\n\n  --md-blue-50: #E3F2FD;\n  --md-blue-100: #BBDEFB;\n  --md-blue-200: #90CAF9;\n  --md-blue-300: #64B5F6;\n  --md-blue-400: #42A5F5;\n  --md-blue-500: #2196F3;\n  --md-blue-600: #1E88E5;\n  --md-blue-700: #1976D2;\n  --md-blue-800: #1565C0;\n  --md-blue-900: #0D47A1;\n  --md-blue-A100: #82B1FF;\n  --md-blue-A200: #448AFF;\n  --md-blue-A400: #2979FF;\n  --md-blue-A700: #2962FF;\n\n  --md-light-blue-50: #E1F5FE;\n  --md-light-blue-100: #B3E5FC;\n  --md-light-blue-200: #81D4FA;\n  --md-light-blue-300: #4FC3F7;\n  --md-light-blue-400: #29B6F6;\n  --md-light-blue-500: #03A9F4;\n  --md-light-blue-600: #039BE5;\n  --md-light-blue-700: #0288D1;\n  --md-light-blue-800: #0277BD;\n  --md-light-blue-900: #01579B;\n  --md-light-blue-A100: #80D8FF;\n  --md-light-blue-A200: #40C4FF;\n  --md-light-blue-A400: #00B0FF;\n  --md-light-blue-A700: #0091EA;\n\n  --md-cyan-50: #E0F7FA;\n  --md-cyan-100: #B2EBF2;\n  --md-cyan-200: #80DEEA;\n  --md-cyan-300: #4DD0E1;\n  --md-cyan-400: #26C6DA;\n  --md-cyan-500: #00BCD4;\n  --md-cyan-600: #00ACC1;\n  --md-cyan-700: #0097A7;\n  --md-cyan-800: #00838F;\n  --md-cyan-900: #006064;\n  --md-cyan-A100: #84FFFF;\n  --md-cyan-A200: #18FFFF;\n  --md-cyan-A400: #00E5FF;\n  --md-cyan-A700: #00B8D4;\n\n  --md-teal-50: #E0F2F1;\n  --md-teal-100: #B2DFDB;\n  --md-teal-200: #80CBC4;\n  --md-teal-300: #4DB6AC;\n  --md-teal-400: #26A69A;\n  --md-teal-500: #009688;\n  --md-teal-600: #00897B;\n  --md-teal-700: #00796B;\n  --md-teal-800: #00695C;\n  --md-teal-900: #004D40;\n  --md-teal-A100: #A7FFEB;\n  --md-teal-A200: #64FFDA;\n  --md-teal-A400: #1DE9B6;\n  --md-teal-A700: #00BFA5;\n\n  --md-green-50: #E8F5E9;\n  --md-green-100: #C8E6C9;\n  --md-green-200: #A5D6A7;\n  --md-green-300: #81C784;\n  --md-green-400: #66BB6A;\n  --md-green-500: #4CAF50;\n  --md-green-600: #43A047;\n  --md-green-700: #388E3C;\n  --md-green-800: #2E7D32;\n  --md-green-900: #1B5E20;\n  --md-green-A100: #B9F6CA;\n  --md-green-A200: #69F0AE;\n  --md-green-A400: #00E676;\n  --md-green-A700: #00C853;\n\n  --md-light-green-50: #F1F8E9;\n  --md-light-green-100: #DCEDC8;\n  --md-light-green-200: #C5E1A5;\n  --md-light-green-300: #AED581;\n  --md-light-green-400: #9CCC65;\n  --md-light-green-500: #8BC34A;\n  --md-light-green-600: #7CB342;\n  --md-light-green-700: #689F38;\n  --md-light-green-800: #558B2F;\n  --md-light-green-900: #33691E;\n  --md-light-green-A100: #CCFF90;\n  --md-light-green-A200: #B2FF59;\n  --md-light-green-A400: #76FF03;\n  --md-light-green-A700: #64DD17;\n\n  --md-lime-50: #F9FBE7;\n  --md-lime-100: #F0F4C3;\n  --md-lime-200: #E6EE9C;\n  --md-lime-300: #DCE775;\n  --md-lime-400: #D4E157;\n  --md-lime-500: #CDDC39;\n  --md-lime-600: #C0CA33;\n  --md-lime-700: #AFB42B;\n  --md-lime-800: #9E9D24;\n  --md-lime-900: #827717;\n  --md-lime-A100: #F4FF81;\n  --md-lime-A200: #EEFF41;\n  --md-lime-A400: #C6FF00;\n  --md-lime-A700: #AEEA00;\n\n  --md-yellow-50: #FFFDE7;\n  --md-yellow-100: #FFF9C4;\n  --md-yellow-200: #FFF59D;\n  --md-yellow-300: #FFF176;\n  --md-yellow-400: #FFEE58;\n  --md-yellow-500: #FFEB3B;\n  --md-yellow-600: #FDD835;\n  --md-yellow-700: #FBC02D;\n  --md-yellow-800: #F9A825;\n  --md-yellow-900: #F57F17;\n  --md-yellow-A100: #FFFF8D;\n  --md-yellow-A200: #FFFF00;\n  --md-yellow-A400: #FFEA00;\n  --md-yellow-A700: #FFD600;\n\n  --md-amber-50: #FFF8E1;\n  --md-amber-100: #FFECB3;\n  --md-amber-200: #FFE082;\n  --md-amber-300: #FFD54F;\n  --md-amber-400: #FFCA28;\n  --md-amber-500: #FFC107;\n  --md-amber-600: #FFB300;\n  --md-amber-700: #FFA000;\n  --md-amber-800: #FF8F00;\n  --md-amber-900: #FF6F00;\n  --md-amber-A100: #FFE57F;\n  --md-amber-A200: #FFD740;\n  --md-amber-A400: #FFC400;\n  --md-amber-A700: #FFAB00;\n\n  --md-orange-50: #FFF3E0;\n  --md-orange-100: #FFE0B2;\n  --md-orange-200: #FFCC80;\n  --md-orange-300: #FFB74D;\n  --md-orange-400: #FFA726;\n  --md-orange-500: #FF9800;\n  --md-orange-600: #FB8C00;\n  --md-orange-700: #F57C00;\n  --md-orange-800: #EF6C00;\n  --md-orange-900: #E65100;\n  --md-orange-A100: #FFD180;\n  --md-orange-A200: #FFAB40;\n  --md-orange-A400: #FF9100;\n  --md-orange-A700: #FF6D00;\n\n  --md-deep-orange-50: #FBE9E7;\n  --md-deep-orange-100: #FFCCBC;\n  --md-deep-orange-200: #FFAB91;\n  --md-deep-orange-300: #FF8A65;\n  --md-deep-orange-400: #FF7043;\n  --md-deep-orange-500: #FF5722;\n  --md-deep-orange-600: #F4511E;\n  --md-deep-orange-700: #E64A19;\n  --md-deep-orange-800: #D84315;\n  --md-deep-orange-900: #BF360C;\n  --md-deep-orange-A100: #FF9E80;\n  --md-deep-orange-A200: #FF6E40;\n  --md-deep-orange-A400: #FF3D00;\n  --md-deep-orange-A700: #DD2C00;\n\n  --md-brown-50: #EFEBE9;\n  --md-brown-100: #D7CCC8;\n  --md-brown-200: #BCAAA4;\n  --md-brown-300: #A1887F;\n  --md-brown-400: #8D6E63;\n  --md-brown-500: #795548;\n  --md-brown-600: #6D4C41;\n  --md-brown-700: #5D4037;\n  --md-brown-800: #4E342E;\n  --md-brown-900: #3E2723;\n\n  --md-grey-50: #FAFAFA;\n  --md-grey-100: #F5F5F5;\n  --md-grey-200: #EEEEEE;\n  --md-grey-300: #E0E0E0;\n  --md-grey-400: #BDBDBD;\n  --md-grey-500: #9E9E9E;\n  --md-grey-600: #757575;\n  --md-grey-700: #616161;\n  --md-grey-800: #424242;\n  --md-grey-900: #212121;\n\n  --md-blue-grey-50: #ECEFF1;\n  --md-blue-grey-100: #CFD8DC;\n  --md-blue-grey-200: #B0BEC5;\n  --md-blue-grey-300: #90A4AE;\n  --md-blue-grey-400: #78909C;\n  --md-blue-grey-500: #607D8B;\n  --md-blue-grey-600: #546E7A;\n  --md-blue-grey-700: #455A64;\n  --md-blue-grey-800: #37474F;\n  --md-blue-grey-900: #263238;\n}","/* Copyright (c) Jupyter Development Team.\n * Distributed under the terms of the Modified BSD License.\n */\n\n/*\n * We assume that the CSS variables in\n * https://github.com/jupyterlab/jupyterlab/blob/master/src/default-theme/variables.css\n * have been defined.\n */\n\n@import \"./phosphor.css\";\n\n:root {\n    --jp-widgets-color: var(--jp-content-font-color1);\n    --jp-widgets-label-color: var(--jp-widgets-color);\n    --jp-widgets-readout-color: var(--jp-widgets-color);\n    --jp-widgets-font-size: var(--jp-ui-font-size1);\n    --jp-widgets-margin: 2px;\n    --jp-widgets-inline-height: 28px;\n    --jp-widgets-inline-width: 300px;\n    --jp-widgets-inline-width-short: calc(var(--jp-widgets-inline-width) / 2 - var(--jp-widgets-margin));\n    --jp-widgets-inline-width-tiny: calc(var(--jp-widgets-inline-width-short) / 2 - var(--jp-widgets-margin));\n    --jp-widgets-inline-margin: 4px; /* margin between inline elements */\n    --jp-widgets-inline-label-width: 80px;\n    --jp-widgets-border-width: var(--jp-border-width);\n    --jp-widgets-vertical-height: 200px;\n    --jp-widgets-horizontal-tab-height: 24px;\n    --jp-widgets-horizontal-tab-width: 144px;\n    --jp-widgets-horizontal-tab-top-border: 2px;\n    --jp-widgets-progress-thickness: 20px;\n    --jp-widgets-container-padding: 15px;\n    --jp-widgets-input-padding: 4px;\n    --jp-widgets-radio-item-height-adjustment: 8px;\n    --jp-widgets-radio-item-height: calc(var(--jp-widgets-inline-height) - var(--jp-widgets-radio-item-height-adjustment));\n    --jp-widgets-slider-track-thickness: 4px;\n    --jp-widgets-slider-border-width: var(--jp-widgets-border-width);\n    --jp-widgets-slider-handle-size: 16px;\n    --jp-widgets-slider-handle-border-color: var(--jp-border-color1);\n    --jp-widgets-slider-handle-background-color: var(--jp-layout-color1);\n    --jp-widgets-slider-active-handle-color: var(--jp-brand-color1);\n    --jp-widgets-menu-item-height: 24px;\n    --jp-widgets-dropdown-arrow: url(\"data:image/svg+xml;base64,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\");\n    --jp-widgets-input-color: var(--jp-ui-font-color1);\n    --jp-widgets-input-background-color: var(--jp-layout-color1);\n    --jp-widgets-input-border-color: var(--jp-border-color1);\n    --jp-widgets-input-focus-border-color: var(--jp-brand-color2);\n    --jp-widgets-input-border-width: var(--jp-widgets-border-width);\n    --jp-widgets-disabled-opacity: 0.6;\n\n    /* From Material Design Lite */\n    --md-shadow-key-umbra-opacity: 0.2;\n    --md-shadow-key-penumbra-opacity: 0.14;\n    --md-shadow-ambient-shadow-opacity: 0.12;\n}\n\n.jupyter-widgets {\n    margin: var(--jp-widgets-margin);\n    box-sizing: border-box;\n    color: var(--jp-widgets-color);\n    overflow: visible;\n}\n\n.jupyter-widgets.jupyter-widgets-disconnected::before {\n    line-height: var(--jp-widgets-inline-height);\n    height: var(--jp-widgets-inline-height);\n}\n\n.jp-Output-result > .jupyter-widgets {\n    margin-left: 0;\n    margin-right: 0;\n}\n\n/* vbox and hbox */\n\n.widget-inline-hbox {\n    /* Horizontal widgets */\n    box-sizing: border-box;\n    display: flex;\n    flex-direction: row;\n    align-items: baseline;\n}\n\n.widget-inline-vbox {\n    /* Vertical Widgets */\n    box-sizing: border-box;\n    display: flex;\n    flex-direction: column;\n    align-items: center;\n}\n\n.widget-box {\n    box-sizing: border-box;\n    display: flex;\n    margin: 0;\n    overflow: auto;\n}\n\n.widget-gridbox {\n    box-sizing: border-box;\n    display: grid;\n    margin: 0;\n    overflow: auto;\n}\n\n.widget-hbox {\n    flex-direction: row;\n}\n\n.widget-vbox {\n    flex-direction: column;\n}\n\n/* General Button Styling */\n\n.jupyter-button {\n    padding-left: 10px;\n    padding-right: 10px;\n    padding-top: 0px;\n    padding-bottom: 0px;\n    display: inline-block;\n    white-space: nowrap;\n    overflow: hidden;\n    text-overflow: ellipsis;\n    text-align: center;\n    font-size: var(--jp-widgets-font-size);\n    cursor: pointer;\n\n    height: var(--jp-widgets-inline-height);\n    border: 0px solid;\n    line-height: var(--jp-widgets-inline-height);\n    box-shadow: none;\n\n    color: var(--jp-ui-font-color1);\n    background-color: var(--jp-layout-color2);\n    border-color: var(--jp-border-color2);\n    border: none;\n}\n\n.jupyter-button i.fa {\n    margin-right: var(--jp-widgets-inline-margin);\n    pointer-events: none;\n}\n\n.jupyter-button:empty:before {\n    content: \"\\200b\"; /* zero-width space */\n}\n\n.jupyter-widgets.jupyter-button:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n.jupyter-button i.fa.center {\n    margin-right: 0;\n}\n\n.jupyter-button:hover:enabled, .jupyter-button:focus:enabled {\n    /* MD Lite 2dp shadow */\n    box-shadow: 0 2px 2px 0 rgba(0, 0, 0, var(--md-shadow-key-penumbra-opacity)),\n                0 3px 1px -2px rgba(0, 0, 0, var(--md-shadow-key-umbra-opacity)),\n                0 1px 5px 0 rgba(0, 0, 0, var(--md-shadow-ambient-shadow-opacity));\n}\n\n.jupyter-button:active, .jupyter-button.mod-active {\n    /* MD Lite 4dp shadow */\n    box-shadow: 0 4px 5px 0 rgba(0, 0, 0, var(--md-shadow-key-penumbra-opacity)),\n                0 1px 10px 0 rgba(0, 0, 0, var(--md-shadow-ambient-shadow-opacity)),\n                0 2px 4px -1px rgba(0, 0, 0, var(--md-shadow-key-umbra-opacity));\n    color: var(--jp-ui-font-color1);\n    background-color: var(--jp-layout-color3);\n}\n\n.jupyter-button:focus:enabled {\n    outline: 1px solid var(--jp-widgets-input-focus-border-color);\n}\n\n/* Button \"Primary\" Styling */\n\n.jupyter-button.mod-primary {\n    color: var(--jp-inverse-ui-font-color1);\n    background-color: var(--jp-brand-color1);\n}\n\n.jupyter-button.mod-primary.mod-active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-brand-color0);\n}\n\n.jupyter-button.mod-primary:active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-brand-color0);\n}\n\n/* Button \"Success\" Styling */\n\n.jupyter-button.mod-success {\n    color: var(--jp-inverse-ui-font-color1);\n    background-color: var(--jp-success-color1);\n}\n\n.jupyter-button.mod-success.mod-active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-success-color0);\n }\n\n.jupyter-button.mod-success:active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-success-color0);\n }\n\n /* Button \"Info\" Styling */\n\n.jupyter-button.mod-info {\n    color: var(--jp-inverse-ui-font-color1);\n    background-color: var(--jp-info-color1);\n}\n\n.jupyter-button.mod-info.mod-active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-info-color0);\n}\n\n.jupyter-button.mod-info:active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-info-color0);\n}\n\n/* Button \"Warning\" Styling */\n\n.jupyter-button.mod-warning {\n    color: var(--jp-inverse-ui-font-color1);\n    background-color: var(--jp-warn-color1);\n}\n\n.jupyter-button.mod-warning.mod-active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-warn-color0);\n}\n\n.jupyter-button.mod-warning:active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-warn-color0);\n}\n\n/* Button \"Danger\" Styling */\n\n.jupyter-button.mod-danger {\n    color: var(--jp-inverse-ui-font-color1);\n    background-color: var(--jp-error-color1);\n}\n\n.jupyter-button.mod-danger.mod-active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-error-color0);\n}\n\n.jupyter-button.mod-danger:active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-error-color0);\n}\n\n/* Widget Button*/\n\n.widget-button, .widget-toggle-button {\n    width: var(--jp-widgets-inline-width-short);\n}\n\n/* Widget Label Styling */\n\n/* Override Bootstrap label css */\n.jupyter-widgets label {\n    margin-bottom: initial;\n}\n\n.widget-label-basic {\n    /* Basic Label */\n    color: var(--jp-widgets-label-color);\n    font-size: var(--jp-widgets-font-size);\n    overflow: hidden;\n    text-overflow: ellipsis;\n    white-space: nowrap;\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-label {\n    /* Label */\n    color: var(--jp-widgets-label-color);\n    font-size: var(--jp-widgets-font-size);\n    overflow: hidden;\n    text-overflow: ellipsis;\n    white-space: nowrap;\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-inline-hbox .widget-label {\n    /* Horizontal Widget Label */\n    color: var(--jp-widgets-label-color);\n    text-align: right;\n    margin-right: calc( var(--jp-widgets-inline-margin) * 2 );\n    width: var(--jp-widgets-inline-label-width);\n    flex-shrink: 0;\n}\n\n.widget-inline-vbox .widget-label {\n    /* Vertical Widget Label */\n    color: var(--jp-widgets-label-color);\n    text-align: center;\n    line-height: var(--jp-widgets-inline-height);\n}\n\n/* Widget Readout Styling */\n\n.widget-readout {\n    color: var(--jp-widgets-readout-color);\n    font-size: var(--jp-widgets-font-size);\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n    overflow: hidden;\n    white-space: nowrap;\n    text-align: center;\n}\n\n.widget-readout.overflow {\n    /* Overflowing Readout */\n\n    /* From Material Design Lite\n        shadow-key-umbra-opacity: 0.2;\n        shadow-key-penumbra-opacity: 0.14;\n        shadow-ambient-shadow-opacity: 0.12;\n     */\n    -webkit-box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2),\n                        0 3px 1px -2px rgba(0, 0, 0, 0.14),\n                        0 1px 5px 0 rgba(0, 0, 0, 0.12);\n\n    -moz-box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2),\n                     0 3px 1px -2px rgba(0, 0, 0, 0.14),\n                     0 1px 5px 0 rgba(0, 0, 0, 0.12);\n\n    box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2),\n                0 3px 1px -2px rgba(0, 0, 0, 0.14),\n                0 1px 5px 0 rgba(0, 0, 0, 0.12);\n}\n\n.widget-inline-hbox .widget-readout {\n    /* Horizontal Readout */\n    text-align: center;\n    max-width: var(--jp-widgets-inline-width-short);\n    min-width: var(--jp-widgets-inline-width-tiny);\n    margin-left: var(--jp-widgets-inline-margin);\n}\n\n.widget-inline-vbox .widget-readout {\n    /* Vertical Readout */\n    margin-top: var(--jp-widgets-inline-margin);\n    /* as wide as the widget */\n    width: inherit;\n}\n\n/* Widget Checkbox Styling */\n\n.widget-checkbox {\n    width: var(--jp-widgets-inline-width);\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-checkbox input[type=\"checkbox\"] {\n    margin: 0px calc( var(--jp-widgets-inline-margin) * 2 ) 0px 0px;\n    line-height: var(--jp-widgets-inline-height);\n    font-size: large;\n    flex-grow: 1;\n    flex-shrink: 0;\n    align-self: center;\n}\n\n/* Widget Valid Styling */\n\n.widget-valid {\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n    width: var(--jp-widgets-inline-width-short);\n    font-size: var(--jp-widgets-font-size);\n}\n\n.widget-valid i:before {\n    line-height: var(--jp-widgets-inline-height);\n    margin-right: var(--jp-widgets-inline-margin);\n    margin-left: var(--jp-widgets-inline-margin);\n\n    /* from the fa class in FontAwesome: https://github.com/FortAwesome/Font-Awesome/blob/49100c7c3a7b58d50baa71efef11af41a66b03d3/css/font-awesome.css#L14 */\n    display: inline-block;\n    font: normal normal normal 14px/1 FontAwesome;\n    font-size: inherit;\n    text-rendering: auto;\n    -webkit-font-smoothing: antialiased;\n    -moz-osx-font-smoothing: grayscale;\n}\n\n.widget-valid.mod-valid i:before {\n    content: \"\\f00c\";\n    color: green;\n}\n\n.widget-valid.mod-invalid i:before {\n    content: \"\\f00d\";\n    color: red;\n}\n\n.widget-valid.mod-valid .widget-valid-readout {\n    display: none;\n}\n\n/* Widget Text and TextArea Stying */\n\n.widget-textarea, .widget-text {\n    width: var(--jp-widgets-inline-width);\n}\n\n.widget-text input[type=\"text\"], .widget-text input[type=\"number\"]{\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-text input[type=\"text\"]:disabled, .widget-text input[type=\"number\"]:disabled, .widget-textarea textarea:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n.widget-text input[type=\"text\"], .widget-text input[type=\"number\"], .widget-textarea textarea {\n    box-sizing: border-box;\n    border: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n    background-color: var(--jp-widgets-input-background-color);\n    color: var(--jp-widgets-input-color);\n    font-size: var(--jp-widgets-font-size);\n    padding: var(--jp-widgets-input-padding) calc( var(--jp-widgets-input-padding) *  2 );\n    flex-grow: 1;\n    min-width: 0; /* This makes it possible for the flexbox to shrink this input */\n    flex-shrink: 1;\n    outline: none !important;\n}\n\n.widget-textarea textarea {\n    height: inherit;\n    width: inherit;\n}\n\n.widget-text input:focus, .widget-textarea textarea:focus {\n    border-color: var(--jp-widgets-input-focus-border-color);\n}\n\n/* Widget Slider */\n\n.widget-slider .ui-slider {\n    /* Slider Track */\n    border: var(--jp-widgets-slider-border-width) solid var(--jp-layout-color3);\n    background: var(--jp-layout-color3);\n    box-sizing: border-box;\n    position: relative;\n    border-radius: 0px;\n}\n\n.widget-slider .ui-slider .ui-slider-handle {\n    /* Slider Handle */\n    outline: none !important; /* focused slider handles are colored - see below */\n    position: absolute;\n    background-color: var(--jp-widgets-slider-handle-background-color);\n    border: var(--jp-widgets-slider-border-width) solid var(--jp-widgets-slider-handle-border-color);\n    box-sizing: border-box;\n    z-index: 1;\n    background-image: none; /* Override jquery-ui */\n}\n\n/* Override jquery-ui */\n.widget-slider .ui-slider .ui-slider-handle:hover, .widget-slider .ui-slider .ui-slider-handle:focus {\n    background-color: var(--jp-widgets-slider-active-handle-color);\n    border: var(--jp-widgets-slider-border-width) solid var(--jp-widgets-slider-active-handle-color);\n}\n\n.widget-slider .ui-slider .ui-slider-handle:active {\n    background-color: var(--jp-widgets-slider-active-handle-color);\n    border-color: var(--jp-widgets-slider-active-handle-color);\n    z-index: 2;\n    transform: scale(1.2);\n}\n\n.widget-slider  .ui-slider .ui-slider-range {\n    /* Interval between the two specified value of a double slider */\n    position: absolute;\n    background: var(--jp-widgets-slider-active-handle-color);\n    z-index: 0;\n}\n\n/* Shapes of Slider Handles */\n\n.widget-hslider .ui-slider .ui-slider-handle {\n    width: var(--jp-widgets-slider-handle-size);\n    height: var(--jp-widgets-slider-handle-size);\n    margin-top: calc((var(--jp-widgets-slider-track-thickness) - var(--jp-widgets-slider-handle-size)) / 2 - var(--jp-widgets-slider-border-width));\n    margin-left: calc(var(--jp-widgets-slider-handle-size) / -2 + var(--jp-widgets-slider-border-width));\n    border-radius: 50%;\n    top: 0;\n}\n\n.widget-vslider .ui-slider .ui-slider-handle {\n    width: var(--jp-widgets-slider-handle-size);\n    height: var(--jp-widgets-slider-handle-size);\n    margin-bottom: calc(var(--jp-widgets-slider-handle-size) / -2 + var(--jp-widgets-slider-border-width));\n    margin-left: calc((var(--jp-widgets-slider-track-thickness) - var(--jp-widgets-slider-handle-size)) / 2 - var(--jp-widgets-slider-border-width));\n    border-radius: 50%;\n    left: 0;\n}\n\n.widget-hslider .ui-slider .ui-slider-range {\n    height: calc( var(--jp-widgets-slider-track-thickness) * 2 );\n    margin-top: calc((var(--jp-widgets-slider-track-thickness) - var(--jp-widgets-slider-track-thickness) * 2 ) / 2 - var(--jp-widgets-slider-border-width));\n}\n\n.widget-vslider .ui-slider .ui-slider-range {\n    width: calc( var(--jp-widgets-slider-track-thickness) * 2 );\n    margin-left: calc((var(--jp-widgets-slider-track-thickness) - var(--jp-widgets-slider-track-thickness) * 2 ) / 2 - var(--jp-widgets-slider-border-width));\n}\n\n/* Horizontal Slider */\n\n.widget-hslider {\n    width: var(--jp-widgets-inline-width);\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n\n    /* Override the align-items baseline. This way, the description and readout\n    still seem to align their baseline properly, and we don't have to have\n    align-self: stretch in the .slider-container. */\n    align-items: center;\n}\n\n.widgets-slider .slider-container {\n    overflow: visible;\n}\n\n.widget-hslider .slider-container {\n    height: var(--jp-widgets-inline-height);\n    margin-left: calc(var(--jp-widgets-slider-handle-size) / 2 - 2 * var(--jp-widgets-slider-border-width));\n    margin-right: calc(var(--jp-widgets-slider-handle-size) / 2 - 2 * var(--jp-widgets-slider-border-width));\n    flex: 1 1 var(--jp-widgets-inline-width-short);\n}\n\n.widget-hslider .ui-slider {\n    /* Inner, invisible slide div */\n    height: var(--jp-widgets-slider-track-thickness);\n    margin-top: calc((var(--jp-widgets-inline-height) - var(--jp-widgets-slider-track-thickness)) / 2);\n    width: 100%;\n}\n\n/* Vertical Slider */\n\n.widget-vbox .widget-label {\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-vslider {\n    /* Vertical Slider */\n    height: var(--jp-widgets-vertical-height);\n    width: var(--jp-widgets-inline-width-tiny);\n}\n\n.widget-vslider .slider-container {\n    flex: 1 1 var(--jp-widgets-inline-width-short);\n    margin-left: auto;\n    margin-right: auto;\n    margin-bottom: calc(var(--jp-widgets-slider-handle-size) / 2 - 2 * var(--jp-widgets-slider-border-width));\n    margin-top: calc(var(--jp-widgets-slider-handle-size) / 2 - 2 * var(--jp-widgets-slider-border-width));\n    display: flex;\n    flex-direction: column;\n}\n\n.widget-vslider .ui-slider-vertical {\n    /* Inner, invisible slide div */\n    width: var(--jp-widgets-slider-track-thickness);\n    flex-grow: 1;\n    margin-left: auto;\n    margin-right: auto;\n}\n\n/* Widget Progress Styling */\n\n.progress-bar {\n    -webkit-transition: none;\n    -moz-transition: none;\n    -ms-transition: none;\n    -o-transition: none;\n    transition: none;\n}\n\n.progress-bar {\n    height: var(--jp-widgets-inline-height);\n}\n\n.progress-bar {\n    background-color: var(--jp-brand-color1);\n}\n\n.progress-bar-success {\n    background-color: var(--jp-success-color1);\n}\n\n.progress-bar-info {\n    background-color: var(--jp-info-color1);\n}\n\n.progress-bar-warning {\n    background-color: var(--jp-warn-color1);\n}\n\n.progress-bar-danger {\n    background-color: var(--jp-error-color1);\n}\n\n.progress {\n    background-color: var(--jp-layout-color2);\n    border: none;\n    box-shadow: none;\n}\n\n/* Horisontal Progress */\n\n.widget-hprogress {\n    /* Progress Bar */\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n    width: var(--jp-widgets-inline-width);\n    align-items: center;\n\n}\n\n.widget-hprogress .progress {\n    flex-grow: 1;\n    margin-top: var(--jp-widgets-input-padding);\n    margin-bottom: var(--jp-widgets-input-padding);\n    align-self: stretch;\n    /* Override bootstrap style */\n    height: initial;\n}\n\n/* Vertical Progress */\n\n.widget-vprogress {\n    height: var(--jp-widgets-vertical-height);\n    width: var(--jp-widgets-inline-width-tiny);\n}\n\n.widget-vprogress .progress {\n    flex-grow: 1;\n    width: var(--jp-widgets-progress-thickness);\n    margin-left: auto;\n    margin-right: auto;\n    margin-bottom: 0;\n}\n\n/* Select Widget Styling */\n\n.widget-dropdown {\n    height: var(--jp-widgets-inline-height);\n    width: var(--jp-widgets-inline-width);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-dropdown > select {\n    padding-right: 20px;\n    border: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n    border-radius: 0;\n    height: inherit;\n    flex: 1 1 var(--jp-widgets-inline-width-short);\n    min-width: 0; /* This makes it possible for the flexbox to shrink this input */\n    box-sizing: border-box;\n    outline: none !important;\n    box-shadow: none;\n    background-color: var(--jp-widgets-input-background-color);\n    color: var(--jp-widgets-input-color);\n    font-size: var(--jp-widgets-font-size);\n    vertical-align: top;\n    padding-left: calc( var(--jp-widgets-input-padding) * 2);\n\tappearance: none;\n\t-webkit-appearance: none;\n\t-moz-appearance: none;\n    background-repeat: no-repeat;\n\tbackground-size: 20px;\n\tbackground-position: right center;\n    background-image: var(--jp-widgets-dropdown-arrow);\n}\n.widget-dropdown > select:focus {\n    border-color: var(--jp-widgets-input-focus-border-color);\n}\n\n.widget-dropdown > select:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n/* To disable the dotted border in Firefox around select controls.\n   See http://stackoverflow.com/a/18853002 */\n.widget-dropdown > select:-moz-focusring {\n    color: transparent;\n    text-shadow: 0 0 0 #000;\n}\n\n/* Select and SelectMultiple */\n\n.widget-select {\n    width: var(--jp-widgets-inline-width);\n    line-height: var(--jp-widgets-inline-height);\n\n    /* Because Firefox defines the baseline of a select as the bottom of the\n    control, we align the entire control to the top and add padding to the\n    select to get an approximate first line baseline alignment. */\n    align-items: flex-start;\n}\n\n.widget-select > select {\n    border: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n    background-color: var(--jp-widgets-input-background-color);\n    color: var(--jp-widgets-input-color);\n    font-size: var(--jp-widgets-font-size);\n    flex: 1 1 var(--jp-widgets-inline-width-short);\n    outline: none !important;\n    overflow: auto;\n    height: inherit;\n\n    /* Because Firefox defines the baseline of a select as the bottom of the\n    control, we align the entire control to the top and add padding to the\n    select to get an approximate first line baseline alignment. */\n    padding-top: 5px;\n}\n\n.widget-select > select:focus {\n    border-color: var(--jp-widgets-input-focus-border-color);\n}\n\n.wiget-select > select > option {\n    padding-left: var(--jp-widgets-input-padding);\n    line-height: var(--jp-widgets-inline-height);\n    /* line-height doesn't work on some browsers for select options */\n    padding-top: calc(var(--jp-widgets-inline-height)-var(--jp-widgets-font-size)/2);\n    padding-bottom: calc(var(--jp-widgets-inline-height)-var(--jp-widgets-font-size)/2);\n}\n\n\n\n/* Toggle Buttons Styling */\n\n.widget-toggle-buttons {\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-toggle-buttons .widget-toggle-button {\n    margin-left: var(--jp-widgets-margin);\n    margin-right: var(--jp-widgets-margin);\n}\n\n.widget-toggle-buttons .jupyter-button:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n/* Radio Buttons Styling */\n\n.widget-radio {\n    width: var(--jp-widgets-inline-width);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-radio-box {\n    display: flex;\n    flex-direction: column;\n    align-items: stretch;\n    box-sizing: border-box;\n    flex-grow: 1;\n    margin-bottom: var(--jp-widgets-radio-item-height-adjustment);\n}\n\n.widget-radio-box label {\n    height: var(--jp-widgets-radio-item-height);\n    line-height: var(--jp-widgets-radio-item-height);\n    font-size: var(--jp-widgets-font-size);\n}\n\n.widget-radio-box input {\n    height: var(--jp-widgets-radio-item-height);\n    line-height: var(--jp-widgets-radio-item-height);\n    margin: 0 calc( var(--jp-widgets-input-padding) * 2 ) 0 1px;\n    float: left;\n}\n\n/* Color Picker Styling */\n\n.widget-colorpicker {\n    width: var(--jp-widgets-inline-width);\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-colorpicker > .widget-colorpicker-input {\n    flex-grow: 1;\n    flex-shrink: 1;\n    min-width: var(--jp-widgets-inline-width-tiny);\n}\n\n.widget-colorpicker input[type=\"color\"] {\n    width: var(--jp-widgets-inline-height);\n    height: var(--jp-widgets-inline-height);\n    padding: 0 2px; /* make the color square actually square on Chrome on OS X */\n    background: var(--jp-widgets-input-background-color);\n    color: var(--jp-widgets-input-color);\n    border: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n    border-left: none;\n    flex-grow: 0;\n    flex-shrink: 0;\n    box-sizing: border-box;\n    align-self: stretch;\n    outline: none !important;\n}\n\n.widget-colorpicker.concise input[type=\"color\"] {\n    border-left: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n}\n\n.widget-colorpicker input[type=\"color\"]:focus, .widget-colorpicker input[type=\"text\"]:focus {\n    border-color: var(--jp-widgets-input-focus-border-color);\n}\n\n.widget-colorpicker input[type=\"text\"] {\n    flex-grow: 1;\n    outline: none !important;\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n    background: var(--jp-widgets-input-background-color);\n    color: var(--jp-widgets-input-color);\n    border: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n    font-size: var(--jp-widgets-font-size);\n    padding: var(--jp-widgets-input-padding) calc( var(--jp-widgets-input-padding) *  2 );\n    min-width: 0; /* This makes it possible for the flexbox to shrink this input */\n    flex-shrink: 1;\n    box-sizing: border-box;\n}\n\n.widget-colorpicker input[type=\"text\"]:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n/* Date Picker Styling */\n\n.widget-datepicker {\n    width: var(--jp-widgets-inline-width);\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-datepicker input[type=\"date\"] {\n    flex-grow: 1;\n    flex-shrink: 1;\n    min-width: 0; /* This makes it possible for the flexbox to shrink this input */\n    outline: none !important;\n    height: var(--jp-widgets-inline-height);\n    border: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n    background-color: var(--jp-widgets-input-background-color);\n    color: var(--jp-widgets-input-color);\n    font-size: var(--jp-widgets-font-size);\n    padding: var(--jp-widgets-input-padding) calc( var(--jp-widgets-input-padding) *  2 );\n    box-sizing: border-box;\n}\n\n.widget-datepicker input[type=\"date\"]:focus {\n    border-color: var(--jp-widgets-input-focus-border-color);\n}\n\n.widget-datepicker input[type=\"date\"]:invalid {\n    border-color: var(--jp-warn-color1);\n}\n\n.widget-datepicker input[type=\"date\"]:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n/* Play Widget */\n\n.widget-play {\n    width: var(--jp-widgets-inline-width-short);\n    display: flex;\n    align-items: stretch;\n}\n\n.widget-play .jupyter-button {\n    flex-grow: 1;\n    height: auto;\n}\n\n.widget-play .jupyter-button:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n/* Tab Widget */\n\n.jupyter-widgets.widget-tab {\n    display: flex;\n    flex-direction: column;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar {\n    /* Necessary so that a tab can be shifted down to overlay the border of the box below. */\n    overflow-x: visible;\n    overflow-y: visible;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar > .p-TabBar-content {\n    /* Make sure that the tab grows from bottom up */\n    align-items: flex-end;\n    min-width: 0;\n    min-height: 0;\n}\n\n.jupyter-widgets.widget-tab > .widget-tab-contents {\n    width: 100%;\n    box-sizing: border-box;\n    margin: 0;\n    background: var(--jp-layout-color1);\n    color: var(--jp-ui-font-color1);\n    border: var(--jp-border-width) solid var(--jp-border-color1);\n    padding: var(--jp-widgets-container-padding);\n    flex-grow: 1;\n    overflow: auto;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar {\n    font: var(--jp-widgets-font-size) Helvetica, Arial, sans-serif;\n    min-height: calc(var(--jp-widgets-horizontal-tab-height) + var(--jp-border-width));\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab {\n    flex: 0 1 var(--jp-widgets-horizontal-tab-width);\n    min-width: 35px;\n    min-height: calc(var(--jp-widgets-horizontal-tab-height) + var(--jp-border-width));\n    line-height: var(--jp-widgets-horizontal-tab-height);\n    margin-left: calc(-1 * var(--jp-border-width));\n    padding: 0px 10px;\n    background: var(--jp-layout-color2);\n    color: var(--jp-ui-font-color2);\n    border: var(--jp-border-width) solid var(--jp-border-color1);\n    border-bottom: none;\n    position: relative;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab.p-mod-current {\n    color: var(--jp-ui-font-color0);\n    /* We want the background to match the tab content background */\n    background: var(--jp-layout-color1);\n    min-height: calc(var(--jp-widgets-horizontal-tab-height) + 2 * var(--jp-border-width));\n    transform: translateY(var(--jp-border-width));\n    overflow: visible;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab.p-mod-current:before {\n    position: absolute;\n    top: calc(-1 * var(--jp-border-width));\n    left: calc(-1 * var(--jp-border-width));\n    content: '';\n    height: var(--jp-widgets-horizontal-tab-top-border);\n    width: calc(100% + 2 * var(--jp-border-width));\n    background: var(--jp-brand-color1);\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab:first-child {\n    margin-left: 0;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab:hover:not(.p-mod-current) {\n    background: var(--jp-layout-color1);\n    color: var(--jp-ui-font-color1);\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-mod-closable > .p-TabBar-tabCloseIcon {\n    margin-left: 4px;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-mod-closable > .p-TabBar-tabCloseIcon:before {\n    font-family: FontAwesome;\n    content: '\\f00d'; /* close */\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabIcon,\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabLabel,\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabCloseIcon {\n    line-height: var(--jp-widgets-horizontal-tab-height);\n}\n\n/* Accordion Widget */\n\n.p-Collapse {\n    display: flex;\n    flex-direction: column;\n    align-items: stretch;\n}\n\n.p-Collapse-header {\n    padding: var(--jp-widgets-input-padding);\n    cursor: pointer;\n    color: var(--jp-ui-font-color2);\n    background-color: var(--jp-layout-color2);\n    border: var(--jp-widgets-border-width) solid var(--jp-border-color1);\n    padding: calc(var(--jp-widgets-container-padding) * 2 / 3) var(--jp-widgets-container-padding);\n    font-weight: bold;\n}\n\n.p-Collapse-header:hover {\n    background-color: var(--jp-layout-color1);\n    color: var(--jp-ui-font-color1);\n}\n\n.p-Collapse-open > .p-Collapse-header {\n    background-color: var(--jp-layout-color1);\n    color: var(--jp-ui-font-color0);\n    cursor: default;\n    border-bottom: none;\n}\n\n.p-Collapse .p-Collapse-header::before {\n    content: '\\f0da\\00A0';  /* caret-right, non-breaking space */\n    display: inline-block;\n    font: normal normal normal 14px/1 FontAwesome;\n    font-size: inherit;\n    text-rendering: auto;\n    -webkit-font-smoothing: antialiased;\n    -moz-osx-font-smoothing: grayscale;\n}\n\n.p-Collapse-open > .p-Collapse-header::before {\n    content: '\\f0d7\\00A0'; /* caret-down, non-breaking space */\n}\n\n.p-Collapse-contents {\n    padding: var(--jp-widgets-container-padding);\n    background-color: var(--jp-layout-color1);\n    color: var(--jp-ui-font-color1);\n    border-left: var(--jp-widgets-border-width) solid var(--jp-border-color1);\n    border-right: var(--jp-widgets-border-width) solid var(--jp-border-color1);\n    border-bottom: var(--jp-widgets-border-width) solid var(--jp-border-color1);\n    overflow: auto;\n}\n\n.p-Accordion {\n    display: flex;\n    flex-direction: column;\n    align-items: stretch;\n}\n\n.p-Accordion .p-Collapse {\n    margin-bottom: 0;\n}\n\n.p-Accordion .p-Collapse + .p-Collapse {\n    margin-top: 4px;\n}\n\n\n\n/* HTML widget */\n\n.widget-html, .widget-htmlmath {\n    font-size: var(--jp-widgets-font-size);\n}\n\n.widget-html > .widget-html-content, .widget-htmlmath > .widget-html-content {\n    /* Fill out the area in the HTML widget */\n    align-self: stretch;\n    flex-grow: 1;\n    flex-shrink: 1;\n    /* Makes sure the baseline is still aligned with other elements */\n    line-height: var(--jp-widgets-inline-height);\n    /* Make it possible to have absolutely-positioned elements in the html */\n    position: relative;\n}\n","/* This file has code derived from PhosphorJS CSS files, as noted below. The license for this PhosphorJS code is:\n\nCopyright (c) 2014-2017, PhosphorJS Contributors\nAll rights reserved.\n\nRedistribution and use in source and binary forms, with or without\nmodification, are permitted provided that the following conditions are met:\n\n* Redistributions of source code must retain the above copyright notice, this\n  list of conditions and the following disclaimer.\n\n* Redistributions in binary form must reproduce the above copyright notice,\n  this list of conditions and the following disclaimer in the documentation\n  and/or other materials provided with the distribution.\n\n* Neither the name of the copyright holder nor the names of its\n  contributors may be used to endorse or promote products derived from\n  this software without specific prior written permission.\n\nTHIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS \"AS IS\"\nAND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE\nIMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE ARE\nDISCLAIMED. IN NO EVENT SHALL THE COPYRIGHT HOLDER OR CONTRIBUTORS BE LIABLE\nFOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL\nDAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR\nSERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS INTERRUPTION) HOWEVER\nCAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY,\nOR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE\nOF THIS SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.\n\n*/\n\n/*\n * The following section is derived from https://github.com/phosphorjs/phosphor/blob/23b9d075ebc5b73ab148b6ebfc20af97f85714c4/packages/widgets/style/tabbar.css \n * We've scoped the rules so that they are consistent with exactly our code.\n */\n\n.jupyter-widgets.widget-tab > .p-TabBar {\n  display: flex;\n  -webkit-user-select: none;\n  -moz-user-select: none;\n  -ms-user-select: none;\n  user-select: none;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar[data-orientation='horizontal'] {\n  flex-direction: row;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar[data-orientation='vertical'] {\n  flex-direction: column;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar > .p-TabBar-content {\n  margin: 0;\n  padding: 0;\n  display: flex;\n  flex: 1 1 auto;\n  list-style-type: none;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar[data-orientation='horizontal'] > .p-TabBar-content {\n  flex-direction: row;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar[data-orientation='vertical'] > .p-TabBar-content {\n  flex-direction: column;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab {\n  display: flex;\n  flex-direction: row;\n  box-sizing: border-box;\n  overflow: hidden;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabIcon,\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabCloseIcon {\n  flex: 0 0 auto;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabLabel {\n  flex: 1 1 auto;\n  overflow: hidden;\n  white-space: nowrap;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab.p-mod-hidden {\n  display: none !important;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging .p-TabBar-tab {\n  position: relative;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging[data-orientation='horizontal'] .p-TabBar-tab {\n  left: 0;\n  transition: left 150ms ease;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging[data-orientation='vertical'] .p-TabBar-tab {\n  top: 0;\n  transition: top 150ms ease;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging .p-TabBar-tab.p-mod-dragging {\n  transition: none;\n}\n\n/* End tabbar.css */\n"]} */","ok":true,"headers":[["content-type","text/css"]],"status":200,"status_text":""}},"base_uri":"https://localhost:8080/","height":285}},"source":["#\n","# the main query\n","#\n","q = \"\"\"search patents where associated_grant_ids in {} \n","  return patents[basics+associated_grant_ids]\"\"\"\n","\n","#\n","# useful libraries for looping\n","#\n","from dimcli.shortcuts import chunks_of\n","from tqdm import tqdm_notebook as progressbar\n","\n","#\n","# let's loop through all grants IDs in chunks and query Dimensions \n","#\n","print(\"===\\nExtracting patents data ...\")\n","results = []\n","\n","for chunk in progressbar(list(chunks_of(list(grantsids), 400))):\n","    data = dsl.query_iterative(q.format(json.dumps(chunk)), verbose=False)\n","    results += data.patents\n","    time.sleep(1)\n","\n","#\n","# put the patents data into a dataframe, remove duplicates and save\n","#\n","patents = pd.DataFrame().from_dict(results)\n","print(\"Patents found: \", len(patents))\n","patents.drop_duplicates(subset='id', inplace=True)\n","print(\"Unique Patents found: \", len(patents))\n","patents.to_csv(\"patents.csv\", index=False)\n","# turning lists into strings to ensure compatibility with CSV loaded data\n","# see also: https://stackoverflow.com/questions/23111990/pandas-dataframe-stored-list-as-string-how-to-convert-back-to-list\n","patents['associated_grant_ids'] = patents['associated_grant_ids'].apply(lambda x: ','.join(map(str, x))) \n","print(\"===\\nDone - data saved as 'patents.csv'\")\n","\n","\n","#\n","# count patents per grant and enrich the original dataset\n","#\n","def patents_for_grantid(grantid):\n","  global patents\n","  return patents[patents['associated_grant_ids'].str.contains(grantid)]\n","\n","print(\"===\\nCounting patents per grant...\")\n","\n","l = []\n","for x in progressbar(grantsids):\n","  l.append(len(patents_for_grantid(x)))\n","\n","#\n","# save the data\n","#\n","grants['patents'] = l\n","grants.to_csv(\"grants_enriched_pubs_patents.csv\", index=False)\n","print(\"===\\nDone - data saved as 'grants_enriched_pubs_patents.csv'\")"],"execution_count":0,"outputs":[{"output_type":"stream","text":["===\n","Extracting patents data ...\n"],"name":"stdout"},{"output_type":"display_data","data":{"application/vnd.jupyter.widget-view+json":{"model_id":"aa8d179376b74b0a9bd1b67cc60c4dab","version_minor":0,"version_major":2},"text/plain":["HBox(children=(IntProgress(value=0, max=13), HTML(value='')))"]},"metadata":{"tags":[]}},{"output_type":"stream","text":["\n","Patents found:  415\n","Unique Patents found:  400\n","===\n","Done - data saved as 'patents.csv'\n","===\n","Counting patents per grant...\n"],"name":"stdout"},{"output_type":"display_data","data":{"application/vnd.jupyter.widget-view+json":{"model_id":"c0bd5db27541482198695a7e77bd8c29","version_minor":0,"version_major":2},"text/plain":["HBox(children=(IntProgress(value=0, max=5000), HTML(value='')))"]},"metadata":{"tags":[]}},{"output_type":"stream","text":["\n","===\n","Done - data saved as 'grants_enriched_pubs_patents.csv'\n"],"name":"stdout"}]},{"cell_type":"markdown","metadata":{"id":"tlFRLS2bKUYl","colab_type":"text"},"source":["Let's quickly preview the patents dataset, and the grants one, which now has an extra column counting patents. "]},{"cell_type":"code","metadata":{"id":"h-jlqkONtCC0","colab_type":"code","outputId":"f6def976-1095-442e-9c25-a033a0eb6bb5","executionInfo":{"status":"ok","timestamp":1573588171874,"user_tz":0,"elapsed":503,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"colab":{"base_uri":"https://localhost:8080/","height":321}},"source":["patents.head(5)"],"execution_count":0,"outputs":[{"output_type":"execute_result","data":{"application/vnd.google.colaboratory.module+javascript":"\n      import \"https://ssl.gstatic.com/colaboratory/data_table/9e554b27bdd509f3/data_table.js\";\n\n      window.createDataTable({\n        data: [[{\n            'v': 0,\n            'f': \"0\",\n        },\n[\"Daniel J. Smith\", \"Martin A. Taubman\"],\n{\n            'v': 5.0,\n            'f': \"5.0\",\n        },\n{\n            'v': 2006.0,\n            'f': \"2006.0\",\n        },\n{\n            'v': 2004,\n            'f': \"2004\",\n        },\n\"Grant\",\n\"grant.2489571,grant.2489689\",\n[\"{'id': 'grid.38142.3c', 'name': 'Harvard University', 'country_name': 'United States'}\"],\n[\"FORSYTH INSTITUTE\", \"Forsyth Dental Infirmary for Children\", \"FORSYTH INST\"],\n\"2006-06-06\",\n\"US-7056517-B2\",\n\"Glucosyltransferase immunogens\"],\n [{\n            'v': 1,\n            'f': \"1\",\n        },\n[\"MARIO PHILIPP\"],\n{\n            'v': 1.0,\n            'f': \"1.0\",\n        },\n{\n            'v': NaN,\n            'f': \"NaN\",\n        },\n{\n            'v': 2003,\n            'f': \"2003\",\n        },\n\"Application\",\n\"grant.2452868\",\n[\"{'id': 'grid.265219.b', 'name': 'Tulane University', 'country_name': 'United States'}\"],\n[\"Administrators of the Tulane Educational Fund\", \"UNIV TULANE\"],\n\"2004-04-08\",\n\"US-20040067517-A1\",\n\"Surface antigens and proteins useful in compositions for the diagnosis and prevention of Lyme disease\"],\n [{\n            'v': 2,\n            'f': \"2\",\n        },\n[\"James Tam\", \"Qitao Yu\", \"Yi-An Lu\", \"Jin-Long Yang\"],\n{\n            'v': 2.0,\n            'f': \"2.0\",\n        },\n{\n            'v': NaN,\n            'f': \"NaN\",\n        },\n{\n            'v': 2004,\n            'f': \"2004\",\n        },\n\"Application\",\n\"grant.2454716\",\n[\"{'id': 'grid.152326.1', 'name': 'Vanderbilt University', 'country_name': 'United States'}\"],\n[\"Vanderbilt University\", \"UNIV VANDERBILT\"],\n\"2005-05-26\",\n\"US-20050113292-A1\",\n\"Compositions of protein mimetics and methods of using same against HIV-1, SARS-coV and the like\"],\n [{\n            'v': 3,\n            'f': \"3\",\n        },\n[\"Clifford J. Beall\", \"Kelly R. Clark\", \"Philip R. Johnson, Jr.\"],\n{\n            'v': NaN,\n            'f': \"NaN\",\n        },\n{\n            'v': 2011.0,\n            'f': \"2011.0\",\n        },\n{\n            'v': 2009,\n            'f': \"2009\",\n        },\n\"Grant\",\n\"grant.5246582\",\n[\"{'id': 'grid.240344.5', 'name': \\\"Nationwide Children's Hospital\\\", 'country_name': 'United States'}\"],\n[\"Nationwide Children's Hospital Inc\", \"NATIONWIDE CHILDREN S HOSPITAL INC\"],\n\"2011-05-17\",\n\"US-7943379-B2\",\n\"Production of rAAV in vero cells using particular adenovirus helpers\"],\n [{\n            'v': 4,\n            'f': \"4\",\n        },\n[\"Jon O. Rayner\", \"Jonathan F. Smith\", \"Bolyn Hubby\", \"Elizabeth A. Reap\"],\n{\n            'v': NaN,\n            'f': \"NaN\",\n        },\n{\n            'v': NaN,\n            'f': \"NaN\",\n        },\n{\n            'v': 2014,\n            'f': \"2014\",\n        },\n\"Application\",\n\"grant.2687621,grant.2687606\",\n[\"{'id': 'grid.422340.3', 'name': 'AlphaVax (United States)', 'country_name': 'United States'}\"],\n[\"AlphaVax Inc\", \"ALPHAVAX INC\"],\n\"2014-07-24\",\n\"US-20140205629-A1\",\n\"TC-83-DERIVED ALPHAVIRUS VECTORS, PARTICLES AND METHODS\"]],\n        columns: [[\"number\", \"index\"], [\"string\", \"inventor_names\"], [\"number\", \"times_cited\"], [\"number\", \"granted_year\"], [\"number\", \"year\"], [\"string\", \"filing_status\"], [\"string\", \"associated_grant_ids\"], [\"string\", \"assignees\"], [\"string\", \"assignee_names\"], [\"string\", \"publication_date\"], [\"string\", \"id\"], [\"string\", \"title\"]],\n        columnOptions: [{\"width\": \"1px\", \"className\": \"index_column\"}],\n        rowsPerPage: 25,\n        helpUrl: \"https://colab.research.google.com/notebooks/data_table.ipynb\",\n      });\n    ","text/html":["<div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>inventor_names</th>\n","      <th>times_cited</th>\n","      <th>granted_year</th>\n","      <th>year</th>\n","      <th>filing_status</th>\n","      <th>associated_grant_ids</th>\n","      <th>assignees</th>\n","      <th>assignee_names</th>\n","      <th>publication_date</th>\n","      <th>id</th>\n","      <th>title</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>[Daniel J. Smith, Martin A. Taubman]</td>\n","      <td>5.0</td>\n","      <td>2006.0</td>\n","      <td>2004</td>\n","      <td>Grant</td>\n","      <td>grant.2489571,grant.2489689</td>\n","      <td>[{'id': 'grid.38142.3c', 'name': 'Harvard Univ...</td>\n","      <td>[FORSYTH INSTITUTE, Forsyth Dental Infirmary f...</td>\n","      <td>2006-06-06</td>\n","      <td>US-7056517-B2</td>\n","      <td>Glucosyltransferase immunogens</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>[MARIO PHILIPP]</td>\n","      <td>1.0</td>\n","      <td>NaN</td>\n","      <td>2003</td>\n","      <td>Application</td>\n","      <td>grant.2452868</td>\n","      <td>[{'id': 'grid.265219.b', 'name': 'Tulane Unive...</td>\n","      <td>[Administrators of the Tulane Educational Fund...</td>\n","      <td>2004-04-08</td>\n","      <td>US-20040067517-A1</td>\n","      <td>Surface antigens and proteins useful in compos...</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>[James Tam, Qitao Yu, Yi-An Lu, Jin-Long Yang]</td>\n","      <td>2.0</td>\n","      <td>NaN</td>\n","      <td>2004</td>\n","      <td>Application</td>\n","      <td>grant.2454716</td>\n","      <td>[{'id': 'grid.152326.1', 'name': 'Vanderbilt U...</td>\n","      <td>[Vanderbilt University, UNIV VANDERBILT]</td>\n","      <td>2005-05-26</td>\n","      <td>US-20050113292-A1</td>\n","      <td>Compositions of protein mimetics and methods o...</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>[Clifford J. Beall, Kelly R. Clark, Philip R. ...</td>\n","      <td>NaN</td>\n","      <td>2011.0</td>\n","      <td>2009</td>\n","      <td>Grant</td>\n","      <td>grant.5246582</td>\n","      <td>[{'id': 'grid.240344.5', 'name': 'Nationwide C...</td>\n","      <td>[Nationwide Children's Hospital Inc, NATIONWID...</td>\n","      <td>2011-05-17</td>\n","      <td>US-7943379-B2</td>\n","      <td>Production of rAAV in vero cells using particu...</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>[Jon O. Rayner, Jonathan F. Smith, Bolyn Hubby...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>2014</td>\n","      <td>Application</td>\n","      <td>grant.2687621,grant.2687606</td>\n","      <td>[{'id': 'grid.422340.3', 'name': 'AlphaVax (Un...</td>\n","      <td>[AlphaVax Inc, ALPHAVAX INC]</td>\n","      <td>2014-07-24</td>\n","      <td>US-20140205629-A1</td>\n","      <td>TC-83-DERIVED ALPHAVIRUS VECTORS, PARTICLES AN...</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>"],"text/plain":["                                      inventor_names  ...                                              title\n","0               [Daniel J. Smith, Martin A. Taubman]  ...                     Glucosyltransferase immunogens\n","1                                    [MARIO PHILIPP]  ...  Surface antigens and proteins useful in compos...\n","2     [James Tam, Qitao Yu, Yi-An Lu, Jin-Long Yang]  ...  Compositions of protein mimetics and methods o...\n","3  [Clifford J. Beall, Kelly R. Clark, Philip R. ...  ...  Production of rAAV in vero cells using particu...\n","4  [Jon O. Rayner, Jonathan F. Smith, Bolyn Hubby...  ...  TC-83-DERIVED ALPHAVIRUS VECTORS, PARTICLES AN...\n","\n","[5 rows x 11 columns]"]},"metadata":{"tags":[]},"execution_count":10}]},{"cell_type":"code","metadata":{"id":"9Uo0g2YVKgOX","colab_type":"code","outputId":"37cafaf2-672d-429f-da3d-3bf5ebd125db","executionInfo":{"status":"ok","timestamp":1573588213433,"user_tz":0,"elapsed":511,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"colab":{"base_uri":"https://localhost:8080/","height":273}},"source":["grants.sort_values(\"patents\", ascending=False).head(5)"],"execution_count":0,"outputs":[{"output_type":"execute_result","data":{"application/vnd.google.colaboratory.module+javascript":"\n      import \"https://ssl.gstatic.com/colaboratory/data_table/9e554b27bdd509f3/data_table.js\";\n\n      window.createDataTable({\n        data: [[{\n            'v': 4250,\n            'f': \"4250\",\n        },\n\"grant.2452138\",\n\"R01AI030904\",\n\"Protective CMI mechanisms of a dual-subtype FIV vaccine\",\n{\n            'v': 4213791,\n            'f': \"4213791\",\n        },\n\"1991-08-01\",\n{\n            'v': 1991.0,\n            'f': \"1991.0\",\n        },\n\"2015-03-31\",\n{\n            'v': 2015,\n            'f': \"2015\",\n        },\n\"University of Florida\",\n\"grid.15276.37\",\n\"United States\",\n\"National Institute of Allergy and Infectious Diseases\",\n\"United States\",\n{\n            'v': 31,\n            'f': \"31\",\n        },\n{\n            'v': 28,\n            'f': \"28\",\n        }],\n [{\n            'v': 4800,\n            'f': \"4800\",\n        },\n\"grant.2643965\",\n\"R43CA081752\",\n\"A NEW CANDIDATE VACCINE FOR LEUKEMIA AND CANCER\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"1999-09-08\",\n{\n            'v': 1999.0,\n            'f': \"1999.0\",\n        },\n\"2000-06-30\",\n{\n            'v': 2000,\n            'f': \"2000\",\n        },\n\"Corixa Corporation\",\n\"grid.284594.6\",\n\"United States\",\n\"National Cancer Institute\",\n\"United States\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n{\n            'v': 20,\n            'f': \"20\",\n        }],\n [{\n            'v': 737,\n            'f': \"737\",\n        },\n\"grant.2424402\",\n\"N01AI005396\",\n\"HIV Vaccine Design and Development Teams-26605396\",\n{\n            'v': 7545418,\n            'f': \"7545418\",\n        },\n\"2000-06-05\",\n{\n            'v': 2000.0,\n            'f': \"2000.0\",\n        },\n\"2005-06-04\",\n{\n            'v': 2005,\n            'f': \"2005\",\n        },\n\"Novartis (United States)\",\n\"grid.418424.f\",\n\"United States\",\n\"National Institute of Allergy and Infectious Diseases\",\n\"United States\",\n{\n            'v': 29,\n            'f': \"29\",\n        },\n{\n            'v': 13,\n            'f': \"13\",\n        }],\n [{\n            'v': 2684,\n            'f': \"2684\",\n        },\n\"grant.2687918\",\n\"U01AI070443\",\n\"Preclinical development of a chimeric tetravalent dengue vaccine\",\n{\n            'v': 2873420,\n            'f': \"2873420\",\n        },\n\"2006-09-26\",\n{\n            'v': 2006.0,\n            'f': \"2006.0\",\n        },\n\"2010-08-31\",\n{\n            'v': 2010,\n            'f': \"2010\",\n        },\n\"Takeda (United States)\",\n\"grid.419849.9\",\n\"United States\",\n\"National Institute of Allergy and Infectious Diseases\",\n\"United States\",\n{\n            'v': 3,\n            'f': \"3\",\n        },\n{\n            'v': 11,\n            'f': \"11\",\n        }],\n [{\n            'v': 2722,\n            'f': \"2722\",\n        },\n\"grant.2474639\",\n\"R01CA084232\",\n\"Cell-based tumor vaccines targeting CD4+ T lymphocytes\",\n{\n            'v': 2595114,\n            'f': \"2595114\",\n        },\n\"2000-04-01\",\n{\n            'v': 2000.0,\n            'f': \"2000.0\",\n        },\n\"2014-01-31\",\n{\n            'v': 2014,\n            'f': \"2014\",\n        },\n\"University of Maryland, Baltimore County\",\n\"grid.266673.0\",\n\"United States\",\n\"National Cancer Institute\",\n\"United States\",\n{\n            'v': 65,\n            'f': \"65\",\n        },\n{\n            'v': 10,\n            'f': \"10\",\n        }]],\n        columns: [[\"number\", \"index\"], [\"string\", \"Grant ID\"], [\"string\", \"Grant Number\"], [\"string\", \"Title\"], [\"number\", \"Funding Amount in USD\"], [\"string\", \"Start Date\"], [\"number\", \"Start Year\"], [\"string\", \"End Date\"], [\"number\", \"End Year\"], [\"string\", \"Research Organization - standardized\"], [\"string\", \"GRID ID\"], [\"string\", \"Country of Research organization\"], [\"string\", \"Funder\"], [\"string\", \"Funder Country\"], [\"number\", \"pubs\"], [\"number\", \"patents\"]],\n        columnOptions: [{\"width\": \"1px\", \"className\": \"index_column\"}],\n        rowsPerPage: 25,\n        helpUrl: \"https://colab.research.google.com/notebooks/data_table.ipynb\",\n      });\n    ","text/html":["<div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>Grant ID</th>\n","      <th>Grant Number</th>\n","      <th>Title</th>\n","      <th>Funding Amount in USD</th>\n","      <th>Start Date</th>\n","      <th>Start Year</th>\n","      <th>End Date</th>\n","      <th>End Year</th>\n","      <th>Research Organization - standardized</th>\n","      <th>GRID ID</th>\n","      <th>Country of Research organization</th>\n","      <th>Funder</th>\n","      <th>Funder Country</th>\n","      <th>pubs</th>\n","      <th>patents</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>4250</th>\n","      <td>grant.2452138</td>\n","      <td>R01AI030904</td>\n","      <td>Protective CMI mechanisms of a dual-subtype FI...</td>\n","      <td>4213791</td>\n","      <td>1991-08-01</td>\n","      <td>1991.0</td>\n","      <td>2015-03-31</td>\n","      <td>2015</td>\n","      <td>University of Florida</td>\n","      <td>grid.15276.37</td>\n","      <td>United States</td>\n","      <td>National Institute of Allergy and Infectious D...</td>\n","      <td>United States</td>\n","      <td>31</td>\n","      <td>28</td>\n","    </tr>\n","    <tr>\n","      <th>4800</th>\n","      <td>grant.2643965</td>\n","      <td>R43CA081752</td>\n","      <td>A NEW CANDIDATE VACCINE FOR LEUKEMIA AND CANCER</td>\n","      <td>0</td>\n","      <td>1999-09-08</td>\n","      <td>1999.0</td>\n","      <td>2000-06-30</td>\n","      <td>2000</td>\n","      <td>Corixa Corporation</td>\n","      <td>grid.284594.6</td>\n","      <td>United States</td>\n","      <td>National Cancer Institute</td>\n","      <td>United States</td>\n","      <td>0</td>\n","      <td>20</td>\n","    </tr>\n","    <tr>\n","      <th>737</th>\n","      <td>grant.2424402</td>\n","      <td>N01AI005396</td>\n","      <td>HIV Vaccine Design and Development Teams-26605396</td>\n","      <td>7545418</td>\n","      <td>2000-06-05</td>\n","      <td>2000.0</td>\n","      <td>2005-06-04</td>\n","      <td>2005</td>\n","      <td>Novartis (United States)</td>\n","      <td>grid.418424.f</td>\n","      <td>United States</td>\n","      <td>National Institute of Allergy and Infectious D...</td>\n","      <td>United States</td>\n","      <td>29</td>\n","      <td>13</td>\n","    </tr>\n","    <tr>\n","      <th>2684</th>\n","      <td>grant.2687918</td>\n","      <td>U01AI070443</td>\n","      <td>Preclinical development of a chimeric tetraval...</td>\n","      <td>2873420</td>\n","      <td>2006-09-26</td>\n","      <td>2006.0</td>\n","      <td>2010-08-31</td>\n","      <td>2010</td>\n","      <td>Takeda (United States)</td>\n","      <td>grid.419849.9</td>\n","      <td>United States</td>\n","      <td>National Institute of Allergy and Infectious D...</td>\n","      <td>United States</td>\n","      <td>3</td>\n","      <td>11</td>\n","    </tr>\n","    <tr>\n","      <th>2722</th>\n","      <td>grant.2474639</td>\n","      <td>R01CA084232</td>\n","      <td>Cell-based tumor vaccines targeting CD4+ T lym...</td>\n","      <td>2595114</td>\n","      <td>2000-04-01</td>\n","      <td>2000.0</td>\n","      <td>2014-01-31</td>\n","      <td>2014</td>\n","      <td>University of Maryland, Baltimore County</td>\n","      <td>grid.266673.0</td>\n","      <td>United States</td>\n","      <td>National Cancer Institute</td>\n","      <td>United States</td>\n","      <td>65</td>\n","      <td>10</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>"],"text/plain":["           Grant ID Grant Number  ... pubs  patents\n","4250  grant.2452138  R01AI030904  ...   31       28\n","4800  grant.2643965  R43CA081752  ...    0       20\n","737   grant.2424402  N01AI005396  ...   29       13\n","2684  grant.2687918  U01AI070443  ...    3       11\n","2722  grant.2474639  R01CA084232  ...   65       10\n","\n","[5 rows x 15 columns]"]},"metadata":{"tags":[]},"execution_count":12}]},{"cell_type":"markdown","metadata":{"colab_type":"text","id":"p3WLpzgLK0qC"},"source":["## Extracting linked Clinical Trials data\n","\n","Now we can repeat the same process once more, for Clinical Trials. The field we need is called  `associated_grant_ids`  (see also the [clinical trials](https://docs.dimensions.ai/dsl/data-sources.html#clinical-trials) docs). \n","\n","As with patents, we can iterate 400 grants at a time cause in general there is much less associated content per grant (compared to publications)."]},{"cell_type":"code","metadata":{"colab_type":"code","outputId":"86d41bb0-cbf4-421f-9489-807a9ed2f4ad","executionInfo":{"status":"ok","timestamp":1573588618819,"user_tz":0,"elapsed":57159,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"id":"NAsb9swiXfTy","colab":{"resources":{"http://localhost:8080/nbextensions/google.colab/colabwidgets/controls.css":{"data":"/* Copyright (c) Jupyter Development Team.
 * Distributed under the terms of the Modified BSD License.
 */

 /* We import all of these together in a single css file because the Webpack
loader sees only one file at a time. This allows postcss to see the variable
definitions when they are used. */

 /*-----------------------------------------------------------------------------
| Copyright (c) Jupyter Development Team.
| Distributed under the terms of the Modified BSD License.
|----------------------------------------------------------------------------*/

 /*
This file is copied from the JupyterLab project to define default styling for
when the widget styling is compiled down to eliminate CSS variables. We make one
change - we comment out the font import below.
*/

 /**
 * The material design colors are adapted from google-material-color v1.2.6
 * https://github.com/danlevan/google-material-color
 * https://github.com/danlevan/google-material-color/blob/f67ca5f4028b2f1b34862f64b0ca67323f91b088/dist/palette.var.css
 *
 * The license for the material design color CSS variables is as follows (see
 * https://github.com/danlevan/google-material-color/blob/f67ca5f4028b2f1b34862f64b0ca67323f91b088/LICENSE)
 *
 * The MIT License (MIT)
 *
 * Copyright (c) 2014 Dan Le Van
 *
 * Permission is hereby granted, free of charge, to any person obtaining a copy
 * of this software and associated documentation files (the "Software"), to deal
 * in the Software without restriction, including without limitation the rights
 * to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
 * copies of the Software, and to permit persons to whom the Software is
 * furnished to do so, subject to the following conditions:
 *
 * The above copyright notice and this permission notice shall be included in
 * all copies or substantial portions of the Software.
 *
 * THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
 * IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
 * FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
 * AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
 * LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
 * OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
 * SOFTWARE.
 */

 /*
The following CSS variables define the main, public API for styling JupyterLab.
These variables should be used by all plugins wherever possible. In other
words, plugins should not define custom colors, sizes, etc unless absolutely
necessary. This enables users to change the visual theme of JupyterLab
by changing these variables.

Many variables appear in an ordered sequence (0,1,2,3). These sequences
are designed to work well together, so for example, `--jp-border-color1` should
be used with `--jp-layout-color1`. The numbers have the following meanings:

* 0: super-primary, reserved for special emphasis
* 1: primary, most important under normal situations
* 2: secondary, next most important under normal situations
* 3: tertiary, next most important under normal situations

Throughout JupyterLab, we are mostly following principles from Google's
Material Design when selecting colors. We are not, however, following
all of MD as it is not optimized for dense, information rich UIs.
*/

 /*
 * Optional monospace font for input/output prompt.
 */

 /* Commented out in ipywidgets since we don't need it. */

 /* @import url('https://fonts.googleapis.com/css?family=Roboto+Mono'); */

 /*
 * Added for compabitility with output area
 */

 :root {

  /* Borders

  The following variables, specify the visual styling of borders in JupyterLab.
   */

  /* UI Fonts

  The UI font CSS variables are used for the typography all of the JupyterLab
  user interface elements that are not directly user generated content.
  */ /* Base font size */ /* Ensures px perfect FontAwesome icons */

  /* Use these font colors against the corresponding main layout colors.
     In a light theme, these go from dark to light.
  */

  /* Use these against the brand/accent/warn/error colors.
     These will typically go from light to darker, in both a dark and light theme
   */

  /* Content Fonts

  Content font variables are used for typography of user generated content.
  */ /* Base font size */


  /* Layout

  The following are the main layout colors use in JupyterLab. In a light
  theme these would go from light to dark.
  */

  /* Brand/accent */

  /* State colors (warn, error, success, info) */

  /* Cell specific styles */
  /* A custom blend of MD grey and blue 600
   * See https://meyerweb.com/eric/tools/color-blend/#546E7A:1E88E5:5:hex */
  /* A custom blend of MD grey and orange 600
   * https://meyerweb.com/eric/tools/color-blend/#546E7A:F4511E:5:hex */

  /* Notebook specific styles */

  /* Console specific styles */

  /* Toolbar specific styles */
}

 /* Copyright (c) Jupyter Development Team.
 * Distributed under the terms of the Modified BSD License.
 */

 /*
 * We assume that the CSS variables in
 * https://github.com/jupyterlab/jupyterlab/blob/master/src/default-theme/variables.css
 * have been defined.
 */

 /* This file has code derived from PhosphorJS CSS files, as noted below. The license for this PhosphorJS code is:

Copyright (c) 2014-2017, PhosphorJS Contributors
All rights reserved.

Redistribution and use in source and binary forms, with or without
modification, are permitted provided that the following conditions are met:

* Redistributions of source code must retain the above copyright notice, this
  list of conditions and the following disclaimer.

* Redistributions in binary form must reproduce the above copyright notice,
  this list of conditions and the following disclaimer in the documentation
  and/or other materials provided with the distribution.

* Neither the name of the copyright holder nor the names of its
  contributors may be used to endorse or promote products derived from
  this software without specific prior written permission.

THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS "AS IS"
AND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE
IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE ARE
DISCLAIMED. IN NO EVENT SHALL THE COPYRIGHT HOLDER OR CONTRIBUTORS BE LIABLE
FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL
DAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR
SERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS INTERRUPTION) HOWEVER
CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY,
OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE
OF THIS SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.

*/

 /*
 * The following section is derived from https://github.com/phosphorjs/phosphor/blob/23b9d075ebc5b73ab148b6ebfc20af97f85714c4/packages/widgets/style/tabbar.css 
 * We've scoped the rules so that they are consistent with exactly our code.
 */

 .jupyter-widgets.widget-tab > .p-TabBar {
  display: -webkit-box;
  display: -ms-flexbox;
  display: flex;
  -webkit-user-select: none;
  -moz-user-select: none;
  -ms-user-select: none;
  user-select: none;
}

 .jupyter-widgets.widget-tab > .p-TabBar[data-orientation='horizontal'] {
  -webkit-box-orient: horizontal;
  -webkit-box-direction: normal;
      -ms-flex-direction: row;
          flex-direction: row;
}

 .jupyter-widgets.widget-tab > .p-TabBar[data-orientation='vertical'] {
  -webkit-box-orient: vertical;
  -webkit-box-direction: normal;
      -ms-flex-direction: column;
          flex-direction: column;
}

 .jupyter-widgets.widget-tab > .p-TabBar > .p-TabBar-content {
  margin: 0;
  padding: 0;
  display: -webkit-box;
  display: -ms-flexbox;
  display: flex;
  -webkit-box-flex: 1;
      -ms-flex: 1 1 auto;
          flex: 1 1 auto;
  list-style-type: none;
}

 .jupyter-widgets.widget-tab > .p-TabBar[data-orientation='horizontal'] > .p-TabBar-content {
  -webkit-box-orient: horizontal;
  -webkit-box-direction: normal;
      -ms-flex-direction: row;
          flex-direction: row;
}

 .jupyter-widgets.widget-tab > .p-TabBar[data-orientation='vertical'] > .p-TabBar-content {
  -webkit-box-orient: vertical;
  -webkit-box-direction: normal;
      -ms-flex-direction: column;
          flex-direction: column;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab {
  display: -webkit-box;
  display: -ms-flexbox;
  display: flex;
  -webkit-box-orient: horizontal;
  -webkit-box-direction: normal;
      -ms-flex-direction: row;
          flex-direction: row;
  -webkit-box-sizing: border-box;
          box-sizing: border-box;
  overflow: hidden;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabIcon,
.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabCloseIcon {
  -webkit-box-flex: 0;
      -ms-flex: 0 0 auto;
          flex: 0 0 auto;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabLabel {
  -webkit-box-flex: 1;
      -ms-flex: 1 1 auto;
          flex: 1 1 auto;
  overflow: hidden;
  white-space: nowrap;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab.p-mod-hidden {
  display: none !important;
}

 .jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging .p-TabBar-tab {
  position: relative;
}

 .jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging[data-orientation='horizontal'] .p-TabBar-tab {
  left: 0;
  -webkit-transition: left 150ms ease;
  transition: left 150ms ease;
}

 .jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging[data-orientation='vertical'] .p-TabBar-tab {
  top: 0;
  -webkit-transition: top 150ms ease;
  transition: top 150ms ease;
}

 .jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging .p-TabBar-tab.p-mod-dragging {
  -webkit-transition: none;
  transition: none;
}

 /* End tabbar.css */

 :root { /* margin between inline elements */

    /* From Material Design Lite */
}

 .jupyter-widgets {
    margin: 2px;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    color: black;
    overflow: visible;
}

 .jupyter-widgets.jupyter-widgets-disconnected::before {
    line-height: 28px;
    height: 28px;
}

 .jp-Output-result > .jupyter-widgets {
    margin-left: 0;
    margin-right: 0;
}

 /* vbox and hbox */

 .widget-inline-hbox {
    /* Horizontal widgets */
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: horizontal;
    -webkit-box-direction: normal;
        -ms-flex-direction: row;
            flex-direction: row;
    -webkit-box-align: baseline;
        -ms-flex-align: baseline;
            align-items: baseline;
}

 .widget-inline-vbox {
    /* Vertical Widgets */
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
    -webkit-box-align: center;
        -ms-flex-align: center;
            align-items: center;
}

 .widget-box {
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    margin: 0;
    overflow: auto;
}

 .widget-gridbox {
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    display: grid;
    margin: 0;
    overflow: auto;
}

 .widget-hbox {
    -webkit-box-orient: horizontal;
    -webkit-box-direction: normal;
        -ms-flex-direction: row;
            flex-direction: row;
}

 .widget-vbox {
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
}

 /* General Button Styling */

 .jupyter-button {
    padding-left: 10px;
    padding-right: 10px;
    padding-top: 0px;
    padding-bottom: 0px;
    display: inline-block;
    white-space: nowrap;
    overflow: hidden;
    text-overflow: ellipsis;
    text-align: center;
    font-size: 13px;
    cursor: pointer;

    height: 28px;
    border: 0px solid;
    line-height: 28px;
    -webkit-box-shadow: none;
            box-shadow: none;

    color: rgba(0, 0, 0, .8);
    background-color: #EEEEEE;
    border-color: #E0E0E0;
    border: none;
}

 .jupyter-button i.fa {
    margin-right: 4px;
    pointer-events: none;
}

 .jupyter-button:empty:before {
    content: "\200b"; /* zero-width space */
}

 .jupyter-widgets.jupyter-button:disabled {
    opacity: 0.6;
}

 .jupyter-button i.fa.center {
    margin-right: 0;
}

 .jupyter-button:hover:enabled, .jupyter-button:focus:enabled {
    /* MD Lite 2dp shadow */
    -webkit-box-shadow: 0 2px 2px 0 rgba(0, 0, 0, .14),
                0 3px 1px -2px rgba(0, 0, 0, .2),
                0 1px 5px 0 rgba(0, 0, 0, .12);
            box-shadow: 0 2px 2px 0 rgba(0, 0, 0, .14),
                0 3px 1px -2px rgba(0, 0, 0, .2),
                0 1px 5px 0 rgba(0, 0, 0, .12);
}

 .jupyter-button:active, .jupyter-button.mod-active {
    /* MD Lite 4dp shadow */
    -webkit-box-shadow: 0 4px 5px 0 rgba(0, 0, 0, .14),
                0 1px 10px 0 rgba(0, 0, 0, .12),
                0 2px 4px -1px rgba(0, 0, 0, .2);
            box-shadow: 0 4px 5px 0 rgba(0, 0, 0, .14),
                0 1px 10px 0 rgba(0, 0, 0, .12),
                0 2px 4px -1px rgba(0, 0, 0, .2);
    color: rgba(0, 0, 0, .8);
    background-color: #BDBDBD;
}

 .jupyter-button:focus:enabled {
    outline: 1px solid #64B5F6;
}

 /* Button "Primary" Styling */

 .jupyter-button.mod-primary {
    color: rgba(255, 255, 255, 1.0);
    background-color: #2196F3;
}

 .jupyter-button.mod-primary.mod-active {
    color: rgba(255, 255, 255, 1);
    background-color: #1976D2;
}

 .jupyter-button.mod-primary:active {
    color: rgba(255, 255, 255, 1);
    background-color: #1976D2;
}

 /* Button "Success" Styling */

 .jupyter-button.mod-success {
    color: rgba(255, 255, 255, 1.0);
    background-color: #4CAF50;
}

 .jupyter-button.mod-success.mod-active {
    color: rgba(255, 255, 255, 1);
    background-color: #388E3C;
 }

 .jupyter-button.mod-success:active {
    color: rgba(255, 255, 255, 1);
    background-color: #388E3C;
 }

 /* Button "Info" Styling */

 .jupyter-button.mod-info {
    color: rgba(255, 255, 255, 1.0);
    background-color: #00BCD4;
}

 .jupyter-button.mod-info.mod-active {
    color: rgba(255, 255, 255, 1);
    background-color: #0097A7;
}

 .jupyter-button.mod-info:active {
    color: rgba(255, 255, 255, 1);
    background-color: #0097A7;
}

 /* Button "Warning" Styling */

 .jupyter-button.mod-warning {
    color: rgba(255, 255, 255, 1.0);
    background-color: #FF9800;
}

 .jupyter-button.mod-warning.mod-active {
    color: rgba(255, 255, 255, 1);
    background-color: #F57C00;
}

 .jupyter-button.mod-warning:active {
    color: rgba(255, 255, 255, 1);
    background-color: #F57C00;
}

 /* Button "Danger" Styling */

 .jupyter-button.mod-danger {
    color: rgba(255, 255, 255, 1.0);
    background-color: #F44336;
}

 .jupyter-button.mod-danger.mod-active {
    color: rgba(255, 255, 255, 1);
    background-color: #D32F2F;
}

 .jupyter-button.mod-danger:active {
    color: rgba(255, 255, 255, 1);
    background-color: #D32F2F;
}

 /* Widget Button*/

 .widget-button, .widget-toggle-button {
    width: 148px;
}

 /* Widget Label Styling */

 /* Override Bootstrap label css */

 .jupyter-widgets label {
    margin-bottom: 0;
    margin-bottom: initial;
}

 .widget-label-basic {
    /* Basic Label */
    color: black;
    font-size: 13px;
    overflow: hidden;
    text-overflow: ellipsis;
    white-space: nowrap;
    line-height: 28px;
}

 .widget-label {
    /* Label */
    color: black;
    font-size: 13px;
    overflow: hidden;
    text-overflow: ellipsis;
    white-space: nowrap;
    line-height: 28px;
}

 .widget-inline-hbox .widget-label {
    /* Horizontal Widget Label */
    color: black;
    text-align: right;
    margin-right: 8px;
    width: 80px;
    -ms-flex-negative: 0;
        flex-shrink: 0;
}

 .widget-inline-vbox .widget-label {
    /* Vertical Widget Label */
    color: black;
    text-align: center;
    line-height: 28px;
}

 /* Widget Readout Styling */

 .widget-readout {
    color: black;
    font-size: 13px;
    height: 28px;
    line-height: 28px;
    overflow: hidden;
    white-space: nowrap;
    text-align: center;
}

 .widget-readout.overflow {
    /* Overflowing Readout */

    /* From Material Design Lite
        shadow-key-umbra-opacity: 0.2;
        shadow-key-penumbra-opacity: 0.14;
        shadow-ambient-shadow-opacity: 0.12;
     */
    -webkit-box-shadow: 0 2px 2px 0 rgba(0, 0, 0, .2),
                        0 3px 1px -2px rgba(0, 0, 0, .14),
                        0 1px 5px 0 rgba(0, 0, 0, .12);

    box-shadow: 0 2px 2px 0 rgba(0, 0, 0, .2),
                0 3px 1px -2px rgba(0, 0, 0, .14),
                0 1px 5px 0 rgba(0, 0, 0, .12);
}

 .widget-inline-hbox .widget-readout {
    /* Horizontal Readout */
    text-align: center;
    max-width: 148px;
    min-width: 72px;
    margin-left: 4px;
}

 .widget-inline-vbox .widget-readout {
    /* Vertical Readout */
    margin-top: 4px;
    /* as wide as the widget */
    width: inherit;
}

 /* Widget Checkbox Styling */

 .widget-checkbox {
    width: 300px;
    height: 28px;
    line-height: 28px;
}

 .widget-checkbox input[type="checkbox"] {
    margin: 0px 8px 0px 0px;
    line-height: 28px;
    font-size: large;
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    -ms-flex-negative: 0;
        flex-shrink: 0;
    -ms-flex-item-align: center;
        align-self: center;
}

 /* Widget Valid Styling */

 .widget-valid {
    height: 28px;
    line-height: 28px;
    width: 148px;
    font-size: 13px;
}

 .widget-valid i:before {
    line-height: 28px;
    margin-right: 4px;
    margin-left: 4px;

    /* from the fa class in FontAwesome: https://github.com/FortAwesome/Font-Awesome/blob/49100c7c3a7b58d50baa71efef11af41a66b03d3/css/font-awesome.css#L14 */
    display: inline-block;
    font: normal normal normal 14px/1 FontAwesome;
    font-size: inherit;
    text-rendering: auto;
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
}

 .widget-valid.mod-valid i:before {
    content: "\f00c";
    color: green;
}

 .widget-valid.mod-invalid i:before {
    content: "\f00d";
    color: red;
}

 .widget-valid.mod-valid .widget-valid-readout {
    display: none;
}

 /* Widget Text and TextArea Stying */

 .widget-textarea, .widget-text {
    width: 300px;
}

 .widget-text input[type="text"], .widget-text input[type="number"]{
    height: 28px;
    line-height: 28px;
}

 .widget-text input[type="text"]:disabled, .widget-text input[type="number"]:disabled, .widget-textarea textarea:disabled {
    opacity: 0.6;
}

 .widget-text input[type="text"], .widget-text input[type="number"], .widget-textarea textarea {
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    border: 1px solid #9E9E9E;
    background-color: white;
    color: rgba(0, 0, 0, .8);
    font-size: 13px;
    padding: 4px 8px;
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    min-width: 0; /* This makes it possible for the flexbox to shrink this input */
    -ms-flex-negative: 1;
        flex-shrink: 1;
    outline: none !important;
}

 .widget-textarea textarea {
    height: inherit;
    width: inherit;
}

 .widget-text input:focus, .widget-textarea textarea:focus {
    border-color: #64B5F6;
}

 /* Widget Slider */

 .widget-slider .ui-slider {
    /* Slider Track */
    border: 1px solid #BDBDBD;
    background: #BDBDBD;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    position: relative;
    border-radius: 0px;
}

 .widget-slider .ui-slider .ui-slider-handle {
    /* Slider Handle */
    outline: none !important; /* focused slider handles are colored - see below */
    position: absolute;
    background-color: white;
    border: 1px solid #9E9E9E;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    z-index: 1;
    background-image: none; /* Override jquery-ui */
}

 /* Override jquery-ui */

 .widget-slider .ui-slider .ui-slider-handle:hover, .widget-slider .ui-slider .ui-slider-handle:focus {
    background-color: #2196F3;
    border: 1px solid #2196F3;
}

 .widget-slider .ui-slider .ui-slider-handle:active {
    background-color: #2196F3;
    border-color: #2196F3;
    z-index: 2;
    -webkit-transform: scale(1.2);
            transform: scale(1.2);
}

 .widget-slider  .ui-slider .ui-slider-range {
    /* Interval between the two specified value of a double slider */
    position: absolute;
    background: #2196F3;
    z-index: 0;
}

 /* Shapes of Slider Handles */

 .widget-hslider .ui-slider .ui-slider-handle {
    width: 16px;
    height: 16px;
    margin-top: -7px;
    margin-left: -7px;
    border-radius: 50%;
    top: 0;
}

 .widget-vslider .ui-slider .ui-slider-handle {
    width: 16px;
    height: 16px;
    margin-bottom: -7px;
    margin-left: -7px;
    border-radius: 50%;
    left: 0;
}

 .widget-hslider .ui-slider .ui-slider-range {
    height: 8px;
    margin-top: -3px;
}

 .widget-vslider .ui-slider .ui-slider-range {
    width: 8px;
    margin-left: -3px;
}

 /* Horizontal Slider */

 .widget-hslider {
    width: 300px;
    height: 28px;
    line-height: 28px;

    /* Override the align-items baseline. This way, the description and readout
    still seem to align their baseline properly, and we don't have to have
    align-self: stretch in the .slider-container. */
    -webkit-box-align: center;
        -ms-flex-align: center;
            align-items: center;
}

 .widgets-slider .slider-container {
    overflow: visible;
}

 .widget-hslider .slider-container {
    height: 28px;
    margin-left: 6px;
    margin-right: 6px;
    -webkit-box-flex: 1;
        -ms-flex: 1 1 148px;
            flex: 1 1 148px;
}

 .widget-hslider .ui-slider {
    /* Inner, invisible slide div */
    height: 4px;
    margin-top: 12px;
    width: 100%;
}

 /* Vertical Slider */

 .widget-vbox .widget-label {
    height: 28px;
    line-height: 28px;
}

 .widget-vslider {
    /* Vertical Slider */
    height: 200px;
    width: 72px;
}

 .widget-vslider .slider-container {
    -webkit-box-flex: 1;
        -ms-flex: 1 1 148px;
            flex: 1 1 148px;
    margin-left: auto;
    margin-right: auto;
    margin-bottom: 6px;
    margin-top: 6px;
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
}

 .widget-vslider .ui-slider-vertical {
    /* Inner, invisible slide div */
    width: 4px;
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    margin-left: auto;
    margin-right: auto;
}

 /* Widget Progress Styling */

 .progress-bar {
    -webkit-transition: none;
    transition: none;
}

 .progress-bar {
    height: 28px;
}

 .progress-bar {
    background-color: #2196F3;
}

 .progress-bar-success {
    background-color: #4CAF50;
}

 .progress-bar-info {
    background-color: #00BCD4;
}

 .progress-bar-warning {
    background-color: #FF9800;
}

 .progress-bar-danger {
    background-color: #F44336;
}

 .progress {
    background-color: #EEEEEE;
    border: none;
    -webkit-box-shadow: none;
            box-shadow: none;
}

 /* Horisontal Progress */

 .widget-hprogress {
    /* Progress Bar */
    height: 28px;
    line-height: 28px;
    width: 300px;
    -webkit-box-align: center;
        -ms-flex-align: center;
            align-items: center;

}

 .widget-hprogress .progress {
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    margin-top: 4px;
    margin-bottom: 4px;
    -ms-flex-item-align: stretch;
        align-self: stretch;
    /* Override bootstrap style */
    height: auto;
    height: initial;
}

 /* Vertical Progress */

 .widget-vprogress {
    height: 200px;
    width: 72px;
}

 .widget-vprogress .progress {
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    width: 20px;
    margin-left: auto;
    margin-right: auto;
    margin-bottom: 0;
}

 /* Select Widget Styling */

 .widget-dropdown {
    height: 28px;
    width: 300px;
    line-height: 28px;
}

 .widget-dropdown > select {
    padding-right: 20px;
    border: 1px solid #9E9E9E;
    border-radius: 0;
    height: inherit;
    -webkit-box-flex: 1;
        -ms-flex: 1 1 148px;
            flex: 1 1 148px;
    min-width: 0; /* This makes it possible for the flexbox to shrink this input */
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    outline: none !important;
    -webkit-box-shadow: none;
            box-shadow: none;
    background-color: white;
    color: rgba(0, 0, 0, .8);
    font-size: 13px;
    vertical-align: top;
    padding-left: 8px;
	appearance: none;
	-webkit-appearance: none;
	-moz-appearance: none;
    background-repeat: no-repeat;
	background-size: 20px;
	background-position: right center;
    background-image: url("data:image/svg+xml;base64,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");
}

 .widget-dropdown > select:focus {
    border-color: #64B5F6;
}

 .widget-dropdown > select:disabled {
    opacity: 0.6;
}

 /* To disable the dotted border in Firefox around select controls.
   See http://stackoverflow.com/a/18853002 */

 .widget-dropdown > select:-moz-focusring {
    color: transparent;
    text-shadow: 0 0 0 #000;
}

 /* Select and SelectMultiple */

 .widget-select {
    width: 300px;
    line-height: 28px;

    /* Because Firefox defines the baseline of a select as the bottom of the
    control, we align the entire control to the top and add padding to the
    select to get an approximate first line baseline alignment. */
    -webkit-box-align: start;
        -ms-flex-align: start;
            align-items: flex-start;
}

 .widget-select > select {
    border: 1px solid #9E9E9E;
    background-color: white;
    color: rgba(0, 0, 0, .8);
    font-size: 13px;
    -webkit-box-flex: 1;
        -ms-flex: 1 1 148px;
            flex: 1 1 148px;
    outline: none !important;
    overflow: auto;
    height: inherit;

    /* Because Firefox defines the baseline of a select as the bottom of the
    control, we align the entire control to the top and add padding to the
    select to get an approximate first line baseline alignment. */
    padding-top: 5px;
}

 .widget-select > select:focus {
    border-color: #64B5F6;
}

 .wiget-select > select > option {
    padding-left: 4px;
    line-height: 28px;
    /* line-height doesn't work on some browsers for select options */
    padding-top: calc(28px - var(--jp-widgets-font-size) / 2);
    padding-bottom: calc(28px - var(--jp-widgets-font-size) / 2);
}

 /* Toggle Buttons Styling */

 .widget-toggle-buttons {
    line-height: 28px;
}

 .widget-toggle-buttons .widget-toggle-button {
    margin-left: 2px;
    margin-right: 2px;
}

 .widget-toggle-buttons .jupyter-button:disabled {
    opacity: 0.6;
}

 /* Radio Buttons Styling */

 .widget-radio {
    width: 300px;
    line-height: 28px;
}

 .widget-radio-box {
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
    -webkit-box-align: stretch;
        -ms-flex-align: stretch;
            align-items: stretch;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    margin-bottom: 8px;
}

 .widget-radio-box label {
    height: 20px;
    line-height: 20px;
    font-size: 13px;
}

 .widget-radio-box input {
    height: 20px;
    line-height: 20px;
    margin: 0 8px 0 1px;
    float: left;
}

 /* Color Picker Styling */

 .widget-colorpicker {
    width: 300px;
    height: 28px;
    line-height: 28px;
}

 .widget-colorpicker > .widget-colorpicker-input {
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    -ms-flex-negative: 1;
        flex-shrink: 1;
    min-width: 72px;
}

 .widget-colorpicker input[type="color"] {
    width: 28px;
    height: 28px;
    padding: 0 2px; /* make the color square actually square on Chrome on OS X */
    background: white;
    color: rgba(0, 0, 0, .8);
    border: 1px solid #9E9E9E;
    border-left: none;
    -webkit-box-flex: 0;
        -ms-flex-positive: 0;
            flex-grow: 0;
    -ms-flex-negative: 0;
        flex-shrink: 0;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    -ms-flex-item-align: stretch;
        align-self: stretch;
    outline: none !important;
}

 .widget-colorpicker.concise input[type="color"] {
    border-left: 1px solid #9E9E9E;
}

 .widget-colorpicker input[type="color"]:focus, .widget-colorpicker input[type="text"]:focus {
    border-color: #64B5F6;
}

 .widget-colorpicker input[type="text"] {
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    outline: none !important;
    height: 28px;
    line-height: 28px;
    background: white;
    color: rgba(0, 0, 0, .8);
    border: 1px solid #9E9E9E;
    font-size: 13px;
    padding: 4px 8px;
    min-width: 0; /* This makes it possible for the flexbox to shrink this input */
    -ms-flex-negative: 1;
        flex-shrink: 1;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
}

 .widget-colorpicker input[type="text"]:disabled {
    opacity: 0.6;
}

 /* Date Picker Styling */

 .widget-datepicker {
    width: 300px;
    height: 28px;
    line-height: 28px;
}

 .widget-datepicker input[type="date"] {
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    -ms-flex-negative: 1;
        flex-shrink: 1;
    min-width: 0; /* This makes it possible for the flexbox to shrink this input */
    outline: none !important;
    height: 28px;
    border: 1px solid #9E9E9E;
    background-color: white;
    color: rgba(0, 0, 0, .8);
    font-size: 13px;
    padding: 4px 8px;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
}

 .widget-datepicker input[type="date"]:focus {
    border-color: #64B5F6;
}

 .widget-datepicker input[type="date"]:invalid {
    border-color: #FF9800;
}

 .widget-datepicker input[type="date"]:disabled {
    opacity: 0.6;
}

 /* Play Widget */

 .widget-play {
    width: 148px;
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-align: stretch;
        -ms-flex-align: stretch;
            align-items: stretch;
}

 .widget-play .jupyter-button {
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    height: auto;
}

 .widget-play .jupyter-button:disabled {
    opacity: 0.6;
}

 /* Tab Widget */

 .jupyter-widgets.widget-tab {
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
}

 .jupyter-widgets.widget-tab > .p-TabBar {
    /* Necessary so that a tab can be shifted down to overlay the border of the box below. */
    overflow-x: visible;
    overflow-y: visible;
}

 .jupyter-widgets.widget-tab > .p-TabBar > .p-TabBar-content {
    /* Make sure that the tab grows from bottom up */
    -webkit-box-align: end;
        -ms-flex-align: end;
            align-items: flex-end;
    min-width: 0;
    min-height: 0;
}

 .jupyter-widgets.widget-tab > .widget-tab-contents {
    width: 100%;
    -webkit-box-sizing: border-box;
            box-sizing: border-box;
    margin: 0;
    background: white;
    color: rgba(0, 0, 0, .8);
    border: 1px solid #9E9E9E;
    padding: 15px;
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    overflow: auto;
}

 .jupyter-widgets.widget-tab > .p-TabBar {
    font: 13px Helvetica, Arial, sans-serif;
    min-height: 25px;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab {
    -webkit-box-flex: 0;
        -ms-flex: 0 1 144px;
            flex: 0 1 144px;
    min-width: 35px;
    min-height: 25px;
    line-height: 24px;
    margin-left: -1px;
    padding: 0px 10px;
    background: #EEEEEE;
    color: rgba(0, 0, 0, .5);
    border: 1px solid #9E9E9E;
    border-bottom: none;
    position: relative;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab.p-mod-current {
    color: rgba(0, 0, 0, 1.0);
    /* We want the background to match the tab content background */
    background: white;
    min-height: 26px;
    -webkit-transform: translateY(1px);
            transform: translateY(1px);
    overflow: visible;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab.p-mod-current:before {
    position: absolute;
    top: -1px;
    left: -1px;
    content: '';
    height: 2px;
    width: calc(100% + 2px);
    background: #2196F3;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab:first-child {
    margin-left: 0;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab:hover:not(.p-mod-current) {
    background: white;
    color: rgba(0, 0, 0, .8);
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-mod-closable > .p-TabBar-tabCloseIcon {
    margin-left: 4px;
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-mod-closable > .p-TabBar-tabCloseIcon:before {
    font-family: FontAwesome;
    content: '\f00d'; /* close */
}

 .jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabIcon,
.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabLabel,
.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabCloseIcon {
    line-height: 24px;
}

 /* Accordion Widget */

 .p-Collapse {
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
    -webkit-box-align: stretch;
        -ms-flex-align: stretch;
            align-items: stretch;
}

 .p-Collapse-header {
    padding: 4px;
    cursor: pointer;
    color: rgba(0, 0, 0, .5);
    background-color: #EEEEEE;
    border: 1px solid #9E9E9E;
    padding: 10px 15px;
    font-weight: bold;
}

 .p-Collapse-header:hover {
    background-color: white;
    color: rgba(0, 0, 0, .8);
}

 .p-Collapse-open > .p-Collapse-header {
    background-color: white;
    color: rgba(0, 0, 0, 1.0);
    cursor: default;
    border-bottom: none;
}

 .p-Collapse .p-Collapse-header::before {
    content: '\f0da\00A0';  /* caret-right, non-breaking space */
    display: inline-block;
    font: normal normal normal 14px/1 FontAwesome;
    font-size: inherit;
    text-rendering: auto;
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
}

 .p-Collapse-open > .p-Collapse-header::before {
    content: '\f0d7\00A0'; /* caret-down, non-breaking space */
}

 .p-Collapse-contents {
    padding: 15px;
    background-color: white;
    color: rgba(0, 0, 0, .8);
    border-left: 1px solid #9E9E9E;
    border-right: 1px solid #9E9E9E;
    border-bottom: 1px solid #9E9E9E;
    overflow: auto;
}

 .p-Accordion {
    display: -webkit-box;
    display: -ms-flexbox;
    display: flex;
    -webkit-box-orient: vertical;
    -webkit-box-direction: normal;
        -ms-flex-direction: column;
            flex-direction: column;
    -webkit-box-align: stretch;
        -ms-flex-align: stretch;
            align-items: stretch;
}

 .p-Accordion .p-Collapse {
    margin-bottom: 0;
}

 .p-Accordion .p-Collapse + .p-Collapse {
    margin-top: 4px;
}

 /* HTML widget */

 .widget-html, .widget-htmlmath {
    font-size: 13px;
}

 .widget-html > .widget-html-content, .widget-htmlmath > .widget-html-content {
    /* Fill out the area in the HTML widget */
    -ms-flex-item-align: stretch;
        align-self: stretch;
    -webkit-box-flex: 1;
        -ms-flex-positive: 1;
            flex-grow: 1;
    -ms-flex-negative: 1;
        flex-shrink: 1;
    /* Makes sure the baseline is still aligned with other elements */
    line-height: 28px;
    /* Make it possible to have absolutely-positioned elements in the html */
    position: relative;
}

/*# sourceMappingURL=data:application/json;base64,{"version":3,"sources":["../node_modules/@jupyter-widgets/controls/css/widgets.css","../node_modules/@jupyter-widgets/controls/css/labvariables.css","../node_modules/@jupyter-widgets/controls/css/materialcolors.css","../node_modules/@jupyter-widgets/controls/css/widgets-base.css","../node_modules/@jupyter-widgets/controls/css/phosphor.css"],"names":[],"mappings":"AAAA;;GAEG;;CAEF;;kCAEiC;;CCNlC;;;+EAG+E;;CAE/E;;;;EAIE;;CCTF;;;;;;;;;;;;;;;;;;;;;;;;;;;;;GA6BG;;CDhBH;;;;;;;;;;;;;;;;;;;EAmBE;;CAGF;;GAEG;;CACF,yDAAyD;;CAC1D,yEAAyE;;CAEzE;;GAEG;;CAOH;;EAEE;;;KAGG;;EAQH;;;;IAIE,CAIwB,oBAAoB,CAGhB,0CAA0C;;EAGxE;;IAEE;;EAOF;;KAEG;;EAOH;;;IAGE,CAWwB,oBAAoB;;;EAU9C;;;;IAIE;;EAOF,kBAAkB;;EAYlB,+CAA+C;;EAsB/C,0BAA0B;EAa1B;4EAC0E;EAE1E;wEACsE;;EAGtE,8BAA8B;;EAK9B,6BAA6B;;EAI7B,6BAA6B;CAQ9B;;CEzMD;;GAEG;;CAEH;;;;GAIG;;CCRH;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;EA8BE;;CAEF;;;GAGG;;CAEH;EACE,qBAAc;EAAd,qBAAc;EAAd,cAAc;EACd,0BAA0B;EAC1B,uBAAuB;EACvB,sBAAsB;EACtB,kBAAkB;CACnB;;CAGD;EACE,+BAAoB;EAApB,8BAAoB;MAApB,wBAAoB;UAApB,oBAAoB;CACrB;;CAGD;EACE,6BAAuB;EAAvB,8BAAuB;MAAvB,2BAAuB;UAAvB,uBAAuB;CACxB;;CAGD;EACE,UAAU;EACV,WAAW;EACX,qBAAc;EAAd,qBAAc;EAAd,cAAc;EACd,oBAAe;MAAf,mBAAe;UAAf,eAAe;EACf,sBAAsB;CACvB;;CAGD;EACE,+BAAoB;EAApB,8BAAoB;MAApB,wBAAoB;UAApB,oBAAoB;CACrB;;CAGD;EACE,6BAAuB;EAAvB,8BAAuB;MAAvB,2BAAuB;UAAvB,uBAAuB;CACxB;;CAGD;EACE,qBAAc;EAAd,qBAAc;EAAd,cAAc;EACd,+BAAoB;EAApB,8BAAoB;MAApB,wBAAoB;UAApB,oBAAoB;EACpB,+BAAuB;UAAvB,uBAAuB;EACvB,iBAAiB;CAClB;;CAGD;;EAEE,oBAAe;MAAf,mBAAe;UAAf,eAAe;CAChB;;CAGD;EACE,oBAAe;MAAf,mBAAe;UAAf,eAAe;EACf,iBAAiB;EACjB,oBAAoB;CACrB;;CAGD;EACE,yBAAyB;CAC1B;;CAGD;EACE,mBAAmB;CACpB;;CAGD;EACE,QAAQ;EACR,oCAA4B;EAA5B,4BAA4B;CAC7B;;CAGD;EACE,OAAO;EACP,mCAA2B;EAA3B,2BAA2B;CAC5B;;CAGD;EACE,yBAAiB;EAAjB,iBAAiB;CAClB;;CAED,oBAAoB;;CD9GpB,QAUqC,oCAAoC;;IA2BrE,+BAA+B;CAIlC;;CAED;IACI,YAAiC;IACjC,+BAAuB;YAAvB,uBAAuB;IACvB,aAA+B;IAC/B,kBAAkB;CACrB;;CAED;IACI,kBAA6C;IAC7C,aAAwC;CAC3C;;CAED;IACI,eAAe;IACf,gBAAgB;CACnB;;CAED,mBAAmB;;CAEnB;IACI,wBAAwB;IACxB,+BAAuB;YAAvB,uBAAuB;IACvB,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,+BAAoB;IAApB,8BAAoB;QAApB,wBAAoB;YAApB,oBAAoB;IACpB,4BAAsB;QAAtB,yBAAsB;YAAtB,sBAAsB;CACzB;;CAED;IACI,sBAAsB;IACtB,+BAAuB;YAAvB,uBAAuB;IACvB,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;IACvB,0BAAoB;QAApB,uBAAoB;YAApB,oBAAoB;CACvB;;CAED;IACI,+BAAuB;YAAvB,uBAAuB;IACvB,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,UAAU;IACV,eAAe;CAClB;;CAED;IACI,+BAAuB;YAAvB,uBAAuB;IACvB,cAAc;IACd,UAAU;IACV,eAAe;CAClB;;CAED;IACI,+BAAoB;IAApB,8BAAoB;QAApB,wBAAoB;YAApB,oBAAoB;CACvB;;CAED;IACI,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;CAC1B;;CAED,4BAA4B;;CAE5B;IACI,mBAAmB;IACnB,oBAAoB;IACpB,iBAAiB;IACjB,oBAAoB;IACpB,sBAAsB;IACtB,oBAAoB;IACpB,iBAAiB;IACjB,wBAAwB;IACxB,mBAAmB;IACnB,gBAAuC;IACvC,gBAAgB;;IAEhB,aAAwC;IACxC,kBAAkB;IAClB,kBAA6C;IAC7C,yBAAiB;YAAjB,iBAAiB;;IAEjB,yBAAgC;IAChC,0BAA0C;IAC1C,sBAAsC;IACtC,aAAa;CAChB;;CAED;IACI,kBAA8C;IAC9C,qBAAqB;CACxB;;CAED;IACI,iBAAiB,CAAC,sBAAsB;CAC3C;;CAED;IACI,aAA4C;CAC/C;;CAED;IACI,gBAAgB;CACnB;;CAED;IACI,wBAAwB;IACxB;;+CAE+E;YAF/E;;+CAE+E;CAClF;;CAED;IACI,wBAAwB;IACxB;;iDAE6E;YAF7E;;iDAE6E;IAC7E,yBAAgC;IAChC,0BAA0C;CAC7C;;CAED;IACI,2BAA8D;CACjE;;CAED,8BAA8B;;CAE9B;IACI,gCAAwC;IACxC,0BAAyC;CAC5C;;CAED;IACI,8BAAwC;IACxC,0BAAyC;CAC5C;;CAED;IACI,8BAAwC;IACxC,0BAAyC;CAC5C;;CAED,8BAA8B;;CAE9B;IACI,gCAAwC;IACxC,0BAA2C;CAC9C;;CAED;IACI,8BAAwC;IACxC,0BAA2C;EAC7C;;CAEF;IACI,8BAAwC;IACxC,0BAA2C;EAC7C;;CAED,2BAA2B;;CAE5B;IACI,gCAAwC;IACxC,0BAAwC;CAC3C;;CAED;IACI,8BAAwC;IACxC,0BAAwC;CAC3C;;CAED;IACI,8BAAwC;IACxC,0BAAwC;CAC3C;;CAED,8BAA8B;;CAE9B;IACI,gCAAwC;IACxC,0BAAwC;CAC3C;;CAED;IACI,8BAAwC;IACxC,0BAAwC;CAC3C;;CAED;IACI,8BAAwC;IACxC,0BAAwC;CAC3C;;CAED,6BAA6B;;CAE7B;IACI,gCAAwC;IACxC,0BAAyC;CAC5C;;CAED;IACI,8BAAwC;IACxC,0BAAyC;CAC5C;;CAED;IACI,8BAAwC;IACxC,0BAAyC;CAC5C;;CAED,kBAAkB;;CAElB;IACI,aAA4C;CAC/C;;CAED,0BAA0B;;CAE1B,kCAAkC;;CAClC;IACI,iBAAuB;IAAvB,uBAAuB;CAC1B;;CAED;IACI,iBAAiB;IACjB,aAAqC;IACrC,gBAAuC;IACvC,iBAAiB;IACjB,wBAAwB;IACxB,oBAAoB;IACpB,kBAA6C;CAChD;;CAED;IACI,WAAW;IACX,aAAqC;IACrC,gBAAuC;IACvC,iBAAiB;IACjB,wBAAwB;IACxB,oBAAoB;IACpB,kBAA6C;CAChD;;CAED;IACI,6BAA6B;IAC7B,aAAqC;IACrC,kBAAkB;IAClB,kBAA0D;IAC1D,YAA4C;IAC5C,qBAAe;QAAf,eAAe;CAClB;;CAED;IACI,2BAA2B;IAC3B,aAAqC;IACrC,mBAAmB;IACnB,kBAA6C;CAChD;;CAED,4BAA4B;;CAE5B;IACI,aAAuC;IACvC,gBAAuC;IACvC,aAAwC;IACxC,kBAA6C;IAC7C,iBAAiB;IACjB,oBAAoB;IACpB,mBAAmB;CACtB;;CAED;IACI,yBAAyB;;IAEzB;;;;OAIG;IACH;;uDAEoD;;IAMpD;;+CAE4C;CAC/C;;CAED;IACI,wBAAwB;IACxB,mBAAmB;IACnB,iBAAgD;IAChD,gBAA+C;IAC/C,iBAA6C;CAChD;;CAED;IACI,sBAAsB;IACtB,gBAA4C;IAC5C,2BAA2B;IAC3B,eAAe;CAClB;;CAED,6BAA6B;;CAE7B;IACI,aAAsC;IACtC,aAAwC;IACxC,kBAA6C;CAChD;;CAED;IACI,wBAAgE;IAChE,kBAA6C;IAC7C,iBAAiB;IACjB,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,qBAAe;QAAf,eAAe;IACf,4BAAmB;QAAnB,mBAAmB;CACtB;;CAED,0BAA0B;;CAE1B;IACI,aAAwC;IACxC,kBAA6C;IAC7C,aAA4C;IAC5C,gBAAuC;CAC1C;;CAED;IACI,kBAA6C;IAC7C,kBAA8C;IAC9C,iBAA6C;;IAE7C,0JAA0J;IAC1J,sBAAsB;IACtB,8CAA8C;IAC9C,mBAAmB;IACnB,qBAAqB;IACrB,oCAAoC;IACpC,mCAAmC;CACtC;;CAED;IACI,iBAAiB;IACjB,aAAa;CAChB;;CAED;IACI,iBAAiB;IACjB,WAAW;CACd;;CAED;IACI,cAAc;CACjB;;CAED,qCAAqC;;CAErC;IACI,aAAsC;CACzC;;CAED;IACI,aAAwC;IACxC,kBAA6C;CAChD;;CAED;IACI,aAA4C;CAC/C;;CAED;IACI,+BAAuB;YAAvB,uBAAuB;IACvB,0BAAwF;IACxF,wBAA2D;IAC3D,yBAAqC;IACrC,gBAAuC;IACvC,iBAAsF;IACtF,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,aAAa,CAAC,iEAAiE;IAC/E,qBAAe;QAAf,eAAe;IACf,yBAAyB;CAC5B;;CAED;IACI,gBAAgB;IAChB,eAAe;CAClB;;CAED;IACI,sBAAyD;CAC5D;;CAED,mBAAmB;;CAEnB;IACI,kBAAkB;IAClB,0BAA4E;IAC5E,oBAAoC;IACpC,+BAAuB;YAAvB,uBAAuB;IACvB,mBAAmB;IACnB,mBAAmB;CACtB;;CAED;IACI,mBAAmB;IACnB,yBAAyB,CAAC,oDAAoD;IAC9E,mBAAmB;IACnB,wBAAmE;IACnE,0BAAiG;IACjG,+BAAuB;YAAvB,uBAAuB;IACvB,WAAW;IACX,uBAAuB,CAAC,wBAAwB;CACnD;;CAED,wBAAwB;;CACxB;IACI,0BAA+D;IAC/D,0BAAiG;CACpG;;CAED;IACI,0BAA+D;IAC/D,sBAA2D;IAC3D,WAAW;IACX,8BAAsB;YAAtB,sBAAsB;CACzB;;CAED;IACI,iEAAiE;IACjE,mBAAmB;IACnB,oBAAyD;IACzD,WAAW;CACd;;CAED,8BAA8B;;CAE9B;IACI,YAA4C;IAC5C,aAA6C;IAC7C,iBAAgJ;IAChJ,kBAAqG;IACrG,mBAAmB;IACnB,OAAO;CACV;;CAED;IACI,YAA4C;IAC5C,aAA6C;IAC7C,oBAAuG;IACvG,kBAAiJ;IACjJ,mBAAmB;IACnB,QAAQ;CACX;;CAED;IACI,YAA6D;IAC7D,iBAAyJ;CAC5J;;CAED;IACI,WAA4D;IAC5D,kBAA0J;CAC7J;;CAED,uBAAuB;;CAEvB;IACI,aAAsC;IACtC,aAAwC;IACxC,kBAA6C;;IAE7C;;oDAEgD;IAChD,0BAAoB;QAApB,uBAAoB;YAApB,oBAAoB;CACvB;;CAED;IACI,kBAAkB;CACrB;;CAED;IACI,aAAwC;IACxC,iBAAwG;IACxG,kBAAyG;IACzG,oBAA+C;QAA/C,oBAA+C;YAA/C,gBAA+C;CAClD;;CAED;IACI,gCAAgC;IAChC,YAAiD;IACjD,iBAAmG;IACnG,YAAY;CACf;;CAED,qBAAqB;;CAErB;IACI,aAAwC;IACxC,kBAA6C;CAChD;;CAED;IACI,qBAAqB;IACrB,cAA0C;IAC1C,YAA2C;CAC9C;;CAED;IACI,oBAA+C;QAA/C,oBAA+C;YAA/C,gBAA+C;IAC/C,kBAAkB;IAClB,mBAAmB;IACnB,mBAA0G;IAC1G,gBAAuG;IACvG,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;CAC1B;;CAED;IACI,gCAAgC;IAChC,WAAgD;IAChD,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,kBAAkB;IAClB,mBAAmB;CACtB;;CAED,6BAA6B;;CAE7B;IACI,yBAAyB;IAIzB,iBAAiB;CACpB;;CAED;IACI,aAAwC;CAC3C;;CAED;IACI,0BAAyC;CAC5C;;CAED;IACI,0BAA2C;CAC9C;;CAED;IACI,0BAAwC;CAC3C;;CAED;IACI,0BAAwC;CAC3C;;CAED;IACI,0BAAyC;CAC5C;;CAED;IACI,0BAA0C;IAC1C,aAAa;IACb,yBAAiB;YAAjB,iBAAiB;CACpB;;CAED,yBAAyB;;CAEzB;IACI,kBAAkB;IAClB,aAAwC;IACxC,kBAA6C;IAC7C,aAAsC;IACtC,0BAAoB;QAApB,uBAAoB;YAApB,oBAAoB;;CAEvB;;CAED;IACI,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,gBAA4C;IAC5C,mBAA+C;IAC/C,6BAAoB;QAApB,oBAAoB;IACpB,8BAA8B;IAC9B,aAAgB;IAAhB,gBAAgB;CACnB;;CAED,uBAAuB;;CAEvB;IACI,cAA0C;IAC1C,YAA2C;CAC9C;;CAED;IACI,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,YAA4C;IAC5C,kBAAkB;IAClB,mBAAmB;IACnB,iBAAiB;CACpB;;CAED,2BAA2B;;CAE3B;IACI,aAAwC;IACxC,aAAsC;IACtC,kBAA6C;CAChD;;CAED;IACI,oBAAoB;IACpB,0BAAwF;IACxF,iBAAiB;IACjB,gBAAgB;IAChB,oBAA+C;QAA/C,oBAA+C;YAA/C,gBAA+C;IAC/C,aAAa,CAAC,iEAAiE;IAC/E,+BAAuB;YAAvB,uBAAuB;IACvB,yBAAyB;IACzB,yBAAiB;YAAjB,iBAAiB;IACjB,wBAA2D;IAC3D,yBAAqC;IACrC,gBAAuC;IACvC,oBAAoB;IACpB,kBAAyD;CAC5D,iBAAiB;CACjB,yBAAyB;CACzB,sBAAsB;IACnB,6BAA6B;CAChC,sBAAsB;CACtB,kCAAkC;IAC/B,kuBAAmD;CACtD;;CACD;IACI,sBAAyD;CAC5D;;CAED;IACI,aAA4C;CAC/C;;CAED;6CAC6C;;CAC7C;IACI,mBAAmB;IACnB,wBAAwB;CAC3B;;CAED,+BAA+B;;CAE/B;IACI,aAAsC;IACtC,kBAA6C;;IAE7C;;kEAE8D;IAC9D,yBAAwB;QAAxB,sBAAwB;YAAxB,wBAAwB;CAC3B;;CAED;IACI,0BAAwF;IACxF,wBAA2D;IAC3D,yBAAqC;IACrC,gBAAuC;IACvC,oBAA+C;QAA/C,oBAA+C;YAA/C,gBAA+C;IAC/C,yBAAyB;IACzB,eAAe;IACf,gBAAgB;;IAEhB;;kEAE8D;IAC9D,iBAAiB;CACpB;;CAED;IACI,sBAAyD;CAC5D;;CAED;IACI,kBAA8C;IAC9C,kBAA6C;IAC7C,kEAAkE;IAClE,0DAAiF;IACjF,6DAAoF;CACvF;;CAID,4BAA4B;;CAE5B;IACI,kBAA6C;CAChD;;CAED;IACI,iBAAsC;IACtC,kBAAuC;CAC1C;;CAED;IACI,aAA4C;CAC/C;;CAED,2BAA2B;;CAE3B;IACI,aAAsC;IACtC,kBAA6C;CAChD;;CAED;IACI,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;IACvB,2BAAqB;QAArB,wBAAqB;YAArB,qBAAqB;IACrB,+BAAuB;YAAvB,uBAAuB;IACvB,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,mBAA8D;CACjE;;CAED;IACI,aAA4C;IAC5C,kBAAiD;IACjD,gBAAuC;CAC1C;;CAED;IACI,aAA4C;IAC5C,kBAAiD;IACjD,oBAA4D;IAC5D,YAAY;CACf;;CAED,0BAA0B;;CAE1B;IACI,aAAsC;IACtC,aAAwC;IACxC,kBAA6C;CAChD;;CAED;IACI,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,qBAAe;QAAf,eAAe;IACf,gBAA+C;CAClD;;CAED;IACI,YAAuC;IACvC,aAAwC;IACxC,eAAe,CAAC,6DAA6D;IAC7E,kBAAqD;IACrD,yBAAqC;IACrC,0BAAwF;IACxF,kBAAkB;IAClB,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,qBAAe;QAAf,eAAe;IACf,+BAAuB;YAAvB,uBAAuB;IACvB,6BAAoB;QAApB,oBAAoB;IACpB,yBAAyB;CAC5B;;CAED;IACI,+BAA6F;CAChG;;CAED;IACI,sBAAyD;CAC5D;;CAED;IACI,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,yBAAyB;IACzB,aAAwC;IACxC,kBAA6C;IAC7C,kBAAqD;IACrD,yBAAqC;IACrC,0BAAwF;IACxF,gBAAuC;IACvC,iBAAsF;IACtF,aAAa,CAAC,iEAAiE;IAC/E,qBAAe;QAAf,eAAe;IACf,+BAAuB;YAAvB,uBAAuB;CAC1B;;CAED;IACI,aAA4C;CAC/C;;CAED,yBAAyB;;CAEzB;IACI,aAAsC;IACtC,aAAwC;IACxC,kBAA6C;CAChD;;CAED;IACI,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,qBAAe;QAAf,eAAe;IACf,aAAa,CAAC,iEAAiE;IAC/E,yBAAyB;IACzB,aAAwC;IACxC,0BAAwF;IACxF,wBAA2D;IAC3D,yBAAqC;IACrC,gBAAuC;IACvC,iBAAsF;IACtF,+BAAuB;YAAvB,uBAAuB;CAC1B;;CAED;IACI,sBAAyD;CAC5D;;CAED;IACI,sBAAoC;CACvC;;CAED;IACI,aAA4C;CAC/C;;CAED,iBAAiB;;CAEjB;IACI,aAA4C;IAC5C,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,2BAAqB;QAArB,wBAAqB;YAArB,qBAAqB;CACxB;;CAED;IACI,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,aAAa;CAChB;;CAED;IACI,aAA4C;CAC/C;;CAED,gBAAgB;;CAEhB;IACI,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;CAC1B;;CAED;IACI,yFAAyF;IACzF,oBAAoB;IACpB,oBAAoB;CACvB;;CAED;IACI,iDAAiD;IACjD,uBAAsB;QAAtB,oBAAsB;YAAtB,sBAAsB;IACtB,aAAa;IACb,cAAc;CACjB;;CAED;IACI,YAAY;IACZ,+BAAuB;YAAvB,uBAAuB;IACvB,UAAU;IACV,kBAAoC;IACpC,yBAAgC;IAChC,0BAA6D;IAC7D,cAA6C;IAC7C,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,eAAe;CAClB;;CAED;IACI,wCAA+D;IAC/D,iBAAmF;CACtF;;CAED;IACI,oBAAiD;QAAjD,oBAAiD;YAAjD,gBAAiD;IACjD,gBAAgB;IAChB,iBAAmF;IACnF,kBAAqD;IACrD,kBAA+C;IAC/C,kBAAkB;IAClB,oBAAoC;IACpC,yBAAgC;IAChC,0BAA6D;IAC7D,oBAAoB;IACpB,mBAAmB;CACtB;;CAED;IACI,0BAAgC;IAChC,gEAAgE;IAChE,kBAAoC;IACpC,iBAAuF;IACvF,mCAA8C;YAA9C,2BAA8C;IAC9C,kBAAkB;CACrB;;CAED;IACI,mBAAmB;IACnB,UAAuC;IACvC,WAAwC;IACxC,YAAY;IACZ,YAAoD;IACpD,wBAA+C;IAC/C,oBAAmC;CACtC;;CAED;IACI,eAAe;CAClB;;CAED;IACI,kBAAoC;IACpC,yBAAgC;CACnC;;CAED;IACI,iBAAiB;CACpB;;CAED;IACI,yBAAyB;IACzB,iBAAiB,CAAC,WAAW;CAChC;;CAED;;;IAGI,kBAAqD;CACxD;;CAED,sBAAsB;;CAEtB;IACI,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;IACvB,2BAAqB;QAArB,wBAAqB;YAArB,qBAAqB;CACxB;;CAED;IACI,aAAyC;IACzC,gBAAgB;IAChB,yBAAgC;IAChC,0BAA0C;IAC1C,0BAAqE;IACrE,mBAA+F;IAC/F,kBAAkB;CACrB;;CAED;IACI,wBAA0C;IAC1C,yBAAgC;CACnC;;CAED;IACI,wBAA0C;IAC1C,0BAAgC;IAChC,gBAAgB;IAChB,oBAAoB;CACvB;;CAED;IACI,sBAAsB,EAAE,qCAAqC;IAC7D,sBAAsB;IACtB,8CAA8C;IAC9C,mBAAmB;IACnB,qBAAqB;IACrB,oCAAoC;IACpC,mCAAmC;CACtC;;CAED;IACI,sBAAsB,CAAC,oCAAoC;CAC9D;;CAED;IACI,cAA6C;IAC7C,wBAA0C;IAC1C,yBAAgC;IAChC,+BAA0E;IAC1E,gCAA2E;IAC3E,iCAA4E;IAC5E,eAAe;CAClB;;CAED;IACI,qBAAc;IAAd,qBAAc;IAAd,cAAc;IACd,6BAAuB;IAAvB,8BAAuB;QAAvB,2BAAuB;YAAvB,uBAAuB;IACvB,2BAAqB;QAArB,wBAAqB;YAArB,qBAAqB;CACxB;;CAED;IACI,iBAAiB;CACpB;;CAED;IACI,gBAAgB;CACnB;;CAID,iBAAiB;;CAEjB;IACI,gBAAuC;CAC1C;;CAED;IACI,0CAA0C;IAC1C,6BAAoB;QAApB,oBAAoB;IACpB,oBAAa;QAAb,qBAAa;YAAb,aAAa;IACb,qBAAe;QAAf,eAAe;IACf,kEAAkE;IAClE,kBAA6C;IAC7C,yEAAyE;IACzE,mBAAmB;CACtB","file":"controls.css","sourcesContent":["/* Copyright (c) Jupyter Development Team.\n * Distributed under the terms of the Modified BSD License.\n */\n\n /* We import all of these together in a single css file because the Webpack\nloader sees only one file at a time. This allows postcss to see the variable\ndefinitions when they are used. */\n\n@import \"./labvariables.css\";\n@import \"./widgets-base.css\";\n","/*-----------------------------------------------------------------------------\n| Copyright (c) Jupyter Development Team.\n| Distributed under the terms of the Modified BSD License.\n|----------------------------------------------------------------------------*/\n\n/*\nThis file is copied from the JupyterLab project to define default styling for\nwhen the widget styling is compiled down to eliminate CSS variables. We make one\nchange - we comment out the font import below.\n*/\n\n@import \"./materialcolors.css\";\n\n/*\nThe following CSS variables define the main, public API for styling JupyterLab.\nThese variables should be used by all plugins wherever possible. In other\nwords, plugins should not define custom colors, sizes, etc unless absolutely\nnecessary. This enables users to change the visual theme of JupyterLab\nby changing these variables.\n\nMany variables appear in an ordered sequence (0,1,2,3). These sequences\nare designed to work well together, so for example, `--jp-border-color1` should\nbe used with `--jp-layout-color1`. The numbers have the following meanings:\n\n* 0: super-primary, reserved for special emphasis\n* 1: primary, most important under normal situations\n* 2: secondary, next most important under normal situations\n* 3: tertiary, next most important under normal situations\n\nThroughout JupyterLab, we are mostly following principles from Google's\nMaterial Design when selecting colors. We are not, however, following\nall of MD as it is not optimized for dense, information rich UIs.\n*/\n\n\n/*\n * Optional monospace font for input/output prompt.\n */\n /* Commented out in ipywidgets since we don't need it. */\n/* @import url('https://fonts.googleapis.com/css?family=Roboto+Mono'); */\n\n/*\n * Added for compabitility with output area\n */\n:root {\n  --jp-icon-search: none;\n  --jp-ui-select-caret: none;\n}\n\n\n:root {\n\n  /* Borders\n\n  The following variables, specify the visual styling of borders in JupyterLab.\n   */\n\n  --jp-border-width: 1px;\n  --jp-border-color0: var(--md-grey-700);\n  --jp-border-color1: var(--md-grey-500);\n  --jp-border-color2: var(--md-grey-300);\n  --jp-border-color3: var(--md-grey-100);\n\n  /* UI Fonts\n\n  The UI font CSS variables are used for the typography all of the JupyterLab\n  user interface elements that are not directly user generated content.\n  */\n\n  --jp-ui-font-scale-factor: 1.2;\n  --jp-ui-font-size0: calc(var(--jp-ui-font-size1)/var(--jp-ui-font-scale-factor));\n  --jp-ui-font-size1: 13px; /* Base font size */\n  --jp-ui-font-size2: calc(var(--jp-ui-font-size1)*var(--jp-ui-font-scale-factor));\n  --jp-ui-font-size3: calc(var(--jp-ui-font-size2)*var(--jp-ui-font-scale-factor));\n  --jp-ui-icon-font-size: 14px; /* Ensures px perfect FontAwesome icons */\n  --jp-ui-font-family: \"Helvetica Neue\", Helvetica, Arial, sans-serif;\n\n  /* Use these font colors against the corresponding main layout colors.\n     In a light theme, these go from dark to light.\n  */\n\n  --jp-ui-font-color0: rgba(0,0,0,1.0);\n  --jp-ui-font-color1: rgba(0,0,0,0.8);\n  --jp-ui-font-color2: rgba(0,0,0,0.5);\n  --jp-ui-font-color3: rgba(0,0,0,0.3);\n\n  /* Use these against the brand/accent/warn/error colors.\n     These will typically go from light to darker, in both a dark and light theme\n   */\n\n  --jp-inverse-ui-font-color0: rgba(255,255,255,1);\n  --jp-inverse-ui-font-color1: rgba(255,255,255,1.0);\n  --jp-inverse-ui-font-color2: rgba(255,255,255,0.7);\n  --jp-inverse-ui-font-color3: rgba(255,255,255,0.5);\n\n  /* Content Fonts\n\n  Content font variables are used for typography of user generated content.\n  */\n\n  --jp-content-font-size: 13px;\n  --jp-content-line-height: 1.5;\n  --jp-content-font-color0: black;\n  --jp-content-font-color1: black;\n  --jp-content-font-color2: var(--md-grey-700);\n  --jp-content-font-color3: var(--md-grey-500);\n\n  --jp-ui-font-scale-factor: 1.2;\n  --jp-ui-font-size0: calc(var(--jp-ui-font-size1)/var(--jp-ui-font-scale-factor));\n  --jp-ui-font-size1: 13px; /* Base font size */\n  --jp-ui-font-size2: calc(var(--jp-ui-font-size1)*var(--jp-ui-font-scale-factor));\n  --jp-ui-font-size3: calc(var(--jp-ui-font-size2)*var(--jp-ui-font-scale-factor));\n\n  --jp-code-font-size: 13px;\n  --jp-code-line-height: 1.307;\n  --jp-code-padding: 5px;\n  --jp-code-font-family: monospace;\n\n\n  /* Layout\n\n  The following are the main layout colors use in JupyterLab. In a light\n  theme these would go from light to dark.\n  */\n\n  --jp-layout-color0: white;\n  --jp-layout-color1: white;\n  --jp-layout-color2: var(--md-grey-200);\n  --jp-layout-color3: var(--md-grey-400);\n\n  /* Brand/accent */\n\n  --jp-brand-color0: var(--md-blue-700);\n  --jp-brand-color1: var(--md-blue-500);\n  --jp-brand-color2: var(--md-blue-300);\n  --jp-brand-color3: var(--md-blue-100);\n\n  --jp-accent-color0: var(--md-green-700);\n  --jp-accent-color1: var(--md-green-500);\n  --jp-accent-color2: var(--md-green-300);\n  --jp-accent-color3: var(--md-green-100);\n\n  /* State colors (warn, error, success, info) */\n\n  --jp-warn-color0: var(--md-orange-700);\n  --jp-warn-color1: var(--md-orange-500);\n  --jp-warn-color2: var(--md-orange-300);\n  --jp-warn-color3: var(--md-orange-100);\n\n  --jp-error-color0: var(--md-red-700);\n  --jp-error-color1: var(--md-red-500);\n  --jp-error-color2: var(--md-red-300);\n  --jp-error-color3: var(--md-red-100);\n\n  --jp-success-color0: var(--md-green-700);\n  --jp-success-color1: var(--md-green-500);\n  --jp-success-color2: var(--md-green-300);\n  --jp-success-color3: var(--md-green-100);\n\n  --jp-info-color0: var(--md-cyan-700);\n  --jp-info-color1: var(--md-cyan-500);\n  --jp-info-color2: var(--md-cyan-300);\n  --jp-info-color3: var(--md-cyan-100);\n\n  /* Cell specific styles */\n\n  --jp-cell-padding: 5px;\n  --jp-cell-editor-background: #f7f7f7;\n  --jp-cell-editor-border-color: #cfcfcf;\n  --jp-cell-editor-background-edit: var(--jp-ui-layout-color1);\n  --jp-cell-editor-border-color-edit: var(--jp-brand-color1);\n  --jp-cell-prompt-width: 100px;\n  --jp-cell-prompt-font-family: 'Roboto Mono', monospace;\n  --jp-cell-prompt-letter-spacing: 0px;\n  --jp-cell-prompt-opacity: 1.0;\n  --jp-cell-prompt-opacity-not-active: 0.4;\n  --jp-cell-prompt-font-color-not-active: var(--md-grey-700);\n  /* A custom blend of MD grey and blue 600\n   * See https://meyerweb.com/eric/tools/color-blend/#546E7A:1E88E5:5:hex */\n  --jp-cell-inprompt-font-color: #307FC1;\n  /* A custom blend of MD grey and orange 600\n   * https://meyerweb.com/eric/tools/color-blend/#546E7A:F4511E:5:hex */\n  --jp-cell-outprompt-font-color: #BF5B3D;\n\n  /* Notebook specific styles */\n\n  --jp-notebook-padding: 10px;\n  --jp-notebook-scroll-padding: 100px;\n\n  /* Console specific styles */\n\n  --jp-console-background: var(--md-grey-100);\n\n  /* Toolbar specific styles */\n\n  --jp-toolbar-border-color: var(--md-grey-400);\n  --jp-toolbar-micro-height: 8px;\n  --jp-toolbar-background: var(--jp-layout-color0);\n  --jp-toolbar-box-shadow: 0px 0px 2px 0px rgba(0,0,0,0.24);\n  --jp-toolbar-header-margin: 4px 4px 0px 4px;\n  --jp-toolbar-active-background: var(--md-grey-300);\n}\n","/**\n * The material design colors are adapted from google-material-color v1.2.6\n * https://github.com/danlevan/google-material-color\n * https://github.com/danlevan/google-material-color/blob/f67ca5f4028b2f1b34862f64b0ca67323f91b088/dist/palette.var.css\n *\n * The license for the material design color CSS variables is as follows (see\n * https://github.com/danlevan/google-material-color/blob/f67ca5f4028b2f1b34862f64b0ca67323f91b088/LICENSE)\n *\n * The MIT License (MIT)\n *\n * Copyright (c) 2014 Dan Le Van\n *\n * Permission is hereby granted, free of charge, to any person obtaining a copy\n * of this software and associated documentation files (the \"Software\"), to deal\n * in the Software without restriction, including without limitation the rights\n * to use, copy, modify, merge, publish, distribute, sublicense, and/or sell\n * copies of the Software, and to permit persons to whom the Software is\n * furnished to do so, subject to the following conditions:\n *\n * The above copyright notice and this permission notice shall be included in\n * all copies or substantial portions of the Software.\n *\n * THE SOFTWARE IS PROVIDED \"AS IS\", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR\n * IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,\n * FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE\n * AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER\n * LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,\n * OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE\n * SOFTWARE.\n */\n:root {\n  --md-red-50: #FFEBEE;\n  --md-red-100: #FFCDD2;\n  --md-red-200: #EF9A9A;\n  --md-red-300: #E57373;\n  --md-red-400: #EF5350;\n  --md-red-500: #F44336;\n  --md-red-600: #E53935;\n  --md-red-700: #D32F2F;\n  --md-red-800: #C62828;\n  --md-red-900: #B71C1C;\n  --md-red-A100: #FF8A80;\n  --md-red-A200: #FF5252;\n  --md-red-A400: #FF1744;\n  --md-red-A700: #D50000;\n\n  --md-pink-50: #FCE4EC;\n  --md-pink-100: #F8BBD0;\n  --md-pink-200: #F48FB1;\n  --md-pink-300: #F06292;\n  --md-pink-400: #EC407A;\n  --md-pink-500: #E91E63;\n  --md-pink-600: #D81B60;\n  --md-pink-700: #C2185B;\n  --md-pink-800: #AD1457;\n  --md-pink-900: #880E4F;\n  --md-pink-A100: #FF80AB;\n  --md-pink-A200: #FF4081;\n  --md-pink-A400: #F50057;\n  --md-pink-A700: #C51162;\n\n  --md-purple-50: #F3E5F5;\n  --md-purple-100: #E1BEE7;\n  --md-purple-200: #CE93D8;\n  --md-purple-300: #BA68C8;\n  --md-purple-400: #AB47BC;\n  --md-purple-500: #9C27B0;\n  --md-purple-600: #8E24AA;\n  --md-purple-700: #7B1FA2;\n  --md-purple-800: #6A1B9A;\n  --md-purple-900: #4A148C;\n  --md-purple-A100: #EA80FC;\n  --md-purple-A200: #E040FB;\n  --md-purple-A400: #D500F9;\n  --md-purple-A700: #AA00FF;\n\n  --md-deep-purple-50: #EDE7F6;\n  --md-deep-purple-100: #D1C4E9;\n  --md-deep-purple-200: #B39DDB;\n  --md-deep-purple-300: #9575CD;\n  --md-deep-purple-400: #7E57C2;\n  --md-deep-purple-500: #673AB7;\n  --md-deep-purple-600: #5E35B1;\n  --md-deep-purple-700: #512DA8;\n  --md-deep-purple-800: #4527A0;\n  --md-deep-purple-900: #311B92;\n  --md-deep-purple-A100: #B388FF;\n  --md-deep-purple-A200: #7C4DFF;\n  --md-deep-purple-A400: #651FFF;\n  --md-deep-purple-A700: #6200EA;\n\n  --md-indigo-50: #E8EAF6;\n  --md-indigo-100: #C5CAE9;\n  --md-indigo-200: #9FA8DA;\n  --md-indigo-300: #7986CB;\n  --md-indigo-400: #5C6BC0;\n  --md-indigo-500: #3F51B5;\n  --md-indigo-600: #3949AB;\n  --md-indigo-700: #303F9F;\n  --md-indigo-800: #283593;\n  --md-indigo-900: #1A237E;\n  --md-indigo-A100: #8C9EFF;\n  --md-indigo-A200: #536DFE;\n  --md-indigo-A400: #3D5AFE;\n  --md-indigo-A700: #304FFE;\n\n  --md-blue-50: #E3F2FD;\n  --md-blue-100: #BBDEFB;\n  --md-blue-200: #90CAF9;\n  --md-blue-300: #64B5F6;\n  --md-blue-400: #42A5F5;\n  --md-blue-500: #2196F3;\n  --md-blue-600: #1E88E5;\n  --md-blue-700: #1976D2;\n  --md-blue-800: #1565C0;\n  --md-blue-900: #0D47A1;\n  --md-blue-A100: #82B1FF;\n  --md-blue-A200: #448AFF;\n  --md-blue-A400: #2979FF;\n  --md-blue-A700: #2962FF;\n\n  --md-light-blue-50: #E1F5FE;\n  --md-light-blue-100: #B3E5FC;\n  --md-light-blue-200: #81D4FA;\n  --md-light-blue-300: #4FC3F7;\n  --md-light-blue-400: #29B6F6;\n  --md-light-blue-500: #03A9F4;\n  --md-light-blue-600: #039BE5;\n  --md-light-blue-700: #0288D1;\n  --md-light-blue-800: #0277BD;\n  --md-light-blue-900: #01579B;\n  --md-light-blue-A100: #80D8FF;\n  --md-light-blue-A200: #40C4FF;\n  --md-light-blue-A400: #00B0FF;\n  --md-light-blue-A700: #0091EA;\n\n  --md-cyan-50: #E0F7FA;\n  --md-cyan-100: #B2EBF2;\n  --md-cyan-200: #80DEEA;\n  --md-cyan-300: #4DD0E1;\n  --md-cyan-400: #26C6DA;\n  --md-cyan-500: #00BCD4;\n  --md-cyan-600: #00ACC1;\n  --md-cyan-700: #0097A7;\n  --md-cyan-800: #00838F;\n  --md-cyan-900: #006064;\n  --md-cyan-A100: #84FFFF;\n  --md-cyan-A200: #18FFFF;\n  --md-cyan-A400: #00E5FF;\n  --md-cyan-A700: #00B8D4;\n\n  --md-teal-50: #E0F2F1;\n  --md-teal-100: #B2DFDB;\n  --md-teal-200: #80CBC4;\n  --md-teal-300: #4DB6AC;\n  --md-teal-400: #26A69A;\n  --md-teal-500: #009688;\n  --md-teal-600: #00897B;\n  --md-teal-700: #00796B;\n  --md-teal-800: #00695C;\n  --md-teal-900: #004D40;\n  --md-teal-A100: #A7FFEB;\n  --md-teal-A200: #64FFDA;\n  --md-teal-A400: #1DE9B6;\n  --md-teal-A700: #00BFA5;\n\n  --md-green-50: #E8F5E9;\n  --md-green-100: #C8E6C9;\n  --md-green-200: #A5D6A7;\n  --md-green-300: #81C784;\n  --md-green-400: #66BB6A;\n  --md-green-500: #4CAF50;\n  --md-green-600: #43A047;\n  --md-green-700: #388E3C;\n  --md-green-800: #2E7D32;\n  --md-green-900: #1B5E20;\n  --md-green-A100: #B9F6CA;\n  --md-green-A200: #69F0AE;\n  --md-green-A400: #00E676;\n  --md-green-A700: #00C853;\n\n  --md-light-green-50: #F1F8E9;\n  --md-light-green-100: #DCEDC8;\n  --md-light-green-200: #C5E1A5;\n  --md-light-green-300: #AED581;\n  --md-light-green-400: #9CCC65;\n  --md-light-green-500: #8BC34A;\n  --md-light-green-600: #7CB342;\n  --md-light-green-700: #689F38;\n  --md-light-green-800: #558B2F;\n  --md-light-green-900: #33691E;\n  --md-light-green-A100: #CCFF90;\n  --md-light-green-A200: #B2FF59;\n  --md-light-green-A400: #76FF03;\n  --md-light-green-A700: #64DD17;\n\n  --md-lime-50: #F9FBE7;\n  --md-lime-100: #F0F4C3;\n  --md-lime-200: #E6EE9C;\n  --md-lime-300: #DCE775;\n  --md-lime-400: #D4E157;\n  --md-lime-500: #CDDC39;\n  --md-lime-600: #C0CA33;\n  --md-lime-700: #AFB42B;\n  --md-lime-800: #9E9D24;\n  --md-lime-900: #827717;\n  --md-lime-A100: #F4FF81;\n  --md-lime-A200: #EEFF41;\n  --md-lime-A400: #C6FF00;\n  --md-lime-A700: #AEEA00;\n\n  --md-yellow-50: #FFFDE7;\n  --md-yellow-100: #FFF9C4;\n  --md-yellow-200: #FFF59D;\n  --md-yellow-300: #FFF176;\n  --md-yellow-400: #FFEE58;\n  --md-yellow-500: #FFEB3B;\n  --md-yellow-600: #FDD835;\n  --md-yellow-700: #FBC02D;\n  --md-yellow-800: #F9A825;\n  --md-yellow-900: #F57F17;\n  --md-yellow-A100: #FFFF8D;\n  --md-yellow-A200: #FFFF00;\n  --md-yellow-A400: #FFEA00;\n  --md-yellow-A700: #FFD600;\n\n  --md-amber-50: #FFF8E1;\n  --md-amber-100: #FFECB3;\n  --md-amber-200: #FFE082;\n  --md-amber-300: #FFD54F;\n  --md-amber-400: #FFCA28;\n  --md-amber-500: #FFC107;\n  --md-amber-600: #FFB300;\n  --md-amber-700: #FFA000;\n  --md-amber-800: #FF8F00;\n  --md-amber-900: #FF6F00;\n  --md-amber-A100: #FFE57F;\n  --md-amber-A200: #FFD740;\n  --md-amber-A400: #FFC400;\n  --md-amber-A700: #FFAB00;\n\n  --md-orange-50: #FFF3E0;\n  --md-orange-100: #FFE0B2;\n  --md-orange-200: #FFCC80;\n  --md-orange-300: #FFB74D;\n  --md-orange-400: #FFA726;\n  --md-orange-500: #FF9800;\n  --md-orange-600: #FB8C00;\n  --md-orange-700: #F57C00;\n  --md-orange-800: #EF6C00;\n  --md-orange-900: #E65100;\n  --md-orange-A100: #FFD180;\n  --md-orange-A200: #FFAB40;\n  --md-orange-A400: #FF9100;\n  --md-orange-A700: #FF6D00;\n\n  --md-deep-orange-50: #FBE9E7;\n  --md-deep-orange-100: #FFCCBC;\n  --md-deep-orange-200: #FFAB91;\n  --md-deep-orange-300: #FF8A65;\n  --md-deep-orange-400: #FF7043;\n  --md-deep-orange-500: #FF5722;\n  --md-deep-orange-600: #F4511E;\n  --md-deep-orange-700: #E64A19;\n  --md-deep-orange-800: #D84315;\n  --md-deep-orange-900: #BF360C;\n  --md-deep-orange-A100: #FF9E80;\n  --md-deep-orange-A200: #FF6E40;\n  --md-deep-orange-A400: #FF3D00;\n  --md-deep-orange-A700: #DD2C00;\n\n  --md-brown-50: #EFEBE9;\n  --md-brown-100: #D7CCC8;\n  --md-brown-200: #BCAAA4;\n  --md-brown-300: #A1887F;\n  --md-brown-400: #8D6E63;\n  --md-brown-500: #795548;\n  --md-brown-600: #6D4C41;\n  --md-brown-700: #5D4037;\n  --md-brown-800: #4E342E;\n  --md-brown-900: #3E2723;\n\n  --md-grey-50: #FAFAFA;\n  --md-grey-100: #F5F5F5;\n  --md-grey-200: #EEEEEE;\n  --md-grey-300: #E0E0E0;\n  --md-grey-400: #BDBDBD;\n  --md-grey-500: #9E9E9E;\n  --md-grey-600: #757575;\n  --md-grey-700: #616161;\n  --md-grey-800: #424242;\n  --md-grey-900: #212121;\n\n  --md-blue-grey-50: #ECEFF1;\n  --md-blue-grey-100: #CFD8DC;\n  --md-blue-grey-200: #B0BEC5;\n  --md-blue-grey-300: #90A4AE;\n  --md-blue-grey-400: #78909C;\n  --md-blue-grey-500: #607D8B;\n  --md-blue-grey-600: #546E7A;\n  --md-blue-grey-700: #455A64;\n  --md-blue-grey-800: #37474F;\n  --md-blue-grey-900: #263238;\n}","/* Copyright (c) Jupyter Development Team.\n * Distributed under the terms of the Modified BSD License.\n */\n\n/*\n * We assume that the CSS variables in\n * https://github.com/jupyterlab/jupyterlab/blob/master/src/default-theme/variables.css\n * have been defined.\n */\n\n@import \"./phosphor.css\";\n\n:root {\n    --jp-widgets-color: var(--jp-content-font-color1);\n    --jp-widgets-label-color: var(--jp-widgets-color);\n    --jp-widgets-readout-color: var(--jp-widgets-color);\n    --jp-widgets-font-size: var(--jp-ui-font-size1);\n    --jp-widgets-margin: 2px;\n    --jp-widgets-inline-height: 28px;\n    --jp-widgets-inline-width: 300px;\n    --jp-widgets-inline-width-short: calc(var(--jp-widgets-inline-width) / 2 - var(--jp-widgets-margin));\n    --jp-widgets-inline-width-tiny: calc(var(--jp-widgets-inline-width-short) / 2 - var(--jp-widgets-margin));\n    --jp-widgets-inline-margin: 4px; /* margin between inline elements */\n    --jp-widgets-inline-label-width: 80px;\n    --jp-widgets-border-width: var(--jp-border-width);\n    --jp-widgets-vertical-height: 200px;\n    --jp-widgets-horizontal-tab-height: 24px;\n    --jp-widgets-horizontal-tab-width: 144px;\n    --jp-widgets-horizontal-tab-top-border: 2px;\n    --jp-widgets-progress-thickness: 20px;\n    --jp-widgets-container-padding: 15px;\n    --jp-widgets-input-padding: 4px;\n    --jp-widgets-radio-item-height-adjustment: 8px;\n    --jp-widgets-radio-item-height: calc(var(--jp-widgets-inline-height) - var(--jp-widgets-radio-item-height-adjustment));\n    --jp-widgets-slider-track-thickness: 4px;\n    --jp-widgets-slider-border-width: var(--jp-widgets-border-width);\n    --jp-widgets-slider-handle-size: 16px;\n    --jp-widgets-slider-handle-border-color: var(--jp-border-color1);\n    --jp-widgets-slider-handle-background-color: var(--jp-layout-color1);\n    --jp-widgets-slider-active-handle-color: var(--jp-brand-color1);\n    --jp-widgets-menu-item-height: 24px;\n    --jp-widgets-dropdown-arrow: url(\"data:image/svg+xml;base64,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\");\n    --jp-widgets-input-color: var(--jp-ui-font-color1);\n    --jp-widgets-input-background-color: var(--jp-layout-color1);\n    --jp-widgets-input-border-color: var(--jp-border-color1);\n    --jp-widgets-input-focus-border-color: var(--jp-brand-color2);\n    --jp-widgets-input-border-width: var(--jp-widgets-border-width);\n    --jp-widgets-disabled-opacity: 0.6;\n\n    /* From Material Design Lite */\n    --md-shadow-key-umbra-opacity: 0.2;\n    --md-shadow-key-penumbra-opacity: 0.14;\n    --md-shadow-ambient-shadow-opacity: 0.12;\n}\n\n.jupyter-widgets {\n    margin: var(--jp-widgets-margin);\n    box-sizing: border-box;\n    color: var(--jp-widgets-color);\n    overflow: visible;\n}\n\n.jupyter-widgets.jupyter-widgets-disconnected::before {\n    line-height: var(--jp-widgets-inline-height);\n    height: var(--jp-widgets-inline-height);\n}\n\n.jp-Output-result > .jupyter-widgets {\n    margin-left: 0;\n    margin-right: 0;\n}\n\n/* vbox and hbox */\n\n.widget-inline-hbox {\n    /* Horizontal widgets */\n    box-sizing: border-box;\n    display: flex;\n    flex-direction: row;\n    align-items: baseline;\n}\n\n.widget-inline-vbox {\n    /* Vertical Widgets */\n    box-sizing: border-box;\n    display: flex;\n    flex-direction: column;\n    align-items: center;\n}\n\n.widget-box {\n    box-sizing: border-box;\n    display: flex;\n    margin: 0;\n    overflow: auto;\n}\n\n.widget-gridbox {\n    box-sizing: border-box;\n    display: grid;\n    margin: 0;\n    overflow: auto;\n}\n\n.widget-hbox {\n    flex-direction: row;\n}\n\n.widget-vbox {\n    flex-direction: column;\n}\n\n/* General Button Styling */\n\n.jupyter-button {\n    padding-left: 10px;\n    padding-right: 10px;\n    padding-top: 0px;\n    padding-bottom: 0px;\n    display: inline-block;\n    white-space: nowrap;\n    overflow: hidden;\n    text-overflow: ellipsis;\n    text-align: center;\n    font-size: var(--jp-widgets-font-size);\n    cursor: pointer;\n\n    height: var(--jp-widgets-inline-height);\n    border: 0px solid;\n    line-height: var(--jp-widgets-inline-height);\n    box-shadow: none;\n\n    color: var(--jp-ui-font-color1);\n    background-color: var(--jp-layout-color2);\n    border-color: var(--jp-border-color2);\n    border: none;\n}\n\n.jupyter-button i.fa {\n    margin-right: var(--jp-widgets-inline-margin);\n    pointer-events: none;\n}\n\n.jupyter-button:empty:before {\n    content: \"\\200b\"; /* zero-width space */\n}\n\n.jupyter-widgets.jupyter-button:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n.jupyter-button i.fa.center {\n    margin-right: 0;\n}\n\n.jupyter-button:hover:enabled, .jupyter-button:focus:enabled {\n    /* MD Lite 2dp shadow */\n    box-shadow: 0 2px 2px 0 rgba(0, 0, 0, var(--md-shadow-key-penumbra-opacity)),\n                0 3px 1px -2px rgba(0, 0, 0, var(--md-shadow-key-umbra-opacity)),\n                0 1px 5px 0 rgba(0, 0, 0, var(--md-shadow-ambient-shadow-opacity));\n}\n\n.jupyter-button:active, .jupyter-button.mod-active {\n    /* MD Lite 4dp shadow */\n    box-shadow: 0 4px 5px 0 rgba(0, 0, 0, var(--md-shadow-key-penumbra-opacity)),\n                0 1px 10px 0 rgba(0, 0, 0, var(--md-shadow-ambient-shadow-opacity)),\n                0 2px 4px -1px rgba(0, 0, 0, var(--md-shadow-key-umbra-opacity));\n    color: var(--jp-ui-font-color1);\n    background-color: var(--jp-layout-color3);\n}\n\n.jupyter-button:focus:enabled {\n    outline: 1px solid var(--jp-widgets-input-focus-border-color);\n}\n\n/* Button \"Primary\" Styling */\n\n.jupyter-button.mod-primary {\n    color: var(--jp-inverse-ui-font-color1);\n    background-color: var(--jp-brand-color1);\n}\n\n.jupyter-button.mod-primary.mod-active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-brand-color0);\n}\n\n.jupyter-button.mod-primary:active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-brand-color0);\n}\n\n/* Button \"Success\" Styling */\n\n.jupyter-button.mod-success {\n    color: var(--jp-inverse-ui-font-color1);\n    background-color: var(--jp-success-color1);\n}\n\n.jupyter-button.mod-success.mod-active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-success-color0);\n }\n\n.jupyter-button.mod-success:active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-success-color0);\n }\n\n /* Button \"Info\" Styling */\n\n.jupyter-button.mod-info {\n    color: var(--jp-inverse-ui-font-color1);\n    background-color: var(--jp-info-color1);\n}\n\n.jupyter-button.mod-info.mod-active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-info-color0);\n}\n\n.jupyter-button.mod-info:active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-info-color0);\n}\n\n/* Button \"Warning\" Styling */\n\n.jupyter-button.mod-warning {\n    color: var(--jp-inverse-ui-font-color1);\n    background-color: var(--jp-warn-color1);\n}\n\n.jupyter-button.mod-warning.mod-active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-warn-color0);\n}\n\n.jupyter-button.mod-warning:active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-warn-color0);\n}\n\n/* Button \"Danger\" Styling */\n\n.jupyter-button.mod-danger {\n    color: var(--jp-inverse-ui-font-color1);\n    background-color: var(--jp-error-color1);\n}\n\n.jupyter-button.mod-danger.mod-active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-error-color0);\n}\n\n.jupyter-button.mod-danger:active {\n    color: var(--jp-inverse-ui-font-color0);\n    background-color: var(--jp-error-color0);\n}\n\n/* Widget Button*/\n\n.widget-button, .widget-toggle-button {\n    width: var(--jp-widgets-inline-width-short);\n}\n\n/* Widget Label Styling */\n\n/* Override Bootstrap label css */\n.jupyter-widgets label {\n    margin-bottom: initial;\n}\n\n.widget-label-basic {\n    /* Basic Label */\n    color: var(--jp-widgets-label-color);\n    font-size: var(--jp-widgets-font-size);\n    overflow: hidden;\n    text-overflow: ellipsis;\n    white-space: nowrap;\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-label {\n    /* Label */\n    color: var(--jp-widgets-label-color);\n    font-size: var(--jp-widgets-font-size);\n    overflow: hidden;\n    text-overflow: ellipsis;\n    white-space: nowrap;\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-inline-hbox .widget-label {\n    /* Horizontal Widget Label */\n    color: var(--jp-widgets-label-color);\n    text-align: right;\n    margin-right: calc( var(--jp-widgets-inline-margin) * 2 );\n    width: var(--jp-widgets-inline-label-width);\n    flex-shrink: 0;\n}\n\n.widget-inline-vbox .widget-label {\n    /* Vertical Widget Label */\n    color: var(--jp-widgets-label-color);\n    text-align: center;\n    line-height: var(--jp-widgets-inline-height);\n}\n\n/* Widget Readout Styling */\n\n.widget-readout {\n    color: var(--jp-widgets-readout-color);\n    font-size: var(--jp-widgets-font-size);\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n    overflow: hidden;\n    white-space: nowrap;\n    text-align: center;\n}\n\n.widget-readout.overflow {\n    /* Overflowing Readout */\n\n    /* From Material Design Lite\n        shadow-key-umbra-opacity: 0.2;\n        shadow-key-penumbra-opacity: 0.14;\n        shadow-ambient-shadow-opacity: 0.12;\n     */\n    -webkit-box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2),\n                        0 3px 1px -2px rgba(0, 0, 0, 0.14),\n                        0 1px 5px 0 rgba(0, 0, 0, 0.12);\n\n    -moz-box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2),\n                     0 3px 1px -2px rgba(0, 0, 0, 0.14),\n                     0 1px 5px 0 rgba(0, 0, 0, 0.12);\n\n    box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2),\n                0 3px 1px -2px rgba(0, 0, 0, 0.14),\n                0 1px 5px 0 rgba(0, 0, 0, 0.12);\n}\n\n.widget-inline-hbox .widget-readout {\n    /* Horizontal Readout */\n    text-align: center;\n    max-width: var(--jp-widgets-inline-width-short);\n    min-width: var(--jp-widgets-inline-width-tiny);\n    margin-left: var(--jp-widgets-inline-margin);\n}\n\n.widget-inline-vbox .widget-readout {\n    /* Vertical Readout */\n    margin-top: var(--jp-widgets-inline-margin);\n    /* as wide as the widget */\n    width: inherit;\n}\n\n/* Widget Checkbox Styling */\n\n.widget-checkbox {\n    width: var(--jp-widgets-inline-width);\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-checkbox input[type=\"checkbox\"] {\n    margin: 0px calc( var(--jp-widgets-inline-margin) * 2 ) 0px 0px;\n    line-height: var(--jp-widgets-inline-height);\n    font-size: large;\n    flex-grow: 1;\n    flex-shrink: 0;\n    align-self: center;\n}\n\n/* Widget Valid Styling */\n\n.widget-valid {\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n    width: var(--jp-widgets-inline-width-short);\n    font-size: var(--jp-widgets-font-size);\n}\n\n.widget-valid i:before {\n    line-height: var(--jp-widgets-inline-height);\n    margin-right: var(--jp-widgets-inline-margin);\n    margin-left: var(--jp-widgets-inline-margin);\n\n    /* from the fa class in FontAwesome: https://github.com/FortAwesome/Font-Awesome/blob/49100c7c3a7b58d50baa71efef11af41a66b03d3/css/font-awesome.css#L14 */\n    display: inline-block;\n    font: normal normal normal 14px/1 FontAwesome;\n    font-size: inherit;\n    text-rendering: auto;\n    -webkit-font-smoothing: antialiased;\n    -moz-osx-font-smoothing: grayscale;\n}\n\n.widget-valid.mod-valid i:before {\n    content: \"\\f00c\";\n    color: green;\n}\n\n.widget-valid.mod-invalid i:before {\n    content: \"\\f00d\";\n    color: red;\n}\n\n.widget-valid.mod-valid .widget-valid-readout {\n    display: none;\n}\n\n/* Widget Text and TextArea Stying */\n\n.widget-textarea, .widget-text {\n    width: var(--jp-widgets-inline-width);\n}\n\n.widget-text input[type=\"text\"], .widget-text input[type=\"number\"]{\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-text input[type=\"text\"]:disabled, .widget-text input[type=\"number\"]:disabled, .widget-textarea textarea:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n.widget-text input[type=\"text\"], .widget-text input[type=\"number\"], .widget-textarea textarea {\n    box-sizing: border-box;\n    border: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n    background-color: var(--jp-widgets-input-background-color);\n    color: var(--jp-widgets-input-color);\n    font-size: var(--jp-widgets-font-size);\n    padding: var(--jp-widgets-input-padding) calc( var(--jp-widgets-input-padding) *  2 );\n    flex-grow: 1;\n    min-width: 0; /* This makes it possible for the flexbox to shrink this input */\n    flex-shrink: 1;\n    outline: none !important;\n}\n\n.widget-textarea textarea {\n    height: inherit;\n    width: inherit;\n}\n\n.widget-text input:focus, .widget-textarea textarea:focus {\n    border-color: var(--jp-widgets-input-focus-border-color);\n}\n\n/* Widget Slider */\n\n.widget-slider .ui-slider {\n    /* Slider Track */\n    border: var(--jp-widgets-slider-border-width) solid var(--jp-layout-color3);\n    background: var(--jp-layout-color3);\n    box-sizing: border-box;\n    position: relative;\n    border-radius: 0px;\n}\n\n.widget-slider .ui-slider .ui-slider-handle {\n    /* Slider Handle */\n    outline: none !important; /* focused slider handles are colored - see below */\n    position: absolute;\n    background-color: var(--jp-widgets-slider-handle-background-color);\n    border: var(--jp-widgets-slider-border-width) solid var(--jp-widgets-slider-handle-border-color);\n    box-sizing: border-box;\n    z-index: 1;\n    background-image: none; /* Override jquery-ui */\n}\n\n/* Override jquery-ui */\n.widget-slider .ui-slider .ui-slider-handle:hover, .widget-slider .ui-slider .ui-slider-handle:focus {\n    background-color: var(--jp-widgets-slider-active-handle-color);\n    border: var(--jp-widgets-slider-border-width) solid var(--jp-widgets-slider-active-handle-color);\n}\n\n.widget-slider .ui-slider .ui-slider-handle:active {\n    background-color: var(--jp-widgets-slider-active-handle-color);\n    border-color: var(--jp-widgets-slider-active-handle-color);\n    z-index: 2;\n    transform: scale(1.2);\n}\n\n.widget-slider  .ui-slider .ui-slider-range {\n    /* Interval between the two specified value of a double slider */\n    position: absolute;\n    background: var(--jp-widgets-slider-active-handle-color);\n    z-index: 0;\n}\n\n/* Shapes of Slider Handles */\n\n.widget-hslider .ui-slider .ui-slider-handle {\n    width: var(--jp-widgets-slider-handle-size);\n    height: var(--jp-widgets-slider-handle-size);\n    margin-top: calc((var(--jp-widgets-slider-track-thickness) - var(--jp-widgets-slider-handle-size)) / 2 - var(--jp-widgets-slider-border-width));\n    margin-left: calc(var(--jp-widgets-slider-handle-size) / -2 + var(--jp-widgets-slider-border-width));\n    border-radius: 50%;\n    top: 0;\n}\n\n.widget-vslider .ui-slider .ui-slider-handle {\n    width: var(--jp-widgets-slider-handle-size);\n    height: var(--jp-widgets-slider-handle-size);\n    margin-bottom: calc(var(--jp-widgets-slider-handle-size) / -2 + var(--jp-widgets-slider-border-width));\n    margin-left: calc((var(--jp-widgets-slider-track-thickness) - var(--jp-widgets-slider-handle-size)) / 2 - var(--jp-widgets-slider-border-width));\n    border-radius: 50%;\n    left: 0;\n}\n\n.widget-hslider .ui-slider .ui-slider-range {\n    height: calc( var(--jp-widgets-slider-track-thickness) * 2 );\n    margin-top: calc((var(--jp-widgets-slider-track-thickness) - var(--jp-widgets-slider-track-thickness) * 2 ) / 2 - var(--jp-widgets-slider-border-width));\n}\n\n.widget-vslider .ui-slider .ui-slider-range {\n    width: calc( var(--jp-widgets-slider-track-thickness) * 2 );\n    margin-left: calc((var(--jp-widgets-slider-track-thickness) - var(--jp-widgets-slider-track-thickness) * 2 ) / 2 - var(--jp-widgets-slider-border-width));\n}\n\n/* Horizontal Slider */\n\n.widget-hslider {\n    width: var(--jp-widgets-inline-width);\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n\n    /* Override the align-items baseline. This way, the description and readout\n    still seem to align their baseline properly, and we don't have to have\n    align-self: stretch in the .slider-container. */\n    align-items: center;\n}\n\n.widgets-slider .slider-container {\n    overflow: visible;\n}\n\n.widget-hslider .slider-container {\n    height: var(--jp-widgets-inline-height);\n    margin-left: calc(var(--jp-widgets-slider-handle-size) / 2 - 2 * var(--jp-widgets-slider-border-width));\n    margin-right: calc(var(--jp-widgets-slider-handle-size) / 2 - 2 * var(--jp-widgets-slider-border-width));\n    flex: 1 1 var(--jp-widgets-inline-width-short);\n}\n\n.widget-hslider .ui-slider {\n    /* Inner, invisible slide div */\n    height: var(--jp-widgets-slider-track-thickness);\n    margin-top: calc((var(--jp-widgets-inline-height) - var(--jp-widgets-slider-track-thickness)) / 2);\n    width: 100%;\n}\n\n/* Vertical Slider */\n\n.widget-vbox .widget-label {\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-vslider {\n    /* Vertical Slider */\n    height: var(--jp-widgets-vertical-height);\n    width: var(--jp-widgets-inline-width-tiny);\n}\n\n.widget-vslider .slider-container {\n    flex: 1 1 var(--jp-widgets-inline-width-short);\n    margin-left: auto;\n    margin-right: auto;\n    margin-bottom: calc(var(--jp-widgets-slider-handle-size) / 2 - 2 * var(--jp-widgets-slider-border-width));\n    margin-top: calc(var(--jp-widgets-slider-handle-size) / 2 - 2 * var(--jp-widgets-slider-border-width));\n    display: flex;\n    flex-direction: column;\n}\n\n.widget-vslider .ui-slider-vertical {\n    /* Inner, invisible slide div */\n    width: var(--jp-widgets-slider-track-thickness);\n    flex-grow: 1;\n    margin-left: auto;\n    margin-right: auto;\n}\n\n/* Widget Progress Styling */\n\n.progress-bar {\n    -webkit-transition: none;\n    -moz-transition: none;\n    -ms-transition: none;\n    -o-transition: none;\n    transition: none;\n}\n\n.progress-bar {\n    height: var(--jp-widgets-inline-height);\n}\n\n.progress-bar {\n    background-color: var(--jp-brand-color1);\n}\n\n.progress-bar-success {\n    background-color: var(--jp-success-color1);\n}\n\n.progress-bar-info {\n    background-color: var(--jp-info-color1);\n}\n\n.progress-bar-warning {\n    background-color: var(--jp-warn-color1);\n}\n\n.progress-bar-danger {\n    background-color: var(--jp-error-color1);\n}\n\n.progress {\n    background-color: var(--jp-layout-color2);\n    border: none;\n    box-shadow: none;\n}\n\n/* Horisontal Progress */\n\n.widget-hprogress {\n    /* Progress Bar */\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n    width: var(--jp-widgets-inline-width);\n    align-items: center;\n\n}\n\n.widget-hprogress .progress {\n    flex-grow: 1;\n    margin-top: var(--jp-widgets-input-padding);\n    margin-bottom: var(--jp-widgets-input-padding);\n    align-self: stretch;\n    /* Override bootstrap style */\n    height: initial;\n}\n\n/* Vertical Progress */\n\n.widget-vprogress {\n    height: var(--jp-widgets-vertical-height);\n    width: var(--jp-widgets-inline-width-tiny);\n}\n\n.widget-vprogress .progress {\n    flex-grow: 1;\n    width: var(--jp-widgets-progress-thickness);\n    margin-left: auto;\n    margin-right: auto;\n    margin-bottom: 0;\n}\n\n/* Select Widget Styling */\n\n.widget-dropdown {\n    height: var(--jp-widgets-inline-height);\n    width: var(--jp-widgets-inline-width);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-dropdown > select {\n    padding-right: 20px;\n    border: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n    border-radius: 0;\n    height: inherit;\n    flex: 1 1 var(--jp-widgets-inline-width-short);\n    min-width: 0; /* This makes it possible for the flexbox to shrink this input */\n    box-sizing: border-box;\n    outline: none !important;\n    box-shadow: none;\n    background-color: var(--jp-widgets-input-background-color);\n    color: var(--jp-widgets-input-color);\n    font-size: var(--jp-widgets-font-size);\n    vertical-align: top;\n    padding-left: calc( var(--jp-widgets-input-padding) * 2);\n\tappearance: none;\n\t-webkit-appearance: none;\n\t-moz-appearance: none;\n    background-repeat: no-repeat;\n\tbackground-size: 20px;\n\tbackground-position: right center;\n    background-image: var(--jp-widgets-dropdown-arrow);\n}\n.widget-dropdown > select:focus {\n    border-color: var(--jp-widgets-input-focus-border-color);\n}\n\n.widget-dropdown > select:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n/* To disable the dotted border in Firefox around select controls.\n   See http://stackoverflow.com/a/18853002 */\n.widget-dropdown > select:-moz-focusring {\n    color: transparent;\n    text-shadow: 0 0 0 #000;\n}\n\n/* Select and SelectMultiple */\n\n.widget-select {\n    width: var(--jp-widgets-inline-width);\n    line-height: var(--jp-widgets-inline-height);\n\n    /* Because Firefox defines the baseline of a select as the bottom of the\n    control, we align the entire control to the top and add padding to the\n    select to get an approximate first line baseline alignment. */\n    align-items: flex-start;\n}\n\n.widget-select > select {\n    border: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n    background-color: var(--jp-widgets-input-background-color);\n    color: var(--jp-widgets-input-color);\n    font-size: var(--jp-widgets-font-size);\n    flex: 1 1 var(--jp-widgets-inline-width-short);\n    outline: none !important;\n    overflow: auto;\n    height: inherit;\n\n    /* Because Firefox defines the baseline of a select as the bottom of the\n    control, we align the entire control to the top and add padding to the\n    select to get an approximate first line baseline alignment. */\n    padding-top: 5px;\n}\n\n.widget-select > select:focus {\n    border-color: var(--jp-widgets-input-focus-border-color);\n}\n\n.wiget-select > select > option {\n    padding-left: var(--jp-widgets-input-padding);\n    line-height: var(--jp-widgets-inline-height);\n    /* line-height doesn't work on some browsers for select options */\n    padding-top: calc(var(--jp-widgets-inline-height)-var(--jp-widgets-font-size)/2);\n    padding-bottom: calc(var(--jp-widgets-inline-height)-var(--jp-widgets-font-size)/2);\n}\n\n\n\n/* Toggle Buttons Styling */\n\n.widget-toggle-buttons {\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-toggle-buttons .widget-toggle-button {\n    margin-left: var(--jp-widgets-margin);\n    margin-right: var(--jp-widgets-margin);\n}\n\n.widget-toggle-buttons .jupyter-button:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n/* Radio Buttons Styling */\n\n.widget-radio {\n    width: var(--jp-widgets-inline-width);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-radio-box {\n    display: flex;\n    flex-direction: column;\n    align-items: stretch;\n    box-sizing: border-box;\n    flex-grow: 1;\n    margin-bottom: var(--jp-widgets-radio-item-height-adjustment);\n}\n\n.widget-radio-box label {\n    height: var(--jp-widgets-radio-item-height);\n    line-height: var(--jp-widgets-radio-item-height);\n    font-size: var(--jp-widgets-font-size);\n}\n\n.widget-radio-box input {\n    height: var(--jp-widgets-radio-item-height);\n    line-height: var(--jp-widgets-radio-item-height);\n    margin: 0 calc( var(--jp-widgets-input-padding) * 2 ) 0 1px;\n    float: left;\n}\n\n/* Color Picker Styling */\n\n.widget-colorpicker {\n    width: var(--jp-widgets-inline-width);\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-colorpicker > .widget-colorpicker-input {\n    flex-grow: 1;\n    flex-shrink: 1;\n    min-width: var(--jp-widgets-inline-width-tiny);\n}\n\n.widget-colorpicker input[type=\"color\"] {\n    width: var(--jp-widgets-inline-height);\n    height: var(--jp-widgets-inline-height);\n    padding: 0 2px; /* make the color square actually square on Chrome on OS X */\n    background: var(--jp-widgets-input-background-color);\n    color: var(--jp-widgets-input-color);\n    border: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n    border-left: none;\n    flex-grow: 0;\n    flex-shrink: 0;\n    box-sizing: border-box;\n    align-self: stretch;\n    outline: none !important;\n}\n\n.widget-colorpicker.concise input[type=\"color\"] {\n    border-left: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n}\n\n.widget-colorpicker input[type=\"color\"]:focus, .widget-colorpicker input[type=\"text\"]:focus {\n    border-color: var(--jp-widgets-input-focus-border-color);\n}\n\n.widget-colorpicker input[type=\"text\"] {\n    flex-grow: 1;\n    outline: none !important;\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n    background: var(--jp-widgets-input-background-color);\n    color: var(--jp-widgets-input-color);\n    border: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n    font-size: var(--jp-widgets-font-size);\n    padding: var(--jp-widgets-input-padding) calc( var(--jp-widgets-input-padding) *  2 );\n    min-width: 0; /* This makes it possible for the flexbox to shrink this input */\n    flex-shrink: 1;\n    box-sizing: border-box;\n}\n\n.widget-colorpicker input[type=\"text\"]:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n/* Date Picker Styling */\n\n.widget-datepicker {\n    width: var(--jp-widgets-inline-width);\n    height: var(--jp-widgets-inline-height);\n    line-height: var(--jp-widgets-inline-height);\n}\n\n.widget-datepicker input[type=\"date\"] {\n    flex-grow: 1;\n    flex-shrink: 1;\n    min-width: 0; /* This makes it possible for the flexbox to shrink this input */\n    outline: none !important;\n    height: var(--jp-widgets-inline-height);\n    border: var(--jp-widgets-input-border-width) solid var(--jp-widgets-input-border-color);\n    background-color: var(--jp-widgets-input-background-color);\n    color: var(--jp-widgets-input-color);\n    font-size: var(--jp-widgets-font-size);\n    padding: var(--jp-widgets-input-padding) calc( var(--jp-widgets-input-padding) *  2 );\n    box-sizing: border-box;\n}\n\n.widget-datepicker input[type=\"date\"]:focus {\n    border-color: var(--jp-widgets-input-focus-border-color);\n}\n\n.widget-datepicker input[type=\"date\"]:invalid {\n    border-color: var(--jp-warn-color1);\n}\n\n.widget-datepicker input[type=\"date\"]:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n/* Play Widget */\n\n.widget-play {\n    width: var(--jp-widgets-inline-width-short);\n    display: flex;\n    align-items: stretch;\n}\n\n.widget-play .jupyter-button {\n    flex-grow: 1;\n    height: auto;\n}\n\n.widget-play .jupyter-button:disabled {\n    opacity: var(--jp-widgets-disabled-opacity);\n}\n\n/* Tab Widget */\n\n.jupyter-widgets.widget-tab {\n    display: flex;\n    flex-direction: column;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar {\n    /* Necessary so that a tab can be shifted down to overlay the border of the box below. */\n    overflow-x: visible;\n    overflow-y: visible;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar > .p-TabBar-content {\n    /* Make sure that the tab grows from bottom up */\n    align-items: flex-end;\n    min-width: 0;\n    min-height: 0;\n}\n\n.jupyter-widgets.widget-tab > .widget-tab-contents {\n    width: 100%;\n    box-sizing: border-box;\n    margin: 0;\n    background: var(--jp-layout-color1);\n    color: var(--jp-ui-font-color1);\n    border: var(--jp-border-width) solid var(--jp-border-color1);\n    padding: var(--jp-widgets-container-padding);\n    flex-grow: 1;\n    overflow: auto;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar {\n    font: var(--jp-widgets-font-size) Helvetica, Arial, sans-serif;\n    min-height: calc(var(--jp-widgets-horizontal-tab-height) + var(--jp-border-width));\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab {\n    flex: 0 1 var(--jp-widgets-horizontal-tab-width);\n    min-width: 35px;\n    min-height: calc(var(--jp-widgets-horizontal-tab-height) + var(--jp-border-width));\n    line-height: var(--jp-widgets-horizontal-tab-height);\n    margin-left: calc(-1 * var(--jp-border-width));\n    padding: 0px 10px;\n    background: var(--jp-layout-color2);\n    color: var(--jp-ui-font-color2);\n    border: var(--jp-border-width) solid var(--jp-border-color1);\n    border-bottom: none;\n    position: relative;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab.p-mod-current {\n    color: var(--jp-ui-font-color0);\n    /* We want the background to match the tab content background */\n    background: var(--jp-layout-color1);\n    min-height: calc(var(--jp-widgets-horizontal-tab-height) + 2 * var(--jp-border-width));\n    transform: translateY(var(--jp-border-width));\n    overflow: visible;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab.p-mod-current:before {\n    position: absolute;\n    top: calc(-1 * var(--jp-border-width));\n    left: calc(-1 * var(--jp-border-width));\n    content: '';\n    height: var(--jp-widgets-horizontal-tab-top-border);\n    width: calc(100% + 2 * var(--jp-border-width));\n    background: var(--jp-brand-color1);\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab:first-child {\n    margin-left: 0;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab:hover:not(.p-mod-current) {\n    background: var(--jp-layout-color1);\n    color: var(--jp-ui-font-color1);\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-mod-closable > .p-TabBar-tabCloseIcon {\n    margin-left: 4px;\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-mod-closable > .p-TabBar-tabCloseIcon:before {\n    font-family: FontAwesome;\n    content: '\\f00d'; /* close */\n}\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabIcon,\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabLabel,\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabCloseIcon {\n    line-height: var(--jp-widgets-horizontal-tab-height);\n}\n\n/* Accordion Widget */\n\n.p-Collapse {\n    display: flex;\n    flex-direction: column;\n    align-items: stretch;\n}\n\n.p-Collapse-header {\n    padding: var(--jp-widgets-input-padding);\n    cursor: pointer;\n    color: var(--jp-ui-font-color2);\n    background-color: var(--jp-layout-color2);\n    border: var(--jp-widgets-border-width) solid var(--jp-border-color1);\n    padding: calc(var(--jp-widgets-container-padding) * 2 / 3) var(--jp-widgets-container-padding);\n    font-weight: bold;\n}\n\n.p-Collapse-header:hover {\n    background-color: var(--jp-layout-color1);\n    color: var(--jp-ui-font-color1);\n}\n\n.p-Collapse-open > .p-Collapse-header {\n    background-color: var(--jp-layout-color1);\n    color: var(--jp-ui-font-color0);\n    cursor: default;\n    border-bottom: none;\n}\n\n.p-Collapse .p-Collapse-header::before {\n    content: '\\f0da\\00A0';  /* caret-right, non-breaking space */\n    display: inline-block;\n    font: normal normal normal 14px/1 FontAwesome;\n    font-size: inherit;\n    text-rendering: auto;\n    -webkit-font-smoothing: antialiased;\n    -moz-osx-font-smoothing: grayscale;\n}\n\n.p-Collapse-open > .p-Collapse-header::before {\n    content: '\\f0d7\\00A0'; /* caret-down, non-breaking space */\n}\n\n.p-Collapse-contents {\n    padding: var(--jp-widgets-container-padding);\n    background-color: var(--jp-layout-color1);\n    color: var(--jp-ui-font-color1);\n    border-left: var(--jp-widgets-border-width) solid var(--jp-border-color1);\n    border-right: var(--jp-widgets-border-width) solid var(--jp-border-color1);\n    border-bottom: var(--jp-widgets-border-width) solid var(--jp-border-color1);\n    overflow: auto;\n}\n\n.p-Accordion {\n    display: flex;\n    flex-direction: column;\n    align-items: stretch;\n}\n\n.p-Accordion .p-Collapse {\n    margin-bottom: 0;\n}\n\n.p-Accordion .p-Collapse + .p-Collapse {\n    margin-top: 4px;\n}\n\n\n\n/* HTML widget */\n\n.widget-html, .widget-htmlmath {\n    font-size: var(--jp-widgets-font-size);\n}\n\n.widget-html > .widget-html-content, .widget-htmlmath > .widget-html-content {\n    /* Fill out the area in the HTML widget */\n    align-self: stretch;\n    flex-grow: 1;\n    flex-shrink: 1;\n    /* Makes sure the baseline is still aligned with other elements */\n    line-height: var(--jp-widgets-inline-height);\n    /* Make it possible to have absolutely-positioned elements in the html */\n    position: relative;\n}\n","/* This file has code derived from PhosphorJS CSS files, as noted below. The license for this PhosphorJS code is:\n\nCopyright (c) 2014-2017, PhosphorJS Contributors\nAll rights reserved.\n\nRedistribution and use in source and binary forms, with or without\nmodification, are permitted provided that the following conditions are met:\n\n* Redistributions of source code must retain the above copyright notice, this\n  list of conditions and the following disclaimer.\n\n* Redistributions in binary form must reproduce the above copyright notice,\n  this list of conditions and the following disclaimer in the documentation\n  and/or other materials provided with the distribution.\n\n* Neither the name of the copyright holder nor the names of its\n  contributors may be used to endorse or promote products derived from\n  this software without specific prior written permission.\n\nTHIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS \"AS IS\"\nAND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE\nIMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE ARE\nDISCLAIMED. IN NO EVENT SHALL THE COPYRIGHT HOLDER OR CONTRIBUTORS BE LIABLE\nFOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL\nDAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR\nSERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS INTERRUPTION) HOWEVER\nCAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY,\nOR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE\nOF THIS SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.\n\n*/\n\n/*\n * The following section is derived from https://github.com/phosphorjs/phosphor/blob/23b9d075ebc5b73ab148b6ebfc20af97f85714c4/packages/widgets/style/tabbar.css \n * We've scoped the rules so that they are consistent with exactly our code.\n */\n\n.jupyter-widgets.widget-tab > .p-TabBar {\n  display: flex;\n  -webkit-user-select: none;\n  -moz-user-select: none;\n  -ms-user-select: none;\n  user-select: none;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar[data-orientation='horizontal'] {\n  flex-direction: row;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar[data-orientation='vertical'] {\n  flex-direction: column;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar > .p-TabBar-content {\n  margin: 0;\n  padding: 0;\n  display: flex;\n  flex: 1 1 auto;\n  list-style-type: none;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar[data-orientation='horizontal'] > .p-TabBar-content {\n  flex-direction: row;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar[data-orientation='vertical'] > .p-TabBar-content {\n  flex-direction: column;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab {\n  display: flex;\n  flex-direction: row;\n  box-sizing: border-box;\n  overflow: hidden;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabIcon,\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabCloseIcon {\n  flex: 0 0 auto;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tabLabel {\n  flex: 1 1 auto;\n  overflow: hidden;\n  white-space: nowrap;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar .p-TabBar-tab.p-mod-hidden {\n  display: none !important;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging .p-TabBar-tab {\n  position: relative;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging[data-orientation='horizontal'] .p-TabBar-tab {\n  left: 0;\n  transition: left 150ms ease;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging[data-orientation='vertical'] .p-TabBar-tab {\n  top: 0;\n  transition: top 150ms ease;\n}\n\n\n.jupyter-widgets.widget-tab > .p-TabBar.p-mod-dragging .p-TabBar-tab.p-mod-dragging {\n  transition: none;\n}\n\n/* End tabbar.css */\n"]} */","ok":true,"headers":[["content-type","text/css"]],"status":200,"status_text":""}},"base_uri":"https://localhost:8080/","height":251}},"source":["#\n","# the main query\n","#\n","q = \"\"\"search clinical_trials where associated_grant_ids in {} \n","  return clinical_trials[basics+associated_grant_ids]\"\"\"\n","\n","\n","#\n","# useful libraries for looping\n","#\n","from dimcli.shortcuts import chunks_of\n","from tqdm import tqdm_notebook as progressbar\n","\n","#\n","# let's loop through all grants IDs in chunks and query Dimensions \n","#\n","print(\"===\\nExtracting clinical trials data ...\")\n","results = []\n","\n","for chunk in progressbar(list(chunks_of(list(grantsids), 400))):\n","    data = dsl.query_iterative(q.format(json.dumps(chunk)), verbose=False)\n","    results += data.clinical_trials\n","    time.sleep(1)\n","\n","#\n","# put the patents data into a dataframe, remove duplicates and save\n","#\n","clinical_trials = pd.DataFrame().from_dict(results)\n","print(\"Clinical Trials found: \", len(clinical_trials))\n","clinical_trials.drop_duplicates(subset='id', inplace=True)\n","print(\"Unique Clinical Trials found: \", len(clinical_trials))\n","clinical_trials.to_csv(\"clinical_trials.csv\", index=False)\n","# NOTE turning lists into strings to ensure compatibility with CSV loaded data\n","# see also: https://stackoverflow.com/questions/23111990/pandas-dataframe-stored-list-as-string-how-to-convert-back-to-list\n","clinical_trials['associated_grant_ids'] = clinical_trials['associated_grant_ids'].apply(lambda x: ','.join(map(str, x))) \n","print(\"===\\nDone - data saved as 'clinical_trials.csv'.\")\n","\n","\n","#\n","# count patents per grant and enrich the original dataset\n","#\n","def cltrials_for_grantid(grantid):\n","  global clinical_trials\n","  return clinical_trials[clinical_trials['associated_grant_ids'].str.contains(grantid)]\n","\n","print(\"===\\nCounting clinical trials per grant...\")\n","l = []\n","for x in progressbar(grantsids):\n","  l.append(len(cltrials_for_grantid(x)))\n","\n","\n","\n","#\n","# save the data\n","#\n","grants['clinical_trials'] = l\n","grants.to_csv(\"grants_enriched_pubs_patents_clinical_trials.csv\", index=False)\n","print(\"===\\nDone - data saved as 'grants_enriched_pubs_patents_clinical_trials.csv'\")"],"execution_count":0,"outputs":[{"output_type":"stream","text":["===\n","Extracting clinical trials data ...\n"],"name":"stdout"},{"output_type":"display_data","data":{"application/vnd.jupyter.widget-view+json":{"model_id":"88586512eb374ce3abe8ae7a114ed5e3","version_minor":0,"version_major":2},"text/plain":["HBox(children=(IntProgress(value=0, max=13), HTML(value='')))"]},"metadata":{"tags":[]}},{"output_type":"stream","text":["Clinical Trials found:  11\n","Unique Clinical Trials found:  11\n","===\n","Done - data saved as 'clinical_trials.csv'.\n","===\n","Counting clinical trials per grant...\n"],"name":"stdout"},{"output_type":"display_data","data":{"application/vnd.jupyter.widget-view+json":{"model_id":"f2bd00f37e244360937e7875c131cd68","version_minor":0,"version_major":2},"text/plain":["HBox(children=(IntProgress(value=0, max=5000), HTML(value='')))"]},"metadata":{"tags":[]}},{"output_type":"stream","text":["===\n","Done - data saved as 'grants_enriched_pubs_patents_clinical_trials.csv'\n"],"name":"stdout"}]},{"cell_type":"code","metadata":{"colab_type":"code","outputId":"b9e7f0aa-bbaa-4fda-dbfe-1fa43ee28f76","executionInfo":{"status":"ok","timestamp":1573588633617,"user_tz":0,"elapsed":718,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"id":"CxoSgn62XfT4","colab":{"base_uri":"https://localhost:8080/","height":273}},"source":["clinical_trials.head(5)"],"execution_count":0,"outputs":[{"output_type":"execute_result","data":{"application/vnd.google.colaboratory.module+javascript":"\n      import \"https://ssl.gstatic.com/colaboratory/data_table/9e554b27bdd509f3/data_table.js\";\n\n      window.createDataTable({\n        data: [[{\n            'v': 0,\n            'f': \"0\",\n        },\n[[\"Beryl A Koblin\", \"PhD\", \"Principal Investigator\", \"New York Blood Center\", \"New York Blood Center\", \"grid.250415.7\"]],\n\"grant.2485747\",\n\"Project UNITY - A Randomized Trial of Enhanced HIV Risk Reduction and Vaccine Education Interventions in Reducing Sexual Risk and Increasing Vaccine Trial Knowledge Among HIV-negative, High-risk Women Who Use Non-injection Drugs\",\n\"NCT00150098\",\n[2005, 2006, 2007, 2008, 2009, 2010]],\n [{\n            'v': 1,\n            'f': \"1\",\n        },\n[[\"Emmanuel B Walter\", \"MPH, MD\", \"Principal Investigator\", \"Duke University Health System\", \"Duke University Health System\", \"grid.412100.6\"]],\n\"grant.2692202\",\n\"Prevention of Influenza in Infants by Immunization of Their Contacts in the Household\",\n\"NCT00570037\",\n[2007, 2008]],\n [{\n            'v': 2,\n            'f': \"2\",\n        },\n[[\"Paul Reiter\", \"PhD\", \"Principal Investigator\", \"Ohio State University Comprehensive Cancer Center\", \"The Ohio State University\", \"grid.261331.4\"]],\n\"grant.2438819,grant.4103659\",\n\"Increasing HPV Vaccine Coverage Among Young Adult Gay and Bisexual Men\",\n\"NCT02835755\",\n[2016, 2017]],\n [{\n            'v': 3,\n            'f': \"3\",\n        },\n[[\"Giuseppe Pantaleo\", \"\", \"Study Chair\", \"CTU Lausanne\", \"\", \"\"], [\"Pierre-Alexandre Bart\", \"MD\", \"Study Chair\", \"Lausanne CRS\", \"\", \"\"]],\n\"grant.2687787\",\n\"A Phase 1b Clinical Trial to Evaluate the Safety and Immunogenicity of Heterologous Prime/Boost Vaccine Regimens (NYVAC-B/rAd5 vs. rAd5/NYVAC-B) in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adult Participants\",\n\"NCT00961883\",\nNaN],\n [{\n            'v': 4,\n            'f': \"4\",\n        },\n[[\"Connie Celum\", \"MD\", \"Study Chair\", \"University of Washington\", \"University of Washington\", \"grid.34477.33\"], [\"Scott Hammer\", \"MD\", \"Study Chair\", \"Columbia University\", \"Columbia University\", \"grid.21729.3f\"]],\n\"grant.2687787\",\n\"A Multi-Site Evaluation of Virologic, Immunologic, and Clinical Natural History of Participants Enrolled in Phase I and Phase II HIV-1 Vaccine Protocols or HIV-1 Vaccine Preparedness Cohorts Who Develop HIV-1 Infection Subsequent to Trial Enrollment\",\n\"NCT00029913\",\n[2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009]]],\n        columns: [[\"number\", \"index\"], [\"string\", \"investigator_details\"], [\"string\", \"associated_grant_ids\"], [\"string\", \"title\"], [\"string\", \"id\"], [\"string\", \"active_years\"]],\n        columnOptions: [{\"width\": \"1px\", \"className\": \"index_column\"}],\n        rowsPerPage: 25,\n        helpUrl: \"https://colab.research.google.com/notebooks/data_table.ipynb\",\n      });\n    ","text/html":["<div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>investigator_details</th>\n","      <th>associated_grant_ids</th>\n","      <th>title</th>\n","      <th>id</th>\n","      <th>active_years</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>[[Beryl A Koblin, PhD, Principal Investigator,...</td>\n","      <td>grant.2485747</td>\n","      <td>Project UNITY - A Randomized Trial of Enhanced...</td>\n","      <td>NCT00150098</td>\n","      <td>[2005, 2006, 2007, 2008, 2009, 2010]</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>[[Emmanuel B Walter, MPH, MD, Principal Invest...</td>\n","      <td>grant.2692202</td>\n","      <td>Prevention of Influenza in Infants by Immuniza...</td>\n","      <td>NCT00570037</td>\n","      <td>[2007, 2008]</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>[[Paul Reiter, PhD, Principal Investigator, Oh...</td>\n","      <td>grant.2438819,grant.4103659</td>\n","      <td>Increasing HPV Vaccine Coverage Among Young Ad...</td>\n","      <td>NCT02835755</td>\n","      <td>[2016, 2017]</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>[[Giuseppe Pantaleo, , Study Chair, CTU Lausan...</td>\n","      <td>grant.2687787</td>\n","      <td>A Phase 1b Clinical Trial to Evaluate the Safe...</td>\n","      <td>NCT00961883</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>[[Connie Celum, MD, Study Chair, University of...</td>\n","      <td>grant.2687787</td>\n","      <td>A Multi-Site Evaluation of Virologic, Immunolo...</td>\n","      <td>NCT00029913</td>\n","      <td>[2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009]</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>"],"text/plain":["                                investigator_details  ...                                      active_years\n","0  [[Beryl A Koblin, PhD, Principal Investigator,...  ...              [2005, 2006, 2007, 2008, 2009, 2010]\n","1  [[Emmanuel B Walter, MPH, MD, Principal Invest...  ...                                      [2007, 2008]\n","2  [[Paul Reiter, PhD, Principal Investigator, Oh...  ...                                      [2016, 2017]\n","3  [[Giuseppe Pantaleo, , Study Chair, CTU Lausan...  ...                                               NaN\n","4  [[Connie Celum, MD, Study Chair, University of...  ...  [2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009]\n","\n","[5 rows x 5 columns]"]},"metadata":{"tags":[]},"execution_count":15}]},{"cell_type":"code","metadata":{"id":"uluFhcWSMSs0","colab_type":"code","outputId":"e4e2d745-28b2-43e8-e228-fe1f61db60b6","executionInfo":{"status":"ok","timestamp":1573588650769,"user_tz":0,"elapsed":515,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"colab":{"base_uri":"https://localhost:8080/","height":273}},"source":["grants.sort_values(\"clinical_trials\", ascending=False).head(5)"],"execution_count":0,"outputs":[{"output_type":"execute_result","data":{"application/vnd.google.colaboratory.module+javascript":"\n      import \"https://ssl.gstatic.com/colaboratory/data_table/9e554b27bdd509f3/data_table.js\";\n\n      window.createDataTable({\n        data: [[{\n            'v': 3877,\n            'f': \"3877\",\n        },\n\"grant.2687787\",\n\"U01AI068614\",\n\"Leadership Group for a Global HIV Vaccine Clinical Trials Network\",\n{\n            'v': 181539904,\n            'f': \"181539904\",\n        },\n\"2006-06-29\",\n{\n            'v': 2006.0,\n            'f': \"2006.0\",\n        },\n\"2013-05-31\",\n{\n            'v': 2013,\n            'f': \"2013\",\n        },\n\"Fred Hutchinson Cancer Research Center\",\n\"grid.270240.3\",\n\"United States\",\n\"National Institute of Allergy and Infectious Diseases\",\n\"United States\",\n{\n            'v': 64,\n            'f': \"64\",\n        },\n{\n            'v': 0,\n            'f': \"0\",\n        },\n{\n            'v': 2,\n            'f': \"2\",\n        }],\n [{\n            'v': 4498,\n            'f': \"4498\",\n        },\n\"grant.2435034\",\n\"P01AI045142\",\n\"DEVELOPMENT OF A NOVEL MULTIENVELOPE AIDS VACCINE\",\n{\n            'v': 7044139,\n            'f': \"7044139\",\n        },\n\"1999-05-15\",\n{\n            'v': 1999.0,\n            'f': \"1999.0\",\n        },\n\"2006-07-31\",\n{\n            'v': 2006,\n            'f': \"2006\",\n        },\n\"St. Jude Children's Research Hospital\",\n\"grid.240871.8\",\n\"United States\",\n\"National Institute of Allergy and Infectious Diseases\",\n\"United States\",\n{\n            'v': 34,\n            'f': \"34\",\n        },\n{\n            'v': 0,\n            'f': \"0\",\n        },\n{\n            'v': 1,\n            'f': \"1\",\n        }],\n [{\n            'v': 4791,\n            'f': \"4791\",\n        },\n\"grant.2695778\",\n\"U19AI065683\",\n\"Malaria Vaccine Trials in Mali\",\n{\n            'v': 4748457,\n            'f': \"4748457\",\n        },\n\"2005-09-01\",\n{\n            'v': 2005.0,\n            'f': \"2005.0\",\n        },\n\"2010-06-30\",\n{\n            'v': 2010,\n            'f': \"2010\",\n        },\n\"University of Maryland, Baltimore\",\n\"grid.411024.2\",\n\"United States\",\n\"National Institute of Allergy and Infectious Diseases\",\n\"United States\",\n{\n            'v': 32,\n            'f': \"32\",\n        },\n{\n            'v': 0,\n            'f': \"0\",\n        },\n{\n            'v': 1,\n            'f': \"1\",\n        }],\n [{\n            'v': 4229,\n            'f': \"4229\",\n        },\n\"grant.2687567\",\n\"U01AI053719\",\n\"INDO-US Collaboration to Develop Rotavirus Vaccines\",\n{\n            'v': 1130283,\n            'f': \"1130283\",\n        },\n\"2003-03-01\",\n{\n            'v': 2003.0,\n            'f': \"2003.0\",\n        },\n\"2008-02-29\",\n{\n            'v': 2008,\n            'f': \"2008\",\n        },\n\"All India Institute of Medical Sciences\",\n\"grid.413618.9\",\n\"India\",\n\"National Institute of Allergy and Infectious Diseases\",\n\"United States\",\n{\n            'v': 2,\n            'f': \"2\",\n        },\n{\n            'v': 0,\n            'f': \"0\",\n        },\n{\n            'v': 1,\n            'f': \"1\",\n        }],\n [{\n            'v': 3814,\n            'f': \"3814\",\n        },\n\"grant.2692202\",\n\"U01IP000074\",\n\"PiiiTCH Study\",\n{\n            'v': 0,\n            'f': \"0\",\n        },\n\"2006-09-15\",\n{\n            'v': 2006.0,\n            'f': \"2006.0\",\n        },\n\"2008-09-14\",\n{\n            'v': 2008,\n            'f': \"2008\",\n        },\n\"Duke University\",\n\"grid.26009.3d\",\n\"United States\",\n\"Centers for Disease Control and Prevention\",\n\"United States\",\n{\n            'v': 2,\n            'f': \"2\",\n        },\n{\n            'v': 0,\n            'f': \"0\",\n        },\n{\n            'v': 1,\n            'f': \"1\",\n        }]],\n        columns: [[\"number\", \"index\"], [\"string\", \"Grant ID\"], [\"string\", \"Grant Number\"], [\"string\", \"Title\"], [\"number\", \"Funding Amount in USD\"], [\"string\", \"Start Date\"], [\"number\", \"Start Year\"], [\"string\", \"End Date\"], [\"number\", \"End Year\"], [\"string\", \"Research Organization - standardized\"], [\"string\", \"GRID ID\"], [\"string\", \"Country of Research organization\"], [\"string\", \"Funder\"], [\"string\", \"Funder Country\"], [\"number\", \"pubs\"], [\"number\", \"patents\"], [\"number\", \"clinical_trials\"]],\n        columnOptions: [{\"width\": \"1px\", \"className\": \"index_column\"}],\n        rowsPerPage: 25,\n        helpUrl: \"https://colab.research.google.com/notebooks/data_table.ipynb\",\n      });\n    ","text/html":["<div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>Grant ID</th>\n","      <th>Grant Number</th>\n","      <th>Title</th>\n","      <th>Funding Amount in USD</th>\n","      <th>Start Date</th>\n","      <th>Start Year</th>\n","      <th>End Date</th>\n","      <th>End Year</th>\n","      <th>Research Organization - standardized</th>\n","      <th>GRID ID</th>\n","      <th>Country of Research organization</th>\n","      <th>Funder</th>\n","      <th>Funder Country</th>\n","      <th>pubs</th>\n","      <th>patents</th>\n","      <th>clinical_trials</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>3877</th>\n","      <td>grant.2687787</td>\n","      <td>U01AI068614</td>\n","      <td>Leadership Group for a Global HIV Vaccine Clin...</td>\n","      <td>181539904</td>\n","      <td>2006-06-29</td>\n","      <td>2006.0</td>\n","      <td>2013-05-31</td>\n","      <td>2013</td>\n","      <td>Fred Hutchinson Cancer Research Center</td>\n","      <td>grid.270240.3</td>\n","      <td>United States</td>\n","      <td>National Institute of Allergy and Infectious D...</td>\n","      <td>United States</td>\n","      <td>64</td>\n","      <td>0</td>\n","      <td>2</td>\n","    </tr>\n","    <tr>\n","      <th>4498</th>\n","      <td>grant.2435034</td>\n","      <td>P01AI045142</td>\n","      <td>DEVELOPMENT OF A NOVEL MULTIENVELOPE AIDS VACCINE</td>\n","      <td>7044139</td>\n","      <td>1999-05-15</td>\n","      <td>1999.0</td>\n","      <td>2006-07-31</td>\n","      <td>2006</td>\n","      <td>St. Jude Children's Research Hospital</td>\n","      <td>grid.240871.8</td>\n","      <td>United States</td>\n","      <td>National Institute of Allergy and Infectious D...</td>\n","      <td>United States</td>\n","      <td>34</td>\n","      <td>0</td>\n","      <td>1</td>\n","    </tr>\n","    <tr>\n","      <th>4791</th>\n","      <td>grant.2695778</td>\n","      <td>U19AI065683</td>\n","      <td>Malaria Vaccine Trials in Mali</td>\n","      <td>4748457</td>\n","      <td>2005-09-01</td>\n","      <td>2005.0</td>\n","      <td>2010-06-30</td>\n","      <td>2010</td>\n","      <td>University of Maryland, Baltimore</td>\n","      <td>grid.411024.2</td>\n","      <td>United States</td>\n","      <td>National Institute of Allergy and Infectious D...</td>\n","      <td>United States</td>\n","      <td>32</td>\n","      <td>0</td>\n","      <td>1</td>\n","    </tr>\n","    <tr>\n","      <th>4229</th>\n","      <td>grant.2687567</td>\n","      <td>U01AI053719</td>\n","      <td>INDO-US Collaboration to Develop Rotavirus Vac...</td>\n","      <td>1130283</td>\n","      <td>2003-03-01</td>\n","      <td>2003.0</td>\n","      <td>2008-02-29</td>\n","      <td>2008</td>\n","      <td>All India Institute of Medical Sciences</td>\n","      <td>grid.413618.9</td>\n","      <td>India</td>\n","      <td>National Institute of Allergy and Infectious D...</td>\n","      <td>United States</td>\n","      <td>2</td>\n","      <td>0</td>\n","      <td>1</td>\n","    </tr>\n","    <tr>\n","      <th>3814</th>\n","      <td>grant.2692202</td>\n","      <td>U01IP000074</td>\n","      <td>PiiiTCH Study</td>\n","      <td>0</td>\n","      <td>2006-09-15</td>\n","      <td>2006.0</td>\n","      <td>2008-09-14</td>\n","      <td>2008</td>\n","      <td>Duke University</td>\n","      <td>grid.26009.3d</td>\n","      <td>United States</td>\n","      <td>Centers for Disease Control and Prevention</td>\n","      <td>United States</td>\n","      <td>2</td>\n","      <td>0</td>\n","      <td>1</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>"],"text/plain":["           Grant ID Grant Number  ... patents  clinical_trials\n","3877  grant.2687787  U01AI068614  ...       0                2\n","4498  grant.2435034  P01AI045142  ...       0                1\n","4791  grant.2695778  U19AI065683  ...       0                1\n","4229  grant.2687567  U01AI053719  ...       0                1\n","3814  grant.2692202  U01IP000074  ...       0                1\n","\n","[5 rows x 16 columns]"]},"metadata":{"tags":[]},"execution_count":16}]},{"cell_type":"markdown","metadata":{"id":"cHc1KcE5AV-E","colab_type":"text"},"source":["## Data Exploration\n","\n","Now we can explore a bit the grants+publications+patents+clinical_trials dataset using the [plotly express](https://plot.ly/python/plotly-express/) library. \n","\n","> If by any chance you couldn't complete the steps above, the final enriched data can be found here: [grants_enriched_pubs_patents_clinical_trials.csv](http://static.michelepasin.org/dsl/grants_enriched_pubs_patents_clinical_trials.csv). Load it with `grants = pd.read_csv()` as above."]},{"cell_type":"code","metadata":{"id":"Ofwh6tfb0NL3","colab_type":"code","colab":{}},"source":["import plotly_express as px"],"execution_count":0,"outputs":[]},{"cell_type":"markdown","metadata":{"id":"H18-dIEjYgPz","colab_type":"text"},"source":["### How many linked objects overall? \n"]},{"cell_type":"code","metadata":{"id":"UpE0HsrcZ6A-","colab_type":"code","outputId":"6c4f7aea-ac65-4028-841c-1d168ea8a7f9","executionInfo":{"status":"ok","timestamp":1573589018808,"user_tz":0,"elapsed":1034,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"colab":{"base_uri":"https://localhost:8080/","height":617}},"source":["df = pd.DataFrame({\n","    'measure' : ['Grants', 'Grants with pubs', 'Grants with Patents', 'Grants with Clinical Trials'],\n","    'count' : [len(grants), len(grants[grants['pubs'] > 0]), len(grants[grants['patents'] > 0]), len(grants[grants['clinical_trials'] > 0])],\n","})\n","\n","px.bar(df, x=\"measure\", y=\"count\", title=f\"Grants: overview of associated objects found\")"],"execution_count":0,"outputs":[{"output_type":"display_data","data":{"text/html":["<html>\n","<head><meta charset=\"utf-8\" /></head>\n","<body>\n","    <div>\n","            <script src=\"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_SVG\"></script><script type=\"text/javascript\">if (window.MathJax) {MathJax.Hub.Config({SVG: {font: \"STIX-Web\"}});}</script>\n","                <script type=\"text/javascript\">window.PlotlyConfig = {MathJaxConfig: 'local'};</script>\n","        <script src=\"https://cdn.plot.ly/plotly-latest.min.js\"></script>    \n","            <div id=\"1953a80d-22bb-484d-bc7c-87c03282a865\" class=\"plotly-graph-div\" style=\"height:600px; width:100%;\"></div>\n","            <script type=\"text/javascript\">\n","                \n","                    window.PLOTLYENV=window.PLOTLYENV || {};\n","                    \n","                if (document.getElementById(\"1953a80d-22bb-484d-bc7c-87c03282a865\")) {\n","                    Plotly.newPlot(\n","                        '1953a80d-22bb-484d-bc7c-87c03282a865',\n","                        [{\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"measure=%{x}<br>count=%{y}\", \"legendgroup\": \"\", \"marker\": {\"color\": \"#636efa\"}, \"name\": \"\", \"offsetgroup\": \"\", \"orientation\": \"v\", \"showlegend\": false, \"textposition\": \"auto\", \"type\": \"bar\", \"x\": [\"Grants\", \"Grants with pubs\", \"Grants with Patents\", \"Grants with Clinical Trials\"], \"xaxis\": \"x\", \"y\": [5000, 1604, 122, 10], \"yaxis\": \"y\"}],\n","                        {\"barmode\": \"relative\", \"height\": 600, \"legend\": {\"tracegroupgap\": 0}, \"template\": {\"data\": {\"bar\": [{\"error_x\": {\"color\": \"#2a3f5f\"}, \"error_y\": {\"color\": \"#2a3f5f\"}, \"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"bar\"}], \"barpolar\": [{\"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"barpolar\"}], \"carpet\": [{\"aaxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"baxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"type\": \"carpet\"}], \"choropleth\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"choropleth\"}], \"contour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"contour\"}], \"contourcarpet\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"contourcarpet\"}], \"heatmap\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmap\"}], \"heatmapgl\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmapgl\"}], \"histogram\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"histogram\"}], \"histogram2d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2d\"}], \"histogram2dcontour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2dcontour\"}], \"mesh3d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"mesh3d\"}], \"parcoords\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"parcoords\"}], \"scatter\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter\"}], \"scatter3d\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter3d\"}], \"scattercarpet\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattercarpet\"}], \"scattergeo\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergeo\"}], \"scattergl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergl\"}], \"scattermapbox\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattermapbox\"}], \"scatterpolar\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolar\"}], \"scatterpolargl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolargl\"}], \"scatterternary\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterternary\"}], \"surface\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"surface\"}], \"table\": [{\"cells\": {\"fill\": {\"color\": \"#EBF0F8\"}, \"line\": {\"color\": \"white\"}}, \"header\": {\"fill\": {\"color\": \"#C8D4E3\"}, \"line\": {\"color\": \"white\"}}, \"type\": \"table\"}]}, \"layout\": {\"annotationdefaults\": {\"arrowcolor\": \"#2a3f5f\", \"arrowhead\": 0, \"arrowwidth\": 1}, \"colorscale\": {\"diverging\": [[0, \"#8e0152\"], [0.1, \"#c51b7d\"], [0.2, \"#de77ae\"], [0.3, \"#f1b6da\"], [0.4, \"#fde0ef\"], [0.5, \"#f7f7f7\"], [0.6, \"#e6f5d0\"], [0.7, \"#b8e186\"], [0.8, \"#7fbc41\"], [0.9, \"#4d9221\"], [1, \"#276419\"]], \"sequential\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"sequentialminus\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"colorway\": [\"#636efa\", \"#EF553B\", \"#00cc96\", \"#ab63fa\", \"#FFA15A\", \"#19d3f3\", \"#FF6692\", \"#B6E880\", \"#FF97FF\", \"#FECB52\"], \"font\": {\"color\": \"#2a3f5f\"}, \"geo\": {\"bgcolor\": \"white\", \"lakecolor\": \"white\", \"landcolor\": \"#E5ECF6\", \"showlakes\": true, \"showland\": true, \"subunitcolor\": \"white\"}, \"hoverlabel\": {\"align\": \"left\"}, \"hovermode\": \"closest\", \"mapbox\": {\"style\": \"light\"}, \"paper_bgcolor\": \"white\", \"plot_bgcolor\": \"#E5ECF6\", \"polar\": {\"angularaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"radialaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"scene\": {\"xaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"yaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"zaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}}, \"shapedefaults\": {\"line\": {\"color\": \"#2a3f5f\"}}, \"ternary\": {\"aaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"baxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"caxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"title\": {\"x\": 0.05}, \"xaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}, \"yaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}}}, \"title\": {\"text\": \"Grants: overview of associated objects found\"}, \"xaxis\": {\"anchor\": \"y\", \"domain\": [0.0, 0.98], \"title\": {\"text\": \"measure\"}}, \"yaxis\": {\"anchor\": \"x\", \"domain\": [0.0, 1.0], \"title\": {\"text\": \"count\"}}},\n","                        {\"responsive\": true}\n","                    ).then(function(){\n","                            \n","var gd = document.getElementById('1953a80d-22bb-484d-bc7c-87c03282a865');\n","var x = new MutationObserver(function (mutations, observer) {{\n","        var display = window.getComputedStyle(gd).display;\n","        if (!display || display === 'none') {{\n","            console.log([gd, 'removed!']);\n","            Plotly.purge(gd);\n","            observer.disconnect();\n","        }}\n","}});\n","\n","// Listen for the removal of the full notebook cells\n","var notebookContainer = gd.closest('#notebook-container');\n","if (notebookContainer) {{\n","    x.observe(notebookContainer, {childList: true});\n","}}\n","\n","// Listen for the clearing of the current output cell\n","var outputEl = gd.closest('.output');\n","if (outputEl) {{\n","    x.observe(outputEl, {childList: true});\n","}}\n","\n","                        })\n","                };\n","                \n","            </script>\n","        </div>\n","</body>\n","</html>"]},"metadata":{"tags":[]}}]},{"cell_type":"markdown","metadata":{"id":"qbVKYDEeN2Z7","colab_type":"text"},"source":["### Patents and Clinical Trials by Year"]},{"cell_type":"code","metadata":{"id":"zdhjqu58bfc5","colab_type":"code","outputId":"aa65286f-503e-4fa4-aeab-07c61166d598","executionInfo":{"status":"ok","timestamp":1573589093912,"user_tz":0,"elapsed":1587,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"colab":{"base_uri":"https://localhost:8080/","height":617}},"source":["px.bar(grants, x=\"End Year\", y=\"patents\", color=\"Funding Amount in USD\", \n","       hover_name=\"Title\", \n","       hover_data=['Grant ID', 'Start Year', 'End Year', 'Funder', 'Funder Country'],\n","       title=f\"Patents per grant\")"],"execution_count":0,"outputs":[{"output_type":"display_data","data":{"text/html":["<html>\n","<head><meta charset=\"utf-8\" /></head>\n","<body>\n","    <div>\n","            <script src=\"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_SVG\"></script><script type=\"text/javascript\">if (window.MathJax) {MathJax.Hub.Config({SVG: {font: \"STIX-Web\"}});}</script>\n","                <script type=\"text/javascript\">window.PlotlyConfig = {MathJaxConfig: 'local'};</script>\n","        <script src=\"https://cdn.plot.ly/plotly-latest.min.js\"></script>    \n","            <div id=\"937d9be2-b5b0-4303-9e90-9137b69e1a2d\" class=\"plotly-graph-div\" style=\"height:600px; width:100%;\"></div>\n","            <script type=\"text/javascript\">\n","                \n","                    window.PLOTLYENV=window.PLOTLYENV || {};\n","                    \n","                if (document.getElementById(\"937d9be2-b5b0-4303-9e90-9137b69e1a2d\")) {\n","                    Plotly.newPlot(\n","                        '937d9be2-b5b0-4303-9e90-9137b69e1a2d',\n","                        [{\"alignmentgroup\": \"True\", \"customdata\": [[\"grant.8172033\", 2004.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7715379\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6962629\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6723913\", 2003.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6722306\", 2005.0, 2009, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716312\", 1991.0, 1993, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.5526688\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.3733803\", 1998.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3274273\", 1977.0, 1980, \"Directorate for Biological Sciences\", \"United States\"], [\"grant.2936015\", 2003.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2863615\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2815666\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2807651\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2800991\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2710461\", 2002.0, 2002, \"National Cancer Institute\", \"United States\"], [\"grant.2657659\", 1992.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640369\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640228\", 1996.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2426045\", 1992.0, 1993, \"National Cancer Institute\", \"United States\"], [\"grant.2426044\", 1992.0, 1993, \"National Cancer Institute\", \"United States\"], [\"grant.2426039\", 1992.0, 1993, \"National Cancer Institute\", \"United States\"], [\"grant.2425936\", 1992.0, 1996, \"National Cancer Institute\", \"United States\"], [\"grant.2425935\", 1992.0, 1993, \"National Cancer Institute\", \"United States\"], [\"grant.2425932\", 1992.0, 1996, \"National Cancer Institute\", \"United States\"], [\"grant.2425010\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424436\", 1990.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8068979\", 2006.0, 2010, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.7106480\", 2010.0, 2011, \"VINNOVA\", \"Sweden\"], [\"grant.2639983\", 1990.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2355874\", 1986.0, 1986, \"Fogarty International Center\", \"United States\"], [\"grant.7566903\", 2007.0, 2008, \"Ministry of Business, Innovation and Employment\", \"New Zealand\"], [\"grant.7042623\", 1990.0, 1993, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040393\", 1992.0, 1993, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6731478\", 1994.0, 1995, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728996\", 1998.0, 2002, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723289\", 2002.0, 2004, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718929\", 1994.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713873\", 1993.0, 1993, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.4442512\", 1985.0, 1986, \"United States Department of the Army\", \"United States\"], [\"grant.4035473\", 2008.0, 2010, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.2987461\", 1992.0, 1993, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2972379\", 1997.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2964974\", 2005.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2957579\", 1993.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2950584\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2920553\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2915638\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2912254\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2880945\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2877426\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2828580\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2805504\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2795214\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2692263\", 2011.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2688631\", 1993.0, 1997, \"National Cancer Institute\", \"United States\"], [\"grant.2657670\", 1993.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640366\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597598\", 2000.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424826\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424691\", 1985.0, 1990, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424653\", 1994.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424634\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424633\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424632\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424631\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424630\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424629\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424455\", 1991.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424372\", 1990.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2393802\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393756\", 2012.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.7987079\", 1996.0, 1999, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8217971\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8176576\", 2012.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8175344\", 2009.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8172020\", 2004.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8166566\", 2000.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7988463\", 2004.0, 2007, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7821014\", 1998.0, 2001, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7688859\", 2006.0, 2006, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7685445\", 2011.0, 2011, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7666696\", 2002.0, 2005, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7664870\", 1999.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7628231\", 2000.0, 2001, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7623308\", 1999.0, 2001, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7575791\", 2016.0, 2017, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.7568437\", 2002.0, 2003, \"Ministry of Business, Innovation and Employment\", \"New Zealand\"], [\"grant.7567590\", 2004.0, 2007, \"Ministry of Business, Innovation and Employment\", \"New Zealand\"], [\"grant.7456676\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7437133\", 2008.0, 2010, \"University Grants Committee\", \"China\"], [\"grant.7167590\", 1997.0, 1999, \"Innovation and Technology Commission\", \"China\"], [\"grant.7149998\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7148384\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7043734\", 1992.0, 1993, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042974\", 1996.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042624\", 1990.0, 1993, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042622\", 1990.0, 1993, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6972056\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6968725\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6966722\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6844591\", 2001.0, 2004, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6735165\", 1989.0, 1991, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6732885\", 1990.0, 1991, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6731341\", 1992.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6730713\", 2010.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6729465\", 1990.0, 1992, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6729082\", 1992.0, 1994, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6726453\", 1999.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725165\", 1996.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725082\", 1992.0, 1994, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725032\", 1991.0, 1993, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6724834\", 1991.0, 1993, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723804\", 2002.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723056\", 2007.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716599\", 1995.0, 1997, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6714669\", 1988.0, 1990, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6714037\", 1990.0, 1992, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713255\", 1997.0, 1999, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6582874\", 2000.0, 2001, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6370857\", 1971.0, 1971, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6363940\", 1970.0, 1970, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6363488\", 1969.0, 1969, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6343961\", 1966.0, 1966, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6317005\", 1976.0, 1976, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6315891\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6233441\", 1986.0, 1986, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6193400\", 2000.0, 2002, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6171313\", 1981.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6169577\", 1981.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5896926\", 2004.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5526642\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5502450\", 2010.0, 2015, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5246711\", 1999.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246674\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246626\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5070451\", 2008.0, 2013, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5061344\", 1999.0, 2001, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.4641309\", 2008.0, 2008, \"The Research Council of Norway\", \"Norway\"], [\"grant.4168271\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.3739684\", 1998.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3706272\", 1985.0, 1987, \"European Commission\", \"Belgium\"], [\"grant.3702523\", 1989.0, 1993, \"European Commission\", \"Belgium\"], [\"grant.3652600\", 2013.0, 2014, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.3309929\", 1981.0, 1981, \"Directorate for Engineering\", \"United States\"], [\"grant.2986898\", 2002.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2985999\", 2003.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2984549\", 1996.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2974921\", 1994.0, 1995, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2971636\", 1999.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2963297\", 1997.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2953859\", 1995.0, 1996, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2951075\", 1998.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2945193\", 2006.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2937592\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2937042\", 2004.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2935778\", 1998.0, 2001, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2914065\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2910038\", 2000.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2899455\", 2005.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2898752\", 2000.0, 2002, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2896132\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2869083\", 2003.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2835164\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2824183\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2813726\", 2003.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2694848\", 2008.0, 2013, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2692184\", 2004.0, 2011, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2687621\", 2003.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687368\", 1994.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687218\", 1990.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687093\", 1987.0, 1990, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666074\", 2006.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2665915\", 2002.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2664798\", 2001.0, 2003, \"National Institute on Deafness and Other Communication Disorders\", \"United States\"], [\"grant.2643578\", 1996.0, 1996, \"National Cancer Institute\", \"United States\"], [\"grant.2643577\", 1996.0, 1997, \"National Cancer Institute\", \"United States\"], [\"grant.2643549\", 1996.0, 1997, \"National Cancer Institute\", \"United States\"], [\"grant.2640348\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640344\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640324\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640316\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640237\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640236\", 1996.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639795\", 1987.0, 1987, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636315\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636304\", 1995.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636298\", 1994.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2625146\", 1992.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2608574\", 1999.0, 2002, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2602929\", 1999.0, 2002, \"National Cancer Institute\", \"United States\"], [\"grant.2597635\", 1999.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2572211\", 1995.0, 1997, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.2566750\", 1991.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566749\", 1990.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566740\", 1990.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566739\", 1990.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566738\", 1990.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2489689\", 1982.0, 2003, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.2474868\", 1999.0, 2002, \"National Cancer Institute\", \"United States\"], [\"grant.2471363\", 1993.0, 1997, \"National Cancer Institute\", \"United States\"], [\"grant.2471277\", 1992.0, 1998, \"National Cancer Institute\", \"United States\"], [\"grant.2471271\", 1992.0, 1997, \"National Cancer Institute\", \"United States\"], [\"grant.2454716\", 1999.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453176\", 1994.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452868\", 1993.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452627\", 1992.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452157\", 1992.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2450816\", 1986.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2433676\", 1985.0, 1985, \"National Cancer Institute\", \"United States\"], [\"grant.2433640\", 1989.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2433628\", 1985.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2428617\", 1981.0, 1986, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.2428003\", 1994.0, 1998, \"National Cancer Institute\", \"United States\"], [\"grant.2425945\", 1994.0, 1998, \"National Cancer Institute\", \"United States\"], [\"grant.2425777\", 1997.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425765\", 1995.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425738\", 1990.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424919\", 1987.0, 1992, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424708\", 1985.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424692\", 1985.0, 1990, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424627\", 1994.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424600\", 1983.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424554\", 1983.0, 1986, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424491\", 1992.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424469\", 1991.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424424\", 2000.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424340\", 1979.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2406847\", 1992.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2393916\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393915\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393914\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393913\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393912\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393911\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393910\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393909\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393908\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393907\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393906\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393905\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393904\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393903\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393902\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393901\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393900\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393899\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393898\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393897\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393896\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393895\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393893\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393892\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393891\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393890\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393889\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393888\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393887\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393886\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393885\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393884\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393883\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393882\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393881\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393880\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393879\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393878\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393877\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393876\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393875\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393874\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393873\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393872\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393871\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393870\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393869\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393868\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393867\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393866\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393865\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393864\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393863\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393862\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393861\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393860\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393859\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393858\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393857\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393856\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393855\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393854\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393853\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393852\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393844\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393841\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393821\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393817\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393814\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393808\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393804\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393800\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393799\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393797\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393795\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393794\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393790\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393786\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2375051\", 1987.0, 1988, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2369583\", 1991.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2356619\", 1994.0, 1995, \"Fogarty International Center\", \"United States\"], [\"grant.8460157\", 2010.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8446709\", 2013.0, 2015, \"Swedish Research Council for Environment Agricultural Sciences and Spatial Planning\", \"Sweden\"], [\"grant.8033537\", 2010.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951286\", 2013.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7942547\", 2008.0, 2011, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7608089\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7502141\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7498852\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7498851\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7475580\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7167585\", 1996.0, 2000, \"Innovation and Technology Commission\", \"China\"], [\"grant.7104247\", 2010.0, 2014, \"VINNOVA\", \"Sweden\"], [\"grant.7062940\", 2016.0, 2017, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.6967906\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6728271\", 2010.0, 2012, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6500725\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6259132\", 1998.0, 1999, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5892064\", 2004.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5761631\", 1999.0, 1999, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5551429\", 2000.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5246672\", 2006.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246671\", 2006.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246586\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246584\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246583\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246582\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246581\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4632144\", 2004.0, 2007, \"Slovenian Research Agency\", \"Slovenia\"], [\"grant.3802932\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2936797\", 2000.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2424522\", 2004.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6315092\", 1976.0, 1976, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.8505364\", 2011.0, 2014, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8495954\", 2014.0, 2017, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8489605\", 2011.0, 2014, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8487606\", 2008.0, 2011, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8352947\", 2015.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8328815\", 2000.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8290380\", 2004.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8219416\", 1999.0, 1999, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8219108\", 1999.0, 2001, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8217961\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8216804\", 1997.0, 1999, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8214678\", 1995.0, 1997, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8209272\", 1991.0, 1993, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8209093\", 1991.0, 1993, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8205967\", 1987.0, 1993, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173982\", 2007.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173409\", 2007.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8172930\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169476\", 2002.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8167666\", 2001.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8034776\", 2009.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8033536\", 2010.0, 2013, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8019012\", 2016.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8018668\", 2012.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8005184\", 2008.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8000977\", 2009.0, 2010, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.7993576\", 2014.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992850\", 2013.0, 2018, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989648\", 2008.0, 2008, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951296\", 2015.0, 2015, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7851731\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7821052\", 1999.0, 2002, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7741443\", 2010.0, 2015, \"Danish Ministry of Higher Education and Science\", \"Denmark\"], [\"grant.7721825\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7721778\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7721598\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7721597\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7715670\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7709652\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7695510\", 2012.0, 2012, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7693092\", 2017.0, 2017, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7692313\", 2010.0, 2012, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7687496\", 2008.0, 2008, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7685141\", 2010.0, 2012, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7684827\", 2011.0, 2012, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7683420\", 2006.0, 2007, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7668688\", 2005.0, 2005, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7666767\", 2005.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665207\", 2002.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665048\", 2002.0, 2004, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665045\", 2001.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665032\", 2002.0, 2007, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658271\", 2006.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658269\", 2003.0, 2004, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7653038\", 1998.0, 2001, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7648001\", 1999.0, 2000, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7647714\", 2001.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7645631\", 2004.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7644460\", 1998.0, 2001, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7632409\", 2004.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7629669\", 2002.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7628997\", 2016.0, 2016, \"Canadian Cancer Society\", \"Canada\"], [\"grant.7628517\", 1996.0, 2001, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7624786\", 2003.0, 2005, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7623304\", 2001.0, 2004, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7622447\", 2002.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7620072\", 1999.0, 2005, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7618695\", 2000.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7608908\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7576541\", 2016.0, 2017, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.7575474\", 2016.0, 2017, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.7550264\", 2000.0, 2003, \"Bloodwise\", \"United Kingdom\"], [\"grant.7550133\", 1998.0, 1999, \"Bloodwise\", \"United Kingdom\"], [\"grant.7501980\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7497479\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7487475\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7486078\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7485113\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7480407\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7475943\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7466232\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7456985\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7453708\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7451192\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7445407\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7172800\", 2015.0, 2017, \"United States-Israel Binational Science Foundation\", \"Israel\"], [\"grant.7164693\", 2015.0, 2016, \"Innovation and Technology Commission\", \"China\"], [\"grant.7162576\", 2014.0, 2016, \"Innovation and Technology Commission\", \"China\"], [\"grant.7150415\", 2013.0, 2013, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7148703\", 2016.0, 2016, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7148315\", 2017.0, 2017, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7043730\", 1993.0, 1996, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043113\", 2003.0, 2011, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042995\", 1997.0, 2000, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042984\", 1994.0, 1996, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042973\", 1996.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042972\", 1993.0, 1996, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040781\", 1997.0, 1998, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040770\", 1994.0, 1997, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6973472\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6968429\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6964936\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6964935\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6964934\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6962076\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6860200\", 2013.0, 2017, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.6841646\", 2017.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6733351\", 1994.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6733063\", 1989.0, 1991, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6732161\", 1988.0, 1990, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6731087\", 1993.0, 1995, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6730637\", 1997.0, 1997, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6729362\", 1990.0, 1992, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728479\", 1991.0, 1994, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727741\", 2000.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727472\", 1990.0, 1992, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727351\", 1993.0, 1995, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727129\", 1995.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6726943\", 1999.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6726066\", 1998.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6724082\", 2004.0, 2008, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6724070\", 2004.0, 2004, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6722617\", 2007.0, 2011, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6722495\", 2007.0, 2011, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6719794\", 1993.0, 1993, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6717775\", 1998.0, 2000, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716449\", 1997.0, 1999, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715829\", 1989.0, 1991, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715708\", 1993.0, 1995, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6584428\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584014\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583657\", 2005.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582621\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582605\", 2005.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582373\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581732\", 2006.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581497\", 2013.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581487\", 2006.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581045\", 2016.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580935\", 2000.0, 2006, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580931\", 2004.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580858\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6373203\", 1971.0, 1971, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6371736\", 1971.0, 1971, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6371621\", 1971.0, 1971, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6354558\", 1967.0, 1967, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6352300\", 1968.0, 1968, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6326766\", 1972.0, 1972, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6322556\", 1972.0, 1972, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6320876\", 1972.0, 1973, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6315181\", 1978.0, 1979, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6312481\", 1976.0, 1976, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6312424\", 1975.0, 1975, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6309272\", 1980.0, 1980, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6300254\", 1973.0, 1973, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6269166\", 1999.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6265050\", 1999.0, 2000, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6199903\", 1983.0, 1983, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6184528\", 1983.0, 1984, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6172495\", 1981.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6168194\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6053442\", 2010.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6035398\", 2010.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5988918\", 2007.0, 2007, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5608798\", 1992.0, 1992, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5592504\", 1991.0, 1991, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5569183\", 1990.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5565949\", 1990.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5565166\", 1989.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5533552\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5531348\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5528462\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5527258\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5502385\", 2010.0, 2013, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5502275\", 2008.0, 2011, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5325527\", 2001.0, 2006, \"Asthma UK\", \"United Kingdom\"], [\"grant.5246712\", 1999.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246675\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246655\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246654\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246653\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246652\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246651\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246650\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246628\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246627\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246625\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246587\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246557\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246556\", 2004.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246416\", 2003.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246378\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246376\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246333\", 2002.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246326\", 2001.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246292\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246291\", 2000.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5206028\", 1998.0, 2000, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5202152\", 2001.0, 2002, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5196804\", 1994.0, 1995, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5195740\", 1994.0, 1997, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5195025\", 1993.0, 1995, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5138636\", 2007.0, 2008, \"Cancer Research UK\", \"United Kingdom\"], [\"grant.5069446\", 2005.0, 2013, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5068098\", 2004.0, 2012, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5066344\", 2013.0, 2016, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5064871\", 2005.0, 2009, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5061881\", 1998.0, 2000, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.5061466\", 1997.0, 1998, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.5061185\", 2001.0, 2002, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.5060853\", 1998.0, 2000, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.4845632\", 2004.0, 2006, \"Israel Science Foundation\", \"Israel\"], [\"grant.4695298\", 2004.0, 2014, \"Juvenile Diabetes Research Foundation\", \"United States\"], [\"grant.4682414\", 2016.0, 2018, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.4661480\", 2011.0, 2012, \"The Research Council of Norway\", \"Norway\"], [\"grant.4644142\", 2012.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4641075\", 2007.0, 2007, \"The Research Council of Norway\", \"Norway\"], [\"grant.4636462\", 2006.0, 2007, \"Slovenian Research Agency\", \"Slovenia\"], [\"grant.4562339\", 1997.0, 2000, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4510775\", 1995.0, 1996, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4453044\", 1998.0, 1999, \"United States Department of Defense\", \"United States\"], [\"grant.4362089\", 2008.0, 2010, \"Slovak Research and Development Agency\", \"Slovakia\"], [\"grant.4192377\", 2008.0, 2011, \"Hungarian Scientific Research Fund\", \"Hungary\"], [\"grant.4171416\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4167878\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4167438\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4106519\", 2005.0, 2010, \"Innovate UK\", \"United Kingdom\"], [\"grant.4035526\", 2004.0, 2007, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.4035380\", 2004.0, 2006, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.4035377\", 2004.0, 2005, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.3749684\", 2000.0, 2005, \"European Commission\", \"Belgium\"], [\"grant.3733024\", 1998.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3731136\", 1999.0, 2001, \"European Commission\", \"Belgium\"], [\"grant.3729873\", 1995.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3728490\", 1993.0, 1994, \"European Commission\", \"Belgium\"], [\"grant.3726127\", 1994.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3708086\", 1984.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3706490\", 1987.0, 1988, \"European Commission\", \"Belgium\"], [\"grant.3702872\", 1989.0, 1993, \"European Commission\", \"Belgium\"], [\"grant.3700936\", 1989.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.3535230\", 2014.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3532347\", 2010.0, 2013, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3529500\", 2010.0, 2013, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3528280\", 2011.0, 2013, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3528140\", 2005.0, 2007, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3527854\", 2007.0, 2009, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3527599\", 2013.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3526938\", 2011.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3526242\", 2009.0, 2012, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3524632\", 2007.0, 2011, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.2987656\", 1998.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2985050\", 1991.0, 1993, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2984254\", 1997.0, 1998, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2982723\", 1993.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2978220\", 1991.0, 1993, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2971136\", 2002.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2968761\", 2005.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2968075\", 1999.0, 2001, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2967309\", 1991.0, 1992, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2960882\", 1992.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2958728\", 2002.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2957327\", 1991.0, 1993, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2942407\", 1995.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2939650\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2937046\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2936941\", 2000.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2932210\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2928975\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2923314\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2921906\", 1991.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2912514\", 1999.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2911669\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2901085\", 1991.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2899804\", 1991.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2892553\", 1996.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2875627\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2874597\", 2004.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2874082\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2857726\", 2003.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2853909\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2846899\", 1994.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2845378\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2835397\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2834880\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2821820\", 2001.0, 2002, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2817654\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2807465\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2798941\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2795749\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2791038\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2789593\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2722085\", 1994.0, 1994, \"National Center for Advancing Translational Sciences\", \"United States\"], [\"grant.2706159\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2698714\", 2013.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2697537\", 2002.0, 2007, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2695257\", 2010.0, 2014, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2693731\", 2003.0, 2007, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2690783\", 2012.0, 2017, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2690760\", 2011.0, 2017, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2687365\", 1994.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687364\", 1994.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687357\", 1994.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687347\", 1994.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687156\", 1989.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687154\", 1988.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666046\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2664366\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2664365\", 1996.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657660\", 1992.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657656\", 1992.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657579\", 1988.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2647175\", 1996.0, 1996, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2643697\", 1997.0, 1999, \"National Cancer Institute\", \"United States\"], [\"grant.2643565\", 1996.0, 1996, \"National Cancer Institute\", \"United States\"], [\"grant.2641009\", 2003.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640640\", 1999.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640550\", 1999.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640356\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640346\", 1996.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640336\", 1996.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640319\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640315\", 1996.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640305\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640255\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640187\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639832\", 1988.0, 1988, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2624939\", 1988.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2608583\", 1999.0, 2002, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2608571\", 1999.0, 2002, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2597656\", 1999.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597626\", 1999.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597599\", 1999.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597536\", 1999.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597279\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597266\", 1996.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597222\", 1997.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2590181\", 1995.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2583049\", 1995.0, 1996, \"National Cancer Institute\", \"United States\"], [\"grant.2579292\", 1995.0, 1997, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2567035\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566836\", 1999.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566752\", 1992.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2564456\", 1993.0, 1997, \"National Center for Advancing Translational Sciences\", \"United States\"], [\"grant.2508306\", 2005.0, 2007, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2454434\", 1999.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453161\", 1994.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452894\", 1993.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452879\", 1993.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452193\", 1991.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2450320\", 1984.0, 1987, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435123\", 2003.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435096\", 2003.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2434876\", 1987.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2433623\", 1985.0, 1986, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2430978\", 2004.0, 2004, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430831\", 1997.0, 2000, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430826\", 1996.0, 2001, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430821\", 1987.0, 1988, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430718\", 1995.0, 1997, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430614\", 1993.0, 1995, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430613\", 1993.0, 1995, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430542\", 1992.0, 1993, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2425744\", 1992.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424990\", 1989.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424954\", 1998.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424953\", 1998.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424952\", 1998.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424951\", 1998.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424889\", 1997.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424801\", 1986.0, 1992, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424782\", 1985.0, 1992, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424743\", 1995.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424740\", 1995.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424712\", 1995.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424651\", 1994.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424636\", 1994.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424626\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424597\", 2005.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424596\", 2005.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424595\", 2006.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424594\", 2006.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424592\", 2006.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424552\", 1983.0, 1986, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424540\", 2003.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424537\", 2003.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424536\", 2004.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424527\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424526\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424512\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424487\", 1982.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424463\", 1991.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424448\", 1991.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424437\", 1990.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424431\", 1981.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424428\", 1980.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424403\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424402\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424401\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424400\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424360\", 1989.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424343\", 1980.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424333\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424332\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424330\", 2004.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424329\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2415704\", 1991.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2409426\", 1992.0, 1998, \"National Institute on Aging\", \"United States\"], [\"grant.2405500\", 1993.0, 1997, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393833\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393831\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393828\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393822\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393812\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393810\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393809\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393798\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393792\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393788\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393775\", 2012.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2390878\", 1993.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2375603\", 1996.0, 1996, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2369988\", 1997.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2369821\", 1994.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2369813\", 1994.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2359845\", 2000.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2356296\", 1990.0, 1991, \"Fogarty International Center\", \"United States\"], [\"grant.2355713\", 1985.0, 1985, \"Fogarty International Center\", \"United States\"], [\"grant.2346752\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346751\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346748\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346743\", 2008.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346629\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346628\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346595\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346594\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346582\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346581\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346548\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346547\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346527\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346526\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346510\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346485\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346484\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346449\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346448\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.100070653\", 2007.0, 2012, \"Leukemia and Lymphoma Society\", \"United States\"], [\"grant.100069317\", 2010.0, 2011, \"Gerber Foundation\", \"United States\"], [\"grant.7992220\", 1988.0, 1991, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951289\", 2013.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951265\", 2008.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7616858\", 2008.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7496086\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7472216\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7446874\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.6723340\", 2002.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6584684\", 2008.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584355\", 2011.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582323\", 2006.0, 2007, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581899\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580202\", 2011.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6499488\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5710170\", 1997.0, 1997, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5502095\", 2009.0, 2011, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5246360\", 2003.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5141545\", 2008.0, 2014, \"Bloodwise\", \"United Kingdom\"], [\"grant.4486180\", 2010.0, 2012, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.3984586\", 2001.0, 2006, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3983756\", 2006.0, 2009, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3899759\", 2008.0, 2009, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3858644\", 2003.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856963\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3529314\", 2007.0, 2010, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.2972456\", 1996.0, 1998, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2424690\", 1985.0, 1990, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.100069716\", 2007.0, 2010, \"W. M. Keck Foundation\", \"United States\"], [\"grant.2424837\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8169343\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6783638\", 2011.0, 2015, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6127074\", 2013.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.2708529\", 1985.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8248988\", 2003.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6734414\", 2012.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.4640689\", 2007.0, 2009, \"The Research Council of Norway\", \"Norway\"], [\"grant.5356862\", 2010.0, 2010, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.6586399\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585096\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583693\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582991\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582151\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581800\", 2014.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.3869376\", 2008.0, 2009, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3765762\", 2001.0, 2005, \"European Commission\", \"Belgium\"], [\"grant.2425528\", 2005.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6784476\", 2014.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8595342\", 2014.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8589748\", 2015.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8458531\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8458109\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8458054\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8457212\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8054101\", 2003.0, 2006, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.8054100\", 2003.0, 2006, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.7999630\", 1985.0, 1988, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989715\", 2008.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7963379\", 2015.0, 2018, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951267\", 2008.0, 2013, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951264\", 2008.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7942548\", 2008.0, 2011, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7635223\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7631633\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7630003\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7626821\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7620636\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7608947\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7590516\", 2017.0, 2018, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.7501851\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7475151\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7390075\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7390050\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7389866\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7161820\", 2007.0, 2007, \"Innovation and Technology Commission\", \"China\"], [\"grant.7149494\", 2015.0, 2015, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7099889\", 2010.0, 2014, \"VINNOVA\", \"Sweden\"], [\"grant.6782435\", 2012.0, 2014, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6585998\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585935\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585926\", 2014.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585903\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585869\", 2014.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585273\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584991\", 2009.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584904\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584557\", 2011.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584345\", 2006.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584272\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583987\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583104\", 2008.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583069\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582938\", 2013.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581894\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581427\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581288\", 2012.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581141\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580969\", 2011.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580705\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580376\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6576981\", 2015.0, 2016, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.6501535\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500969\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500765\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6118127\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5857550\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5849868\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5128659\", 2016.0, 2018, \"Australian Research Council\", \"Australia\"], [\"grant.4672399\", 2014.0, 2015, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4656617\", 2011.0, 2012, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4651170\", 2014.0, 2015, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4649198\", 2014.0, 2015, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4047540\", 2001.0, 2004, \"National Oceanic and Atmospheric Administration\", \"United States\"], [\"grant.3983507\", 2008.0, 2012, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3926442\", 2005.0, 2008, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3869522\", 2007.0, 2008, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3856976\", 2012.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856958\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3636168\", 2012.0, 2014, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3636164\", 2010.0, 2014, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2707046\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706133\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706132\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706121\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706120\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425329\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425152\", 2003.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346454\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346453\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346452\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346451\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346450\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7194761\", 2015.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7172017\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500978\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500814\", 2016.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500392\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500217\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499433\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499403\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245883\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723025\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347707\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6246546\", 1987.0, 1989, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5012180\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5009549\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.2581616\", 2006.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8564619\", 2017.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8564045\", 2016.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8563756\", 2015.0, 2018, \"Department of Biotechnology\", \"India\"], [\"grant.8563659\", 2015.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8563658\", 2016.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8563337\", 2014.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8563045\", 2014.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8563043\", 2014.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8563042\", 2014.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8563041\", 2014.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8562912\", 2013.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8562432\", 2013.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8562161\", 2012.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8561665\", 2011.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8561576\", 2012.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8561573\", 2012.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8561429\", 2011.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8560657\", 2009.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560624\", 2009.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8560476\", 2010.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8560405\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560221\", 2011.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560117\", 2008.0, 2011, \"Department of Biotechnology\", \"India\"], [\"grant.8559105\", 2009.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8559074\", 2008.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8559052\", 2007.0, 2011, \"Department of Biotechnology\", \"India\"], [\"grant.8559051\", 2009.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8559050\", 2008.0, 2011, \"Department of Biotechnology\", \"India\"], [\"grant.8515700\", 2006.0, 2008, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8515699\", 2004.0, 2006, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8514844\", 2009.0, 2014, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8513725\", 1996.0, 1998, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8513721\", 2007.0, 2010, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8513720\", 2005.0, 2005, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8512475\", 2003.0, 2005, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8512474\", 2001.0, 2003, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8512461\", 1991.0, 1993, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8511997\", 2004.0, 2007, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8511996\", 2001.0, 2004, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8509953\", 1996.0, 2000, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8509657\", 2009.0, 2011, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8509656\", 2007.0, 2009, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8506007\", 2016.0, 2017, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8505275\", 2009.0, 2009, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8504517\", 2013.0, 2016, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8504516\", 2012.0, 2015, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8497993\", 2006.0, 2008, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8497992\", 2004.0, 2006, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8497452\", 1996.0, 2000, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8495457\", 2016.0, 2018, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8494876\", 2005.0, 2007, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8494875\", 2003.0, 2005, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8485215\", 2001.0, 2006, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8445296\", 2019.0, 2019, \"VINNOVA\", \"Sweden\"], [\"grant.8220284\", 2000.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8220277\", 2000.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8220260\", 2000.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8219111\", 1999.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8217953\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8217940\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8217931\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8216797\", 1997.0, 1999, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8211499\", 1992.0, 1994, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8211072\", 1992.0, 1994, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8209941\", 1991.0, 1993, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8208830\", 1990.0, 1993, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8208822\", 1990.0, 1992, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8207779\", 1989.0, 1992, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8207091\", 1989.0, 1991, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8206776\", 1988.0, 1990, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8206012\", 1987.0, 1990, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8205580\", 1977.0, 1979, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8176372\", 2011.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173991\", 2007.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8172695\", 2005.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8172132\", 2004.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169730\", 2002.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8069030\", 2008.0, 2012, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8069029\", 2008.0, 2012, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8069028\", 2008.0, 2010, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8068980\", 2006.0, 2008, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8048328\", 2007.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8048326\", 2007.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8034489\", 2012.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8034470\", 2012.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8034462\", 2012.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8034461\", 2012.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8005612\", 2009.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8001843\", 2007.0, 2008, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.7999578\", 1985.0, 1987, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7993965\", 2015.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7993361\", 2014.0, 2018, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992821\", 2012.0, 2015, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992820\", 2012.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992218\", 1988.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992040\", 1986.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7991987\", 1986.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990907\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990549\", 2010.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990456\", 2010.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990362\", 2013.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990358\", 2013.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990357\", 2010.0, 2013, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989450\", 2007.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989449\", 2007.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989070\", 2007.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988831\", 2005.0, 2007, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988536\", 2004.0, 2006, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988249\", 2003.0, 2006, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7987929\", 2001.0, 2004, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7979234\", 2011.0, 2013, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7953162\", 2000.0, 2004, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7953078\", 1995.0, 1999, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952422\", 1993.0, 1997, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952403\", 1990.0, 1993, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952013\", 2002.0, 2011, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7942597\", 2012.0, 2015, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7942596\", 2012.0, 2015, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7940840\", 2009.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7939785\", 2000.0, 2002, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7934359\", 2012.0, 2013, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7933704\", 2012.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7917520\", 2012.0, 2017, \"Patient-Centered Outcomes Research Institute\", \"United States\"], [\"grant.7915417\", 2014.0, 2018, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.7915152\", 2013.0, 2018, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.7850866\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7821641\", 1996.0, 1999, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7821008\", 1998.0, 2001, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7821001\", 1996.0, 1999, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7820997\", 2001.0, 2003, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7743584\", 2014.0, 2018, \"Danish Ministry of Higher Education and Science\", \"Denmark\"], [\"grant.7742854\", 2013.0, 2016, \"Danish Ministry of Higher Education and Science\", \"Denmark\"], [\"grant.7736921\", 2005.0, 2008, \"Department of Science and Technology\", \"India\"], [\"grant.7723182\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7721815\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7717098\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7716935\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7715161\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7698924\", 2012.0, 2013, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7697763\", 2013.0, 2013, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7695709\", 2015.0, 2016, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7694896\", 2013.0, 2014, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7694534\", 2017.0, 2018, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7694487\", 2016.0, 2017, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7687875\", 2007.0, 2008, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7686772\", 2009.0, 2009, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7686658\", 2008.0, 2009, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7686599\", 2008.0, 2009, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7670238\", 2007.0, 2007, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7669718\", 2008.0, 2011, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7668452\", 2016.0, 2016, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7667057\", 2000.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7666943\", 1996.0, 2001, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665268\", 1999.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665027\", 2014.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658619\", 2003.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658608\", 1999.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658433\", 2001.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658042\", 2000.0, 2000, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7654329\", 2014.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7652669\", 1996.0, 1999, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7647878\", 2005.0, 2007, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7646358\", 2003.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7646357\", 1998.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7642061\", 2007.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7632456\", 1997.0, 1999, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7626776\", 2001.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7625380\", 2007.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7625186\", 2002.0, 2007, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7623484\", 2001.0, 2004, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7623431\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7618679\", 2002.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7618672\", 2005.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7606416\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7594392\", 2018.0, 2018, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7578413\", 2018.0, 2018, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7575561\", 2016.0, 2017, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.7550363\", 2001.0, 2003, \"Bloodwise\", \"United Kingdom\"], [\"grant.7549515\", 1986.0, 1989, \"Bloodwise\", \"United Kingdom\"], [\"grant.7549488\", 1985.0, 1986, \"Bloodwise\", \"United Kingdom\"], [\"grant.7545804\", 2018.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.7502338\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7501589\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7498870\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7497586\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7496354\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7496127\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7496124\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7493180\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7492793\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7492787\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7491681\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7491122\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7490400\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7490008\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7488330\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7487607\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7483093\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7482716\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7480563\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7479983\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7479288\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7477822\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7477815\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7477713\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7476579\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7475646\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7475018\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7473902\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7473160\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7472051\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7470759\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7466607\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7466586\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7466408\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7461778\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7460590\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7457969\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7456810\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7455882\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7454862\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7453221\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7452629\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7452447\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7448161\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7446869\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7446551\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7446325\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7445767\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7437134\", 2009.0, 2012, \"University Grants Committee\", \"China\"], [\"grant.7389994\", 2017.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7174252\", 2003.0, 2007, \"United States-Israel Binational Science Foundation\", \"Israel\"], [\"grant.7167621\", 1996.0, 1999, \"Innovation and Technology Commission\", \"China\"], [\"grant.7167575\", 1996.0, 2000, \"Innovation and Technology Commission\", \"China\"], [\"grant.7167421\", 1998.0, 2000, \"Innovation and Technology Commission\", \"China\"], [\"grant.7164928\", 2014.0, 2016, \"Innovation and Technology Commission\", \"China\"], [\"grant.7164864\", 2014.0, 2016, \"Innovation and Technology Commission\", \"China\"], [\"grant.7162955\", 2008.0, 2010, \"Innovation and Technology Commission\", \"China\"], [\"grant.7162624\", 2014.0, 2016, \"Innovation and Technology Commission\", \"China\"], [\"grant.7161695\", 2008.0, 2010, \"Innovation and Technology Commission\", \"China\"], [\"grant.7161678\", 2009.0, 2012, \"Innovation and Technology Commission\", \"China\"], [\"grant.7150246\", 2013.0, 2013, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7150219\", 2013.0, 2013, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7149996\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7149920\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7149707\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7149706\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7149341\", 2015.0, 2015, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7148379\", 2017.0, 2017, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7148301\", 2017.0, 2017, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7132364\", 2009.0, 2010, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132354\", 2008.0, 2009, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132057\", 2005.0, 2006, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7092364\", 2001.0, 2003, \"Arthritis Foundation\", \"United States\"], [\"grant.7092356\", 2003.0, 2008, \"Arthritis Foundation\", \"United States\"], [\"grant.7092198\", 1995.0, 1998, \"Arthritis Foundation\", \"United States\"], [\"grant.7067163\", 2012.0, 2014, \"Patient-Centered Outcomes Research Institute\", \"United States\"], [\"grant.7043745\", 1997.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043744\", 1996.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043740\", 1995.0, 1996, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043737\", 1993.0, 1997, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043735\", 1992.0, 1995, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043733\", 1992.0, 1995, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043732\", 1991.0, 1994, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043729\", 1990.0, 1995, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043727\", 1991.0, 1995, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043100\", 1998.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042971\", 1993.0, 1996, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042970\", 1993.0, 1995, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042592\", 1991.0, 1994, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042330\", 1995.0, 1997, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040790\", 1998.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7034048\", 2006.0, 2009, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6967805\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6967534\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6967408\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6962426\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6953177\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6946159\", 2010.0, 2011, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.6946050\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6945935\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6945300\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6945026\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6944786\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6860319\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6860300\", 2017.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6818448\", 2017.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6734648\", 2013.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6731388\", 1989.0, 1991, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6731147\", 1993.0, 1995, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6730760\", 1991.0, 1993, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6729550\", 1999.0, 2002, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728861\", 1990.0, 1992, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728001\", 2010.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725574\", 2006.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725405\", 2005.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725179\", 1995.0, 1997, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6724329\", 2004.0, 2008, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6724106\", 2004.0, 2008, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723172\", 2001.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6722974\", 2007.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6722602\", 2006.0, 2008, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6720807\", 1996.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6720035\", 1988.0, 1990, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718348\", 1999.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718034\", 1989.0, 1991, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716733\", 1995.0, 1997, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716718\", 1996.0, 1997, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716680\", 1996.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715381\", 1993.0, 1995, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715100\", 1996.0, 2000, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713671\", 1999.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6712624\", 1991.0, 1994, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6663780\", 2015.0, 2019, \"Melanoma Research Alliance\", \"United States\"], [\"grant.6663543\", 2017.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6616218\", 2014.0, 2019, \"American Association For Cancer Research\", \"United States\"], [\"grant.6586479\", 2014.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586475\", 2005.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586470\", 2000.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586428\", 2003.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586415\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586392\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586326\", 2013.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586273\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586259\", 2012.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586159\", 2004.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586008\", 2009.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585987\", 2007.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585866\", 2006.0, 2008, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585814\", 2009.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585424\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585377\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585159\", 2013.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585141\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585127\", 2005.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585062\", 2014.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585020\", 2006.0, 2007, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584897\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584861\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584856\", 2012.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584640\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584506\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584389\", 2011.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584320\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584287\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584260\", 2006.0, 2007, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584213\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584100\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584093\", 2013.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584078\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584077\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584012\", 2005.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583923\", 2005.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583828\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583741\", 2006.0, 2007, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583613\", 2006.0, 2006, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583610\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583559\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583471\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583359\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583353\", 2013.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583250\", 2005.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583171\", 2005.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583079\", 2007.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583022\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582921\", 2015.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582895\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582745\", 2005.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582691\", 2004.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582558\", 2004.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582368\", 2008.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582345\", 2006.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582286\", 2013.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582270\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582237\", 2006.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582215\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581950\", 2005.0, 2006, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581943\", 2012.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581933\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581770\", 2003.0, 2006, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581662\", 2005.0, 2007, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581623\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581600\", 2007.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581572\", 2004.0, 2006, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581544\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581351\", 2006.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581329\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581172\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581167\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581010\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580958\", 2011.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580957\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580938\", 2008.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580830\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580809\", 2000.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580712\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580342\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580316\", 2008.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580274\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580244\", 2005.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580193\", 2006.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6504939\", 2015.0, 2016, \"Alberta Innovates\", \"Canada\"], [\"grant.6504851\", 2014.0, 2015, \"Alberta Innovates\", \"Canada\"], [\"grant.6368111\", 1969.0, 1969, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6366318\", 1970.0, 1970, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6340767\", 1965.0, 1965, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6336065\", 1980.0, 1980, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6335184\", 1980.0, 1980, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6328118\", 1974.0, 1975, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6318414\", 1979.0, 1980, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6313954\", 1975.0, 1975, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6313345\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6313002\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6310572\", 1975.0, 1975, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6310525\", 1980.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6310227\", 1978.0, 1979, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6309820\", 1979.0, 1980, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6308457\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6300678\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6294950\", 1975.0, 1975, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6285974\", 1978.0, 1979, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6272688\", 1999.0, 2000, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6272293\", 2000.0, 2000, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6270561\", 1973.0, 1973, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6269227\", 2000.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6268936\", 1998.0, 2000, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6267466\", 1998.0, 1998, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6266897\", 1988.0, 1988, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6265249\", 1998.0, 2000, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6264328\", 1998.0, 2000, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6245628\", 1987.0, 1987, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6241900\", 1987.0, 1987, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6238029\", 1986.0, 1986, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6236810\", 1986.0, 1986, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6235447\", 1986.0, 1986, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6221933\", 1985.0, 1985, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6213659\", 1984.0, 1984, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6212038\", 1984.0, 1984, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6205842\", 1984.0, 1984, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6192396\", 1998.0, 1999, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6186191\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6184222\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6181805\", 1982.0, 1983, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6180998\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6180034\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6179947\", 1983.0, 1984, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6168559\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6164015\", 1981.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6163599\", 1981.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6158872\", 1981.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6158686\", 1981.0, 1983, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6134788\", 2013.0, 2014, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6066977\", 2011.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5963633\", 2006.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5934697\", 2016.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5929096\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5924338\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5895865\", 2004.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5860041\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5850910\", 2003.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5811526\", 2001.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5809369\", 2001.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5795950\", 2001.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5721027\", 1997.0, 1997, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5716163\", 1997.0, 1997, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5703840\", 1996.0, 1996, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5612658\", 1992.0, 1992, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5610847\", 1992.0, 1992, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5592399\", 1991.0, 1991, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5588292\", 1991.0, 1991, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5577894\", 1990.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5571242\", 1990.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5569035\", 1990.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5557987\", 1989.0, 1989, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5546953\", 2001.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5533198\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5529646\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5528720\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5524673\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5502747\", 2009.0, 2013, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5502458\", 2007.0, 2010, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5502068\", 2009.0, 2013, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5502035\", 2006.0, 2009, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5502020\", 2008.0, 2011, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5501712\", 2006.0, 2011, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5491140\", 2016.0, 2018, \"Israel Science Foundation\", \"Israel\"], [\"grant.5430432\", 1999.0, 1999, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5330014\", 2012.0, 2012, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5329652\", 2012.0, 2012, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5246899\", 2001.0, 2011, \"National Cancer Institute\", \"United States\"], [\"grant.5246898\", 2001.0, 2011, \"National Cancer Institute\", \"United States\"], [\"grant.5246737\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246678\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246677\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246676\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246673\", 2006.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246585\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246580\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246573\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246572\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246528\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246523\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246522\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246520\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246519\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246518\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246517\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246516\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246471\", 2004.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246470\", 2004.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246460\", 2003.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246415\", 2003.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246414\", 2003.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246413\", 2003.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246377\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246375\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246374\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246373\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246362\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246361\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246355\", 2003.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5216155\", 2004.0, 2009, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5215901\", 2006.0, 2010, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5214123\", 2004.0, 2006, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5213219\", 2005.0, 2007, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5211010\", 2003.0, 2007, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5210364\", 2003.0, 2006, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5208623\", 2005.0, 2005, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5207729\", 1998.0, 2000, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5202017\", 1999.0, 2003, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5201826\", 2000.0, 2002, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5200653\", 1998.0, 2002, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5200583\", 1999.0, 2001, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5200284\", 1999.0, 2002, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5199988\", 1999.0, 2001, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5199861\", 1998.0, 2000, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5199583\", 2000.0, 2004, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5199241\", 2000.0, 2002, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5197260\", 1995.0, 1998, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5196596\", 1995.0, 2002, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5071186\", 2012.0, 2016, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5071090\", 2010.0, 2012, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5070666\", 2012.0, 2015, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5070548\", 2004.0, 2008, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5069978\", 2011.0, 2014, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5069908\", 2010.0, 2014, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5069646\", 2008.0, 2012, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5068787\", 2012.0, 2015, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5068391\", 2005.0, 2009, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5067627\", 2011.0, 2015, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5067554\", 2009.0, 2014, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5067428\", 2010.0, 2013, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5067287\", 2007.0, 2011, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5066859\", 2007.0, 2010, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5066823\", 2008.0, 2011, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5066726\", 2007.0, 2011, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5066201\", 2004.0, 2007, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5065299\", 2007.0, 2011, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5065243\", 2010.0, 2016, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5064719\", 2009.0, 2013, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5061893\", 1998.0, 2000, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.5061411\", 2006.0, 2009, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.5061178\", 2004.0, 2006, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.5060857\", 1997.0, 1997, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.4933887\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4847532\", 2006.0, 2009, \"Israel Science Foundation\", \"Israel\"], [\"grant.4788607\", 2004.0, 2012, \"German Research Foundation\", \"Germany\"], [\"grant.4787773\", 2004.0, 2011, \"German Research Foundation\", \"Germany\"], [\"grant.4767408\", 2001.0, 2010, \"German Research Foundation\", \"Germany\"], [\"grant.4743415\", 1999.0, 2001, \"German Research Foundation\", \"Germany\"], [\"grant.4712414\", 2009.0, 2012, \"National Science Center\", \"Poland\"], [\"grant.4699846\", 2004.0, 2011, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.4698120\", 2004.0, 2011, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.4698047\", 2008.0, 2012, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.4696218\", 2000.0, 2002, \"Juvenile Diabetes Research Foundation\", \"United States\"], [\"grant.4679884\", 2001.0, 2005, \"The Research Council of Norway\", \"Norway\"], [\"grant.4679007\", 2005.0, 2009, \"The Research Council of Norway\", \"Norway\"], [\"grant.4673673\", 2014.0, 2015, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.4668582\", 2012.0, 2013, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.4653188\", 2006.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4642241\", 2010.0, 2010, \"The Research Council of Norway\", \"Norway\"], [\"grant.4640698\", 2002.0, 2006, \"The Research Council of Norway\", \"Norway\"], [\"grant.4639761\", 2005.0, 2006, \"The Research Council of Norway\", \"Norway\"], [\"grant.4638064\", 2008.0, 2009, \"The Research Council of Norway\", \"Norway\"], [\"grant.4637482\", 2008.0, 2010, \"Slovenian Research Agency\", \"Slovenia\"], [\"grant.4636020\", 2009.0, 2012, \"Slovenian Research Agency\", \"Slovenia\"], [\"grant.4577354\", 2001.0, 2003, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4577044\", 2001.0, 2003, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4501254\", 2008.0, 2010, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4451771\", 1998.0, 1999, \"United States Department of the Army\", \"United States\"], [\"grant.4449427\", 1994.0, 1995, \"United States Department of the Army\", \"United States\"], [\"grant.4441774\", 1994.0, 1995, \"United States Department of the Army\", \"United States\"], [\"grant.4411106\", 1988.0, 1989, \"United States Department of the Army\", \"United States\"], [\"grant.4365216\", 2007.0, 2009, \"Ministry of Education, Science, Research and Sport of the Slovak Republic\", \"Slovakia\"], [\"grant.4359918\", 2005.0, 2007, \"Ministry of Education, Science, Research and Sport of the Slovak Republic\", \"Slovakia\"], [\"grant.4169035\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4169013\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4025012\", 1987.0, 1988, \"National Endowment for the Humanities\", \"United States\"], [\"grant.4014669\", 1993.0, 1993, \"National Endowment for the Humanities\", \"United States\"], [\"grant.4009508\", 1995.0, 1998, \"National Endowment for the Humanities\", \"United States\"], [\"grant.4000021\", 1994.0, 1995, \"National Endowment for the Humanities\", \"United States\"], [\"grant.3983232\", 2014.0, 2015, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3983001\", 2014.0, 2019, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3937863\", 2008.0, 2015, \"Alberta Innovates\", \"Canada\"], [\"grant.3936269\", 2008.0, 2014, \"Alberta Innovates\", \"Canada\"], [\"grant.3857719\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857714\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857709\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3812833\", 2012.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3765676\", 2001.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3758497\", 2000.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3748458\", 1999.0, 2002, \"European Commission\", \"Belgium\"], [\"grant.3744479\", 2000.0, 2002, \"European Commission\", \"Belgium\"], [\"grant.3742708\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3741466\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3734650\", 1997.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3733935\", 1999.0, 2002, \"European Commission\", \"Belgium\"], [\"grant.3733798\", 1998.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3733451\", 1997.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3732551\", 1997.0, 2001, \"European Commission\", \"Belgium\"], [\"grant.3729405\", 1991.0, 1994, \"European Commission\", \"Belgium\"], [\"grant.3728553\", 1995.0, 1998, \"European Commission\", \"Belgium\"], [\"grant.3728251\", 1996.0, 1999, \"European Commission\", \"Belgium\"], [\"grant.3728156\", 1996.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3726362\", 1996.0, 1998, \"European Commission\", \"Belgium\"], [\"grant.3725647\", 1995.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3724558\", 1988.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.3722730\", 1994.0, 1996, \"European Commission\", \"Belgium\"], [\"grant.3721317\", 1996.0, 1999, \"European Commission\", \"Belgium\"], [\"grant.3721082\", 1994.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3720248\", 1993.0, 1994, \"European Commission\", \"Belgium\"], [\"grant.3720142\", 1996.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3708816\", 1984.0, 1987, \"European Commission\", \"Belgium\"], [\"grant.3707102\", 1982.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3704927\", 1984.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3701541\", 1984.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3701540\", 1984.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3700937\", 1989.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.3700838\", 1990.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.3654213\", 2013.0, 2014, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.3648386\", 2013.0, 2014, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.3635542\", 2001.0, 2001, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3627751\", 2002.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3568934\", 2013.0, 2015, \"Australian Research Council\", \"Australia\"], [\"grant.3568475\", 2012.0, 2014, \"Australian Research Council\", \"Australia\"], [\"grant.3534703\", 2014.0, 2015, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3534560\", 2014.0, 2015, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3534398\", 2013.0, 2015, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3532496\", 2010.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3532197\", 2010.0, 2013, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3530564\", 2000.0, 2004, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3529752\", 2012.0, 2015, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3529532\", 2005.0, 2008, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3528804\", 2007.0, 2010, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3528569\", 2014.0, 2016, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3526005\", 2007.0, 2012, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3525583\", 2010.0, 2013, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3525132\", 2011.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3524741\", 2003.0, 2006, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3219565\", 1971.0, 1972, \"National Science Foundation\", \"United States\"], [\"grant.2988739\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2984732\", 1996.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2983275\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2983032\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2982550\", 1991.0, 1992, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2981934\", 1995.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2981566\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2979837\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2974877\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2968154\", 1991.0, 1992, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2965354\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2963789\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2962827\", 2000.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2957389\", 1996.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2955810\", 1999.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2955686\", 2002.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2950864\", 1994.0, 1996, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2949454\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2949291\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2947979\", 1991.0, 1992, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2943297\", 2005.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2941820\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2936514\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2934649\", 1999.0, 2002, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2933624\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2930402\", 2003.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2927950\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2926979\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2925616\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2922486\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2920384\", 2002.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2919077\", 2001.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2919001\", 1998.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2912988\", 1997.0, 2002, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2911688\", 2002.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2911376\", 1991.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2910140\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2905508\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2904392\", 2002.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2902965\", 2004.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2900056\", 1995.0, 1998, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2896764\", 1991.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2895087\", 1992.0, 1995, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2878108\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2877530\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2875336\", 1999.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2874545\", 1991.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2874092\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2871835\", 1998.0, 2001, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2870999\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2870975\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2867924\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2867499\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2866559\", 1994.0, 1995, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2865004\", 2001.0, 2002, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2863719\", 1994.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2850068\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2846353\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2842052\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2835764\", 2004.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2829384\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2825619\", 2005.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2821847\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2816881\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2813322\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2808920\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2799721\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2798408\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2798291\", 2000.0, 2001, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2795798\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2792691\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2707018\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706836\", 2008.0, 2008, \"National Institute of Neurological Disorders and Stroke\", \"United States\"], [\"grant.2706240\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706208\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706196\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706173\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2702582\", 2010.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2698721\", 2013.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2698712\", 2013.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2698071\", 2002.0, 2008, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2597418\", 1999.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566869\", 2001.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2471645\", 1993.0, 1997, \"National Cancer Institute\", \"United States\"], [\"grant.2455014\", 1999.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2430609\", 1993.0, 2000, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2425472\", 2005.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424945\", 1997.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424533\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424530\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424521\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424511\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424510\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424509\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424508\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424475\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424336\", 2006.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424335\", 2005.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424327\", 2005.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424317\", 2005.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424315\", 2005.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2393894\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393834\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393832\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393825\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393823\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393818\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393815\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393806\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393781\", 2012.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393765\", 2012.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393762\", 2012.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393757\", 2012.0, 2014, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393745\", 2012.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2346803\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346802\", 2008.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346801\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346800\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346799\", 2008.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346798\", 2008.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346745\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346744\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346742\", 2008.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2343520\", 2007.0, 2008, \"National Cancer Institute\", \"United States\"], [\"grant.6125262\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5946523\", 2006.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.4921725\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.2711162\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.8144729\", 2014.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7172501\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172492\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172476\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172475\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172474\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172464\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172024\", 2014.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7170302\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501678\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501676\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501549\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501534\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501449\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500868\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500311\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499762\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499609\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5578606\", 1991.0, 1993, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5245887\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245886\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245881\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245880\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245879\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245877\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245876\", 2015.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245875\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245873\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245872\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245871\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245870\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245869\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245868\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245867\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245866\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245864\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4940208\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.3857027\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857026\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857022\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857021\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857020\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857018\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857017\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857016\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857015\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857014\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857013\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857012\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857011\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857010\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857009\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3749682\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.2347716\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347715\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347713\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347712\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347711\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347710\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347709\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347706\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347705\", 2013.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347704\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347703\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347702\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347701\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347700\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8593316\", 2014.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8106367\", 2012.0, 2016, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7874837\", 2016.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6783786\", 2011.0, 2016, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6723674\", 2014.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6581736\", 2014.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6107935\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.4890245\", 2013.0, 2017, \"National Centre for Research and Development\", \"Poland\"], [\"grant.3950330\", 2013.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3817924\", 2014.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3815156\", 2011.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3654851\", 2013.0, 2014, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2769922\", 2006.0, 2009, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2718430\", 1994.0, 1994, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2709168\", 2002.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425014\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425013\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425012\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425011\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347755\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3811630\", 2009.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.2724237\", 2010.0, 2012, \"National Cancer Institute\", \"United States\"], [\"grant.2723417\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7665986\", 2010.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.6720191\", 2003.0, 2003, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6381020\", 2015.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.5596486\", 1992.0, 1994, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5501782\", 2016.0, 2018, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.7001888\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5932057\", 2005.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.2709799\", 1992.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2687851\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7560606\", 2012.0, 2016, \"National Council for Scientific and Technological Development\", \"Brazil\"], [\"grant.3634487\", 2005.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.8107232\", 2003.0, 2005, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8106298\", 2013.0, 2016, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7877531\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7875034\", 2018.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7644259\", 2003.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7644256\", 2006.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.6887620\", 1995.0, 1997, \"Czech Science Foundation\", \"Czechia\"], [\"grant.6734139\", 2011.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6732327\", 2012.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6714226\", 2010.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6378493\", 2014.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6140485\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6092952\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5861265\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.4936643\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4914039\", 2000.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4908668\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4579636\", 2014.0, 2019, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3743835\", 2000.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3576877\", 2008.0, 2009, \"Australian Research Council\", \"Australia\"], [\"grant.3572390\", 2002.0, 2004, \"Australian Research Council\", \"Australia\"], [\"grant.3030814\", 2003.0, 2005, \"Directorate for Engineering\", \"United States\"], [\"grant.3030807\", 2003.0, 2005, \"Directorate for Engineering\", \"United States\"], [\"grant.2726463\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723432\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723219\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709263\", 2006.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709246\", 2005.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709237\", 2004.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709213\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5147109\", 2009.0, 2010, \"NIHR Evaluation Trials and Studies Coordinating Centre\", \"United Kingdom\"], [\"grant.3774990\", 2007.0, 2011, \"European Commission\", \"Belgium\"], [\"grant.2726425\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459886\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172484\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499752\", 2014.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5880876\", 2004.0, 2005, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5245884\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857024\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3732274\", 1996.0, 1999, \"European Commission\", \"Belgium\"], [\"grant.3638486\", 2013.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3630621\", 2006.0, 2010, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2709212\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424468\", 1991.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8595279\", 2014.0, 2016, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8594208\", 2016.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8591102\", 2015.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8446493\", 2010.0, 2010, \"Swedish Research Council for Environment Agricultural Sciences and Spatial Planning\", \"Sweden\"], [\"grant.8218376\", 1999.0, 2001, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8041818\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8036880\", 2015.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8025091\", 2016.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8025090\", 2016.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8025089\", 2016.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8025088\", 2016.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7986569\", 1997.0, 2000, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7652306\", 2005.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7608126\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7560596\", 2014.0, 2017, \"National Council for Scientific and Technological Development\", \"Brazil\"], [\"grant.7559701\", 2014.0, 2017, \"National Council for Scientific and Technological Development\", \"Brazil\"], [\"grant.7400758\", 2013.0, 2016, \"Ministry of Science and Higher Education\", \"Poland\"], [\"grant.7390106\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7389561\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7211661\", 2017.0, 2018, \"Alberta Innovates\", \"Canada\"], [\"grant.7170506\", 2016.0, 2017, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.7170505\", 2017.0, 2018, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.7170202\", 2017.0, 2017, \"National Cancer Institute\", \"United States\"], [\"grant.7131991\", 2004.0, 2005, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.6897600\", 2001.0, 2005, \"Ministry of Education Youth and Sports\", \"Czechia\"], [\"grant.6735776\", 2013.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734643\", 2013.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6733494\", 2011.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6586489\", 2015.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586167\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585950\", 2007.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585864\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585745\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585214\", 2009.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584814\", 2009.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584759\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584546\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584455\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584450\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584406\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584404\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584109\", 2015.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584024\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583631\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583583\", 2015.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583497\", 2011.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583423\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583264\", 2013.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583173\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583098\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583000\", 2015.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582999\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582987\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582771\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582742\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582706\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582244\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582226\", 2010.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582137\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581980\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581846\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581809\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581790\", 2011.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581425\", 2013.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581394\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581259\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581039\", 2008.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580990\", 2009.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580975\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580961\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580430\", 2000.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580190\", 2011.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6500971\", 2016.0, 2017, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.6500600\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500029\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499437\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6015965\", 2009.0, 2014, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5900519\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5869803\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5246526\", 2004.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245891\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245785\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5144861\", 2014.0, 2019, \"National Institute for Health Research\", \"United Kingdom\"], [\"grant.4893018\", 2014.0, 2015, \"United States Department of the Army\", \"United States\"], [\"grant.4702691\", 2015.0, 2018, \"National Science Center\", \"Poland\"], [\"grant.4694137\", 2016.0, 2017, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.4551429\", 2001.0, 2004, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4540717\", 2005.0, 2007, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4161796\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4045940\", 2003.0, 2005, \"National Oceanic and Atmospheric Administration\", \"United States\"], [\"grant.4040616\", 2003.0, 2005, \"National Oceanic and Atmospheric Administration\", \"United States\"], [\"grant.3984324\", 2008.0, 2013, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3983030\", 2004.0, 2008, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3857103\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857090\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857030\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856249\", 2014.0, 2016, \"National Cancer Institute\", \"United States\"], [\"grant.3771580\", 2007.0, 2012, \"European Commission\", \"Belgium\"], [\"grant.3759147\", 2002.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3726131\", 1994.0, 1995, \"European Commission\", \"Belgium\"], [\"grant.3627196\", 2006.0, 2008, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3624371\", 2004.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3568375\", 2012.0, 2015, \"Australian Research Council\", \"Australia\"], [\"grant.2757767\", 2011.0, 2014, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2726424\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2712019\", 1999.0, 2001, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2706262\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706261\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706257\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706256\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706135\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706134\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706123\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706119\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706118\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706115\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706114\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706113\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2658141\", 2012.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2449044\", 2013.0, 2017, \"National Institute on Aging\", \"United States\"], [\"grant.2425380\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425071\", 2001.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347720\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2344566\", 2013.0, 2015, \"National Cancer Institute\", \"United States\"], [\"grant.2438487\", 2004.0, 2007, \"National Center for Advancing Translational Sciences\", \"United States\"], [\"grant.8592540\", 2016.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8591411\", 2009.0, 2019, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8574771\", 2010.0, 2010, \"Breast Cancer Society of Canada\", \"Canada\"], [\"grant.8565074\", 2018.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8564502\", 2016.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8564392\", 2016.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8564076\", 2016.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8563355\", 2014.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8562762\", 2013.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8561092\", 2012.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8560406\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560404\", 2010.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8560168\", 2011.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8559075\", 2009.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8559057\", 2007.0, 2010, \"Department of Biotechnology\", \"India\"], [\"grant.8559047\", 2008.0, 2011, \"Department of Biotechnology\", \"India\"], [\"grant.8514300\", 2002.0, 2005, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8513722\", 2011.0, 2014, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8512105\", 2016.0, 2017, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8509618\", 2003.0, 2005, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8509617\", 2001.0, 2003, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8507925\", 1996.0, 2000, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8505547\", 2009.0, 2009, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8505546\", 2012.0, 2015, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8494481\", 2010.0, 2014, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8488885\", 1995.0, 1998, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8486017\", 1986.0, 1987, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8485222\", 2012.0, 2015, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8215714\", 1996.0, 1998, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8107229\", 2003.0, 2004, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8070874\", 2014.0, 2017, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8070873\", 2014.0, 2017, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8070872\", 2014.0, 2017, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8070871\", 2014.0, 2017, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8070870\", 2014.0, 2017, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8068997\", 2007.0, 2010, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8068992\", 2006.0, 2008, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8068981\", 2006.0, 2007, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8048327\", 2007.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7999613\", 1985.0, 1988, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7999604\", 1985.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7999573\", 1984.0, 1988, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7999438\", 1982.0, 1984, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992719\", 2012.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992663\", 1991.0, 1991, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992247\", 1989.0, 1992, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992176\", 1988.0, 1992, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992114\", 1992.0, 1995, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992113\", 1990.0, 1991, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992093\", 1992.0, 1995, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992092\", 1990.0, 1991, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7991943\", 1987.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990361\", 2013.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990359\", 2013.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990055\", 2009.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989716\", 2008.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989660\", 2008.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989511\", 2007.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989508\", 2007.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988963\", 2006.0, 2008, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988826\", 2005.0, 2007, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988307\", 2004.0, 2005, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988084\", 2001.0, 2005, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7987789\", 1999.0, 2002, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7987708\", 2000.0, 2001, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7968467\", 1977.0, 1977, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7936517\", 2014.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7936234\", 2015.0, 2018, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7934392\", 2012.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7911448\", 2019.0, 2019, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7894792\", 1987.0, 1990, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.7878400\", 2016.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874354\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7851738\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7850972\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7850587\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7850585\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7832860\", 2009.0, 2010, \"Arnold and Mabel Beckman Foundation\", \"United States\"], [\"grant.7827744\", 2018.0, 2019, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7736617\", 2011.0, 2014, \"Department of Science and Technology\", \"India\"], [\"grant.7735618\", 2006.0, 2009, \"Department of Science and Technology\", \"India\"], [\"grant.7700954\", 2013.0, 2013, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7697237\", 2015.0, 2016, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7696953\", 2012.0, 2013, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7696886\", 2013.0, 2014, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7696299\", 2016.0, 2016, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7687242\", 2009.0, 2009, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7684163\", 2012.0, 2012, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7670754\", 2015.0, 2016, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7670286\", 2005.0, 2008, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7669326\", 2014.0, 2018, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7669027\", 2006.0, 2006, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7667098\", 2007.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7662845\", 2008.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7651615\", 2001.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7638223\", 2003.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7622450\", 2001.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7619028\", 2008.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7606382\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7550482\", 2003.0, 2004, \"Bloodwise\", \"United Kingdom\"], [\"grant.7502649\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7499459\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7499218\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7499047\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7486134\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7479088\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7478175\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7465104\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7459155\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7457000\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7451639\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7450913\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7449704\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7447431\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7446594\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7445541\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7433140\", 2006.0, 2008, \"University Grants Committee\", \"China\"], [\"grant.7407196\", 2009.0, 2013, \"National Centre for Research and Development\", \"Poland\"], [\"grant.7390001\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7172641\", 2014.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7170046\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7155115\", 2004.0, 2006, \"Financial Markets Foundation for Children\", \"Australia\"], [\"grant.7149455\", 2015.0, 2015, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7132410\", 2009.0, 2010, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132355\", 2008.0, 2009, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132231\", 2008.0, 2009, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132151\", 2007.0, 2008, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132082\", 2006.0, 2007, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7119583\", 2010.0, 2012, \"Swedish Research Council\", \"Sweden\"], [\"grant.7109539\", 2009.0, 2012, \"Swedish Research Council\", \"Sweden\"], [\"grant.7082427\", 2015.0, 2016, \"Juvenile Diabetes Research Foundation\", \"United States\"], [\"grant.7050128\", 2016.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.7043747\", 1996.0, 1998, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043738\", 1995.0, 1996, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043141\", 2008.0, 2009, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043098\", 1998.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042329\", 1995.0, 1997, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042317\", 1994.0, 1995, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040554\", 2006.0, 2007, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040497\", 1997.0, 2000, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6946051\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6897580\", 1999.0, 2000, \"Ministry of Education Youth and Sports\", \"Czechia\"], [\"grant.6896534\", 2011.0, 2014, \"Ministry of Industry and Trade\", \"Czechia\"], [\"grant.6838452\", 2017.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6808619\", 2014.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.6784314\", 2014.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6730239\", 1998.0, 2003, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727681\", 2014.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725541\", 2006.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725469\", 2007.0, 2009, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723851\", 2003.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723630\", 2003.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723325\", 2002.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6722622\", 2006.0, 2009, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6721150\", 2009.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716567\", 2009.0, 2011, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715624\", 1999.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713982\", 2009.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6663534\", 2017.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586329\", 2007.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586246\", 2005.0, 2008, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586174\", 2009.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586069\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585995\", 2010.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585899\", 2006.0, 2007, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585892\", 2009.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585854\", 2008.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585784\", 2005.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585750\", 2011.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585632\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585333\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585297\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585194\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585174\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585001\", 2013.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584798\", 2016.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584784\", 2011.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584730\", 2004.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584586\", 2012.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584577\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584372\", 2012.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584276\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584258\", 2014.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584081\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583962\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583804\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583532\", 2012.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583522\", 2013.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583118\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583065\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582905\", 2009.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582843\", 2007.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582827\", 2003.0, 2004, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582644\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582624\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582595\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582570\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582231\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582229\", 2013.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582223\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582172\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582074\", 2011.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582065\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581842\", 2007.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581686\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581626\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581582\", 2011.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581454\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581388\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581057\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580952\", 2004.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580853\", 2004.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580838\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580808\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580797\", 2006.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580650\", 2009.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580563\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580385\", 2013.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580374\", 2011.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580283\", 2015.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6500883\", 2010.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6383528\", 2008.0, 2011, \"Alberta Innovates\", \"Canada\"], [\"grant.6346669\", 1965.0, 1965, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6344144\", 1965.0, 1965, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6320450\", 1980.0, 1980, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6318196\", 1976.0, 1976, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6315037\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6313398\", 1980.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6312268\", 1978.0, 1978, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6311355\", 1980.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6310840\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6268587\", 1998.0, 1998, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6263047\", 1998.0, 1998, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6261734\", 1998.0, 1998, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6261713\", 1988.0, 1988, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6219378\", 1985.0, 1985, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6219113\", 1986.0, 1986, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6206358\", 1983.0, 1983, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6184545\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6159196\", 1981.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6156843\", 2014.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6121147\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6112342\", 2013.0, 2014, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6072994\", 2011.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6036749\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6036094\", 2009.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6028416\", 2009.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6000794\", 2008.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5994958\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5987989\", 2007.0, 2007, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5975123\", 2007.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5921930\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5900336\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5883958\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5874094\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5868586\", 2015.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5831528\", 2002.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5568161\", 1990.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5562717\", 1989.0, 1989, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5552615\", 2000.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5523176\", 2015.0, 2018, \"Alberta Innovates\", \"Canada\"], [\"grant.5392972\", 2006.0, 2006, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5245678\", 2010.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245677\", 2015.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5217877\", 2007.0, 2008, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5205699\", 1996.0, 1998, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5185722\", 1987.0, 1991, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5184334\", 1984.0, 1987, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5127911\", 2016.0, 2018, \"Australian Research Council\", \"Australia\"], [\"grant.5068881\", 2009.0, 2012, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.4900549\", 2002.0, 2005, \"International Human Frontier Science Program Organization\", \"France\"], [\"grant.4853338\", 2012.0, 2014, \"Volkswagen Foundation\", \"Germany\"], [\"grant.4759025\", 2000.0, 2003, \"German Research Foundation\", \"Germany\"], [\"grant.4716904\", 2009.0, 2012, \"National Science Center\", \"Poland\"], [\"grant.4682361\", 2015.0, 2018, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.4673194\", 2009.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.4671755\", 2006.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4671560\", 2009.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.4670969\", 2009.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.4665556\", 2003.0, 2005, \"The Research Council of Norway\", \"Norway\"], [\"grant.4652669\", 2012.0, 2013, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4652646\", 2012.0, 2013, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4649874\", 2011.0, 2013, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4646557\", 2001.0, 2004, \"The Research Council of Norway\", \"Norway\"], [\"grant.4578598\", 2000.0, 2002, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4569274\", 1994.0, 1996, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4489548\", 2009.0, 2011, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4455107\", 2015.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.4411536\", 1984.0, 1985, \"United States Department of the Army\", \"United States\"], [\"grant.4360865\", 2010.0, 2013, \"Ministry of Education, Science, Research and Sport of the Slovak Republic\", \"Slovakia\"], [\"grant.4360740\", 2007.0, 2009, \"Ministry of Education, Science, Research and Sport of the Slovak Republic\", \"Slovakia\"], [\"grant.4358725\", 2007.0, 2009, \"Ministry of Education, Science, Research and Sport of the Slovak Republic\", \"Slovakia\"], [\"grant.4113804\", 2009.0, 2017, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.3936854\", 2007.0, 2014, \"Alberta Innovates\", \"Canada\"], [\"grant.3936613\", 2011.0, 2011, \"Alberta Innovates\", \"Canada\"], [\"grant.3936324\", 2012.0, 2014, \"Alberta Innovates\", \"Canada\"], [\"grant.3882865\", 2007.0, 2013, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3857726\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857725\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857724\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857722\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857718\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857717\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857712\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857711\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857707\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857704\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3856851\", 2010.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3823776\", 2007.0, 2008, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3810813\", 2011.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3776489\", 2009.0, 2013, \"European Commission\", \"Belgium\"], [\"grant.3745760\", 1998.0, 2001, \"European Commission\", \"Belgium\"], [\"grant.3728264\", 1994.0, 1995, \"European Commission\", \"Belgium\"], [\"grant.3708037\", 1989.0, 1991, \"European Commission\", \"Belgium\"], [\"grant.3707096\", 1982.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3700062\", 1988.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.3641531\", 2010.0, 2011, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3641529\", 2008.0, 2012, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3634752\", 2003.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3633304\", 2001.0, 2003, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3631322\", 2001.0, 2004, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3630183\", 2001.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3626707\", 2007.0, 2007, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3624593\", 2012.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3579359\", 2008.0, 2011, \"Australian Research Council\", \"Australia\"], [\"grant.3534575\", 2014.0, 2015, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3534289\", 2014.0, 2016, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3533959\", 2011.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3529219\", 2011.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3526706\", 2009.0, 2012, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3526045\", 2011.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3525527\", 2007.0, 2010, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.2960566\", 1997.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2958077\", 1998.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2955084\", 1992.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2935828\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2934662\", 1992.0, 1995, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2932892\", 1995.0, 1998, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2922759\", 2000.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2919468\", 1997.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2906395\", 2004.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2892234\", 1994.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2889085\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2888595\", 2003.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2840073\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2829016\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2803549\", 1997.0, 1998, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2711624\", 1999.0, 2002, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709220\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709217\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709216\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2654337\", 2001.0, 2002, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2640565\", 1999.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640533\", 1998.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640045\", 1992.0, 1992, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2430556\", 2002.0, 2003, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2425177\", 2003.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425009\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425008\", 1999.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425007\", 1999.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425006\", 1999.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425005\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425004\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425003\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425002\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425001\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424565\", 1993.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347296\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347290\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2344594\", 2012.0, 2014, \"National Cancer Institute\", \"United States\"], [\"grant.100071392\", 2008.0, 2011, \"Rheumatology Research Foundation\", \"United States\"], [\"grant.8571244\", 2014.0, 2015, \"Ontario Institute for Cancer Research\", \"Canada\"], [\"grant.8182708\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8108623\", 1995.0, 1998, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7876865\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7667275\", 2008.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7573170\", 2017.0, 2017, \"The Research Council of Norway\", \"Norway\"], [\"grant.7172465\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172057\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7035746\", 2001.0, 2004, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7020002\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6958979\", 2008.0, 2009, \"Alzheimer's Drug Discovery Foundation\", \"United States\"], [\"grant.6782476\", 2012.0, 2014, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6779368\", 2014.0, 2014, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6718669\", 2010.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6585082\", 2015.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581567\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6500531\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499878\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6083410\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6067495\", 2011.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6039996\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5979969\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5693464\", 1996.0, 1997, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5534219\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5246649\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5150921\", 2015.0, 2018, \"Scottish Government Health and Social Care Directorates\", \"United Kingdom\"], [\"grant.5003535\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4987483\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4980963\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4968317\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4566767\", 1997.0, 2001, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4566381\", 1996.0, 1998, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4122515\", 2008.0, 2013, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.3928388\", 2013.0, 2018, \"Ministry of Research, Innovation and Science\", \"Canada\"], [\"grant.3921156\", 2008.0, 2009, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3843484\", 2012.0, 2012, \"Innovate UK\", \"United Kingdom\"], [\"grant.3830612\", 2007.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3829753\", 2007.0, 2010, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3578378\", 2004.0, 2006, \"Australian Research Council\", \"Australia\"], [\"grant.3575849\", 2004.0, 2006, \"Australian Research Council\", \"Australia\"], [\"grant.3570522\", 2011.0, 2013, \"Australian Research Council\", \"Australia\"], [\"grant.3569846\", 2011.0, 2013, \"Australian Research Council\", \"Australia\"], [\"grant.3566220\", 2012.0, 2014, \"Australian Research Council\", \"Australia\"], [\"grant.3562866\", 2012.0, 2014, \"Australian Research Council\", \"Australia\"], [\"grant.2709696\", 1992.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709222\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709221\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709169\", 2002.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2707079\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425673\", 1999.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425671\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425670\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425597\", 2011.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425596\", 2006.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425595\", 2006.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425593\", 2010.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425559\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425557\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425556\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425551\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425475\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425433\", 2004.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425432\", 2004.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425431\", 2004.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2350080\", 2013.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2350059\", 2013.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346793\", 2008.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346792\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346791\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346750\", 2008.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657943\", 2003.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2451354\", 1987.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7667819\", 2008.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.5678539\", 1996.0, 1997, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.3791018\", 2012.0, 2016, \"European Commission\", \"Belgium\"], [\"grant.2711561\", 1996.0, 2002, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2695872\", 2010.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458954\", 2010.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424817\", 1996.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424751\", 1995.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424750\", 1995.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4896895\", 2014.0, 2016, \"Russian Science Foundation\", \"Russia\"], [\"grant.8218859\", 1999.0, 2001, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8218788\", 1999.0, 2001, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8171714\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170951\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170771\", 2003.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169338\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8107149\", 2004.0, 2007, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7878050\", 2014.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7877498\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874725\", 2015.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7764034\", 2018.0, 2019, \"VINNOVA\", \"Sweden\"], [\"grant.7646394\", 2014.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7155174\", 2012.0, 2014, \"Financial Markets Foundation for Children\", \"Australia\"], [\"grant.7035732\", 1999.0, 2001, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6896550\", 2009.0, 2012, \"Ministry of Industry and Trade\", \"Czechia\"], [\"grant.6736064\", 2012.0, 2016, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734893\", 2013.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6733474\", 2011.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723455\", 2013.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718920\", 2008.0, 2011, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716490\", 2008.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6665071\", 2016.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.6146427\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6030319\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6009389\", 2008.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5991944\", 2008.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5954535\", 2006.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5923641\", 2016.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5863354\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5128942\", 2014.0, 2018, \"Australian Research Council\", \"Australia\"], [\"grant.4982560\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4975021\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938417\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4035064\", 2009.0, 2010, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.3811194\", 2011.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3751805\", 2002.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3574802\", 2004.0, 2007, \"Australian Research Council\", \"Australia\"], [\"grant.2726419\", 2009.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2726418\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2712047\", 1995.0, 1995, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709255\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709251\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709249\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709204\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2692209\", 2006.0, 2009, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2687951\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2644200\", 2000.0, 2001, \"National Cancer Institute\", \"United States\"], [\"grant.2451110\", 1988.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8605530\", 2013.0, 2015, \"Robert Wood Johnson Foundation\", \"United States\"], [\"grant.8505272\", 2015.0, 2018, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8255921\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7646359\", 2005.0, 2007, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7433662\", 2013.0, 2015, \"University Grants Committee\", \"China\"], [\"grant.6443851\", 2016.0, 2017, \"National Center for Emerging and Zoonotic Infectious Diseases\", \"United States\"], [\"grant.6379228\", 2014.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.5799261\", 2001.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5245878\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5002002\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4995055\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4985797\", 2010.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4959800\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4959052\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4902945\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4664479\", 2008.0, 2011, \"The Research Council of Norway\", \"Norway\"], [\"grant.4578801\", 2014.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4404204\", 2008.0, 2009, \"United States Department of Defense\", \"United States\"], [\"grant.3857019\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3810632\", 2008.0, 2011, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3740989\", 1999.0, 2001, \"European Commission\", \"Belgium\"], [\"grant.3640066\", 2010.0, 2015, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3637315\", 2011.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2726420\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2718448\", 1996.0, 2000, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2711159\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709791\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709257\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2658405\", 1988.0, 1990, \"National Cancer Institute\", \"United States\"], [\"grant.2641845\", 2011.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639272\", 1997.0, 1998, \"National Institute on Aging\", \"United States\"], [\"grant.2455328\", 2001.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453659\", 1997.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8336713\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8329109\", 2011.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169853\", 2003.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7654331\", 2008.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7646360\", 2010.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7630520\", 2013.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.6895933\", 2011.0, 2014, \"Technology Agency of the Czech Republic\", \"Czechia\"], [\"grant.6848880\", 2016.0, 2016, \"California Institute for Regenerative Medicine\", \"United States\"], [\"grant.6716817\", 2006.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716223\", 2006.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.5863289\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5128696\", 2016.0, 2018, \"Australian Research Council\", \"Australia\"], [\"grant.4985692\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4920061\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4905273\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4898035\", 2011.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4541353\", 2003.0, 2005, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.3846417\", 2012.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3846351\", 2012.0, 2012, \"Innovate UK\", \"United Kingdom\"], [\"grant.3836293\", 2012.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3825471\", 2009.0, 2010, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3764201\", 2006.0, 2010, \"European Commission\", \"Belgium\"], [\"grant.3753923\", 2002.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3750984\", 2002.0, 2005, \"European Commission\", \"Belgium\"], [\"grant.3743638\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3657208\", 2013.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.3637796\", 2008.0, 2011, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2773787\", 2007.0, 2011, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2709256\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709228\", 2004.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640301\", 1997.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7666252\", 2009.0, 2012, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665836\", 2008.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7201078\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5737923\", 1998.0, 1999, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5733477\", 1998.0, 1999, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.4675373\", 2006.0, 2008, \"The Research Council of Norway\", \"Norway\"], [\"grant.4643905\", 2008.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4457723\", 2015.0, 2019, \"Royal Society\", \"United Kingdom\"], [\"grant.4457698\", 2011.0, 2015, \"Royal Society\", \"United Kingdom\"], [\"grant.3641781\", 2010.0, 2012, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3629515\", 2005.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2709733\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2704615\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687501\", 2000.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640816\", 2001.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640477\", 1998.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2602795\", 1998.0, 2000, \"National Cancer Institute\", \"United States\"], [\"grant.2486616\", 2009.0, 2014, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2458301\", 2009.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456583\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452630\", 1992.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3739224\", 1996.0, 1998, \"European Commission\", \"Belgium\"], [\"grant.2762017\", 2008.0, 2013, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2550560\", 2004.0, 2009, \"National Institute of Mental Health\", \"United States\"], [\"grant.2454639\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7145585\", 2008.0, 2009, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.2458524\", 2009.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6714841\", 2006.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.4316876\", 2015.0, 2017, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2666760\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2658057\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641453\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2567129\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459697\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457459\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452884\", 1993.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8574610\", 2013.0, 2016, \"Alex's Lemonade Stand Foundation\", \"United States\"], [\"grant.8462567\", 2011.0, 2014, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8456193\", 2013.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8345233\", 2016.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8345230\", 2016.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8329560\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8216494\", 1997.0, 1999, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8205069\", 1987.0, 1991, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8184628\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8174468\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7742845\", 2013.0, 2017, \"Danish Ministry of Higher Education and Science\", \"Denmark\"], [\"grant.7666219\", 2010.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7638735\", 2006.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7206349\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7172498\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172487\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172485\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172432\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7022403\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7016017\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7014356\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7004808\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7003466\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6988267\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6944901\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6501119\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6379290\", 2014.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6146605\", 2014.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5604349\", 1992.0, 1994, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5245865\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5220334\", 2008.0, 2012, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5071867\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4997073\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4979100\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4955222\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4948991\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938318\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4929868\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4918970\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4539488\", 2004.0, 2007, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4406518\", 2008.0, 2009, \"United States Department of the Army\", \"United States\"], [\"grant.3935679\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3841651\", 2013.0, 2013, \"Innovate UK\", \"United Kingdom\"], [\"grant.3818017\", 2009.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3817834\", 2009.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3813009\", 2011.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3806983\", 2014.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3775566\", 2007.0, 2010, \"European Commission\", \"Belgium\"], [\"grant.3641057\", 2013.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3638768\", 2012.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3636813\", 2013.0, 2014, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3067850\", 2006.0, 2006, \"Directorate for Engineering\", \"United States\"], [\"grant.2726422\", 2010.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2726416\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723430\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2712030\", 1996.0, 1999, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711999\", 1993.0, 1993, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709790\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709244\", 2005.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709091\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709090\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709088\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709086\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704634\", 2005.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704628\", 2005.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704604\", 2000.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687150\", 1988.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657831\", 1999.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641718\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640564\", 1999.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636410\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2558965\", 1999.0, 2006, \"National Institute of Neurological Disorders and Stroke\", \"United States\"], [\"grant.2451050\", 1986.0, 1990, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8331301\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7665046\", 2010.0, 2012, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7631957\", 2008.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.5810873\", 2002.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5737049\", 1998.0, 1999, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5565937\", 1990.0, 1991, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.4909556\", 2007.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4729728\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4480704\", 2014.0, 2017, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.3791043\", 2014.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.3778860\", 2007.0, 2010, \"European Commission\", \"Belgium\"], [\"grant.3776536\", 2006.0, 2012, \"European Commission\", \"Belgium\"], [\"grant.3766949\", 2005.0, 2009, \"European Commission\", \"Belgium\"], [\"grant.3765327\", 2005.0, 2007, \"European Commission\", \"Belgium\"], [\"grant.3135709\", 2012.0, 2017, \"Directorate for Engineering\", \"United States\"], [\"grant.2726767\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2692186\", 2004.0, 2011, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2687918\", 2006.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666472\", 2011.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666264\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640832\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2638358\", 2012.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2604855\", 2007.0, 2010, \"National Cancer Institute\", \"United States\"], [\"grant.2601369\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2582899\", 1992.0, 1993, \"National Cancer Institute\", \"United States\"], [\"grant.2459468\", 2012.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458019\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453751\", 1997.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424809\", 1996.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424762\", 1995.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424753\", 1995.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424739\", 1995.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424715\", 1995.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424714\", 1995.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424713\", 1995.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424711\", 1995.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7674238\", 2015.0, 2016, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7145476\", 2004.0, 2005, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.8330424\", 2013.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8195513\", 2016.0, 2019, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7145367\", 1999.0, 2000, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7143322\", 2004.0, 2005, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.6381570\", 2016.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6381112\", 2016.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.4119569\", 2011.0, 2014, \"Michael Smith Foundation for Health Research\", \"Canada\"], [\"grant.3623486\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2718419\", 1993.0, 2002, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2688054\", 2009.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2668272\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641837\", 2010.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641738\", 2010.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641270\", 2005.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2581359\", 1999.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2575565\", 2012.0, 2015, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2475260\", 2001.0, 2004, \"National Cancer Institute\", \"United States\"], [\"grant.2474639\", 2000.0, 2014, \"National Cancer Institute\", \"United States\"], [\"grant.2459890\", 2013.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458998\", 2011.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2454989\", 2001.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2454038\", 1998.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2444968\", 1984.0, 1990, \"National Institute on Aging\", \"United States\"], [\"grant.8574909\", 2005.0, 2008, \"Ontario Institute for Cancer Research\", \"Canada\"], [\"grant.8451257\", 2017.0, 2018, \"United States Department of Defense\", \"United States\"], [\"grant.8342308\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8335660\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8215501\", 1996.0, 1998, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8171485\", 2003.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7749356\", 2016.0, 2017, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7658431\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7178376\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7175809\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7155172\", 2010.0, 2012, \"Financial Markets Foundation for Children\", \"Australia\"], [\"grant.7145974\", 2014.0, 2015, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7145973\", 2014.0, 2015, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.6898658\", 2015.0, 2016, \"Technology Agency of the Czech Republic\", \"Czechia\"], [\"grant.6665260\", 2016.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.6434353\", 2014.0, 2017, \"National Council for Scientific and Technological Development\", \"Brazil\"], [\"grant.6192914\", 2009.0, 2012, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6151353\", 2014.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6144228\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6137871\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6126425\", 2013.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6126244\", 2013.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6091507\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6089432\", 2012.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6083982\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6081969\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6005234\", 2008.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5982630\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5954904\", 2006.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5952636\", 2006.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5501860\", 2016.0, 2019, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5128726\", 2016.0, 2018, \"Australian Research Council\", \"Australia\"], [\"grant.4995647\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4988160\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4957740\", 2002.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4930861\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4929762\", 2005.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4903563\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4898322\", 2016.0, 2019, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.4785156\", 2004.0, 2006, \"German Research Foundation\", \"Germany\"], [\"grant.4639323\", 2008.0, 2010, \"The Research Council of Norway\", \"Norway\"], [\"grant.4639129\", 2009.0, 2012, \"The Research Council of Norway\", \"Norway\"], [\"grant.4498646\", 2007.0, 2009, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4491503\", 2012.0, 2014, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4404905\", 2008.0, 2009, \"United States Department of the Army\", \"United States\"], [\"grant.4295482\", 2015.0, 2019, \"Innovate UK\", \"United Kingdom\"], [\"grant.4124086\", 2009.0, 2014, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.4035582\", 2007.0, 2009, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.3949435\", 2014.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3928563\", 2007.0, 2012, \"Ministry of Research, Innovation and Science\", \"Canada\"], [\"grant.3865901\", 2014.0, 2015, \"Innovate UK\", \"United Kingdom\"], [\"grant.3844884\", 2013.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3818388\", 2012.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3714886\", 1989.0, 1993, \"European Commission\", \"Belgium\"], [\"grant.3630766\", 2007.0, 2010, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2763714\", 2012.0, 2013, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2723221\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2715650\", 1988.0, 1991, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.2687858\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640246\", 1995.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636361\", 2000.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435122\", 2003.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424828\", 1996.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424679\", 1984.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8591204\", 2015.0, 2019, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8460363\", 2017.0, 2018, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8322418\", 2016.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170828\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8106986\", 2005.0, 2007, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7878549\", 2016.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7877701\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7876441\", 2018.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7876107\", 2016.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7875969\", 2016.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7875387\", 2013.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874648\", 2016.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874420\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874167\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7667097\", 2009.0, 2012, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7666870\", 2015.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665052\", 2004.0, 2007, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665044\", 2013.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7656556\", 2009.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7652308\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7651334\", 2010.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7629111\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7441200\", 2012.0, 2016, \"Mesothelioma Applied Research Foundation\", \"United States\"], [\"grant.7171754\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7171753\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7170694\", 2015.0, 2017, \"National Cancer Institute\", \"United States\"], [\"grant.7170367\", 2017.0, 2018, \"National Cancer Institute\", \"United States\"], [\"grant.7170051\", 2017.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169931\", 2012.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169712\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169682\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169663\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7043105\", 1999.0, 2002, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6944652\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6918355\", 2016.0, 2018, \"European Molecular Biology Organization\", \"Germany\"], [\"grant.6896523\", 2011.0, 2014, \"Ministry of Industry and Trade\", \"Czechia\"], [\"grant.6894372\", 2006.0, 2008, \"Ministry of Health\", \"Czechia\"], [\"grant.6892045\", 1996.0, 1998, \"Ministry of Health\", \"Czechia\"], [\"grant.6890299\", 2003.0, 2007, \"Ministry of Agriculture\", \"Czechia\"], [\"grant.6842704\", 2017.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6782853\", 2012.0, 2014, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6781706\", 2011.0, 2013, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6779573\", 2014.0, 2015, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6736731\", 2012.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6735856\", 2013.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6735120\", 2014.0, 2016, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734755\", 2013.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734733\", 2013.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734493\", 2012.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6733436\", 2011.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6729651\", 2010.0, 2012, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6729464\", 2009.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727555\", 2002.0, 2004, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6719701\", 2015.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718063\", 2010.0, 2012, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6717351\", 2011.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6717315\", 2011.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716641\", 2008.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715616\", 2003.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6663756\", 2010.0, 2013, \"Melanoma Research Alliance\", \"United States\"], [\"grant.6501588\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501538\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501493\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501452\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501422\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501274\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501039\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500835\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500039\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499682\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6378521\", 2014.0, 2015, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6163461\", 2014.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6154182\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6104573\", 2012.0, 2014, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6052241\", 2010.0, 2011, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6051363\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6036546\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6030160\", 2009.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6025747\", 2009.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6014906\", 2009.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6003007\", 2008.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6002508\", 2008.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5958855\", 2006.0, 2007, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5924448\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5906334\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5877614\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5876809\", 2004.0, 2005, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5872498\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5869872\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5836707\", 2003.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5828744\", 2003.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5824909\", 2002.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5815366\", 2002.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5648738\", 2006.0, 2007, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5597699\", 1992.0, 1994, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5245953\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245950\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245948\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245945\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245944\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245943\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245939\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245937\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245936\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245935\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245934\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245933\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245932\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245928\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245927\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245925\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245924\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245922\", 2014.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245921\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245920\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245918\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245914\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245907\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245903\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245624\", 2007.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245623\", 2007.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245622\", 2007.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245617\", 2007.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245616\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245615\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245614\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245613\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245612\", 2007.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245610\", 2007.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245609\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245608\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245607\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245208\", 2015.0, 2017, \"National Cancer Institute\", \"United States\"], [\"grant.5073020\", 2016.0, 2017, \"Medical Research Council\", \"United Kingdom\"], [\"grant.4944049\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4924046\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4904457\", 2002.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4561045\", 1997.0, 1997, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4555134\", 2001.0, 2005, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4546340\", 2004.0, 2007, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4522499\", 2012.0, 2014, \"National Agency for Research\", \"France\"], [\"grant.3857112\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857104\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857065\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857064\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857063\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857062\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857060\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857058\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857056\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857055\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857054\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857052\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857051\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857049\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857048\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857044\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857043\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857041\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856792\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856791\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856790\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856772\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856771\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856769\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856768\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856767\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856766\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856765\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856764\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856763\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856762\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856761\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856760\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856759\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856758\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856757\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856756\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856755\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856754\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3824163\", 2009.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3823145\", 2012.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3778836\", 2008.0, 2010, \"European Commission\", \"Belgium\"], [\"grant.3764850\", 2004.0, 2009, \"European Commission\", \"Belgium\"], [\"grant.3749525\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3737709\", 1997.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3568675\", 2012.0, 2014, \"Australian Research Council\", \"Australia\"], [\"grant.3535570\", 2014.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2715730\", 1990.0, 1997, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.2711573\", 2002.0, 2002, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709087\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706161\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706160\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2692261\", 2011.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2692183\", 2004.0, 2011, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2687964\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687955\", 2007.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687666\", 2004.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641946\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2608115\", 2004.0, 2007, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.2598780\", 2005.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456829\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455959\", 2003.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435046\", 1999.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425260\", 2003.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425119\", 2002.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2354950\", 2011.0, 2017, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2350072\", 2014.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2350065\", 2013.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347753\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347752\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347747\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347746\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347745\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347744\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347743\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347741\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347740\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347738\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347736\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347734\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347732\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347295\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347294\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347293\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347289\", 2010.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347288\", 2010.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347286\", 2011.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347285\", 2011.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347284\", 2011.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347283\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346797\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346796\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346795\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346794\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346772\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346771\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346770\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346769\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346768\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346762\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346761\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346760\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346759\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346758\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346757\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346756\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346755\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346754\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346753\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346640\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346639\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346638\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346637\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346636\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346635\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346634\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346632\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346627\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346626\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346625\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346624\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346623\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346622\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346621\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346620\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346619\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346618\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346617\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346616\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346615\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346614\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346613\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346612\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346611\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346610\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346606\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346605\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346603\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346602\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346601\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346600\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346599\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346598\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346597\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346596\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346593\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346592\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346591\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346590\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346589\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346588\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346587\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346585\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346584\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346580\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346579\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346578\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346577\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346576\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346575\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346574\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346573\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346572\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346571\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346570\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346569\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346568\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346566\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346565\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346564\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346563\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346562\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346561\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346560\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346559\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346558\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346557\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346556\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346555\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346554\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346553\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346552\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346545\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346543\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346542\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346541\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346540\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346539\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346538\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346537\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346536\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346535\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346534\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346533\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346532\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346531\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346525\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346524\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346523\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346522\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346521\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346520\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346519\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346518\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346517\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346516\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346514\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346509\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346508\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346507\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346506\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346505\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346504\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346503\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346502\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346501\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346500\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346499\", 2007.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346498\", 2007.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346495\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346494\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346493\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346492\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346491\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346490\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346489\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346488\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346487\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346486\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2344491\", 2011.0, 2013, \"National Cancer Institute\", \"United States\"], [\"grant.8610139\", 2007.0, 2008, \"Robert Wood Johnson Foundation\", \"United States\"], [\"grant.8579320\", 2018.0, 2019, \"United States Department of the Army\", \"United States\"], [\"grant.8572899\", 2012.0, 2013, \"Ontario Institute for Cancer Research\", \"Canada\"], [\"grant.8569729\", 2006.0, 2007, \"CancerCare Manitoba\", \"Canada\"], [\"grant.8565507\", 2018.0, 2018, \"Department of Biotechnology\", \"India\"], [\"grant.8564388\", 2016.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8564082\", 2016.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8563871\", 2015.0, 2018, \"Department of Biotechnology\", \"India\"], [\"grant.8563305\", 2014.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8563040\", 2014.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8562784\", 2013.0, 2018, \"Department of Biotechnology\", \"India\"], [\"grant.8562757\", 2013.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8562431\", 2013.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8562366\", 2013.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8562365\", 2013.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8562156\", 2012.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8561994\", 2013.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8561785\", 2012.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8561598\", 2011.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8561575\", 2012.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8561572\", 2012.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8561569\", 2012.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8561568\", 2012.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8561567\", 2012.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8561494\", 2012.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8561094\", 2011.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8560863\", 2010.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8560702\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560674\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560493\", 2008.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8560411\", 2011.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8560410\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560408\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560305\", 2010.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8560215\", 2007.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8560171\", 2007.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8560114\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560031\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8559996\", 2007.0, 2010, \"Department of Biotechnology\", \"India\"], [\"grant.8559990\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8559937\", 2006.0, 2010, \"Department of Biotechnology\", \"India\"], [\"grant.8559873\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8559861\", 2009.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8559049\", 2010.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8559046\", 2009.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8559045\", 2007.0, 2010, \"Department of Biotechnology\", \"India\"], [\"grant.8515281\", 2017.0, 2018, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8505548\", 2012.0, 2012, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8497451\", 2000.0, 2003, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8497448\", 2004.0, 2006, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8492684\", 2016.0, 2017, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8485877\", 2010.0, 2014, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8456354\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8450872\", 2015.0, 2016, \"United States Department of the Army\", \"United States\"], [\"grant.8385722\", 2019.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.8218824\", 1999.0, 2001, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8211545\", 1993.0, 1996, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8186853\", 2016.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8183858\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8181157\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173944\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173186\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170800\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170752\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170018\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169351\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8167514\", 2001.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8107157\", 2004.0, 2005, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8106662\", 2009.0, 2011, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8106079\", 2015.0, 2018, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8081142\", 1982.0, 1985, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8070298\", 2015.0, 2019, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8070297\", 2015.0, 2019, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8070293\", 2015.0, 2019, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8069684\", 2015.0, 2018, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8068998\", 2008.0, 2010, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8068993\", 2007.0, 2009, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8054102\", 2003.0, 2006, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.8041593\", 2010.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8036881\", 2015.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8036722\", 2014.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8034479\", 2012.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8023963\", 2005.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8019041\", 2016.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8003914\", 1992.0, 1996, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8001077\", 2011.0, 2012, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.7999276\", 1978.0, 1979, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7993550\", 2014.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992772\", 2012.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992112\", 1988.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992091\", 1987.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7991654\", 1991.0, 1993, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990743\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990742\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990741\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990740\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990244\", 2010.0, 2015, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989781\", 2008.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989780\", 2008.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989779\", 2008.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988709\", 2005.0, 2007, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988460\", 2004.0, 2006, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7987175\", 1997.0, 1999, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7987167\", 1997.0, 2000, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7986679\", 1995.0, 1999, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7986571\", 1993.0, 1997, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7986568\", 1993.0, 1996, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7986566\", 1993.0, 1996, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7963522\", 2016.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7963422\", 2015.0, 2018, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7953453\", 1996.0, 1997, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7953163\", 1999.0, 2002, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7953114\", 1996.0, 1999, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7953112\", 1996.0, 1999, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952527\", 1997.0, 2000, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952494\", 1995.0, 1998, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952387\", 1989.0, 1993, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952277\", 2014.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951285\", 2012.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7939768\", 1997.0, 2001, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7934122\", 2017.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7878743\", 2017.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7878387\", 2016.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7878132\", 2014.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7877873\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7877641\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7876543\", 2015.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7875422\", 2013.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874578\", 2016.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874365\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874342\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7854022\", 2007.0, 2009, \"Ford Foundation\", \"United States\"], [\"grant.7851210\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7825840\", 2015.0, 2016, \"Uniformed Services University of the Health Sciences\", \"United States\"], [\"grant.7821010\", 1998.0, 2001, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7764353\", 2017.0, 2018, \"United States Department of the Army\", \"United States\"], [\"grant.7736401\", 2009.0, 2012, \"Department of Science and Technology\", \"India\"], [\"grant.7697897\", 2013.0, 2014, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7694260\", 2014.0, 2015, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7681939\", 2009.0, 2009, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7670327\", 2004.0, 2004, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7669734\", 2015.0, 2017, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7667461\", 2005.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7664944\", 2006.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7660038\", 2013.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658043\", 2002.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7657790\", 2012.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7646362\", 2008.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7643463\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7643219\", 2008.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7640347\", 2010.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7630516\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7626822\", 2010.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7617634\", 2006.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7610021\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7609730\", 2015.0, 2016, \"Science and Engineering Research Board\", \"India\"], [\"grant.7608227\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7550388\", 2002.0, 2004, \"Bloodwise\", \"United Kingdom\"], [\"grant.7550184\", 1999.0, 2002, \"Bloodwise\", \"United Kingdom\"], [\"grant.7502771\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7495652\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7486795\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7478477\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7476327\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7473054\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7466278\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7453344\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7446466\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7437175\", 2007.0, 2009, \"University Grants Committee\", \"China\"], [\"grant.7433396\", 2008.0, 2011, \"University Grants Committee\", \"China\"], [\"grant.7428097\", 2014.0, 2016, \"University Grants Committee\", \"China\"], [\"grant.7407419\", 2016.0, 2019, \"National Science Center\", \"Poland\"], [\"grant.7389944\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7389680\", 2017.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7389650\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7389647\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7204754\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7183855\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7172652\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172642\", 2015.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172177\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7171780\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7171779\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7171361\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169661\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169658\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169636\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7167652\", 1995.0, 1998, \"Innovation and Technology Commission\", \"China\"], [\"grant.7166385\", 2008.0, 2010, \"Innovation and Technology Commission\", \"China\"], [\"grant.7166056\", 2009.0, 2010, \"Innovation and Technology Commission\", \"China\"], [\"grant.7166054\", 2009.0, 2010, \"Innovation and Technology Commission\", \"China\"], [\"grant.7150051\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7140909\", 2011.0, 2012, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7140908\", 2011.0, 2012, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132079\", 2007.0, 2008, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7121561\", 2011.0, 2013, \"VINNOVA\", \"Sweden\"], [\"grant.7121461\", 2012.0, 2013, \"VINNOVA\", \"Sweden\"], [\"grant.7049077\", 2016.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.7043750\", 2000.0, 2001, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043094\", 2014.0, 2015, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042337\", 1997.0, 1998, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042336\", 1997.0, 1998, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7027773\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7025507\", 2017.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.7022667\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7018877\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7009269\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7002205\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6989342\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6949912\", 2017.0, 2018, \"Fund for Scientific Research\", \"Belgium\"], [\"grant.6944544\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6896091\", 2005.0, 2007, \"Ministry of Education Youth and Sports\", \"Czechia\"], [\"grant.6895027\", 2011.0, 2014, \"Ministry of Health\", \"Czechia\"], [\"grant.6860321\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6860231\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6857517\", 2005.0, 2007, \"Ministry of Education, Universities and Research\", \"Italy\"], [\"grant.6792174\", 2014.0, 2017, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.6785800\", 2012.0, 2015, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6784292\", 2012.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6775789\", 2012.0, 2016, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6736385\", 2013.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6735254\", 2010.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734608\", 2013.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734606\", 2012.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734536\", 2013.0, 2016, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734309\", 2012.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6732590\", 2009.0, 2009, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6731983\", 2014.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728300\", 2014.0, 2016, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728257\", 2010.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728176\", 2010.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727551\", 2010.0, 2012, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6721784\", 2015.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716522\", 2009.0, 2009, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716069\", 2008.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6714938\", 2009.0, 2012, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6714625\", 2008.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713836\", 2009.0, 2012, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713438\", 2009.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6710344\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6665669\", 2016.0, 2019, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.6620139\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6586245\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586158\", 2006.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586118\", 2012.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586057\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586048\", 2005.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586014\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585997\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585976\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585956\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585946\", 2015.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585942\", 2015.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585914\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585634\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585612\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585589\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585586\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585423\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585351\", 2004.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585328\", 2016.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585277\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585251\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585136\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585027\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584993\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584850\", 2006.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584848\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584845\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584829\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584806\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584800\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584797\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584777\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584720\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584666\", 2012.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584493\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584467\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584441\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584432\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584336\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584308\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584301\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584273\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584214\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584206\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584151\", 2013.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584136\", 2007.0, 2008, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584098\", 2010.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584086\", 2015.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584073\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584067\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584061\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584059\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584047\", 2013.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584038\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583914\", 2008.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583847\", 2008.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583842\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583825\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583815\", 2007.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583742\", 2013.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583725\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583645\", 2013.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583627\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583621\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583587\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583580\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583473\", 2011.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583461\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583407\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583342\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583302\", 2012.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583288\", 2011.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583263\", 2016.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583217\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583127\", 2003.0, 2004, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583035\", 2008.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582996\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582961\", 2010.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582958\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582848\", 2010.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582822\", 2010.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582719\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582668\", 2007.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582628\", 2007.0, 2008, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582557\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582548\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582542\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582500\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582340\", 2016.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582339\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582310\", 2011.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582295\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582178\", 2006.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582119\", 2010.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582060\", 2008.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582051\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581990\", 2010.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581941\", 2005.0, 2006, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581793\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581714\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581702\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581700\", 2006.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581601\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581595\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581503\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581421\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581364\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581325\", 2016.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581316\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581313\", 2006.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581280\", 2010.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581271\", 2011.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581221\", 2016.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581206\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581196\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581169\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581131\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581126\", 2011.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581123\", 2011.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581115\", 2006.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581020\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580908\", 2006.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580890\", 2015.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580836\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580835\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580803\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580786\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580745\", 2010.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580649\", 2012.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580576\", 2012.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580564\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580559\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580484\", 2013.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580403\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580386\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580304\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580266\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580261\", 2006.0, 2008, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580223\", 2013.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580182\", 2012.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580179\", 2003.0, 2008, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6501370\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501028\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500987\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499448\", 2014.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499443\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6369955\", 1971.0, 1971, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6347725\", 1966.0, 1966, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6344179\", 1965.0, 1965, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6316491\", 1978.0, 1978, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6311022\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6289275\", 1979.0, 1979, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6260168\", 1988.0, 1988, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6243074\", 1987.0, 1987, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6233945\", 1986.0, 1986, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6193744\", 2001.0, 2002, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6192027\", 2000.0, 2001, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6190734\", 1997.0, 1998, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6189018\", 1998.0, 1998, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6187641\", 2000.0, 2001, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6154969\", 2014.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6128334\", 2013.0, 2014, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6124081\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6120738\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6096975\", 2012.0, 2014, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6059097\", 2011.0, 2013, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6010588\", 2008.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5996145\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5924715\", 2016.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5919672\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5909934\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5878597\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5875292\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5872775\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5866656\", 2015.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5864910\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5861645\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5856674\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5847585\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5847284\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5829932\", 2014.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5826474\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5815012\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5814353\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5814043\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5812232\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5809744\", 2013.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5749055\", 1999.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5452530\", 1996.0, 1996, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5451369\", 1996.0, 1996, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5325910\", 1999.0, 2001, \"Asthma UK\", \"United Kingdom\"], [\"grant.5245909\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245786\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5218024\", 2002.0, 2003, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5207502\", 2002.0, 2005, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5203540\", 2002.0, 2003, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5202775\", 2002.0, 2005, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5197165\", 1996.0, 2000, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5196035\", 1994.0, 1999, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5181420\", 1986.0, 1989, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5140527\", 2005.0, 2010, \"Cancer Research UK\", \"United Kingdom\"], [\"grant.5139795\", 2012.0, 2015, \"Bloodwise\", \"United Kingdom\"], [\"grant.5041907\", 2001.0, 2002, \"University of California - Cancer Research Coordinating Committee\", \"United States\"], [\"grant.5014857\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5006764\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5005894\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5004249\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4991934\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4973345\", 2010.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4971252\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4966996\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4962853\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4960564\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4957450\", 2006.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4952980\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4951199\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4950725\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4943778\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4941775\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938724\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4937991\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4932812\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4924967\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4924180\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4918569\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4914216\", 2000.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4912945\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4903965\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4892909\", 2014.0, 2015, \"United States Department of the Army\", \"United States\"], [\"grant.4853334\", 2008.0, 2011, \"Volkswagen Foundation\", \"Germany\"], [\"grant.4799742\", 2006.0, 2008, \"German Research Foundation\", \"Germany\"], [\"grant.4774701\", 2003.0, 2006, \"German Research Foundation\", \"Germany\"], [\"grant.4762047\", 2002.0, 2004, \"German Research Foundation\", \"Germany\"], [\"grant.4760941\", 2000.0, 2010, \"German Research Foundation\", \"Germany\"], [\"grant.4760813\", 2000.0, 2003, \"German Research Foundation\", \"Germany\"], [\"grant.4744457\", 1999.0, 2006, \"German Research Foundation\", \"Germany\"], [\"grant.4704204\", 2014.0, 2017, \"National Science Center\", \"Poland\"], [\"grant.4703174\", 2014.0, 2018, \"National Science Center\", \"Poland\"], [\"grant.4700536\", 2011.0, 2014, \"National Science Center\", \"Poland\"], [\"grant.4669594\", 2007.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4667828\", 2009.0, 2010, \"The Research Council of Norway\", \"Norway\"], [\"grant.4659338\", 2008.0, 2008, \"The Research Council of Norway\", \"Norway\"], [\"grant.4649510\", 2009.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.4649346\", 2011.0, 2012, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4647673\", 2007.0, 2007, \"The Research Council of Norway\", \"Norway\"], [\"grant.4578575\", 2001.0, 2004, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4578365\", 2000.0, 2004, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4577798\", 2000.0, 2001, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4520509\", 2012.0, 2013, \"National Agency for Research\", \"France\"], [\"grant.4491575\", 2009.0, 2011, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4472561\", 2015.0, 2016, \"The Icelandic Centre for Research\", \"Iceland\"], [\"grant.4455522\", 2015.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.4439726\", 2010.0, 2011, \"United States Department of the Army\", \"United States\"], [\"grant.4414245\", 2004.0, 2005, \"United States Department of the Navy\", \"United States\"], [\"grant.4388528\", 2003.0, 2004, \"United States Department of the Army\", \"United States\"], [\"grant.4172834\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4035481\", 2009.0, 2011, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.4035270\", 2003.0, 2005, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.3983436\", 2011.0, 2015, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3983037\", 2009.0, 2016, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3958702\", 2015.0, 2016, \"Innovate UK\", \"United Kingdom\"], [\"grant.3951980\", 2014.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3951949\", 2014.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3936592\", 2013.0, 2018, \"Alberta Innovates\", \"Canada\"], [\"grant.3936423\", 2013.0, 2016, \"Alberta Innovates\", \"Canada\"], [\"grant.3898960\", 2007.0, 2009, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3873602\", 2013.0, 2015, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3866316\", 2014.0, 2016, \"Innovate UK\", \"United Kingdom\"], [\"grant.3864778\", 2012.0, 2013, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.3857720\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857710\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857113\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856956\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3852689\", 2015.0, 2015, \"Directorate for Engineering\", \"United States\"], [\"grant.3831853\", 2012.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3826462\", 2012.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3823830\", 2012.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3818730\", 2010.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3814830\", 2011.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3804783\", 2012.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3803020\", 2014.0, 2016, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.3767650\", 1999.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3763985\", 2001.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3759847\", 2001.0, 2002, \"European Commission\", \"Belgium\"], [\"grant.3728055\", 1995.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3724885\", 1988.0, 1991, \"European Commission\", \"Belgium\"], [\"grant.3723073\", 1994.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3722905\", 1995.0, 1998, \"European Commission\", \"Belgium\"], [\"grant.3707655\", 1990.0, 1994, \"European Commission\", \"Belgium\"], [\"grant.3706322\", 1984.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3704851\", 1989.0, 1991, \"European Commission\", \"Belgium\"], [\"grant.3701397\", 1985.0, 1987, \"European Commission\", \"Belgium\"], [\"grant.3700414\", 1989.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.3643227\", 2009.0, 2018, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3637822\", 2013.0, 2016, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3637682\", 2013.0, 2016, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3634826\", 2001.0, 2002, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3633305\", 2002.0, 2003, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3632595\", 2002.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3628432\", 2000.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3628313\", 2001.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3577639\", 2003.0, 2005, \"Australian Research Council\", \"Australia\"], [\"grant.3576834\", 2002.0, 2004, \"Australian Research Council\", \"Australia\"], [\"grant.3573998\", 2003.0, 2006, \"Australian Research Council\", \"Australia\"], [\"grant.3572850\", 2009.0, 2012, \"Australian Research Council\", \"Australia\"], [\"grant.3571261\", 2004.0, 2007, \"Australian Research Council\", \"Australia\"], [\"grant.3570402\", 2009.0, 2013, \"Australian Research Council\", \"Australia\"], [\"grant.3531001\", 2009.0, 2012, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3530308\", 2005.0, 2008, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3527792\", 2005.0, 2006, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3525856\", 2007.0, 2008, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3104434\", 2009.0, 2013, \"Directorate for Social, Behavioral & Economic Sciences\", \"United States\"], [\"grant.2975118\", 1998.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2923517\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2907618\", 2002.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2897984\", 1994.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2897604\", 2002.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2890649\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2868164\", 1992.0, 1993, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2846662\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2845972\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2842611\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2839616\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2803801\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2786005\", 2011.0, 2014, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2785892\", 2006.0, 2009, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2783837\", 2010.0, 2015, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2769709\", 2010.0, 2013, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2754059\", 2010.0, 2017, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2726564\", 2010.0, 2016, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2726423\", 2009.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2726421\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2726417\", 2009.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2726415\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723429\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723071\", 2009.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2712715\", 1996.0, 2000, \"National Institutes of Health Clinical Center\", \"United States\"], [\"grant.2712046\", 1995.0, 1995, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711205\", 1991.0, 1991, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711169\", 1990.0, 1991, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709250\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709243\", 2005.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709238\", 2005.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709208\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709206\", 2002.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709167\", 2002.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708553\", 1985.0, 1992, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708458\", 1985.0, 1987, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706122\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706116\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688037\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687949\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687703\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687484\", 1999.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2669265\", 2009.0, 2012, \"National Cancer Institute\", \"United States\"], [\"grant.2668278\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2644101\", 1999.0, 2000, \"National Cancer Institute\", \"United States\"], [\"grant.2643860\", 1998.0, 1999, \"National Cancer Institute\", \"United States\"], [\"grant.2641629\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641339\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641242\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641097\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640968\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640965\", 2002.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640907\", 2003.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640880\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640182\", 1994.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2601232\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2600952\", 2012.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599022\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2544527\", 1992.0, 1996, \"Agency for Healthcare Research and Quality\", \"United States\"], [\"grant.2506017\", 1992.0, 2005, \"National Eye Institute\", \"United States\"], [\"grant.2485747\", 2003.0, 2007, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2459206\", 2011.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458313\", 2008.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435112\", 2003.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435103\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425590\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425589\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425446\", 2010.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425142\", 2003.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424838\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424825\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424824\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424823\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2417267\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2369962\", 1997.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347135\", 2013.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459198\", 2011.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4294554\", 2015.0, 2018, \"Medical Research Council\", \"United Kingdom\"], [\"grant.7673939\", 2016.0, 2017, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7146038\", 2015.0, 2016, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.6382318\", 2016.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.3859869\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2692222\", 2007.0, 2011, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2666434\", 2010.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458298\", 2009.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7430482\", 2015.0, 2018, \"University Grants Committee\", \"China\"], [\"grant.6952757\", 2017.0, 2019, \"National Cancer Institute\", \"United States\"], [\"grant.6380452\", 2015.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.5503451\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4295315\", 2015.0, 2018, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.4103659\", 2015.0, 2018, \"National Cancer Institute\", \"United States\"], [\"grant.3867852\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3733061\", 1997.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3625269\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3535533\", 2014.0, 2016, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2754548\", 2011.0, 2015, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2692257\", 2011.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2692202\", 2006.0, 2008, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2688086\", 2009.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688014\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687686\", 2004.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2658051\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657928\", 2002.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2645385\", 2009.0, 2010, \"National Cancer Institute\", \"United States\"], [\"grant.2641871\", 2011.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2612876\", 2010.0, 2013, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2601484\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2600266\", 2010.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599911\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599769\", 2008.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2581895\", 2011.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2567250\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458818\", 2010.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456916\", 2006.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456421\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2355138\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8579772\", 2010.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8459443\", 2015.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8339888\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8181151\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7749383\", 2012.0, 2013, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7673878\", 2016.0, 2017, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7665291\", 2010.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7651902\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7641966\", 2007.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7616855\", 2012.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7566317\", 2003.0, 2008, \"Ministry of Business, Innovation and Employment\", \"New Zealand\"], [\"grant.7124299\", 2015.0, 2016, \"VINNOVA\", \"Sweden\"], [\"grant.7109721\", 2016.0, 2018, \"VINNOVA\", \"Sweden\"], [\"grant.7029068\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6715541\", 2003.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713972\", 2005.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6663822\", 2013.0, 2016, \"Melanoma Research Alliance\", \"United States\"], [\"grant.6501302\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6049130\", 2010.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5829752\", 2003.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5823968\", 2002.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5721408\", 1997.0, 1998, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5664360\", 1995.0, 1997, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5475778\", 2016.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5223759\", 2010.0, 2011, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.4899209\", 2006.0, 2007, \"California HIV/AIDS Research Program\", \"United States\"], [\"grant.4660769\", 2014.0, 2017, \"The Research Council of Norway\", \"Norway\"], [\"grant.4640178\", 2008.0, 2012, \"The Research Council of Norway\", \"Norway\"], [\"grant.4633981\", 1996.0, 2001, \"Slovenian Research Agency\", \"Slovenia\"], [\"grant.4485915\", 2011.0, 2013, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4415436\", 2004.0, 2005, \"United States Department of the Army\", \"United States\"], [\"grant.4390182\", 2002.0, 2003, \"United States Department of the Navy\", \"United States\"], [\"grant.3940618\", 2015.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.3784451\", 2010.0, 2014, \"European Commission\", \"Belgium\"], [\"grant.3784425\", 2010.0, 2014, \"European Commission\", \"Belgium\"], [\"grant.3772404\", 2009.0, 2012, \"European Commission\", \"Belgium\"], [\"grant.3129185\", 2011.0, 2015, \"Directorate for Engineering\", \"United States\"], [\"grant.3081070\", 2007.0, 2008, \"Directorate for Social, Behavioral & Economic Sciences\", \"United States\"], [\"grant.2960431\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2918611\", 2005.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2711784\", 1993.0, 1998, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709010\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704625\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704605\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687787\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687506\", 2000.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2668265\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2668260\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657974\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657783\", 1998.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641688\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641619\", 2008.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641309\", 2005.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641121\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641056\", 2003.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640855\", 2002.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640759\", 2001.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2604455\", 2006.0, 2009, \"National Cancer Institute\", \"United States\"], [\"grant.2598688\", 2004.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598334\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597967\", 2004.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597799\", 2001.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2583453\", 2002.0, 2003, \"National Cancer Institute\", \"United States\"], [\"grant.2581808\", 2010.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2576351\", 1998.0, 2000, \"Agency for Healthcare Research and Quality\", \"United States\"], [\"grant.2566915\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566904\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2526101\", 2000.0, 2013, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2468650\", 1985.0, 1992, \"National Cancer Institute\", \"United States\"], [\"grant.2457755\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457231\", 2005.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457183\", 2006.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453301\", 1995.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2392441\", 2003.0, 2007, \"United States National Library of Medicine\", \"United States\"], [\"grant.2350946\", 2005.0, 2010, \"National Center for Advancing Translational Sciences\", \"United States\"], [\"grant.100072047\", 2014.0, 2018, \"V Foundation for Cancer Research\", \"United States\"], [\"grant.2769275\", 2011.0, 2015, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.7143297\", 2004.0, 2005, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.4731287\", 2015.0, 2018, \"National Agency for Research\", \"France\"], [\"grant.3859527\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3728056\", 1995.0, 1998, \"European Commission\", \"Belgium\"], [\"grant.2642043\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709072\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8593212\", 2012.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8593181\", 2015.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8592576\", 2015.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8591458\", 2015.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8591433\", 2015.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8573271\", 2011.0, 2013, \"Alex's Lemonade Stand Foundation\", \"United States\"], [\"grant.8573193\", 2007.0, 2010, \"Ontario Institute for Cancer Research\", \"Canada\"], [\"grant.8568312\", 2011.0, 2011, \"The Taylor Matthews Foundation\", \"United States\"], [\"grant.8519075\", 2013.0, 2014, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.8461487\", 2017.0, 2018, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8459735\", 2015.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8329544\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8328985\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8216461\", 1997.0, 1999, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8198250\", 2016.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8181152\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8178839\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8176925\", 2013.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173632\", 2007.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8107190\", 2003.0, 2007, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8107088\", 2004.0, 2006, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8106827\", 2008.0, 2009, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8106823\", 2008.0, 2010, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8041819\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7749605\", 2016.0, 2017, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7632107\", 2011.0, 2012, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7630521\", 2007.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7617679\", 2014.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7615531\", 2018.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7441243\", 2007.0, 2008, \"Mesothelioma Applied Research Foundation\", \"United States\"], [\"grant.7413138\", 2011.0, 2014, \"Ministry of Science and Higher Education\", \"Poland\"], [\"grant.7210090\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7201259\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7198956\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7195059\", 2015.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7188506\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7172307\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172128\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7170344\", 2017.0, 2018, \"National Cancer Institute\", \"United States\"], [\"grant.7170037\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7145281\", 2005.0, 2006, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7126490\", 2013.0, 2015, \"Swedish Research Council\", \"Sweden\"], [\"grant.7111444\", 2015.0, 2016, \"VINNOVA\", \"Sweden\"], [\"grant.7110393\", 2013.0, 2015, \"Swedish Research Council\", \"Sweden\"], [\"grant.7107704\", 2011.0, 2013, \"VINNOVA\", \"Sweden\"], [\"grant.7102560\", 2014.0, 2016, \"Swedish Research Council\", \"Sweden\"], [\"grant.7094056\", 2012.0, 2014, \"VINNOVA\", \"Sweden\"], [\"grant.7093414\", 2014.0, 2016, \"Swedish Research Council\", \"Sweden\"], [\"grant.7054358\", 2017.0, 2019, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.7052734\", 2015.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.7035750\", 2000.0, 2001, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7035728\", 1998.0, 2001, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7027530\", 2017.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7017474\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7009470\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7007594\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6989562\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6985802\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6984632\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6956996\", 2017.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6898601\", 2014.0, 2017, \"Technology Agency of the Czech Republic\", \"Czechia\"], [\"grant.6898238\", 2012.0, 2016, \"Ministry of Agriculture\", \"Czechia\"], [\"grant.6897461\", 2012.0, 2015, \"Ministry of Education Youth and Sports\", \"Czechia\"], [\"grant.6895869\", 1997.0, 2001, \"Ministry of Industry and Trade\", \"Czechia\"], [\"grant.6894818\", 2008.0, 2011, \"Ministry of Health\", \"Czechia\"], [\"grant.6893995\", 2004.0, 2006, \"Ministry of Health\", \"Czechia\"], [\"grant.6893013\", 1999.0, 2001, \"Ministry of Health\", \"Czechia\"], [\"grant.6892489\", 1997.0, 1999, \"Ministry of Health\", \"Czechia\"], [\"grant.6892046\", 1996.0, 1998, \"Ministry of Health\", \"Czechia\"], [\"grant.6891741\", 2002.0, 2004, \"Academy of Sciences of the Czech Republic\", \"Czechia\"], [\"grant.6890237\", 2008.0, 2011, \"Ministry of Defence\", \"Czechia\"], [\"grant.6889913\", 1995.0, 1997, \"Ministry of Health\", \"Czechia\"], [\"grant.6889759\", 1998.0, 2002, \"Ministry of Education Youth and Sports\", \"Czechia\"], [\"grant.6887770\", 2009.0, 2011, \"Czech Science Foundation\", \"Czechia\"], [\"grant.6885923\", 2003.0, 2005, \"Ministry of Industry and Trade\", \"Czechia\"], [\"grant.6789856\", 2010.0, 2013, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6782698\", 2011.0, 2015, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6782088\", 2012.0, 2015, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6779627\", 2015.0, 2019, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6779163\", 2014.0, 2015, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6778182\", 2012.0, 2013, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6736604\", 2012.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734404\", 2012.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718161\", 2003.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715102\", 2004.0, 2008, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6714516\", 2004.0, 2006, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6710383\", 2017.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6665051\", 2014.0, 2016, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.6585701\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585522\", 2015.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585009\", 2013.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584480\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583202\", 2014.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582837\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582602\", 2014.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582377\", 2015.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582318\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582277\", 2015.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582039\", 2014.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581667\", 2013.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581629\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581606\", 2015.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580667\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580592\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580348\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580253\", 2014.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6501410\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501086\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499761\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6445309\", 2016.0, 2019, \"Innovate UK\", \"United Kingdom\"], [\"grant.6151642\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6098547\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6091957\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6071280\", 2011.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6070744\", 2011.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6042157\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6024774\", 2009.0, 2011, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6012718\", 2008.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6012401\", 2008.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5992262\", 2007.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5938062\", 2005.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5931400\", 2005.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5920808\", 2016.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5911040\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5900028\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5869490\", 2015.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5861515\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5799529\", 2001.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5501390\", 2013.0, 2018, \"Royal Society\", \"United Kingdom\"], [\"grant.5495378\", 2016.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.5245789\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245788\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245787\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245784\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245782\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245762\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5244950\", 2008.0, 2018, \"National Cancer Institute\", \"United States\"], [\"grant.5151711\", 2007.0, 2010, \"NIHR Trainees Coordinating Centre\", \"United Kingdom\"], [\"grant.5072711\", 2016.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.5014322\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5006402\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5000845\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4996505\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4980908\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4980502\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4977004\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4967684\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4965799\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4965440\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4964345\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4959645\", 2012.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4953588\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4949617\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4944670\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4944517\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4943857\", 2012.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4942414\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938676\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938143\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4936988\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4936799\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4931966\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4931866\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4930008\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4929469\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4666876\", 2010.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4661763\", 2009.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4645568\", 2013.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4642003\", 2012.0, 2017, \"The Research Council of Norway\", \"Norway\"], [\"grant.4579186\", 2015.0, 2019, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4533901\", 2007.0, 2009, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4511421\", 1996.0, 1996, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4457248\", 2013.0, 2018, \"Royal Society\", \"United Kingdom\"], [\"grant.4446312\", 2009.0, 2010, \"United States Department of the Army\", \"United States\"], [\"grant.4444178\", 1994.0, 1995, \"United States Department of the Army\", \"United States\"], [\"grant.4419560\", 2010.0, 2011, \"United States Department of the Army\", \"United States\"], [\"grant.4385415\", 1995.0, 1996, \"United States Department of the Army\", \"United States\"], [\"grant.4383163\", 1995.0, 1996, \"United States Department of the Army\", \"United States\"], [\"grant.4294354\", 2014.0, 2017, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.4293335\", 2013.0, 2018, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.4128821\", 2013.0, 2017, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.4102510\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4045744\", 2003.0, 2006, \"National Oceanic and Atmospheric Administration\", \"United States\"], [\"grant.4045136\", 2003.0, 2005, \"National Oceanic and Atmospheric Administration\", \"United States\"], [\"grant.3955540\", 2014.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3930806\", 2013.0, 2016, \"Australian Research Council\", \"Australia\"], [\"grant.3930761\", 2013.0, 2016, \"Australian Research Council\", \"Australia\"], [\"grant.3928619\", 2004.0, 2009, \"Ministry of Research, Innovation and Science\", \"Canada\"], [\"grant.3865714\", 2014.0, 2015, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.3856962\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856961\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856960\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856941\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856253\", 2014.0, 2016, \"National Cancer Institute\", \"United States\"], [\"grant.3843674\", 2013.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3832512\", 2004.0, 2009, \"Agricultural Research Service\", \"United States\"], [\"grant.3826010\", 2009.0, 2011, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3820381\", 2010.0, 2011, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3820195\", 2009.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3810125\", 2011.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3804353\", 2016.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3769133\", 2000.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3765856\", 2002.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3761112\", 2002.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3760628\", 2001.0, 2005, \"European Commission\", \"Belgium\"], [\"grant.3753632\", 2002.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3751931\", 2002.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3750111\", 2002.0, 2002, \"European Commission\", \"Belgium\"], [\"grant.3641111\", 2011.0, 2014, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3635581\", 2006.0, 2011, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3632484\", 2008.0, 2008, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3576905\", 2009.0, 2011, \"Australian Research Council\", \"Australia\"], [\"grant.3576794\", 2005.0, 2008, \"Australian Research Council\", \"Australia\"], [\"grant.3570931\", 2011.0, 2014, \"Australian Research Council\", \"Australia\"], [\"grant.3568449\", 2012.0, 2015, \"Australian Research Council\", \"Australia\"], [\"grant.3563226\", 2012.0, 2014, \"Australian Research Council\", \"Australia\"], [\"grant.3562443\", 2013.0, 2015, \"Australian Research Council\", \"Australia\"], [\"grant.3492809\", 2014.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2801262\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2776175\", 2012.0, 2015, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2770636\", 2010.0, 2012, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2762266\", 1991.0, 2006, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2761525\", 2013.0, 2016, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2756358\", 2012.0, 2017, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2723441\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2722129\", 1996.0, 1996, \"National Center for Advancing Translational Sciences\", \"United States\"], [\"grant.2712045\", 1995.0, 1995, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2712003\", 1993.0, 1999, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711997\", 1993.0, 1998, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711203\", 1991.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711160\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711158\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709708\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709209\", 2003.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708936\", 1998.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708932\", 1998.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708555\", 1985.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706445\", 2010.0, 2010, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2706209\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706207\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706205\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706204\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706150\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706130\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688061\", 2009.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2668279\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2668269\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666814\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2658005\", 2005.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657883\", 2001.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657708\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657702\", 1994.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657621\", 1991.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2651130\", 1986.0, 1986, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2640676\", 2000.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640147\", 1993.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639812\", 1988.0, 1988, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636318\", 1997.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2602712\", 1996.0, 1999, \"National Cancer Institute\", \"United States\"], [\"grant.2600054\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597874\", 2001.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2487387\", 2013.0, 2018, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2468799\", 1986.0, 1990, \"National Cancer Institute\", \"United States\"], [\"grant.2456215\", 2004.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456201\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455147\", 2000.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2454397\", 1999.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453038\", 1997.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452253\", 1991.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435222\", 2012.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2434259\", 1988.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2430874\", 1989.0, 1995, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430828\", 1997.0, 1997, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2425461\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425460\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425358\", 2004.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425357\", 2004.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424781\", 1986.0, 1988, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424621\", 1994.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424563\", 1992.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424464\", 1991.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2409638\", 1994.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2370535\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2350078\", 2012.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347550\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347549\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347548\", 2011.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347179\", 2011.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346749\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2344565\", 2013.0, 2013, \"National Cancer Institute\", \"United States\"], [\"grant.100073101\", 2009.0, 2012, \"Arnold and Mabel Beckman Foundation\", \"United States\"], [\"grant.100071919\", 2016.0, 2019, \"V Foundation for Cancer Research\", \"United States\"], [\"grant.100070343\", 2006.0, 2009, \"Leukemia and Lymphoma Society\", \"United States\"], [\"grant.7924078\", 2008.0, 2012, \"Medical Research Council\", \"United Kingdom\"], [\"grant.7083241\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.7025940\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6709532\", 2017.0, 2018, \"Russian Science Foundation\", \"Russia\"], [\"grant.6617953\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6376359\", 2016.0, 2018, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.5831961\", 2002.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5796747\", 2001.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5792510\", 2001.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5222977\", 2010.0, 2013, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.4294792\", 2013.0, 2018, \"Medical Research Council\", \"United Kingdom\"], [\"grant.3952092\", 2014.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3858813\", 2014.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3744387\", 2000.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3633986\", 2003.0, 2004, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3493444\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3146991\", 2013.0, 2013, \"Directorate for Engineering\", \"United States\"], [\"grant.2765536\", 2007.0, 2008, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2711594\", 1997.0, 2002, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2692253\", 2010.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2687567\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687497\", 2000.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2668262\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657735\", 1996.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641758\", 2010.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640474\", 1998.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599383\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599315\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598551\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598339\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597759\", 2000.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2583675\", 2005.0, 2006, \"National Cancer Institute\", \"United States\"], [\"grant.2567423\", 2011.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2473620\", 1998.0, 2003, \"National Cancer Institute\", \"United States\"], [\"grant.2459539\", 2012.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459098\", 2010.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458596\", 2011.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455944\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455051\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455044\", 2000.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452208\", 1991.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452138\", 1991.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2439912\", 1997.0, 2012, \"National Center for Advancing Translational Sciences\", \"United States\"], [\"grant.8330234\", 2013.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8211596\", 1993.0, 1995, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170790\", 2003.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169256\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8166485\", 2001.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8107435\", 2002.0, 2005, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7707767\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7652313\", 2008.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7645924\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7645922\", 2010.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7644719\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7643364\", 2013.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7624864\", 2011.0, 2012, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7622446\", 2000.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7620844\", 2010.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7618683\", 2006.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7186510\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7159514\", 2017.0, 2018, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.7073217\", 2016.0, 2019, \"Royal Society of New Zealand\", \"New Zealand\"], [\"grant.7028964\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7016683\", 2014.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7010204\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7002558\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6988179\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6894983\", 2010.0, 2013, \"Ministry of Health\", \"Czechia\"], [\"grant.6841109\", 2017.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6777237\", 2011.0, 2013, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6726168\", 2010.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6720824\", 2005.0, 2009, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6720627\", 2004.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716293\", 2004.0, 2006, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715153\", 2004.0, 2008, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713348\", 2003.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6443782\", 2018.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6381913\", 2014.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6380616\", 2016.0, 2018, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6380515\", 2014.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6158985\", 2014.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6153433\", 2014.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6148084\", 2014.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6146666\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6144510\", 2014.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6141219\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6130025\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6121924\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6118451\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6090612\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6090601\", 2012.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6088330\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6077873\", 2011.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6065481\", 2011.0, 2013, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6062567\", 2011.0, 2013, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6052099\", 2010.0, 2011, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6042942\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6039143\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5991816\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5882059\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5879816\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5871293\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5821105\", 2002.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5127033\", 2016.0, 2018, \"Australian Research Council\", \"Australia\"], [\"grant.5125629\", 2016.0, 2018, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.4943714\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4941994\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938852\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938364\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4937787\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4934608\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4926171\", 2005.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4910016\", 2006.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4908338\", 2005.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4791473\", 2006.0, 2011, \"German Research Foundation\", \"Germany\"], [\"grant.4675083\", 2006.0, 2008, \"The Research Council of Norway\", \"Norway\"], [\"grant.4554277\", 2002.0, 2005, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4548758\", 2007.0, 2007, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4503412\", 2002.0, 2006, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4477008\", 2015.0, 2017, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4426331\", 2010.0, 2011, \"United States Department of the Army\", \"United States\"], [\"grant.4388526\", 2003.0, 2004, \"United States Department of the Army\", \"United States\"], [\"grant.4035669\", 2006.0, 2008, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.3984049\", 2013.0, 2017, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3983896\", 2013.0, 2018, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3866240\", 2012.0, 2015, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.3865504\", 2014.0, 2017, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.3843118\", 2013.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3842325\", 2014.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.3841931\", 2013.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3837227\", 2012.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3834845\", 2007.0, 2011, \"Agricultural Research Service\", \"United States\"], [\"grant.3833869\", 2010.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3812426\", 2012.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3756712\", 2001.0, 2002, \"European Commission\", \"Belgium\"], [\"grant.3755519\", 2001.0, 2005, \"European Commission\", \"Belgium\"], [\"grant.3755459\", 2002.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3752777\", 2002.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3750411\", 2002.0, 2008, \"European Commission\", \"Belgium\"], [\"grant.3749572\", 2001.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3748922\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3745255\", 1999.0, 2001, \"European Commission\", \"Belgium\"], [\"grant.3742514\", 2000.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3710988\", 1993.0, 1996, \"European Commission\", \"Belgium\"], [\"grant.3642631\", 2013.0, 2015, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3629180\", 2004.0, 2008, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3629179\", 2005.0, 2008, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3626830\", 2007.0, 2007, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3624329\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3579092\", 2010.0, 2012, \"Australian Research Council\", \"Australia\"], [\"grant.3579004\", 2003.0, 2006, \"Australian Research Council\", \"Australia\"], [\"grant.3573546\", 2010.0, 2012, \"Australian Research Council\", \"Australia\"], [\"grant.3571454\", 2008.0, 2010, \"Australian Research Council\", \"Australia\"], [\"grant.3571208\", 2006.0, 2008, \"Australian Research Council\", \"Australia\"], [\"grant.3357900\", 1987.0, 1991, \"Directorate for Engineering\", \"United States\"], [\"grant.2769793\", 2008.0, 2010, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2754972\", 2010.0, 2012, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2753546\", 2006.0, 2009, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2723261\", 2009.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2718153\", 1989.0, 1989, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2709746\", 1992.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709229\", 2004.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709203\", 2002.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709136\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708776\", 1993.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708519\", 1985.0, 1987, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706170\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2695788\", 2005.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641784\", 2011.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641642\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640145\", 1993.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639711\", 2012.0, 2014, \"National Institute on Aging\", \"United States\"], [\"grant.2636725\", 2001.0, 2003, \"National Cancer Institute\", \"United States\"], [\"grant.2459800\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458975\", 2010.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457552\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455420\", 2001.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425382\", 2004.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2386508\", 2000.0, 2001, \"National Heart Lung and Blood Institute\", \"United States\"], [\"grant.2370356\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2359891\", 2003.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.100054928\", 2012.0, 2014, \"American Federation for Aging Research\", \"United States\"], [\"grant.7135136\", 2004.0, 2005, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.3958472\", 2015.0, 2016, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2770973\", 2012.0, 2016, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2695840\", 2009.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8594467\", 2015.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8457856\", 2015.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8329770\", 2012.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8186858\", 2016.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8184633\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8176846\", 2013.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7819398\", 2018.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.7661394\", 2007.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7651941\", 2018.0, 2019, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7641972\", 2011.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7621487\", 2012.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7200856\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7189151\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7134188\", 2001.0, 2002, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7069383\", 2012.0, 2014, \"Research Manitoba\", \"Canada\"], [\"grant.7043117\", 2006.0, 2008, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042976\", 1999.0, 2002, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042975\", 1999.0, 2002, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6986688\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6971184\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6950274\", 2014.0, 2016, \"Fund for Scientific Research\", \"Belgium\"], [\"grant.6815040\", 2017.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.6728763\", 2001.0, 2003, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718339\", 2005.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6622479\", 2014.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.6381177\", 2016.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.5977328\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5943537\", 2005.0, 2007, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5941026\", 2005.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5938747\", 2005.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5927000\", 2005.0, 2007, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5682037\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5585646\", 2002.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5245885\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5210881\", 2006.0, 2009, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.4950921\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4899319\", 2010.0, 2012, \"California HIV/AIDS Research Program\", \"United States\"], [\"grant.4674892\", 2009.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4662133\", 2014.0, 2018, \"The Research Council of Norway\", \"Norway\"], [\"grant.4640691\", 2008.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4640383\", 2007.0, 2011, \"The Research Council of Norway\", \"Norway\"], [\"grant.4538557\", 2008.0, 2010, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4425384\", 2000.0, 2001, \"United States Department of the Navy\", \"United States\"], [\"grant.4241520\", 2015.0, 2017, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.3939966\", 2015.0, 2019, \"European Commission\", \"Belgium\"], [\"grant.3857025\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3811139\", 2010.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3800649\", 2013.0, 2019, \"European Commission\", \"Belgium\"], [\"grant.3797302\", 2012.0, 2014, \"European Commission\", \"Belgium\"], [\"grant.3797051\", 2013.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.3796233\", 2013.0, 2016, \"European Commission\", \"Belgium\"], [\"grant.3796117\", 2013.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.3791598\", 2012.0, 2013, \"European Research Council\", \"Belgium\"], [\"grant.3781384\", 2010.0, 2014, \"European Commission\", \"Belgium\"], [\"grant.3765546\", 2003.0, 2009, \"European Commission\", \"Belgium\"], [\"grant.3635549\", 2005.0, 2006, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3630295\", 2005.0, 2012, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3630291\", 2005.0, 2012, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3628122\", 2005.0, 2009, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3628116\", 2005.0, 2010, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3623723\", 2014.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2953673\", 2012.0, 2014, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2766843\", 2008.0, 2012, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2711478\", 1995.0, 1999, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711194\", 1990.0, 1990, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2710976\", 2008.0, 2008, \"National Cancer Institute\", \"United States\"], [\"grant.2705299\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704638\", 2005.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704622\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704613\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2695767\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688088\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688026\", 2008.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687854\", 2007.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687829\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687735\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687614\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666008\", 2004.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2665739\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641999\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641546\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641131\", 2005.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640943\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2638327\", 1999.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636466\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636457\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2625454\", 1997.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2605071\", 2009.0, 2012, \"National Cancer Institute\", \"United States\"], [\"grant.2601356\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598512\", 2005.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598293\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2581944\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2581467\", 2003.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2580180\", 2004.0, 2008, \"Fogarty International Center\", \"United States\"], [\"grant.2566828\", 1999.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2545177\", 2012.0, 2017, \"Agency for Healthcare Research and Quality\", \"United States\"], [\"grant.2477018\", 2004.0, 2010, \"National Cancer Institute\", \"United States\"], [\"grant.2459067\", 2010.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458505\", 2009.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2454744\", 1999.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2451211\", 1988.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2451063\", 1987.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435060\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435034\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2409929\", 2001.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2359952\", 2008.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2354952\", 2012.0, 2019, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.8550559\", 2017.0, 2018, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.6661828\", 2017.0, 2018, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.4704416\", 2014.0, 2019, \"National Science Center\", \"Poland\"], [\"grant.7144747\", 2013.0, 2014, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7143376\", 2003.0, 2004, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7142769\", 2001.0, 2002, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7043118\", 2005.0, 2012, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043103\", 1999.0, 2005, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6856356\", 2008.0, 2010, \"Ministry of Education, Universities and Research\", \"Italy\"], [\"grant.6671033\", 2014.0, 2016, \"Nova Scotia Health Research Foundation\", \"Canada\"], [\"grant.6618513\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6416942\", 2016.0, 2018, \"National Agency for Research\", \"France\"], [\"grant.6378716\", 2015.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3701645\", 1991.0, 1994, \"European Commission\", \"Belgium\"], [\"grant.3499383\", 2013.0, 2014, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2723442\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2638362\", 2008.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2633208\", 2011.0, 2012, \"Agency for Healthcare Research and Quality\", \"United States\"], [\"grant.2600460\", 2010.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599137\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2567237\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458846\", 2010.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7145428\", 2001.0, 2002, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7143720\", 2006.0, 2007, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7133861\", 2001.0, 2002, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7083896\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.7048257\", 2016.0, 2018, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6932398\", 2017.0, 2018, \"Directorate for Engineering\", \"United States\"], [\"grant.6434842\", 2013.0, 2016, \"National Council for Scientific and Technological Development\", \"Brazil\"], [\"grant.5475786\", 2016.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4898746\", 2016.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4526619\", 2015.0, 2017, \"National Agency for Research\", \"France\"], [\"grant.4242390\", 2015.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4054922\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3829290\", 2010.0, 2015, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3728428\", 1996.0, 1999, \"European Commission\", \"Belgium\"], [\"grant.3624085\", 2014.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2766618\", 1998.0, 2010, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2711483\", 1993.0, 1998, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2695668\", 1989.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688036\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687950\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687700\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687360\", 1994.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2679944\", 2007.0, 2010, \"National Institute of General Medical Sciences\", \"United States\"], [\"grant.2669267\", 2009.0, 2012, \"National Cancer Institute\", \"United States\"], [\"grant.2666620\", 2011.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641555\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641424\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641235\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2638361\", 2008.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636978\", 2004.0, 2006, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2636590\", 2008.0, 2010, \"National Institute of Arthritis and Musculoskeletal and Skin Diseases\", \"United States\"], [\"grant.2636516\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2633028\", 2009.0, 2010, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2632159\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2602760\", 1997.0, 1999, \"National Cancer Institute\", \"United States\"], [\"grant.2600220\", 2010.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599545\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599245\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598200\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598185\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597362\", 2002.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2501723\", 2006.0, 2011, \"National Institute of Biomedical Imaging and Bioengineering\", \"United States\"], [\"grant.2485752\", 2003.0, 2009, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2475426\", 2002.0, 2006, \"National Cancer Institute\", \"United States\"], [\"grant.2459532\", 2012.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459430\", 2011.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459193\", 2011.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457778\", 2009.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457417\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456177\", 2005.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455862\", 2002.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455572\", 2001.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2454563\", 2000.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453938\", 1999.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453675\", 1997.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453157\", 1994.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452634\", 1992.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2449442\", 1977.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2449186\", 1974.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2418466\", 2008.0, 2009, \"National Cancer Institute\", \"United States\"], [\"grant.7925321\", 2008.0, 2011, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2711626\", 2003.0, 2003, \"United States Food and Drug Administration\", \"United States\"], [\"grant.8519056\", 2013.0, 2014, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.7749733\", 2016.0, 2017, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7673664\", 2016.0, 2017, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7618456\", 2015.0, 2018, \"Canadian Cancer Society\", \"Canada\"], [\"grant.7043121\", 2005.0, 2012, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040510\", 2013.0, 2016, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6460791\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6381145\", 2016.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.5504997\", 2016.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3703693\", 1989.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.2723204\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723133\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2710571\", 2005.0, 2005, \"National Cancer Institute\", \"United States\"], [\"grant.2641917\", 2011.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641846\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641825\", 2010.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641582\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641474\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641417\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2600613\", 2012.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599420\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2581841\", 2010.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459891\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459207\", 2011.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458958\", 2010.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8615120\", 2002.0, 2003, \"Robert Wood Johnson Foundation\", \"United States\"], [\"grant.8588543\", 2016.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8573811\", 2003.0, 2006, \"Ontario Institute for Cancer Research\", \"Canada\"], [\"grant.8458609\", 2013.0, 2014, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8457229\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8343971\", 2016.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8340455\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8339653\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8334613\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8334535\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8333847\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8329741\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8328946\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8216959\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8214963\", 1996.0, 1998, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8214438\", 1995.0, 1997, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8207596\", 1989.0, 1991, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8184627\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8184513\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8183781\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8183778\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8183360\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8174921\", 2009.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8171709\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8145336\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7767266\", 2016.0, 2017, \"United States Department of the Army\", \"United States\"], [\"grant.7766966\", 2016.0, 2017, \"Defense Threat Reduction Agency\", \"United States\"], [\"grant.7765761\", 2016.0, 2017, \"United States Department of Defense\", \"United States\"], [\"grant.7724040\", 2018.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7667260\", 2005.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7664869\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7656538\", 2007.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7651336\", 2008.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7649919\", 2008.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7640714\", 2009.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7635437\", 2008.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7632116\", 2008.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7624865\", 2011.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7621645\", 2007.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7209085\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7202920\", 2015.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7198131\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7189701\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7186623\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7181817\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7178941\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7170931\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7140864\", 2010.0, 2011, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7138381\", 1996.0, 1997, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7125513\", 2012.0, 2013, \"Swedish Research Council\", \"Sweden\"], [\"grant.7123318\", 2009.0, 2010, \"Swedish Research Council\", \"Sweden\"], [\"grant.7119830\", 2010.0, 2012, \"Swedish Research Council\", \"Sweden\"], [\"grant.7107975\", 2013.0, 2018, \"Swedish Foundation for Strategic Research\", \"Sweden\"], [\"grant.7096947\", 2016.0, 2017, \"Swedish Research Council\", \"Sweden\"], [\"grant.7095071\", 2010.0, 2012, \"Swedish Research Council\", \"Sweden\"], [\"grant.7043000\", 2000.0, 2003, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042563\", 2004.0, 2010, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7024736\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7022578\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7013810\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7012934\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6999438\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6994947\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6994410\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6991532\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6991520\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6991182\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6990117\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6983221\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6983019\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6981617\", 2014.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6980454\", 2014.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6932286\", 2017.0, 2018, \"Directorate for Engineering\", \"United States\"], [\"grant.6891494\", 1998.0, 2000, \"Czech Science Foundation\", \"Czechia\"], [\"grant.6888017\", 2010.0, 2013, \"Czech Science Foundation\", \"Czechia\"], [\"grant.6849449\", 2016.0, 2016, \"California Institute for Regenerative Medicine\", \"United States\"], [\"grant.6793067\", 2015.0, 2016, \"United States Department of Defense\", \"United States\"], [\"grant.6759552\", 2013.0, 2013, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.6665244\", 2016.0, 2018, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.6663844\", 2015.0, 2018, \"Melanoma Research Alliance\", \"United States\"], [\"grant.6621694\", 2017.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.6502258\", 2016.0, 2019, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.6381108\", 2016.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.6239164\", 1987.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5894519\", 2004.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5838858\", 2003.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5819445\", 2002.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5813252\", 2002.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5798285\", 2001.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5778403\", 2000.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5762242\", 1999.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5653175\", 1994.0, 1995, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5636461\", 1994.0, 1995, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5634704\", 1993.0, 1993, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5602201\", 1992.0, 1994, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5537052\", 2015.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5145795\", 2003.0, 2008, \"Cancer Research UK\", \"United Kingdom\"], [\"grant.5018695\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5017925\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5009211\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5006128\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5005113\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5004063\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5001338\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4998819\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4998575\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4995025\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4986606\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4984532\", 2011.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4981684\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4973116\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4962484\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4961959\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4961830\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4958898\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4956057\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4952485\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4951856\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4940647\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938462\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4934796\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4933015\", 2007.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4932126\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4930753\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4928248\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4927844\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4927113\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4926392\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4926144\", 2007.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4924377\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4912662\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4912066\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4903278\", 2009.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4893254\", 2014.0, 2015, \"United States Department of the Army\", \"United States\"], [\"grant.4638867\", 2011.0, 2014, \"The Research Council of Norway\", \"Norway\"], [\"grant.4579336\", 2016.0, 2018, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4579119\", 2014.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4550783\", 2002.0, 2005, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4515357\", 1996.0, 2002, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4488747\", 2009.0, 2014, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4487266\", 2011.0, 2013, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4485815\", 2010.0, 2012, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4481761\", 2013.0, 2015, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4446596\", 1985.0, 1986, \"United States Department of the Army\", \"United States\"], [\"grant.4369312\", 2012.0, 2013, \"United States Department of the Army\", \"United States\"], [\"grant.4119613\", 2005.0, 2007, \"Michael Smith Foundation for Health Research\", \"Canada\"], [\"grant.4035533\", 2013.0, 2014, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.3846713\", 2013.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3840565\", 2010.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3833138\", 2010.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3830372\", 2010.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3823937\", 2011.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3815912\", 2011.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3813523\", 2007.0, 2008, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3811209\", 2006.0, 2011, \"Agricultural Research Service\", \"United States\"], [\"grant.3806816\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3783912\", 2010.0, 2012, \"European Commission\", \"Belgium\"], [\"grant.3747160\", 2000.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3743602\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3730420\", 1997.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3643075\", 2009.0, 2011, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3643010\", 2013.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3640055\", 2010.0, 2013, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3639922\", 2011.0, 2014, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3639862\", 2012.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3635735\", 2012.0, 2015, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3630957\", 2008.0, 2012, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3629169\", 2003.0, 2006, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3627644\", 2007.0, 2010, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2815876\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2782054\", 2007.0, 2008, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2775543\", 2009.0, 2014, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2753642\", 2010.0, 2012, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2711569\", 1997.0, 1999, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711541\", 2000.0, 2002, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711209\", 1992.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709727\", 1992.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2708830\", 1995.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704647\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2695923\", 2010.0, 2015, \"National Center for Complementary and Integrative Health\", \"United States\"], [\"grant.2695778\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688081\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687721\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687202\", 1989.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666811\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657817\", 1999.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657569\", 1989.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2654335\", 1998.0, 1999, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2646969\", 1990.0, 1990, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2643965\", 1999.0, 2000, \"National Cancer Institute\", \"United States\"], [\"grant.2641521\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641308\", 2005.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641156\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641134\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640884\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640647\", 2000.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640492\", 1998.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640479\", 1998.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640473\", 1998.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640225\", 1995.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640198\", 1994.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639892\", 1989.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639810\", 1988.0, 1988, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636506\", 2012.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636420\", 2004.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2601233\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597386\", 1997.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2577671\", 1998.0, 1999, \"National Institute of Mental Health\", \"United States\"], [\"grant.2568118\", 1991.0, 1993, \"National Cancer Institute\", \"United States\"], [\"grant.2567052\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2480171\", 2009.0, 2014, \"National Cancer Institute\", \"United States\"], [\"grant.2467344\", 1984.0, 1988, \"National Cancer Institute\", \"United States\"], [\"grant.2456685\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456117\", 2003.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2451240\", 1989.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424927\", 1988.0, 1992, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2370445\", 2005.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8586139\", 2019.0, 2019, \"European Commission\", \"Belgium\"], [\"grant.8550870\", 2017.0, 2018, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.8550869\", 2017.0, 2018, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.8458639\", 2015.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8458394\", 2017.0, 2019, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8334271\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8185917\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8178837\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7664581\", 2014.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7647386\", 2012.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7642410\", 2008.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7640114\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7636485\", 2005.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7623307\", 2007.0, 2007, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7620846\", 2017.0, 2018, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7138827\", 1997.0, 1998, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7099836\", 2015.0, 2018, \"Swedish Research Council\", \"Sweden\"], [\"grant.7050174\", 2016.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.7040500\", 1999.0, 2003, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6996265\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6805630\", 2014.0, 2018, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.6382115\", 2014.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6224508\", 1985.0, 1987, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6004587\", 2008.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5910597\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5802355\", 2001.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5800369\", 2001.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5796849\", 2001.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5754852\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5750850\", 1999.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5716915\", 2009.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5637120\", 1994.0, 1994, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5503915\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5349803\", 2011.0, 2011, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5054576\", 2016.0, 2017, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.4942762\", 2016.0, 2018, \"The Research Council of Norway\", \"Norway\"], [\"grant.4895796\", 2014.0, 2016, \"Russian Science Foundation\", \"Russia\"], [\"grant.4694512\", 2008.0, 2010, \"Juvenile Diabetes Research Foundation\", \"United States\"], [\"grant.4679006\", 2005.0, 2009, \"The Research Council of Norway\", \"Norway\"], [\"grant.4660408\", 2007.0, 2012, \"The Research Council of Norway\", \"Norway\"], [\"grant.4659393\", 2012.0, 2017, \"The Research Council of Norway\", \"Norway\"], [\"grant.4646343\", 2006.0, 2010, \"The Research Council of Norway\", \"Norway\"], [\"grant.4645097\", 2006.0, 2007, \"The Research Council of Norway\", \"Norway\"], [\"grant.4642173\", 2007.0, 2011, \"The Research Council of Norway\", \"Norway\"], [\"grant.4534271\", 2007.0, 2009, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4475728\", 2012.0, 2015, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4472767\", 2012.0, 2014, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4274070\", 2015.0, 2015, \"European Commission\", \"Belgium\"], [\"grant.4057204\", 2015.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.3953270\", 2014.0, 2015, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3945629\", 2013.0, 2015, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3939603\", 2015.0, 2019, \"European Commission\", \"Belgium\"], [\"grant.3847452\", 2013.0, 2015, \"Innovate UK\", \"United Kingdom\"], [\"grant.3847218\", 2013.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3839140\", 2012.0, 2015, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3836265\", 2010.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3816560\", 2009.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3800484\", 2013.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.3800251\", 2013.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.3798782\", 2013.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.3796896\", 2013.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.3795062\", 2013.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.3778054\", 2007.0, 2010, \"European Commission\", \"Belgium\"], [\"grant.3776776\", 2006.0, 2008, \"European Commission\", \"Belgium\"], [\"grant.3776766\", 2009.0, 2012, \"European Commission\", \"Belgium\"], [\"grant.3775456\", 2009.0, 2011, \"European Commission\", \"Belgium\"], [\"grant.3769804\", 2005.0, 2007, \"European Commission\", \"Belgium\"], [\"grant.3749469\", 1998.0, 1999, \"European Commission\", \"Belgium\"], [\"grant.3736252\", 1998.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3721586\", 1996.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3135164\", 2011.0, 2013, \"Directorate for Engineering\", \"United States\"], [\"grant.2766098\", 2007.0, 2008, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2765030\", 2009.0, 2011, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2726426\", 2011.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2711566\", 1997.0, 1998, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711200\", 1991.0, 1991, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2704629\", 2004.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704602\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2692264\", 2011.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2689373\", 2006.0, 2009, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2688035\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687963\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687948\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687707\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687655\", 2003.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687645\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2658044\", 2006.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657851\", 2000.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657802\", 1998.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657756\", 1997.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2650996\", 2012.0, 2014, \"National Institute of General Medical Sciences\", \"United States\"], [\"grant.2645340\", 2008.0, 2010, \"National Cancer Institute\", \"United States\"], [\"grant.2644024\", 1999.0, 2001, \"National Cancer Institute\", \"United States\"], [\"grant.2641283\", 2005.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641280\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640997\", 2003.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640928\", 2002.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640815\", 2001.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640772\", 2001.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640696\", 2001.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640674\", 2001.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640635\", 2001.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640537\", 1998.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636444\", 2006.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2632162\", 2009.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2631500\", 2007.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2604709\", 2009.0, 2011, \"National Cancer Institute\", \"United States\"], [\"grant.2601355\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2600357\", 2011.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599306\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598906\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598853\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598797\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598470\", 2005.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598285\", 2003.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598003\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597976\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597911\", 2002.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597795\", 2001.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597419\", 1997.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597353\", 2001.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2585998\", 2013.0, 2018, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2581500\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2581365\", 1999.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566930\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2471015\", 1992.0, 1996, \"National Cancer Institute\", \"United States\"], [\"grant.2459743\", 2012.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459536\", 2012.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458866\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457499\", 2006.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456659\", 2004.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456070\", 2003.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453081\", 1994.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435196\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2434960\", 1994.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424625\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424575\", 1993.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2420915\", 2000.0, 2005, \"National Cancer Institute\", \"United States\"], [\"grant.2410235\", 2009.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.100071932\", 2016.0, 2018, \"V Foundation for Cancer Research\", \"United States\"], [\"grant.8594124\", 2012.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8591790\", 2015.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8550889\", 2017.0, 2018, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.8550496\", 2017.0, 2018, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.8472155\", 2017.0, 2018, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.8456826\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8456825\", 2018.0, 2019, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8456820\", 2017.0, 2018, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8219774\", 2000.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8215413\", 1996.0, 1998, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173004\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8171715\", 2004.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8171555\", 2004.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170908\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170796\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170794\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170663\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170645\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170640\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170373\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169342\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169087\", 2002.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169047\", 2002.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8168649\", 2002.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8168333\", 2002.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8167459\", 2001.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8167453\", 2001.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8108168\", 1997.0, 1999, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8107600\", 2001.0, 2006, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8106422\", 2012.0, 2014, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7923972\", 2019.0, 2019, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.7878131\", 2014.0, 2018, \"National Health and Medical Research Council\", \"Australia\"]], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"<b>%{hovertext}</b><br><br>End Year=%{customdata[2]}<br>patents=%{y}<br>Grant ID=%{customdata[0]}<br>Start Year=%{customdata[1]}<br>Funder=%{customdata[3]}<br>Funder Country=%{customdata[4]}<br>Funding Amount in USD=%{marker.color}\", \"hovertext\": [\"\\u75ab\\u82d7\\uff0d\\u6574\\u4f53\\u65b9\\u6848\", \"Engineering Inhalable Vaccines\", \"Engineering Inhalable Vaccines\", \"HIV Vaccine research\", \"HIV Vaccine Development\", \"Dengue virus vaccine.\", \"Engineering Inhalable Vaccines\", \"Schistosomiasis Vaccine Network.\", \"Pneumococcal Ribosomal Vaccines\", \"Rational vaccine design\", \"Rational vaccine design\", \"Aquaticulture vaccines\", \"Aquaticulture vaccines\", \"Vaccines for aquaculture\", \"Cancer Vaccine Development\", \"CRYPTOSPORIDIUM RECOMBINANT VACCINES\", \"ANTIRETROVIAL DNA VACCINE\", \"VACCINE FOR LEISHMANIASIS\", \"CANCER VACCINE PRODUCTION\", \"CANCER VACCINE PRODUCTION\", \"CANCER VACCINE PRODUCTION\", \"CANCER VACCINE PRODUCTION\", \"CANCER VACCINE PRODUCTION\", \"CANCER VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"VACCINES FOR SAIDS\", \"Entwicklung viraler Vektorvakzinen/Markervakzinen\", \"Herpes Vaccine project\", \"VACCINE DELIVERY SYSTEM FOR LIVE ROTAVIRUS VACCINES\", \"IMMUNOLOGICAL STUDIES IN VACCINES OF RABIES VACCINE\", \"Vaccine adjuvant commercialisation project\", \"Shelf life of vaccines\", \"Duck viral Hepatitis vaccine\", \"Novel vaccines against AIDS\", \"Synthetic peptides as vaccines\", \"Klebsiella Vaccines and Immunotherapeutics\", \"Malaria and Vaccine Research\", \"Vaccines for complex organisms\", \"DENGUE VACCINE DEVELOPMENT\", \"Novel Vaccines for Measles\", \"Streptococcal mastitis vaccine development\", \"Bovine adenovirus vectored vaccines\", \"Vaccine formulation and delivery\", \"Streptococcal mastitis vaccine development\", \"Vaccins th\\u00e9rapeutiques anti-cancer\", \"Subunit vaccines for aquaculture\", \"Pan-PRovincial Vaccine ENTerprise\", \"Vaccine formulation and delivery\", \"Vaccines for farm fish\", \"Vaccins th\\u00e9rapeutiques anti-cancer\", \"Vaccins th\\u00e9rapeutiques anti-cancer\", \"Vaccines for farm fish\", \"Improving cancer vaccine efficacy\", \"NEW VACCINE SURVEILLANCE NETWORK\", \"MACROPHAGE-BASED MELANOMA VACCINE\", \"HELICOBACTER PYLORI MUCOSAL VACCINE\", \"MALARIA VACCINE ADJUVANT DEVELOPMENT\", \"HIV GP120 GLYCOCONJUGATE VACCINES\", \"SIMIAN VACCINE EVALUATION UNITS\", \"TESTING VACCINES IN CHILDREN\", \"HLA AND VACCINES (BAA)\", \"AIDS VACCINE EVALUATION UNITS\", \"AIDS VACCINE EVALUATION UNITS\", \"AIDS VACCINE EVALUATION UNITS\", \"AIDS VACCINE EVALUATION UNITS\", \"AIDS VACCINE EVALUATION UNITS\", \"AIDS VACCINE EVALUATION UNITS\", \"EVALUATION OF CANDIDATE VACCINES\", \"AIDS VACCINE EVALUATION UNITS\", \"IMMUNIZATION & VACCINES FOR CHILDREN\", \"Hepatatis B Vaccine Pilot\", \"Verbundprojekt: Verfahren zur Impfstoffentwicklung: Rekombinante Impfstoffe Impfstoffe gegen virale Erkrankungen von Salmoniden\", \"\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7684\\u673a\\u7406\", \"\\u574f\\u6b7b\\u6746\\u83cc\\u91cd\\u7ec4\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u7814\\u7a76\", \"2009\\u4e9a\\u6d32DNA\\u75ab\\u82d7\\u56fd\\u9645\\u5e74\\u4f1a\", \"2004\\u5e74DNA\\u75ab\\u82d7\\u56fd\\u9645\\u4f1a\\u8bae\", \"\\u7b2c\\u4e09\\u5c4a\\u75ab\\u82d7\\u7814\\u7a76\\u5e74\\u4f1a\", \"BioChancePLUS: Therapeutische Vakzinierung gegen Multiple Sklerose\", \"Improved Vaccines for Breast Cancer Immunotherapy\", \"Sterilization Vaccine for Cattle\", \"Vaccine Production in Plants\", \"Novel vaccine formulations against tuberculosis\", \"Development of recombinant TB vaccine\", \"Hepatitis C: Vaccines and Immunotherapy\", \"DNA vaccine for chlamydia\", \"nd\", \"New Generation Recombinant Viral Vaccine Vectors\", \"The automated synthesis of tuberculosis vaccines\", \"\\uc2e0\\ubcc0\\uc885 \\uc778\\ud50c\\ub8e8\\uc5d4\\uc790 \\ubc14\\uc774\\ub7ec\\uc2a4 \\uc81c\\uc5b4 \\uc5f0\\uad6c\", \"Mucosal Vaccine against HIV-1 Infection\", \"Oral DNA Vaccines\", \"Microcontainers for oral vaccine delivery\", \"Microcontainers for oral vaccine delivery\", \"EC collaborative study for tetanus vaccines\", \"Antigenic properties of vaccine virus strains\", \"Alternative methods of formulating FMDV vaccines\", \"To maintain the footandmouth vaccine bank\", \"Vaccins et adjuvants pour la vache laiti\\u00e8re\", \"Prototype vaccine against sea lice\", \"Thermal Stabilization of Phage and Vaccines\", \"A DNA Vaccine to Prevent Schistosomiasis\", \"Immune response to malaria vaccine candidate\", \"Development of a contraceptive vaccine\", \"Challenging the malaria vaccine development strategy\", \"Diabetes Vaccine Development Centre (DVDC)\", \"Vivax malaria sporozoite vaccine development\", \"New vaccines produced by genetic engineering\", \"A Mucosal HIV Polytype Vaccine\", \"HIV (AIDS) vaccine delivery vectors\", \"A vaccine for cervical cancer\", \"Development of an oral pneumococcal vaccine.\", \"Development of new types of vaccines.\", \"DNA and avipox vaccines for HIV.\", \"Characterisation of Neisseria meningitidis vaccine candidates\", \"Towards a vaccine against hepatitis e\", \"A modern vaccine against leptospirosis\", \"Development of an improved pneumococcal vaccine\", \"Additional vaccine antigens for chlamydia\", \"To support the Vaccine Leadership Conference\", \"\\u98a8\\u8a3a\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u98a8\\u75b9\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u6d41\\u884c\\u6027\\u8033\\u4e0b\\u817a\\u708e\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u5408\\u6210\\u30de\\u30e9\\u30ea\\u30a2\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u7814\\u7a76\", \"Biochemical characterization of a vaccine\", \"\\u5358\\u7d14\\u30d8\\u30eb\\u30da\\u30b9\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u7814\\u7a76\", \"\\u30d1\\u30e9\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u65b0\\u898f\\u816b\\u760d\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4f5c\\u88fd\", \"Anti-Vaccine Blog Annotation Project\", \"Vaccine-based immunotherapy of cancer\", \"HIV VACCINE PRODUCTION\", \"Therapeutics/Vaccine Teams\", \"Tularemia Vaccine Development\", \"\\u5e7d\\u95e8\\u87ba\\u6746\\u83cc\\u78f7\\u9178\\u9499\\u7eb3\\u7c73\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"Anti-tick Vaccines\", \"SEVAPLANT - Secure Vaccine Production in Plants\", \"Development of Novel Vaccines through Glycoengineering\", \"Mucosal vaccines against autoimmune disease\", \"DEVELOPMENT OF MALARIA VACCINE\", \"VACCINES AGAINST TROPICAL THEILERIOSIS\", \"Creation of an anti-diarrhea vaccine\", \"Fish Biologics Symposium: Serodiagnostics and Vaccines\", \"Oral delievery of vaccines to salmonids\", \"Tumor associated carbohydrates and vaccine design\", \"Vaccines for bovine respiratory disease\", \"Vaccines for bovine respiratory disease\", \"D\\u00e9veloppement_d'un vaccin contre Streptococcus suis\", \"Development of subunit Streptococcus suis vaccines\", \"Development of subunit Streptococcus suis vaccines\", \"D\\u00e9veloppement_dun vaccin contre Streptococcus suis\", \"Carbohydrate-based anti cancer vaccines\", \"Vaccines comprising heat-sensitive transgenes\", \"A vaccine to inhibit tick feeding\", \"Porcine cicovirus pathogenesis and vaccine development\", \"DNA vaccine for avian influenza\", \"Oral delivery of vaccines and immunomodulators\", \"Bioinformatics and intelligent vaccine design\", \"Tumor Associated Carbohydrates and Vaccine design\", \"Developing plant based vaccines from forages\", \"Bovine adenovirus-3 vectored vaccines\", \"Possible peptide vaccine candidtates for leishmania\", \"Recombinant vaccine development for tenacibaculum maritimum\", \"Oral delievery of vaccines to salmonids\", \"Annual Conference on Vaccine Research\", \"Varicella and Viral Vaccine Preventable Disease\", \"Alphavirus Replicon Vaccines to Encephalitis Viruses\", \"MALARIA VACCINE RESEARCH AND DEVELOPMENT PROJECT\", \"STRATEGIES FOR HIV VACCINE DEVELOPMENT\", \"LIPOSOME MICROENCAPSULATION OF VACCINE ANTIGENS\", \"MULTIVALENT VACCINE FOR LYMPHATIC FILARIASIS\", \"An Envelope Containing HIV Pseudovirion Vaccine\", \"MICROBIAL POPULATION STRATEGY FOR VACCINE DEVELOPMENT\", \"THERAPEUTIC TUMOR VACCINE AGAINST MUC-1\", \"SYNTHESIS OF RNA CANCER VACCINES\", \"DEVELOPMENT OF SYNTHETIC CANCER VACCINES\", \"NOVEL VACCINE FOR HELICOBACTER PYLORI\", \"HIV-1 VACCINE FOR DEVELOPING COUNTRIES\", \"DEVELOPMENT OF CAMPYLOBACTER FLAGELLIN SUBUNIT VACCINE\", \"DEVELOPMENT OF A NOVEL VACCINE STRATEGY\", \"SUSTAINED RELEASE FOR VACCINES AND ADJUVANTS\", \"BIODEGRADABLE MINERAL MICROSPHERE ADJUVANTS FOR VACCINES\", \"SYNTHETIC VACCINES UTILIZING BACULOVIRUS POLYHEDRA\", \"DEVELOPMENT OF ROTAVIRUS DNA VACCINES\", \"BIVALENT CONJUGATED RSV PNEUMOCOCCUS VACCINE\", \"AVIRULENT SALMONELLA HOST-VECTOR VACCINE SYSTEMS\", \"SALMONELLA/HUMAN IMMUNODEFICIENCY VIRUS VACCINE VECTOR\", \"A VACCINE FOR IMMUNE MEDIATED DIABETES\", \"CHIMERIC HER-2 PEPTIDE VACCINE\", \"CYTOMEGALOVIRUS VECTORS FOR HIV VACCINE DEVELOPMENT\", \"A RECOMBINANT PORPHYROMONAS GINGIVALIS VACCINE\", \"INDO-US VACCINE ACTION PROGRAM\", \"INDO-US VACCINE ACTION PROGRAM\", \"INDO-US VACCINE ACTION PROGRAM\", \"INDO-US VACCINE ACTION PROGRAM\", \"INDO-US VACCINE ACTION PROGRAM\", \"CHILDHOOD VACCINES AND DENTAL CARIES IMMUNITY\", \"ENHANCING TUMOR VACCINE IMMUNOGENICITY BY ANTIGAL\", \"IMMUNOLOGICAL EFFECTS OF MELANOMA VACCINE THERAPY\", \"BREAST TUMOR SPECIFIC IMMUNITY--VACCINE DESIGN\", \"ANTITUMOR ARTIFICIAL RECEPTORS AS CANCER VACCINES\", \"IMMUNOLOGICALLY FOCUSED APPROACH TO AIDS VACCINE\", \"VACCINE INTERVENTION FOR LYME BORRELIOSIS\", \"SECOND-GENERATION VACCINES AGAINST LYME DISEASE\", \"MICROSPHERES TO ENHANCE VACCINE IMMUNOGENICITY\", \"RATIONALE FOR SPOROZOITE MALARIA VACCINE DEVELOPMENT\", \"NONLIVING VACCINE AGAINST S MANSONI\", \"MONOCLONAL ANTIBODY ANTI-IDIOTYPE TUMOR VACCINES\", \"ADENOVIRUS RECOMBINANTS FOR VACCINE EFFICACY\", \"DEVELOP LIVE ATTENUATED CYTOMEGALOVIRUS VACCINES\", \"INVESTIGATION OF ANTICARIES VACCINE IN PRIMATES\", \"MODELS FOR AIDS VACCINE RESEARCH\", \"MODELS FOR AIDS VACCINE RESEARCH\", \"OPERATE EXPERIMENTAL VIRUS VACCINE LABORATORY\", \"MFG OF YEAST-PRODUCED MALARIA VACCINES\", \"INFECTIOUS AGENTS, VACCINES &ANTIMICROBIALS IN HUMANS\", \"EXPERIMENTAL VIRUS VACCINE PRODUCTION LABORATORY\", \"EFFICACY TRIAL OF COLD-ADAPTED VACCINES\", \"TESTING VACCINES IN ADOLESCENTS AND ADULTS\", \"HIV VACCINE TRIALS AND EPIDEMIOLOGY REPOSITORY\", \"DEVELOP A VACCINE FOR GONORRHEA\", \"DEVELOP AN ACELLULAR BORDETELLA PERTUSSIS VACCINE\", \"INVESTIGATIONAL NEW DRUGS AND VACCINES\", \"ADVERSE REACTIONS OF CHILDHOOD VACCINES\", \"MALARIA VACCINE PRODUCTION &SUPPORT SERVICES\", \"CLINICAL EVALUATION OF LIVE HERPESVIRUS VACCINE\", \"ACELLULAR VACCINES AGAINST BACTERIAL PATHOGENS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"MISSISSIPPI IMMUNIZATION AND VACCINE GRANT\", \"Immunization and Vaccines for Children Program\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANT\", \"IMMUNIZATION AND VACCINES FOR CHILDREN PROGRAM\", \"IMMUNIZATIONS AND VACCINE FOR CHILDREN\", \"IMMUNIZATIONS AND VACCINES FOR CHILDREN GRANTS\", \"Immunization and Vaccines for Children Program\", \"MINNESOTA STATEWIDE IMMUNIZATION & VACCINES PROGRAM\", \"ARIZONA IMMUNIZATION AND VACCINE FOR CHILDREN\", \"IMMUNIZATION AND VACCINES FOR CHILDREN\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANT\", \"NEW JERSEY VACCINE PREVENTABLE DISEASE PROGRAM\", \"NEVADA IMMUNIZATION AND VACCINES FOR CHILDREN\", \"IMMUNIZATIONS AND VACCINES FOR CHILDREN\", \"IMMUNIZATION AND VACCINES FOR CHILDREN PROGRAM\", \"EVALUATION OF GENETICALLY ENGINEERED ROTAVIRUS VACCINES\", \"GROUP B STREPTOCOCCAL OLIGOSACCHARIDE-CONJUGATE VACCINE\", \"NOVEL APPROACH TOWARD RETROVIRAL VACCINE DESIGN\", \"Develop low-cost prophylactic vaccines against HCV, and therapeutic vaccines against HBV\", \"Development of diagnostic tools and vaccines\", \"Potenzierung von Impfstoffen durch gezieltes Design der Glykosylierung - IPoGly (Impfstoffpotenzierung durch Glykosylierung)\", \"EDCTP: Malaria Vakzine, vorbereitende Arbeiten zur Entwicklung zweier Malaria Impfstoffe\", \"Verbundprojekt: Innovative bakterielle Tumorimpfstoffe - Teilprojekt 1: Bakterielles Prostatakrebsvakzin\", \"Development of Porphyric Intracellular Leishmania Parasite for the Effect vaccine and Vaccine Delivery System\", \"DNA \\ubc31\\uc2e0 \\ubc0f \\ubc31\\uc2e0\\ubcf4\\uc870\\uc81c \\uc804\\ub2ec\\uc744 \\uc704\\ud55c \\ud6a8\\uc728\\uc801\\uc774\\uace0 \\uc2a4\\ub9c8\\ud2b8\\ud55c \\ub9c8\\uc774\\ud06c\\ub2c8\\ub4e4\\uc2dc\\uc2a4\\ud15c \\uac1c\\ubc1c\", \"\\uc778\\uc720\\ub450\\uc885\\ubc14\\uc774\\ub7ec\\uc2a4 \\ubc31\\uc2e0 \\uc81c\\ud488\\ud654 \\ubc0f \\ucc28\\uc138\\ub300 \\uc778\\uc720\\ub450\\uc885\\ubc14\\uc774\\ub7ec\\uc2a4 \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc778\\uc720\\ub450\\uc885\\ubc14\\uc774\\ub7ec\\uc2a4 4\\uac00 \\ubc31\\uc2e0\\uc758 \\uc81c\\ud488\\ud654 \\ubc0f \\uc778\\uc720\\ub450\\uc885\\ubc14\\uc774\\ub7ec\\uc2a4 10\\uac00 \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc800\\uc628\\uc801\\uc751 \\uc57d\\ub3c5 \\uc0dd\\ubc31\\uc2e0\\ud615 \\ub9cc\\ub2a5\\ub3c5\\uac10\\ubc31\\uc2e0 \\uac1c\\ubc1c \\uc5f0\\uad6c\", \"Vaccine Biotechnology: Genetically Engineered Chimeric Protein Vaccine Against Foot-and-Mouth Disease\", \"Therapeutic cancer vaccine for test in human\", \"The Vaccine Project\", \"Ing\\u00e9nierie d'un plateforme vaccinale et d\\u00e9veloppement d'un vaccin v\\u00e9t\\u00e9rinaire contre la gripp\", \"Hepatitis C vaccine preparedness: feasibility of field-based vaccine trials\", \"A MUCOSAL PROPHYLACTIC VACCINE AGAINST COCCIDIOIDOMYCOSIS\", \"\\u9b5a\\u985e\\u5bc4\\u751f\\u866b\\u306b\\u5bfe\\u3059\\u308b\\u907a\\u4f1d\\u5b50\\u7d44\\u63db\\u3048\\u30ef\\u30af\\u30c1\\u30f3\\u304a\\u3088\\u3073DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u9b5a\\u985e\\u30a6\\u30a4\\u30eb\\u30b9\\u3092\\u7528\\u3044\\u305fDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u4ee3\\u308f\\u308b\\u65b0\\u305f\\u306aRNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u7d44\\u307f\\u63db\\u3048BCG\\u30ef\\u30af\\u30c1\\u30f3\\u30b7\\u30b9\\u30c6\\u30e0\\u3092\\u7528\\u3044\\u305f\\u3001\\u3046\\u8755\\u4e88\\u9632\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u65b0\\u898f\\u7c98\\u819c\\u30ef\\u30af\\u30c1\\u30f3\\u30ad\\u30e3\\u30ea\\u30a2\\u30fc\\u306e\\u958b\\u767a\\u304a\\u3088\\u3073\\u30a8\\u30a4\\u30ba\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"HIV Vaccine Design and Dev. Teams Part A - Preventative Vaccines\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS PART A - PREVENTATIVE VACCINES\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS, PART B-THERAPEUTIC VACCINES\", \"HIV VACCINES DESIGN &DEVELOPMENT TEAMS-PART B-THERAPEUTIC VACCINE\", \"HIV Vaccines Design and Dev. Teams Part A - Preventative Vaccine\", \"HIV VACCINES DESIGN AND DEVELOPMENT TEAMS PART A - PREVENTATIVE VACCINE\", \"HIV Vaccine Design and Development, Part A-Preventative Vaccines\", \"Priprava tumorskih vakcin: hibridomi in gensko spremenjene vakcine (basic research project)\", \"Economics of Vaccines and Immunization Policies, Programs, and Practices for Adults: Prioritysetting for adult vaccines\", \"Nanoparticle delivery systems for cancer vaccines - applications to a MUC1 lipopeptide cancer vaccine\", \"Millenium Vaccine Initiative-Novel Vaccines for TB and Malaria-26625480\", \"\\u73fe\\u884c\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u304b\\u308f\\u308b\\u526f\\u4f5c\\u7528\\u306e\\u306a\\u3044\\u7834\\u50b7\\u98a8\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4f5c\\u6210\\u6cd5\\u3068, \\u305d\\u306e\\u4e8c\\u7a2e(\\u30b8\\u30d5\\u30c6\\u30ea\\u30a2\\u30fb\\u7834\\u50b7\\u98a8)\\u6df7\\u5408\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"Evaluatie van afgiftesystemen voor mRNA kanker vaccins\", \"Naar een universeel op mRNA-gebaseerd therapeutisch vaccin tegen HIV\", \"Ontwikkeling van een generische microparticulaire vaccin formulatie\", \"Ontwikkeling van een vaccin tegen Ascaris suum bij het varken.\", \"\\u611f\\u67d3\\u514d\\u75ab\\u3001\\u75ab\\u82d7\\u4e0e\\u6cbb\\u7597\\u6027\\u6297\\u4f53\\u53cc\\u8fb9\\u7814\\u8ba8\\u4f1a\", \"\\u7528\\u8f6c\\u57fa\\u56e0\\u690d\\u7269\\u751f\\u4ea7\\u53e3\\u670d\\u75ab\\u82d7\", \"\\u626b\\u63cf\\u63a2\\u9488\\u663e\\u5fae\\u5b66\\u7814\\u5236\\u7ec6\\u80de\\u514d\\u75ab\\u75ab\\u82d7\", \"\\u75ab\\u82d7\\u9632\\u6cbb\\u4eba\\u7c7b\\u4e73\\u5934\\u7624\\u75c5\\u6bd2\\u611f\\u67d3\\u53ca\\u5bab\\u9888\\u764c\\u7684\\u7814\\u7a76\", \"\\u4eba\\u514d\\u75ab\\u7f3a\\u9677\\u75c5\\u6bd2\\u591a\\u80bd\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u809d\\u7247\\u5438\\u866bDNA\\u75ab\\u82d7\\u7814\\u7a76\", \"\\u65b0\\u578b\\u809d\\u708e\\u75c5\\u6bd2\\u57fa\\u56e0\\u514b\\u9686\\u4e0eDNA\\u75ab\\u82d7\\u7814\\u7a76\", \"BCG\\u591a\\u4ef7\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u8111\\u5305\\u866b\\u7ec6\\u80de\\u7cfb\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u4e59\\u578b\\u8111\\u708e\\u6d3b\\u75ab\\u82d7\\u6bd2\\u682a\\u7684\\u57fa\\u56e0\\u5206\\u6790\", \"\\u732a\\u4f2a\\u72c2\\u72ac\\u75c5\\u75c5\\u6bd2\\u91cd\\u7ec4\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u827e\\u6ecb\\u75c5\\u75ab\\u82d7\\u65b0\\u578b\\u7b56\\u7565\\u4e0e\\u76f8\\u5173\\u514d\\u75ab\\u5b66\\u7814\\u7a76\", \"\\u759f\\u75be\\u75ab\\u82d7\\u53ca\\u5176\\u76f8\\u5173\\u57fa\\u7840\\u514d\\u75ab\\u5b66\\u7684\\u7814\\u7a76\", \"\\u9f3b\\u54bd\\u764c\\u591a\\u80bd\\u75ab\\u82d7\\u7814\\u7a76\\u53ca\\u4e34\\u5e8a\\u7597\\u6548\\u8bc4\\u4ef7\", \"\\u65b0\\u7684\\u759f\\u75be\\u75ab\\u82d7\\u9776\\u70b9\\u57fa\\u56e0\\u7684\\u529f\\u80fd\\u7814\\u7a76\", \"\\u4e19\\u578b\\u809d\\u708e\\u75c5\\u6bd2\\u6837\\u9897\\u7c92\\u75ab\\u82d7\\u7684\\u57fa\\u7840\\u7814\\u7a76\", \"Entwicklung optimaler Herstellungsprozesse artifizieller Malariavakzine\", \"Potenzierung von Impfstoffen durch gezieltes Design der Glykosylierung\", \"Kreuzprotektive und thermostabile Humane Papillomavirus Vakzine - T-panHPVvac\", \"Therapeutischer Impfstoff zur Behandlung von Zervixdysplasien\", \"ForMaT: Diagnostika- und Impfstoffentwicklung f\\u00fcr vernachl\\u00e4ssigte Infektionskrankheiten\", \"EXIST-Forschungstranfer: Entwicklung eines Impfstoffes gegen Malaria.\", \"Individualisierte Tumorimpfstoffe mittels eines viralen Vektors\", \"GO-Bio 5: VEROVACCINES - Tierimpfstoffe auf Hefebasis\", \"BioPharma: Allianz f\\u00fcr Antiinfektiva, Chemotherapeutika und Impfstoffe\", \"EDCTP: Malaria-Impfstoff-Entwicklung: zwei EDCTP Projekte\", \"Identification Of Novel Targets For Effective Drugs/Vaccines Against\", \"MUC1 as a Potential Breast Cancer Vaccine\", \"Centre for Nano-vaccines (sagsnr.: 09-067052)\", \"Oncolytic virus vaccine to cure different kinds of cancer\", \"Screening for immunogenic antigens for Zika virus vaccine\", \"Oncolytic virus vaccine to cure different kinds of cancer\", \"Oncolytic virus vaccine to cure different kinds of cancer\", \"Single-walled carbon nanotubes as delivery vehicle of vaccines\", \"Bioprocess Sciences and Technology of Viral Vaccines\", \"Antigen Discovery for Human Helminth Vaccines Using Immunomics\", \"Vaccines That Induce Broadly Protective Antibodies Against Influenza\", \"Quillaja Saponin Adjuvants in Carbohydrate Cancer Vaccines\", \"Indo-U.S. Asthma Research Collaborative Group: Asthma Vaccine\", \"Quillaja Saponin Adjuvants in Carbohydrate Cancer Vaccines\", \"Development of a Recombinant DNA Vaccine Against Blackleg\", \"Toward Enhanced Pulmonary Delivery of Vaccines\", \"Developing a prototype MMR vaccine\", \"Lactococcus lactis live vaccines against leishmaniasis\", \"Strategic training program in vaccine development and delivery\", \"Needle-free Vaccines for Respiratory Viruses\", \"Development of proteosome-based vaccines for protozoan pathogens\", \"Mechanisms of dendritic cell-based cancer vaccines\", \"CIHR Team in Structure-Based Vaccine Design\", \"Transferring binding regions as vaccine agents\", \"Structural studies on antiidiotypic antibody vaccines\", \"Vaccine antigens for C. pneumoniae atherosclerosis\", \"Development of a Vaccine Against Canine Leishmaniasis\", \"Novel Dendritic Cell-based Vaccine of Cancer\", \"Human alloimmune responses and HIV-1 vaccine development\", \"Transdermal delivery systems for protein medicines and vaccines\", \"Towards a Type 1 Diabetes Vaccine\", \"Cancer Vaccines: Targeting Cancer Genes for Immunotherapy\", \"The role of Alloimmunization in HIV vaccine design\", \"Development of a novel intranasal vaccine against measles\", \"A DNA vaccine for chlamydia trachomatis\", \"Delivery of genetic vaccines through Microporated Skin\", \"Post-genomic studies of BCG vaccines\", \"Transcutaneous vaccines: Delivery and mechanisms of immune induction\", \"Aptamer-mRNA Chimera-The Next Generation RNA vaccine\", \"nd\", \"D\\u00e9terminants des couvertures vaccinales chez les enfants \\u00e2g\\u00e9s de 1 an et 2 ans au Qu\\u00e9bec et impact \\u00e9pid\\u00e9miologique des retards vaccinaux\", \"DEVELOPMENT OF DNA VACCINES AGAINST CUTANEOUS T CELL LYMPHOMA\", \"DNA VACCINES AS INDUCERS OF IMMUNITY AGAINST  HAEMATOLOGICAL MALIGNANCIES\", \"\\ubbf8\\uc138\\ub9c9\\uc0c1 \\uad6c\\uc870\\ubb3c\\uc744 \\uc774\\uc6a9\\ud55c \\ube44\\uc138\\ud3ec \\ud56d\\uc554 \\ubc31\\uc2e0\", \"\\ucc28\\uc138\\ub300 \\uacb0\\ud575\\ubc31\\uc2e0\\uc758 \\ubc29\\uc5b4\\uba74\\uc5ed \\ubc14\\uc774\\uc624\\ub9c8\\ucee4 \\ubc1c\\uad74\", \"\\ub2e4\\uc81c\\ub0b4\\uc131 \\uacb0\\ud575\\uc744 \\ud45c\\uc801\\uc73c\\ub85c \\ud558\\ub294 \\uce58\\ub8cc\\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc5f0\\uad6c\", \"\\ub2e4\\uacf5\\uc131 \\uc2e4\\ub9ac\\uce74 \\ub098\\ub178\\uc785\\uc790\\ub97c \\uc774\\uc6a9\\ud55c \\uc554\\ubc31\\uc2e0 \\uc804\\ub2ec\\uccb4 \\uc5f0\\uad6c\", \"\\uc2a4\\ub9c8\\ud2b8 \\ubc31\\uc2e0 \\uacbd\\ud53c \\uc81c\\ud615 \\ubc0f \\ub808\\uc774\\uc800 \\uba74\\uc5ed\\ubcf4\\uc870\\uc81c \\uac1c\\ubc1c\", \"\\uac1c\\ubc1c \\ub3c4\\uc0c1\\uad6d\\uc744 \\uc704\\ud55c \\ubc31\\uc2e0 \\uac1c\\ubc1c \\uc9c0\\uc6d0 \\ud504\\ub85c\\uadf8\\ub7a8\", \"\\uc720\\uc0b0\\uade0 \\ud56d\\uc6d0\\uc6b4\\ubc18\\uccb4\\ub97c \\ub9e4\\uac1c\\ub85c \\ud558\\ub294 \\uae09\\uc5ec\\ud615\\uc5b4\\ub958\\ubc31\\uc2e0 \\uac1c\\ubc1c \\uc5f0\\uad6c\", \"\\uc0c8\\ub85c\\uc6b4 \\uacb0\\ud575 \\uc0dd\\ubc31\\uc2e0 \\ud6c4\\ubcf4 \\ubb3c\\uc9c8\\uc758 \\uac1c\\ubc1c \\ubc0f \\ubd84\\uc11d\", \"Terpene \\uc131\\ubd84\\uc744 \\uc774\\uc6a9\\ud55c \\uc9c4\\uade0\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc0c8\\ub85c\\uc6b4 \\uacb0\\ud575 \\uc0dd\\ubc31\\uc2e0 \\ud6c4\\ubcf4 \\ubb3c\\uc9c8\\uc758 \\uac1c\\ubc1c \\ubc0f \\ubd84\\uc11d\", \"\\uc2e0\\uaddc \\uacb0\\ud575\\uc608\\ubc29\\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc0ac\\uc5c5 \\uae30\\ud68d\\uc5f0\\uad6c\", \"\\uc0c8\\ub85c\\uc6b4 \\uacb0\\ud575 \\uc0dd\\ubc31\\uc2e0 \\ud6c4\\ubcf4 \\ubb3c\\uc9c8\\uc758 \\uac1c\\ubc1c \\ubc0f \\ubd84\\uc11d\", \"H. pylori infection and oral enteric vaccines\", \"A New Therapeutic Vaccine for HIV/AIDS\", \"A New Therapeutic Vaccine for HIV/AIDS\", \"Generation of HyperImmunogenic vaccines against human viral pathogens\", \"Delivery of vaccine antigens on virus like particles\", \"Less is more in TB vaccines\", \"Development of a potency test for leptospira vaccines\", \"Bovine TB vaccine programme advisor, Prof Douglas Young\", \"Improved selection methods for emergency FMD vaccines\", \"Improved selection methods for emergency FMD vaccines\", \"Protective immune responses induced by FMDV vaccine\", \"Antigenic properties of vaccine virus strains\", \"Live salmonella vaccines for the protection of poultry\", \"`The development of live, rationallyattenuated salmonella vaccines`\", \"Bioprocess Sciences and Technology of Viral Vaccines\", \"Synthesis of a Potential Lyme Disease Vaccine\", \"Oncolytic virus vaccine to cure different kinds of cancer\", \"Oncolytic virus vaccine to cure different kinds of cancer\", \"Oncolytic virus vaccine to cure different kinds of cancer\", \"Targeted microneedle insertion for epidermal vaccine delivery and biosensing\", \"FcR\\u4ecb\\u5bfc\\u7684\\u5177\\u6709\\u7279\\u5f02\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u65b0\\u578bRSV\\u7c98\\u819c\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"Development of RNA vaccine against dengue virus infection\", \"Construction of designer immunogens for use as vaccines\", \"Development of a possible vaccine for gonorrhoea\", \"Designing novel chemicals as potential influenza vaccines\", \"An improved vaccine for hepatitis B virus\", \"Schistosome proteolytic enzymes as drug and vaccine tar gets\", \"Development of a vaccine to prevent malaria transmissio n\", \"Development of AIDS vaccine using synthesized peptides.\", \"Factors affecting the immunogenicity of pertussis vaccines\", \"Search for active components for a malaria vaccine\", \"The development of a safer whooping cough vaccine\", \"Towards a vaccine against infantile diarrhoeal disease\", \"Development of a Plant-Derived Oral Vaccine for Measles\", \"Development of a nucleic acid vaccine for schistosomiasis\", \"Intestinal adapatation, Intususspection and rotavirus vaccine, applied clinical nutrition\", \"Bacterial delivery of DNA vaccines: salmonella - endosome interactions\", \"Clinical trials of RV3 oral human neonatal rotavirus vaccine\", \"CD8+ T cell immunity to viruses and recombinant vaccines\", \"How to turn malaria proteins into a vaccine\", \"A cytotoxic T cell epitope based vaccine for HIV\", \"The development of an oral whooping cough vaccine\", \"Why are live vaccines often better than killed?\", \"Relevance of bacterial surface structure to vaccine dev elopment\", \"To develop and test a DNA vaccine for HIV\", \"To develop novel vesicle-derived vaccines against Mycobacterium tuberculosis.\", \"To develop nanoemulsions and adjuvants for nasal-spray vaccines\", \"To support CMV vector-based Vaccine Concept\", \"To develop an inexpensive therapeutic vaccine for human papillomavirus\", \"To produce better and cheaper vaccines against polio\", \"To fund a vaccine discovery (antibody) consortium\", \"To conduct a pneumococcal vaccine impact assessment in Bangladesh\", \"To develop a Global HIV Vaccine Research Cryorepository (GHRC)\", \"To test a novel universal influenza vaccine\", \"To develop a genetically engineered recombinant hookworm vaccine\", \"To conduct an analysis of pediatric enteric vaccine development\", \"To develop a unique delivery system for vaccines whose major health impact is in high burden countries allowing the conversion of existing injectable vaccines into oral and/or inhalation vaccines and expedite development of novel mucosal vaccines\", \"\\u72c2\\u72ac\\u75c5\\u65e5\\u5375\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6539\\u826f\", \"\\u30dc\\u30c4\\u30ea\\u30cc\\u30b9\\u4e2d\\u6bd2\\u306e\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6539\\u5584\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76(\\u7d992\\u5e74)\", \"\\u6d41\\u884c\\u6027\\u8033\\u4e0b\\u819c\\u708e\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30dc\\u30c3\\u30ea\\u30cc\\u30b9\\u4e2d\\u6bd2\\u306e\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6539\\u5584\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u7cbe\\u88fd\\u4e09\\u7a2e\\u6df7\\u5408(D.T.P)\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u8a66\\u9a13\\u7684\\u7814\\u7a76\", \"\\u7cbe\\u88fd\\u72c2\\u72ac\\u75c5\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u54ac\\u50b7\\u5f8c\\u514d\\u75ab\\u6cd5\\u306e\\u7814\\u7a76\", \"\\u6c34\\u75d8\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u6c34\\u75d8\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u5927\\u8178\\u83ccK1\\u682a\\u306e\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u7814\\u7a76\", \"\\u7dd1\\u81bf\\u83cc\\u306e\\u6eb6\\u89e3\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"SHIV\\u3092\\u7528\\u3044\\u305fAIDS\\u5f31\\u6bd2\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u9593\\u767a\", \"\\u8178\\u7ba1\\u5bc4\\u751f\\u866b\\u306b\\u5bfe\\u3059\\u308b\\u7c98\\u819c\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"HB \\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u6b6f\\u79d1\\u533b\\u5e2b\\u306eB\\u578b\\u809d\\u708e\\u4e88\\u9632\\u5bfe\\u7b56\\u306b\\u3064\\u3044\\u3066\", \"\\u6297\\u9f72\\u8755\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u80ba\\u708e\\u7403\\u83cc\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5b9f\\u7528\\u5316\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u6297\\u539f\\u7279\\u7570\\u7684\\u6297\\u816b\\u760d\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u3068\\u305d\\u306e\\u5fdc\\u7528\", \"DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u81ea\\u5df1\\u514d\\u75ab\\u6027\\u7cd6\\u5c3f\\u75c5\\u306e\\u5bdb\\u89e3\", \"Programmed Activation\\u306b\\u57fa\\u3065\\u304f\\u4eba\\u5de5DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5275\\u88fd\", \"\\u4e73\\u5e7c\\u5150\\u306b\\u304a\\u3051\\u308b\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u5bfe\\u3059\\u308b\\u514d\\u75ab\\u539f\\u6027\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u907a\\u4f1d\\u5b50\\u7d44\\u63db\\u3048\\u306b\\u3088\\u308b\\u305b\\u3063\\u305d\\u3046\\u75c5\\u30c8\\u30ad\\u30bd\\u30a4\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"MHC\\u975e\\u62d8\\u675f\\u6027\\u5408\\u6210\\u3046\\u8755\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u7814\\u7a76\", \"\\u86cb\\u767d\\u8cea\\u5de5\\u5b66\\u3092\\u5229\\u7528\\u3057\\u305f\\u8755\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5206\\u5b50\\u8a2d\\u8a08\", \"\\u9d8f\\u30b3\\u30af\\u30b7\\u30b8\\u30a6\\u30e0\\u306e\\u30b3\\u30f3\\u30dd\\u30fc\\u30cd\\u30f3\\u30c8\\u30fb\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u5bb6\\u79bd\\u306b\\u5bfe\\u3059\\u308b\\u907a\\u4f1d\\u5b50\\u7d44\\u307f\\u63db\\u3048\\u30a6\\u30a3\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u7528\\u30d9\\u30af\\u30bf\\u30fc\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"Bioprocess Sciences and Technology of Viral Vaccines\", \"Stability of a dry whole cell malaria vaccine\", \"Excipient investigation for improving Herpes simpex II vaccine processing\", \"Targeted microneedle insertion for epidermal vaccine delivery and biosensing\", \"Novel vaccine approaches for protecting against helminth parasites\", \"Immunisation disparities and vaccine-preventable diseases in New Zealand\", \"T cell vaccines for asthma and allergic rhinitis\", \"Clinical Grade H9N2 Influenza Vaccine\", \"NIAID HIV VACCINE RESEARCH EDUCATION INITIATIVE\", \"Simian Vaccine Evaluation Units\", \"SIMIAN VACCINE EVALUATION UNIT\", \"Simian Vaccine Evaluation Unit (SVEU)\", \"SIMIAN VACCINE EVALUATION UNIT\", \"Simian Vaccine Evaluation Unit (SVEU)\", \"SIMIAN VACCINE EVALUATION UNIT\", \"Tularemia Vaccine Development Team\", \"TULAREMIA VACCINE DEVELOPMENT TEAM\", \"TULAREMIA VACCINE DEVELOPMENT TEAM\", \"HIV Vaccine Design and Development Teams\", \"Tuberculosis Research Materials and Vaccine Testing\", \"TUBERCULOSIS RESEARCH MATERIALS AND VACCINE TESTING\", \"Production and Testing of Anthrax Vaccine\", \"HIV Vaccine Design and Development Teams\", \"HIV Vaccine Design and Development Teams\", \"Vaccine and Treatment Evaluation Unit\", \"Vaccine and Treatment Evaluation Unit\", \"Malaria Vaccine Production and Support Services\", \"MALARIA VACCINE PRODUCTION AND SUPPORT SERVICES\", \"Molecular analysis of immune responses to malaria peptide vaccines\", \"Immunologische Kontrolle der Zeckeninduzierten Immunmodulation: Eine Vakzinestrategie.\", \"Conserved CTL Epitopes in HIV-1 as Potential Vaccines.\", \"Biodegradable microspheres as a novel vaccine delivery system\", \"Development of a vaccine against HELICOBACTER PYLORI infection\", \"Robo4 protein as a cancer vaccine\", \"\\u80be\\u7efc\\u5408\\u5f81\\u51fa\\u8840\\u70ed\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u9ebb\\u75b9\\u6d41\\u884c\\u682a\\u7684\\u6297\\u539f\\u53d8\\u5f02\\u5bf9\\u75ab\\u82d7\\u6548\\u679c\\u5f71\\u54cd\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u86cb\\u767d\\u8d28\\u7ec4\\u5b66\\u7684\\u5154\\u652f\\u6c14\\u7ba1\\u8d25\\u8840\\u6ce2\\u6c0f\\u6746\\u83cc\\u53cd\\u5411\\u75ab\\u82d7\\u5b66\\u7814\\u7a76\", \"PRRS\\u591a\\u4ef7\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7814\\u7a76\\u7684\\u65b0\\u7b56\\u7565\", \"Breast Cancer Vaccines from Plants\", \"Basic Studies in Super Vaccines\", \"Vaccines Based on DNA Adenine Methylase Technology\", \"Mechanism of action of DNA vaccines\", \"Development of a novel carrier/adjuvant for intranasal vaccines\", \"Australia III - DVDC  (Diabetes Vaccine Development Center)\", \"Improving whole-organism vaccines against malaria by genetic modification\", \"AquaSolve: Nanobead vaccine delivery platform for aquaculture\", \"Effective vaccine against winter ulcer in salmon.\", \"Low cost production of biopharmaceuticals and vaccines in plants\", \"Rekombinantno cepivo proti aviarni influenci\", \"Development of a recombinant BCG vaccine - DPT\", \"Peptides and proteins for vaccines and therapeutics\", \"Development of Naked DNA Vaccine: Brucella\", \"Preparation of liquid live vaccine against rubella\", \"Construction and characterization of live-attenuated enterobacterial vaccine candidates\", \"Evaluation of an oncolytic vaccine in dogs\", \"Bioprocess Sciences and Technology of Viral Vaccines\", \"Targeted microneedle insertion for epidermal vaccine delivery and biosensing\", \"Controlled Release Nanoparticle vaccines\", \"Novel dendritic cell-based vaccine of cancer\", \"Transdermal delivery systems for protein medicines and vaccines\", \"Transdermal delivery systems for protein medicines and vaccines\", \"European vaccine effort against hiv/aids\", \"Biosafety of vaccines based on self-replicating recombinant alphavirus\", \"Selection of P. Falciparum antigene for MPES vaccine development\", \"New approaches for the development of enterobacterial vaccine strains\", \"Development of vaccines against coccidiosis through biotechnology\", \"Oral vaccine against cholera with Built-in adjuvanticity\", \"CHEMICAL SYNTHESIS OF HEPATITIS B VACCINES\", \"DEVELOPMENT OF AN EFFICIENT VACCINE (AIDS)\", \"DEVELOPMENT OF SYNTHETIC VACCINES AGAINST NEMATODE INFECTIONS\", \"DEVELOPMENT OF VACCINE AGAINST CHAGAS' DISEASE\", \"EVAL OF IMPCT OF JAPANESE ENCEPHALITIS VACCINE IN CAMBODIA\", \"Rational design of an AIP56-based anti-pasteurellosis vaccine\", \"Exploring pathogen diversity in disease epidemiology and vaccine research\", \"Melhoramento da imunogenicidade de vacinas de DNA\", \"Development of DNA vaccine prototypes for veterinary trypanosomiasis\", \"Development of DNA vaccine prototypes for veterinary trypanosomiasis\", \"Anti-ghrelin vaccine: a feasible alternative for obesity treatment?\", \"Smart porous particles for pulmonary drug and vaccine delivery\", \"Impact of the conjugate pneumococcal vaccines on pneumococcal ecology\", \"Vaccine potential of different Leishmania infantum proteins\", \"Development of subunit anti-viral vaccines for salmonid fish\", \"Towards a live vaccine against cryptobiosis in salmonids\", \"D\\u00e9veloppement d'un vaccin contre Streptococcus suis\", \"Enhancing vaccine efficacy by molecular chimerization to cytokines\", \"Development of vaccines for BVDV, BRSV and PI-3\", \"Development of vaccine vector for human immunodeficiency virus\", \"Identification of tumor-associated antigens as cancer vaccine targets\", \"Design of a glycoconjugate vaccine against group A streptococcus\", \"Development of a subunit vaccine for haemophilus somnus\", \"Increasing vaccine efficiency through defined adjuvant use\", \"Design of a glycoconjugate vaccine against group A streptococcus\", \"Development of a multivalent recombinant fowlpox virus vaccine\", \"Development of a molecularly defined vaccine for Myxosporean parasites\", \"Role of TLR4 binding adjuvant in improving cancer vaccines\", \"Attenuating West Nile: The search for a Love Vaccine\", \"Development of porcine adenovirus-3 as a vaccine vector\", \"Attenuating West Nile: The search for a Love Vaccine\", \"Recombinant fowl adenovirus based vaccine against avian influenza\", \"Novel biodegradeable hydrogel for hiv vaccine delivery\", \"Human adenovirus-based vaccines and mammalian expression vectors\", \"Oral vaccines: Targetting to improve induction of mucosal immunity\", \"Diagnostics of fish diseases and development of vaccines\", \"Development of a recombinant vaccine for porcine transmissible gastroenteritis\", \"Development of an effective recombinant Actinobacillus pleuropneumoniae vaccine\", \"Liposome-cytokine formulations as vaccine delivery systems\", \"Synthesis of cyclic oligonucleotide analogues as mucosal vaccine adjuvants\", \"Creating edible forage-based vaccines against bovine pneumonic pasteurellosis\", \"Novel Multi-Strain Vaccines against HIV-1\", \"Development of vaccine vector for human immunodeficiency virus\", \"Novel Multi-Strain Vaccines against HIV-1\", \"Development of a bovine adenovirus vaccine vector\", \"Novel Multi-Strain Vaccines against HIV-1\", \"In vitro qualification of a SPIO labeled vaccine\", \"Evaluation of fowl adenovirus based recombinant vaccines for poultry\", \"Development of vaccine vector for human immunodeficiency virus\", \"Development of Synthetic Glycoconjugate Vaccines for Active Tumor Immunotherapy\", \"Development of Synthetic Glycoconjugate Vaccines for Active Tumor Immunotherapy\", \"Optimization of vaccine production in algae using engineered bioreactors\", \"D\\u00e9veloppement d'un vaccin att\\u00e9nu\\u00e9 contre la colibacillose aviaire\", \"The Effects of Chemotherapy on Gene-Based Cancer Vaccines\", \"D\\u00e9veloppement d'un vaccin att\\u00e9nu\\u00e9 contre la colibacillose aviaire\", \"UPDATING COMPUTER FACILITIES FOR THE VACCINE LABORATORY\", \"HIV Vaccine Research and Development\", \"INTRODUCING THE USE OF SEASONAL INFLUENZA VACCINES\", \"Enhanced surveillance for newly vaccine preventable disease\", \"Discovery of Biological and Immunological Biomarkers for TB Vaccines\", \"STUDYING THE MEASLES INFECTIONS &DEVELOPMENT OF MEASLES VACCINES\", \"Innovations in Vaccine Clinical Trials and Pharmacovigilance\", \"SUPPORTING INFLUENZA VACCINE INTRODUCTION IN LOW-MIDDLE INCOME COUNTRIES\", \"EPITOPE POLYMORPHISM IN P FALCIPARUM VACCINE ANIGENS\", \"DESIGN AND IMMUNE MECHANISMS OF P FALCIPARUM CS VACCINE\", \"ANTIGENIZED ANTIBODY AND GENE IN MALARIA VACCINE\", \"LIVE ATTENUATED MULTIPLY DELETED HIV1 VACCINE FOR AIDS\", \"COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS\", \"NOVEL IMDEF VIRUS VACCINES IN NHP MODELS\", \"Development of multi-antigen subunit SARS vaccines\", \"STRUCTURAL AND CONFORMATIONAL ASPECTS IN PEPTIDE VACCINE\", \"RECOMBINANT L MONOCYTOGENES AS AN SIV VACCINE\", \"CELL CULTURE PRODUCTION OF T GONDII T 263 VACCINE\", \"VACCINE TO TREAT HEPATITIS B VIRUS INFECTION\", \"ATTENUATION OF THE NYCBH VACCINE STRAIN OF VACCINIA\", \"ADHESIN BASED VACCINE TO PREVENT URINARY TRACT INFECTION\", \"DEVELOPMENT OF TUMOR VACCINES USING GPI LINKED MOLECULES\", \"THERAPEUTIC TUMOR VACCINE AGAINST HER 2/NEU\", \"Allergy Protection by Active IgE B Cell Vaccines\", \"EPITOPE-DRIVEN HIV VACCINE TARGETING DENDRITIC CELLS\", \"ORAL DELIVERY OF ENCAPSULATED MULTIMERIC AIDS VACCINES\", \"DEVELOPMENT OF A VACCINE FOR CLOSTRIDIUM DIFFICILE\", \"UBIQUITIN FUSION FOR PEPTIDE IMMUNE DISPLAY AND VACCINES\", \"LYME VACCINE BASED ON BORRELIA DECORIN ADHESIN\", \"PEPTIDE ANTIIGE VACCINE FOR IMMUNOTHERAPY OF ALLERGY\", \"LYME VACCINE BASED ON BORRELIA TRANSFERIN RECEPTORS\", \"ORAL HIV-1 VACCINE TECHNOLOGIES USING OPTIVAX COPOLYMER\", \"PEPTIDE BASED VACCINE FOR PRIMATE MODEL OF AIDS\", \"ORAL, LIVE, ATTENUATED VIBRIO VECTORED SSONNEI VACCINE\", \"ATTENUATION OF THE NYCBH VACCINE STRAIN OF VACCINIA\", \"CS PROTEIN T-EPITOPE POLYMORPHISM--MALARIA VACCINE\", \"A TARGETED PLANT-BASED VACCINE FOR TYPE I DIABETES\", \"APC-TARGETING VACCINE FOR PREVENTION OF TYPE I DIABETES\", \"DEVELOPMENT/EVALUATION OF HYBRID NOVEL MUCOSAL VACCINES\", \"NEW STRATEGIES FOR BACTERIAL DELIVERY OF DNA VACCINES\", \"HIV VACCINE STRATEGIES BASED ON A GOAT LENTIVIRUS--CAEV\", \"DEVELOPMENT OF ENHANCED HIV 1 PSEUDOVIRION VACCINES\", \"DEVELOPMENT OF AN ORAL MULTIVALENT SHIGELLA/ETEC VACCINE\", \"DEVELOPMENT OF A GENETIC VACCINE FOR M TUBERCULOSIS\", \"DETOXIFIED BACTERIAL TOXINS AS CTL VACCINE MOLECULES\", \"MUCOSAL VACCINES--HEAT LABILE TOXIN/ANTIGEN FUSIONS\", \"INTERNATIONAL CONFERENCE ON VACCINES FOR CANCER AND AIDS\", \"HEPATITIS B VACCINE ACCEPTANCE BY NURSING HOME WORKERS\", \"DNA/MVA HIV Vaccine for India\", \"MUCOSAL IMMUNITY TO VIRULENT AND VACCINE-STRAIN CMV\", \"EVALUATION OF ARI ORGANISMS FOR VACCINE DEVELOPMENT\", \"DEVELOPMENT OF SUBUNIT VACCINE FOR M PULMONIS IN MICE\", \"DC TUMOR CONJUGATE VACCINE FOR IMMUNOTHERAPY\", \"EVALUATION STUDIES--DNA VACCINE EXPRESSING SIVSM VLP\", \"DNA VACCINES-RESPONSES TO VECTORS WITH RABIES ANTIGENS\", \"DEVELOPMENT OF A POX-VECTORED MEASLES VACCINE\", \"MEASLES &MEASLES VACCINES--MECHANISMS OF IMMUNE INJURY\", \"GENE EXPRESSION FOR S MANSONI VACCINE ANTIGEN\", \"PREVENTION OF NEONATAL BACTEREMIA WITH PILUS VACCINE\", \"HSV-1 Amplicon Vectors for HIV Vaccine Delivery\", \"HIV, TB, and Malaria Vaccine Development for Africa\", \"HSV VACCINE DESIGN--ABLATION OF VIRULENCE AND LATENCY\", \"DNA TECHNIQUES FOR PRODUCTION OF A VACCINE TO AIDS\", \"EVALUATE SAFETY OF VACCINES TO PREVENT SHIGELLOSIS-275953226\", \"CONJUGATE VACCINES DESIGNED TO PREVENT TYPHOID FEVER-275973269\", \"KILLED ORAL CHOLERA VACCINE EFFECTIVENESS TRIAL--VIETNAM-275973264\", \"TEST OF ACELLULAR PERTUSSIS VACCINE IN INFANTS\", \"EVALUATION OF TYPHOID FEVER VI CONJUGATE VACCINE\", \"U.S. CLINICAL TRIAL OF ACELLULAR PERTUSSIS VACCINE\", \"U.S. CLINICAL TRIAL OF ACELLULAR PERTUSSIS VACCINE\", \"PRODUCTION OF NICHD DPT VACCINE FOR U.S. CLINICAL TRIALS\", \"OPERATION OF &EXPERIMENTAL VIRUS VACCINE PRODUCTION LAB\", \"ADVERSE CONSEQUENCES OF PERTUSSIS AND RUBELLA VACCINES\", \"PRIMATE IMMUNOLOGY LABORATORY FOR AIDS VACCINE R&D\", \"Evaluation of Vaccines and Therapies in Adults/Elderly-26685342\", \"LAB SUP. FOR AIDS VACCINE &OTHER PREVENT. CLINICAL TRIA\", \"PHASE II PNEUMOCOCCAL CONJUGATE VACCINE STUDY IN THE GAM\", \"TB Research Materials and Vaccine testing-26675320\", \"STUDY OF MALARIA VACCINES IN HUMAN VOLUNTEERS\", \"FACILITY FOR STUDY OF INFECTIOUS DISEASE AND VACCINES\", \"MAO/EVALUATION OF AIDS VACCINES IN NONHUMAN PRIMATE\", \"EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE MODELS\", \"EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE MODELS\", \"VACCINE DEVELOPMENT--ESTABLISHMENT OF PRIORITIES FOR U S\", \"CORRELATE IMMUNE PROTECTION IN AIDS VACCINE RECIPIENTS\", \"CENTRAL LAB FOR AIDS/HIV VACCINE EFFICACY TRIALS\", \"Production and Testing of a MVA Vaccine-266040072\", \"Population Genetics Analysis Program: Immunity to Vaccines/Infections--266040069\", \"POPULATION GENETICS ANALYSIS PROGRAM IMMUNITY TO VACCINES/INFECTION-266040068\", \"POPULATION GENETICS ANALYSIS PROGRAM:  IMMUNITY TO VACCINES/INFECTIONS-266040067\", \"POPULATION GENETICS ANALYSIS PROGRAM IMMUNITY TO VACCINES/INFECTION-266040064\", \"HAEMOPHILUS INFLUENZA TYPE B VACCINE IN HIGH RISK INFANT\", \"HIV Vaccine Design and Development Teams /HVDDT/-26630042\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVDDT)-266030030\", \"HIV Vaccine Design and Development Teams /HVDDT/-26630029\", \"DEVELOPMENT AND TESTING OF VACCINES AGAINST ANTHRAX-266025494\", \"Development and Testing of Vaccines Against Anthrax-266025492\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS-266025458\", \"STUDY ISSUES AND PRIORITIES FOR NEW VACCINE DEVELOPMENT\", \"EVAL OF VACCINE PROPH AGAINST INFECT DISEASES IN CHILDRN\", \"CENTRAL LAB FOR AIDS VACCINE CLINICAL TRIALS\", \"EVALUATION IN MONKEYS OF VACCINES FOR SAIDS\", \"DEVELOP AN H INFLUENZAE TYPE B VACCINE\", \"FACILITY FOR STUDY OF INFECTIOUS DISEASES, VACCINES\", \"HIV Vaccine Design and Development Teams-26605397\", \"HIV Vaccine Design and Development Teams-26605396\", \"HIV Vaccine Design and Development Teams-26605395\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS-266005394\", \"DEVELOP LIVE ATTENTUATED COLD ADAPTED INFLUENZA VACCINE\", \"TEST RESPIRATORY VIRUS AND BACTERIAL VACCINES IN INFANTS\", \"POPULATION GENETICS ANALYSIS PROGRAM IMMUNITY TO VACCINES/INFECTION-266000068\", \"POPULATION GENETICS ANALYSIS PROGRAM:  IMMUNITY TO VACCINES/INFECTIONS-266000067\", \"POPULATION GENETICS ANALYSIS PROGRAM: IMMUNITY TO VACCINES/INFECTIONS--266000065\", \"POPULATION GENETICS ANALYSIS PROGRAM IMMUNITY TO VACCINES/INFECTION-266000064\", \"IMMUNE INTERACTIONS OF GONORRHEA AND VACCINE DEVELOPMENT\", \"ANTIBODY DIVERSITY, AGE AND INFLUENZA VACCINE EFFICACY\", \"HEALTH CARE WORKER COMPLIANCE WITH HEPATITIS B VACCINE\", \"PREVENTING AND MITIGATING VACCINE PREVENTABLE DISEASE THROUGH IMMUNIZATION\", \"TO PREVENT VACCINE-PREVENTABLE DISEASE THROUGH MAINTAINING IMMUNIZATION STRUCTURE\", \"Immunization Grant and Vaccines for Children's Program\", \"NEBRASKA IMMUNIZATION AND VACCINES FOR CHILDREN PROGRAM\", \"GUAM IMMUNIZATION AND VACCINES FOR CHILDREN PROGRAMS\", \"GEORGIA IMMUNIZATIONS AND VACCINES FOR CHILDREN GRANTS\", \"FSM IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"PREVENTION & CONTROL OF COMMUNICABLE AND VACCINE PREVENTABLE DISEASES\", \"KY IMMUNIZATION PROGRAM IMMUNIZATION & VACCINE FOR CHILDREN PROGRAM\", \"HAWAII IMMUNIZATION AND VACCINES FOR CHILDREN PROGRAM\", \"Building Capacity for Immunization Billing and Vaccine Barcode Reading\", \"NEISSERIA MENINGITIDIS GROUP B;IDIOTYPES AND VACCINES\", \"ATTENUATED SHIGELLA AS TOXIGENIC E COLI VACCINE\", \"VACCINE POTENTIAL OF PAR PROTEINS OF TRYPANOSOMA CRUZI\", \"LIVE AND ATTENUATED VIBRIO CHOLERAE VACCINE STRAINS\", \"DEVELOPMENT OF A SINGLE DOSE TETANUS VACCINE\", \"SALMONELLA AS A VACCINE TOOL AGAINST HIV\", \"FACTORS INFLUENCING HIB DISEASE AND VACCINE EFFICACY\", \"DEVELOPMENT OF VACCINE AGAINST GROUP B STREPTOCOCCI\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Advanced Development of Multivalent Filovirus Vaccines\", \"Development of an Anthrax Vaccine\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Unit\", \"Global HIV AIDS Vaccine Enterprise Secretariat\", \"GLOBAL HIV VACCINE ENTERPRISE\", \"Translational Development of Novel Vaccine Therapies\", \"Rotavirus vaccine and prevention of hospitalization\", \"Verbundprojekt: EUREKA-Projekt: Malaria-Impfstoff (EU 101) - Teilvorhaben: Gentechnologische Entwicklung einer Malaria-Vakzine - Phase 2\", \"'EDCTP-Malaria Impfstoff: Biometrie und Parasiten-Quantifizierung zur Entwicklung neuer malariaimpfstoffe, -medikamente und -miagnostika in Afrika.'\", \"EDCTP-HIV-Vakzine I: Durchf\\u00fchrung eine Phase IB HIV Impfstoffstudie (DNA / NYVAC) in Mbeya, Tansania.\", \"Investigation of Novel Vaccine Strategies for Influenza: Targeting Innate and Adaptive Immunity for Cross-protective Vaccines\", \"\\uc77c\\ubc18\\ubc31\\uc2e0 \\ub610\\ub294 \\uae34\\uae09\\ubc31\\uc2e0\\uc81c\\uc81c\\uc758 \\ub1cc\\uad6c\\uc870 \\ubc0f \\uae30\\ub2a5\\uc5d0 \\ub300\\ud55c \\uc548\\uc804\\uc131 \\uc2e0\\uc18d\\uac80\\uc815\", \"\\ube44\\ub9cc \\ub9c8\\uc6b0\\uc2a4\\uc5d0\\uc11c\\uc758 \\ud638\\ud761\\uae30 \\ubc14\\uc774\\ub7ec\\uc2a4\\uc5d0 \\ub300\\ud55c \\ubc31\\uc2e0\\uc758 \\ud6a8\\ub2a5 \\uce21\\uc815 \\ubc0f \\ube44\\ub9cc \\uac1c\\uc120\\uc744 \\ud1b5\\ud55c \\ubc31\\uc2e0 \\uc5ed\\ub7c9 \\uac15\\ud654 \\ud3c9\\uac00\", \"\\ub9c8\\uc6b0\\uc2a4 \\ubaa8\\ub378\\uc5d0\\uc11c \\ubaa8\\uccb4\\uc758 \\uacb0\\ud575 \\uac10\\uc5fc\\uc774 \\uc2e0\\uc0dd\\uc544\\uc758 \\uacb0\\ud575 \\ubc31\\uc2e0 \\ud6a8\\uacfc\\uc5d0 \\ubbf8\\uce58\\ub294 \\uc601\\ud5a5 \\ubc0f \\uc2e0\\uaddc \\uacb0\\ud575 \\ubc31\\uc2e0 \\ud6a8\\ub2a5 \\uac80\\uc99d\", \"Development of vaccine strategies for measles and malaria using oral bacterial vectors and edible plant vaccines\", \"To test a new bacterial synthesis method to produce glycoconjugate vaccines to generate an improved vaccine against pneumococcal disease.\", \"To produce more poliovirus vaccine supply by silencing non-essential virus resistance genes to develop enhanced vaccine cell lines.\", \"To support the AIDS Vaccine 2006 conference which will bring together scientists in the field of HIV vaccine research.\", \"To develop and field test a durable liner for vaccine carriers to protect vaccines from freezing.\", \"To develop an envelope vaccine antigen that allows immune recognition and is an effective vaccine antigen\", \"DEVELOPMENT OF A NOVEL SALMONELLA PARATYPHI A VACCINE\", \"\\u30d2\\u30c8\\u7cbe\\u5b50\\u6297\\u539f\\u3092\\u7528\\u3044\\u305f\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u53ca\\u3073\\u907a\\u4f1d\\u5b50\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u751f\\u6b96\\u514d\\u75ab\\u5b66\\u7684\\u7814\\u7a76\", \"RV3 Rotavirus Vaccine: A Phase II clinical trial for a human neonatal rotavirus vaccine for the global community\", \"Development of a Coronavirus Vaccine\", \"Insights into CD4+ T cell responses against cancer vaccines from analysis of responses to a conventional vaccine\", \"Adjuvant properties of cellular vaccines: combination of cellular pertussis vaccine and BCG with Streptococcus pneumoniae antigens\", \"Pathogen-derived immunomodulatory molecules: future immunotherapeutics and vaccines\", \"Can plant plastids produce a candidate flu vaccine\", \"Information dissemination on the human papillomavirus vaccine\", \"Development of a Coronavirus Vaccine\", \"Task X8: Efficacy Testing of Ebola Virus Vaccines\", \"USE OF THE VACCINE ADJUVANT FOR IMMUNOMODULATION OF THE INFECTION CAUSED BY TRYPANOSOMA BRUCEI: AN APPROACH TO VACCINE DESIGN\", \"Development of DNA-based vaccines for bovine viral diarrhoea virus. D\\u00e9veloppement des vaccins \\u00e0 base d'ADN le virus de diarrh\\u00e9e bovine.\", \"TESTING VACCINES IN CHILDREN\", \"Frameshifts as a Cancer Vaccine\", \"SIMIAN VACCINE EVALUATION UNITS\", \"HPV\\u53cc\\u542f\\u52a8\\u5b50DNA\\u75ab\\u82d7\\u548c\\u91cd\\u7ec4\\u817a\\u75c5\\u6bd2\\u75ab\\u82d7\\u7684\\u8054\\u5408\\u5e94\\u7528\\u7814\\u7a76\", \"Vaccines against helminth infections (acronym PARAVAC)\", \"The mechanisms of macrophage dependent vaccine\", \"Recombinant Vaccines for Prevention of AIDS and Other Diseases\", \"SARS\\u75ab\\u82d7\\u9ad8\\u5206\\u5b50\\u8f7d\\u4f53\\u7684\\u6a21\\u62df\\u7814\\u7a76\", \"Characterisation of rotavirus vaccine escape - potential for significant impact on vaccination program\", \"Conference: Genetic vaccines - benefits and challenges\", \"\\u0423\\u0447\\u0430\\u0441\\u0442\\u0438\\u0435 \\u0432 GENE-BASED VACCINES - GBV2010 Conference\", \"To development of a new safer Oral Polio Vaccine against type 2 strain (nOPV2) with lower risk of circulating vaccine derived polio virus (cVDVP) or vaccine associated paralytic poliomyelitis (VAPP) than existing Sabin mOPV 2\", \"To test a new vaccine technology that modulates a host cytokine response to HIV vaccines. If successful, this technology may also enhance T-cell mediated immunity to other vaccine antigens, such as Tuberculosis.\", \"To produce new and more potent vaccines with increased stability by testing a vaccine platform based on protein crystals (MicroCubes) produced by insect viruses for developing a candidate vaccine against HIV.\", \"To develop better polio vaccines by researching whether adding immune pressure against proteins found in the attenuated strains of the oral polio vaccine leads to the emergence of recombinant circulating vaccine-derived polioviruses\", \"To develop and test a vaccine combining a novel placental malaria vaccine candidate with the cervical cancer vaccine, with the potential of inducing a strong protective response against both diseases simultaneously\", \"To bring together African researchers, vaccine implementers and public health academics to share information regarding rotavirus vaccines within Africa, and to exchange information and lessons regarding the impact of the vaccines\", \"Sometimes it's take that hill, sometimes it's take that vaccine:  the Persian Gulf war and the anthrax vaccine controversy\", \"Training in vaccine research: vaccine against peptic ulcer\", \"Tularemia Vaccine Development\", \"Polymeric microparticulate vaccine formulations based on hydrogen bonding\", \"Production of a recombinant vaccine against human cytomegalovirus in plant cells\", \"GSK VACCINES - COURS INTRO MIN PME Convention -Course with Minor Entrepreneurschip\", \"Vaccine Effectiveness: An integrated approach for monitoring influenza vaccine effectiveness to inform public health policy and influenza immunization program implementation\", \"Vaccine Effectiveness: An integrated approach for monitoring influenza vaccine effectiveness to inform public health policy and influenza immunization program implementation\", \"Vaccine Effectiveness: An integrated approach for monitoring influenza vaccine effectiveness to inform public health policy and influenza immunization program implementation\", \"Vaccine Effectiveness: An integrated approach for monitoring influenza vaccine effectiveness to inform public health policy and influenza immunization program implementation\", \"Verbundprojekt: Integriertes, patientennahes Verfahren zur Herstellung einer therapeutischen zellul\\u00e4ren Vakzine im geschlossenen System, Teilvorhaben: Genetisch modifizierte DC-Vakzine mit verbesserter Antigenpr\\u00e4sentation\", \"Verbundprojekt: Integriertes, patientennahes Verfahren zur Herstellung einer therapeutischen zellul\\u00e4ren Vakzine im geschlossenen System, Teilvorhaben: Geschlossenes, GMP-f\\u00e4higes Verfahren f\\u00fcr DC-Vakzine\", \"Verbundprojekt: Impfstoffentwicklung Gegen Herpesviren: Ein flexibles System zur gezielten Antigen-Variation bei Humanen Influenza-Viren f\\u00fcr die Herstellung von Vakzinen\", \"ERA Net EuroTransBio-2: Neue Technologie f\\u00fcr erfolgreiche Impfstoffstrategien: Crossbeta Adjuvanz-Technologie am Beispiel von Protein-basierten Impfstoffen gegen Influenza H5N1 Viren\", \"Verbundprojekt: Entwicklung eines low-cost intranasalen Vaccines mit universellem Schutz gegen Pneumococcus Infektionen, Teilprojekt: Sicherheits- und Wirksamkeitsuntersuchungen des Vaccines\", \"EDCTP - Malariaimpfstoffe I: F\\u00f6rderung der immunologischen und der klinischen Forschungs-Kompetenz im Rahmen multizentrischer, internationaler klinischer Studien an Malariavakzinen der Phasen I bis IIb\", \"EDCTP-HIV-Vakzine I: Bestimmung der zellul\\u00e4ren Immunantwort nach Impfung mit einer DNA / MVA HIV Vakzine bei 70 Freiwilligen.\", \"Verbundprojekt: Innovative bakterielle Tumorimpfstoffe - Teilprojekt 2/3: Entwicklung eines oralen rekombinanten Salmonellenvakzins der zweiten Generation f\\u00fcr die Tumortherapie\", \"Best Brains Exchange: 'Achievement of Optimal Vaccine Coverage Rates in Canada: Identifying and Addressing the Problem of Vaccine Hesitancy', February 3, 2015, Ottawa.\", \"Best Brains Exchange: 'Achievement of Optimal Vaccine Coverage Rates in Canada: Identifying and Addressing the Problem of Vaccine Hesitancy', February 3, 2015, Ottawa.\", \"Best Brains Exchange: 'Achievement of Optimal Vaccine Coverage Rates in Canada: Identifying and Addressing the Problem of Vaccine Hesitancy', February 3, 2015, Ottawa.\", \"Best Brains Exchange: 'Achievement of Optimal Vaccine Coverage Rates in Canada: Identifying and Addressing the Problem of Vaccine Hesitancy', February 3, 2015, Ottawa.\", \"Best Brains Exchange: 'Achievement of Optimal Vaccine Coverage Rates in Canada: Identifying and Addressing the Problem of Vaccine Hesitancy', February 3, 2015, Ottawa.\", \"Investigation of the role of envelope glycoprotein in virulence/attenulation of live japanese encephalitis virus (JEV) vaccine SA14-14-2insights into rational design of flaviviral vaccines\", \"The nature and extent of vaccine hesitancy among chiropractors and naturopaths:  identifying how vaccination views impact practice\", \"\\uacbd\\uc81c\\ub3d9\\ubb3c\\uc6a9 \\ubc31\\uc2e0 \\uc81c\\uc870\\uc5d0 \\uc788\\uc5b4 \\ud3ec\\ub974\\ub9d0\\ub9b0 \\ub300\\uccb4\\uc81c \\ubc1c\\uad74 \\ubc0f \\uc774\\ub97c \\ud65c\\uc6a9\\ud55c \\uc2e0 \\uac1c\\ub150 \\uc0ac\\uade0 \\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc5d0 \\uad00\\ud55c \\uae30\\ucd08 \\uc5f0\\uad6c\", \"\\ud604\\uc7ac \\ubc31\\uc2e0\\uc758 \\ud55c\\uacc4\\ub97c \\uadf9\\ubcf5\\ud55c \\uc0c8\\ub85c\\uc6b4 \\ub300\\uc0c1\\ud3ec\\uc9c4 \\ubc31\\uc2e0\\ud6c4\\ubcf4 \\ubc1c\\uad74 \\ubc0f \\uc791\\uc6a9\\uae30\\uc804 \\uaddc\\uba85\", \"To develop new synthetic DNA vaccines encoding designed CSP antigens to provide a new generation advanced CSP component for a prophylactic malaria vaccine\", \"To develop a plan for the identification of immune correlates of vaccine efficacy that will enable vaccine product development and licensure to improve global population health\", \"To evaluate benefits of inactivated vaccine as a booster following vaccination with live attenuated influenza vaccine in young children in developing countries\", \"Production of High Efficiency Recombinant Foot-and-mouth Disease Vaccine for Pre-clinical and Clinical Trials and Commercial Vaccine Production\", \"Evaluation of the effect of vaccines on overall health in Danish children: Changing the paradigm of vaccine policy in high-income countries\", \"Antigen targeting and activation of dendritic cells for vaccine design\", \"Chlamydophila psittaci recombinant vaccine development\", \"To optimize the process of WHO biannual influenza vaccine virus selection towards appropriate influenza vaccine composition recommendations for tropical countries\", \"To determine whether mucosal immunity against poliovirus can be enhanced by providing an additional dose of inactivated poliovirus vaccine to children previously immunized with oral poliovirus vaccine\", \"To reduce child mortality through increasing vaccine visibility in 6 states, and through increasing availability of vaccines in Lagos state.\", \"To test whether injection of a vaccine into laser-exposed skin can significantly enhance immune responses stimulated by the vaccine\", \"To convene professionals from developing countries working in research, development, manufacturing and supply of vaccines, towards the common goal of increasing the availability of high-quality vaccines\", \"To test for use in a vaccine a live single-cycle poliovirus that has been modified to eliminate its ability to re-emerge as vaccine-derived poliovirus.\", \"To advocate for HIV vaccines research and development and facilitate the African AIDS Vaccine Programme's transition to an independent operational African program outside of WHO\", \"To develop new architectural and construction guidelines for vaccine storage rooms in hot climates that incorporate passive solar thermal technologies to keep vaccines at recommended temperatures.\", \"To develop a novel HIV-1 RV144-like vaccine regimen using an improved vaccine vector Mycobacterium bovis Bacillus Calmette-Guerin\", \"To establish a global laboratory support network that will benefit AIDS vaccine development as it relates to vaccine-elicited antibody responses\", \"To produce more poliovirus vaccine supply while reducing production costs by silencing non-essential virus resistance genes to develop enhanced vaccine cell lines\", \"To develop cell phone sensors that monitor refrigerated vaccine stocks and generate geo-tagged alerts when vaccines reach critical temperatures.\", \"To study whether reducing the ability of lysomes to digest protein antigens in vaccines could enhance the vaccine\\u2019s ability to elicit antibody and T cell responses.\", \"To employ novel, rational design strategies to generate an oral/mucosal vaccine formulation that could significantly contribute to developing vaccines to improve global health\", \"To investigate the use of lyophilized Salk IPV to serve as basis for a combination vaccine strategy with a pentavalent vaccine\", \"To develop a vaccine platform that uses bacteriophages that are structurally stable in extreme environments to manufacture inexpensive, stable, and easy-to-produce vaccines.\", \"To test the hypothesis that selling vaccines through medicine shops in emerging markets can lead to profits for both vaccine developers and the small business owners.\", \"To develop an affordable, easy-to-use, and effective stable liquid multi-dose rotavirus vaccine delivery system for introduction to vaccine partners in developing countries\", \"To test the feasibility of using microneedle patches to deliver the inactivated polio vaccine (IPV) instead of using intramuscular vaccine shots.\", \"To reduce severe illness and death among infants and children by evaluating non-replicating rotavirus vaccine candidates as viable alternatives to oral, live attenuated rotavirus vaccines\", \"To engineer an adenovirus vaccine vector that could be used in an HIV vaccine to elicit the strong immune response.\", \"To design a novel vaccine platform based on protein microcrystals produced by insect viruses, to induce a vigorous immune response without the need for refrigerated vaccine storage.\", \"D\\u00e9veloppement d'une plateforme vaccinale hautement versatile bas\\u00e9e sur les nanoparticules du virus mosa\\u00efque de la papaye\", \"A HUMAN TOXOPLASMA GONDII VACCINE\", \"DEVELOPMENT OF A PROPHYLACTIC ONCHOCERCIASIS VACCINE\", \"COMBINING PARASITE AND VECTOR COMPONENTS FOR DEVELOPMENT OF A LEISHMANIA VACCINE\", \"A basic study on combination vaccines of rotavirus and norovirus\", \"Malaria vaccine development based on multifunctional hybrid vaccine platform\", \"\\u591a\\u6a5f\\u80fd\\u578b\\u30ef\\u30af\\u30c1\\u30f3\\u30d7\\u30e9\\u30c3\\u30c8\\u30d5\\u30a9\\u30fc\\u30e0\\u3092\\u57fa\\u76e4\\u3068\\u3057\\u305f\\u30de\\u30e9\\u30ea\\u30a2\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u7814\\u7a76\", \"Enhanced multivalent vaccine responses using a novel vaccine vector system\", \"Caract\\u00e9risation et \\u00e9valuation du potentiel immunostimulant de saponines triterp\\u00e9niques naturelles et h\\u00e9misynth\\u00e9tiques comme adjuvants potentiels de vaccins\", \"Mise au point d'un vaccin sous-unitaire contre les infections \\u00e0 Salmonella et Streptococcus suis chez le porc.\", \"Effets des capsules polysaccharidiques sialyl\\u00e9es de bact\\u00e9ries Gram Positif sur la capacit\\u00e9 immunog\\u00e9nique de vaccins conjugu\\u00e9s\", \"Development of a sub-unit vaccine to protect swine against the infections caused by Streptococcus suis\", \"SIGNATURE-TAGGED MUTAGENESIS: A NOVEL AND RAPID APPROACH FOR DEVELOPMENT OF AQUACULTURE VACCINES\", \"Harnessing the immunostimulatory activity of chitosan to produce potent vaccine adjuvants\", \"HIV vaccine acceptability among vulnerable communities in Thailand\", \"Pan-PRovincial Vaccine ENTerprise (PREVENT) / Pr\\u00e9vention de la propagation de l'insuffisance fonctionnelle des organes (PPIFO)\", \"Task X3: Production and Testing of Conjugate Cholera Vaccine\", \"Task X 4: Assessment of Simple Adjuvants to Enhance Anthrax Vaccines\", \"Heterogeneous prime boost vaccines for Chlamydia trachomatis.\", \"Heterogeneous prime boost vaccines for Chlamydia trachomatis.\", \"Targeting the hydrophobic domain of biothreat pathogens for vaccine development\", \"Development of Assays to Evaluate Filovirus Vaccines\", \"Development of Assays to Evaluate Filovirus Vaccines\", \"Preclinical Development of Oral Anthrax Vaccine\", \"Preclinical Development of Oral Anthrax Vaccine\", \"Development and Production of Inactivated H5N1 Influenza Vaccine\", \"Development of a Recombinant SARS Vaccine\", \"GLOBAL HIV VACCINE ENTERPRISE\", \"GLOBAL HIV VACCINE ENTERPRISE\", \"GLOBAL HIV VACCINE ENTERPRISE\", \"GLOBAL HIV VACCINE ENTERPRISE\", \"GLOBAL HIV VACCINE ENTERPRISE\", \"\\u8fdf\\u7f13\\u7231\\u5fb7\\u534e\\u6c0f\\u83cc\\u5f31\\u6bd2\\u8f7d\\u4f53\\u75ab\\u82d7\\u7684\\u5f02\\u6e90\\u6297\\u539f\\u5448\\u9012\\u548c\\u514d\\u75ab\\u4fdd\\u62a4\", \"SIMIAN VACCINE EVALUATION UNITS - Animal Maintenance and Care\", \"SVEU - Efficacy of HIV Clade C Vaccine Candidate with GP120 Boost\", \"IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS\", \"IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS\", \"IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS\", \"IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS\", \"IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS\", \"SIMIAN VACCINE EVALUATION UNITS: Conduct Study P190\", \"Recombinant Vaccines for Prevention of AIDS and Other Diseases\", \"SVEU - Efficacy of HIV Clade C Vaccine Candidate with GP120 Boost\", \"STUDIES ON ENZYME-LINKED IMMUNOSORBENT ASSAY FOR EVALUATION OF IMMUNIZATION\", \"\\u57fa\\u4e8e\\u540c\\u79cd\\u5f02\\u578b\\uff08Heterologous prime\\uff0dboost\\uff09\\u75ab\\u82d7\\u514d\\u75ab\\u7b56\\u7565\\u589e\\u5f3a\\u65e5\\u672c\\u8840\\u5438\\u866b\\u75c5\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u53ca\\u5176\\u673a\\u7406\\u7684\\u7814\\u7a76\", \"\\u4e2d\\u56fdEIAV\\u75ab\\u82d7\\u514d\\u75ab\\u539f\\u7684\\u591a\\u6837\\u6027\\u6784\\u6210\\u4e0e\\u8bf1\\u5bfc\\u4fdd\\u62a4\\u6027\\u514d\\u75ab\\u7684\\u76f8\\u5173\\u6027\\u7814\\u7a76\", \"2nd Annual Vaccine Renaissance Conference, RI\", \"Validation of Molecular Diagnostics and Vaccine for Classical Swine Fever\", \"Development of auxotrophic vaccines against M. tuberculosis.\", \"Preclinical trials of a quadrivalent hepatitis C virus vaccine\", \"Development of oral pellet Fowl Cholera Vaccine\", \"Development of a Live Attenuated Vaccine against Hemorrhagic Septicemia\", \"Development of envelope based dengue tetravalent all-in-one vaccine\", \"Status of Veterinary Vaccines and Diagnostics in India A comprehensive review\", \"Nano-Newcastle disease virus vaccine pathway to commercialization\", \"Development of recombinant vaccine for control of salmonellosis in poultry\", \"DEVELOPMENT OF RECOMBINANT FUSION PROTEIN VACCINE FOR\", \"Modulation of TLR5 mediated T regulatory functions in cholera vaccine\", \"Development of vaccines and diagnostics against hospital acquired infections:\", \"Predictors of Poor Immune Response to Rotavirus Vaccine in Infants.\", \"Identification of the potential vaccine candidate antigens of clostridium chauvoei\", \"Development of Malaria Vaccines Using the Influenza\", \"Development of a Recombinant Combination Blood Stage Vaccine\", \"DEVELOPMENT OF NEW LIVE ATTENUATED VACCINE CANDIDATES FOR KALA - AZAR\", \"Construction of multivalent protein vaccine against Staphylococuss aureus and immunogenicity\", \"Adenovirus vectored vaccines for foot and mouth disease.\", \"Development of smart nano carriers for oral vaccine delivery\", \"Establishment of the Core Vaccine Research Unit (CVRU)\", \"Development of HPV 18 Chimaeric vaccine candidate\", \"DEVELOPMENT OF CHIKUNGUNYA VACCINE CANDIDATE\", \"Indo Norwegian platform on fish and shellfish vaccine development.\", \"Development of DNA based vaccine against\", \"Development of Vaccine for control of bovine tuberculosis.\", \"Development of Recombinant Vaccine for Infectious bursal disease virus.\", \"Development of Recombinant Fusion Protein Vaccine for Mycobacterium avium subsp.Paratuberculosis.\", \"Recombinante expressie van door middel van RNAi geselecteerde kandidaatvaccin antigenen van Ostertagia ostertagi in Caenorhabditis elegans\", \"Recombinante expressie van door middel van RNAi geselecteerde kandidaat-vaccin antigenen van Ostertagia ostertagi in Caenorhabditis elegans.\", \"Een ge\\u00efntegreerde preklinische strategie voor het ontwikkelen van verbeterde dendritische cel vaccins tegen longkanker\", \"Ontwikkeling van een Chlamydia psittaci DNA vaccin voor de bestrijding van chlamydiosis bij kalkoenen.\", \"Ontwikkeling van een Chlamydia trachomatis kandidaat recombinant vaccin voor mucosale toediening.\", \"\\\"Biomics\\\" als innovatieve benadering voor Chlamydia trachomatis vaccin ontwikkeling.\", \"Ontwikkeling van F1- en P-gebaseerde subunit vaccins tegen aviaire escherichia coli infectie (APEC).\", \"Ontwikkeling van F1-gebaseerde subunit vaccins tegen aviaire E. coli infectie.\", \"De rol van interferon-gamma in de immuniteit ge\\u00efnduceerd door het sporozo\\u00efet malaria vaccin.\", \"Preklinische ontwikkeling van RNA-gemodifieerde dendritische celvaccins voor kanker en HIV.\", \"Preklinische ontwikkeling van RNA gemodifieerde dendritische celvaccins voor kanker en HIV.\", \"Studie van de variabiliteit van humaan immunodefici\\u00ebntie virussen. Implicaties voor vaccin en antivirale interventie strategie\\u00ebn.\", \"Ontwikkeling en validering van een oraal influenza A vaccin gebaseerd op M2e-uitdrukkende fagen\", \"Ontwikkeling en validering van een oraal influenza A vaccin gebaseerd op M2e-uitdrukkende fagen\", \"Production of immunogenic tumor lysate loaded mesoporous silica nanoparticles as anti-cancer vaccine\", \"Identificatie van het immunologisch werkingsmechanisme van het influenza matrixeiwit-2 ectodomein vaccin.\", \"Formulatie van vaccin antigenen in intelligente stimuli-responsieve ultra-kleine nanpoartikels\", \"Ontwikkeling van microparticulaire kanker vaccins door formulatie van tumor-specifieke antigenen met immuno-modulerende polymeren.\", \"Ontwikkeling en evaluatie van een recombinant vaccin tegen malaria bij het rund veroorzaakt door Theileria parva\", \"Ontwikkeling en evaluatie van een recombinant vaccin tegen malaria bij het rund veroorzaakt door Theileria parva.\", \"Een nieuw tuberculose vaccin gebaseerd op genetische vaccinatie met cultuurfiltraat-antigenen.\", \"RNA synthetische biologie voor de genetische aanmaak van een programmeerbaar \\u00e9\\u00e9nmaal toe te dienen slim RNA vaccin\", \"Vaccins tegen tuberculose: identificatie en karakterisatie van de immunologische parameters die immune bescherming verlenen.\", \"Vaccins tegen tuberculose : identificatie en karakterisatie van de immunolo- gische parameters die immune bescherming verlenen.\", \"Ontwikkeling van een tumorvaccin gebruikmakend van antigeen getransfecteerde dendritische cellen: een ex vivo studie.\", \"Vaccine for all\", \"\\u4ee5\\u51cf\\u6bd2\\u6c99\\u95e8\\u6c0f\\u83cc\\u4e3a\\u8f7d\\u4f53\\u7684HCV\\u591a\\u8868\\u4f4d\\u6838\\u9178\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u5229\\u7528\\u8f6c\\u57fa\\u56e0\\u7d2b\\u82b1\\u82dc\\u84ff\\u7814\\u7a76\\u809d\\u7247\\u5438\\u866b\\u98df\\u7528\\u75ab\\u82d7\", \"MAF-J6-1\\u53ca\\u5176\\u53d7\\u4f53\\u878d\\u5408\\u57fa\\u56e0\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u65b0\\u57ce\\u75c5\\u6bd2\\u5728\\u80bf\\u7624\\u75ab\\u82d7\\u5236\\u5907\\u4e2d\\u7684\\u4f5c\\u7528\", \"\\u6076\\u6027\\u759f\\u57fa\\u56e0\\u5728\\u4eba\\u4f24\\u5bd2\\u6746\\u83cc\\u75ab\\u82d7\\u682a\\u4e2d\\u8fdb\\u884c\\u56db\\u73af\\u7d20\\u8bf1\\u5bfc\\u8868\\u8fbe\", \"HPV16\\u57fa\\u56e0\\u5de5\\u7a0b\\u9884\\u9632\\u75ab\\u82d7\\u53ca\\u5176\\u4f5c\\u7528\\u7684\\u7ec6\\u80de\\u4e0e\\u5206\\u5b50\\u751f\\u7269\\u7814\\u7a76\", \"\\u4e19\\u578b\\u809d\\u708e\\u590d\\u5408\\u591a\\u4ef7\\u57fa\\u56e0\\u5de5\\u7a0b\\u53e3\\u670d\\u6d3b\\u83cc\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u6297\\u4e73\\u5934\\u7624\\u75c5\\u6bd2\\u611f\\u67d3\\u7684\\u5d4c\\u5408\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7684\\u7ec6\\u80de\\u5206\\u5b50\\u751f\\u7269\\u5b66\", \"\\u5bb6\\u755c\\u75c5\\u6bd2\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u901a\\u7528\\u8f7d\\u4f53\\u7684\\u6784\\u5efa\", \"\\u9999\\u8549\\u75c5\\u6bd2\\u75c5\\u8840\\u6e05\\u5b66\\u5feb\\u901f\\u68c0\\u9a8c\\u6280\\u672f\\u53ca\\u6297\\u75c5\\u6bd2\\u75ab\\u82d7\\u7b5b\\u9009\\u7684\\u7814\\u7a76\", \"\\u725b\\u4f20\\u67d3\\u6027\\u9f3b\\u6c14\\u7ba1\\u708e\\u5355\\u514b\\u9686\\u6297\\u4f53\\u8bca\\u65ad\\u8bd5\\u5242\\u53ca\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u7814\\u5236\", \"\\u970d\\u4e71\\u9ad8\\u6548\\u75ab\\u82d7\\u7684\\u7814\\u5236\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\\u7684\\u63a2\\u8ba8\", \"\\u798f\\u6c0f\\u5fd7\\u8d3a\\u6c0f\\u83cc\\u6297\\u72ec\\u7279\\u578b\\u6297\\u4f53\\u4f5c\\u4e3a\\u75ab\\u82d7\\u7684\\u53ef\\u884c\\u6027\\u7814\\u7a76\", \"\\u6076\\u6027\\u759f\\u539f\\u866b\\u914d\\u5b50\\u75ab\\u82d7\\u57fa\\u7840\\u7814\\u7a76--\\u914d\\u5b50\\u9776\\u6297\\u539f\\u5206\\u6790\", \"\\u53e3\\u8e44\\u75ab\\u75ab\\u82d7\\u7814\\u5236\\u7684\\u65b0\\u6280\\u672f\\u53ca\\u5176\\u5e94\\u7528\\u57fa\\u7840\\u7814\\u7a76\", \"\\u5e94\\u7528\\u57fa\\u56e0\\u5de5\\u7a0b\\u6280\\u672f\\u5236\\u5907\\u6059\\u866b\\u75c5\\u7acb\\u514b\\u6b21\\u4f53\\u6297\\u539f\\u53ca\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u6742\\u4ea4\\u7ec6\\u80de\\u6d3b\\u7624\\u82d7\\u6297\\u767d\\u8840\\u75c5\\u4f5c\\u7528\\u7684\\u7814\\u7a76\", \"\\u8f6e\\u72b6\\u75c5\\u6bd2\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7684\\u7814\\u5236\\u53ca\\u5176\\u4e34\\u5e8a\\u5e94\\u7528\", \"\\u4e09\\u7532\\u57fa\\u58f3\\u805a\\u7cd6\\u65b0\\u57ce\\u75abDNA\\u75ab\\u82d7\\u7eb3\\u7c73\\u7c92\\u7684\\u5236\\u5907\\u53ca\\u5176\\u7406\\u5316\\u7279\\u6027\", \"T\\u7ec6\\u80de\\u75ab\\u82d7\\u8bf1\\u5bfc\\u7684CD4+\\u8c03\\u8282\\u6027T\\u7ec6\\u80de\\u5e94\\u7b54(\\u514d\\u75ab\\u53cc\\u8fb9\\u4f1a)\", \"\\u589e\\u5f3aIgA\\u5e94\\u7b54\\u6297\\u6210\\u4eba\\u7259\\u5468\\u708eDNA\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u7528\\u53cc\\u6b67\\u6746\\u83cc\\u505a\\u8f7d\\u4f53\\u6784\\u5efaETEC\\u5b9a\\u5c45\\u56e0\\u5b50I\\u91cd\\u7ec4\\u8f7d\\u4f53\\u75ab\\u82d7\", \"\\u9a6c\\u94c3\\u85af\\u665a\\u75ab\\u82d7\\u6301\\u4e45\\u6297\\u6027\\u4e0e\\u52a0\\u5de5\\u54c1\\u8d28\\u6539\\u826f\", \"Verbundprojekt: Entwicklung eines Rotlauf-Impfstoffs f\\u00fcr Gefl\\u00fcgel - Teilprojekt 2\", \"Verbundprojekt: Entwicklung eines Rotlauf-Impfstoffs f\\u00fcr Gefl\\u00fcgel - Teilprojekt 1\", \"Entwicklung eines Impfstoffes zur Prophylaxe der Chlamydiose des Rindes\", \"Pilotstudie zum Einsatz kommerziell erh\\u00e4ltlicher AIV H5-Impfstoffe\", \"Verbundprojekt: Topische Vakzinierung mit funktionalen Nanopartikeln - Teilvorhaben: Getriggerte Freisetzung von Vakzinen aus LbL-Nanopartikeln\", \"Verbundprojekt: Topische Vakzinierung mit funktionalen Nanopartikeln - Teilvorhaben: Synthese und Analyse von Vakzinkomponenten\", \"CI3: Pr\\u00e4klinische Entwicklung einer prophylaktischen RNA Vakzine gegen Influenza\", \"CI3: Tumorimpfstoffe basierend auf onkolytischen Masernviren, Teilprojekt Ribological\", \"CI3: IVAC - Individualisierte Vakzine zur Therapie des malignen Melanoms, Teilprojekt Ribological\", \"CI3: IVAC - Individualisierte Vakzine zur Therapie des malignen Melanoms - Teilprojekt TRON\", \"Forschungspr\\u00e4mie: Vom Forschungsergebnis zum pharmazeutischen Produkt - Entwicklung von Aufreinigungsprozessen f\\u00fcr eine Impfstoffplattform\", \"EXIST-Gr\\u00fcnderstipendium: Pylorix - Neue Impfstoffe und Antibiotika gegen Helicobacter pylori\", \"Verbundprojekt: Entwicklung von Impfstoffen Gegen Viren der Herpesgruppe - Teil 1\", \"KMU-innovativ-16: Entwicklung mRNA-basierter mukosaler Impfstoffe - 'MukoVak'\", \"GO-Bio 4B: Imevax - Neue Impfstoffe gegen Erreger chronischer Infektionen\", \"ERA Net EuroTransBIO-5: Neue DC-basierte Vakzine gegen Brustkrebs (PDC-VAC)\", \"ERA Net EuroTransBIO-5: Neue DC-basierte Vakzine gegen Brustkrebs (PDC-Vac)\", \"Verbundprojekt: Pr\\u00fcfprogramm eines Synthetischen, veterin\\u00e4rmedizinisch Einsetzbaren Peptid-Impfstoffes\", \"Arbeiten zur Entwicklung einer Vaccine und Immuntherapie Gegen AIDS\", \"Gentechnologische Gewinnung von AIDS-Antigenen - neue Wege zur AIDS-Diagnostik und zur Impfstoffentwicklung\", \"GO-Bio 4: Entwicklung neuer Impfstoffe gegen Erreger chronischer und nosokomialer Infektionen\", \"KMU-innovativ-5: Entwicklung einer panspezifischen RNA Vakzine gegen Influenza A - FluVac\", \"ERA-Net EuroTransBIO-4: Entwicklung eines DNA-Impfstoffes gegen Hepatitis B.\", \"Verbundprojekt: Optimierung der industriellen zellkulturbasierten Herstellung von Influenza Vakzinen, TP: 5\", \"Verbundprojekt: Optimierung der industriellen zellkulturbasierten Herstellung von Influenza Vakzinen, TP 1\", \"Go-Bio 1B: Pharmakologisch optimierte Ribonukleins\\u00e4uren als rekombinante Impfstoffe und Immunadjuvantien\", \"BioChancePLUS-4: Entwicklung eines immunologisch wirksamen therapeutischen Impfstoffs zur Behandlung von Glioblastomen.\", \"BioChancePLUS-4: Entwicklung eines immunologisch wirksamen therapeutischen Impfstoffs zur Behandlung von Glioblastomen\", \"GO-Bio1: Pharmakologisch optimierte Ribonukleins\\u00e4uren als rekombinante Impfstoffe und Immunadjuvantien\", \"BioChancePLUS: Entwicklung eines Sequenz-stabilisierten RNA-Impfstoffs (RNActiveTM) gegen Krebserkrankungen\", \"BioChancePLUS: Neuartige Verfahren zur Entwicklung verbesserter Lebendimpfstoffe\", \"Verbundprojekt: BioProfile Braunschweig/G\\u00f6ttingen/Hannover: Entwicklung von bakteriellen Negativmarker-Impfstoffen f\\u00fcr landwirtschaftliche Nutztiere\", \"BioChance: Synthetische Gene: Verbessertes Sicherheits- und Wirksamkeitsprofil von DNA-Impfstoffen und Gentherapie-Vektoren\", \"KMU-innovativ: Entwicklung eines Produktionsverfahrens zur Herstellung stabiler RNA-Impfstoffe (StabiRNA)\", \"Herstellung und Erprobung genmodifizierter Tumorzellvakzine\", \"Herstellung und Erprobung genmodifizierter Tumorzellvakzine\", \"Aktive und Passive Immunisierung Gegen Pseudomonas Aeruginosa mit Gentechnisch Gewonnenen Vaccinen\", \"Aktive und Passive Immunisierung Gegen Pseudomonas Aeruginosa mit Gentechnologisch Gewonnenen Vaccinen\", \"F\\u00f6rderung einer Initiative zur Entwicklung und Verwertung von Impfstoffen\", \"Verbundprojekt: Individualisierte Tumorimpfstoffe - Individualized Vaccines for Cancer (IVAC), Teilprojekt (TP) 2\", \"Verbundprojekt: Individualisierte Tumorimpfstoffe - Individualized Vaccines for Cancer (IVAC), Teilprojekt (TP) 1\", \"Verbundprojekt Translationales Sarkom-Netzwerk (TranSaRNet): Verbesserung der Tumorvakzine-Therapie\", \"Verbundprojekt: Entwicklung einer RNA-DC Vakzine im Melanommodell\", \"Entwicklung und Validierung von prophylaktischen und therapeutischen Impfstoffkandidaten gegen die Chagas Krankheit\", \"ERA-Net: Selbst-replizierender RNA-Impfstoff gegen Hepatitis C Genotyp 2, zielgerichtet auf dendritische Zellen\", \"Does a Customized Website Affect HPV Vaccine Use among Latino Adolescents and Young Adults?\", \"\\u80bf\\u7624\\u5fae\\u73af\\u5883\\u4e2dEPCs\\u88c2\\u89e3\\u7269\\u81f4\\u654f\\u7684DC\\u75ab\\u82d7\\u6297\\u80bf\\u7624\\u8840\\u7ba1\\u751f\\u6210\\u7684\\u7814\\u7a76\", \"\\u643a\\u5e26\\u767b\\u9769\\u75c5\\u6bd2CTL\\u8868\\u4f4d\\u7684\\u5d4c\\u5408VLP\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"Animal Challenge study of novel shigella vaccine antigens common to multiple serotypes\", \"Mucin-Based Breast Tumor Vaccine-Can Help Be Generated Where Help is Needed?\", \"Development of a Novel Vaccine with Fusions of Human Dendritic and Breast Cancer Cells\", \"Development of Human Dendritic Cell Vaccines for Treatment of Breast Cancer\", \"DNA-Based Vaccine for Treatment of Breast Cancer\", \"Dansk titel: En plante-produceret vaccine mod grise PRRS\", \"Dansk titel: Produktion af allergivacciner m\\u00e5lrettet mod antigen pr\\u00e6senterende celler\", \"Probiotics For Food Preservation, Functional Foods As Vaccine And Vector For Delivery Systems\", \"NSERC/Sanofi Industrial Research Chair in vaccine mathematics, modelling and manufacturing\", \"Vaccine-induced protection against bacterial infections in Arctic charr (Salvelinus alpinus)\", \"Bilan de masse permettant le d\\u00e9veloppement de nouveaux vaccins et anticorps \\u00e0 base de plantes\", \"Interactions Between Vaccines and Excipients Affecting Thermal Stability After Spray-Drying\", \"Development of Orf virus (ORFV) as a multivalent vaccine vector platform against Toxoplasma gondii\", \"Characterization of Rotavirus Strains and Development of Candidate Vaccine Derived From Children With Diarrhea.\", \"Development of Dendritic Cell-Based Vaccines With Osteotropism for Treatment of Bone Metastasis\", \"Characterization and Development of CELiD for Gene Transfer and DNA Vaccine Purposes\", \"Identification and Development of Potential Subunit Vaccine Candidates Against Leptospirosis\", \"Immunomodulation of Neu5Gc Glycopeptides with Biomaterials: A Potential Vaccine Platform.\", \"Programming Protective Efficacy of BCG-Vaccine Using Novel TLRs Adjuvant Nano-Formulations\", \"Animal Model Malaria: Its Application to Preclinical Trials of Adenoviral Anti-Malaria Vaccine\", \"Designing an Effective T-Cell Vaccine for Rheumatic Fever and Rheumatic Heart Disease\", \"Development of Therapeutic Vaccine Against Bovine Papilloma Virus Induced Equine Sarcoids\", \"Control of Contagious Bovine Pleuropneumonia: The Need for Vaccine Development\", \"Analysis of the immune response in mice to Semliki Forest-based vaccine vectors\", \"Harnessing the immunostimluatory activity of chitosan to produce potent vaccine adjuvants\", \"Validation of lipoproteins/lipopeptides as adjuvants and antigens for a new pertussis vaccine\", \"Recombinant human papillomavirus 16 vaccine against cervical cancer in women\", \"Immunogenecity and functional analysis of an amoebic vaccine candidate\", \"Leishmania vaccine development II: Transition from in vitro studies to clinical trials\", \"A Nano-on-micro Delivery System for a Vaccine/Adjuvant againts Helicobacter pylori\", \"Canadian network for vaccines and immunotherapeutics of cancer and chronic viral diseases (CANVAC)\", \"Immune correlates of protection in SIV and HIV vaccine development\", \"Antibody libraries for discovering vaccine leads against HIV-1\", \"Initiative to develop a Canada-wide vaccine epidemiology and clinical trials consortium\", \"Developing novel vaccines for respiratory syncytial virus and parainfluenza virus type 3\", \"Novel molecular approaches for the development of live vaccines against leishmaniasis\", \"Nanoparticle delivery of cancer vaccines and immunomodulators for overcoming immunosuppression\", \"MHC supertypes and epitope-based HIV-1 vaccine design\", \"MHC supertypes and epitopes-based HIV-1 vaccine design\", \"Development of a neonatal pertussis vaccine: One shot for life\", \"Development of a vaccine for Chlamydia pneumoniae infection in a rabbit model\", \"HIV therapy trials:  Assessment of antiretroviral drug treatments and vaccine development\", \"Topical toll-like receptor activation for optimization of vaccine immune responses\", \"Analysis of genetic variations between strains of the Bacille Calmette-Guerin vaccine.\", \"Targeted cancer vaccines: Synthesis and evaluation of clustered cancer associated carbohydrate antigens\", \"Generation of a novel therapeutic dendritic cell- based HIV vaccine\", \"Innovative vaccine development and delivery to induce mucosal immunity\", \"Linking Innate and Specific Immunity to Develop Single Dose Vaccine for Neonates\", \"Development of oral parvo virus vaccine combined with probiotics as spray\", \"Do Pentavalent vaccines have sex-differential non-specific effects?\", \"Elucidating the therapeutic potential of plasmacytoid dendritic cells in cell-based vaccines.\", \"Centre de recherche en infectiologie porcine et avicole (CRIPA)\", \"Phase I/II clinical trial of DNA idiotype vaccines in untreated stage A CLL\", \"Analysis of molecules important for vaccine protection against EBV infection\", \"Analysis of molecules important for vaccine protection against EBV infection\", \"\\u5358\\u7403\\u306e\\u63a5\\u7740\\u6a5f\\u69cb\\u306e\\u89e3\\u660e\\u304a\\u3088\\u3073\\u6a39\\u72b6\\u7d30\\u80de\\u7642\\u6cd5\\u30ef\\u30af\\u30c1\\u30f3\\u88fd\\u9020\\u6280\\u8853\\u3078\\u306e\\u5fdc\\u7528\", \"\\ud610\\uae30\\uc801\\uc870\\uac74\\uc5d0\\uc11c \\ubc30\\uc591\\ub41c \\uc2e0\\uac1c\\ub150\\uc758 \\ucf5c\\ub808\\ub77c \\ubc31\\uc2e0 \\uac1c\\ubc1c \\ubc0f \\ud6a8\\ub2a5\\ud3c9\\uac00\", \"\\ub098\\ub178 \\uae30\\ubc18 Bioparticle\\uc758 \\uc2e0\\uac1c\\ub150 \\ubc31\\uc2e0 \\uc804\\ub2ec\\uccb4 \\uac1c\\ubc1c \\ubc0f \\ubc29\\uc5b4 \\uba74\\uc5ed \\uc5f0\\uad6c\", \"\\uc778\\uc720\\ub450\\uc885\\ubc14\\uc774\\ub7ec\\uc2a4 10\\uac00 \\ubc31\\uc2e0\\uc758 \\uba74\\uc5ed\\ud559\\uc801 \\uae30\\uc804 \\ubc0f \\ubd84\\uc11d\\ubc95 \\uac1c\\ubc1c\", \"\\uc2e0\\uac1c\\ub150 delivery system\\uacfc Secretory \\ubc1c\\ud604 vector\\ub97c \\uc774\\uc6a9\\ud55c \\uac10\\uc5fc\\ubcd1\\uc608\\ubc29\\uc6a9 \\ubc31\\uc2e0\\uac1c\\ubc1c\", \"\\ubc14\\uc774\\ub7ec\\uc2a4 \\uc9c8\\ubcd1 \\uc608\\ubc29\\uacfc \\uce58\\ub8cc\\ub97c \\uc704\\ud55c \\ucc28\\uc138\\ub300 \\uc720\\ub2c8\\ubc84\\uc124 \\ubc31\\uc2e0\\uac1c\\ubc1c\", \"TM4SF5\\ub97c \\ud45c\\uc801\\uc73c\\ub85c \\ud558\\ub294 \\ucdcc\\uc7a5\\uc554 \\uc608\\ubc29 \\ubc0f \\uce58\\ub8cc\\ubc31\\uc2e0\\uc758 \\ud6a8\\ub2a5 \\ubc0f \\uc791\\uc6a9\\uae30\\uc804 \\uaddc\\uba85\", \"\\ucf5c\\ub808\\ub77c \\ub3c5\\uc18c\\ubc14\\uc774\\ub7ec\\uc2a4 CTX phage\\uc758 \\uc9c4\\ud654\\uc640 \\ucf5c\\ub808\\ub77c \\ubc31\\uc2e0 \\ub514\\uc790\\uc778\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"\\ubd84\\ud574\\uc131 \\uace0\\ubd84\\uc790 PLGA\\ub97c \\uc774\\uc6a9\\ud55c \\uc5b4\\ub958 \\ubc31\\uc2e0\\uc758 \\uc57d\\ub9ac\\uc801, \\uba74\\uc5ed\\ud559\\uc801 \\ud3c9\\uac00\", \"\\ub124\\ud314 \\uace0\\uc0b0\\uc9c0\\uc5ed \\uc2e0\\uc7ac\\uc0dd \\uc5d0\\ub108\\uc9c0\\uc6d0\\uc744 \\uc774\\uc6a9\\ud55c \\uc6d0\\uac70\\ub9ac \\ubc31\\uc2e0 \\uc804\\ub2ec \\uc2dc\\uc2a4\\ud15c\\uc758 \\uad6c\\ucd95\", \"\\uba74\\uc5ed\\uc6d0\\uc131\\uc774 \\uac15\\ud654\\ub41c \\ud56d\\uc6d0\\uc744 \\uc774\\uc6a9\\ud55c \\ub385\\uae30 \\ubc14\\uc774\\ub7ec\\uc2a4 \\ubc29\\uc5b4\\uc6a9 \\uacbd\\uad6c\\ubc31\\uc2e0 \\uae30\\uc220 \\uc5f0\\uad6c\", \"\\uac10\\uc5fc\\uc131 \\uc9c8\\ud658 \\uc608\\ubc29 \\ubc31\\uc2e0\\uc758 \\ub9c8\\uc774\\ud06c\\ub85c\\ub2c8\\ub4e4 \\uae30\\ubc18 \\ud328\\uce58\\ub85c\\uc758 \\uc751\\uc6a9 \\ubc0f \\uc2e4\\uc6a9\\ud654 \\uc5f0\\uad6c\", \"\\uc545\\uc131\\ub1cc\\uc885\\uc591\\uc5d0\\uc11c Branched multipeptide vaccine\\uc758 \\ud65c\\uc131\\uae30\\uc804 \\uc5f0\\uad6c \\ubc0f \\uc751\\uc6a9\", \"\\ub09c\\uce58\\uc131\\uc554 \\uce58\\ub8cc\\uc6a9 \\uba74\\uc5ed\\uc138\\ud3ec \\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc744 \\uc704\\ud55c \\uc885\\uc591 \\uba74\\uc5ed\\ud559\\uc801 \\uc5f0\\uad6c\", \"\\uacb0\\ud575\\ub9cc\\uc131\\uac10\\uc5fc \\ud2b9\\uc774\\ud56d\\uc6d0\\uc744 \\uc774\\uc6a9\\ud55c \\uacb0\\ud575\\uc608\\ubc29\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc544\\uba54\\ubc14\\uc131 \\uc218\\ub9c9\\ub1cc\\uc5fc \\ubc31\\uc2e0\\uc744 \\uc704\\ud55c \\ud2b9\\uc774 \\uc720\\uc804\\uc790 \\ubc0f \\ubca1\\ud130 \\uc2dc\\uc2a4\\ud15c \\uac1c\\ubc1c\", \"\\ubc31\\uc2e0 \\ud50c\\ub7ab\\ud3fc \\uc801\\uc6a9\\uc744 \\uc704\\ud55c \\ub3fc\\uc9c0 \\ud30c\\ub77c\\uc778\\ud50c\\ub8e8\\uc5d4\\uc790 \\ubc14\\uc774\\ub7ec\\uc2a4 \\uae30\\ubc18 \\ubca1\\ud130 \\uac1c\\ubc1c\", \"\\ud55c\\uc77c \\uc5ec\\ub958\\uc791\\uac00\\uc758   \\ube44\\uad50\\uc5f0\\uad6c  -\\ud788\\ub77c\\ubc14\\uc57c\\uc2dc \\ub2e4\\uc774\\ucf54\\uc640 \\ubc31\\uc2e0\\uc560 \\uc744 \\uc911\\uc2ec\\uc73c\\ub85c\", \"\\uccb4\\uc801\\ubcc0\\ub3d9\\uce21\\uc815\\uc7a5\\uce58 \\uae30\\ubc18 \\ube44\\uc8fc\\uc0ac\\ud615 \\ubc31\\uc2e0\\uc804\\ub2ec \\uc6d0\\ucc9c\\uae30\\uc220\\uac1c\\ubc1c\", \"\\ub098\\ub178\\ubc31\\uc2e0: \\ud56d\\uc6d0 \\ud2b9\\uc774 \\uba74\\uc5ed\\ubc18\\uc751 \\uc99d\\uc9c4\\uc744 \\uc704\\ud55c \\uc0c8\\ub85c\\uc6b4 \\uc804\\ub7b5\", \"\\ud504\\ub85c\\ud14c\\uc624\\ubbf9\\uc2a4\\uc640 DNA \\ubc31\\uc2e0\\uae30\\uc220\\uc744 \\uc774\\uc6a9\\ud55c \\ud6a8\\uacfc\\uc801\\uc778 \\ub3cc\\ub3d4 \\uc774\\ub9ac\\ub3c4\\ubc14\\uc774\\ub7ec\\uc2a4 \\ud56d\\uc6d0 \\ud0d0\\uc0c9\", \"\\uba74\\uc5ed\\uc870\\uc808\\ubd84\\uc790\\ub97c \\ubc1c\\ud604\\ud558\\ub294 \\ubc14\\uc774\\ub7ec\\uc2a4 \\uc720\\uc0ac\\uc785\\uc790 \\uae30\\ubc18 \\ubc31\\uc2e0 \\ud50c\\ub7ab\\ud3fc \\uac1c\\ubc1c\", \"\\uc885\\uc591\\uce58\\ub8cc\\ubc31\\uc2e0 \\ubc0f \\uc720\\uc804\\uc790/\\ud56d\\uccb4/\\ub2e8\\ubc31\\uc9c8 \\uce58\\ub8cc\\uc81c\\uc758 \\ubcf5\\ud569 \\ud56d\\uc885\\uc591\\uce58\\ub8cc\\ud6a8\\uacfc \\uaddc\\uba85\", \"\\ud3d0\\uad6c\\uade0 \\ud611\\ub9c9 \\ub2e4\\ub2f9\\uccb4\\uc758 \\uc0dd\\ud569\\uc131 \\uae30\\uc804\\uc744 \\uc774\\uc6a9\\ud55c \\ud611\\ub9c9 \\ub2e4\\ub2f9 \\ubc31\\uc2e0 \\uc720\\ub3c4\\uccb4 \\uac1c\\ubc1c\", \"\\uc870\\uc9c1\\uc774\\uc2dd\\uc2dc \\uba74\\uc5ed\\uac70\\ubd80\\ubc18\\uc751\\uc744 \\uc5b5\\uc81c\\ud558\\uae30 \\uc704\\ud55c \\uc218\\uc9c0\\uc0c1 \\uc138\\ud3ec \\ubc31\\uc2e0\\uc81c\\uc791\", \"\\ubc31\\uc2e0 \\ud6a8\\ub2a5 \\uc99d\\uac00\\ub97c \\uc704\\ud574 CD8+ T \\uc138\\ud3ec \\uc5d0\\ud53c\\ud1a0\\ud504\\uc758 \\uc6b0\\uc120 \\uc21c\\uc704\\ub97c \\uc2e0\\uc0dd\\uc544 \\ub9c8\\uc6b0\\uc2a4\\uc640 \\uc131\\uccb4 \\ub9c8\\uc6b0\\uc2a4\\uc5d0\\uc11c \\ube44\\uad50 \\uc5f0\\uad6c\", \"\\ubc14\\uc774\\ub7ec\\uc2a4 \\uc720\\uc0ac\\uc785\\uc790\\ub97c \\uc774\\uc6a9\\ud558\\uc5ec \\ud638\\ud761\\uae30 \\uc138\\ud3ec\\uc735\\ud569 \\ubc14\\uc774\\ub7ec\\uc2a4 \\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc744 \\uc704\\ud55c \\uadfc\\uac04 \\uc5f0\\uad6c\", \"\\ud3f4\\ub9ac\\uac10\\ub9c8\\uae00\\ub8e8\\ud0d0\\uc0b0 \\ub098\\ub178 \\uc544\\uc96c\\ubc88\\ud2b8 \\uc18c\\uc7ac\\ub97c \\uc774\\uc6a9\\ud55c \\uc778\\ud50c\\ub8e8\\uc5d4\\uc790 \\ub300\\uc720\\ud589 \\ub300\\uc751 \\ubc31\\uc2e0 \\uc5f0\\uad6c\", \"\\uba54\\ucee4\\ub2c8\\uc998 \\uae30\\ubc18 \\ub3c5\\uac10\\ubc14\\uc774\\ub7ec\\uc2a4 \\uc57d\\ub3c5\\ud654 \\uc0dd\\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"\\ud56d\\uc6d0\\ubcf4\\uc870\\uc81c(adjuvant)\\ub85c\\uc11c \\ub098\\ub178\\ubc31\\uc2e0\\uc804\\ub2ec\\uc2dc\\uc2a4\\ud15c\\uc758 \\uae30\\uc804 \\ubc0f \\ud6a8\\ub2a5 \\uc5f0\\uad6c\", \"\\uc124\\ud558\\uc811\\uc885\\uc5d0 \\uc758\\ud55c RSV \\ubc31\\uc2e0 \\uc720\\ub3c4 \\ud638\\uc0b0\\uad6c\\uc99d\\uc758 \\ubc1c\\uc0dd\\uae30\\uc804 \\uc5f0\\uad6c\", \"\\ud569\\uc131 \\uacb0\\ud575\\ub2e8\\ubc31\\uc744 \\uc774\\uc6a9\\ud55c \\ud56d\\uacb0\\ud575 \\uba74\\uc5ed\\uae30\\uc791 \\ubd84\\uc11d\\uacfc \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc554/\\uc815\\uc18c \\ud56d\\uc6d0 CAGE \\ub2e8\\ubc31\\uc9c8\\uc744 \\uc774\\uc6a9\\ud55c \\ud56d\\uc554 \\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"\\ubc15\\ud14c\\ub9ac\\uc544 \\uc6d0\\ud615\\uc9c8\\uccb4 \\uc720\\ub798 \\ub098\\ub178\\uc18c\\ud3ec\\uccb4\\ub97c \\uc774\\uc6a9\\ud55c \\ud328\\ud608\\uc99d \\ubc0f \\uc554\\ubc31\\uc2e0 \\uac1c\\ubc1c\\uacfc \\uba74\\uc5ed\\ud559\\uc801 \\uae30\\uc791 \\uc5f0\\uad6c\", \"\\uc0c8\\ub85c\\uc6b4 \\uc57d\\ub3c5\\ud654\\ubcc0\\uc774\\uc8fc\\ub97c \\uc774\\uc6a9\\ud55c \\uc18c \\ube0c\\ub8e8\\uc140\\ub77c\\ubcd1 \\uc608\\ubc29\\uc6a9 \\uc0dd\\uade0 \\ubc31\\uc2e0\\uc8fc \\uac1c\\ubc1c\", \"\\uac1c \\uc778\\ud50c\\ub8e8\\uc5d4\\uc790 \\ubc14\\uc774\\ub7ec\\uc2a4\\uc758 \\uba74\\uc5ed\\ubcd1\\ub9ac \\uae30\\uc804 \\uc5f0\\uad6c \\ubc0f \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\ud55c\\uad6d\\uc758 \\uc54c\\ub7ec\\uc820\\uc744 \\uc774\\uc6a9\\ud55c \\uc7ac\\uc870\\ud569 \\uc54c\\ub7ec\\uc9c0 \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc591\\uc2dd\\uc5b4\\ub958\\uc758 \\ube44\\ube0c\\ub9ac\\uc624\\uc99d\\uc5d0 \\ub300\\ud55c \\uc7ac\\uc870\\ud569 cadaver \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\ud56d\\uc6b0\\uc2dd \\ubc31\\uc2e0\\uc73c\\ub85c\\uc11c S. mutans\\uc5d0 \\ub300\\ud55c \\ub2e8\\uc77c\\ud56d\\uccb4\\uc758 \\ud6a8\\uacfc\", \"B \\uc138\\ud3ec\\ub97c \\ud56d\\uc6d0 \\uc81c\\uc2dc\\uc138\\ud3ec\\ub85c \\ud65c\\uc6a9\\ud55c \\uc790\\uad81\\uacbd\\ubd80\\uc554 \\uce58\\ub8cc\\ubc31\\uc2e0 \\uac1c\\ubc1c \\uae30\\ud68d\", \"\\uc2e0\\uc7ac\\uc870\\ud569 \\ubca1\\ud130 \\uc2dc\\uc2a4\\ud15c\\uc744 \\uc801\\uc6a9\\ud55c \\ub178\\ub85c\\ubc14\\uc774\\ub7ec\\uc2a4 \\ubc31\\uc2e0\\uac1c\\ubc1c\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"\\uc2dd\\uc911\\ub3c5 \\ubc1c\\uc0dd\\uac10\\uc18c\\ub97c \\uc704\\ud55c Salmonella Typhimurium\\uc758 \\uc608\\ubc29 \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\ucc28\\uc138\\ub300 \\ubc31\\uc2e0\\uac1c\\ubc1c\\uc744 \\uc704\\ud55c \\uc218\\uc9c0\\uc0c1\\uc138\\ud3ec subset targeting strategy\\uc640 \\uba74\\uc5ed\\uc81c\\uc5b4 \\uba54\\uce74\\ub2c8\\uc998 \\uc5f0\\uad6c\", \"\\uc885\\uc591\\uce58\\ub8cc\\uc6a9 \\uc720\\uc804\\uc790\\ubc31\\uc2e0\\uc758 \\uac1c\\ubc1c \\ubc0f \\uce58\\ub8cc\\uae30\\uc804 \\uaddc\\uba85\", \"Streptococcus parauberis \\ubcd1\\uc6d0\\uc131\\uad00\\ub828 \\uc138\\ud3ec \\ud45c\\uba74 fibronectin-binding adhesins\\uc758 \\uae30\\ub2a5\\ud574\\uc11d \\ubc0f vaccine \\uac1c\\ubc1c\", \"\\uace0\\ubcd1\\uc6d0\\uc131 W-Beijing \\uacb0\\ud575\\uade0\\uc8fc\\ub97c \\uc774\\uc6a9\\ud55c \\uacb0\\ud575\\uc608\\ubc29\\ubc31\\uc2e0\\ud6c4\\ubcf4\\ub4e4\\uc758 \\uc608\\ubc29\\ud6a8\\uacfc\\ud3c9\\uac00\", \"\\ucca8\\ub2e8 \\uc720\\uc804\\uacf5\\ud559\\uae30\\ubc95\\uc744 \\uc774\\uc6a9\\ud55c \\uc0b4\\ubaa8\\ub12c\\ub77c \\ubc31\\uc2e0\\uc758 \\uac1c\\ubc1c \\ubc0f \\ud6a8\\ub2a5\\uc5f0\\uad6c\", \"\\uc0ac\\uc721\\uc628\\ub3c4\\uad00\\ub9ac\\uc5d0 \\uc758\\ud55c \\uc5b4\\ub958 \\ubc14\\uc774\\ub7ec\\uc2a4\\uc758 \\ubcd1\\ub3c5\\uc131 \\uc81c\\uc5b4\\uc640 \\uc0dd\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\ub178\\ub85c\\ubc14\\uc774\\ub7ec\\uc2a4 VLPs \\ubc0f synthetic peptides\\ub97c \\uc774\\uc6a9\\ud55c \\uac10\\uc5fc \\ubc0f \\ubc31\\uc2e0 \\uc5f0\\uad6c\", \"Role of the PD-1/PD-L pathway in HIV-1 vaccine design\", \"To convene global experts to address RSV vaccine research and development issues\", \"Novel Idiotype-Based Genetic Vaccines for the Treatment of Lymphoid Malignancies\", \"Manufacturing Technology Centre for Human Vaccines and Pharmaceuticals\", \"Development of DNA Vaccine Biotechnology in Hong Kong\", \"IND Filing and Phase I Clinical Trial of a Malaria Vaccine TBV25H\", \"Liver Cancer Vaccine Development:- Cell Culture Scale-Up Prototype Production Prior IND Application\", \"Liver Cancer Vaccine Development:- Cell Culture Scale-Up Prototype Production Prior IND Application\", \"Development of Novel Second Generation Broad-spectrum hTERTC27-based Therapeutic Tumor Vaccine\", \"Liver Cancer Vaccine Development:- Cell Culture Scale-Up Prototype Production Prior IND Application\", \"Development of HPV Therapeutic Vaccine and Related Immunotherapy for Treating Cervical Cancer\", \"Development of Recombinant Vaccine Candidates for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)\", \"Generation of an adenovirus-based vaccine against infection with cytomegalovirus\", \"The effect of early measles vaccine on pneumococcal carriage\", \"LOW-TOX: Enabling Highly Efficient, Low-Toxicity Fish Vaccines\", \"Accelerating development of vaccines against cancer with pigs as a large animal model (CANVACPIG)\", \"Structure-based design of a vaccine to prevent severe childhood malaria\", \"The cellular immunogenicity of HPV-vaccines in adults with HIV infection\", \"Vaccine induced T cell responses at respiratory surfaces \\u2013 the requirement for long-term protection\", \"Developing a therapeutic TB vaccine through molecular design and immunization route\", \"Design of a microfluidics method for preparation of the liposomal vaccine adjuvant CAF09\", \"Malaria Vaccine Development: Protecting Our Troops\", \"Tulane/Xavier Vaccine Peptide Program\", \"Tulane/Xavier Vaccine Development/Engineering Project\", \"DNA Vaccine-Mediated Immunotherapy for an Animal Model for Rheumatois Arthritis\", \"Reverse Genomics: Portin Microarrays to Guide Tolerizing DNA Vaccine Treatment of Rheumatoid Arthritis\", \"Outer Surface Protein (Osp) C Vaccine for Lyme Disease\", \"Pilot Project: Using Parent Preferences in Decisions about Childhood Vaccines\", \"Evaluation of alternative methods for the detection of porcine cytomegalovirus in veterinary vaccines\", \"The development of a monoclonal antibodybased ELISA for measuring antibodies to leptospira vaccines\", \"Validation of tests used in the quality control of vaccines [was VM0107]\", \"Development of in vitro tests for the determination of the potency of Clostridial vaccines\", \"Evaluation of the immunosuppression test for live infectious bursal disease vaccines\", \"Validation of tests used in the quality control of vaccines [became VM0114]\", \"Development of methods for detecting retroviruses and other viruses in cell lines and vaccines\", \"Development of methods for detecting chicken anaemia virus in vaccines\", \"Development & evaluation of standards to assess QC methods for cat & dog vaccines [became VM0112]\", \"Development of vaccine candidates for protection of badgers against infection with Mycobacterium bovis\", \"Protective immune responses induced by FMDV vaccine\", \"Maintenance and quality control of the vaccine bank\", \"Identification of the origin of footandmouth Disease outbreaks and improved selection methods for vaccines\", \"Development of vaccines to protect badgers against M. bovis [was part SE0110]\", \"Live Salmonella vaccines for the protection of poultry (continuation of OZ0131)\", \"Development of a vaccine to control the poultry red mite & improve laying hen welfare.\", \"Engineering the Surface of Transferrin Binding Protein B for Vaccine\", \"Mechanism of action of a novel respiratory syncytial virus subunit vaccine formulation.\", \"Application of a new small RNA molecule as a vaccine adjuvant\", \"Effects of sialylated capsular polysaccharides from Streptococci on the immunogenic capacity ofconjugate vaccines\", \"Development of live attenuated respiratory syncytial virus vaccines with novel thermal stable fusion protein\", \"93518024\", \"New Application of a DNA-nanorod Platform for Vaccine Development\", \"Serological Vaccine Standards for Ebola, Zika and MersCoV\", \"Development of inducible expression-inactivated Leishmania as vaccine carries\", \"Adjuvant free vaccines and companion diagnostics to control emerging flaviviruses\", \"Using engineered gut bacteria-derived microvesicles for plague vaccines\", \"To support the pre-clinical development of a measles and rubella vaccine microarray patch\", \"This grant will enable vaccine experts from developing countries to participate in the Vaccine Bioprocess and Commercialization three-day workshop in June 2017. The skills learned will improve technology transfer and improve local vaccine development and manufacturing so that vaccines can be provided at an affordable price, which will, in turn, lead to local employment.\", \"\\u7d30\\u80de\\u5185\\u6a19\\u7684\\u5316\\u30b9\\u30de\\u30fc\\u30c8\\u30ca\\u30ce\\uff24\\uff24\\uff33\\u3092\\u7528\\u3044\\u305f\\u52b9\\u7387\\u7684\\u304b\\u3064\\u5b89\\u5168\\u306a\\u304c\\u3093\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Research fellowship to study HIV vaccines\", \"Diagnostic probes and vaccines against dysentry due to shigella flexneri\", \"Will Synthetic T cell determinants be a useful componen t of influenza vaccines?\", \"An animal model to test vaccines against cervical cance r\", \"Genetically disabled murine cytomegalovirus vaccines: efficacy of single-cycle replication mutants\", \"Vaccine to be taken by mothers to prevent rotaviral dia rrhoea in children\", \"Identification of novel stage-specific vaccine candidates for schistosomes using local antibody secreting cell probes\", \"A model for evidence based introduction of a new vacine to Australia - human papillomavirus vaccine\", \"Preparing for group A streptococcal vaccines: epidemiology and immunology of group A streps in Fiji\", \"Studies on a recombinant attenuated salmonella vaccine carrying HIV antigens\", \"Evidence-based health policy and modelling research in vaccine preventable diseases\", \"Secretory and Surface Proteins of Blood-feeding Helminths: Roles in Parasitism and Effacies as Vaccines\", \"The epidemiology and economic impact of vaccine preventable, childhood respiratory infections in the community\", \"Immuno-epidemiological studies of vaccine responses in developing world populations\", \"Enhancing and evaluating T cell responses to candidate HIV prime-boost vaccines\", \"Assessment of a surface component of the malaria parasi te for use in a vaccine\", \"Immunisation with an oral vaccine against bronchitis mode of action\", \"Phase variation of LPS expression in Neisseria meningitidis; role in pathogenesis and vaccine development.\", \"Box jellyfish venom toxins: how they act,study of vaccines and specific antitoxin\", \"Devlopment of a vaccine against hookworm infection in d ogs and humans\", \"Testing vaccine to prevent pneumonia in high risk child ren\", \"Meningococcal surface structures: role in disease and p otential as a vaccine candidates\", \"A model for understanding human papillomavirus infectio n, and a vaccine\", \"The potential of influenza vaccines designed to stimulate crossreactive T-cell immunity\", \"Development of mucosal anti-adhesive vaccines against group A streptococci\", \"A novel type of vaccine for use against sexually transm itted chlamydial disease\", \"Humanized melanoma mouse models for translational assessment of neoantigen-based vaccines\", \"To assess the impact of pneumococcal conjugate vaccine used in a 3+0 schedule\", \"Therapeutic CD8 vaccines against conserved E7 HPV epitopes identified by MS\", \"To explore development of a nimble and focused experimental medicine (EM) approach to vaccine research\", \"To develop single dose vaccines for neonates by linking innate and specific immunity\", \"To develop a stealth measles vaccine which can be administered safely to young infants\", \"To fund effective and affordable dengue vaccines for children in dengue-endemic areas\", \"To further explore an innovative strategy to develop a vaccine against HIV pathogenesis.\", \"To develop more accurate and timely measurement of population immunity generated by polio vaccines\", \"To develop a bivalent conjugate vaccine against S. Typhi and S. Paratyphi A\", \"To support phase I clinical trials with the new oral polio vaccine-2 formulation\", \"To improve the effectiveness of oral poliovirus vaccine in lower-income settings\", \"To support the think tank: HIV Vaccines for Developing Countries: Initiation of Trials in Africa\", \"To continue support of the Global HIV Vaccine Research Cryorepository (GHRC)\", \"To develop and license an improved vaccine against tuberculosis for use in high burden countries\", \"To conduct a landscape analysis of potential pandemic flu vaccine technologies\", \"To conduct research related to the influence of adenovirus infections on HIV-1 vaccine performance\", \"To test a potentially novel vaccine target towards malaria eradication\", \"To support broad literacy and current awareness around vaccines and global health\", \"To assess the dengue vaccine development efforts underway at Chengdu Institute of Biological Products (CDIBP)\", \"To evaluate the effect of pneumococcal conjugate vaccine given in the routine infant schedule\", \"To develop a novel delivery strategy for HIV vaccine antigens\", \"For the creation of \\\"The State of Vaccine Confidence Report\\u201d and web-based supplemental resources\", \"To support a conference entitled \\\"Vaccines for viruses in developing countries\\\"\", \"To provide conference support for the Global Vaccine Research Forum\", \"To develop \\u201csingle-shot\\u201d ultra-stable vaccine formulations that reduce costs for vaccinations\", \"To develop global consensus on regulatory specifications for evaluation of second generation HPV vaccines\", \"To support the development of a preventive vaccine against HIV-1\", \"To evaluate and develop a cross-species synthetic saccharide vaccine for malaria\", \"To develop an effective HIV vaccine to control the transmission of human immodeficiency viruses\", \"To develop an effective and safer poliovirus vaccine to prevent paralytic poliomyelitis\", \"To research Human Polyomavirus BKV as a HIV Vaccine Vector\", \"To fund a conference called Stop Cervical Cancer: Accelerating Global Access to HPV Vaccines\", \"To co-sponsor a scientific workshop to discuss immune correlates of protection on HIV vaccines\", \"To develop technology for rapid low cost delivery of malaria vaccine\", \"To develop safe, effective, and affordable vaccines for introduction into the developing world\", \"To develop a reduced antigen and reduced dose inulin-adjuvanted inactivated poliovirus vaccine.\", \"To use polymeric nanoparticles and engineered proteins to deliver vaccines to immune cells\", \"To develop a live, recombinant, attenuated Salmonella anti-pneumococcal vaccine for newborns\", \"To convene an international symposium to discuss enteric diseases vaccines.\", \"To provide estimates of vaccine impact across relevant countries and under various scenarios\", \"To convene an international symposium to discuss the latest information on ETEC vaccines\", \"To convene an international symposium to discuss upstream rotavirus vaccine candidates and worldwide supply issues.\", \"To facilitate the eradication of polio by understanding mechanisms of protection afforded by vaccines\", \"To engineer a live virus with a self-destruct sequence for use in a vaccine\", \"To produce antigens for use in edible vaccines against infectious diseases.\", \"To design an effective vaccine against HIV: An Alternative Hypothesis\", \"To application of epidemiological models to guide and evaluate control of vaccine-preventable infections\", \"To create novel mouse models for testing live attenuated vaccines\", \"To reduce the time and cost for trials of vaccines against bacterial pneumonia\", \"To develop immunogens for a vaccine that will prevent pregnancy malaria globally\", \"To use newly identified intracellular signaling molecules as components of DNA vaccines against malaria.\", \"To evaluate efficiency of PnuVax's novel conjugation chemistry for making pneumococcal conjugate vaccine\", \"To complete the development of a novel vaccine against cholera\", \"To create novel mouse models for testing HIV and HCV vaccines\", \"To develop and license an improved TB vaccine for use in high burden countries\", \"To support the development and evaluation of HPV vaccines and related diagnostics\", \"To develop needleless vaccines for tuberculosis that are safe, stable and effective\", \"To develop novel recombinant adenovirus, plasmid DNA, and mycobacteria vector-based vaccines for HIV-1\", \"To evaluate the impact of pnuemococcal conjugate vaccine in Togo\", \"To research use of a nanopatch delivery of DNA-based malaria vaccines to skin\", \"To produce an effective, manufacturable, affordable and sustainable Human Hookworm Vaccine (HHV)\", \"To fund a partnership for influenza vaccine introduction in low and lower middle-income countries\", \"To convene an international symposium on enteric disease vaccine development\", \"To develop a novel vector/protein HIV-1 Env vaccine for the developing world\", \"To develop a technology platform for the production of highly immunogenic and affordable polysaccharide vaccines.\", \"To identify and validate new antigens for a vaccine to prevent malaria in pregnant women\", \"To evaluate the effect of pneumococcal conjugate vaccine given in the routine infant schedule\", \"To determine if preexisting gut immunity predicts shedding of poliovirus vaccine.\", \"To support research and development of new influenza vaccines to address pandemic influenza\", \"To support components of the Annual Conference on Vaccine Research\", \"To prevent exportation of pneumococcal surface GAPDH and create an attenuated vaccine\", \"To fund pre-emptive use of a cholera vaccine in vulnerable populations at risk\", \"To develop and validate a novel vaccine for Animal African Trypanosomiasis\", \"To define the protective nature of antibodies that emerge after boosting of the RV144 vaccines\", \"To reduce manufacturing costs of mass-immunization vaccine candidates and simultaneously improve manufacturing efficiencies..\", \"To convene an international conference on global progress regarding the development of new TB vaccines\", \"To improve delivery and efficacy of vaccines for children in less developed countries..\", \"To provide training and guidance to developing country vaccine manufacturers through their Network organization\", \"To work to design components of an HIV vaccine using groups of related envelope sequences.\", \"For protein glycan coupling technology and the development of novel conjugate vaccines\", \"To develop a stealth measles vaccine that is safe and effective in immunizing young infants\", \"To identify new vaccines that induce broadly neutralizing antibodies against HIV\", \"To develop a novel arthropod-based vaccine system against leishmaniasis\", \"To research whether the immune responses to DNA vaccines can be enhanced with novel adjuvants.\", \"To identify antibody correlates of protection for efficacious vaccines to enable product development\", \"To measure the impact of Hib vaccine introduction in Senegal\", \"To use novel recombinant Adenovirus (Ad) vector technologies to develop an HIV vaccine\", \"Extension Submission - Pre-Clinical Development of a Malaria Vaccine\", \"Pre-Clinical Development of a Malaria Vaccine\", \"\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u57fa\\u790e\\u7684\\u554f\\u984c\\u306e\\u7814\\u7a76\", \"\\u72c2\\u72ac\\u75c5\\u9d8f\\u5375\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6539\\u826f\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30cb\\u30e5\\u30fc\\u30ab\\u30c3\\u30b9\\u30eb\\u75c5\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76(\\u7d992\\u5e74)\", \"\\u30a2\\u30e6\\u306e\\u30d3\\u30d6\\u30ea\\u30aa\\u75c5\\u4e0d\\u6d3b\\u5316\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u514d\\u75ab\\u6a5f\\u69cb\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"Salmonella typhimurium \\u306e\\u30ea\\u30dc\\u30be\\u30fc\\u30e0\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u514d\\u75ab\\u539f\\u6027\\u306e\\u89e3\\u660e\", \"\\u7dd1\\u81bf\\u83cc\\u306e\\u30ef\\u30af\\u30c1\\u30f3\\u53ca\\u3073\\u8840\\u6e05\\u8a3a\\u65ad\\u6db2\\u306e\\u958b\\u767a\\u6539\\u826f\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a2\\u30ec\\u30eb\\u30ae\\u30fc\\u526f\\u4f5c\\u7528\\u306e\\u306a\\u3044, \\u30d7\\u30eb\\u30e9\\u30f3\\u7d50\\u5408\\u30c8\\u30ad\\u30bd\\u30a4\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u7814\\u7a76\", \"\\u767e\\u65e5\\u305c\\u304d\\u83cc\\u611f\\u67d3\\u9632\\u5fa1\\u6297\\u539f\\u5206\\u753b\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u8a66\\u4f5c\\u7684\\u7814\\u7a76\", \"\\u9b5a\\u985e\\u306e\\u514d\\u75ab\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u57f9\\u990a\\u7d30\\u80de\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u72c2\\u72ac\\u75c5\\u4e88\\u9632\\u65b9\\u5f0f\\u306e\\u78ba\\u7acb\", \"\\u72c2\\u72ac\\u75c5\\u7d44\\u7e54\\u57f9\\u990a\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5b9f\\u7528\\u5316\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u5674\\u9727\\u6cd5\\u306b\\u3088\\u308b\\u9b5a\\u985e\\u306e\\u514d\\u75ab\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u9b5a\\u985e\\u306e\\u7d30\\u83cc\\u611f\\u67d3\\u75c7\\u306b\\u5bfe\\u3059\\u308b\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u7d30\\u80de\\u58c1\\u95a2\\u9023\\u5408\\u6210\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u3092\\u7528\\u3044\\u305f\\u65b0\\u3057\\u3044\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306e\\u305f\\u3081\\u306e\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u7dd1\\u81bf\\u83cc\\u578b\\u5225\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u81e8\\u5e8a\\u7684\\u7814\\u7a76\", \"\\u767d\\u8840\\u75c5\\u60a3\\u8005\\u53ca\\u3073\\u60aa\\u6027\\u56fa\\u578b\\u816b\\u760d\\u60a3\\u8005\\u306b\\u65bc\\u3051\\u308b\\u6c34\\u75d8\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u63a5\\u7a2e\\u306b\\u3064\\u3044\\u3066\", \"\\u30ef\\u30af\\u30c1\\u30f3\\u30a2\\u30a6\\u30a4\\u30eb\\u30b9\\u8840\\u7403\\u51dd\\u96c6\\u7d20\\u306b\\u3088\\u308b\\u7d30\\u80de\\u819c\\u4fee\\u98fe\\u306e\\u7814\\u7a76\", \"\\u9d8f\\u306e\\u30ed\\u30a4\\u30b3\\u30c1\\u30c8\\u30be\\u30fc\\u30f3\\u75c5\\u306e\\u4e88\\u9632\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\\u7279\\u306b\\u30b9\\u30dd\\u30ed\\u30be\\u30a4\\u30c8\\u30fb\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3064\\u3044\\u3066\", \"\\u30a4\\u30cc\\u30d8\\u30eb\\u30da\\u30b9\\u30a6\\u30a4\\u30eb\\u30b9\\u3092\\u30d9\\u30af\\u30bf\\u30fc\\u3068\\u3057\\u3066\\u7528\\u3044\\u305f\\u30cd\\u30aa\\u30b9\\u30dd\\u30fc\\u30e9\\u539f\\u866b\\u306e\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\", \"\\u7c98\\u819c\\u514d\\u75ab\\u3092\\u7528\\u3044\\u305fA\\u7fa4\\u30ec\\u30f3\\u30b5\\u7403\\u83cc\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u30de\\u30ec\\u30c3\\u30af\\u75c5\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u816b\\u760d\\u5f62\\u6210\\u9632\\u5fa1\\u6a5f\\u69cb\\u306e\\u7814\\u7a76\", \"\\u30de\\u30ec\\u30c3\\u30af\\u75c5\\u306b\\u5bfe\\u3059\\u308b\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4f5c\\u7528\\u6a5f\\u69cb\\u306e\\u89e3\\u6790\", \"\\u4eba\\u5de5\\u5408\\u6210\\u907a\\u4f1d\\u5b50\\u3092\\u7528\\u3044\\u305f\\u30ec\\u30b3\\u30f3\\u30d3\\u30ca\\u30f3\\u30c8SERA\\u86cb\\u767d\\u8cea\\u306b\\u3088\\u308b\\u30de\\u30e9\\u30ea\\u30a2\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5b9f\\u7528\\u5316\", \"\\u71b1\\u5e2f\\u30bf\\u30a4\\u30ec\\u30ea\\u30a2\\u75c7\\u306b\\u5bfe\\u3059\\u308b\\u30b5\\u30d6\\u30e6\\u30cb\\u30c3\\u30c8\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a \\u2015 \\u6709\\u52b9\\u306a\\u6297\\u539f\\u306e\\u540c\\u5b9a\\u3068\\u7cbe\\u88fd\", \"\\u6297\\u30a4\\u30c7\\u30a3\\u30aa\\u30bf\\u30a4\\u30d7\\u6297\\u4f53\\u3092\\u7528\\u3044\\u305f\\u65b0\\u3057\\u3044\\u65e5\\u672c\\u8133\\u708e\\u30a6\\u30a3\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306e\\u305f\\u3081\\u306e\\u57fa\\u790e\\u7814\\u7a76\", \"\\u7d44\\u63db\\u3048\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6297\\u539f\\u7279\\u7570\\u7684\\u514d\\u75ab\\u8a98\\u5c0e\\u80fd\\u306e\\u89e3\\u6790\\u3068\\u8ee2\\u63db\", \"\\u30cd\\u30b3\\u30d8\\u30eb\\u30da\\u30b9\\u30a6\\u30a4\\u30eb\\u30b91\\u578b\\u3092\\u30d9\\u30af\\u30bf\\u30fc\\u3068\\u3057\\u3066\\u7528\\u3044\\u305f\\u30cd\\u30b3\\u514d\\u75ab\\u4e0d\\u5168\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\", \"\\u5404\\u7a2e\\u75c5\\u539f\\u6027\\u8178\\u5185\\u7d30\\u83cc\\u3068\\u764c\\u306b\\u5bfe\\u3059\\u308bYersinia\\u306e\\u6b7b\\u83cc\\u306e\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u52b9\\u679c\", \"HB\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u5bfe\\u3059\\u308b\\u6297pre-S\\u6297\\u4f53\\u306eresponse\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u767e\\u65e5\\u54b3\\u30b3\\u30f3\\u30dd\\u30fc\\u30cd\\u30f3\\u30c8\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4e88\\u9632\\u52b9\\u679c\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u6c34\\u75d8\\u30a6\\u30a4\\u30eb\\u30b9\\u5f31\\u6bd2\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u306eDNA\\u30de\\u30fc\\u30ab\\u30fc\\u306b\\u95a2\\u3059\\u308b\\u89e3\\u6790\", \"\\u65b0\\u305f\\u306b\\u5206\\u96e2\\u3057\\u305f1,6-\\u03b1-D-glucan synthase\\u306e\\u3046\\u8755\\u30ef\\u30af\\u30c1\\u30f3\\u5229\\u7528\", \"\\u6c34\\u75d8\\u30a6\\u30a4\\u30eb\\u30b9-\\u5f31\\u6bd2\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u306e DNA \\u30de\\u30fc\\u30ab\\u30fc\\u306e\\u69cb\\u9020\\u89e3\\u6790\", \"\\u30b3\\u30ec\\u30e9\\u83cc\\u30ea\\u30dd\\u591a\\u7cd6(LPS)\\u3068\\u30b3\\u30ec\\u30e9\\u5916\\u6bd2\\u7d20\\u306e\\u5316\\u5b66\\u7684\\u7d50\\u5408\\u306b\\u3088\\u308b\\u65b0\\u30b3\\u30ec\\u30e9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u30b3\\u30ec\\u30e9\\u30ef\\u30af\\u30c1\\u30f3\\u6539\\u826f\\u306e\\u305f\\u3081\\u306e, \\u30e2\\u30ce\\u30af\\u30ed\\u30fc\\u30ca\\u30eb\\u6297\\u4f53\\u306b\\u3088\\u308b\\u30b3\\u30ec\\u30e9\\u83cc\\u5916\\u819c\\u306e\\u6297\\u539f\\u6027\\u306e\\u89e3\\u6790\", \"\\u30a6\\u30b7\\u767d\\u8840\\u75c5\\u306e\\u7279\\u7570\\u6297\\u4f53\\u306b\\u3088\\u308b\\u8a3a\\u65ad\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u4e88\\u9632\", \"Development of molecular adjuvants for DNA vaccines in the malaria model\", \"\\u30a2\\u30e6\\u306e\\u30d3\\u30d6\\u30ea\\u30aa\\u75c5\\u4e0d\\u6d3b\\u5316\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u514d\\u75ab\\u6a5f\\u69cb\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30d2\\u30c8\\u30ed\\u30bf\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u57f9\\u990a\\u7d30\\u80de\\u306b\\u3088\\u308b\\u5206\\u96e2\\u3068\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u4f5c\\u88fd\\u306e\\u8a66\\u307f\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u52b9\\u679c\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76(\\u7279\\u306b, \\u5730\\u57df\\u96c6\\u56e3\\u3092\\u5bfe\\u8c61\\u3068\\u3057\\u3066)\", \"Yersinia\\u306e\\u7d4c\\u53e3\\u6b7b\\u83cc\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u30de\\u30a6\\u30b9\\u8178\\u7ba1\\u5b9a\\u7740\\u963b\\u6b62\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u7834\\u50b7\\u98a8\\u6bd2\\u7d20\\u306e\\u8fc5\\u901f\\u9ad8\\u5ea6\\u7d14\\u5316\\u6cd5\\u3068\\u305d\\u306e\\u7cbe\\u88fd\\u4e09\\u7a2e\\u6df7\\u5408\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"\\u5408\\u6210\\u30da\\u30d7\\u30c1\\u30c9\\u306b\\u3088\\u308bB\\u578b\\u809d\\u708e\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u6210\\u4ebaT\\u7d30\\u80de\\u767d\\u8840\\u75c5\\u30fb\\u30ea\\u30f3\\u30d1\\u816b(ATL)\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u81ea\\u7531\\u751f\\u6d3b\\u6027\\u7d68\\u6bdb\\u866b\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u539f\\u866b\\u611f\\u67d3\\u9632\\u5fa1\\u52b9\\u679c\", \"\\u5e7c\\u82e5\\u30de\\u30a6\\u30b9\\u306b\\u304a\\u3051\\u308b\\u30c8\\u30ea\\u30d1\\u30ce\\u30bd\\u30fc\\u30de\\u75c7\\u306e\\u7814\\u7a76:\\u30ef\\u30af\\u30c1\\u30f3\\u52b9\\u679c\\u306b\\u53ca\\u307c\\u3059\\u4fee\\u98fe\\u8981\\u56e0\", \"\\u30ec\\u30d7\\u30c8\\u30b9\\u30d4\\u30e9\\u75c7\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u65b0\\u3057\\u3044\\u691c\\u5b9a\\u7528\\u5b9f\\u9a13\\u52d5\\u7269\\u3068\\u3057\\u3066\\u306e\\u30b9\\u30ca\\u30cd\\u30ba\\u30df\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"S.mutans \\u306e\\u7cbe\\u88fd\\u83cc\\u4f53\\u6297\\u539f\\u3092\\u30ef\\u30af\\u30c1\\u30f3\\u3068\\u3059\\u308b\\u6297\\u3046\\u8755\\u514d\\u75ab\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u65b0\\u898f\\u524d\\u7acb\\u817a\\u764c\\u30de\\u30a6\\u30b9\\u5b9f\\u9a13\\u30e2\\u30c7\\u30eb\\u306e\\u78ba\\u7acb\\u3068\\u764c\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5275\\u6210\", \"SSXa1\\u3092\\u6a19\\u7684\\u3068\\u3059\\u308b\\u30de\\u30a6\\u30b9\\u81ea\\u5bb6\\u6297\\u539f\\u764c\\u30ef\\u30af\\u30c1\\u30f3\\u30e2\\u30c7\\u30eb\\u306e\\u69cb\\u7bc9\\u3068\\u514d\\u75ab\\u89e3\\u6790\", \"\\u30d7\\u30ed\\u30c6\\u30aa\\u30fc\\u30e0\\u89e3\\u6790\\u306b\\u3088\\u308b\\u30c8\\u30ad\\u30bd\\u30d7\\u30e9\\u30ba\\u30de\\u539f\\u866b\\u306e\\u65b0\\u898f\\u30ef\\u30af\\u30c1\\u30f3\\u30fb\\u85ac\\u5264\\u6a19\\u7684\\u5206\\u5b50\\u306e\\u63a2\\u7d22\", \"\\u5b89\\u5168\\u304b\\u3064\\u6709\\u52b9\\u306a\\u7c98\\u819c\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u3092\\u7528\\u3044\\u305f\\u3001\\u7d4c\\u9f3b\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u52b9\\u679c\\u7684\\u306a\\u81a3\\u5185\\u514d\\u75ab\\u8a98\\u5c0e\", \"\\u30ad\\u30e9\\u30fcT\\u7d30\\u80de\\u3068\\u30d8\\u30eb\\u30d1\\u30fcT\\u7d30\\u80de\\u3092\\u6d3b\\u6027\\u5316\\u3059\\u308b\\u3001\\u304c\\u3093\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u81e8\\u5e8a\\u5fdc\\u7528\", \"PolyIC\\u3092\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u306b\\u3057\\u305f\\u820c\\u4e0b\\u514d\\u75ab\\u306b\\u3088\\u308b\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u83cc\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306e\\u7814\\u7a76\", \"\\u30af\\u30eb\\u30de\\u30a8\\u30d3\\u985e\\u306eWSS\\u30a6\\u30a4\\u30eb\\u30b9\\u611f\\u67d3\\u75c7\\u306b\\u5bfe\\u3059\\u308b\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"The potential of self-polymerizing Spy0128 as vaccine adjuvant\", \"\\u30d2\\u30c8\\u30d1\\u30d4\\u30ed\\u30fc\\u30de\\u30a6\\u30a4\\u30eb\\u30b9\\u611f\\u67d3\\u306b\\u5bfe\\u3059\\u308b\\u65b0\\u898fL2\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30b9\\u30ea\\u30f3B\\u9396\\u30da\\u30d7\\u30c1\\u30c9\\u9023\\u7d50MHCclassII\\u907a\\u4f1d\\u5b50\\u3092\\u7528\\u3044\\u305fDNA\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\", \"\\u764c\\u7d30\\u80de\\u2015\\u30a2\\u30ed\\u6a39\\u72b6\\u7d30\\u80de\\u878d\\u5408\\u306b\\u3088\\u308b\\u764c\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u30b7\\u30b9\\u30c6\\u30e0\\u306e\\u958b\\u767a\", \"\\u6d88\\u5316\\u5668\\u764c\\u306b\\u5bfe\\u3059\\u308b\\u764c\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u306e\\u958b\\u767a\", \"\\u6210\\u4ebaT\\u7d30\\u80de\\u767d\\u8840\\u75c5\\u30a6\\u30a4\\u30eb\\u30b9\\u306b\\u5bfe\\u3059\\u308bDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u611f\\u67d3\\u4e88\\u9632\\u52b9\\u679c\\u306e\\u691c\\u8a0e\", \"\\u30ea\\u30b9\\u30c6\\u30ea\\u30a2\\u30fb\\u30e2\\u30ce\\u30b5\\u30a4\\u30c9\\u30b2\\u30cd\\u30b9\\u306b\\u5bfe\\u3059\\u308bDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u3068\\u305d\\u306e\\u9ad8\\u52b9\\u7387\\u5316\", \"\\u60aa\\u6027\\u795e\\u7d4c\\u81a0\\u816b\\u306b\\u5bfe\\u3059\\u308b\\u30b5\\u30a4\\u30c8\\u30ab\\u30a4\\u30f3\\u767a\\u73fe\\u816b\\u760d\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u306e\\u958b\\u767a\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u7d4c\\u9f3b\\u5674\\u9727\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6297\\u4f53\\u53cd\\u5fdc\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"B30-MDP\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30a6\\u30a4\\u30eb\\u30b9\\u4eba\\u5de5\\u817a\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u611f\\u67d3\\u9632\\u5fa1\\u80fd\", \"\\u30d2\\u30c8\\u30b5\\u30a4\\u30c8\\u30e1\\u30ac\\u30ed\\u30a6\\u30a4\\u30eb\\u30b9(HCMV)\\u907a\\u4f1d\\u5b50\\u7d44\\u307f\\u63db\\u3048\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u7814\\u7a76\", \"B30-MDP\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30a6\\u30a3\\u30eb\\u30b9\\u4eba\\u5de5\\u819c\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308a\\u8a98\\u5c0e\\u3055\\u308c\\u305fCTL\\u306e\\u7279\\u5fb4\", \"B30-MPP\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30a6\\u30a4\\u30eb\\u30b9\\u4eba\\u5de5\\u819c\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u7d30\\u80de\\u6027\\u514d\\u75ab\", \"\\u30c8\\u30ad\\u30f3\\u30d7\\u30e9\\u30ba\\u30de\\u611f\\u67d3\\u9632\\u5fa1\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u30de\\u30ec\\u30c3\\u30af\\u75c5\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u306e\\u767a\\u75c5\\u9632\\u5fa1\\u306b\\u95a2\\u308f\\u308b\\u907a\\u4f1d\\u5b50\\u306e\\u30af\\u30ed\\u30fc\\u30cb\\u30f3\\u30b0\", \"\\u5408\\u6210\\u30da\\u30d7\\u30c1\\u30c9\\u3092\\u7528\\u3044\\u305f\\u3046\\u8755\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u764c\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u306b\\u6709\\u7528\\u306a\\u6a39\\u72b6\\u7d30\\u80de\\u30b5\\u30d6\\u30bb\\u30c3\\u30c8\\u306e\\u89e3\\u6790\", \"The development and production of recombinant Parapoxvirus vectors for viral vaccine therapy and cancer immunotherapy\", \"Mechanism of action of a novel respiratory syncytial virus subunit vaccine formulation.\", \"Effects of sialylated capsular polysaccharides from Streptococci on the immunogenic capacity of conjugate vaccines\", \"Signaling mechanisms of dectin-1 endosomes and anti-fungal vaccine optimization\", \"The use of virus-like particles as vaccines and therapies against cancer\", \"Targeting vaccines to human antigen-presenting cells with synthetic glycopeptides\", \"Experimental bacterial infections: improved models for vaccine and treatment development\", \"Increasing the potency of dendritic cell based vaccines for treatment of cancer\", \"The impact of pneumococcal vaccine on hospital admission in young children with pneumonia\", \"Phase 3 Clinical Trial for Stage 4 Melanoma using the Dendritic Cell Vaccine\", \"Development and evaluation of a MERS-virus epitope based vaccine\", \"\\u0423\\u0447\\u0430\\u0441\\u0442\\u0438\\u0435 \\u0432 \\u041c\\u0435\\u0436\\u0434\\u0443\\u043d\\u0430\\u0440\\u043e\\u0434\\u043d\\u043e\\u0439 \\u043a\\u043e\\u043d\\u0444\\u0435\\u0440\\u0435\\u043d\\u0446\\u0438\\u0438 \\\"Liposome advances: progress in drug and vaccine delivery\\\"\", \"\\u0421\\u0442\\u0430\\u0431\\u0438\\u043b\\u044c\\u043d\\u043e\\u0441\\u0442\\u044c \\u0433\\u0435\\u043c\\u0430\\u0433\\u0433\\u043b\\u044e\\u0442\\u0438\\u043d\\u0438\\u043d\\u0430 - \\u0444\\u0430\\u043a\\u0442\\u043e\\u0440 \\u043d\\u0438\\u0437\\u043a\\u043e\\u0439 \\u0438\\u043c\\u043c\\u0443\\u043d\\u043e\\u0433\\u0435\\u043d\\u043d\\u043e\\u0441\\u0442\\u0438 \\u0432\\u0430\\u043a\\u0446\\u0438\\u043d \\u043f\\u0440\\u043e\\u0442\\u0438\\u0432 \\u0432\\u044b\\u0441\\u043e\\u043a\\u043e\\u043f\\u0430\\u0442\\u043e\\u0433\\u0435\\u043d\\u043d\\u044b\\u0445 \\u0432\\u0438\\u0440\\u0443\\u0441\\u043e\\u0432 \\u0433\\u0440\\u0438\\u043f\\u043f\\u0430\", \"\\u0420\\u0430\\u0437\\u0440\\u0430\\u0431\\u043e\\u0442\\u043a\\u0430  \\u0414\\u041d\\u041a\\u2013\\u0432\\u0430\\u043a\\u0446\\u0438\\u043d \\u0434\\u043b\\u044f \\u043f\\u0440\\u0438\\u043c\\u0435\\u043d\\u0435\\u043d\\u0438\\u044f \\u0432 \\u0431\\u0438\\u043e\\u043c\\u0435\\u0434\\u0438\\u0446\\u0438\\u043d\\u0435\", \"HPV TYPE 16 VACCINE TRIAL IN COSTA RICA\", \"HPV TYPE 16 VACCINE TRIAL IN COSTA RICA\", \"NIAID Vaccine Immune T-cell and Antibody Laboratory (NVITAL)\", \"Evaluation of NIAID's HIV Vaccine Research Education Initiative\", \"EVALUATION OF NIAID'S HIV VACCINE RESEARCH EDUCATION INITIATIVE\", \"Evaluation of NIAID's HIV Vaccine Research Education Initiative\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS - PART B\", \"HIV Vaccine Design and Dev. Teams for Preventation and Treatment\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS FOR PREVENTION AND TREATMENT\", \"Assessing Safety of Cell Substrates and Vaccine Components\", \"ASSESSING THE SAFETY OF CELL SUBSTRATES AND VACCINE COMPONENTS\", \"Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine\", \"Population Genetics Analysis Program: Immunity to Vaccines/Infections\", \"Population Genetics Analysis Program: Immunity to Vaccines/Infections\", \"Population Genetics Analysis Program: Immunity to Vaccines/Infections\", \"Population Genetics Analysis Program: Immunity to Vaccines/Infections\", \"POPULATION GENETICS ANALYSIS PROGRAM: IMMUNITY TO VACCINES/INFECTIONS\", \"Population Genetics Analysis Program: Immunity to Vaccines/Infections\", \"POPULATION GENETICS ANALYSIS PROGRAM IMMUNITY TO VACCINES/INFECTION\", \"Malaria Vaccines:  Clinical Research &Trial Sites in Endemic Areas\", \"MALARIA VACCINES: CLINICAL RESEARCH AND TRIAL SITES IN ENDEMIC AREAS\", \"Development, Testing and Evaluation of a Live Attenuated (LVS) Vaccine\", \"PRODUCTION AND TESTING OF ANTHRAX RECOMBINANT PROTECTIVE ANTIGEN (RPA) VACCINE\", \"Production and Testing of Anthrax rPA Vaccine\", \"PRODUCTION AND TESTING OF ANTHRAX RECOMBINANT PROTECTIVE ANTIGEN (RPA) VACCINE\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVDDT)\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVDDT)\", \"HIV Vaccine Design and Development Teams (HVDDT)\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVVDT)\", \"HLA Typing and Epitope Mapping Relative to HIV Vaccine Design\", \"HLA TYPING AND EPITOPE MAPPING RELATIVE TO HIV VACCINE DESIGN\", \"REAGENT RESOURCE SUPPORT FOR AIDS VACCINE DEVELOPMENT\", \"Rational optimization of peptide vaccines for immunotherapy of cancer (SCORE)\", \"Probing Hierarchical Self-Assemblies Relevant for Drug and Vaccine Design by Employing Scanning Tunnelling Microscopy\", \"Virus Like Particles and Salmonella-based Vaccines against Human papillomavirus and Cervical Cancer\", \"Development of approaches to rapidly assess engineered HIV vaccine candidates\", \"Therapeutic vaccination against chronic Hepatitis B by intralymphatic administration of a naked DNA vaccine\", \"DDoSVax - in search of a vaccine for distributed denial of service attacks\", \"Antigen processing and presentation via vaccine adjuvants in the antigen-presenting cells\", \"Immune responses to salmonella-based and subunit human papilloma-virus type 16 (HPV 16) vaccines\", \"Antigen sampling and presentation in mucosal tissues: implications for mucosal vaccine design\", \"Combinatorial biomimetic chemistry - A source of new reagents forchemical biology and drug and vaccine discovery\", \"The outer membrane protein UspA1 of Moraxella catarrhalis as a vaccine candidate\", \"In vitro und in vivo Charakterisierung von CpG Oligonukleotiden als Adjuvantien f\\u00fcr einen FIV-DNA Impfstoff.\", \"Decyphering distinctive features of early life immune responses to vaccine antigens\", \"Identification of human astrocytoma antigens: a necessary step for vaccine development\", \"Safety and immunogenicity of a recombinant attenuated salmonella live vaccine expressing H. Pylori urease\", \"Virus like particles and Salmonella-based Vaccines against Human Papillomavirus and Cervical Cancer\", \"Virulence gene probes for bacterial safety monitoring, medical diagnostics, vaccine development and quality control\", \"Development of a live vaccine against HELICOBACTER PYLORI based on the molecular understanding of gastritis\", \"Measles virus (MV) reverse genetics; rescued MV variants and chimera as vaccines and vectors\", \"CD40L\\u57fa\\u56e0\\u4fee\\u9970\\u5355\\u7eaf\\u75b1\\u75b9\\u75c5\\u6bd2\\u6cbb\\u7597\\u6027DNA\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u8fdf\\u7f13\\u7231\\u5fb7\\u534e\\u83cc\\u83cc\\u8715\\u75ab\\u82d7\\u7684\\u7814\\u5236\\u53ca\\u5176\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u5236\", \"MCP1 /CCR2\\u5728\\u547c\\u5438\\u9053\\u5408\\u80de\\u75c5\\u6bd2\\u75ab\\u82d7\\u589e\\u5f3a\\u6027\\u75be\\u75c5\\u4e2d\\u7684\\u5173\\u952e\\u4f5c\\u7528\\u7814\\u7a76\", \"\\u5229\\u7528\\u6cb9\\u83dc\\u79cd\\u5b50\\u4f5c\\u755c\\u79bd\\u53e3\\u670d\\u75ab\\u82d7\\u751f\\u7269\\u53cd\\u5e94\\u5668\\u7684\\u7814\\u7a76\", \"IBDV\\u4e1d\\u7d20\\u86cb\\u767d-\\u58f3\\u805a\\u7cd6DNA\\u5fae\\u7403\\u75ab\\u82d7\\u5236\\u5907\\u53ca\\u514d\\u75ab\\u539f\\u6027\\u7814\\u7a76\", \"\\u80c3\\u764c\\u76f8\\u5173\\u80bf\\u7624\\u6297\\u539f\\u591a\\u8868\\u4f4d\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u4e0e\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"\\u7eb3\\u7c73\\u58f3\\u805a\\u7cd6\\u57fa\\u56e0\\u9012\\u9001\\u8f7d\\u4f53\\u4e0e\\u65b0\\u578b\\u5355\\u7eaf\\u75b1\\u75b9\\u6cbb\\u7597\\u6027DNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u591a\\u91cd\\u9776\\u5411\\u4e8e\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u7684\\u6297\\u6076\\u6027\\u9ed1\\u8272\\u7d20\\u7624DNA\\u75ab\\u82d7\\u7eb3\\u7c73\\u4f20\\u9012\\u7cfb\\u7edf\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u5bf9DC\\u7ec6\\u80de\\u529f\\u80fd\\u5f71\\u54cd\\u7684HBs\\u6297\\u539f\\u591a\\u6001\\u6027\\u53ca\\u65b0\\u578b\\u4e59\\u809dDNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"CD40L\\u57fa\\u56e0\\u4fee\\u9970HBeAg\\u591aT\\u7ec6\\u80de\\u8868\\u4f4dDNA\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u7528\\u8863\\u85fb\\u53f6\\u7eff\\u4f53\\u9ad8\\u6548\\u8868\\u8fbe\\u79bd\\u6d41\\u611f\\u9972\\u7528\\u75ab\\u82d7\\u7814\\u7a76\", \"\\u6c99\\u773c\\u8863\\u539f\\u4f53MOMP\\u6297\\u539fT-B\\u8054\\u5408\\u8868\\u4f4d\\u9274\\u5b9a\\u53ca\\u5176MAP\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u6027\\u7814\\u7a76\", \"\\u57fa\\u4e8eCTB\\u7684I\\u578b\\u7cd6\\u5c3f\\u75c5\\u86cb\\u767d\\u75ab\\u82d7\\u8bbe\\u8ba1\\u53ca\\u5176\\u529f\\u80fd\\u7814\\u7a76\", \"\\u4f5c\\u4e3a\\u57fa\\u56e0\\u75ab\\u82d7\\u8f7d\\u4f53\\u7684\\u6d77\\u6c34\\u9c7c\\u80a0\\u9053\\u4e73\\u9178\\u6746\\u83cc\\u7cfb\\u7edf\\u6784\\u5efa\", \"HIV-1 B\\uff07/C\\u91cd\\u7ec4\\u4e9a\\u578bgag-tat\\u878d\\u5408\\u57fa\\u56e0 DNA \\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u5154\\u761f\\u75c5\\u6bd2\\u6297\\u539f\\u8868\\u4f4d\\u7684\\u9274\\u5b9a\\u53ca\\u8868\\u4f4d\\u75ab\\u82d7\\u7814\\u7a76\", \"I\\u578b\\u7cd6\\u5c3f\\u75c5\\u53e3\\u670d\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u548c\\u5728\\u5bb6\\u8695\\u4e2d\\u8868\\u8fbe\\u53ca\\u5176\\u4f5c\\u7528\\u673a\\u7406\\u7814\\u7a76\", \"4-1BBL\\u91cd\\u7ec4\\u8d28\\u7c92\\u589e\\u5f3a\\u4e59\\u809d\\u75ab\\u82d7\\u6297\\u75c5\\u6bd2\\u514d\\u75ab\\u6cbb\\u7597\\u7684\\u4f50\\u5242\\u4f5c\\u7528\", \"\\u624b\\u8db3\\u53e3\\u75c5\\u4e3b\\u8981\\u75c5\\u539fEV71 VP1\\u91cd\\u7ec4\\u6746\\u72b6\\u75c5\\u6bd2\\u75ab\\u82d7\\u8f7d\\u4f53\\u7814\\u7a76\", \"\\u4f24\\u5bd2\\u548c\\u526f\\u4f24\\u5bd2\\u901a\\u7528\\u578b\\u7cd6\\u80bd\\u7ed3\\u5408\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u514d\\u75ab\\u4fdd\\u62a4\\u6027\\u7814\\u7a76\", \"Development of Feline Vaccines Containing Antigens and Adjuvants Produced Entirely in Tobacco Plants\", \"Alzheimer`s vaccine that avoids inflammatory side effects.\", \"Alzheimer`s vaccine that avoids inflammatory side effects\", \"Development of Live Attenuated FIV Vaccines Expressing Feline Cytokines\", \"\\u9996\\u4f8b\\u6162\\u75c5\\u6bd2\\u75ab\\u82d7\\uff0d\\u9a6c\\u4f20\\u67d3\\u6027\\u8d2b\\u8840\\u51cf\\u6bd2\\u75ab\\u82d7\\u514d\\u75ab\\u673a\\u7406\\u7684\\u7814\\u7a76\", \"Development of novel genetic cancer vaccines encoding dendritic cell activation receptors\", \"Development of a multivalent therapeutic HPV-16 and HPV-18 -specific vaccine\", \"Development of a multivalent therapeutic HPV-16 and HPV-18 -specific vaccine\", \"Entwicklung und klinische Erprobung eines Salmonellen-basierten Helicobacter-Impfstoffs\", \"Development of a DNA vaccine against Schistosoma japonicum              (A 4)\", \"Produkcyjna i \\u015brodowiskowa weryfikacja stosowania szczepionek bakteryjnych i nawozu mikroelementowego.\", \"Inkomsten op project 00627: Bereiding van vaccins tegen de ziekte van Aujeszky (deel Berns)\", \"Inkomsten op project 00627: Bereiding van vaccins tegen de ziekte van Aujeszky (deel Gielkens)\", \"Protein Misfolding in a New Spotlight - The design of new and safer vaccines\", \"Targetting Plant-Based Vaccines for Prevention of Type I Diabetes\", \"GAVI-oriented research at the Centre for International Health: Participation in a rotavirus vaccine trial.\", \"Development of vaccines and diagnostic tools against a new bacterial fish pathogen\", \"S\\u00e9curit\\u00e9 de l'utilisation du vaccin vivant att\\u00e9nu\\u00e9 contre l'influenza chez les enfants et adolescents avec fibrose kystique.\", \"L'homme invisible: Facteurs influen\\u00e7ant la connaissance et les intetions de recevoir le vaccine VPH\", \"Centre de Recherche en Infectiologie Porcine (CRIP)\", \"Improved vaccines against intracellular pathogens by combining PHARMAQ and Isconova adjuvant technologies\", \"Poxviruses in Norway: Biodiversity, characteristics and recombinations between naturally occuring and genetically engineered vaccine viruses\", \"Internasjonalt seminar \\\"4th International Veterinary Vaccines and Diagnostics Conference, 25. - 30. june 2006\\\"\", \"Live, attenuatet vaccine against infectious pancreatic necrosis in Atlantic salmon fry\", \"Rekombinantno cepivo proti aviarni influenci za peroralno uporabo (CRP)\", \"Cepiva nove generacije proti Helicobacter pylori (applied research project)\", \"Recombinant baculovirus occlusion bodies as a novel vaccine delivery system.\", \"Development of a mucosally active ISCOMS based diphtheria toxoid vaccine.\", \"Mucosal immunization with recombinant Lactobacillus casei: development of vaccines against Streptococcus pneumoniae diseases\", \"Development of a Prototype Multivalent, Oral Vaccine for Traveler's Diarrhea\", \"Biodegradable Bioadherent Microcapsules for Orally Administered Sustained Release Vaccines\", \"Delivery of Vaccines by Biodegradable Polymeric Microcapsules with Bioadhesion Properties\", \"SYNTHETIC VACCINES: TEST OF CONCEPTS AND APPLICATION TO RIFT VALLEY FEVER VIRUS\", \"Biological and immunological properties of saccharidic antigens of pathogens -utilization for preparation of subcellular vaccines\", \"Efficasy of an experimental recombinant vaccine against herpes simplex virus in animal model(s)\", \"Analytics on Blog and Tweet Reactions to Vaccine-related Incidents\", \"Mechanism of action of a novel respiratory syncytial virus subunit vaccine formulation.\", \"History of the Introduction of the Salk Polio Vaccine as a Public Event\", \"Ethical Disputes in Experimental Medicine: The 1935 Polio Vaccine Controversy\", \"Ethical Constraints in Medical Science: Clinical Testing of Vaccines, 1930-60\", \"Colleague Control and Experimental Ethics: American Vaccine-Research Communities, 1920-60\", \"BPVacc: Development of a vaccine against meliodosis with Burkholderia pseudomallei antigens\", \"Design, Synthesis, and Development of Carbohydrate\\u2013Based Vaccines, Therapeutics, Diagnostics, and Medical Devices.\", \"A Novel Vaccine for the Prevention and Cure of Type 1 Diabetes\", \"The AHFMR Interdisciplinary Team in Vaccine Design and Implementation\", \"SYSTEM ENHANCEMENTS AND SUPPORT TO FULLY INTEGRATE ALERT IIS WITH VTRCKS AND VACCINE MANAGEMENT FUNCTIONS\", \"ENHANCE AN IIS TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING AND MANAGEMENT SYSTEM\", \"ENHANCING NEVADAS IMMUNIZATION INFORMATION SYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING & MGMT SYSTEM\", \"IMMUNOGENICITY, POTENCY, AND STABILITY OF ELECTRON BEAM-BASED SALMONELLA VACCINES\", \"Training in vaccine development: combined glycoconjugate vaccine against meningococcus a,c, w135,y\", \"Vaccines and the hypothetical risk of autoimmune reactions: development of evaluation methods.\", \"Novel mechanisms of live, bacterial vaccines in protection against salmonella and other food-borne zoonoses\", \"Workshops on the molecular biology and immunology of malaria vaccines\", \"Programme EVA (European Vaccine against Aids) centralised facility for Aids reagents\", \"Siv/hiv vaccines : detecting efficacy and explaining inefficacy\", \"Herpesvirus vector vaccines against helminth parasite infections in calves and sheep\", \"Development of a clade C-based HIV-1 vaccine for China\", \"Production and characterisation of mutant leishmania lacking proteinase genes as attenuated live vaccines\", \"PRODUCTION OF RECOMBINANT IMMUNE COMPLEXES IN TRANSGENIC PLANTS FOR SYSTEMIC AND MUCOSAL VACCINES\", \"Safety, immunogenicity and field efficacy studies of a plasmodium falciparum malaria pre-erythrocytic stage vaccine.\", \"Genetic variation and attenuation of human respiratory syncytial virus : implications for vaccine development\", \"Development of new safe and economical recombinant hepatitis virus vaccines and diagnostic materials\", \"Development of vaccine approaches for the control of infection and inflammatoryreactions in parasitic diseases\", \"Efficacy of rsh28gst as an antifecundity vaccine - Immune mechanisms in experimental models and in man\", \"The application of transfection technology to malaria vaccine devel opment\", \"Genetically engineered vaccines a single molecule comprising antigen, targeting-device and adjuvant activity\", \"Preparation and characterization of an experimental anti-diotype vaccine against Echinococcus Granulosus\", \"Basic studies on the development of a vaccine against Haemorrhagic fever with renal syndrome\", \"Combined multi antigen mucosal vaccines: optimization of local and systemic immunity\", \"Recombinant Viral Particulate Proteins as Tools for New Vaccines and Diagnostics\", \"A network for malaria vaccine evaluation and testing in experimental primate models\", \"European union network for evaluation of nucleic acid-based vaccines for induction of antiviral immunity\", \"PESTE DES PETITS RUMINANTS DIAGNOSIS; EPIDEMIOLOGY AND CONTROL BY VACCINE\", \"PRODUCTION OF A VACCINE FOR FOOT- AND-MOUTH DISEASE VIRUS USING RECOMBINANT DNA\", \"PRODUCTION OF A FOOT-AND-MOUTH DISEASE VACCINE BY CHEMICAL S YNTHESIS\", \"TOWARDS A GENETICALLY ENGINEERED VACCINE AGAINST PORCINE TRANSMISSIBLE GASTROENTERITIS VIRUS (TGEV)\", \"THE APPLICATION OF RECOMBINANT DNA TECHNOLOGY TO THE DEVELOPMENT OF PORCINE ROTAVIRUS VACCINES\", \"EVALUATION OF ADULT SCHISTOSOMA MANSONI SURFACE MEMBRANE ANTIGENES AS VACCINE CONSTITUENTS AND IMMUNODIGNOSTIC REAGENTS\", \"DEVELOPMENT OF DIAGNOSTIC TECHNIQUES AND VACCINES FOR CRIMEAN CONGO HAEMORRHAGIC FEVER\", \"Monitoring and diagnosis of a vaccine manufacturing process using spectro-fluorescence\", \"Transmission dynamics of live coccidiosis vaccines: Does management have an impact?\", \"Orphan Vaccines - Bridging the Gaps conference, Queensland Australia, Aug 2001\", \"Anti-Trichuris vaccines: larval antigens and cytokines.\", \"Alphaherpesvirus recombination: safety implications for attenuated Herpesvirus vaccines\", \"Exploiting the lymphatic system for next generation vaccine development\", \"Molecular approaches to develop an insect cell production system for Hepatitis C vaccine candidate.\", \"Avian influenza hemagglutinin subunit DNA vaccines with targeting sequences in frame with DIVA strategy\", \"Immunogenicity of vaccine candidate antigens from Staphylococcus pseudintermedius in Canis canis\", \"Development and pre-clinical evaluation of a new HIV-1 vaccine concept\", \"Retroviral like particles: improving potential as candidate vaccines for Hepatitis C\", \"Bovine Viral Diarrhea Virus (BVDV): diagnosis, genotype characterization, vaccine efficacy and transmission studies\", \"TherMelVac- dendritic cell-targeted peptide vaccine against melanoma by ligand-modified nanoparticles\", \"Development of experimental DNA vaccines against sheep Maedi-Visna virus\", \"Synthesis, optimization and intensification of bioseparation processes for DNA vaccine manufacturing\", \"Development of a new Nab based strategy to produce a universal HIV vaccine\", \"Integrated methodologies for the development of bi and three-valent DNA-vaccines against Helycobacter pylori\", \"BACULOME-Engineering cellular energetics for improvement of bioprocesses: metabolic modeling for enhanced vaccines production.\", \"Pre-clinical assays of a GAPDH-based vaccine against Group B Streptococcus infection\", \"Studies to produce an exopolysaccharide-vaccine to protect cystic fibrosis patients against Burkholderia cepacia infections\", \"DEVELOPMENT OF A RADIATION-AND/OR HEATATTENTUATED VACCINE FOR CONTROL OF CUTANEOUS LEISHMANIASIS\", \"NSERC/Bioniche Chairs in vaccines to reduce food and water contamination\", \"Development of a broad spectrum recombinant vaccine against respiratory pathogens of cattle\", \"NSERC/Bioniche Chairs in Vaccines to Reduce Food and Water Contamination\", \"NSERC/Bioniche Industrial Research Chair in Vaccines to Reduce Food and Water Contamination\", \"Controlled-release delivery of liposome-associated and micelle-associated glycoconjugate fish vaccines\", \"D\\u00e9veloppement d'un vaccin contre les infections dues \\u00e0 Streptococcus suis s\\u00e9rotype 2 chez l'esp\\u00e8ce porcine\", \"NSERC/Bioniche Industrial Research Chair in Vaccines to Reduce Food and Water Contamination\", \"NSERC/Bioniche Industrial Research Chair in Vaccines to Reduce Food and Water Contamination\", \"NSERC/Bioniche Chairs in vaccines to reduce food and water contamination\", \"Control of the bovine respiratory disease complex: the development of novel vaccine alternatives\", \"NSERC/Bioniche Chairs in Vaccines to Reduce Food and Water Contamination\", \"NSERC/Bioniche Industrial Research Chair in Vaccines to Reduce Food and Water Contamination\", \"Enhancement of DNA vaccine efficacy by targeting antigen presenting cells\", \"Development of an oral vaccine in alfalfa against transmissible gastroenteritis virus in swine\", \"Canadian Network for Vaccines and Immunotherapeutics of Cancer and Chronic Viral Diseases (CANVAC)\", \"A proteomics approach to the development of a recombinant \\\"Aeromonas salmonicida\\\" vaccine\", \"Development of a live-attenuated oral E. coli vaccine for poultry\", \"the evalutation of antigens for a vaccine against aeromonas spp\", \"Development of new alternative vaccine delivery approaches for the prevention of human disease\", \"Clinical and commercial applications of an O-sialoglycoprotease in bone marrow transplantation and vaccine development\", \"Host: parasite interaction in bovine pneumonic pasteurellosis: the immunological basis for a novel vaccine strategies\", \"A new method to create conjugate vaccine with fine control of T-cell epitopes\", \"Development of a Prion vaccine using a unique PrP-Sc epitope\", \"Outer membrane proteins for iron uptake: candidate vaccine against Actinobacillus pleuropneumoniae\", \"Development of a Vaccine for Atlantic Salmon against Aeromonas sp.\", \"Development of an Edible Vaccine for Shipping Fever Using Transgenic Forage Crops\", \"Development of new alternative vaccine delivery approaches for the prevention of human disease\", \"Development of novel depot-based vaccine formulations for therapeutic cancer and infectious diseases\", \"Development of a Vaccine for Atlantic Salmon against Aeromonas sp.\", \"Design and evaluation of DNA vaccines using cell-targeting polymeric vectors\", \"Adjuvant activity of Complement component C3d in novel vaccine strategies for cattle\", \"Development of an enterophemorrhagic 0157:H7 E. coli pediatric vaccine\", \"HPLC for purification of glycolipid and glycopeptide conjugates; novel molecules with vaccine potential\", \"Facteurs de virulence des coronavirus h\\u00e9magglutinants et, valeur vaccinale et diagnostique des prot\\u00e9ines recombinantes\", \"Design of therapeutic vaccines for chronic hepatitis B virus infection\", \"Development of a vaccine for bovine pneumonic pasteurellosis using recombinant antigens of Pasteurella haemolytica Al\", \"Identification of novel mucosal adjuvants and immune biomarkers for neonatal respiratory syncytial virus vaccine development\", \"Development of an Edible Vaccine for Shipping Fever Using Transgenic Forage Crops\", \"Selection of the optimal CpG as an adjuvant for S. aureus Vaccine\", \"Reverse vaccinology, a genomics approach to vaccine development for A. pleuropneumoniae\", \"Recombinant bovine viral diarrhea virus gp53 as subunit vaccine and diagnostic tool\", \"Development of bovine adenovirus vector and its use for the engineering of viral vaccines\", \"Control of the bovine respiratory disease complex: The development of novel vaccine alternatives\", \"Development of novel depot-based vaccine formulations for therapeutic cancer and infectious diseases\", \"A new method to create conjugate vaccine with fine control of T-cell epitopes\", \"Development of a vaccine against Myxobolus cerebralis, the causative agent of whirling disease in fr\", \"Development of STb-fimbrial vaccine for enterotoxigenic Escherichia coli post-weaning diarrhea in pigs\", \"Testing the Efficacy of Novel Pandemic Influenza and Hepatitis B Vaccine Formulations\", \"Development of transgenic alfalfa expressing the P. haemolytica leukotoxin as an oral vaccine in cattle\", \"Developing vaccines using lambda phage particle display and dna technology\", \"Identification of novel mucosal adjuvants and immune biomarkers for neonatal respiratory syncytial virus vaccine development\", \"Identification of novel mucosal adjuvants and immune biomarkers for neonatal respiratory syncytial virus vaccine development\", \"Bioencapsulation of HIV gag secreting myoblasts in alginate microparticles as an HIV vaccine strategy\", \"Design of a viral vector for the development of ployvalent vaccines for cattle\", \"A proteomics approach to the development of a recombinant \\\"Aeromonas salmonicida\\\" vaccine\", \"Engineering of recombinant bovine respiratory syncytial virus vaccine using bovine adenovirus vector\", \"Evaluation of alternative vaccine delivery routes and assessment of their mode of action\", \"Exploring the use of peptide-lipid conjugates in novel depot-based vaccine formulations.\", \"Development of a Vaccine for Atlantic Salmon against Aeromonas sp.\", \"Structural characterization of new bacterial polysaccharides and their use in vaccine design\", \"Bioencapsulation of HIV gag secreting myoblasts in alginate microparticles as an HIV vaccine strategy\", \"Mathematical approaches for controlling emerging and re-emerging diseases using vaccines\", \"Monitoring and diagnosis of a vaccine manufacturing process using spectro-fluorescence\", \"Evaluation of alternative vaccine delivery routes and assessment of their mode of action\", \"Development of a Prion vaccine using a unique PrP-Sc epitope\", \"D\\u00e9veloppement de proc\\u00e9d\\u00e9 pour la production d'un vaccin influenza en culture cellulaire\", \"Evaluation of alternative vaccine delivery routes and assessment of their mode of action\", \"Development of novel depot-based vaccine formulations for therapeutic cancer and infectious diseases\", \"Development of a vaccine against Myxobolus cerebralis, the causative agent of whirling disease in fr\", \"Development of an Edible Vaccine for Shipping Fever Using Transgenic Forage Crops\", \"Design and evaluation of DNA vaccines using cell-targeting polymeric vectors\", \"Bio-Warfare Agent detection and development of a third-generation plague vaccine\", \"Support Vaccine Safety Task Force through HHS\", \"NIAID/MRMC Comprehensive HIV/AIDS Therapeutic and Non-Vaccine Prev Clin, Research\", \"New Scientific Approaches to Facilitate Development of Vaccines\", \"Development of Live Oral Vaccine for Protection against Bacillus Anthracis\", \"Assessing Safety of Cell Substrates and Vaccine Components\", \"THE IMMUNIZATION PROGRAM WAS CREATED TO REDUCE THE INCIDENCE OF VACCINE-PREVENTAB\", \"INTRODUCING THE USE OF SEASONAL INFLUENZA VACCINE IN PUBLIC HEALTH\", \"Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs in Chi\", \"EVALUATE THE LONG-TERM PROTECTION FROM HEPATITIS A AND B VACCINE AMONG\", \"A RATIONAL APPROACH TO DEVELOPING A KILLED HIV-1 VACCINE\", \"Statistical Center for Rotavirus Vaccine in India\", \"CLINICAL TRIAL OF MELANOMA VACCINE AND IL-2 IN LIPOSOME\", \"THERAPORE-HIV AS A VACCINE TO ELICIT T CELL RESPONSE\", \"DEVELOPMENT OF A CONTRACEPTIVE VACCINE\", \"HIV Vaccine Design and Development, Part A-Preventative Vaccines\", \"PRODUCTION OF A RECOMBINANT H5 N1 VACCINE FOR PHASE 1\", \"HLA TYPING AND EPITOPE MAPPING RELATIVE TO HIV VACCINE DESIGN-266030024\", \"Development and Testing of a Modified Vaccinia Ankara /MVA/ Vaccine-266030016\", \"PHASE III PNEUMOCOCCAL CONJUGATE VACCINE STIDY IN THE GAMBIA-266025477\", \"Expanded Phase II and IV Vaccine Trials in Humans-26625455\", \"EXPANDED PHASE II AND IV VACCINE TRIALS IN HUMANS-266025454\", \"Expanded Phase II and IV Vaccine Trials in Humans-26625453\", \"Expanded Phase II and IV Vaccine Trials in Humans-26625452\", \"HLA TYPING AND EPITOPE MAPPING GUIDE TO HIV VACCINE DESIGN-266015442\", \"PRODUCTION AND TESTING OF A MODIFIED VACCINIA ANKARA /MVA/ VACCINE.-266000072\", \"PRODUCTION OF TESTING OF A MODIFIED VACCINIA ANKARA /MVA/ VACCINE-266000071\", \"DEVELOPMENT TESTING AND EVALUATION OF CANDIDATE VACCINES AGAINST PLAGU-266000034\", \"MALARIA VACCINES: CLINICAL RESEARCH AND TRIAL SITES IN ENDEMIC AREAS-2-266000016\", \"HIV VACCINES DESIGN AND DEVELOPMENT TEAMS PART A - PREVENTATIVE VACCIN-266000008\", \"TO SUPPORT IMMUNIZATIONS & THE VACCINES FOR CHILDREN PROG STATEWIDE IN NEW MEXICO\", \"CDC-RFA-IP13-1301, Virgin Islands Immunizations and Vaccines for Children Grants\", \"PROVIDE FUNDING FOR OKLAHOMA STATE DOH TO PROVIDE VACCINE SERVICES TO THE STATE\", \"PREVENT DISEASE, DISABILITY & DEATH FROM VACCINE PREVENTABLE DISEASE IN CHILDREN.\", \"2013 COOPERATIVE AGREEMENT APPLICATION FOR THE IMMUNIZATION, VACCINE FOR CHILDREN\", \"IMMUNIZATION VACCINES FOR CHILDREN GRANT FOR INFRASTRUCTURE TO STATE OF MICHIGAN\", \"PROVIDE IMMUNIZATION SVCS FOR TO CONTROL VACCINE PREVENTABLE DISEASE TRANSMISSION\", \"PUERTO RICO'S IMMUNIZATION & VACCINES FOR CHILDREN 2013-2017 PROGRAM PLAN\", \"Improve Vaccine Management, Storage and Handling in the Republic of the Marshall\", \"Improve vaccine management, storage and handling at provider and grantee level\", \"Nevada State Immunization Program: to improve vaccine management, storage and han\", \"Program Area 5 - Improve Vaccine management, storage and handling at provider\", \"Improve Vaccine Management, Storage and Handling at the Provider and Grantee\", \"Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV\", \"Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV\", \"Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV\", \"Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV\", \"Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV\", \"Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV\", \"Development of Mutivalent Filovirus (Ebola and Marburg) Vaccines\", \"Development of an Anthrax Vaccine\", \"Development of a Third Generation Anthrax Vaccine\", \"SBIR TOPIC 241 LIPID NANO-PARTICLE THERAPEUTIC CERVICAL CANCER VACCINE\", \"The development of hypertension vaccine toward clinical application.\", \"Development of RNA vaccine with fish retrovirus, a substitution of DNA vaccine, for fish viral diseases\", \"\\u57fa\\u56e0\\u91cd\\u7ec4\\u9175\\u6bcdPSMA\\u75ab\\u82d7\\u6297\\u524d\\u5217\\u817a\\u764c\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"MOUSE SYSTEM FOR EVALUATION OF CHOLERA VACCINE\", \"\\u7cd6\\u80bd\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u3001\\u5408\\u6210\\u4e0e\\u6027\\u8d28\\u7814\\u7a76\", \"SVEU - Maintenance of NHPs\", \"SVEU - Maintenance of Nonhuman Primates\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"Evaluation of Immune Responses to a Trimerically Stabilized gp120 Immunogen\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"SVEU - Core Activities - Administrative and Technical Support\", \"SVEU - Maintenance of NHPs\", \"SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"TIER 2 SHIV-C CHALLENAGE OF NONHUMAN PRIMATES PREVIOUSLY PROTECTED FROM TIER 1 SHIV-C CHALLENGE\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"Conduct of Virus In Vivo Titration Study (P196): ?In Vivo SHIV Titration via Intrarectal Route in Indian-origin Rhesus Macaques?\", \"SVEU - Core Activities - Administrative and Technical Support\", \"SVEU - Maintenance of Nonhuman Primates\", \"DEVELOPMENTS IN UPPER AIRWAY MUCOSAL INFLUENZA VIRUS VACCINES\", \"SVEU - Maintenance of NHPs\", \"SVEU - Core Activities - Administrative and Technical Support\", \"SVEU - Maintenance of Nonhuman Primates\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"SVEU - IMMUNOGENICITY OF A NONINTEGRATING INTEGRASE-DEFECTIVE LENTIVIRAL VECTOR\", \"IN VIVO SHIV TITRATION VIA INTRATECTAL ROUTE IN INDIAN-ORIGIN RHESUS MACAQUES\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"Conduct Study P189\", \"SVEU - Prime Boost Efficacy, Boosting Immunization, and Virus Challenge Studies\", \"SVEU - CONDUCT OF STUDIES IN NONHUMAN PRIMATES: REIMMUNIZATION AND CHALLENG\", \"SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"TIER 2 SHIV-C CHALLENAGE OF NONHUMAN PRIMATES PREVIOUSLY PROTECTED FROM TIER 1 SHIV-C CHALLENGE\", \"PREPARATION OF SHIV VIRUS STOCK\", \"Conduct of Virus In Vivo Titration Study (P196): ?In Vivo SHIV Titration via Intrarectal Route in Indian-origin Rhesus Macaques?\", \"\\u80f0\\u817a\\u764cMUC4\\u6297\\u539f\\u591a\\u8868\\u4f4d\\u5d4c\\u5408DNA\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u548c\\u514d\\u75ab\\u7814\\u7a76\", \"SVEU - Maintenance of NHPs\", \"SVEU - Core Activities - Administrative and Technical Support\", \"SVEU - Evaluation of Prime-Boost Regimen Emplyoing Clade C Proteins\", \"SVEU - Maintenance of Nonhuman Primates\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"IN VIVO SHIV TITRATION VIA INTRATECTAL ROUTE IN INDIAN-ORIGIN RHESUS MACAQUES\", \"SVEU - Prime Boost Efficacy, Boosting Immunization, and Virus Challenge Studies\", \"SVEU - CONDUCT OF STUDIES IN NONHUMAN PRIMATES: REIMMUNIZATION AND CHALLENG\", \"SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"IN VIVO SHIV TITRATION VIS INTRARECTAL ROUTE IN INDIAN-ORIGIN REHESUS MACAQUES\", \"TIER 2 SHIV-C CHALLENAGE OF NONHUMAN PRIMATES PREVIOUSLY PROTECTED FROM TIER 1 SHIV-C CHALLENGE\", \"PREPARATION OF SHIV VIRUS STOCK\", \"European network for vaccine evaluation in primates: combined vector immunisations for aids vaccine development\", \"SVEU - Maintenance of NHPs\", \"SVEU - Core Activities - Administrative and Technical Support\", \"SVEU - IMMUNOGENICITY OF A NONINTEGRATING INTEGRASE-DEFECTIVE LENTIVIRAL VECTOR\", \"SVEU - Evaluation of Prime-Boost Regimen Emplyoing Clade C Proteins\", \"SVEU - Reimmunization and Challenge Studies\", \"SVEU - Maintenance of Nonhuman Primates\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"SVEU - Prime Boost Efficacy, Boosting Immunization, and Virus Challenge Studies\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - CONDUCT OF STUDIES IN NONHUMAN PRIMATES: REIMMUNIZATION AND CHALLENG\", \"SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"Polymeric microparticulate vaccine formulations based on hydrogen bonding\", \"Enhancing the efficacy of poultry vaccines using innate immune adjuvants\", \"How do cross-reactive memory B cells affect influenza vaccine titers?\", \"Understanding Bacille Calmette Guerin's immune-defenses to generate a truly protective TB vaccine.\", \"Dengue fever vaccine: Towards low cost production and delivery\", \"To inform members of Congress that 1) U.S. investments in vaccine research and development are working, 2) that there are some exciting new directions in vaccine research that could lead to new or improved vaccines for many of the most intractable infectious diseases, for which we do not have vaccines or only partially effective vaccines, and 3) to provide an outline of the resources needed that could dramatically accelerate these advances\", \"Development of multi-peptide tumor vaccine for renal cell carcinoma\", \"Jadalna szczepionka przeciwko wirusowi grypy dla drobiu (Oral vaccine against influenza virus for poultry).\", \"MANNHEIMIA HAEMOLYTICA CHIMERIC PROTEIN VACCINE FOR DELIVERY OF MULTIPLE OUTER MEMBRANE PROTEIN AND LEUKOTOXIN ANTIGENS\", \"EVALUATION OF LIVE, ATTENUATED BRUCELLA VACCINE CANDIDATES\", \"IMMUNOINFORMATICS DRIVEN, GENOME DERIVED FISH VACCINE AGAINST THE BACTERIAL PATHOGEN V. ANGUILLARUM\", \"Market assessment and feasibility study on fowl adenovirus (FAdV) vaccine in chicken\", \"Dissection of protective responses to heterologous Campylobacter vaccines\", \"IMMUNOGENICITY OF ROUTINE CHILDHOOD VACCINES IN HIV POSITIVE CHILDREN\", \"Influenza Vaccine Development\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV Vaccine Design and Development Teams, Part A- Preventative Vaccines\", \"GENETICS OF BOVINE VACCINE RESPONSE\", \"FLSC - Vaccine Branch HIV Vaccine Primate Study\", \"Biodefense/Emerging Infection Vaccine Studies\", \"Understanding the publics' response to the H1N1 vaccine\", \"Determinants of the clearance of HIV infected cells by successful AIDS vaccines\", \"DETECTION AND CONTROL OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EMERGING VIRAL DISEASES OF SWINE\", \"RESEARCHES ON IMPROVEMENT OF PERTUSSIS VACCINE\", \"Chromatin nanofibre as a therapeutic cancer vaccine\", \"\\u521b\\u4f24\\u5f27\\u83ccDNA\\u75ab\\u82d7\\u514d\\u75ab\\u6b27\\u6d32\\u9cd7\\u9ca1\\u7684\\u7814\\u7a76\", \"Novel Vaccines against Pseudomonas aeruginosa and Other Microorganisms\", \"REGIONAL SYSTEM FOR VACCINES\", \"Seattle Vaccine Trials Unit\", \"Estudo das poss\\u00edveis interfer\\u00eancias dos m\\u00faltiplos componentes na avalia\\u00e7\\u00e3o da pot\\u00eancia do ant\\u00edgeno da hepatite b, nas vacinas combinadas\", \"Contribution to the WHO Global Vaccine Research Forum to be held at Salvador da Bahia, Brazil on the 12 - 15 June 2005.\", \"Immunogenicity and efficacy of vaccines for pneumonic pasteurelllosis in lambs\", \"Better control of Bacterial Cold Water Disease in farmed rainbow trout by the development of an effective Flavobacterium psychrophilum vaccine\", \"Developing a quadrivalent HCV vaccine\", \"Population-level vaccine safety monitoring: risk assessment and policy implications\", \"Use of Streptococcus gordonii as a live oral vector to prevent infectious diseases\", \"Use of Streptococcus gordonii as a live oral vaccine vehicle\", \"Vyu\\u017eit\\u00ed klonovan\\u00e9ho imunoregula\\u010dn\\u00edho IL-2 genu pro p\\u0159\\u00edpravu protin\\u00e1dorov\\u00fdch vakcin\", \"Immunisation practice and policy development in Australia: responding to urgent priorities in prevention of endemic and epidemic infectious diseases in children.\", \"Innate immune effector recruiting potential of HIV-1 human vaccine induced antibodies\", \"Single versus combination pneumococcal conjugate vaccines (13PCV and PHiD-CV) for high-risk Aboriginal children (COMBO)\", \"ORAL VACCINATION OF DOMESTIC SHEEP AGAINST MANNHEIMIA HAEMOLYTICA LEUKOTOXIN UTILIZING A NOVEL RECOMBINANT BACTERIOPHAGE\", \"A New nanoparticle glycogen for development of vaccine against malaria\", \"Spreading immune-reactions in esophageal cancer patients who were given cancer vaccine and whose tumors co-express additional antigens\", \"Lipid immunity in rhesus monkeys and development of a new anti-tuberculosis vaccine\", \"\\u81ea\\u5236\\u53e3\\u670dDNA\\u75ab\\u82d7\\u7684\\u7c98\\u819c\\u8868\\u8fbe\\u90e8\\u4f4d\\u4e0e\\u8bf1\\u5bfc\\u80a0IEL\\u6548\\u5e94\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u9f20\\u900f\\u660e\\u5e26DNA\\u514d\\u75ab\\u4e0d\\u80b2\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"HIV\\u58f3\\u4f53\\u86cb\\u767d\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u539f\\u6027\\u7814\\u7a76\", \"A multi-component high efficacy malaria vaccine.\", \"The development of vaccines to prevent shigella infections\", \"Enhancing immunogenicity of DNA vaccines by targeted delivery to antigen presenting cells\", \"Novel vaccines and serotyping scheme for Haemophilus parasuis\", \"Exploratory Research On Engineering The Service Sector: Collaborative Research: Research on Designing Vaccine Formularies for Childhood Immunization\", \"Exploratory Research On Engineering The Service Sector: Collaborative Research: Research on Designing Vaccine Formularies for Childhood Immunization\", \"Immunology Core\", \"Ebola Vaccine Immune Correlates and Mechanism of Protection\", \"Malaria Vaccine:  BSAM\", \"Testing of Blood Samples for Immune Response and Vaccine\", \"Ebola Vaccine Immune Correlates and Mechanism of Protection\", \"Testing of Blood Samples for Immune Response and Vaccine Research\", \"Vaccine Studies in HIV-infected Subjects\", \"Head-to-head comparison of two H1N1 swine influenza vaccines in children aged 6 months to 12 years\", \"Efficacious vaccine formulation system for prophylactic control of influenza pandemics\", \"ARRA: Process Development and Manufacture of Universal Influenza Vaccine\", \"VLP Vaccine Technology\", \"Immunogenicity and Efficacy of a Bivalent Clade B gp120 Protein Boost for aDNA/MVA Vaccine\", \"EFFICACY OF DNA AND PROTEIN CO-IMMUNIZATION PROTOCOL TO PROTECT MACAQUES FORM SHIV INFECTION\", \"\\u91cd\\u75c7\\u6025\\u6027\\u547c\\u5438\\u5668\\u75c7\\u5019\\u7fa4(SARS)\\u30a6\\u30a4\\u30eb\\u30b9\\u306b\\u5bfe\\u3059\\u308b\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u3068\\u514d\\u75ab\\u9632\\u5fa1\\u6a5f\\u69cb\\u306e\\u7814\\u7a76\", \"EFFICACY OF DNA AND PROTEIN CO-IMMUNIZATION PROTOCOL TO PROTECT MACAQUES FORM SHIV INFECTION\", \"EFFICACY OF DNA AND PROTEIN CO-IMMUNIZATION PROTOCOL TO PROTECT MACAQUES FORM SHIV INFECTION\", \"An evaluation of HIB vaccination and description of risk factors for HIB vaccine failure in Europe\", \"Advancing human and veterinary vaccinology.\", \"Pneumococcal vaccine escape: genome-wide characterisation of recombinants arising after vaccine implementation.\", \"Biodefense/Emerging Infection Vaccine Studies\", \"VACCINE PRODUCTION FACILITY\", \"Development of mass spectrometry methods for the quantification and characterization of antigens during the vaccine development process\", \"Vaccine and diagnostics development against swine dysentery\", \"Development of a vaccine against reproductive failure in pigs\", \"Development and comparative evaluation of three new generation BRSV DIVA vaccines and a corresponding DIVA test\", \"\\u7cbe\\u5b50\\u8868\\u9762\\u86cb\\u767dDNA \\u75ab\\u82d7\\u751f\\u7269\\u63a7\\u5236\\u5bb3\\u9f20\\u7684\\u7814\\u7a76\", \"Verbundprojekt: Development of a hepatitis C vaccine by targeted delivery of nanogel RNA-replicon constructs (HCVAX) - Teilvorhaben: Immunologische funktionelle Assays f\\u00fcr die in vitro Analyse eines Nanogel-basierten Hepatitis C Impfstoffes\", \"CI3: Realisierung von Software, Planungs- und Steuerungsmodulen f\\u00fcr die beschleunigte automatisierte Herstellung individualisierter MUTANOM-Vakzine (IVAC IT) - Teilvorhaben: Einsatz von innovativen Softwarel\\u00f6sungen als Grundlage zur iterativen Verbesserung von IVAC MUTANOME Impfstoffen\", \"Zwanzig20 - InfectControl 2020 - Verbundvorhaben: Molekulare Serologie zur schnellen Bestimmung der Impftiter gegen impf-pr\\u00e4ventable Infektionskrankheiten (STIKO-Liste) bei Migranten und anderen Patientengruppen, Teilvorhaben: STIKO-Serologie - TV4\", \"Zwanzig20 - InfectControl 2020 - Verbundvorhaben: Molekulare Serologie zur schnellen Bestimmung der Impftiter gegen impf-pr\\u00e4ventable Infektionskrankheiten (STIKO-Liste) bei Migranten und anderen Patientengruppen, Teilvorhaben: STIKO-Serologie - TV3\", \"Zwanzig20 - InfectControl 2020 - Verbundvorhaben: Molekulare Serologie zur schnellen Bestimmung der Impftiter gegen impf-pr\\u00e4ventable Infektionskrankheiten (STIKO-Liste) bei Migranten und anderen Patientengruppen, Teilvorhaben: STIKO-Serologie - TV 2 'Mikroarrays'\", \"Zwanzig20 - InfectControl 2020 - Verbundvorhaben: Molekulare Serologie zur schnellen Bestimmung der Impftiter gegen impf-pr\\u00e4ventable Infektionskrankheiten (STIKO-Liste) bei Migranten und anderen Patientengruppen, Teilvorhaben: STIKO-Serologie - TV1\", \"Entwicklung von in vitro Methoden als Ersatz f\\u00fcr Letalchaellengeversuche an Fischen zur Beurteilung von Vakzinen - Phase II - Teilprojekt 2: Optimierung und Standardisierung eines ELISA-Systems f\\u00fcr Furunkulose-Vakzine\", \"Development of Molecular Adjuvants for HIV-1 Canarypox  Vaccines\", \"Construction and studies on vaccine potential of chimeric protein molecules comprising immunodominant regions of outer membrane proteins of enterobacteriacease for application as broad spectrum vaccine against salmonella shigella E Coil and proteus\", \"Associa\\u00e7\\u00e3o entre ant\\u00edgenos tumorais ao v\\u00edrus vacinal da febre amarela yf 17d como vetor vacinal contra o c\\u00e2ncer\", \"Associa\\u00e7\\u00e3o entre ant\\u00edgenos tumorais ao v\\u00edrus vacinal da febre amarela yf 17d como vetor vacinal contra o c\\u00e2ncer\", \"Immunogenno\\u015b\\u0107 szczepienia przypominaj\\u0105cego przeciw krztu\\u015bcowi przy u\\u017cyciu szczepionki typu dTap u dzieci z nowotworami i po transplantacji kom\\u00f3rek hematopoetycznych.\", \"To better track vaccines and improve supply chains in developing countries by using radio-frequency identification tags (RFID) on vaccine packages that can be detected by near field communication (NFC) found on most smartphones\", \"To ensure quality vaccines are available when needed by developing an application along with blockchain technology to monitor the supply chains delivering vaccines from producers to health workers\", \"Cytomegalovirus (CMV) vaccine development: A study of viral tropism, genomic diversity and neutralizing epitopes in CMV positive clinical samples\", \"IGF::OT::IGF:THE SCRIPPS RESEARCH INSTITUTE. TASK ORDER 2 (HHSN275201500006I/HHSN27500002).PRODUCTION AND DISTRIBUTION OF INVESTIGATIONAL GHRELIN VACCINES--GHRELIN VACCINE AGAINST RAT HORMONE. 09/21/\", \"IGF::OT::IGF:The Scripps Research Institute. Task Order 3 (HHSN275201500006I/HHSN27500003).Production and Distribution of Investigational Ghrelin Vaccines--Ghrelin Vaccine Against Rat Hormone. 09/21/\", \"CPCRN Special Project on HPV Vaccine Uptake\", \"Cancer Vaccine (for Continued Development of Molecular Switching Vaccines Using Genetically Modified Listeria for Cancer, Infectious Disease and Bio-Defense)\", \"Odvozen\\u00ed a charakterizace oslaben\\u00e9 linie Eimeria flavescens a v\\u00fdvoj vakc\\u00edny proti kokcidi\\u00f3ze kr\\u00e1l\\u00edk\\u016f.\", \"Optimizing a vaccine for HPV immunotherapy\", \"Developing drugs and vaccines for malaria by undertaking experimental studies in humans\", \"RV3 Rotavirus Vaccine: A human neonatal rotavirus vaccine for the Asia-Pacific region\", \"To improve understanding of how conjugate vaccines impact pneumococcal ecology and to inform how vaccines of higher valences can be most effectively used to reduce the burden of pneumococcal illness\", \"To support the implementation of phase IV clinical trials in adults to evaluate the safety and reactogenicity of monovalent type 2 and trivalent Oral Polio Vaccine for future comparisons with data on new Oral Polio Vaccines\", \"To design, produce and test in preclinical and clinical studies new material forms of drugs and vaccines for improved drug and vaccine delivery to patients in developing countries\", \"To identify biomarkers of correlates of protection against pre-erythrocytic (PE) malaria infection that will enable down selection of vaccine antigens and predict outcomes of trials for anti-infection vaccines against Plasmodium falciparum\", \"To study the pattern and severity of childhood pneumonia before and after pneumococcal vaccination, evaluate the vaccine status of children with severe illnesses, and analyze the cost effectiveness of the pneumococcal vaccine in Malawi\", \"To generate information on the impact of a Japanese encephalitis vaccination program, using a safe, affordable Japanese encephalitis vaccine produced by a developing country manufacturer, and to support expanded use of the vaccine\", \"To test the efficacy of administering two approved vaccines directly under the tongue, which could help improve vaccine delivery, compliance, and enhance immunity against a variety of pathogens.\", \"To assess delivery strategies for tetanus vaccine during pregnancy and to understand how antenatal care and maternal immunization can be strengthened to optimally deliver current and future vaccines to pregnant women\", \"To build imaging capacity (PET-CT scanning) of the Tulane National Primate Research Center for TB vaccine studies as a part of a service component of the Collaboration for TB Vaccine Discovery (CTVD)\", \"To further optimize the immune response to a combined placental malaria and cervical cancer vaccine and investigate the scalability and efficient production of such a vaccine for the developing world.\", \"To use a new vaccine technology to produce non-infectious poliovirus-like particles that can be used in one highly effective, low-cost polio vaccine capable of inducing protective immunity against all circulating serotypes.\", \"To accelerate the development of therapeutics and vaccines by formalizing an experimental medicine model of Cryptosporidium hominis, the most prevalent cause of human cryptosporidiosis, that can be used to test candidate therapeutics and vaccines\", \"To develop a novel vaccine for TB based on existing BCG vaccines modifi ed to express a gene that is specifi c to latent TB in order to generate a robust immune response to a latent infection.\", \"To reduce cholera burden globally and make the case for rational use of oral cholera vaccines by evaluating strategies to most effectively deploy Oral Cholera Vaccines across multiple settings\", \"To develop a blueprint for strengthening global vaccine safety and coordination between different agencies working on vaccine safety issues, identifying core capacities at various levels, and how these activities can be can be funded and sustained\", \"To evaluate the safety of oral polio vaccine (OPV) by monitoring the incidence of vaccine-associated paralytic poliomyelitis (VAPP) in China, and to provide useful genomic & bio-feature information for developing a safer OPV\", \"To develop and update an assessment framework for the long-term viability of vaccine manufacturers for the traditional Expanded Program on Immunization vaccines and insights into factors that influence their success\", \"To catalyze TB vaccine research and development in China and promote collaboration between international and Chinese researchers with the common goal of developing new, more effective TB vaccines\", \"To enable development of the Vaccine Development and Introduction Platforms, which will position PATH to evaluate and progress a robust pipeline of global health vaccine projects from product concept to impact with industry-standard quality, speed, and effectiveness\", \"To examine the etiology of cases of diarrhea at one rotavirus vaccine clinical trial site in India in order to gather data that will help establish priorities for future enteric vaccine development\", \"To test the theory that providing children with antihelminthic and anti-giardiasis drugs prior to administration of an oral typhoid vaccine ill produce a robust immune response to the vaccine.\", \"To identify, evaluate, and apply platform vaccine formulation and stabilization technologies to accelerate the development and introduction of safe, efficacious, and programmatically suitable vaccines in low- to middle-income countries\", \"To translate the History of Vaccines website into Hindi, Urdu and Arabic and increase the reach of the site to audiences that currently have little access to reliable information about vaccines in their native languages\", \"To improve a malaria vaccine by combining it with a monoclonal antibody to increase competition for the vaccine antigen by antibody-producing immune cells, and with a molecule to prolong the survival of those immune cells\", \"To build imaging capacity (PET-CT scanning) of the University of Pittsburgh for TB vaccine studies as a part of a service component of the Collaboration for TB Vaccine Discovery (CTVD)\", \"To maximize impact and accelerate development of new TB vaccines by creating and applying novel mathematical models to estimate the main target product profiles drivers for epidemiological impact of new TB vaccines\", \"To provide capacity building support for International Vaccine Institute to execute its 2015 strategic plan in support of its mission to discover, develop and deliver safe, effective, and affordable vaccines for global health\", \"To assess safety and tolerability of different vaccine regimens with Ad26.Mos4.HIV, Ad26.Mos.HIV and Clade C gp140 and immunogenicity between the different vaccine regimens with Ad26.Mos4.HIV, Ad26.Mos.HIV and Clade C gp140\", \"To establish a program to link new vaccine discoveries with vaccine manufacturers in developing countries while simultaneously evaluating ways to help these manufacturers purchase rights to these innovative candidates.\", \"To develop an effective, stable intranasal nanoemulsion adjuvanted respiratory syncytial virus (RSV) vaccine for the developing world without the hyper-reactivity observed with prior RSV vaccines in clinical trials\", \"To accelerate the successful uptake of human papillomavirus vaccine in Gavi eligible countries and other low-resource settings by providing key information for national decision-making and planning on human papillomavirus vaccine introduction\", \"To determine if live attenuated influenza vaccine (LAIV) or trivalent influenza vaccine (TIV) affects the density and / or duration of pneumococcal colonization in healthy adults using the EHPC (Experimental Human Pneumococcal Carriage) model\", \"To integrate characteristics of heat shock proteins from thermophilic organisms, which live at relatively high temperatures, into attenuated bacterial vaccines to enhance viability and immunogenicity these vaccines during the freeze-drying process\", \"To identify malaria vaccine targets for the liver-stage of infection using novel, parasite cultivation strategies. These newly identified antigens may be used to supplement the existing RTS,S vaccine, improving levels of protection from malaria\", \"To assess the capacity of six China National Biotec Group institutes to meet World Health Organization requirements for priority vaccines, to improve their potential to provide safe, effective, and affordable vaccines\", \"To reduce the burden of dengue in developing countries by accelerating the introduction of safe and broadly protective dengue vaccines into public sector programs, especially for children, and support the development of dengue vaccine candidates\", \"To generate evidence and a prediction model to inform vaccine scheduling and the design of alternative Pneumococcal conjugate vaccine regimens focused on reducing carriage, person-to-person transmission and optimizing herd protection from disease\", \"To sustain and increase political support and financing for HIV vaccine research and development from European Union institutions and key Member States to help accelerate product development by ensuring a robust pipeline of vaccine candidates\", \"To design a mosquito that can produce and secrete a malaria vaccine protein into a host\\u2019s skin. The hope is that such mosquitoes could deliver protective vaccines against other infectious diseases as well.\", \"To reduce the burden of cholera in endemic and epidemic settings with the use of a single dose regimen of the cholera vaccine developed by International Vaccine Institute (IVI) and recently licensed in India by Shantha Biotechnics\", \"To develop a new vaccine technology that accumulates a high number of antigen-specific cells in the lymph nodes at the time of immunization to improve vaccine effectiveness\", \"To explore the value proposition and technical feasibility of blow-fill-seal for oral and injectable vaccines (IPV, Penta, HPV, PCV, Rota and Cholera), including other pipeline vaccines in development\", \"To develop a vaccine for leishmaniasis by focusing on the scientific and practical issues leading to the development of effective vaccines and therapies, initially in Brazil and India\", \"To facilitate the discovery of a safe, effective and practical HIV-1 vaccine by using valid laboratory criteria and Good Clinical Laboratory Practices to monitor antibody responses in the systemic and mucosal compartment in vaccine testing\", \"IGF::OT::IGF:THE SCRIPPS RESEARCH INSTITUTE. TASK ORDER 2 (HHSN275201500006I/HHSN27500002).PRODUCTION AND DISTRIBUTION OF INVESTIGATIONAL GHRELIN VACCINES--GHRELIN VACCINE AGAINST RAT HORMONE. 09/21/\", \"Task X14:  Evaluation of Ebola Vaccines\", \"DEVELOPMENT OF A WEST NILE VIRUS VACCINE\", \"Nonhuman Primate Core Functional Genomics Laboratory for AIDS Vaccines Research a\", \"Basic study on novel vaccine strategy for avian influenza\", \"B\\u7d30\\u80de\\u8868\\u5c64\\u3067\\u306e\\u5206\\u5b50\\u8a8d\\u8b58\\u5236\\u5fa1\\u306b\\u3088\\u308b\\u30e6\\u30cb\\u30d0\\u30fc\\u30b5\\u30eb\\u30ca\\u30ce\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5275\\u88fd\", \"Development of novel pertussis vaccine\", \"PRODUCTION AND TESTING OF A MODIFIED VACCINIA ANKARA (MVA) VACCINE\", \"Nonhuman Primate Core Functional Genomics Laboratory for AIDS Vaccines Research a\", \"Task X14:  Evaluation of Ebola Vaccines\", \"NIHR Health Protection Research Unit in Immunisation\", \"NanoVector Vaccine Potentiation\", \"Konstrukcja szczepionek odporno\\u015bciowych opartych na \\u017cywych szczepach Salmonella enterica Typhimurium zawieraj\\u0105cych rekombinowane fagi nitkowate\", \"Improving the duration of immunity for FMD vaccines\", \"Novas estrat\\u00e9gias vacinas para pat\\u00f3genos ent\\u00e9ricos: vacinas contra diarr\\u00e9ia baseadas no fator de coloniza\\u00e7\\u00e3o I (CFA/I) de Escherichia coli enterotoxig\\u00eanica (ETEC)\", \"Desenvolvimento de vacina celular anti-pneumoc\\u00f3cica: utiliza\\u00e7\\u00e3o de cepa n\\u00e3o capsulada de Streptococcus pneumoniae\", \"Transmission dynamics of live coccidiosis vaccines: Does management have an impact?\", \"Ultrasound mediated delivery of vaccines for aquaculture\", \"Development of a Reverse Genetics System to Produce Live, Attenuated Infectious Salmon Anemia Virus (ISAV) Vaccine Candidates\", \"Surface proteins of Staphylococcus aureus involved in nasal colonization biofilm formation and immune evasion. Potential for vaccine development\", \"Construction & Development of a New Prototype Measles-Mumps-Rubella Vaccine Based on Recombinant RNA\", \"A NUTRITIVE VACCINE ADJUVANT AGAINST INFLUENZA\", \"CHLAMYDIA TRACHOMATIS VACCINE SAFETY AND EFFICACY EVALUATION IN NONHUMAN PRIMATES\", \"Nonhuman Primate Core Functional Genomics Laboratory for AIDS Vaccines Research a\", \"Multi-Antigen Vaccine for Lung Cancer PreventionPOP: 09/18/2014-09/17/2016\", \"New preventative and therapeutic Hepatits C vaccines: from pre-clinical to phase I\", \"The second phase of a european malaria vaccine development consortium\", \"An international Primate Vaccine Evaluation Network (PVEN) for the optimal use of a variety of primate species for the evaluation of vaccines and other tools against the major infectious diseases in developing countries\", \"Evaluation of the safety and immunogenicity of a new tuberculosis vaccine, MVA85A, as a booster vaccine for BCG, in a series of Phase II clinical trials in South Africa.\", \"PRODUCTION AND TESTING OF A MODIFIED VACCINIA ANKARA (MVA) VACCINE\", \"A single vaccine for influenza and pneumonia\", \"Improving the quality of FMD vaccines by understanding the correlation of vaccine-induced protection with immune responses in cattle\", \"ARRA: H1N1 and Other ARRA Equipment\", \"The Determination of Phosphorus in Vaccines\", \"Development of oral vaccine tech for multivalent protection against Shigella\", \"Development of technology for a combination anthrax-plague live oral vaccine\", \"Development of oral vaccine tech for multivalent protection against Shigella\", \"Development of technology for a combination anthrax-plague live oral vaccine\", \"Development of Anti-Ebola MHC Tetramers to Evaluate Vaccines\", \"Development of Anti-Ebola MHC Tetramers to Evaluate Vaccines\", \"Guinea Pig Model for Shigellosis Vaccine Development\", \"Characterization of the Mechanism of Action of Vaccine Adjuvants\", \"Characterization of the Mechanism of Action of Vaccine Adjuvants\", \"Development of New Tools for Influenza Vaccines\", \"Development of Assays and Pre-clinical Evaluation of Francisella Vaccines\", \"Assays for Characterization and Efficacy Evaluation of Anthrax Vaccines\", \"Robust, defined, animal-free cell culture medium for the production of vaccines\", \"Effectiveness of the Influenza Vaccine in the Aging Population\", \"Production/Testing of a MVA Vaccine\", \"HIV Vaccine Production, PreClinical Testing, FDA Submissions\", \"Nonhuman Primate Core Functional Genomics Laboratory for AIDS Vaccines Research a\", \"Use of TERT Vaccine in Prevention of Lung Cancer in Animal Models\", \"Exploratory Center for Vaccinology Research (RMI)\", \"RNA synthetic biology for genetic engineering of a programmable one-shot smart RNA vaccine\", \"An integrated strategy for preclinical development of improved vaccines against dendritrische cell lung cancer\", \"Developing a novel cancer vaccine using IDO2-silenced DCs for breast cancer\", \"VACCINATION AND PROTECTION STUDIES FOR A TARGETED NANOPARTICULATE ORAL VACCINE AGAINST SHIGELLOSIS\", \"Development of Molecular Diagnostics and Immunotherapeutic Vaccines for Prawn and Brinjal Allergy\", \"Development of Nanoparticle or Microparticle Adjuvanted Subunit Oral Vaccine against Poultry Salmonellosis\", \"Development of a novel \\\"broad-spectrum\\\" subunit vaccine for Bluetongue disease in animals\", \"Programming protective humoral responses with novel vaccine formulations against Dengue Virus.\", \"Innate Predictors of Adaptive BCG and HBV Vaccine-induce Responses in Bangalore Adolescents\", \"Development of prophylactic as well as therapeutic DNA vaccine for canine mammary cancer\", \"Evaulation of novel adjuvants for mucosal priming following cutaneous delivery of vaccine\", \"Development of envelope domain III-based Dengue Virus-like particle (VLP) Vaccine candidates\", \"Targeted nanoparticulate oral vaccine against shigellosis: mimicking shigell's strqategy of infection\", \"Development of DNA vaccine to combat Edwardsiella tarda infection in commercially important food fishes.\", \"Immuno-prophylactic evaluation of potential vaccine candidates against Fasciola gigantica in domestic animals.\", \"Development of Calcium Phosphate Nanoparticle based DNA vaccine against FMD(Foot and Mouth Disease)\", \"Karakterisatie en evaluatie van kandidaat vaccin antigenen tegenover de lebmaag-nematode Ostertagia ostertagi bij het rund.\", \"Onderzoek naar het gebruik van mRNA moleculen als alternatief voor een Chlamydophila psittaci DNA vaccin\", \"Development of an mRNA-based vaccine to treat HPV-positive oropharyngeal squamous cell carcinoma: immunogenicity, therapeutic efficacy and safety.\", \"Ontwikkeling van een cellular HIV vaccin gebaseerd op dendritische cellen ge- transfecteerd met mRNA coderend voor HIV antigenen.\", \"Ontwikkeling van een cellulair HIV vaccin gebaseerd op dendritische cellen getransfecteerd met mRNA coderend voor HIV antigenen.\", \"Inductie van een cellulaire immuunrespons tegen idiotype determinanten. Lymfoma vaccinatie : vaccin productie en evaluatie van de immuunrespons.\", \"De ontwikkeling van RSV vaccins op basis van virus like partikels die korte fragmenten van RSV oppervlakte-eiwitten presenteren.\", \"Onderzoek naar de structurele en mechanistische eigenschappen van een nieuwe RSV therapie en een nieuw RSV vaccin.\", \"Ophelderen van het mechanisme van verbeterde protectie door een M. bovis BCG mutant als een vaccin tegen Mycobacterium tuberculosis infectie\", \"Immunobiologie van gastheer-trypanosoom interacties : identificatie van immunopathologische trypanosoom componenten en ontwikkeling van anti-\\\"ziekte\\\" vaccins.\", \"Zuivering en studie van adenylaat cyclase van Bordetella pertussis : met het oogop een eventuele toepassing ervan in een verbeterd acellulair kinkhoest vaccin.\", \"T cel immunogeniciteit van RHAMM en BMI-1: ontwikkeling van een multi-antigenisch dendritisch celvaccin voor hematologische maligniteiten\", \"\\u65b0\\u4e00\\u4ee3HPV16E7\\u6838\\u9178\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u6297\\u764c\\u7684\\u7ec6\\u80de\\u4e0e\\u5206\\u5b50\\u751f\\u7269\\u5b66\", \"DNA Immunization Against Rhodococcus equi pneumonia of Foals using an Attenuated Salmonella Vaccine Vector\", \"Verbundprojekt: Entwicklung innovativer bestandsspezifischer Impfstoffe f\\u00fcr Gefl\\u00fcgel zur vereinfachten Applikation (innoVAK4DART) - Teilprojekt: 5\", \"Verbundprojekt: Entwicklung innovativer bestandsspezifischer Impfstoffe f\\u00fcr Gefl\\u00fcgel zur vereinfachten Applikation (innoVAK4DART) - Teilprojekt: 4\", \"Verbundprojekt: Entwicklung innovativer bestandsspezifischer Impfstoffe f\\u00fcr Gefl\\u00fcgel zur vereinfachten Applikation (innoVAK4DART) - Teilprojekt 3\", \"Verbundprojekt: Entwicklung innovativer bestandsspezifischer Impfstoffe f\\u00fcr Gefl\\u00fcgel zur vereinfachten Applikation (innoVAK4DART) - Teilprojekt 2\", \"Verbundprojekt: Entwicklung innovativer bestandsspezifischer Impfstoffe f\\u00fcr Gefl\\u00fcgel zur vereinfachten Applikation (innoVAK4DART) - Teilprojekt 1\", \"Verbundprojekt: Neuartiger Ansatz zur Entwicklung eines heterosubtypischen Marker-Impfstoffs gegen die avi\\u00e4re Influenza in Gefl\\u00fcgel - Teilprojekt 2\", \"Verbundprojekt: Neuartiger Ansatz zur Entwicklung eines heterosubtypischen Marker-Impfstoffs gegen die avi\\u00e4re Influenza in Gefl\\u00fcgel - Teilprojekt 1\", \"Entwicklung einer Subunit- und inaktivierten Vollvirus-Vakzine zur Immunisierung von Katzen gegen eine Influenza H5N1-Infektion\", \"Verbundprojekt: Topische Vakzinierung mit funktionalen Nanopartikeln - Teilvorhaben: Hautpenetration und immunologische Validierung von funktionalen Nanopartikelvakzinen\", \"EUREKA-Projekt: Malaria-Impfstoff (EU 101) - Teilvorhaben 1 (Zur Anwendung in Entwicklungsl\\u00e4ndern)\", \"Entwicklung eines Malaria-Impfstoffes: Teilvorhaben 2 und 3 - zur Anwendung in Entwicklungsl\\u00e4ndern\", \"Herstellung eines synthetischen, veterin\\u00e4rmedizinisch Verwendbaren Peptid-Impfstoffes Gegen Virusleukaemie mit dem Ziel der Entwicklung Humanmedizinischer Pharmaka\", \"Verbundprojekt: Entwicklung eines Impfstoffs Gegen Herpes Simplex-Virus, Gewonnen mit Hilfe eines Bakteriellen Systems\", \"KMU-innovativ-8: VakMech - Wirkmechanismus von mRNA-Vakzinen als Basis der n\\u00e4chsten Technologiegeneration\", \"Neues Prinzip einer Vermehrungsf\\u00e4higen Totvakzine am Modell der infekti\\u00f6sen Bovinen Rhinotracheitits (Ibr)\", \"Verbundprojekt: Ein Flexibles System zur gezielten Antigen-Variation bei Humanen Influenza-Viren f\\u00fcr die Herstellung von Vakzinen\", \"Verbundprojekt: Molekulargenetische Entwicklung eines Impfstoffes Gegen Herpesviren zum Einsatz in der Tiermedizin\", \"Verbundprojekt: Gentechnologische Bearbeitung des menschenpathogenen Hanta-Virus mit dem Ziel, einen Impfstoff zu entwickeln\", \"Verbundprojekt: Gentechnologische Bearbeitung des menschenpathogenen Hanta-Virus mit dem Ziel, einen Impfstoff zu entwickeln\", \"Verbundprojekt: Gentechnologische Bearbeitung des menschenpathogenen Hanta-Virus mit dem Ziel, einen Impfstoff zu entwickeln\", \"Verbundprojekt: Gentechnologische Bearbeitung des menschenpathogenen Hanta-Virus mit dem Ziel, einen Impfstoff zu entwickeln\", \"Entwicklung von Verfahren zur effizienten Herstellung von Antik\\u00f6rpern und synthetischen Vakzinen mittels neuartiger Antigen-Lipopeptid-Konjugate\", \"Verbundprojekt: Optimierung der industriellen zellbasierten Herstellung von Influenzavakzine (saisonal und pandemisch), TP 4\", \"Verbundprojekt: Optimierung der industriellen zellkulturbasierten Herstellung von Influenza Vakzinen (saisonal und pandemisch), TP 2\", \"ERA Net EuroTransBio-3: Entwicklung einer anti-CETP Vakzine f\\u00fcr die Vorbeugung und Behandlung der Arteriosklerose\", \"ERA Net EuroTransBio-2: Entwicklung von Crossbetas Adjuvanz Technologie. Eine neue Technologie zur Verbesserung von Impfstoffeigenschaften\", \"KMU-innovativ-1: CSC - Entwicklung eines tumorstammzell-spezifischen therapeutischen Impfstoffs zur Behandlung von Tumoren\", \"BioChancePLUS-4: Entwicklung eines effizienten mRNA basierten Impfstoffes gegen schwer konventionell therapierbare Infektionskrankheiten am Beispiel von CMV\", \"BioChancePLUS-4: 'IgE-AAV' Partikel als Vakzine zur Behandlung von Asthma und anderen allergischen Erkrankungen\", \"BioProfile Stuttgart/Neckar-Alb: Verfahren zur Entwicklung eines therapeutischen Impfstoffs zur Anwendung von Pankreaskarzinomen\", \"BioChancePLUS-2: Verbundprojekt: Therapeutische Tumorimpfstoffe auf der Basis von universellen Tumorantigenen und des Polyoma-Tr\\u00e4gersystems\", \"BioProfile Braunschweig/G\\u00f6ttingen/Hannover: Entwicklung einer rekombinanten Vakzine gegen Dictycaulus viviparus, den Lungenwurm der Rinder\", \"Genom-basierte Untersuchungen zur Expression und Produktion von Impfstoffen gegen virale Erkrankungen von Tieren in transgenen Pflanzen.\", \"Modellregion M\\u00fcnchen: Die Entwicklung von Impfstoffen auf molekularbiologischem Wege gegen Erreger menschlicher Infektionskrankheiten\", \"Modellregion M\\u00fcnchen: Entwicklung neuartiger Impfstoffe zur prophylaktischen Bek\\u00e4mpfung bakterieller Infektionen und deren chronischen Folgeerkrankungen\", \"Entwicklung einer Chicken Factor freien H\\u00fchnerherde f\\u00fcr wissenschaftlich experimentelle und diagnostische Zwecke sowie zur Impfstoffherstellung\", \"Phase I/II-Studie zur Verminderung von R\\u00fcckf\\u00e4llen beim Melanom mit einem Vakzin gegen mutierte Tumorantigene.\", \"JPND Verbundprojekt CrossSeeds: Charakterisierung modifizierter Amyloidpeptide zur Ableitung von Impfstoff-Strategien und spezifischen Nachweismethoden\", \"Pilot Studie zur therapeutischen Impfung von Patienten mit einer chronischen HBV Infektion mittels eines neuen Impfstoff aus Kuba\", \"Major Cell Culture Improvements Needed for a Live Attenuated RSV Vaccine to be Economically Feasible\", \"Verbundprojekt: Thermoelektrischer Solark\\u00fchlschrank zur Aufbewahrung von Impfseren in Entlegenen Krankenstationen der Entwicklungsl\\u00e4nder\", \"Investigating the altered landscape of enteric viruses causing severe gastroenteritis in Australian children following rotavirus vaccine introduction\", \"Mechanisms of B cell immunodominance to influenza virus\", \"Generation of a genetically-stable live vaccine candidate against infectious bursal disease virus (IBDV) through mutagen- driven lethal mutagenesis\", \"\\u201cPlasmodium SCOT1 Mutant As Experimental Malaria Vaccine: Implications For Inducing Pre-Erythrocytic And Cross-Stage Immunity\\u2019\\u2019.\", \"Enhancement Of The Immunogenicity And Protective Efficacy Of Lipopeptide Vaccine Against Mycobacterium Tuberculosis Using Peptidomimetics And Conjugation With Isoniazid\", \"Enhancement Of The Immunogenicity And Protective Efficacy Of Lipopeptide Vaccine Against Mycobacterium Tuberculosis Using Peptidomimetics And Conjugation With Isoniazid\", \"Transplastomic chloroplasts as bioreactors for the synthesis of antigen-based vaccines and enzymes for bomass degradation\", \"Development of a Curative Therapeutic Vaccine for the Treatment of Large Established Tumors in Mice\", \"Evaluation of Plasmodium falciparum erythrocyte binding antigens as malaria vaccine candidates\", \"Probiotic lactic acid bacteria as anticholera oral edible vaccine to be used as a functional food\", \"Attenuation and Characterisation of Eimeria spp for Development and Increasing Live Vaccine Product Quality of Avian Coccidiosis\", \"Simulation of the Dynamics of Viral Evolution Aiming at Engineering Effective Vaccines: A Computer-Aided Study on HIV\", \"Evaluation and Development of Some Potent and Safe Plant-Derived Immunostimulants as Adjuvants for Sub-Unit Vaccines\", \"Screening for Critical Genes from Plasmodium Falciparum as Potential Drug Targets/Vaccine Candidates Against Malaria\", \"Development of Vaccine Using Recombinant Protein and Attenuated Mutant Technologies for the Prevention of Mycobacterial and Leptospiral Infection\", \"The Network of Digestive Gut Enzymes in Ticks: Isolation, Characterization and Their Promise as Molecular Vaccines\", \"Development and Use of Attenuated Salmonella as a Vaccine Vector for Expression of Antigen From an Unrelated Organism\", \"BPVacc: Development of a vaccine against meliodosis with Burkholderia pseudomallei antigens\", \"Industrial Supplement - Construction & Development of a new prototype measles-mumps-rubella vaccine based on recombinant RNA\", \"Targeting microRNA to drive a successful host response to Mycobacterium tuberculosis \\u2013 engineering a better vaccine\", \"Construction and development of a new prototype measles-mumps-rubella vaccine based on recombinant RNA\", \"Development of native and recombinant mumps virus subunit nasal vaccines using proteosome technology\", \"Effects of Lipid Virulence Factors (PDIM/PGLs) on Virulence and Immunogenicity of BCG Vaccine Strains\", \"The relationship between socio-political forces and bioethics with respect to future access to HIV vaccines\", \"Science, Controversy, and Genetically Modified Plants: Participant Observation of the Creation of New Genetic Knowledge and Edible Vaccines.\", \"Understanding the communication between gene-modified cells and the immune system:  Development of new gene therapies and vaccines\", \"Travel support to attend the AIDS Vaccine 2008 Parternship Development Forum in Cape Town, South Africa\", \"Development of glycoprotein E1/E2-immunoglobulin (Ig) chaimeric subunit vaccine candidates against chikungunya viru in E.Coil\", \"Application of DNA vaccines to the clinic: a phase II study of idiotypic vaccination for follicle centre lymphoma\", \"IL-12 \\uc720\\ub3c4\\uc131 \\uc0c8\\ub85c\\uc6b4 \\uba74\\uc5ed\\ud65c\\uc131\\uc81c\\ub85c\\uc11c \\uc6d0\\ucda9 \\uc720\\ub798 \\ud504\\ub85c\\ud544\\ub9b0\\uc758 \\uba74\\uc5ed \\uc99d\\uac15 \\ubc0f \\uc790\\uac00\\uc554 \\ubc31\\uc2e0 \\ud6a8\\uacfc \\uaddc\\uba85\", \"\\uc2e0\\ubcc0\\uc885 \\ubc14\\uc774\\ub7ec\\uc2a4\\uc758 \\ubd84\\uc790\\uc9c4\\ud654 \\uc5f0\\uad6c \\ubc0f \\ub2e8\\ubc31\\uc9c8 \\ub098\\ub178\\uc785\\uc790 \\uae30\\ubc18 \\ucc28\\uc138\\ub300 \\ubcf5\\ud569\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uac10\\uc5fc\\uc131 \\uac00\\ucd95\\uc9c8\\ubcd1 \\uc81c\\uc5b4\\ub97c \\uc704\\ud55c \\ubaa8\\ub2c8\\ud130\\ub9c1 \\uae30\\ubc95 \\uac1c\\ubc1c \\ubc0f \\ud6a8\\ubaa8 \\ub514\\uc2a4\\ud50c\\ub808\\uc774 \\uae30\\ubc18\\uc758 \\ucc28\\uc138\\ub300 \\ubc31\\uc2e0 \\uc751\\uc6a9\", \"\\ud654\\ud559\\uc801 \\uc720\\ub3c4 \\ubc15\\ud14c\\ub9ac\\uc544\\uace0\\uc2a4\\ud2b8(BG)\\ub97c \\uc774\\uc6a9\\ud55c \\uadf8\\ub78c\\uc74c\\uc131\\uade0 \\ubc0f \\uadf8\\ub78c\\uc591\\uc131\\uade0 \\ubc31\\uc2e0 \\ubc0f \\uba74\\uc5ed\\uc99d\\uac15\\uc81c \\uac1c\\ubc1c\", \"TM4SF5 \\ud3a9\\ud0c0\\uc774\\ub4dc-CpG-DNA-\\ub9ac\\ud3ec\\uc880 \\ubcf5\\ud569\\uccb4 \\ubc31\\uc2e0\\uc5d0 \\uc758\\ud55c \\ub300\\uc7a5\\uc554 \\uc5b5\\uc81c \\uae30\\uc804 \\uaddc\\uba85\", \"\\uc0b4\\ubaa8\\ub12c\\ub77c \\ubc0f \\ube0c\\ub8e8\\uc140\\ub77c \\uc0dd\\uade0\\ubc31\\uc2e0\\uc758 \\uba74\\uc5ed\\ubc18\\uc751 \\ud5a5\\uc0c1 \\ubc0f \\uba74\\uc5ed\\ubc18\\uc751 \\uae30\\uac04 \\uc7a5\\uae30\\ud654\\ub97c \\uc704\\ud55c \\ub098\\ub178\\ucea1\\uc290\\ud654\\uae30\\uc220 \\uc751\\uc6a9\", \"GSK-3\\u03b2 \\uc758\\uc874\\uc801\\uc778 IDO \\ubc1c\\ud604\\uc870\\uc808\\uae30\\uc791\\uc744 \\ud1b5\\ud55c \\uc218\\uc9c0\\uc0c1\\uc138\\ud3ec \\uae30\\ubc18\\uc758 \\uc554 \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\ub098\\ub178 \\uc218\\uc1a1\\uccb4\\ub97c \\uc774\\uc6a9\\ud558\\uc5ec \\uc5ec\\ub7ec \\uc720\\uc804\\uc790\\ub97c \\ub3d9\\uc2dc\\uc5d0 \\uc804\\ub2ec\\ud558\\ub294 \\uc790\\uad81\\uacbd\\ubd80\\uc554 \\ub2e4\\uac00 \\ubc31\\uc2e0 \\uc2dc\\uc2a4\\ud15c \\uc5f0\\uad6c\", \"\\uc2e4\\ubb3c\\uc635\\uc158\\uacfc SIS/SIR \\ubaa8\\ud615\\uc744 \\uc774\\uc6a9\\ud55c \\ubc31\\uc2e0\\uc758 \\ucd5c\\uc801\\ube44\\ucd95 \\uad00\\ub9ac\\uc5d0 \\ub300\\ud55c \\uc5f0\\uad6c\", \"High-throughput immunomics \\ubc29\\ubc95\\uc744 \\uc774\\uc6a9\\ud55c \\uc0c8\\ub85c\\uc6b4 \\uc0bc\\uc77c\\uc5f4\\ub9d0\\ub77c\\ub9ac\\uc544 \\ubc31\\uc2e0  \\ud56d\\uc6d0\\uc758 \\ubc1c\\uad74 \\ubc0f \\uc791\\uc6a9 \\uae30\\uc804 \\uaddc\\uba85\", \"Bomb bacteria-type \\uc7ac\\uc870\\ud569 Live Edwardsiella tarda \\uc81c\\uc791 \\ubc0f \\uc774\\ub97c \\uc774\\uc6a9\\ud55c \\ubcf5\\ud569\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc5f0\\uc1c4\\uc0c1\\uad6c\\uade0 (Streptococcus iniae)\\uc758 \\ud45c\\uba74 \\ub2e8\\ubc31\\uc9c8\\uc744 \\ubc1c\\ud604\\ud558\\ub294 \\ub119\\uce58\\uc790\\uc0dd \\uc720\\uc0b0\\uade0\\uc744 \\uc774\\uc6a9\\ud55c \\uae09\\uc5ec\\ud615 \\uc5b4\\ub958\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc758\\ub300\\uc0dd \\ucf54\\ud638\\ud2b8\\uc5d0\\uc11c A\\ud615 \\uac04\\uc5fc \\ubc31\\uc2e0 1\\ud68c \\uc811\\uc885\\uc758 \\ud6a8\\uacfc \\ud3c9\\uac00\", \"\\uc2e0\\uaddc \\uc885\\uc591\\uc778\\uc790 SCP3\\uc758 Jab1\\uc758\\uc874\\uc801 \\ud56d\\uc554\\uba74\\uc5ed\\ub0b4\\uc131 \\ubc0f \\uc554\\uc804\\uc774 \\uae30\\uc804 \\uc5f0\\uad6c \\ubc0f SCP3 \\uc554\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc624\\ubbf9\\uc2a4 \\uae30\\ubc18 \\uc0bc\\uc77c\\uc5f4\\uc6d0\\ucda9 \\uc720\\uc131\\uc0dd\\uc2dd\\uae30 \\ud2b9\\uc774 \\ub2e8\\ubc31\\uc9c8 \\ub300\\ub2e8\\uc704 \\ubc1c\\uad74\\uc744 \\ud1b5\\ud55c\\uc804\\ud30c \\ucc28\\ub2e8 \\ubc31\\uc2e0 \\ud6c4\\ubcf4\\ubb3c\\uc9c8 \\ub3c4\\ucd9c \\uc5f0\\uad6c\", \"\\uc608\\ubc29 \\ubc31\\uc2e0, \\uc9c4\\ub2e8\\ubc95, \\uce58\\ub8cc\\ubc95, \\uc608\\ud6c4 \\ud310\\uc815\\ubc95 \\uac1c\\ubc1c\\uc744 \\uc704\\ud55c MRSA\\uc640 \\uc218\\ud37c\\ubc15\\ud14c\\ub9ac\\uc544\\uc758 \\ud0c0\\uac9f \\ubc1c\\uad74\", \"Identification of Viral Peptide Candidates for the Development of Second Generation Cervical Cancer Vaccines Tailored for Chinese Women\", \"Nowy uniwersalny wektor i jego zastosowanie do konstrukcji szczepionki nowej generacji\", \"To develop an inexpensive, broadly protective (universal) influenza A virus vaccine in pre-clinical animal studies\", \"Vaccine and Treatment Evaluation Unit: Respiratory Syncytial Virus Diagnostic and Vaccine Assays\", \"Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever\", \"A pilot study to determine the appropriate design for a trial of acellular pertussis vaccine given at birth\", \"Magnetic resonance imaging-assisted design of a thermostable and self-administrable tuberculosis vaccine for inhalation\", \"Development of a Staphylococcus aureus Candida sp. Vaccine\", \"Development of a Staphylococcus aureus Candida sp. Vaccine\", \"Plant-Based Expression Systems for New Vaccines and Therapeutics\", \"Development of Novel Vaccines and Therapeutics Using Plant-Based Expression Systems\", \"Development of a Staphylococcus aureus Candida sp. Vaccine\", \"Development of rice plants for the delivery of oral vaccines\", \"SYSTEMS BIOLOGY IN HOST-PATHOGEN INTERACTIONS \\u2013 IMPLICATIONS FOR VACCINE TARGET DISCOVERY\", \"Development of an antidiabetogenic enterovirus vaccine for prevention of type 1 diabetes\", \"DETECTION AND CONTROL OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EMERGING VIRAL DISEASES OF SWINE\", \"Development of in vitro assay to replace the hamster potency test used for evaluating commercial L.hardjo vaccines\", \"Development & evaluation of standard preparations for assessing QC methods for cat and dog vaccines [was VM0101]\", \"Field trial to assess the safety and efficacy of BCG vaccine admininster parenterally (part of project CB0115)\", \"The development of animal models to test candidate vaccines for M. bovis infection in badgers (continuation of SE0130)\", \"Development of vaccines to protect badgers against M. bovis: development of surrogate assays [was part SE0110]\", \"The development of vaccines for the protection of badgers against infection with Mycobacterium bovis [became SE0122/3]\", \"The rational selection of candidate antigens for inclusion in vaccines against bovine mastitis caused by S.uberis\", \"Genetic and immune basis of protection against infectious bursal disease virus (IBDV) by defined molecular vaccines\", \"Multi-valent Hantvirus-Vaccine (MVA SEO-HTN: Vacc) and a ferret model of disease\", \"Vakc\\u00edna proti kokcidi\\u00f3ze koz\", \"*V\\u00fdvoj univerz\\u00e1ln\\u00ed vakc\\u00edny proti ch\\u0159ipce prasat respektuj\\u00edc\\u00ed aktu\\u00e1ln\\u00ed epizootologickou situaci v \\u010cesk\\u00e9 republice a ve sv\\u011bt\\u011b.\", \"\\u6a5f\\u80fd\\u6027\\u30da\\u30d7\\u30c1\\u30c9\\u306e\\u69cb\\u9020\\u6d3b\\u6027\\u76f8\\u95a2\\u306b\\u57fa\\u3065\\u304f\\u6700\\u9069\\u8a2d\\u8a08\\u3068\\u65b0\\u898f\\u304c\\u3093\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"Application of Protein Capsular Matrix Vaccine Technology to the Development of a Novel Form of Killed Whole Cell Vaccines\", \"Glycopolymer-based vaccine nanocarriers\", \"Bacterial DNA and DNA vaccines as regulators of macrophage function and as a therapeutic approach to Leishmani\", \"Development of a self-adjuvanting mucosal vaccine candidate against Group A Streptococcus using lipid core technology\", \"Identifying determinants of mycobacterial pathogenesis and understanding host immunity for devel. of novel anti-TB vaccine\", \"Understanding the mechanisms of action and optimising the ISCOMATRIX\\ufffd adjuvant for the development of human vaccines\", \"The development of a group A streptococcal vaccine and understanding the immunopathogenesis of rheumatic heart disease\", \"Defining the T cell epitopes of vaccinia and ectromelia viruses: exploring immunodominance in recombinant vaccines and r\", \"The impact of a conjugate pneumococcal vaccine on pneumococcal carriage, antibiotic resistance, & otitis media in Aborig\", \"Efficacy and mode of action of a pro-apoptotic, TLR7-specific ligand adjuvant in anti-tumour vaccine immune responses.\", \"Studying the function and mechanism of histone ADP-ribosylation; (ii) Lipo-peptide--protein vaccine development\", \"H1N1 Optimal use of vaccine to mitigate a second wave of H1N1 2009 influenza in Australia\", \"Development of hybrid HPV/HIV VLPs, a novel vaccine to prevent both HIV and HPV infection\", \"H1N1 Estimating the protective effect of seasonal influenza vaccine against medically attended ILI due to novel influenz\", \"To convene a group of experts to discuss the value of vaccines in reducing the impact of antimicrobial resistance\", \"To create a favorable social environment for accelerated ethical research and global delivery of HIV/AIDS vaccines\", \"To create a favorable social environment for accelerated ethical research and global delivery of HIV/AIDS vaccines\", \"To build additional evidence to understand where typhoid vaccine is needed in Africa and accelerate its delivery where needed\", \"To develop and field test solar powered, battery-free icepack freezers to cool vaccines during transport and immunization sessions.\", \"To convene an international symposium to review the potential contribution of new vaccines to improving global health\", \"To support clinic renovations in support of the Center for HIV/AIDS Vaccine Immunology clinical trials in Africa\", \"To identify actions necessary to accelerate introduction and uptake of cholera vaccines in high burden endemic regions in India\", \"To develop and deploy genetic tests useful for monitoring drug resistance, vaccine responses, and disease severity\", \"To provide financial support for participants from developing countries to attend an international conference on AIDS vaccine\", \"To develop and license a low cost booster vaccine to develop immunity against all serotypes of polio virus\", \"To develop a new vaccine for rotavirus that uses low-technology engineering methods suitable for the developing world.\", \"To assess pneumococcal carriage in children 4 -5 years after introduction of PCV10 (Pneumococcal conjugate vaccine) in Kenya\", \"To create a novel DNA vaccine delivery system that targets dendritic cells in GI mucosal tissues.\", \"To develop an inexpensive, safe, and effective oral vaccine against invasive Salmonella disease using gas-filled bacterial vesicles.\", \"To develop a broad-range vaccine, using your knowledge of bioinformatics, biochemistry, and immunology in an interdisciplinary approach\", \"To reduce HIV infections by supporting research addressing the role of mucosal immunology in HIV protection for vaccine development.\", \"To develop a randomized control trial to assess the non-specific effects of oral poliovirus vaccine in Bangladesh\", \"To develop protein chips that encapsulate poliovirus-like particles (PLP) for use as a safe and effective polio vaccine.\", \"To assess the advantage of plant-derived vaccines as an inexpensive technique compared to traditional production methods\", \"To explore alternative cost-effective delivery methods for inactivated poliovirus vaccine based on the Sabin strains (Sabin-IPV)\", \"To develop an IPV vaccine adjuvanted with CAF01 that is able to enhance mucosal immunity and promote dose-sparing\", \"To develop and license a quadrivalent HPV vaccine available to the masses at an affordable cost\", \"To convene global stakeholders to develop consensus with respect to preferred product characteristics for a TB vaccine\", \"To provide preliminary evidence in order to determine the most effective vaccine strategy for Hepatitis E virus (HEV)\", \"To develop receptor blocking malaria vaccines based on a combination of a novel RBL family of Plasmodium merozoite proteins\", \"To test three components from the mosquito\\u2019s innate signaling pathways for possible use in a malaria vaccine\", \"To identify unique immune responses in individuals who resist tuberculosis infection to guide future vaccine design\", \"To develop improved vaccines against HIV/AIDS for use throughout the world, in particular in high disease burden countries\", \"For the analysis of samples and data from Scientific Advisory Board-approved vaccine trials and natural history studies\", \"To test a large scale deployment of 75 passive vaccine storage devices in different rural settings across Ethiopia\", \"To maximize immunization coverage for children across the developing world by reliably providing vaccines at the point-of-care\", \"To conduct a Phase I HIV vaccine study that will compare the immunogenicity of different centralized gene (env) constructs\", \"To develop a vaccine in both developing and developed nations that prevents the transmission of HIV\", \"To bring together worldwide researchers to discuss the latest findings and trends associated with TB vaccines\", \"To design and test self-assembling peptide vaccine materials that are stable in the face of significant temperature fluctuations.\", \"To develop the optimal techniques for cryopreservation of human mucosal tissues for use in assessing HIV vaccines and microbicides.\", \"To evaluate the immunogenicity and impact of a reduced 13 valent pneumococcal conjugate vaccine (PCV13) dosing schedule\", \"To test the ability of a low-cost plant-based synthetic biology method to produce an RNA malaria vaccine.\", \"To change characteristics in gram-negative bacteria to test an innovative approach for new vaccine generation\", \"To identify novel immune targets and studies on mechanisms of protective immunity in order to accelerate rational vaccine development\", \"To better understand if clearance of malaria will improve T cell function and improve immune responses to vaccines\", \"To develop and characterize a naturally infected Guinea Pig model that can be used for vaccine evaluation.\", \"To understand the impact of pneumococcal conjugate vaccine (PCV) to nasopharynx microbiome in Africa and Southeast countries\", \"To discover new mucosal immunity targets for the design of cheap vaccines effective against all serotypes of pneumococci\", \"To accelerate the development of a global pediatric HIV/AIDS vaccine through basic research and Phase I clinical trials\", \"To develop a new vaccine for tuberculosis that uses an arabinomannan-protein conjugate to elicit strong antibody-mediated immunity.\", \"To test whether changes in the bacteria that naturally reside in human bowels affect vaccine responsiveness.\", \"To design recombinant viruses that can generate self-assembling poliovirus-like particles for use in a poliovirus vaccine.\", \"To develop and test a device for rapid detection of freeze-damage in widely used adjuvant-type vaccines.\", \"To develop Unmanned Aerial Vehicles (UAVs) that can be deployed via cell phones to transport vaccines to rural locations\", \"To fund epidemiological and clinical endpoint definition studies in support of adjuvanted purified and inactivated vaccine development\", \"To provide solutions to the problem of HIV and host genetic diversity to HIV vaccine development\", \"To support the development of an attenuated Plasmodium falciparum sporozoite vaccine to reduce malaria infection, morbidity, and mortality\", \"To provide technical assistance to develop a research plan for the impact evaluation of pneumococcal conjugate vaccine in India\", \"To develop a novel method to validate new potential drug and vaccine gene targets in the malaria parasite\", \"To develop a vaccine that elicits durable cellular and humoral immunity to HIV-1 by targeting dendritic cells\", \"To understand the burden of disease for cholera in Africa and build evidence to support cholera vaccine adoption there\", \"To support the development of typhoid conjugate vaccine cost-effectiveness models to inform optimal delivery strategy\", \"To develop and clinically test economically donor-friendly adjuvanted trivalent Inactivated Polio virus (IPV) vaccines with reduced IPV doses\", \"To develop a non-infectious poliovirus vaccine using encapsidated replicons or mature empty capsids that retain full immunogenicity.\", \"To provide research, develop and improve technologies and manufacture vaccines to improve health in developing countries\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"Influence of Parental Concern about Vaccine Safety on Incomplete Immunization of Alberta Pre-School Children\", \"\\u9d8f\\u80ce\\u5150\\u7d30\\u80de\\u306e\\u6d6e\\u904a\\u57f9\\u990a\\u306b\\u3088\\u308b\\u65e5\\u672c\\u8133\\u708e\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u88fd\\u9020(\\u7d992\\u5e74)\", \"\\u30b8\\u30d5\\u30c6\\u30ea\\u30a2(D), \\u767e\\u65e5\\u54b3(D), \\u7834\\u50b7\\u98a8(T), \\u9ebb\\u75b9(M), \\u6df7\\u5408\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5b9f\\u7528\\u5316\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u306e\\u5e38\\u5728\\u3059\\u308b\\u6771\\u5357\\u30a2\\u30b8\\u30a2\\u306e\\u8abf\\u67fb\\u3068\\u4e88\\u9632\\u52b9\\u679c\\u306e\\u9ad8\\u3044\\u30ef\\u30af\\u30c1\\u30f3\\u88fd\\u9020\\u306e\\u7814\\u7a76\", \"\\u7dd1\\u81bf\\u83cc\\u611f\\u67d3\\u75c7\\u306e\\u30ef\\u30af\\u30c1\\u30f3, \\u6cbb\\u7642\\u7528\\u03b3\\u30b0\\u30ed\\u30d6\\u30ea\\u30f3\\u53ca\\u3073\\u8a3a\\u65ad\\u6db2\\u306e\\u81e8\\u5e8a\\u5fdc\\u7528\", \"\\u7dd1\\u81bf\\u83cc\\u4e09\\u7a2e\\u6df7\\u5408\\u30ef\\u30af\\u30c1\\u30f3\\u53ca\\u3073\\u305d\\u306e\\u6297\\u03b3-\\u30b0\\u30ed\\u30d6\\u30ea\\u30f3\\u306e\\u81e8\\u5e8a\\u5fdc\\u7528\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u907a\\u4f1d\\u5b50\\u7d44\\u307f\\u63db\\u3048\\u306b\\u3088\\u308b\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u6e29\\u5ea6\\u611f\\u53d7\\u6027\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u89aa\\u682a\\u306e\\u4f5c\\u88fd\", \"\\u7dd1\\u81bf\\u83cc3\\u7a2e\\u6df7\\u5408\\u30ef\\u30af\\u30c1\\u30f3\\u53ca\\u3073\\u6297\\u83cc\\u4f53\\u6210\\u5206(OEP), \\u83cc\\u4f53\\u5916\\u9175\\u7d20\\u6297\\u4f53\\u306e\\u81e8\\u5e8a\\u5fdc\\u7528\", \"\\u7d44\\u7e54\\u57f9\\u990a\\u72c2\\u72ac\\u75c5\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4eba\\u4f53\\u63a5\\u7a2e\\u52b9\\u679c\\u53ca\\u3073\\u6700\\u9069\\u63a5\\u7a2e\\u6cd5\\u306e\\u7814\\u7a76\", \"\\u9b5a\\u7fa4\\u3092\\u5bfe\\u7167\\u3068\\u3059\\u308b\\u6d78\\u6f2c\\u30ef\\u30af\\u30c1\\u30f3\\u51e6\\u7406\\u65b9\\u6cd5\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u4f1d\\u67d3\\u6027\\u6c17\\u7ba1\\u652f\\u708e\\u30a6\\u30a4\\u30eb\\u30b9\\u30b9\\u30d1\\u30a4\\u30af\\u86cb\\u767d\\u3092\\u767a\\u73fe\\u3059\\u308b\\u30de\\u30ec\\u30c3\\u30af\\u75c5\\u30a6\\u30a4\\u30eb\\u30b9\\u8840\\u6e052\\u578b\\u306e\\u30ea\\u30b3\\u30f3\\u30d3\\u30ca\\u30f3\\u30c8\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u6297\\u816b\\u760d\\u514d\\u75ab\\u306e\\u30e2\\u30c7\\u30eb\\u3068\\u3057\\u3066\\u306e\\u30de\\u30ec\\u30c3\\u30af\\u75c5\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4f5c\\u7528\\u6a5f\\u5e8f\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u6f5c\\u4f0fHIV-1\\u6d3b\\u6027\\u5316\\u6a5f\\u5e8f\\u306e\\u89e3\\u660e\\u304a\\u3088\\u3073AIDS\\u767a\\u75c7\\u4e88\\u9632\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u5358\\u30af\\u30ed\\u30fc\\u30f3\\u6297\\u4f53\\u306b\\u3088\\u308b\\u75c5\\u539f\\u30ec\\u30d7\\u30c8\\u30b9\\u30d4\\u30e9\\u611f\\u67d3\\u9632\\u5fa1\\u6297\\u539f\\u306e\\u69cb\\u9020\\u89e3\\u6790\\u3068\\u6210\\u5206\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Trypanosoma cruzi \\u7a2e\\u7279\\u7570\\u6297\\u539f\\u306e\\u8a3a\\u65ad\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30bf\\u30a4\\u56fd\\u5317\\u90e8\\u306b\\u304a\\u3051\\u308b\\u65e5\\u672c\\u8133\\u708e\\u4f1d\\u64ad\\u8981\\u56e0\\u306e\\u751f\\u614b\\u5b66\\u7684\\u7814\\u7a76\\u3068\\u4e88\\u9632\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u52b9\\u679c\\u5224\\u5b9a\", \"\\u6c34\\u75d8\\u30a6\\u30a3\\u30eb\\u30b9\\u30b2\\u30ce\\u30e0\\u306e\\u69cb\\u9020\\u89e3\\u6790\\u304a\\u3088\\u3073\\u6c34\\u75d8\\u30a6\\u30a3\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u306e\\u5206\\u5b50\\u30de\\u30fc\\u30ab\\u30fc\\u306e\\u540c\\u5b9a\", \"\\u30cf\\u30b7\\u30ab\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u91ce\\u751f\\u682a\\u304b\\u3089\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u3078\\u306e\\u99b4\\u5316\\u73fe\\u8c61\\u306e\\u5206\\u5b50\\u751f\\u7269\\u5b66\\u7684\\u89e3\\u6790\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u306e\\u5e38\\u5728\\u3059\\u308b\\u6771\\u5357\\u30a2\\u30b8\\u30a2\\u306e\\u8abf\\u67fb\\u3068\\u4e88\\u9632\\u52b9\\u679c\\u306e\\u9ad8\\u3044\\u30ef\\u30af\\u30c1\\u30f3\\u88fd\\u9020\\u306e\\u7814\\u7a76\", \"\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u306b\\u304a\\u3051\\u308b\\u514d\\u75ab\\u6291\\u5236\\u89e3\\u9664\\u3068\\u514d\\u75ab\\u8ce6\\u6d3b\\u306e\\u5206\\u5b50\\u6a5f\\u69cb\\u306e\\u89e3\\u660e\", \"Parents' preferences for vaccination for their children in Japan\", \"\\u9769\\u65b0\\u7684\\u4eba\\u5de5\\u30ed\\u30f3\\u30b0\\u30da\\u30d7\\u30c1\\u30c9\\u764c\\u30ef\\u30af\\u30c1\\u30f3\\u3001H/K-HELP\\u306e\\u6297\\u816b\\u760d\\u514d\\u75ab\\u6d3b\\u6027\\u5316\\u6a5f\\u5e8f\\u306e\\u89e3\\u660e\", \"Development of transcutaneous vaccine with efficacy and safety for the overcoming infectious diseases\", \"Development of tailor made peptide vaccines for renal cell carcinoma\", \"\\u30d5\\u30a1\\u30fc\\u30b8\\u30c7\\u30a3\\u30b9\\u30d7\\u30ec\\u30a4\\u6cd5\\u3092\\u7528\\u3044\\u305f\\u6297\\u4f53\\u69d8\\u7d20\\u5b50\\u306e\\u958b\\u767a\\u3068\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"Characterization of abortion related factor of intracellular protozoan parasite Neospora caninum and its application for vaccine development\", \"Novel oral vaccine using genetically engineering bifidobacterium displaying antigen on its cell-surface\", \"Development of Novel Oral Vaccine Delivery System for Mucosal Immunization in Gut-Associated Lymphoid Tissue\", \"\\u982d\\u981a\\u90e8\\u60aa\\u6027\\u816b\\u760d\\u306b\\u5bfe\\u3059\\u308bFAK\\u3068EphA2\\u3092\\u6a19\\u7684\\u3068\\u3057\\u305f\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u306e\\u958b\\u767a\", \"Development of a prophylactic vaccine effective against a broader spectrum of HPVs associated with cervical cancer and basic research on therapeutic HPV vaccine for cervical cancer\", \"Attitudes Towards and Acceptance of HPV Vaccine in Japanese Mothers of Adolescents living in the UK and Australia\", \"Development of subunit cocktail vaccine against bovine babesiosis\", \"Development of the toxoid vaccines and neutralizing monoclonal antibodies against Shiga toxins\", \"\\u30b5\\u30a4\\u30c8\\u30e1\\u30ac\\u30ed\\u30a6\\u30a4\\u30eb\\u30b9\\u306b\\u3088\\u308b\\u773c\\u75be\\u60a3\\u306e\\u65b0\\u898f\\u6cbb\\u7642\\u6cd5\\u3068\\u30b2\\u30ce\\u30e0\\u7de8\\u96c6\\u6280\\u8853\\u306b\\u3088\\u308b\\u30ef\\u30af\\u30c1\\u30f3\\u4f5c\\u6210\", \"WT1\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u3092\\u4e2d\\u5fc3\\u3068\\u3057\\u305f\\u60aa\\u6027\\u795e\\u7d4c\\u81a0\\u816b\\u5e79\\u7d30\\u80de\\u6a19\\u7684\\u7642\\u6cd5\\u306e\\u63a2\\u7d22\", \"\\u30c0\\u30cb\\u30a2\\u30ec\\u30eb\\u30b2\\u30f3\\u86cb\\u767d\\u8cea\\u306e\\u9ad8\\u6b21\\u69cb\\u9020\\u306b\\u7126\\u70b9\\u3092\\u3042\\u3066\\u305fIgE\\u30a8\\u30d4\\u30c8\\u30fc\\u30d7\\u89e3\\u6790\\u53ca\\u3073\\u30ef\\u30af\\u30c1\\u30f3\\u8a2d\\u8a08\", \"B\\u578b\\u809d\\u708e\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u6297\\u4f53\\u7372\\u5f97\\u4f8b\\u306e\\u3046\\u3061HB_s\\u6297\\u4f53\\u304c\\u9670\\u6027\\u5316\\u3057\\u305f\\u4f8b\\u306e\\u514d\\u75ab\\u5b66\\u7684\\u691c\\u8a0e\", \"\\u75c5\\u539f\\u30ec\\u30d7\\u30c8\\u30b9\\u30d4\\u30e9\\u611f\\u67d3\\u9632\\u5fa1\\u51dd\\u96c6\\u6297\\u539f\\u3092\\u7528\\u3044\\u305f\\u6210\\u5206\\u30ef\\u30af\\u30c1\\u30f3\\u53ca\\u3073\\u8fc5\\u901f\\u8a3a\\u65ad\\u6cd5\\u306e\\u958b\\u767a\", \"\\u65b0\\u3057\\u3044\\u907a\\u4f1d\\u5b50\\u64cd\\u4f5c\\u6280\\u8853\\u3092\\u7528\\u3044\\u305f\\\"\\u534a\\u751f\\\"\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u3068\\u5fdc\\u7528\", \"Engineering Peptide-MHC/co-stimulator-based Nanoparticle Vaccines for the Treatment of Metastatic Cancer\", \"\\u0418\\u0437\\u0443\\u0447\\u0435\\u043d\\u0438\\u0435 \\u0441\\u0432\\u043e\\u0439\\u0441\\u0442\\u0432 \\u0440\\u0435\\u043a\\u043e\\u043c\\u0431\\u0438\\u043d\\u0430\\u043d\\u0442\\u043d\\u044b\\u0445 \\u0441\\u0442\\u0440\\u0435\\u043f\\u0442\\u043e\\u043a\\u043e\\u043a\\u043a\\u043e\\u0432\\u044b\\u0445 \\u043f\\u043e\\u043b\\u0438\\u043f\\u0435\\u043f\\u0442\\u0438\\u0434\\u043e\\u0432  \\u0432 \\u043a\\u0430\\u0447\\u0435\\u0441\\u0442\\u0432\\u0435  \\u043a\\u043e\\u043c\\u043f\\u043e\\u043d\\u0435\\u043d\\u0442\\u043e\\u0432 \\u0432\\u0430\\u043a\\u0446\\u0438\\u043d\\u044b \\u043f\\u0440\\u043e\\u0442\\u0438\\u0432 \\u0441\\u0442\\u0440\\u0435\\u043f\\u0442\\u043e\\u043a\\u043e\\u043a\\u043a\\u043e\\u0432 \\u0433\\u0440\\u0443\\u043f\\u043f\\u044b \\u0412\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Persistence of protection against invasive bacterial disease-Memory B cell responses in infants after meningococcal vaccines\", \"Prophylactic vaccine against Human papillomavirus 16: Mucosal immunity in the genital tract elicited by Salmonella recombinant strains\", \"Inaktivierte Vakzinen gegen das Afrikanische Schweinepest- virus (ASPV) : Molekulare Basis der immunogenen Proteine.\", \"Verminderung der zur Kontrolle von Tollwutimpfstoffen ben\\u00f6- tigten Anzahl M\\u00e4use in der Human- und Veterin\\u00e4rmedizin\", \"Developing a chlamydial vaccine for koalas\", \"\\u57fa\\u4e8eCTL\\u8868\\u4f4d\\u548cTn\\u6297\\u539f\\u7684\\u6cbb\\u7597\\u6027\\u62df\\u80bd\\u80bf\\u7624\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u3001\\u5408\\u6210\\u53ca\\u6784\\u6548\\u5173\\u7cfb\", \"The basis of the irradiated sporozoite vaccine: identification of Plasmodium genes essential for development to liver stages\", \"Generating regional rotavirus vaccine strains through reverse genetics to alleviate viral diarrhoea in Africa (extension: Dr. Hester O'Neill)\", \"Kombinierte CpG-Oligodeoxynukleotid/Lipopeptid Liposomen als neuer immunmodulatorischer Impfstoff gegen Hepatitis C Virus Infektion\", \"Terapia czerniaka u myszy przy pomocy szczepionki zawieraj\\u0105cej kom\\u00f3rki dendrytyczne JAWSII.\", \"Impact of a novel vaccine candidate against Group B Streptococcus-induced neonatal diseases on commensal microbiota\", \"Etudes cliniques en vaccinologie visant en particulier \\u00e0 \\u00e9valuer l impact \\u00e9pid\\u00e9miologique de diff\\u00e9rents vaccins et \\u00e0 am\\u00e9liorer leur impact populationnel\", \"Statistical Methods for Identifying Correlates of Risk and Surrogate Endpoints in Vaccine Trials\", \"Etudes cliniques en vaccinologie visant en particulier \\u00e0 \\u00e9valuer l impact \\u00e9pid\\u00e9miologique de diff\\u00e9rents vaccins et \\u00e0 am\\u00e9liorer leur impact populationnel\", \"D\\u00e9veloppement d'indicateurs novateurs de performance de la couverture vaccinale au Burkina Faso et dans les pays \\u00e0 revenu faible et interm\\u00e9diaire\", \"Development of phase I vaccine against Staphylococcus epidermis infections resulting from implant associated surgery - Avslutning dr.grad\", \"G\\u00e9n\\u00e9ration de nanoparticules dans le but de d\\u00e9velopper un vaccin universel contre la grippe\", \"G\\u00e9n\\u00e9ration de nanoparticules dans le but de d\\u00e9velopper un vaccin universel contre la grippe\", \"Centre de Recherche en Infectiologie Porcine (CRIP)\", \"New cancer vaccines based on Troy-bodies, telomerase as tumor-specific antigen, and CD40-activated B cells as APC\", \"Elucidating the potential of baculovirions as an effective and safe 'DNA vaccine' delivery system.\", \"Vacina brasileira contra a meningite meningoc\\u00f3cica b e c\", \"RNA interference and recombinant protein prodution for identification of antigens to develop an anti-tick vaccine\", \"ENHANCING AN IMMUNIZATION INFORMATION SYSTEM (IIS) TO INTERFACE WITH CDCs VTRACKS VACCINE ORDERING AND MANAGEMENT SYSTEM\", \"BACULOVIRUS RECOMBINANTS THAT EXPRESS HEPATITIS B VIRUS SURFACE AN TIGEN: DEMONSTRATION FOR PRODUCTION OF SUBUNIT VACCINES\", \"Development of diagnostic techniques for detection of pathogens transmitted by ticks and procedures for preparation of vaccines against ticks\", \"Molecular-biological characterisation of selected tick saliva proteins as potential antigens for development of anti-tick vaccine\", \"Protractive activity of anti-rabies vaccines for rabies-like lyssavirus infections; possibility of influencing it by using adjuvant substances.\", \"New technology to improve vaccines for immunotherapy of cancer: antibody-mediated targeting of synthetic peptide constructs\", \"Immune Responses and Regulation in Hepatitis C Virus (HCV) Infection: Implications for Vaccine/Immunotheraphy\", \"Influence of Parental Concern about Vaccine Safety on Incomplete Immunization of Alberta Pre-School Children\", \"Small Molecule Agonists of RIG-I as Adjuvants for Hepatitis C and other Viral Vaccines\", \"Chair in Social Justice, Equity and Diversity\", \"PPHF 2014: IMMUNIZTAION: ENHANCE AN IMMUNIZATION INFORMATIONSYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING AND MANAGEMENT SYSTEM\", \"PPHF 2014: IMMUNIZATION ENHANCE AN IMMUNIZATION INFORMATION SYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING & MGMT SYSTEM\", \"TO ENHANCE THE STATEWIDE IMMUNIZATION REGISTRY (IRIS) TO INTERFACE WITH CDCs NATIONAL VACCINE ORDERING AND INVENTORY MGMT SYSTEM (VTRCKS)\", \"PPHF 2014: IMMUNIZATION-ENHANCE AN IMMUNIZATION INFORMATION SYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING AND MANAGEMENT SYSTEM\", \"PPHF 2014: IMMUNIZATION ENHANCE AN IMMUNIZATION INFORMATION SYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING & MANAGEMENT SYSTEM\", \"IMMUNIZATION ENHANEMENTS OF OUR IMMUNIZATION INFORMATION SYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING & MGMT SYSTEM\", \"BUILDING ON THE EXISTING NYSIIS VTRCKS INTERFACE TO ENHANCE VACCINE INVENTORY , ACCOUNTABILITY AND USABILITY OF THE NYSIIS SYSTEM\", \"ENHANCING IDAHOS IIS IN ELECTRONICALLY COLLECTING FROM PROVIDERS INFORMATION ON WASTED AND RETURNED VACCINES FOR EXPORT TO VTRCKS\", \"NORTH CAROLINA IMMUNIZATION REGISTRY WHICH IS THE STATE IMMUNIZATION INFORMATION SYSTEM WILL IMPROVE INTERFACE CAPACITY WITH CDCs VACCINE ORDERING\", \"PPHF 2014: IMMUNIZATION: ENHANCE AN IMMUNIZATION INFO SYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING & MGMT SYSTEM\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"PRESERVING A TENUOUS RESOURCE: MAINTENANCE OF A PROMISING VACCINE STRAIN OF TOXOPLASMA GONDII\", \"NOVEL VACCINES FOR JOHNE'S DISEASE\", \"European Network of Vaccine Development and Research\", \"Recombinant vaccines against tuberculosis challenge in normal as we ll as transgenic, HLADR-expressing, IA-deficient mice\", \"Construction of potential rotavirus vaccines and evaluation of their capacity for inducing both humoral and cellular immunity\", \"IMMUNOLOGICAL PROTECTION MECHANISM AND ASSESSMENT OF CANDIDA TE VACCINE PREPARATIONS IN A NONHUMAN PRIMATE MODEL FOR SCHI STOSOMIASIS\", \"THE PRODUCTION OF A NOVEL VACCINE AGAINST INFECTIOUS BRONCHITIS VIRUS (IBV) BY THE USE OF GENETIC ENGINEERING TECHNIQUES\", \"DEVELOPMENT OF DIAGNOSTICS FOR T. EVANSI IN CAMELS AND WATER BUFFALOES. PERSPECTIVES IN VACCINE DEVELOPMENT\", \"Development of an oral adenovirus-based vaccine against influenza for pandemic protection.\", \"Development of an oral adenovirus-based vaccine against influenza for pandemic protection.\", \"Out of Africa: British trypanosomes as vaccine vehicles against important cattle pathogens.\", \"Analysis of candidate pre-erythrocytic vaccines against malaria in semi-immune Africans.\", \"Investigation of pre-erythrocytic malaria vaccines in a mouse model using transgenic parasites.\", \"Expression of recombinant antigen-antibody fusion complexes for developing new vaccines.\", \"WHO MALVAC 2007 Meeting\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Characterisation and development of adjuvants for new generation veterinary and human vaccines\", \"Establishment of a flexible insect cell platform for fast production of pseudo-typed VLPs for drug and vaccine development\", \"A combination of two gp41 peptides for a new prophylactic vaccine both neutralizing HIV-1 and inhibiting CD4 depletion\", \"Development of a mucosal hepatitis B vaccine: Design and mechanistic studies of a prototypic multi-component polymeric delivery system.\", \"ER_TRANSPROT -\\u201cEhrlichia ruminantium proteome analysis: a complementary approach to transcriptomics towards increased knowledge on heartwater pathogenesis and vaccine development\", \"Development of ultra-sensitive detection methods and plant nano-vaccines for the fungi Fusarium spp. using nanotechnological devices.\", \"Helicobacter pylori diversity in pathogenesis, antibiotic resistance, and evasion from natural and vaccine-induced immune responses (HELDIVPAT)\", \"The Leishmania TDR1 family-related gene: functional studies and evaluation of TDR1 recombinant protein and knockout vaccines against leishmaniasis.\", \"D\\u00e9veloppement d'un vaccin recombinant contre l'infection par le virus du syndrome reproducteur et respiratoire des porcs (SRRP)\", \"D\\u00e9veloppement dun vaccin recombinant contre linfection par le virus du syndrome reproducteur et respiratoire des porcs (SRRP)\", \"Development of caulobacters as a vaccine presentation system for the passive immunization of hatchery salmonids against IHNV virus\", \"Peptide epitopes for the HIV -1 neutralizing antibodies 2F5 and 2G12 as anti HIV-1 vaccine candidates\", \"Plant molecular pharming: application for the development of an experimental recombinant subunit vaccine against human respiratory syncytial virus\", \"Construction and testing of vaccine proteins against pseudomonas infections using the Caulobacter crescentus S-Layer presentation\", \"Vaccins sous-unitaires induisant une immunit\\u00e9 mucosale effectrice contre l'infection par le virus du syndrome reproducteur et respiratoire porcin\", \"The Hu-SCID mouse: An experimental model for the development and testing of candidate TB vaccines\", \"In ovo and mucosal delivery of CpG-ODN in chickens as an immunostimulant and vaccine adjuvant\", \"Immunologie des prot\\u00e9ines structurales du virus du syndrome reproducteur et respiratoire du porc (SRRP) et valeur vaccinale des prot\\u00e9ines recombinantes\", \"Canadian Network for Vaccines and Immunotherapeutics of Cancer and Chronic Viral Diseases (CANVAC)                    (2006 Renewal Competition)\", \"Peptide epitopes for the HIV -1 neutralizing antibodies 2F5 and 2G12 as anti HIV-1 vaccine candidates\", \"Discovering the optimal signals for T cell proliferation and differentiation: the key to effective vaccines and immunotherapy\", \"Canadian plaform for a cell culture based influenza vaccine production network (IVPN)  ( Funding request for full application preparation.)\", \"Developing vaccine and immunotherapeutic strategies for the prevention and treatment of cancer and viral diseases (CANVAC)\", \"Safety of live vaccines that establish life-long, persis\", \"SARS DNA Recombinant Adenoviral Vaccine\", \"Develop /Production Of A SARS DNA Plasmid Vaccine\", \"West Nile Virus DNA Plasmid Vaccine\", \"High Speed Automated Influenza Vaccine Harvester\", \"LIPOSOMAL VACCINE ADJUVANT FOR INFLUENZA IMMUNIZATION\", \"LIPOSOME-BASED VACCINE ADJUVANT SYSTEM FOR HIV\", \"FUNGAL EXPRESSION OF DENGUE PROTEINS FOR VACCINES\", \"PHASE 2 STUDY IF E COLI O157-REPA CONJUGATE VACCINE IN 2-5 YEAR OLD CH-275023337\", \"SARS Vaccine Development\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"]HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"VACCINE EFFECTS IN PREGNANT MODEL &OFFSPRING\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Efficacy of a Multi-Antigen Vaccine in the Prevention of Methylnitrosourea\", \"Promoting Tolerogenic Dendritic Cell Migration In Vivo As A Potential For Autoimmune Vaccine Therapy\", \"Evaluation of immune responses engendered in CEA transgenic mice by a vaccine formulation composed of a recombinant CEA N domain antigen and GSK AS15 adjuvant\", \"\\u9002\\u7528\\u4e8e\\u9ca4\\u7684\\u201c\\u81ea\\u6740\\u6027\\u201dDNA\\u75ab\\u82d7\\u8f7d\\u4f53\\u6e05\\u9664\\u673a\\u5236\\u3001\\u6e05\\u9664\\u6548\\u679c\\u53ca\\u514d\\u75ab\\u7814\\u7a76\", \"Live avirulent vaccine against E. coli infections in broilers.\", \"OptiMalVax: Optimizing a deployable high efficacy malaria vaccine\", \"Novel Vaccines for Measles\", \"Gave fra Stiftelsen Kristian Gerhard Jebsen til K.G. Jebsen-senter for forskning p\\u00e5 influensavaksiner\", \"Evaluation of the Immunogenicity and Efficacy of a DNA Prime/Protein Boost Vaccine\", \"Identifying correlates of protection afforded by (Delta)GY SIVmac239 attenuated virus vaccine\", \"Development of vaccines & strategy for their use to control ulcer disease in coldwater ornamental fish.\", \"\\u4eba\\u5de5\\u5408\\u6210\\u65b0\\u578b\\u817a\\u75c5\\u6bd2\\u53ca\\u5176\\u4f5c\\u4e3a\\u75ab\\u82d7\\u8f7d\\u4f53\\u7684\\u7814\\u7a76\", \"Oral Amyloid AAV Vaccine for Alzheimer's Disease\", \"Bench top flow cytometer\", \"Building Vaccinology Expertise in South-East Asia.\", \"A Novel Vaccine Platform for Trimeric Envelope Proteins: HIV-1 envelope\", \"To enable participation by vaccine experts from developing countries in a workshop to be held on the MIT campus to improve technology transfer and improve local vaccine development and manufacturing so that vaccines can be provided at an affordable price, which will, in turn, lead to local employment\", \"To develop an economically donor-friendly IPV vaccine with a reduced IPV dose of at least 5 fold. This vaccine will despite the lower dose of IPV show an immunogenicity which equals or surpasses the current full dose IPV vaccine.\", \"Simian Vaccine Evaluation Units\", \"Efficacy of Conserved Element SIV Gag Vaccine in Control of SIVmac239 Viremia\", \"The application  to cancer vaccine of SSF that mimics pulmonary surfactant\", \"Killer T cell inducing peptide vaccine against malaria infection\", \"Establishment of dendritic cell-based vaccine in combination with chemotherapy for oral cancer patients\", \"Development of dendritic cell vaccine modified with a ligand of NKT cells against tuberculosis\", \"Synthesis of Tn and Sialyl Tn Antigen-Lipid A Analog Conjugate for Synthetic Vaccines\", \"Optimizing Vaccine Formulations for Veterinary Vaccines\", \"Simian Vaccine Evaluation Unit (SVEU)\", \"Seasonal influenza vaccine effectiveness in Asthma\", \"\\u51cf\\u6bd2\\u8fdf\\u7f13\\u7231\\u5fb7\\u534e\\u6c0f\\u83cc\\u4f5c\\u4e3a\\u75ab\\u82d7\\u8f7d\\u4f53\\u5448\\u9012\\u5f02\\u6e90\\u6297\\u539f\\u7684\\u7814\\u7a76\", \"\\u8bf1\\u5bfc\\u548c\\u589e\\u5f3a\\u80a0\\u9053\\u7c98\\u819c\\u6297HIV\\u611f\\u67d3\\u514d\\u75ab\\u53cd\\u5e94\\u7684\\u75ab\\u82d7\\u514d\\u75ab\\u5b9e\\u9a8c\\u7814\\u7a76\", \"TLR\\u914d\\u4f53\\u9006\\u8f6cCD4+CD25+\\u8c03\\u8282\\u6027T\\u7ec6\\u80de\\u5bf9\\u65e5\\u672c\\u8840\\u5438\\u866b\\u8868\\u4f4d\\u75ab\\u82d7\\u6548\\u5e94\\u6291\\u5236\\u7684\\u5206\\u5b50\\u673a\\u5236\", \"\\u8f7d\\u4f53\\u9aa8\\u67b6CpG\\u5316\\u4fee\\u9970\\u5bf9\\u65b0\\u578b\\u590d\\u5236\\u5b50DNA\\u75ab\\u82d7\\u514d\\u75ab\\u8c03\\u8282\\u4f5c\\u7528\\u7814\\u7a76\", \"Vacinas de polissacar\\u00eddeos\", \"Desenvolvimento de vacinas para uso humano: da bancada para a produ\\u00e7\\u00e3o\", \"Immunological memory induced by attenuated malaria parasites\", \"Mobile Computer-Assisted Survey Research Laboratory for HIV Vaccine Implementation Science\", \"Towards a science of community engagement in international HIV vaccine research:  an embedded multinational case study of the social impact of a failed HIV vaccine trial\", \"Feasibility of applying an innovative bioprocessing methodology in a novel vaccine approach\", \"IMMUNOSUPPRESSION BY TICK SALIVA AND VACCINE DEVELOPMENT\", \"PREVENTION OF THE IPNV CARRIER STATE WITH DNA AND SUBUNIT VACCINES\", \"Development and Assessment of Chimaeric Feline Caliciviruses as Vaccines\", \"Proteomics and vaccine development in swine dysentery\", \"Designing effective Gram negative bacterial vaccines\", \"Multifunctional biodegradable nanoparticles for enhanced DNA vaccine delivery\", \"Designing new generation adjuvants for allergy and parasite vaccines\", \"Understanding heat shock protein complex vaccines\", \"EVALUATION OF ADVERSE ALLERGIC REACTIONS TO VACCINES\", \"West Nile Virus Vaccine Development\", \"SARS Coronavirus Vaccine Development\", \"Ebola Vaccine Development\", \"Characterization of Y. pestis antigens for the development of a novel vaccine\", \"HIV Vaccine Production\", \"HIV Vaccine Production\", \"HIV Vaccine Production\", \"Evaluation of NIAID's HIV Vaccine Research Education Initiative\", \"Evaluation of NIAID's HIV Vaccine Research Education Initiative\", \"Evaluation of NIAID's HIV Vaccine Research Education Initiative\", \"Evaluation of NIAID's HIV Vaccine Research Education Initiative\", \"Simian Vaccine Evaluation Units\", \"Simian Vaccine Evaluation Unit (SVEU)\", \"Simian Vaccine Evaluation Unit (SVEU)\", \"Simian Vaccine Evaluation Unit (SVEU)\", \"HIV Vaccine Design and Dev. Teams for Preventation and Treatment\", \"Tuberculosis Research Materials and Vaccine Testing\", \"TB VACCINE TESTING\", \"Tuberculosis Research Materials and Vaccine Testing\", \"Development of BSL-2 Neutralization Assays to Evaluate Filovirus Vaccines\", \"HIV/AIDS Therapeutic and Non-vaccine Prevention Clinical Research\", \"HVDDT: HIV-1 Vaccine Candidates Delivered by VSV Vectors\", \"HIV-1 VACCINE CANDIDATES DELIVERED BY VSV VECTORS\", \"HIV-1 VACCINE CANDIDATES DELIVERED BY VSV VECTORS\", \"Advanced Development of Multivalent Filovirus Vaccines\", \"DNA Vaccine Delivery System for Biodefense with dengue\", \"EIAV Envelope Variation and Vaccine Efficacy\", \"Comparison and basis of efficacy in commercial conventional vaccines against the H5N1 influenza virus.\", \"Examination of Side Effects occured after Vaccination\", \"Vaccine Design and Immune Responses\", \"Vaccine Safety:  Neurotoxicity safety test development,\", \"Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans\", \"Influence of maternal antibodies on a Sendai virus-vectored RSV vaccine\", \"MAO/DETECTION OF ANTIBODIES AND PROTEINS\", \"MAO/DETECTION OF ANTIBODIES &PROTEINS--ISOLATION OF VIR\", \"MAO/DETECTION OF ANTIBODIES &PROTEINS--ISOLATION OF VIR\", \"DESIGNING LIVE INFLUENZA UNIVERSAL VACCINE BASED ON NEW GENE\\u2013ENGINEERING AND IMMUNOGENETICS APPROACHES\", \"\\u7ed3\\u6838\\u75c5B7/hsp\\u5d4c\\u5408DNA \\u75ab\\u82d7\\u7814\\u7a76\", \"\\u53cc\\u91cd\\u7ec4\\u75c5\\u6bd2\\u75ab\\u82d7\\u4e2d\\u767d\\u7ec6\\u80de\\u4ecb\\u7d20\\u20142 \\u514d\\u75ab\\u4f50\\u5242\\u6d3b\\u6027\\u7684\\u7814\\u7a76\", \"I\\u578b\\u7cd6\\u5c3f\\u75c5\\u53cd\\u4e49DNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u9776\\u5411\\u878d\\u5408\\u9632\\u9f8bDNA\\u75ab\\u82d7\\u7684\\u7814\\u5236\\u548c\\u7c98\\u819c\\u514d\\u75ab\\u9632\\u9f8b\\u7684\\u4f5c\\u7528\\u673a\\u5236\", \"\\u57fa\\u56e0\\u67aa\\u4ecb\\u5bfc\\u5355\\u7eaf\\u75b1\\u75b9\\u75c5\\u6bd2gD2DNA\\u75ab\\u82d7\\u514d\\u75ab\\u7684\\u7814\\u7a76\", \"\\u7ec6\\u7c92\\u68d8\\u7403\\u7ee6\\u866b\\u91cd\\u7ec4BCG-Eg95\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"Bovine pneumonic pasteurellosis: a model for development of novel vaccine platforms\", \"The STARSS e-Health system for post-marketing safety surveillance of drugs and vaccines.\", \"Novel HIV-1 glycoprotein vaccines with enhanced presentation of broad neutralization epitopes\", \"Formulation of a pan-species, multi-stage vaccine for the malaria eradication agenda\", \"Next generation of targeted dendritic cell vaccines for cancer treatment\", \"Safety and uptake of the Measles, Mumps, Rubella and Varicella (MMR-V) vaccine\", \"Developing more accurate measures of immune response and vaccine efficacy of standard and novel schedules of two new pneumococcal conjugate vaccines (Prevenar13 or Synflorix) in indigenous infants\", \"Use of polylactidecoglycolide microparticles as an oral vaccine delivery system for farmed fish (LINKSAL17)\", \"*Pr\\u016fmyslov\\u00fd v\\u00fdzkum nejkomplexn\\u011bj\\u0161\\u00ed (v 1 vakcina\\u010dn\\u00ed d\\u00e1vce 11 antigen\\u016f) vakc\\u00edny Biocan Max DHPPi+L5CR, chr\\u00e1n\\u00edc\\u00ed celosv\\u011btov\\u011b psy proti z\\u00e1va\\u017en\\u00fdm infek\\u010dn\\u00edm onemocn\\u011bn\\u00edm, kterou m\\u016f\\u017ee veterin\\u00e1rn\\u00ed l\\u00e9ka\\u0159 pou\\u017e\\u00edt kdekoliv na sv\\u011bt\\u011b bez ohledu na lok\\u00e1ln\\u00ed v\\u00fdzkyt kmen\\u016f.\", \"Applying active hospital-based case ascertainment to assess vaccine effectiveness and safety\", \"Vaccine discovery for human mucosal pathogens: identifying novel vaccine antigens that are stably expressed during host interactions, using analysis of cell-contact and phasevarion mediated expression profiles\", \"The influence of HIV on T cell function and application to vaccine design.\", \"Boosting effectiveness of new vaccines for dengue ,HFMD and influenza by targeting vaccine antigens to Clec9A on dendritic cells.\", \"RV3 rotavirus vaccine: Phase I and II clinical trials of a human neonatal rotavirus vaccine for the global community\", \"Regulation of pulmonary immune responses to subunit vaccines against tuberculosis\", \"Prime-Target Vaccination in Malaria\", \"Construction of novel platforms for herpes simplex virus attenuated vaccines\", \"Use of long overlapping peptides for cancer vaccine and Treg control for potentiating immune response\", \"Study on the anti-allergic DNA vaccines with nanoparticle in gut mucosal immune system\", \"Analysis of efficacy of a vaccine inducing confined avirulent virus replication against immunodeficiency virus infection\", \"Development of a new class of lipid-based vaccines against tuberculosis\", \"Development of a novel vaccine platform based on Adeno associated virus.\", \"Identification of Neospora virulence factor and its application for the vaccine development\", \"Alphaherpesvirus vaccination, recombination and latency\", \"HBcAg-DNA\\u590d\\u5408\\u75ab\\u82d7\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"\\u53ef\\u9884\\u9632\\u5a74\\u5e7c\\u513f\\u547c\\u5438\\u9053\\u5408\\u80de\\u75c5\\u6bd2\\u611f\\u67d3\\u7684\\u53e3\\u670dDNA\\u75ab\\u82d7\", \"trpD\\u57fa\\u56e0\\u6572\\u9664\\u8026\\u8054\\u9776\\u5411\\u9012\\u9001GLS/IL-12\\u7684\\u91cd\\u7ec4BCG\\u6cbb\\u7597\\u6027\\u6d3b\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"Developing an RSV vaccine: Investigating possible adjuvants\", \"DETERMINING VIRUS-LIKE PARTICLE (VLP) FEASIBILITY FOR NEW PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VIRUS (PRRSV) VACCINES\", \"European malaria vaccine initiative\", \"Immunological mechanisms underlying the protective immune responses induced by botulinum oil adjuvanted vaccine\", \"Production of Alternate Adenovector Filovirus Vaccines\", \"Development/production of seasonal, pandemic and universa influenza DNA vaccines\", \"TIME COURSE OF LOT UTILIZATION\", \"Production of Alternate Adenovector Filovirus Vaccines\", \"Development/production of H3/H1 influenza DNA plasmid vaccine\", \"Development/production of a Marburg rAd Vaccine\", \"Production/Testing Of A Recombinant Modified Vaccine Ank\", \"Understanding &Estimating Costs of Vaccine Development,Production and Pricing\", \"Nanoemulsions as novel adjuvents for influenza virus vaccines\", \"ENGINEERED OPSONINS FOR WHOLE CELL TUMOR VACCINES\", \"VACCINATION AGAINST S MANSONI WITH STPI AND SM23\", \"Establishing the Human Vaccines Project as a paradigm for accelerating vaccine development against major global diseases\", \"Bescherming tegen influenza A en modulering van antigenpresentatie door matrix eiwit 2 ectodomein-specifieke antistoffen\", \"\\u57fa\\u4e8eMHC-I\\u77ed\\u80bd\\u7684\\u8fd8\\u539f\\u54cd\\u5e94\\u578b\\u5c0f\\u5206\\u5b50\\u6c34\\u51dd\\u80f6\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u7684\\u5236\\u5907\\u53ca\\u5176\\u8bf1\\u5bfc\\u7ec6\\u80de\\u514d\\u75ab\\u53cd\\u5e94\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"Varicella zoster virus as an HIV vaccine vector: Immunogenicity and protective efficacy in the SIV macaque model\", \"Dose-ranging study of safety, reactogenicity and immunogenicity of a human papillomavirus vaccine administered intradermally and intramuscularly to adults aged 20 to 26 years\", \"MagaVax vaccine for Ebola\", \"MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF INFECTIOUS BURSAL DISEASE VIRUSES\", \"Development of DC-vaccine against tuberclulosis\", \"EFFIVAVY OF CONSERVED ELEMENT SIV GAG VACCINCE IN CONTROL OF SIVmac239 VIREMIA\", \"\\u57fa\\u4e8ehTERT T\\u7ec6\\u80de\\u8868\\u4f4d\\u7684\\u591a\\u6297\\u539f\\u80bd(MAP)\\u75ab\\u82d7\\u8bbe\\u8ba1\\u53ca\\u5176\\u6297\\u80bf\\u7624\\u6548\\u5e94\\u7814\\u7a76\", \"\\u65b0\\u7532\\u578bH1N1\\u6d41\\u611f\\u75c5\\u6bd2\\u57fa\\u56e0\\u5de5\\u7a0b\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u5bf9\\u6297\\u75c5\\u6bd2\\u611f\\u67d3\\u7684\\u7814\\u7a76\", \"\\u514d\\u75ab\\u4e3b\\u5bfc\\u6548\\u5e94\\u5728\\u75ab\\u82d7\\u8f7d\\u4f53\\u4e2d\\u7684\\u4f5c\\u7528\\u53ca\\u6d88\\u9664\", \"\\u6162\\u75c5\\u6bd2\\u75ab\\u82d7\\u8bf1\\u5bfc\\u7684\\u514d\\u75ab\\u5e94\\u7b54\\u4e0e\\u514d\\u75ab\\u4fdd\\u62a4\\u5173\\u7cfb\\u7814\\u7a76\", \"\\u4ee5\\u7ec6\\u83cc\\u9b3c\\u5f71\\u4e3a\\u8f7d\\u4f53\\u7684\\u53cc\\u91cd\\u9776\\u5411DNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\\u7b56\\u7565\", \"\\u591a\\u805a\\u4e9a\\u57fa\\u75ab\\u82d7\\u5c42\\u6790\\u4ecb\\u8d28\\u7684\\u8bbe\\u8ba1\\u53ca\\u6027\\u80fd\\u7814\\u7a76\", \"Novel vaccines (vaccibodies) against avian influenza and prostate cancer.\", \"Predictors of rotavirus vaccine virus replication, immune response and clinical protection following oral rotavirus vaccination in Malawian children.\", \"Improved Venezuelan equine encephalitis virus vaccines\", \"EFFIVAVY OF CONSERVED ELEMENT SIV GAG VACCINCE IN CONTROL OF SIVmac239 VIREMIA\", \"BRUCELLOSIS VACCINE, MT\", \"DNA vaccines for aquaculture: Development and testing of plasmid vectors for vaccination against bacterial and viral fish pathogens.\", \"New childhood vaccines for Malawi: Impact of a national pneumococcal and rotavirus vaccine roll-out on child mortality and disease burden, in a region of sub-optimal strain coverage.\", \"New childhood vaccines for Malawi: Impact of a national pneumococcal and rotavirus vaccine roll-out on child mortality and disease burden, in a region of sub-optimal strain coverage.\", \"Development And Production Of Filovirus DNA Plasmid Vaccines\", \"FIELD TRIAL OF KILLED ORAL CHOLERA VACCINES IN VIETNAM\", \"DEVELOPMENT OF AN SRID POTENCY TEST FOR RABIES VACCINE\", \"CONTROL TESTING OF WHOLE CELL AND ACELLULAR PERTUSSIS VACCINES\", \"Development And Production Of Filovirus DNA Plasmid Vaccines\", \"MONOCLONAL ANTIBODY ANTI-IDIOTYPE TUMOR VACCINES\", \"Robust, animal-free cell culture medium for the production of vaccines\", \"OPTIVAX ADJUVANT--IMPROVE INFLUENZA VIRUS VACCINE\", \"Rabies Virus-Based Vectors as an HIV-1 Vaccine\", \"DESIGN AND ANALYSIS OF HIV VACCINE TRIALS\", \"\\u53d1\\u70ed\\u4f34\\u8840\\u5c0f\\u677f\\u51cf\\u5c11\\u7efc\\u5408\\u5f81\\u75c5\\u6bd2\\u65b0\\u578b\\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u5236\\u7684\\u7cfb\\u7edf\\u75ab\\u82d7\\u5b66\\u7814\\u7a76\\u53ca\\u5176\\u5728HIV\\u75ab\\u82d7\\u7814\\u7a76\\u4e2d\\u7684\\u5e94\\u7528\", \"\\u592a\\u7a7a\\u8bf1\\u53d8\\u80bf\\u7624\\u7ec6\\u80de\\u5236\\u5907\\u7624\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"Pan-Provincial Vaccine Enterprise (PREVENT), Saskatoon\", \"CIHR/CHVI Team in HIV Vaccine Design Based on Novel Strategies to Induce Protective Mucosal Cellular and Humoral Immunity\", \"Transcutaneous microsphere vaccine technology\", \"Multiepitopov\\u00e1 syntetick\\u00e1 vakc\\u00edna proti boreli\\u00f3ze pro veterin\\u00e1rn\\u00ed aplikace\", \"Immunization strategies to prevent Zika viral congenital eye and brain disease\", \"The use of inulin-based adjuvants to enhance the effectiveness and population coverage of influenza vaccination\", \"Self Adjuvanting CTL-Based Influenza Vaccines for Human Use\", \"Translational research of therapeutic vaccine to improve the quality of anti-hypertensive therapy\", \"Optimisation of a novel hybrid vaccine for liver fluke disease in cattle\", \"\\u201c\\u6a21\\u62df\\u75c5\\u6bd2\\u201d\\u578b\\u75ab\\u82d7\\u7684\\u4f18\\u5316\\u8bbe\\u8ba1\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"\\u8840\\u5438\\u866b\\u75c5\\u5408\\u6210\\u591a\\u80bd\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u8349\\u539f\\u5154\\u5c3e\\u9f20\\u900f\\u660e\\u5e263\\u57fa\\u56e0\\u75ab\\u82d7\\u514d\\u75ab\\u4e0d\\u80b2\\u7684\\u7814\\u7a76\", \"Novel DNA-Launched Attenuated Vaccine for VEE Virus SBIR Phase II\", \"Avalia\\u00e7\\u00e3o sorol\\u00f3gica de vacina experimental contra a enterotoxemia causada pela toxina \\u00e9psilon do Clostridium perfringens tipo d em caprinos\", \"Development of a Universal Meningococcal Vaccine\", \"Method for manufacture of biodegradable microsphere as matrices for control and stabilisation of aluminium containing vaccine adjuvants\", \"OPTIMIZING THE IMMUNE RESPONSE TO ALUMINUM-CONTAINING VACCINES\", \"IMPROVING THE SAFETY AND EFFICACY OF MAREK`S DISEASE VIRUS VACCINE CANDIDATES EXPRESSING THE MEQ PROTEIN FROM CVI988 VACCINE STRAIN\", \"Development of a Dendritic Cell-targeted Vaccine against AIDS\", \"Study of immunogenicity of DNA HIV-1 env, gag and pol plasmid vaccines boosted with MVA in Tanzania; HIV vaccine immunogenicity study\", \"Novel vaccination strategies and vaccine formulations for epidemic and pandemic influenza control\", \"Food safety screening: synthetic glucocorticoids\", \"Transcutaneous microsphere vaccine technology\", \"Predicting Vaccine escape: Improving strategic vaccine design.\", \"Interaction between live and killed vaccines: effect of DTP combined vaccine on T cell memory after measles vaccination\", \"Production of New Adenovector Constructs with Fiber-Shaft Modifications\", \"Establishment of a Vaccine Pilot Plant\", \"IN VIVO MODELS FOR SUPERANTIGEN VACCINES\", \"Generating Antigen-Specific Immune Memory\", \"Herpes viruses as re-activating Vaccine Vectors: Protective Efficacy of a Varicella Zoster-HIV Vaccine in the SIV Macaque model\\\"\", \"\\u9a6c\\u4f20\\u67d3\\u6027\\u8d2b\\u8840\\u75c5\\u6bd2\\u5f31\\u6bd2\\u75ab\\u82d7\\u682a\\u548c\\u4eb2\\u672c\\u5f3a\\u6bd2\\u682a\\u7684\\u4f53\\u5185\\u8fdb\\u5316\\u53ca\\u5176\\u4e0e\\u514d\\u75ab\\u5e94\\u7b54\\u5173\\u7cfb\\u7814\\u7a76\", \"Role of dendritic cells during vaccine therapy in hepatitis B virus carriers.\", \"Study on the DNA immunization against microbial infection\", \"Development and validation of  delivery technology for  gene based prophylactic vaccines\", \"Development of an outer membrane vesicle vaccine for Africa against serogroup A and W-135 meningococcal disease\", \"Protein thermal stability using amorphous silica\", \"New flexible frameworks for catalysis, energy materials and nanotechnology\", \"Development of A549 cells as a cell substrate for vaccine production\", \"AIDS Vaccine 2005 International Conference.\", \"THE EFFECTS OF DPT VACCINE ON HEPATIC DRUG METABOLISM\", \"Vitrification-stabilized Multivalent Botulinum Vaccines\", \"HIV VACCINE CLINICAL TRIALS UNIT\", \"Development of a non-living subunit rotavirus vaccine\", \"EVALUATION OF LIPOSOME BASED HERPES VACCINES\", \"PEPTIDE SPECIFIC CD8 T CELLS AS MARKER OF VACCINE ACTION\", \"Adenovirus-based Nanoparticle Vaccines\", \"Mechanisms of Mycobacterial Antigen Processing\", \"Augmentation of DNA Vaccine-Elicited Immunity to HIV/SIV\", \"SAPONIN ADJUVANT ENHANCED PNEUMOCOCCAL VACCINE\", \"A concerted european approach towards the development of amalaria vaccine\", \"Prime-boost vaccination using influenza A H5N1 vaccines\", \"Post-trial HIV Vaccines: Receptivity, Risk &Disparities\", \"DEVELOP AND EVALUATE NEW LEPROSY AND TB VACCINES\", \"Attenuated West Nile Virus Live Vaccine for Human Use\", \"Ontology-based Information Network to Support Vaccine Research\", \"Enhancing Australia's pandemic influenza vaccine output by increasing the yeild of vaccine from eggs\", \"Immunopharmacotherapy for Mitigating Opioid Addiction\", \"Pre-Exposure Prophylaxis Against Francisella tularensis\", \"Enhanced Oral Vaccine Delivery Vehicle\", \"Topical Adjuvants to Enhance the Efficacy of Influenza Vaccines\", \"Anthrax DNA vaccine for non-invasive immunization on skin\", \"Pre-Exposure Prophylaxis Against Francisella tularensis\", \"Prophylactic Vaccines for Schistosomiasis\", \"MEASLES VACCINES--IMMUNE RESPONSES AND ATYPICAL MEASLES\", \"Engineering the Lymph Node Environment with Therapeutic Vaccine Depots to Combat Neuroblastoma\", \"Development and evaluation of a knowledge translation strategy to improve influenza immunization rates among pregnant women\", \"Studies on the Development of an Effective Vaccine Against Hepatitis C Virus\", \"\\u57fa\\u4e8e\\u970d\\u4e71\\u6bd2\\u7d20AB5\\u7ed3\\u6784\\u7684\\u4e2a\\u4f53\\u5316\\u81ea\\u7ec4\\u88c5\\u6297\\u764c\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u6c49\\u6ee9\\u75c5\\u6bd2\\u5d4c\\u5408\\u75ab\\u82d7\\uff08VLP/DNA\\uff09\\u7684\\u5236\\u5907\\u53ca\\u5176\\u514d\\u75ab\\u5b66\\u7279\\u6027\\u7684\\u7814\\u7a76\", \"\\u7532\\u809d\\u51cf\\u6bd2\\u6d3b\\u75ab\\u82d7\\u7684\\u6297\\u4f53\\u6301\\u4e45\\u6027\\u4e0e\\u514d\\u75ab\\u8bb0\\u5fc6\\u7814\\u7a76\", \"\\u9a6c\\u7acb\\u514b\\u6c0f\\u75c5\\u2161\\u3001\\u2162\\u578b\\u75c5\\u6bd2(Z4+FC126)\\u514d\\u75ab\\u534f\\u540c\\u673a\\u7406\\u7814\\u7a76\", \"\\u5185\\u8499\\u9521\\u76df\\u4e2d\\u90e8\\u8349\\u539f\\u751f\\u6001\\u7cfb\\u7edf\\u7ed3\\u6784\\u529f\\u80fd\\u751f\\u4ea7\\u529b\\u63d0\\u9ad8\\u9014\\u5f84\\u7814\\u7a76\", \"\\u6c49\\u6ee9\\u75c5\\u6bd2\\u65b0\\u578b\\u75ab\\u82d7--\\u514d\\u75ab\\u589e\\u5f3a\\u578bVLPs\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u3001\\u514d\\u75ab\\u5b66\\u7279\\u6027\\u548c\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u7684\\u7814\\u7a76\", \"\\u4e2d\\u56fd\\u9ad8\\u5371\\u578b\\u4eba\\u4e73\\u5934\\u7624\\u75c5\\u6bd216/58/18\\u5d4c\\u5408\\u75c5\\u6bd2\\u6837\\u9897\\u7c92\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"idMALVAC: Establishing immunological correlates of protection against malaria vaccine candidates using functional bioassays and proteomic deciphering of host-parasite interactions\", \"Development and evaluation of a recombinant porcine adenovirus vaccine for post-exposure protection against Ebolavirus\", \"Immunogenicity of pneumococcal vaccine in liver transplant recipients\", \"\\u9ad8\\u6548\\u8bf1\\u5bfc2\\u578b\\u514d\\u75ab\\u5e94\\u7b54\\u7684\\u964d\\u538b\\u75ab\\u82d7\\u5448\\u9012\\u7cfb\\u7edfCpG ODN-VLP\\u7814\\u7a76\", \"Elicitation of ?4?7-Competitive Antibodies in Rhesus Macaques by a Synthetic V2 Immunogen\", \"Study to investigate the immunogenicity and efficacy of a rVSV-HIVenv Prime, HIV envelope protein boost vaccination regimen and DNA-HIV Prime, rVSV-HIVenv boost vaccination regimen\", \"In Vivo SHIV/SIV Titration via Mucosal Route in Indian-origin Rhesus Macaques\", \"Conduct Study P193: Evaluation of Immune Responses after Priming with Newcastle Disease Virus and Boosting with Trimeric gp145 Proteins from Indian and African Clade C HIV-1 Isolates\", \"\\u57fa\\u4e8e\\u667a\\u80fd\\u5316\\u591a\\u7cd6\\u7eb3\\u7c73\\u51dd\\u80f6\\u7684\\u80bf\\u7624\\u75ab\\u82d7\\u53ca\\u6297\\u80bf\\u7624\\u4f5c\\u7528\\u7814\\u7a76\", \"CEA\\u8054\\u54084-1BBL\\u57fa\\u56e0\\u75ab\\u82d7\\u6297\\u5927\\u80a0\\u764c\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u5e03\\u6c0f\\u83cc\\u51cf\\u6bd2\\u75ab\\u82d7\\u682aM5-90\\u7684bp26\\u86cb\\u767d\\u8868\\u4f4d\\u5206\\u5b50\\u4fee\\u9970\\u4e0e\\u521d\\u6b65\\u514d\\u75ab\\u8bc4\\u4ef7\", \"\\u53cc\\u6297\\u539f\\u53cc\\u9776\\u5411\\u4e73\\u817a\\u764cDNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\\u7b56\\u7565\", \"\\u57fa\\u4e8eBin1b\\u7684\\u96c4\\u6027\\u514d\\u75ab\\u8282\\u80b2DNA\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u5176\\u6548\\u5e94\\u7814\\u7a76\", \"\\u4ee5\\u7ec6\\u83cc\\u83cc\\u5f71\\u4e3a\\u8f7d\\u4f53\\u7684\\u65b0\\u578b\\u6dcb\\u75c5\\u5948\\u745f\\u83cc\\u9776\\u5411\\u9ecf\\u819c\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"Preclinical Crimean Congo Haemorraghic Fever Vaccine Development\", \"Conduct Study P193: Evaluation of Immune Responses after Priming with Newcastle Disease Virus and Boosting with Trimeric gp145 Proteins from Indian and African Clade C HIV-1 Isolates\", \"DISCOVERY OF PROTECTIVE ANTIGENS FOR NOVEL JOHNE'S DISEASES VACCINES\", \"Development of novel Norovirus vaccines using virus vector\", \"Development of adjuvant-combined nasal influenza vaccine\", \"Conduct Study P193: Evaluation of Immune Responses after Priming with Newcastle Disease Virus and Boosting with Trimeric gp145 Proteins from Indian and African Clade C HIV-1 Isolates\", \"Manipulation of particulate vaccine delivery vehicles to target dendritic cells\", \"\\u8349\\u539f\\u5154\\u5c3e\\u9f20\\u5375\\u900f\\u660e\\u5e263DNA\\u75ab\\u82d7\\u7c98\\u819c\\u514d\\u75ab\\u53ca\\u9975\\u6599\\u91ca\\u653e\\u6548\\u679c\\u7684\\u7814\\u7a76\", \"L-rhamnose\\u4fee\\u9970\\u5bf9\\u80bf\\u7624\\u76f8\\u5173\\u7cd6\\u6297\\u539f\\u75ab\\u82d7\\u6548\\u5e94\\u7684\\u5f71\\u54cd\", \"\\u8f6c\\u57fa\\u56e0\\u7403\\u866b\\u6fc0\\u53d1\\u9e21\\u6297\\u79bd\\u6d41\\u611f\\u7684\\u4fdd\\u62a4\\u6027\\u7c98\\u819c\\u514d\\u75ab\\u5e94\\u7b54\\u673a\\u5236\", \"\\u4e59\\u8111\\u75c5\\u6bd2\\u57fa\\u56e0\\u7ec4\\u591a\\u533a\\u6bb5\\u6784\\u5efaDNA\\u75ab\\u82d7\\u589e\\u5f3a\\u6548\\u5e94\\u4e3b\\u8981\\u73af\\u8282\\u7814\\u7a76\", \"\\u5e7d\\u95e8\\u87ba\\u6746\\u83cc\\u76ca\\u751f\\u83cc\\u578b\\u53e3\\u670d\\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u844e\\u8349\\u82b1\\u7c89\\u4e3b\\u8981\\u53d8\\u5e94\\u539f\\u6838\\u9178\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u80a0\\u9053M\\u7ec6\\u80de\\u9776\\u5411\\u53e3\\u670d\\u80bf\\u7624\\u7eb3\\u7c73\\u4e73\\u5242\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u8054\\u5408\\u5e94\\u7528\\u5355\\u78f7\\u9178\\u9170\\u8102\\u8d28\\uff08MPL\\uff09\\u7684WapA\\u9632\\u9f8bDNA\\u75ab\\u82d7\\u589e\\u5f3a\\u7c98\\u819c\\u514d\\u75ab\\u53cd\\u5e94\\u7684\\u6548\\u5e94\\u53ca\\u5176\\u673a\\u5236\\u7814\\u7a76\", \"Vacinas de DNA contra Streptococcus pneumoniae: avalia\\u00e7\\u00e3o do ant\\u00edgeno pneumolisina e de interleucinas\", \"GeMI-Vax as a multi-life stage  malaria vaccine\", \"Optimized second-generation recombinant mycobacteria vaccine vectors against HIV\", \"Market viability of ImmBioVax vaccines against H. Pylori and C. Difficile\", \"DNA VACCINES FOR BRUCELLA\", \"BRUCELLOSIS VACCINE, MT\", \"''BRUCELLOSIS VACCINE, MT''\", \"Methods for Safety Evaluation of Vaccination Schedules\", \"Immunogenicity and protective efficacy of intranasal delNS1(H5N1) influenza vaccine\", \"Developing a novel single dose prime-boost vaccine against malaria\", \"Developing a novel single dose prime-boost vaccine against malaria\", \"Wellcome Trust Clinical PhD Programme, University of Liverpool 'Health Priorities in the Developing World'\", \"SBIR Phase I: A New Vaccine Development Method\", \"Development/production of universal influenza vaccines\", \"Establishment and operation of a Vaccine Pilot Plant\", \"Marburg Vaccine Development\", \"MOLECULAR TEST FOR REVERTANT MUTATIONS IN LIVE VIRUS VAC\", \"DEVELOPMENT OF AN SURID POTENCY TEST FOR RABIES VACCINE\", \"DEVELOPMENT OF TESTS FOR ACELLULAR PERTUSSIS VACCINES\", \"Marburg Vaccine Development\", \"Malaria Vaccine:  AMA1-rEPA\", \"Malaria Vaccine:  AMA1-C1/ISA 720\", \"Malaria Vaccine:  BSAM\", \"Malaria Vaccine: AMA1-C1\", \"Smallpox subunit vaccine in the C-PERL expression system\", \"Alphavirus Replicon Vaccines against Influenza\", \"Chimeric yellow fever 17D/Dengue vaccines\", \"IMMUNE AND BIOLOGICAL STRATEGIES FOR AIDS VACCINES\", \"Generation of bPIV3-vectored PIV and RSV Vaccines\", \"Development of a VEEV, WEEV, EEEV DNA Vaccine Delivered by Electroporation\", \"NEW CONJUGATE VACCINE FOR GRAM NEGATIVE SEPSIS\", \"Vaccine enhancement through antigen targeting\", \"T-Cell Vaccine-A Clinical Trail for Progressive MS\", \"SYSTEMATIC APPROACH TO VACCINES FOR RETROVIRAL DISEASES\", \"\\u58f3\\u805a\\u7cd6-\\u67b8\\u675e\\u591a\\u7cd6\\u5fae\\u7c92\\u5e7d\\u95e8\\u87ba\\u65cb\\u6746\\u83cc\\u75ab\\u82d7Hp-WAE\\u7684\\u6cbb\\u7597\\u4f5c\\u7528\\u53ca\\u673a\\u5236\\u7814\\u7a76\", \"The next generation of vaccines: characterization of virus-like particle (VLP) vaccines made in plants.\", \"Improvement of a cattle vaccine against Escherichia coli serotype O157:H7\", \"\\u60aa\\u6027\\u9ed2\\u8272\\u816b\\u306b\\u5bfe\\u3059\\u308bcalreticulin/TRP-2DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"GENE GUN-MEDIATED INOCULATION OF ORIENTED DNA VACCINES AGAINST AN INTRACELLULAR PATHOGEN\", \"Molecular Assembly and Stability of Human Hepatitis B Virus Surface Antigen Vaccine\", \"\\u56ca\\u5c3e\\u86b4\\u75c5\\u591a\\u671f\\u590d\\u5408\\u57fa\\u56e0\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"Adjuvants and Glucan Particle Vaccines\", \"Study of Monophosphoril lipid A, from Bordetella pertussis LPS, mechanisms as Influenza vaccine adjuvant\", \"Identification of vaccine candidates using reverse vaccinology\", \"Improved vaccines for Bluetongue Disease\", \"The European malaria vaccine development association\", \"Ration design and standardized evaluation of novel genetic vaccines.\", \"Novel antigen-adjuvant vehicle as an effective influenza vaccine\", \"A Game Theoretic Approach to Pediatric Vaccine Pricing\", \"ARRA: Animal Model Support of Universal Influenza Vaccine\", \"Enhanced Surveillance: New Vaccine Preventable Diseases\", \"Preclinical development of a chimeric tetravalent dengue vaccine\", \"Novel nanotechnology based oral influenza vaccines\", \"Vaccine-induced CD8+ T cell memory\", \"Innovative Single-Dose Hepatitis B Vaccine Formulation\", \"A novel vaccine: botulinum neurotoxin subunit on a viral carrier.\", \"Immunotherapy after ASCT for MM Using hTERT Vaccination + Vaccine-primed T cells\", \"Universal T cell targeted influenza vaccine\", \"SPECIFIC IMMUNOTHERPY OF CANCER WITH VACCINES\", \"Developing a Novel Mumps Virus Vaccine\", \"Improved Vaccines for Rift Valley Fever Virus\", \"HIV and SIV Vaccines and Mucosal Immunity\", \"MAO/EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE MOD\", \"MAO/EVALUATION OF AIDS VACCINES\", \"MAO/EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE\", \"EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE MODELS\", \"MAO/EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE\", \"MAO/EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE\", \"EVALUATION OF RECOMBINANT BCG/SIV VACCINES\", \"EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE\", \"Multitarget-Display Viruslike Particle-Based Vaccine to Combat Lyme Disease\", \"Conjugate Vaccines to Prevent Shigellosis\", \"\\u57fa\\u4e8ecDNA\\u8868\\u8fbe\\u5e93\\u68af\\u7ea7\\u7ec4\\u5206\\u514d\\u75ab\\u9ad8\\u901a\\u91cf\\u7b5b\\u9009\\u6297\\u5185\\u810f\\u5229\\u4ec0\\u66fc\\u75c5\\u75ab\\u82d7\\u5019\\u9009\\u5206\\u5b50\", \"\\u9e21\\u7403\\u866b\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u523a\\u6fc0\\u6027\\u6297\\u539f\\u7684\\u786e\\u5b9a\\u53ca\\u5176\\u5e94\\u7528\", \"Enhancing the Immunogenicity of a Dengue-2 DNA Vaccine with Adjuvants and Anti-FC and RI Antibodies\", \"Androgen Deprivation as an Immunomodulatory Therapy in Combination with DNA Vaccines for the Treatment of Prostate Cancer\", \"DEVELOPING A PARAINFLUENZA VIRUS 5 (PIV5)-BASED PRRSV VACCINE\", \"Emerging Viral Vaccine Antigen Insert Consortium (EVAC)\", \"The use of CpG adjuvants, bio-degradable microparticles, and microneedle technology for the design of novel single-dose vaccines\", \"Ultra-low dose Influenza vaccines\", \"Etec Epidemiology And Vaccine Research In Lower Egypt\", \"Assessment of the Immunogenicity and Protective Efficacy of a Multiagent DNA Vacc\", \"THERAPEUTIC TB VACCINE\", \"Ad4 vectored HIV-Env vaccines with improved immunogenicity\", \"Development of Multivalent Vaccines Against Yellow Fever and Arena Viruses\", \"Adjuvants for Agile Vaccine Development\", \"MOLECULAR APPROACHES TO HUMAN VIRAL VACCINES\", \"Vaccine-induced HIV antibody responses in infants\", \"POLYVALENT VACCINE IN IL-2+GM-CSF LIPOSOMES FOR MELANOMA\", \"Cell-based tumor vaccines targeting CD4+ T lymphocytes\", \"Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine\", \"Boosting Flu Vaccination without Adjuvant Injection\", \"DEVELOPMENT OF ROTAVIRUS DNA VACCINES\", \"Genetic Vaccines Against HIV Mutants\", \"CLINICAL EFFICACY OF PNEUMOCOCCAL VACCINE IN THE ELDERLY\", \"Interaction between conventional cancer therapy and gene-based cancer vaccines\", \"Passively Regulated Cryogenic (PaRC) Vial System for Vaccine Distribution and Administration\", \"\\u65b0\\u578b\\u80f6\\u8d28\\u7624\\u590d\\u5408\\u6297\\u539fDC\\u75ab\\u82d7\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u7684\\u529f\\u80fd\\u7814\\u7a76\", \"ATRQ\\u03b2-001\\u75ab\\u82d7\\u901a\\u8fc7AT1R/APJ\\u5f02\\u4e8c\\u805a\\u5316\\u6297\\u8840\\u7ba1\\u91cd\\u6784\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u4e59\\u578b\\u809d\\u708e\\u75c5\\u6bd2\\u8868\\u9762\\u6297\\u539f\\u57fa\\u56e0\\u514d\\u75ab\\u7684\\u7814\\u7a76\", \"\\u589e\\u5f3aHIV\\u75ab\\u82d7\\u8bf1\\u5bfc\\u514d\\u75ab\\u5e94\\u7b54\\u7b56\\u7565\\u7684\\u63a2\\u8ba8\", \"Phase 2 Study of a Live Attenuated Measles Virus-Vectored Chikungunya Vaccine in Previously Exposed Versus Unexposed Adults Ages 51 to 65\", \"Prophylactic HIV Vaccines for Social Networks of Injection Drug Users\", \"\\u9776\\u5411DC\\u7684FSHR\\u975e\\u75c5\\u7406\\u8868\\u4f4d\\u7684\\u65b0\\u578b\\u907f\\u5b55\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u53ca\\u6548\\u5e94\\u7814\\u7a76\", \"O157\\u591a\\u7cd6\\u86cb\\u767d\\u75ab\\u82d7\\u7684\\u7cd6\\u94fe\\u6570\\u76ee\\u53ca\\u957f\\u5ea6\\u6700\\u4f73\\u914d\\u6bd4\\u7814\\u7a76\", \"Can a pneumococcal H. influenzae protein D conjugate vaccine (PHiD-CV) reduce the frequency of NTHi infection in the lower airway (defined by >10E4 cfu/ml bronchoalveolar lavage) and upper airway (nasopharynx) colonisation of children with chronic suppurative lung disease?\", \"Using VacSIM Delivery to Enhance Malaria Vaccine Efficacy\", \"Using VacSIM Delivery to Enhance Malaria Vaccine Efficacy\", \"V\\u00fdvoj unik\\u00e1tn\\u00edch vakc\\u00edn proti z\\u00e1va\\u017en\\u00fdm onemocn\\u011bn\\u00edm zv\\u00ed\\u0159at\", \"Vaccine microencapsulation for single dose delayed release delivery.\", \"Desenvolvimento nacional de vacina para a preven\\u00e7\\u00e3o de doen\\u00e7a reum\\u00e1tica card\\u00edaca\", \"In vivo induced Bacterial Ghosts from live attenuated bacter\", \"Evaluation of hypertension vaccine using pig model\", \"Development of the novel technique intended to the prophylaxis and treatment of neglected tropical diseases\", \"Development of next generation transdermal vaccine for cancer treatment\", \"Development of a novel vaccine to control virulent strains of Marek's disease virus: enhancement of vaccine efficacy by modulating the host immunosuppression pathway\", \"Basic study for development of a novel anti-tuberculosis vaccine using magnetite nanoparticles\", \"Development of safety vaccine using spleen- and dendritice cells-targeted nano device\", \"Comparative study on differences between  polio and vaccine-derived polio\", \"Development of the transcutaneous influenza vaccine formulation using an self-dissolving microneedle patch\", \"Development of a new type of anti-tuberculosis vaccines by the use of lipid immunity\", \"Basic research of the antigen delivery system that it aimed at the optimization of the DNA vaccine for cancer prevention\", \"Superantigen pulsed DCs supports the induction of tumor immunity\", \"The study of the mechanism of therapeutic efficacy of novel vaccines on Tuberculosis-infection and the induction of cytotoxic T cells by the vaccines\", \"Dynamics of circulating rotavirus strains after vaccine introduction in Brazil.\", \"Targeting cancer vaccines to human dendritic cells via CD301\", \"Development of a live vaccine for gut health in poultry\", \"\\u8bc4\\u4ef7\\u9cd7\\u5f27\\u83cc\\u51cf\\u6bd2\\u6d3b\\u75ab\\u82d7\\u4f53\\u5185\\u514d\\u75ab\\u6548\\u529b\\u7684\\u65b0\\u65b9\\u6cd5\", \"\\u95f4\\u65e5\\u759f\\u539f\\u866b\\u4f20\\u64ad\\u963b\\u65ad\\u75ab\\u82d7\\u5019\\u9009\\u86cb\\u767dPvs25\\u548cPvs28\\u75ab\\u82d7\\u6548\\u679c\\u7684\\u7814\\u7a76\", \"\\u72ac\\u6297\\u7ec6\\u7c92\\u68d8\\u7403\\u7ee6\\u866b\\u611f\\u67d3\\u7684\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7814\\u7a76\", \"\\u5149\\u52a8\\u529b\\u5b66\\u80bf\\u7624\\u75ab\\u82d7\\u6cbb\\u7597\\u548c\\u9884\\u9632\\u4e0a\\u76ae\\u6027\\u5375\\u5de2\\u764c\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u65e5\\u672c\\u8840\\u5438\\u866b\\u75c5\\u75ab\\u82d7\\u53d1\\u5c55\\u7b56\\u7565\\u7814\\u7a76\\uff1a\\u8f90\\u7167\\u81f4\\u5f31\\u5c3e\\u86b4\\u8bf1\\u5bfc\\u9ad8\\u4fdd\\u62a4\\u6027\\u6548\\u5e94\\u673a\\u7406\\u7684\\u5206\\u5b50\\u514d\\u75ab\\u5b66\\u8bc4\\u4ef7\", \"\\u58f3\\u805a\\u7cd6\\u7eb3\\u7c73\\u7c92\\u88c5\\u8f7dHP BabA2/UreI\\u57fa\\u56e0\\u53cc\\u4ef7\\u9ecf\\u819cDNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"Use of a Novel Parent-Report Measure to Improve Childhood Vaccine Uptake\", \"Entwicklung eines Impfstoffs gegen Tuberkulose basierend auf Kohlenhydraten\", \"Development of novel vaccine candidates to prevent primary or reactivated tuberculosis\", \"Development of novel vaccine candidates to prevent primary or reactivated tuberculosis\", \"Conjugated vaccines: from the laboratory to pilot scale 3\", \"Use of nanoparticles in vaccines against bacterial meningitis\", \"Malarial Vaccines Utilizing Antigen/Adjuvant Display on Viral-Like Particles\", \"Development of autogenous vaccines for the control of amoebic gill disease in farmed salmon\", \"Development of a defective live virus vaccine against porcine reproductive and respiratory syndrome.\", \"Investigations of polyphosphazenes as adjuvants for mucosal vaccines\", \"EVALUATING EFFICACY OF A NOVEL BVDV MULTI-ANTIGEN VACCINE\", \"HIV Vaccine Trial Preparedness: Socio-behavioural Challenges of HIV Vaccine Development\", \"Tablet Vaccines\", \"Low cost, broadly efficacious Pneumococcal vaccine\", \"RECOMBINANT VACCINES FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME\", \"Vaccination against the viral haemorrhagic septicaemia: comparison between a live attenuated virus, a preparation of killed virus and a genetically engineered subunit vaccine\", \"Flu vaccine for heterosubtypic protection.\", \"Exploiting plant synthetic biology for the production of glycoproteins in plant chloroplasts.\", \"Malaria Vaccine:  AMA1-C1/ISA 720\", \"PEPTIDE POLYMERS AS VACCINE CANDIDATES\", \"San Francisco Vaccine and Prevention Unit\", \"LIVE VIBRIO CHOLERA AS AN ORAL SIV VACCINE VECTOR\", \"MUCOSAL VACCINE DELIVERY SYSTEMS\", \"Novel Prophylactic HIV Vaccines Based on rAAV Vectors\", \"CENTRAL IMMUNOLOGY LAB FOR AIDS VACCINE CLINICAL TRIALS\", \"DEVELOP LIVE ATTENUATED COLD-ADAPTED INFLUENZA VACCINE\", \"PARAGONE: vaccines for animal parasites\", \"Developing a Novel Modular Nanoparticle Vaccine Strategy to Induce Durable Systemic and Mucosal HIV Envelope Specific Antibodies\", \"\\u57fa\\u4e8e\\u8ba1\\u5212\\u884c\\u4e3a\\u7406\\u8bba\\u7684HPV\\u75ab\\u82d7\\u652f\\u4ed8\\u610f\\u613f\\u4e0e\\u9700\\u6c42\\u9884\\u6d4b\\u7814\\u7a76\", \"CART\\u57fa\\u56e0\\u75ab\\u82d7\\u5728\\u5417\\u5561\\u4f9d\\u8d56\\u548c\\u590d\\u5438\\u4e2d\\u7684\\u4f5c\\u7528\\u53ca\\u5176\\u795e\\u7ecf\\u673a\\u5236\", \"Isolation of unique coccidial antigens for coccidial vaccine development\", \"Evaluation and optimisation of paediatric vaccination programs in Australia and the region\", \"Enhancing the immune response to disordered malaria antigens\", \"Mucosal human immunodeficiency virus vaccine late pre-clinical evaluation\", \"Quantifying the effectiveness of pertussis vaccine in older adults\", \"Understanding immune memory diversity\", \"Viral entry and the development of vaccines.\", \"Group A streptococcal human challenge study: accelerating vaccine development\", \"Improving Therapeutic Delivery by Understanding Nanoparticle Interactions with Cells\", \"Strategies to reduce the burden of gastroenteritis in Aboriginal children.\", \"Virus-like-particles for vaccines produced in plants:  immunologic and structural characterization\", \"Long-term preservation of a whole parasite malaria vaccine for storage and delivery in the tropics\", \"Needle-free vaccines for respiratory viruses\", \"Understanding the unusual effectiveness of Virus-Like Particle (VLP) vaccines made in plants\", \"Parents, Daughters, and the HPV Vaccine: Factors Affecting Parental Decision-Making in a Universal Immunization Program\", \"Discovery of new B cell immunogens for HIV vaccines\", \"Community Engagement in HIV Vaccine Research: Advancing HIV Vaccine Trial Preparedness among Men who have Sex with Men in India\", \"Evaluation of viral sensitizer technology in improving egg-based influenza vaccine manufacturing processes\", \"Randomized phase II study of adjuvant WT-1 analog peptide vaccine in patients with malignant pleural mesothelioma after completion of combined modality therapy.\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine Treatment and Evaluation Unit\", \"IGF::OT::IGF TESTING OF COMBINATION IMMUNO AND CHEMOPREVENTION STRATEGIES FOR LYNCH SYNDROME GASTROINTESTINAL CANCER\", \"IGF::OT::IGF A PILOT STUDY OF MUC1 VACCINE IN CURRENT AND FORMER SMOKERS AT HIGH RISK FOR LUNG CANCER\", \"Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever\", \"VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES\", \"Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)\", \"Novel Innate Immune Adjuvant for Avian Influenza. West Nile Virus, and ZIKA Vaccines\", \"Development of Adjuvant with Vaccines for Tuberculosis and Shigellosis\", \"Development of badger vaccines\", \"Novel multivalent vaccines against haemorrhagic fevers\", \"Viral attenuation and pathogenesis\", \"*V\\u00fdvoj vakc\\u00edny k zabr\\u00e1n\\u011bn\\u00ed p\\u0159enosu kl\\u00ed\\u0161\\u0165aty p\\u0159en\\u00e1\\u0161en\\u00fdch n\\u00e1kaz na b\\u00e1zi Ferritinu-2 pro veterin\\u00e1rn\\u00ed a hum\\u00e1nn\\u00ed pou\\u017eit\\u00ed.\", \"Imunoterapie chronick\\u00e9 myeloidn\\u00ed leukemie: v\\u00fdvoj a testov\\u00e1n\\u00ed experiment\\u00e1ln\\u00edch vakc\\u00edm v my\\u0161\\u00edm syst\\u00e9mu a imunologick\\u00e1 studie pacient\\u016f\", \"Kombinovan\\u00e9 vakc\\u00edny s imunomodula\\u010dn\\u00edmi \\u00fa\\u010dinky v prevenci a l\\u00e9\\u010db\\u011b infekc\\u00ed a imunodeficienc\\u00ed\", \"V\\u00fdvoj vektor\\u016f, nosi\\u010d\\u016f a adjuvans pro konstrukci DNA vakc\\u00edn\", \"\\u30ca\\u30c1\\u30e5\\u30e9\\u30eb\\u30da\\u30d7\\u30c1\\u30c9\\u306e\\u7db2\\u7f85\\u7684\\u89e3\\u6790\\u306b\\u3088\\u308b\\u53e3\\u8154\\u304c\\u3093\\u5e79\\u7d30\\u80de\\u7279\\u7570\\u7684\\u518d\\u767a\\u4e88\\u9632\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Formulation of ultrasmall vaccine nanoparticles\", \"Evaluation of highly immunogenic tumor cell vaccines in combination with regulatory T-cell depletion\", \"A phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine.\", \"Molecular characterisation of the dendritic cell receptor Clec9a and its ligand interactions\", \"Assessing vaccine effectiveness of publicly funded vaccination programs in Queensland\", \"Developing a safe vaccine against group A streptococci\", \"Antibody-Dependent Cellular Cytotoxicity based immunity to Influenza\", \"Generating an effective vaccine response against the intrinsically unstructured malaria antigen Merozoite Surface Protein 2\", \"Development of Carbohydrate Based Self-adjuvanting Vaccine Delivery System\", \"Nanoparticle Vaccines for HIV\", \"Preclinical studies of group A streptococcal vaccine candidates\", \"HIV and HCV Vaccines and Immunopathogenesis.\", \"Optimising immunity towards cancers by vaccination.\", \"Pre-clinica evaluation of a novel HIV-1 vaccine statrgy\", \"Comparative effectiveness of vaccine-induced SIV-specific CD8 T cells\", \"Prophylactic vaccine to prevent cytomegalovirus disease\", \"Immunological Prevention of Cysticercosis and Hydatid Disease\", \"Population genomics of Plasmodium falciparum surface antigen genes\", \"A study to investigate alternative regimens for pneumococcal vaccination of infants in a developing country\", \"Entrapment and deletion of melanoma-specific T cells at vaccination sites\", \"VTEU: Phase I Influenza Vaccine Clinical Trial\", \"VTEU: Phase I Malaria Vaccine Clinical Trial\", \"Development of Adjuvant with Vaccines for Tuberculosis and Shigellosis\", \"Novel Innate Immune Adjuvant for Avian Influenza and West Nile Virus Vaccines\", \"VTEU: Shigella Vaccine Trial\", \"VTEU: Phase I Malaria Vaccine Study\", \"Assay Work for Malaria Vaccines - VTEU\", \"VTEU: Assay Work for Influenza Vaccines\", \"VTEU: Assay Work for Yellow Fever Vaccines\", \"Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)\", \"DEVELOPMENT OF AD-VECTORED VACCINES INDUCING BROAD IMMUNITY TO SWINE INFLUENZA\", \"Development of cancer peptide vaccine that can induce tumor-specific CTLs and Th cells.\", \"Development of Nasal Vaccine agaisnt RS virus based on neonatal innate immunity\", \"Identification of the antibody induced by the new vaccine against Alzheimer's diseasese induces\", \"Development of novel vaccine against tuberculosis using recombinant BCG expressing SOCS1 antagonist\", \"Development of macrophage migration inhibitory factor DNA vaccine against inflammatory ocular disease\", \"Development of immunotherapy for hepatocellular carcinoma by peptide vaccine\", \"Development of a tailor-made type of cancer vaccine treatment\", \"Search for immunopotentiating adjuvants in cancer vaccine therapy for gynecologic malignancies\", \"The creation and safety assessment of cytokine adjuvant and nano-carrier for mucosal vaccine\", \"Establishment of a novel vaccine against Mycobacterium tuberculosis employing carbohydrate-coated liposomes\", \"Construction of influenza virosome and its development to preparation of vaccine\", \"The study of DNA vaccine potency against hamster oral papillomavirus-associated oral cancer\", \"\\u30af\\u30ed\\u30b9\\u30c8\\u30ea\\u30b8\\u30a6\\u30e0\\u30fb\\u30c7\\u30a3\\u30d5\\u30a3\\u30b7\\u30eb\\u611f\\u67d3\\u75c7\\u306b\\u5bfe\\u3059\\u308bDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u3068\\u5fdc\\u7528\", \"\\u7d4c\\u9f3b\\u6295\\u4e0e\\u578b\\u30ea\\u30dd\\u30bd\\u30fc\\u30e0\\u30ef\\u30af\\u30c1\\u30f3\\u3092\\u7528\\u3044\\u305f\\u65b0\\u898f\\u975e\\u4fb5\\u8972\\u6027\\u5b50\\u5bae\\u9838\\u304c\\u3093\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Induction of vaccine-elicited T cell responses by non-natural amino acids\", \"\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u7c98\\u819c\\u514d\\u75ab\\u8a98\\u5c0e\\u53ef\\u80fd\\u306aprime/boost\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Fundamental study on delivery system of DNA vaccine-embedded CPH nanoparticles for cancer prevention using oral mucosa\", \"The prophylactic effect of IL-17A DNA vaccine on arthritis\", \"Developmental research of new generation DNA vaccine against microorganism using synthesized DNA\", \"\\u897f\\u30ca\\u30a4\\u30eb\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u30ef\\u30af\\u30c1\\u30f3\\u8a66\\u4f5c\\u3068\\u305d\\u306e\\u8a55\\u4fa1\", \"Development of mucosal vaccines for prevention of prevention of respiratory infectious diseases\", \"\\u514d\\u75ab\\u8abf\\u7bc0\\u907a\\u4f1d\\u5b50\\u3068\\u306e\\u30d5\\u30e5\\u30fc\\u30b8\\u30e7\\u30f3DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u7d30\\u80de\\u5185\\u5bc4\\u751f\\u539f\\u866b\\u611f\\u67d3\\u5236\\u5fa1\\u306e\\u65b0\\u6226\\u7565\", \"\\u4e8c\\u672c\\u9396RNA\\u3092\\u7528\\u3044\\u305f\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u4f75\\u7528\\u7d4c\\u9f3b\\u4e0d\\u6d3b\\u5316\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Immunopotentiation by immunoadjuvants of human viral vaccines\", \"Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)\", \"Assay Work for Influenza Vaccines - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Phase 1 Malaria Vaccine Trial  - VTEU\", \"Assay Work for Yellow Fever Vaccines - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Phase I Malaria Vaccine Clinical Trial - VTEU\", \"Assay Work for Plague Vaccines - VTEU\", \"Assay Work for Herpes Vaccines - VTEU\", \"Assay Work for Influenza Vaccines - VTEU\", \"Assay Work for TB Vaccines - VTEU\", \"Assay Work for Malaria Vaccines - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Phase I Trial of Tuberculosis Vaccine - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Phase I Malaria Vaccine Study - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Respiratory Syncytial Virus: Diagnostic and Vaccine Assays  - VTEU\", \"Assay Work for Yellow Fever Vaccines - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Phase I Trial of Filovirus Vaccine  - VTEU\", \"Assay Work for Malaria Vaccines - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Vaccine and Treatment Evaluation Unit\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine Treatment and Evaluation Unit\", \"Vaccine and Treatment Evaluation Unit\", \"IGF::OT::IGF TESTING OF COMBINATION IMMUNO AND CHEMOPREVENTION STRATEGIES FOR LYNCH SYNDROME GASTROINTESTINAL CANCER\", \"Zika: a safe recombinant vaccine with proof of efficacy in rodents\", \"\\u6297\\u52a8\\u8109\\u7ca5\\u6837\\u786c\\u5316DNA\\u75ab\\u82d7/\\u58f3\\u805a\\u7cd6\\u7eb3\\u7c73\\u7c92\\u9f3b\\u8154\\u7ed9\\u836f\\u7684\\u7814\\u7a76\", \"\\u6c49\\u5766\\u75c5\\u6bd2\\u706d\\u6d3b\\u75ab\\u82d7\\u7ecf\\u547c\\u5438\\u9053\\u7c98\\u819c\\u514d\\u75ab\\u7684\\u7814\\u7a76\", \"\\u7eb3\\u7c73\\u7c92\\u5b50\\u4f5c\\u4e3a\\u8840\\u5438\\u866b\\u75c5\\u75ab\\u82d7\\u4f50\\u5242\\u7684\\u5e94\\u7528\\u7814\\u7a76\", \"Yuji Sato | National Institutes of Health - Jap\\u00e3o\", \"Produ\\u00e7\\u00e3o de vacina de DNA recombinante para o v\\u00edrus dengue-3\", \"Vacinas conjugadas: da bancada para escala piloto - 2\", \"Development of an innovative sub-unit vaccine against toxoplasmosis\", \"STAGED VACCINE DEVELOPMENT: IMMUNOPROPHYLAXIS BY GENE TRANSFER\", \"Development of Inulin Acetate-Based Adjuvant\", \"Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)\", \"Vaccine and Treatment Evaluation Units\", \"Respiratory Syncytial Virus: Diagnostic and Vaccine Assays  - VTEU\", \"Vaccine and Treatment Evaluation Units\", \"Phase 1 Malaria Vaccine Trial  - VTEU\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Phase I Trial of Tuberculosis Vaccine - VTEU\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Respiratory Syncytial Virus: Diagnostic and Vaccine Assays  - VTEU\", \"Phase IIb Pneumococcal Conjugate Vaccine Trial - VTEU\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Safety and Immunogenicity of Shigella Vaccines - VTEU\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Unit\", \"PROSTAGLANDIN PRODUCTION DURING ORTHOPOXVIRUS INFECTIONS\", \"DEVELOPMENT OF IMPROVED VACCINES AGAINST AVIAN PATHOGENS AND POULTRY BORNE FOOD SAFETY TARGETS\", \"Establishment, Strategy and Initial activities of the TuBerculosis Vaccine Initiative : Coordination of European efforts with global research initiatives\", \"An Integrated project for the design and testing of vaccine candidates against tuberculosis: Identification, development and clinical studies\", \"A european malaria vaccine development consortium: euromalvac 1\", \"European Vaccine against AIDS: Centralised facility\", \"New methods for the chemical synthesis of a library of glycopeptide-based tri-component cancer vaccines\", \"Targeting neutralizing epitopes in the MPER of HIV Env\", \"DEVELOPMENT OF DETOXIFIED PERTUSSIS TOXIN FOR ACELLULAR WHOOPING COUGH VACCINE\", \"Vaccinia-based Smallpox Vaccine Safety\", \"Malaria Vaccine:  AMA1-C2\", \"HIV Vaccine Research and Development\", \"HIV Vaccine Research and Development\", \"Enhanced Surveillance for New Vaccine Preventable Disease\", \"Enhanced Surveillance-Newly Vaccine Preventable Diseases\", \"Self-administered microneedle patches for influenza vaccines\", \"Pandemic influenza DNA vaccine Development\", \"Comparative Study of Influenza Vaccines in Adults\", \"A Novel Cassette System for the Assembly of VLP Vaccines\", \"An Adenoviral-Based Mucosal Vaccine for AIDS\", \"Combined TNFSF and TLR stimulation of HIV vaccines\", \"Efficacy of soybean-based vaccines using a model antigen\", \"Animal models to design &evaluate improved VZV vaccines\", \"NEW LIVE VIRAL VECTORS AS CANDIDATE AIDS VACCINES\", \"Task 13/C26: Influenza Challenge Models and Assays for Influenza Vaccines\", \"Vaccine and Treatment Evaluation Units (VTEUs)\", \"Human methamphetamine vaccine:  Translational Avante Garde Award\", \"Assessing Safety of Cell Substrates and Vaccine Components\", \"Evaluation of Anti-Poliovirus Drugs and Vaccines\", \"Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)\", \"Development of a Nanoemulsion Adjuvant with a Vaccine for Pandemic Influenza\", \"VACCINE AND TREATMENT EVALUATION UNITS (VTEUS)\", \"Novel Innate Immune Adjuvant for Avian Influenza and West Nile Virus Vaccines\", \"VACCINE AND TREATMENT EVALUATION UNITS (VTEUS)\", \"Development of Adjuvant with Vaccines for Tuberculosis and Shigellosis\", \"VACCINE AND TREATMENT EVALUATION UNITS (VTEU)\", \"VACCINE TREATMENT AND EVALUATION UNITS (VTEU)\", \"VACCINE AND TREATMENT EVALUATION UNITS (VTEU)\", \"Vaccine and Treatment Evaluation Units (VTEUs)\", \"Vaccine and Treatment Evaluation Units (VTEUs)\", \"VACCINE AND TREATMENT EVALUATION UNITS (VTEU)\", \"VACCINE TREATMENT EVALUATION UNITS (VTEUS)\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"THERAPEUTIC IMMUNIZATION AGAINST HIV WITH ADJUVANT-ENHANCED DNA AND MULTI-EPITOP\", \"THERAPEUTIC IMMUNIZATION AGAINST HIV WITH ADJUVANT-ENHANCED DNA AND MULTI-EPITOP\", \"THERAPEUTIC IMMUNIZATION AGAINST HIV WITH ADJUVANT-ENHANCED DNA AND MULTI-EPITOP\", \"THERAPEUTIC IMMUNIZATION AGAINST HIV WITH ADJUVANT-ENHANCED DNA AND MULTI-EPITOP\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE TREATMENT EVALUATION UNITS\", \"VACCINE TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Unit\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Unit\", \"SBIR TOPIC 255, PHASE II: SYNTHETIC VACCINES AGAINST PROSTATE CANCER\", \"Colloquium on protecting public trust in immunization -- 2007\", \"Development of a Flexible, Live Tetravalent Dengue Vaccine\", \"Imaging Immunotherapy Development of MRI Probes for In Vivo Tracking of Cell-based Therapies\", \"Molecular Epidemiology and Surveillance Network For Human Papillomavirus in Manitoba Women - a Pilot Study\", \"Development of novel recombinant BCG expressing ESAT-6 that activatesNLRP3, to increase vaccine efficacy against pulmonary andlatent TB infection\", \"Development and evaluation of DIVA-based vaccine utilizing an Indian isolate of classical swine fever virus.\", \"Sub viral particle based Infectious bursal disease vaccine: a way forward towards translation from lab to land\", \"Understanding the immune mechanism of host disease and development of marker vaccines and DIVA test for Peste des Petits ruminants\", \"Development of recombinant BCG vaccine and complimentary diagnostics for TB control in cattle\", \"Development of recombinant antigen based diagnostics and chimeric plant virus-like particle based vaccine for infectious bursal disease virus\", \"Development of novel nanoparticle based hepatitis B (HBV) vaccine with enhanced antigen presentation and prolonged immunity\", \"Development of virus-like particle (VLP) of Japanese encephalitis virus as a potential vaccine candidate\", \"Development of recombinant sheep pox vectored Peste des petits ruminants (PPR) vaccine for small ruminants\", \"Proof of concept studies on FMDV genetics vaccines targeted to antigen presenting cells in guinea pigs\", \"Genetic characterisation of variability in immune responses of sheep and goat for PPR and ET vaccine elicited immune response\", \"Develop a receptor blocking malaria vaccine against Plasmodium falciparum based on a novel combination of three blood stage antigens (PfAARP + PfRH2 + PfF2)\", \"\\\"Establishing immunological correlates of protection against malaria vaccine candidate using functional bio-assays and Proteomic deciphering of Host-Parasite Interactions\\\"\", \"Development of nanodelivery system of DNA based RNAi vaccine against WSSV in tiger shrimp, Peneaus monodon\", \"DEVELOPMENT OF SMALL PEPTIDE BASED NANOSTRUCTURES AS VEHICLES FOR TUMOR SPECIFIC DRUG AND THERAPEUTIC VACCINE DELIVERY\", \"Development of Contraceptive Vaccine and Novel Delivery Strategies for Wildlife with Special Reference to Street Dog Population Management\", \"Development and pre-clinical studies on safety and immunogenicity of novel candidate vaccines against Salmonella enterica serovar Typhi and Paratyphi\", \"Chemoenzymatic assembly of defined protein dendrimers for vaccine use: Immunogenicity and protective efficacy of multivalent PspA constructs from Streptococcus pneumoniae\", \"Characterization of Plasmodium falciparum merozoite surface complex for the development of a multicomponent subunit vaccine\", \"\\\"Mapping of the Resource Requirements for Basic Science and Biomedical Research for Development of Drugs, Diagnostics, Vaccines, Implants and Devices\\\"\", \"Experimental studies on therapy of cancers expressing hCG / hCG\\u00df with a recombinant highly immunogenic vaccine against hCG\", \"Generation of an improved Newcastle disease virus vaccine candidate using a novel reverse genetics technology\", \"Functional Characterization of genes in Leishmania Parasites by RNAi Technology for Drug Discovery and Vaccine Development.\", \"Functional characterization of the role of the Plasmodium falciparum reticulocyte homology proteins, in erythrocyte invasion and their evaluation as potential vaccine candidates\", \"Development of Standardization and field evaluation of thermostable newcastlle disease vaccine strains for use in village chicken.\", \"Multiple antigen peptide approach (MAP) incorporating B-T constructs of F1 and V antigens of Y. pestis in nanoparticles for plague vaccine.\", \"Vitamin D supplementation to improve immune responses to vaccines administered in early infancy- The NutriVac - D Trial\", \"Recovery of infectious chandipura Virus Entirely from cDNA clones and its application in vaccine development\", \"Isolation and characterization of animal adenoviruses for development of a novel viral vector for vaccine delivery\", \"rBCG85C- a candidate TB vaccine: Removal of antibiotic resistance marker, modifications for stabilization of antigen expression and efficacy studies\", \"Development and characterization of Autologous NKT cell based dendritic cell Vaccine for Active Specific Immunotherapy of oral squamous cell carcinoma\", \"A Randomise control Trail of recombinant live oral Cholera Vaccine in Estern Kolkata using cGMP grade material\", \"Design and testing of a CD40 ligand adjuvanted HIV virus-like particle (VLP) as a candidate vaccine against HIV/AIDS\", \"Construction of genomic library of Leptospira interrogans serovar Autumnalis for the identification of immunogenic proteins and development DNA Vaccine\", \"Development of liposome-encapsulated recombinant DNA/protein vaccine(s) for H5N1 and other Influenza viruses\", \"Construction and Characterization of Genetically Engineered Chimeric HIV-1 Envelope Protein Modulating Virus Neutralization: Implication and Relevance in Vaccine development.\", \"Improved immunogenecity of enterovirus antigen by use of microparticles carriers- a proof principle study for development of multivalent enterovirus vaccine.\", \"Rational Development of an effective Vaccine for the prevention of Staphylococcal Mastitis in bovines using mouse mastitis as a model system\", \"Development of blood-stage vaccines for Plasmodium falciparum malaria based on the EBA and PfRH proteins\", \"Development of oral vaccine against Clostridium perfringens employing translation fusion of immunodominant epitopes of beta toxin with heat table labile enterotoxin B\", \"Development of a novel marker vaccine for Bovine Herpesvirus-I(BHV-1) and companion diagnostic test.\", \"Designing heat stable lasota vaccine using vacuum foam drying for efficient treatment of new castle disease.\", \"Maximalisatie van het anti-tumoraal potentieel van next-generation dendritische celvaccins door combinatie van interleukine-15 en in situ neutralisatie van geprogrammeerde celdoodliganden\", \"Onderzoek naar het werkingsmechanisme van een nieuw vaccin tegen het respiratoir syncytieel virus op basis van het ectodomein van het \\\"small hydrophobic protein\\\".\", \"Optimalisering van tuberculose DNA vaccins koderend voor een trehalosemycolyl-transferase (Ag85A) en voor een fosfaat transport receptor (PstS-3) van Mycobacterium tuberculosis.\", \"Analyse van de immunogeniciteit en het protektief vermogen van DNA vaccins tegen M. ulcerans infectie (Buruli Ulcer) in muizen en cavia's.\", \"Towards a \\u201cnegative\\u201d cellular vaccine for the treatment of multiple sclerosis: counter-acting epitope spreading for long-lasting tolerance induction using mRNA-electroporated tolerogenic dendritic cells.\", \"Verbetering van de T cel stimulatoire capaciteit van immature dendritische cellen met als doel de ontwikkeling van een potent anti-tumor vaccin: de TriMix methodologie.\", \"Respiratory mucosal immunization with a novel simian adenovirus-based vaccine against tuberculosis: Overcoming pre-existing anti-human adenovirus type 5 immunity\", \"Layer-by-Layer Multiple Antigen Nano-delivery Platform for Malaria Vaccine\", \"To fund participants from LMIC's to attend a three-day workshop that will explore the critical issues at each stage of vaccine development\", \"\\u65b0\\u578b\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u5bf9\\u7ed3\\u6838\\u75c5\\u9884\\u9632\\u4f5c\\u7528\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u75d8\\u82d7\\u75c5\\u6bd2\\u7624\\u82d7\\u514d\\u75ab\\u6709\\u6548\\u6297\\u539f\\u6210\\u5206\\u7684\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"\\u51cf\\u6bd2\\u6c99\\u95e8\\u6c0f\\u83cc\\u4f20\\u9012\\u7684\\u57fa\\u4e8e\\u5fae\\u57fa\\u56e0\\u4e0eAIDA-1\\u81ea\\u8f6c\\u8fd0\\u86cb\\u767d\\u7684\\u65b0\\u578b\\u80bf\\u7624\\u75ab\\u82d7\", \"\\u9c7c\\u7c7b\\u8679\\u5f69\\u75c5\\u6bd2\\u65b0\\u578b\\u75ab\\u82d7\\u7814\\u53d1\\u548c\\u673a\\u5236\\u63a2\\u8ba8\", \"\\u8fdb\\u4e00\\u6b65\\u7814\\u7a76\\u6297\\u6d41\\u611f\\u75c5\\u6bd2TH DDV\\u514d\\u75ab\\u7b56\\u7565\\u7684\\u5e7f\\u8c31\\u6027\\u548c\\u4fdd\\u62a4\\u673a\\u5236\", \"\\u5229\\u7528\\u5e72\\u6270\\u7d20\\u654f\\u611f\\u75ab\\u82d7\\u75c5\\u6bd2\\u91cd\\u7ec4\\u7cfb\\u7edf\\u5bf9A\\u578b\\u6d41\\u611f\\u75c5\\u6bd2H5N1 NS1\\u86cb\\u767d\\u5728\\u9003\\u907f\\u5929\\u7136\\u548c\\u83b7\\u5f97\\u6027\\u514d\\u75ab\\u4e2d\\u4f5c\\u7528\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u4f20\\u67d3\\u6027\\u6cd5\\u6c0f\\u56ca\\u75c5\\u591a\\u8868\\u4f4d\\u75ab\\u82d7\\u5206\\u5b50\\u8bbe\\u8ba1\\u53ca\\u5176\\u514d\\u75ab\\u6548\\u5e94\\u7684\\u7814\\u7a76\", \"\\u4ee5\\u7eb3\\u7c73\\u7c92\\u5b50\\u4e3a\\u4f50\\u5242\\u7684\\u5c4b\\u5c18\\u87a8\\u75ab\\u82d7\\u514d\\u75ab\\u6cbb\\u7597\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u6838\\u9178\\u75ab\\u82d7pcDNA3-\\u03b3anxB1\\u8bf1\\u5bfc\\u732a\\u56ca\\u5c3e\\u86b4\\u7ec6\\u80de\\u51cb\\u4ea1\\u7684\\u673a\\u7406\", \"\\u6d41\\u611f\\u75c5\\u6bd2\\u8840\\u51dd\\u7d20\\u548c\\u795e\\u7ecf\\u6c28\\u9178\\u9176\\u57fa\\u56e0\\u6297\\u6d41\\u611f\\u5173\\u952e\\u5e8f\\u5217\\u89e3\\u6790\", \"\\u91cd\\u7ec4\\u6838\\u5c0f\\u4f53\\u901a\\u7528\\u6027Th\\u7ec6\\u80de\\u8868\\u4f4d\\u8bf1\\u5bfcSLE\\u53e3\\u670d\\u8010\\u53d7\\u7684\\u7814\\u7a76\", \"\\u5e94\\u7528\\u65b0\\u578b\\u80bf\\u7624\\u6d3b\\u75ab\\u82d7\\u6cbb\\u7597\\u5927\\u9f20\\u8bf1\\u53d1\\u6027\\u5375\\u5de2\\u764c\\u5b9e\\u9a8c\\u7814\\u7a76\", \"Vaccination against Rhodococcus equi pneumonia of foals.\", \"Ear Tip Necrosis in Swine\", \"Enhacning immunity to avian influenza viruses\", \"Kooperation mit Brasilien - Entwicklung einer T.Cruzi-Vaccine und deren Pr\\u00fcfung auf Wirksamkeit in Tiermodellen unter besonderer Ber\\u00fccksichtigung sicherheitspharmakologischer Bestimmungen\", \"Entwicklung neuer und Verbesserung bestehender Diagnostik-Methoden zum Nachweis des Koi-Herpesvirus (KHV) sowie Entwicklung und Etablierung eines wirksamen Impfstoffes\", \"Entwicklung neuer und Verbesserung bestehender Diagnostik-Methoden zum Nachweis des Koi-Herpesvirus (KHV) sowie Entwicklung und Etablierung eines wirksamen Impfstoffes\", \"Entwicklung neuer und Verbesserung bestehender Diagnostik-Methoden zum Nachweis des Koi-Herpesvirus (KHV) sowie Entwicklung und Etablierung eines wirksamen Impfstoffes\", \"Untersuchungen zum mukosalen Immunsystem beim Huhn und seine Reaktion auf Koinfektionen als Basis zur Entwicklung neuer Impfstoffstrategien\", \"Verbundprojekt: Neuartiger Ansatz zur Entwicklung eines heterosubtypischen Marker-Impfstoffs gegen die avi\\u00e4re Influenza in Gefl\\u00fcgel - Teilprojekt 1 (Anschlussprojekt)\", \"Entwicklung eines diagnostischen Systems zur Entdeckung von West-Nile-Virus(WNV)- Infektionen und Entwicklung eines gentechnischen Impfstoffes gegen diese Infektion\", \"Verbundprojekt: Integriertes, patientennahes Verfahren zur Herstellung einer therapeutischen zellul\\u00e4ren Vakzine im geschlossenen System, Teilvorhaben: Gewinnung Kultivierung und Charaktisierung von DC\", \"Verbundprojekt: Nadelfreie Injektion von fl\\u00fcssigen oder pulverf\\u00f6rmigen biomolekularen Arzneimitteln (Bio-Injekt) - Teilvorhaben: Pharmazeutische Technologie und Charakterisierung pulverf\\u00f6rmiger Vakzine\", \"CI3: Realisierung von Software, Planungs- und Steuerungsmodulen f\\u00fcr die beschleunigte automatisierte Herstellung individualisierter MUTANOM-Vakzine (IVAC IT) - Teilvorhaben: Software und Steuerungsmodule f\\u00fcr die GMP Produktion\", \"CI3: Entwicklung individualisierter MUTANOM-Vakzine - From Proof of Concept to Proof of Market (IVAC MUTANOM 2.0) - Teilvorhaben: Individualisierte Immundiagnostik und Leitstruktur\", \"CI3: Herstellung und pr\\u00e4klinische Validierung eines auf chim\\u00e4ren virus-like particles (VLPs) basierenden Impfstoffes zur Tumorvakzinierung, Projektteil Tulip\", \"Analyse der Lokalisation, Orientierung und Interaktion von Proteinen durch Mikroskopie, Toponomics und Bioinformatics zur Identifikation von Wirts-Pathogen-Interaktionen, Resistenztransportern in Trophoblasten und Vakzinkandidaten\", \"Entwicklung eines Biomolek\\u00fcl-Kopierers zur Erzeugung neuartiger Next Generation Mikroarrays - erste Anwendungen f\\u00fcr 10.000 Wirkstoffe, Enzyme und Impfstoffe - BioKopierer\", \"Deutsch-israelische Zusammenarbeit auf dem Gebiet der Aquakultur - Teilprojekt ISR-Aq3: Orale Vakzinierung von Nutzfischen: Verbesserung verschiedener Vakzinen und neue Anwendungsmethoden\", \"EXIST-Forschungstransfer: Entwicklung eines Subunit-Impfstoffes (Totimpfstoff) gegen Malaria basierend auf neu identifizierten Parasitenantigenen aus den Leberstadien der Erreger\", \"Entwicklung einer Chicken Factor freien H\\u00fchnerherde f\\u00fcr wissenschaftlich experimentelle und diagnostische Zwecke sowie zur Impfstoffherstellung\", \"ERA Net EuroTransBio-8: Plurivax: Ausbau und Weiterentwicklung der Enten-Hepatitis VLP(virus like particle) Plattformtechnologie zur Herstellung von Vakzinen f\\u00fcr den Veterin\\u00e4rbereich.\", \"KMU-innovativ-9: Entwicklung eines EliSpot-Testsystems zur Impf\\u00fcberwachung von HPV und Ableitung neuer Impfstoff- und Therapieans\\u00e4tze' ('HPV-EliSpot')\", \"Verbundprojekt: Gentechnologische Bearbeitung des menschenpathogenen Hanta-Virus mit dem Ziel, einen Impfstoff zu entwickeln - Teilvorhaben 2\", \"Verbundprojekt: Gentechnologische Bearbeitung des menschenpathogenen Hanta-Virus mit dem Ziel, einen Impfstoff zu entwickeln - Teilvorhaben 1\", \"Entwicklung eines Produktionsverfahrens f\\u00fcr S- und S/L-Partikel f\\u00fcr die Herstellung eines verbesserten Impfstoffs und Empfindlicher Diagnostikverfahren f\\u00fcr Hepatitis B\", \"ERA-NET PathoGenoMics 3: Diversit\\u00e4t von Helicobacter pylori: Rolle in Pathogenese, Antibiotikaresistenz und der Umgehung nat\\u00fcrlicher und impfstoffinduzierter Immunreaktionen (HELDIVPAT), Teilprojekt Magdeburg\", \"ERA-NET PathoGenoMics 3: Diversit\\u00e4t von Helicobacter pylori: Rolle in Pathogenese, Antibiotikaresistenz und der Umgehung nat\\u00fcrlicher und impfstoffinduzierter Immunreaktionen (HELDIVPAT), Teilprojekt M\\u00fcnchen\", \"ERA-NET PathoGenoMics 3: Diversit\\u00e4t von Helicobacter pylori: Rolle in Pathogenese, Antibiotikaresistenz und der Umgehung nat\\u00fcrlicher und impfstoffinduzierter Immunreaktionen (HELDIVPAT), Teilprojekt Hannover, Josenhans\", \"ERA-NET PathoGenoMics 3: Diversit\\u00e4t von Helicobacter pylori: Rolle in Pathogenese, Antibiotikaresistenz und der Umgehung nat\\u00fcrlicher und impfstoffinduzierter Immunreaktionen (HELDIVPAT), Teilprojekt Hannover, Suerbaum\", \"GO-Bio 3: DENOVO - Entwicklung einer Plattformtechnologie f\\u00fcr das Targeting genetischer Vakzine auf der Basis eines nat\\u00fcrlichen Opsonins\", \"Aufreinigungstechnologie-Verbundprojekt: Einsatz synthetischer Liganden zur Aufreinigung sialins\\u00e4urehaltiger, rekombinanter humaner Proteine und Impfstoff-Antigene, TP 3\", \"Aufreinigungstechnologie-Verbundprojekt: Einsatz synthetischer Liganden zur Aufreinigung sialins\\u00e4urehaltiger, rekombinanter humaner Proteine und Impfstoff-Antigene, TP 2\", \"Aufreinigungstechnologie-Verbundprojekt: Einsatz synthetischer Liganden zur Aufreinigung sialins\\u00e4urehaltiger, rekombinanter humaner Proteine und Impfstoff-Antigene, TP 1\", \"BioProfile Stuttgart/Neckar-Alb: Identifizierung, Selektion und Validierung von Tumor-assoziierten Peptiden von Magenkarzinomen zur Definition eines therapeutischen Impfstoffs auf Basis immunogener Peptid-Epitope\", \"BioChancePLUS: DNAShield, ein leicht adaptierbarer Vakzin-Prototyp mit schnellem Wirkeintritt auf der Grundlage von Antigen-exprimierenden (MIDGE-TH1P) und Antigen-gekoppelten (DNABarrier) DNA-Konstrukten\", \"Verbundprojekt: Entwicklung von Methoden zur Herstellung und Anwendung einer Vakzine zur Behandlung von Humanpapillomvirus-assoziiertem Zervixkarzinom\", \"Entwicklung von Alternativmethoden zur Pr\\u00fcfung von Clostridiumimpfstoffen - Teilprojekt 2: Abl\\u00f6sung von Tierversuchen bei der Chargenpr\\u00fcfung (DAB 10)\", \"Verbundprojekt: Ersatz des Neurovirulenztests an S\\u00e4ugetieren zur Sicherheitspr\\u00fcfung von Polioimpfviruschargen. Teilprojekt 2: Etablierung nichtradioaktiver Detektionsmethoden.\", \"Ersatz von Tierversuchen bei der Wirksamkeitspr\\u00fcfung von Clostridien-Immunpr\\u00e4paraten - Teilprojekt 3: Ersatzmethoden zur Pr\\u00fcfung von Rauschbrand-Impfstoffen\", \"Entwicklung von in vitro-Methoden als Ersatz f\\u00fcr Letalchallengeversuche an Fischen zur Beurteilung von Vakzinen - Teilprojekt 2: Epitopspezifischer Enzymimmunoassay\", \"Entwicklung von in vitro-Methoden als Ersatz f\\u00fcr Letalchallengeversuche an Fischen zur Beurteilung von Vakzinen - Teilprojekt 1: Lymphozytenproliferationstest\", \"Verbundprojekt: Entwicklung einer neuartigen Behandlungsstrategie von Allergien: zielgerichtete Glycan-Allergen Immuntherapie, Teilprojekt: Impfstoff-Charakterisierung und bioanalytische Methodenentwicklung\", \"Verbundprojekt: Entwicklung eines kosteneffizienten Impfstoffs gegen Zervixkarzinome - ein prophylaktischer Ansatz, Teilprojekt: Entwicklung von gereinigten Antigenen und Evaluierung der Immunogenit\\u00e4t\", \"Lebend-Impfstoffe f\\u00fcr Schleimhautimmunit\\u00e4t: Vergleichsstudien mit Shigella, Salmonella und Streptokokken als Tr\\u00e4gerst\\u00e4mme f\\u00fcr rekombinante Antigene aus Krankheitserregern.\", \"Entwicklung und Erprobung eines konditionalen Immortalisationssystems prim\\u00e4rer humaner Tumorzellen zur Konstruktion gentechnisch modifizierter Tumorzellvakzine\", \"Entwicklung eines konditionalen Immortalisationssystems prim\\u00e4rer humaner Tumorzellen zur Konstruktion gentechnisch modifizierter autologer Tumorzellvakzine\", \"Verbund: Immuntherapie mit genetisch ver\\u00e4nderten Zellen: Einf\\u00fchrung von kostimulatorischen Molek\\u00fclen in frisch isolierte autologe Tumorzellvakzine mittels rekombinanter bifunktioneller Konjugate und Gentransfer\", \"Komplikationen der Organtransplantationen durch Herpesviren: Cytomegalovirus Latenz in der Lunge und Entwicklung einer Vakzine mit rekombinanten inkompletten Viruspartikeln\", \"AIDS-Verbund G\\u00f6ttingen: Austestung Chimaerer, nicht infekti\\u00f6ser Hiv-1 Virus-\\u00e4hnlicher Partikel als Vakzinekandidat im S-Hiv Makakenmodell\", \"Pseudomembranoese Colitis durch Clostridium Difficile Toxine: Isolierung und Charakterisierung von Liganden- und Wirtsstruktur zur Entwicklung einer Vakzine\", \"Verbundprojekt HIVERA VIHDUAVAX: Entwicklung eines neuen HIV-1 Impfstoffs mit bivalenten Eigenschaften durch Kombination von zwei gp41 Epitopen: Neutralisation von HIV-1 und CD4 Zell-Depletion\", \"EDCTP HIV-Vakzine:TaMoVac II - Evaluierung der Sicherheit und der Immunantwort nach HIV-Impfung mit einem DNA-Prime/MVA/gp140-Boost-Ansatz in Mbeya Tansania\", \"Verbundprojekt: Entwicklung und klinische Anwendung von genetisch hergestellten Vakzinen basierend auf dem Tumorartigen Muzin zur Behandlung von Patienten mit Pankreas- oder Mammakarzinomen\", \"Verbundprojekt: Kirgisisch-Deutsche Hepatitis B Initiative - Bildung einer nachhaltigen binationalen Infrastruktur f\\u00fcr epidemiologische und impfungsbezogene Forschung, Teilvorhaben: Twincore\", \"Otitis media, hearing loss and school readiness of Indigenous children followed from birth in two randomised controlled trials of novel pneumococcal conjugate vaccine schedules (VOICES. Vaccines to prevent Otitis media In Children Entering School)\", \"Low-Cost Portable Inhalation Therapy Platform for Needle-Free DNA-Based Influenza Vaccination\", \"Hepatitis C vaccine\", \"The role of capsid protein nucleolar localisation in chikungunya virus: implications for vaccine development\", \"Sytemic and mucosal functional antibodies in protection against HIV\", \"Comparing pneumococcal vaccines in a high risk population: a randomised controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea\", \"Development of a safe live genetically attenuated blood stage malaria vaccine\", \"Multistage vaccines for the prevention of tuberculosis\", \"Artificial synthesis of the type III secretion system translocon. A new approach to vaccine design\", \"Monitoring the gap between evidence and vaccination behaviour by sampling the location-specific consumption of health information from news and social media\", \"For research on teens' knowledge of & sources for information about abstinence, contraception & STDs & for an article identifying challenges to HPV vaccine rollout, public education & acceptability\", \"Modulation of T effector memory (TEM) vs T Central Memory (TCM) ratio for the immunotherapy and vaccine strategy for Tuberculosis.\", \"HPV Knowledge & HPV Vaccine Update Among US Navy Personnel 18-26 Years Old\", \"Characterization of the GRP 170 Peptide Binding Protein in Murine and Patients' Tumors and Its Use in the Development of New Breast Cancer Vaccines\", \"Layer by Layer Multiple Antigen Nano-delivery Platform for Malaria Vaccine\", \"Antigen and genome characterization of viral nervous necrosis virus (VNNV) of fish for development of diagnostics and vaccine\", \"Development of a Novel Anthrax-Subunit Vaccine Based on Protective Antigens of Bacillus Anthracis and the Innate Immunity Agonist FliC Flagellin of Salmonella\", \"Evaluating the Current Immune Status of Subjects Against Lymphatic Filariasis Infection in India and Assessing the Need for a Prophylactic Vaccine\", \"A Novel Policy to Improve Vaccine Coverage of Health Care Workers in New South Wales, Australia: Process and Impact Evaluation\", \"Sequencing of commercially available MMR vaccine virus strains and attenuation of cloned virus genes by site directed mutagenesis.\", \"H2020 Catalyst Award: Profiling \\u2018immune signatures\\u2019 predictive of outcome in Staphylococcus aureus infection: Advancing next generation vaccine design\", \"Detailed analysis of the \\\"helper\\\" and \\\"effector: function by CD4+ T cells in antitumor immunity: relevance to the design of therapeutic vaccines for cancer\", \"Dendritic cell targeting of antigens for enhanced immune responses: developing a universal adjuvant vector for theraputics and vaccines.\", \"The impact of publicly funded human papillomavirus (HPV) vaccination on cervical dysplasia: The Ontario Grade 8 HPV vaccine cohort study\", \"Can a modified vaccine reduce the rate of large local reactions to the pre-school booster with DTPa-IPV?\", \"Cancer vaccines targeting the ganglioside tumor-marker GD2\", \"Herpes viruses as Re-activating Vaccine Vectors: Protective Efficacy of a Varicella Zoster-HIV Vaccine in the SIV Macaque model\", \"Defining innovating cancer vaccine based on virus-like particles by targeting multiple antigens\", \"Development of an Implementation Guide for Long Term Care Homes Planning to Use the Ottawa Influenza Vaccine Decision Aid\", \"Structural characterization of the HIV-1 Env trimer as a guide for the development of a vaccine immunogen.\", \"Novel transdermal vaccine delivery\", \"Optimizing H1N1 Vaccination Uptake among Health Care Workers\", \"Viral modulators of inflammation and vascular perturbation\", \"Vaccine adjuvant Co-delivery with food allergen via intestinal mucosa as a novel allergen- specific immunotherpy approach to food allergy\", \"Comrehending the role of mucosal-associated immunity during host pathogen following avibacterium paragallinarum infection in poultry (chicken and japanese quail) for development a futristic mucosal vaccine\", \"Investigation and characterization of protective immune responses generated against novel vaccine candidates isolated from non- albicans Candida species in murine systemic candidiasis.\", \"Application of DNA vaccines to the clinic: a phase II study of idiotypic vaccination for follicle centre lymphoma. Pilot studies in myeloma and CLL\", \"APPLICATION OF DNA VACCINES TO THE CLINIC: A PHASE II STUDY OF IDIOTYPIC VACCINATION FOR FOLLICLE CENTRE LYMPHOMA. PRE-PROTOCOL STUDIES IN MYLEOMA AND CLL\", \"Disialyl Neu5Ac\\u02512-3Gal\\u03b21-3[Neu5Ac\\u02512-6]GalNAc-R\\uc758 \\uc554\\ud56d\\uc6d0, \\uc554\\uc9c4\\ub2e8 \\ubc0f \\uc554\\ubc31\\uc2e0 \\ub2f9\\uc0ac\\uc2ac\\ud654\\ud569\\ubb3c \\uac1c\\ubc1c\\uc744 \\uc704\\ud55c \\uc735\\ud569\\uacfc\\ud559\\uc5f0\\uad6c\", \"\\uccb4\\ub0b4 \\uc554\\uc138\\ud3ec \\uc720\\ub3c4\\ub97c \\ud1b5\\ud574 \\uc2e4\\uc2dc\\uac04 \\uc554\\ud2b9\\uc774\\ud56d\\uc6d0\\uc758 \\uc0dd\\uc131\\uc774 \\uac00\\ub2a5\\ud55c 3\\ucc28\\uc6d0 \\uc2a4\\uce90\\ud3f4\\ub4dc \\uae30\\ubc18 All-in-One \\uc554\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc2e0\\uac1c\\ub150 delivery system\\uacfc Secretory \\ubc1c\\ud604 vector\\ub97c \\uc774\\uc6a9\\ud55c \\uc0b4\\ubaa8\\ub12c\\ub77c\\uade0\\uc99d \\ubc0f \\ubcd1\\uc6d0\\uc131 \\ub300\\uc7a5\\uade0\\uc99d \\uc608\\ubc29\\uc758 \\ub3d9\\uc2dc\\ub2e4\\uac00\\uc608\\ubc29\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc5ec\\ub4dc\\ub984 \\uce58\\ub8cc\\uc81c \\uac1c\\ubc1c\\uacfc \\uad00\\ub828\\ud558\\uc5ec \\uc5ec\\ub4dc\\ub984 \\uc804 \\uc784\\uc0c1 \\ub9c8\\uc6b0\\uc2a4 \\ubaa8\\ub378 \\uac1c\\ubc1c \\ubc0f \\ub9c8\\uc6b0\\uc2a4\\uc5d0\\uc11c P. acnes \\uae30\\ubc18 \\ubd88\\ud65c\\uc131\\ud654 \\ubc31\\uc2e0 \\ud6a8\\uacfc\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"\\uc6d0\\uc608\\ucc44\\uc18c\\uae30\\ubc18 \\ud56d\\uc6d0 \\uc735\\ud569\\ubc31\\uc2e0\\ub2e8\\ubc31\\uc9c8 \\uac70\\ub300\\ubd84\\uc790 \\uad6c\\uc870\\uac1c\\uc120 \\ubc0f \\ubc1c\\ud604\\uc2dc\\uc2a4\\ud15c \\uad6c\\ucd95\\uc744 \\ud1b5\\ud55c \\uc804\\ub9bd\\uc120 \\uc554 \\uc608\\ubc29 \\ubc0f \\uce58\\ub8cc \\ud6a8\\uacfc \\uadf9\\ub300\\ud654 \\uae30\\uc220\\uac1c\\ubc1c\", \"\\ub385\\uae30 \\uba74\\uc5ed\\ubcf5\\ud569\\uccb4\\uc758 \\uace0\\ubc1c\\ud604 \\uc2dd\\ubb3c\\uccb4 \\ud655\\ubcf4 \\ubc0f \\ub3d9\\ubb3c\\uc2e4\\ud5d8\\uc744 \\ud1b5\\ud55c 4\\uac00 \\ub385\\uae30\\ubc31\\uc2e0 \\ud6c4\\ubcf4\\ubb3c\\uc9c8\\uc758 \\ubc29\\uc5b4\\ub2a5\\ub825 \\uac80\\uc815\", \"\\ub9cc\\uc131 C\\ud615 \\uac04\\uc5fc\\uc5d0 \\ub300\\ud55c HCV DNA vaccine\\uacfc sPD-1-Fc\\uc758 \\uce58\\ub8cc \\ud6a8\\ub2a5 \\ubc0f \\uadf8 \\uc791\\uc6a9 \\uae30\\uc791\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"Metabolomics profiling\\uc744 \\uc774\\uc6a9\\ud55c \\uc5b4\\ub958 \\uba74\\uc5ed\\ubc18\\uc751 \\ud45c\\uc9c0\\uc778\\uc790 \\uac1c\\ubc1c \\ubc0f \\ud574\\uc0b0\\uc2dd\\ubb3c\\uc720\\ub798\\ub85c\\ubd80\\ud130  \\ub119\\uce58 \\ubd88\\ud65c\\ud654 \\ubc31\\uc2e0\\uc758 ajuvant \\uac1c\\ubc1c\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"\\uac00\\ucd95 \\uc218\\uc778\\uc131 \\uc9c8\\ubcd1 \\uc608\\ubc29\\uc744 \\uc704\\ud55c \\ub2e4\\uae30\\ub2a5\\uc131 \\uace0\\ubd84\\uc790 \\ubbf8\\ub9bd\\uc790 \\ubc0f \\uc720\\uc0b0\\uade0\\uccb4\\ub97c \\uc774\\uc6a9\\ud55c \\ubcf5\\ud569 \\uacbd\\uad6c\\ubc31\\uc2e0 \\uc804\\ub2ec \\uc2dc\\uc2a4\\ud15c\\uc758 \\uac1c\\ubc1c \\ubc0f \\ud3c9\\uac00\", \"A comparison study of humoral and cellular immune responses in very young infants after intradermal versus intramuscular injection of influenza vaccine\", \"Efficacy of recombinant Epstein-Barr virus (EBV) vaccine in patients with nasopharyngeal cancer who had residual EBV DNA load after conventional therapy\", \"EFFECTIVENESS OF ROTAVIRUS VACCINE IN HONG KONG CHILDREN\", \"Ocena aktywno\\u015bci przeciwnowotworowej chemioimmunoterapii z udzia\\u0142em nanokoniugat\\u00f3w metotreksatu oraz szczepionek na bazie kom\\u00f3rek dendrytycznych z wyciszon\\u0105 ekspresj\\u0105 receptora IL-10\", \"To use mathematical modelling to evaluate the added-value of a schistosomiasis vaccine to current Mass Drug Administration approaches and identify optimal delivery systems\", \"To support the 2018 Sabin Gold Medal Award which recognizes individuals who have helped to reduce needless human suffering from vaccine-preventable and neglected tropical diseases\", \"To evaluate nasopharyngeal carriage in children with pneumonia 4 years post introduction of pneumococcal conjugate vaccine vaccination to determine herd impact on unimmunized\", \"To convene an international conference to discuss and share broadly the latest HIV vaccine, microbicide, and ARV-based prevention research\", \"\\u65b0\\u578b\\u5e7d\\u95e8\\u87ba\\u6746\\u83cc\\u591a\\u80bd\\u7eb3\\u7c73\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u4fdd\\u62a4\\u6548\\u5e94\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u54ee\\u5598\\u75ab\\u82d7\\u91cd\\u7ec4BCG\\u4e0e\\u80a0\\u9053\\u9ecf\\u819c\\u7ec6\\u80de\\u76f8\\u4e92\\u4f5c\\u7528\\u7684\\u4fe1\\u53f7\\u4f20\\u5bfc\", \"Vaccine and Treatment Evaluation Unit: Phase I Malaria Vaccine Study\", \"Vaccine and Treatment Evaluation Unit: Phase I Trial of Filovirus Vaccine\", \"Vaccine and Treatment Evaluation Unit: Assay Work for Yellow Fever Vaccines\", \"VACCINE AND EVALUTION TREATMENT UNITS:PHASE I CLINICAL TRIAL OF A HPV VACCINE CANDIDATE\", \"VACCINE AND EVALUTION TREATMENT UNITS:PHASE I CLINICAL TRIAL OF A NOROVIRUS VACCINE CANDIDATE\", \"VACCINE AND TREATMENT EVALUATION UNITS: Phase I Clinical Trial to Evaluate an E. Coli Vaccine\", \"Vaccine and Treatment Evaluation Unit: Phase I Trial of a Yellow Fever Virus Vaccine\", \"Vaccine and Treatment Evaluation Unit: Malaria Vaccine Development\", \"Vaccine and Treatment Evaluation Unit: Phase I Trial of a Yellow Fever Virus Vaccine\", \"Development of Infectious Bursal Disease Virus (IBDV) Vaccines for the Poultry Industries in Hong Kong and Southern China\", \"Development of Robust, Scaleable and Cost Effective Technologies for the Large-scale Production of Plasmid DNA for Therapy or Vaccine\", \"Development of Robust, Scaleable and Cost Effective Technologies for the Large-scale Production of Plasmid DNA for Therapy or Vaccine\", \"Development of Robust, Scaleable and Cost Effective Technologies for the Large-scale Production of Plasmid DNA for Therapy or Vaccine\", \"The use of the ex vivo placental perfusion model to study placental malaria vaccine efficacy and the biology of parasite sequestration\", \"Secreted HSP Vaccine for Malaria Prophylaxis\", \"Secreted HSP Vaccine for Malaria Prophylaxis\", \"Malaria Vaccine Development-Rapid T Cell Antigen Discovery Using Human T Cell Screens of a P. falciparum Proteomic Library\", \"Eurostarsproject, New-Vac, 5934, Isconova AB, New vaccines against intracellular pathogens in salmom\", \"Dry formulation of vaccine\", \"RECOMBINANT SUBUNIT VACCINE AGAINST PISCINE FRANCISELLOSIS\", \"The development of an in vitro inactivation test for Rabies vaccine using reverse transcriptase polymerase chain\", \"Social science study to accompany the Badger Vaccine Deployment\", \"The development of animal models to test candidate vaccines for M. bovis infection in badgers\", \"Development of vaccine candidates for protection of badgers against infection with Mycobacterium bovis\", \"Preclinical development of candidate Zika virus vaccines using mouse models\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u63a5\\u7a2e\\u653f\\u7b56\\u5909\\u66f4\\u306b\\u4f34\\u3046\\u533b\\u7642\\u7d4c\\u6e08\\u5b66\\u7684\\u52b9\\u679c\\u306e\\u89e3\\u660e\", \"\\u674e\\u65af\\u7279\\u83cc\\u8f7d\\u4f53\\u5728\\u589e\\u5f3a\\u4e19\\u578b\\u809d\\u708e\\u75c5\\u6bd2\\u91cd\\u7ec4\\u591a\\u8868\\u4f4d\\u6811\\u7a81\\u7ec6\\u80de\\u75ab\\u82d7\\u4e2d\\u7684\\u4f5c\\u7528\", \"\\u57fa\\u4e8e\\u91cd\\u7ec4MS2\\u566c\\u83cc\\u4f53\\u6837\\u9897\\u7c92\\u7684\\u80bf\\u7624RNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"VP22\\u589e\\u5f3a\\u94dc\\u7eff\\u5047\\u5355\\u80de\\u83ccDNA\\u75ab\\u82d7\\u514d\\u75ab\\u6548\\u529b\\u7684\\u8bc4\\u4ef7\", \"\\u77f3\\u6591\\u9c7c\\u7279\\u5f02\\u6027CpG ODN\\u7684\\u7b5b\\u9009\\u53ca\\u5176\\u4f5c\\u4e3aSGIV\\u75ab\\u82d7\\u4f50\\u5242\\u7684\\u7814\\u7a76\", \"\\u6162\\u6027\\u4e59\\u809d\\u65b0\\u578b\\u53ef\\u590d\\u5236\\u578bDNA\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u589e\\u6548\\u7b56\\u7565\\u7814\\u7a76\", \"Characterisation of the Group A Streptococcus M-like proteins and their potential as vaccine antigens\", \"PRECLINICAL PoC OF MULTIVALENT VACCINE AGENTS & TECHNOLOGY PLATFORM\", \"Mykorhizn\\u00ed technologie pro trvale udr\\u017eitelnou zem\\u011bd\\u011blskou produkci ovocn\\u00fdch plodin (MYCOTAGRIF)\", \"Prevalence HPV infekc\\u00ed ve vakcinovan\\u00e9 populaci \\u017een \\u010cR\", \"To develop a measles and rubella vaccine microarray patch that meets the preferred product characteristics and contributes to global measles and rubella elimination\", \"To develop monoclonal antibodies to all pneumococcal serotypes and have a repository so that these can be used in future vaccine development\", \"LA VACCINAZIONE ANTINFLUENZALE IN ETA\\u00e2   PEDIATRICA COPERTURA VACCINALE NEI BAMBINI CON MALATTIA CRONICA E IN QUELLI SANI ED EFFICACIA DEL VACCINO DURANTE IL PERIODO EPIDEMICO\", \"\\u65b0\\u80bf\\u7624\\u6297\\u539f\\u4eba\\u5de5\\u8868\\u4f4d\\u80bdSurvivin\\u5e8f\\u5217\\u7684\\u53d1\\u73b0\\u53ca\\u5176\\u7eb3\\u7c73\\u75ab\\u82d7\\u8054\\u5408IFN-\\u03b3\\u9776\\u5411\\u8111\\u80bf\\u7624\\u5e72\\u7ec6\\u80de\\u6cbb\\u7597\\u7814\\u7a76\", \"Development of customizable attenuated and vector vaccines to protect against porcine reproductive and respiratory syndrome (PRRS), essential for a successful treatment\", \"BIOVACSAFE ? Biomarkers for enhanced vaccine safety\", \"Selection of Mycoplasma mycoides subsp. mycoides candidate vaccine molecules through identification of monoclonal antibodies that inhibit pathogen-host cell adhesion\", \"Pneumococcal conjugate vaccine (PCV) schedules for the Northern Territory (NT): randomised controlled trial of booster vaccines to broaden and strengthen protection from invasive and mucosal infections.\", \"A dual antigen synthetic peptide subunit vaccine approach to prevent streptococcal associated cardiovascular disease\", \"Improving subunit vaccines against tuberculosis for pulmonary delivery\", \"Mucosal vaccine for Hendra virus\", \"New candidate vaccines to prevent tuberculosis: preclinical assessment of efficacy, safety and mechanism of protection\", \"A multi-protein vaccine targeting the oral pathogens associated with chronic periodontitis\", \"RV3 rotavirus vaccine: developing a neonatal rotavirus vaccine formulation for the global community\", \"A novel Hepatitis B virus genotype in Indigenous Australians: impact on vaccine efficacy and clinical outcomes\", \"A novel paradigm for immunity and vaccine development against group A streptococcus\", \"Research Fellowship\", \"Research Fellowship - Grant ID:637303\", \"Apical membrane proteins as targets for a schistosomiasis vaccine\", \"A new approach to the design and evaluation of T cell vaccines for cancer and infectious disease.\", \"Novel vaccine formulation for immunotherapy of adenocarcinomas\", \"Immunity and pathogenesis in Tropical and Infectious Diseases: Implications for Vaccines and\", \"Application of Protein Microarrays to Develop a Cross-Species Malaria Vaccine\", \"Heterosubtypic T cell-inducing vaccines for influenza in humans\", \"Multiple vector vaccine for hepatitis C virus.\", \"H1N1 Ability of H1N1-09 and seasonal influenza vaccines to reduce symptoms and halt spread of H1N1-09 infection in ferre\", \"To generate data to inform country- and global-level decision-making related to fractional dose inactivated poliovirus vaccine (fIPV) introduction\", \"The impact of the intestinal environment on the immunogenicity of oral vaccines in Zimbabwean infants\", \"Evaluation of the technical & commercial viability of developing an accelerated MERS vaccine\", \"To develop compostable vaccine packaging to diminish the environmental impact of mass vaccination campaigns in developing countries lacking adequate disposal infrastructure.\", \"To create a centralized, comprehensive, integrated and publicly accessible bioinformatics platform that will enable TB drug and vaccine discovery missions\", \"To insure that populations at risk of cholera will benefit from receiving oral cholera vaccine (OCV) in an appropriate and effective manner.\", \"To foster the exploration and innovation needed to identify, develop and deliver the right TB vaccines to those most in need\", \"To create awareness about the need for and challenges facing the research and development of HIV/AIDS vaccines for Africa\", \"To develop a broad-spectrum \\u2018universal\\u2019 vaccine effective against infective sporozoites, disease-causing blood-stages and transmissible sexual stages of most species of human malaria\", \"To conduct initial primate studies that can significantly accelerate the clinical development of a safe, effective AIDS vaccine with activity across clades\", \"To discover biomarkers in blood that can be used to identify individuals at risk of developing active tuberculosis (TB) for priority enrollment into TB vaccine trials\", \"To design and evaluate so-called \\u201cinfinite-epitope\\u201d vaccines for their potential to provide simultaneous and broad protective immunity to the many variant forms of HIV.\", \"To examine a new mechanism that may influence rotavirus vaccine take, and improve our understanding of immunological correlates of protection\", \"To support for the 2015 Sabin Gold Medal Award which recognizes individuals who have helped to reduce needless human suffering from vaccine-preventable and neglected tropical diseases\", \"To develop a novel vector for HIV vaccines based on non-integrating lentivirus vectors that directly target the specialized cells that present antigens to the immune system\", \"To develop an oral HIV vaccine based on Clostridium perfringens to deliver large amounts of antigens to gut-associated lymphoid tissue, a major site of HIV activity\", \"To develop high quality master seed viruses and cell lines that are relevant for foot-and-mouth disease virus vaccine production for East Africa\", \"To identify malaria peptide antigens that present themselves on the surface of infected liver cells for use in the development of new malaria vaccines.\", \"To target T-cells against these ERV antigens. If true, new host-directed vaccines could be developed to eliminate HIV infected cells.\", \"To develop and test a low-cost cellular architecture that can track an individual\\u2019s immunization status, disseminate vaccine-related information, and track at-risk populations.\", \"To introduce and monitor the effects of Haemophilus influenzae type b (Hib) conjugate vaccine in high-risk infant populations in Mali, West Africa\", \"To convene global experts to consider the issues around the design and delivery of effectiveness studies for typhoid conjugate vaccines.\", \"To develop a software-based modeling tool that allows vaccine program managers to analyze all clinical and logistical factors that determine the cost per dose administered.\", \"To apply a new liquid stabilizing technology to create thermostable vaccines that can withstand extremes of temperature and eliminate the need for a cold chain.\", \"To develop a microchip to assess the functioning of single T cells to evaluate HIV-specific T cell response in future HIV vaccine trials\", \"To construct and test a vaccine platform that utilizes low-cost, stable surfactant vesicles to deliver antigens for a sustained immune response\", \"To develop and field test a simple inexpensive micro-hydroturbine that can drive a generator to power vaccine refrigerators and other health care facility equipment.\", \"To engineer, produce, and assess target antigens for developing a potent and cost-effective vaccine to control and prevent influenza infections\", \"To study if a bacterial protease inhibitor from Brucella is a new molecular pattern that could be useful for improving mucosal (oral) delivery of anti-infectious vaccines\", \"To test the theory that poor immunity generated by the oral poliovirus vaccine (OPV) may be responsible for persistence of the disease.\", \"To define a shared strategy and related action plan as well as Monitoring and Evaluation framework to enhance sustainable access to vaccines in Middle Income countries (MICs)\", \"To further research the production and immune stimulating effects of multi-antigen and adjuvant formulations that could be used in a low-cost, long-lasting malaria vaccine.\", \"To evaluate the population effectiveness of rotavirus vaccine introduction in the context of a comprehensive diarrhoea control pilot in Zambia\\u2019s Lusaka Province\", \"To develop a non-live polio vaccine using liposomes to entrap and deliver defined poliovirus antigens effectively to the immune system\", \"To identify the potential causal role of antibodies in MTB control in vivo in an effort to guide future vaccine design\", \"To develop a printable label for vaccine vials to indicate when they have been exposed to temperatures below a set threshold, which would compromise activity.\", \"To evaluate the ability of nanoparticle based vaccines to induce Env-specific protective antibody responses against HIV infection in non human primates\", \"To make the first description of specific histo-blood group antigens (HBGAs) in Zambian children and to assess their influence on immunogenicity of rotavirus vaccines.\", \"To convene experts to discuss new information about vibrios in the environment particularly in relation to diarrhea/enteric diseases, diagnostics, and vaccines\", \"To engineer a highly immunogenic virus to express replication-restricted poliovirus proteins for use in a new nasal spray polio vaccine.\", \"To develop a bio-compatible, biodegradable polymer device that can be placed under the skin to introduce vaccines and antigens to the immune system\", \"To test an innovative single vial system (SVS) technology that allows for easier transport, reconstitution, and storage of vaccines with lyophilized components\", \"To develop high-throughput glycan microarrays to identify glycan antigens, determine their chemical structure, and design glycan-peptide vaccines for future testing.\", \"To generate chimeric Plasmodium falciparum that expresses the antigens of another malaria parasite, P. vivax, allowing them to be evaluated as vaccine candidates.\", \"To develop novel vaccines for African trypanosomiasis, a neglected disease of animals and humans in sub-Saharan Africa that is transmitted by an infected tsetse fly bite\", \"To develop an effective, low cost, oral, human neonatal rotavirus vaccine aimed at prevention of rotavirus gastroenteritis from birth, for infants and children worldwide\", \"To apply highly sensitive quantitative molecular diagnostics for pathogens to understand the etiology of severe diarrhea in post-rotavirus vaccine communities\", \"To enhance the impact of immunization on childhood mortality by defining the potential heterologous effects of vaccines, and adjusting immunization policies if deemed appropriate\", \"To provide information on the potential cost-effectiveness of additional investments in several ongoing, vaccine-improvement initiatives aimed at reducing the global disease burden of measles\", \"To develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases\", \"To support the planning of a phase I clinical trial in Belgium for the Oral Polio Vaccines being developed by a consortium of researchers\", \"To develop and test a vaccine delivery system that uses Norovirus virus-like particles (VLPs) to deliver desired antigens directly to the gut mucosa\", \"To develop a vaccine for Salmonella that uses a serotype-independent Salmonella antigen combined with an adjuvant to deliver immunity against all serotypes of the bacteria.\", \"To support pre-clinical and early clinical development of a novel TB vaccine for use in high burden countries in the developing world\", \"To optimize and augment methods to identify mucosal immune factors that may contribute to HIV prevention and vaccine-induced protection.\", \"To increase capacity to conduct HIV vaccine clinical trials, including licensure trials, in highly impacted populations in clade C region of southern Africa.\", \"To provide technical assistance for the Institute of Medical Biology\\u2019s pursuit of World Health Organization prequalification for their Sabin Inactivated Poliovirus vaccine (sIPV)\", \"To work to develop a single dose vaccine that can be given as close to birth as possible to protect against multiple diseases.\", \"To develop a vaccine imunogen capable of eliciting broadly neutralizing antibodies to prevent infection with the HIV strains most common in Africa\", \"To study the complex sugar coating that surrounds and protects HIV to see if parts of this shield can serve as targets for a vaccine\", \"To develop a novel vaccine approach that is based on blocking mosquito transmission of these disease agents rather than inducing pathogen-specific immunity.\", \"To establish a program to search for new innovative, potentially high risk, ideas/technologies that may offer promise to the HIV vaccine research and development field\", \"To leverage recent discoveries involving the immunobiology of TLR11 to develop a tractable small animal model for preclinical testing of ETEC vaccine candidates.\", \"To develop an IPV vaccine adjuvanted with CAF01 that is able to promote significant dose-sparing and enhance mucosal immunity.\", \"To support cholera modeling activities using data from endemic and epidemic settings, in order to better understand how to target vaccine use for highest impact\", \"To incorporate engineered frameshifting gene cassettes into vaccine vectors in hopes of eliciting broader T helper and cytotoxic T cell response, leading to better protection against disease.\", \"To develop a novel vaccine against salivary proteins of sand fl ies with the aim to induce a strong immune response against the parasite\", \"To develop a mutable vaccine in which the gene coding for the antigen mutates a million times more frequently than a typical gene to trigger immune response\", \"To produce a multi-stage malaria vaccine using transgenic sporozoites, generating protective immunity against early stages of infection and antibodies to block transmission via mosquitoes\", \"To develop a low-cost, single-dose, oral polio vaccine using a live, safe adenovirus containing protein-encoding genes from poliovirus.\", \"To develop an evidence base for the determinants of maternal vaccine acceptance to inform future maternal vaccination demand creation strategies in low- and middle-income countries\", \"To develop novel pulsed antigen-releasing single-injection vaccine delivery systems to facilitate pediatric immunizations in Developing World circumstances where repeated patient access can be problematic.\", \"To provide a low cost pneumococcal vaccine to reduce morbidity and mortality from pneumococcal diseases of infants and children in developing countries\", \"To target T-cells against ERV antigens. If true, new host-directed vaccines could be developed to eliminate HIV infected cells.\", \"To convene a meeting of experts in meningococcal disease to determine how to monitor the long-term impact of meningococcal vaccines in Africa\", \"To develop a standardized analytical commutability protocol that Developing Country Vaccine Manufacturers may use for evaluating Vi-conjugate ELISA assays and reference standards to support product registration\", \"To better monitor viral infections and vaccine efficacy in populations throughout the world in order to enhance our ability to improve human health and detect emerging epidemics\", \"To disseminate the most up-to-date information on gastric cancer and the development of possible vaccines; and to encourage research and collaboration on gastric cancer worldwide\", \"To test whether a prototype malaria vaccine which targets a newly identifi ed dendritic cell molecule will produce a strong antibody response without the use of adjuvants.\", \"To produce libraries of DNA fragments encoding thousands of peptides from malaria parasite proteins, for use in production and testing of malaria vaccine formulations\", \"To test novel technologies for developing more effective neonatal vaccines to improve infant health and survival, particularly in low income countries and the world's poorest communities\", \"To develop a single-injection delayed-release T-solium (swine tapeworm) vaccine that would require a one-time access to facilitate control programs in the Developing World\", \"To identify why oral poliovirus and rotavirus vaccines are less effective in the developing world, in order to develop new approaches to protect children from enteric diseases\", \"To reduce the burden of cholera through the deployment of the killed whole cell oral cholera vaccine in endemic and epidemic settings\", \"To enhance IDRI\\u2019s capabilities to provide industry quality adjuvants and formulations for the development of vaccines for diseases in the developing world\", \"To analyze paired mother infant sera from HIV positive mothers to determine the effectiveness of trans-placental antibody transfer for vaccine preventable diseases (flu, pneumo, and tetanus)\", \"To enhance global awareness and visibility of AIDS vaccine research and development in developing countries among the general public and decisionmakers\", \"To explore whether green fluorescent protein is endowed with unique immunological properties which could be used to develop a universal fl u vaccine.\", \"To develop an oral vaccine for tuberculosis that uses rice seeds that express proteins that will induce immunity in the gastrointestinal tract and in the respiratory mucosa.\", \"To reduce disability and deaths due to cholera in epidemic and outbreak settings through the introduction of an additional control tool, oral cholera vaccines\", \"To develop a comprehensive framework and tools for a systematic and coordinated approach to rotavirus vaccine implementation evaluation at country, regional, and global levels\", \"To support for the 2016 Sabin Gold Medal Award which recognizes individuals who have helped to reduce needless human suffering from vaccine-preventable and neglected tropical diseases\", \"To develop live bacterial-based contraceptive vaccines that deliver testis- and sperm-specific antigens to sterilize rodent populations that destroy food crops.\", \"To define the relationship between anti-HIV-1 Env antibody specificity and Fc-mediated effector function to guide HIV-1 vaccine development\", \"To develop a library of media compounds needed to optimize in vitro production of infective malaria sporozites needed for use in an effective vaccine\", \"To define the qualities of an HIV vaccine that will make it sufficiently immunogenic to elicit protective responses in humans\", \"To enable and drive the development of improved and appropriate vaccines against invasive pneumococcal disease for use in high burden low income countries\", \"To use a genetic approach to identify cellular targets that mediate adjuvant effects to accelerate the design of vaccines against globally persistent pathogens\", \"To develop a versatile pollen mimetic transcutaneous vaccination platform with built-in adjuvant properties for needle-free transdermal delivery of vaccine antigens via hair follicles\", \"To develop an Animal Health Services Franchising Business for the delivery of vaccines and pharmaceuticals to smallholder farmers in Kenya\", \"To convene experts in HIV virology and vaccinology to examine role of acute and early infections in HIV vaccine development.\", \"To prevent deaths from vaccine-preventable diseases (VPD) by developing an accurate and field-friendly method to assess effective vaccination coverage in young children\", \"To try to improve the immune response to oral poliovirus vaccine among children in India by treating enteric infections before vaccination.\", \"To provide critical evidence about the population impact of a highly promising pneumococcal conjugate vaccine, PCV10, on radiologically and ultrasound confirmed pneumonia in rural Bangladesh\", \"To guide development of broadly effective vaccines against enteric infections by measuring etiology and burden of severe diarrhea among young children in developing countries\", \"To test the hypothesis that immunizing newborns with soluble rather than particulate antigens will overcome maternal-mediated suppression of infant immune responses to vaccines.\", \"To develop a tuberculosis vaccine that uses polyester biobeads produced in mycobacteria that carry a large repertoire of known and undiscovered antigens on their surface.\", \"To test computational design and experimental approaches that could lead to significantly improved next generation vaccine candidates for human immunodeficiency virus/simian immunodeficiency virus (HIV/SIV)\", \"To develop a printable label that can be used on vaccines to indicate when contents have surpassed a set temperature threshold or exceeded a cumulative temperature limit.\", \"To test the Nearest Neighbor immunogen hypothesis and could lead to significantly improved next generation HIV-1 Env vaccine candidates\", \"To convene an international conference to discuss and share broadly the latest HIV vaccine, microbicide, and ARV-based prevention research\", \"To explore the technical and regulatory feasibility of Micropellet technology for the development of cost-effective novel combination vaccines that are thermal stable\", \"To support development of an attenuated Plasmodium falciparum sporozoite vaccine to reduce malaria infection, morbidity, and mortality in infants and children in Africa\", \"To evaluate the capacity of a new intradermal vaccine using polypropylene sulfide nanoparticles to induce immunity against HIV, Tuberculosis, and Cytomegalovirus infections\", \"To develop the concept that a vaccine can prevent HIV transmission by the trapping of virus-antibody complexes in cervical and cervical/vaginal mucus\", \"To fund the activities of the ACO which support the Alliance in their work on developing a safe, effective and globally accessible HIV vaccine\", \"To develop children\\u2019s ankle bands with electrochemical indicators that change color at specified intervals to remind mothers of their childrens\\u2019 vaccine due dates.\", \"To develop and test an aluminum wicking medium that can be used in an evaporative, passive-cooling refrigeration system for vaccine storage and delivery in dry climates.\", \"To plan for clinical and environmental surveillance of enteric fever in India, and to identify sites of vaccine evaluation with or without complementary sanitary interventions\", \"To engineer Salmonella and Shigella vaccine vectors to overproduce an essential antigen to stimulate gamma delta T cells, to boost mucosal immune response against these enteric pathogens\", \"To develop novel vaccines against HIV, with an approach to modify HIV envelope protein to enhance its immunogenic potency for clinical development\", \"To develop a new oral poliovirus type 2 vaccine (OPV-2) to greatly improve the chances of success of the global eradication of all three poliovirus serotypes\", \"To develop a safe, effective and affordable vaccine for the prevention and control of HIV-AIDS, especially in developing countries\", \"To create requirements and engineering specifications to develop new \\u201cnet zero energy\\u201d warehouse and distribution systems for vaccines and drugs in developing countries.\", \"To conduct the Global Health Series of conferences on HIV/AIDS, tuberculosis, malaria, parasitic diseases, and common infectious disease challenges, such as vaccine development\", \"To evaluate the infant response to pneumococcal vaccination in a Belgian cohort of infants whose mothers were previously vaccinated with tetanus, diphtheria, acellular pertussis vaccine (Tdap)\", \"To develop microcapsules that allow vaccines to be released only after bypassing the acidic stomach environment and arriving at the mucosal tissues of the lower gastrointestinal tract\", \"To discover novel pathways of host defense against Mtb that will impact development of vaccines and host-directed therapies for tuberculosis\", \"To understand host factors associated with infection of tuberculosis in order to develop new diagnostic tools, host-directed therapeutics or vaccines\", \"To test a mobile phone short message service (SMS) system that provides texts to parents to improve timely immunizations, increase vaccine acceptance, and report of side effects.\", \"To develop evidence for improving the performance of live, attenuated, orally delivered rotavirus vaccines in infants in the developing world\", \"To develop an efficacious vaccine against malaria using novel nanoparticle-based technologies termed Interbilayer-Crosslinked Multilamellar Vesicles (ICMVs) and malarial antigens\", \"To improve infant vaccine responses and early childhood development by identifying the mechanisms of and solutions to the detrimental impact of maternal parasitic infection.\", \"To determine whether novel synthetic molecules (imidazoquinolines) are able to activate newborns white blood cells as candidate vaccine adjuvants to dramatically enhance immunization of infants.\", \"To develop a customizable Geographical Information System web application platform that integrates existing data in a particular region to maximize delivery of vaccines to target populations.\", \"To reduce disability and deaths due to cholera in epidemic settings through the introduction of oral cholera vaccines, an additional control tool\", \"To develop a mobile-phone based \\u201cbulletin-board\\u201d for capturing and broadcasting availability and demand information for vaccines and medicines.\", \"To support the development of novel vaccine approaches that aim to decrease transmission of the Malaria parasite from mosquito to human\", \"To establish an internet-based global monitoring and rapid alert system for finding, analyzing, and counteracting misinformation communication campaigns regarding vaccines to support global immunization efforts.\", \"To provide foundation grantees with novel and innovative industry quality adjuvants and formulations to enhance the success of pre-clinical and clinical vaccine development\", \"To support a project to develop a public haplotype resource for monitoring drug resistance, vaccine responses, and markers of disease severity in malaria\", \"To expand efforts to identify populations and build capacity in India where future pivotal TB vaccine trials can be conducted\", \"To futher develop \\u201choming factors\\u201d as vaccine adjuvants that induce the development of memory T cells and generate site-specific immunity against pathogens in the gut.\", \"To evaluate the effect of high levels of maternal antibody on the infant's response to pneumococcal conjugate vaccine given in the routine infant schedule\", \"IGF::OT::IGF STAGED VACCINE DEVELOPMENT\", \"IGF::OT::IGF STAGE VACCINE DEVELOPMENT\", \"IGF::OT::IGF PRODUCTION OF PDNA VACCINE EXPRESSING FLSC\", \"Task X10: Ebola Vaccine Immunogenicity and Efficacy Testing\", \"STAGED VACCINE DEVELOPMENT OF ADENIVIRUS-4 VECTORED VACCINE FOR HUMAN IMMUNODEFICIENCY VIRUS\", \"\\u30c7\\u30f3\\u30b0\\u71b1, \\u51fa\\u8840\\u71b1\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u514d\\u75ab\\u5b66\\u7684\\u6027\\u72b6\\u306e\\u691c\\u8a0e\\u306a\\u3089\\u3073\\u306b\\u305d\\u308c\\u306b\\u57fa\\u304f\\u30ef\\u30af\\u30c1\\u30f3\\u8a66\\u4f5c\\u306e\\u7814\\u7a76\", \"\\u30b8\\u30d5\\u30c6\\u30ea\\u30a2(D)\\u767e\\u65e5\\u54b3(P)\\u7834\\u50b7\\u98a8(T)\\u9ebb\\u75b9(M)\\u6df7\\u5408\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5b9f\\u7528\\u5316\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76(\\u7d992\\u5e74)\", \"\\u7d30\\u83cc\\u611f\\u67d3\\u75c7\\u306e\\u65b0\\u3057\\u3044\\u59ff\\u306e\\u628a\\u63e1\\u53ca\\u3073\\u83cc\\u4ea4\\u4ee3\\u75c7\\u306e\\u4e88\\u9632\\u6cbb\\u7642\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u7814\\u7a76(\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5)\", \"\\u767e\\u65e5\\u54b3\\u8597\\u306e\\u7523\\u751f\\u3059\\u308b\\u8d64\\u8840\\u7403\\u51dd\\u96c6\\u7d20\\u306e\\u7c21\\u6613\\u8fc5\\u901f\\u306a\\u5206\\u96e2\\u7cbe\\u88fd\\u3068\\u6539\\u826f\\u767e\\u65e5\\u54b3\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"\\u6bd2\\u7d20\\u30d5\\u30e9\\u30b0\\u30e1\\u30f3\\u30c8\\u3092\\u5fdc\\u7528\\u3057\\u305f\\u73fe\\u884c\\u306e\\u3082\\u306e\\u306b\\u304b\\u308f\\u308b\\u7834\\u50b7\\u98a8\\u30ef\\u30af\\u30c1\\u30f3\\u3068\\u6297\\u6bd2\\u7d20\\u6a19\\u6e96\\u5316\\u6cd5\\u306e\\u4f5c\\u6210\", \"NDV\\u4e0d\\u6d3b\\u5316\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u5bfe\\u3059\\u308b\\u6297\\u4f53\\u7523\\u751f\\u80fd\\u306e\\u7570\\u306a\\u308b\\u30a6\\u30ba\\u30e9\\u306e\\u80b2\\u7a2e\\u3068\\u9078\\u629c\\u7cfb\\u306e\\u514d\\u75ab\\u5b66\\u7684\\u7279\\u6027\", \"\\u30de\\u30e9\\u30ea\\u30a2\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306e\\u57fa\\u790e\\u7684\\u7814\\u7a76:\\u30de\\u30e9\\u30ea\\u30a2\\u539f\\u866b\\u5f37\\u6bd2\\u682a\\u3068\\u5f31\\u6bd2\\u682a\\u3068\\u306e\\u907a\\u4f1d\\u5b50\\u767a\\u73fe\\u306e\\u6bd4\\u8f03\", \"\\u30de\\u30e9\\u30ea\\u30a2\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306e\\u57fa\\u790e\\u7684\\u7814\\u7a76:\\u30de\\u30e9\\u30ea\\u30a2\\u539f\\u866b\\u5f37\\u6bd2\\u682a\\u3068\\u5f31\\u6bd2\\u682a\\u3068\\u306e\\u907a\\u4f1d\\u5b50\\u767a\\u73fe\\u306e\\u6bd4\\u8f03\", \"\\u30de\\u30e9\\u30ea\\u30a2\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306e\\u57fa\\u790e\\u7684\\u7814\\u7a76:\\u30de\\u30e9\\u30ea\\u30a2\\u539f\\u866b\\u5f37\\u6bd2\\u682a\\u3068\\u5f31\\u6bd2\\u682a\\u3068\\u306e\\u907a\\u4f1d\\u5b50\\u767a\\u73fe\\u306e\\u6bd4\\u8f03\", \"Structural characterization of major timothy grass pollen allergens: Basis for the rational development of vaccines against grass pollen allergy\", \"Structural characterization of the major timothy grass pollen allergen, Phl p: Basis for the rationale development of vaccines against grass pollen allergy\", \"A Phase I Study of a Bcr-abl peptide based Vaccine with GM-CSF as an Adjuvant in Patients with Chronic Myleogenous Leikemia\", \"A Phase I Study of a Bcr-abl peptide based Vaccine with GM-CSF as an Adjuvant in Patients with Chronic Myleogenous Leukemia\", \"Rescue of Infectious Newcastle Disease Virus (NDV) from Cloned cDNA for the development of a Novel Vaccine against AIDS\", \"IL-27\\u306b\\u3088\\u308a\\u5206\\u5316\\u8a98\\u5c0e\\u3057\\u305fDC\\u524d\\u99c6\\u7d30\\u80de\\u3092\\u7528\\u3044\\u305f\\u65b0\\u3057\\u3044\\u764cDC\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u306e\\u958b\\u767a\", \"NKT\\u7d30\\u80de\\u3068\\u6a39\\u72b6\\u7d30\\u80de\\u306b\\u3088\\u308b\\u4e0a\\u6c17\\u9053\\u7c98\\u819c\\u514d\\u75ab\\u5fdc\\u7b54\\u306e\\u89e3\\u6790\\u3068\\u7d4c\\u9f3b\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5c55\\u958b\", \"Dynamics of Pneumococcal carriage and emergence of high virulence clone after introduction of vaccine in Japan\", \"Development of vaccines against leishmaniasis using polyvalent CDV vaccine and cytokine adjuvant.\", \"DNA macromolecule as a vaccine antigen scaffold for organization of the antigens into repetitively ordered arrays\", \"Malaria vaccine platform technology\", \"Development of an oral delivery vehicle for HIV-1 DNA vaccines to stimulate mucosal immune responses\", \"Vaccine development against hepatitis virus by transcutaneous peptide immunization with TLR7 ligand.\", \"Development of vaccine therapy for pulmonary arterial hypertension\", \"\\u767e\\u65e5\\u54b3\\u83cc\\u306e\\u611f\\u67d3\\u6210\\u7acb\\u6a5f\\u69cb\\u306e\\u89e3\\u660e\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u3078\\u306e\\u5fdc\\u7528\", \"M13\\u30d5\\u30a1\\u30fc\\u30b8\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308bB\\u7d30\\u80de\\u6d3b\\u6027\\u5316\\u6a5f\\u69cb\\u306e\\u89e3\\u660e\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u52b9\\u679c\\u306e\\u691c\\u8a0e\", \"Development of the noninvasive nasal spray vaccine for prevention of cervical cancer using the next generation type virus vector.\", \"Analysis of mechanisms related to the induction of mucosal immunity in Peyer's patches against oral vaccine\", \"Basic research for \\\"RSV pregnant women vaccine\\\" by clinical isolates aimed at overcoming RSV infection\", \"\\u6297\\u7d50\\u6838\\u30ef\\u30af\\u30c1\\u30f3\\u52b9\\u679c\\u306e\\u5897\\u5f37\\u3092\\u76ee\\u6307\\u3057\\u305f\\u7d50\\u6838\\u83cc/BCG\\u306b\\u3088\\u308b\\u9632\\u5fa1\\u514d\\u75ab\\u5236\\u5fa1\\u6a5f\\u5e8f\\u306e\\u89e3\\u660e\", \"\\u907a\\u4f1d\\u5b50\\u7d44\\u63db\\u3048\\u30cb\\u30ef\\u30c8\\u30ea\\u3092\\u7528\\u3044\\u305f\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u88fd\\u9020\\u306e\\u52b9\\u7387\\u5316\\u306b\\u5411\\u3051\\u305f\\u7814\\u7a76\", \"\\u30d8\\u30d1\\u30c8\\u30be\\u30fc\\u30f3\\u306b\\u5bfe\\u3059\\u308b\\u514d\\u75ab\\u5fdc\\u7b54\\u306b\\u95a2\\u4e0e\\u3059\\u308b\\u6297\\u539f\\u86cb\\u767d\\u306e\\u540c\\u5b9a\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"Vaccines against periodontitis using DNA ORIGAMI and imidazoquinolines\", \"\\u4e0b\\u75e2\\u75c7\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u5206\\u5b50\\u75ab\\u5b66\\u3001\\u69cb\\u9020\\u306e\\u7279\\u5fb4\\u3001\\u9032\\u5316\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u8a2d\\u8a08\", \"Development of a new influenza vaccine of global standard.\", \"\\u5fc3\\u7b4b\\u6897\\u585e\\u306b\\u5bfe\\u3059\\u308b\\u30a2\\u30f3\\u30b8\\u30aa\\u30c6\\u30f3\\u30b7\\u30f3\\uff12\\u30ef\\u30af\\u30c1\\u30f3\\u3092\\u7528\\u3044\\u305f\\u65b0\\u898f\\u6cbb\\u7642\\u6cd5\\u306e\\u958b\\u767a\", \"\\u30aa\\u30ea\\u30b4\\uff24\\uff2e\\uff21\\u30ab\\u30d7\\u30bb\\u30eb\\u3092\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u3068\\u3059\\u308b\\u4e73\\u9178\\u83cc\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5275\\u88fd\", \"\\u7d44\\u63db\\u3048\\u30ef\\u30af\\u30b7\\u30cb\\u30a2\\u30a6\\u30a4\\u30eb\\u30b9\\u3092\\u7528\\u3044\\u305f\\u6297\\uff28\\uff34\\uff2c\\uff36\\uff0d\\uff11\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u72c2\\u72ac\\u75c5\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u4f1d\\u64ad\\u30c0\\u30a4\\u30ca\\u30df\\u30af\\u30b9\\u53ca\\u3073\\u30ef\\u30af\\u30c1\\u30f3\\u6226\\u7565\\u7814\\u7a76\", \"\\u30d8\\u30ea\\u30b3\\u30d0\\u30af\\u30bf\\u30fc\\u30d4\\u30ed\\u30ea\\u306e\\u75c5\\u539f\\u6027\\u56e0\\u5b50\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u7cd6\\u9396\\u6297\\u539f\\u306e\\u5316\\u5b66\\u5408\\u6210\\u3068\\u8907\\u5408\\u578b\\u5408\\u6210\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5c55\\u958b\", \"\\u30ef\\u30af\\u30c1\\u30f3\\u30cf\\u30b6\\u30fc\\u30c9\\u306e\\u514b\\u670d\\u3092\\u76ee\\u6307\\u3057\\u305f\\u65b0\\u898f\\u7d4c\\u76ae\\u30ca\\u30ce\\u30ad\\u30e3\\u30ea\\u30a2\\u306e\\u8a2d\\u8a08\", \"Enhancement of protection against various microbial infection by the modification of dominance of Thl or Th2 immune responses\", \"\\u043d\\u0430\\u0443\\u0447\\u043d\\u043e\\u0439 \\u043a\\u043e\\u043d\\u0444\\u0435\\u0440\\u0435\\u043d\\u0446\\u0438\\u0438-14 \\u0432\\u0441\\u0442p\\u0435\\u0447\\u0430 \\u0415\\u0432p\\u043e\\u043f\\u0435\\u0439\\u0441\\u043a\\u043e\\u0433\\u043e \\u043e\\u0431\\u0449\\u0435\\u0441\\u0442\\u0432\\u0430 \\u043f\\u043e \\u0442\\u0435\\u0445\\u043d\\u043e\\u043b\\u043e\\u0433\\u0438\\u0438 \\u043a\\u043b\\u0435\\u0442\\u043e\\u043a \\u0436\\u0438\\u0432\\u043e\\u0442\\u043d\\u044b\\u0445 \\\"\\u0422\\u0435\\u0445\\u043d\\u043e\\u043b\\u043e\\u0433\\u0438\\u044f \\u043a\\u043b\\u0435\\u0442\\u043e\\u043a \\u0436\\u0438\\u0432\\u043e\\u0442\\u043d\\u044b\\u0445: \\u043e\\u0442 \\u0432\\u0430\\u043a\\u0446\\u0438\\u043d \\u0434\\u043e \\u043c\\u0435\\u0434\\u0438\\u0446\\u0438\\u043d\\u0441\\u043a\\u043e\\u0439 \\u0433\\u0435\\u043d\\u0435\\u0442\\u0438\\u043a\\u0438\", \"\\u043c\\u0435\\u0436\\u0434\\u0443\\u043d\\u0430\\u0440\\u043e\\u0434\\u043d\\u043e\\u0439 \\u043a\\u043e\\u043d\\u0444\\u0435\\u0440\\u0435\\u043d\\u0446\\u0438\\u0438 \\u043f\\u043e\\u0434 \\u044d\\u0433\\u0438\\u0434\\u043e\\u0439 European Society for Animal Cell Technology 14th ESACT Meeting Animal Cell Technology: from Vaccines to Genetic Medicine\", \"A double-blind placebo-controlled trial of an HLA-restricted, allergen-derived T cell peptide vaccine in cat-allergic asthma\", \"Vaccine and Treatment Evaluation Unit - Assay Work for CMV Vaccines\", \"Task X9: Development of Standardized Filovirus Immune Assays and Reagents\", \"Dendritic-cell (DC) based vaccines; influence of DC maturational stage and maturational stimuli on their efficacy to induce a specific anti-tumor T cell response.\", \"Feline leukemia virus infection: Factors that influence the sus- ceptibility of the host, the pathogenesis of the infection, and the efficacy of vaccines\", \"Development of a specific immunotherapy in pollen related food allergy: low IgE binding carrot allergens as potential vaccines. (MHV-Beitrag)\", \"A fine characterization of the T cell response induced by active immunization in melanoma patients: a pivotal step for vaccine development.\", \"Analysis of particular features of the immune responses to vaccine antigens during the neonatal period: importance of antigen presentation systems. (S C O R E A)\", \"Analysis of particular features of the immune responses to vaccine antigens during the neonatal period: importance of anti- gen presentation systems\", \"Studies of the cross-protective antibodies elicited after immunization with E.coli J5 vaccine for the prevention of gram-negative shock and death\", \"A randomised Feasability adjuvant autologous renal carcinoma vaccine (ARCV) comparing ARCV to ARCV/interleukin-2 to control (the ART trial)\", \"Understanding success or failure: evaluating DNA vaccine-induced human CD8+ T-cell responses as a function of peptide-MHC stability\", \"Enhanced dendritic cell recruitment and anti-tumor efficacy in a breast cancer DNA vaccine that includes IRES driven expression of cytokine biological adjuvants\", \"\\u53ef\\u6298\\u53e0\\u56db\\u4ef7A\\u03b215\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u7279\\u5f02\\u6027\\u53ca\\u5b89\\u5168\\u6027\\u7814\\u7a76\", \"\\u65b0\\u578bDC\\u9776\\u5411\\u6027MUC1-VNTRn\\u7eb3\\u7c73\\u6838\\u9178\\u75ab\\u82d7\\u7684\\u4f18\\u5316\\u6784\\u5efa\\u53ca\\u6297\\u80f0\\u817a\\u764c\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u542bHSV-2 gD\\u57fa\\u56e0\\u91cd\\u7ec4\\u817a\\u75c5\\u6bd2\\u4fee\\u9970\\u7684\\u6297II\\u578b\\u5355\\u7eaf\\u75b1\\u75b9\\u75c5\\u6bd2\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"\\u4e73\\u9178\\u4e73\\u7403\\u83cc\\u9012\\u5448\\u7684\\u55dc\\u80ba\\u519b\\u56e2\\u83cc\\u65b0\\u578bFlaA/MompS\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u548c\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"\\u65b0\\u578b\\u53cc\\u529f\\u80fd\\u9776\\u5411\\u6cbb\\u7597\\u6027\\u878d\\u5408\\u86cb\\u767d\\u75ab\\u82d7\\u53ca\\u5176\\u6291\\u7624\\u4f5c\\u7528\\u7814\\u7a76\", \"\\u6297\\u80bf\\u7624\\u8840\\u7ba1\\u751f\\u6210\\u65b0\\u578b\\u4f50\\u5242\\u75ab\\u82d7Hydrolipid-bFGF\\u6297\\u80bf\\u7624\\u4f5c\\u7528\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\", \"\\u6709\\u6548\\u6d3b\\u5316\\u7c98\\u819c\\u514d\\u75ab\\u53cd\\u5e94\\u7684\\u827e\\u6ecb\\u75c5\\u75ab\\u82d7\\u7b56\\u7565\\u7814\\u7a76\", \"\\u4ee5\\u58f3\\u805a\\u7cd6\\u4e3a\\u8f7d\\u4f53\\u7684\\u5c4b\\u5c18\\u87a8\\u4f4e\\u53d8\\u5e94\\u539f\\u6027DNA\\u9ecf\\u819c\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u9f3b\\u8154\\u514d\\u75ab\\u6548\\u679c\\u7814\\u7a76\", \"\\u4eba\\u9ad8\\u81f4\\u75c5\\u6027\\u79bd\\u6d41\\u611fH5N1\\u75c5\\u6bd2\\u901a\\u7528\\u578b\\u75ab\\u82d7\\u57fa\\u7840\\u7814\\u7a76\", \"\\u827e\\u6ecb\\u75c5\\u81ea\\u7136\\u611f\\u67d3\\u4e0e\\u75ab\\u82d7\\u8bf1\\u5bfc\\u4ea7\\u751f\\u6297\\u4f53\\u7684\\u9274\\u522b\\u7814\\u7a76\", \"\\u4ee5\\u53d1\\u5939RNA\\u8868\\u8fbe\\u76d2\\u4f5c\\u4e3a\\u4f50\\u5242\\u7684\\u65b0\\u578bDNA\\u75ab\\u82d7\\u8f7d\\u4f53\\u7814\\u7a76\", \"\\u7ed3\\u6838\\u5206\\u679d\\u6746\\u83cc\\u6301\\u7eed\\u611f\\u67d3\\u671f\\u6297\\u539f(latency antigens)\\u7684\\u91cd\\u7ec4BCG\\u75ab\\u82d7\\u7814\\u7a76\", \"hCGbeta-CTP\\u591a\\u805a\\u4f53\\u548cC3d\\u7247\\u6bb5\\u5d4c\\u5408\\u80bd\\u7684\\u751f\\u7269\\u5408\\u6210\\u53ca\\u5176\\u5728\\u80bf\\u7624\\u6cbb\\u7597\\u4e2d\\u7684\\u5e94\\u7528\", \"\\u566c\\u83cc\\u4f53\\u6d3b\\u8f7d\\u4f53HPV16\\u300118\\u8054\\u5408\\u591a\\u4ef7\\u9884\\u9632\\u6027\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u53cc\\u5206\\u5b50\\u4fee\\u9970\\u7684\\u6297\\u539f\\u9012\\u5448\\u7ec6\\u80de\\u9776\\u5411\\u80bf\\u7624\\u7eb3\\u7c73\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u5375\\u900f\\u660e\\u5e26DNA\\u907f\\u5b55\\u75ab\\u82d7\\u8bf1\\u53d1\\u751f\\u6b96\\u9053\\u7c98\\u819c\\u514d\\u75ab\\u53cd\\u5e94\\u7684\\u7814\\u7a76\", \"\\u901a\\u7528\\u578bDC\\u9776\\u5411\\u8102\\u8d28\\u4f53\\u75ab\\u82d7\\u7684\\u6297\\u80bf\\u7624\\u4f5c\\u7528\\u673a\\u7406\\u7814\\u7a76\", \"\\u75ab\\u82d7\\u591a\\u80bd\\u7eb3\\u7c73\\u8f7d\\u836f\\u65b0\\u5206\\u5b50\\u7684\\u7814\\u7a76\", \"\\u6d3e\\u4f0a\\u5c14\\u96c6\\u5408\\u6dcb\\u5df4\\u7ed3\\u5b9a\\u4f4d\\u53e3\\u670d\\u75ab\\u82d7\\u7eb3\\u7c73\\u7c92\\u7ed9\\u836f\\u7cfb\\u7edf\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u809d\\u7d20\\u9176CTL\\u8868\\u4f4d\\u591a\\u6297\\u539f\\u80bd(MAP)\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u53ca\\u5176\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"PB\\u8f6c\\u5ea7\\u5b50\\u4ecb\\u5bfc\\u7684\\u81ea\\u6740\\u57fa\\u56e0\\u5bf9\\u81ea\\u4f53\\u80bf\\u7624\\u6d3b\\u75ab\\u82d7\\u7684\\u9776\\u5411\\u6740\\u4f24\\u4f5c\\u7528\", \"\\u95f4\\u65e5\\u759f\\u591a\\u8868\\u4f4d\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u5ba4\\u7814\\u7a76\", \"\\u4eba\\u4e73\\u5934\\u7624\\u75c5\\u6bd216\\u578bE7\\u6838\\u9178\\u75ab\\u82d7\\u7684\\u5236\\u5907\\u7814\\u7a76\", \"PSCA\\u9897\\u7c92-DNA\\u590d\\u5408\\u75ab\\u82d7\\u6297\\u80f0\\u817a\\u764c\\u6548\\u5e94\\u7684\\u7814\\u7a76\", \"\\u7518\\u9732\\u7cd6\\u5316\\u58f3\\u805a\\u7cd6\\u4ecb\\u5bfc\\u7684\\u6297\\u52a8\\u8109\\u7ca5\\u6837\\u786c\\u5316DNA\\u75ab\\u82d7\\u7ecf\\u7c98\\u819c\\u514d\\u75ab\", \"Next Generation of Multivalent Adenovirus Vaccines Based on Novel Virus-Like Particle (VLP) Technology\", \"Generating regional rotavirus vaccine strains through reverse genetics to alleviate viral diarrhoea in Africa (Senior Fellowship for Dr. Hester Gertruida O'Neill)\", \"Entwicklung RNS basierter Impfstoffe zur Induktion integrierter T und B-Zellimmunantworten gegen molekular definierte Tumorantigene              (A15)\", \"Evaluierung der Effektivit\\u00e4t der Vakzinebehandlung des Prostatakarzinoms in Kombination mit nicht-myeloablativer Knochenmarktransplantation im Tiermodell\", \"Bestimmung der antigen-Spezifit\\u00e4t der T-Zellantwort gegen eine genmodifizierte, polyvalente Vakzine bei der chronischen lymphatischen Leuk\\u00e4mie (CLL)              (C 4)\", \"Native display of Borrelia antigens on the surface of hepatitis B virus capsids: Improved prophylactic and potential therapeutic vaccines against Lyme disease\", \"Identification of low-molecular mass ligands for targeting of subunit vaccines to Peyer`s patch M cells\", \"Das Merozoitenoberfl\\u00e4chenprotein 1 (MSP-1), ein Kandidat f\\u00fcr einen Impfstoff gegen P.falciparum-Infektionen: Untersuchungen zur zellul\\u00e4ren Immunantwort des Menschen              (A01)\", \"Doustna szczepionka przeciwko endoglinie skojarzona z terapi\\u0105 genow\\u0105 IL-12 polaryzuje mikro\\u015brodowisko nowotworowe z proangiogennego i immunosupresyjnego na \\u015brodowisko antyangiogenne i immunostymuluj\\u0105ce.\", \"Badania nad wielofunkcyjn\\u0105 szczepionk\\u0105 przeciwko C.albicans wykorzystuj\\u0105c\\u0105 kierowanie do kom\\u00f3rek dendrytycznych i aktywacj\\u0119 receptora dektynowego.\", \"Ocena odpowiedzi humoralnej poszczepieniu trzynastowalentn\\u0105 skoniugowan\\u0105 szczepionk\\u0105 pneumokokow\\u0105 u dzieci i m\\u0142odzie\\u017cy z nieswoistymi zapeleniami jeltit.\", \"A multi-pronged approach to find endogenous agRNAs\", \"Development of a proposal on Norwegian engagement and collaborative projects in a phase III trial of oral rotavirus vaccine ORV 116E in Indi\", \"Development of an improved vaccine towards meningococcal disease in sub-Saharan Africa\", \"\\u00c9tude de l immunodominance de type T CD8+ dans un contexte d infection par le Virus de l Immunod\\u00e9ficience Humaine : implications dans l \\u00e9laboration d un nouveau vaccin.\", \"D\\u00e9veloppement de formulations pour vaccins conventionnels suite \\u00e0 l'\\u00e9tude du comportement des particules inject\\u00e9es avec l'injecteur sans aiguille du LOCUS\", \"Development of vaccine concepts that protect farmed fish throughout the entire production cycle\", \"Investigation into the immunological basis for enhancing immunity to Marek's disease by using re-vaccination with Marek's disease vaccines.\", \"The regulation of HIV-1 specific T-cell immune responses: influence of highly active antiretroviral drugs cytokines and vaccines.\", \"For additional refurbishment costs associated with Phase II of the Vaccine Unit of the Division of Infectious Diseases.\", \"Development of a bivalent vaccine against hepatitis B and C viruses\", \"Nisin obtention in milk whey medium, evaluation of antimicrobial application in food biopreservation, pharmaceutics products; and vaccines adjuvant\", \"Recombinant BCG expressing Pasteurella antigens\", \"To enhance the IIS for AFIX assessment functionality so the IIS, IRIS, will serve as a single reference source to ensure consistent vaccine coverage reporting statewide.\", \"Testing of a Novel Skin Electroporation Procedure for Multivalent Alphavirus DNA Vaccine Delivery\", \"Marine Mammal Vaccines\", \"Innovative Manufacturing Techniques for Polysaccharide-Protein Conjugate Vaccines\", \"Genomic-guided discovery of new interventions against neglected parasitic diseases.\", \"A combined early and late HIV-1 protein-specific exosome-targeted T cell vaccine capable of counteracting immune suppressions and stimulating CD8+ CTL responses in absence of\", \"Development of mucosal vaccines against Bordetella pertussis\", \"The role of bacterial outer membrane proteins in the pathogenesis of chronic lung infection: Potential vaccine candidates or novel drug targets\", \"Chemical Biology on Carbohydrates - Approaches Towards Potential Drugs and Vaccines against Infectious Diseases and Cancer\", \"Breaking the cold chain for oral recombinant vaccines\", \"CROSS-PROTECTION EFFICACY AND CUSTOMIZATION OF THE EBEAM SALMONELLA VACCINE FOR THE POULTRY INDUSTRY\", \"NEXT GENERATION VACCINE FOR INFECTIOUS BOVINE KERATOCONJUCTIVITIS\", \"Development of a Vaccine against the Hepatitis C Virus (HCV) and Demonstration of Efficacy in Intravenous Drug Users\", \"Do Current Immunization Delivery and Surveillance Systems Adequately Promote and Measure Uptake of the Measles, Mumps, Rubella and Varicella (MMR-V) Vaccine?\", \"Inuit women's understanding of human papillomavirus:  implications for health education and prevention in Nunavik, Qu\\u00e9bec\", \"Love alone won't protect your daughter:  HPV vaccine and the moral negotiations of Ontario parents\", \"Development of novel attenuated PRRS vaccine and disease model.\", \"IAH Jenner Influenza Fellowship\", \"THE PURPOSE OF THE PROPOSED PROJECT IS TO ENHANCE THE VERMONT IMMUNIZATION REGISTRY BY RESEARCHING, EVALUATING AND IMPLEMENTING A VACCINE\", \"ENHANCING ALASKAS VACCINE ORDERING & MGMT TOOLS IN THE IMMUNIZATION INFORMATION SYSTEMS (IIS) TO IMPROVE THE INTERFACE WITH CDCs VTRCKS SYSTEM\", \"STAGED VACCINE DEVELOPMENT OF ADENIVIRUS-4 VECTORED VACCINE FOR HUMAN IMMUNODEFICIENCY VIRUS\", \"Task X9: Development of Standardized Filovirus Immune Assays and Reagents\", \"SBIR Phase I: Silk: A New Approach to Developing a Heat-stable Rotavirus Vaccine\", \"''BRUCELLOSIS VACCINES FOR LIVESTOCK''\", \"EVALUATION OF THE ROLE OF CELL-MEDIATED IMMUNITY IN EFFICACY OF EXPERIMENTAL ALTERNATIVE SCHEDULE OF LIVE ATTENUATED RB51 VACCINE AGAINST BRUCELLOSIS IN CATTLE\", \"EVALUATION OF A SEROTYPE 1 MAREKS DISEASE VIRUS (MDV) AS VECTOR VACCINE TO CONTROL INFECTIOUS BURSAL DISEASE (IBD) IN CHICKENS\", \"DEVELOPMENT OF HIGHLY EFFECTIVE VACCINE TO PREVENT FISH TUBERCULOSIS FOR AQUACULTURE\", \"LIVE-ATTENUATED INFLUENZA VIRUSES (LAIV) VACCINES FOR THE PREVENTION AND CONTROL OF SWINE INFLUENZA\", \"TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION\", \"Design Molecular Vaccines for Type 1 Diabetes\", \"Support for the organisation of a study entitled \\\"update of the cost/std database on european vaccine research\\\" held in bergen/norway in 1999\", \"Novel \\\"non live\\\" vaccine for animal healthcare enabling southern Europe to overcome a serious isue in sheep/cattle farming\", \"Integrated diagnostic and recombinant vaccinedevelopment for cowdriosis and anaplasmosis\", \"A network for the development, evaluation and testing of anti-paras ite vaccines in experimental non-human primate models\", \"IDENTIFICATION OF IMMUNOREACTIVE POLYPEPTIDES INVOLVED IN THE IMMUNE RESPONS AGAINST HIV & T-CRUZI AS A BASIS FOR DIAGNOSTIC AND VACCINE DEVELOPMENT\", \"Mapping of T & B cell epitopes on the major surface antigen 1 of plasmodium vivax, a candidate for vaccine development\", \"Development of an improved vaccine against Mycobacterum Tubercolosis\", \"A STUDY OF THE EPIDEMIOLOGY OF TROPICAL BOVINE THEILERIOSIS IN TUNISIA WITH RELEVANCE TO THE DEVELOPMENT OF A VACCINE\", \"PRODUCTION OF A VACCINE TO BOVINE LEUKEMIA VIRUS ; A MODEL SYSTEM OF PREVENTION AGAINST A WORLDWIDE SPREAD RETROVIRUS-INDUCED NEOPLASM\", \"CHARACTERIZATION OF SOLUBLE PLASMODIUM FALCIPARUM ANTIGENS BY MEANS OF DNA-RECOMBINANT TECHNIQUE AND IMMUNOCHEMICAL METHODS WITH THE PURPOSE OF DEVELOPING A MALARIA VACCINE\", \"THE DEVELOPMENT OF SEXUAL STAGE VACCINES OF PLASMODIUM FALCIPARUM FOR SUPPLEMENTARY CONTROL OF MALARIA TRANSMISSION A MOLECULAR BIOLOGICAL APPROACH\", \"LABORATORY AND FIELD EVALUATION OF DEFINED ANTIGEN VACCINES AGAINST SCHISTOSOMA BOVIS AND S. JAPONICUM IN ANIMALS AND OF DEFINED ANTIGENS FOR THE IMMUNODIAGNOSIS OF HUMANS\", \"Development and Early Clinical Evaluation of a conjugate vaccine that protects against typhoid fever caused by the Salmonella enterica serovars typhi and paratyphi\", \"Development of a multivalent Shigella bioconjugate vaccine to prevent deadly diarrhea in children\", \"Development of a multivalent Shigella bioconjugate vaccine to prevent deadly diarrhea in children\", \"Investigation of novel vaccines against Japanese encephalitis virus infection by virus-like particle or genetic vaccination approach.\", \"A randomised comparative study of the immunogenicity of modified, multisite, intradermal post-exposure rabies vaccine regimens.\", \"The development of recombiant modified vaccinia virus Ankara vaccine delivery systems of increased immunogenicity by manipulation of immunomodulatory genes.\", \"Carriage of hypervirulent meningococci before and after the introduction of serogroup C conjugate polysaccharide vaccine in the UK.\", \"Schistosoma mansoni proteases involved in haemoglobin digestion: efficacy as vaccine molecules and elucidation of immunological parameters required for protection.\", \"Development of novel vaccine delivery systems for induction of mucosal immunity in a large animal model\", \"Characterisation and Stability of ISCOM Vaccines\", \"Development of an Attenuated Infectious Laryngotracheitis Virus Vaccine\", \"Development of an anti-Chlamydia vaccine for the koala\", \"Novel lipid-based adjuvants for induction of mucosal immunity\", \"Optimising the body's immune response with a Nanopatch that delivers biomolecules to the skin\", \"Implications for therapy and disease presentation of the changes triggered by the use of the pneumococcal 7-valent conjugate vaccine\", \"The Leishmania SIR2 family-related gene: functional studies and evaluation of SIR2 recombinant DNA and knockout vaccine to protect against Leishmnaniasis\", \"New approach on the development of an efficient vaccine against streptococcal infection by modulating the conditions of expression, production, purification and formulation\", \"New approach on the development of an efficient vaccine against streptococcal infection by modulating the conditions of expression, production, purification and formulation\", \"Integration of Spatial and Social Network Analysis in Vaccine Trials\", \"Development of DNA-based vaccines for bovine viral diarrhoea virus. D\\u00e9veloppement des vaccins \\u00e0 base dADN le virus de diarrh\\u00e9e bovine.\", \"Generation of murine tumor cell lines that express human HLA-A2 and over-express genes of interest for pre-clinical evaluation and novel cancer vaccine development\", \"Development of a vaccine for sterile immunity to infectious salmon anaemia (ISA) virus and diagnostic kits for ISA virus and antibodies\", \"Development of fowl adenovirus as a vaccine for Newcastle disease and as a gene delivery system to improve feed utilization in poultry\", \"Developing MUC-1 cancer vaccines with the caulobacter S-layer:  use of whole cells as a platform for cancer therapy\", \"Generation of murine tumor cell lines that express human HLA-A2 and over-express genes of interest for pre-clinical evaluation and novel cancer vaccine development\", \"Development of a sea lice vaccine for farmed salmon; collaborative research at the Dept. of Agriculture and Fisheries, Marine Laboratory, Aberdeen, Scotland, U.K.\", \"Generation of murine tumor cell lines that express human HLA-A2 and over-express genes of interest for pre-clinical evaluation and novel cancer vaccine development\", \"Development of Immunomodulators and Vaccines to Reduce Fish Infections of the Intracellular Parasite Microsporidia Using In vivo and In vitro Research Techniques\", \"Using reverse vaccinology to identify novel antigens for vaccine development against Mannheimia haemolytica as a model for bacterial agents associated with bovine respiratory disease\", \"Towards a carbohydrate vaccine for HIV-1: Exploring the Immunogenicity and Antigenicity of the Glycan Shield on the HIV-1 Envelope Glycoprotein, gp120\", \"Towards a carbohydrate vaccine for HIV-1: Exploring the Immunogenicity and Antigenicity of the Glycan Shield on the HIV-1 Envelope Glycoprotein, gp120\", \"Understanding and manipulating chemokines and their receptors in the context of adjuvants\", \"Molecular Genetics of Influenza haemagglutinin production: Developing a rational basis for optimising vaccine yield\", \"A multivalent vaccine and single platform diagnostic for bacterial respiratory diseases of pigs\", \"Structurally modified master seed viruses to enhance conventional foot-and-mouth disease virus vaccine protection\", \"A multivalent vaccine and single platform diagnostic for bacterial respiratory diseases of pigs\", \"Production , purification and preparation of various candidiate vaccines\", \"Development and Production of alphavirus vaccines\", \"HIV LCMV vaccines\", \"Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine\", \"Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine\", \"Ebola Vaccine Development\", \"Chlamydial Immunity and Vaccine Development\", \"PHASE I-II TRIAL OF A GENETIC VACCINE FOR HIV INFECTION\", \"COMPARISON OF LEDERLE DTPH AND DTP VACCINES\", \"POTENCY TEST FOR JAPANESE ENCEPHALITIS VIRUS VACCINE, INACTIVATED, LYOPHILIZED\", \"VIROLOGICAL STUDIES OF RECIPIENTS OF HIV-1 VACCINES\", \"Development/production of H5 influenza DNA plasmid vaccine\", \"Ebola Vaccine Development\", \"Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine\", \"Multiclade HIV-1 DNA Plasmid Vaccine With Plasmid Cytoki\", \"Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine\", \"HIV/AIDS Vaccine Development\", \"TESTING OF ROTAVIRUS VACCINE CANDIDATES IN VENEZUELA AND PERU\", \"CLINICAL AND EXPERIMENTAL STUDIES OF HEPATITIS B VACCINES\", \"Guinea Pig Model for Shigellosis\", \"Storage of serum samples from a smallpox vaccine-associated myocarditis study\", \"Mucosal Vector with TLR3 agonist for protection against VEE\", \"DNA Vaccine for Seasonal &Pandemic Influenza\", \"A single-dose prophylactic Japanese Encephalitis vaccine\", \"HIV VACCINE TRAILS NETWORK LEADERSHIP GROUP\", \"Evaluation of a CCR5 Vaccine for HIV infection in the SIV/Macaque Model\", \"PRODUCTION OF NON-EGG GROWN INFLUENZA VACCINES\", \"WHOLE CELL TUMOR VACCINES BASED ON GPI LINKED MOLECULE\", \"CHIMERIC CELL-SURFACE CYTOKINE FOR TUMOR VACCINES\", \"A Novel Immune Modulator/ Adjuvant for HIV Vaccines\", \"Development of a Recombinant Subunit Ebola Vaccine\", \"Novel Adenovirus Vectors for Biodefense Vaccines\", \"Evaluation of rotavirus vaccines in a primate model\", \"DNA Vaccines for Anthrax: Targeting Afferent Immunity\", \"Rational Anthrax Vaccine with Structural Epitopes on VLP\", \"Membrane-Stabilized Lymphotoxin As a Vaccine Adjuvant\", \"A Unique AIDS Vaccine Candidate For Multiple HIV Strains\", \"LIVE ORAL BACTERIAL VACCINE EVALUATION\", \"Rational Approach to Optimize Immune Potency of DNA Vaccines\", \"Mucoadhesive Polymers for Sublingual Vaccine Delivery\", \"Novel DNA/VLP Vaccines Against Influenza\", \"DIFFUSION AND ADOPTION OF CHILDREN'S VACCINE GUIDELINES\", \"THERAPEUTIC VACCINES TO REDUCE OCULAR HSV RECURRENCE\", \"HIV Vaccine Trials in Women\", \"Novel Vaccine Technology for Chikungunya\", \"Effect of Helminth Infection on HIV-1 Vaccines\", \"An Adjuvanted Therapeutic DNA Vaccine for AIDS\", \"Preclinical-Clinical Paramyxovirus Vaccine Development\", \"Therapeutics/Vaccine Teams\", \"Therapeutics/Vaccine Teams\", \"Task 09 (C21): Development of a Murine Model for Plague Vaccines\", \"Reagent Research Support\", \"VACCINE PRODUCTION FACILITY\", \"SIMIAN VACCINE EVALUATION UNITS\", \"SIMIAN VACCINE EVALUATION UNITS\", \"SIMIAN VACCINE EVALUATION UNITS\", \"CD40L and GITRL adjuvants for adenoviral vaccines against HIV\", \"STATISTICAL METHODS FOR ANALYSES OF HIV VACCINE TRIALS\", \"Task A12: SMALL ANIMAL MODELS FOR MYCOBACTERIA  VACCINE TESTING\", \"A dual vaccine strategy against filovirus infection\", \"Impact of maternally derived antibodies and infant microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants.\", \"Evaluation of Protein Capsule Matrix Vaccines Against Campylobacter jejuni\", \"Clinical Evaluation of an Improved Adenovirus Vaccine\", \"A Dengue/Zika Vaccine That Avoids Antibody-Dependent Enhancement\", \"Development of a Universal Influenza B Vaccine\", \"Enhanced Surveillance for New Vaccine Preventable Diseases\", \"Development of a tularemia vaccine that is safer and more potent than LVS\", \"HA Surface Presented Yeast Flu Vaccine and Its Enhancement by CD154 Codisplay\", \"Role of PD1-Based Vaccine-Elicited CD8+ T Lymphocytes in Modulating MDSC-associated Immunosuppression\", \"Antibodies to melanoma vaccine peptides\", \"A NEW CLASS OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) AUTOGENOUS VACCINE PRODUCED IN A NOVEL PORCINE MACROPHAGE CELL LINE\", \"Stabilization of Influenza Vaccine by Silica-Coating\", \"Development of autogenous vaccines for the control of amoebic gill disease in farmed Atlantic salmon\", \"Increasing HPV Vaccine Coverage among Young Adult Gay and Bisexual Men\", \"Next Generation sequencing of yellow fever 17D vaccine virus\", \"NEW MOLECULAR APPROACHES FOR IMPROVED VACCINES TO POULTRY DISEASES\", \"An immunomodulatory yeast-derived beta glucan as a component of a conjugate\", \"Chemical Strategies for Developing Improved Vaccines against Phenethylamines\", \"Development and comparative evaluation of three new generation BRSV DIVA vaccines and a corresponding DIVA test\", \"Enhanced Surveillance for New Vaccine Preventable Disease\", \"PiiiTCH Study\", \"Development of stable and rapidly acting adjuvanted vaccines for biodefense\", \"Bivalent Recombinant LHn Botulinum Vaccine (Serotypes A and B)\", \"Development of a Global GBS Vaccine\", \"Topical adjuvants to enhance the efficacy of influenza vaccines\", \"Prophylactic Anthrax Toxin Vaccine\", \"Development of a Novel Her2/neu Expressing Adenovirus for Treatment\", \"Trivalent Arenaviral Vaccine Based on Virus-Like Particle Vectors (VLPVs)\", \"School Mandates for Human Papillomavirus Vaccination: Use of an Agent-Based Model\", \"Laser-based powder vaccine delivery for improved newborn immunization\", \"Addressing Intra-/Inter-Clade Diversity in HIV Vaccine Design by Immune Focusing\", \"Development of live attenuated influenza virus vaccine\", \"Targeted Gene Expression from NL63 Vaccine Vectors\", \"Vaccine Renaissance Conference at the Institute for Immunology and Informatics\", \"Integration of Spatial and Social Network Analysis in Vaccine Trials\", \"Oral Vaccine Platform for Yersinia pestis\", \"Passive-Active Immunization Strategies Against Pediatric AIDS\", \"Poxvirus Immunity and DNA/MVA HIV Vaccines\", \"Directing the Immune System via Polymeric Combinations of Molecular Signals\", \"Understanding the issues surrounding parents'decisions to accept new vaccines for their children: A psychological theory-based approach.\", \"Identification of biomarkers indicative of Respiratory Syncytial Virus (RSV) vaccine-induced immune responses\", \"\\u57fa\\u4e8eDDA/TDB\\u9633\\u79bb\\u5b50\\u8102\\u8d28\\u4f53\\u4e3a\\u4f50\\u5242\\u7684\\u65b0\\u578b\\u6d41\\u611f\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u7ecf\\u9f3b\\u7c98\\u819c\\u514d\\u75ab\\u6548\\u5e94\\u4e0e\\u673a\\u5236\\u7814\\u7a76\", \"\\u8868\\u8fbe\\u9e21\\u4f20\\u67d3\\u6027\\u652f\\u6c14\\u7ba1\\u708e\\u75c5\\u6bd2S1\\u548cN\\u86cb\\u767d\\u91cd\\u7ec4\\u65b0\\u57ce\\u75ab\\u75c5\\u6bd2\\u7684\\u6784\\u5efa\\u53ca\\u514d\\u75ab\\u4fdd\\u62a4\\u8bc4\\u4ef7\", \"Use of the Dual Platform Immunization (DuPI) Approach to Develop a Tetravalent Dengue Vaccine\", \"Controlled Release of Inactivated Chikungunya Virus Vaccine Candidate: A Single Vaccination Approach for Long-Term Immunity\", \"Development of a Single Shot, Neonatal Pertussis Vaccine\", \"Public deliberation on vaccine hesitancy\", \"In vivo evaluation of conventional and experimental avian influenza A (H5N1) virus vaccines\", \"Novel cross-protective (universal) vaccine for influenza infections\", \"Novel tuberculosis vaccine for cattle\", \"ImmuneTrack - for optimisation of vaccine stock management in Uganda\", \"Development of a therapeutic vaccine against genital herpes simplex virus 2 infection\", \"A Novel Vaccine Platform for Preventing Zika Virus Infection\", \"Pre-clinical development of a chemically synthetic anti-toxic vaccine against malaria\", \"Improving efficacy of vaccination against the gut pathogen Helicobacter pylori\", \"Next Generation Vaccines to Augment Anti-PD-1 Immunotherapy for Melanoma\", \"Rapid Development of Vaccines for Emerging Viruses\", \"\\u7d4c\\u76ae\\u514d\\u75ab\\u88fd\\u5264\\u306e\\u5229\\u4fbf\\u6027\\u30fb\\u6c4e\\u7528\\u6027\\u5411\\u4e0a\\u306b\\u9069\\u3046\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u306e\\u540c\\u5b9a\\u3068\\u69cb\\u9020\\u6539\\u5909\\u6297\\u539f\\u5206\\u5b50\\u306e\\u5275\\u88fd\", \"\\u30e6\\u30d3\\u30ad\\u30c1\\u30f3\\u30d7\\u30ed\\u30c6\\u30a2\\u30bd\\u30fc\\u30e0\\u7cfb\\u306e\\u5fdc\\u7528\\u306b\\u3088\\u308b\\u7d30\\u80de\\u5185\\u5bc4\\u751f\\u539f\\u866b\\u306b\\u5bfe\\u3059\\u308bDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Development of effective immunization by DNA vaccine against iron-acquisition protein of periodontopathic bacteria\", \"\\u725b\\u306e\\u30dc\\u30c4\\u30ea\\u30cc\\u30b9C\\u578b\\u3001D\\u578b\\u4e2d\\u6bd2\\u306e\\u4e21\\u65b9\\u306b\\u52b9\\u679c\\u306e\\u3042\\u308b\\u30ea\\u30b3\\u30f3\\u30d3\\u30ca\\u30f3\\u30c8\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4f5c\\u88fd\", \"Deparment of vaccine for new type of Vibrio cholerae O139 Bengal\", \"Ultra-dense peptide array analysis of naturally acquired and vaccine-induced P. falciparum immunity\", \"11th International Symposium on Dendritic Cells in Fundamental and Clinical Immunology / DC2010: Forum on Vaccine Science\", \"CD40L and GITRL adjuvants for anti-HIV Ad5 vector vaccines\", \"Development of photochemical internalisation for enhancement of therapeutic and prophylactic vaccination\", \"The Immunogenicity and Protective Efficacy of Plant-Derived Influenza H5N1 Vaccine in Preclinical Models.\", \"Razvoj avtolognih tumorskih vakcin (basic research project)\", \"Vaccine against Streptococcus pneumoniae based on choline-binding proteins\", \"Needleless Intradermal Vaccine Delivery System Using Ultrasound\", \"Boost-Phase Sub-Unit Vaccine Development for Binary Vaccines Against Infectious Diseases and Biological Warfare Agents\", \"MAnufacturing process for Cold-chain Independent VIrosome-based VAccines\", \"Discovery and preclinical development of new generation tuberculosis vaccines\", \"Improvement of current and development of new vaccines for theileriosis and babesios of small ruminants\", \"Initiative on Optimizing Malaria Vaccine Lab Assays Evaluation\", \"Markov Decision Process Models for Optimizing Vaccine Administration\", \"Parental Decision Making in the Context of New Medical Technologies: The HPV Vaccine and its Potential Challenges\", \"Engineered porcine adenovirus type 3 as a vaccine vector\", \"Engineered porcine adenovirus type 3 as a vaccine vector\", \"IMMUNOPATHOGENESIS OF RUBELLA VIRUS ASSOCIATED AUTOIMMUN\", \"Immune Responses to Vaccinia Virus Vaccination\", \"Development of Alphavirus Replicon Vaccine Against SARS\", \"DNA Based Generation of Avian Influenza virus Vaccines\", \"Leadership Group for a Global HIV Vaccine Clinical Trials Network\", \"COALITION FOR HIV VACCINE DEVELOPMENT\", \"DNA BASED GENERATION OF AVIAN INFLUENZA VIRUS VACCINES\", \"CHIMERIC YELLOW FEVER 17D/DENGUE AND WEST NILE VACCINES\", \"Development of an anti-malaria toxin vaccine candidate\", \"HETEROCONJUGATE VACCINES AGAINST HERPES SIMPLEX VIRUS\", \"Development of a plant-grown subunit vaccine against respiratory syncytial virus\", \"Improved influenza A virus vaccines using alpha-Gal epitope modification\", \"An improved targeted vaccine strategy against anthrax\", \"A GENOME-DERIVED, EPITOPE-DRIVEN TULAREMIA VACCINE\", \"Development of a Plant-based Vaccine aganist HIV\", \"DNA Tolerizing Vaccine Therapy for Multiple Sclerosis\", \"A CMV vaccine with modified immuno-modulatory properties\", \"Multifunctional nanoparticles for targeted DNA vaccine delivery\", \"Passive-Active Vaccine Strategies Against Pediatric AIDS\", \"Recombinant Sendai Virus as a Novel HIV Vaccine Vector\", \"AIDS Prevention: Mucosally-Targeted Plant Based Vaccines\", \"Rabies Virus-Based Vectors as an HIV -1 Vaccine\", \"Conference on Gene-Based Vaccines\", \"HIV Vaccines\", \"EFFECT OF COMMUNITY PHARMACISTS ON ADULT IMMUNIZATION\", \"Multi-component and easily administrated anthrax vaccine\", \"Geographical Analysis in Vaccine Efficacy Trials\", \"Vaccines for Prevention of Experimental Congenital CMV\", \"IMMUNOPREVENTION OF HTLV INFECTION\", \"The Effect of Helminth Infection on HIV-1 Vaccines\", \"TB Vaccine Development in Nonhuman Primate Model\", \"HIV/FIV-cat model: a model to identify vaccine epitopes\", \"Acquisition and Natural History of Genital HPV Infection\", \"Childhood Vaccine Policy in the U.S. Since 1955\", \"Center for Research in Emerging Infections and Vaccines\", \"Lymph Node-Targeted Cancer Vaccines\", \"Improving the quality of FMD vaccines by understanding the correlation of vaccine-induced protection with humoral and cellular immune responses\", \"A Phase I Study of a DNA-Based Vaccine Targeting Prostatic Acid Phosphatase (PAP) in Patients with Stage D0 Prostate Cancer\", \"Risks, Controversies & Vaccinations\", \"Newcastle Disease Virus Vectored Vaccine against Poliomyelitis\", \"Development and Testing of an Oral B Subunit-Whole Cell Cholera Vaccine Protecting Against Both O1 and O139 Cholera\", \"Enhancing protective antibody responses for a GM-CSF adjuvanted HIV vaccine\", \"Clinical Trials of  Biodefense Vaccines (Dengue, West Nile Virus, TBEV)\", \"Evolution of the influenza A virus quasispecies in naive and immune hosts\", \"Development of equine herpesvirus 1 vaccine based on new insights into the pathogenesis of foeto- and neuro virulent equine herpesvirus 1 strains\", \"Development and use of new genetic engineering and testing for BCG-based anti-tuberculosis vaccines\", \"Modulation of NK cells by alpha herpes viruses with the aim of optimizing vaccines and virotherapy\", \"Development of Salmonella live attenuated vaccine strains for various serotypes in layers+ broilers\", \"Clinical Development of RNA Nanoparticle Vaccines Targeting Recurrent Pediatric Brain Cancers\", \"In vivo MR Imaging to assess delivery and efficacy of dendritic cell vaccines\", \"Immunology vaccine\", \"\\u00c9tudiante-chercheuse \\u00e9toile June 2013\", \"Influence of pre-existing HIV cross-reactive CD4 T cells on vaccine responses to new Env immunogens\", \"Immunogenic characterization of plant-specific glyco-epitopes present on influenza virus-like particle vaccines produced in Nicotiana benthamiana\", \"\\u65b0\\u578b\\u591a\\u4ef7\\u53e3\\u670dHPV\\u9884\\u9632\\u6027\\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u57fa\\u4e8eDC\\u7684TLR\\u53ca\\u5176\\u4fe1\\u53f7\\u8f6c\\u5bfc\\u901a\\u8def\\u5728\\u65b0\\u578b\\u4e59\\u809dDNA\\u75ab\\u82d7\\u5f39\\u6027\\u7eb3\\u7c73\\u7c92\\u7ecf\\u76ae\\u514d\\u75ab\\u4e2d\\u7684\\u4f5c\\u7528\\u53ca\\u5176\\u673a\\u5236\\u7814\\u7a76\", \"\\u5229\\u7528\\u8f6c\\u57fa\\u56e0\\u690d\\u7269\\u751f\\u4ea7\\u9e21\\u9a6c\\u7acb\\u514b\\u6c0f\\u75c5\\u75ab\\u82d7\", \"2016\\u5e74\\u5ea6\\u6d77\\u5ce1\\u4e24\\u5cb8\\u6c34\\u751f\\u751f\\u7269\\u8d44\\u6e90\\u9886\\u57df\\u9879\\u76ee\\u4e2d\\u671f\\u5b66\\u672f\\u4ea4\\u6d41\\u7814\\u8ba8\\u4f1a\", \"\\u4eff\\u751f\\u7845\\u77ff\\u5316\\u63d0\\u9ad8\\u75ab\\u82d7\\u70ed\\u7a33\\u5b9a\\u6027\\u7684\\u7814\\u7a76\", \"VLP\\u9897\\u7c92\\u6297\\u539f\\u964d\\u538b\\u75ab\\u82d7\\u514d\\u75ab\\u5e94\\u7b54\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u542b\\u6709GM-CSF\\u6216CD40L\\u7684\\u6c49\\u6ee9\\u75c5\\u6bd2\\u5d4c\\u5408VLPs\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u5b66\\u7279\\u6027\\u7814\\u7a76\", \"\\u75d8\\u82d7\\u75c5\\u6bd2\\u8f7d\\u4f53\\u91cd\\u7ec4AIDS\\u75ab\\u82d7\\u4e0e\\u7c98\\u819c\\u4e0a\\u76ae\\u7ec6\\u80de\\u7684\\u76f8\\u4e92\\u4f5c\\u7528\", \"Avian adenoviruses; molecular bilogy, vaccine, diagnostics\", \"Characterization of and challenge studies with infectious bronchitis virus isolates of Ontario\", \"Control of Salmonella in Market Hogs Using Immunizations\", \"Controlling Salmonellosis in Broiler Chickens Using a Multivalent Attenuated Vaccine That Also Controls Necrotic Enteritis\", \"Verbundprojekt: Development of a hepatitis C vaccine by targeted delivery of nanogel RNA-replicon constructs (HCVAX) - Teilvorhaben: Identifizierung und Generierung synthetischer Adjuvantien f\\u00fcr die Verwendung mit Nanogel-verpackten RNA-Replicon Impfstoffen und deren in vitro und in vivo Validierung\", \"A Novel Influenza Vaccine with Enhanced Immunogenic Hemagglutinin Stalk Domain\", \"A sub-unit based vaccine for Salmonella\", \"Topical enhancement of vaccination\", \"Canadian Immunization Research Network\", \"Use of the Baboon Model of Pertussis to Evaluate Strategies for Next Generation Pertussis Vaccines\", \"WT-1 analog peptide vaccine in patients with malignant mesothelioma\", \"Prototypy szczepionek przeciwko Neisseria gonorrhoeae oparte o \\u017cywe szczepy bakterii zawieraj\\u0105c bia\\u0142ka lub aktywne fagi nitkowate z Neisseria gonorrhoeae\", \"\\u53e3\\u670dAg85A DNA\\u75ab\\u82d7\\u80a0\\u9ecf\\u819c\\u7ec6\\u80de\\u5185\\u4f20\\u611f\\u5668\\u53ca\\u4f20\\u5bfc\\u9014\\u5f84\\u4e0e\\u9002\\u5e94\\u6027\\u514d\\u75ab\\u5e94\\u7b54\\u8bf1\\u5bfc\", \"\\u529f\\u80fd\\u5316\\u6c27\\u5316\\u77f3\\u58a8\\u70ef\\u4f5c\\u4e3a\\u65b0\\u578b\\u7eb3\\u7c73\\u4f50\\u5242\\u5728\\u80bf\\u7624DNA\\u75ab\\u82d7\\u4e2d\\u7684\\u7814\\u7a76\", \"\\u9488\\u5bf9\\u80bf\\u7624\\u5fae\\u73af\\u5883\\u9ad3\\u7cfb\\u6291\\u5236\\u7ec6\\u80de\\u7684\\u65b0\\u578bImC\\u75ab\\u82d7\\u6297\\u80bf\\u7624\\u4f5c\\u7528\\u53ca\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"\\u4ea7\\u751f\\u514d\\u75ab\\u4fdd\\u62a4\\u6027\\u7684\\u706d\\u6d3b\\u8fdf\\u7f13\\u7231\\u5fb7\\u534e\\u6c0f\\u83cc\\u7684\\u4f5c\\u7528\\u673a\\u5236\", \"JEV\\u75ab\\u82d7\\u4ea4\\u53c9\\u4fdd\\u62a4\\u767b\\u9769\\u75c5\\u6bd2\\u611f\\u67d3\\u7684\\u673a\\u7406\\u7814\\u7a76\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"Nonhuman Primate Core Functional Genomics Laboratory for AIDS Vaccines Research a\", \"IGF::OT::IGF  A Phase I Trial of the Safety and Immunogenicity of RG1-VLP, a candidate broadly protective vaccine for the prevention of HPV-associated cancer\", \"Determining the Impact of Semisynthetic Saponin Immunologic Adjuvant Titerquil-1055 on Influenza Vaccine Immunogenicity and Stability\", \"Second-Generation Therapeutic DNA Lymphoma Vaccines\", \"CHOLERA, MUCOSAL VACCINES AND IMMUNOMODULATION\", \"Immunological and histochemical assessment of an Alzheimer\\u00b4s vaccine\", \"Alphavirus replicon vectors as vaccines\", \"Simplexia - development of a vaccine against HSV-2 infection\", \"Do host genetic factors restrict natural rotavirus infection and vaccine performance in Nicaragua?\", \"Therapeutic vaccines for the treatment of severe atopic dermatitis and asthma\", \"Tools to study the effects of rotavirus vaccination in Burkina Faso\", \"Immunogenicity and safety of HPV vaccine in immunosuppressed women due to solid organ transplant and rheumatologic disease. Study 1: Evaluation of primary imune response to vaccination\", \"Development of statistical tools for the analysis of complex data: application to associations between reactogenicity and innate/adaptive answer immune related to the adjuvded vaccines for man.\", \"PKD Control  studies on the immune response in fish and vaccine development.\", \"Development of vaccination methods for the control of bacterial kidney disease (BKD) in salmonids (LINKSAL10)\", \"Baboon Model of Pertussis to Evaluate Strategies for Next Generation Vaccines\", \"MUC1\\u6a21\\u62df\\u8868\\u4f4d\\u591a\\u80bd\\u75ab\\u82d7\\u8bbe\\u8ba1\\u53ca\\u5176\\u6297\\u80bf\\u7624\\u6548\\u5e94\\u7814\\u7a76\", \"\\u4eba3\\u578b\\u30017\\u578b\\u817a\\u75c5\\u6bd2\\u53cc\\u4ef7\\u51cf\\u6bd2\\u91cd\\u7ec4\\u75ab\\u82d7\\u5019\\u9009\\u682a\\u7684\\u6784\\u5efa\\u53ca\\u514d\\u75ab\\u539f\\u6027\\u7814\\u7a76\", \"\\u732a\\u761f\\u75c5\\u6bd2\\u7cd6\\u86cb\\u767dE2\\u9ad8\\u53d8\\u533a\\u5bf9\\u75ab\\u82d7C\\u682a\\u83b7\\u5f97\\u6027\\u514d\\u75ab\\u5e94\\u7b54\\u5f71\\u54cd\\u7684\\u7814\\u7a76\", \"\\u4ee5Her2/neu\\u4e3a\\u9776\\u70b9\\u7684\\u65b0\\u578bVLP\\u75ab\\u82d7\\u514d\\u75ab\\u5e94\\u7b54\\u7814\\u7a76\", \"\\u7ec6\\u7c92\\u68d8\\u7403\\u86b4G1Y162\\u6297\\u539f\\u4f18\\u52bf\\u8868\\u4f4d\\u7684\\u7b5b\\u9009\\u53ca\\u5176\\u514d\\u75ab\\u7279\\u6027\\u7684\\u7814\\u7a76\", \"\\u4ee5\\u756a\\u8304\\u679c\\u5b9e\\u4e3a\\u53d7\\u4f53\\u8868\\u8fbe\\u7ed3\\u6838\\u5206\\u679d\\u6746\\u83ccAg85B-ESAT-6-WbbL\\u878d\\u5408\\u86cb\\u767d\\u53ca\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"Development of a novel fungal vaccine with glycolipid antigens\", \"Optimalizace vakcina\\u010dn\\u00edho sch\\u00e9matu oslaben\\u00e9 vakc\\u00edny Salmonella Enteritidis vedouc\\u00ed k dlouhodob\\u00e9 ochran\\u011b dr\\u016fbe\\u017ee p\\u0159ed infekc\\u00ed salmonelami\", \"Mo\\u017enosti vakcinace prasat inaktivovanou vakc\\u00ednou pro tlumen\\u00ed v\\u00fdskytu salmonel v chovech prasat\", \"V\\u00fdzkum a v\\u00fdvoj vakc\\u00edny proti onemocn\\u011bn\\u00ed doln\\u00edch cest d\\u00fdchac\\u00edch v ozdraven\\u00fdch chovech prasat\", \"Biodegradabiln\\u00ed syst\\u00e9my s prolongovanou liberac\\u00ed vakc\\u00edn\", \"Vyu\\u017eit\\u00ed dendritick\\u00fdch bun\\u011bk nalo\\u017een\\u00fdch univerz\\u00e1ln\\u00edmi n\\u00e1dorov\\u00fdmi antigeny pro p\\u0159\\u00edpravu protin\\u00e1dorov\\u00fdch vakc\\u00edn\", \"Kombinovan\\u00e1 imunoterapie n\\u00e1dor\\u016f vyvolan\\u00fdch lidsk\\u00fdm papillomavirem\", \"Kombinovan\\u00e1 l\\u00e9\\u010dba zbytkov\\u00e9 n\\u00e1dorov\\u00e9 choroby pomoc\\u00ed IL-2 a GM-CSF vyu\\u017e\\u00edvaj\\u00edc\\u00ed rekombinantn\\u00edch cytokin\\u016f a geneticky modifikovan\\u00fdch vakcin.\", \"V\\u00fdvoj rekombinantn\\u00edch vir\\u016f vakcinie s geny pro cytokiny pro l\\u00e9\\u010dbu n\\u00e1dor\\u016f.\", \"Prevence IDDM BCG vakc\\u00ednou : Lidsk\\u00fd model p\\u0159irozen\\u00e9 vn\\u00edmavosti /rezistence na infekci Mycobacterium bovis BCG.\", \"Protin\\u00e1dorov\\u00e9 vakciny p\\u0159ipraven\\u00e9 f\\u00faz\\u00ed n\\u00e1dorov\\u00fdch a dendritick\\u00fdch bun\\u011bk\", \"FRANCIS - V\\u00fdvoj nov\\u00fdch profylaktick\\u00fdch prost\\u0159edk\\u016f proti infekci Francisella tularensis\", \"KANVAKOL - vakc\\u00edna k l\\u00e9\\u010db\\u011b vlekl\\u00fdch kvasinkov\\u00fdch z\\u00e1n\\u011bt\\u016f pochvy.\", \"Studium mechanismu p\\u016fsoben\\u00ed bakteri\\u00e1ln\\u00edch toxin\\u016f\", \"Biologicky bezpe\\u010dn\\u00fd expresn\\u00ed syst\\u00e9m zalo\\u017een\\u00fd na rostlinn\\u00fdch virech pro transientn\\u00ed expresi papillomavirov\\u00fdch onkoprotein\\u016f a v\\u00fdvoj terapeutick\\u00e9 vakc\\u00edny\", \"*Biotechnologie v\\u00fdroby antigen\\u016f Borrelia burgdorferi sensu lato pro p\\u0159\\u00edpravu prototypu vakc\\u00edny proti Lymesk\\u00e9 boreli\\u00f3ze.\", \"Assessment of vaccine efficacy for Malaria and Tuberculosis in a co-infection setting relevant for disease endemic sub-Saharan African regions.\", \"Analysis of vaccine induced immunity in cattle against the gastrointestinal namatode Ostertagia ostertagi\", \"Evolution of the influenza A virus quasispecies in naive and immune hosts\", \"A \\\"negative\\\" dendritic-cell based vaccine for the treatment of multiple sclerosis: a first-in-man multicenter trial.\", \"A Randomized, Double-Blinded, Controlled with GARDASIL\\u00ae Phase 3 Clinical Trial.\", \"Preclinical development of an optimised dendritic cell-based vaccine against acute myeloid leukemia.\", \"Research Fellowship\", \"A polyvalent group A streptococcal vaccine\", \"Attenuated and recombinant mycobacterial strains as novel vaccines to control tuberculosis\", \"Study of HPV 6 L1 virus like paticles as Therapeutic vaccine for genital warts and recurrent respiratory papillomatosis.\", \"Molecular approaches to developing subunit vaccines with improved efficacy against tuberculosis\", \"To support the 5th Global Forum on TB Vaccines, which brings together stakeholders from around the world and across all areas of research to facilitate dialogue and to promote partnership and collaboration with the goal of accelerating TB vaccine R&D\", \"Pre-clinical development of an affordable, safe and efficacious four-in-one dengue vaccine candidate\", \"To test the theory that a measured dose of vitamin A (retinoic acid) given with an oral vaccine will enhance immunoglobulin secretions in the gut, thus boosting the mucosal immune response. If successful, vitamin A could be used as an effective adjuvant for oral vaccines that target diarrhea, a leading cause of death among children worldwide.\", \"To expand CanSino\\u2019s capability to conduct clinical trials in Africa so that, in the future, CanSino will be able to provide low cost and high quality vaccines to African countries and to help prevent common diseases for poor, low-income or otherwise underserved communities that otherwise would lack access to such vaccines at an affordable price\", \"To evaluate the ability of the BEN-1 vaccine to act as a highly effective and safe Contagious Bovine Pleuropneumonia (CBPP) vaccine that meets target product profile and that is a pivotal enabler for the control and then possibly elimination of the disease in Africa\", \"To develop and deploy a low-cost, easy-to-use remote temperature monitoring system for cold chain monitoring which sends SMS alerts to reduce vaccine spoilage and integrates with existing electronic logistics management systems to improve distribution and management of vaccines at different levels of the supply chain\", \"To develop and deploy a low-cost, easy-to-use remote temperature monitoring (RTM) system for cold chain monitoring, which sends SMS alerts to reduce vaccine spoilage and integrates with existing electronic logistics management systems to improve distribution and management of vaccines at different levels of the supply chain\", \"To assess the safety, reactogenicity, immunogenicity and impact on intestinal shedding of 1 dose of a monovalent type 2 high dose inactivated poliovirus vaccine compared to a licensed trivalent inactivated poliovirus vaccine when given concomitantly with bOPV to infants early in life\", \"To assess the feasibility of a project to establish poliovirus surveillance in Cap Verde following a switch from oral polio vaccine (OPV) to inactivated polio vaccine (IPV) to monitor ongoing viral circulation and to use a challenge study to understand the sensitivity of environmental surveillance and to develop a project protocol based on this feasibility study\", \"To convene an international gathering of professionals from developing countries working in research, development, manufacturing and supply of vaccines, towards the common goal of protecting people against known and emerging viral and bacterial infectious diseases by increasing the availability of high-quality vaccines\", \"To develop a vaccine vector based on a prototype vaccine for herpes simplex virus 2 (HSV-2) that encodes multiple CD8 T cell epitopes from HIV proteins, and test its ability to stimulate a robust CD8 T cell response against HIV\", \"To build consensus among the world\\u2019s immunization costing experts on how best to systematically improve immunization service delivery costs for by donors, national governments, and multilateral agencies to advance vaccine development and health policies and programs aimed at reducing vaccine preventable diseases among children, adolescents and adult populations\", \"To boost the effect of vaccines against rotavirus infection, which causes diarrhea, by developing a pig model to mimic the gut conditions of children in developing countries who do not respond to vaccines, which can be used to test interventions.\", \"To convene an international gathering of professionals working in research, development, manufacturing and supply of vaccines, towards the common goal of protecting people against known and emerging viral and bacterial infectious diseases by increasing the availability of high-quality vaccines produced in developing countries\", \"To help inform evidence-based dialogue and public health policy related to vaccines in India, working closely with the Indian Ministry of Health, local experts, and local partners on including vaccines within comprehensive approaches to protect children from life-threatening diseases - namely diarrhea, pneumonia, and meningitis\", \"To support the 4th Global Forum on Tuberculosis (TB) Vaccines intended to build on the success of the prior three conferences in bringing together researchers from all sectors for an in depth review and discussion of progress and gaps in TB vaccine research and development\", \"To design, produce, characterize and assess the immunogenicity of nanoparticles of multiple, specific symmetries that present the prefusion forms of human respiratory syncytial virus (hRSV) F and human metapneumonia virus (hMPV) F, to potentially generate novel vaccine design concepts for hRSV/hMPV vaccines suitable for maternal immunization\", \"To develop a microneedle patch that can be used for safe, efficacious and cost-effective delivery of inactivated poliovirus vaccine (IPV) as part of the polio Eradication and Endgame strategic plan to stop the use of oral polio vaccine (OPV) worldwide by the end of 2019\", \"To develop a microneedle patch that can be used for safe, efficacious and cost-effective delivery of inactivated poliovirus vaccine (IPV) as part of the polio Eradication and Endgame strategic plan to stop the use of oral polio vaccine (OPV) worldwide by the end of 2019\", \"To cover the expenses for the initial activities which are necessary in order to prepare Intravacc to be ready to start to produce, test and document new Oral Polio Vaccine type 2 (nOPV2) poliovirus Master- and Working seed lots (for two concepts) to ensure future production of live polio vaccines as soon as possible after the Product Development\", \"Task X9:  Agilvax Phage Display for Multiple Vaccine Candidates\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"Task A91: Development of a Murine Model of Subcutaneous (SC) Melioidosis for Use in Vaccine Evaluation\", \"Newton Fund - Development of an oral, thermostable enteric fever vaccine: saving lives and supporting tourism in Mexico\", \"Development new immunotherapy for pediatric cancer using human iPSCs\", \"Development of the Novel Therapeutic Strategy for Cerebral Infarction; The Efficacy of  Angiotensin II DNA Vaccine in Rat Model of Cerebral Infarction.\", \"Development of immunomodulatory  p53-targeted vaccine for mouse model of prostate cancer\", \"Basic Study of orally-delivered vaccine development using a new innate immunity inducer\", \"Development of DNA vaccine against intracellular microbial pathogens by using artificially synthesized genes\", \"Immunogenicity, effectiveness and safety of 2009 A (H1N1) pandemicinfluenza vaccine in high risk population.\", \"Development of novel oncofetal antigen targeting immunotherapy for refractory ovarian carcinoma\", \"Persistent infection of Hepatitis C Virus\", \"Reverse genetics for rotavirus and its applications\", \"The development of the polysomal RNA vaccine to the ovarian cancer\", \"\\u96e3\\u6cbb\\u6027\\u539f\\u866b\\u611f\\u67d3\\u75c7\\u306b\\u5bfe\\u3059\\u308b\\u7d30\\u80de\\u6027\\u514d\\u75ab\\u8a98\\u5c0e\\u578b\\u30ef\\u30af\\u30c1\\u30f3\\u30b7\\u30b9\\u30c6\\u30e0\\u306e\\u8a55\\u4fa1\", \"Inhibition of S.mutans colonization by the DNA vaccine targeted on GTFC and It's anti-cariogenic effects\", \"Reconstitution of a novel recombinant Marek's disease virus as a vector vaccine against poultry red mites\", \"\\u30ec\\u30cb\\u30f3\\u30a2\\u30f3\\u30b8\\u30aa\\u30c6\\u30f3\\u30b7\\u30f3\\u7cfb\\u3092\\u6a19\\u7684\\u3068\\u3057\\u305f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Preclinical and clinical study of influenza microneedle vaccine and analysis of immunity induction mechanism\", \"\\uff22\\u578b\\u809d\\u708e\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u5bfe\\u3059\\u308b\\u521d\\u671f\\u304a\\u3088\\u3073\\u8a18\\u61b6\\u514d\\u75ab\\u5fdc\\u7b54\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"Virus Like Nano-Particle as the delivery tool of vaccine adjuvant\", \"Analysis of adjuvant action Escherichia coli enterotoxin\", \"Parasite digestive enzymes: targets for new drugs and vaccines\", \"Making a yeast-based candidate vaccine against Porcine Epidemic Diarrhea Virus  (PEDV)\", \"Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases\", \"Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases\", \"Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases\", \"TO X13: Evaluation of an E. coli Vaccine Candidate - Immunogenicity Testing\", \"Task X11:Evaluation of Clinical Samples from a Dengue Vaccine Clinical Trial\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"Expansion of Product Development Capacity\", \"Modelling the impact of vaccination targeted against serogroup B meningococcal disease.\", \"A novel prophylactic vaccine and delivery platform to prevent Clostridium difficile infections\", \"\\u65b0\\u57ce\\u75abDNA\\u75ab\\u82d7\\u4e09\\u7532\\u57fa\\u58f3\\u805a\\u7cd6\\u7eb3\\u7c73\\u7c92\\u9ecf\\u819c\\u514d\\u75ab\\u4f20\\u9012\\u7cfb\\u7edf\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u4f5c\\u7528\\u673a\\u5236\\u7814\\u7a76\", \"IL-28B\\u548cCD25\\u6297\\u4f53\\u6291\\u5236\\u8c03\\u8282\\u6027T\\u7ec6\\u80de\\u589e\\u5f3a\\u7ed3\\u6838\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u514d\\u75ab\\u6d3b\\u6027\\u5b9e\\u9a8c\\u7814\\u7a76\", \"PglB\\u4ecb\\u5bfc\\u7684\\u4e00\\u6b65\\u5408\\u6210\\u591a\\u7cd6\\uff0d\\u86cb\\u767d\\u7f00\\u5408\\u7269\\u75ab\\u82d7\\u5e73\\u53f0\\u6784\\u5efa\", \"\\u5976\\u725b\\u4e73\\u623f\\u708e\\u91d1\\u9ec4\\u8272\\u8461\\u8404\\u7403\\u83cc\\u591a\\u4e9a\\u5355\\u4f4d\\u5d4c\\u5408\\u86cb\\u767d\\u6297\\u539f\\u8868\\u8fbe\\u53ca\\u514d\\u75ab\\u539f\\u6027\\u7814\\u7a76\", \"\\u5d4c\\u5408RSV\\u6297\\u539f\\u8868\\u4f4d\\u7684\\u91cd\\u7ec4\\u6d41\\u611f\\u51cf\\u6bd2\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u514d\\u75ab\\u4fdd\\u62a4\", \"\\u5a74\\u513f\\u4e59\\u809d\\u75ab\\u82d7\\u5e94\\u7b54\\u7684\\u6bcd\\u6e90\\u6027\\u7ec6\\u80de\\u5047\\u8bf4\\u53ca\\u5176\\u9a8c\\u8bc1\", \"\\u8102\\u591a\\u7cd6\\u8868\\u4f4d\\u6a21\\u62df\\u80bd\\u75ab\\u82d7\\u8bf1\\u5bfc\\u518d\\u6b21\\u514d\\u75ab\\u5e94\\u7b54\\u7684\\u7814\\u7a76\", \"MAGE\\u591a\\u8868\\u4f4d\\u80bd\\u80bf\\u7624\\u7eb3\\u7c73\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u5f27\\u83cc\\u5916\\u819c\\u86cb\\u767d\\u5728\\u9175\\u6bcd\\u83cc\\u7ec6\\u80de\\u8868\\u9762\\u4e0a\\u7684\\u5c55\\u793a\\u548c\\u4f5c\\u4e3a\\u591a\\u4ef7\\u6d3b\\u75ab\\u82d7\\u7684\\u6f5c\\u5728\\u5e94\\u7528\", \"\\u57fa\\u4e8e\\u5fae\\u9488\\u7ed9\\u836f\\u7cfb\\u7edf\\u7684DNA\\u805a\\u9633\\u79bb\\u5b50\\u7eb3\\u7c73\\u590d\\u5408\\u7269\\u76ae\\u5185\\u514d\\u75ab\\u6548\\u5e94\\u53ca\\u5176\\u673a\\u7406\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u6297\\u4f53\\u7684\\u9488\\u5bf9\\u767b\\u9769\\u75c5\\u6bd2\\u591a\\u80bd\\u75ab\\u82d7\\u7684\\u6784\\u5efa\", \"\\u7eb3\\u7c73\\u5c42\\u72b6\\u53cc\\u6c22\\u6c27\\u5316\\u7269/\\u4e8c\\u6c27\\u5316\\u7845\\u4f5c\\u4e3aDNA\\u75ab\\u82d7\\u9012\\u9001\\u7cfb\\u7edf\\u7684\\u7814\\u7a76\", \"\\u51cf\\u6bd2\\u6c99\\u95e8\\u6c0f\\u83cc\\u9012\\u5448\\u7684TGEV S/N\\u53cc\\u57fa\\u56e0\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u4e0e\\u514d\\u75ab\\u8bf1\\u5bfc\\u89c4\\u5f8b\\u7814\\u7a76\", \"\\u65b0\\u578bMUC1 DNA\\u75ab\\u82d7\\u7684\\u4f18\\u5316\\u6784\\u5efa\\u53ca\\u6cbb\\u7597\\u80f0\\u817a\\u764c\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u5171\\u8868\\u8fbegB\\u53ca\\u9776\\u5411BAK SiRNA\\u7684\\u65b0\\u578b\\u75ab\\u82d7\\u5728\\u52a8\\u7269\\u6a21\\u578b\\u4e0a\\u6297CMV\\u80ce\\u4ed4\\u611f\\u67d3\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u809d\\u7d20\\u9176\\u4e0d\\u540cCTL\\u8868\\u4f4d\\u6df7\\u5408\\u591a\\u80bd\\u75ab\\u82d7\\u6297\\u80bf\\u7624\\u6548\\u5e94\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"OK-432\\u80bf\\u7624\\u75ab\\u82d7\\u6297\\u80bf\\u7624\\u4f5c\\u7528\\u7684\\u4fe1\\u53f7\\u4f20\\u5bfc\\u673a\\u5236\", \"TRAG-3\\u6297\\u539f\\u4e3a\\u9776\\u6807\\u7684\\u65b0\\u578b\\u80bf\\u7624\\u75ab\\u82d7\\u6cbb\\u7597\\u80ba\\u764c\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u6076\\u6027\\u80bf\\u7624\\u65b0\\u578b\\u6cbb\\u7597\\u6027\\u75ab\\u82d7\\u7684\\u5e94\\u7528\\u57fa\\u7840\\u7814\\u7a76\", \"\\u7c98\\u819c\\u4f50\\u5242LTB\\u4f18\\u5316\\u6dcb\\u75c5\\u7eb3\\u7c73\\u6838\\u9178\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u514d\\u75ab\\u5171\\u523a\\u6fc0\\u56e0\\u5b504-1BBL\\u589e\\u5f3aDNA\\u75ab\\u82d7\\u7ec6\\u80de\\u514d\\u75ab\\u53cd\\u5e94\\u7684\\u673a\\u7406\\u7814\\u7a76\", \"\\u526f\\u7ed3\\u6838\\u5206\\u679d\\u6746\\u83cc\\u975e\\u53d8\\u6001\\u53cd\\u5e94\\u6027\\u514d\\u75ab\\u4fdd\\u62a4\\u57fa\\u56e0\\u7684\\u7814\\u7a76\", \"\\u9a6c\\u4f20\\u67d3\\u6027\\u8d2b\\u8840\\u75c5\\u6bd2\\u51cf\\u6bd2\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"L\\u578b\\u9499\\u901a\\u9053\\u6cbb\\u7597\\u6027\\u964d\\u538b\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u9776\\u5411\\u7259\\u5468\\u708eDNA\\u75ab\\u82d7\\u7684\\u7814\\u5236\\u548c\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"IDO\\u57fa\\u56e0\\u4fee\\u9970\\u7684T\\u7ec6\\u80de\\u8868\\u4f4d\\u75ab\\u82d7\\u8bf1\\u5bfc\\u6297-GBM\\u80be\\u708e\\u514d\\u75ab\\u8010\\u53d7\\u7684\\u6548\\u5e94\\u673a\\u5236\\u7814\\u7a76\", \"Novel vaccine candidates against meningococcal disease\", \"Development of a food-grade Lactobacillus-based oral vaccine delivery system\", \"Joining forces to produce next-generation vaccines against enterotoxigenic Escherichia coli\", \"Protection against intracellular pathogens - T-cell based immunity and vaccines\", \"A strategic vision to drive the control of enteric fever through vaccination\", \"Desenvolvimento de uma nova estrat\\u00e9gia vacinal com propriedades profil\\u00e1ticas e terap\\u00eauticas contra a s\\u00edndrome hemol\\u00edtica ur\\u00eamica (SHU) associada a Linhagens de Escherichia coli enterohemorr\\u00e1gica (EHEC) produtorass da toxina Shiga-like (Stx)\", \"Yuji Sato | National Institute of Health - Jap\\u00e3o\", \"Parasite digestive enzymes: targets for new drugs and vaccines\", \"GeMI-Vax as a multi-life stage  malaria vaccine\", \"Orally Administered Bioadherent Sustained Release Microencapsulated Vaccines\", \"Nanoparticle Technology for Minimally-invasive Delivery of DNA Vaccines\", \"Biodegradable Bioadherent Microcapsules for Orally Administered Sustained Release Vaccines\", \"Absorbable Gels for Modulated Bioavailability of Vaccines\", \"Selection versus mutation: reducing the risk of vaccine reversion\", \"DEVELOPMENT OF IMMUNOPROPHYLAXIS FOR RESPIRATORY DISEASE\", \"Chemical Immunology to modulate cross-presentation for improved vaccines\", \"VLP-based Vaccines for Targeting Staphylococcus aureus Secreted Virulence Factors\", \"Novel Oral Vaccine for Infectious Salmon Anemia\", \"Whole Killed ISA Virus Vaccine\", \"IMPROVED HERPESVIRUS OF TURKEY (HVT) VECTOR VACCINE TO CONTROL INFECTIOUS BURSAL DISEASE (IBD) IN CHICKENS\", \"Investigating a novel, physical adjuvant for improving immune responses of vaccines\", \"Development of a novel vaccine targeting parasite tegument proteins for liver fluke disease in livestock\", \"Establishment of a national GLP Core Facility to Monitor Immune Responses in Humans to Prophylactic and or Therapeutic Vaccines Against Infectious Diseases, Cancer and Autoimmunity\", \"Enhancing potency and efficacy of herpesvirus of turkeys-based multivalent vaccines against avian influenza viruses\", \"Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases\", \"Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases\", \"Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"IGF::OT::IGF  Base Contract Title:  Preclinical In Vitro and In Vivo Agent Development Assays, Task Order Title:  A Polyvalent Vaccine Against Fusion Proteins Observed in Solid Tumors, Period of Perfo\", \"Optimisation of bacteriophage M13-based DNA and chimeric (DNA/ protein) vaccines\", \"VACCINOLOGY AND IMMUNITY OF AQUATIC ANIMALS\", \"LIVE ATTENUATED EDWARDSIELLA ICTALURI VACCINES FOR PREVENTION OF ENTERIC SEPTICEMIA OF CATFISH\", \"INTEGRATIVE APPROACHES FOR ILTV VACCINES\", \"BATH/ORAL LIVE RECOMBINANT EDWARDSIELLA VACCINE FOR THE AQUACULTURE INDUSTRY\", \"IDENTIFICATION OF COMMON ANTIGENS TO CREATE A UNIVERSAL PORCINE ETEC VACCINE\", \"Baboon Model of Pertussis to Evaluate Strategies for Next Generation Vaccines\", \"Generation of recombinant yellow fever virus (strain 17d) vaccine vectors to deliver heterologous antigens\", \"Generation of mumps virus vaccine vectors for heterologous antigens.\", \"Identification of new bradyzoite surface antigens for use in toxoplasma gondii vaccines and diagnostics\", \"Artificial chimeric proteins as diagnostic, vaccine, and gene therapy carriers\", \"High throughput vaccine evaluation\", \"Fourth advanced vaccinology course (ADVAC-4)\", \"Third advanced vaccinology course (ADVAC-3)\", \"T Cell Inducing Vaccines.\", \"Clinical evaluation of innovative tuberculosis vaccination strategies.\", \"Pneumococcal Conjugate Vaccine Trian in Adults: Blantyre, Malawi.\", \"Development of an attenuated vaccine to control the emerging bovine respiratory pathogen Mycoplasma bovis\", \"Vaccine against leptospirosis\", \"Development of dense gas technology platforms for the formulation of oral vaccines\", \"Development of a safe and immunogenic anti-chlamydia vaccine for the koala\", \"Mathematical modelling of breast cancer immunity: guiding the development of preventative breast cancer vaccines\", \"Mathematical modelling can provide vital information on the effectiveness and practical implementation of microbicides and vaccines against HIV\", \"Dissecting virus neutralizing determinants to guide HCV vaccine development\", \"Development of novel immune stimulators for poultry\", \"Pre-clinical development of a simian adenovirus vectored respiratory syncytial virus (RSV) vaccine\", \"Pre-clinical Development of an Adenovirus Vectored Universal Influenza Vaccine\", \"The characterisation of vaccine protection: models of AIDS vaccine development\", \"Development and testing of novel recombinant pnemococcal glyconjugate vaccines\", \"Differentiation of Infection in Vaccinated Animals for PPR and FMD\", \"ARRA: Development of Universal Influenza Assays\", \"DEVELOPMENT OF FIV RECOMBINANT VACCINE\", \"LOT SPECIFIC CLUSTERING OF SIDS\", \"STABILITY OF TETANUS AND DIPHTHERIA TOXINS\", \"RABIES IMMUNIZATION ANTIBODY DETECTION IN AT RISK PERSON\", \"REACTIONS FOLLOWING IMMUNIZATION WITH JAPANESE ENCEPHALITIS VIRUS VACCINE\", \"DEVELOPMENT OF AN ELISA FOR RABIES VACCINE POTENCY\", \"RABIES IMMUNIZATION ANTIBODY DETECTION IN AT-RISK PERSONNEL\", \"QUANTITATION OF POLYSACCHARIDE (PS) CONTENT IN HIB CONJUGATE VACCINES BY HPLC\", \"The T Cell Response to Hepatitis B Vaccine in Healthy Ad\", \"Novel Therapies For Herpes Simplex Virus Infections\", \"DEVELOPMENT OF NOVEL MUCOSAL VACCINE STRATEGIES\", \"ROTAVIRUS VACCINE TRIAL IN UMEA, SWEDEN\", \"Development of a Combination HIV-1 and Heroin Vaccine for NIDA\", \"New Scientific Approaches to Facilitate Development of Vaccines\", \"In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense\", \"In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense\", \"In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense\", \"Development of clinical correlates of efficacy for vaccines against Francisella\", \"Development of Assays to Assess Novel Cell Substrates\", \"Capsule conjugate vaccines against Campylobacter jejuni\", \"LIVE ATTENUATED VACCINES FOR PANDEMIC PREPAREDNESS\", \"NOVEL TECHNOLOGIES APPLIED TO A DENQUE DNA VACCINE\", \"Dissecting virus neutralizing determinants to guide HCV vaccine development\", \"Development of Influenza Virus-Like Particle (VLP) Vaccines\", \"Vaccination Against Ixodes scapularis Tick Bites\", \"BIODEGRADABLE MINERAL MICROSPHERE ADJUVANTS FOR VACCINES\", \"JAPANESE ENCEPHALITIS VACCINE FROM MUTATED CDNA CLONE\", \"VACCINE DELIVERY SYSTEM FOR LIVE ROTAVIRUS VACCINES\", \"RECOMBINANT CONTRACEPTIVE VACCINES\", \"DEVELOPMENT OF A REPLICATION-DEFECTIVE HSV-2 VACCINE\", \"ATTENUATED LIVE VIBRIO CHOLERAE-VECTORED ETEC VACCINE\", \"SYNTHETIC PEPTIDES AS CARRIERS FOR CONJUGATE VACCINES\", \"PRODUCTION AND PRESERVATION OF AN ORAL CHOLERA VACCINE\", \"CLINICAL TRIAL OF AN IMPROVED MELANOMA VACCINE\", \"Development of needle-free, vectorless, RNA-based vaccines for HIV\", \"Lactobacilli: A Vaccine Delivery Vehicle for Women\", \"Rational design and targeted selection of DNA-scaffolded nicotine vaccines\", \"IDIOTYPE VACCINES FOR CANCER PATIENTS\", \"Oral Vaccine to Inhalation Rabies\", \"Vaccine-enhanced respiratory syncytial virus disease\", \"LIVE, ATTENUATED, RECOMBINANT VACCINE - WEST NILE VIRUS\", \"Human T Cell Antigens of Mycobacterium tuberculosis\", \"ENHANCED SAFETY &EFFICACY OF AIDS VACCINES BY IFN DELTA\", \"HAEMOPHILUS INFLUENZAE B CONJUGATE VACCINE EFFICACY\", \"Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development\", \"RECOMBINANT DNA-DERIVED PERTUSSIS SUBUNIT VACCINE   13.\", \"IMMUNOGENICITY OF PERTUSSIS TOXOID\", \"EPIDEMIOLOGY OF SHIGELLA INFECTION IN CHILDREN\", \"ASSESSING THE SAFETY OF CELL SUBSTRATES AND VACCINE COMPONENTS\", \"ASSESSING THE SAFETY OF CELL SUBSTRATES AND VACCINE COMPONENTS\", \"MASTER CONTRACT FOR PRECLINICAL DEVELOPMENT AIDS RESEARCH (BASIC)\", \"MASTER CONTRACT FOR PRECLINICAL DEVELOPMENT AIDS RESEARCH (BASIC)\", \"AN EFFICACY TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES\", \"PNEUMOCOCCAL REFERENCE LABORATORY\", \"OPERATION OF &EXPERIMENTAL VIRUS VACCINE PRODUCTION LAB\", \"PERTUSSIS CLINICAL TRIAL (PART 2)\", \"RECOMBINANT SALMONELLA AS AN ORAL HIV VACCINE\", \"Propagation Enhancement of Chimeric Lentiviral Vaccines\", \"Development of clinical correlates of efficacy for vaccines against Francisella\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"Task C11 NHP Model for Filovirus Vaccine: Efficacy and Immunogenecity Testing\", \"Advanced Development of Multivalent Filovirus Vaccines\", \"Development of Muc1 Vaccine for the Prevention of Pancreatic Cancer\", \"Testing The True Potential of CD8 T cells to Protect against Immunodefinciency Virus Infection via Novel Vaccination\", \"Development of Salmonella-based MYCN vaccine for immunotherapy of neuroblastoma\", \"Genetic Vaccines Eliciting Lymphoma-specific T-cell Immunity\", \"The study of efficacy and immune correlates to an inactivated H5N1 vaccine in non-human primates\", \"Trivalent Lassa, Ebola and Marburg viral vaccine (Tri-LEMvac)\", \"Engineering an intranasal universal influenza vaccine\", \"DESIGNING LIVE INFLUENZA UNIVERSAL VACCINE BASED ON NEW GENE\\u2013ENGINEERING AND IMMUNOGENETICS APPROACHES\", \"Development of an Innovative, Effective RNA-based Vaccine for Chikungunya Virus\", \"The Interplay of Oral Vaccines, Oral Immunity and the Oral Microbiome in Infants\", \"\\u30de\\u30e9\\u30ea\\u30a2\\u4f1d\\u642c\\u963b\\u6b62\\u7c98\\u819c\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"LIMPII\\u3001\\u30e6\\u30d3\\u30ad\\u30c1\\u30f3\\u878d\\u5408\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u514d\\u75ab\\u5fdc\\u7b54\\u3068\\u611f\\u67d3\\u9632\\u5fa1\", \"\\u514d\\u75ab\\u8abf\\u7bc0\\u907a\\u4f1d\\u5b50\\u3068\\u306e\\u30d5\\u30e5\\u30fc\\u30b8\\u30e7\\u30f3DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u7d30\\u80de\\u5185\\u5bc4\\u751f\\u539f\\u866b\\u611f\\u67d3\\u5236\\u5fa1\\u306e\\u65b0\\u6226\\u7565\", \"Phase II Double-blind, randomized, Placebo-controlled Study to evaluate the Safety and Immunogenicity of H1, an adjuvanted TB subunit vaccine (AG85B-ESAT-6 plus IC31), in HIV-infected, BCG vaccinated Adults with CD4 Lymphocyte Counts greater than 350\", \"HIV EPIDEMIOLOGY AND PREVENTION / International AIDS Vaccine Initiative\", \"IMPROVED INFECTIOUS LARYNGOTRACHEITIS VIRUS VACCINES AGAINST NEWCASTLE DISEASE VIRUS WORKSHOP\", \"A Comprehensive Pre-Natal Intervention to Increase Vaccine Coverage\", \"A cluster for tuberculosis vaccine development\", \"Whooping cough vaccine and vaccination in the Netherlands since 1950.\", \"Development of VPL Vaccine for RSV\", \"SBIR Phase I: Development of Polymer Gel-Based Indicators to Monitor the Exposure of Individual Vaccine Vials to Harmful Temperatures\", \"Immune correlates to an inactivated H5N1 vaccine in humans\", \"Safety, immunogenicity and mechanism of action of DNA va\", \"Improving Vaccination Coverage Among Adolescents\", \"INDO-US Collaboration to Develop Rotavirus Vaccines\", \"(HVTN) HIV VACCINE TRIAL UNITS\", \"PULSED ELECTRIC FIELD DELIVERED DENGUE VACCINE\", \"LYME VACCINE BASED ON BORRELIA DECORIN ADHESIN\", \"Novel Protein Adjuvant for Flu Vaccines\", \"HETEROCONJUGATE VACCINES AGAINST HERPES SIMPLEX VIRUS\", \"Pro-Apoptotic BCG as an HCV vaccine vector\", \"Vaccines to Generate Neutralizing Anti-HIV Antibodies\", \"Chimeric Adenovirus Vaccine Vectors for HIV/SIV\", \"Enhancing HIV-1 vaccine immunogenicity using hsp70\", \"EXPRESSION OF SIVmac239 GP120 IN TRANSGENIC MAIZE\", \"Annual Sabin Colloquium on Cancer Vaccines and Immunotherapy\", \"A novel DNA-launched live attenuated Chikungunya vaccine\", \"CANCER VACCINES TO HPV-16 ASSOCIATED TUMOR\", \"Advancing a Lead Candidate Hantavirus Pulmonary Syndrome DNA Vaccine\", \"Functional genomic analysis of the CD8 T cell response to HIV vaccines in\", \"A Small Animal Model for Viscerotropic Disease to Improve Yellow Fever Vaccine\", \"Appropriate Pneumococcal Vaccination in Infants in Fiji\", \"DOMAIN-SPECIFIC SEROLOGY FOR SIV/SHIV VACCINE EVALUATION\", \"DETERMINANTS OF VACCINE PROTECTION IN A SIV MODEL\", \"Development and Testing of New Tuberculosis Vaccines\", \"Protective CMI mechanisms of a dual-subtype FIV vaccine\", \"Multiscale Modeling Tools for Structural Biology\", \"\\u5e94\\u7528\\u591a\\u4ef7\\u75ab\\u82d7\\u514d\\u75abhuCD4/CCR5\\u8f6c\\u57fa\\u56e0\\u5c0f\\u9f20\\u7b5b\\u9009\\u5e7f\\u8c31\\u6297HIV-1\\u4e2d\\u548c\\u6027\\u6297\\u4f53\", \"T\\u7ec6\\u80de\\u75ab\\u82d7\\u53ca\\u5176\\u8bf1\\u5bfc\\u7684\\u6297\\u514b\\u9686\\u578bT\\u7ec6\\u80de\\u7684\\u7814\\u7a76\", \"HIV\\u58f3\\u4f53\\u86cb\\u767d\\u75ab\\u82d7\\u5728\\u8f6c\\u57fa\\u56e0\\u67b8\\u675e\\u6839\\u7cfb\\u4e2d\\u7684\\u5206\\u6ccc\\u8868\\u8fbe\", \"\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u9776\\u5411\\u6027DNA\\u75ab\\u82d7\\u6cbb\\u7597\\u54ee\\u5598\\u7684\\u8bd5\\u9a8c\\u7814\\u7a76\", \"\\u57fa\\u56e0\\u4fee\\u9970\\u7684\\u80ba\\u764c\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u75ab\\u82d7\\u53ca\\u5176\\u6297\\u764c\\u673a\\u5236\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"A New Approach to Immunization Against E. coli Infections in Broilers\", \"Peut-on pr\\u00e9venir la r\\u00e9ponse d\\u00e9l\\u00e9t\\u00e8re du d\\u00e9oxynival\\u00e9nol (DON) sur la r\\u00e9ponse vaccinale chez le poulet?\", \"Development of Novel Vaccine strategies against HIV-1 infection\", \"Research on the social and cultural aspects of implementing HIV vaccine programs among MSM and FSWs in Asia and Africa\", \"CIHR/CHVI Team in the soci-cultural aspects of implementing HIV vaccine programs among MSM and FSWs in Asia and Africa\", \"Enhancing Care and Prevention in HIV Vaccine Trials: An International, Interdisciplinary Collaboration\", \"Preventing Respiratory Syncytial Virus (RSV) infection with a novel antigen-adjuvant platform\", \"Social, Behavioral and Ethical Challenges of HIV Vaccine Development\", \"The immunobiology of recombinant adenovirus vaccines\", \"Understanding H1N1 Immunization Knowledge, Attitudes and Behavior in Pregnant Women in British Columbia\", \"Collaborative vaccine development - SSI (Denmark) and VIDO (Canada)\", \"\\u6d77\\u85fb\\u9178\\u94a0\\u6c34\\u51dd\\u80f6\\u5305\\u88c5\\u4ee5\\u63d0\\u5347\\u817a\\u75c5\\u6bd2\\u8f7d\\u4f53\\u6d41\\u611f\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u6548\\u7387\\u7684\\u673a\\u5236\\u7814\\u7a76\", \"Clinical trial of duration of immunity of the yellow fever vaccine in army recruits, participants of the study \\u201c17DD yellow fever vaccine. A double blind, randomized clinical trial of immunogenicity and safety on a dose-response study\\u201d, done in 2009\", \"PilVax: a novel peptide delivery strategy for the development of vaccines\", \"Mucosal Single-Cycle Vaccines against Zika Virus\", \"\\u540c\\u6e90\\u6a21\\u5efaHSV2\\u514d\\u75ab\\u4fdd\\u62a4\\u53ca\\u514d\\u75ab\\u9003\\u907f\\u86cb\\u767d\\u7684\\u591a\\u8868\\u4f4d\\u878d\\u5408\\u75ab\\u82d7\", \"\\u514d\\u75ab\\u539f\\u6027\\u6c28\\u57fa\\u9178\\u5728\\u80bf\\u7624\\u75ab\\u82d7HER-2/neu\\u8bbe\\u8ba1\\u4e2d\\u7684\\u5e94\\u7528\\u53ca\\u5176\\u514d\\u75ab\\u5e94\\u7b54\\u673a\\u5236\\u7814\\u7a76\", \"\\u6c49\\u5766\\u75c5\\u6bd2\\u65b0\\u578bVLPs\\u75ab\\u82d7\\u53ca\\u5176\\u5728\\u5c0f\\u9f20\\u4e2d\\u8bf1\\u5bfc\\u7684\\u514d\\u75ab\\u53cd\\u5e94\\u7814\\u7a76\", \"\\u8679\\u5f69\\u75c5\\u6bd2\\u7eb3\\u7c73\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u8f7d\\u4f53\\u6784\\u5efa\\u4e0e\\u8de8\\u819c\\u673a\\u7406\\u7814\\u7a76\", \"V\\u00fdvoj vakc\\u00edn nam\\u00ed\\u0159en\\u00fdch proti znak\\u016fm n\\u00e1dorov\\u00fdch kmenov\\u00fdch bun\\u011bk\", \"\\u5fd7\\u8cc0\\u6bd2\\u7d20\\u306b\\u5bfe\\u3059\\u308bB\\u9396\\u6a19\\u7684\\u578b\\u7d44\\u63db\\u3048\\u30c8\\u30ad\\u30bd\\u30a4\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5206\\u5b50\\u69cb\\u7bc9\", \"Feasibility and safety of a WT1-targeted cancer vaccine in patients with malignant mesothelioma and locally advanced breast cancer: an open label phase I trial.\", \"Australia Fellowship\", \"Child and Adolescent Immunisation\", \"Therapeutic Cancer Vaccines\", \"Kunjin replicon based vaccines for HIV\", \"HIV Infection: Immunology and Vaccine Design\", \"A new scrambled antigen vaccine (SAVINE) approach: Proof-of-concept in non-human primates for HIV-1\", \"Global HIV/AIDS Vaccine Enterprise\", \"DETECTION AND CONTROL OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EMERGING VIRAL DISEASES OF SWINE\", \"NATURE`S ADJUVANT: THE EVOLUTIONARY CONSERVED ROLE OF COMPLEMENT COMPONENT 3D (C3D) IN ENHANCING B-CELL RESPONSES\", \"PATHOGENOMICS OF INFECTIOUS LARYNGOTRACHEITIS VIRUS\", \"Development study of next generation therapeutic vaccine for clinical application\", \"A molecular mechanism of cancer vaccine enhancement\", \"Establishment of near infrared laser adjuvants: An exploration of new mechanisms in light reception\", \"Long-Term Reduction of High Blood Pressure by Angiotensin II DNA Vaccine in Spontaneously Hypertensive Rats\", \"Statistical analysis of an influenza infection system\", \"Evaluation of novel transmission blocking vaccine antigen using infected patient's blood from endemic area\", \"The development of new angiotensin II receptor vaccine\", \"Analysis of the factor of low immune responses to pneumococcal conjugate vaccine and Hemophilus influenzae type b conjugate vaccine in immunocompromised children\", \"Study of oral vaccine prevent from neosporosis\", \"Synergistic enhancement of tumor vaccine efficacy mediated by herbal medicines\", \"Development of MIF vaccine therapy against inflammation-related colon carcinogenesis\", \"Generation of new DNA vaccine plasmid for the therapy of Alzheimer's disease\", \"Development of recombinant vaccine for lassa fever using replication-incompetent rabies viral vector.\", \"receptor\", \"Development of a novel vaccine carrier for the next-generation influenza universal vaccine\", \"The prevention of MRSA prosthetic vascular graft infection by using a DNA vaccine\", \"Development of cancer peptide vaccine therapy for oral cancer\", \"Attitudes Towards and Acceptance of HPV Vaccine in Mothers of Adolescent Girls: Maximizing the Impact of HPV Vaccine in Japan\", \"Analysis of dendritic cells in gynecologic cancer patients during WT1 peptide vaccine\", \"Elucidation of immunological mechanism in malignant brain tumor of HUVEC vaccine and expansion of adaptation to hemangioblastoma\", \"Functional Vaccine Carriers by using Chemically Modified Fullerene Nanostructures\", \"Improved safety and immunogenicity of rabies live vaccine by a reverse genetics approach\", \"Studies on the route of pertussis vaccination and immune response : a fundamental study of intranasaly immunization\", \"Optimising the efficacy of mycoplasma vaccines in the field\", \"Improved conjugate vaccines derived from a bacterial immunomodulatory protein\", \"\\u9ad8\\u5206\\u5b50\\u907f\\u5b55\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u8fd0\\u7528\\u86cb\\u767d\\u8d28\\u7ec4\\u5b66\\u65b9\\u6cd5\\u7b5b\\u9009\\u7259\\u5468\\u75c5\\u75ab\\u82d7\\u5019\\u9009p.g\\u6297\\u539f\\u7684\\u53cd\\u5411\\u75ab\\u82d7\\u5b66\\u7814\\u7a76\", \"\\u591a\\u623f\\u68d8\\u7403\\u7ee6\\u866b\\u91cd\\u7ec4Bb-EmII/3-10-Em14-3-3\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"\\u5b9e\\u65f6\\u5b9a\\u91cfPCR\\u5728\\u6838\\u9178\\u75ab\\u82d7\\u751f\\u7269\\u5206\\u5e03\\u4e0e\\u751f\\u7269\\u5b89\\u5168\\u6027\\u7814\\u7a76\\u4e2d\\u7684\\u5e94\\u7528\", \"N-\\u7532\\u57fa-D-\\u5929\\u95e8\\u51ac\\u6c28\\u9178\\u53d7\\u4f532B\\u4e9a\\u57fa\\u8868\\u4f4d\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u9547\\u75db\\u6548\\u5e94\\u7684\\u7814\\u7a76\", \"\\u7ec6\\u7c92\\u68d8\\u7403\\u7ee6\\u866b\\u7ec8\\u672b\\u5bbf\\u4e3b\\u91cd\\u7ec4\\u86cb\\u767d\\u591a\\u4ef7\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u548c\\u514d\\u75ab\\u4fdd\\u62a4\\u6027\\u7814\\u7a76\", \"PfCP-2.9\\u759f\\u75be\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u56ca\\u866bDNA\\u75ab\\u82d7\\u8bf1\\u5bfc\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u5236\\u7684\\u86cb\\u767d\\u8d28\\u7ec4\\u5b66\\u57fa\\u7840\", \"CD4+\\u8c03\\u8282T\\u7ec6\\u80de\\u5728T\\u7ec6\\u80de\\u75ab\\u82d7\\u6cbb\\u7597\\u7c7b\\u98ce\\u5173\\u4e2d\\u7684\\u4f5c\\u7528\", \"Protein lipidation in plants: requirements and potential for the production of lipoprotein vaccines\", \"China, bilateral cooperation on fish vaccine development\", \"Desenvolvimento de vacina de subunidade para a profilaxia da leptospirose su\\u00edna, padroniza\\u00e7\\u00e3o em hamster e avalia\\u00e7\\u00e3o da imunidade ativa e passiva em su\\u00ednos\", \"Caridad Zayas Vignier | Inst. Finlay - Cuba\", \"Desenvolvimento de vacina contra o estreptococo beta hemol\\u00edtico do grupo A\", \"Synthesis and characterization of conjugates obtained from Streptococcus pneumoniae capsular polysaccharide and PspA as vaccines candidates\", \"Multiagent Synthetic DNA Vaccines Delivered by Noninvasive Electroporation\", \"Innovative Manufacturing Techniques for Polysaccharide-Protein Conjugate Vaccines\", \"Dendritic cell targeted adenovirus vaccine vector\", \"Understanding cellular immunity to Staphylococcus aureus is required for novel anti-S. aureus vaccine design\", \"Modulation of innate and adaptive immunity by particulate adjuvants for improved parenteral and mucosal vaccination\", \"Development of a BRSV-ISCOM DIVA vaccine and corresponding DIVA test for future creation, identification and protection of BRSV free zones\", \"Technical development of a novel vaccine vehicle for cattle pathogens\", \"Development of a novel VLP based vaccine for malaria\", \"Staphylococcus aureus Infections - Development of A Novel, Effective Vaccine\", \"Formulation of VZV to protect virus during manufacture and generate a thermo-stable vaccine to ensure market supply\", \"A NOVEL VACCINE AGAINST STREPTOCOCCUS EQUI SUBSP. EQUI FOR HORSES\", \"FOOT-AND-MOUTH DISEASE VIRUS (FMDV) COUNTERMEASURES DISCOVERY\", \"GENERATION AND ANALYSIS OF A RECOMBINANT MAREK'S DISEASE VIRUS WITH MUTATION IN THE MEQ AND RIBONUCLEOTIDE REDUCTASE GENES FOR POTENTIAL USE AS VACCINE.\", \"GENERATION OF A DOUBLE DELETION MUTANT VIRUS TO IMPROVE SAFETY AND EFFICACY OF A MAREK'S DISEASE VACCINE.\", \"Enhancement of nasal vaccination - improved immune protection, safety and cost-effectivness through optimisation of mucosal and nasal delivery system.\", \"Identification of efficacious delivery systems for recombinant and nucleic acid construct vaccines (EFFICACIOUS DELIVERY)\", \"Novel strategies for a safe rotavirus vaccine\", \"Workshop / training courses on vaccine quality control with three rs methods (VAC-TRAIN)\", \"Phase 1/2 clinical testing of clade C-based HIV-1 candidate vaccines in China\", \"European research programme for improved vaccine safety surveillance\", \"Towards a vaccine against helicobacter pylori\", \"DNA vaccination of aquaculture fish with emphasis on VHSV in rainbow trout as a model\", \"Development of an improved vaccine against contagious bovine pleuropneumonia\", \"AN AROMATIC DEPENDENT MUTANT OF AEROMONAS SALMONICIDA AS A LIVE VACCINE FOR FURUNCULOSIS IN SALMONID FISH. STUDIES ON THE IMMUNE RESPONSE OF VACCINATED FISH AND ON THE FATE OF BACTERIA AFTER VACCINATION, IN THE HOST AND IN THE ENVIRONMENT\", \"Development of an effective inactivated rotavirus vaccine (IRV) for developing countries: definition of rationale, business case, technical feasibility and overall development plan.\", \"Parasite evolution in response toblood stage candidate malaria vaccines.\", \"Parasite evolution in response toblood stage candidate malaria vaccines.\", \"Development and introduction of vaccines against infectious diseases: MMR in the Netherlands, 1973-85  .\", \"Stable Vaccines Delivered on Oral Thin Films\", \"Improving immune response to vaccines by selective targeting of epithelial regions with the Nanopatch\", \"Genomic sequencing and comparative genomic analysis for animal bacterial vaccine discovery\", \"Investigation of the resilience of immune memory to manipulation by pathogens\", \"Development of a prime-boost anti-cancer vaccine\", \"Using transgenic plant-based production and delivery systems to develop an avian influenza vaccine\", \"Engineering Creativity Award: Development of Small Scale Facilities for Vaccine\", \"Vectored Blood Stage Malaria Vaccine\", \"Towards improved vaccines for control of avian pathogenic Escherichia coli in poultry\", \"The development of a blood-stage vectored vaccine against Plasmodium falciparum malaria\", \"Imaging Viral Immunity\", \"TRIAL OF A NEW HEMOPHILUS INFLUENZAE TYPE B VACCINE\", \"ADVERSE ALLERGIC REACTIONS TO VACCINES\", \"A Phase I Clinical Trial of a Multiclade HIV-1 Vaccine\", \"Evaluating a Multicomponent Ebola Vaccine In Adult Volun\", \"Imaging Viral Immunity\", \"Chlamydial Immunity and Vaccine Development\", \"SECOND AND THIRD-GENERATION HEPATITIS B VACCINES\", \"Malaria Vaccines: Clinical Research and Trial Sites in Endemic Areas\", \"Plant-derived vaccines against hepatitis C Cooperative *\", \"Infectious DNA (i-DNA) Vaccine for Yellow Fever\", \"Adjuvant-containing chimeric virus-like particles as improved influenza vaccines\", \"BOVINE RESPIRATORY SYNCYTIAL VIRUS AS A HUMAN VACCINE\", \"Novel Formulation of Flu Vaccine for the Aged\", \"A Novel Vaccine for Cancer\", \"Mucosal Immunization Against P. aeruginosa by Modified Adenovirus Vectors\", \"Capsule conjugate vaccines against ETEC and Campylobacter\", \"Novel Vaccine Strategies Against Ebola Virus\", \"Chracteristics of An M. Tuberculosis Derived Vaccine\", \"Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine\", \"GENETIC DETERMINANTS MEDIATING VIRUS INDUCED LUNG INJURY\", \"Improved meningococcal vesicle vaccines\", \"Predoctoral Fellowship for Minority Students\", \"Targeting CD137 to enhance RSV peptide vaccine efficacy in aged mice\", \"Clinical Translation of a Mammaglobin cDNA Vaccine for Breast Cancer Prevention and Therapy\", \"Stabilisation of Newcastle Disease vaccine formulated in sugar-glass on polypropylene membranes\", \"Clinical assessment of a novel simian adenovirus-vectored influenza vaccine designed to induce broadly protective immunity\", \"Translational Immunology Research and Accelerated [vaccine] Development (TRIAD)\", \"Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development\", \"Eliciting and identifying broad anti-HIV immune response with a Polyvalent Anti-HIV Vaccine\", \"\\u8fd0\\u7528\\u65b0\\u578b\\u7edf\\u8ba1\\u5b66\\u4e34\\u5e8a\\u8bd5\\u9a8c\\u8bbe\\u8ba1\\u65b9\\u6cd5\\u8bbe\\u8ba1\\u4e2d\\u56fd\\u9996\\u6b21\\u827e\\u6ecb\\u75c5\\u75ab\\u82d7\\u6709\\u6548\\u6027\\u548c\\u514d\\u75ab\\u539f\\u6027\\u7684IIb\\u671f\\u4e34\\u5e8a\\u8bd5\\u9a8c(\\u4e2d\\u7f8e\\u751f\\u7269\\u533b\\u5b66\\u5408\\u4f5c\\u8bd5\\u70b9\\u9879\\u76ee)\", \"\\u6ee4\\u6ce1\\u8f85\\u52a9T\\u7ec6\\u80de\\u5728\\u4e59\\u809d\\u75ab\\u82d7\\u514d\\u75ab\\u5e94\\u7b54\\u4e2d\\u7684\\u8868\\u578b\\u548c\\u529f\\u80fd\\u5206\\u6790\\u53ca\\u8c03\\u63a7\\u673a\\u5236\\u7814\\u7a76\", \"\\u7ed3\\u6838\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u8bf1\\u5bfc\\u7684\\u8bb0\\u5fc6\\u6027T\\u7ec6\\u80de\\u4e9a\\u578b\\u7279\\u5f81\\u3001\\u5206\\u5316\\u8c03\\u63a7\\u53ca\\u4fdd\\u62a4\\u6548\\u5e94\\u7814\\u7a76\", \"Notch\\u4fe1\\u53f7\\u5728\\u547c\\u5438\\u9053\\u75c5\\u6bd2\\u75ab\\u82d7\\u589e\\u5f3a\\u6027\\u80ba\\u90e8\\u514d\\u75ab\\u75c5\\u7406\\u4e2d\\u7684\\u4f5c\\u7528\\u53ca\\u673a\\u5236\\u7814\\u7a76\", \"RNA particles for Preparedness against Infectious Diseases\", \"Targeted Dendritic Cell Vaccines for Influenza: Providing a vaccine to all 33M Canadians\", \"Planning and development of a Sexually Transmitted Infections Vaccine Consortium in British Columbia (STRIVE-BC)\", \"A DNA-Based Universal Seasonal Influenza Vaccine Phase I Safety and Immunogenicity Study\", \"Development of small molecule viral sensitizers to boost vaccine manufacturing\", \"\\u65b0\\u578bGM-CSF\\u951a\\u5b9a\\u7684\\u8180\\u80f1\\u764c\\u80bf\\u7624\\u5e72\\u7ec6\\u80de\\u75ab\\u82d7\\u7684\\u6cbb\\u7597\\u4f5c\\u7528\\u53ca\\u76f8\\u5173\\u673a\\u5236\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u83cc\\u5f71\\u9012\\u9001\\u7cfb\\u7edf\\u7684\\u6885\\u6bd2\\u87ba\\u65cb\\u4f53\\u65b0\\u578b\\u591a\\u8868\\u4f4d\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u4fdd\\u62a4\\u6548\\u5e94\\u53ca\\u673a\\u5236\", \"The identification of breast tumor antigens targeted by the immune response during tumor rejection\", \"Sociocultural acceptability of a future HIV vaccine: Perspectives of frontline health care workers in Karnataka, India\", \"Development of an oral BCG vaccine bait formulation for badgers\", \"Protective immune responses induced by FMDV vaccine in target species and their epidemiological significance\", \"Matching the antigenic properties of footandmouth disease vaccine virus strains with those of field strains\", \"\\u4f2a\\u72c2\\u72ac\\u75c5\\u75c5\\u6bd2/\\u65e5\\u672c\\u8111\\u708e\\u75c5\\u6bd2\\u590d\\u5236\\u5b50\\u5d4c\\u5408\\u75ab\\u82d7\\u8f7d\\u4f53\\u7684\\u6784\\u5efa\\u53ca\\u8bc4\\u4ef7\", \"Formulation and optimization studies of spray-drying to prepare a thermally stabilized vaccine model\", \"Development of a murine model of oral adenovirus vectored vaccine.\", \"Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems\", \"Improved vaccines against tuberculosis based on dendritic cell manipulation\", \"Understanding Immune Control of HIV\", \"Manufacturing and Development for Rapid Access Ebola Vaccine (EBOMAN) \\u2013 Sofia ref.: 115850\", \"Self-Administered Vaccines Directed Against Plague and MERS\", \"\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u3068\\u3057\\u3066\\u7570\\u7a2e\\u6297\\u539f\\u3092\\u4ed8\\u52a0\\u3057\\u305f\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"The burden of rotavirus diarrhea : Estimating the cumulative incidence among children less than 3 years of age\", \"Antitumor immunity by OK-432-conjugated tumor vaccine in mice cancer model\", \"\\u9020\\u8840\\u7d30\\u80de\\u79fb\\u690d\\u60a3\\u8005\\u306b\\u5bfe\\u3059\\u308b\\u3001\\u514d\\u75ab\\u6291\\u5236\\u3092\\u60f9\\u8d77\\u3057\\u306a\\u3044\\u9ebb\\u75b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Development of heterologous vaccines using MPT51, a novel secretory protein of Mycobacterium tubeiculosis\", \"\\u30af\\u30eb\\u30de\\u30a8\\u30d3\\u306e\\u691c\\u75ab\\u95a2\\u9023\\u907a\\u4f1d\\u5b50\\u306e\\u6a5f\\u80fd\\u89e3\\u6790\", \"\\u7d30\\u80de\\u5185\\u5bc4\\u751f\\u6027\\u75c5\\u539f\\u4f53\\u306e\\u514d\\u75ab\\u56de\\u907f\\u6a5f\\u69cb\\u306b\\u5bfe\\u5fdc\\u3057\\u305fDNA\\u30ef\\u30af\\u30c1\\u30f3\\u30fb\\u907a\\u4f1d\\u5b50\\u6cbb\\u7642\\u306e\\u6226\\u7565\\u7684\\u57fa\\u76e4\", \"P187 - MULTIPLY EXPOSED VAGINALLY, UNINFECTED MACAQUE MODEL\", \"Mucosal vaccine strategies against human papillomavirus and cervical cancer\", \"\\u65b0\\u578b\\u4e73\\u9178\\u83cc\\u8868\\u9762\\u5c55\\u793a\\u7cfb\\u7edf\\u53ca\\u5176\\u4f5c\\u4e3a\\u75ab\\u82d7\\u8f7d\\u4f53\\u7684\\u524d\\u671f\\u57fa\\u7840\\u7814\\u7a76\", \"Dendritic Cell-Directed Vaccine Against HIV\", \"Application of Open Source Licensing to Vaccine and Medicine Discovery and Development\", \"Fish Virus Vaccines (ViVaFish)\", \"Developing vaccines against diarrhea caused by Enterotoxigenic Escherichia coli and Shigella (EntVac)\", \"TRUKKET XXXXXXXXXXXElectroporation enhanced technology for delivery of DNA vaccines against brucellosis .........\", \"Escalonamento do processo de produ\\u00e7\\u00e3o de vacina recombinante contra Rhodococcus equi\", \"Prediction of Hyperbaric Oxygen Toxicity\", \"Pre-clinical Development of a Vaccine for the Treatment of Heroin Addiction\", \"TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development\", \"P187 - MULTIPLY EXPOSED VAGINALLY, UNINFECTED MACAQUE MODEL\", \"POLYVALENT T CELL MOSAIC VACCINE TO CROSS-PROTECT SWINE AGAINST HETEROLOGOUS PRRSSV STRAINS\", \"Developing and Testing a novel, low-cost, effective HOOKworm VACcine to Control Human Hookworm Infection in endemic countries\", \"Development of an oral Helicobacter Pylori vaccine\", \"A \\u201cUniversal\\u201d Influenza Vaccine through Synthetic, Dendritic Cell-Targeted, Self-Replicating RNA Vaccines\", \"Innovation Partnership for a Roadmap on Vaccines in Europe\", \"Combinatorial immunization strategy to educate the immune system towards cross recognition and coverage against antigenic drift in seasonal influenza virus exposure\", \"ARCAS: Analysis of the Route to Commercialisation of MVA based influenza  vaccines\", \"Development of Vaccines for bTV, EHDV and AHSV\", \"Mucosal Vaccines for Poverty Related Diseases\", \"UK HIV Vaccine Consortium report.\", \"Development of effective live vaccines for prevention of anaplasmosis and babesiosis.\", \"Development of effective live vaccines for prevention of anaplasmosis and babesiosis.\", \"Adapting recombinant anti-tick vaccines to livestock in Africa.\", \"Adapting recombinant anti-tick vaccines to livestock in Africa.\", \"Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infections\", \"Development of small molecule viral sensitizers to boost vaccine manufacturing\", \"Combating highly pathogenic avian influenza: novel vaccination strategies\", \"AEROSOL INFECTION OF MICE AS A MODEL FOR PERTUSSIS INFEC\", \"IMMUNOGENICITY OF TWO DIFFERENT MEASLES VACCINES IN HAITIAN INFANTS\", \"Development of a Vaccine for HIVAIDS: Cellular Immunity\", \"South-West European HIV Vaccine Clinical Trial Unit\", \"Development of an VEE Replicon Vaccine Against Smallpox\", \"Development of ProtollinTM Plague Vaccine\", \"An Inactivated Influenza Nasal Powder Vaccine\", \"Optimizing the Immunogenicity of MVA-Based AIDS Vaccines\", \"Development of a Next Generation Anthrax Vaccine, dmPA7909\", \"Dose Optimization, Production &Tox Testing of Replicon-Vaccines for Smallpox\", \"Development of HIV Vaccine Clinical Trials Phase I-II-III in Dominican Republic\", \"South-West European HIV Vaccine Clinical Trial Unit\", \"Development of Recombinant SARS VLP Vaccines\", \"Preclinical Development of a Recombinant Dengue Vaccine\", \"GENERATION OF NOVEL RECOMBINANT RABIES VIRUS VACCINES\", \"Protective CMI mechanisms of a dual-subtype FIV vaccine\", \"TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION\", \"Potent Vaccine Adjuvant Therapeutic\", \"Novel Smallpox Vaccine Derived from VV/VAR Immunome\", \"Development of an Oral Anthrax Vaccine\", \"Non-invasive delivery of skin-targeted tetanus vaccines\", \"A novel vaccine: botulinum neurotoxin subunit on a viral carrier.\", \"A Novel Therapy for Staphyloccocal Enterotoxin B poisoning\", \"DELETED PHOP/PHOQ S TYPHI AS A LIVE ORAL VACCINE VECTOR\", \"Stress management and vaccine response among women at risk for breast cancer\", \"Increasing efficacy of an Adenovirus vaccine targeting Clostridium difficile usin\", \"Mast Cell Activator as Adjuvant for Biodefense Vaccines\", \"Transdermal vaccine delivery platform technology\", \"HIV Vaccines\", \"HIV Vaccine Development\", \"Epitope Driven HIV Vaccine Development AI50528-01A1\", \"HIV 1 VACCINE AND IMMUNITY STUDY\", \"Randomized Intervention Trial to Evaluate a Vaccine Social Media Website\", \"Optimization of Peptide Based Vaccines for Cancer\", \"Generation and Evaluation of Pro-Apoptotic rBCG and Viral Vectors as TB Vaccine C\", \"Novel vaccines for broad protection against avian influenza\", \"VACCINE APPROACHES TO PREVENT HIV/AIDS IN CHILDREN\", \"DEVELOPMENTAL ASPECTS OF AN IDIOTYPE VACCINE\", \"CLINICALLY RELEVANT MODELS FOR IDIOTYPE HBSAG VACCINE\", \"HUMAN IMMUNE RESPONSES TO HPV VACCINES\", \"DEVELOPMENT OF A NOVEL MULTIENVELOPE AIDS VACCINE\", \"Tuberculosis Vaccine Strategy Using Salmonella Vectors\", \"Gene Variation and Responsiveness to Influenza Vaccines\", \"Development of a Practical Heroin-HIV Vaccine\", \"Development of a Modified mRNA-Based Vaccine for Lassa Virus\", \"Global mapping of HPV vaccine hesitancy: determinants, monitoring and identification of strategies for effective implementation\", \"Ocena potencja\\u0142u epidemicznego szczep\\u00f3w Bordetella pertussis w warunkach obni\\u017conej odpowiedzi poszczepiennej jako element poszukiwania przyczyn obni\\u017conej efektywno\\u015bci szczepie\\u0144 przeciw krztu\\u015bcowi\", \"Clec9A Targeting Antibodies as a New Immunotherapy for Prostate Cancer\", \"Vaccine Immunotherapy for Prostate Cancer\", \"Xenoantigens as Tumor Antigens for the Development of Prostate Cancer Vaccines\", \"Continuation of the development for vaccines against bovine TB in cattle\", \"Generation of Vaccine Candidates Against Mycobacterium bovis\", \"\\\"Strategie combinate basate sulla vaccinazione a DNA per curare i carcinomi ErbB-2/neu positivi e le loro recidive\\\"\", \"Scotia Scholar Award 2014\", \"Development of polyvalent inactivated rhinovirus vaccine\", \"Development of Dendritic Cell-based prophylactic and therapeutic Ebola vaccines\", \"COMMERCIALIZATION OF A SYNTHETIC, LIVE-ATTENUATED FMDV VACCINE\", \"Development of second generation vaccines against parvoviruses\", \"13TSB_SynBio: Engineering immune-cell-targeting bacteria to express vaccines from within the body\", \"ARRA: Clinical Support for Universal Influenza Development\", \"Human Rabies Virus Vaccine Development\", \"Geographic access to care and HPV vaccine uptake among ethnic minority girls\", \"Development of a Sublingual Measles Vaccine\", \"A tri-antigen nasal anthrax vaccine against toxins and vegetative bacilli\", \"Cellular Immune Responses Induced by SIVdelta-vif plus IL-15 DNA Vaccine\", \"The safety of pneumococcal polysaccharide vaccine in children - a followup study.\", \"Vaccine Strategies for Tularemia\", \"Preclinical Evaluation of Antigen-Specific DNA Vaccines as a Treatment for Prostate Cancer\", \"Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metastatic Breast Cancer\", \"EML-VAC: Multivalent replicon vaccine against Ebola, Marburg and Lassa viruses\", \"COMMERCIALIZATION OF A SYNTHETIC, LIVE-ATTENUATED FMDV VACCINE\", \"I-Corps: Enhancing Vaccine Performance\", \"Vacina oral recombinante contra raiva\", \"Development of a Non-adjuvanted VLP Vaccine against Stealth H7N9 Influenza\", \"Development of Structurally Defined QS-17/18-Based Vaccine Adjuvants\", \"leveraging On t-cell immune resPonse To Improve influenza VACcines.\", \"Novel vaccine to enhance breadth of influenza immunity by skin vaccination\", \"Improving the therapeutic efficacy of a lead vaccine against plague using a novel adjuvant system\", \"CONTROL OF INFECTIOUS BRONCHITIS IN POULTRY\", \"New generation vaccines based on recombinant self-replicating alphavirus rna\", \"Diversity of Immune Responses Elicited by HIV Vaccines\", \"Development of a vaccine against HIV and AIDS\", \"DEVELOPMENT AND EVALUATION OF QUALITY CONTROL METHODS FO\", \"DEVELOPMENT OF AN AIDS PROTOTYPE VACCINE USING SIV\", \"Development of a Next Generation Anthrax Vaccine, AV7909\", \"Adjuvant Enhanced Antiviral Immunity\", \"Developing recombinant coronavirus vaccines for SARS\", \"Ontogeny of Measles Immunity in Infants\", \"Targeting vaccine vectors and antigens to dendritic cells using protein L.\", \"Non-peptidic HIV vaccine\", \"Humoral Immune Responses to Virus-like Particle Vaccine Candidates for RSV\", \"Enhancement of mucosal antibody responses to HIV vaccine\", \"Rapid deployment DNA vaccine for pandemic influenza\", \"Mucosal modified vaccinina Ankara-based plaque vaccines\", \"Delivery system development for a reservoir targeted Lyme disease vaccine\", \"A Peptide-Based Vaccine to Nicotine\", \"Acne Vaccines Targeting a Surface Sialidase and a Secreted CAMP Factor Toxin\", \"Rational Design of Live Attenuated Influenza A Vaccine Candidates\", \"Evaluation of Flavivirus Live Attenuated Vaccine Recombination Potential\", \"Controlled Trial of Live Attenuated Influenza Vaccine in Very Premature Infants\", \"POTENTIATION OF CD8+ T CELL RESPONSE TO MELANOMA VACCINE\", \"Laser treatment to enhance therapeutic HPV DNA vaccine potency\", \"Development and Evaluation of a Dual-Antigen Nasal Brucella Vaccine\", \"T. cruzi immune evasion factors and vaccine design\", \"HIV Vaccines in Th2 Biased Recipients\", \"Vaccine-enhanced respiratory syncytial virus disease\", \"Evaluation of Anti-endotoxin Vaccine for Human Use\", \"Nanocarriers for transcutaneous delivery of vaccines\", \"An HB Vaccine Model For HIV Vaccine Trials in Drug Users\", \"Polypeptide Vaccine In IL-2 Liposomes For Prostate Ca\", \"rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses\", \"Building novel vaccines on a borrowed coat\", \"Subunit Vaccines for Brucella Pathogens\", \"New Vaccine against Influenza\", \"Collaborative Development of a Vaccine against Cutaneous and Visceral Leishmanias\", \"New Approaches to Schistosome vaccine antigen discovery\", \"An Envelope Containing HIV Pseudovirion Vaccine\", \"Poly-functional analyses of vaccine-induced T cell responses\", \"VACCINE TRIALS USING INDIVIDUAL AND ECOLOGICAL UNITS\", \"Evaluation of Anti-endotoxin Vaccine for Human Use\", \"FIVDELTAVIF DNA Vaccines with Cytokine Adjuvants\", \"Ontogeny of Measles Immunity in Infants\", \"CONTROLLED RELEASE SYSTEMS AS VACCINE ADJUVANTS\", \"PATHOGENIC ROLE OF H. INFLUENZAE SURFACE PROTEINS\", \"LIVE VIRUS VACCINES AS DOMINANT NEGATIVE MUTANTS\", \"Survivin &Interferon-alpha as Cancer Vaccine Therapy in Pancreatic Cancer\", \"Molecular profiling consortium: biomarker identification and interaction analysis of EPI vaccines\", \"Viral Latency and Virus Detection\", \"Influenza: making vaccines in plants\", \"GMP Production of Candidate Pan-Group 2 Influenza A Virus Vaccines\", \"Universal Influenza T Cell-Targeted Mucosal Vaccines\", \"Combining oncolytic vaccines (OVax) with surgery and immune modulation to prevent postoperative cancer recurrence and metastases\", \"Evaluation of the protection efficacy of vaccines against bovine TB in a natural transmission setting.\", \"Transmission and VaccineInduced Protection of Marek's Disease\", \"Genetically determined susceptibility to rotavirus and rotavirus vaccine failure in sub-Saharan Africa\", \"Addresing Efficacy of a Dengue vaccine candidate in a macaque challenge model\", \"Multivalent Oral Vaccine against Enterotoxigenic Escherichia coli and Enteric Fevers\", \"EUROPEAN VACCINE AGAINST AIDS\", \"Clinical Trials of  Biodefense Vaccines (Dengue)\", \"Laboratory And Preclinical Studies Of Flaviviruses\", \"Vaccine Clinical Trials\", \"Rapid  Response Vaccines for Botulinum Neurotoxins\", \"Adenovirus-vectored RSV vaccine not inhibited by maternal immunity\", \"Synthetic Nanoparticle based Universal Influenza Vaccine\", \"Surrogate endpoints for correlating protective immunity in response to influenza\", \"Adjuvanted Influenza Vaccine\", \"Lyophilization of Plasmodium falciparum sporozoite vaccine\", \"Enhancing TB vaccine with gene silencing\", \"A Lassa Vaccine in primates with AIDS\", \"Immunological Mechanisms of Vaccination\", \"Development of a Recombinant Tetravalent Dengue Vaccine Based on a Subunit Envelo\", \"A novel anti-spore nasal vaccine for protection from anthrax\", \"Novel Bioconjugate Vaccines to Prevent Staphylococcus aureus Infection\", \"Continuing an education campaign on vaccines and immunization\", \"Rationeel ontwerp van een therapeutisch vaccin tegen HIV-1 gebaseerd op een nieuwe formulering van nanopartikel\", \"Clinical optimization of an autologous tumour vaccine strategy for the treatment of Chronic Lymphocytic Leukemia\", \"Highly stable trimerization of HIV-1 envelope based antigens will improve their immunogenicity and capacity to elicit a neutralizing antibody responses\", \"Augmentation of a Canine Melanoma Vaccine with Immunomodulatory Antibodies\", \"Ad-NK4\\u4fee\\u9970\\u7684\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u75ab\\u82d7\\u6297\\u9aa8\\u9ad3\\u7624\\u514d\\u75ab\\u4f5c\\u7528\\u7814\\u7a76\", \"\\u80ba\\u52a8\\u8109\\u9ad8\\u538b\\u5185\\u76ae\\u7d20ETA\\u53d7\\u4f53\\u6cbb\\u7597\\u6027\\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u6059\\u866b\\u75c5\\u4e1c\\u65b9\\u4f53Karp\\u682a\\u878d\\u5408\\u6297\\u539f\\u7684\\u83b4\\u82e3\\u53f6\\u7eff\\u4f53\\u751f\\u7269\\u5c01\\u88c5\\u8868\\u8fbe\\u3001\\u80f6\\u56ca\\u5316\\u53ca\\u514d\\u75ab\\u6548\\u5e94\\u8bc4\\u4ef7\", \"\\u798f\\u6c0f\\u5fd7\\u8d3a\\u6c0f\\u83cc\\u591a\\u7cd6\\u7ed3\\u5408\\u75ab\\u82d7\\u7684\\u4f53\\u5185\\u751f\\u7269\\u5408\\u6210\\u7814\\u7a76\", \"\\u4e19\\u578b\\u809d\\u708e\\u75c5\\u6bd2\\u65b0\\u578b\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"DEC-205/PLGA-\\u809d\\u7d20\\u9176CD4+\\u3001CD8+T\\u7ec6\\u80de\\u8054\\u5408\\u8868\\u4f4d\\u80bd\\u7eb3\\u7c73\\u9897\\u7c92\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u6548\\u5e94\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u4e91\\u5357\\u7701\\u72c2\\u72ac\\u75c5\\u6bd2\\u7cd6\\u86cb\\u767d\\u57fa\\u56e0\\u5206\\u6790\\u53ca\\u6297\\u539f\\u6027\\u7814\\u7a76\", \"\\u9776\\u5411\\u90ce\\u683c\\u7f55\\u6c0f\\u7ec6\\u80de\\u7684Eppin\\u4f18\\u52bf\\u8868\\u4f4d\\u907f\\u5b55\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u4e0e\\u7814\\u7a76\", \"\\u4eba\\u4e73\\u5934\\u7624\\u75c5\\u6bd216\\u578b\\u9884\\u9632\\u6027\\u75ab\\u82d7\\u7684\\u53ef\\u884c\\u6027\\u7814\\u7a76\", \"\\u620a\\u578b\\u809d\\u708e\\u75c5\\u6bd2CDNA\\u57fa\\u56e0\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u53e3\\u670d\\u7f13\\u91ca\\u957f\\u6548\\u970d\\u4e71\\u5fae\\u7403\\u83cc\\u82d7\\u7684\\u52a8\\u7269\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u4e2d\\u56fd\\u4e0e\\u4e16\\u754c\\u6c14\\u5019\\u53ca\\u519c\\u4e1a\\u6c14\\u5019\\u76f8\\u4f3c\\u7814\\u7a76*3\", \"EV71 VP1\\\"\\u98df\\u54c1\\u7ea7\\\"\\u4e73\\u9178\\u83cc\\u6d3b\\u8f7d\\u4f53\\u75ab\\u82d7\\u53ca\\u5f02\\u6e90\\u6297\\u539f\\u8054\\u5408\\u514d\\u75ab\\u8bf1\\u5bfc\\u9ecf\\u819c\\u548c\\u7cfb\\u7edf\\u514d\\u75ab\\u7684\\u7814\\u7a76\", \"MSP2\\u7684\\u6297\\u759f\\u75be\\u75ab\\u82d7\\u6f5c\\u80fd\\u76f8\\u5173\\u6027\\u8d28\\u7684\\u5206\\u5b50\\u673a\\u5236\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u4e73\\u817a\\u4e0a\\u76ae\\u7ec6\\u80deFcRn\\u80de\\u541e\\u8f6c\\u8fd0\\u9014\\u5f84\\u7684\\u91d1\\u9ec4\\u8272\\u8461\\u8404\\u7403\\u83cc\\u591a\\u4ef7\\u6bd2\\u529b\\u56e0\\u5b50\\u75ab\\u82d7\\u8bbe\\u8ba1\\u53ca\\u5176\\u8bf1\\u5bfc\\u514d\\u75ab\\u5e94\\u7b54\\u6548\\u679c\\u7684\\u7814\\u7a76\", \"\\u9e45\\u7ec6\\u5c0f\\u75c5\\u6bd2VP3\\u57fa\\u56e0\\u4e0e\\u9e45\\u03b3\\u5e72\\u6270\\u7d20\\u57fa\\u56e0\\u91cd\\u7ec4\\u79bd\\u75d8\\u75c5\\u6bd2\\u7684\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u53ca\\u5176\\u673a\\u5236\\u7814\\u7a76\", \"FcRn\\u4ecb\\u5bfc\\u7684\\u6297\\u7ec6\\u7c92\\u68d8\\u7403\\u86b4\\u9776\\u5411\\u9ecf\\u819c\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u589e\\u5f3a\\u4f53\\u6db2\\u514d\\u75ab\\u5e94\\u7b54\\u7684\\u673a\\u5236\\u7814\\u7a76\", \"\\u9f3b\\u9ecf\\u819c\\u63a5\\u79cdA\\u03b2\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u9884\\u9632AD\\u7684\\u7597\\u6548\\u8bc4\\u4ef7\\u53ca\\u514d\\u75ab\\u673a\\u5236\\u5206\\u6790\", \"\\u65b0\\u578b\\u53e3\\u670dHIV-1\\u7c98\\u819c\\u514d\\u75ab\\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u6c1f\\u4ee3\\u80bf\\u7624\\u76f8\\u5173\\u7cd6\\u6297\\u539f\\u7684\\u5316\\u5b66\\u9176\\u6cd5\\u5408\\u6210\\u53ca\\u5176\\u5728\\u80bf\\u7624\\u7cd6\\u75ab\\u82d7\\u4e2d\\u7684\\u5e94\\u7528\", \"Enhanced HIV Vaccine by CNT-enabled Mucosal Delivery\", \"Production of Inactivated Vaccines Using Supralethal Irradiation\", \"Passively Regulated Cryogenic (PaRC) Vial System for Vaccine Distribution and Administration\", \"Surfactant-vesicle based gonorrhea vaccine\", \"Developing a Chlamydia trachomatis vaccine by optomizing dendritic cell responses.\", \"Development of Novel Molecular Adjuvants for Genetic Vaccination\", \"Influenza Vaccine Effectiveness Against Serious Outcomes\", \"Short Term Travel Grant to Attend AIDS Vaccine 2008 Partner Development Forum\", \"A Study of an HPV VLP Vaccine in a Cohort of HIV Positive Girls and Women\", \"Vaccination during pregnancy: issues in translational ethics and research ethics\", \"Towards a Broad-Spectrum Meningococcal Vaccine:  Preparation and validation of modified outer membrane vesicle vaccines.\", \"Development of a Salmonella Poultry and Human Vaccine based on  Secreted Bacterial Products\", \"CHVI Team in Social and Behavioral Research on HIV Vaccines\", \"Understanding recent influenza drifts and efficacy of new mucosal vaccines\", \"\\u80ba\\u9012\\u9001\\u70ad\\u75bd\\u75ab\\u82d7\\u5e72\\u7c89\\u6c14\\u6eb6\\u80f6\\u7528\\u4ee5\\u9884\\u9632\\u5438\\u5165\\u6027\\u70ad\\u75bd\\u7684\\u7814\\u7a76\", \"\\\"\\u82b3\\u9999\\u8f9f\\u79fd\\\"\\u4e2d\\u836f\\u4f5c\\u4e3a\\u6d41\\u611f\\u75ab\\u82d7\\u7c98\\u819c\\u4f50\\u5242\\u7684\\u6d3b\\u6027\\u53ca\\u5176\\u9f3b\\u7c98\\u819c\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"\\u4e73\\u9178\\u83cc\\u83cc\\u5f71\\u4f5c\\u4e3aDNA\\u75ab\\u82d7\\u5305\\u88c5\\u8f7d\\u4f53\\u8bf1\\u5bfc\\u514d\\u75ab\\u5e94\\u7b54\\u7684\\u7814\\u7a76\", \"\\u970d\\u4e71\\u6bd2\\u7d20A\\u3001B\\u4e9a\\u5355\\u4f4d\\u589e\\u5f3aDNA\\u75ab\\u82d7\\u514d\\u75ab\\u6548\\u679c\\u7684\\u4f50\\u5242\\u6d3b\\u6027\\u548c\\u673a\\u5236\\u7814\\u7a76\", \"\\u643a\\u5e26Her2/neu\\u7684\\u7ea2\\u7ec6\\u80de\\u4f5c\\u4e3a\\u6297\\u4e73\\u817a\\u764c\\u75ab\\u82d7\\u7684\\u4f5c\\u7528\\u548c\\u514d\\u75ab\\u673a\\u5236\", \"GnIH\\u548cINH\\u57fa\\u56e0\\u75ab\\u82d7\\u8054\\u5408\\u514d\\u75ab\\u5927\\u9f20\\u548c\\u725b\\u7684\\u6548\\u679c\\u53ca\\u4f5c\\u7528\\u673a\\u5236\\u63a2\\u8ba8\", \"\\u57fa\\u4e8e\\u51b7\\u80c1\\u8feb\\u8bf1\\u5bfc\\u4e0b\\u76f8\\u5bb9\\u6027\\u6eb6\\u8d28\\u80de\\u5185\\u79ef\\u7d2f\\u7684\\u9cd7\\u5f27\\u83cc\\u6d3b\\u75ab\\u82d7\\u51bb\\u5e72\\u8010\\u53d7\\u5206\\u5b50\\u673a\\u5236\", \"Progress and Pathways Toward an Effective HIV Vaccine\", \"Development of a Recombinant Listeria Monocytogenes Booster Vaccine against Tuberculosis\", \"Synthesis of Clustered ST-Antigens for the Development of Novel Breast Cancer Vaccines\", \"Antibody affinity maturation and protective effect of B cell responses elicited by HIV-1 Env vaccination of non-human primates\", \"BUILDING BETTER VACCINES; LEARNING FROM VIRUSES\", \"Preparation for a phase I/II study of a new TB vaccine candidate\", \"Gastrointestinal viral infections and novel mucosal vaccines\", \"A cooperative platform for development of Asian and European diagnostics and vaccines for autoimmune diseases\", \"Viral Vectors as Recombinant Vaccines\", \"Improved selection methods for emergency FMD vaccines\", \"Development of strategies for control of classical swine fever by emergency vaccination with live attenuated vaccine\", \"\\u57fa\\u4e8e\\u5927\\u89c4\\u6a21PCR\\u6280\\u672f\\u9ad8\\u901a\\u91cf\\u5236\\u5907DNA\\u75ab\\u82d7\\u65b9\\u6cd5\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u8bf1\\u5bfc\\u548c\\u589e\\u5f3a\\u9ecf\\u819c\\u514d\\u75ab\\u6548\\u5e94\\u7684B\\u7fa4\\u6d41\\u8111\\u75ab\\u82d7\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u725bUK\\u682a\\u8f6e\\u72b6\\u75c5\\u6bd2\\u62ee\\u6297\\u2160\\u578bIFN\\u4fe1\\u53f7\\u8f6c\\u5bfc\\u901a\\u8def\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u8fd1\\u7ea2\\u5916\\u8367\\u5149/\\u6fc0\\u5149\\u62c9\\u66fc\\u53cc\\u6a21\\u5f0f\\u6210\\u50cf\\u6280\\u672f\\u7528\\u4e8e\\u80bf\\u7624\\u9776\\u5411\\u7ec6\\u83cc\\u75ab\\u82d7\\u7684\\u4f53\\u5185\\u5206\\u5e03\\u7814\\u7a76\", \"\\u8d1f\\u8f7dgp96-Ki67\\u80bd\\u590d\\u5408\\u7269\\u7684DC\\u75ab\\u82d7\\u5bf9\\u80be\\u764c\\u7684\\u6297\\u80bf\\u7624\\u6548\\u5e94\\u7814\\u7a76\", \"HIV-1 gp120\\u4e0e\\u6709\\u6548\\u75c5\\u6bd2\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u8bf1\\u5bfcTfh\\u7ec6\\u80de\\u6d3b\\u5316\\u53ca\\u6297\\u4f53\\u751f\\u6210\\u80fd\\u529b\\u7684\\u6bd4\\u8f83\\u7814\\u7a76\", \"TLR3\\u914d\\u4f53\\u63d0\\u9ad8H9\\u4e9a\\u578b\\u79bd\\u6d41\\u611f\\u75ab\\u82d7\\u5bf9\\u9e21\\u7684\\u7ec6\\u80de\\u514d\\u75ab\\u673a\\u7406\\u7814\\u7a76\", \"\\u65b0\\u578b\\u53ef\\u964d\\u89e3\\u7684HPEI-YS\\u9776\\u5411\\u57fa\\u56e0\\u75ab\\u82d7\\u8f7d\\u4f53\\u7528\\u4e8e\\u80bf\\u7624\\u514d\\u75ab\\u57fa\\u56e0\\u6cbb\\u7597\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u8d1f\\u6027\\u8c03\\u63a7\\u9aa8\\u9ad3\\u95f4\\u5145\\u8d28\\u5e72\\u7ec6\\u80de\\u7684FAP\\u03b1- - \\u589e\\u5f3a\\u591a\\u53d1\\u6027\\u9aa8\\u9ad3\\u7624\\u75ab\\u82d7\\u6297\\u7624\\u6548\\u5e94\\u7684\\u65b0\\u7b56\\u7565\", \"\\u7f8a\\u4f20\\u67d3\\u6027\\u8113\\u75b1\\u75c5\\u6bd2\\u4fdd\\u62a4\\u6027\\u6297\\u539f\\u8868\\u4f4d\\u7b5b\\u9009\\u53ca\\u8868\\u4f4d\\u4f5c\\u56fe\\u7814\\u7a76\", \"MMSA-1\\u4e0eDKK1\\u8054\\u5408\\u591a\\u8868\\u4f4d\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u53ca\\u6297\\u9aa8\\u9ad3\\u7624\\u7814\\u7a76\", \"\\u732a\\u5e26\\u7ee6\\u866b\\u91cd\\u7ec4Bb-TSO45W-4B-TSOL18\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"\\u725b\\u6e90\\u72ac\\u65b0\\u5b62\\u5b50\\u866bNcSRS2-NcGRA7\\u590d\\u5408\\u57fa\\u56e0\\u6838\\u9178\\u75ab\\u82d7\\u4e0e\\u91cd\\u7ec4\\u817a\\u75c5\\u6bd2\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u53ca\\u5176\\u673a\\u5236\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u917f\\u9152\\u9175\\u6bcd\\u9776\\u5411\\u6027\\u9012\\u5448\\u548c\\u8868\\u8fbe\\u7684DNA\\u75ab\\u82d7\\u7814\\u7a76\", \"T\\u7ec6\\u80de\\u53d7\\u4f53\\u8bc6\\u522b\\u80bf\\u7624\\u591a\\u80bd\\u75ab\\u82d7\\u7684\\u7ed3\\u6784\\u548c\\u529f\\u80fd\\u7814\\u7a76\", \"I-Corps: Nanotechnology for Boosting Vaccine Efficacy and Longevity\", \"V\\u00fdvoj nov\\u00fdch vakcin pro genovou l\\u00e9\\u010dbu zhoubn\\u00fdch n\\u00e1dor\\u016f, zalo\\u017een\\u00fd na kooperaci APC a TH bun\\u011bk\", \"Nanoliposomy pro v\\u00fdvoj rekombinantn\\u00edch vakc\\u00edn a c\\u00edlen\\u00fdch imunoterapeutik\", \"2nd Generation Vaccine for the Treatment of Glioblastoma\", \"Next-Generation Adenovirus Vaccine\", \"\\u0418\\u043d\\u0444\\u043e\\u0440\\u043c\\u0430\\u0446\\u0438\\u043e\\u043d\\u043d\\u044b\\u0435 \\u0442\\u0435\\u0445\\u043d\\u043e\\u043b\\u043e\\u0433\\u0438\\u0438 \\u043e\\u0442\\u0431\\u043e\\u0440\\u0430 \\u043f\\u0430\\u0446\\u0438\\u0435\\u043d\\u0442\\u043e\\u0432 \\u043e\\u043d\\u043a\\u043e\\u043b\\u043e\\u0433\\u0438\\u0447\\u0435\\u0441\\u043a\\u043e\\u0433\\u043e \\u043f\\u0440\\u043e\\u0444\\u0438\\u043b\\u044f \\u0434\\u043b\\u044f \\u043f\\u0440\\u0438\\u043c\\u0435\\u043d\\u0435\\u043d\\u0438\\u044f \\u0434\\u0435\\u043d\\u0434\\u0440\\u0438\\u0442\\u043d\\u043e\\u043a\\u043b\\u0435\\u0442\\u043e\\u0447\\u043d\\u044b\\u0445 \\u0432\\u0430\\u043a\\u0446\\u0438\\u043d.\", \"Immune-complex mimetics (ICMs): an adjuvant free approach to controlling the major diseases for which no vaccines are available\", \"Improving cancer vaccines with agonistic antibodies to CD40 and CD27\", \"Equipment to Support Prophylactic Antibacterial Vaccine Development\", \"Cost effectiveness of poultry vaccination for control of H9N2 avian influenza in Pakistan\", \"Room temperature stable MVA-GP pox vectored vaccine against CCHF\", \"Basic Research on the Development of Recombinant Vaccines for Animals by Genetic Engineering\", \"Establishment of the screening system of vaccine candidate genes against cysticercosis using Nod-scid mice.\", \"Basic study of gene therapy to hepatitis C virus infection by using virus-like particle.\", \"Development of therapeutic RANKL vaccination approach against inflammatory alveolar-bone-destruction\", \"\\u7c98\\u819c\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u57fa\\u790e\\u7814\\u7a76:HIV\\u7279\\u7570\\u7684\\u5206\\u6ccc\\u578bIgA\\u8a98\\u5c0e\\u30b7\\u30b9\\u30c6\\u30e0\\u306e\\u958b\\u767a\", \"Basic and clinical studies for development of peptide vaccine for colorectal cancer\", \"Comparison of DNA sequences on VZV glycoproteins of the Oka vaccine and parental Oka strains\", \"Study on efficacy and improvement of diphtheria and tetanus toxoids and pertussis (DPT) vaccine\", \"Development of orally administrable pertussis vaccine\", \"Studies on the development of mucosal vaccine adjuvant\", \"\\u7dd1\\u81bf\\u83cc\\u611f\\u67d3\\u30de\\u30a6\\u30b9\\u306b\\u304a\\u3051\\u308b\\u907a\\u4f1d\\u5b50\\u64cd\\u4f5c\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6709\\u52b9\\u6027\\u304a\\u3088\\u3073\\u514d\\u75ab\\u5b66\\u7684\\u6a5f\\u5e8f\\u306e\\u691c\\u8a0e\", \"Antigenic diversity and gene sequences of measles virus in the presence of antibodies\", \"Improving a plant vaccine platform modulation of the plant defence system\", \"DNA fusion gene vaccines against prostate cancer\", \"EV71\\u75c5\\u6bd2\\u8863\\u58f3\\u86cb\\u767dVP1\\u57fa\\u56e0\\u7684\\u4f18\\u5316\\u548c\\u514d\\u75ab\\u539f\\u6027\\u7684\\u7814\\u7a76\", \"\\u534f\\u540c\\u6d3b\\u5316TLR4\\u548cTLR9\\u7684\\u9776\\u5411DC\\u759f\\u75be\\u7ea2\\u5916\\u671f\\u8102\\u8d28\\u4f53\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u643a\\u5e26TGEV S\\u548cPEDV S\\u53cc\\u57fa\\u56e0\\u7684\\u51cf\\u6bd2\\u6c99\\u95e8\\u6c0f\\u83cc\\u53e3\\u670d\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"DNA-\\u75d8\\u75c5\\u6bd2\\u75ab\\u82d7\\u521d\\u514d\\u52a0\\u5f3a\\u65b9\\u6848\\u6240\\u8bf1\\u5bfc\\u7684\\u9ad8\\u529f\\u80fd\\u4eb2\\u548c\\u529b\\u7684CD8+T\\u7ec6\\u80de\\u7684\\u5206\\u5b50\\u7279\\u5f81\", \"\\u7ec6\\u7c92\\u68d8\\u7403\\u7ee6\\u866bBCG-egG1Y162\\u91cd\\u7ec4\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u548c\\u4fdd\\u62a4\\u673a\\u5236\\u7814\\u7a76\", \"\\u80bf\\u7624\\u75ab\\u82d7\\u65b0\\u578b\\u6c22\\u6c27\\u5316\\u94dd\\u51dd\\u80f6/\\u591a\\u7cd6\\u590d\\u5408\\u4f50\\u5242\\uff08Al-PS\\uff09\\u7684\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"SVCV\\u53cd\\u5411\\u9057\\u4f20\\u7cfb\\u7edf\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u4f20\\u9001\\u5206\\u5b50\\u75ab\\u82d7\\u673a\\u5236\\u7814\\u7a76\", \"\\u591a\\u57fa\\u56e0\\u8868\\u8fbe\\u5bb6\\u8695\\u751f\\u7269\\u53cd\\u5e94\\u5668\\u7ecf\\u6d4e\\u9ad8\\u6548\\u7ec4\\u88c5\\u7532\\u578bH1N1\\u6d41\\u611f\\u75c5\\u6bd2\\u6837\\u9897\\u7c92\\u53ca\\u5176\\u514d\\u75ab\\u539f\\u6027\\u7814\\u7a76\", \"TLR3\\u5728HBsAg\\u9633\\u6027\\u6bcd\\u4eb2\\u5a74\\u513f\\u4e59\\u809d\\u75ab\\u82d7\\u65e0\\u5f31\\u5e94\\u7b54\\u4e2d\\u7684\\u4f5c\\u7528\", \"D39\\u25b31672\\u7f3a\\u9677\\u83cc\\u682a\\u7c98\\u819c\\u63a5\\u79cd\\u5bf9\\u80ba\\u708e\\u94fe\\u7403\\u83cc\\u611f\\u67d3\\u7684\\u4fdd\\u62a4\\u4f5c\\u7528\\u53ca\\u673a\\u5236\\u7814\\u7a76\", \"\\u4e19\\u578b\\u809d\\u708e\\u75c5\\u6bd2\\u6297\\u539f\\u8868\\u4f4d\\u7684\\u9897\\u7c92\\u5316\\u5bf9\\u5176\\u514d\\u75ab\\u539f\\u6027\\u7684\\u5f71\\u54cd\", \"\\u8868\\u89c2\\u9057\\u4f20\\u4fee\\u9970\\u7684MHC-II\\u57fa\\u56e0\\u7ec6\\u80de\\u75ab\\u82d7\\u6cbb\\u7597\\u80f0\\u817a\\u764c\\u7684\\u673a\\u7406\\u7814\\u7a76\", \"\\u7ec6\\u7c92\\u68d8\\u7403\\u7ee6\\u866b\\u91cd\\u7ec4Bb-Eg95-EgA31\\u878d\\u5408\\u57fa\\u56e0\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"\\u9776\\u5411\\u80bf\\u7624\\u5e72\\u7ec6\\u80de\\u7684\\u6811\\u7a81\\u7ec6\\u80de\\u75ab\\u82d7\\u6cbb\\u7597\\u6076\\u6027\\u8111\\u80f6\\u8d28\\u7624\\u7684\\u5b9e\\u9a8c\\u53ca\\u4f5c\\u7528\\u673a\\u5236\\u7814\\u7a76\", \"\\u8868\\u8fbeAg85B\\u3001ESAT-6\\u548cMPT64\\u57fa\\u56e0\\u6838\\u9178\\u75ab\\u82d7\\u514d\\u75ab\\u5e94\\u7b54\\u53ca\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u86cb\\u767d\\u82af\\u7247\\u6280\\u672f\\u7684\\u65b0\\u578b\\u4e59\\u809d\\u75c5\\u6bd2\\u4f18\\u52bf\\u8868\\u4f4d\\u80bd\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u5c0f\\u53cd\\u520d\\u517d\\u75ab\\u75c5\\u6bd2\\u53cd\\u5411\\u9057\\u4f20\\u64cd\\u4f5c\\u5e73\\u53f0\\u5efa\\u7acb\\u53ca\\u6807\\u8bb0\\u75ab\\u82d7\\u6784\\u5efa\", \"\\u6291\\u5236\\u80be\\u7d20\\u6d3b\\u6027\\u7684\\u77ed\\u80bd\\u7eb3\\u7c73\\u75ab\\u82d7\\u7814\\u7a76\", \"\\u732a\\u7e41\\u6b96\\u4e0e\\u547c\\u5438\\u7efc\\u5408\\u5f81\\u201c\\u81ea\\u6740\\u6027\\u201dDNA\\u75ab\\u82d7\\u7814\\u7a76\", \"\\u91cd\\u7ec4\\u5c3f\\u7d20\\u9176-BCG\\u9884\\u9632\\u5e7d\\u95e8\\u87ba\\u6746\\u83cc\\u611f\\u67d3\\u7684\\u514d\\u75ab\\u673a\\u5236\", \"\\u6211\\u56fd\\u513f\\u7ae5\\u80ba\\u708e\\u94fe\\u7403\\u83cc\\u5206\\u79bb\\u682a\\u86cb\\u767d\\u8d28\\u6297\\u539f\\u7684\\u5206\\u5b50\\u6d41\\u884c\\u75c5\\u5b66\\u7814\\u7a76\", \"\\u53bb\\u9664Treg\\u7ec6\\u80de\\u8054\\u5408IL-15\\u589e\\u5f3aDC\\u75ab\\u82d7\\u7684\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u6cbb\\u7597\\u7814\\u7a76\", \"\\u8c03\\u8282\\u6027T\\u7ec6\\u80de\\u5bf9\\u8840\\u5438\\u866b\\u75ab\\u82d7\\u4fdd\\u62a4\\u6027\\u6548\\u679c\\u7684\\u5f71\\u54cd\\u53ca\\u673a\\u5236\\u7814\\u7a76\", \"\\u6297\\u6d88\\u5316\\u7cfb\\u6076\\u6027\\u80bf\\u7624hTERT\\u5e7f\\u8c31\\u75ab\\u82d7\\u7684\\u5206\\u5b50\\u8bbe\\u8ba1\\u53ca\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u4ee5\\u6c99\\u95e8\\u83cc\\u7684\\u83cc\\u6bdb\\u4e3a\\u8f7d\\u4f53\\u7684\\u591a\\u4ef7HIV-1\\u75ab\\u82d7\", \"\\u57fa\\u4e8e\\u53cc\\u6b67\\u6746\\u83cc\\u8868\\u8fbe\\u7cfb\\u7edf\\u7684EV71 VP1\\u4e9a\\u5355\\u4f4d\\u53e3\\u670d\\u6d3b\\u75ab\\u82d7\\u7814\\u7a76\", \"\\u6162\\u75c5\\u6bd2\\u8f7d\\u4f53\\u7ed3\\u6838\\u75c5\\u6cbb\\u7597\\u6027\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u809d\\u764c\\u5e72\\u7ec6\\u80de/DC\\u75ab\\u82d7\\u589e\\u5f3a\\u6297\\u809d\\u764c\\u514d\\u75ab\\u5e94\\u7b54\\u53ca\\u673a\\u5236\\u7814\\u7a76\", \"\\u65b0\\u578b\\u4f50\\u5242\\u5bf9\\u547c\\u5438\\u9053\\u5408\\u80de\\u75c5\\u6bd2\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u589e\\u5f3a\\u7684\\u80ba\\u90e8\\u514d\\u75ab\\u75c5\\u7406\\u7684\\u514d\\u75ab\\u8c03\\u8282\\u4f5c\\u7528\\u53ca\\u673a\\u5236\\u7814\\u7a76\", \"\\u53e3\\u670d\\u9776\\u5411\\u75ab\\u82d7\\u63a7\\u5236\\u91ca\\u653e\\u7684\\u57fa\\u7840\\u7814\\u7a76\", \"\\u4ee5\\u75c5\\u6bd2\\u6837\\u9897\\u7c92(VLP)\\u4e3a\\u5bf9\\u7167\\u7814\\u7a76\\u91cd\\u7ec4\\u817a\\u75c5\\u6bd2\\u75ab\\u82d7\\u5bf9\\u8bfa\\u5982\\u75c5\\u6bd2(NV)\\u7684\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\", \"\\u65b0\\u578b\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u75ab\\u82d7\\u6cbb\\u7597\\u524d\\u5217\\u817a\\u764c\\u53ca\\u5176\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u9526\\u706f\\u7b3c\\u591a\\u7cd6\\u5728\\u6838\\u9178\\u75ab\\u82d7\\u4e2d\\u514d\\u75ab\\u589e\\u5f3a\\u4f5c\\u7528\\u7684\\u7814\\u7a76\", \"\\u80a0\\u9053\\u75c5\\u6bd271\\u578bDNA\\u75ab\\u82d7\\u5236\\u5907\\u53ca\\u5176\\u514d\\u75ab\\u6548\\u679c\\u7684\\u4f18\\u5316\", \"\\u6297\\u5bab\\u9888\\u764c\\u7a7f\\u819c\\u80bd\\u878d\\u5408\\u6027\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u53ca\\u4f5c\\u7528\\u7814\\u7a76\", \"\\u75ab\\u82d7\\u7684\\u65b0\\u578b\\u9776\\u5411\\u8f93\\u9001\\u4f53\\u7cfb\\u53ca\\u5176\\u673a\\u5236\\u7814\\u7a76\", \"Enhanced HIV Vaccine by CNT-enabled Mucosal Delivery\", \"E! 5934 Improved vaccines against intracellular pathogens in aquaculture - combining PHARMAQ and Isconova technology\", \"Clinical development of DB Fusion, a serotype-independent vaccine to prevent Shigella dysentery\", \"Generating and improving novel vaccine candidates targeting multiple stages of Malaria\", \"Imuniza\\u00e7\\u00e3o com a vacina pneumoc\\u00f3cica durante a gesta\\u00e7\\u00e3o em mulheres infecctadas pelo v\\u00edrus da imunodefici\\u00eancia humana (HIV): resposta vacinal materna e transmiss\\u00e3o placent\\u00e1ria de anticorpos espec\\u00edficos\", \"Study of the necessary immunological effector mechanisms for the development of vaccine against tuberculosis\", \"Pneumococcal conjugate vaccine: capsular polysaccharide - pneumococcal surface protein A\", \"Control of diarrhea induced by enterotoxigenic Escherichia coli (ETEC) strains: vaccine formulations based on the CFA/I fimbriae, CfaE adhesin, heat-labile toxin (LT), and a new vaccine protection experimental model\", \"Vaccine efficiency test in type 1 bovine Herpesvirus and in types 1 and 2 bovine pestevirus in experimental guinea pig and caprine experimental models\", \"Vacinas para o controle da dengue administradas pelas vias intra-d\\u00e9rmica e transcut\\u00e2nea\", \"THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP A VACCINE DELIVERY SYSTEM WHICH WILL STIMULATE, RAPIDLY, A STATE OF NON-SPECIFIC PROTECTION WHILE IT ENHANCES THE SPECIFIC IMMUNE RESPONSE TO THE VACCINE AND SHORTENS THE INDUCTION PERIOD FOR DEVELOPMENT OF\", \"Development of a Recombinant Vaccine Against Streptococcus Pyogenes Infection and Disease\", \"Developing a Chlamydia trachomatis vaccine by optimizing dendritic cell responses\", \"Targeted disabled infectious single cycle (DISC) Bovine Adenovirus (BAdV)-3 as vaccine delivery vector\", \"Feasibility assessment of a novel vaccine platform for the stratified therapeutic vaccine intervention in non-small cell lung cancer.\", \"POLYVALENT VACCINE TO PROTECT POULTRY FROM AVIAN INFLUENZA\", \"DEVELOPMENT OF A SIMPLE KILLED ENTEROTOXIGENIC E. COLI VACCINE FOR WEANED PIGS\", \"DESIGN OF LIVE ATTENUATED VACCINIA VIRUS VACCINE VECTORS FOR THE DEVELOPMENT OF POLYVALENT VACCINES\", \"ANTIGEN DELIVERY SYSTEM FOR ELICITATION OF PROTECTIVE IMMUNITY AGAINST JOHNE?S DISEASE\", \"DEVELOPMENT OF VIRAL VECTORS FOR POLYVALENT ANIMAL VACCINES\", \"EVALUATION OF B. THURENGIENSIS SPORE-BASED VACCINES EXPRESSING ORF-4 AND ORF-5 OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS\", \"COUNTERMEASURES TO PREVENT AND CONTROL BRUCELLOSIS IN LIVESTOCK AND WILDLIFE RESERVOIRS\", \"An unconventional, effector memory T cell vaccine for influenza\", \"Investigation of influenza immune responses and vaccine efficacy correlates by global expression profiling and immunological analyses in the ferret model of influenza\", \"Development of an efficacious vaccine against animal brucellosis that is harmless for humans\", \"A new vaccine strategy against serogroup b meningococcal infection: from antigen discovery to clinical trials\", \"New mycobacterial tuberculosis antigens for diagnosis and vaccines\", \"Community Engagement and Ethical Practice in Vaccine Research.\", \"Generating and improving novel vaccine candidates targeting multiple stages of Malaria\", \"Statistical analysis and modelling of the effect of conjugate vaccine and systemic capsular antibody on carriage and transmission of Streptococcus pneumoniae in Kenyan children.\", \"Novel vaccine against haemorrhagic septicaemia in cattle and buffalo for use by resource poor farmers.\", \"Anaplasmosis vaccine development for west Africa: genetic and immunologic analysis of endemic strains\", \"Towards the development of a universal influenza vaccine: Investigation of heterosubtypic humoral and cellular immune responses to influenza induced by vaccination with viral\", \"An effectiveness study of 7-valent Pneumococcal Conjugate Vaccine administered through EPI in the Kilifi Demographic Surveillance Survey Area.\", \"Synthesis of bacterial polysaccharide vaccines in plants.\", \"Longitudinal characterization of immunity induced by a novel TB vaccine, MVA85A, in humans.\", \"Synthetic Toll-like Receptor 4 Agonists as Potential Adjuvants for Use in Animal Vaccines\", \"Two Dose E-Z Measles Vaccine Trial: Boosting Of Immune Responses In Bissau\", \"Development of rationally attenuated live vaccines for effective control of infectious bronchitis\", \"IAH Jenner Fellowship: Assessing the efficacy of recombinant viral vaccines to induce heterosubtypic immunity to influenza in birds\", \"VACCINE POTENCY:  DEVELOPMENT AND VALIDATION OF IPV ELIS\", \"Aerosol Infection of Mice as a Model for Pertussis Infec\", \"IN VIVO POTENCY OF INACTIVATED POLIOVIRUS VACCINE\", \"QUANTITATIVE ANALYSIS OF HIB PS IN DTP-HIB CONJUGATE COMBINED VACCINE\", \"Malaria Vaccine Development Branch (MVDB)\", \"Development &Manufacture of an MDR Tuberculosis Vaccine\", \"Bastyr/UW Oncomycology Translational Research Center\", \"Malaria Vaccine Trials in Mali\", \"Multivalent Vaccine for Viral Hemorrhagic Fever\", \"Recombinant Subunit West Nile Virus Vaccine Development\", \"VACCINE DEVELOPMENT FOR IMMUNODEFICIENCY VIRUSES\", \"Development of Chimeric Vesiculo/Alphaviruses as an Alphavirus Vaccine\", \"SELECTION OF RSV SUBGROUP A &B VACCINE CANDIDATES\", \"ORAL MALARIA VACCINE DEVELOPMENT IN A P. BERGHEI MODEL\", \"VACCINE/HEALTH ECONOMICS LINEAR PROGRAMMING SOFTWARE\", \"EFFICACY OF E COLI PILUS VACCINE FOR URINARY INFECTION\", \"A NEW CANDIDATE VACCINE FOR LEUKEMIA AND CANCER\", \"Development of a Bacterial Ghost DNA vaccine for Influenza using antibody epitope\", \"Development of a DNA Vaccine Against Influenza Virus\", \"Synthesis and Optimization of a Malaria Vaccine\", \"Oral Smallpox Vaccine Development\", \"Needle-Free Delivery of Subunit Rotavirus Vaccines\", \"CD1 PRESENTED VACCINES TO PREVENT CHLAMYDIA INFECTION\", \"IMPROVING DNA VACCINES FOR HIV1\", \"EXPRESSION OF MALARIA MSP-1 P42 C-TERMINAL FRAGMENT\", \"VAGINAL IMMUNIZATION AGAINST URINARY TRACT INFECTIONS\", \"VACCINE FOR MYCOBACTERIUM TUBERCULOSIS\", \"WATER SOLUBLE POLYMER MICROSPHERES AS VACCINE VEHICLES\", \"SYNTHETIC GLYCO-CONJUGATE VACCINE AGAINST MENINGOCOCCI\", \"ORAL MALARIA VACCINE DEVELOPMENT INA P BERGHEI MODEL\", \"A novel vaccine against vaginal Chlamydia trachomatis\", \"A novel recombinant vaccine against Cryptococcus.\", \"Identification of protective pneumococcal antigens from a surface protein library\", \"TARGETED DELIVERY OF MUSCOSAL HIV1 RNA VACCINE\", \"HIV VACCINE VOLUNTEERS--PERSONALITY, MOTIVATION, AND RIS\", \"CORRELATION OF ANTIBODY RESPONSE TO MELANOMA VACCINE...\", \"NASAL ANTHRAX VACCINE DELIVERY FORMULATIONS\", \"Diindolylmethane enhances the efficacy of preventive vaccines in an HPV transgeni\", \"IMMUNOGENICITY OF A POLYVALENT MELANOMA ANTIGEN VACCINE\", \"Alphavirus-based Vaccine for Prevention of MPV Infection\", \"Tools for Testing HIV Immune-Control and Vaccine Models\", \"ORAL MALARIA VACCINE DEVELOPMENT--P. BERGHEI MODEL\", \"PROTEIN-POLYSACCHARIDE PNEUMOCOCCAL CONJUGATE VACCINES\", \"HIV Vaccines via 2G12 Carbohydrate Epitope Mimicry\", \"PnuBioVax\\u2122: next-generation vaccine for a personalised and effective immune response against Streptococcus pneumoniae.\", \"Novel Live Vaccines with Modified Lipid A for the Prevention of Shigella Diarrheal Disease\", \"Novel Live Vaccines with Modified Lipid A for the Prevention of Shigella Diarrheal Disease\", \"Generation and characterization of a bivalent replication-competent vaccine against Ebola virus and human immunodeficiency virus\", \"Unpacking Vaccine Hesitancy among Perinatal Healthcare Providers: Influences on Beliefs and Practices\", \"\\u767b\\u9769\\u75c5\\u6bd2\\u56db\\u4ef7\\u75ab\\u82d7\\u514d\\u75ab\\u65b0\\u7b56\\u7565\\u7684\\u7814\\u7a76\", \"\\u6784\\u5efa\\u65b0\\u9896\\u7684\\u51cf\\u6bd2\\u6c99\\u95e8\\u8f7d\\u4f53\\u9012\\u9001\\u9e2d\\u761fDNA\\u75ab\\u82d7\", \"\\u57fa\\u4e8e\\u591a\\u57fa\\u56e0\\u5171\\u8868\\u8fbe\\u8f7d\\u4f53\\u7684\\u901a\\u7528\\u578b\\u6d41\\u611f\\u75ab\\u82d7\\u7814\\u7a76\", \"Investigating tropical enteropathy as a cause of oral rotavirus vaccine failure in the developing world\", \"The examination of a novel viral vector and immunogens for HIV/SIV vaccine development in a non-human primate model\", \"Uptake of The Human Papillomavirus Vaccine in Canada: Barriers and Facilitators.\", \"Dissecting the mechanisms of protection by attenuated Nef-deleted HIV vaccine\", \"Qualitative and quantitative parameters of correlates of protection in HIV-1 vaccines\", \"Accelerated Chlamydia trachomatis Immunoproteomic Vaccine Enterprise\", \"Increasing HPV vaccine uptake in the school-based program in rural and remote British Columbia\", \"Vaccine Development Against Novel Breast Cancer Antigens\", \"Development of a mucosal vaccine against Helicobacter pylori infection including Phase I clinical testing in India\", \"POTENT VACCINE FORMULAS FOR JOHNE`S DISEASE\", \"New strategies for vaccines against infectious bronchitis and the elucidation of pathogenicity and immunity\", \"\\u9a6c\\u4f20\\u67d3\\u6027\\u8d2b\\u8840\\u75c5\\u6bd2\\u5f31\\u6bd2\\u75ab\\u82d7\\u682a\\u4e0e\\u5f3a\\u6bd2\\u682a\\u611f\\u67d3\\u5bf9\\u9776\\u7ec6\\u80de\\u4f5c\\u7528\\u5dee\\u5f02\\u7684\\u7814\\u7a76\", \"Long-term immunogenicity and clinical efficacy of the quadrivalent HPV vaccine in HIV positive girls and women\", \"PROBIOTICS AS TOOLS TO IMPROVE IMMUNE RESPONSE TO VACCINE AGENTS DELIVERED THROUGH THE RESPIRATORY MUCOSAL SURFACE IN FARM ANIMALS\", \"Preventive measurement for vaccine brak of Marek's Disease, Divelopment of the vaccine in particular\", \"\\u6297\\u4f53\\u4f9d\\u5b58\\u6027\\u611f\\u67d3\\u5897\\u5f37\\u73fe\\u8c61\\u3092\\u5229\\u7528\\u3057\\u305f\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u306e\\u958b\\u767a\", \"\\u30cd\\u30aa\\u30b9\\u30dd\\u30e9\\u75c7\\u3092\\u30e2\\u30c7\\u30eb\\u3068\\u3057\\u305f\\u7d4c\\u53e3\\u6295\\u4e0e\\u578b\\u85fb\\u985e\\u30af\\u30e9\\u30df\\u30c9\\u30e2\\u30ca\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4f5c\\u51fa\", \"HCV\\u611f\\u67d3\\u30c1\\u30f3\\u30d1\\u30f3\\u30b8\\u30fc\\u306b\\u5bfe\\u3059\\u308bHCVDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u52b9\\u679c\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"Active specific immunotherapy with MN\\\\CA IX antigen peptide vaccines for renal cell carcinoma\", \"\\u6b6f\\u5468\\u75c5\\u539f\\u6027\\u83cc\\u306e\\u30b7\\u30b9\\u30c6\\u30a4\\u30f3\\u30d7\\u30ed\\u30c6\\u30a2\\u30fc\\u30bc\\u3092\\u6a19\\u7684\\u3068\\u3057\\u305fDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u30ca\\u30ce\\u30c6\\u30af\\u30ce\\u30ed\\u30b8\\u30fc\\u3092\\u7528\\u3044\\u305f\\u6b21\\u4e16\\u4ee3\\u7d4c\\u9f3b\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u3068\\u3001\\u305d\\u308c\\u306b\\u3088\\u308b\\u514d\\u75ab\\u8a98\\u5c0e\\u6a5f\\u5e8f\\u306e\\u89e3\\u660e\", \"Molecular and immunological analysis of periodontopathic bacterial attachment factors\", \"\\u81ea\\u7136\\u514d\\u75ab\\u5236\\u5fa1\\u306b\\u3088\\u308b\\u547c\\u5438\\u5668\\u75be\\u60a3\\u306e\\u4e88\\u9632\\u304a\\u3088\\u3073\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\", \"\\u30ed\\u30bf\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u306e\\u91ce\\u751f\\u682a\\u3068\\u306e\\u907a\\u4f1d\\u5b50\\u4ea4\\u96d1\\u4f53\\u306e\\u89e3\\u6790\", \"Development of Immune-Modulated HIV Vaccines\", \"\\u0420\\u0430\\u0437\\u0440\\u0430\\u0431\\u043e\\u0442\\u043a\\u0430 \\u0438 \\u043f\\u0440\\u0438\\u043c\\u0435\\u043d\\u0435\\u043d\\u0438\\u0435 \\u043d\\u043e\\u0432\\u044b\\u0445 \\u0442\\u0435\\u0445\\u043d\\u043e\\u043b\\u043e\\u0433\\u0438\\u0439 \\u043f\\u0440\\u0438 \\u043a\\u043e\\u043d\\u0441\\u0442\\u0440\\u0443\\u0438\\u0440\\u043e\\u0432\\u0430\\u043d\\u0438\\u0438 \\u0434\\u0438\\u0430\\u0433\\u043d\\u043e\\u0441\\u0442\\u0438\\u0447\\u0435\\u0441\\u043a\\u0438\\u0445 \\u0438 \\u0432\\u0430\\u043a\\u0446\\u0438\\u043d\\u043d\\u044b\\u0445 \\u043f\\u0440\\u0435\\u043f\\u0430\\u0440\\u0430\\u0442\\u043e\\u0432 \\u043f\\u0440\\u043e\\u0442\\u0438\\u0432 \\u043b\\u0438\\u0445\\u043e\\u0440\\u0430\\u0434\\u043a\\u0438 \\u0434\\u043e\\u043b\\u0438\\u043d\\u044b \\u0420\\u0438\\u0444\\u0442\", \"Improving the efficacy of hepatitis B prophylactic vaccines\", \"Veien til vellykket DNA-vaksinering av laks mot virussykdommer\", \"Development of methods for enhancement of nucleic acids-based antiviral vaccines immunogenicity\", \"DENDRITIC CELL ARRAYS FOR T1D NANOPARTICLE-BASED VACCINE DEVELOPMENT\", \"EFFEKTIVE VAKSINER OG VAKSINESTRATEGIER FOR TORSK, FOKUS P\\u00c5 BAKTERIELLE AGENS\", \"Vibriosis and furunculosis vaccines for Atlantic cod: efficacy, protective antigens and specific immune responses\", \"Meningococcal vaccines for Africa: Impact of MenAfriVac on serogroup A transmission and clinical evaluation of a new protein-based vaccine\", \"Novel strategies for immunisation against intracellular pathogens of Atlantic salmon\", \"Project establishment: Development of vaccine(s) against infections with diarrheagenic Escherichia coli and Shigella\", \"Immunisation strategies against viral pathogens of Atlantic salmon\", \"Efeito modulador de estrat\\u00e9gias vacinais para tuberculose na encefalite autoimune experimental (EAE)\", \"Genomic characterization of the Bordetella pertussis strain used to produce the anti-pertussis vaccine at Butantan Institute\", \"Studies of the immunogenic and protective properties of third generation vaccines against american tegumentar leishmaniasis\", \"Commercialisation of a world changing invention for the stabilisation and delivery of vaccines\", \"Structural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy\", \"INNOVATIVE STRATEGIES TO ENHANCE PRRSV SPECIFIC INNATE AND MUCOSAL IMMUNITY: IMPLICATION FOR DEVELOPMENT OF BROADLY PROTECTIVE PRRS VACCINE\", \"ROLE OF M-PROTEIN IN PROTECTION AND VIRULENCE OF STREPTOCOCCUS EQUI SUBSP. EQUI\", \"Eliciting Mucosal Immunity to Tuberculosis\", \"Star ID (Star Intradermal)\", \"Developing Stable Liquid Pandemic Influenza Vaccines to Improve Shelf Life, Facilitate Distribution, and Increase Pandemic Preparedness\", \"UNIVERSAL FLU VACCINE BY A NOROVIRUS P PARTICLE PLATFORM\", \"PEPTIDE NANOPARTICLES AS NOVEL IMMUNOGENS: DESIGN AND ANALYSIS OF AVIAN INFLUENZA VACCINE\", \"COMPETITION FOR ANTERIOR PLASMA CELL NICHES DETERMINES THE SUCCESS OF VACCINES\", \"Development of a universal influenza vaccine based on tandem core technology\", \"Reach  \\u03b1-synuclein-dependent neurodegeneration: clinical development of therapeutic AFFITOPE vaccines for Parkinson\\u2019s disease and multisystem atrophy\", \"Clinical development of a VAR2CSA-based placental malaria vaccine\", \"Universal Flu Vaccine\", \"Universal Influenza Vaccines Secured\", \"Mucosal nano vaccine candidate for HIV\", \"Use of CpG oligodeoxynucleotides to improve the immunogenicity of vaccines\", \"Optimisation of the development of Poverty-Related-Diseases (PRD) vaccines by a transversal approach, addressing common gaps and challenges\", \"Plant Production of Vaccines\", \"Vaccine Strategies for Combined Targeting of Innate and Adaptive Immune Pathways\", \"An investigation into the incorporation and release of vaccines from polylactid acid microspheres\", \"Development of tuberculosis vaccine with consistent efficacy in differentregions of the world\", \"Evaluation of respiratory vaccines for children in South East Asia. Streptococcus pneumoniae (and Hib) conjugate vaccincs in prevention of childhood pneumonia in developing countries\", \"I-Corps: SwiftVax - A Green Manufacturing Platform for Faster, Cheaper, and Scalable Vaccine Manufacturing\", \"Two Dose E-Z Measles Vaccine Trial: Boosting of Immune Responses\", \"Plant Production of Vaccines\", \"Production of a Broadly Neutralizing HIV Antibodies\", \"IMMUNOPATHOGENESIS OF RUBELLA VIRUS ASSOCIATED AUTOIMMUN\", \"IMMUNIZATION OF SIX AND NINE MONTH OLD INFANTS AGAINST MEASLES\", \"Novel cell-culture derived split influenza vaccine\", \"Production of Non-Egg grown Influenza Vaccines\", \"Core_Prospective population-based estimation of influenza vaccine effectiveness a\", \"Avian Flu A/H5N1 Vaccine Development in Vietnam\", \"Multi-gene Subunit Vaccine Platform Against Y. pestis\", \"Production of an NP-ISS conjugate vaccine to combat pandemic influenza.\", \"Non-Viral Pandemic Influenza Vaccine Development\", \"Development of a vaccine for Ebola virus in plant system\", \"Influenza DNA Vaccine for Biodefense/Pandemic Readiness\", \"Multi-gene plague vaccine with expanded protection\", \"Evaluation and Production of a Multivalent Adenoviral Plague Vaccine\", \"Transcriptionally Active PCR to Improve DNA Vaccines\", \"MALARIA VACCINE\", \"DEVELOPMENT OF LIPID VACCINES FOR TUBERCULOSIS\", \"Use of Spray-Drying as a Manufacturing Process for Oral Adenovirus Vaccine\", \"Multivalent HPV Capsomere Vaccines\", \"THERAPEUTIC DNA VACCINES TO TREAT B CELL LYMPHOMA\", \"Influenza Virus-like Particles As Vaccines\", \"A Mucosal Vaccine for HSV-2\", \"Novel Delivery of a New Vaccine for Tuberculosis\", \"Development of an Intranasal Rotavirus Subunit Vaccine\", \"A Max-Ad Vaccine for Mucosal Immunity to HIV\", \"DESIGN &DEVELOPMENT OF A MULTIEPITOPE VACCINE: MALARIA\", \"Noninvasive delivery of skin-targeted anthrax vaccines\", \"EXPRESSION OF P FALCIPARUM LSA-1 SUBUNITS\", \"NONINVASIVE DELIVERY OF SKIN-TARGETED RABIES VACCINES\", \"POLYMERS FOR AUGMENTING R BOTULINUM VACCINE EFFICACY\", \"New attenuated anthrax vaccine\", \"Recombinant hPIV3 and RSV Sendai Virus Vaccine Phase I Clinical Trial Development\", \"BCG as an HIV vaccine vector\", \"Exploiting the Unique T Cell Response to CMV for a Cancer Vaccine\", \"Rabbit model to assess reactogenicity and immunogenicity of Salmonella vaccines\", \"E. coli O157:  H7 Vaccine Development\", \"BCG as an HIV vaccine vector\", \"Avian Influenza Virus Vaccines Bearing Immunomodulators\", \"Vaccine potential of promiscuous mycobacterial peptides\", \"Novel Adjuvant Formulations for Genetic Vaccines\", \"Development of a New Tularemia Vaccine\", \"New genetic vaccine to protect aganist botulism\", \"Immunodominant epitopes of a smallpox vaccine in humans\", \"TNFSF APC activators for HIV Vaccines\", \"Pro-Apoptotic Tuberculosis Vaccine\", \"TRANSCRIPTION-REGULATING VECTORS FOR ANTIVIRAL VACCINES\", \"NOVEL, LIVE, RECOMBINANT YEAST BASED HIV VACCINE\", \"Oral Vaccine-Induced Cellular Immunity Against HIV-1\", \"Annual Conference on Vaccine Research\", \"Conference HIV Vaccine Development Progress &Prospects\", \"CONFERENCE ON HIV VACCINE DEVELOPMENT\", \"Host SNPs and Altered Responses to Influenza Vaccine\", \"GANGLIOSIDE MEDIATED IMMUNOTHERAPY OF CANCER\", \"NKT cells as modulators of AIDS vaccine efficacy\", \"Development of Enabling Vector/Antigen Expression Technology for an Orally-Delive\", \"Novel Adjuvant Discovery in Vaccine Therapy\", \"QUALITATIVE NATURE OF ANTIBODIES TO HCV GLYCOPROTEIN SUBUNIT VACCINE IN HUMANS\", \"Vaccine Development in Leishmaniasis\", \"The Immunobiology of the Hemoglobin Receptor of H. ducreyi\", \"SALMONELLA VECTORED MULTIVALENT VACCINES\", \"Correlates of protection against SIV/SHIV challenge\", \"LIVE ATTENUATED MULTIPLY DELETED HIV1 VACCINE FOR AIDS\", \"STATISTICAL &CLINICAL COORDINATING CENTER (SC)\", \"CORE IMMUN. LAB FOR ASSESS. OF AIDS VACCINES IN PRIMATES\", \"MIDCAREER INVESTIGATOR AWARD IN PATIENT ORIENTED RESEARC\", \"Induction of Mucosal Cellular Immunity by HIV-1 Vaccine Vectors\", \"A novel polyvalent vaccine against EBV+ lymphoma\", \"BIOVACSAFE \\u2013 Biomarkers for enhanced vaccine safety\", \"Innovation Mandate Phase 1 Sebastiaan Theuns 150269 (resubmission 140777): Development of a roaal attenuated rotavirus vaccines for gilts, sows and piglets to prevent farrowing and weaning diarrhea\", \"Development of a Recombinant VSV-Based Vaccine for Lassa Fever\", \"Development of a Recombinant VSV-Based Vaccine for Nipah Virus\", \"Vaccines for Pseudomonas aeruginosa\", \"The Road Ahead: HIV Vaccines\", \"HIV Vaccines: Progress, Failures and New Directions\", \"HIV Vaccines: Where do we go next?\", \"\\u8868\\u8fbe\\u4eba\\u7cbe\\u5b50\\u819c\\u86cb\\u767d\\u7684\\u6c99\\u95e8\\u6c0f\\u83cc\\u7684\\u5236\\u5907\\u53ca\\u514d\\u75ab\\u5e94\\u7b54\\u7684\\u7814\\u7a76\", \"\\u732a\\u4f2a\\u72c2\\u72ac\\u75c5\\u548c\\u7ec6\\u5c0f\\u75c5\\u6bd2\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u732a\\u5706\\u73af\\u75c5\\u6bd2\\u6d3b\\u75ab\\u82d7\\u8f7d\\u4f53\\u7684\\u6784\\u5efa\\u53ca\\u514d\\u75ab\\u539f\\u6027\\u5206\\u6790\", \"\\u5229\\u7528\\u4eba\\u4f53\\u5929\\u7136\\u6297\\u4f53\\u6cbb\\u7597\\u80bf\\u7624\", \"\\u4eba\\u7ed3\\u6838\\u6746\\u83cc\\u591a\\u6297\\u539f\\u57fa\\u56e0\\u91cd\\u7ec4BCG\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"IL-15cDNA\\u534f\\u540cHPV16E6E7\\u65b0\\u578brAAV\\u75ab\\u82d7\\u7684\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u7814\\u7a76\", \"\\u624b\\u6027\\u591a\\u91cd\\u6297\\u539f\\u80bd\\u75ab\\u82d7\\u7684\\u5236\\u5907\\u53ca\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u53e3\\u8e44\\u75abDNA\\u75ab\\u82d7\\u7c98\\u819c\\u514d\\u75ab\\u6548\\u679c\\u7684\\u7814\\u7a76\", \"\\u9c7c\\u7c7b\\u6dcb\\u5df4\\u56ca\\u80bf\\u75c5\\u6bd2\\u4e2d\\u548c\\u5355\\u514b\\u9686\\u6297\\u4f53\\u7814\\u5236\\u53ca\\u5176\\u6d41\\u884c\\u75c5\\u5b66\\u7814\\u7a76\", \"\\u4f0a\\u6c0f\\u9525\\u866bVSG\\u6297\\u539f\\u5e93\\u5efa\\u7acb\\u53ca\\u5176\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u7406\", \"\\u9a6c\\u7acb\\u514b\\u6c0f\\u75c5\\u75ab\\u82d7\\u4e8c\\u6b21\\u514d\\u75ab\\u589e\\u5f3a\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u673a\\u7406\\u7684\\u7814\\u7a76\", \"\\u5e7d\\u95e8\\u87ba\\u6746\\u83cc\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8eIi\\u5206\\u5b50\\u7684HCV-NS3 Th1\\u8868\\u4f4d\\u57fa\\u56e0\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u53ca\\u529f\\u80fd\\u7814\\u7a76\", \"\\u5229\\u7528\\u751f\\u7269\\u964d\\u89e3\\u5fae\\u7403\\u5236\\u505a\\u6297\\u764c\\u75c7\\u53cc\\u529f\\u80fd\\u878d\\u5408\\u86cb\\u767d\\u514d\\u75ab\\u75ab\\u82d7\", \"\\u4ee5\\u51cf\\u6bd2\\u6c99\\u95e8\\u6c0f\\u83cc\\u4e3a\\u8f7d\\u4f53\\u4e8c\\u4ef7\\u9632\\u9f8bDNA\\u75ab\\u82d7\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u8c37\\u6c28\\u9178\\u8131\\u7fa7\\u9176DNA\\u75ab\\u82d7\\u9884\\u9632\\u80f0\\u5c9b\\u708e\\u7814\\u7a76\", \"\\u8f6c\\u57fa\\u56e0\\u690d\\u7269\\u53ef\\u98df\\u5d4c\\u5408\\u4f53\\u9632\\u9f8b\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u95f4\\u65e5\\u759f\\u539f\\u866b\\u4f20\\u64ad\\u963b\\u65ad\\u75ab\\u82d7\\u5019\\u9009\\u86cb\\u767dPvs25\\u548cPvs28\\u57fa\\u56e0\\u7684\\u514b\\u9686\\u548c\\u8868\\u8fbe\", \"CpG\\u5be1\\u6838\\u82f7\\u9178\\u4f5c\\u4e3a\\u4eba\\u7528\\u75ab\\u82d7\\u4f50\\u5242\\u7684\\u7814\\u7a76\", \"Investigation of porcine reproductive and respiratory syndrome: chronic losses, vaccine use and export markets.\", \"PRRS Virus:  The Implications for the Breeding Herd\", \"Subunit vaccines directed against Salmonella Enteritidis in poultry\", \"Avalia\\u00e7\\u00e3o das estrat\\u00e9gias de vacina\\u00e7\\u00e3o para a gripe: impacto da muta\\u00e7\\u00e3o viral\", \"Hepatitis C vaccines\"], \"legendgroup\": \"\", \"marker\": {\"color\": [1208, 26956, 26403, 442366, 236067, 130890, 27386, 0, 46000, 7138, 13447, 23051, 24761, 4363, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 61313, 0, 1136603, 29617, 0, 0, 22635, 67917, 6767, 70976, 447769, 63197, 1750550, 36032, 50000, 86356, 20686, 259061, 178772, 38760, 4498, 31616, 3230548, 49951, 4184, 4498, 4546, 4184, 15247, 3455122, 0, 0, 0, 485633, 838646, 0, 0, 52371, 113783, 378543, 113000, 534630, 39000, 0, 0, 8807296, 1265722, 183534, 120798, 1901, 5854, 1691, 1086, 512009, 200000, 0, 0, 295003, 101459, 9841, 67329, 1514, 81841, 182350, 0, 66584, 638466, 579532, 88992, 23691, 230794, 74889, 552165, 3391, 3391, 3391, 71382, 229287, 46740, 78134, 5147415, 84188, 136593, 33003, 120675, 133297, 68538, 116900, 64693, 298213, 96548, 158968, 148678, 109364, 40000, 5523, 5523, 6907, 6907, 8978, 11050, 6907, 0, 6559, 12430, 6934, 3518, 3578777, 126906, 5519281, 0, 0, 50929, 8860, 4071, 0, 0, 0, 4364, 6536, 19106, 96926, 10998, 21960, 64288, 45902, 23952, 66739, 193054, 4998, 79436, 105178, 4216, 72085, 102599, 52765, 4216, 580948, 16102, 4216, 1634, 15000, 752462, 7497149, 0, 0, 0, 310000, 247200, 100000, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 160465, 130785, 239250, 0, 0, 0, 0, 0, 0, 0, 409875, 0, 0, 0, 858983, 1709592, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 740515, 0, 0, 0, 0, 0, 229246, 0, 0, 0, 0, 6077974, 0, 0, 12176449, 28595532, 4359668, 3559620, 12787854, 132483632, 4848248, 2354105, 1027633, 3370321, 22485676, 5545506, 6238876, 4581647, 13332202, 5265499, 9078858, 19171620, 13750234, 12782071, 84654136, 9773650, 18633488, 11954660, 13452676, 9133450, 27272696, 19894560, 20886180, 36897780, 23057106, 30695332, 14725251, 32415946, 20465260, 18486918, 16958976, 14506256, 13074784, 35935876, 58067576, 7377398, 19605318, 6612114, 6472027, 36378536, 11256214, 22522020, 25629016, 51502832, 39530888, 5346605, 13795530, 11807857, 7599557, 24289670, 7587053, 6787449, 16585636, 7824550, 18607916, 31860150, 9059135, 10058390, 14692051, 5550667, 4430576, 19247618, 10479382, 41633856, 15583782, 21286744, 14626625, 8323787, 22845980, 9981773, 16824272, 14710428, 0, 0, 0, 9100510, 447887, 377233, 93832, 766222, 36686, 0, 0, 0, 0, 454005, 526155, 15896, 3391, 56978, 449984, 18068, 36058, 9665, 17502, 3352012, 3352012, 5042594, 3418543, 3200598, 7976947, 1700000, 0, 149989, 294474, 0, 12432, 0, 0, 0, 0, 12042, 845, 2053, 6039, 21740, 14488, 17863, 11414, 5168, 8618, 6024, 2103, 27526, 37887, 3262, 16909, 365392, 357548, 1172455, 2215626, 131436, 569700, 571409, 3935142, 146344, 15864, 43096, 248741, 4424845, 3463, 3463, 3463, 3463, 16174, 154056, 0, 0, 0, 0, 0, 0, 0, 15347, 14769, 3184, 346628, 63651, 235501, 7556, 71400, 27317, 28049, 64572, 66623, 0, 107932, 63697, 3017, 35506, 68775, 103437, 32616, 332091, 56581, 60383, 1514, 29817, 113067, 746244, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 60000, 26697, 179388, 881665, 385160, 449644, 292991, 105796, 810873, 652432, 256438, 232602, 185946, 653455, 150889, 3391, 3391, 3391, 3391, 37718, 0, 37533, 441609, 72348, 70796, 111817, 69224, 197208, 123855, 29704, 203274, 99460, 171630, 111784, 37292, 170570, 8896, 160408, 414742, 60047, 199095, 106640, 109212, 149976, 100000, 440000, 6294086, 2871805, 3543549, 1847820, 25293370, 6376130, 7782675, 385144, 18000000, 807080, 804741, 5178, 8287, 11740, 6768, 6906, 6906, 8978, 17265, 17956, 10360, 12914, 24172, 9323, 31546, 16256, 6213, 42130, 11740, 22102, 14803, 183583, 11034, 7104, 6688, 7597, 4833, 13118, 156508, 3518, 3518, 39124, 927884, 90826, 435809, 0, 2685906, 4388000, 2090968, 3464000, 6720850, 6369000, 4640567, 0, 6978780, 4000000, 5042594, 515844, 4270280, 0, 1300000, 2600000, 791496, 17271, 5293544, 4312612, 149592, 0, 29019, 142572, 307034, 0, 0, 0, 0, 0, 51865, 54650, 127444, 212413, 117981, 8965963, 0, 355035, 272177, 8529, 0, 0, 0, 70000, 233401, 55902, 4071, 90554, 45275, 2736860, 67080, 72594, 37264, 9080219, 0, 0, 0, 0, 0, 0, 0, 0, 0, 75190, 145174, 217382, 163587, 83746, 32656, 66351, 116280, 208503, 148018, 142445, 9540, 52358, 15503, 78576, 22291, 129424, 129905, 43628, 128223, 23745, 161733, 116966, 4090, 14278, 373818, 15247, 4216, 16102, 351165, 298383, 3939, 243286, 206369, 59485, 3654, 408329, 17520, 292, 8812, 216848, 27926, 4090, 4363, 22598, 18511, 19546, 17498, 29109, 14442, 30328, 0, 22663000, 696000, 0, 299525, 0, 1492900, 1373500, 0, 0, 0, 0, 0, 0, 284375, 0, 0, 0, 0, 0, 0, 0, 0, 552946, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 163941, 164000, 150000, 237750, 368846, 181850, 0, 0, 0, 0, 0, 0, 100000, 142814, 0, 0, 0, 1010353, 1273968, 0, 0, 0, 0, 11606890, 14490691, 0, 0, 0, 217249, 0, 0, 0, 0, 0, 0, 0, 0, 411574, 0, 750000, 0, 979767, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3773578, 7545418, 3213894, 2527964, 0, 0, 0, 0, 0, 0, 0, 0, 0, 12239874, 24666320, 23776040, 6919041, 3954801, 26897364, 3732639, 10030916, 13007636, 9628383, 835028, 0, 0, 0, 0, 0, 113650, 0, 0, 2723435, 371377, 13496364, 13072863, 2809421, 383103, 2729831, 372250, 2628793, 358447, 2746553, 374527, 2634897, 359304, 337232, 2758811, 376202, 1735409, 1735409, 6250000, 20000, 2247441, 79683, 211751, 1102716, 0, 0, 0, 46858, 100000, 99632, 357500, 98231, 896490, 449620, 4956, 322481, 1000, 0, 0, 9265633, 327096, 16141, 25831, 1644104, 152343, 170773, 0, 1200000, 2560239, 23024, 0, 39940, 3320228, 12078, 514201, 33782, 0, 3081165, 100000, 428770, 100000, 100000, 98212, 16141, 234957, 336464, 0, 0, 0, 1790, 1777, 1159, 2328, 142191, 654734, 174044, 277036, 69213, 1443557, 541177, 873846, 932, 2129, 1954, 957, 1433, 86605, 7168, 0, 0, 1494972, 328953, 333428, 51269, 247887, 449950, 0, 1299500, 501069, 510006, 100000, 54970, 100000, 487273, 100000, 8958936, 33736704, 222411, 100000, 100000, 800000, 382750, 100000, 100000, 2325773, 100000, 19901076, 100000, 100000, 11631, 438932, 441905, 444428, 34797, 155419, 20711, 272219, 11666, 10079, 17503, 4374, 190050, 294426, 104331, 2318236, 1323948, 196323, 30458, 243699, 99667, 261000, 261000, 165000, 88000, 263474, 10718, 1077813, 1270842, 517816, 1060037, 985801, 31104, 233204, 23078, 1576546, 157372, 1624996, 1369907, 223386, 1286013, 7281277, 1685828, 13116, 31631, 30049, 17500, 51355, 7421, 63483, 36587, 46728, 117550, 49584, 43453, 62245, 17397, 39505, 68810, 73800, 41174, 327733, 1073308, 311686, 56582, 39299, 51907, 156211, 54452, 81445, 870473, 157697, 480900, 63231, 93480, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 11191, 15698, 16906, 16906, 16909, 14488, 16907, 14488, 14483, 6150, 5380, 5168, 4303, 5168, 3442, 5169, 5168, 5164, 5169, 3094, 2103, 976, 604, 84702, 548392, 118430, 234734, 1294061, 279496, 299989, 747533, 155782, 2581731, 806049, 18539, 136301, 915606, 281182, 6792983, 38579, 696583, 71909, 775776, 549251, 5681136, 897548, 373761, 91725, 786127, 3854579, 123733, 718296, 1745503, 324227, 330698, 593649, 561875, 519040, 376405, 339022, 164629, 394723, 32871900, 544826, 1039442, 210836, 31240, 14023, 120251, 1575648, 0, 0, 45224, 105000, 200000, 150000, 40000, 2387117, 2204022, 8388, 154056, 13477, 3030, 13477, 26956, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 8757, 26734, 143822, 118381, 75264, 140407, 407088, 8135774, 116837, 52134, 26446, 395105, 13261, 36949, 291086, 30684, 34445, 13762, 31616, 16338, 100615, 225876, 15330, 1418041, 1266966, 59322, 22798, 410418, 11370, 86733, 36257, 2500, 4818, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 121627, 113300, 120540, 4684442, 386100, 743073, 40362, 40620, 124074, 128841, 202342, 177902, 446022, 38448, 629535, 1007992, 1251342, 22020, 376648, 372787, 205046, 3495000, 1328340, 1788000, 70000, 375000, 74767, 641817, 79486, 511097, 66051, 425772, 172317, 150186, 105840, 332693, 351204, 409410, 252737, 416405, 793905, 420331, 194121, 960309, 3391, 3391, 13200, 26403, 1563412, 0, 507796, 643644, 642366, 493002, 643391, 1238633, 30692, 20757, 682359, 109023, 155631, 150234, 98359, 173588, 101922, 34250, 86172, 106134, 355284, 348763, 64748, 314526, 137939, 128758, 56550, 101151, 84345, 107886, 139249, 214282, 127081, 400427, 174132, 67638, 2000000, 535445, 1515000, 257314, 4510133, 20360592, 49680144, 463650, 1547782, 406436, 7730969, 3018257, 40000, 5988943, 200665216, 2182670, 6455989, 399912, 105000, 198725, 785326, 10628405, 125000, 49720, 400000, 1169363, 1672400, 697763, 999385, 2595505, 121000, 100000, 50000, 25536, 100000, 8000000, 587998, 100000, 15178461, 45795, 181868, 52382, 65707, 323499, 100000, 100000, 997235, 1300000, 17405098, 8097894, 8998623, 100000, 3298464, 695413, 6885862, 82906200, 3692385, 979908, 17121364, 2032736, 100000, 13791587, 622196, 38500, 5935024, 100000, 10390332, 294422, 100000, 38750000, 341619, 100000, 5504889, 2610892, 3940062, 14998390, 25000, 738589, 2626088, 100000, 917380, 12840000, 98734, 100000, 100000, 4631720, 3211791, 9185813, 9858, 12118, 4142, 5178, 4039, 6076, 5454, 33564, 33151, 5662, 17266, 12430, 11740, 40061, 29008, 41439, 2932, 2900, 4833, 29698, 16256, 11128, 13814, 16625, 30844, 9169, 6214, 30844, 23133, 5523, 6213, 5523, 6907, 6907, 6213, 5524, 3452, 19338, 0, 5868, 5523, 41442, 5523, 22792, 216196, 50422, 13814, 15194, 16574, 58704, 41803, 47274, 16333, 35586, 38848, 29431, 12942, 26755, 15521, 1972, 4113, 15633, 11568, 9915, 9190, 4734, 6314, 6688, 5944, 5523, 7597, 6907, 6213, 9873, 4692, 3518, 27386, 3518, 368354, 759468, 368354, 391043, 220699, 139427, 222135, 0, 0, 0, 0, 3893007, 2475253, 300244, 300132, 2605933, 4504514, 1807525, 1700000, 0, 1063489, 4850824, 1136659, 833523, 2095686, 970149, 895126, 2426364, 2426364, 0, 3945003, 0, 2415964, 0, 38000000, 1300000, 2600000, 1136715, 1136715, 127482, 127482, 3090667, 515907, 176449, 526055, 0, 202761, 99374, 1373, 175294, 254095, 104559, 134026, 0, 234160, 99201, 94392, 762005, 73705, 274848, 474793, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 103806, 225085, 105232, 44984, 40870, 180196, 0, 0, 0, 0, 58881, 2292, 3832, 1335832, 190944, 109024, 255214, 17503, 14889, 310096, 16543, 281330, 15555, 194992, 0, 0, 128341, 153852, 0, 100000, 70000, 70000, 59777, 30375, 11729, 4071, 4071, 750, 4750, 119000, 30000, 133517, 2211404, 1234210, 4798781, 700000, 470729, 284625, 0, 176424, 94601, 0, 202402, 703596, 1697952, 0, 0, 0, 805186, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 14558, 33977, 11631, 190580, 287882, 551253, 61059, 62685, 244027, 224199, 207917, 53609, 161223, 110065, 225739, 134336, 246507, 238736, 213304, 93927, 26000, 190644, 130306, 105367, 156547, 5974, 41373, 197648, 250751, 129479, 124344, 195552, 410374, 269851, 221659, 5801500, 13676, 104370, 4184, 25052, 47372, 231657, 13447, 19690, 197992, 24761, 7138, 483, 8757, 8812, 37236, 42383, 151008, 35614, 124232, 425964, 335043, 18753, 4124, 40522, 383574, 149806, 61877, 249348, 20216, 14278, 23560, 211157, 3939, 223462, 3939, 17630, 37236, 15328, 43922, 12913, 40000, 20216, 3939, 15368, 74256, 2042, 11945, 14997, 8757, 18396, 4216, 29109, 29109, 23569, 11525, 35262, 312700, 5000, 1240957, 2796534, 166666, 2254678, 1079999, 719883, 725000, 0, 189000, 77142, 0, 1371344, 0, 12988052, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 12912147, 4962999, 12743213, 23722558, 6081296, 26740972, 8376947, 11099589, 200000, 832647, 836253, 307405, 900000, 1312685, 2529017, 3342566, 5258144, 6573776, 4663588, 5818745, 11351920, 10000000, 149291, 46798, 129672, 24545, 0, 463753, 209612, 255699, 307005, 2265914, 533784, 368553, 632260, 259942, 204988, 2166265, 299702, 611569, 127190, 518332, 129943, 279086, 250136, 47027, 200527, 247522, 342398, 590969, 61940, 39631, 260807, 115753, 127065, 332996, 2163717, 259157, 438924, 503347, 110840, 93756, 219135, 33389, 196137, 243744, 121834, 237885, 570443, 154229, 352580, 438713, 2069231, 247531, 285645, 488790, 242453, 449958, 90032, 2860561, 191821, 239730, 276309, 335623, 1436214, 232415, 549981, 625247, 89448, 734103, 2066824, 269544, 278866, 474656, 0, 0, 600108, 0, 467820, 23165, 166811, 331358, 374989, 0, 0, 9705, 591008, 0, 2673357, 110985, 78512, 0, 0, 2186845, 0, 9808478, 31219180, 94733, 122302, 0, 56901, 105485, 32164, 127290, 0, 3004113, 0, 18180, 0, 0, 494472, 63052, 218826, 115696, 88299, 394665, 286490, 2927343, 0, 44079, 55375, 156568, 36061, 14488, 30306, 2760093, 1342449, 64655, 111991, 110477, 39522, 6394689, 10050972, 5305432, 0, 1149705, 2627641, 723267, 957312, 4626733, 13400000, 3743620, 746628, 1347763, 115466, 609583, 1879802, 0, 2101817, 486798, 2543724, 0, 0, 0, 0, 424610, 13284, 457876, 1051770, 214536, 251869, 281392, 364448, 375122, 61388, 49831, 0, 0, 7603, 100000, 100000, 209056, 24333, 122391, 61006, 4927000, 417016, 187878, 330375, 2288617, 131330, 3095548, 8322236, 6671738, 2164081, 3266919, 100000, 2155957, 1999982, 813050, 100000, 3283816, 100000, 662094, 1091584, 1068783, 405750, 50000, 10928780, 77256, 100000, 600000, 249261, 100000, 1600000, 129913, 4982891, 4472467, 99991, 5930094, 1326233, 2597817, 100000, 455878, 1782978, 10044535, 2047398, 1199081, 100000, 13430939, 100000, 715789, 15000000, 31925352, 93963, 157455, 440933, 2737556, 218199, 176607, 32060, 1421912, 2969205, 8942639, 5837308, 100000, 129485, 270289, 0, 0, 31693, 150079, 252834, 1884051, 964737, 224981, 1113776, 3183629, 884531, 12112367, 4392553, 0, 2951225, 6072797, 252019, 687443, 3314695, 0, 115000, 85000, 115000, 85000, 200000, 250000, 106000, 162000, 114000, 165000, 76000, 85000, 1516871, 953844, 243579, 89573, 2564723, 443988, 1799453, 0, 0, 0, 46163, 70075, 118059, 65794, 106699, 255862, 85433, 132827, 779042, 80696, 133985, 81001, 56670, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 12048, 0, 513128, 268146, 203123, 261659, 552013, 836661, 635484, 252680, 1272513, 2241990, 659051, 1214576, 1049542, 402705, 76164, 174288, 877427, 455829, 254784, 549424, 348852, 718672, 271024, 677935, 108627, 104249, 881036, 436313, 836093, 680681, 282847, 426764, 888499, 1852226, 625588, 93269, 66346, 464221, 10536, 0, 765044, 236595, 467142, 68713, 103111, 66379, 27064, 19300, 0, 79197, 12004, 0, 0, 0, 0, 0, 0, 0, 3870, 261289, 593483, 17119, 16338, 15957, 29214, 3836, 135408, 8908, 51561, 50804, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 53609, 618330, 2700800, 284831, 6964520, 97911, 682841, 5594000, 3502000, 3634039, 1698000, 2540478, 35233, 257058, 175648, 0, 109560, 97254, 882018, 333436, 598339, 334652, 564519, 304563, 612888, 4927, 2434208, 37232, 120593, 0, 157549, 238071, 392357, 194218, 325419, 144001, 68282, 61486, 469297, 72436, 106387, 135190, 136700, 19323722, 701129, 11203452, 100000, 89000, 134282, 1093389, 603646, 305325, 757785, 100000, 778266, 100000, 100000, 100000, 2902288, 100561, 100000, 48391, 1299811, 326293, 1892006, 340202, 169739, 100000, 100000, 2984509, 8029763, 2387938, 868090, 2047166, 7473711, 15000000, 10000, 100000, 1469628, 1197569, 100000, 100000, 2050341, 353295, 1745409, 3550000, 100000, 2697613, 100000, 99550, 100000, 100000, 93882, 6000000, 9792730, 1429611, 906539, 100000, 23034708, 9184036, 609150, 34717072, 100000, 2503510, 593314, 60820, 3106, 4349, 34536, 14780, 17957, 33842, 33153, 27626, 22792, 9169, 8403, 6876, 5524, 4833, 60091, 4833, 5523, 11050, 34512, 46798, 61401, 47262, 232270, 18055, 50211, 49504, 34312, 14430, 177460, 32960, 156594, 35497, 43742, 42879, 31559, 6213, 6213, 17502, 126489, 0, 698949, 700000, 0, 143595, 76035, 57822, 254924, 0, 0, 0, 0, 48474, 0, 8990, 6065, 40481, 6741, 172901, 4962, 4962, 5762, 394683, 92200, 0, 0, 962494, 92550, 1254206, 17542, 27041, 1653087, 1083754, 32352, 158210, 478014, 495914, 700000, 700000, 693022, 700000, 530337, 675415, 668888, 250000, 698272, 651370, 0, 99682, 13227582, 0, 0, 0, 0, 0, 3108448, 8005393, 220394, 393024, 183912, 358668, 10004, 10928292, 276317, 61237, 149116, 162809, 207485, 162328, 133010, 234142, 174671, 87628, 12016, 26896, 112209, 258754, 297553, 170948, 136977, 233654, 3525888, 24988, 14442, 23272, 18051, 0, 0, 0, 0, 0, 0, 0, 0, 0, 245150, 158846, 0, 0, 0, 277934, 541959, 0, 514485, 0, 145000, 10792404, 2045144, 669243, 150000, 0, 35187, 0, 369799, 85975, 151024, 715267, 1593039, 163368, 104502, 130794, 0, 0, 127719, 30000, 551049, 23204, 53067, 54024, 45632, 53717, 40126, 16583, 3264, 182163, 159934, 60106, 44874, 29916, 30715, 0, 0, 0, 28151, 69179, 39572, 0, 0, 53005, 225064, 242564, 444710, 304637, 246609, 0, 0, 0, 0, 99508, 3691, 1029, 16181, 60000, 321632, 1310836, 2993798, 2435221, 1413590, 3283375, 6297694, 1793396, 1000000, 426223, 3836004, 257740, 821096, 242736, 2740852, 1792234, 4000000, 4326403, 7055360, 1320390, 58478, 1443106, 0, 17002768, 2964667, 0, 0, 0, 0, 12074, 14488, 20863, 24240, 9664, 24240, 0, 341368, 562499, 567934, 56751, 91578, 154242, 62303, 2827097, 227450, 345343, 420770, 345750, 979747, 430039, 264513, 32478, 158006, 43646, 210414, 157856, 37595, 149659, 603515, 26517, 26517, 25253, 83088, 150000, 830704, 58004, 14695725, 6031409, 0, 3710279, 5300620, 5300619, 0, 0, 2985700, 204019, 774884, 377815, 0, 38248, 236905, 66995, 225000, 0, 26753, 77788, 52197, 50616, 11815, 35324, 44874, 30715, 703494, 532417, 749999, 610218, 284348, 922365, 1306122, 2273034, 5931410, 0, 0, 0, 3725819, 0, 158820, 0, 3075652, 0, 35187, 318635, 12080, 8439847, 1198845, 265892, 1577020, 2355304, 199021, 170763, 156568, 291775, 24545, 24545, 22090, 1624180, 0, 776428, 39572, 0, 375000, 4625863, 1340958, 1976817, 904115, 278198, 551080, 5968686, 2733246, 65974672, 0, 144262, 7067, 34737, 24644, 22179, 28879, 1145452, 132039, 870706, 3122237, 9091, 0, 5388306, 12074176, 117500, 0, 0, 1871266, 2158469, 2022231, 0, 0, 1806275, 1970145, 461348, 3686016, 1068034, 199915, 1589558, 709102, 2779602, 587238, 144811, 2666650, 2028150, 719493, 0, 104363, 132940, 26974, 26974, 50616, 24142, 5166, 129661, 42327, 1119651, 104345, 292514, 111158, 303353, 465058, 149505, 129321, 93247, 88425, 36990, 35383, 36990, 36990, 451559, 445044, 0, 32113, 175162, 867569, 211084, 27730, 31631, 59836, 26517, 29916, 37948, 24809, 32252, 0, 119607, 193700, 38301, 0, 283854, 302799, 1558344, 3741548, 81007, 240389, 123199, 99937, 87090464, 191620736, 6816766, 0, 0, 0, 1149705, 1594234, 1691450, 4571373, 4388414, 4118394, 6490848, 1827779, 0, 750000, 299495, 0, 104000, 3977843, 0, 73047, 297212, 69741, 41531, 25464, 21507, 0, 460625, 0, 116147, 1168526, 18602506, 11072727, 1472178, 368000, 3600000, 1101809, 2873420, 421237, 308000, 96565, 2509160, 709842, 412500, 0, 1833975, 1403333, 3875811, 0, 0, 0, 0, 0, 40000, 0, 0, 385631, 1003866, 25828, 372089, 439850, 545616, 450000, 673197, 113556, 399808, 0, 1406421, 26000, 300000, 599895, 886845, 0, 152997, 1048913, 2595114, 5020398, 2759672, 995610, 1368221, 0, 0, 999997, 106780, 35187, 9640, 12079, 2750059, 8759, 111158, 127034, 160625, 729996, 1017724, 948927, 130504, 0, 0, 34512, 149649, 45237, 41188, 36196, 56727, 46273, 190456, 186402, 48130, 41305, 163227, 137114, 832820, 338400, 30049, 22090, 18118, 25253, 200748, 25253, 453725, 0, 13205, 1041432, 0, 0, 120000, 484301, 886827, 82030, 0, 133254, 235362, 229805, 0, 0, 952830, 189866, 1637386, 0, 7333610, 0, 99938, 2203357, 0, 0, 0, 192572, 25476, 23024, 0, 220641, 486905, 429523, 338615, 315205, 540720, 1518048, 418384, 94296, 100005, 125204, 646101, 503006, 87612, 86956, 231230, 258005, 100000, 5590, 82586, 151260, 390096, 2639002, 6412369, 763534, 3307969, 1546239, 560648, 622353, 0, 3237783, 1018196, 50712, 460354, 36362, 0, 0, 0, 630350, 87126, 601061, 591421, 592147, 284575, 376035, 529757, 17733272, 135800, 385879, 604672, 441027, 752052, 325412, 1160801, 300000, 4825191, 845285, 2814783, 2901850, 75154, 138132, 48753, 30442, 38524, 1933277, 0, 23645, 32478, 45791, 36084, 48978, 53717, 49025, 294118, 214523, 50880, 50880, 32374, 36496, 44737, 35497, 93473, 42591, 43742, 137604, 23284, 44847, 51914, 16227, 151152, 2823243, 236233, 280264, 1555265, 2767600, 363918, 90057, 299974, 274978, 52261, 89053, 1056336, 277593, 954161, 323706, 137248, 375778, 1022794, 1213064, 277215, 4098006, 2549706, 336281, 307228, 343826, 171226, 84504, 251317, 501265, 315741, 36669, 649581, 104980, 867107, 743576, 3506, 305211, 679964, 74555, 26709, 27730, 25364, 0, 0, 0, 343114, 223056, 225000, 3529059, 335005, 57339, 344492, 67121, 344940, 339191, 35983, 411019, 290933, 59634, 356164, 285964, 363731, 600083, 333338, 301498, 4402, 300000, 374688, 300000, 300000, 1681983, 123745, 300000, 230381, 300000, 379243, 52453, 383846, 300000, 275912, 76157, 90157, 300000, 176652, 300000, 0, 0, 603289, 22562190, 3294831, 0, 406185, 2551532, 0, 0, 3010820, 17222880, 52000000, 2710474, 1341560, 7662077, 5613677, 4311175, 296731, 586500, 428110, 806160, 1492314, 6670070, 845992, 154474, 4033446, 696600, 99992, 2244621, 5516166, 328127, 6770054, 371344, 5490179, 466955, 332887, 348579, 349613, 297960, 328061, 390743, 1651037, 1869229, 3804245, 14455413, 9113435, 3183629, 4654902, 1358731, 1833080, 25800, 1306067, 292954, 12110276, 1000000, 1000000, 1000000, 1000000, 1100000, 165729, 50000, 135867, 300025, 500000, 50000, 794044, 500000, 548024, 300000, 600000, 1000000, 500000, 500000, 500000, 500000, 2000000, 500000, 650000, 1414886, 1914885, 300000, 50000, 500000, 1000000, 600000, 1100000, 500000, 500000, 300000, 500000, 1200000, 500000, 1500000, 500000, 1018554, 500000, 600000, 600000, 1721918, 650000, 300000, 500000, 500000, 50000, 300000, 476679, 600000, 1100000, 500000, 1000000, 1000000, 1500000, 500014, 250000, 1363051, 600000, 462625, 50000, 1701238, 300000, 600000, 500000, 600000, 500000, 1100000, 1002259, 300000, 256667, 600000, 500000, 1100000, 500000, 500000, 629614, 500000, 300000, 250000, 600000, 1000000, 500000, 1000000, 1000000, 475886, 1225886, 540544, 50000, 300000, 500000, 600000, 500000, 300000, 500000, 1000000, 712157, 2000000, 1000000, 50000, 744662, 300000, 573540, 100000, 600000, 500000, 1200000, 1000000, 55000, 1000000, 577778, 250000, 100000, 300000, 600000, 600000, 500000, 500000, 229626, 300000, 1000000, 500000, 1650000, 500000, 333309, 300000, 500000, 50000, 600000, 668081, 500000, 300000, 1483094, 50000, 451256, 0, 0, 18235, 105670, 26242, 333837, 785613, 81055, 181553, 59295, 80687, 29689, 85043, 543790, 855517, 108416, 347282, 190183, 102142, 133431, 218645, 62225, 84499, 132923, 122643, 53181, 28412, 87972, 291644, 40482, 191060, 387537, 51163, 2095674, 168072, 84115, 206470, 105876, 109695, 209795, 137705, 162423, 79855, 69033, 0, 0, 0, 0, 0, 0, 15845, 149998, 35000, 12074, 5282, 35966, 229517, 38248, 65685, 32055, 21815, 21815, 21815, 24240, 21744, 0, 0, 0, 231609, 371817, 451992, 336879, 258716, 886943, 1806623, 364829, 570102, 155119, 2210362, 1774396, 4990726, 1924083, 150244, 198548, 170442, 389872, 552029, 192626, 731315, 342510, 281403, 326450, 280075, 310364, 2218550, 169987, 364405, 941022, 526467, 330858, 918448, 248687, 166655, 471743, 396818, 425601, 4476, 169357, 242139, 225358, 223823, 411901, 374966, 395762, 287568, 169854, 946302, 701792, 173865, 1009125, 389948, 361225, 393705, 423186, 759019, 667743, 664963, 505814, 360521, 275000, 38426, 14708, 200000, 499999, 4976, 0, 0, 0, 13916, 27895, 5349, 20132, 2409, 231386, 157625, 428361, 92324, 15957, 149074, 87338, 93285, 651400, 59290, 59784, 66530, 95752, 70103, 0, 0, 0, 0, 0, 0, 0, 0, 0, 86160, 122599, 66982, 40062, 337459, 40000, 496438, 749999, 36318, 87335, 3218382, 327462, 1360130, 3039, 194950, 312232, 485555, 767273, 311677, 125479, 257434, 16249, 16249, 19861, 295138, 573749, 2725993, 404888, 75383, 0, 199259, 65464, 286567, 239079, 433250, 24704, 96462, 96462, 40207, 36990, 36990, 0, 577937, 326819, 155737, 2313835, 1662279, 64636, 0, 0, 0, 0, 1715612, 596372, 554242, 174934, 499073, 694093, 105455, 842370, 380529, 633567, 769096, 477988, 287893, 139279, 14651668, 425320, 297529, 467887, 251556, 942923, 503022, 217169, 100000, 8280212, 4995354, 1500000, 44078, 1758440, 1854359, 430153, 100000, 265696, 20000, 1954441, 100000, 1494536, 100000, 100000, 98455, 4222128, 132130, 100000, 100000, 100000, 100000, 100000, 2663930, 100000, 100000, 497671, 826426, 2530317, 84554, 3239928, 100000, 7810252, 78522, 30459, 99115, 98427, 99996, 100000, 100000, 880000, 3902497, 2475646, 1117685, 550470, 3559859, 105417, 100000, 100000, 1303692, 2840871, 6938504, 1038645, 100000, 3969624, 99972, 100000, 5000000, 317693, 158739, 471557, 100000, 100000, 100000, 100000, 100000, 998300, 300000, 1530000, 999998, 229861, 50025, 2020533, 15000, 100000, 100000, 2511087, 970344, 16207773, 3553004, 4349073, 103985, 73750, 100000, 100000, 544773, 878292, 20000, 100000, 6965308, 100000, 9990782, 1499862, 7502819, 100000, 5188438, 40000, 1732980, 100000, 2381694, 30319836, 100000, 100000, 2358606, 100000, 7416108, 749216, 1795242, 8339709, 848000, 6886056, 100137, 98047, 100000, 236785, 100000, 7699399, 1325223, 5761970, 100000, 3745079, 63258, 100000, 2000000, 998090, 100000, 9588867, 1588114, 2000134, 100000, 100000, 2680283, 100000, 839483, 100000, 1376376, 2831215, 68696, 990225, 349159, 199797, 199442, 75289, 344576, 3239039, 7597, 5732, 3106, 3038, 15885, 12430, 6214, 6213, 6907, 0, 0, 0, 0, 0, 32132, 35272, 45598, 47999, 48654, 61221, 28038, 32954, 30544, 37673, 43558, 32060, 41440, 41440, 41954, 14998, 7941, 153114, 17828, 20711, 17601, 28513, 39874, 27692, 21226, 21226, 17281, 134092, 0, 0, 173800, 200000, 1222829, 0, 147331, 49994, 132123, 477171, 588647, 5388, 0, 0, 50000, 63269, 31631, 52197, 36375, 44874, 11815, 43790, 49152, 27644, 44874, 10031, 28418, 26517, 24545, 29916, 34725, 33389, 34725, 28046, 49152, 27730, 21815, 12074, 23024, 46080, 100000, 0, 0, 0, 0, 0, 0, 0, 161521, 254516, 64829, 27538, 189461, 35442, 40469, 13440, 25594, 122341, 634779, 131301, 366806, 0, 133320, 450000, 69997, 100000, 1825370, 20372, 116907, 63810, 240432, 2037317, 163802, 0, 99333, 4134427, 195389, 37092, 36596, 291264, 27882, 489169, 614072, 195082, 1761782, 150000, 500000, 0, 0, 80000, 375000, 3321832, 475752, 56834, 1687336, 12553, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7170458, 3146567, 2037393, 3473, 203834, 309556, 1250019, 366958, 279064, 131974, 152218, 272985, 77692, 843112, 242438, 119761, 33466, 18368, 301183, 81237, 20216, 562956, 133838, 211520, 29109, 4300, 8757, 17498, 14997, 19546, 18511, 676283, 1112489, 932571, 54193, 1793362, 1934424, 11022684, 5822186, 27046474, 8736822, 17873060, 6777742, 0, 0, 0, 0, 5400619, 1149705, 7322441, 0, 6232846, 3530037, 0, 0, 70000, 13680, 1246796, 5771762, 6505821, 124686256, 1000000, 26000, 0, 0, 599314, 951338, 433476, 298422, 148163, 98000, 95872, 497617, 0, 393210, 413875, 415204, 0, 1542675, 1653241, 3167056, 1885691, 2869421, 3691362, 6027830, 15067360, 358137, 3164485, 1025578, 0, 715315, 0, 270000, 0, 1219723, 5135559, 1307957, 225284, 6507730, 675386, 600000, 1067820, 670197, 1323632, 125500, 161250, 99948, 224993, 260785, 382920, 426250, 1205314, 149450, 59796, 639632, 3294116, 0, 9054372, 1805738, 2606237, 1287837, 5819399, 123567, 222146, 375910, 432439, 448015, 423500, 489914, 61000, 147260, 1233215, 1818457, 2064580, 2254727, 16980, 13692, 68640, 38248, 812000, 267964, 16980, 75443, 137729, 160015, 1605046, 33628, 58417, 449875, 118061, 395117, 270000, 41801392, 33025, 44843, 108801, 14311, 493431, 360695, 19803, 100000, 1637114, 851858, 0, 0, 69540, 69997, 6036395, 15978946, 3994998, 1360148, 336957, 8234, 58580, 243993, 0, 863263, 4839367, 1400000, 181539904, 10254597, 26000, 26000, 3320986, 764116, 581068, 578784, 408908, 831922, 144408, 100000, 99999, 408485, 209719, 450000, 446025, 378503, 8000, 15000, 0, 157500, 116212, 2198212, 0, 743208, 3327766, 1087229, 5970977, 215235, 4000000, 600000, 1399240, 736307, 396651, 418000, 0, 566331, 2041400, 0, 0, 0, 0, 0, 0, 0, 0, 0, 192569, 13692, 47452, 31631, 12673, 7225, 38248, 124340, 24213, 42166, 0, 0, 0, 0, 676455, 259621, 151332, 23274, 5588065, 280000, 100000, 112638, 127034, 39477, 36318, 46658, 125449, 1871237, 2796093, 95414, 223002, 962500, 689385, 59100, 376024, 301904, 392169, 179873, 84223, 0, 0, 80476, 589441, 350000, 91641, 33773, 35383, 88425, 73955, 88425, 57569, 880111, 456077, 743184, 626037, 445348, 542256, 77128, 220158, 265480, 104407, 507379, 43739, 155930, 257888, 1233845, 0, 0, 0, 0, 0, 0, 701047, 580953, 265112, 483026, 360670, 150000, 1023577, 988742, 150000, 1521491, 999550, 732257, 1475832, 88669, 60375, 100000, 39742, 99772, 34721, 9786362, 35000, 2697432, 1124690, 1696952, 99921, 29589, 2646088, 134680, 505635, 45237, 44571, 55375, 47262, 48889, 240173, 52496, 42324, 44970, 39214, 30050, 124637, 37595, 43558, 161300, 44034, 26755, 25131, 81205, 209730, 737737, 29014, 550747, 255693, 700445, 2585724, 4568697, 399600, 140426, 52197, 47452, 55361, 55361, 29885, 29916, 26517, 30715, 51088, 42327, 32252, 15842, 30715, 26920, 29916, 31409, 15842, 25772, 43790, 0, 43790, 25253, 29455, 23353, 21892, 24809, 694349, 532177, 51032, 590797, 586530, 0, 0, 81205, 627143, 100000, 99999, 597630, 69828, 12604, 0, 0, 415875, 190400, 157591, 0, 500382, 219185, 101097, 208696, 13706, 302399, 380129, 2530213, 458635, 148517, 0, 374770, 234125, 372000, 0, 370000, 197169, 224182, 149561, 196143, 132939, 53353, 92845, 2190696, 2499219, 34320, 382193, 406424, 324494, 424619, 362663, 248622, 1532436, 21900, 116150, 1041867, 17597300, 882908, 680854, 851102, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 320000, 1406814, 193426, 420061, 204023, 172000, 217000, 1632408, 26000, 26000, 792744, 2947514, 748024, 0, 0, 0, 0, 218442, 0, 0, 0, 0, 470025, 467610, 3328489, 0, 1063222, 1740596, 2951659, 3700771, 0, 0, 11354158, 0, 0, 0, 500000, 621848, 1886200, 13830000, 0, 0, 0, 0, 0, 145200, 100000, 2474435, 2420050, 2368328, 1769568, 20885824, 398919, 300000, 600000, 600000, 932246, 895497, 584330, 0, 224998, 400001, 27577, 17021, 0, 271609, 4407307, 503000, 3956523, 4812732, 47678, 225000, 149999, 198866, 0, 1600000, 1130283, 10162663, 26000, 0, 600000, 0, 438917, 378517, 510000, 491313, 300000, 9000, 174300, 490920, 3279471, 4852474, 1719828, 1168026, 1322281, 2392170, 6338002, 4213791, 10351716, 48429, 6808, 8455, 23024, 19322, 0, 19254, 1875, 8759, 745315, 8759, 177122, 25276, 1035844, 56206, 21775, 36318, 203600, 574284, 437250, 26031, 32309, 38599, 40207, 489858, 37533, 0, 3734634, 1587390, 135486, 257980, 5816677, 86359, 958333, 0, 149861, 0, 25531, 34407, 33260, 42919, 41789, 145009, 38399, 46798, 47999, 45922, 52840, 55375, 53781, 62753, 58158, 48220, 55299, 55299, 34312, 34532, 37785, 42591, 64641, 418113, 258135, 28229, 33389, 30719, 29382, 26517, 30719, 182975, 191490, 9761, 0, 25186, 0, 0, 0, 0, 69670, 120000, 82810, 462857, 2142816, 66784, 502470, 237220, 3315873, 234501, 0, 0, 0, 0, 20961, 1282553, 1934701, 94338, 1910593, 1384883, 609220, 544766, 767710, 777730, 159617, 226773, 20935, 50208, 566303, 820763, 500176, 358142, 195078, 434961, 90000, 1374450, 316051, 294333, 4418753, 0, 0, 0, 0, 616870, 1394166, 0, 558430, 3561650, 117986, 599998, 0, 298738, 100000, 1669379, 2886225, 1222614, 3442578, 544748, 72612, 152188, 159864, 100000, 2314243, 215254, 1257462, 12965744, 0, 78252, 47528, 25476, 122035, 24213, 58998, 140064, 7712, 317208, 379009, 95274, 63515, 113700, 26772, 2763721, 326574, 309965, 40386, 18857, 0, 56360, 146466, 186576, 1146241, 668634, 19970, 29044, 31819, 13255, 131014, 20877, 16608, 245277, 382433, 52354, 208017, 451756, 3098696, 2591738, 342470, 0, 69700, 320176, 20608244, 57154, 495000, 7056595, 1723265, 7064241, 600782, 5464655, 198381, 3996185, 20580348, 164608, 1721382, 124287, 183003, 1812122, 1859892, 387251, 1011749, 0, 0, 1266575, 743738, 3300000, 7992403, 6061068, 14315660, 5351252, 1000000, 2384636, 1749940, 1040921, 3269254, 312821, 98672, 600000, 577222, 1027407, 203609, 565250, 669400, 200970, 0, 425920, 396546, 608762, 711903, 20000, 12000, 120012, 144500, 495470, 1249045, 845161, 1634395, 2198199, 0, 0, 3289767, 7044139, 328849, 97206, 7159204, 3033132, 0, 126259, 530862, 99053, 329137, 14104144, 2502254, 323895, 16322, 216388, 740216, 99811, 0, 273897, 8654779, 829600, 36593, 439758, 286525, 76000, 935655, 1850112, 976673, 2039956, 634097, 1195400, 50000, 0, 590546, 396647, 671795, 2444922, 224999, 0, 0, 817620, 3540942, 0, 0, 2794326, 8475960, 3699069, 1177779, 318375, 997723, 411250, 600000, 207016, 667079, 3000000, 99510, 100000, 600000, 31834, 276534, 0, 462228, 418502, 356675, 491375, 367875, 398399, 1982832, 3349338, 1199353, 5335752, 2093325, 2188091, 1115984, 2189690, 1437732, 770436, 3520665, 870326, 1911423, 1353871, 1984483, 0, 0, 0, 136080, 979552, 0, 0, 5085001, 276606, 346000, 12005060, 1355228, 64154, 660003, 591329, 0, 31443522, 9883449, 0, 587806, 589058, 598005, 599994, 600000, 500464, 452375, 487500, 10000, 2183992, 3295345, 3489967, 749630, 0, 0, 16987, 13199, 26974, 111357, 73217, 124340, 108798, 108798, 88425, 31631, 13283, 10240, 6604, 8616, 122035, 129661, 79321, 80846, 79321, 13172, 25772, 124340, 999998, 990021, 149999, 268434, 38403, 91634, 87129, 8045, 1306502, 13140, 187131, 129410, 1113619, 103291, 36318, 46658, 39477, 36318, 111158, 127034, 127034, 20400, 1155000, 80000, 258340, 87603, 66064, 3775742, 81836, 220237, 609070, 1564750, 99678, 83600, 38770, 40207, 37155, 37155, 37155, 37155, 37155, 80386, 80386, 80386, 83600, 24405, 22777, 50000, 97981, 574390, 3241524, 1999175, 0, 183896, 300000, 61147, 0, 579002, 192015, 27816, 26803, 94681, 47922, 28974, 29755, 12265, 10207, 22456, 6297, 53343, 223348, 0, 31631, 31631, 44288, 30049, 30049, 56942, 52197, 47452, 55361, 52197, 23993, 15468, 28418, 43790, 50858, 52225, 30715, 49152, 25772, 25772, 26920, 40870, 46710, 26517, 10514, 46080, 33789, 43790, 49152, 20529, 24809, 37946, 46080, 27644, 33389, 303623, 100000, 800810, 3320711, 77464, 0, 0, 0, 0, 0, 0, 50000, 749505, 10307, 93816, 234506, 99892, 100000, 0, 111497, 140000, 0, 0, 489963, 322294, 1504226, 2472345, 0, 47683, 234092, 143360, 1674934, 1132822, 64139, 2547521, 225600, 275834, 25272, 18153, 666369, 341100, 0, 0, 0, 0, 0, 4095564, 4038890, 4748457, 1854702, 3615940, 0, 1156616, 750200, 0, 0, 0, 0, 578126, 500000, 130750, 428289, 125499, 127989, 0, 0, 0, 0, 0, 0, 0, 600000, 99999, 412619, 0, 0, 0, 96846, 1754766, 0, 1568348, 1029043, 0, 0, 143200, 57206, 446437, 1112464, 13692, 121458, 108798, 134242, 124340, 122118, 54344, 98354, 87612, 118700, 139649, 153787, 315000, 514197, 99846, 1563521, 37155, 887063, 0, 174057, 34590, 44737, 16214, 29185, 17021, 25518, 92901, 32997, 18587, 270000, 0, 146776, 399400, 0, 110000, 176680, 1278115, 2359049, 1083337, 48986, 1167454, 0, 0, 0, 55489, 187122, 61812, 0, 9051385, 292456, 150083, 2200000, 499943, 375000, 3766138, 7080653, 7178411, 4833804, 7030446, 2101788, 106995, 1273485, 2735563, 1269603, 0, 0, 0, 50000, 502767, 612654, 70558096, 0, 0, 3489073, 848254, 4101223, 0, 1653159, 3216687, 2388206, 2876373, 818377, 1089169, 2923479, 1848292, 856254, 420908, 298464, 373315, 281484, 1010042, 583103, 189617, 100000, 400000, 302335, 100000, 177172, 100000, 0, 865145, 126000, 960732, 369570, 423938, 420750, 294015, 392593, 363766, 399165, 616668, 630000, 412295, 422100, 305965, 458313, 0, 371250, 50000, 20000, 0, 151000, 0, 3203238, 5754468, 3423141, 1282020, 1179438, 1514433, 0, 5581859, 8458070, 852857, 0, 570888, 253260, 200000, 0, 0, 1864897, 1864897, 1883749, 11311, 14657, 15405, 14488, 10844, 34725, 24980, 9664, 23024, 24240, 21815, 21815, 27267, 21815, 23024, 25451, 21740, 21740, 20536, 23006, 18114, 19322, 0, 0, 0, 0, 353299], \"coloraxis\": \"coloraxis\"}, \"name\": \"\", \"offsetgroup\": \"\", \"orientation\": \"v\", \"showlegend\": false, \"textposition\": \"auto\", \"type\": \"bar\", \"x\": [2004, 2018, 2017, 2007, 2009, 1993, 2016, 2000, 1980, 2004, 2005, 2005, 2006, 2011, 2002, 1996, 1997, 1996, 1993, 1993, 1993, 1996, 1993, 1996, 2006, 1996, 2010, 2011, 1991, 1986, 2008, 1993, 1993, 1995, 2002, 2004, 1998, 1993, 1986, 2010, 1993, 2000, 2009, 1994, 2013, 2011, 2008, 2005, 2008, 2013, 2012, 2008, 2007, 2017, 1997, 1997, 1997, 2004, 2001, 1990, 1999, 2000, 2000, 2000, 2000, 2000, 2000, 1996, 1995, 2017, 2015, 1999, 2000, 2012, 2009, 2004, 2000, 2007, 2001, 2006, 2011, 2005, 2003, 2001, 2001, 2017, 2003, 2007, 2011, 2010, 1999, 2014, 2014, 1993, 1999, 1993, 1993, 2017, 2017, 2017, 2004, 1991, 1991, 1998, 2017, 1992, 1994, 2001, 1998, 1994, 1993, 1993, 2007, 2013, 1997, 1990, 1992, 1999, 2001, 1971, 1970, 1969, 1966, 1976, 1977, 1986, 2002, 1981, 1981, 2004, 2016, 2015, 2008, 2008, 2010, 2013, 2001, 2008, 2015, 2000, 1987, 1993, 2014, 1981, 2003, 2006, 1997, 1995, 2000, 1999, 1996, 1999, 2011, 2013, 2006, 2001, 2009, 2004, 2010, 2002, 2009, 2006, 2008, 2009, 2004, 2013, 2011, 2009, 1996, 1996, 1990, 2007, 2008, 2003, 1996, 1997, 1997, 1997, 1997, 1997, 1997, 1997, 1998, 1987, 1997, 1997, 1996, 1997, 2002, 2002, 2002, 1997, 1993, 1994, 1993, 1993, 1993, 2003, 2002, 1997, 1998, 1997, 2004, 2004, 1998, 1998, 1997, 1991, 1985, 1989, 1985, 1986, 1998, 1998, 2002, 1999, 1996, 1992, 1991, 1990, 1999, 1985, 1986, 1995, 1994, 2007, 1985, 1997, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 1988, 1991, 1995, 2017, 2015, 2014, 2014, 2011, 2017, 2016, 2016, 2016, 2015, 2000, 2014, 2017, 2017, 2012, 2018, 1999, 2004, 1999, 2001, 2011, 2011, 2010, 2010, 2008, 2010, 2010, 2007, 2016, 2003, 2004, 1976, 2014, 2017, 2014, 2011, 2015, 2000, 2004, 1999, 2001, 2000, 1999, 1997, 1993, 1993, 1993, 2007, 2008, 2007, 2002, 2003, 2012, 2013, 2019, 2016, 2009, 2010, 2016, 2018, 2008, 2015, 2018, 2002, 2015, 2018, 2018, 2018, 2018, 2018, 2018, 2012, 2017, 2012, 2008, 2012, 2012, 2007, 2005, 2006, 2002, 2004, 2003, 2007, 2006, 2004, 2001, 2000, 2002, 2008, 2001, 2006, 2003, 2016, 2001, 2005, 2004, 2003, 2005, 2002, 2017, 2017, 2017, 2003, 1999, 2016, 2016, 2014, 2013, 2013, 2014, 2015, 2011, 2012, 2012, 2011, 2011, 2017, 2016, 2016, 2013, 2016, 2017, 1996, 2011, 2000, 1996, 1999, 1996, 1998, 1997, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2019, 1998, 1991, 1990, 1995, 1997, 1992, 1994, 2001, 1992, 1995, 1998, 2001, 2001, 2008, 2004, 2011, 2011, 1993, 2000, 1999, 1991, 1995, 2012, 2015, 2012, 2016, 2013, 2018, 2013, 2019, 2009, 2017, 2006, 2005, 2014, 1971, 1971, 1971, 1967, 1968, 1972, 1972, 1973, 1979, 1976, 1975, 1980, 1973, 2001, 2000, 1983, 1984, 1981, 1982, 2010, 2010, 2007, 1992, 1991, 1990, 1990, 1990, 2016, 2016, 2016, 2016, 2013, 2011, 2006, 2008, 2008, 2008, 2013, 2008, 2013, 2008, 2013, 2010, 2010, 2010, 2010, 2008, 2011, 2007, 2008, 2008, 2008, 2006, 2008, 2014, 2000, 2002, 1995, 1997, 1995, 2008, 2013, 2012, 2016, 2009, 2000, 1998, 2002, 2000, 2006, 2014, 2018, 2012, 2013, 2007, 2007, 2000, 1996, 1999, 2010, 2011, 2015, 2015, 2015, 2010, 2007, 2006, 2005, 2005, 2000, 2001, 1997, 1994, 1997, 1986, 1988, 1993, 1992, 2015, 2013, 2013, 2013, 2007, 2009, 2014, 2014, 2012, 2011, 2000, 1993, 1998, 1994, 1993, 2003, 2007, 2001, 1992, 1994, 2003, 1993, 1997, 2011, 2006, 2004, 2007, 2009, 2008, 1994, 2004, 2010, 1994, 1994, 2000, 2013, 2008, 2010, 2004, 2007, 1997, 2008, 2011, 2011, 2002, 2007, 2008, 2013, 2011, 2006, 2012, 1994, 2008, 2016, 2007, 2014, 2007, 2017, 2017, 1997, 1997, 1997, 1998, 1998, 1998, 2008, 1997, 1996, 1997, 1997, 1993, 1996, 1999, 1996, 2004, 2000, 2001, 1997, 1996, 1996, 1997, 1996, 1997, 1997, 1997, 1988, 1989, 2002, 2002, 2002, 2002, 2005, 2002, 1997, 1998, 1999, 1997, 1996, 1997, 2005, 2003, 1995, 1997, 2007, 2003, 2006, 1998, 1997, 1997, 1987, 2009, 2009, 1997, 1986, 2004, 2000, 2001, 1988, 1997, 1995, 1995, 1993, 1997, 1991, 2003, 2003, 2005, 2000, 2004, 1992, 1992, 1998, 1999, 1997, 1999, 1997, 2000, 2005, 2006, 2006, 2006, 2006, 1986, 2004, 2003, 2004, 2004, 2005, 2005, 1985, 1996, 1996, 1996, 1985, 1985, 2005, 2005, 2005, 2005, 1993, 1985, 2005, 2005, 2006, 2005, 1996, 1998, 1997, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2015, 1993, 1996, 1999, 1995, 1994, 2002, 1991, 1985, 2014, 2014, 2013, 2011, 2008, 2008, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2009, 2009, 2012, 2011, 1991, 2014, 2012, 2011, 2016, 2014, 2011, 2005, 2009, 2012, 2007, 2013, 2015, 2018, 1997, 2011, 2012, 2014, 2012, 2006, 2009, 2009, 2012, 2016, 2010, 1998, 1990, 2010, 2001, 2005, 2015, 2015, 2008, 2004, 2014, 2009, 2010, 2018, 2011, 2016, 2014, 2012, 2014, 2009, 2005, 2012, 2017, 2017, 2018, 2017, 2017, 2017, 2017, 2006, 2006, 1988, 2010, 2018, 2013, 2012, 2011, 2015, 2015, 2015, 2015, 2015, 2017, 2018, 2016, 2015, 2019, 2019, 2019, 2007, 2015, 2014, 2014, 2016, 2014, 2016, 2010, 2014, 2013, 2012, 2014, 2018, 2012, 2013, 2013, 2009, 2017, 2015, 2014, 2013, 2017, 2013, 2018, 2013, 2010, 2016, 2018, 2018, 2018, 2016, 2018, 2018, 2018, 2015, 2012, 2015, 2015, 2004, 2012, 2008, 2008, 2018, 2014, 2014, 2014, 2009, 2011, 2010, 2011, 2010, 2007, 2012, 2014, 2013, 2014, 2014, 2014, 2016, 2018, 2016, 2019, 2017, 2018, 2018, 2017, 2018, 2018, 2015, 1989, 2013, 2013, 2007, 2019, 2019, 2018, 2017, 2019, 2017, 2016, 2016, 2016, 2015, 2016, 2017, 2014, 2014, 2013, 2015, 2015, 2013, 2012, 2015, 2013, 2013, 2011, 2013, 2012, 2011, 2013, 2011, 2008, 2006, 2014, 1998, 2010, 2005, 2005, 2003, 1993, 2007, 2004, 2000, 2011, 2009, 2017, 2009, 2016, 2015, 2008, 2006, 2000, 2018, 2007, 2005, 2006, 2019, 2002, 2002, 2002, 2000, 2000, 2000, 2000, 1999, 1994, 1994, 1993, 1993, 1992, 1992, 1991, 1990, 1990, 1979, 2011, 2007, 2005, 2004, 2005, 2012, 2012, 2010, 2008, 2009, 2010, 2016, 2016, 2016, 2016, 2010, 2008, 1987, 2017, 2018, 2015, 2014, 1989, 1989, 1989, 2014, 2012, 2012, 2016, 2016, 2013, 2009, 2009, 2010, 2007, 2006, 2006, 2004, 2013, 2004, 1999, 1997, 1993, 2011, 2015, 2015, 2012, 2002, 2013, 2014, 2017, 2018, 2018, 2018, 1999, 2001, 1999, 2003, 2018, 2016, 2008, 2018, 2018, 2018, 2018, 2018, 2013, 2013, 2016, 2014, 2018, 2017, 2008, 2009, 2009, 2009, 2007, 2011, 2016, 2003, 2001, 2003, 2017, 2006, 2002, 2002, 2000, 2017, 1999, 2007, 2006, 2002, 2008, 1999, 2002, 2008, 2007, 2004, 2010, 2006, 2010, 2017, 2018, 2018, 2017, 2003, 1989, 1986, 2019, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2015, 2015, 2015, 2015, 2015, 2015, 2014, 2014, 2013, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2015, 2015, 2015, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2012, 2011, 2010, 2011, 2011, 2012, 2010, 2011, 2011, 2010, 2011, 2010, 2012, 2010, 2012, 2018, 2007, 1999, 2000, 2000, 2016, 2016, 2010, 2016, 2010, 2012, 2013, 2013, 2014, 2014, 2014, 2014, 2015, 2017, 2017, 2010, 2009, 2006, 2003, 2008, 1998, 2014, 1999, 1999, 1996, 1997, 1995, 1995, 1994, 1995, 1995, 1999, 1996, 1995, 1994, 1997, 1999, 2009, 2017, 2017, 2017, 2017, 2019, 2011, 2018, 2018, 2018, 2018, 2018, 2019, 2017, 2019, 2017, 1991, 1995, 1993, 2002, 1992, 2013, 2007, 2010, 1997, 2008, 2008, 2010, 2010, 2008, 1998, 1990, 2001, 1991, 1997, 1997, 1998, 1995, 2000, 2001, 1994, 2019, 2018, 2019, 2016, 2011, 2005, 2012, 2010, 2019, 2015, 2019, 2017, 2005, 2016, 2012, 2008, 2015, 2019, 2017, 2015, 2010, 2013, 2015, 2007, 2010, 2019, 2017, 2019, 2013, 2017, 2018, 2010, 2007, 2011, 2010, 2019, 2014, 2011, 2012, 2005, 2017, 2007, 2006, 2014, 2011, 2013, 2014, 2019, 2011, 2012, 2014, 2010, 2016, 2013, 2011, 2009, 2012, 2012, 2012, 2018, 2010, 2011, 2016, 2006, 2017, 2014, 2006, 2007, 2013, 2015, 2006, 2011, 2012, 2019, 2018, 2019, 2013, 2015, 2019, 2009, 2014, 2010, 2011, 2010, 2009, 2019, 2009, 2013, 2016, 2015, 1969, 1970, 1965, 1980, 1980, 1975, 1980, 1975, 1977, 1977, 1975, 1981, 1979, 1980, 1977, 1977, 1975, 1979, 2000, 2000, 1973, 2001, 2000, 1998, 1988, 2000, 2000, 1987, 1987, 1986, 1986, 1986, 1985, 1984, 1984, 1984, 1999, 1982, 1982, 1983, 1982, 1982, 1984, 1982, 1981, 1982, 1982, 1983, 2014, 2012, 2006, 2017, 2019, 2019, 2004, 2017, 2003, 2001, 2001, 2001, 1997, 1997, 1996, 1992, 1992, 1991, 1991, 1990, 1990, 1990, 1989, 2001, 2016, 2016, 2016, 2016, 2013, 2010, 2013, 2009, 2011, 2011, 2018, 1999, 2012, 2012, 2011, 2011, 2008, 2008, 2008, 2008, 2011, 2008, 2010, 2009, 2009, 2008, 2009, 2009, 2009, 2008, 2009, 2008, 2009, 2011, 2011, 2010, 2007, 2013, 2013, 2008, 2008, 2008, 2008, 2008, 2008, 2010, 2009, 2010, 2006, 2007, 2007, 2006, 2005, 2000, 2003, 2002, 2002, 2001, 2002, 2001, 2000, 2004, 2002, 1998, 2002, 2016, 2012, 2015, 2008, 2014, 2014, 2012, 2015, 2009, 2015, 2014, 2013, 2011, 2010, 2011, 2011, 2007, 2011, 2016, 2013, 2000, 2009, 2006, 1997, 2010, 2009, 2012, 2011, 2010, 2001, 2012, 2011, 2011, 2012, 2002, 2005, 2009, 2015, 2013, 2010, 2010, 2006, 2006, 2009, 2010, 2012, 2003, 2003, 2010, 1999, 1995, 1995, 1989, 2009, 2007, 2015, 2015, 1988, 1993, 1998, 1995, 2015, 2019, 2015, 2014, 2016, 2016, 2016, 2016, 2003, 2004, 2002, 2002, 2003, 2003, 2000, 2002, 2003, 2000, 2001, 1994, 1998, 1999, 1997, 1998, 1997, 1992, 1996, 1999, 1997, 1994, 2000, 1987, 1986, 1986, 1986, 1986, 1992, 1992, 2014, 2014, 2001, 2005, 2015, 2014, 2015, 2015, 2015, 2014, 2013, 2004, 2015, 2008, 2010, 2016, 2012, 2013, 2014, 2006, 1972, 2006, 1999, 2005, 2007, 1992, 1997, 2007, 2010, 2006, 1992, 2005, 2010, 2003, 1999, 2006, 2003, 1996, 2008, 2012, 1992, 2010, 2005, 2009, 2002, 2006, 2004, 2013, 2010, 2007, 2008, 2005, 2003, 1999, 2002, 2005, 1994, 2009, 2006, 2004, 2007, 1998, 1994, 1995, 2012, 2006, 2000, 1994, 2010, 2001, 2010, 2007, 2008, 2010, 1995, 2002, 1997, 2012, 2010, 2005, 2007, 2010, 2007, 2013, 2010, 2010, 2009, 2011, 2011, 2001, 2005, 2007, 2008, 2008, 2008, 2008, 2008, 2008, 2012, 2016, 2016, 2008, 2002, 2003, 1997, 2003, 2000, 2013, 1998, 2005, 2005, 2005, 2004, 2004, 2004, 2004, 2005, 2006, 2005, 2005, 2006, 2005, 2012, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2015, 2015, 2015, 2014, 2015, 2014, 2015, 2013, 2012, 2015, 2015, 2012, 2012, 2011, 2008, 2016, 2008, 2006, 1992, 2018, 2018, 2018, 2018, 2018, 2018, 2019, 2018, 2018, 2017, 2017, 2017, 2017, 2016, 2017, 2017, 2017, 2017, 1993, 2016, 2016, 2016, 2016, 2015, 2014, 2015, 2015, 2015, 2015, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2008, 2015, 2015, 2015, 2015, 2015, 2014, 2014, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2003, 2014, 2014, 2015, 2014, 2015, 2014, 2014, 2014, 2013, 2015, 2014, 2014, 2014, 2014, 2017, 2016, 2019, 2016, 2017, 2015, 2016, 2017, 2014, 2019, 2012, 2014, 2009, 1994, 2008, 2006, 2006, 2006, 2006, 2015, 2014, 2012, 2018, 2011, 2003, 2019, 1994, 2018, 2014, 2006, 1992, 2013, 2016, 2005, 2005, 2016, 2019, 2019, 2006, 2009, 1997, 2014, 2017, 2014, 2017, 2017, 2015, 2018, 2008, 2002, 2007, 2019, 2004, 2009, 2004, 2005, 2005, 2016, 2018, 2012, 2006, 2008, 2008, 2008, 2010, 2011, 2010, 2018, 2019, 2018, 2005, 2016, 2016, 1999, 2017, 2010, 2008, 1997, 2016, 2018, 2017, 2010, 2001, 2014, 2017, 2019, 2019, 2019, 2019, 2000, 2006, 2017, 2017, 2017, 2016, 2019, 2019, 2018, 2017, 2018, 2017, 2005, 2005, 2015, 2017, 2013, 2016, 2019, 2010, 2014, 2014, 2019, 2012, 2019, 2019, 2015, 2013, 2019, 2010, 2017, 2011, 2014, 2017, 2011, 2019, 2014, 2011, 2019, 2017, 2018, 2019, 2018, 2018, 2019, 2010, 2013, 2018, 2019, 2012, 2018, 2015, 2018, 2019, 2018, 2009, 2018, 2014, 2019, 2005, 2017, 2017, 2018, 2018, 2017, 2014, 2019, 2017, 2015, 2016, 2018, 2019, 2015, 2018, 2017, 2004, 2007, 2015, 2005, 2005, 2013, 2008, 2015, 2015, 2015, 2016, 2012, 2006, 1995, 2008, 2015, 2015, 2014, 2010, 2001, 2010, 2010, 2009, 2009, 2011, 2010, 2011, 2011, 2010, 2010, 2010, 2010, 2015, 2017, 2009, 2008, 2014, 2015, 2007, 2018, 2019, 2010, 2019, 2019, 2019, 2019, 2017, 2015, 2015, 2013, 2015, 2014, 2012, 2010, 2011, 2005, 2014, 2017, 2005, 2003, 2000, 2009, 2015, 2014, 1998, 1987, 2015, 1998, 2004, 2017, 2017, 2017, 2017, 2017, 2010, 2008, 2007, 2010, 1988, 1989, 1988, 1984, 2014, 1991, 1992, 1992, 1995, 1991, 1995, 1991, 1989, 2016, 2016, 2012, 2010, 2009, 2009, 2009, 2008, 2007, 2005, 2005, 2002, 2001, 1977, 2014, 2018, 2012, 2019, 1990, 2019, 2019, 2018, 2018, 2018, 2018, 2010, 2019, 2014, 2009, 2013, 2016, 2013, 2014, 2016, 2009, 2012, 2016, 2008, 2018, 2006, 2008, 2009, 2003, 2003, 2006, 2008, 2017, 2004, 2016, 2016, 2016, 2016, 2013, 2014, 2013, 2011, 2010, 2012, 2011, 2011, 2011, 2010, 2012, 2010, 2008, 2013, 2019, 2019, 2018, 2006, 2015, 2010, 2009, 2009, 2008, 2007, 2012, 2012, 2016, 2019, 1998, 1996, 2009, 1999, 1997, 1995, 2007, 2000, 2018, 2000, 2014, 2018, 2017, 2018, 2003, 2018, 2010, 2009, 2007, 2005, 2005, 2009, 2013, 2011, 2001, 2010, 2017, 2014, 2008, 2017, 2013, 2010, 2007, 2013, 2011, 2005, 2016, 2013, 2019, 2011, 2014, 2010, 2019, 2017, 2012, 2005, 2017, 2013, 2016, 2018, 2016, 2011, 2012, 2019, 2018, 2017, 2019, 2017, 2018, 2013, 2004, 2013, 2016, 2019, 2013, 2010, 2019, 2018, 2015, 2017, 2011, 2013, 2014, 2010, 2012, 2013, 2014, 2017, 2010, 2005, 2015, 2011, 2012, 2016, 2019, 2019, 2012, 2017, 2016, 2011, 1965, 1965, 1980, 1976, 1977, 1981, 1978, 1981, 1977, 1998, 1998, 1998, 1988, 1985, 1986, 1983, 1982, 1981, 2015, 2016, 2014, 2012, 2012, 2009, 2010, 2010, 2008, 2007, 2009, 2019, 2019, 2017, 2018, 2019, 2003, 1990, 1989, 2001, 2018, 2006, 2016, 2015, 2008, 1998, 1991, 1987, 2018, 2012, 2005, 2014, 2003, 2012, 2018, 2010, 2010, 2010, 2010, 2005, 2013, 2013, 2013, 2004, 2002, 1996, 2011, 2016, 1985, 2013, 2009, 2009, 2017, 2014, 2011, 2014, 2013, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2019, 2008, 2012, 2013, 2001, 1995, 1991, 1986, 1992, 2011, 2012, 2005, 2003, 2004, 2005, 2007, 2015, 2011, 2015, 2016, 2014, 2014, 2012, 2014, 2010, 2000, 1999, 1994, 2005, 1995, 1998, 2003, 2000, 2009, 1997, 2007, 2004, 2006, 2008, 1998, 2002, 2005, 2005, 2005, 2002, 2000, 2000, 1992, 2003, 2009, 2006, 2000, 2000, 2001, 2006, 2006, 2006, 2006, 2006, 2001, 2015, 2014, 2014, 2011, 2015, 2017, 1998, 2019, 2010, 2017, 2018, 2018, 2004, 2015, 2009, 2014, 2014, 2010, 2015, 2014, 2013, 2016, 2015, 2012, 2012, 2008, 1997, 2016, 2013, 2018, 2013, 2011, 2011, 2012, 2001, 1998, 2013, 2018, 2009, 2012, 2012, 2010, 2006, 2006, 2013, 2013, 2014, 2014, 1992, 2006, 2005, 2006, 2009, 2009, 2006, 2006, 2012, 2012, 2010, 2011, 2013, 2013, 2013, 2013, 2010, 2011, 2012, 2012, 2013, 2013, 2014, 2012, 2012, 2015, 2009, 2015, 2011, 1997, 2016, 2002, 2017, 2016, 2000, 1998, 1999, 2016, 2001, 2001, 2006, 2005, 2003, 2005, 2007, 2017, 2019, 2018, 2019, 2016, 2014, 2001, 2012, 2016, 2017, 2014, 2015, 2011, 2010, 2017, 2017, 2012, 2009, 2010, 2008, 2018, 2018, 2018, 2007, 2007, 2007, 2010, 2014, 2006, 2007, 2016, 2012, 1995, 2008, 2008, 2008, 2004, 2009, 2013, 2001, 2002, 2015, 2018, 2017, 2007, 2015, 2017, 2019, 2002, 2016, 2013, 2013, 2010, 2012, 2011, 2012, 2011, 2017, 2009, 2016, 2011, 2001, 2015, 2017, 2012, 2000, 1992, 1992, 2008, 1990, 2012, 1998, 2010, 2001, 2017, 2014, 2003, 2017, 2015, 2016, 2014, 2016, 2007, 2007, 2018, 2018, 2006, 2006, 2006, 2019, 2005, 2014, 2012, 2017, 2010, 2010, 2006, 2005, 2003, 2015, 2011, 2011, 2008, 2008, 1999, 2012, 2008, 2016, 1999, 1999, 2008, 2013, 2019, 2015, 2012, 2005, 1992, 2009, 2007, 2002, 1999, 2000, 2014, 2015, 2010, 1995, 1998, 2013, 2009, 2005, 2009, 2014, 2007, 2017, 2013, 2013, 2010, 2010, 2018, 2014, 2002, 2016, 2014, 2016, 2018, 2018, 2013, 1999, 1991, 2018, 2010, 2017, 2013, 2009, 2016, 2018, 2018, 2018, 2018, 2015, 2015, 2014, 2014, 2014, 2014, 2018, 2017, 2017, 2016, 1994, 2017, 2012, 2010, 2013, 2011, 2007, 2011, 2010, 2010, 2012, 2007, 2009, 2017, 2013, 2014, 2013, 2013, 2019, 2010, 2017, 2017, 2014, 2006, 2018, 2018, 2018, 1999, 1993, 1992, 2008, 2008, 2008, 2008, 2008, 2008, 2009, 2004, 1998, 2003, 2011, 1999, 2007, 2006, 1990, 2017, 2012, 2011, 2002, 1999, 1991, 2009, 2018, 2017, 2018, 2010, 2012, 2009, 2007, 2017, 2010, 2011, 2010, 2013, 2010, 2004, 2016, 2010, 2016, 1993, 2017, 2012, 2007, 2000, 1998, 2000, 1999, 1999, 2000, 1998, 1998, 2016, 2005, 2013, 2019, 2000, 2005, 2019, 2017, 2014, 2017, 2002, 2013, 2000, 2012, 2013, 2008, 2000, 2015, 2004, 2014, 2019, 2018, 2004, 2006, 1990, 2008, 2018, 2018, 2017, 1998, 2004, 2017, 2010, 2016, 2016, 2012, 2015, 2015, 2016, 2017, 2017, 2012, 2015, 2017, 2017, 2015, 2015, 2015, 2018, 2015, 2015, 2010, 2008, 2009, 2009, 2019, 2018, 2013, 2006, 2004, 2007, 2009, 2007, 2019, 2006, 2010, 2012, 2009, 2014, 2009, 2019, 2014, 2009, 2016, 2012, 2015, 2014, 2017, 1993, 2010, 2013, 2011, 1991, 2013, 1995, 2002, 2007, 2003, 1989, 2019, 2018, 2018, 2005, 2007, 2019, 2019, 2019, 2018, 2019, 2018, 2019, 2019, 2019, 2012, 2016, 2007, 2016, 2009, 2010, 2013, 2015, 2016, 2017, 2017, 2017, 2018, 2017, 2017, 2018, 2018, 2018, 2002, 2018, 2018, 2014, 2008, 1998, 2007, 2019, 2014, 2013, 2015, 2014, 2015, 2016, 2015, 2015, 2015, 2015, 2012, 2013, 2004, 2017, 2012, 2013, 2015, 2010, 2005, 2013, 2018, 2017, 2017, 2017, 2017, 2016, 2018, 2016, 2017, 2017, 2015, 2016, 2017, 2014, 2011, 2012, 2012, 2012, 2010, 2012, 2010, 2010, 2007, 2019, 2019, 2017, 2005, 2018, 2018, 2004, 2003, 2003, 2002, 2007, 1994, 2016, 2016, 2018, 2017, 2018, 2018, 2017, 2017, 2017, 2016, 2016, 2016, 2018, 2017, 2018, 2016, 2018, 2018, 2016, 2018, 2018, 2017, 2018, 2018, 2016, 2016, 2016, 2016, 2017, 2017, 2017, 2017, 2016, 2019, 2017, 2017, 2017, 2017, 2017, 2008, 2010, 2004, 1997, 2005, 2007, 2014, 2016, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2016, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2013, 2017, 2010, 2009, 2003, 2000, 2014, 2019, 1997, 2002, 2008, 2011, 2010, 2017, 2011, 2013, 2011, 2008, 2014, 2007, 2007, 2010, 2010, 2005, 2012, 2010, 2017, 2014, 2013, 2014, 2016, 2014, 2016, 2014, 2016, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2015, 2015, 2015, 2014, 2014, 2016, 2014, 2012, 2015, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2012, 2012, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2014, 2013, 2008, 2019, 2013, 2007, 2018, 2019, 2017, 2018, 2017, 2017, 2018, 2016, 2017, 2014, 2016, 2017, 2017, 2015, 2014, 2015, 2015, 2015, 2016, 2013, 2014, 2014, 2014, 2013, 2013, 2012, 2015, 2013, 2013, 2012, 2012, 2012, 2013, 2013, 2010, 2013, 2010, 2013, 2012, 2014, 2012, 2010, 2018, 2012, 2003, 2006, 2017, 2014, 2015, 2016, 2019, 2001, 1996, 2018, 2017, 2017, 2010, 2008, 2005, 2005, 2005, 2005, 2003, 2005, 2011, 2018, 1985, 2019, 2019, 2019, 2018, 2010, 2009, 2006, 2014, 2017, 2017, 2017, 2010, 2019, 1996, 2012, 1979, 2017, 2016, 1989, 1989, 1993, 2014, 2014, 2014, 2014, 2015, 2012, 2012, 2012, 2007, 2006, 1999, 2000, 1999, 1997, 1996, 1996, 2017, 2018, 1997, 2002, 1999, 1999, 2000, 1998, 1993, 2016, 2017, 2001, 2019, 2018, 2017, 2017, 2019, 2019, 2018, 2018, 2019, 2019, 2019, 2009, 2018, 2016, 2001, 2018, 2012, 2014, 2015, 2009, 2004, 2017, 2006, 2008, 2013, 2003, 2013, 2011, 2010, 2009, 2013, 2010, 2011, 2011, 2017, 2016, 2017, 2004, 2002, 2016, 2016, 2013, 2013, 2015, 2014, 2010, 2010, 2012, 2009, 2011, 2016, 2019, 2019, 2018, 2019, 2019, 2016, 2016, 2017, 2019, 2017, 2017, 2017, 2017, 2018, 2018, 2018, 1998, 2010, 2010, 2010, 2014, 2012, 2012, 2008, 2013, 2013, 2017, 2001, 2015, 1998, 1998, 2019, 2019, 2015, 2015, 2014, 2014, 2014, 2018, 2018, 2007, 2014, 2019, 2019, 2007, 2017, 2015, 2017, 2016, 2017, 2013, 2015, 2015, 2016, 2014, 2009, 2017, 2016, 2014, 2014, 2012, 2017, 2009, 2013, 2012, 2010, 2012, 2010, 2019, 2019, 2018, 2014, 2014, 2016, 2018, 2005, 2018, 2017, 2018, 2010, 2017, 2015, 2011, 2010, 2018, 2014, 2011, 2013, 2009, 2017, 2014, 2013, 2012, 2012, 2015, 2009, 2014, 2014, 2017, 2015, 2013, 2014, 2019, 2014, 2018, 2018, 2011, 2014, 2012, 2014, 2010, 2013, 2019, 2015, 2019, 2018, 2008, 2014, 2015, 2011, 2014, 2019, 2016, 2018, 2019, 2011, 2014, 2010, 2010, 2012, 2015, 2015, 2015, 2010, 2010, 2010, 2011, 2012, 2018, 2014, 2019, 2016, 2016, 2017, 2019, 2004, 2009, 2014, 2014, 2018, 2018, 2014, 2019, 2009, 2008, 2010, 2013, 2013, 2018, 2016, 2014, 2017, 2010, 2011, 2015, 2014, 2011, 2015, 2006, 2018, 2013, 2019, 2012, 2014, 2014, 2018, 2014, 2019, 2017, 2018, 2010, 2015, 2015, 2017, 2015, 2014, 2018, 2011, 2016, 2016, 2009, 2014, 2010, 2017, 2014, 2019, 2018, 2014, 2016, 2017, 2016, 2011, 2013, 2017, 2013, 2019, 2013, 2019, 2008, 2015, 2016, 2008, 2017, 2017, 2017, 2018, 2018, 1971, 1966, 1965, 1978, 1977, 1979, 1988, 1987, 1986, 2002, 2001, 1998, 1998, 2001, 2015, 2014, 2016, 2016, 2014, 2013, 2009, 2008, 2018, 2019, 2019, 2017, 2018, 2018, 2016, 2017, 2017, 2018, 2017, 2018, 2016, 2017, 2016, 2016, 2016, 2016, 2015, 2001, 1996, 1996, 2001, 2017, 2017, 2003, 2005, 2003, 2005, 2000, 1999, 1989, 2010, 2015, 2002, 2013, 2013, 2013, 2013, 2011, 2010, 2010, 2012, 2012, 2011, 2006, 2011, 2007, 2006, 2011, 2008, 2008, 2008, 2008, 2012, 2010, 2005, 2002, 2005, 2012, 2015, 2011, 2008, 2006, 2004, 2010, 2003, 2006, 2017, 2018, 2014, 2010, 2010, 2008, 2010, 2012, 2007, 2004, 2004, 2001, 2013, 2011, 2016, 2017, 2011, 2005, 2004, 2015, 2011, 2005, 2015, 2016, 2016, 2014, 2016, 2018, 2016, 2009, 2015, 2016, 2013, 2016, 2016, 2016, 2017, 2015, 2014, 2014, 2016, 2012, 2013, 2018, 2016, 2000, 2006, 2002, 1997, 1991, 1997, 1998, 1994, 1986, 1991, 1987, 1992, 2018, 2016, 2016, 2002, 2003, 2005, 2005, 2005, 2005, 2004, 2006, 2012, 2007, 2013, 2012, 2008, 2006, 2008, 2013, 1999, 2012, 2006, 1997, 2005, 2011, 1993, 2010, 2013, 2013, 2008, 2007, 2014, 2009, 2015, 2013, 2017, 2016, 2016, 2012, 2016, 2012, 2018, 2016, 2000, 1995, 1991, 1991, 2008, 2008, 2008, 2005, 2008, 2008, 1992, 1987, 2010, 2010, 2012, 2013, 2010, 2008, 2012, 2000, 2000, 1999, 2010, 2009, 2009, 2006, 2005, 2003, 2003, 2005, 1994, 2017, 2015, 2009, 1996, 2005, 2007, 2016, 2014, 2007, 2010, 2013, 2013, 2012, 2011, 2001, 2001, 2001, 2001, 2010, 1998, 2013, 2018, 2018, 2017, 2016, 2017, 2017, 2011, 2012, 2015, 2018, 2019, 2016, 2018, 2018, 2018, 2018, 2000, 2016, 2016, 2015, 2017, 2008, 2014, 2012, 2008, 2013, 2007, 2010, 2013, 2013, 2017, 2013, 2012, 2011, 2019, 2012, 2013, 2010, 2008, 2018, 2011, 2016, 2018, 2017, 2013, 2017, 2011, 2017, 2009, 2013, 2008, 2016, 2018, 2019, 2005, 2007, 2016, 2018, 2010, 2003, 2003, 1998, 1997, 2019, 2011, 2007, 2017, 2012, 2001, 2013, 2005, 2003, 2018, 2014, 2014, 2012, 2015, 2008, 2009, 2008, 1998, 2008, 2009, 2005, 2013, 2007, 2000, 2000, 2010, 2004, 2015, 2011, 2006, 2007, 2004, 2003, 2002, 2009, 2006, 2005, 2006, 2005, 2003, 2011, 2000, 2005, 2005, 2013, 1992, 2011, 2012, 2010, 2012, 2007, 2010, 2018, 2015, 2005, 2018, 2017, 1998, 2015, 2008, 2017, 2018, 2018, 2018, 2017, 2013, 2010, 2011, 2014, 2018, 2016, 2013, 2013, 1999, 2016, 2017, 2017, 2013, 2009, 2007, 2006, 2009, 2010, 2014, 2017, 2012, 2008, 2017, 2018, 2008, 2014, 2016, 2016, 2016, 2016, 2016, 2018, 2018, 2018, 2018, 2006, 2015, 2016, 2015, 2013, 2016, 2014, 2016, 2019, 2017, 2001, 2001, 2017, 2015, 2014, 2014, 2015, 2015, 2015, 2019, 2017, 2016, 2015, 2001, 2011, 2006, 2001, 1999, 1998, 2004, 2011, 1997, 2002, 2011, 2005, 2013, 2015, 2015, 2019, 2015, 2013, 2017, 2015, 2005, 2008, 2006, 2018, 2016, 2014, 2016, 2017, 2016, 2016, 2016, 2015, 2015, 2010, 2015, 2015, 2013, 2017, 2015, 2018, 2019, 2019, 2014, 2016, 2017, 2018, 2019, 2017, 2015, 2015, 2012, 2012, 2012, 2011, 2009, 2009, 2010, 2006, 2006, 2018, 2019, 2019, 2019, 2017, 2002, 2018, 2018, 2018, 2018, 2018, 2016, 2017, 2016, 2018, 2010, 2017, 2013, 2013, 2013, 2013, 2011, 2011, 2007, 2012, 2010, 2010, 2012, 2012, 2012, 2011, 2011, 2011, 2012, 2006, 2010, 2010, 2010, 2007, 2006, 2010, 2010, 2010, 2013, 2013, 2013, 2017, 2019, 2009, 1996, 2018, 2010, 1995, 2011, 1996, 1996, 2017, 2018, 2017, 2018, 2006, 2005, 2016, 2016, 2016, 2009, 2015, 2018, 2018, 2018, 2015, 2016, 2014, 2009, 2011, 2011, 2012, 2016, 2016, 2004, 2006, 2003, 2005, 2006, 2003, 2002, 2014, 2011, 2008, 2011, 2008, 2014, 2015, 2014, 2015, 2018, 2010, 2015, 2012, 2006, 2016, 2017, 2010, 1996, 1995, 1999, 1998, 1992, 1992, 1992, 1992, 2003, 2005, 1999, 1985, 2010, 2009, 2009, 2010, 2009, 2011, 2010, 2013, 2000, 2000, 2014, 2013, 2004, 2001, 1998, 1993, 1986, 2002, 1994, 1988, 1998, 1999, 2012, 2004, 2018, 1990, 2008, 2010, 2003, 2012, 2000, 1995, 2018, 1989, 1995, 1997, 2010, 2010, 2012, 2011, 1988, 1998, 1998, 2003, 1998, 2009, 2012, 2014, 2013, 2012, 2013, 2013, 2013, 2012, 2019, 2009, 2012, 2018, 2019, 2018, 2018, 2018, 2004, 2002, 2001, 2013, 2018, 2017, 2019, 2004, 2004, 2016, 2013, 2008, 2002, 2015, 2008, 2006, 2000, 1999, 2013, 1999, 2011, 2009, 2007, 2006, 2003, 2006, 2014, 2003, 2018, 2017, 2016, 2005, 2005, 2007, 2012, 2015, 2012, 2013, 1995, 2003, 2005, 2003, 2005, 2018, 2008, 2010, 2013, 2010, 2015, 2012, 2011, 2011, 2006, 2016, 2018, 2019, 2019, 2014, 2015, 2014, 2014, 2013, 2019, 2013, 2015, 2009, 2005, 2006, 2008, 2005, 2018, 2016, 2018, 2019, 2018, 2016, 2016, 2017, 2018, 2017, 2016, 2016, 2016, 2015, 2016, 2015, 2012, 2013, 2013, 2011, 2012, 2012, 2008, 2018, 2017, 2018, 2004, 2018, 2018, 2006, 2008, 2008, 2008, 2007, 2008, 2008, 2009, 2005, 2011, 2008, 2005, 2007, 2006, 2017, 2011, 2004, 2008, 2017, 2018, 2015, 2017, 2014, 2017, 2014, 2016, 2011, 2012, 2016, 2002, 2005, 2006, 2004, 2008, 2003, 2003, 2001, 2004, 1996, 2015, 2008, 2008, 2007, 2016, 2012, 2006, 2012, 2010, 2008, 1991, 2010, 2012, 2009, 2015, 1989, 1992, 2004, 2002, 2008, 2008, 1987, 2009, 2012, 2012, 2011, 1994, 2014, 2003, 2018, 2017, 2012, 2014, 2015, 2001, 2006, 2007, 2014, 2005, 2016, 2016, 2015, 2018, 2016, 2012, 2018, 2018, 2013, 2018, 2009, 2019, 2013, 2015, 2016, 2016, 2002, 2014, 2008, 2002, 2002, 2015, 2017, 2016, 2017, 2003, 2007, 2017, 2017, 2008, 2007, 2006, 2006, 2007, 2008, 2003, 2015, 2009, 2011, 2012, 2013, 2018, 2013, 2011, 2010, 2001, 2017, 2019, 2015, 2012, 2019, 2014, 2018, 2016, 2017, 2013, 2014, 2009, 2006, 2012, 2012, 2009, 2010, 2019, 2014, 2012, 1999, 1990, 2008, 2014, 2009, 2007, 2009, 2009, 2012, 2011, 2012, 2014, 2010, 2008, 2011, 2008, 2014, 2012, 2009, 2005, 2004, 2010, 2009, 1999, 2012, 2016, 2007, 2007, 2013, 2004, 2008, 2003, 2017, 2010, 2014, 2015, 2005, 1993, 1989, 2005, 2006, 2004, 2011, 2019, 2018, 2018, 2019, 2014, 2004, 2002, 2012, 2005, 2010, 2016, 2018, 2018, 2016, 1994, 2014, 2010, 2015, 2012, 2013, 2010, 2010, 2012, 2002, 2007, 2002, 2018, 2018, 2018, 2016, 2019, 2019, 2017, 2019, 2017, 2015, 1999, 2019, 2010, 1998, 1998, 2013, 2013, 2010, 2011, 2010, 2012, 2013, 2010, 2009, 2008, 2017, 2006, 2010, 2014, 2010, 2011, 1999, 2012, 2011, 2010, 2006, 2005, 2003, 2011, 2009, 2006, 2019, 2017, 2017, 2014, 2013, 2009, 2006, 2012, 2004, 2009, 2006, 2010, 1996, 1989, 1996, 2009, 2011, 2003, 2014, 2017, 2017, 2018, 2012, 2016, 2017, 2017, 2019, 1992, 2018, 2018, 2005, 2015, 2014, 2013, 2011, 2010, 2009, 2015, 2010, 2011, 2016, 2018, 2016, 2003, 2018, 2006, 2014, 2017, 2018, 2018, 2018, 2017, 2017, 2017, 2015, 2013, 2000, 1998, 1997, 1991, 2018, 2018, 2018, 2018, 2018, 2009, 2006, 2017, 2017, 2017, 2017, 2019, 2006, 2010, 2008, 2008, 2013, 2009, 2011, 2008, 2016, 2011, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2018, 2011, 1997, 2013, 2010, 2012, 2018, 2017, 2012, 2003, 2010, 2015, 2015, 2015, 2014, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2014, 2014, 2018, 2000, 2013, 2016, 2016, 2013, 2018, 2018, 2017, 2019, 2017, 1990, 2006, 2004, 2003, 2002, 2003, 2001, 2001, 1995, 1995, 1993, 1994, 2018, 2008, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2007, 2011, 2011, 2010, 2011, 2012, 2012, 2012, 2006, 2006, 2011, 2010, 2010, 2007, 2007, 2012, 2012, 2010, 2012, 2000, 2010, 2009, 2012, 2012, 2008, 2012, 2015, 2014, 2018, 2017, 2005, 2002, 2014, 2013, 2012, 2015, 1986, 2013, 2007, 2014, 2014, 2012, 2013, 2013, 2013, 2016, 2008, 2011, 2016, 2012, 2004, 2003, 2000, 2011, 2017, 2013, 2014, 2017, 2015, 2012, 2006, 2010, 2012, 2008, 2014, 2012, 1999, 2002, 1992, 1992, 2006, 2010, 2015, 2010, 2012, 2009, 1994, 2015, 2002, 1991, 1999, 1990, 2000, 2010, 2006, 2005, 2005, 2005, 2001, 1999, 1998, 1999, 1996, 1994, 1989, 1988, 2015, 2006, 2016, 1999, 1999, 1993, 2007, 2014, 1988, 2010, 2010, 1991, 1992, 2007, 2019, 2018, 2018, 2016, 2019, 2017, 2018, 2017, 2017, 2013, 2011, 2010, 2008, 2007, 2018, 1998, 2018, 2017, 2003, 2015, 2018, 2019, 1987, 2009, 2019, 2002, 2002, 2002, 2012, 2001, 2012, 1994, 2018, 2011, 2017, 2018, 2016, 2010, 2009, 2012, 2017, 2010, 2007, 2011, 2009, 2015, 2014, 2015, 2017, 2015, 2015, 2019, 2015, 2014, 2015, 2014, 2012, 2017, 2017, 2017, 2018, 2018, 2010, 2008, 2012, 2011, 2007, 1999, 2000, 1997, 2013, 2008, 2011, 2018, 1998, 1991, 2006, 2005, 2016, 2009, 2013, 2009, 2010, 2010, 2004, 2006, 2016, 2007, 2002, 2001, 2014, 2010, 2001, 2007, 2008, 2003, 2003, 2003, 2002, 2003, 2003, 2003, 1999, 2010, 2010, 2012, 2011, 2016, 2014, 2009, 2009, 2009, 2009, 2009, 2007, 2004, 2005, 2003, 2004, 2000, 2003, 2018, 2005, 2000, 2006, 1996, 2018, 2018, 2015, 2012, 2008, 2011, 1999, 2012, 2005, 2000, 1998, 2005, 2014, 2018, 2018, 2017, 2018, 2018, 2018, 2017, 2019, 2018, 2002, 1998, 2008, 2007, 2004, 2005, 2005, 2005, 2005, 2005, 2005, 2005, 2005, 2004, 2004, 2004, 2005, 2003, 2003, 1999, 2006, 2014, 2019, 2018], \"xaxis\": \"x\", \"y\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 6, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 1, 9, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 6, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 2, 13, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 5, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 6, 0, 6, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 11, 1, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 10, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 4, 0, 0, 0, 0, 1, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 2, 0, 6, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 6, 28, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 3, 0, 0, 0, 6, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 2, 3, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 20, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 1, 0, 0, 1, 0, 0, 2, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 7, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 7, 0, 0, 0, 0, 0, 5, 0, 0, 1, 0, 0, 0, 0, 4, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], \"yaxis\": \"y\"}],\n","                        {\"barmode\": \"relative\", \"coloraxis\": {\"colorbar\": {\"title\": {\"text\": \"Funding Amount in USD\"}}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"height\": 600, \"legend\": {\"tracegroupgap\": 0}, \"template\": {\"data\": {\"bar\": [{\"error_x\": {\"color\": \"#2a3f5f\"}, \"error_y\": {\"color\": \"#2a3f5f\"}, \"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"bar\"}], \"barpolar\": [{\"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"barpolar\"}], \"carpet\": [{\"aaxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"baxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"type\": \"carpet\"}], \"choropleth\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"choropleth\"}], \"contour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"contour\"}], \"contourcarpet\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"contourcarpet\"}], \"heatmap\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmap\"}], \"heatmapgl\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmapgl\"}], \"histogram\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"histogram\"}], \"histogram2d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2d\"}], \"histogram2dcontour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2dcontour\"}], \"mesh3d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"mesh3d\"}], \"parcoords\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"parcoords\"}], \"scatter\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter\"}], \"scatter3d\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter3d\"}], \"scattercarpet\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattercarpet\"}], \"scattergeo\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergeo\"}], \"scattergl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergl\"}], \"scattermapbox\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattermapbox\"}], \"scatterpolar\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolar\"}], \"scatterpolargl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolargl\"}], \"scatterternary\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterternary\"}], \"surface\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"surface\"}], \"table\": [{\"cells\": {\"fill\": {\"color\": \"#EBF0F8\"}, \"line\": {\"color\": \"white\"}}, \"header\": {\"fill\": {\"color\": \"#C8D4E3\"}, \"line\": {\"color\": \"white\"}}, \"type\": \"table\"}]}, \"layout\": {\"annotationdefaults\": {\"arrowcolor\": \"#2a3f5f\", \"arrowhead\": 0, \"arrowwidth\": 1}, \"colorscale\": {\"diverging\": [[0, \"#8e0152\"], [0.1, \"#c51b7d\"], [0.2, \"#de77ae\"], [0.3, \"#f1b6da\"], [0.4, \"#fde0ef\"], [0.5, \"#f7f7f7\"], [0.6, \"#e6f5d0\"], [0.7, \"#b8e186\"], [0.8, \"#7fbc41\"], [0.9, \"#4d9221\"], [1, \"#276419\"]], \"sequential\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"sequentialminus\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"colorway\": [\"#636efa\", \"#EF553B\", \"#00cc96\", \"#ab63fa\", \"#FFA15A\", \"#19d3f3\", \"#FF6692\", \"#B6E880\", \"#FF97FF\", \"#FECB52\"], \"font\": {\"color\": \"#2a3f5f\"}, \"geo\": {\"bgcolor\": \"white\", \"lakecolor\": \"white\", \"landcolor\": \"#E5ECF6\", \"showlakes\": true, \"showland\": true, \"subunitcolor\": \"white\"}, \"hoverlabel\": {\"align\": \"left\"}, \"hovermode\": \"closest\", \"mapbox\": {\"style\": \"light\"}, \"paper_bgcolor\": \"white\", \"plot_bgcolor\": \"#E5ECF6\", \"polar\": {\"angularaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"radialaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"scene\": {\"xaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"yaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"zaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}}, \"shapedefaults\": {\"line\": {\"color\": \"#2a3f5f\"}}, \"ternary\": {\"aaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"baxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"caxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"title\": {\"x\": 0.05}, \"xaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}, \"yaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}}}, \"title\": {\"text\": \"Patents per grant\"}, \"xaxis\": {\"anchor\": \"y\", \"domain\": [0.0, 0.98], \"title\": {\"text\": \"End Year\"}}, \"yaxis\": {\"anchor\": \"x\", \"domain\": [0.0, 1.0], \"title\": {\"text\": \"patents\"}}},\n","                        {\"responsive\": true}\n","                    ).then(function(){\n","                            \n","var gd = document.getElementById('937d9be2-b5b0-4303-9e90-9137b69e1a2d');\n","var x = new MutationObserver(function (mutations, observer) {{\n","        var display = window.getComputedStyle(gd).display;\n","        if (!display || display === 'none') {{\n","            console.log([gd, 'removed!']);\n","            Plotly.purge(gd);\n","            observer.disconnect();\n","        }}\n","}});\n","\n","// Listen for the removal of the full notebook cells\n","var notebookContainer = gd.closest('#notebook-container');\n","if (notebookContainer) {{\n","    x.observe(notebookContainer, {childList: true});\n","}}\n","\n","// Listen for the clearing of the current output cell\n","var outputEl = gd.closest('.output');\n","if (outputEl) {{\n","    x.observe(outputEl, {childList: true});\n","}}\n","\n","                        })\n","                };\n","                \n","            </script>\n","        </div>\n","</body>\n","</html>"]},"metadata":{"tags":[]}}]},{"cell_type":"code","metadata":{"id":"wiLbh_AobhuZ","colab_type":"code","outputId":"aa876b3b-07ed-4898-ec4f-88156850ccb1","executionInfo":{"status":"ok","timestamp":1573589122398,"user_tz":0,"elapsed":1674,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"colab":{"base_uri":"https://localhost:8080/","height":617}},"source":["px.bar(grants, x=\"End Year\", y=\"clinical_trials\", color=\"Funding Amount in USD\", \n","       hover_name=\"Title\", \n","       hover_data=['Grant ID', 'Start Year', 'End Year', 'Funder', 'Funder Country'],\n","       title=f\"Clinical Trials per grant\")"],"execution_count":0,"outputs":[{"output_type":"display_data","data":{"text/html":["<html>\n","<head><meta charset=\"utf-8\" /></head>\n","<body>\n","    <div>\n","            <script src=\"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_SVG\"></script><script type=\"text/javascript\">if (window.MathJax) {MathJax.Hub.Config({SVG: {font: \"STIX-Web\"}});}</script>\n","                <script type=\"text/javascript\">window.PlotlyConfig = {MathJaxConfig: 'local'};</script>\n","        <script src=\"https://cdn.plot.ly/plotly-latest.min.js\"></script>    \n","            <div id=\"91945063-1f92-4c13-a7e7-375179a7cf89\" class=\"plotly-graph-div\" style=\"height:600px; width:100%;\"></div>\n","            <script type=\"text/javascript\">\n","                \n","                    window.PLOTLYENV=window.PLOTLYENV || {};\n","                    \n","                if (document.getElementById(\"91945063-1f92-4c13-a7e7-375179a7cf89\")) {\n","                    Plotly.newPlot(\n","                        '91945063-1f92-4c13-a7e7-375179a7cf89',\n","                        [{\"alignmentgroup\": \"True\", \"customdata\": [[\"grant.8172033\", 2004.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7715379\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6962629\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6723913\", 2003.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6722306\", 2005.0, 2009, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716312\", 1991.0, 1993, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.5526688\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.3733803\", 1998.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3274273\", 1977.0, 1980, \"Directorate for Biological Sciences\", \"United States\"], [\"grant.2936015\", 2003.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2863615\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2815666\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2807651\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2800991\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2710461\", 2002.0, 2002, \"National Cancer Institute\", \"United States\"], [\"grant.2657659\", 1992.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640369\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640228\", 1996.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2426045\", 1992.0, 1993, \"National Cancer Institute\", \"United States\"], [\"grant.2426044\", 1992.0, 1993, \"National Cancer Institute\", \"United States\"], [\"grant.2426039\", 1992.0, 1993, \"National Cancer Institute\", \"United States\"], [\"grant.2425936\", 1992.0, 1996, \"National Cancer Institute\", \"United States\"], [\"grant.2425935\", 1992.0, 1993, \"National Cancer Institute\", \"United States\"], [\"grant.2425932\", 1992.0, 1996, \"National Cancer Institute\", \"United States\"], [\"grant.2425010\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424436\", 1990.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8068979\", 2006.0, 2010, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.7106480\", 2010.0, 2011, \"VINNOVA\", \"Sweden\"], [\"grant.2639983\", 1990.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2355874\", 1986.0, 1986, \"Fogarty International Center\", \"United States\"], [\"grant.7566903\", 2007.0, 2008, \"Ministry of Business, Innovation and Employment\", \"New Zealand\"], [\"grant.7042623\", 1990.0, 1993, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040393\", 1992.0, 1993, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6731478\", 1994.0, 1995, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728996\", 1998.0, 2002, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723289\", 2002.0, 2004, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718929\", 1994.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713873\", 1993.0, 1993, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.4442512\", 1985.0, 1986, \"United States Department of the Army\", \"United States\"], [\"grant.4035473\", 2008.0, 2010, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.2987461\", 1992.0, 1993, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2972379\", 1997.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2964974\", 2005.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2957579\", 1993.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2950584\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2920553\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2915638\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2912254\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2880945\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2877426\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2828580\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2805504\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2795214\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2692263\", 2011.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2688631\", 1993.0, 1997, \"National Cancer Institute\", \"United States\"], [\"grant.2657670\", 1993.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640366\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597598\", 2000.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424826\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424691\", 1985.0, 1990, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424653\", 1994.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424634\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424633\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424632\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424631\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424630\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424629\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424455\", 1991.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424372\", 1990.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2393802\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393756\", 2012.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.7987079\", 1996.0, 1999, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8217971\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8176576\", 2012.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8175344\", 2009.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8172020\", 2004.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8166566\", 2000.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7988463\", 2004.0, 2007, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7821014\", 1998.0, 2001, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7688859\", 2006.0, 2006, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7685445\", 2011.0, 2011, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7666696\", 2002.0, 2005, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7664870\", 1999.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7628231\", 2000.0, 2001, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7623308\", 1999.0, 2001, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7575791\", 2016.0, 2017, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.7568437\", 2002.0, 2003, \"Ministry of Business, Innovation and Employment\", \"New Zealand\"], [\"grant.7567590\", 2004.0, 2007, \"Ministry of Business, Innovation and Employment\", \"New Zealand\"], [\"grant.7456676\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7437133\", 2008.0, 2010, \"University Grants Committee\", \"China\"], [\"grant.7167590\", 1997.0, 1999, \"Innovation and Technology Commission\", \"China\"], [\"grant.7149998\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7148384\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7043734\", 1992.0, 1993, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042974\", 1996.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042624\", 1990.0, 1993, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042622\", 1990.0, 1993, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6972056\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6968725\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6966722\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6844591\", 2001.0, 2004, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6735165\", 1989.0, 1991, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6732885\", 1990.0, 1991, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6731341\", 1992.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6730713\", 2010.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6729465\", 1990.0, 1992, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6729082\", 1992.0, 1994, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6726453\", 1999.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725165\", 1996.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725082\", 1992.0, 1994, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725032\", 1991.0, 1993, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6724834\", 1991.0, 1993, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723804\", 2002.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723056\", 2007.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716599\", 1995.0, 1997, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6714669\", 1988.0, 1990, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6714037\", 1990.0, 1992, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713255\", 1997.0, 1999, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6582874\", 2000.0, 2001, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6370857\", 1971.0, 1971, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6363940\", 1970.0, 1970, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6363488\", 1969.0, 1969, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6343961\", 1966.0, 1966, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6317005\", 1976.0, 1976, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6315891\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6233441\", 1986.0, 1986, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6193400\", 2000.0, 2002, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6171313\", 1981.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6169577\", 1981.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5896926\", 2004.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5526642\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5502450\", 2010.0, 2015, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5246711\", 1999.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246674\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246626\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5070451\", 2008.0, 2013, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5061344\", 1999.0, 2001, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.4641309\", 2008.0, 2008, \"The Research Council of Norway\", \"Norway\"], [\"grant.4168271\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.3739684\", 1998.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3706272\", 1985.0, 1987, \"European Commission\", \"Belgium\"], [\"grant.3702523\", 1989.0, 1993, \"European Commission\", \"Belgium\"], [\"grant.3652600\", 2013.0, 2014, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.3309929\", 1981.0, 1981, \"Directorate for Engineering\", \"United States\"], [\"grant.2986898\", 2002.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2985999\", 2003.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2984549\", 1996.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2974921\", 1994.0, 1995, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2971636\", 1999.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2963297\", 1997.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2953859\", 1995.0, 1996, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2951075\", 1998.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2945193\", 2006.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2937592\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2937042\", 2004.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2935778\", 1998.0, 2001, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2914065\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2910038\", 2000.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2899455\", 2005.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2898752\", 2000.0, 2002, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2896132\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2869083\", 2003.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2835164\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2824183\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2813726\", 2003.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2694848\", 2008.0, 2013, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2692184\", 2004.0, 2011, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2687621\", 2003.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687368\", 1994.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687218\", 1990.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687093\", 1987.0, 1990, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666074\", 2006.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2665915\", 2002.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2664798\", 2001.0, 2003, \"National Institute on Deafness and Other Communication Disorders\", \"United States\"], [\"grant.2643578\", 1996.0, 1996, \"National Cancer Institute\", \"United States\"], [\"grant.2643577\", 1996.0, 1997, \"National Cancer Institute\", \"United States\"], [\"grant.2643549\", 1996.0, 1997, \"National Cancer Institute\", \"United States\"], [\"grant.2640348\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640344\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640324\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640316\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640237\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640236\", 1996.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639795\", 1987.0, 1987, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636315\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636304\", 1995.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636298\", 1994.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2625146\", 1992.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2608574\", 1999.0, 2002, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2602929\", 1999.0, 2002, \"National Cancer Institute\", \"United States\"], [\"grant.2597635\", 1999.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2572211\", 1995.0, 1997, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.2566750\", 1991.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566749\", 1990.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566740\", 1990.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566739\", 1990.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566738\", 1990.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2489689\", 1982.0, 2003, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.2474868\", 1999.0, 2002, \"National Cancer Institute\", \"United States\"], [\"grant.2471363\", 1993.0, 1997, \"National Cancer Institute\", \"United States\"], [\"grant.2471277\", 1992.0, 1998, \"National Cancer Institute\", \"United States\"], [\"grant.2471271\", 1992.0, 1997, \"National Cancer Institute\", \"United States\"], [\"grant.2454716\", 1999.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453176\", 1994.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452868\", 1993.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452627\", 1992.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452157\", 1992.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2450816\", 1986.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2433676\", 1985.0, 1985, \"National Cancer Institute\", \"United States\"], [\"grant.2433640\", 1989.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2433628\", 1985.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2428617\", 1981.0, 1986, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.2428003\", 1994.0, 1998, \"National Cancer Institute\", \"United States\"], [\"grant.2425945\", 1994.0, 1998, \"National Cancer Institute\", \"United States\"], [\"grant.2425777\", 1997.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425765\", 1995.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425738\", 1990.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424919\", 1987.0, 1992, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424708\", 1985.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424692\", 1985.0, 1990, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424627\", 1994.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424600\", 1983.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424554\", 1983.0, 1986, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424491\", 1992.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424469\", 1991.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424424\", 2000.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424340\", 1979.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2406847\", 1992.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2393916\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393915\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393914\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393913\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393912\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393911\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393910\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393909\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393908\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393907\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393906\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393905\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393904\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393903\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393902\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393901\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393900\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393899\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393898\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393897\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393896\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393895\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393893\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393892\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393891\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393890\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393889\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393888\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393887\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393886\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393885\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393884\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393883\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393882\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393881\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393880\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393879\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393878\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393877\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393876\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393875\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393874\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393873\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393872\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393871\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393870\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393869\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393868\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393867\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393866\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393865\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393864\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393863\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393862\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393861\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393860\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393859\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393858\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393857\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393856\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393855\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393854\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393853\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393852\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393844\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393841\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393821\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393817\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393814\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393808\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393804\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393800\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393799\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393797\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393795\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393794\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393790\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393786\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2375051\", 1987.0, 1988, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2369583\", 1991.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2356619\", 1994.0, 1995, \"Fogarty International Center\", \"United States\"], [\"grant.8460157\", 2010.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8446709\", 2013.0, 2015, \"Swedish Research Council for Environment Agricultural Sciences and Spatial Planning\", \"Sweden\"], [\"grant.8033537\", 2010.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951286\", 2013.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7942547\", 2008.0, 2011, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7608089\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7502141\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7498852\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7498851\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7475580\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7167585\", 1996.0, 2000, \"Innovation and Technology Commission\", \"China\"], [\"grant.7104247\", 2010.0, 2014, \"VINNOVA\", \"Sweden\"], [\"grant.7062940\", 2016.0, 2017, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.6967906\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6728271\", 2010.0, 2012, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6500725\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6259132\", 1998.0, 1999, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5892064\", 2004.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5761631\", 1999.0, 1999, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5551429\", 2000.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5246672\", 2006.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246671\", 2006.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246586\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246584\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246583\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246582\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246581\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4632144\", 2004.0, 2007, \"Slovenian Research Agency\", \"Slovenia\"], [\"grant.3802932\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2936797\", 2000.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2424522\", 2004.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6315092\", 1976.0, 1976, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.8505364\", 2011.0, 2014, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8495954\", 2014.0, 2017, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8489605\", 2011.0, 2014, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8487606\", 2008.0, 2011, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8352947\", 2015.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8328815\", 2000.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8290380\", 2004.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8219416\", 1999.0, 1999, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8219108\", 1999.0, 2001, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8217961\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8216804\", 1997.0, 1999, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8214678\", 1995.0, 1997, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8209272\", 1991.0, 1993, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8209093\", 1991.0, 1993, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8205967\", 1987.0, 1993, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173982\", 2007.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173409\", 2007.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8172930\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169476\", 2002.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8167666\", 2001.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8034776\", 2009.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8033536\", 2010.0, 2013, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8019012\", 2016.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8018668\", 2012.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8005184\", 2008.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8000977\", 2009.0, 2010, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.7993576\", 2014.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992850\", 2013.0, 2018, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989648\", 2008.0, 2008, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951296\", 2015.0, 2015, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7851731\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7821052\", 1999.0, 2002, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7741443\", 2010.0, 2015, \"Danish Ministry of Higher Education and Science\", \"Denmark\"], [\"grant.7721825\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7721778\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7721598\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7721597\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7715670\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7709652\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7695510\", 2012.0, 2012, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7693092\", 2017.0, 2017, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7692313\", 2010.0, 2012, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7687496\", 2008.0, 2008, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7685141\", 2010.0, 2012, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7684827\", 2011.0, 2012, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7683420\", 2006.0, 2007, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7668688\", 2005.0, 2005, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7666767\", 2005.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665207\", 2002.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665048\", 2002.0, 2004, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665045\", 2001.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665032\", 2002.0, 2007, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658271\", 2006.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658269\", 2003.0, 2004, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7653038\", 1998.0, 2001, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7648001\", 1999.0, 2000, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7647714\", 2001.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7645631\", 2004.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7644460\", 1998.0, 2001, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7632409\", 2004.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7629669\", 2002.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7628997\", 2016.0, 2016, \"Canadian Cancer Society\", \"Canada\"], [\"grant.7628517\", 1996.0, 2001, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7624786\", 2003.0, 2005, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7623304\", 2001.0, 2004, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7622447\", 2002.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7620072\", 1999.0, 2005, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7618695\", 2000.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7608908\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7576541\", 2016.0, 2017, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.7575474\", 2016.0, 2017, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.7550264\", 2000.0, 2003, \"Bloodwise\", \"United Kingdom\"], [\"grant.7550133\", 1998.0, 1999, \"Bloodwise\", \"United Kingdom\"], [\"grant.7501980\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7497479\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7487475\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7486078\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7485113\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7480407\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7475943\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7466232\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7456985\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7453708\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7451192\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7445407\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7172800\", 2015.0, 2017, \"United States-Israel Binational Science Foundation\", \"Israel\"], [\"grant.7164693\", 2015.0, 2016, \"Innovation and Technology Commission\", \"China\"], [\"grant.7162576\", 2014.0, 2016, \"Innovation and Technology Commission\", \"China\"], [\"grant.7150415\", 2013.0, 2013, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7148703\", 2016.0, 2016, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7148315\", 2017.0, 2017, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7043730\", 1993.0, 1996, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043113\", 2003.0, 2011, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042995\", 1997.0, 2000, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042984\", 1994.0, 1996, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042973\", 1996.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042972\", 1993.0, 1996, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040781\", 1997.0, 1998, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040770\", 1994.0, 1997, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6973472\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6968429\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6964936\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6964935\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6964934\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6962076\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6860200\", 2013.0, 2017, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.6841646\", 2017.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6733351\", 1994.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6733063\", 1989.0, 1991, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6732161\", 1988.0, 1990, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6731087\", 1993.0, 1995, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6730637\", 1997.0, 1997, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6729362\", 1990.0, 1992, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728479\", 1991.0, 1994, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727741\", 2000.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727472\", 1990.0, 1992, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727351\", 1993.0, 1995, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727129\", 1995.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6726943\", 1999.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6726066\", 1998.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6724082\", 2004.0, 2008, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6724070\", 2004.0, 2004, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6722617\", 2007.0, 2011, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6722495\", 2007.0, 2011, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6719794\", 1993.0, 1993, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6717775\", 1998.0, 2000, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716449\", 1997.0, 1999, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715829\", 1989.0, 1991, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715708\", 1993.0, 1995, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6584428\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584014\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583657\", 2005.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582621\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582605\", 2005.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582373\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581732\", 2006.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581497\", 2013.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581487\", 2006.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581045\", 2016.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580935\", 2000.0, 2006, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580931\", 2004.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580858\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6373203\", 1971.0, 1971, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6371736\", 1971.0, 1971, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6371621\", 1971.0, 1971, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6354558\", 1967.0, 1967, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6352300\", 1968.0, 1968, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6326766\", 1972.0, 1972, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6322556\", 1972.0, 1972, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6320876\", 1972.0, 1973, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6315181\", 1978.0, 1979, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6312481\", 1976.0, 1976, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6312424\", 1975.0, 1975, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6309272\", 1980.0, 1980, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6300254\", 1973.0, 1973, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6269166\", 1999.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6265050\", 1999.0, 2000, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6199903\", 1983.0, 1983, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6184528\", 1983.0, 1984, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6172495\", 1981.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6168194\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6053442\", 2010.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6035398\", 2010.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5988918\", 2007.0, 2007, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5608798\", 1992.0, 1992, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5592504\", 1991.0, 1991, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5569183\", 1990.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5565949\", 1990.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5565166\", 1989.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5533552\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5531348\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5528462\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5527258\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5502385\", 2010.0, 2013, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5502275\", 2008.0, 2011, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5325527\", 2001.0, 2006, \"Asthma UK\", \"United Kingdom\"], [\"grant.5246712\", 1999.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246675\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246655\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246654\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246653\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246652\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246651\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246650\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246628\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246627\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246625\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246587\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246557\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246556\", 2004.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246416\", 2003.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246378\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246376\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246333\", 2002.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246326\", 2001.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246292\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246291\", 2000.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5206028\", 1998.0, 2000, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5202152\", 2001.0, 2002, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5196804\", 1994.0, 1995, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5195740\", 1994.0, 1997, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5195025\", 1993.0, 1995, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5138636\", 2007.0, 2008, \"Cancer Research UK\", \"United Kingdom\"], [\"grant.5069446\", 2005.0, 2013, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5068098\", 2004.0, 2012, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5066344\", 2013.0, 2016, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5064871\", 2005.0, 2009, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5061881\", 1998.0, 2000, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.5061466\", 1997.0, 1998, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.5061185\", 2001.0, 2002, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.5060853\", 1998.0, 2000, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.4845632\", 2004.0, 2006, \"Israel Science Foundation\", \"Israel\"], [\"grant.4695298\", 2004.0, 2014, \"Juvenile Diabetes Research Foundation\", \"United States\"], [\"grant.4682414\", 2016.0, 2018, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.4661480\", 2011.0, 2012, \"The Research Council of Norway\", \"Norway\"], [\"grant.4644142\", 2012.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4641075\", 2007.0, 2007, \"The Research Council of Norway\", \"Norway\"], [\"grant.4636462\", 2006.0, 2007, \"Slovenian Research Agency\", \"Slovenia\"], [\"grant.4562339\", 1997.0, 2000, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4510775\", 1995.0, 1996, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4453044\", 1998.0, 1999, \"United States Department of Defense\", \"United States\"], [\"grant.4362089\", 2008.0, 2010, \"Slovak Research and Development Agency\", \"Slovakia\"], [\"grant.4192377\", 2008.0, 2011, \"Hungarian Scientific Research Fund\", \"Hungary\"], [\"grant.4171416\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4167878\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4167438\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4106519\", 2005.0, 2010, \"Innovate UK\", \"United Kingdom\"], [\"grant.4035526\", 2004.0, 2007, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.4035380\", 2004.0, 2006, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.4035377\", 2004.0, 2005, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.3749684\", 2000.0, 2005, \"European Commission\", \"Belgium\"], [\"grant.3733024\", 1998.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3731136\", 1999.0, 2001, \"European Commission\", \"Belgium\"], [\"grant.3729873\", 1995.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3728490\", 1993.0, 1994, \"European Commission\", \"Belgium\"], [\"grant.3726127\", 1994.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3708086\", 1984.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3706490\", 1987.0, 1988, \"European Commission\", \"Belgium\"], [\"grant.3702872\", 1989.0, 1993, \"European Commission\", \"Belgium\"], [\"grant.3700936\", 1989.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.3535230\", 2014.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3532347\", 2010.0, 2013, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3529500\", 2010.0, 2013, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3528280\", 2011.0, 2013, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3528140\", 2005.0, 2007, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3527854\", 2007.0, 2009, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3527599\", 2013.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3526938\", 2011.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3526242\", 2009.0, 2012, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3524632\", 2007.0, 2011, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.2987656\", 1998.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2985050\", 1991.0, 1993, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2984254\", 1997.0, 1998, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2982723\", 1993.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2978220\", 1991.0, 1993, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2971136\", 2002.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2968761\", 2005.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2968075\", 1999.0, 2001, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2967309\", 1991.0, 1992, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2960882\", 1992.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2958728\", 2002.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2957327\", 1991.0, 1993, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2942407\", 1995.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2939650\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2937046\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2936941\", 2000.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2932210\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2928975\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2923314\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2921906\", 1991.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2912514\", 1999.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2911669\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2901085\", 1991.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2899804\", 1991.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2892553\", 1996.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2875627\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2874597\", 2004.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2874082\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2857726\", 2003.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2853909\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2846899\", 1994.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2845378\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2835397\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2834880\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2821820\", 2001.0, 2002, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2817654\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2807465\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2798941\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2795749\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2791038\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2789593\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2722085\", 1994.0, 1994, \"National Center for Advancing Translational Sciences\", \"United States\"], [\"grant.2706159\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2698714\", 2013.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2697537\", 2002.0, 2007, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2695257\", 2010.0, 2014, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2693731\", 2003.0, 2007, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2690783\", 2012.0, 2017, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2690760\", 2011.0, 2017, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2687365\", 1994.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687364\", 1994.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687357\", 1994.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687347\", 1994.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687156\", 1989.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687154\", 1988.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666046\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2664366\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2664365\", 1996.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657660\", 1992.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657656\", 1992.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657579\", 1988.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2647175\", 1996.0, 1996, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2643697\", 1997.0, 1999, \"National Cancer Institute\", \"United States\"], [\"grant.2643565\", 1996.0, 1996, \"National Cancer Institute\", \"United States\"], [\"grant.2641009\", 2003.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640640\", 1999.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640550\", 1999.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640356\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640346\", 1996.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640336\", 1996.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640319\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640315\", 1996.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640305\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640255\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640187\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639832\", 1988.0, 1988, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2624939\", 1988.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2608583\", 1999.0, 2002, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2608571\", 1999.0, 2002, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2597656\", 1999.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597626\", 1999.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597599\", 1999.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597536\", 1999.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597279\", 1996.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597266\", 1996.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597222\", 1997.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2590181\", 1995.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2583049\", 1995.0, 1996, \"National Cancer Institute\", \"United States\"], [\"grant.2579292\", 1995.0, 1997, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2567035\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566836\", 1999.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566752\", 1992.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2564456\", 1993.0, 1997, \"National Center for Advancing Translational Sciences\", \"United States\"], [\"grant.2508306\", 2005.0, 2007, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2454434\", 1999.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453161\", 1994.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452894\", 1993.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452879\", 1993.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452193\", 1991.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2450320\", 1984.0, 1987, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435123\", 2003.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435096\", 2003.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2434876\", 1987.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2433623\", 1985.0, 1986, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2430978\", 2004.0, 2004, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430831\", 1997.0, 2000, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430826\", 1996.0, 2001, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430821\", 1987.0, 1988, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430718\", 1995.0, 1997, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430614\", 1993.0, 1995, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430613\", 1993.0, 1995, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430542\", 1992.0, 1993, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2425744\", 1992.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424990\", 1989.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424954\", 1998.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424953\", 1998.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424952\", 1998.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424951\", 1998.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424889\", 1997.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424801\", 1986.0, 1992, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424782\", 1985.0, 1992, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424743\", 1995.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424740\", 1995.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424712\", 1995.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424651\", 1994.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424636\", 1994.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424626\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424597\", 2005.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424596\", 2005.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424595\", 2006.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424594\", 2006.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424592\", 2006.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424552\", 1983.0, 1986, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424540\", 2003.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424537\", 2003.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424536\", 2004.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424527\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424526\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424512\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424487\", 1982.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424463\", 1991.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424448\", 1991.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424437\", 1990.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424431\", 1981.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424428\", 1980.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424403\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424402\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424401\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424400\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424360\", 1989.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424343\", 1980.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424333\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424332\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424330\", 2004.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424329\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2415704\", 1991.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2409426\", 1992.0, 1998, \"National Institute on Aging\", \"United States\"], [\"grant.2405500\", 1993.0, 1997, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393833\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393831\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393828\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393822\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393812\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393810\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393809\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393798\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393792\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393788\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393775\", 2012.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2390878\", 1993.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2375603\", 1996.0, 1996, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2369988\", 1997.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2369821\", 1994.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2369813\", 1994.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2359845\", 2000.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2356296\", 1990.0, 1991, \"Fogarty International Center\", \"United States\"], [\"grant.2355713\", 1985.0, 1985, \"Fogarty International Center\", \"United States\"], [\"grant.2346752\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346751\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346748\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346743\", 2008.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346629\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346628\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346595\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346594\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346582\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346581\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346548\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346547\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346527\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346526\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346510\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346485\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346484\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346449\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346448\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.100070653\", 2007.0, 2012, \"Leukemia and Lymphoma Society\", \"United States\"], [\"grant.100069317\", 2010.0, 2011, \"Gerber Foundation\", \"United States\"], [\"grant.7992220\", 1988.0, 1991, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951289\", 2013.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951265\", 2008.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7616858\", 2008.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7496086\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7472216\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7446874\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.6723340\", 2002.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6584684\", 2008.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584355\", 2011.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582323\", 2006.0, 2007, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581899\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580202\", 2011.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6499488\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5710170\", 1997.0, 1997, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5502095\", 2009.0, 2011, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5246360\", 2003.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5141545\", 2008.0, 2014, \"Bloodwise\", \"United Kingdom\"], [\"grant.4486180\", 2010.0, 2012, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.3984586\", 2001.0, 2006, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3983756\", 2006.0, 2009, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3899759\", 2008.0, 2009, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3858644\", 2003.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856963\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3529314\", 2007.0, 2010, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.2972456\", 1996.0, 1998, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2424690\", 1985.0, 1990, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.100069716\", 2007.0, 2010, \"W. M. Keck Foundation\", \"United States\"], [\"grant.2424837\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8169343\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6783638\", 2011.0, 2015, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6127074\", 2013.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.2708529\", 1985.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8248988\", 2003.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6734414\", 2012.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.4640689\", 2007.0, 2009, \"The Research Council of Norway\", \"Norway\"], [\"grant.5356862\", 2010.0, 2010, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.6586399\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585096\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583693\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582991\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582151\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581800\", 2014.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.3869376\", 2008.0, 2009, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3765762\", 2001.0, 2005, \"European Commission\", \"Belgium\"], [\"grant.2425528\", 2005.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6784476\", 2014.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8595342\", 2014.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8589748\", 2015.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8458531\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8458109\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8458054\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8457212\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8054101\", 2003.0, 2006, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.8054100\", 2003.0, 2006, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.7999630\", 1985.0, 1988, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989715\", 2008.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7963379\", 2015.0, 2018, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951267\", 2008.0, 2013, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951264\", 2008.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7942548\", 2008.0, 2011, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7635223\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7631633\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7630003\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7626821\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7620636\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7608947\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7590516\", 2017.0, 2018, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.7501851\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7475151\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7390075\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7390050\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7389866\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7161820\", 2007.0, 2007, \"Innovation and Technology Commission\", \"China\"], [\"grant.7149494\", 2015.0, 2015, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7099889\", 2010.0, 2014, \"VINNOVA\", \"Sweden\"], [\"grant.6782435\", 2012.0, 2014, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6585998\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585935\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585926\", 2014.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585903\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585869\", 2014.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585273\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584991\", 2009.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584904\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584557\", 2011.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584345\", 2006.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584272\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583987\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583104\", 2008.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583069\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582938\", 2013.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581894\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581427\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581288\", 2012.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581141\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580969\", 2011.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580705\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580376\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6576981\", 2015.0, 2016, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.6501535\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500969\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500765\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6118127\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5857550\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5849868\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5128659\", 2016.0, 2018, \"Australian Research Council\", \"Australia\"], [\"grant.4672399\", 2014.0, 2015, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4656617\", 2011.0, 2012, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4651170\", 2014.0, 2015, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4649198\", 2014.0, 2015, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4047540\", 2001.0, 2004, \"National Oceanic and Atmospheric Administration\", \"United States\"], [\"grant.3983507\", 2008.0, 2012, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3926442\", 2005.0, 2008, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3869522\", 2007.0, 2008, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3856976\", 2012.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856958\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3636168\", 2012.0, 2014, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3636164\", 2010.0, 2014, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2707046\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706133\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706132\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706121\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706120\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425329\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425152\", 2003.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346454\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346453\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346452\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346451\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346450\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7194761\", 2015.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7172017\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500978\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500814\", 2016.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500392\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500217\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499433\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499403\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245883\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723025\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347707\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6246546\", 1987.0, 1989, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5012180\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5009549\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.2581616\", 2006.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8564619\", 2017.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8564045\", 2016.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8563756\", 2015.0, 2018, \"Department of Biotechnology\", \"India\"], [\"grant.8563659\", 2015.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8563658\", 2016.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8563337\", 2014.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8563045\", 2014.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8563043\", 2014.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8563042\", 2014.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8563041\", 2014.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8562912\", 2013.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8562432\", 2013.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8562161\", 2012.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8561665\", 2011.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8561576\", 2012.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8561573\", 2012.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8561429\", 2011.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8560657\", 2009.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560624\", 2009.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8560476\", 2010.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8560405\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560221\", 2011.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560117\", 2008.0, 2011, \"Department of Biotechnology\", \"India\"], [\"grant.8559105\", 2009.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8559074\", 2008.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8559052\", 2007.0, 2011, \"Department of Biotechnology\", \"India\"], [\"grant.8559051\", 2009.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8559050\", 2008.0, 2011, \"Department of Biotechnology\", \"India\"], [\"grant.8515700\", 2006.0, 2008, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8515699\", 2004.0, 2006, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8514844\", 2009.0, 2014, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8513725\", 1996.0, 1998, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8513721\", 2007.0, 2010, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8513720\", 2005.0, 2005, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8512475\", 2003.0, 2005, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8512474\", 2001.0, 2003, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8512461\", 1991.0, 1993, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8511997\", 2004.0, 2007, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8511996\", 2001.0, 2004, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8509953\", 1996.0, 2000, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8509657\", 2009.0, 2011, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8509656\", 2007.0, 2009, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8506007\", 2016.0, 2017, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8505275\", 2009.0, 2009, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8504517\", 2013.0, 2016, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8504516\", 2012.0, 2015, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8497993\", 2006.0, 2008, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8497992\", 2004.0, 2006, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8497452\", 1996.0, 2000, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8495457\", 2016.0, 2018, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8494876\", 2005.0, 2007, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8494875\", 2003.0, 2005, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8485215\", 2001.0, 2006, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8445296\", 2019.0, 2019, \"VINNOVA\", \"Sweden\"], [\"grant.8220284\", 2000.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8220277\", 2000.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8220260\", 2000.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8219111\", 1999.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8217953\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8217940\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8217931\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8216797\", 1997.0, 1999, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8211499\", 1992.0, 1994, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8211072\", 1992.0, 1994, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8209941\", 1991.0, 1993, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8208830\", 1990.0, 1993, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8208822\", 1990.0, 1992, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8207779\", 1989.0, 1992, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8207091\", 1989.0, 1991, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8206776\", 1988.0, 1990, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8206012\", 1987.0, 1990, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8205580\", 1977.0, 1979, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8176372\", 2011.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173991\", 2007.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8172695\", 2005.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8172132\", 2004.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169730\", 2002.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8069030\", 2008.0, 2012, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8069029\", 2008.0, 2012, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8069028\", 2008.0, 2010, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8068980\", 2006.0, 2008, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8048328\", 2007.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8048326\", 2007.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8034489\", 2012.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8034470\", 2012.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8034462\", 2012.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8034461\", 2012.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8005612\", 2009.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8001843\", 2007.0, 2008, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.7999578\", 1985.0, 1987, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7993965\", 2015.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7993361\", 2014.0, 2018, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992821\", 2012.0, 2015, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992820\", 2012.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992218\", 1988.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992040\", 1986.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7991987\", 1986.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990907\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990549\", 2010.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990456\", 2010.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990362\", 2013.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990358\", 2013.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990357\", 2010.0, 2013, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989450\", 2007.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989449\", 2007.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989070\", 2007.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988831\", 2005.0, 2007, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988536\", 2004.0, 2006, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988249\", 2003.0, 2006, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7987929\", 2001.0, 2004, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7979234\", 2011.0, 2013, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7953162\", 2000.0, 2004, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7953078\", 1995.0, 1999, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952422\", 1993.0, 1997, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952403\", 1990.0, 1993, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952013\", 2002.0, 2011, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7942597\", 2012.0, 2015, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7942596\", 2012.0, 2015, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7940840\", 2009.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7939785\", 2000.0, 2002, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7934359\", 2012.0, 2013, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7933704\", 2012.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7917520\", 2012.0, 2017, \"Patient-Centered Outcomes Research Institute\", \"United States\"], [\"grant.7915417\", 2014.0, 2018, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.7915152\", 2013.0, 2018, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.7850866\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7821641\", 1996.0, 1999, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7821008\", 1998.0, 2001, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7821001\", 1996.0, 1999, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7820997\", 2001.0, 2003, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7743584\", 2014.0, 2018, \"Danish Ministry of Higher Education and Science\", \"Denmark\"], [\"grant.7742854\", 2013.0, 2016, \"Danish Ministry of Higher Education and Science\", \"Denmark\"], [\"grant.7736921\", 2005.0, 2008, \"Department of Science and Technology\", \"India\"], [\"grant.7723182\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7721815\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7717098\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7716935\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7715161\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7698924\", 2012.0, 2013, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7697763\", 2013.0, 2013, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7695709\", 2015.0, 2016, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7694896\", 2013.0, 2014, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7694534\", 2017.0, 2018, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7694487\", 2016.0, 2017, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7687875\", 2007.0, 2008, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7686772\", 2009.0, 2009, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7686658\", 2008.0, 2009, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7686599\", 2008.0, 2009, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7670238\", 2007.0, 2007, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7669718\", 2008.0, 2011, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7668452\", 2016.0, 2016, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7667057\", 2000.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7666943\", 1996.0, 2001, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665268\", 1999.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665027\", 2014.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658619\", 2003.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658608\", 1999.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658433\", 2001.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658042\", 2000.0, 2000, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7654329\", 2014.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7652669\", 1996.0, 1999, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7647878\", 2005.0, 2007, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7646358\", 2003.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7646357\", 1998.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7642061\", 2007.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7632456\", 1997.0, 1999, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7626776\", 2001.0, 2002, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7625380\", 2007.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7625186\", 2002.0, 2007, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7623484\", 2001.0, 2004, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7623431\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7618679\", 2002.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7618672\", 2005.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7606416\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7594392\", 2018.0, 2018, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7578413\", 2018.0, 2018, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7575561\", 2016.0, 2017, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.7550363\", 2001.0, 2003, \"Bloodwise\", \"United Kingdom\"], [\"grant.7549515\", 1986.0, 1989, \"Bloodwise\", \"United Kingdom\"], [\"grant.7549488\", 1985.0, 1986, \"Bloodwise\", \"United Kingdom\"], [\"grant.7545804\", 2018.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.7502338\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7501589\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7498870\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7497586\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7496354\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7496127\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7496124\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7493180\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7492793\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7492787\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7491681\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7491122\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7490400\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7490008\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7488330\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7487607\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7483093\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7482716\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7480563\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7479983\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7479288\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7477822\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7477815\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7477713\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7476579\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7475646\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7475018\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7473902\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7473160\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7472051\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7470759\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7466607\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7466586\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7466408\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7461778\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7460590\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7457969\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7456810\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7455882\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7454862\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7453221\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7452629\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7452447\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7448161\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7446869\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7446551\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7446325\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7445767\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7437134\", 2009.0, 2012, \"University Grants Committee\", \"China\"], [\"grant.7389994\", 2017.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7174252\", 2003.0, 2007, \"United States-Israel Binational Science Foundation\", \"Israel\"], [\"grant.7167621\", 1996.0, 1999, \"Innovation and Technology Commission\", \"China\"], [\"grant.7167575\", 1996.0, 2000, \"Innovation and Technology Commission\", \"China\"], [\"grant.7167421\", 1998.0, 2000, \"Innovation and Technology Commission\", \"China\"], [\"grant.7164928\", 2014.0, 2016, \"Innovation and Technology Commission\", \"China\"], [\"grant.7164864\", 2014.0, 2016, \"Innovation and Technology Commission\", \"China\"], [\"grant.7162955\", 2008.0, 2010, \"Innovation and Technology Commission\", \"China\"], [\"grant.7162624\", 2014.0, 2016, \"Innovation and Technology Commission\", \"China\"], [\"grant.7161695\", 2008.0, 2010, \"Innovation and Technology Commission\", \"China\"], [\"grant.7161678\", 2009.0, 2012, \"Innovation and Technology Commission\", \"China\"], [\"grant.7150246\", 2013.0, 2013, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7150219\", 2013.0, 2013, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7149996\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7149920\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7149707\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7149706\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7149341\", 2015.0, 2015, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7148379\", 2017.0, 2017, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7148301\", 2017.0, 2017, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7132364\", 2009.0, 2010, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132354\", 2008.0, 2009, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132057\", 2005.0, 2006, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7092364\", 2001.0, 2003, \"Arthritis Foundation\", \"United States\"], [\"grant.7092356\", 2003.0, 2008, \"Arthritis Foundation\", \"United States\"], [\"grant.7092198\", 1995.0, 1998, \"Arthritis Foundation\", \"United States\"], [\"grant.7067163\", 2012.0, 2014, \"Patient-Centered Outcomes Research Institute\", \"United States\"], [\"grant.7043745\", 1997.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043744\", 1996.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043740\", 1995.0, 1996, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043737\", 1993.0, 1997, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043735\", 1992.0, 1995, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043733\", 1992.0, 1995, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043732\", 1991.0, 1994, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043729\", 1990.0, 1995, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043727\", 1991.0, 1995, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043100\", 1998.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042971\", 1993.0, 1996, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042970\", 1993.0, 1995, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042592\", 1991.0, 1994, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042330\", 1995.0, 1997, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040790\", 1998.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7034048\", 2006.0, 2009, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6967805\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6967534\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6967408\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6962426\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6953177\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6946159\", 2010.0, 2011, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.6946050\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6945935\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6945300\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6945026\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6944786\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6860319\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6860300\", 2017.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6818448\", 2017.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6734648\", 2013.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6731388\", 1989.0, 1991, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6731147\", 1993.0, 1995, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6730760\", 1991.0, 1993, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6729550\", 1999.0, 2002, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728861\", 1990.0, 1992, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728001\", 2010.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725574\", 2006.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725405\", 2005.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725179\", 1995.0, 1997, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6724329\", 2004.0, 2008, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6724106\", 2004.0, 2008, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723172\", 2001.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6722974\", 2007.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6722602\", 2006.0, 2008, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6720807\", 1996.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6720035\", 1988.0, 1990, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718348\", 1999.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718034\", 1989.0, 1991, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716733\", 1995.0, 1997, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716718\", 1996.0, 1997, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716680\", 1996.0, 1998, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715381\", 1993.0, 1995, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715100\", 1996.0, 2000, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713671\", 1999.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6712624\", 1991.0, 1994, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6663780\", 2015.0, 2019, \"Melanoma Research Alliance\", \"United States\"], [\"grant.6663543\", 2017.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6616218\", 2014.0, 2019, \"American Association For Cancer Research\", \"United States\"], [\"grant.6586479\", 2014.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586475\", 2005.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586470\", 2000.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586428\", 2003.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586415\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586392\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586326\", 2013.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586273\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586259\", 2012.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586159\", 2004.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586008\", 2009.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585987\", 2007.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585866\", 2006.0, 2008, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585814\", 2009.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585424\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585377\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585159\", 2013.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585141\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585127\", 2005.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585062\", 2014.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585020\", 2006.0, 2007, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584897\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584861\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584856\", 2012.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584640\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584506\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584389\", 2011.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584320\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584287\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584260\", 2006.0, 2007, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584213\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584100\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584093\", 2013.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584078\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584077\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584012\", 2005.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583923\", 2005.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583828\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583741\", 2006.0, 2007, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583613\", 2006.0, 2006, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583610\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583559\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583471\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583359\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583353\", 2013.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583250\", 2005.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583171\", 2005.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583079\", 2007.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583022\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582921\", 2015.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582895\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582745\", 2005.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582691\", 2004.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582558\", 2004.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582368\", 2008.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582345\", 2006.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582286\", 2013.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582270\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582237\", 2006.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582215\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581950\", 2005.0, 2006, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581943\", 2012.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581933\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581770\", 2003.0, 2006, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581662\", 2005.0, 2007, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581623\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581600\", 2007.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581572\", 2004.0, 2006, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581544\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581351\", 2006.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581329\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581172\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581167\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581010\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580958\", 2011.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580957\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580938\", 2008.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580830\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580809\", 2000.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580712\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580342\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580316\", 2008.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580274\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580244\", 2005.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580193\", 2006.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6504939\", 2015.0, 2016, \"Alberta Innovates\", \"Canada\"], [\"grant.6504851\", 2014.0, 2015, \"Alberta Innovates\", \"Canada\"], [\"grant.6368111\", 1969.0, 1969, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6366318\", 1970.0, 1970, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6340767\", 1965.0, 1965, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6336065\", 1980.0, 1980, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6335184\", 1980.0, 1980, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6328118\", 1974.0, 1975, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6318414\", 1979.0, 1980, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6313954\", 1975.0, 1975, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6313345\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6313002\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6310572\", 1975.0, 1975, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6310525\", 1980.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6310227\", 1978.0, 1979, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6309820\", 1979.0, 1980, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6308457\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6300678\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6294950\", 1975.0, 1975, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6285974\", 1978.0, 1979, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6272688\", 1999.0, 2000, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6272293\", 2000.0, 2000, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6270561\", 1973.0, 1973, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6269227\", 2000.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6268936\", 1998.0, 2000, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6267466\", 1998.0, 1998, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6266897\", 1988.0, 1988, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6265249\", 1998.0, 2000, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6264328\", 1998.0, 2000, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6245628\", 1987.0, 1987, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6241900\", 1987.0, 1987, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6238029\", 1986.0, 1986, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6236810\", 1986.0, 1986, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6235447\", 1986.0, 1986, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6221933\", 1985.0, 1985, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6213659\", 1984.0, 1984, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6212038\", 1984.0, 1984, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6205842\", 1984.0, 1984, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6192396\", 1998.0, 1999, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6186191\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6184222\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6181805\", 1982.0, 1983, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6180998\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6180034\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6179947\", 1983.0, 1984, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6168559\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6164015\", 1981.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6163599\", 1981.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6158872\", 1981.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6158686\", 1981.0, 1983, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6134788\", 2013.0, 2014, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6066977\", 2011.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5963633\", 2006.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5934697\", 2016.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5929096\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5924338\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5895865\", 2004.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5860041\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5850910\", 2003.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5811526\", 2001.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5809369\", 2001.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5795950\", 2001.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5721027\", 1997.0, 1997, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5716163\", 1997.0, 1997, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5703840\", 1996.0, 1996, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5612658\", 1992.0, 1992, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5610847\", 1992.0, 1992, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5592399\", 1991.0, 1991, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5588292\", 1991.0, 1991, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5577894\", 1990.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5571242\", 1990.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5569035\", 1990.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5557987\", 1989.0, 1989, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5546953\", 2001.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5533198\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5529646\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5528720\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5524673\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5502747\", 2009.0, 2013, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5502458\", 2007.0, 2010, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5502068\", 2009.0, 2013, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5502035\", 2006.0, 2009, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5502020\", 2008.0, 2011, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5501712\", 2006.0, 2011, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5491140\", 2016.0, 2018, \"Israel Science Foundation\", \"Israel\"], [\"grant.5430432\", 1999.0, 1999, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5330014\", 2012.0, 2012, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5329652\", 2012.0, 2012, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5246899\", 2001.0, 2011, \"National Cancer Institute\", \"United States\"], [\"grant.5246898\", 2001.0, 2011, \"National Cancer Institute\", \"United States\"], [\"grant.5246737\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246678\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246677\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246676\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246673\", 2006.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246585\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246580\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246573\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246572\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246528\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246523\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246522\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246520\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246519\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246518\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246517\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246516\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246471\", 2004.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246470\", 2004.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246460\", 2003.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246415\", 2003.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246414\", 2003.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246413\", 2003.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246377\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246375\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246374\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246373\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246362\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246361\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5246355\", 2003.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5216155\", 2004.0, 2009, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5215901\", 2006.0, 2010, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5214123\", 2004.0, 2006, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5213219\", 2005.0, 2007, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5211010\", 2003.0, 2007, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5210364\", 2003.0, 2006, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5208623\", 2005.0, 2005, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5207729\", 1998.0, 2000, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5202017\", 1999.0, 2003, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5201826\", 2000.0, 2002, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5200653\", 1998.0, 2002, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5200583\", 1999.0, 2001, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5200284\", 1999.0, 2002, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5199988\", 1999.0, 2001, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5199861\", 1998.0, 2000, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5199583\", 2000.0, 2004, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5199241\", 2000.0, 2002, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5197260\", 1995.0, 1998, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5196596\", 1995.0, 2002, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5071186\", 2012.0, 2016, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5071090\", 2010.0, 2012, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5070666\", 2012.0, 2015, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5070548\", 2004.0, 2008, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5069978\", 2011.0, 2014, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5069908\", 2010.0, 2014, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5069646\", 2008.0, 2012, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5068787\", 2012.0, 2015, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5068391\", 2005.0, 2009, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5067627\", 2011.0, 2015, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5067554\", 2009.0, 2014, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5067428\", 2010.0, 2013, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5067287\", 2007.0, 2011, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5066859\", 2007.0, 2010, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5066823\", 2008.0, 2011, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5066726\", 2007.0, 2011, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5066201\", 2004.0, 2007, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5065299\", 2007.0, 2011, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5065243\", 2010.0, 2016, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5064719\", 2009.0, 2013, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.5061893\", 1998.0, 2000, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.5061411\", 2006.0, 2009, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.5061178\", 2004.0, 2006, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.5060857\", 1997.0, 1997, \"UC Discovery Grants (formerly IUCRP)\", \"United States\"], [\"grant.4933887\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4847532\", 2006.0, 2009, \"Israel Science Foundation\", \"Israel\"], [\"grant.4788607\", 2004.0, 2012, \"German Research Foundation\", \"Germany\"], [\"grant.4787773\", 2004.0, 2011, \"German Research Foundation\", \"Germany\"], [\"grant.4767408\", 2001.0, 2010, \"German Research Foundation\", \"Germany\"], [\"grant.4743415\", 1999.0, 2001, \"German Research Foundation\", \"Germany\"], [\"grant.4712414\", 2009.0, 2012, \"National Science Center\", \"Poland\"], [\"grant.4699846\", 2004.0, 2011, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.4698120\", 2004.0, 2011, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.4698047\", 2008.0, 2012, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.4696218\", 2000.0, 2002, \"Juvenile Diabetes Research Foundation\", \"United States\"], [\"grant.4679884\", 2001.0, 2005, \"The Research Council of Norway\", \"Norway\"], [\"grant.4679007\", 2005.0, 2009, \"The Research Council of Norway\", \"Norway\"], [\"grant.4673673\", 2014.0, 2015, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.4668582\", 2012.0, 2013, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.4653188\", 2006.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4642241\", 2010.0, 2010, \"The Research Council of Norway\", \"Norway\"], [\"grant.4640698\", 2002.0, 2006, \"The Research Council of Norway\", \"Norway\"], [\"grant.4639761\", 2005.0, 2006, \"The Research Council of Norway\", \"Norway\"], [\"grant.4638064\", 2008.0, 2009, \"The Research Council of Norway\", \"Norway\"], [\"grant.4637482\", 2008.0, 2010, \"Slovenian Research Agency\", \"Slovenia\"], [\"grant.4636020\", 2009.0, 2012, \"Slovenian Research Agency\", \"Slovenia\"], [\"grant.4577354\", 2001.0, 2003, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4577044\", 2001.0, 2003, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4501254\", 2008.0, 2010, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4451771\", 1998.0, 1999, \"United States Department of the Army\", \"United States\"], [\"grant.4449427\", 1994.0, 1995, \"United States Department of the Army\", \"United States\"], [\"grant.4441774\", 1994.0, 1995, \"United States Department of the Army\", \"United States\"], [\"grant.4411106\", 1988.0, 1989, \"United States Department of the Army\", \"United States\"], [\"grant.4365216\", 2007.0, 2009, \"Ministry of Education, Science, Research and Sport of the Slovak Republic\", \"Slovakia\"], [\"grant.4359918\", 2005.0, 2007, \"Ministry of Education, Science, Research and Sport of the Slovak Republic\", \"Slovakia\"], [\"grant.4169035\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4169013\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4025012\", 1987.0, 1988, \"National Endowment for the Humanities\", \"United States\"], [\"grant.4014669\", 1993.0, 1993, \"National Endowment for the Humanities\", \"United States\"], [\"grant.4009508\", 1995.0, 1998, \"National Endowment for the Humanities\", \"United States\"], [\"grant.4000021\", 1994.0, 1995, \"National Endowment for the Humanities\", \"United States\"], [\"grant.3983232\", 2014.0, 2015, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3983001\", 2014.0, 2019, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3937863\", 2008.0, 2015, \"Alberta Innovates\", \"Canada\"], [\"grant.3936269\", 2008.0, 2014, \"Alberta Innovates\", \"Canada\"], [\"grant.3857719\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857714\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857709\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3812833\", 2012.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3765676\", 2001.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3758497\", 2000.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3748458\", 1999.0, 2002, \"European Commission\", \"Belgium\"], [\"grant.3744479\", 2000.0, 2002, \"European Commission\", \"Belgium\"], [\"grant.3742708\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3741466\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3734650\", 1997.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3733935\", 1999.0, 2002, \"European Commission\", \"Belgium\"], [\"grant.3733798\", 1998.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3733451\", 1997.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3732551\", 1997.0, 2001, \"European Commission\", \"Belgium\"], [\"grant.3729405\", 1991.0, 1994, \"European Commission\", \"Belgium\"], [\"grant.3728553\", 1995.0, 1998, \"European Commission\", \"Belgium\"], [\"grant.3728251\", 1996.0, 1999, \"European Commission\", \"Belgium\"], [\"grant.3728156\", 1996.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3726362\", 1996.0, 1998, \"European Commission\", \"Belgium\"], [\"grant.3725647\", 1995.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3724558\", 1988.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.3722730\", 1994.0, 1996, \"European Commission\", \"Belgium\"], [\"grant.3721317\", 1996.0, 1999, \"European Commission\", \"Belgium\"], [\"grant.3721082\", 1994.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3720248\", 1993.0, 1994, \"European Commission\", \"Belgium\"], [\"grant.3720142\", 1996.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3708816\", 1984.0, 1987, \"European Commission\", \"Belgium\"], [\"grant.3707102\", 1982.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3704927\", 1984.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3701541\", 1984.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3701540\", 1984.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3700937\", 1989.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.3700838\", 1990.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.3654213\", 2013.0, 2014, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.3648386\", 2013.0, 2014, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.3635542\", 2001.0, 2001, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3627751\", 2002.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3568934\", 2013.0, 2015, \"Australian Research Council\", \"Australia\"], [\"grant.3568475\", 2012.0, 2014, \"Australian Research Council\", \"Australia\"], [\"grant.3534703\", 2014.0, 2015, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3534560\", 2014.0, 2015, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3534398\", 2013.0, 2015, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3532496\", 2010.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3532197\", 2010.0, 2013, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3530564\", 2000.0, 2004, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3529752\", 2012.0, 2015, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3529532\", 2005.0, 2008, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3528804\", 2007.0, 2010, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3528569\", 2014.0, 2016, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3526005\", 2007.0, 2012, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3525583\", 2010.0, 2013, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3525132\", 2011.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3524741\", 2003.0, 2006, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3219565\", 1971.0, 1972, \"National Science Foundation\", \"United States\"], [\"grant.2988739\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2984732\", 1996.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2983275\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2983032\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2982550\", 1991.0, 1992, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2981934\", 1995.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2981566\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2979837\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2974877\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2968154\", 1991.0, 1992, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2965354\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2963789\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2962827\", 2000.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2957389\", 1996.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2955810\", 1999.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2955686\", 2002.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2950864\", 1994.0, 1996, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2949454\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2949291\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2947979\", 1991.0, 1992, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2943297\", 2005.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2941820\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2936514\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2934649\", 1999.0, 2002, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2933624\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2930402\", 2003.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2927950\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2926979\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2925616\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2922486\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2920384\", 2002.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2919077\", 2001.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2919001\", 1998.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2912988\", 1997.0, 2002, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2911688\", 2002.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2911376\", 1991.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2910140\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2905508\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2904392\", 2002.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2902965\", 2004.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2900056\", 1995.0, 1998, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2896764\", 1991.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2895087\", 1992.0, 1995, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2878108\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2877530\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2875336\", 1999.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2874545\", 1991.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2874092\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2871835\", 1998.0, 2001, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2870999\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2870975\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2867924\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2867499\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2866559\", 1994.0, 1995, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2865004\", 2001.0, 2002, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2863719\", 1994.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2850068\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2846353\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2842052\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2835764\", 2004.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2829384\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2825619\", 2005.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2821847\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2816881\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2813322\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2808920\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2799721\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2798408\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2798291\", 2000.0, 2001, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2795798\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2792691\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2707018\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706836\", 2008.0, 2008, \"National Institute of Neurological Disorders and Stroke\", \"United States\"], [\"grant.2706240\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706208\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706196\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706173\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2702582\", 2010.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2698721\", 2013.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2698712\", 2013.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2698071\", 2002.0, 2008, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2597418\", 1999.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566869\", 2001.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2471645\", 1993.0, 1997, \"National Cancer Institute\", \"United States\"], [\"grant.2455014\", 1999.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2430609\", 1993.0, 2000, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2425472\", 2005.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424945\", 1997.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424533\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424530\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424521\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424511\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424510\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424509\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424508\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424475\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424336\", 2006.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424335\", 2005.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424327\", 2005.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424317\", 2005.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424315\", 2005.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2393894\", 2003.0, 2012, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393834\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393832\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393825\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393823\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393818\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393815\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393806\", 2013.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393781\", 2012.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393765\", 2012.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393762\", 2012.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393757\", 2012.0, 2014, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2393745\", 2012.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2346803\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346802\", 2008.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346801\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346800\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346799\", 2008.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346798\", 2008.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346745\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346744\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346742\", 2008.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2343520\", 2007.0, 2008, \"National Cancer Institute\", \"United States\"], [\"grant.6125262\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5946523\", 2006.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.4921725\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.2711162\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.8144729\", 2014.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7172501\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172492\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172476\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172475\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172474\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172464\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172024\", 2014.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7170302\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501678\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501676\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501549\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501534\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501449\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500868\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500311\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499762\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499609\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5578606\", 1991.0, 1993, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5245887\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245886\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245881\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245880\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245879\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245877\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245876\", 2015.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245875\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245873\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245872\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245871\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245870\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245869\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245868\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245867\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245866\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245864\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4940208\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.3857027\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857026\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857022\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857021\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857020\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857018\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857017\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857016\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857015\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857014\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857013\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857012\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857011\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857010\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857009\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3749682\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.2347716\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347715\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347713\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347712\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347711\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347710\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347709\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347706\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347705\", 2013.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347704\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347703\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347702\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347701\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347700\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8593316\", 2014.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8106367\", 2012.0, 2016, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7874837\", 2016.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6783786\", 2011.0, 2016, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6723674\", 2014.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6581736\", 2014.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6107935\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.4890245\", 2013.0, 2017, \"National Centre for Research and Development\", \"Poland\"], [\"grant.3950330\", 2013.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3817924\", 2014.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3815156\", 2011.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3654851\", 2013.0, 2014, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2769922\", 2006.0, 2009, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2718430\", 1994.0, 1994, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2709168\", 2002.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425014\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425013\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425012\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425011\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347755\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3811630\", 2009.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.2724237\", 2010.0, 2012, \"National Cancer Institute\", \"United States\"], [\"grant.2723417\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7665986\", 2010.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.6720191\", 2003.0, 2003, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6381020\", 2015.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.5596486\", 1992.0, 1994, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5501782\", 2016.0, 2018, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.7001888\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5932057\", 2005.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.2709799\", 1992.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2687851\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7560606\", 2012.0, 2016, \"National Council for Scientific and Technological Development\", \"Brazil\"], [\"grant.3634487\", 2005.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.8107232\", 2003.0, 2005, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8106298\", 2013.0, 2016, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7877531\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7875034\", 2018.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7644259\", 2003.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7644256\", 2006.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.6887620\", 1995.0, 1997, \"Czech Science Foundation\", \"Czechia\"], [\"grant.6734139\", 2011.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6732327\", 2012.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6714226\", 2010.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6378493\", 2014.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6140485\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6092952\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5861265\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.4936643\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4914039\", 2000.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4908668\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4579636\", 2014.0, 2019, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3743835\", 2000.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3576877\", 2008.0, 2009, \"Australian Research Council\", \"Australia\"], [\"grant.3572390\", 2002.0, 2004, \"Australian Research Council\", \"Australia\"], [\"grant.3030814\", 2003.0, 2005, \"Directorate for Engineering\", \"United States\"], [\"grant.3030807\", 2003.0, 2005, \"Directorate for Engineering\", \"United States\"], [\"grant.2726463\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723432\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723219\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709263\", 2006.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709246\", 2005.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709237\", 2004.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709213\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5147109\", 2009.0, 2010, \"NIHR Evaluation Trials and Studies Coordinating Centre\", \"United Kingdom\"], [\"grant.3774990\", 2007.0, 2011, \"European Commission\", \"Belgium\"], [\"grant.2726425\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459886\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172484\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499752\", 2014.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5880876\", 2004.0, 2005, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5245884\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857024\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3732274\", 1996.0, 1999, \"European Commission\", \"Belgium\"], [\"grant.3638486\", 2013.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3630621\", 2006.0, 2010, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2709212\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424468\", 1991.0, 1997, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8595279\", 2014.0, 2016, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8594208\", 2016.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8591102\", 2015.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8446493\", 2010.0, 2010, \"Swedish Research Council for Environment Agricultural Sciences and Spatial Planning\", \"Sweden\"], [\"grant.8218376\", 1999.0, 2001, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8041818\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8036880\", 2015.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8025091\", 2016.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8025090\", 2016.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8025089\", 2016.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8025088\", 2016.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7986569\", 1997.0, 2000, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7652306\", 2005.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7608126\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7560596\", 2014.0, 2017, \"National Council for Scientific and Technological Development\", \"Brazil\"], [\"grant.7559701\", 2014.0, 2017, \"National Council for Scientific and Technological Development\", \"Brazil\"], [\"grant.7400758\", 2013.0, 2016, \"Ministry of Science and Higher Education\", \"Poland\"], [\"grant.7390106\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7389561\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7211661\", 2017.0, 2018, \"Alberta Innovates\", \"Canada\"], [\"grant.7170506\", 2016.0, 2017, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.7170505\", 2017.0, 2018, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.7170202\", 2017.0, 2017, \"National Cancer Institute\", \"United States\"], [\"grant.7131991\", 2004.0, 2005, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.6897600\", 2001.0, 2005, \"Ministry of Education Youth and Sports\", \"Czechia\"], [\"grant.6735776\", 2013.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734643\", 2013.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6733494\", 2011.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6586489\", 2015.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586167\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585950\", 2007.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585864\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585745\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585214\", 2009.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584814\", 2009.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584759\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584546\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584455\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584450\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584406\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584404\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584109\", 2015.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584024\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583631\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583583\", 2015.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583497\", 2011.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583423\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583264\", 2013.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583173\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583098\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583000\", 2015.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582999\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582987\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582771\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582742\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582706\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582244\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582226\", 2010.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582137\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581980\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581846\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581809\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581790\", 2011.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581425\", 2013.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581394\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581259\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581039\", 2008.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580990\", 2009.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580975\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580961\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580430\", 2000.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580190\", 2011.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6500971\", 2016.0, 2017, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.6500600\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500029\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499437\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6015965\", 2009.0, 2014, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5900519\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5869803\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5246526\", 2004.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245891\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245785\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5144861\", 2014.0, 2019, \"National Institute for Health Research\", \"United Kingdom\"], [\"grant.4893018\", 2014.0, 2015, \"United States Department of the Army\", \"United States\"], [\"grant.4702691\", 2015.0, 2018, \"National Science Center\", \"Poland\"], [\"grant.4694137\", 2016.0, 2017, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.4551429\", 2001.0, 2004, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4540717\", 2005.0, 2007, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4161796\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4045940\", 2003.0, 2005, \"National Oceanic and Atmospheric Administration\", \"United States\"], [\"grant.4040616\", 2003.0, 2005, \"National Oceanic and Atmospheric Administration\", \"United States\"], [\"grant.3984324\", 2008.0, 2013, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3983030\", 2004.0, 2008, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3857103\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857090\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857030\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856249\", 2014.0, 2016, \"National Cancer Institute\", \"United States\"], [\"grant.3771580\", 2007.0, 2012, \"European Commission\", \"Belgium\"], [\"grant.3759147\", 2002.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3726131\", 1994.0, 1995, \"European Commission\", \"Belgium\"], [\"grant.3627196\", 2006.0, 2008, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3624371\", 2004.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3568375\", 2012.0, 2015, \"Australian Research Council\", \"Australia\"], [\"grant.2757767\", 2011.0, 2014, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2726424\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2712019\", 1999.0, 2001, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2706262\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706261\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706257\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706256\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706135\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706134\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706123\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706119\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706118\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706115\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706114\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706113\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2658141\", 2012.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2449044\", 2013.0, 2017, \"National Institute on Aging\", \"United States\"], [\"grant.2425380\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425071\", 2001.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347720\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2344566\", 2013.0, 2015, \"National Cancer Institute\", \"United States\"], [\"grant.2438487\", 2004.0, 2007, \"National Center for Advancing Translational Sciences\", \"United States\"], [\"grant.8592540\", 2016.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8591411\", 2009.0, 2019, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8574771\", 2010.0, 2010, \"Breast Cancer Society of Canada\", \"Canada\"], [\"grant.8565074\", 2018.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8564502\", 2016.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8564392\", 2016.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8564076\", 2016.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8563355\", 2014.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8562762\", 2013.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8561092\", 2012.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8560406\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560404\", 2010.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8560168\", 2011.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8559075\", 2009.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8559057\", 2007.0, 2010, \"Department of Biotechnology\", \"India\"], [\"grant.8559047\", 2008.0, 2011, \"Department of Biotechnology\", \"India\"], [\"grant.8514300\", 2002.0, 2005, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8513722\", 2011.0, 2014, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8512105\", 2016.0, 2017, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8509618\", 2003.0, 2005, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8509617\", 2001.0, 2003, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8507925\", 1996.0, 2000, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8505547\", 2009.0, 2009, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8505546\", 2012.0, 2015, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8494481\", 2010.0, 2014, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8488885\", 1995.0, 1998, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8486017\", 1986.0, 1987, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8485222\", 2012.0, 2015, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8215714\", 1996.0, 1998, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8107229\", 2003.0, 2004, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8070874\", 2014.0, 2017, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8070873\", 2014.0, 2017, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8070872\", 2014.0, 2017, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8070871\", 2014.0, 2017, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8070870\", 2014.0, 2017, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8068997\", 2007.0, 2010, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8068992\", 2006.0, 2008, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8068981\", 2006.0, 2007, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8048327\", 2007.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7999613\", 1985.0, 1988, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7999604\", 1985.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7999573\", 1984.0, 1988, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7999438\", 1982.0, 1984, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992719\", 2012.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992663\", 1991.0, 1991, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992247\", 1989.0, 1992, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992176\", 1988.0, 1992, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992114\", 1992.0, 1995, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992113\", 1990.0, 1991, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992093\", 1992.0, 1995, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992092\", 1990.0, 1991, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7991943\", 1987.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990361\", 2013.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990359\", 2013.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990055\", 2009.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989716\", 2008.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989660\", 2008.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989511\", 2007.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989508\", 2007.0, 2009, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988963\", 2006.0, 2008, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988826\", 2005.0, 2007, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988307\", 2004.0, 2005, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988084\", 2001.0, 2005, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7987789\", 1999.0, 2002, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7987708\", 2000.0, 2001, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7968467\", 1977.0, 1977, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7936517\", 2014.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7936234\", 2015.0, 2018, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7934392\", 2012.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7911448\", 2019.0, 2019, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7894792\", 1987.0, 1990, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.7878400\", 2016.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874354\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7851738\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7850972\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7850587\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7850585\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7832860\", 2009.0, 2010, \"Arnold and Mabel Beckman Foundation\", \"United States\"], [\"grant.7827744\", 2018.0, 2019, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7736617\", 2011.0, 2014, \"Department of Science and Technology\", \"India\"], [\"grant.7735618\", 2006.0, 2009, \"Department of Science and Technology\", \"India\"], [\"grant.7700954\", 2013.0, 2013, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7697237\", 2015.0, 2016, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7696953\", 2012.0, 2013, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7696886\", 2013.0, 2014, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7696299\", 2016.0, 2016, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7687242\", 2009.0, 2009, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7684163\", 2012.0, 2012, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7670754\", 2015.0, 2016, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7670286\", 2005.0, 2008, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7669326\", 2014.0, 2018, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7669027\", 2006.0, 2006, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7667098\", 2007.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7662845\", 2008.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7651615\", 2001.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7638223\", 2003.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7622450\", 2001.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7619028\", 2008.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7606382\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7550482\", 2003.0, 2004, \"Bloodwise\", \"United Kingdom\"], [\"grant.7502649\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7499459\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7499218\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7499047\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7486134\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7479088\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7478175\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7465104\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7459155\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7457000\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7451639\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7450913\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7449704\", 2010.0, 2011, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7447431\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7446594\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7445541\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7433140\", 2006.0, 2008, \"University Grants Committee\", \"China\"], [\"grant.7407196\", 2009.0, 2013, \"National Centre for Research and Development\", \"Poland\"], [\"grant.7390001\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7172641\", 2014.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7170046\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7155115\", 2004.0, 2006, \"Financial Markets Foundation for Children\", \"Australia\"], [\"grant.7149455\", 2015.0, 2015, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7132410\", 2009.0, 2010, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132355\", 2008.0, 2009, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132231\", 2008.0, 2009, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132151\", 2007.0, 2008, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132082\", 2006.0, 2007, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7119583\", 2010.0, 2012, \"Swedish Research Council\", \"Sweden\"], [\"grant.7109539\", 2009.0, 2012, \"Swedish Research Council\", \"Sweden\"], [\"grant.7082427\", 2015.0, 2016, \"Juvenile Diabetes Research Foundation\", \"United States\"], [\"grant.7050128\", 2016.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.7043747\", 1996.0, 1998, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043738\", 1995.0, 1996, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043141\", 2008.0, 2009, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043098\", 1998.0, 1999, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042329\", 1995.0, 1997, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042317\", 1994.0, 1995, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040554\", 2006.0, 2007, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040497\", 1997.0, 2000, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6946051\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6897580\", 1999.0, 2000, \"Ministry of Education Youth and Sports\", \"Czechia\"], [\"grant.6896534\", 2011.0, 2014, \"Ministry of Industry and Trade\", \"Czechia\"], [\"grant.6838452\", 2017.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6808619\", 2014.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.6784314\", 2014.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6730239\", 1998.0, 2003, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727681\", 2014.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725541\", 2006.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6725469\", 2007.0, 2009, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723851\", 2003.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723630\", 2003.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723325\", 2002.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6722622\", 2006.0, 2009, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6721150\", 2009.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716567\", 2009.0, 2011, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715624\", 1999.0, 2001, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713982\", 2009.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6663534\", 2017.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586329\", 2007.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586246\", 2005.0, 2008, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586174\", 2009.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586069\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585995\", 2010.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585899\", 2006.0, 2007, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585892\", 2009.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585854\", 2008.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585784\", 2005.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585750\", 2011.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585632\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585333\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585297\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585194\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585174\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585001\", 2013.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584798\", 2016.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584784\", 2011.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584730\", 2004.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584586\", 2012.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584577\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584372\", 2012.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584276\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584258\", 2014.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584081\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583962\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583804\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583532\", 2012.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583522\", 2013.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583118\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583065\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582905\", 2009.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582843\", 2007.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582827\", 2003.0, 2004, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582644\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582624\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582595\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582570\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582231\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582229\", 2013.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582223\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582172\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582074\", 2011.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582065\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581842\", 2007.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581686\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581626\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581582\", 2011.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581454\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581388\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581057\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580952\", 2004.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580853\", 2004.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580838\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580808\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580797\", 2006.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580650\", 2009.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580563\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580385\", 2013.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580374\", 2011.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580283\", 2015.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6500883\", 2010.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6383528\", 2008.0, 2011, \"Alberta Innovates\", \"Canada\"], [\"grant.6346669\", 1965.0, 1965, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6344144\", 1965.0, 1965, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6320450\", 1980.0, 1980, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6318196\", 1976.0, 1976, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6315037\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6313398\", 1980.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6312268\", 1978.0, 1978, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6311355\", 1980.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6310840\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6268587\", 1998.0, 1998, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6263047\", 1998.0, 1998, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6261734\", 1998.0, 1998, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6261713\", 1988.0, 1988, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6219378\", 1985.0, 1985, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6219113\", 1986.0, 1986, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6206358\", 1983.0, 1983, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6184545\", 1982.0, 1982, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6159196\", 1981.0, 1981, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6156843\", 2014.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6121147\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6112342\", 2013.0, 2014, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6072994\", 2011.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6036749\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6036094\", 2009.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6028416\", 2009.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6000794\", 2008.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5994958\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5987989\", 2007.0, 2007, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5975123\", 2007.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5921930\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5900336\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5883958\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5874094\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5868586\", 2015.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5831528\", 2002.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5568161\", 1990.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5562717\", 1989.0, 1989, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5552615\", 2000.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5523176\", 2015.0, 2018, \"Alberta Innovates\", \"Canada\"], [\"grant.5392972\", 2006.0, 2006, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5245678\", 2010.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245677\", 2015.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5217877\", 2007.0, 2008, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5205699\", 1996.0, 1998, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5185722\", 1987.0, 1991, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5184334\", 1984.0, 1987, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5127911\", 2016.0, 2018, \"Australian Research Council\", \"Australia\"], [\"grant.5068881\", 2009.0, 2012, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.4900549\", 2002.0, 2005, \"International Human Frontier Science Program Organization\", \"France\"], [\"grant.4853338\", 2012.0, 2014, \"Volkswagen Foundation\", \"Germany\"], [\"grant.4759025\", 2000.0, 2003, \"German Research Foundation\", \"Germany\"], [\"grant.4716904\", 2009.0, 2012, \"National Science Center\", \"Poland\"], [\"grant.4682361\", 2015.0, 2018, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.4673194\", 2009.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.4671755\", 2006.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4671560\", 2009.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.4670969\", 2009.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.4665556\", 2003.0, 2005, \"The Research Council of Norway\", \"Norway\"], [\"grant.4652669\", 2012.0, 2013, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4652646\", 2012.0, 2013, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4649874\", 2011.0, 2013, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4646557\", 2001.0, 2004, \"The Research Council of Norway\", \"Norway\"], [\"grant.4578598\", 2000.0, 2002, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4569274\", 1994.0, 1996, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4489548\", 2009.0, 2011, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4455107\", 2015.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.4411536\", 1984.0, 1985, \"United States Department of the Army\", \"United States\"], [\"grant.4360865\", 2010.0, 2013, \"Ministry of Education, Science, Research and Sport of the Slovak Republic\", \"Slovakia\"], [\"grant.4360740\", 2007.0, 2009, \"Ministry of Education, Science, Research and Sport of the Slovak Republic\", \"Slovakia\"], [\"grant.4358725\", 2007.0, 2009, \"Ministry of Education, Science, Research and Sport of the Slovak Republic\", \"Slovakia\"], [\"grant.4113804\", 2009.0, 2017, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.3936854\", 2007.0, 2014, \"Alberta Innovates\", \"Canada\"], [\"grant.3936613\", 2011.0, 2011, \"Alberta Innovates\", \"Canada\"], [\"grant.3936324\", 2012.0, 2014, \"Alberta Innovates\", \"Canada\"], [\"grant.3882865\", 2007.0, 2013, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3857726\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857725\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857724\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857722\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857718\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857717\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857712\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857711\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857707\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857704\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3856851\", 2010.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3823776\", 2007.0, 2008, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3810813\", 2011.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3776489\", 2009.0, 2013, \"European Commission\", \"Belgium\"], [\"grant.3745760\", 1998.0, 2001, \"European Commission\", \"Belgium\"], [\"grant.3728264\", 1994.0, 1995, \"European Commission\", \"Belgium\"], [\"grant.3708037\", 1989.0, 1991, \"European Commission\", \"Belgium\"], [\"grant.3707096\", 1982.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3700062\", 1988.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.3641531\", 2010.0, 2011, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3641529\", 2008.0, 2012, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3634752\", 2003.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3633304\", 2001.0, 2003, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3631322\", 2001.0, 2004, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3630183\", 2001.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3626707\", 2007.0, 2007, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3624593\", 2012.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3579359\", 2008.0, 2011, \"Australian Research Council\", \"Australia\"], [\"grant.3534575\", 2014.0, 2015, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3534289\", 2014.0, 2016, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3533959\", 2011.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3529219\", 2011.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3526706\", 2009.0, 2012, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3526045\", 2011.0, 2014, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3525527\", 2007.0, 2010, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.2960566\", 1997.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2958077\", 1998.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2955084\", 1992.0, 1994, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2935828\", 2004.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2934662\", 1992.0, 1995, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2932892\", 1995.0, 1998, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2922759\", 2000.0, 2003, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2919468\", 1997.0, 2000, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2906395\", 2004.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2892234\", 1994.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2889085\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2888595\", 2003.0, 2004, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2840073\", 2005.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2829016\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2803549\", 1997.0, 1998, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2711624\", 1999.0, 2002, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709220\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709217\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709216\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2654337\", 2001.0, 2002, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2640565\", 1999.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640533\", 1998.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640045\", 1992.0, 1992, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2430556\", 2002.0, 2003, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2425177\", 2003.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425009\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425008\", 1999.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425007\", 1999.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425006\", 1999.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425005\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425004\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425003\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425002\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425001\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424565\", 1993.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347296\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347290\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2344594\", 2012.0, 2014, \"National Cancer Institute\", \"United States\"], [\"grant.100071392\", 2008.0, 2011, \"Rheumatology Research Foundation\", \"United States\"], [\"grant.8571244\", 2014.0, 2015, \"Ontario Institute for Cancer Research\", \"Canada\"], [\"grant.8182708\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8108623\", 1995.0, 1998, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7876865\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7667275\", 2008.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7573170\", 2017.0, 2017, \"The Research Council of Norway\", \"Norway\"], [\"grant.7172465\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172057\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7035746\", 2001.0, 2004, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7020002\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6958979\", 2008.0, 2009, \"Alzheimer's Drug Discovery Foundation\", \"United States\"], [\"grant.6782476\", 2012.0, 2014, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6779368\", 2014.0, 2014, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6718669\", 2010.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6585082\", 2015.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581567\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6500531\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499878\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6083410\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6067495\", 2011.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6039996\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5979969\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5693464\", 1996.0, 1997, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5534219\", 2015.0, 2016, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5246649\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5150921\", 2015.0, 2018, \"Scottish Government Health and Social Care Directorates\", \"United Kingdom\"], [\"grant.5003535\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4987483\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4980963\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4968317\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4566767\", 1997.0, 2001, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4566381\", 1996.0, 1998, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4122515\", 2008.0, 2013, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.3928388\", 2013.0, 2018, \"Ministry of Research, Innovation and Science\", \"Canada\"], [\"grant.3921156\", 2008.0, 2009, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3843484\", 2012.0, 2012, \"Innovate UK\", \"United Kingdom\"], [\"grant.3830612\", 2007.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3829753\", 2007.0, 2010, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3578378\", 2004.0, 2006, \"Australian Research Council\", \"Australia\"], [\"grant.3575849\", 2004.0, 2006, \"Australian Research Council\", \"Australia\"], [\"grant.3570522\", 2011.0, 2013, \"Australian Research Council\", \"Australia\"], [\"grant.3569846\", 2011.0, 2013, \"Australian Research Council\", \"Australia\"], [\"grant.3566220\", 2012.0, 2014, \"Australian Research Council\", \"Australia\"], [\"grant.3562866\", 2012.0, 2014, \"Australian Research Council\", \"Australia\"], [\"grant.2709696\", 1992.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709222\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709221\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709169\", 2002.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2707079\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425673\", 1999.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425671\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425670\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425597\", 2011.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425596\", 2006.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425595\", 2006.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425593\", 2010.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425559\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425557\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425556\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425551\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425475\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425433\", 2004.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425432\", 2004.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425431\", 2004.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2350080\", 2013.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2350059\", 2013.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346793\", 2008.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346792\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346791\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346750\", 2008.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657943\", 2003.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2451354\", 1987.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7667819\", 2008.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.5678539\", 1996.0, 1997, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.3791018\", 2012.0, 2016, \"European Commission\", \"Belgium\"], [\"grant.2711561\", 1996.0, 2002, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2695872\", 2010.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458954\", 2010.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424817\", 1996.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424751\", 1995.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424750\", 1995.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4896895\", 2014.0, 2016, \"Russian Science Foundation\", \"Russia\"], [\"grant.8218859\", 1999.0, 2001, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8218788\", 1999.0, 2001, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8171714\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170951\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170771\", 2003.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169338\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8107149\", 2004.0, 2007, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7878050\", 2014.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7877498\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874725\", 2015.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7764034\", 2018.0, 2019, \"VINNOVA\", \"Sweden\"], [\"grant.7646394\", 2014.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7155174\", 2012.0, 2014, \"Financial Markets Foundation for Children\", \"Australia\"], [\"grant.7035732\", 1999.0, 2001, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6896550\", 2009.0, 2012, \"Ministry of Industry and Trade\", \"Czechia\"], [\"grant.6736064\", 2012.0, 2016, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734893\", 2013.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6733474\", 2011.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6723455\", 2013.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718920\", 2008.0, 2011, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716490\", 2008.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6665071\", 2016.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.6146427\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6030319\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6009389\", 2008.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5991944\", 2008.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5954535\", 2006.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5923641\", 2016.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5863354\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5128942\", 2014.0, 2018, \"Australian Research Council\", \"Australia\"], [\"grant.4982560\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4975021\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938417\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4035064\", 2009.0, 2010, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.3811194\", 2011.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3751805\", 2002.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3574802\", 2004.0, 2007, \"Australian Research Council\", \"Australia\"], [\"grant.2726419\", 2009.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2726418\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2712047\", 1995.0, 1995, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709255\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709251\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709249\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709204\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2692209\", 2006.0, 2009, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2687951\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2644200\", 2000.0, 2001, \"National Cancer Institute\", \"United States\"], [\"grant.2451110\", 1988.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8605530\", 2013.0, 2015, \"Robert Wood Johnson Foundation\", \"United States\"], [\"grant.8505272\", 2015.0, 2018, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8255921\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7646359\", 2005.0, 2007, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7433662\", 2013.0, 2015, \"University Grants Committee\", \"China\"], [\"grant.6443851\", 2016.0, 2017, \"National Center for Emerging and Zoonotic Infectious Diseases\", \"United States\"], [\"grant.6379228\", 2014.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.5799261\", 2001.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5245878\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5002002\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4995055\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4985797\", 2010.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4959800\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4959052\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4902945\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4664479\", 2008.0, 2011, \"The Research Council of Norway\", \"Norway\"], [\"grant.4578801\", 2014.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4404204\", 2008.0, 2009, \"United States Department of Defense\", \"United States\"], [\"grant.3857019\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3810632\", 2008.0, 2011, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3740989\", 1999.0, 2001, \"European Commission\", \"Belgium\"], [\"grant.3640066\", 2010.0, 2015, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3637315\", 2011.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2726420\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2718448\", 1996.0, 2000, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2711159\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709791\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709257\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2658405\", 1988.0, 1990, \"National Cancer Institute\", \"United States\"], [\"grant.2641845\", 2011.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639272\", 1997.0, 1998, \"National Institute on Aging\", \"United States\"], [\"grant.2455328\", 2001.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453659\", 1997.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8336713\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8329109\", 2011.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169853\", 2003.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7654331\", 2008.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7646360\", 2010.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7630520\", 2013.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.6895933\", 2011.0, 2014, \"Technology Agency of the Czech Republic\", \"Czechia\"], [\"grant.6848880\", 2016.0, 2016, \"California Institute for Regenerative Medicine\", \"United States\"], [\"grant.6716817\", 2006.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716223\", 2006.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.5863289\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5128696\", 2016.0, 2018, \"Australian Research Council\", \"Australia\"], [\"grant.4985692\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4920061\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4905273\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4898035\", 2011.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4541353\", 2003.0, 2005, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.3846417\", 2012.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3846351\", 2012.0, 2012, \"Innovate UK\", \"United Kingdom\"], [\"grant.3836293\", 2012.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3825471\", 2009.0, 2010, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3764201\", 2006.0, 2010, \"European Commission\", \"Belgium\"], [\"grant.3753923\", 2002.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3750984\", 2002.0, 2005, \"European Commission\", \"Belgium\"], [\"grant.3743638\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3657208\", 2013.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.3637796\", 2008.0, 2011, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2773787\", 2007.0, 2011, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2709256\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709228\", 2004.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640301\", 1997.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7666252\", 2009.0, 2012, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665836\", 2008.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7201078\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5737923\", 1998.0, 1999, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5733477\", 1998.0, 1999, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.4675373\", 2006.0, 2008, \"The Research Council of Norway\", \"Norway\"], [\"grant.4643905\", 2008.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4457723\", 2015.0, 2019, \"Royal Society\", \"United Kingdom\"], [\"grant.4457698\", 2011.0, 2015, \"Royal Society\", \"United Kingdom\"], [\"grant.3641781\", 2010.0, 2012, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3629515\", 2005.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2709733\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2704615\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687501\", 2000.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640816\", 2001.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640477\", 1998.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2602795\", 1998.0, 2000, \"National Cancer Institute\", \"United States\"], [\"grant.2486616\", 2009.0, 2014, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2458301\", 2009.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456583\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452630\", 1992.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3739224\", 1996.0, 1998, \"European Commission\", \"Belgium\"], [\"grant.2762017\", 2008.0, 2013, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2550560\", 2004.0, 2009, \"National Institute of Mental Health\", \"United States\"], [\"grant.2454639\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7145585\", 2008.0, 2009, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.2458524\", 2009.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6714841\", 2006.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.4316876\", 2015.0, 2017, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2666760\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2658057\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641453\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2567129\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459697\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457459\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452884\", 1993.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8574610\", 2013.0, 2016, \"Alex's Lemonade Stand Foundation\", \"United States\"], [\"grant.8462567\", 2011.0, 2014, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8456193\", 2013.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8345233\", 2016.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8345230\", 2016.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8329560\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8216494\", 1997.0, 1999, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8205069\", 1987.0, 1991, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8184628\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8174468\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7742845\", 2013.0, 2017, \"Danish Ministry of Higher Education and Science\", \"Denmark\"], [\"grant.7666219\", 2010.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7638735\", 2006.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7206349\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7172498\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172487\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172485\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172432\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7022403\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7016017\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7014356\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7004808\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7003466\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6988267\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6944901\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6501119\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6379290\", 2014.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6146605\", 2014.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5604349\", 1992.0, 1994, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5245865\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5220334\", 2008.0, 2012, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5071867\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4997073\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4979100\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4955222\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4948991\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938318\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4929868\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4918970\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4539488\", 2004.0, 2007, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4406518\", 2008.0, 2009, \"United States Department of the Army\", \"United States\"], [\"grant.3935679\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3841651\", 2013.0, 2013, \"Innovate UK\", \"United Kingdom\"], [\"grant.3818017\", 2009.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3817834\", 2009.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3813009\", 2011.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3806983\", 2014.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3775566\", 2007.0, 2010, \"European Commission\", \"Belgium\"], [\"grant.3641057\", 2013.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3638768\", 2012.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3636813\", 2013.0, 2014, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3067850\", 2006.0, 2006, \"Directorate for Engineering\", \"United States\"], [\"grant.2726422\", 2010.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2726416\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723430\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2712030\", 1996.0, 1999, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711999\", 1993.0, 1993, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709790\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709244\", 2005.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709091\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709090\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709088\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709086\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704634\", 2005.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704628\", 2005.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704604\", 2000.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687150\", 1988.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657831\", 1999.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641718\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640564\", 1999.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636410\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2558965\", 1999.0, 2006, \"National Institute of Neurological Disorders and Stroke\", \"United States\"], [\"grant.2451050\", 1986.0, 1990, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8331301\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7665046\", 2010.0, 2012, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7631957\", 2008.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.5810873\", 2002.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5737049\", 1998.0, 1999, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5565937\", 1990.0, 1991, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.4909556\", 2007.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4729728\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4480704\", 2014.0, 2017, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.3791043\", 2014.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.3778860\", 2007.0, 2010, \"European Commission\", \"Belgium\"], [\"grant.3776536\", 2006.0, 2012, \"European Commission\", \"Belgium\"], [\"grant.3766949\", 2005.0, 2009, \"European Commission\", \"Belgium\"], [\"grant.3765327\", 2005.0, 2007, \"European Commission\", \"Belgium\"], [\"grant.3135709\", 2012.0, 2017, \"Directorate for Engineering\", \"United States\"], [\"grant.2726767\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2692186\", 2004.0, 2011, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2687918\", 2006.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666472\", 2011.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666264\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640832\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2638358\", 2012.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2604855\", 2007.0, 2010, \"National Cancer Institute\", \"United States\"], [\"grant.2601369\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2582899\", 1992.0, 1993, \"National Cancer Institute\", \"United States\"], [\"grant.2459468\", 2012.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458019\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453751\", 1997.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424809\", 1996.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424762\", 1995.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424753\", 1995.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424739\", 1995.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424715\", 1995.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424714\", 1995.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424713\", 1995.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424711\", 1995.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7674238\", 2015.0, 2016, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7145476\", 2004.0, 2005, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.8330424\", 2013.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8195513\", 2016.0, 2019, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7145367\", 1999.0, 2000, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7143322\", 2004.0, 2005, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.6381570\", 2016.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6381112\", 2016.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.4119569\", 2011.0, 2014, \"Michael Smith Foundation for Health Research\", \"Canada\"], [\"grant.3623486\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2718419\", 1993.0, 2002, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2688054\", 2009.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2668272\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641837\", 2010.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641738\", 2010.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641270\", 2005.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2581359\", 1999.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2575565\", 2012.0, 2015, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2475260\", 2001.0, 2004, \"National Cancer Institute\", \"United States\"], [\"grant.2474639\", 2000.0, 2014, \"National Cancer Institute\", \"United States\"], [\"grant.2459890\", 2013.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458998\", 2011.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2454989\", 2001.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2454038\", 1998.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2444968\", 1984.0, 1990, \"National Institute on Aging\", \"United States\"], [\"grant.8574909\", 2005.0, 2008, \"Ontario Institute for Cancer Research\", \"Canada\"], [\"grant.8451257\", 2017.0, 2018, \"United States Department of Defense\", \"United States\"], [\"grant.8342308\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8335660\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8215501\", 1996.0, 1998, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8171485\", 2003.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7749356\", 2016.0, 2017, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7658431\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7178376\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7175809\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7155172\", 2010.0, 2012, \"Financial Markets Foundation for Children\", \"Australia\"], [\"grant.7145974\", 2014.0, 2015, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7145973\", 2014.0, 2015, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.6898658\", 2015.0, 2016, \"Technology Agency of the Czech Republic\", \"Czechia\"], [\"grant.6665260\", 2016.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.6434353\", 2014.0, 2017, \"National Council for Scientific and Technological Development\", \"Brazil\"], [\"grant.6192914\", 2009.0, 2012, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6151353\", 2014.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6144228\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6137871\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6126425\", 2013.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6126244\", 2013.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6091507\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6089432\", 2012.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6083982\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6081969\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6005234\", 2008.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5982630\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5954904\", 2006.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5952636\", 2006.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5501860\", 2016.0, 2019, \"Health Research Council of New Zealand\", \"New Zealand\"], [\"grant.5128726\", 2016.0, 2018, \"Australian Research Council\", \"Australia\"], [\"grant.4995647\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4988160\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4957740\", 2002.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4930861\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4929762\", 2005.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4903563\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4898322\", 2016.0, 2019, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.4785156\", 2004.0, 2006, \"German Research Foundation\", \"Germany\"], [\"grant.4639323\", 2008.0, 2010, \"The Research Council of Norway\", \"Norway\"], [\"grant.4639129\", 2009.0, 2012, \"The Research Council of Norway\", \"Norway\"], [\"grant.4498646\", 2007.0, 2009, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4491503\", 2012.0, 2014, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4404905\", 2008.0, 2009, \"United States Department of the Army\", \"United States\"], [\"grant.4295482\", 2015.0, 2019, \"Innovate UK\", \"United Kingdom\"], [\"grant.4124086\", 2009.0, 2014, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.4035582\", 2007.0, 2009, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.3949435\", 2014.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3928563\", 2007.0, 2012, \"Ministry of Research, Innovation and Science\", \"Canada\"], [\"grant.3865901\", 2014.0, 2015, \"Innovate UK\", \"United Kingdom\"], [\"grant.3844884\", 2013.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3818388\", 2012.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3714886\", 1989.0, 1993, \"European Commission\", \"Belgium\"], [\"grant.3630766\", 2007.0, 2010, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2763714\", 2012.0, 2013, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2723221\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2715650\", 1988.0, 1991, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.2687858\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640246\", 1995.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636361\", 2000.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435122\", 2003.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424828\", 1996.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424679\", 1984.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8591204\", 2015.0, 2019, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8460363\", 2017.0, 2018, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8322418\", 2016.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170828\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8106986\", 2005.0, 2007, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7878549\", 2016.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7877701\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7876441\", 2018.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7876107\", 2016.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7875969\", 2016.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7875387\", 2013.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874648\", 2016.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874420\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874167\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7667097\", 2009.0, 2012, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7666870\", 2015.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665052\", 2004.0, 2007, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7665044\", 2013.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7656556\", 2009.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7652308\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7651334\", 2010.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7629111\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7441200\", 2012.0, 2016, \"Mesothelioma Applied Research Foundation\", \"United States\"], [\"grant.7171754\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7171753\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7170694\", 2015.0, 2017, \"National Cancer Institute\", \"United States\"], [\"grant.7170367\", 2017.0, 2018, \"National Cancer Institute\", \"United States\"], [\"grant.7170051\", 2017.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169931\", 2012.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169712\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169682\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169663\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7043105\", 1999.0, 2002, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6944652\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6918355\", 2016.0, 2018, \"European Molecular Biology Organization\", \"Germany\"], [\"grant.6896523\", 2011.0, 2014, \"Ministry of Industry and Trade\", \"Czechia\"], [\"grant.6894372\", 2006.0, 2008, \"Ministry of Health\", \"Czechia\"], [\"grant.6892045\", 1996.0, 1998, \"Ministry of Health\", \"Czechia\"], [\"grant.6890299\", 2003.0, 2007, \"Ministry of Agriculture\", \"Czechia\"], [\"grant.6842704\", 2017.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6782853\", 2012.0, 2014, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6781706\", 2011.0, 2013, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6779573\", 2014.0, 2015, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6736731\", 2012.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6735856\", 2013.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6735120\", 2014.0, 2016, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734755\", 2013.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734733\", 2013.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734493\", 2012.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6733436\", 2011.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6729651\", 2010.0, 2012, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6729464\", 2009.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727555\", 2002.0, 2004, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6719701\", 2015.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718063\", 2010.0, 2012, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6717351\", 2011.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6717315\", 2011.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716641\", 2008.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715616\", 2003.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6663756\", 2010.0, 2013, \"Melanoma Research Alliance\", \"United States\"], [\"grant.6501588\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501538\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501493\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501452\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501422\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501274\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501039\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500835\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500039\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499682\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6378521\", 2014.0, 2015, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6163461\", 2014.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6154182\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6104573\", 2012.0, 2014, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6052241\", 2010.0, 2011, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6051363\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6036546\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6030160\", 2009.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6025747\", 2009.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6014906\", 2009.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6003007\", 2008.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6002508\", 2008.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5958855\", 2006.0, 2007, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5924448\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5906334\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5877614\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5876809\", 2004.0, 2005, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5872498\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5869872\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5836707\", 2003.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5828744\", 2003.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5824909\", 2002.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5815366\", 2002.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5648738\", 2006.0, 2007, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5597699\", 1992.0, 1994, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5245953\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245950\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245948\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245945\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245944\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245943\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245939\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245937\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245936\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245935\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245934\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245933\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245932\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245928\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245927\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245925\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245924\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245922\", 2014.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245921\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245920\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245918\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245914\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245907\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245903\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245624\", 2007.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245623\", 2007.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245622\", 2007.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245617\", 2007.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245616\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245615\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245614\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245613\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245612\", 2007.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245610\", 2007.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245609\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245608\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245607\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245208\", 2015.0, 2017, \"National Cancer Institute\", \"United States\"], [\"grant.5073020\", 2016.0, 2017, \"Medical Research Council\", \"United Kingdom\"], [\"grant.4944049\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4924046\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4904457\", 2002.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4561045\", 1997.0, 1997, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4555134\", 2001.0, 2005, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4546340\", 2004.0, 2007, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4522499\", 2012.0, 2014, \"National Agency for Research\", \"France\"], [\"grant.3857112\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857104\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857065\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857064\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857063\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857062\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857060\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857058\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857056\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857055\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857054\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857052\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857051\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857049\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857048\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857044\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857043\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3857041\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856792\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856791\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856790\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856772\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856771\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856769\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856768\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856767\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856766\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856765\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856764\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856763\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856762\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856761\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856760\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856759\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856758\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856757\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856756\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856755\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856754\", 2007.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3824163\", 2009.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3823145\", 2012.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3778836\", 2008.0, 2010, \"European Commission\", \"Belgium\"], [\"grant.3764850\", 2004.0, 2009, \"European Commission\", \"Belgium\"], [\"grant.3749525\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3737709\", 1997.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3568675\", 2012.0, 2014, \"Australian Research Council\", \"Australia\"], [\"grant.3535570\", 2014.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2715730\", 1990.0, 1997, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.2711573\", 2002.0, 2002, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709087\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706161\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706160\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2692261\", 2011.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2692183\", 2004.0, 2011, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2687964\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687955\", 2007.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687666\", 2004.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641946\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2608115\", 2004.0, 2007, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.2598780\", 2005.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456829\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455959\", 2003.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435046\", 1999.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425260\", 2003.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425119\", 2002.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2354950\", 2011.0, 2017, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2350072\", 2014.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2350065\", 2013.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347753\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347752\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347747\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347746\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347745\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347744\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347743\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347741\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347740\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347738\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347736\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347734\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347732\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347295\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347294\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347293\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347289\", 2010.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347288\", 2010.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347286\", 2011.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347285\", 2011.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347284\", 2011.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347283\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346797\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346796\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346795\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346794\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346772\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346771\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346770\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346769\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346768\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346762\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346761\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346760\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346759\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346758\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346757\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346756\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346755\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346754\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346753\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346640\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346639\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346638\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346637\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346636\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346635\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346634\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346632\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346627\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346626\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346625\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346624\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346623\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346622\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346621\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346620\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346619\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346618\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346617\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346616\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346615\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346614\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346613\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346612\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346611\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346610\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346606\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346605\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346603\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346602\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346601\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346600\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346599\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346598\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346597\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346596\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346593\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346592\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346591\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346590\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346589\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346588\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346587\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346585\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346584\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346580\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346579\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346578\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346577\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346576\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346575\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346574\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346573\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346572\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346571\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346570\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346569\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346568\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346566\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346565\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346564\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346563\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346562\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346561\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346560\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346559\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346558\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346557\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346556\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346555\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346554\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346553\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346552\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346545\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346543\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346542\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346541\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346540\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346539\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346538\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346537\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346536\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346535\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346534\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346533\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346532\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346531\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346525\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346524\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346523\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346522\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346521\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346520\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346519\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346518\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346517\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346516\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346514\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346509\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346508\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346507\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346506\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346505\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346504\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346503\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346502\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346501\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346500\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346499\", 2007.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346498\", 2007.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346495\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346494\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346493\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346492\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346491\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346490\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346489\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346488\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346487\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346486\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2344491\", 2011.0, 2013, \"National Cancer Institute\", \"United States\"], [\"grant.8610139\", 2007.0, 2008, \"Robert Wood Johnson Foundation\", \"United States\"], [\"grant.8579320\", 2018.0, 2019, \"United States Department of the Army\", \"United States\"], [\"grant.8572899\", 2012.0, 2013, \"Ontario Institute for Cancer Research\", \"Canada\"], [\"grant.8569729\", 2006.0, 2007, \"CancerCare Manitoba\", \"Canada\"], [\"grant.8565507\", 2018.0, 2018, \"Department of Biotechnology\", \"India\"], [\"grant.8564388\", 2016.0, 2019, \"Department of Biotechnology\", \"India\"], [\"grant.8564082\", 2016.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8563871\", 2015.0, 2018, \"Department of Biotechnology\", \"India\"], [\"grant.8563305\", 2014.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8563040\", 2014.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8562784\", 2013.0, 2018, \"Department of Biotechnology\", \"India\"], [\"grant.8562757\", 2013.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8562431\", 2013.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8562366\", 2013.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8562365\", 2013.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8562156\", 2012.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8561994\", 2013.0, 2017, \"Department of Biotechnology\", \"India\"], [\"grant.8561785\", 2012.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8561598\", 2011.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8561575\", 2012.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8561572\", 2012.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8561569\", 2012.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8561568\", 2012.0, 2016, \"Department of Biotechnology\", \"India\"], [\"grant.8561567\", 2012.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8561494\", 2012.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8561094\", 2011.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8560863\", 2010.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8560702\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560674\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560493\", 2008.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8560411\", 2011.0, 2015, \"Department of Biotechnology\", \"India\"], [\"grant.8560410\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560408\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560305\", 2010.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8560215\", 2007.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8560171\", 2007.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8560114\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8560031\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8559996\", 2007.0, 2010, \"Department of Biotechnology\", \"India\"], [\"grant.8559990\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8559937\", 2006.0, 2010, \"Department of Biotechnology\", \"India\"], [\"grant.8559873\", 2010.0, 2013, \"Department of Biotechnology\", \"India\"], [\"grant.8559861\", 2009.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8559049\", 2010.0, 2014, \"Department of Biotechnology\", \"India\"], [\"grant.8559046\", 2009.0, 2012, \"Department of Biotechnology\", \"India\"], [\"grant.8559045\", 2007.0, 2010, \"Department of Biotechnology\", \"India\"], [\"grant.8515281\", 2017.0, 2018, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8505548\", 2012.0, 2012, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8497451\", 2000.0, 2003, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8497448\", 2004.0, 2006, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8492684\", 2016.0, 2017, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8485877\", 2010.0, 2014, \"Research Foundation - Flanders\", \"Belgium\"], [\"grant.8456354\", 2014.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8450872\", 2015.0, 2016, \"United States Department of the Army\", \"United States\"], [\"grant.8385722\", 2019.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.8218824\", 1999.0, 2001, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8211545\", 1993.0, 1996, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8186853\", 2016.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8183858\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8181157\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173944\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173186\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170800\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170752\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170018\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169351\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8167514\", 2001.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8107157\", 2004.0, 2005, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8106662\", 2009.0, 2011, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8106079\", 2015.0, 2018, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8081142\", 1982.0, 1985, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8070298\", 2015.0, 2019, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8070297\", 2015.0, 2019, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8070293\", 2015.0, 2019, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8069684\", 2015.0, 2018, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8068998\", 2008.0, 2010, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8068993\", 2007.0, 2009, \"Federal Ministry of Food and Agriculture\", \"Germany\"], [\"grant.8054102\", 2003.0, 2006, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.8041593\", 2010.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8036881\", 2015.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8036722\", 2014.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8034479\", 2012.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8023963\", 2005.0, 2010, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8019041\", 2016.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8003914\", 1992.0, 1996, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.8001077\", 2011.0, 2012, \"Federal Ministry for Economic Affairs and Energy\", \"Germany\"], [\"grant.7999276\", 1978.0, 1979, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7993550\", 2014.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992772\", 2012.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992112\", 1988.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7992091\", 1987.0, 1989, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7991654\", 1991.0, 1993, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990743\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990742\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990741\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990740\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7990244\", 2010.0, 2015, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989781\", 2008.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989780\", 2008.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7989779\", 2008.0, 2012, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988709\", 2005.0, 2007, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7988460\", 2004.0, 2006, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7987175\", 1997.0, 1999, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7987167\", 1997.0, 2000, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7986679\", 1995.0, 1999, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7986571\", 1993.0, 1997, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7986568\", 1993.0, 1996, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7986566\", 1993.0, 1996, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7963522\", 2016.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7963422\", 2015.0, 2018, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7953453\", 1996.0, 1997, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7953163\", 1999.0, 2002, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7953114\", 1996.0, 1999, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7953112\", 1996.0, 1999, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952527\", 1997.0, 2000, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952494\", 1995.0, 1998, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952387\", 1989.0, 1993, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7952277\", 2014.0, 2016, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7951285\", 2012.0, 2017, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7939768\", 1997.0, 2001, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7934122\", 2017.0, 2019, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7878743\", 2017.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7878387\", 2016.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7878132\", 2014.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7877873\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7877641\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7876543\", 2015.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7875422\", 2013.0, 2018, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874578\", 2016.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874365\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7874342\", 2017.0, 2019, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.7854022\", 2007.0, 2009, \"Ford Foundation\", \"United States\"], [\"grant.7851210\", 2017.0, 2018, \"Science and Engineering Research Board\", \"India\"], [\"grant.7825840\", 2015.0, 2016, \"Uniformed Services University of the Health Sciences\", \"United States\"], [\"grant.7821010\", 1998.0, 2001, \"Susan G. Komen Breast Cancer Foundation\", \"United States\"], [\"grant.7764353\", 2017.0, 2018, \"United States Department of the Army\", \"United States\"], [\"grant.7736401\", 2009.0, 2012, \"Department of Science and Technology\", \"India\"], [\"grant.7697897\", 2013.0, 2014, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7694260\", 2014.0, 2015, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7681939\", 2009.0, 2009, \"Council for International Exchange of Scholars\", \"United States\"], [\"grant.7670327\", 2004.0, 2004, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7669734\", 2015.0, 2017, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.7667461\", 2005.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7664944\", 2006.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7660038\", 2013.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7658043\", 2002.0, 2003, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7657790\", 2012.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7646362\", 2008.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7643463\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7643219\", 2008.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7640347\", 2010.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7630516\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7626822\", 2010.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7617634\", 2006.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7610021\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7609730\", 2015.0, 2016, \"Science and Engineering Research Board\", \"India\"], [\"grant.7608227\", 2016.0, 2017, \"Science and Engineering Research Board\", \"India\"], [\"grant.7550388\", 2002.0, 2004, \"Bloodwise\", \"United Kingdom\"], [\"grant.7550184\", 1999.0, 2002, \"Bloodwise\", \"United Kingdom\"], [\"grant.7502771\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7495652\", 2015.0, 2016, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7486795\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7478477\", 2012.0, 2013, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7476327\", 2014.0, 2015, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7473054\", 2013.0, 2014, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7466278\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7453344\", 2009.0, 2010, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7446466\", 2011.0, 2012, \"National Research Foundation of Korea\", \"South Korea\"], [\"grant.7437175\", 2007.0, 2009, \"University Grants Committee\", \"China\"], [\"grant.7433396\", 2008.0, 2011, \"University Grants Committee\", \"China\"], [\"grant.7428097\", 2014.0, 2016, \"University Grants Committee\", \"China\"], [\"grant.7407419\", 2016.0, 2019, \"National Science Center\", \"Poland\"], [\"grant.7389944\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7389680\", 2017.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7389650\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7389647\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.7204754\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7183855\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7172652\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172642\", 2015.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172177\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7171780\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7171779\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7171361\", 2007.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169661\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169658\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7169636\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7167652\", 1995.0, 1998, \"Innovation and Technology Commission\", \"China\"], [\"grant.7166385\", 2008.0, 2010, \"Innovation and Technology Commission\", \"China\"], [\"grant.7166056\", 2009.0, 2010, \"Innovation and Technology Commission\", \"China\"], [\"grant.7166054\", 2009.0, 2010, \"Innovation and Technology Commission\", \"China\"], [\"grant.7150051\", 2014.0, 2014, \"Danish Agency for Science and Higher Education\", \"Denmark\"], [\"grant.7140909\", 2011.0, 2012, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7140908\", 2011.0, 2012, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7132079\", 2007.0, 2008, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7121561\", 2011.0, 2013, \"VINNOVA\", \"Sweden\"], [\"grant.7121461\", 2012.0, 2013, \"VINNOVA\", \"Sweden\"], [\"grant.7049077\", 2016.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.7043750\", 2000.0, 2001, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043094\", 2014.0, 2015, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042337\", 1997.0, 1998, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042336\", 1997.0, 1998, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7027773\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7025507\", 2017.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.7022667\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7018877\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7009269\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7002205\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6989342\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6949912\", 2017.0, 2018, \"Fund for Scientific Research\", \"Belgium\"], [\"grant.6944544\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6896091\", 2005.0, 2007, \"Ministry of Education Youth and Sports\", \"Czechia\"], [\"grant.6895027\", 2011.0, 2014, \"Ministry of Health\", \"Czechia\"], [\"grant.6860321\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6860231\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6857517\", 2005.0, 2007, \"Ministry of Education, Universities and Research\", \"Italy\"], [\"grant.6792174\", 2014.0, 2017, \"Science and Technology Department of Zhejiang Province\", \"China\"], [\"grant.6785800\", 2012.0, 2015, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6784292\", 2012.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6775789\", 2012.0, 2016, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6736385\", 2013.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6735254\", 2010.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734608\", 2013.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734606\", 2012.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734536\", 2013.0, 2016, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734309\", 2012.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6732590\", 2009.0, 2009, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6731983\", 2014.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728300\", 2014.0, 2016, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728257\", 2010.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6728176\", 2010.0, 2014, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6727551\", 2010.0, 2012, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6721784\", 2015.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716522\", 2009.0, 2009, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716069\", 2008.0, 2013, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6714938\", 2009.0, 2012, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6714625\", 2008.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713836\", 2009.0, 2012, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713438\", 2009.0, 2010, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6710344\", 2017.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6665669\", 2016.0, 2019, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.6620139\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.6586245\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586158\", 2006.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586118\", 2012.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586057\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586048\", 2005.0, 2005, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6586014\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585997\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585976\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585956\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585946\", 2015.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585942\", 2015.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585914\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585634\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585612\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585589\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585586\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585423\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585351\", 2004.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585328\", 2016.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585277\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585251\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585136\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585027\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584993\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584850\", 2006.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584848\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584845\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584829\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584806\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584800\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584797\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584777\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584720\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584666\", 2012.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584493\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584467\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584441\", 2011.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584432\", 2010.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584336\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584308\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584301\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584273\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584214\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584206\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584151\", 2013.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584136\", 2007.0, 2008, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584098\", 2010.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584086\", 2015.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584073\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584067\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584061\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584059\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584047\", 2013.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584038\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583914\", 2008.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583847\", 2008.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583842\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583825\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583815\", 2007.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583742\", 2013.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583725\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583645\", 2013.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583627\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583621\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583587\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583580\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583473\", 2011.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583461\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583407\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583342\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583302\", 2012.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583288\", 2011.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583263\", 2016.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583217\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583127\", 2003.0, 2004, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583035\", 2008.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582996\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582961\", 2010.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582958\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582848\", 2010.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582822\", 2010.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582719\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582668\", 2007.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582628\", 2007.0, 2008, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582557\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582548\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582542\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582500\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582340\", 2016.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582339\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582310\", 2011.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582295\", 2008.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582178\", 2006.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582119\", 2010.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582060\", 2008.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582051\", 2010.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581990\", 2010.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581941\", 2005.0, 2006, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581793\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581714\", 2011.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581702\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581700\", 2006.0, 2012, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581601\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581595\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581503\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581421\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581364\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581325\", 2016.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581316\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581313\", 2006.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581280\", 2010.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581271\", 2011.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581221\", 2016.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581206\", 2012.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581196\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581169\", 2016.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581131\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581126\", 2011.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581123\", 2011.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581115\", 2006.0, 2009, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581020\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580908\", 2006.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580890\", 2015.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580836\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580835\", 2016.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580803\", 2015.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580786\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580745\", 2010.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580649\", 2012.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580576\", 2012.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580564\", 2009.0, 2011, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580559\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580484\", 2013.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580403\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580386\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580304\", 2012.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580266\", 2015.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580261\", 2006.0, 2008, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580223\", 2013.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580182\", 2012.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580179\", 2003.0, 2008, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6501370\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501028\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6500987\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499448\", 2014.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499443\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6369955\", 1971.0, 1971, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6347725\", 1966.0, 1966, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6344179\", 1965.0, 1965, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6316491\", 1978.0, 1978, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6311022\", 1977.0, 1977, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6289275\", 1979.0, 1979, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6260168\", 1988.0, 1988, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6243074\", 1987.0, 1987, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6233945\", 1986.0, 1986, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6193744\", 2001.0, 2002, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6192027\", 2000.0, 2001, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6190734\", 1997.0, 1998, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6189018\", 1998.0, 1998, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6187641\", 2000.0, 2001, \"FWF Austrian Science Fund\", \"Austria\"], [\"grant.6154969\", 2014.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6128334\", 2013.0, 2014, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6124081\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6120738\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6096975\", 2012.0, 2014, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6059097\", 2011.0, 2013, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6010588\", 2008.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5996145\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5924715\", 2016.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5919672\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5909934\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5878597\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5875292\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5872775\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5866656\", 2015.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5864910\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5861645\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5856674\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5847585\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5847284\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5829932\", 2014.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5826474\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5815012\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5814353\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5814043\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5812232\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5809744\", 2013.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5749055\", 1999.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5452530\", 1996.0, 1996, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5451369\", 1996.0, 1996, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5325910\", 1999.0, 2001, \"Asthma UK\", \"United Kingdom\"], [\"grant.5245909\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245786\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5218024\", 2002.0, 2003, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5207502\", 2002.0, 2005, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5203540\", 2002.0, 2003, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5202775\", 2002.0, 2005, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5197165\", 1996.0, 2000, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5196035\", 1994.0, 1999, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5181420\", 1986.0, 1989, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.5140527\", 2005.0, 2010, \"Cancer Research UK\", \"United Kingdom\"], [\"grant.5139795\", 2012.0, 2015, \"Bloodwise\", \"United Kingdom\"], [\"grant.5041907\", 2001.0, 2002, \"University of California - Cancer Research Coordinating Committee\", \"United States\"], [\"grant.5014857\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5006764\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5005894\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5004249\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4991934\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4973345\", 2010.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4971252\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4966996\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4962853\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4960564\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4957450\", 2006.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4952980\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4951199\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4950725\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4943778\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4941775\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938724\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4937991\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4932812\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4924967\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4924180\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4918569\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4914216\", 2000.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4912945\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4903965\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4892909\", 2014.0, 2015, \"United States Department of the Army\", \"United States\"], [\"grant.4853334\", 2008.0, 2011, \"Volkswagen Foundation\", \"Germany\"], [\"grant.4799742\", 2006.0, 2008, \"German Research Foundation\", \"Germany\"], [\"grant.4774701\", 2003.0, 2006, \"German Research Foundation\", \"Germany\"], [\"grant.4762047\", 2002.0, 2004, \"German Research Foundation\", \"Germany\"], [\"grant.4760941\", 2000.0, 2010, \"German Research Foundation\", \"Germany\"], [\"grant.4760813\", 2000.0, 2003, \"German Research Foundation\", \"Germany\"], [\"grant.4744457\", 1999.0, 2006, \"German Research Foundation\", \"Germany\"], [\"grant.4704204\", 2014.0, 2017, \"National Science Center\", \"Poland\"], [\"grant.4703174\", 2014.0, 2018, \"National Science Center\", \"Poland\"], [\"grant.4700536\", 2011.0, 2014, \"National Science Center\", \"Poland\"], [\"grant.4669594\", 2007.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4667828\", 2009.0, 2010, \"The Research Council of Norway\", \"Norway\"], [\"grant.4659338\", 2008.0, 2008, \"The Research Council of Norway\", \"Norway\"], [\"grant.4649510\", 2009.0, 2010, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.4649346\", 2011.0, 2012, \"Fonds de Recherche du Qu\\u00e9bec \\u2013 Nature et technologies\", \"Canada\"], [\"grant.4647673\", 2007.0, 2007, \"The Research Council of Norway\", \"Norway\"], [\"grant.4578575\", 2001.0, 2004, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4578365\", 2000.0, 2004, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4577798\", 2000.0, 2001, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4520509\", 2012.0, 2013, \"National Agency for Research\", \"France\"], [\"grant.4491575\", 2009.0, 2011, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4472561\", 2015.0, 2016, \"The Icelandic Centre for Research\", \"Iceland\"], [\"grant.4455522\", 2015.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.4439726\", 2010.0, 2011, \"United States Department of the Army\", \"United States\"], [\"grant.4414245\", 2004.0, 2005, \"United States Department of the Navy\", \"United States\"], [\"grant.4388528\", 2003.0, 2004, \"United States Department of the Army\", \"United States\"], [\"grant.4172834\", 2014.0, 2015, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.4035481\", 2009.0, 2011, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.4035270\", 2003.0, 2005, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.3983436\", 2011.0, 2015, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3983037\", 2009.0, 2016, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3958702\", 2015.0, 2016, \"Innovate UK\", \"United Kingdom\"], [\"grant.3951980\", 2014.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3951949\", 2014.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3936592\", 2013.0, 2018, \"Alberta Innovates\", \"Canada\"], [\"grant.3936423\", 2013.0, 2016, \"Alberta Innovates\", \"Canada\"], [\"grant.3898960\", 2007.0, 2009, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3873602\", 2013.0, 2015, \"Social Sciences and Humanities Research Council\", \"Canada\"], [\"grant.3866316\", 2014.0, 2016, \"Innovate UK\", \"United Kingdom\"], [\"grant.3864778\", 2012.0, 2013, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.3857720\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857710\", 2014.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.3857113\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856956\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3852689\", 2015.0, 2015, \"Directorate for Engineering\", \"United States\"], [\"grant.3831853\", 2012.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3826462\", 2012.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3823830\", 2012.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3818730\", 2010.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3814830\", 2011.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3804783\", 2012.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3803020\", 2014.0, 2016, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.3767650\", 1999.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3763985\", 2001.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3759847\", 2001.0, 2002, \"European Commission\", \"Belgium\"], [\"grant.3728055\", 1995.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3724885\", 1988.0, 1991, \"European Commission\", \"Belgium\"], [\"grant.3723073\", 1994.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3722905\", 1995.0, 1998, \"European Commission\", \"Belgium\"], [\"grant.3707655\", 1990.0, 1994, \"European Commission\", \"Belgium\"], [\"grant.3706322\", 1984.0, 1986, \"European Commission\", \"Belgium\"], [\"grant.3704851\", 1989.0, 1991, \"European Commission\", \"Belgium\"], [\"grant.3701397\", 1985.0, 1987, \"European Commission\", \"Belgium\"], [\"grant.3700414\", 1989.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.3643227\", 2009.0, 2018, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3637822\", 2013.0, 2016, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3637682\", 2013.0, 2016, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3634826\", 2001.0, 2002, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3633305\", 2002.0, 2003, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3632595\", 2002.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3628432\", 2000.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3628313\", 2001.0, 2005, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3577639\", 2003.0, 2005, \"Australian Research Council\", \"Australia\"], [\"grant.3576834\", 2002.0, 2004, \"Australian Research Council\", \"Australia\"], [\"grant.3573998\", 2003.0, 2006, \"Australian Research Council\", \"Australia\"], [\"grant.3572850\", 2009.0, 2012, \"Australian Research Council\", \"Australia\"], [\"grant.3571261\", 2004.0, 2007, \"Australian Research Council\", \"Australia\"], [\"grant.3570402\", 2009.0, 2013, \"Australian Research Council\", \"Australia\"], [\"grant.3531001\", 2009.0, 2012, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3530308\", 2005.0, 2008, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3527792\", 2005.0, 2006, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3525856\", 2007.0, 2008, \"Foundation for Science and Technology\", \"Portugal\"], [\"grant.3104434\", 2009.0, 2013, \"Directorate for Social, Behavioral & Economic Sciences\", \"United States\"], [\"grant.2975118\", 1998.0, 1999, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2923517\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2907618\", 2002.0, 2006, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2897984\", 1994.0, 1997, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2897604\", 2002.0, 2005, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2890649\", 2010.0, 2011, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2868164\", 1992.0, 1993, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2846662\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2845972\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2842611\", 2012.0, 2013, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2839616\", 2007.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2803801\", 2006.0, 2007, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2786005\", 2011.0, 2014, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2785892\", 2006.0, 2009, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2783837\", 2010.0, 2015, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2769709\", 2010.0, 2013, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2754059\", 2010.0, 2017, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2726564\", 2010.0, 2016, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2726423\", 2009.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2726421\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2726417\", 2009.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2726415\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723429\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723071\", 2009.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2712715\", 1996.0, 2000, \"National Institutes of Health Clinical Center\", \"United States\"], [\"grant.2712046\", 1995.0, 1995, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711205\", 1991.0, 1991, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711169\", 1990.0, 1991, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709250\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709243\", 2005.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709238\", 2005.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709208\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709206\", 2002.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709167\", 2002.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708553\", 1985.0, 1992, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708458\", 1985.0, 1987, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706122\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706116\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688037\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687949\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687703\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687484\", 1999.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2669265\", 2009.0, 2012, \"National Cancer Institute\", \"United States\"], [\"grant.2668278\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2644101\", 1999.0, 2000, \"National Cancer Institute\", \"United States\"], [\"grant.2643860\", 1998.0, 1999, \"National Cancer Institute\", \"United States\"], [\"grant.2641629\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641339\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641242\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641097\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640968\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640965\", 2002.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640907\", 2003.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640880\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640182\", 1994.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2601232\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2600952\", 2012.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599022\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2544527\", 1992.0, 1996, \"Agency for Healthcare Research and Quality\", \"United States\"], [\"grant.2506017\", 1992.0, 2005, \"National Eye Institute\", \"United States\"], [\"grant.2485747\", 2003.0, 2007, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2459206\", 2011.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458313\", 2008.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435112\", 2003.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435103\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425590\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425589\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425446\", 2010.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425142\", 2003.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424838\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424825\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424824\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424823\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2417267\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2369962\", 1997.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347135\", 2013.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459198\", 2011.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4294554\", 2015.0, 2018, \"Medical Research Council\", \"United Kingdom\"], [\"grant.7673939\", 2016.0, 2017, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7146038\", 2015.0, 2016, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.6382318\", 2016.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.3859869\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2692222\", 2007.0, 2011, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2666434\", 2010.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458298\", 2009.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7430482\", 2015.0, 2018, \"University Grants Committee\", \"China\"], [\"grant.6952757\", 2017.0, 2019, \"National Cancer Institute\", \"United States\"], [\"grant.6380452\", 2015.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.5503451\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4295315\", 2015.0, 2018, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.4103659\", 2015.0, 2018, \"National Cancer Institute\", \"United States\"], [\"grant.3867852\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3733061\", 1997.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3625269\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3535533\", 2014.0, 2016, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2754548\", 2011.0, 2015, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2692257\", 2011.0, 2017, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2692202\", 2006.0, 2008, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2688086\", 2009.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688014\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687686\", 2004.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2658051\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657928\", 2002.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2645385\", 2009.0, 2010, \"National Cancer Institute\", \"United States\"], [\"grant.2641871\", 2011.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2612876\", 2010.0, 2013, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2601484\", 2013.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2600266\", 2010.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599911\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599769\", 2008.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2581895\", 2011.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2567250\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458818\", 2010.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456916\", 2006.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456421\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2355138\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8579772\", 2010.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8459443\", 2015.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8339888\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8181151\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7749383\", 2012.0, 2013, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7673878\", 2016.0, 2017, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7665291\", 2010.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7651902\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7641966\", 2007.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7616855\", 2012.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7566317\", 2003.0, 2008, \"Ministry of Business, Innovation and Employment\", \"New Zealand\"], [\"grant.7124299\", 2015.0, 2016, \"VINNOVA\", \"Sweden\"], [\"grant.7109721\", 2016.0, 2018, \"VINNOVA\", \"Sweden\"], [\"grant.7029068\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6715541\", 2003.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713972\", 2005.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6663822\", 2013.0, 2016, \"Melanoma Research Alliance\", \"United States\"], [\"grant.6501302\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6049130\", 2010.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5829752\", 2003.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5823968\", 2002.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5721408\", 1997.0, 1998, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5664360\", 1995.0, 1997, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5475778\", 2016.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5223759\", 2010.0, 2011, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.4899209\", 2006.0, 2007, \"California HIV/AIDS Research Program\", \"United States\"], [\"grant.4660769\", 2014.0, 2017, \"The Research Council of Norway\", \"Norway\"], [\"grant.4640178\", 2008.0, 2012, \"The Research Council of Norway\", \"Norway\"], [\"grant.4633981\", 1996.0, 2001, \"Slovenian Research Agency\", \"Slovenia\"], [\"grant.4485915\", 2011.0, 2013, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4415436\", 2004.0, 2005, \"United States Department of the Army\", \"United States\"], [\"grant.4390182\", 2002.0, 2003, \"United States Department of the Navy\", \"United States\"], [\"grant.3940618\", 2015.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.3784451\", 2010.0, 2014, \"European Commission\", \"Belgium\"], [\"grant.3784425\", 2010.0, 2014, \"European Commission\", \"Belgium\"], [\"grant.3772404\", 2009.0, 2012, \"European Commission\", \"Belgium\"], [\"grant.3129185\", 2011.0, 2015, \"Directorate for Engineering\", \"United States\"], [\"grant.3081070\", 2007.0, 2008, \"Directorate for Social, Behavioral & Economic Sciences\", \"United States\"], [\"grant.2960431\", 2008.0, 2009, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2918611\", 2005.0, 2008, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2711784\", 1993.0, 1998, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709010\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704625\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704605\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687787\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687506\", 2000.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2668265\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2668260\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657974\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657783\", 1998.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641688\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641619\", 2008.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641309\", 2005.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641121\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641056\", 2003.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640855\", 2002.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640759\", 2001.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2604455\", 2006.0, 2009, \"National Cancer Institute\", \"United States\"], [\"grant.2598688\", 2004.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598334\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597967\", 2004.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597799\", 2001.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2583453\", 2002.0, 2003, \"National Cancer Institute\", \"United States\"], [\"grant.2581808\", 2010.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2576351\", 1998.0, 2000, \"Agency for Healthcare Research and Quality\", \"United States\"], [\"grant.2566915\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566904\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2526101\", 2000.0, 2013, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2468650\", 1985.0, 1992, \"National Cancer Institute\", \"United States\"], [\"grant.2457755\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457231\", 2005.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457183\", 2006.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453301\", 1995.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2392441\", 2003.0, 2007, \"United States National Library of Medicine\", \"United States\"], [\"grant.2350946\", 2005.0, 2010, \"National Center for Advancing Translational Sciences\", \"United States\"], [\"grant.100072047\", 2014.0, 2018, \"V Foundation for Cancer Research\", \"United States\"], [\"grant.2769275\", 2011.0, 2015, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.7143297\", 2004.0, 2005, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.4731287\", 2015.0, 2018, \"National Agency for Research\", \"France\"], [\"grant.3859527\", 2014.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3728056\", 1995.0, 1998, \"European Commission\", \"Belgium\"], [\"grant.2642043\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709072\", 2007.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8593212\", 2012.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8593181\", 2015.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8592576\", 2015.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8591458\", 2015.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8591433\", 2015.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8573271\", 2011.0, 2013, \"Alex's Lemonade Stand Foundation\", \"United States\"], [\"grant.8573193\", 2007.0, 2010, \"Ontario Institute for Cancer Research\", \"Canada\"], [\"grant.8568312\", 2011.0, 2011, \"The Taylor Matthews Foundation\", \"United States\"], [\"grant.8519075\", 2013.0, 2014, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.8461487\", 2017.0, 2018, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8459735\", 2015.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8329544\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8328985\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8216461\", 1997.0, 1999, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8198250\", 2016.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8181152\", 2015.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8178839\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8176925\", 2013.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173632\", 2007.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8107190\", 2003.0, 2007, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8107088\", 2004.0, 2006, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8106827\", 2008.0, 2009, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8106823\", 2008.0, 2010, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8041819\", 2011.0, 2014, \"Federal Ministry of Education and Research\", \"Germany\"], [\"grant.7749605\", 2016.0, 2017, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7632107\", 2011.0, 2012, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7630521\", 2007.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7617679\", 2014.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7615531\", 2018.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7441243\", 2007.0, 2008, \"Mesothelioma Applied Research Foundation\", \"United States\"], [\"grant.7413138\", 2011.0, 2014, \"Ministry of Science and Higher Education\", \"Poland\"], [\"grant.7210090\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7201259\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7198956\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7195059\", 2015.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7188506\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7172307\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7172128\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7170344\", 2017.0, 2018, \"National Cancer Institute\", \"United States\"], [\"grant.7170037\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7145281\", 2005.0, 2006, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7126490\", 2013.0, 2015, \"Swedish Research Council\", \"Sweden\"], [\"grant.7111444\", 2015.0, 2016, \"VINNOVA\", \"Sweden\"], [\"grant.7110393\", 2013.0, 2015, \"Swedish Research Council\", \"Sweden\"], [\"grant.7107704\", 2011.0, 2013, \"VINNOVA\", \"Sweden\"], [\"grant.7102560\", 2014.0, 2016, \"Swedish Research Council\", \"Sweden\"], [\"grant.7094056\", 2012.0, 2014, \"VINNOVA\", \"Sweden\"], [\"grant.7093414\", 2014.0, 2016, \"Swedish Research Council\", \"Sweden\"], [\"grant.7054358\", 2017.0, 2019, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.7052734\", 2015.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.7035750\", 2000.0, 2001, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7035728\", 1998.0, 2001, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7027530\", 2017.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7017474\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7009470\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7007594\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6989562\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6985802\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6984632\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6956996\", 2017.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6898601\", 2014.0, 2017, \"Technology Agency of the Czech Republic\", \"Czechia\"], [\"grant.6898238\", 2012.0, 2016, \"Ministry of Agriculture\", \"Czechia\"], [\"grant.6897461\", 2012.0, 2015, \"Ministry of Education Youth and Sports\", \"Czechia\"], [\"grant.6895869\", 1997.0, 2001, \"Ministry of Industry and Trade\", \"Czechia\"], [\"grant.6894818\", 2008.0, 2011, \"Ministry of Health\", \"Czechia\"], [\"grant.6893995\", 2004.0, 2006, \"Ministry of Health\", \"Czechia\"], [\"grant.6893013\", 1999.0, 2001, \"Ministry of Health\", \"Czechia\"], [\"grant.6892489\", 1997.0, 1999, \"Ministry of Health\", \"Czechia\"], [\"grant.6892046\", 1996.0, 1998, \"Ministry of Health\", \"Czechia\"], [\"grant.6891741\", 2002.0, 2004, \"Academy of Sciences of the Czech Republic\", \"Czechia\"], [\"grant.6890237\", 2008.0, 2011, \"Ministry of Defence\", \"Czechia\"], [\"grant.6889913\", 1995.0, 1997, \"Ministry of Health\", \"Czechia\"], [\"grant.6889759\", 1998.0, 2002, \"Ministry of Education Youth and Sports\", \"Czechia\"], [\"grant.6887770\", 2009.0, 2011, \"Czech Science Foundation\", \"Czechia\"], [\"grant.6885923\", 2003.0, 2005, \"Ministry of Industry and Trade\", \"Czechia\"], [\"grant.6789856\", 2010.0, 2013, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6782698\", 2011.0, 2015, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6782088\", 2012.0, 2015, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6779627\", 2015.0, 2019, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6779163\", 2014.0, 2015, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6778182\", 2012.0, 2013, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6736604\", 2012.0, 2017, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6734404\", 2012.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718161\", 2003.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715102\", 2004.0, 2008, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6714516\", 2004.0, 2006, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6710383\", 2017.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6665051\", 2014.0, 2016, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.6585701\", 2012.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585522\", 2015.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6585009\", 2013.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6584480\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6583202\", 2014.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582837\", 2013.0, 2016, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582602\", 2014.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582377\", 2015.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582318\", 2009.0, 2010, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582277\", 2015.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6582039\", 2014.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581667\", 2013.0, 2013, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581629\", 2014.0, 2017, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6581606\", 2015.0, 2015, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580667\", 2014.0, 2018, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580592\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580348\", 2014.0, 2019, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6580253\", 2014.0, 2014, \"Bill & Melinda Gates Foundation\", \"United States\"], [\"grant.6501410\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6501086\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6499761\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6445309\", 2016.0, 2019, \"Innovate UK\", \"United Kingdom\"], [\"grant.6151642\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6098547\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6091957\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6071280\", 2011.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6070744\", 2011.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6042157\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6024774\", 2009.0, 2011, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6012718\", 2008.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6012401\", 2008.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5992262\", 2007.0, 2010, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5938062\", 2005.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5931400\", 2005.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5920808\", 2016.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5911040\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5900028\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5869490\", 2015.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5861515\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5799529\", 2001.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5501390\", 2013.0, 2018, \"Royal Society\", \"United Kingdom\"], [\"grant.5495378\", 2016.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.5245789\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245788\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245787\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245784\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245782\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5245762\", 2015.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5244950\", 2008.0, 2018, \"National Cancer Institute\", \"United States\"], [\"grant.5151711\", 2007.0, 2010, \"NIHR Trainees Coordinating Centre\", \"United Kingdom\"], [\"grant.5072711\", 2016.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.5014322\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5006402\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5000845\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4996505\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4980908\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4980502\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4977004\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4967684\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4965799\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4965440\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4964345\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4959645\", 2012.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4953588\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4949617\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4944670\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4944517\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4943857\", 2012.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4942414\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938676\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938143\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4936988\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4936799\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4931966\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4931866\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4930008\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4929469\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4666876\", 2010.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4661763\", 2009.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4645568\", 2013.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4642003\", 2012.0, 2017, \"The Research Council of Norway\", \"Norway\"], [\"grant.4579186\", 2015.0, 2019, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4533901\", 2007.0, 2009, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4511421\", 1996.0, 1996, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4457248\", 2013.0, 2018, \"Royal Society\", \"United Kingdom\"], [\"grant.4446312\", 2009.0, 2010, \"United States Department of the Army\", \"United States\"], [\"grant.4444178\", 1994.0, 1995, \"United States Department of the Army\", \"United States\"], [\"grant.4419560\", 2010.0, 2011, \"United States Department of the Army\", \"United States\"], [\"grant.4385415\", 1995.0, 1996, \"United States Department of the Army\", \"United States\"], [\"grant.4383163\", 1995.0, 1996, \"United States Department of the Army\", \"United States\"], [\"grant.4294354\", 2014.0, 2017, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.4293335\", 2013.0, 2018, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.4128821\", 2013.0, 2017, \"Netherlands Organisation for Scientific Research\", \"Netherlands\"], [\"grant.4102510\", 2015.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4045744\", 2003.0, 2006, \"National Oceanic and Atmospheric Administration\", \"United States\"], [\"grant.4045136\", 2003.0, 2005, \"National Oceanic and Atmospheric Administration\", \"United States\"], [\"grant.3955540\", 2014.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3930806\", 2013.0, 2016, \"Australian Research Council\", \"Australia\"], [\"grant.3930761\", 2013.0, 2016, \"Australian Research Council\", \"Australia\"], [\"grant.3928619\", 2004.0, 2009, \"Ministry of Research, Innovation and Science\", \"Canada\"], [\"grant.3865714\", 2014.0, 2015, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.3856962\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856961\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856960\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856941\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3856253\", 2014.0, 2016, \"National Cancer Institute\", \"United States\"], [\"grant.3843674\", 2013.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3832512\", 2004.0, 2009, \"Agricultural Research Service\", \"United States\"], [\"grant.3826010\", 2009.0, 2011, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3820381\", 2010.0, 2011, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3820195\", 2009.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3810125\", 2011.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3804353\", 2016.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3769133\", 2000.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3765856\", 2002.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3761112\", 2002.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3760628\", 2001.0, 2005, \"European Commission\", \"Belgium\"], [\"grant.3753632\", 2002.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3751931\", 2002.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3750111\", 2002.0, 2002, \"European Commission\", \"Belgium\"], [\"grant.3641111\", 2011.0, 2014, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3635581\", 2006.0, 2011, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3632484\", 2008.0, 2008, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3576905\", 2009.0, 2011, \"Australian Research Council\", \"Australia\"], [\"grant.3576794\", 2005.0, 2008, \"Australian Research Council\", \"Australia\"], [\"grant.3570931\", 2011.0, 2014, \"Australian Research Council\", \"Australia\"], [\"grant.3568449\", 2012.0, 2015, \"Australian Research Council\", \"Australia\"], [\"grant.3563226\", 2012.0, 2014, \"Australian Research Council\", \"Australia\"], [\"grant.3562443\", 2013.0, 2015, \"Australian Research Council\", \"Australia\"], [\"grant.3492809\", 2014.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2801262\", 2009.0, 2010, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2776175\", 2012.0, 2015, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2770636\", 2010.0, 2012, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2762266\", 1991.0, 2006, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2761525\", 2013.0, 2016, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2756358\", 2012.0, 2017, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2723441\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2722129\", 1996.0, 1996, \"National Center for Advancing Translational Sciences\", \"United States\"], [\"grant.2712045\", 1995.0, 1995, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2712003\", 1993.0, 1999, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711997\", 1993.0, 1998, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711203\", 1991.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711160\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711158\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709708\", 1990.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709209\", 2003.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708936\", 1998.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708932\", 1998.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708555\", 1985.0, 1985, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706445\", 2010.0, 2010, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2706209\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706207\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706205\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706204\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706150\", 2011.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706130\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688061\", 2009.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2668279\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2668269\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666814\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2658005\", 2005.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657883\", 2001.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657708\", 1996.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657702\", 1994.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657621\", 1991.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2651130\", 1986.0, 1986, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2640676\", 2000.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640147\", 1993.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639812\", 1988.0, 1988, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636318\", 1997.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2602712\", 1996.0, 1999, \"National Cancer Institute\", \"United States\"], [\"grant.2600054\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597874\", 2001.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2487387\", 2013.0, 2018, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2468799\", 1986.0, 1990, \"National Cancer Institute\", \"United States\"], [\"grant.2456215\", 2004.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456201\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455147\", 2000.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2454397\", 1999.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453038\", 1997.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452253\", 1991.0, 1995, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435222\", 2012.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2434259\", 1988.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2430874\", 1989.0, 1995, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2430828\", 1997.0, 1997, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2425461\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425460\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425358\", 2004.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425357\", 2004.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424781\", 1986.0, 1988, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424621\", 1994.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424563\", 1992.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424464\", 1991.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2409638\", 1994.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2370535\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2350078\", 2012.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347550\", 2013.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347549\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347548\", 2011.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2347179\", 2011.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2346749\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2344565\", 2013.0, 2013, \"National Cancer Institute\", \"United States\"], [\"grant.100073101\", 2009.0, 2012, \"Arnold and Mabel Beckman Foundation\", \"United States\"], [\"grant.100071919\", 2016.0, 2019, \"V Foundation for Cancer Research\", \"United States\"], [\"grant.100070343\", 2006.0, 2009, \"Leukemia and Lymphoma Society\", \"United States\"], [\"grant.7924078\", 2008.0, 2012, \"Medical Research Council\", \"United Kingdom\"], [\"grant.7083241\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.7025940\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6709532\", 2017.0, 2018, \"Russian Science Foundation\", \"Russia\"], [\"grant.6617953\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6376359\", 2016.0, 2018, \"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"grant.5831961\", 2002.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5796747\", 2001.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5792510\", 2001.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5222977\", 2010.0, 2013, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.4294792\", 2013.0, 2018, \"Medical Research Council\", \"United Kingdom\"], [\"grant.3952092\", 2014.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3858813\", 2014.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3744387\", 2000.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3633986\", 2003.0, 2004, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3493444\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3146991\", 2013.0, 2013, \"Directorate for Engineering\", \"United States\"], [\"grant.2765536\", 2007.0, 2008, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2711594\", 1997.0, 2002, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2692253\", 2010.0, 2015, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2687567\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687497\", 2000.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2668262\", 2000.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657735\", 1996.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641758\", 2010.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640474\", 1998.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599383\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599315\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598551\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598339\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597759\", 2000.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2583675\", 2005.0, 2006, \"National Cancer Institute\", \"United States\"], [\"grant.2567423\", 2011.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2473620\", 1998.0, 2003, \"National Cancer Institute\", \"United States\"], [\"grant.2459539\", 2012.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459098\", 2010.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458596\", 2011.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455944\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455051\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455044\", 2000.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452208\", 1991.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452138\", 1991.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2439912\", 1997.0, 2012, \"National Center for Advancing Translational Sciences\", \"United States\"], [\"grant.8330234\", 2013.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8211596\", 1993.0, 1995, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170790\", 2003.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169256\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8166485\", 2001.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8107435\", 2002.0, 2005, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7707767\", 2017.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.7652313\", 2008.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7645924\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7645922\", 2010.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7644719\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7643364\", 2013.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7624864\", 2011.0, 2012, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7622446\", 2000.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7620844\", 2010.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7618683\", 2006.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7186510\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7159514\", 2017.0, 2018, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.7073217\", 2016.0, 2019, \"Royal Society of New Zealand\", \"New Zealand\"], [\"grant.7028964\", 2017.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7016683\", 2014.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7010204\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7002558\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6988179\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6894983\", 2010.0, 2013, \"Ministry of Health\", \"Czechia\"], [\"grant.6841109\", 2017.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6777237\", 2011.0, 2013, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.6726168\", 2010.0, 2015, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6720824\", 2005.0, 2009, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6720627\", 2004.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6716293\", 2004.0, 2006, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6715153\", 2004.0, 2008, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6713348\", 2003.0, 2005, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6443782\", 2018.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6381913\", 2014.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6380616\", 2016.0, 2018, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6380515\", 2014.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6158985\", 2014.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6153433\", 2014.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6148084\", 2014.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6146666\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6144510\", 2014.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6141219\", 2014.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6130025\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6121924\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6118451\", 2013.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6090612\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6090601\", 2012.0, 2016, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6088330\", 2012.0, 2015, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6077873\", 2011.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6065481\", 2011.0, 2013, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6062567\", 2011.0, 2013, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6052099\", 2010.0, 2011, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6042942\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6039143\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5991816\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5882059\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5879816\", 2015.0, 2017, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5871293\", 2015.0, 2018, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5821105\", 2002.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5127033\", 2016.0, 2018, \"Australian Research Council\", \"Australia\"], [\"grant.5125629\", 2016.0, 2018, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.4943714\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4941994\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938852\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938364\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4937787\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4934608\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4926171\", 2005.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4910016\", 2006.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4908338\", 2005.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4791473\", 2006.0, 2011, \"German Research Foundation\", \"Germany\"], [\"grant.4675083\", 2006.0, 2008, \"The Research Council of Norway\", \"Norway\"], [\"grant.4554277\", 2002.0, 2005, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4548758\", 2007.0, 2007, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4503412\", 2002.0, 2006, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4477008\", 2015.0, 2017, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4426331\", 2010.0, 2011, \"United States Department of the Army\", \"United States\"], [\"grant.4388526\", 2003.0, 2004, \"United States Department of the Army\", \"United States\"], [\"grant.4035669\", 2006.0, 2008, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.3984049\", 2013.0, 2017, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3983896\", 2013.0, 2018, \"Science Foundation Ireland\", \"Ireland\"], [\"grant.3866240\", 2012.0, 2015, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.3865504\", 2014.0, 2017, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.3843118\", 2013.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3842325\", 2014.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.3841931\", 2013.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3837227\", 2012.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3834845\", 2007.0, 2011, \"Agricultural Research Service\", \"United States\"], [\"grant.3833869\", 2010.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3812426\", 2012.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3756712\", 2001.0, 2002, \"European Commission\", \"Belgium\"], [\"grant.3755519\", 2001.0, 2005, \"European Commission\", \"Belgium\"], [\"grant.3755459\", 2002.0, 2006, \"European Commission\", \"Belgium\"], [\"grant.3752777\", 2002.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3750411\", 2002.0, 2008, \"European Commission\", \"Belgium\"], [\"grant.3749572\", 2001.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3748922\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3745255\", 1999.0, 2001, \"European Commission\", \"Belgium\"], [\"grant.3742514\", 2000.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3710988\", 1993.0, 1996, \"European Commission\", \"Belgium\"], [\"grant.3642631\", 2013.0, 2015, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3629180\", 2004.0, 2008, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3629179\", 2005.0, 2008, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3626830\", 2007.0, 2007, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3624329\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3579092\", 2010.0, 2012, \"Australian Research Council\", \"Australia\"], [\"grant.3579004\", 2003.0, 2006, \"Australian Research Council\", \"Australia\"], [\"grant.3573546\", 2010.0, 2012, \"Australian Research Council\", \"Australia\"], [\"grant.3571454\", 2008.0, 2010, \"Australian Research Council\", \"Australia\"], [\"grant.3571208\", 2006.0, 2008, \"Australian Research Council\", \"Australia\"], [\"grant.3357900\", 1987.0, 1991, \"Directorate for Engineering\", \"United States\"], [\"grant.2769793\", 2008.0, 2010, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2754972\", 2010.0, 2012, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2753546\", 2006.0, 2009, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2723261\", 2009.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2718153\", 1989.0, 1989, \"National Institute of Child Health and Human Development\", \"United States\"], [\"grant.2709746\", 1992.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709229\", 2004.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709203\", 2002.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2709136\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708776\", 1993.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2708519\", 1985.0, 1987, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2706170\", 2009.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2695788\", 2005.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641784\", 2011.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641642\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640145\", 1993.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639711\", 2012.0, 2014, \"National Institute on Aging\", \"United States\"], [\"grant.2636725\", 2001.0, 2003, \"National Cancer Institute\", \"United States\"], [\"grant.2459800\", 2013.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458975\", 2010.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457552\", 2008.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455420\", 2001.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2425382\", 2004.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2386508\", 2000.0, 2001, \"National Heart Lung and Blood Institute\", \"United States\"], [\"grant.2370356\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2359891\", 2003.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.100054928\", 2012.0, 2014, \"American Federation for Aging Research\", \"United States\"], [\"grant.7135136\", 2004.0, 2005, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.3958472\", 2015.0, 2016, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2770973\", 2012.0, 2016, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2695840\", 2009.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8594467\", 2015.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8457856\", 2015.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8329770\", 2012.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8186858\", 2016.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8184633\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8176846\", 2013.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7819398\", 2018.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.7661394\", 2007.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7651941\", 2018.0, 2019, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7641972\", 2011.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7621487\", 2012.0, 2015, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7200856\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7189151\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7134188\", 2001.0, 2002, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7069383\", 2012.0, 2014, \"Research Manitoba\", \"Canada\"], [\"grant.7043117\", 2006.0, 2008, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042976\", 1999.0, 2002, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042975\", 1999.0, 2002, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6986688\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6971184\", 2016.0, 2017, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.6950274\", 2014.0, 2016, \"Fund for Scientific Research\", \"Belgium\"], [\"grant.6815040\", 2017.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.6728763\", 2001.0, 2003, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6718339\", 2005.0, 2007, \"National Health and Medical Research Council\", \"Australia\"], [\"grant.6622479\", 2014.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.6381177\", 2016.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.5977328\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5943537\", 2005.0, 2007, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5941026\", 2005.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5938747\", 2005.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5927000\", 2005.0, 2007, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5682037\", 2007.0, 2008, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5585646\", 2002.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5245885\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5210881\", 2006.0, 2009, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.4950921\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4899319\", 2010.0, 2012, \"California HIV/AIDS Research Program\", \"United States\"], [\"grant.4674892\", 2009.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4662133\", 2014.0, 2018, \"The Research Council of Norway\", \"Norway\"], [\"grant.4640691\", 2008.0, 2013, \"The Research Council of Norway\", \"Norway\"], [\"grant.4640383\", 2007.0, 2011, \"The Research Council of Norway\", \"Norway\"], [\"grant.4538557\", 2008.0, 2010, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4425384\", 2000.0, 2001, \"United States Department of the Navy\", \"United States\"], [\"grant.4241520\", 2015.0, 2017, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.3939966\", 2015.0, 2019, \"European Commission\", \"Belgium\"], [\"grant.3857025\", 2014.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3811139\", 2010.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3800649\", 2013.0, 2019, \"European Commission\", \"Belgium\"], [\"grant.3797302\", 2012.0, 2014, \"European Commission\", \"Belgium\"], [\"grant.3797051\", 2013.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.3796233\", 2013.0, 2016, \"European Commission\", \"Belgium\"], [\"grant.3796117\", 2013.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.3791598\", 2012.0, 2013, \"European Research Council\", \"Belgium\"], [\"grant.3781384\", 2010.0, 2014, \"European Commission\", \"Belgium\"], [\"grant.3765546\", 2003.0, 2009, \"European Commission\", \"Belgium\"], [\"grant.3635549\", 2005.0, 2006, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3630295\", 2005.0, 2012, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3630291\", 2005.0, 2012, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3628122\", 2005.0, 2009, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3628116\", 2005.0, 2010, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3623723\", 2014.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2953673\", 2012.0, 2014, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2766843\", 2008.0, 2012, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2711478\", 1995.0, 1999, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711194\", 1990.0, 1990, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2710976\", 2008.0, 2008, \"National Cancer Institute\", \"United States\"], [\"grant.2705299\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704638\", 2005.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704622\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704613\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2695767\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688088\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688026\", 2008.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687854\", 2007.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687829\", 2007.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687735\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687614\", 2003.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666008\", 2004.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2665739\", 2008.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641999\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641546\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641131\", 2005.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640943\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2638327\", 1999.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636466\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636457\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2625454\", 1997.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2605071\", 2009.0, 2012, \"National Cancer Institute\", \"United States\"], [\"grant.2601356\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598512\", 2005.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598293\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2581944\", 2012.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2581467\", 2003.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2580180\", 2004.0, 2008, \"Fogarty International Center\", \"United States\"], [\"grant.2566828\", 1999.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2545177\", 2012.0, 2017, \"Agency for Healthcare Research and Quality\", \"United States\"], [\"grant.2477018\", 2004.0, 2010, \"National Cancer Institute\", \"United States\"], [\"grant.2459067\", 2010.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458505\", 2009.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2454744\", 1999.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2451211\", 1988.0, 1993, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2451063\", 1987.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435060\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435034\", 1999.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2409929\", 2001.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2359952\", 2008.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2354952\", 2012.0, 2019, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.8550559\", 2017.0, 2018, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.6661828\", 2017.0, 2018, \"Swiss National Science Foundation\", \"Switzerland\"], [\"grant.4704416\", 2014.0, 2019, \"National Science Center\", \"Poland\"], [\"grant.7144747\", 2013.0, 2014, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7143376\", 2003.0, 2004, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7142769\", 2001.0, 2002, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7043118\", 2005.0, 2012, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7043103\", 1999.0, 2005, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6856356\", 2008.0, 2010, \"Ministry of Education, Universities and Research\", \"Italy\"], [\"grant.6671033\", 2014.0, 2016, \"Nova Scotia Health Research Foundation\", \"Canada\"], [\"grant.6618513\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6416942\", 2016.0, 2018, \"National Agency for Research\", \"France\"], [\"grant.6378716\", 2015.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3701645\", 1991.0, 1994, \"European Commission\", \"Belgium\"], [\"grant.3499383\", 2013.0, 2014, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2723442\", 2010.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2638362\", 2008.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2633208\", 2011.0, 2012, \"Agency for Healthcare Research and Quality\", \"United States\"], [\"grant.2600460\", 2010.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599137\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2567237\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458846\", 2010.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7145428\", 2001.0, 2002, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7143720\", 2006.0, 2007, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7133861\", 2001.0, 2002, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7083896\", 2017.0, 2018, \"Innovate UK\", \"United Kingdom\"], [\"grant.7048257\", 2016.0, 2018, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6932398\", 2017.0, 2018, \"Directorate for Engineering\", \"United States\"], [\"grant.6434842\", 2013.0, 2016, \"National Council for Scientific and Technological Development\", \"Brazil\"], [\"grant.5475786\", 2016.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4898746\", 2016.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4526619\", 2015.0, 2017, \"National Agency for Research\", \"France\"], [\"grant.4242390\", 2015.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.4054922\", 2015.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3829290\", 2010.0, 2015, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3728428\", 1996.0, 1999, \"European Commission\", \"Belgium\"], [\"grant.3624085\", 2014.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2766618\", 1998.0, 2010, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2711483\", 1993.0, 1998, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2695668\", 1989.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688036\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687950\", 2007.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687700\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687360\", 1994.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2679944\", 2007.0, 2010, \"National Institute of General Medical Sciences\", \"United States\"], [\"grant.2669267\", 2009.0, 2012, \"National Cancer Institute\", \"United States\"], [\"grant.2666620\", 2011.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641555\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641424\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641235\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2638361\", 2008.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636978\", 2004.0, 2006, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2636590\", 2008.0, 2010, \"National Institute of Arthritis and Musculoskeletal and Skin Diseases\", \"United States\"], [\"grant.2636516\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2633028\", 2009.0, 2010, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2632159\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2602760\", 1997.0, 1999, \"National Cancer Institute\", \"United States\"], [\"grant.2600220\", 2010.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599545\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599245\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598200\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598185\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597362\", 2002.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2501723\", 2006.0, 2011, \"National Institute of Biomedical Imaging and Bioengineering\", \"United States\"], [\"grant.2485752\", 2003.0, 2009, \"National Institute on Drug Abuse\", \"United States\"], [\"grant.2475426\", 2002.0, 2006, \"National Cancer Institute\", \"United States\"], [\"grant.2459532\", 2012.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459430\", 2011.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459193\", 2011.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457778\", 2009.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457417\", 2006.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456177\", 2005.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455862\", 2002.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2455572\", 2001.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2454563\", 2000.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453938\", 1999.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453675\", 1997.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453157\", 1994.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2452634\", 1992.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2449442\", 1977.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2449186\", 1974.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2418466\", 2008.0, 2009, \"National Cancer Institute\", \"United States\"], [\"grant.7925321\", 2008.0, 2011, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2711626\", 2003.0, 2003, \"United States Food and Drug Administration\", \"United States\"], [\"grant.8519056\", 2013.0, 2014, \"Fonds de Recherche du Qu\\u00e9bec - Sant\\u00e9\", \"Canada\"], [\"grant.7749733\", 2016.0, 2017, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7673664\", 2016.0, 2017, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7618456\", 2015.0, 2018, \"Canadian Cancer Society\", \"Canada\"], [\"grant.7043121\", 2005.0, 2012, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7040510\", 2013.0, 2016, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6460791\", 2016.0, 2017, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.6381145\", 2016.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.5504997\", 2016.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3703693\", 1989.0, 1992, \"European Commission\", \"Belgium\"], [\"grant.2723204\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2723133\", 2009.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2710571\", 2005.0, 2005, \"National Cancer Institute\", \"United States\"], [\"grant.2641917\", 2011.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641846\", 2012.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641825\", 2010.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641582\", 2009.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641474\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641417\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2600613\", 2012.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599420\", 2008.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2581841\", 2010.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459891\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459207\", 2011.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458958\", 2010.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8615120\", 2002.0, 2003, \"Robert Wood Johnson Foundation\", \"United States\"], [\"grant.8588543\", 2016.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8573811\", 2003.0, 2006, \"Ontario Institute for Cancer Research\", \"Canada\"], [\"grant.8458609\", 2013.0, 2014, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8457229\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8343971\", 2016.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8340455\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8339653\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8334613\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8334535\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8333847\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8329741\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8328946\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8216959\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8214963\", 1996.0, 1998, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8214438\", 1995.0, 1997, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8207596\", 1989.0, 1991, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8184627\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8184513\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8183781\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8183778\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8183360\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8174921\", 2009.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8171709\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8145336\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7767266\", 2016.0, 2017, \"United States Department of the Army\", \"United States\"], [\"grant.7766966\", 2016.0, 2017, \"Defense Threat Reduction Agency\", \"United States\"], [\"grant.7765761\", 2016.0, 2017, \"United States Department of Defense\", \"United States\"], [\"grant.7724040\", 2018.0, 2019, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7667260\", 2005.0, 2006, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7664869\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7656538\", 2007.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7651336\", 2008.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7649919\", 2008.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7640714\", 2009.0, 2009, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7635437\", 2008.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7632116\", 2008.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7624865\", 2011.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7621645\", 2007.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7209085\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7202920\", 2015.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7198131\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7189701\", 2014.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7186623\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7181817\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7178941\", 2013.0, 2016, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7170931\", 2017.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.7140864\", 2010.0, 2011, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7138381\", 1996.0, 1997, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7125513\", 2012.0, 2013, \"Swedish Research Council\", \"Sweden\"], [\"grant.7123318\", 2009.0, 2010, \"Swedish Research Council\", \"Sweden\"], [\"grant.7119830\", 2010.0, 2012, \"Swedish Research Council\", \"Sweden\"], [\"grant.7107975\", 2013.0, 2018, \"Swedish Foundation for Strategic Research\", \"Sweden\"], [\"grant.7096947\", 2016.0, 2017, \"Swedish Research Council\", \"Sweden\"], [\"grant.7095071\", 2010.0, 2012, \"Swedish Research Council\", \"Sweden\"], [\"grant.7043000\", 2000.0, 2003, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7042563\", 2004.0, 2010, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.7024736\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7022578\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7013810\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7012934\", 2012.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6999438\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6994947\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6994410\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6991532\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6991520\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6991182\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6990117\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6983221\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6983019\", 2012.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6981617\", 2014.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6980454\", 2014.0, 2014, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6932286\", 2017.0, 2018, \"Directorate for Engineering\", \"United States\"], [\"grant.6891494\", 1998.0, 2000, \"Czech Science Foundation\", \"Czechia\"], [\"grant.6888017\", 2010.0, 2013, \"Czech Science Foundation\", \"Czechia\"], [\"grant.6849449\", 2016.0, 2016, \"California Institute for Regenerative Medicine\", \"United States\"], [\"grant.6793067\", 2015.0, 2016, \"United States Department of Defense\", \"United States\"], [\"grant.6759552\", 2013.0, 2013, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.6665244\", 2016.0, 2018, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.6663844\", 2015.0, 2018, \"Melanoma Research Alliance\", \"United States\"], [\"grant.6621694\", 2017.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.6502258\", 2016.0, 2019, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.6381108\", 2016.0, 2017, \"Innovate UK\", \"United Kingdom\"], [\"grant.6239164\", 1987.0, 1990, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5894519\", 2004.0, 2006, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5838858\", 2003.0, 2004, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5819445\", 2002.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5813252\", 2002.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5798285\", 2001.0, 2003, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5778403\", 2000.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5762242\", 1999.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5653175\", 1994.0, 1995, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5636461\", 1994.0, 1995, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5634704\", 1993.0, 1993, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5602201\", 1992.0, 1994, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5537052\", 2015.0, 2018, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.5145795\", 2003.0, 2008, \"Cancer Research UK\", \"United Kingdom\"], [\"grant.5018695\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5017925\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5009211\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5006128\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5005113\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5004063\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.5001338\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4998819\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4998575\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4995025\", 2011.0, 2013, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4986606\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4984532\", 2011.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4981684\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4973116\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4962484\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4961959\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4961830\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4958898\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4956057\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4952485\", 2004.0, 2006, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4951856\", 2009.0, 2011, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4940647\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4938462\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4934796\", 2005.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4933015\", 2007.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4932126\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4930753\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4928248\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4927844\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4927113\", 1998.0, 2000, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4926392\", 2008.0, 2010, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4926144\", 2007.0, 2009, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4924377\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4912662\", 2010.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4912066\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4903278\", 2009.0, 2012, \"National Natural Science Foundation of China\", \"China\"], [\"grant.4893254\", 2014.0, 2015, \"United States Department of the Army\", \"United States\"], [\"grant.4638867\", 2011.0, 2014, \"The Research Council of Norway\", \"Norway\"], [\"grant.4579336\", 2016.0, 2018, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4579119\", 2014.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.4550783\", 2002.0, 2005, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4515357\", 1996.0, 2002, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4488747\", 2009.0, 2014, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4487266\", 2011.0, 2013, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4485815\", 2010.0, 2012, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4481761\", 2013.0, 2015, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4446596\", 1985.0, 1986, \"United States Department of the Army\", \"United States\"], [\"grant.4369312\", 2012.0, 2013, \"United States Department of the Army\", \"United States\"], [\"grant.4119613\", 2005.0, 2007, \"Michael Smith Foundation for Health Research\", \"Canada\"], [\"grant.4035533\", 2013.0, 2014, \"Saskatchewan Health Research Foundation\", \"Canada\"], [\"grant.3846713\", 2013.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3840565\", 2010.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3833138\", 2010.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3830372\", 2010.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3823937\", 2011.0, 2013, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3815912\", 2011.0, 2016, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3813523\", 2007.0, 2008, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3811209\", 2006.0, 2011, \"Agricultural Research Service\", \"United States\"], [\"grant.3806816\", 2014.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.3783912\", 2010.0, 2012, \"European Commission\", \"Belgium\"], [\"grant.3747160\", 2000.0, 2004, \"European Commission\", \"Belgium\"], [\"grant.3743602\", 2000.0, 2003, \"European Commission\", \"Belgium\"], [\"grant.3730420\", 1997.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3643075\", 2009.0, 2011, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3643010\", 2013.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3640055\", 2010.0, 2013, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3639922\", 2011.0, 2014, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3639862\", 2012.0, 2017, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3635735\", 2012.0, 2015, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3630957\", 2008.0, 2012, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3629169\", 2003.0, 2006, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.3627644\", 2007.0, 2010, \"Wellcome Trust\", \"United Kingdom\"], [\"grant.2815876\", 2011.0, 2012, \"Natural Sciences and Engineering Research Council\", \"Canada\"], [\"grant.2782054\", 2007.0, 2008, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2775543\", 2009.0, 2014, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2753642\", 2010.0, 2012, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2711569\", 1997.0, 1999, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711541\", 2000.0, 2002, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711209\", 1992.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2709727\", 1992.0, 1992, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2708830\", 1995.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704647\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2695923\", 2010.0, 2015, \"National Center for Complementary and Integrative Health\", \"United States\"], [\"grant.2695778\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2688081\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687721\", 2004.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687202\", 1989.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2666811\", 2013.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657817\", 1999.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657569\", 1989.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2654335\", 1998.0, 1999, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2646969\", 1990.0, 1990, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.2643965\", 1999.0, 2000, \"National Cancer Institute\", \"United States\"], [\"grant.2641521\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641308\", 2005.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641156\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641134\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640884\", 2003.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640647\", 2000.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640492\", 1998.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640479\", 1998.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640473\", 1998.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640225\", 1995.0, 1996, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640198\", 1994.0, 1994, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639892\", 1989.0, 1989, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2639810\", 1988.0, 1988, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636506\", 2012.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636420\", 2004.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2601233\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597386\", 1997.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2577671\", 1998.0, 1999, \"National Institute of Mental Health\", \"United States\"], [\"grant.2568118\", 1991.0, 1993, \"National Cancer Institute\", \"United States\"], [\"grant.2567052\", 2004.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2480171\", 2009.0, 2014, \"National Cancer Institute\", \"United States\"], [\"grant.2467344\", 1984.0, 1988, \"National Cancer Institute\", \"United States\"], [\"grant.2456685\", 2004.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456117\", 2003.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2451240\", 1989.0, 1991, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424927\", 1988.0, 1992, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2370445\", 2005.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.8586139\", 2019.0, 2019, \"European Commission\", \"Belgium\"], [\"grant.8550870\", 2017.0, 2018, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.8550869\", 2017.0, 2018, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.8458639\", 2015.0, 2016, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8458394\", 2017.0, 2019, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8334271\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8185917\", 2015.0, 2018, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8178837\", 2014.0, 2017, \"National Natural Science Foundation of China\", \"China\"], [\"grant.7664581\", 2014.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7647386\", 2012.0, 2013, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7642410\", 2008.0, 2011, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7640114\", 2009.0, 2010, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7636485\", 2005.0, 2008, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7623307\", 2007.0, 2007, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7620846\", 2017.0, 2018, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.7138827\", 1997.0, 1998, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.7099836\", 2015.0, 2018, \"Swedish Research Council\", \"Sweden\"], [\"grant.7050174\", 2016.0, 2017, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.7040500\", 1999.0, 2003, \"Department for Environment Food and Rural Affairs\", \"United Kingdom\"], [\"grant.6996265\", 2013.0, 2015, \"National Natural Science Foundation of China\", \"China\"], [\"grant.6805630\", 2014.0, 2018, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.6382115\", 2014.0, 2019, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.6224508\", 1985.0, 1987, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.6004587\", 2008.0, 2009, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5910597\", 2016.0, 2019, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5802355\", 2001.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5800369\", 2001.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5796849\", 2001.0, 2002, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5754852\", 2010.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5750850\", 1999.0, 2001, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5716915\", 2009.0, 2012, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5637120\", 1994.0, 1994, \"Japan Society for the Promotion of Science\", \"Japan\"], [\"grant.5503915\", 2016.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.5349803\", 2011.0, 2011, \"Russian Foundation for Basic Research\", \"Russia\"], [\"grant.5054576\", 2016.0, 2017, \"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"], [\"grant.4942762\", 2016.0, 2018, \"The Research Council of Norway\", \"Norway\"], [\"grant.4895796\", 2014.0, 2016, \"Russian Science Foundation\", \"Russia\"], [\"grant.4694512\", 2008.0, 2010, \"Juvenile Diabetes Research Foundation\", \"United States\"], [\"grant.4679006\", 2005.0, 2009, \"The Research Council of Norway\", \"Norway\"], [\"grant.4660408\", 2007.0, 2012, \"The Research Council of Norway\", \"Norway\"], [\"grant.4659393\", 2012.0, 2017, \"The Research Council of Norway\", \"Norway\"], [\"grant.4646343\", 2006.0, 2010, \"The Research Council of Norway\", \"Norway\"], [\"grant.4645097\", 2006.0, 2007, \"The Research Council of Norway\", \"Norway\"], [\"grant.4642173\", 2007.0, 2011, \"The Research Council of Norway\", \"Norway\"], [\"grant.4534271\", 2007.0, 2009, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4475728\", 2012.0, 2015, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4472767\", 2012.0, 2014, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.4274070\", 2015.0, 2015, \"European Commission\", \"Belgium\"], [\"grant.4057204\", 2015.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.3953270\", 2014.0, 2015, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3945629\", 2013.0, 2015, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3939603\", 2015.0, 2019, \"European Commission\", \"Belgium\"], [\"grant.3847452\", 2013.0, 2015, \"Innovate UK\", \"United Kingdom\"], [\"grant.3847218\", 2013.0, 2014, \"Innovate UK\", \"United Kingdom\"], [\"grant.3839140\", 2012.0, 2015, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3836265\", 2010.0, 2014, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3816560\", 2009.0, 2012, \"National Institute of Food and Agriculture\", \"United States\"], [\"grant.3800484\", 2013.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.3800251\", 2013.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.3798782\", 2013.0, 2017, \"European Commission\", \"Belgium\"], [\"grant.3796896\", 2013.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.3795062\", 2013.0, 2018, \"European Commission\", \"Belgium\"], [\"grant.3778054\", 2007.0, 2010, \"European Commission\", \"Belgium\"], [\"grant.3776776\", 2006.0, 2008, \"European Commission\", \"Belgium\"], [\"grant.3776766\", 2009.0, 2012, \"European Commission\", \"Belgium\"], [\"grant.3775456\", 2009.0, 2011, \"European Commission\", \"Belgium\"], [\"grant.3769804\", 2005.0, 2007, \"European Commission\", \"Belgium\"], [\"grant.3749469\", 1998.0, 1999, \"European Commission\", \"Belgium\"], [\"grant.3736252\", 1998.0, 2000, \"European Commission\", \"Belgium\"], [\"grant.3721586\", 1996.0, 1997, \"European Commission\", \"Belgium\"], [\"grant.3135164\", 2011.0, 2013, \"Directorate for Engineering\", \"United States\"], [\"grant.2766098\", 2007.0, 2008, \"Medical Research Council\", \"United Kingdom\"], [\"grant.2765030\", 2009.0, 2011, \"Biotechnology and Biological Sciences Research Council\", \"United Kingdom\"], [\"grant.2726426\", 2011.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2711566\", 1997.0, 1998, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2711200\", 1991.0, 1991, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2704629\", 2004.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2704602\", 2000.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2692264\", 2011.0, 2016, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2689373\", 2006.0, 2009, \"Centers for Disease Control and Prevention\", \"United States\"], [\"grant.2688035\", 2008.0, 2013, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687963\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687948\", 2007.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687707\", 2005.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687655\", 2003.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2687645\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2658044\", 2006.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657851\", 2000.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657802\", 1998.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2657756\", 1997.0, 2001, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2650996\", 2012.0, 2014, \"National Institute of General Medical Sciences\", \"United States\"], [\"grant.2645340\", 2008.0, 2010, \"National Cancer Institute\", \"United States\"], [\"grant.2644024\", 1999.0, 2001, \"National Cancer Institute\", \"United States\"], [\"grant.2641283\", 2005.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2641280\", 2006.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640997\", 2003.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640928\", 2002.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640815\", 2001.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640772\", 2001.0, 2002, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640696\", 2001.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640674\", 2001.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640635\", 2001.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2640537\", 1998.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2636444\", 2006.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2632162\", 2009.0, 2010, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2631500\", 2007.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2604709\", 2009.0, 2011, \"National Cancer Institute\", \"United States\"], [\"grant.2601355\", 2013.0, 2016, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2600357\", 2011.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2599306\", 2007.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598906\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598853\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598797\", 2006.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598470\", 2005.0, 2009, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598285\", 2003.0, 2007, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2598003\", 2002.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597976\", 2002.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597911\", 2002.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597795\", 2001.0, 2004, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597419\", 1997.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2597353\", 2001.0, 2003, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2585998\", 2013.0, 2018, \"United States Food and Drug Administration\", \"United States\"], [\"grant.2581500\", 2004.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2581365\", 1999.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2566930\", 2003.0, 2006, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2471015\", 1992.0, 1996, \"National Cancer Institute\", \"United States\"], [\"grant.2459743\", 2012.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2459536\", 2012.0, 2018, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2458866\", 2010.0, 2015, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2457499\", 2006.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456659\", 2004.0, 2008, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2456070\", 2003.0, 2011, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2453081\", 1994.0, 1999, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2435196\", 2009.0, 2012, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2434960\", 1994.0, 2005, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424625\", 1994.0, 2000, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2424575\", 1993.0, 1998, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.2420915\", 2000.0, 2005, \"National Cancer Institute\", \"United States\"], [\"grant.2410235\", 2009.0, 2014, \"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"grant.100071932\", 2016.0, 2018, \"V Foundation for Cancer Research\", \"United States\"], [\"grant.8594124\", 2012.0, 2018, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8591790\", 2015.0, 2017, \"Belgian Federal Science Policy Office\", \"Belgium\"], [\"grant.8550889\", 2017.0, 2018, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.8550496\", 2017.0, 2018, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.8472155\", 2017.0, 2018, \"Congressionally Directed Medical Research Programs\", \"United States\"], [\"grant.8456826\", 2016.0, 2017, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8456825\", 2018.0, 2019, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8456820\", 2017.0, 2018, \"Canadian Institutes of Health Research\", \"Canada\"], [\"grant.8219774\", 2000.0, 2002, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8215413\", 1996.0, 1998, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8173004\", 2006.0, 2008, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8171715\", 2004.0, 2007, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8171555\", 2004.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170908\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170796\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170794\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170663\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170645\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170640\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8170373\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169342\", 2003.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169087\", 2002.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8169047\", 2002.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8168649\", 2002.0, 2004, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8168333\", 2002.0, 2005, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8167459\", 2001.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8167453\", 2001.0, 2003, \"National Natural Science Foundation of China\", \"China\"], [\"grant.8108168\", 1997.0, 1999, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8107600\", 2001.0, 2006, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.8106422\", 2012.0, 2014, \"Ministry of Agriculture, Food and Rural Affairs\", \"Canada\"], [\"grant.7923972\", 2019.0, 2019, \"S\\u00e3o Paulo Research Foundation\", \"Brazil\"], [\"grant.7878131\", 2014.0, 2018, \"National Health and Medical Research Council\", \"Australia\"]], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"<b>%{hovertext}</b><br><br>End Year=%{customdata[2]}<br>clinical_trials=%{y}<br>Grant ID=%{customdata[0]}<br>Start Year=%{customdata[1]}<br>Funder=%{customdata[3]}<br>Funder Country=%{customdata[4]}<br>Funding Amount in USD=%{marker.color}\", \"hovertext\": [\"\\u75ab\\u82d7\\uff0d\\u6574\\u4f53\\u65b9\\u6848\", \"Engineering Inhalable Vaccines\", \"Engineering Inhalable Vaccines\", \"HIV Vaccine research\", \"HIV Vaccine Development\", \"Dengue virus vaccine.\", \"Engineering Inhalable Vaccines\", \"Schistosomiasis Vaccine Network.\", \"Pneumococcal Ribosomal Vaccines\", \"Rational vaccine design\", \"Rational vaccine design\", \"Aquaticulture vaccines\", \"Aquaticulture vaccines\", \"Vaccines for aquaculture\", \"Cancer Vaccine Development\", \"CRYPTOSPORIDIUM RECOMBINANT VACCINES\", \"ANTIRETROVIAL DNA VACCINE\", \"VACCINE FOR LEISHMANIASIS\", \"CANCER VACCINE PRODUCTION\", \"CANCER VACCINE PRODUCTION\", \"CANCER VACCINE PRODUCTION\", \"CANCER VACCINE PRODUCTION\", \"CANCER VACCINE PRODUCTION\", \"CANCER VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"VACCINES FOR SAIDS\", \"Entwicklung viraler Vektorvakzinen/Markervakzinen\", \"Herpes Vaccine project\", \"VACCINE DELIVERY SYSTEM FOR LIVE ROTAVIRUS VACCINES\", \"IMMUNOLOGICAL STUDIES IN VACCINES OF RABIES VACCINE\", \"Vaccine adjuvant commercialisation project\", \"Shelf life of vaccines\", \"Duck viral Hepatitis vaccine\", \"Novel vaccines against AIDS\", \"Synthetic peptides as vaccines\", \"Klebsiella Vaccines and Immunotherapeutics\", \"Malaria and Vaccine Research\", \"Vaccines for complex organisms\", \"DENGUE VACCINE DEVELOPMENT\", \"Novel Vaccines for Measles\", \"Streptococcal mastitis vaccine development\", \"Bovine adenovirus vectored vaccines\", \"Vaccine formulation and delivery\", \"Streptococcal mastitis vaccine development\", \"Vaccins th\\u00e9rapeutiques anti-cancer\", \"Subunit vaccines for aquaculture\", \"Pan-PRovincial Vaccine ENTerprise\", \"Vaccine formulation and delivery\", \"Vaccines for farm fish\", \"Vaccins th\\u00e9rapeutiques anti-cancer\", \"Vaccins th\\u00e9rapeutiques anti-cancer\", \"Vaccines for farm fish\", \"Improving cancer vaccine efficacy\", \"NEW VACCINE SURVEILLANCE NETWORK\", \"MACROPHAGE-BASED MELANOMA VACCINE\", \"HELICOBACTER PYLORI MUCOSAL VACCINE\", \"MALARIA VACCINE ADJUVANT DEVELOPMENT\", \"HIV GP120 GLYCOCONJUGATE VACCINES\", \"SIMIAN VACCINE EVALUATION UNITS\", \"TESTING VACCINES IN CHILDREN\", \"HLA AND VACCINES (BAA)\", \"AIDS VACCINE EVALUATION UNITS\", \"AIDS VACCINE EVALUATION UNITS\", \"AIDS VACCINE EVALUATION UNITS\", \"AIDS VACCINE EVALUATION UNITS\", \"AIDS VACCINE EVALUATION UNITS\", \"AIDS VACCINE EVALUATION UNITS\", \"EVALUATION OF CANDIDATE VACCINES\", \"AIDS VACCINE EVALUATION UNITS\", \"IMMUNIZATION & VACCINES FOR CHILDREN\", \"Hepatatis B Vaccine Pilot\", \"Verbundprojekt: Verfahren zur Impfstoffentwicklung: Rekombinante Impfstoffe Impfstoffe gegen virale Erkrankungen von Salmoniden\", \"\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7684\\u673a\\u7406\", \"\\u574f\\u6b7b\\u6746\\u83cc\\u91cd\\u7ec4\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u7814\\u7a76\", \"2009\\u4e9a\\u6d32DNA\\u75ab\\u82d7\\u56fd\\u9645\\u5e74\\u4f1a\", \"2004\\u5e74DNA\\u75ab\\u82d7\\u56fd\\u9645\\u4f1a\\u8bae\", \"\\u7b2c\\u4e09\\u5c4a\\u75ab\\u82d7\\u7814\\u7a76\\u5e74\\u4f1a\", \"BioChancePLUS: Therapeutische Vakzinierung gegen Multiple Sklerose\", \"Improved Vaccines for Breast Cancer Immunotherapy\", \"Sterilization Vaccine for Cattle\", \"Vaccine Production in Plants\", \"Novel vaccine formulations against tuberculosis\", \"Development of recombinant TB vaccine\", \"Hepatitis C: Vaccines and Immunotherapy\", \"DNA vaccine for chlamydia\", \"nd\", \"New Generation Recombinant Viral Vaccine Vectors\", \"The automated synthesis of tuberculosis vaccines\", \"\\uc2e0\\ubcc0\\uc885 \\uc778\\ud50c\\ub8e8\\uc5d4\\uc790 \\ubc14\\uc774\\ub7ec\\uc2a4 \\uc81c\\uc5b4 \\uc5f0\\uad6c\", \"Mucosal Vaccine against HIV-1 Infection\", \"Oral DNA Vaccines\", \"Microcontainers for oral vaccine delivery\", \"Microcontainers for oral vaccine delivery\", \"EC collaborative study for tetanus vaccines\", \"Antigenic properties of vaccine virus strains\", \"Alternative methods of formulating FMDV vaccines\", \"To maintain the footandmouth vaccine bank\", \"Vaccins et adjuvants pour la vache laiti\\u00e8re\", \"Prototype vaccine against sea lice\", \"Thermal Stabilization of Phage and Vaccines\", \"A DNA Vaccine to Prevent Schistosomiasis\", \"Immune response to malaria vaccine candidate\", \"Development of a contraceptive vaccine\", \"Challenging the malaria vaccine development strategy\", \"Diabetes Vaccine Development Centre (DVDC)\", \"Vivax malaria sporozoite vaccine development\", \"New vaccines produced by genetic engineering\", \"A Mucosal HIV Polytype Vaccine\", \"HIV (AIDS) vaccine delivery vectors\", \"A vaccine for cervical cancer\", \"Development of an oral pneumococcal vaccine.\", \"Development of new types of vaccines.\", \"DNA and avipox vaccines for HIV.\", \"Characterisation of Neisseria meningitidis vaccine candidates\", \"Towards a vaccine against hepatitis e\", \"A modern vaccine against leptospirosis\", \"Development of an improved pneumococcal vaccine\", \"Additional vaccine antigens for chlamydia\", \"To support the Vaccine Leadership Conference\", \"\\u98a8\\u8a3a\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u98a8\\u75b9\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u6d41\\u884c\\u6027\\u8033\\u4e0b\\u817a\\u708e\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u5408\\u6210\\u30de\\u30e9\\u30ea\\u30a2\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u7814\\u7a76\", \"Biochemical characterization of a vaccine\", \"\\u5358\\u7d14\\u30d8\\u30eb\\u30da\\u30b9\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u7814\\u7a76\", \"\\u30d1\\u30e9\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u65b0\\u898f\\u816b\\u760d\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4f5c\\u88fd\", \"Anti-Vaccine Blog Annotation Project\", \"Vaccine-based immunotherapy of cancer\", \"HIV VACCINE PRODUCTION\", \"Therapeutics/Vaccine Teams\", \"Tularemia Vaccine Development\", \"\\u5e7d\\u95e8\\u87ba\\u6746\\u83cc\\u78f7\\u9178\\u9499\\u7eb3\\u7c73\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"Anti-tick Vaccines\", \"SEVAPLANT - Secure Vaccine Production in Plants\", \"Development of Novel Vaccines through Glycoengineering\", \"Mucosal vaccines against autoimmune disease\", \"DEVELOPMENT OF MALARIA VACCINE\", \"VACCINES AGAINST TROPICAL THEILERIOSIS\", \"Creation of an anti-diarrhea vaccine\", \"Fish Biologics Symposium: Serodiagnostics and Vaccines\", \"Oral delievery of vaccines to salmonids\", \"Tumor associated carbohydrates and vaccine design\", \"Vaccines for bovine respiratory disease\", \"Vaccines for bovine respiratory disease\", \"D\\u00e9veloppement_d'un vaccin contre Streptococcus suis\", \"Development of subunit Streptococcus suis vaccines\", \"Development of subunit Streptococcus suis vaccines\", \"D\\u00e9veloppement_dun vaccin contre Streptococcus suis\", \"Carbohydrate-based anti cancer vaccines\", \"Vaccines comprising heat-sensitive transgenes\", \"A vaccine to inhibit tick feeding\", \"Porcine cicovirus pathogenesis and vaccine development\", \"DNA vaccine for avian influenza\", \"Oral delivery of vaccines and immunomodulators\", \"Bioinformatics and intelligent vaccine design\", \"Tumor Associated Carbohydrates and Vaccine design\", \"Developing plant based vaccines from forages\", \"Bovine adenovirus-3 vectored vaccines\", \"Possible peptide vaccine candidtates for leishmania\", \"Recombinant vaccine development for tenacibaculum maritimum\", \"Oral delievery of vaccines to salmonids\", \"Annual Conference on Vaccine Research\", \"Varicella and Viral Vaccine Preventable Disease\", \"Alphavirus Replicon Vaccines to Encephalitis Viruses\", \"MALARIA VACCINE RESEARCH AND DEVELOPMENT PROJECT\", \"STRATEGIES FOR HIV VACCINE DEVELOPMENT\", \"LIPOSOME MICROENCAPSULATION OF VACCINE ANTIGENS\", \"MULTIVALENT VACCINE FOR LYMPHATIC FILARIASIS\", \"An Envelope Containing HIV Pseudovirion Vaccine\", \"MICROBIAL POPULATION STRATEGY FOR VACCINE DEVELOPMENT\", \"THERAPEUTIC TUMOR VACCINE AGAINST MUC-1\", \"SYNTHESIS OF RNA CANCER VACCINES\", \"DEVELOPMENT OF SYNTHETIC CANCER VACCINES\", \"NOVEL VACCINE FOR HELICOBACTER PYLORI\", \"HIV-1 VACCINE FOR DEVELOPING COUNTRIES\", \"DEVELOPMENT OF CAMPYLOBACTER FLAGELLIN SUBUNIT VACCINE\", \"DEVELOPMENT OF A NOVEL VACCINE STRATEGY\", \"SUSTAINED RELEASE FOR VACCINES AND ADJUVANTS\", \"BIODEGRADABLE MINERAL MICROSPHERE ADJUVANTS FOR VACCINES\", \"SYNTHETIC VACCINES UTILIZING BACULOVIRUS POLYHEDRA\", \"DEVELOPMENT OF ROTAVIRUS DNA VACCINES\", \"BIVALENT CONJUGATED RSV PNEUMOCOCCUS VACCINE\", \"AVIRULENT SALMONELLA HOST-VECTOR VACCINE SYSTEMS\", \"SALMONELLA/HUMAN IMMUNODEFICIENCY VIRUS VACCINE VECTOR\", \"A VACCINE FOR IMMUNE MEDIATED DIABETES\", \"CHIMERIC HER-2 PEPTIDE VACCINE\", \"CYTOMEGALOVIRUS VECTORS FOR HIV VACCINE DEVELOPMENT\", \"A RECOMBINANT PORPHYROMONAS GINGIVALIS VACCINE\", \"INDO-US VACCINE ACTION PROGRAM\", \"INDO-US VACCINE ACTION PROGRAM\", \"INDO-US VACCINE ACTION PROGRAM\", \"INDO-US VACCINE ACTION PROGRAM\", \"INDO-US VACCINE ACTION PROGRAM\", \"CHILDHOOD VACCINES AND DENTAL CARIES IMMUNITY\", \"ENHANCING TUMOR VACCINE IMMUNOGENICITY BY ANTIGAL\", \"IMMUNOLOGICAL EFFECTS OF MELANOMA VACCINE THERAPY\", \"BREAST TUMOR SPECIFIC IMMUNITY--VACCINE DESIGN\", \"ANTITUMOR ARTIFICIAL RECEPTORS AS CANCER VACCINES\", \"IMMUNOLOGICALLY FOCUSED APPROACH TO AIDS VACCINE\", \"VACCINE INTERVENTION FOR LYME BORRELIOSIS\", \"SECOND-GENERATION VACCINES AGAINST LYME DISEASE\", \"MICROSPHERES TO ENHANCE VACCINE IMMUNOGENICITY\", \"RATIONALE FOR SPOROZOITE MALARIA VACCINE DEVELOPMENT\", \"NONLIVING VACCINE AGAINST S MANSONI\", \"MONOCLONAL ANTIBODY ANTI-IDIOTYPE TUMOR VACCINES\", \"ADENOVIRUS RECOMBINANTS FOR VACCINE EFFICACY\", \"DEVELOP LIVE ATTENUATED CYTOMEGALOVIRUS VACCINES\", \"INVESTIGATION OF ANTICARIES VACCINE IN PRIMATES\", \"MODELS FOR AIDS VACCINE RESEARCH\", \"MODELS FOR AIDS VACCINE RESEARCH\", \"OPERATE EXPERIMENTAL VIRUS VACCINE LABORATORY\", \"MFG OF YEAST-PRODUCED MALARIA VACCINES\", \"INFECTIOUS AGENTS, VACCINES &ANTIMICROBIALS IN HUMANS\", \"EXPERIMENTAL VIRUS VACCINE PRODUCTION LABORATORY\", \"EFFICACY TRIAL OF COLD-ADAPTED VACCINES\", \"TESTING VACCINES IN ADOLESCENTS AND ADULTS\", \"HIV VACCINE TRIALS AND EPIDEMIOLOGY REPOSITORY\", \"DEVELOP A VACCINE FOR GONORRHEA\", \"DEVELOP AN ACELLULAR BORDETELLA PERTUSSIS VACCINE\", \"INVESTIGATIONAL NEW DRUGS AND VACCINES\", \"ADVERSE REACTIONS OF CHILDHOOD VACCINES\", \"MALARIA VACCINE PRODUCTION &SUPPORT SERVICES\", \"CLINICAL EVALUATION OF LIVE HERPESVIRUS VACCINE\", \"ACELLULAR VACCINES AGAINST BACTERIAL PATHOGENS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"MISSISSIPPI IMMUNIZATION AND VACCINE GRANT\", \"Immunization and Vaccines for Children Program\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANT\", \"IMMUNIZATION AND VACCINES FOR CHILDREN PROGRAM\", \"IMMUNIZATIONS AND VACCINE FOR CHILDREN\", \"IMMUNIZATIONS AND VACCINES FOR CHILDREN GRANTS\", \"Immunization and Vaccines for Children Program\", \"MINNESOTA STATEWIDE IMMUNIZATION & VACCINES PROGRAM\", \"ARIZONA IMMUNIZATION AND VACCINE FOR CHILDREN\", \"IMMUNIZATION AND VACCINES FOR CHILDREN\", \"IMMUNIZATION AND VACCINES FOR CHILDREN GRANT\", \"NEW JERSEY VACCINE PREVENTABLE DISEASE PROGRAM\", \"NEVADA IMMUNIZATION AND VACCINES FOR CHILDREN\", \"IMMUNIZATIONS AND VACCINES FOR CHILDREN\", \"IMMUNIZATION AND VACCINES FOR CHILDREN PROGRAM\", \"EVALUATION OF GENETICALLY ENGINEERED ROTAVIRUS VACCINES\", \"GROUP B STREPTOCOCCAL OLIGOSACCHARIDE-CONJUGATE VACCINE\", \"NOVEL APPROACH TOWARD RETROVIRAL VACCINE DESIGN\", \"Develop low-cost prophylactic vaccines against HCV, and therapeutic vaccines against HBV\", \"Development of diagnostic tools and vaccines\", \"Potenzierung von Impfstoffen durch gezieltes Design der Glykosylierung - IPoGly (Impfstoffpotenzierung durch Glykosylierung)\", \"EDCTP: Malaria Vakzine, vorbereitende Arbeiten zur Entwicklung zweier Malaria Impfstoffe\", \"Verbundprojekt: Innovative bakterielle Tumorimpfstoffe - Teilprojekt 1: Bakterielles Prostatakrebsvakzin\", \"Development of Porphyric Intracellular Leishmania Parasite for the Effect vaccine and Vaccine Delivery System\", \"DNA \\ubc31\\uc2e0 \\ubc0f \\ubc31\\uc2e0\\ubcf4\\uc870\\uc81c \\uc804\\ub2ec\\uc744 \\uc704\\ud55c \\ud6a8\\uc728\\uc801\\uc774\\uace0 \\uc2a4\\ub9c8\\ud2b8\\ud55c \\ub9c8\\uc774\\ud06c\\ub2c8\\ub4e4\\uc2dc\\uc2a4\\ud15c \\uac1c\\ubc1c\", \"\\uc778\\uc720\\ub450\\uc885\\ubc14\\uc774\\ub7ec\\uc2a4 \\ubc31\\uc2e0 \\uc81c\\ud488\\ud654 \\ubc0f \\ucc28\\uc138\\ub300 \\uc778\\uc720\\ub450\\uc885\\ubc14\\uc774\\ub7ec\\uc2a4 \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc778\\uc720\\ub450\\uc885\\ubc14\\uc774\\ub7ec\\uc2a4 4\\uac00 \\ubc31\\uc2e0\\uc758 \\uc81c\\ud488\\ud654 \\ubc0f \\uc778\\uc720\\ub450\\uc885\\ubc14\\uc774\\ub7ec\\uc2a4 10\\uac00 \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc800\\uc628\\uc801\\uc751 \\uc57d\\ub3c5 \\uc0dd\\ubc31\\uc2e0\\ud615 \\ub9cc\\ub2a5\\ub3c5\\uac10\\ubc31\\uc2e0 \\uac1c\\ubc1c \\uc5f0\\uad6c\", \"Vaccine Biotechnology: Genetically Engineered Chimeric Protein Vaccine Against Foot-and-Mouth Disease\", \"Therapeutic cancer vaccine for test in human\", \"The Vaccine Project\", \"Ing\\u00e9nierie d'un plateforme vaccinale et d\\u00e9veloppement d'un vaccin v\\u00e9t\\u00e9rinaire contre la gripp\", \"Hepatitis C vaccine preparedness: feasibility of field-based vaccine trials\", \"A MUCOSAL PROPHYLACTIC VACCINE AGAINST COCCIDIOIDOMYCOSIS\", \"\\u9b5a\\u985e\\u5bc4\\u751f\\u866b\\u306b\\u5bfe\\u3059\\u308b\\u907a\\u4f1d\\u5b50\\u7d44\\u63db\\u3048\\u30ef\\u30af\\u30c1\\u30f3\\u304a\\u3088\\u3073DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u9b5a\\u985e\\u30a6\\u30a4\\u30eb\\u30b9\\u3092\\u7528\\u3044\\u305fDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u4ee3\\u308f\\u308b\\u65b0\\u305f\\u306aRNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u7d44\\u307f\\u63db\\u3048BCG\\u30ef\\u30af\\u30c1\\u30f3\\u30b7\\u30b9\\u30c6\\u30e0\\u3092\\u7528\\u3044\\u305f\\u3001\\u3046\\u8755\\u4e88\\u9632\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u65b0\\u898f\\u7c98\\u819c\\u30ef\\u30af\\u30c1\\u30f3\\u30ad\\u30e3\\u30ea\\u30a2\\u30fc\\u306e\\u958b\\u767a\\u304a\\u3088\\u3073\\u30a8\\u30a4\\u30ba\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"HIV Vaccine Design and Dev. Teams Part A - Preventative Vaccines\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS PART A - PREVENTATIVE VACCINES\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS, PART B-THERAPEUTIC VACCINES\", \"HIV VACCINES DESIGN &DEVELOPMENT TEAMS-PART B-THERAPEUTIC VACCINE\", \"HIV Vaccines Design and Dev. Teams Part A - Preventative Vaccine\", \"HIV VACCINES DESIGN AND DEVELOPMENT TEAMS PART A - PREVENTATIVE VACCINE\", \"HIV Vaccine Design and Development, Part A-Preventative Vaccines\", \"Priprava tumorskih vakcin: hibridomi in gensko spremenjene vakcine (basic research project)\", \"Economics of Vaccines and Immunization Policies, Programs, and Practices for Adults: Prioritysetting for adult vaccines\", \"Nanoparticle delivery systems for cancer vaccines - applications to a MUC1 lipopeptide cancer vaccine\", \"Millenium Vaccine Initiative-Novel Vaccines for TB and Malaria-26625480\", \"\\u73fe\\u884c\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u304b\\u308f\\u308b\\u526f\\u4f5c\\u7528\\u306e\\u306a\\u3044\\u7834\\u50b7\\u98a8\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4f5c\\u6210\\u6cd5\\u3068, \\u305d\\u306e\\u4e8c\\u7a2e(\\u30b8\\u30d5\\u30c6\\u30ea\\u30a2\\u30fb\\u7834\\u50b7\\u98a8)\\u6df7\\u5408\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"Evaluatie van afgiftesystemen voor mRNA kanker vaccins\", \"Naar een universeel op mRNA-gebaseerd therapeutisch vaccin tegen HIV\", \"Ontwikkeling van een generische microparticulaire vaccin formulatie\", \"Ontwikkeling van een vaccin tegen Ascaris suum bij het varken.\", \"\\u611f\\u67d3\\u514d\\u75ab\\u3001\\u75ab\\u82d7\\u4e0e\\u6cbb\\u7597\\u6027\\u6297\\u4f53\\u53cc\\u8fb9\\u7814\\u8ba8\\u4f1a\", \"\\u7528\\u8f6c\\u57fa\\u56e0\\u690d\\u7269\\u751f\\u4ea7\\u53e3\\u670d\\u75ab\\u82d7\", \"\\u626b\\u63cf\\u63a2\\u9488\\u663e\\u5fae\\u5b66\\u7814\\u5236\\u7ec6\\u80de\\u514d\\u75ab\\u75ab\\u82d7\", \"\\u75ab\\u82d7\\u9632\\u6cbb\\u4eba\\u7c7b\\u4e73\\u5934\\u7624\\u75c5\\u6bd2\\u611f\\u67d3\\u53ca\\u5bab\\u9888\\u764c\\u7684\\u7814\\u7a76\", \"\\u4eba\\u514d\\u75ab\\u7f3a\\u9677\\u75c5\\u6bd2\\u591a\\u80bd\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u809d\\u7247\\u5438\\u866bDNA\\u75ab\\u82d7\\u7814\\u7a76\", \"\\u65b0\\u578b\\u809d\\u708e\\u75c5\\u6bd2\\u57fa\\u56e0\\u514b\\u9686\\u4e0eDNA\\u75ab\\u82d7\\u7814\\u7a76\", \"BCG\\u591a\\u4ef7\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u8111\\u5305\\u866b\\u7ec6\\u80de\\u7cfb\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u4e59\\u578b\\u8111\\u708e\\u6d3b\\u75ab\\u82d7\\u6bd2\\u682a\\u7684\\u57fa\\u56e0\\u5206\\u6790\", \"\\u732a\\u4f2a\\u72c2\\u72ac\\u75c5\\u75c5\\u6bd2\\u91cd\\u7ec4\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u827e\\u6ecb\\u75c5\\u75ab\\u82d7\\u65b0\\u578b\\u7b56\\u7565\\u4e0e\\u76f8\\u5173\\u514d\\u75ab\\u5b66\\u7814\\u7a76\", \"\\u759f\\u75be\\u75ab\\u82d7\\u53ca\\u5176\\u76f8\\u5173\\u57fa\\u7840\\u514d\\u75ab\\u5b66\\u7684\\u7814\\u7a76\", \"\\u9f3b\\u54bd\\u764c\\u591a\\u80bd\\u75ab\\u82d7\\u7814\\u7a76\\u53ca\\u4e34\\u5e8a\\u7597\\u6548\\u8bc4\\u4ef7\", \"\\u65b0\\u7684\\u759f\\u75be\\u75ab\\u82d7\\u9776\\u70b9\\u57fa\\u56e0\\u7684\\u529f\\u80fd\\u7814\\u7a76\", \"\\u4e19\\u578b\\u809d\\u708e\\u75c5\\u6bd2\\u6837\\u9897\\u7c92\\u75ab\\u82d7\\u7684\\u57fa\\u7840\\u7814\\u7a76\", \"Entwicklung optimaler Herstellungsprozesse artifizieller Malariavakzine\", \"Potenzierung von Impfstoffen durch gezieltes Design der Glykosylierung\", \"Kreuzprotektive und thermostabile Humane Papillomavirus Vakzine - T-panHPVvac\", \"Therapeutischer Impfstoff zur Behandlung von Zervixdysplasien\", \"ForMaT: Diagnostika- und Impfstoffentwicklung f\\u00fcr vernachl\\u00e4ssigte Infektionskrankheiten\", \"EXIST-Forschungstranfer: Entwicklung eines Impfstoffes gegen Malaria.\", \"Individualisierte Tumorimpfstoffe mittels eines viralen Vektors\", \"GO-Bio 5: VEROVACCINES - Tierimpfstoffe auf Hefebasis\", \"BioPharma: Allianz f\\u00fcr Antiinfektiva, Chemotherapeutika und Impfstoffe\", \"EDCTP: Malaria-Impfstoff-Entwicklung: zwei EDCTP Projekte\", \"Identification Of Novel Targets For Effective Drugs/Vaccines Against\", \"MUC1 as a Potential Breast Cancer Vaccine\", \"Centre for Nano-vaccines (sagsnr.: 09-067052)\", \"Oncolytic virus vaccine to cure different kinds of cancer\", \"Screening for immunogenic antigens for Zika virus vaccine\", \"Oncolytic virus vaccine to cure different kinds of cancer\", \"Oncolytic virus vaccine to cure different kinds of cancer\", \"Single-walled carbon nanotubes as delivery vehicle of vaccines\", \"Bioprocess Sciences and Technology of Viral Vaccines\", \"Antigen Discovery for Human Helminth Vaccines Using Immunomics\", \"Vaccines That Induce Broadly Protective Antibodies Against Influenza\", \"Quillaja Saponin Adjuvants in Carbohydrate Cancer Vaccines\", \"Indo-U.S. Asthma Research Collaborative Group: Asthma Vaccine\", \"Quillaja Saponin Adjuvants in Carbohydrate Cancer Vaccines\", \"Development of a Recombinant DNA Vaccine Against Blackleg\", \"Toward Enhanced Pulmonary Delivery of Vaccines\", \"Developing a prototype MMR vaccine\", \"Lactococcus lactis live vaccines against leishmaniasis\", \"Strategic training program in vaccine development and delivery\", \"Needle-free Vaccines for Respiratory Viruses\", \"Development of proteosome-based vaccines for protozoan pathogens\", \"Mechanisms of dendritic cell-based cancer vaccines\", \"CIHR Team in Structure-Based Vaccine Design\", \"Transferring binding regions as vaccine agents\", \"Structural studies on antiidiotypic antibody vaccines\", \"Vaccine antigens for C. pneumoniae atherosclerosis\", \"Development of a Vaccine Against Canine Leishmaniasis\", \"Novel Dendritic Cell-based Vaccine of Cancer\", \"Human alloimmune responses and HIV-1 vaccine development\", \"Transdermal delivery systems for protein medicines and vaccines\", \"Towards a Type 1 Diabetes Vaccine\", \"Cancer Vaccines: Targeting Cancer Genes for Immunotherapy\", \"The role of Alloimmunization in HIV vaccine design\", \"Development of a novel intranasal vaccine against measles\", \"A DNA vaccine for chlamydia trachomatis\", \"Delivery of genetic vaccines through Microporated Skin\", \"Post-genomic studies of BCG vaccines\", \"Transcutaneous vaccines: Delivery and mechanisms of immune induction\", \"Aptamer-mRNA Chimera-The Next Generation RNA vaccine\", \"nd\", \"D\\u00e9terminants des couvertures vaccinales chez les enfants \\u00e2g\\u00e9s de 1 an et 2 ans au Qu\\u00e9bec et impact \\u00e9pid\\u00e9miologique des retards vaccinaux\", \"DEVELOPMENT OF DNA VACCINES AGAINST CUTANEOUS T CELL LYMPHOMA\", \"DNA VACCINES AS INDUCERS OF IMMUNITY AGAINST  HAEMATOLOGICAL MALIGNANCIES\", \"\\ubbf8\\uc138\\ub9c9\\uc0c1 \\uad6c\\uc870\\ubb3c\\uc744 \\uc774\\uc6a9\\ud55c \\ube44\\uc138\\ud3ec \\ud56d\\uc554 \\ubc31\\uc2e0\", \"\\ucc28\\uc138\\ub300 \\uacb0\\ud575\\ubc31\\uc2e0\\uc758 \\ubc29\\uc5b4\\uba74\\uc5ed \\ubc14\\uc774\\uc624\\ub9c8\\ucee4 \\ubc1c\\uad74\", \"\\ub2e4\\uc81c\\ub0b4\\uc131 \\uacb0\\ud575\\uc744 \\ud45c\\uc801\\uc73c\\ub85c \\ud558\\ub294 \\uce58\\ub8cc\\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc5f0\\uad6c\", \"\\ub2e4\\uacf5\\uc131 \\uc2e4\\ub9ac\\uce74 \\ub098\\ub178\\uc785\\uc790\\ub97c \\uc774\\uc6a9\\ud55c \\uc554\\ubc31\\uc2e0 \\uc804\\ub2ec\\uccb4 \\uc5f0\\uad6c\", \"\\uc2a4\\ub9c8\\ud2b8 \\ubc31\\uc2e0 \\uacbd\\ud53c \\uc81c\\ud615 \\ubc0f \\ub808\\uc774\\uc800 \\uba74\\uc5ed\\ubcf4\\uc870\\uc81c \\uac1c\\ubc1c\", \"\\uac1c\\ubc1c \\ub3c4\\uc0c1\\uad6d\\uc744 \\uc704\\ud55c \\ubc31\\uc2e0 \\uac1c\\ubc1c \\uc9c0\\uc6d0 \\ud504\\ub85c\\uadf8\\ub7a8\", \"\\uc720\\uc0b0\\uade0 \\ud56d\\uc6d0\\uc6b4\\ubc18\\uccb4\\ub97c \\ub9e4\\uac1c\\ub85c \\ud558\\ub294 \\uae09\\uc5ec\\ud615\\uc5b4\\ub958\\ubc31\\uc2e0 \\uac1c\\ubc1c \\uc5f0\\uad6c\", \"\\uc0c8\\ub85c\\uc6b4 \\uacb0\\ud575 \\uc0dd\\ubc31\\uc2e0 \\ud6c4\\ubcf4 \\ubb3c\\uc9c8\\uc758 \\uac1c\\ubc1c \\ubc0f \\ubd84\\uc11d\", \"Terpene \\uc131\\ubd84\\uc744 \\uc774\\uc6a9\\ud55c \\uc9c4\\uade0\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc0c8\\ub85c\\uc6b4 \\uacb0\\ud575 \\uc0dd\\ubc31\\uc2e0 \\ud6c4\\ubcf4 \\ubb3c\\uc9c8\\uc758 \\uac1c\\ubc1c \\ubc0f \\ubd84\\uc11d\", \"\\uc2e0\\uaddc \\uacb0\\ud575\\uc608\\ubc29\\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc0ac\\uc5c5 \\uae30\\ud68d\\uc5f0\\uad6c\", \"\\uc0c8\\ub85c\\uc6b4 \\uacb0\\ud575 \\uc0dd\\ubc31\\uc2e0 \\ud6c4\\ubcf4 \\ubb3c\\uc9c8\\uc758 \\uac1c\\ubc1c \\ubc0f \\ubd84\\uc11d\", \"H. pylori infection and oral enteric vaccines\", \"A New Therapeutic Vaccine for HIV/AIDS\", \"A New Therapeutic Vaccine for HIV/AIDS\", \"Generation of HyperImmunogenic vaccines against human viral pathogens\", \"Delivery of vaccine antigens on virus like particles\", \"Less is more in TB vaccines\", \"Development of a potency test for leptospira vaccines\", \"Bovine TB vaccine programme advisor, Prof Douglas Young\", \"Improved selection methods for emergency FMD vaccines\", \"Improved selection methods for emergency FMD vaccines\", \"Protective immune responses induced by FMDV vaccine\", \"Antigenic properties of vaccine virus strains\", \"Live salmonella vaccines for the protection of poultry\", \"`The development of live, rationallyattenuated salmonella vaccines`\", \"Bioprocess Sciences and Technology of Viral Vaccines\", \"Synthesis of a Potential Lyme Disease Vaccine\", \"Oncolytic virus vaccine to cure different kinds of cancer\", \"Oncolytic virus vaccine to cure different kinds of cancer\", \"Oncolytic virus vaccine to cure different kinds of cancer\", \"Targeted microneedle insertion for epidermal vaccine delivery and biosensing\", \"FcR\\u4ecb\\u5bfc\\u7684\\u5177\\u6709\\u7279\\u5f02\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u65b0\\u578bRSV\\u7c98\\u819c\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"Development of RNA vaccine against dengue virus infection\", \"Construction of designer immunogens for use as vaccines\", \"Development of a possible vaccine for gonorrhoea\", \"Designing novel chemicals as potential influenza vaccines\", \"An improved vaccine for hepatitis B virus\", \"Schistosome proteolytic enzymes as drug and vaccine tar gets\", \"Development of a vaccine to prevent malaria transmissio n\", \"Development of AIDS vaccine using synthesized peptides.\", \"Factors affecting the immunogenicity of pertussis vaccines\", \"Search for active components for a malaria vaccine\", \"The development of a safer whooping cough vaccine\", \"Towards a vaccine against infantile diarrhoeal disease\", \"Development of a Plant-Derived Oral Vaccine for Measles\", \"Development of a nucleic acid vaccine for schistosomiasis\", \"Intestinal adapatation, Intususspection and rotavirus vaccine, applied clinical nutrition\", \"Bacterial delivery of DNA vaccines: salmonella - endosome interactions\", \"Clinical trials of RV3 oral human neonatal rotavirus vaccine\", \"CD8+ T cell immunity to viruses and recombinant vaccines\", \"How to turn malaria proteins into a vaccine\", \"A cytotoxic T cell epitope based vaccine for HIV\", \"The development of an oral whooping cough vaccine\", \"Why are live vaccines often better than killed?\", \"Relevance of bacterial surface structure to vaccine dev elopment\", \"To develop and test a DNA vaccine for HIV\", \"To develop novel vesicle-derived vaccines against Mycobacterium tuberculosis.\", \"To develop nanoemulsions and adjuvants for nasal-spray vaccines\", \"To support CMV vector-based Vaccine Concept\", \"To develop an inexpensive therapeutic vaccine for human papillomavirus\", \"To produce better and cheaper vaccines against polio\", \"To fund a vaccine discovery (antibody) consortium\", \"To conduct a pneumococcal vaccine impact assessment in Bangladesh\", \"To develop a Global HIV Vaccine Research Cryorepository (GHRC)\", \"To test a novel universal influenza vaccine\", \"To develop a genetically engineered recombinant hookworm vaccine\", \"To conduct an analysis of pediatric enteric vaccine development\", \"To develop a unique delivery system for vaccines whose major health impact is in high burden countries allowing the conversion of existing injectable vaccines into oral and/or inhalation vaccines and expedite development of novel mucosal vaccines\", \"\\u72c2\\u72ac\\u75c5\\u65e5\\u5375\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6539\\u826f\", \"\\u30dc\\u30c4\\u30ea\\u30cc\\u30b9\\u4e2d\\u6bd2\\u306e\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6539\\u5584\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76(\\u7d992\\u5e74)\", \"\\u6d41\\u884c\\u6027\\u8033\\u4e0b\\u819c\\u708e\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30dc\\u30c3\\u30ea\\u30cc\\u30b9\\u4e2d\\u6bd2\\u306e\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6539\\u5584\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u7cbe\\u88fd\\u4e09\\u7a2e\\u6df7\\u5408(D.T.P)\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u8a66\\u9a13\\u7684\\u7814\\u7a76\", \"\\u7cbe\\u88fd\\u72c2\\u72ac\\u75c5\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u54ac\\u50b7\\u5f8c\\u514d\\u75ab\\u6cd5\\u306e\\u7814\\u7a76\", \"\\u6c34\\u75d8\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u6c34\\u75d8\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u5927\\u8178\\u83ccK1\\u682a\\u306e\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u7814\\u7a76\", \"\\u7dd1\\u81bf\\u83cc\\u306e\\u6eb6\\u89e3\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"SHIV\\u3092\\u7528\\u3044\\u305fAIDS\\u5f31\\u6bd2\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u9593\\u767a\", \"\\u8178\\u7ba1\\u5bc4\\u751f\\u866b\\u306b\\u5bfe\\u3059\\u308b\\u7c98\\u819c\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"HB \\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u6b6f\\u79d1\\u533b\\u5e2b\\u306eB\\u578b\\u809d\\u708e\\u4e88\\u9632\\u5bfe\\u7b56\\u306b\\u3064\\u3044\\u3066\", \"\\u6297\\u9f72\\u8755\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u80ba\\u708e\\u7403\\u83cc\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5b9f\\u7528\\u5316\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u6297\\u539f\\u7279\\u7570\\u7684\\u6297\\u816b\\u760d\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u3068\\u305d\\u306e\\u5fdc\\u7528\", \"DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u81ea\\u5df1\\u514d\\u75ab\\u6027\\u7cd6\\u5c3f\\u75c5\\u306e\\u5bdb\\u89e3\", \"Programmed Activation\\u306b\\u57fa\\u3065\\u304f\\u4eba\\u5de5DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5275\\u88fd\", \"\\u4e73\\u5e7c\\u5150\\u306b\\u304a\\u3051\\u308b\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u5bfe\\u3059\\u308b\\u514d\\u75ab\\u539f\\u6027\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u907a\\u4f1d\\u5b50\\u7d44\\u63db\\u3048\\u306b\\u3088\\u308b\\u305b\\u3063\\u305d\\u3046\\u75c5\\u30c8\\u30ad\\u30bd\\u30a4\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"MHC\\u975e\\u62d8\\u675f\\u6027\\u5408\\u6210\\u3046\\u8755\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u7814\\u7a76\", \"\\u86cb\\u767d\\u8cea\\u5de5\\u5b66\\u3092\\u5229\\u7528\\u3057\\u305f\\u8755\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5206\\u5b50\\u8a2d\\u8a08\", \"\\u9d8f\\u30b3\\u30af\\u30b7\\u30b8\\u30a6\\u30e0\\u306e\\u30b3\\u30f3\\u30dd\\u30fc\\u30cd\\u30f3\\u30c8\\u30fb\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u5bb6\\u79bd\\u306b\\u5bfe\\u3059\\u308b\\u907a\\u4f1d\\u5b50\\u7d44\\u307f\\u63db\\u3048\\u30a6\\u30a3\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u7528\\u30d9\\u30af\\u30bf\\u30fc\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"Bioprocess Sciences and Technology of Viral Vaccines\", \"Stability of a dry whole cell malaria vaccine\", \"Excipient investigation for improving Herpes simpex II vaccine processing\", \"Targeted microneedle insertion for epidermal vaccine delivery and biosensing\", \"Novel vaccine approaches for protecting against helminth parasites\", \"Immunisation disparities and vaccine-preventable diseases in New Zealand\", \"T cell vaccines for asthma and allergic rhinitis\", \"Clinical Grade H9N2 Influenza Vaccine\", \"NIAID HIV VACCINE RESEARCH EDUCATION INITIATIVE\", \"Simian Vaccine Evaluation Units\", \"SIMIAN VACCINE EVALUATION UNIT\", \"Simian Vaccine Evaluation Unit (SVEU)\", \"SIMIAN VACCINE EVALUATION UNIT\", \"Simian Vaccine Evaluation Unit (SVEU)\", \"SIMIAN VACCINE EVALUATION UNIT\", \"Tularemia Vaccine Development Team\", \"TULAREMIA VACCINE DEVELOPMENT TEAM\", \"TULAREMIA VACCINE DEVELOPMENT TEAM\", \"HIV Vaccine Design and Development Teams\", \"Tuberculosis Research Materials and Vaccine Testing\", \"TUBERCULOSIS RESEARCH MATERIALS AND VACCINE TESTING\", \"Production and Testing of Anthrax Vaccine\", \"HIV Vaccine Design and Development Teams\", \"HIV Vaccine Design and Development Teams\", \"Vaccine and Treatment Evaluation Unit\", \"Vaccine and Treatment Evaluation Unit\", \"Malaria Vaccine Production and Support Services\", \"MALARIA VACCINE PRODUCTION AND SUPPORT SERVICES\", \"Molecular analysis of immune responses to malaria peptide vaccines\", \"Immunologische Kontrolle der Zeckeninduzierten Immunmodulation: Eine Vakzinestrategie.\", \"Conserved CTL Epitopes in HIV-1 as Potential Vaccines.\", \"Biodegradable microspheres as a novel vaccine delivery system\", \"Development of a vaccine against HELICOBACTER PYLORI infection\", \"Robo4 protein as a cancer vaccine\", \"\\u80be\\u7efc\\u5408\\u5f81\\u51fa\\u8840\\u70ed\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u9ebb\\u75b9\\u6d41\\u884c\\u682a\\u7684\\u6297\\u539f\\u53d8\\u5f02\\u5bf9\\u75ab\\u82d7\\u6548\\u679c\\u5f71\\u54cd\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u86cb\\u767d\\u8d28\\u7ec4\\u5b66\\u7684\\u5154\\u652f\\u6c14\\u7ba1\\u8d25\\u8840\\u6ce2\\u6c0f\\u6746\\u83cc\\u53cd\\u5411\\u75ab\\u82d7\\u5b66\\u7814\\u7a76\", \"PRRS\\u591a\\u4ef7\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7814\\u7a76\\u7684\\u65b0\\u7b56\\u7565\", \"Breast Cancer Vaccines from Plants\", \"Basic Studies in Super Vaccines\", \"Vaccines Based on DNA Adenine Methylase Technology\", \"Mechanism of action of DNA vaccines\", \"Development of a novel carrier/adjuvant for intranasal vaccines\", \"Australia III - DVDC  (Diabetes Vaccine Development Center)\", \"Improving whole-organism vaccines against malaria by genetic modification\", \"AquaSolve: Nanobead vaccine delivery platform for aquaculture\", \"Effective vaccine against winter ulcer in salmon.\", \"Low cost production of biopharmaceuticals and vaccines in plants\", \"Rekombinantno cepivo proti aviarni influenci\", \"Development of a recombinant BCG vaccine - DPT\", \"Peptides and proteins for vaccines and therapeutics\", \"Development of Naked DNA Vaccine: Brucella\", \"Preparation of liquid live vaccine against rubella\", \"Construction and characterization of live-attenuated enterobacterial vaccine candidates\", \"Evaluation of an oncolytic vaccine in dogs\", \"Bioprocess Sciences and Technology of Viral Vaccines\", \"Targeted microneedle insertion for epidermal vaccine delivery and biosensing\", \"Controlled Release Nanoparticle vaccines\", \"Novel dendritic cell-based vaccine of cancer\", \"Transdermal delivery systems for protein medicines and vaccines\", \"Transdermal delivery systems for protein medicines and vaccines\", \"European vaccine effort against hiv/aids\", \"Biosafety of vaccines based on self-replicating recombinant alphavirus\", \"Selection of P. Falciparum antigene for MPES vaccine development\", \"New approaches for the development of enterobacterial vaccine strains\", \"Development of vaccines against coccidiosis through biotechnology\", \"Oral vaccine against cholera with Built-in adjuvanticity\", \"CHEMICAL SYNTHESIS OF HEPATITIS B VACCINES\", \"DEVELOPMENT OF AN EFFICIENT VACCINE (AIDS)\", \"DEVELOPMENT OF SYNTHETIC VACCINES AGAINST NEMATODE INFECTIONS\", \"DEVELOPMENT OF VACCINE AGAINST CHAGAS' DISEASE\", \"EVAL OF IMPCT OF JAPANESE ENCEPHALITIS VACCINE IN CAMBODIA\", \"Rational design of an AIP56-based anti-pasteurellosis vaccine\", \"Exploring pathogen diversity in disease epidemiology and vaccine research\", \"Melhoramento da imunogenicidade de vacinas de DNA\", \"Development of DNA vaccine prototypes for veterinary trypanosomiasis\", \"Development of DNA vaccine prototypes for veterinary trypanosomiasis\", \"Anti-ghrelin vaccine: a feasible alternative for obesity treatment?\", \"Smart porous particles for pulmonary drug and vaccine delivery\", \"Impact of the conjugate pneumococcal vaccines on pneumococcal ecology\", \"Vaccine potential of different Leishmania infantum proteins\", \"Development of subunit anti-viral vaccines for salmonid fish\", \"Towards a live vaccine against cryptobiosis in salmonids\", \"D\\u00e9veloppement d'un vaccin contre Streptococcus suis\", \"Enhancing vaccine efficacy by molecular chimerization to cytokines\", \"Development of vaccines for BVDV, BRSV and PI-3\", \"Development of vaccine vector for human immunodeficiency virus\", \"Identification of tumor-associated antigens as cancer vaccine targets\", \"Design of a glycoconjugate vaccine against group A streptococcus\", \"Development of a subunit vaccine for haemophilus somnus\", \"Increasing vaccine efficiency through defined adjuvant use\", \"Design of a glycoconjugate vaccine against group A streptococcus\", \"Development of a multivalent recombinant fowlpox virus vaccine\", \"Development of a molecularly defined vaccine for Myxosporean parasites\", \"Role of TLR4 binding adjuvant in improving cancer vaccines\", \"Attenuating West Nile: The search for a Love Vaccine\", \"Development of porcine adenovirus-3 as a vaccine vector\", \"Attenuating West Nile: The search for a Love Vaccine\", \"Recombinant fowl adenovirus based vaccine against avian influenza\", \"Novel biodegradeable hydrogel for hiv vaccine delivery\", \"Human adenovirus-based vaccines and mammalian expression vectors\", \"Oral vaccines: Targetting to improve induction of mucosal immunity\", \"Diagnostics of fish diseases and development of vaccines\", \"Development of a recombinant vaccine for porcine transmissible gastroenteritis\", \"Development of an effective recombinant Actinobacillus pleuropneumoniae vaccine\", \"Liposome-cytokine formulations as vaccine delivery systems\", \"Synthesis of cyclic oligonucleotide analogues as mucosal vaccine adjuvants\", \"Creating edible forage-based vaccines against bovine pneumonic pasteurellosis\", \"Novel Multi-Strain Vaccines against HIV-1\", \"Development of vaccine vector for human immunodeficiency virus\", \"Novel Multi-Strain Vaccines against HIV-1\", \"Development of a bovine adenovirus vaccine vector\", \"Novel Multi-Strain Vaccines against HIV-1\", \"In vitro qualification of a SPIO labeled vaccine\", \"Evaluation of fowl adenovirus based recombinant vaccines for poultry\", \"Development of vaccine vector for human immunodeficiency virus\", \"Development of Synthetic Glycoconjugate Vaccines for Active Tumor Immunotherapy\", \"Development of Synthetic Glycoconjugate Vaccines for Active Tumor Immunotherapy\", \"Optimization of vaccine production in algae using engineered bioreactors\", \"D\\u00e9veloppement d'un vaccin att\\u00e9nu\\u00e9 contre la colibacillose aviaire\", \"The Effects of Chemotherapy on Gene-Based Cancer Vaccines\", \"D\\u00e9veloppement d'un vaccin att\\u00e9nu\\u00e9 contre la colibacillose aviaire\", \"UPDATING COMPUTER FACILITIES FOR THE VACCINE LABORATORY\", \"HIV Vaccine Research and Development\", \"INTRODUCING THE USE OF SEASONAL INFLUENZA VACCINES\", \"Enhanced surveillance for newly vaccine preventable disease\", \"Discovery of Biological and Immunological Biomarkers for TB Vaccines\", \"STUDYING THE MEASLES INFECTIONS &DEVELOPMENT OF MEASLES VACCINES\", \"Innovations in Vaccine Clinical Trials and Pharmacovigilance\", \"SUPPORTING INFLUENZA VACCINE INTRODUCTION IN LOW-MIDDLE INCOME COUNTRIES\", \"EPITOPE POLYMORPHISM IN P FALCIPARUM VACCINE ANIGENS\", \"DESIGN AND IMMUNE MECHANISMS OF P FALCIPARUM CS VACCINE\", \"ANTIGENIZED ANTIBODY AND GENE IN MALARIA VACCINE\", \"LIVE ATTENUATED MULTIPLY DELETED HIV1 VACCINE FOR AIDS\", \"COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS\", \"NOVEL IMDEF VIRUS VACCINES IN NHP MODELS\", \"Development of multi-antigen subunit SARS vaccines\", \"STRUCTURAL AND CONFORMATIONAL ASPECTS IN PEPTIDE VACCINE\", \"RECOMBINANT L MONOCYTOGENES AS AN SIV VACCINE\", \"CELL CULTURE PRODUCTION OF T GONDII T 263 VACCINE\", \"VACCINE TO TREAT HEPATITIS B VIRUS INFECTION\", \"ATTENUATION OF THE NYCBH VACCINE STRAIN OF VACCINIA\", \"ADHESIN BASED VACCINE TO PREVENT URINARY TRACT INFECTION\", \"DEVELOPMENT OF TUMOR VACCINES USING GPI LINKED MOLECULES\", \"THERAPEUTIC TUMOR VACCINE AGAINST HER 2/NEU\", \"Allergy Protection by Active IgE B Cell Vaccines\", \"EPITOPE-DRIVEN HIV VACCINE TARGETING DENDRITIC CELLS\", \"ORAL DELIVERY OF ENCAPSULATED MULTIMERIC AIDS VACCINES\", \"DEVELOPMENT OF A VACCINE FOR CLOSTRIDIUM DIFFICILE\", \"UBIQUITIN FUSION FOR PEPTIDE IMMUNE DISPLAY AND VACCINES\", \"LYME VACCINE BASED ON BORRELIA DECORIN ADHESIN\", \"PEPTIDE ANTIIGE VACCINE FOR IMMUNOTHERAPY OF ALLERGY\", \"LYME VACCINE BASED ON BORRELIA TRANSFERIN RECEPTORS\", \"ORAL HIV-1 VACCINE TECHNOLOGIES USING OPTIVAX COPOLYMER\", \"PEPTIDE BASED VACCINE FOR PRIMATE MODEL OF AIDS\", \"ORAL, LIVE, ATTENUATED VIBRIO VECTORED SSONNEI VACCINE\", \"ATTENUATION OF THE NYCBH VACCINE STRAIN OF VACCINIA\", \"CS PROTEIN T-EPITOPE POLYMORPHISM--MALARIA VACCINE\", \"A TARGETED PLANT-BASED VACCINE FOR TYPE I DIABETES\", \"APC-TARGETING VACCINE FOR PREVENTION OF TYPE I DIABETES\", \"DEVELOPMENT/EVALUATION OF HYBRID NOVEL MUCOSAL VACCINES\", \"NEW STRATEGIES FOR BACTERIAL DELIVERY OF DNA VACCINES\", \"HIV VACCINE STRATEGIES BASED ON A GOAT LENTIVIRUS--CAEV\", \"DEVELOPMENT OF ENHANCED HIV 1 PSEUDOVIRION VACCINES\", \"DEVELOPMENT OF AN ORAL MULTIVALENT SHIGELLA/ETEC VACCINE\", \"DEVELOPMENT OF A GENETIC VACCINE FOR M TUBERCULOSIS\", \"DETOXIFIED BACTERIAL TOXINS AS CTL VACCINE MOLECULES\", \"MUCOSAL VACCINES--HEAT LABILE TOXIN/ANTIGEN FUSIONS\", \"INTERNATIONAL CONFERENCE ON VACCINES FOR CANCER AND AIDS\", \"HEPATITIS B VACCINE ACCEPTANCE BY NURSING HOME WORKERS\", \"DNA/MVA HIV Vaccine for India\", \"MUCOSAL IMMUNITY TO VIRULENT AND VACCINE-STRAIN CMV\", \"EVALUATION OF ARI ORGANISMS FOR VACCINE DEVELOPMENT\", \"DEVELOPMENT OF SUBUNIT VACCINE FOR M PULMONIS IN MICE\", \"DC TUMOR CONJUGATE VACCINE FOR IMMUNOTHERAPY\", \"EVALUATION STUDIES--DNA VACCINE EXPRESSING SIVSM VLP\", \"DNA VACCINES-RESPONSES TO VECTORS WITH RABIES ANTIGENS\", \"DEVELOPMENT OF A POX-VECTORED MEASLES VACCINE\", \"MEASLES &MEASLES VACCINES--MECHANISMS OF IMMUNE INJURY\", \"GENE EXPRESSION FOR S MANSONI VACCINE ANTIGEN\", \"PREVENTION OF NEONATAL BACTEREMIA WITH PILUS VACCINE\", \"HSV-1 Amplicon Vectors for HIV Vaccine Delivery\", \"HIV, TB, and Malaria Vaccine Development for Africa\", \"HSV VACCINE DESIGN--ABLATION OF VIRULENCE AND LATENCY\", \"DNA TECHNIQUES FOR PRODUCTION OF A VACCINE TO AIDS\", \"EVALUATE SAFETY OF VACCINES TO PREVENT SHIGELLOSIS-275953226\", \"CONJUGATE VACCINES DESIGNED TO PREVENT TYPHOID FEVER-275973269\", \"KILLED ORAL CHOLERA VACCINE EFFECTIVENESS TRIAL--VIETNAM-275973264\", \"TEST OF ACELLULAR PERTUSSIS VACCINE IN INFANTS\", \"EVALUATION OF TYPHOID FEVER VI CONJUGATE VACCINE\", \"U.S. CLINICAL TRIAL OF ACELLULAR PERTUSSIS VACCINE\", \"U.S. CLINICAL TRIAL OF ACELLULAR PERTUSSIS VACCINE\", \"PRODUCTION OF NICHD DPT VACCINE FOR U.S. CLINICAL TRIALS\", \"OPERATION OF &EXPERIMENTAL VIRUS VACCINE PRODUCTION LAB\", \"ADVERSE CONSEQUENCES OF PERTUSSIS AND RUBELLA VACCINES\", \"PRIMATE IMMUNOLOGY LABORATORY FOR AIDS VACCINE R&D\", \"Evaluation of Vaccines and Therapies in Adults/Elderly-26685342\", \"LAB SUP. FOR AIDS VACCINE &OTHER PREVENT. CLINICAL TRIA\", \"PHASE II PNEUMOCOCCAL CONJUGATE VACCINE STUDY IN THE GAM\", \"TB Research Materials and Vaccine testing-26675320\", \"STUDY OF MALARIA VACCINES IN HUMAN VOLUNTEERS\", \"FACILITY FOR STUDY OF INFECTIOUS DISEASE AND VACCINES\", \"MAO/EVALUATION OF AIDS VACCINES IN NONHUMAN PRIMATE\", \"EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE MODELS\", \"EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE MODELS\", \"VACCINE DEVELOPMENT--ESTABLISHMENT OF PRIORITIES FOR U S\", \"CORRELATE IMMUNE PROTECTION IN AIDS VACCINE RECIPIENTS\", \"CENTRAL LAB FOR AIDS/HIV VACCINE EFFICACY TRIALS\", \"Production and Testing of a MVA Vaccine-266040072\", \"Population Genetics Analysis Program: Immunity to Vaccines/Infections--266040069\", \"POPULATION GENETICS ANALYSIS PROGRAM IMMUNITY TO VACCINES/INFECTION-266040068\", \"POPULATION GENETICS ANALYSIS PROGRAM:  IMMUNITY TO VACCINES/INFECTIONS-266040067\", \"POPULATION GENETICS ANALYSIS PROGRAM IMMUNITY TO VACCINES/INFECTION-266040064\", \"HAEMOPHILUS INFLUENZA TYPE B VACCINE IN HIGH RISK INFANT\", \"HIV Vaccine Design and Development Teams /HVDDT/-26630042\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVDDT)-266030030\", \"HIV Vaccine Design and Development Teams /HVDDT/-26630029\", \"DEVELOPMENT AND TESTING OF VACCINES AGAINST ANTHRAX-266025494\", \"Development and Testing of Vaccines Against Anthrax-266025492\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS-266025458\", \"STUDY ISSUES AND PRIORITIES FOR NEW VACCINE DEVELOPMENT\", \"EVAL OF VACCINE PROPH AGAINST INFECT DISEASES IN CHILDRN\", \"CENTRAL LAB FOR AIDS VACCINE CLINICAL TRIALS\", \"EVALUATION IN MONKEYS OF VACCINES FOR SAIDS\", \"DEVELOP AN H INFLUENZAE TYPE B VACCINE\", \"FACILITY FOR STUDY OF INFECTIOUS DISEASES, VACCINES\", \"HIV Vaccine Design and Development Teams-26605397\", \"HIV Vaccine Design and Development Teams-26605396\", \"HIV Vaccine Design and Development Teams-26605395\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS-266005394\", \"DEVELOP LIVE ATTENTUATED COLD ADAPTED INFLUENZA VACCINE\", \"TEST RESPIRATORY VIRUS AND BACTERIAL VACCINES IN INFANTS\", \"POPULATION GENETICS ANALYSIS PROGRAM IMMUNITY TO VACCINES/INFECTION-266000068\", \"POPULATION GENETICS ANALYSIS PROGRAM:  IMMUNITY TO VACCINES/INFECTIONS-266000067\", \"POPULATION GENETICS ANALYSIS PROGRAM: IMMUNITY TO VACCINES/INFECTIONS--266000065\", \"POPULATION GENETICS ANALYSIS PROGRAM IMMUNITY TO VACCINES/INFECTION-266000064\", \"IMMUNE INTERACTIONS OF GONORRHEA AND VACCINE DEVELOPMENT\", \"ANTIBODY DIVERSITY, AGE AND INFLUENZA VACCINE EFFICACY\", \"HEALTH CARE WORKER COMPLIANCE WITH HEPATITIS B VACCINE\", \"PREVENTING AND MITIGATING VACCINE PREVENTABLE DISEASE THROUGH IMMUNIZATION\", \"TO PREVENT VACCINE-PREVENTABLE DISEASE THROUGH MAINTAINING IMMUNIZATION STRUCTURE\", \"Immunization Grant and Vaccines for Children's Program\", \"NEBRASKA IMMUNIZATION AND VACCINES FOR CHILDREN PROGRAM\", \"GUAM IMMUNIZATION AND VACCINES FOR CHILDREN PROGRAMS\", \"GEORGIA IMMUNIZATIONS AND VACCINES FOR CHILDREN GRANTS\", \"FSM IMMUNIZATION AND VACCINES FOR CHILDREN GRANTS\", \"PREVENTION & CONTROL OF COMMUNICABLE AND VACCINE PREVENTABLE DISEASES\", \"KY IMMUNIZATION PROGRAM IMMUNIZATION & VACCINE FOR CHILDREN PROGRAM\", \"HAWAII IMMUNIZATION AND VACCINES FOR CHILDREN PROGRAM\", \"Building Capacity for Immunization Billing and Vaccine Barcode Reading\", \"NEISSERIA MENINGITIDIS GROUP B;IDIOTYPES AND VACCINES\", \"ATTENUATED SHIGELLA AS TOXIGENIC E COLI VACCINE\", \"VACCINE POTENTIAL OF PAR PROTEINS OF TRYPANOSOMA CRUZI\", \"LIVE AND ATTENUATED VIBRIO CHOLERAE VACCINE STRAINS\", \"DEVELOPMENT OF A SINGLE DOSE TETANUS VACCINE\", \"SALMONELLA AS A VACCINE TOOL AGAINST HIV\", \"FACTORS INFLUENCING HIB DISEASE AND VACCINE EFFICACY\", \"DEVELOPMENT OF VACCINE AGAINST GROUP B STREPTOCOCCI\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Advanced Development of Multivalent Filovirus Vaccines\", \"Development of an Anthrax Vaccine\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Unit\", \"Global HIV AIDS Vaccine Enterprise Secretariat\", \"GLOBAL HIV VACCINE ENTERPRISE\", \"Translational Development of Novel Vaccine Therapies\", \"Rotavirus vaccine and prevention of hospitalization\", \"Verbundprojekt: EUREKA-Projekt: Malaria-Impfstoff (EU 101) - Teilvorhaben: Gentechnologische Entwicklung einer Malaria-Vakzine - Phase 2\", \"'EDCTP-Malaria Impfstoff: Biometrie und Parasiten-Quantifizierung zur Entwicklung neuer malariaimpfstoffe, -medikamente und -miagnostika in Afrika.'\", \"EDCTP-HIV-Vakzine I: Durchf\\u00fchrung eine Phase IB HIV Impfstoffstudie (DNA / NYVAC) in Mbeya, Tansania.\", \"Investigation of Novel Vaccine Strategies for Influenza: Targeting Innate and Adaptive Immunity for Cross-protective Vaccines\", \"\\uc77c\\ubc18\\ubc31\\uc2e0 \\ub610\\ub294 \\uae34\\uae09\\ubc31\\uc2e0\\uc81c\\uc81c\\uc758 \\ub1cc\\uad6c\\uc870 \\ubc0f \\uae30\\ub2a5\\uc5d0 \\ub300\\ud55c \\uc548\\uc804\\uc131 \\uc2e0\\uc18d\\uac80\\uc815\", \"\\ube44\\ub9cc \\ub9c8\\uc6b0\\uc2a4\\uc5d0\\uc11c\\uc758 \\ud638\\ud761\\uae30 \\ubc14\\uc774\\ub7ec\\uc2a4\\uc5d0 \\ub300\\ud55c \\ubc31\\uc2e0\\uc758 \\ud6a8\\ub2a5 \\uce21\\uc815 \\ubc0f \\ube44\\ub9cc \\uac1c\\uc120\\uc744 \\ud1b5\\ud55c \\ubc31\\uc2e0 \\uc5ed\\ub7c9 \\uac15\\ud654 \\ud3c9\\uac00\", \"\\ub9c8\\uc6b0\\uc2a4 \\ubaa8\\ub378\\uc5d0\\uc11c \\ubaa8\\uccb4\\uc758 \\uacb0\\ud575 \\uac10\\uc5fc\\uc774 \\uc2e0\\uc0dd\\uc544\\uc758 \\uacb0\\ud575 \\ubc31\\uc2e0 \\ud6a8\\uacfc\\uc5d0 \\ubbf8\\uce58\\ub294 \\uc601\\ud5a5 \\ubc0f \\uc2e0\\uaddc \\uacb0\\ud575 \\ubc31\\uc2e0 \\ud6a8\\ub2a5 \\uac80\\uc99d\", \"Development of vaccine strategies for measles and malaria using oral bacterial vectors and edible plant vaccines\", \"To test a new bacterial synthesis method to produce glycoconjugate vaccines to generate an improved vaccine against pneumococcal disease.\", \"To produce more poliovirus vaccine supply by silencing non-essential virus resistance genes to develop enhanced vaccine cell lines.\", \"To support the AIDS Vaccine 2006 conference which will bring together scientists in the field of HIV vaccine research.\", \"To develop and field test a durable liner for vaccine carriers to protect vaccines from freezing.\", \"To develop an envelope vaccine antigen that allows immune recognition and is an effective vaccine antigen\", \"DEVELOPMENT OF A NOVEL SALMONELLA PARATYPHI A VACCINE\", \"\\u30d2\\u30c8\\u7cbe\\u5b50\\u6297\\u539f\\u3092\\u7528\\u3044\\u305f\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u53ca\\u3073\\u907a\\u4f1d\\u5b50\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u751f\\u6b96\\u514d\\u75ab\\u5b66\\u7684\\u7814\\u7a76\", \"RV3 Rotavirus Vaccine: A Phase II clinical trial for a human neonatal rotavirus vaccine for the global community\", \"Development of a Coronavirus Vaccine\", \"Insights into CD4+ T cell responses against cancer vaccines from analysis of responses to a conventional vaccine\", \"Adjuvant properties of cellular vaccines: combination of cellular pertussis vaccine and BCG with Streptococcus pneumoniae antigens\", \"Pathogen-derived immunomodulatory molecules: future immunotherapeutics and vaccines\", \"Can plant plastids produce a candidate flu vaccine\", \"Information dissemination on the human papillomavirus vaccine\", \"Development of a Coronavirus Vaccine\", \"Task X8: Efficacy Testing of Ebola Virus Vaccines\", \"USE OF THE VACCINE ADJUVANT FOR IMMUNOMODULATION OF THE INFECTION CAUSED BY TRYPANOSOMA BRUCEI: AN APPROACH TO VACCINE DESIGN\", \"Development of DNA-based vaccines for bovine viral diarrhoea virus. D\\u00e9veloppement des vaccins \\u00e0 base d'ADN le virus de diarrh\\u00e9e bovine.\", \"TESTING VACCINES IN CHILDREN\", \"Frameshifts as a Cancer Vaccine\", \"SIMIAN VACCINE EVALUATION UNITS\", \"HPV\\u53cc\\u542f\\u52a8\\u5b50DNA\\u75ab\\u82d7\\u548c\\u91cd\\u7ec4\\u817a\\u75c5\\u6bd2\\u75ab\\u82d7\\u7684\\u8054\\u5408\\u5e94\\u7528\\u7814\\u7a76\", \"Vaccines against helminth infections (acronym PARAVAC)\", \"The mechanisms of macrophage dependent vaccine\", \"Recombinant Vaccines for Prevention of AIDS and Other Diseases\", \"SARS\\u75ab\\u82d7\\u9ad8\\u5206\\u5b50\\u8f7d\\u4f53\\u7684\\u6a21\\u62df\\u7814\\u7a76\", \"Characterisation of rotavirus vaccine escape - potential for significant impact on vaccination program\", \"Conference: Genetic vaccines - benefits and challenges\", \"\\u0423\\u0447\\u0430\\u0441\\u0442\\u0438\\u0435 \\u0432 GENE-BASED VACCINES - GBV2010 Conference\", \"To development of a new safer Oral Polio Vaccine against type 2 strain (nOPV2) with lower risk of circulating vaccine derived polio virus (cVDVP) or vaccine associated paralytic poliomyelitis (VAPP) than existing Sabin mOPV 2\", \"To test a new vaccine technology that modulates a host cytokine response to HIV vaccines. If successful, this technology may also enhance T-cell mediated immunity to other vaccine antigens, such as Tuberculosis.\", \"To produce new and more potent vaccines with increased stability by testing a vaccine platform based on protein crystals (MicroCubes) produced by insect viruses for developing a candidate vaccine against HIV.\", \"To develop better polio vaccines by researching whether adding immune pressure against proteins found in the attenuated strains of the oral polio vaccine leads to the emergence of recombinant circulating vaccine-derived polioviruses\", \"To develop and test a vaccine combining a novel placental malaria vaccine candidate with the cervical cancer vaccine, with the potential of inducing a strong protective response against both diseases simultaneously\", \"To bring together African researchers, vaccine implementers and public health academics to share information regarding rotavirus vaccines within Africa, and to exchange information and lessons regarding the impact of the vaccines\", \"Sometimes it's take that hill, sometimes it's take that vaccine:  the Persian Gulf war and the anthrax vaccine controversy\", \"Training in vaccine research: vaccine against peptic ulcer\", \"Tularemia Vaccine Development\", \"Polymeric microparticulate vaccine formulations based on hydrogen bonding\", \"Production of a recombinant vaccine against human cytomegalovirus in plant cells\", \"GSK VACCINES - COURS INTRO MIN PME Convention -Course with Minor Entrepreneurschip\", \"Vaccine Effectiveness: An integrated approach for monitoring influenza vaccine effectiveness to inform public health policy and influenza immunization program implementation\", \"Vaccine Effectiveness: An integrated approach for monitoring influenza vaccine effectiveness to inform public health policy and influenza immunization program implementation\", \"Vaccine Effectiveness: An integrated approach for monitoring influenza vaccine effectiveness to inform public health policy and influenza immunization program implementation\", \"Vaccine Effectiveness: An integrated approach for monitoring influenza vaccine effectiveness to inform public health policy and influenza immunization program implementation\", \"Verbundprojekt: Integriertes, patientennahes Verfahren zur Herstellung einer therapeutischen zellul\\u00e4ren Vakzine im geschlossenen System, Teilvorhaben: Genetisch modifizierte DC-Vakzine mit verbesserter Antigenpr\\u00e4sentation\", \"Verbundprojekt: Integriertes, patientennahes Verfahren zur Herstellung einer therapeutischen zellul\\u00e4ren Vakzine im geschlossenen System, Teilvorhaben: Geschlossenes, GMP-f\\u00e4higes Verfahren f\\u00fcr DC-Vakzine\", \"Verbundprojekt: Impfstoffentwicklung Gegen Herpesviren: Ein flexibles System zur gezielten Antigen-Variation bei Humanen Influenza-Viren f\\u00fcr die Herstellung von Vakzinen\", \"ERA Net EuroTransBio-2: Neue Technologie f\\u00fcr erfolgreiche Impfstoffstrategien: Crossbeta Adjuvanz-Technologie am Beispiel von Protein-basierten Impfstoffen gegen Influenza H5N1 Viren\", \"Verbundprojekt: Entwicklung eines low-cost intranasalen Vaccines mit universellem Schutz gegen Pneumococcus Infektionen, Teilprojekt: Sicherheits- und Wirksamkeitsuntersuchungen des Vaccines\", \"EDCTP - Malariaimpfstoffe I: F\\u00f6rderung der immunologischen und der klinischen Forschungs-Kompetenz im Rahmen multizentrischer, internationaler klinischer Studien an Malariavakzinen der Phasen I bis IIb\", \"EDCTP-HIV-Vakzine I: Bestimmung der zellul\\u00e4ren Immunantwort nach Impfung mit einer DNA / MVA HIV Vakzine bei 70 Freiwilligen.\", \"Verbundprojekt: Innovative bakterielle Tumorimpfstoffe - Teilprojekt 2/3: Entwicklung eines oralen rekombinanten Salmonellenvakzins der zweiten Generation f\\u00fcr die Tumortherapie\", \"Best Brains Exchange: 'Achievement of Optimal Vaccine Coverage Rates in Canada: Identifying and Addressing the Problem of Vaccine Hesitancy', February 3, 2015, Ottawa.\", \"Best Brains Exchange: 'Achievement of Optimal Vaccine Coverage Rates in Canada: Identifying and Addressing the Problem of Vaccine Hesitancy', February 3, 2015, Ottawa.\", \"Best Brains Exchange: 'Achievement of Optimal Vaccine Coverage Rates in Canada: Identifying and Addressing the Problem of Vaccine Hesitancy', February 3, 2015, Ottawa.\", \"Best Brains Exchange: 'Achievement of Optimal Vaccine Coverage Rates in Canada: Identifying and Addressing the Problem of Vaccine Hesitancy', February 3, 2015, Ottawa.\", \"Best Brains Exchange: 'Achievement of Optimal Vaccine Coverage Rates in Canada: Identifying and Addressing the Problem of Vaccine Hesitancy', February 3, 2015, Ottawa.\", \"Investigation of the role of envelope glycoprotein in virulence/attenulation of live japanese encephalitis virus (JEV) vaccine SA14-14-2insights into rational design of flaviviral vaccines\", \"The nature and extent of vaccine hesitancy among chiropractors and naturopaths:  identifying how vaccination views impact practice\", \"\\uacbd\\uc81c\\ub3d9\\ubb3c\\uc6a9 \\ubc31\\uc2e0 \\uc81c\\uc870\\uc5d0 \\uc788\\uc5b4 \\ud3ec\\ub974\\ub9d0\\ub9b0 \\ub300\\uccb4\\uc81c \\ubc1c\\uad74 \\ubc0f \\uc774\\ub97c \\ud65c\\uc6a9\\ud55c \\uc2e0 \\uac1c\\ub150 \\uc0ac\\uade0 \\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc5d0 \\uad00\\ud55c \\uae30\\ucd08 \\uc5f0\\uad6c\", \"\\ud604\\uc7ac \\ubc31\\uc2e0\\uc758 \\ud55c\\uacc4\\ub97c \\uadf9\\ubcf5\\ud55c \\uc0c8\\ub85c\\uc6b4 \\ub300\\uc0c1\\ud3ec\\uc9c4 \\ubc31\\uc2e0\\ud6c4\\ubcf4 \\ubc1c\\uad74 \\ubc0f \\uc791\\uc6a9\\uae30\\uc804 \\uaddc\\uba85\", \"To develop new synthetic DNA vaccines encoding designed CSP antigens to provide a new generation advanced CSP component for a prophylactic malaria vaccine\", \"To develop a plan for the identification of immune correlates of vaccine efficacy that will enable vaccine product development and licensure to improve global population health\", \"To evaluate benefits of inactivated vaccine as a booster following vaccination with live attenuated influenza vaccine in young children in developing countries\", \"Production of High Efficiency Recombinant Foot-and-mouth Disease Vaccine for Pre-clinical and Clinical Trials and Commercial Vaccine Production\", \"Evaluation of the effect of vaccines on overall health in Danish children: Changing the paradigm of vaccine policy in high-income countries\", \"Antigen targeting and activation of dendritic cells for vaccine design\", \"Chlamydophila psittaci recombinant vaccine development\", \"To optimize the process of WHO biannual influenza vaccine virus selection towards appropriate influenza vaccine composition recommendations for tropical countries\", \"To determine whether mucosal immunity against poliovirus can be enhanced by providing an additional dose of inactivated poliovirus vaccine to children previously immunized with oral poliovirus vaccine\", \"To reduce child mortality through increasing vaccine visibility in 6 states, and through increasing availability of vaccines in Lagos state.\", \"To test whether injection of a vaccine into laser-exposed skin can significantly enhance immune responses stimulated by the vaccine\", \"To convene professionals from developing countries working in research, development, manufacturing and supply of vaccines, towards the common goal of increasing the availability of high-quality vaccines\", \"To test for use in a vaccine a live single-cycle poliovirus that has been modified to eliminate its ability to re-emerge as vaccine-derived poliovirus.\", \"To advocate for HIV vaccines research and development and facilitate the African AIDS Vaccine Programme's transition to an independent operational African program outside of WHO\", \"To develop new architectural and construction guidelines for vaccine storage rooms in hot climates that incorporate passive solar thermal technologies to keep vaccines at recommended temperatures.\", \"To develop a novel HIV-1 RV144-like vaccine regimen using an improved vaccine vector Mycobacterium bovis Bacillus Calmette-Guerin\", \"To establish a global laboratory support network that will benefit AIDS vaccine development as it relates to vaccine-elicited antibody responses\", \"To produce more poliovirus vaccine supply while reducing production costs by silencing non-essential virus resistance genes to develop enhanced vaccine cell lines\", \"To develop cell phone sensors that monitor refrigerated vaccine stocks and generate geo-tagged alerts when vaccines reach critical temperatures.\", \"To study whether reducing the ability of lysomes to digest protein antigens in vaccines could enhance the vaccine\\u2019s ability to elicit antibody and T cell responses.\", \"To employ novel, rational design strategies to generate an oral/mucosal vaccine formulation that could significantly contribute to developing vaccines to improve global health\", \"To investigate the use of lyophilized Salk IPV to serve as basis for a combination vaccine strategy with a pentavalent vaccine\", \"To develop a vaccine platform that uses bacteriophages that are structurally stable in extreme environments to manufacture inexpensive, stable, and easy-to-produce vaccines.\", \"To test the hypothesis that selling vaccines through medicine shops in emerging markets can lead to profits for both vaccine developers and the small business owners.\", \"To develop an affordable, easy-to-use, and effective stable liquid multi-dose rotavirus vaccine delivery system for introduction to vaccine partners in developing countries\", \"To test the feasibility of using microneedle patches to deliver the inactivated polio vaccine (IPV) instead of using intramuscular vaccine shots.\", \"To reduce severe illness and death among infants and children by evaluating non-replicating rotavirus vaccine candidates as viable alternatives to oral, live attenuated rotavirus vaccines\", \"To engineer an adenovirus vaccine vector that could be used in an HIV vaccine to elicit the strong immune response.\", \"To design a novel vaccine platform based on protein microcrystals produced by insect viruses, to induce a vigorous immune response without the need for refrigerated vaccine storage.\", \"D\\u00e9veloppement d'une plateforme vaccinale hautement versatile bas\\u00e9e sur les nanoparticules du virus mosa\\u00efque de la papaye\", \"A HUMAN TOXOPLASMA GONDII VACCINE\", \"DEVELOPMENT OF A PROPHYLACTIC ONCHOCERCIASIS VACCINE\", \"COMBINING PARASITE AND VECTOR COMPONENTS FOR DEVELOPMENT OF A LEISHMANIA VACCINE\", \"A basic study on combination vaccines of rotavirus and norovirus\", \"Malaria vaccine development based on multifunctional hybrid vaccine platform\", \"\\u591a\\u6a5f\\u80fd\\u578b\\u30ef\\u30af\\u30c1\\u30f3\\u30d7\\u30e9\\u30c3\\u30c8\\u30d5\\u30a9\\u30fc\\u30e0\\u3092\\u57fa\\u76e4\\u3068\\u3057\\u305f\\u30de\\u30e9\\u30ea\\u30a2\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u7814\\u7a76\", \"Enhanced multivalent vaccine responses using a novel vaccine vector system\", \"Caract\\u00e9risation et \\u00e9valuation du potentiel immunostimulant de saponines triterp\\u00e9niques naturelles et h\\u00e9misynth\\u00e9tiques comme adjuvants potentiels de vaccins\", \"Mise au point d'un vaccin sous-unitaire contre les infections \\u00e0 Salmonella et Streptococcus suis chez le porc.\", \"Effets des capsules polysaccharidiques sialyl\\u00e9es de bact\\u00e9ries Gram Positif sur la capacit\\u00e9 immunog\\u00e9nique de vaccins conjugu\\u00e9s\", \"Development of a sub-unit vaccine to protect swine against the infections caused by Streptococcus suis\", \"SIGNATURE-TAGGED MUTAGENESIS: A NOVEL AND RAPID APPROACH FOR DEVELOPMENT OF AQUACULTURE VACCINES\", \"Harnessing the immunostimulatory activity of chitosan to produce potent vaccine adjuvants\", \"HIV vaccine acceptability among vulnerable communities in Thailand\", \"Pan-PRovincial Vaccine ENTerprise (PREVENT) / Pr\\u00e9vention de la propagation de l'insuffisance fonctionnelle des organes (PPIFO)\", \"Task X3: Production and Testing of Conjugate Cholera Vaccine\", \"Task X 4: Assessment of Simple Adjuvants to Enhance Anthrax Vaccines\", \"Heterogeneous prime boost vaccines for Chlamydia trachomatis.\", \"Heterogeneous prime boost vaccines for Chlamydia trachomatis.\", \"Targeting the hydrophobic domain of biothreat pathogens for vaccine development\", \"Development of Assays to Evaluate Filovirus Vaccines\", \"Development of Assays to Evaluate Filovirus Vaccines\", \"Preclinical Development of Oral Anthrax Vaccine\", \"Preclinical Development of Oral Anthrax Vaccine\", \"Development and Production of Inactivated H5N1 Influenza Vaccine\", \"Development of a Recombinant SARS Vaccine\", \"GLOBAL HIV VACCINE ENTERPRISE\", \"GLOBAL HIV VACCINE ENTERPRISE\", \"GLOBAL HIV VACCINE ENTERPRISE\", \"GLOBAL HIV VACCINE ENTERPRISE\", \"GLOBAL HIV VACCINE ENTERPRISE\", \"\\u8fdf\\u7f13\\u7231\\u5fb7\\u534e\\u6c0f\\u83cc\\u5f31\\u6bd2\\u8f7d\\u4f53\\u75ab\\u82d7\\u7684\\u5f02\\u6e90\\u6297\\u539f\\u5448\\u9012\\u548c\\u514d\\u75ab\\u4fdd\\u62a4\", \"SIMIAN VACCINE EVALUATION UNITS - Animal Maintenance and Care\", \"SVEU - Efficacy of HIV Clade C Vaccine Candidate with GP120 Boost\", \"IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS\", \"IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS\", \"IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS\", \"IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS\", \"IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS\", \"SIMIAN VACCINE EVALUATION UNITS: Conduct Study P190\", \"Recombinant Vaccines for Prevention of AIDS and Other Diseases\", \"SVEU - Efficacy of HIV Clade C Vaccine Candidate with GP120 Boost\", \"STUDIES ON ENZYME-LINKED IMMUNOSORBENT ASSAY FOR EVALUATION OF IMMUNIZATION\", \"\\u57fa\\u4e8e\\u540c\\u79cd\\u5f02\\u578b\\uff08Heterologous prime\\uff0dboost\\uff09\\u75ab\\u82d7\\u514d\\u75ab\\u7b56\\u7565\\u589e\\u5f3a\\u65e5\\u672c\\u8840\\u5438\\u866b\\u75c5\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u53ca\\u5176\\u673a\\u7406\\u7684\\u7814\\u7a76\", \"\\u4e2d\\u56fdEIAV\\u75ab\\u82d7\\u514d\\u75ab\\u539f\\u7684\\u591a\\u6837\\u6027\\u6784\\u6210\\u4e0e\\u8bf1\\u5bfc\\u4fdd\\u62a4\\u6027\\u514d\\u75ab\\u7684\\u76f8\\u5173\\u6027\\u7814\\u7a76\", \"2nd Annual Vaccine Renaissance Conference, RI\", \"Validation of Molecular Diagnostics and Vaccine for Classical Swine Fever\", \"Development of auxotrophic vaccines against M. tuberculosis.\", \"Preclinical trials of a quadrivalent hepatitis C virus vaccine\", \"Development of oral pellet Fowl Cholera Vaccine\", \"Development of a Live Attenuated Vaccine against Hemorrhagic Septicemia\", \"Development of envelope based dengue tetravalent all-in-one vaccine\", \"Status of Veterinary Vaccines and Diagnostics in India A comprehensive review\", \"Nano-Newcastle disease virus vaccine pathway to commercialization\", \"Development of recombinant vaccine for control of salmonellosis in poultry\", \"DEVELOPMENT OF RECOMBINANT FUSION PROTEIN VACCINE FOR\", \"Modulation of TLR5 mediated T regulatory functions in cholera vaccine\", \"Development of vaccines and diagnostics against hospital acquired infections:\", \"Predictors of Poor Immune Response to Rotavirus Vaccine in Infants.\", \"Identification of the potential vaccine candidate antigens of clostridium chauvoei\", \"Development of Malaria Vaccines Using the Influenza\", \"Development of a Recombinant Combination Blood Stage Vaccine\", \"DEVELOPMENT OF NEW LIVE ATTENUATED VACCINE CANDIDATES FOR KALA - AZAR\", \"Construction of multivalent protein vaccine against Staphylococuss aureus and immunogenicity\", \"Adenovirus vectored vaccines for foot and mouth disease.\", \"Development of smart nano carriers for oral vaccine delivery\", \"Establishment of the Core Vaccine Research Unit (CVRU)\", \"Development of HPV 18 Chimaeric vaccine candidate\", \"DEVELOPMENT OF CHIKUNGUNYA VACCINE CANDIDATE\", \"Indo Norwegian platform on fish and shellfish vaccine development.\", \"Development of DNA based vaccine against\", \"Development of Vaccine for control of bovine tuberculosis.\", \"Development of Recombinant Vaccine for Infectious bursal disease virus.\", \"Development of Recombinant Fusion Protein Vaccine for Mycobacterium avium subsp.Paratuberculosis.\", \"Recombinante expressie van door middel van RNAi geselecteerde kandidaatvaccin antigenen van Ostertagia ostertagi in Caenorhabditis elegans\", \"Recombinante expressie van door middel van RNAi geselecteerde kandidaat-vaccin antigenen van Ostertagia ostertagi in Caenorhabditis elegans.\", \"Een ge\\u00efntegreerde preklinische strategie voor het ontwikkelen van verbeterde dendritische cel vaccins tegen longkanker\", \"Ontwikkeling van een Chlamydia psittaci DNA vaccin voor de bestrijding van chlamydiosis bij kalkoenen.\", \"Ontwikkeling van een Chlamydia trachomatis kandidaat recombinant vaccin voor mucosale toediening.\", \"\\\"Biomics\\\" als innovatieve benadering voor Chlamydia trachomatis vaccin ontwikkeling.\", \"Ontwikkeling van F1- en P-gebaseerde subunit vaccins tegen aviaire escherichia coli infectie (APEC).\", \"Ontwikkeling van F1-gebaseerde subunit vaccins tegen aviaire E. coli infectie.\", \"De rol van interferon-gamma in de immuniteit ge\\u00efnduceerd door het sporozo\\u00efet malaria vaccin.\", \"Preklinische ontwikkeling van RNA-gemodifieerde dendritische celvaccins voor kanker en HIV.\", \"Preklinische ontwikkeling van RNA gemodifieerde dendritische celvaccins voor kanker en HIV.\", \"Studie van de variabiliteit van humaan immunodefici\\u00ebntie virussen. Implicaties voor vaccin en antivirale interventie strategie\\u00ebn.\", \"Ontwikkeling en validering van een oraal influenza A vaccin gebaseerd op M2e-uitdrukkende fagen\", \"Ontwikkeling en validering van een oraal influenza A vaccin gebaseerd op M2e-uitdrukkende fagen\", \"Production of immunogenic tumor lysate loaded mesoporous silica nanoparticles as anti-cancer vaccine\", \"Identificatie van het immunologisch werkingsmechanisme van het influenza matrixeiwit-2 ectodomein vaccin.\", \"Formulatie van vaccin antigenen in intelligente stimuli-responsieve ultra-kleine nanpoartikels\", \"Ontwikkeling van microparticulaire kanker vaccins door formulatie van tumor-specifieke antigenen met immuno-modulerende polymeren.\", \"Ontwikkeling en evaluatie van een recombinant vaccin tegen malaria bij het rund veroorzaakt door Theileria parva\", \"Ontwikkeling en evaluatie van een recombinant vaccin tegen malaria bij het rund veroorzaakt door Theileria parva.\", \"Een nieuw tuberculose vaccin gebaseerd op genetische vaccinatie met cultuurfiltraat-antigenen.\", \"RNA synthetische biologie voor de genetische aanmaak van een programmeerbaar \\u00e9\\u00e9nmaal toe te dienen slim RNA vaccin\", \"Vaccins tegen tuberculose: identificatie en karakterisatie van de immunologische parameters die immune bescherming verlenen.\", \"Vaccins tegen tuberculose : identificatie en karakterisatie van de immunolo- gische parameters die immune bescherming verlenen.\", \"Ontwikkeling van een tumorvaccin gebruikmakend van antigeen getransfecteerde dendritische cellen: een ex vivo studie.\", \"Vaccine for all\", \"\\u4ee5\\u51cf\\u6bd2\\u6c99\\u95e8\\u6c0f\\u83cc\\u4e3a\\u8f7d\\u4f53\\u7684HCV\\u591a\\u8868\\u4f4d\\u6838\\u9178\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u5229\\u7528\\u8f6c\\u57fa\\u56e0\\u7d2b\\u82b1\\u82dc\\u84ff\\u7814\\u7a76\\u809d\\u7247\\u5438\\u866b\\u98df\\u7528\\u75ab\\u82d7\", \"MAF-J6-1\\u53ca\\u5176\\u53d7\\u4f53\\u878d\\u5408\\u57fa\\u56e0\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u65b0\\u57ce\\u75c5\\u6bd2\\u5728\\u80bf\\u7624\\u75ab\\u82d7\\u5236\\u5907\\u4e2d\\u7684\\u4f5c\\u7528\", \"\\u6076\\u6027\\u759f\\u57fa\\u56e0\\u5728\\u4eba\\u4f24\\u5bd2\\u6746\\u83cc\\u75ab\\u82d7\\u682a\\u4e2d\\u8fdb\\u884c\\u56db\\u73af\\u7d20\\u8bf1\\u5bfc\\u8868\\u8fbe\", \"HPV16\\u57fa\\u56e0\\u5de5\\u7a0b\\u9884\\u9632\\u75ab\\u82d7\\u53ca\\u5176\\u4f5c\\u7528\\u7684\\u7ec6\\u80de\\u4e0e\\u5206\\u5b50\\u751f\\u7269\\u7814\\u7a76\", \"\\u4e19\\u578b\\u809d\\u708e\\u590d\\u5408\\u591a\\u4ef7\\u57fa\\u56e0\\u5de5\\u7a0b\\u53e3\\u670d\\u6d3b\\u83cc\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u6297\\u4e73\\u5934\\u7624\\u75c5\\u6bd2\\u611f\\u67d3\\u7684\\u5d4c\\u5408\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7684\\u7ec6\\u80de\\u5206\\u5b50\\u751f\\u7269\\u5b66\", \"\\u5bb6\\u755c\\u75c5\\u6bd2\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u901a\\u7528\\u8f7d\\u4f53\\u7684\\u6784\\u5efa\", \"\\u9999\\u8549\\u75c5\\u6bd2\\u75c5\\u8840\\u6e05\\u5b66\\u5feb\\u901f\\u68c0\\u9a8c\\u6280\\u672f\\u53ca\\u6297\\u75c5\\u6bd2\\u75ab\\u82d7\\u7b5b\\u9009\\u7684\\u7814\\u7a76\", \"\\u725b\\u4f20\\u67d3\\u6027\\u9f3b\\u6c14\\u7ba1\\u708e\\u5355\\u514b\\u9686\\u6297\\u4f53\\u8bca\\u65ad\\u8bd5\\u5242\\u53ca\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u7814\\u5236\", \"\\u970d\\u4e71\\u9ad8\\u6548\\u75ab\\u82d7\\u7684\\u7814\\u5236\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\\u7684\\u63a2\\u8ba8\", \"\\u798f\\u6c0f\\u5fd7\\u8d3a\\u6c0f\\u83cc\\u6297\\u72ec\\u7279\\u578b\\u6297\\u4f53\\u4f5c\\u4e3a\\u75ab\\u82d7\\u7684\\u53ef\\u884c\\u6027\\u7814\\u7a76\", \"\\u6076\\u6027\\u759f\\u539f\\u866b\\u914d\\u5b50\\u75ab\\u82d7\\u57fa\\u7840\\u7814\\u7a76--\\u914d\\u5b50\\u9776\\u6297\\u539f\\u5206\\u6790\", \"\\u53e3\\u8e44\\u75ab\\u75ab\\u82d7\\u7814\\u5236\\u7684\\u65b0\\u6280\\u672f\\u53ca\\u5176\\u5e94\\u7528\\u57fa\\u7840\\u7814\\u7a76\", \"\\u5e94\\u7528\\u57fa\\u56e0\\u5de5\\u7a0b\\u6280\\u672f\\u5236\\u5907\\u6059\\u866b\\u75c5\\u7acb\\u514b\\u6b21\\u4f53\\u6297\\u539f\\u53ca\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u6742\\u4ea4\\u7ec6\\u80de\\u6d3b\\u7624\\u82d7\\u6297\\u767d\\u8840\\u75c5\\u4f5c\\u7528\\u7684\\u7814\\u7a76\", \"\\u8f6e\\u72b6\\u75c5\\u6bd2\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7684\\u7814\\u5236\\u53ca\\u5176\\u4e34\\u5e8a\\u5e94\\u7528\", \"\\u4e09\\u7532\\u57fa\\u58f3\\u805a\\u7cd6\\u65b0\\u57ce\\u75abDNA\\u75ab\\u82d7\\u7eb3\\u7c73\\u7c92\\u7684\\u5236\\u5907\\u53ca\\u5176\\u7406\\u5316\\u7279\\u6027\", \"T\\u7ec6\\u80de\\u75ab\\u82d7\\u8bf1\\u5bfc\\u7684CD4+\\u8c03\\u8282\\u6027T\\u7ec6\\u80de\\u5e94\\u7b54(\\u514d\\u75ab\\u53cc\\u8fb9\\u4f1a)\", \"\\u589e\\u5f3aIgA\\u5e94\\u7b54\\u6297\\u6210\\u4eba\\u7259\\u5468\\u708eDNA\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u7528\\u53cc\\u6b67\\u6746\\u83cc\\u505a\\u8f7d\\u4f53\\u6784\\u5efaETEC\\u5b9a\\u5c45\\u56e0\\u5b50I\\u91cd\\u7ec4\\u8f7d\\u4f53\\u75ab\\u82d7\", \"\\u9a6c\\u94c3\\u85af\\u665a\\u75ab\\u82d7\\u6301\\u4e45\\u6297\\u6027\\u4e0e\\u52a0\\u5de5\\u54c1\\u8d28\\u6539\\u826f\", \"Verbundprojekt: Entwicklung eines Rotlauf-Impfstoffs f\\u00fcr Gefl\\u00fcgel - Teilprojekt 2\", \"Verbundprojekt: Entwicklung eines Rotlauf-Impfstoffs f\\u00fcr Gefl\\u00fcgel - Teilprojekt 1\", \"Entwicklung eines Impfstoffes zur Prophylaxe der Chlamydiose des Rindes\", \"Pilotstudie zum Einsatz kommerziell erh\\u00e4ltlicher AIV H5-Impfstoffe\", \"Verbundprojekt: Topische Vakzinierung mit funktionalen Nanopartikeln - Teilvorhaben: Getriggerte Freisetzung von Vakzinen aus LbL-Nanopartikeln\", \"Verbundprojekt: Topische Vakzinierung mit funktionalen Nanopartikeln - Teilvorhaben: Synthese und Analyse von Vakzinkomponenten\", \"CI3: Pr\\u00e4klinische Entwicklung einer prophylaktischen RNA Vakzine gegen Influenza\", \"CI3: Tumorimpfstoffe basierend auf onkolytischen Masernviren, Teilprojekt Ribological\", \"CI3: IVAC - Individualisierte Vakzine zur Therapie des malignen Melanoms, Teilprojekt Ribological\", \"CI3: IVAC - Individualisierte Vakzine zur Therapie des malignen Melanoms - Teilprojekt TRON\", \"Forschungspr\\u00e4mie: Vom Forschungsergebnis zum pharmazeutischen Produkt - Entwicklung von Aufreinigungsprozessen f\\u00fcr eine Impfstoffplattform\", \"EXIST-Gr\\u00fcnderstipendium: Pylorix - Neue Impfstoffe und Antibiotika gegen Helicobacter pylori\", \"Verbundprojekt: Entwicklung von Impfstoffen Gegen Viren der Herpesgruppe - Teil 1\", \"KMU-innovativ-16: Entwicklung mRNA-basierter mukosaler Impfstoffe - 'MukoVak'\", \"GO-Bio 4B: Imevax - Neue Impfstoffe gegen Erreger chronischer Infektionen\", \"ERA Net EuroTransBIO-5: Neue DC-basierte Vakzine gegen Brustkrebs (PDC-VAC)\", \"ERA Net EuroTransBIO-5: Neue DC-basierte Vakzine gegen Brustkrebs (PDC-Vac)\", \"Verbundprojekt: Pr\\u00fcfprogramm eines Synthetischen, veterin\\u00e4rmedizinisch Einsetzbaren Peptid-Impfstoffes\", \"Arbeiten zur Entwicklung einer Vaccine und Immuntherapie Gegen AIDS\", \"Gentechnologische Gewinnung von AIDS-Antigenen - neue Wege zur AIDS-Diagnostik und zur Impfstoffentwicklung\", \"GO-Bio 4: Entwicklung neuer Impfstoffe gegen Erreger chronischer und nosokomialer Infektionen\", \"KMU-innovativ-5: Entwicklung einer panspezifischen RNA Vakzine gegen Influenza A - FluVac\", \"ERA-Net EuroTransBIO-4: Entwicklung eines DNA-Impfstoffes gegen Hepatitis B.\", \"Verbundprojekt: Optimierung der industriellen zellkulturbasierten Herstellung von Influenza Vakzinen, TP: 5\", \"Verbundprojekt: Optimierung der industriellen zellkulturbasierten Herstellung von Influenza Vakzinen, TP 1\", \"Go-Bio 1B: Pharmakologisch optimierte Ribonukleins\\u00e4uren als rekombinante Impfstoffe und Immunadjuvantien\", \"BioChancePLUS-4: Entwicklung eines immunologisch wirksamen therapeutischen Impfstoffs zur Behandlung von Glioblastomen.\", \"BioChancePLUS-4: Entwicklung eines immunologisch wirksamen therapeutischen Impfstoffs zur Behandlung von Glioblastomen\", \"GO-Bio1: Pharmakologisch optimierte Ribonukleins\\u00e4uren als rekombinante Impfstoffe und Immunadjuvantien\", \"BioChancePLUS: Entwicklung eines Sequenz-stabilisierten RNA-Impfstoffs (RNActiveTM) gegen Krebserkrankungen\", \"BioChancePLUS: Neuartige Verfahren zur Entwicklung verbesserter Lebendimpfstoffe\", \"Verbundprojekt: BioProfile Braunschweig/G\\u00f6ttingen/Hannover: Entwicklung von bakteriellen Negativmarker-Impfstoffen f\\u00fcr landwirtschaftliche Nutztiere\", \"BioChance: Synthetische Gene: Verbessertes Sicherheits- und Wirksamkeitsprofil von DNA-Impfstoffen und Gentherapie-Vektoren\", \"KMU-innovativ: Entwicklung eines Produktionsverfahrens zur Herstellung stabiler RNA-Impfstoffe (StabiRNA)\", \"Herstellung und Erprobung genmodifizierter Tumorzellvakzine\", \"Herstellung und Erprobung genmodifizierter Tumorzellvakzine\", \"Aktive und Passive Immunisierung Gegen Pseudomonas Aeruginosa mit Gentechnisch Gewonnenen Vaccinen\", \"Aktive und Passive Immunisierung Gegen Pseudomonas Aeruginosa mit Gentechnologisch Gewonnenen Vaccinen\", \"F\\u00f6rderung einer Initiative zur Entwicklung und Verwertung von Impfstoffen\", \"Verbundprojekt: Individualisierte Tumorimpfstoffe - Individualized Vaccines for Cancer (IVAC), Teilprojekt (TP) 2\", \"Verbundprojekt: Individualisierte Tumorimpfstoffe - Individualized Vaccines for Cancer (IVAC), Teilprojekt (TP) 1\", \"Verbundprojekt Translationales Sarkom-Netzwerk (TranSaRNet): Verbesserung der Tumorvakzine-Therapie\", \"Verbundprojekt: Entwicklung einer RNA-DC Vakzine im Melanommodell\", \"Entwicklung und Validierung von prophylaktischen und therapeutischen Impfstoffkandidaten gegen die Chagas Krankheit\", \"ERA-Net: Selbst-replizierender RNA-Impfstoff gegen Hepatitis C Genotyp 2, zielgerichtet auf dendritische Zellen\", \"Does a Customized Website Affect HPV Vaccine Use among Latino Adolescents and Young Adults?\", \"\\u80bf\\u7624\\u5fae\\u73af\\u5883\\u4e2dEPCs\\u88c2\\u89e3\\u7269\\u81f4\\u654f\\u7684DC\\u75ab\\u82d7\\u6297\\u80bf\\u7624\\u8840\\u7ba1\\u751f\\u6210\\u7684\\u7814\\u7a76\", \"\\u643a\\u5e26\\u767b\\u9769\\u75c5\\u6bd2CTL\\u8868\\u4f4d\\u7684\\u5d4c\\u5408VLP\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"Animal Challenge study of novel shigella vaccine antigens common to multiple serotypes\", \"Mucin-Based Breast Tumor Vaccine-Can Help Be Generated Where Help is Needed?\", \"Development of a Novel Vaccine with Fusions of Human Dendritic and Breast Cancer Cells\", \"Development of Human Dendritic Cell Vaccines for Treatment of Breast Cancer\", \"DNA-Based Vaccine for Treatment of Breast Cancer\", \"Dansk titel: En plante-produceret vaccine mod grise PRRS\", \"Dansk titel: Produktion af allergivacciner m\\u00e5lrettet mod antigen pr\\u00e6senterende celler\", \"Probiotics For Food Preservation, Functional Foods As Vaccine And Vector For Delivery Systems\", \"NSERC/Sanofi Industrial Research Chair in vaccine mathematics, modelling and manufacturing\", \"Vaccine-induced protection against bacterial infections in Arctic charr (Salvelinus alpinus)\", \"Bilan de masse permettant le d\\u00e9veloppement de nouveaux vaccins et anticorps \\u00e0 base de plantes\", \"Interactions Between Vaccines and Excipients Affecting Thermal Stability After Spray-Drying\", \"Development of Orf virus (ORFV) as a multivalent vaccine vector platform against Toxoplasma gondii\", \"Characterization of Rotavirus Strains and Development of Candidate Vaccine Derived From Children With Diarrhea.\", \"Development of Dendritic Cell-Based Vaccines With Osteotropism for Treatment of Bone Metastasis\", \"Characterization and Development of CELiD for Gene Transfer and DNA Vaccine Purposes\", \"Identification and Development of Potential Subunit Vaccine Candidates Against Leptospirosis\", \"Immunomodulation of Neu5Gc Glycopeptides with Biomaterials: A Potential Vaccine Platform.\", \"Programming Protective Efficacy of BCG-Vaccine Using Novel TLRs Adjuvant Nano-Formulations\", \"Animal Model Malaria: Its Application to Preclinical Trials of Adenoviral Anti-Malaria Vaccine\", \"Designing an Effective T-Cell Vaccine for Rheumatic Fever and Rheumatic Heart Disease\", \"Development of Therapeutic Vaccine Against Bovine Papilloma Virus Induced Equine Sarcoids\", \"Control of Contagious Bovine Pleuropneumonia: The Need for Vaccine Development\", \"Analysis of the immune response in mice to Semliki Forest-based vaccine vectors\", \"Harnessing the immunostimluatory activity of chitosan to produce potent vaccine adjuvants\", \"Validation of lipoproteins/lipopeptides as adjuvants and antigens for a new pertussis vaccine\", \"Recombinant human papillomavirus 16 vaccine against cervical cancer in women\", \"Immunogenecity and functional analysis of an amoebic vaccine candidate\", \"Leishmania vaccine development II: Transition from in vitro studies to clinical trials\", \"A Nano-on-micro Delivery System for a Vaccine/Adjuvant againts Helicobacter pylori\", \"Canadian network for vaccines and immunotherapeutics of cancer and chronic viral diseases (CANVAC)\", \"Immune correlates of protection in SIV and HIV vaccine development\", \"Antibody libraries for discovering vaccine leads against HIV-1\", \"Initiative to develop a Canada-wide vaccine epidemiology and clinical trials consortium\", \"Developing novel vaccines for respiratory syncytial virus and parainfluenza virus type 3\", \"Novel molecular approaches for the development of live vaccines against leishmaniasis\", \"Nanoparticle delivery of cancer vaccines and immunomodulators for overcoming immunosuppression\", \"MHC supertypes and epitope-based HIV-1 vaccine design\", \"MHC supertypes and epitopes-based HIV-1 vaccine design\", \"Development of a neonatal pertussis vaccine: One shot for life\", \"Development of a vaccine for Chlamydia pneumoniae infection in a rabbit model\", \"HIV therapy trials:  Assessment of antiretroviral drug treatments and vaccine development\", \"Topical toll-like receptor activation for optimization of vaccine immune responses\", \"Analysis of genetic variations between strains of the Bacille Calmette-Guerin vaccine.\", \"Targeted cancer vaccines: Synthesis and evaluation of clustered cancer associated carbohydrate antigens\", \"Generation of a novel therapeutic dendritic cell- based HIV vaccine\", \"Innovative vaccine development and delivery to induce mucosal immunity\", \"Linking Innate and Specific Immunity to Develop Single Dose Vaccine for Neonates\", \"Development of oral parvo virus vaccine combined with probiotics as spray\", \"Do Pentavalent vaccines have sex-differential non-specific effects?\", \"Elucidating the therapeutic potential of plasmacytoid dendritic cells in cell-based vaccines.\", \"Centre de recherche en infectiologie porcine et avicole (CRIPA)\", \"Phase I/II clinical trial of DNA idiotype vaccines in untreated stage A CLL\", \"Analysis of molecules important for vaccine protection against EBV infection\", \"Analysis of molecules important for vaccine protection against EBV infection\", \"\\u5358\\u7403\\u306e\\u63a5\\u7740\\u6a5f\\u69cb\\u306e\\u89e3\\u660e\\u304a\\u3088\\u3073\\u6a39\\u72b6\\u7d30\\u80de\\u7642\\u6cd5\\u30ef\\u30af\\u30c1\\u30f3\\u88fd\\u9020\\u6280\\u8853\\u3078\\u306e\\u5fdc\\u7528\", \"\\ud610\\uae30\\uc801\\uc870\\uac74\\uc5d0\\uc11c \\ubc30\\uc591\\ub41c \\uc2e0\\uac1c\\ub150\\uc758 \\ucf5c\\ub808\\ub77c \\ubc31\\uc2e0 \\uac1c\\ubc1c \\ubc0f \\ud6a8\\ub2a5\\ud3c9\\uac00\", \"\\ub098\\ub178 \\uae30\\ubc18 Bioparticle\\uc758 \\uc2e0\\uac1c\\ub150 \\ubc31\\uc2e0 \\uc804\\ub2ec\\uccb4 \\uac1c\\ubc1c \\ubc0f \\ubc29\\uc5b4 \\uba74\\uc5ed \\uc5f0\\uad6c\", \"\\uc778\\uc720\\ub450\\uc885\\ubc14\\uc774\\ub7ec\\uc2a4 10\\uac00 \\ubc31\\uc2e0\\uc758 \\uba74\\uc5ed\\ud559\\uc801 \\uae30\\uc804 \\ubc0f \\ubd84\\uc11d\\ubc95 \\uac1c\\ubc1c\", \"\\uc2e0\\uac1c\\ub150 delivery system\\uacfc Secretory \\ubc1c\\ud604 vector\\ub97c \\uc774\\uc6a9\\ud55c \\uac10\\uc5fc\\ubcd1\\uc608\\ubc29\\uc6a9 \\ubc31\\uc2e0\\uac1c\\ubc1c\", \"\\ubc14\\uc774\\ub7ec\\uc2a4 \\uc9c8\\ubcd1 \\uc608\\ubc29\\uacfc \\uce58\\ub8cc\\ub97c \\uc704\\ud55c \\ucc28\\uc138\\ub300 \\uc720\\ub2c8\\ubc84\\uc124 \\ubc31\\uc2e0\\uac1c\\ubc1c\", \"TM4SF5\\ub97c \\ud45c\\uc801\\uc73c\\ub85c \\ud558\\ub294 \\ucdcc\\uc7a5\\uc554 \\uc608\\ubc29 \\ubc0f \\uce58\\ub8cc\\ubc31\\uc2e0\\uc758 \\ud6a8\\ub2a5 \\ubc0f \\uc791\\uc6a9\\uae30\\uc804 \\uaddc\\uba85\", \"\\ucf5c\\ub808\\ub77c \\ub3c5\\uc18c\\ubc14\\uc774\\ub7ec\\uc2a4 CTX phage\\uc758 \\uc9c4\\ud654\\uc640 \\ucf5c\\ub808\\ub77c \\ubc31\\uc2e0 \\ub514\\uc790\\uc778\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"\\ubd84\\ud574\\uc131 \\uace0\\ubd84\\uc790 PLGA\\ub97c \\uc774\\uc6a9\\ud55c \\uc5b4\\ub958 \\ubc31\\uc2e0\\uc758 \\uc57d\\ub9ac\\uc801, \\uba74\\uc5ed\\ud559\\uc801 \\ud3c9\\uac00\", \"\\ub124\\ud314 \\uace0\\uc0b0\\uc9c0\\uc5ed \\uc2e0\\uc7ac\\uc0dd \\uc5d0\\ub108\\uc9c0\\uc6d0\\uc744 \\uc774\\uc6a9\\ud55c \\uc6d0\\uac70\\ub9ac \\ubc31\\uc2e0 \\uc804\\ub2ec \\uc2dc\\uc2a4\\ud15c\\uc758 \\uad6c\\ucd95\", \"\\uba74\\uc5ed\\uc6d0\\uc131\\uc774 \\uac15\\ud654\\ub41c \\ud56d\\uc6d0\\uc744 \\uc774\\uc6a9\\ud55c \\ub385\\uae30 \\ubc14\\uc774\\ub7ec\\uc2a4 \\ubc29\\uc5b4\\uc6a9 \\uacbd\\uad6c\\ubc31\\uc2e0 \\uae30\\uc220 \\uc5f0\\uad6c\", \"\\uac10\\uc5fc\\uc131 \\uc9c8\\ud658 \\uc608\\ubc29 \\ubc31\\uc2e0\\uc758 \\ub9c8\\uc774\\ud06c\\ub85c\\ub2c8\\ub4e4 \\uae30\\ubc18 \\ud328\\uce58\\ub85c\\uc758 \\uc751\\uc6a9 \\ubc0f \\uc2e4\\uc6a9\\ud654 \\uc5f0\\uad6c\", \"\\uc545\\uc131\\ub1cc\\uc885\\uc591\\uc5d0\\uc11c Branched multipeptide vaccine\\uc758 \\ud65c\\uc131\\uae30\\uc804 \\uc5f0\\uad6c \\ubc0f \\uc751\\uc6a9\", \"\\ub09c\\uce58\\uc131\\uc554 \\uce58\\ub8cc\\uc6a9 \\uba74\\uc5ed\\uc138\\ud3ec \\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc744 \\uc704\\ud55c \\uc885\\uc591 \\uba74\\uc5ed\\ud559\\uc801 \\uc5f0\\uad6c\", \"\\uacb0\\ud575\\ub9cc\\uc131\\uac10\\uc5fc \\ud2b9\\uc774\\ud56d\\uc6d0\\uc744 \\uc774\\uc6a9\\ud55c \\uacb0\\ud575\\uc608\\ubc29\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc544\\uba54\\ubc14\\uc131 \\uc218\\ub9c9\\ub1cc\\uc5fc \\ubc31\\uc2e0\\uc744 \\uc704\\ud55c \\ud2b9\\uc774 \\uc720\\uc804\\uc790 \\ubc0f \\ubca1\\ud130 \\uc2dc\\uc2a4\\ud15c \\uac1c\\ubc1c\", \"\\ubc31\\uc2e0 \\ud50c\\ub7ab\\ud3fc \\uc801\\uc6a9\\uc744 \\uc704\\ud55c \\ub3fc\\uc9c0 \\ud30c\\ub77c\\uc778\\ud50c\\ub8e8\\uc5d4\\uc790 \\ubc14\\uc774\\ub7ec\\uc2a4 \\uae30\\ubc18 \\ubca1\\ud130 \\uac1c\\ubc1c\", \"\\ud55c\\uc77c \\uc5ec\\ub958\\uc791\\uac00\\uc758   \\ube44\\uad50\\uc5f0\\uad6c  -\\ud788\\ub77c\\ubc14\\uc57c\\uc2dc \\ub2e4\\uc774\\ucf54\\uc640 \\ubc31\\uc2e0\\uc560 \\uc744 \\uc911\\uc2ec\\uc73c\\ub85c\", \"\\uccb4\\uc801\\ubcc0\\ub3d9\\uce21\\uc815\\uc7a5\\uce58 \\uae30\\ubc18 \\ube44\\uc8fc\\uc0ac\\ud615 \\ubc31\\uc2e0\\uc804\\ub2ec \\uc6d0\\ucc9c\\uae30\\uc220\\uac1c\\ubc1c\", \"\\ub098\\ub178\\ubc31\\uc2e0: \\ud56d\\uc6d0 \\ud2b9\\uc774 \\uba74\\uc5ed\\ubc18\\uc751 \\uc99d\\uc9c4\\uc744 \\uc704\\ud55c \\uc0c8\\ub85c\\uc6b4 \\uc804\\ub7b5\", \"\\ud504\\ub85c\\ud14c\\uc624\\ubbf9\\uc2a4\\uc640 DNA \\ubc31\\uc2e0\\uae30\\uc220\\uc744 \\uc774\\uc6a9\\ud55c \\ud6a8\\uacfc\\uc801\\uc778 \\ub3cc\\ub3d4 \\uc774\\ub9ac\\ub3c4\\ubc14\\uc774\\ub7ec\\uc2a4 \\ud56d\\uc6d0 \\ud0d0\\uc0c9\", \"\\uba74\\uc5ed\\uc870\\uc808\\ubd84\\uc790\\ub97c \\ubc1c\\ud604\\ud558\\ub294 \\ubc14\\uc774\\ub7ec\\uc2a4 \\uc720\\uc0ac\\uc785\\uc790 \\uae30\\ubc18 \\ubc31\\uc2e0 \\ud50c\\ub7ab\\ud3fc \\uac1c\\ubc1c\", \"\\uc885\\uc591\\uce58\\ub8cc\\ubc31\\uc2e0 \\ubc0f \\uc720\\uc804\\uc790/\\ud56d\\uccb4/\\ub2e8\\ubc31\\uc9c8 \\uce58\\ub8cc\\uc81c\\uc758 \\ubcf5\\ud569 \\ud56d\\uc885\\uc591\\uce58\\ub8cc\\ud6a8\\uacfc \\uaddc\\uba85\", \"\\ud3d0\\uad6c\\uade0 \\ud611\\ub9c9 \\ub2e4\\ub2f9\\uccb4\\uc758 \\uc0dd\\ud569\\uc131 \\uae30\\uc804\\uc744 \\uc774\\uc6a9\\ud55c \\ud611\\ub9c9 \\ub2e4\\ub2f9 \\ubc31\\uc2e0 \\uc720\\ub3c4\\uccb4 \\uac1c\\ubc1c\", \"\\uc870\\uc9c1\\uc774\\uc2dd\\uc2dc \\uba74\\uc5ed\\uac70\\ubd80\\ubc18\\uc751\\uc744 \\uc5b5\\uc81c\\ud558\\uae30 \\uc704\\ud55c \\uc218\\uc9c0\\uc0c1 \\uc138\\ud3ec \\ubc31\\uc2e0\\uc81c\\uc791\", \"\\ubc31\\uc2e0 \\ud6a8\\ub2a5 \\uc99d\\uac00\\ub97c \\uc704\\ud574 CD8+ T \\uc138\\ud3ec \\uc5d0\\ud53c\\ud1a0\\ud504\\uc758 \\uc6b0\\uc120 \\uc21c\\uc704\\ub97c \\uc2e0\\uc0dd\\uc544 \\ub9c8\\uc6b0\\uc2a4\\uc640 \\uc131\\uccb4 \\ub9c8\\uc6b0\\uc2a4\\uc5d0\\uc11c \\ube44\\uad50 \\uc5f0\\uad6c\", \"\\ubc14\\uc774\\ub7ec\\uc2a4 \\uc720\\uc0ac\\uc785\\uc790\\ub97c \\uc774\\uc6a9\\ud558\\uc5ec \\ud638\\ud761\\uae30 \\uc138\\ud3ec\\uc735\\ud569 \\ubc14\\uc774\\ub7ec\\uc2a4 \\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc744 \\uc704\\ud55c \\uadfc\\uac04 \\uc5f0\\uad6c\", \"\\ud3f4\\ub9ac\\uac10\\ub9c8\\uae00\\ub8e8\\ud0d0\\uc0b0 \\ub098\\ub178 \\uc544\\uc96c\\ubc88\\ud2b8 \\uc18c\\uc7ac\\ub97c \\uc774\\uc6a9\\ud55c \\uc778\\ud50c\\ub8e8\\uc5d4\\uc790 \\ub300\\uc720\\ud589 \\ub300\\uc751 \\ubc31\\uc2e0 \\uc5f0\\uad6c\", \"\\uba54\\ucee4\\ub2c8\\uc998 \\uae30\\ubc18 \\ub3c5\\uac10\\ubc14\\uc774\\ub7ec\\uc2a4 \\uc57d\\ub3c5\\ud654 \\uc0dd\\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"\\ud56d\\uc6d0\\ubcf4\\uc870\\uc81c(adjuvant)\\ub85c\\uc11c \\ub098\\ub178\\ubc31\\uc2e0\\uc804\\ub2ec\\uc2dc\\uc2a4\\ud15c\\uc758 \\uae30\\uc804 \\ubc0f \\ud6a8\\ub2a5 \\uc5f0\\uad6c\", \"\\uc124\\ud558\\uc811\\uc885\\uc5d0 \\uc758\\ud55c RSV \\ubc31\\uc2e0 \\uc720\\ub3c4 \\ud638\\uc0b0\\uad6c\\uc99d\\uc758 \\ubc1c\\uc0dd\\uae30\\uc804 \\uc5f0\\uad6c\", \"\\ud569\\uc131 \\uacb0\\ud575\\ub2e8\\ubc31\\uc744 \\uc774\\uc6a9\\ud55c \\ud56d\\uacb0\\ud575 \\uba74\\uc5ed\\uae30\\uc791 \\ubd84\\uc11d\\uacfc \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc554/\\uc815\\uc18c \\ud56d\\uc6d0 CAGE \\ub2e8\\ubc31\\uc9c8\\uc744 \\uc774\\uc6a9\\ud55c \\ud56d\\uc554 \\ubc31\\uc2e0 \\uac1c\\ubc1c\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"\\ubc15\\ud14c\\ub9ac\\uc544 \\uc6d0\\ud615\\uc9c8\\uccb4 \\uc720\\ub798 \\ub098\\ub178\\uc18c\\ud3ec\\uccb4\\ub97c \\uc774\\uc6a9\\ud55c \\ud328\\ud608\\uc99d \\ubc0f \\uc554\\ubc31\\uc2e0 \\uac1c\\ubc1c\\uacfc \\uba74\\uc5ed\\ud559\\uc801 \\uae30\\uc791 \\uc5f0\\uad6c\", \"\\uc0c8\\ub85c\\uc6b4 \\uc57d\\ub3c5\\ud654\\ubcc0\\uc774\\uc8fc\\ub97c \\uc774\\uc6a9\\ud55c \\uc18c \\ube0c\\ub8e8\\uc140\\ub77c\\ubcd1 \\uc608\\ubc29\\uc6a9 \\uc0dd\\uade0 \\ubc31\\uc2e0\\uc8fc \\uac1c\\ubc1c\", \"\\uac1c \\uc778\\ud50c\\ub8e8\\uc5d4\\uc790 \\ubc14\\uc774\\ub7ec\\uc2a4\\uc758 \\uba74\\uc5ed\\ubcd1\\ub9ac \\uae30\\uc804 \\uc5f0\\uad6c \\ubc0f \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\ud55c\\uad6d\\uc758 \\uc54c\\ub7ec\\uc820\\uc744 \\uc774\\uc6a9\\ud55c \\uc7ac\\uc870\\ud569 \\uc54c\\ub7ec\\uc9c0 \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc591\\uc2dd\\uc5b4\\ub958\\uc758 \\ube44\\ube0c\\ub9ac\\uc624\\uc99d\\uc5d0 \\ub300\\ud55c \\uc7ac\\uc870\\ud569 cadaver \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\ud56d\\uc6b0\\uc2dd \\ubc31\\uc2e0\\uc73c\\ub85c\\uc11c S. mutans\\uc5d0 \\ub300\\ud55c \\ub2e8\\uc77c\\ud56d\\uccb4\\uc758 \\ud6a8\\uacfc\", \"B \\uc138\\ud3ec\\ub97c \\ud56d\\uc6d0 \\uc81c\\uc2dc\\uc138\\ud3ec\\ub85c \\ud65c\\uc6a9\\ud55c \\uc790\\uad81\\uacbd\\ubd80\\uc554 \\uce58\\ub8cc\\ubc31\\uc2e0 \\uac1c\\ubc1c \\uae30\\ud68d\", \"\\uc2e0\\uc7ac\\uc870\\ud569 \\ubca1\\ud130 \\uc2dc\\uc2a4\\ud15c\\uc744 \\uc801\\uc6a9\\ud55c \\ub178\\ub85c\\ubc14\\uc774\\ub7ec\\uc2a4 \\ubc31\\uc2e0\\uac1c\\ubc1c\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"\\uc2dd\\uc911\\ub3c5 \\ubc1c\\uc0dd\\uac10\\uc18c\\ub97c \\uc704\\ud55c Salmonella Typhimurium\\uc758 \\uc608\\ubc29 \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\ucc28\\uc138\\ub300 \\ubc31\\uc2e0\\uac1c\\ubc1c\\uc744 \\uc704\\ud55c \\uc218\\uc9c0\\uc0c1\\uc138\\ud3ec subset targeting strategy\\uc640 \\uba74\\uc5ed\\uc81c\\uc5b4 \\uba54\\uce74\\ub2c8\\uc998 \\uc5f0\\uad6c\", \"\\uc885\\uc591\\uce58\\ub8cc\\uc6a9 \\uc720\\uc804\\uc790\\ubc31\\uc2e0\\uc758 \\uac1c\\ubc1c \\ubc0f \\uce58\\ub8cc\\uae30\\uc804 \\uaddc\\uba85\", \"Streptococcus parauberis \\ubcd1\\uc6d0\\uc131\\uad00\\ub828 \\uc138\\ud3ec \\ud45c\\uba74 fibronectin-binding adhesins\\uc758 \\uae30\\ub2a5\\ud574\\uc11d \\ubc0f vaccine \\uac1c\\ubc1c\", \"\\uace0\\ubcd1\\uc6d0\\uc131 W-Beijing \\uacb0\\ud575\\uade0\\uc8fc\\ub97c \\uc774\\uc6a9\\ud55c \\uacb0\\ud575\\uc608\\ubc29\\ubc31\\uc2e0\\ud6c4\\ubcf4\\ub4e4\\uc758 \\uc608\\ubc29\\ud6a8\\uacfc\\ud3c9\\uac00\", \"\\ucca8\\ub2e8 \\uc720\\uc804\\uacf5\\ud559\\uae30\\ubc95\\uc744 \\uc774\\uc6a9\\ud55c \\uc0b4\\ubaa8\\ub12c\\ub77c \\ubc31\\uc2e0\\uc758 \\uac1c\\ubc1c \\ubc0f \\ud6a8\\ub2a5\\uc5f0\\uad6c\", \"\\uc0ac\\uc721\\uc628\\ub3c4\\uad00\\ub9ac\\uc5d0 \\uc758\\ud55c \\uc5b4\\ub958 \\ubc14\\uc774\\ub7ec\\uc2a4\\uc758 \\ubcd1\\ub3c5\\uc131 \\uc81c\\uc5b4\\uc640 \\uc0dd\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\ub178\\ub85c\\ubc14\\uc774\\ub7ec\\uc2a4 VLPs \\ubc0f synthetic peptides\\ub97c \\uc774\\uc6a9\\ud55c \\uac10\\uc5fc \\ubc0f \\ubc31\\uc2e0 \\uc5f0\\uad6c\", \"Role of the PD-1/PD-L pathway in HIV-1 vaccine design\", \"To convene global experts to address RSV vaccine research and development issues\", \"Novel Idiotype-Based Genetic Vaccines for the Treatment of Lymphoid Malignancies\", \"Manufacturing Technology Centre for Human Vaccines and Pharmaceuticals\", \"Development of DNA Vaccine Biotechnology in Hong Kong\", \"IND Filing and Phase I Clinical Trial of a Malaria Vaccine TBV25H\", \"Liver Cancer Vaccine Development:- Cell Culture Scale-Up Prototype Production Prior IND Application\", \"Liver Cancer Vaccine Development:- Cell Culture Scale-Up Prototype Production Prior IND Application\", \"Development of Novel Second Generation Broad-spectrum hTERTC27-based Therapeutic Tumor Vaccine\", \"Liver Cancer Vaccine Development:- Cell Culture Scale-Up Prototype Production Prior IND Application\", \"Development of HPV Therapeutic Vaccine and Related Immunotherapy for Treating Cervical Cancer\", \"Development of Recombinant Vaccine Candidates for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)\", \"Generation of an adenovirus-based vaccine against infection with cytomegalovirus\", \"The effect of early measles vaccine on pneumococcal carriage\", \"LOW-TOX: Enabling Highly Efficient, Low-Toxicity Fish Vaccines\", \"Accelerating development of vaccines against cancer with pigs as a large animal model (CANVACPIG)\", \"Structure-based design of a vaccine to prevent severe childhood malaria\", \"The cellular immunogenicity of HPV-vaccines in adults with HIV infection\", \"Vaccine induced T cell responses at respiratory surfaces \\u2013 the requirement for long-term protection\", \"Developing a therapeutic TB vaccine through molecular design and immunization route\", \"Design of a microfluidics method for preparation of the liposomal vaccine adjuvant CAF09\", \"Malaria Vaccine Development: Protecting Our Troops\", \"Tulane/Xavier Vaccine Peptide Program\", \"Tulane/Xavier Vaccine Development/Engineering Project\", \"DNA Vaccine-Mediated Immunotherapy for an Animal Model for Rheumatois Arthritis\", \"Reverse Genomics: Portin Microarrays to Guide Tolerizing DNA Vaccine Treatment of Rheumatoid Arthritis\", \"Outer Surface Protein (Osp) C Vaccine for Lyme Disease\", \"Pilot Project: Using Parent Preferences in Decisions about Childhood Vaccines\", \"Evaluation of alternative methods for the detection of porcine cytomegalovirus in veterinary vaccines\", \"The development of a monoclonal antibodybased ELISA for measuring antibodies to leptospira vaccines\", \"Validation of tests used in the quality control of vaccines [was VM0107]\", \"Development of in vitro tests for the determination of the potency of Clostridial vaccines\", \"Evaluation of the immunosuppression test for live infectious bursal disease vaccines\", \"Validation of tests used in the quality control of vaccines [became VM0114]\", \"Development of methods for detecting retroviruses and other viruses in cell lines and vaccines\", \"Development of methods for detecting chicken anaemia virus in vaccines\", \"Development & evaluation of standards to assess QC methods for cat & dog vaccines [became VM0112]\", \"Development of vaccine candidates for protection of badgers against infection with Mycobacterium bovis\", \"Protective immune responses induced by FMDV vaccine\", \"Maintenance and quality control of the vaccine bank\", \"Identification of the origin of footandmouth Disease outbreaks and improved selection methods for vaccines\", \"Development of vaccines to protect badgers against M. bovis [was part SE0110]\", \"Live Salmonella vaccines for the protection of poultry (continuation of OZ0131)\", \"Development of a vaccine to control the poultry red mite & improve laying hen welfare.\", \"Engineering the Surface of Transferrin Binding Protein B for Vaccine\", \"Mechanism of action of a novel respiratory syncytial virus subunit vaccine formulation.\", \"Application of a new small RNA molecule as a vaccine adjuvant\", \"Effects of sialylated capsular polysaccharides from Streptococci on the immunogenic capacity ofconjugate vaccines\", \"Development of live attenuated respiratory syncytial virus vaccines with novel thermal stable fusion protein\", \"93518024\", \"New Application of a DNA-nanorod Platform for Vaccine Development\", \"Serological Vaccine Standards for Ebola, Zika and MersCoV\", \"Development of inducible expression-inactivated Leishmania as vaccine carries\", \"Adjuvant free vaccines and companion diagnostics to control emerging flaviviruses\", \"Using engineered gut bacteria-derived microvesicles for plague vaccines\", \"To support the pre-clinical development of a measles and rubella vaccine microarray patch\", \"This grant will enable vaccine experts from developing countries to participate in the Vaccine Bioprocess and Commercialization three-day workshop in June 2017. The skills learned will improve technology transfer and improve local vaccine development and manufacturing so that vaccines can be provided at an affordable price, which will, in turn, lead to local employment.\", \"\\u7d30\\u80de\\u5185\\u6a19\\u7684\\u5316\\u30b9\\u30de\\u30fc\\u30c8\\u30ca\\u30ce\\uff24\\uff24\\uff33\\u3092\\u7528\\u3044\\u305f\\u52b9\\u7387\\u7684\\u304b\\u3064\\u5b89\\u5168\\u306a\\u304c\\u3093\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Research fellowship to study HIV vaccines\", \"Diagnostic probes and vaccines against dysentry due to shigella flexneri\", \"Will Synthetic T cell determinants be a useful componen t of influenza vaccines?\", \"An animal model to test vaccines against cervical cance r\", \"Genetically disabled murine cytomegalovirus vaccines: efficacy of single-cycle replication mutants\", \"Vaccine to be taken by mothers to prevent rotaviral dia rrhoea in children\", \"Identification of novel stage-specific vaccine candidates for schistosomes using local antibody secreting cell probes\", \"A model for evidence based introduction of a new vacine to Australia - human papillomavirus vaccine\", \"Preparing for group A streptococcal vaccines: epidemiology and immunology of group A streps in Fiji\", \"Studies on a recombinant attenuated salmonella vaccine carrying HIV antigens\", \"Evidence-based health policy and modelling research in vaccine preventable diseases\", \"Secretory and Surface Proteins of Blood-feeding Helminths: Roles in Parasitism and Effacies as Vaccines\", \"The epidemiology and economic impact of vaccine preventable, childhood respiratory infections in the community\", \"Immuno-epidemiological studies of vaccine responses in developing world populations\", \"Enhancing and evaluating T cell responses to candidate HIV prime-boost vaccines\", \"Assessment of a surface component of the malaria parasi te for use in a vaccine\", \"Immunisation with an oral vaccine against bronchitis mode of action\", \"Phase variation of LPS expression in Neisseria meningitidis; role in pathogenesis and vaccine development.\", \"Box jellyfish venom toxins: how they act,study of vaccines and specific antitoxin\", \"Devlopment of a vaccine against hookworm infection in d ogs and humans\", \"Testing vaccine to prevent pneumonia in high risk child ren\", \"Meningococcal surface structures: role in disease and p otential as a vaccine candidates\", \"A model for understanding human papillomavirus infectio n, and a vaccine\", \"The potential of influenza vaccines designed to stimulate crossreactive T-cell immunity\", \"Development of mucosal anti-adhesive vaccines against group A streptococci\", \"A novel type of vaccine for use against sexually transm itted chlamydial disease\", \"Humanized melanoma mouse models for translational assessment of neoantigen-based vaccines\", \"To assess the impact of pneumococcal conjugate vaccine used in a 3+0 schedule\", \"Therapeutic CD8 vaccines against conserved E7 HPV epitopes identified by MS\", \"To explore development of a nimble and focused experimental medicine (EM) approach to vaccine research\", \"To develop single dose vaccines for neonates by linking innate and specific immunity\", \"To develop a stealth measles vaccine which can be administered safely to young infants\", \"To fund effective and affordable dengue vaccines for children in dengue-endemic areas\", \"To further explore an innovative strategy to develop a vaccine against HIV pathogenesis.\", \"To develop more accurate and timely measurement of population immunity generated by polio vaccines\", \"To develop a bivalent conjugate vaccine against S. Typhi and S. Paratyphi A\", \"To support phase I clinical trials with the new oral polio vaccine-2 formulation\", \"To improve the effectiveness of oral poliovirus vaccine in lower-income settings\", \"To support the think tank: HIV Vaccines for Developing Countries: Initiation of Trials in Africa\", \"To continue support of the Global HIV Vaccine Research Cryorepository (GHRC)\", \"To develop and license an improved vaccine against tuberculosis for use in high burden countries\", \"To conduct a landscape analysis of potential pandemic flu vaccine technologies\", \"To conduct research related to the influence of adenovirus infections on HIV-1 vaccine performance\", \"To test a potentially novel vaccine target towards malaria eradication\", \"To support broad literacy and current awareness around vaccines and global health\", \"To assess the dengue vaccine development efforts underway at Chengdu Institute of Biological Products (CDIBP)\", \"To evaluate the effect of pneumococcal conjugate vaccine given in the routine infant schedule\", \"To develop a novel delivery strategy for HIV vaccine antigens\", \"For the creation of \\\"The State of Vaccine Confidence Report\\u201d and web-based supplemental resources\", \"To support a conference entitled \\\"Vaccines for viruses in developing countries\\\"\", \"To provide conference support for the Global Vaccine Research Forum\", \"To develop \\u201csingle-shot\\u201d ultra-stable vaccine formulations that reduce costs for vaccinations\", \"To develop global consensus on regulatory specifications for evaluation of second generation HPV vaccines\", \"To support the development of a preventive vaccine against HIV-1\", \"To evaluate and develop a cross-species synthetic saccharide vaccine for malaria\", \"To develop an effective HIV vaccine to control the transmission of human immodeficiency viruses\", \"To develop an effective and safer poliovirus vaccine to prevent paralytic poliomyelitis\", \"To research Human Polyomavirus BKV as a HIV Vaccine Vector\", \"To fund a conference called Stop Cervical Cancer: Accelerating Global Access to HPV Vaccines\", \"To co-sponsor a scientific workshop to discuss immune correlates of protection on HIV vaccines\", \"To develop technology for rapid low cost delivery of malaria vaccine\", \"To develop safe, effective, and affordable vaccines for introduction into the developing world\", \"To develop a reduced antigen and reduced dose inulin-adjuvanted inactivated poliovirus vaccine.\", \"To use polymeric nanoparticles and engineered proteins to deliver vaccines to immune cells\", \"To develop a live, recombinant, attenuated Salmonella anti-pneumococcal vaccine for newborns\", \"To convene an international symposium to discuss enteric diseases vaccines.\", \"To provide estimates of vaccine impact across relevant countries and under various scenarios\", \"To convene an international symposium to discuss the latest information on ETEC vaccines\", \"To convene an international symposium to discuss upstream rotavirus vaccine candidates and worldwide supply issues.\", \"To facilitate the eradication of polio by understanding mechanisms of protection afforded by vaccines\", \"To engineer a live virus with a self-destruct sequence for use in a vaccine\", \"To produce antigens for use in edible vaccines against infectious diseases.\", \"To design an effective vaccine against HIV: An Alternative Hypothesis\", \"To application of epidemiological models to guide and evaluate control of vaccine-preventable infections\", \"To create novel mouse models for testing live attenuated vaccines\", \"To reduce the time and cost for trials of vaccines against bacterial pneumonia\", \"To develop immunogens for a vaccine that will prevent pregnancy malaria globally\", \"To use newly identified intracellular signaling molecules as components of DNA vaccines against malaria.\", \"To evaluate efficiency of PnuVax's novel conjugation chemistry for making pneumococcal conjugate vaccine\", \"To complete the development of a novel vaccine against cholera\", \"To create novel mouse models for testing HIV and HCV vaccines\", \"To develop and license an improved TB vaccine for use in high burden countries\", \"To support the development and evaluation of HPV vaccines and related diagnostics\", \"To develop needleless vaccines for tuberculosis that are safe, stable and effective\", \"To develop novel recombinant adenovirus, plasmid DNA, and mycobacteria vector-based vaccines for HIV-1\", \"To evaluate the impact of pnuemococcal conjugate vaccine in Togo\", \"To research use of a nanopatch delivery of DNA-based malaria vaccines to skin\", \"To produce an effective, manufacturable, affordable and sustainable Human Hookworm Vaccine (HHV)\", \"To fund a partnership for influenza vaccine introduction in low and lower middle-income countries\", \"To convene an international symposium on enteric disease vaccine development\", \"To develop a novel vector/protein HIV-1 Env vaccine for the developing world\", \"To develop a technology platform for the production of highly immunogenic and affordable polysaccharide vaccines.\", \"To identify and validate new antigens for a vaccine to prevent malaria in pregnant women\", \"To evaluate the effect of pneumococcal conjugate vaccine given in the routine infant schedule\", \"To determine if preexisting gut immunity predicts shedding of poliovirus vaccine.\", \"To support research and development of new influenza vaccines to address pandemic influenza\", \"To support components of the Annual Conference on Vaccine Research\", \"To prevent exportation of pneumococcal surface GAPDH and create an attenuated vaccine\", \"To fund pre-emptive use of a cholera vaccine in vulnerable populations at risk\", \"To develop and validate a novel vaccine for Animal African Trypanosomiasis\", \"To define the protective nature of antibodies that emerge after boosting of the RV144 vaccines\", \"To reduce manufacturing costs of mass-immunization vaccine candidates and simultaneously improve manufacturing efficiencies..\", \"To convene an international conference on global progress regarding the development of new TB vaccines\", \"To improve delivery and efficacy of vaccines for children in less developed countries..\", \"To provide training and guidance to developing country vaccine manufacturers through their Network organization\", \"To work to design components of an HIV vaccine using groups of related envelope sequences.\", \"For protein glycan coupling technology and the development of novel conjugate vaccines\", \"To develop a stealth measles vaccine that is safe and effective in immunizing young infants\", \"To identify new vaccines that induce broadly neutralizing antibodies against HIV\", \"To develop a novel arthropod-based vaccine system against leishmaniasis\", \"To research whether the immune responses to DNA vaccines can be enhanced with novel adjuvants.\", \"To identify antibody correlates of protection for efficacious vaccines to enable product development\", \"To measure the impact of Hib vaccine introduction in Senegal\", \"To use novel recombinant Adenovirus (Ad) vector technologies to develop an HIV vaccine\", \"Extension Submission - Pre-Clinical Development of a Malaria Vaccine\", \"Pre-Clinical Development of a Malaria Vaccine\", \"\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u57fa\\u790e\\u7684\\u554f\\u984c\\u306e\\u7814\\u7a76\", \"\\u72c2\\u72ac\\u75c5\\u9d8f\\u5375\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6539\\u826f\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30cb\\u30e5\\u30fc\\u30ab\\u30c3\\u30b9\\u30eb\\u75c5\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76(\\u7d992\\u5e74)\", \"\\u30a2\\u30e6\\u306e\\u30d3\\u30d6\\u30ea\\u30aa\\u75c5\\u4e0d\\u6d3b\\u5316\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u514d\\u75ab\\u6a5f\\u69cb\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"Salmonella typhimurium \\u306e\\u30ea\\u30dc\\u30be\\u30fc\\u30e0\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u514d\\u75ab\\u539f\\u6027\\u306e\\u89e3\\u660e\", \"\\u7dd1\\u81bf\\u83cc\\u306e\\u30ef\\u30af\\u30c1\\u30f3\\u53ca\\u3073\\u8840\\u6e05\\u8a3a\\u65ad\\u6db2\\u306e\\u958b\\u767a\\u6539\\u826f\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a2\\u30ec\\u30eb\\u30ae\\u30fc\\u526f\\u4f5c\\u7528\\u306e\\u306a\\u3044, \\u30d7\\u30eb\\u30e9\\u30f3\\u7d50\\u5408\\u30c8\\u30ad\\u30bd\\u30a4\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u7814\\u7a76\", \"\\u767e\\u65e5\\u305c\\u304d\\u83cc\\u611f\\u67d3\\u9632\\u5fa1\\u6297\\u539f\\u5206\\u753b\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u8a66\\u4f5c\\u7684\\u7814\\u7a76\", \"\\u9b5a\\u985e\\u306e\\u514d\\u75ab\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u57f9\\u990a\\u7d30\\u80de\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u72c2\\u72ac\\u75c5\\u4e88\\u9632\\u65b9\\u5f0f\\u306e\\u78ba\\u7acb\", \"\\u72c2\\u72ac\\u75c5\\u7d44\\u7e54\\u57f9\\u990a\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5b9f\\u7528\\u5316\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u5674\\u9727\\u6cd5\\u306b\\u3088\\u308b\\u9b5a\\u985e\\u306e\\u514d\\u75ab\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u9b5a\\u985e\\u306e\\u7d30\\u83cc\\u611f\\u67d3\\u75c7\\u306b\\u5bfe\\u3059\\u308b\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u7d30\\u80de\\u58c1\\u95a2\\u9023\\u5408\\u6210\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u3092\\u7528\\u3044\\u305f\\u65b0\\u3057\\u3044\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306e\\u305f\\u3081\\u306e\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u7dd1\\u81bf\\u83cc\\u578b\\u5225\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u81e8\\u5e8a\\u7684\\u7814\\u7a76\", \"\\u767d\\u8840\\u75c5\\u60a3\\u8005\\u53ca\\u3073\\u60aa\\u6027\\u56fa\\u578b\\u816b\\u760d\\u60a3\\u8005\\u306b\\u65bc\\u3051\\u308b\\u6c34\\u75d8\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u63a5\\u7a2e\\u306b\\u3064\\u3044\\u3066\", \"\\u30ef\\u30af\\u30c1\\u30f3\\u30a2\\u30a6\\u30a4\\u30eb\\u30b9\\u8840\\u7403\\u51dd\\u96c6\\u7d20\\u306b\\u3088\\u308b\\u7d30\\u80de\\u819c\\u4fee\\u98fe\\u306e\\u7814\\u7a76\", \"\\u9d8f\\u306e\\u30ed\\u30a4\\u30b3\\u30c1\\u30c8\\u30be\\u30fc\\u30f3\\u75c5\\u306e\\u4e88\\u9632\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\\u7279\\u306b\\u30b9\\u30dd\\u30ed\\u30be\\u30a4\\u30c8\\u30fb\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3064\\u3044\\u3066\", \"\\u30a4\\u30cc\\u30d8\\u30eb\\u30da\\u30b9\\u30a6\\u30a4\\u30eb\\u30b9\\u3092\\u30d9\\u30af\\u30bf\\u30fc\\u3068\\u3057\\u3066\\u7528\\u3044\\u305f\\u30cd\\u30aa\\u30b9\\u30dd\\u30fc\\u30e9\\u539f\\u866b\\u306e\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\", \"\\u7c98\\u819c\\u514d\\u75ab\\u3092\\u7528\\u3044\\u305fA\\u7fa4\\u30ec\\u30f3\\u30b5\\u7403\\u83cc\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u30de\\u30ec\\u30c3\\u30af\\u75c5\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u816b\\u760d\\u5f62\\u6210\\u9632\\u5fa1\\u6a5f\\u69cb\\u306e\\u7814\\u7a76\", \"\\u30de\\u30ec\\u30c3\\u30af\\u75c5\\u306b\\u5bfe\\u3059\\u308b\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4f5c\\u7528\\u6a5f\\u69cb\\u306e\\u89e3\\u6790\", \"\\u4eba\\u5de5\\u5408\\u6210\\u907a\\u4f1d\\u5b50\\u3092\\u7528\\u3044\\u305f\\u30ec\\u30b3\\u30f3\\u30d3\\u30ca\\u30f3\\u30c8SERA\\u86cb\\u767d\\u8cea\\u306b\\u3088\\u308b\\u30de\\u30e9\\u30ea\\u30a2\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5b9f\\u7528\\u5316\", \"\\u71b1\\u5e2f\\u30bf\\u30a4\\u30ec\\u30ea\\u30a2\\u75c7\\u306b\\u5bfe\\u3059\\u308b\\u30b5\\u30d6\\u30e6\\u30cb\\u30c3\\u30c8\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a \\u2015 \\u6709\\u52b9\\u306a\\u6297\\u539f\\u306e\\u540c\\u5b9a\\u3068\\u7cbe\\u88fd\", \"\\u6297\\u30a4\\u30c7\\u30a3\\u30aa\\u30bf\\u30a4\\u30d7\\u6297\\u4f53\\u3092\\u7528\\u3044\\u305f\\u65b0\\u3057\\u3044\\u65e5\\u672c\\u8133\\u708e\\u30a6\\u30a3\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306e\\u305f\\u3081\\u306e\\u57fa\\u790e\\u7814\\u7a76\", \"\\u7d44\\u63db\\u3048\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6297\\u539f\\u7279\\u7570\\u7684\\u514d\\u75ab\\u8a98\\u5c0e\\u80fd\\u306e\\u89e3\\u6790\\u3068\\u8ee2\\u63db\", \"\\u30cd\\u30b3\\u30d8\\u30eb\\u30da\\u30b9\\u30a6\\u30a4\\u30eb\\u30b91\\u578b\\u3092\\u30d9\\u30af\\u30bf\\u30fc\\u3068\\u3057\\u3066\\u7528\\u3044\\u305f\\u30cd\\u30b3\\u514d\\u75ab\\u4e0d\\u5168\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\", \"\\u5404\\u7a2e\\u75c5\\u539f\\u6027\\u8178\\u5185\\u7d30\\u83cc\\u3068\\u764c\\u306b\\u5bfe\\u3059\\u308bYersinia\\u306e\\u6b7b\\u83cc\\u306e\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u52b9\\u679c\", \"HB\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u5bfe\\u3059\\u308b\\u6297pre-S\\u6297\\u4f53\\u306eresponse\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u767e\\u65e5\\u54b3\\u30b3\\u30f3\\u30dd\\u30fc\\u30cd\\u30f3\\u30c8\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4e88\\u9632\\u52b9\\u679c\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u6c34\\u75d8\\u30a6\\u30a4\\u30eb\\u30b9\\u5f31\\u6bd2\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u306eDNA\\u30de\\u30fc\\u30ab\\u30fc\\u306b\\u95a2\\u3059\\u308b\\u89e3\\u6790\", \"\\u65b0\\u305f\\u306b\\u5206\\u96e2\\u3057\\u305f1,6-\\u03b1-D-glucan synthase\\u306e\\u3046\\u8755\\u30ef\\u30af\\u30c1\\u30f3\\u5229\\u7528\", \"\\u6c34\\u75d8\\u30a6\\u30a4\\u30eb\\u30b9-\\u5f31\\u6bd2\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u306e DNA \\u30de\\u30fc\\u30ab\\u30fc\\u306e\\u69cb\\u9020\\u89e3\\u6790\", \"\\u30b3\\u30ec\\u30e9\\u83cc\\u30ea\\u30dd\\u591a\\u7cd6(LPS)\\u3068\\u30b3\\u30ec\\u30e9\\u5916\\u6bd2\\u7d20\\u306e\\u5316\\u5b66\\u7684\\u7d50\\u5408\\u306b\\u3088\\u308b\\u65b0\\u30b3\\u30ec\\u30e9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u30b3\\u30ec\\u30e9\\u30ef\\u30af\\u30c1\\u30f3\\u6539\\u826f\\u306e\\u305f\\u3081\\u306e, \\u30e2\\u30ce\\u30af\\u30ed\\u30fc\\u30ca\\u30eb\\u6297\\u4f53\\u306b\\u3088\\u308b\\u30b3\\u30ec\\u30e9\\u83cc\\u5916\\u819c\\u306e\\u6297\\u539f\\u6027\\u306e\\u89e3\\u6790\", \"\\u30a6\\u30b7\\u767d\\u8840\\u75c5\\u306e\\u7279\\u7570\\u6297\\u4f53\\u306b\\u3088\\u308b\\u8a3a\\u65ad\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u4e88\\u9632\", \"Development of molecular adjuvants for DNA vaccines in the malaria model\", \"\\u30a2\\u30e6\\u306e\\u30d3\\u30d6\\u30ea\\u30aa\\u75c5\\u4e0d\\u6d3b\\u5316\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u514d\\u75ab\\u6a5f\\u69cb\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30d2\\u30c8\\u30ed\\u30bf\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u57f9\\u990a\\u7d30\\u80de\\u306b\\u3088\\u308b\\u5206\\u96e2\\u3068\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u4f5c\\u88fd\\u306e\\u8a66\\u307f\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u52b9\\u679c\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76(\\u7279\\u306b, \\u5730\\u57df\\u96c6\\u56e3\\u3092\\u5bfe\\u8c61\\u3068\\u3057\\u3066)\", \"Yersinia\\u306e\\u7d4c\\u53e3\\u6b7b\\u83cc\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u30de\\u30a6\\u30b9\\u8178\\u7ba1\\u5b9a\\u7740\\u963b\\u6b62\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u7834\\u50b7\\u98a8\\u6bd2\\u7d20\\u306e\\u8fc5\\u901f\\u9ad8\\u5ea6\\u7d14\\u5316\\u6cd5\\u3068\\u305d\\u306e\\u7cbe\\u88fd\\u4e09\\u7a2e\\u6df7\\u5408\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"\\u5408\\u6210\\u30da\\u30d7\\u30c1\\u30c9\\u306b\\u3088\\u308bB\\u578b\\u809d\\u708e\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u6210\\u4ebaT\\u7d30\\u80de\\u767d\\u8840\\u75c5\\u30fb\\u30ea\\u30f3\\u30d1\\u816b(ATL)\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u81ea\\u7531\\u751f\\u6d3b\\u6027\\u7d68\\u6bdb\\u866b\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u539f\\u866b\\u611f\\u67d3\\u9632\\u5fa1\\u52b9\\u679c\", \"\\u5e7c\\u82e5\\u30de\\u30a6\\u30b9\\u306b\\u304a\\u3051\\u308b\\u30c8\\u30ea\\u30d1\\u30ce\\u30bd\\u30fc\\u30de\\u75c7\\u306e\\u7814\\u7a76:\\u30ef\\u30af\\u30c1\\u30f3\\u52b9\\u679c\\u306b\\u53ca\\u307c\\u3059\\u4fee\\u98fe\\u8981\\u56e0\", \"\\u30ec\\u30d7\\u30c8\\u30b9\\u30d4\\u30e9\\u75c7\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u65b0\\u3057\\u3044\\u691c\\u5b9a\\u7528\\u5b9f\\u9a13\\u52d5\\u7269\\u3068\\u3057\\u3066\\u306e\\u30b9\\u30ca\\u30cd\\u30ba\\u30df\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"S.mutans \\u306e\\u7cbe\\u88fd\\u83cc\\u4f53\\u6297\\u539f\\u3092\\u30ef\\u30af\\u30c1\\u30f3\\u3068\\u3059\\u308b\\u6297\\u3046\\u8755\\u514d\\u75ab\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u65b0\\u898f\\u524d\\u7acb\\u817a\\u764c\\u30de\\u30a6\\u30b9\\u5b9f\\u9a13\\u30e2\\u30c7\\u30eb\\u306e\\u78ba\\u7acb\\u3068\\u764c\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5275\\u6210\", \"SSXa1\\u3092\\u6a19\\u7684\\u3068\\u3059\\u308b\\u30de\\u30a6\\u30b9\\u81ea\\u5bb6\\u6297\\u539f\\u764c\\u30ef\\u30af\\u30c1\\u30f3\\u30e2\\u30c7\\u30eb\\u306e\\u69cb\\u7bc9\\u3068\\u514d\\u75ab\\u89e3\\u6790\", \"\\u30d7\\u30ed\\u30c6\\u30aa\\u30fc\\u30e0\\u89e3\\u6790\\u306b\\u3088\\u308b\\u30c8\\u30ad\\u30bd\\u30d7\\u30e9\\u30ba\\u30de\\u539f\\u866b\\u306e\\u65b0\\u898f\\u30ef\\u30af\\u30c1\\u30f3\\u30fb\\u85ac\\u5264\\u6a19\\u7684\\u5206\\u5b50\\u306e\\u63a2\\u7d22\", \"\\u5b89\\u5168\\u304b\\u3064\\u6709\\u52b9\\u306a\\u7c98\\u819c\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u3092\\u7528\\u3044\\u305f\\u3001\\u7d4c\\u9f3b\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u52b9\\u679c\\u7684\\u306a\\u81a3\\u5185\\u514d\\u75ab\\u8a98\\u5c0e\", \"\\u30ad\\u30e9\\u30fcT\\u7d30\\u80de\\u3068\\u30d8\\u30eb\\u30d1\\u30fcT\\u7d30\\u80de\\u3092\\u6d3b\\u6027\\u5316\\u3059\\u308b\\u3001\\u304c\\u3093\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u81e8\\u5e8a\\u5fdc\\u7528\", \"PolyIC\\u3092\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u306b\\u3057\\u305f\\u820c\\u4e0b\\u514d\\u75ab\\u306b\\u3088\\u308b\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u83cc\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306e\\u7814\\u7a76\", \"\\u30af\\u30eb\\u30de\\u30a8\\u30d3\\u985e\\u306eWSS\\u30a6\\u30a4\\u30eb\\u30b9\\u611f\\u67d3\\u75c7\\u306b\\u5bfe\\u3059\\u308b\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"The potential of self-polymerizing Spy0128 as vaccine adjuvant\", \"\\u30d2\\u30c8\\u30d1\\u30d4\\u30ed\\u30fc\\u30de\\u30a6\\u30a4\\u30eb\\u30b9\\u611f\\u67d3\\u306b\\u5bfe\\u3059\\u308b\\u65b0\\u898fL2\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30b9\\u30ea\\u30f3B\\u9396\\u30da\\u30d7\\u30c1\\u30c9\\u9023\\u7d50MHCclassII\\u907a\\u4f1d\\u5b50\\u3092\\u7528\\u3044\\u305fDNA\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\", \"\\u764c\\u7d30\\u80de\\u2015\\u30a2\\u30ed\\u6a39\\u72b6\\u7d30\\u80de\\u878d\\u5408\\u306b\\u3088\\u308b\\u764c\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u30b7\\u30b9\\u30c6\\u30e0\\u306e\\u958b\\u767a\", \"\\u6d88\\u5316\\u5668\\u764c\\u306b\\u5bfe\\u3059\\u308b\\u764c\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u306e\\u958b\\u767a\", \"\\u6210\\u4ebaT\\u7d30\\u80de\\u767d\\u8840\\u75c5\\u30a6\\u30a4\\u30eb\\u30b9\\u306b\\u5bfe\\u3059\\u308bDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u611f\\u67d3\\u4e88\\u9632\\u52b9\\u679c\\u306e\\u691c\\u8a0e\", \"\\u30ea\\u30b9\\u30c6\\u30ea\\u30a2\\u30fb\\u30e2\\u30ce\\u30b5\\u30a4\\u30c9\\u30b2\\u30cd\\u30b9\\u306b\\u5bfe\\u3059\\u308bDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u3068\\u305d\\u306e\\u9ad8\\u52b9\\u7387\\u5316\", \"\\u60aa\\u6027\\u795e\\u7d4c\\u81a0\\u816b\\u306b\\u5bfe\\u3059\\u308b\\u30b5\\u30a4\\u30c8\\u30ab\\u30a4\\u30f3\\u767a\\u73fe\\u816b\\u760d\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u306e\\u958b\\u767a\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u7d4c\\u9f3b\\u5674\\u9727\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6297\\u4f53\\u53cd\\u5fdc\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"B30-MDP\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30a6\\u30a4\\u30eb\\u30b9\\u4eba\\u5de5\\u817a\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u611f\\u67d3\\u9632\\u5fa1\\u80fd\", \"\\u30d2\\u30c8\\u30b5\\u30a4\\u30c8\\u30e1\\u30ac\\u30ed\\u30a6\\u30a4\\u30eb\\u30b9(HCMV)\\u907a\\u4f1d\\u5b50\\u7d44\\u307f\\u63db\\u3048\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u7814\\u7a76\", \"B30-MDP\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30a6\\u30a3\\u30eb\\u30b9\\u4eba\\u5de5\\u819c\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308a\\u8a98\\u5c0e\\u3055\\u308c\\u305fCTL\\u306e\\u7279\\u5fb4\", \"B30-MPP\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30a6\\u30a4\\u30eb\\u30b9\\u4eba\\u5de5\\u819c\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u7d30\\u80de\\u6027\\u514d\\u75ab\", \"\\u30c8\\u30ad\\u30f3\\u30d7\\u30e9\\u30ba\\u30de\\u611f\\u67d3\\u9632\\u5fa1\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u7814\\u7a76\", \"\\u30de\\u30ec\\u30c3\\u30af\\u75c5\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u306e\\u767a\\u75c5\\u9632\\u5fa1\\u306b\\u95a2\\u308f\\u308b\\u907a\\u4f1d\\u5b50\\u306e\\u30af\\u30ed\\u30fc\\u30cb\\u30f3\\u30b0\", \"\\u5408\\u6210\\u30da\\u30d7\\u30c1\\u30c9\\u3092\\u7528\\u3044\\u305f\\u3046\\u8755\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u764c\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u306b\\u6709\\u7528\\u306a\\u6a39\\u72b6\\u7d30\\u80de\\u30b5\\u30d6\\u30bb\\u30c3\\u30c8\\u306e\\u89e3\\u6790\", \"The development and production of recombinant Parapoxvirus vectors for viral vaccine therapy and cancer immunotherapy\", \"Mechanism of action of a novel respiratory syncytial virus subunit vaccine formulation.\", \"Effects of sialylated capsular polysaccharides from Streptococci on the immunogenic capacity of conjugate vaccines\", \"Signaling mechanisms of dectin-1 endosomes and anti-fungal vaccine optimization\", \"The use of virus-like particles as vaccines and therapies against cancer\", \"Targeting vaccines to human antigen-presenting cells with synthetic glycopeptides\", \"Experimental bacterial infections: improved models for vaccine and treatment development\", \"Increasing the potency of dendritic cell based vaccines for treatment of cancer\", \"The impact of pneumococcal vaccine on hospital admission in young children with pneumonia\", \"Phase 3 Clinical Trial for Stage 4 Melanoma using the Dendritic Cell Vaccine\", \"Development and evaluation of a MERS-virus epitope based vaccine\", \"\\u0423\\u0447\\u0430\\u0441\\u0442\\u0438\\u0435 \\u0432 \\u041c\\u0435\\u0436\\u0434\\u0443\\u043d\\u0430\\u0440\\u043e\\u0434\\u043d\\u043e\\u0439 \\u043a\\u043e\\u043d\\u0444\\u0435\\u0440\\u0435\\u043d\\u0446\\u0438\\u0438 \\\"Liposome advances: progress in drug and vaccine delivery\\\"\", \"\\u0421\\u0442\\u0430\\u0431\\u0438\\u043b\\u044c\\u043d\\u043e\\u0441\\u0442\\u044c \\u0433\\u0435\\u043c\\u0430\\u0433\\u0433\\u043b\\u044e\\u0442\\u0438\\u043d\\u0438\\u043d\\u0430 - \\u0444\\u0430\\u043a\\u0442\\u043e\\u0440 \\u043d\\u0438\\u0437\\u043a\\u043e\\u0439 \\u0438\\u043c\\u043c\\u0443\\u043d\\u043e\\u0433\\u0435\\u043d\\u043d\\u043e\\u0441\\u0442\\u0438 \\u0432\\u0430\\u043a\\u0446\\u0438\\u043d \\u043f\\u0440\\u043e\\u0442\\u0438\\u0432 \\u0432\\u044b\\u0441\\u043e\\u043a\\u043e\\u043f\\u0430\\u0442\\u043e\\u0433\\u0435\\u043d\\u043d\\u044b\\u0445 \\u0432\\u0438\\u0440\\u0443\\u0441\\u043e\\u0432 \\u0433\\u0440\\u0438\\u043f\\u043f\\u0430\", \"\\u0420\\u0430\\u0437\\u0440\\u0430\\u0431\\u043e\\u0442\\u043a\\u0430  \\u0414\\u041d\\u041a\\u2013\\u0432\\u0430\\u043a\\u0446\\u0438\\u043d \\u0434\\u043b\\u044f \\u043f\\u0440\\u0438\\u043c\\u0435\\u043d\\u0435\\u043d\\u0438\\u044f \\u0432 \\u0431\\u0438\\u043e\\u043c\\u0435\\u0434\\u0438\\u0446\\u0438\\u043d\\u0435\", \"HPV TYPE 16 VACCINE TRIAL IN COSTA RICA\", \"HPV TYPE 16 VACCINE TRIAL IN COSTA RICA\", \"NIAID Vaccine Immune T-cell and Antibody Laboratory (NVITAL)\", \"Evaluation of NIAID's HIV Vaccine Research Education Initiative\", \"EVALUATION OF NIAID'S HIV VACCINE RESEARCH EDUCATION INITIATIVE\", \"Evaluation of NIAID's HIV Vaccine Research Education Initiative\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS - PART B\", \"HIV Vaccine Design and Dev. Teams for Preventation and Treatment\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS FOR PREVENTION AND TREATMENT\", \"Assessing Safety of Cell Substrates and Vaccine Components\", \"ASSESSING THE SAFETY OF CELL SUBSTRATES AND VACCINE COMPONENTS\", \"Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine\", \"Population Genetics Analysis Program: Immunity to Vaccines/Infections\", \"Population Genetics Analysis Program: Immunity to Vaccines/Infections\", \"Population Genetics Analysis Program: Immunity to Vaccines/Infections\", \"Population Genetics Analysis Program: Immunity to Vaccines/Infections\", \"POPULATION GENETICS ANALYSIS PROGRAM: IMMUNITY TO VACCINES/INFECTIONS\", \"Population Genetics Analysis Program: Immunity to Vaccines/Infections\", \"POPULATION GENETICS ANALYSIS PROGRAM IMMUNITY TO VACCINES/INFECTION\", \"Malaria Vaccines:  Clinical Research &Trial Sites in Endemic Areas\", \"MALARIA VACCINES: CLINICAL RESEARCH AND TRIAL SITES IN ENDEMIC AREAS\", \"Development, Testing and Evaluation of a Live Attenuated (LVS) Vaccine\", \"PRODUCTION AND TESTING OF ANTHRAX RECOMBINANT PROTECTIVE ANTIGEN (RPA) VACCINE\", \"Production and Testing of Anthrax rPA Vaccine\", \"PRODUCTION AND TESTING OF ANTHRAX RECOMBINANT PROTECTIVE ANTIGEN (RPA) VACCINE\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVDDT)\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVDDT)\", \"HIV Vaccine Design and Development Teams (HVDDT)\", \"HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVVDT)\", \"HLA Typing and Epitope Mapping Relative to HIV Vaccine Design\", \"HLA TYPING AND EPITOPE MAPPING RELATIVE TO HIV VACCINE DESIGN\", \"REAGENT RESOURCE SUPPORT FOR AIDS VACCINE DEVELOPMENT\", \"Rational optimization of peptide vaccines for immunotherapy of cancer (SCORE)\", \"Probing Hierarchical Self-Assemblies Relevant for Drug and Vaccine Design by Employing Scanning Tunnelling Microscopy\", \"Virus Like Particles and Salmonella-based Vaccines against Human papillomavirus and Cervical Cancer\", \"Development of approaches to rapidly assess engineered HIV vaccine candidates\", \"Therapeutic vaccination against chronic Hepatitis B by intralymphatic administration of a naked DNA vaccine\", \"DDoSVax - in search of a vaccine for distributed denial of service attacks\", \"Antigen processing and presentation via vaccine adjuvants in the antigen-presenting cells\", \"Immune responses to salmonella-based and subunit human papilloma-virus type 16 (HPV 16) vaccines\", \"Antigen sampling and presentation in mucosal tissues: implications for mucosal vaccine design\", \"Combinatorial biomimetic chemistry - A source of new reagents forchemical biology and drug and vaccine discovery\", \"The outer membrane protein UspA1 of Moraxella catarrhalis as a vaccine candidate\", \"In vitro und in vivo Charakterisierung von CpG Oligonukleotiden als Adjuvantien f\\u00fcr einen FIV-DNA Impfstoff.\", \"Decyphering distinctive features of early life immune responses to vaccine antigens\", \"Identification of human astrocytoma antigens: a necessary step for vaccine development\", \"Safety and immunogenicity of a recombinant attenuated salmonella live vaccine expressing H. Pylori urease\", \"Virus like particles and Salmonella-based Vaccines against Human Papillomavirus and Cervical Cancer\", \"Virulence gene probes for bacterial safety monitoring, medical diagnostics, vaccine development and quality control\", \"Development of a live vaccine against HELICOBACTER PYLORI based on the molecular understanding of gastritis\", \"Measles virus (MV) reverse genetics; rescued MV variants and chimera as vaccines and vectors\", \"CD40L\\u57fa\\u56e0\\u4fee\\u9970\\u5355\\u7eaf\\u75b1\\u75b9\\u75c5\\u6bd2\\u6cbb\\u7597\\u6027DNA\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u8fdf\\u7f13\\u7231\\u5fb7\\u534e\\u83cc\\u83cc\\u8715\\u75ab\\u82d7\\u7684\\u7814\\u5236\\u53ca\\u5176\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u5236\", \"MCP1 /CCR2\\u5728\\u547c\\u5438\\u9053\\u5408\\u80de\\u75c5\\u6bd2\\u75ab\\u82d7\\u589e\\u5f3a\\u6027\\u75be\\u75c5\\u4e2d\\u7684\\u5173\\u952e\\u4f5c\\u7528\\u7814\\u7a76\", \"\\u5229\\u7528\\u6cb9\\u83dc\\u79cd\\u5b50\\u4f5c\\u755c\\u79bd\\u53e3\\u670d\\u75ab\\u82d7\\u751f\\u7269\\u53cd\\u5e94\\u5668\\u7684\\u7814\\u7a76\", \"IBDV\\u4e1d\\u7d20\\u86cb\\u767d-\\u58f3\\u805a\\u7cd6DNA\\u5fae\\u7403\\u75ab\\u82d7\\u5236\\u5907\\u53ca\\u514d\\u75ab\\u539f\\u6027\\u7814\\u7a76\", \"\\u80c3\\u764c\\u76f8\\u5173\\u80bf\\u7624\\u6297\\u539f\\u591a\\u8868\\u4f4d\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u4e0e\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"\\u7eb3\\u7c73\\u58f3\\u805a\\u7cd6\\u57fa\\u56e0\\u9012\\u9001\\u8f7d\\u4f53\\u4e0e\\u65b0\\u578b\\u5355\\u7eaf\\u75b1\\u75b9\\u6cbb\\u7597\\u6027DNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u591a\\u91cd\\u9776\\u5411\\u4e8e\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u7684\\u6297\\u6076\\u6027\\u9ed1\\u8272\\u7d20\\u7624DNA\\u75ab\\u82d7\\u7eb3\\u7c73\\u4f20\\u9012\\u7cfb\\u7edf\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u5bf9DC\\u7ec6\\u80de\\u529f\\u80fd\\u5f71\\u54cd\\u7684HBs\\u6297\\u539f\\u591a\\u6001\\u6027\\u53ca\\u65b0\\u578b\\u4e59\\u809dDNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"CD40L\\u57fa\\u56e0\\u4fee\\u9970HBeAg\\u591aT\\u7ec6\\u80de\\u8868\\u4f4dDNA\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u7528\\u8863\\u85fb\\u53f6\\u7eff\\u4f53\\u9ad8\\u6548\\u8868\\u8fbe\\u79bd\\u6d41\\u611f\\u9972\\u7528\\u75ab\\u82d7\\u7814\\u7a76\", \"\\u6c99\\u773c\\u8863\\u539f\\u4f53MOMP\\u6297\\u539fT-B\\u8054\\u5408\\u8868\\u4f4d\\u9274\\u5b9a\\u53ca\\u5176MAP\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u6027\\u7814\\u7a76\", \"\\u57fa\\u4e8eCTB\\u7684I\\u578b\\u7cd6\\u5c3f\\u75c5\\u86cb\\u767d\\u75ab\\u82d7\\u8bbe\\u8ba1\\u53ca\\u5176\\u529f\\u80fd\\u7814\\u7a76\", \"\\u4f5c\\u4e3a\\u57fa\\u56e0\\u75ab\\u82d7\\u8f7d\\u4f53\\u7684\\u6d77\\u6c34\\u9c7c\\u80a0\\u9053\\u4e73\\u9178\\u6746\\u83cc\\u7cfb\\u7edf\\u6784\\u5efa\", \"HIV-1 B\\uff07/C\\u91cd\\u7ec4\\u4e9a\\u578bgag-tat\\u878d\\u5408\\u57fa\\u56e0 DNA \\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u5154\\u761f\\u75c5\\u6bd2\\u6297\\u539f\\u8868\\u4f4d\\u7684\\u9274\\u5b9a\\u53ca\\u8868\\u4f4d\\u75ab\\u82d7\\u7814\\u7a76\", \"I\\u578b\\u7cd6\\u5c3f\\u75c5\\u53e3\\u670d\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u548c\\u5728\\u5bb6\\u8695\\u4e2d\\u8868\\u8fbe\\u53ca\\u5176\\u4f5c\\u7528\\u673a\\u7406\\u7814\\u7a76\", \"4-1BBL\\u91cd\\u7ec4\\u8d28\\u7c92\\u589e\\u5f3a\\u4e59\\u809d\\u75ab\\u82d7\\u6297\\u75c5\\u6bd2\\u514d\\u75ab\\u6cbb\\u7597\\u7684\\u4f50\\u5242\\u4f5c\\u7528\", \"\\u624b\\u8db3\\u53e3\\u75c5\\u4e3b\\u8981\\u75c5\\u539fEV71 VP1\\u91cd\\u7ec4\\u6746\\u72b6\\u75c5\\u6bd2\\u75ab\\u82d7\\u8f7d\\u4f53\\u7814\\u7a76\", \"\\u4f24\\u5bd2\\u548c\\u526f\\u4f24\\u5bd2\\u901a\\u7528\\u578b\\u7cd6\\u80bd\\u7ed3\\u5408\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u514d\\u75ab\\u4fdd\\u62a4\\u6027\\u7814\\u7a76\", \"Development of Feline Vaccines Containing Antigens and Adjuvants Produced Entirely in Tobacco Plants\", \"Alzheimer`s vaccine that avoids inflammatory side effects.\", \"Alzheimer`s vaccine that avoids inflammatory side effects\", \"Development of Live Attenuated FIV Vaccines Expressing Feline Cytokines\", \"\\u9996\\u4f8b\\u6162\\u75c5\\u6bd2\\u75ab\\u82d7\\uff0d\\u9a6c\\u4f20\\u67d3\\u6027\\u8d2b\\u8840\\u51cf\\u6bd2\\u75ab\\u82d7\\u514d\\u75ab\\u673a\\u7406\\u7684\\u7814\\u7a76\", \"Development of novel genetic cancer vaccines encoding dendritic cell activation receptors\", \"Development of a multivalent therapeutic HPV-16 and HPV-18 -specific vaccine\", \"Development of a multivalent therapeutic HPV-16 and HPV-18 -specific vaccine\", \"Entwicklung und klinische Erprobung eines Salmonellen-basierten Helicobacter-Impfstoffs\", \"Development of a DNA vaccine against Schistosoma japonicum              (A 4)\", \"Produkcyjna i \\u015brodowiskowa weryfikacja stosowania szczepionek bakteryjnych i nawozu mikroelementowego.\", \"Inkomsten op project 00627: Bereiding van vaccins tegen de ziekte van Aujeszky (deel Berns)\", \"Inkomsten op project 00627: Bereiding van vaccins tegen de ziekte van Aujeszky (deel Gielkens)\", \"Protein Misfolding in a New Spotlight - The design of new and safer vaccines\", \"Targetting Plant-Based Vaccines for Prevention of Type I Diabetes\", \"GAVI-oriented research at the Centre for International Health: Participation in a rotavirus vaccine trial.\", \"Development of vaccines and diagnostic tools against a new bacterial fish pathogen\", \"S\\u00e9curit\\u00e9 de l'utilisation du vaccin vivant att\\u00e9nu\\u00e9 contre l'influenza chez les enfants et adolescents avec fibrose kystique.\", \"L'homme invisible: Facteurs influen\\u00e7ant la connaissance et les intetions de recevoir le vaccine VPH\", \"Centre de Recherche en Infectiologie Porcine (CRIP)\", \"Improved vaccines against intracellular pathogens by combining PHARMAQ and Isconova adjuvant technologies\", \"Poxviruses in Norway: Biodiversity, characteristics and recombinations between naturally occuring and genetically engineered vaccine viruses\", \"Internasjonalt seminar \\\"4th International Veterinary Vaccines and Diagnostics Conference, 25. - 30. june 2006\\\"\", \"Live, attenuatet vaccine against infectious pancreatic necrosis in Atlantic salmon fry\", \"Rekombinantno cepivo proti aviarni influenci za peroralno uporabo (CRP)\", \"Cepiva nove generacije proti Helicobacter pylori (applied research project)\", \"Recombinant baculovirus occlusion bodies as a novel vaccine delivery system.\", \"Development of a mucosally active ISCOMS based diphtheria toxoid vaccine.\", \"Mucosal immunization with recombinant Lactobacillus casei: development of vaccines against Streptococcus pneumoniae diseases\", \"Development of a Prototype Multivalent, Oral Vaccine for Traveler's Diarrhea\", \"Biodegradable Bioadherent Microcapsules for Orally Administered Sustained Release Vaccines\", \"Delivery of Vaccines by Biodegradable Polymeric Microcapsules with Bioadhesion Properties\", \"SYNTHETIC VACCINES: TEST OF CONCEPTS AND APPLICATION TO RIFT VALLEY FEVER VIRUS\", \"Biological and immunological properties of saccharidic antigens of pathogens -utilization for preparation of subcellular vaccines\", \"Efficasy of an experimental recombinant vaccine against herpes simplex virus in animal model(s)\", \"Analytics on Blog and Tweet Reactions to Vaccine-related Incidents\", \"Mechanism of action of a novel respiratory syncytial virus subunit vaccine formulation.\", \"History of the Introduction of the Salk Polio Vaccine as a Public Event\", \"Ethical Disputes in Experimental Medicine: The 1935 Polio Vaccine Controversy\", \"Ethical Constraints in Medical Science: Clinical Testing of Vaccines, 1930-60\", \"Colleague Control and Experimental Ethics: American Vaccine-Research Communities, 1920-60\", \"BPVacc: Development of a vaccine against meliodosis with Burkholderia pseudomallei antigens\", \"Design, Synthesis, and Development of Carbohydrate\\u2013Based Vaccines, Therapeutics, Diagnostics, and Medical Devices.\", \"A Novel Vaccine for the Prevention and Cure of Type 1 Diabetes\", \"The AHFMR Interdisciplinary Team in Vaccine Design and Implementation\", \"SYSTEM ENHANCEMENTS AND SUPPORT TO FULLY INTEGRATE ALERT IIS WITH VTRCKS AND VACCINE MANAGEMENT FUNCTIONS\", \"ENHANCE AN IIS TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING AND MANAGEMENT SYSTEM\", \"ENHANCING NEVADAS IMMUNIZATION INFORMATION SYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING & MGMT SYSTEM\", \"IMMUNOGENICITY, POTENCY, AND STABILITY OF ELECTRON BEAM-BASED SALMONELLA VACCINES\", \"Training in vaccine development: combined glycoconjugate vaccine against meningococcus a,c, w135,y\", \"Vaccines and the hypothetical risk of autoimmune reactions: development of evaluation methods.\", \"Novel mechanisms of live, bacterial vaccines in protection against salmonella and other food-borne zoonoses\", \"Workshops on the molecular biology and immunology of malaria vaccines\", \"Programme EVA (European Vaccine against Aids) centralised facility for Aids reagents\", \"Siv/hiv vaccines : detecting efficacy and explaining inefficacy\", \"Herpesvirus vector vaccines against helminth parasite infections in calves and sheep\", \"Development of a clade C-based HIV-1 vaccine for China\", \"Production and characterisation of mutant leishmania lacking proteinase genes as attenuated live vaccines\", \"PRODUCTION OF RECOMBINANT IMMUNE COMPLEXES IN TRANSGENIC PLANTS FOR SYSTEMIC AND MUCOSAL VACCINES\", \"Safety, immunogenicity and field efficacy studies of a plasmodium falciparum malaria pre-erythrocytic stage vaccine.\", \"Genetic variation and attenuation of human respiratory syncytial virus : implications for vaccine development\", \"Development of new safe and economical recombinant hepatitis virus vaccines and diagnostic materials\", \"Development of vaccine approaches for the control of infection and inflammatoryreactions in parasitic diseases\", \"Efficacy of rsh28gst as an antifecundity vaccine - Immune mechanisms in experimental models and in man\", \"The application of transfection technology to malaria vaccine devel opment\", \"Genetically engineered vaccines a single molecule comprising antigen, targeting-device and adjuvant activity\", \"Preparation and characterization of an experimental anti-diotype vaccine against Echinococcus Granulosus\", \"Basic studies on the development of a vaccine against Haemorrhagic fever with renal syndrome\", \"Combined multi antigen mucosal vaccines: optimization of local and systemic immunity\", \"Recombinant Viral Particulate Proteins as Tools for New Vaccines and Diagnostics\", \"A network for malaria vaccine evaluation and testing in experimental primate models\", \"European union network for evaluation of nucleic acid-based vaccines for induction of antiviral immunity\", \"PESTE DES PETITS RUMINANTS DIAGNOSIS; EPIDEMIOLOGY AND CONTROL BY VACCINE\", \"PRODUCTION OF A VACCINE FOR FOOT- AND-MOUTH DISEASE VIRUS USING RECOMBINANT DNA\", \"PRODUCTION OF A FOOT-AND-MOUTH DISEASE VACCINE BY CHEMICAL S YNTHESIS\", \"TOWARDS A GENETICALLY ENGINEERED VACCINE AGAINST PORCINE TRANSMISSIBLE GASTROENTERITIS VIRUS (TGEV)\", \"THE APPLICATION OF RECOMBINANT DNA TECHNOLOGY TO THE DEVELOPMENT OF PORCINE ROTAVIRUS VACCINES\", \"EVALUATION OF ADULT SCHISTOSOMA MANSONI SURFACE MEMBRANE ANTIGENES AS VACCINE CONSTITUENTS AND IMMUNODIGNOSTIC REAGENTS\", \"DEVELOPMENT OF DIAGNOSTIC TECHNIQUES AND VACCINES FOR CRIMEAN CONGO HAEMORRHAGIC FEVER\", \"Monitoring and diagnosis of a vaccine manufacturing process using spectro-fluorescence\", \"Transmission dynamics of live coccidiosis vaccines: Does management have an impact?\", \"Orphan Vaccines - Bridging the Gaps conference, Queensland Australia, Aug 2001\", \"Anti-Trichuris vaccines: larval antigens and cytokines.\", \"Alphaherpesvirus recombination: safety implications for attenuated Herpesvirus vaccines\", \"Exploiting the lymphatic system for next generation vaccine development\", \"Molecular approaches to develop an insect cell production system for Hepatitis C vaccine candidate.\", \"Avian influenza hemagglutinin subunit DNA vaccines with targeting sequences in frame with DIVA strategy\", \"Immunogenicity of vaccine candidate antigens from Staphylococcus pseudintermedius in Canis canis\", \"Development and pre-clinical evaluation of a new HIV-1 vaccine concept\", \"Retroviral like particles: improving potential as candidate vaccines for Hepatitis C\", \"Bovine Viral Diarrhea Virus (BVDV): diagnosis, genotype characterization, vaccine efficacy and transmission studies\", \"TherMelVac- dendritic cell-targeted peptide vaccine against melanoma by ligand-modified nanoparticles\", \"Development of experimental DNA vaccines against sheep Maedi-Visna virus\", \"Synthesis, optimization and intensification of bioseparation processes for DNA vaccine manufacturing\", \"Development of a new Nab based strategy to produce a universal HIV vaccine\", \"Integrated methodologies for the development of bi and three-valent DNA-vaccines against Helycobacter pylori\", \"BACULOME-Engineering cellular energetics for improvement of bioprocesses: metabolic modeling for enhanced vaccines production.\", \"Pre-clinical assays of a GAPDH-based vaccine against Group B Streptococcus infection\", \"Studies to produce an exopolysaccharide-vaccine to protect cystic fibrosis patients against Burkholderia cepacia infections\", \"DEVELOPMENT OF A RADIATION-AND/OR HEATATTENTUATED VACCINE FOR CONTROL OF CUTANEOUS LEISHMANIASIS\", \"NSERC/Bioniche Chairs in vaccines to reduce food and water contamination\", \"Development of a broad spectrum recombinant vaccine against respiratory pathogens of cattle\", \"NSERC/Bioniche Chairs in Vaccines to Reduce Food and Water Contamination\", \"NSERC/Bioniche Industrial Research Chair in Vaccines to Reduce Food and Water Contamination\", \"Controlled-release delivery of liposome-associated and micelle-associated glycoconjugate fish vaccines\", \"D\\u00e9veloppement d'un vaccin contre les infections dues \\u00e0 Streptococcus suis s\\u00e9rotype 2 chez l'esp\\u00e8ce porcine\", \"NSERC/Bioniche Industrial Research Chair in Vaccines to Reduce Food and Water Contamination\", \"NSERC/Bioniche Industrial Research Chair in Vaccines to Reduce Food and Water Contamination\", \"NSERC/Bioniche Chairs in vaccines to reduce food and water contamination\", \"Control of the bovine respiratory disease complex: the development of novel vaccine alternatives\", \"NSERC/Bioniche Chairs in Vaccines to Reduce Food and Water Contamination\", \"NSERC/Bioniche Industrial Research Chair in Vaccines to Reduce Food and Water Contamination\", \"Enhancement of DNA vaccine efficacy by targeting antigen presenting cells\", \"Development of an oral vaccine in alfalfa against transmissible gastroenteritis virus in swine\", \"Canadian Network for Vaccines and Immunotherapeutics of Cancer and Chronic Viral Diseases (CANVAC)\", \"A proteomics approach to the development of a recombinant \\\"Aeromonas salmonicida\\\" vaccine\", \"Development of a live-attenuated oral E. coli vaccine for poultry\", \"the evalutation of antigens for a vaccine against aeromonas spp\", \"Development of new alternative vaccine delivery approaches for the prevention of human disease\", \"Clinical and commercial applications of an O-sialoglycoprotease in bone marrow transplantation and vaccine development\", \"Host: parasite interaction in bovine pneumonic pasteurellosis: the immunological basis for a novel vaccine strategies\", \"A new method to create conjugate vaccine with fine control of T-cell epitopes\", \"Development of a Prion vaccine using a unique PrP-Sc epitope\", \"Outer membrane proteins for iron uptake: candidate vaccine against Actinobacillus pleuropneumoniae\", \"Development of a Vaccine for Atlantic Salmon against Aeromonas sp.\", \"Development of an Edible Vaccine for Shipping Fever Using Transgenic Forage Crops\", \"Development of new alternative vaccine delivery approaches for the prevention of human disease\", \"Development of novel depot-based vaccine formulations for therapeutic cancer and infectious diseases\", \"Development of a Vaccine for Atlantic Salmon against Aeromonas sp.\", \"Design and evaluation of DNA vaccines using cell-targeting polymeric vectors\", \"Adjuvant activity of Complement component C3d in novel vaccine strategies for cattle\", \"Development of an enterophemorrhagic 0157:H7 E. coli pediatric vaccine\", \"HPLC for purification of glycolipid and glycopeptide conjugates; novel molecules with vaccine potential\", \"Facteurs de virulence des coronavirus h\\u00e9magglutinants et, valeur vaccinale et diagnostique des prot\\u00e9ines recombinantes\", \"Design of therapeutic vaccines for chronic hepatitis B virus infection\", \"Development of a vaccine for bovine pneumonic pasteurellosis using recombinant antigens of Pasteurella haemolytica Al\", \"Identification of novel mucosal adjuvants and immune biomarkers for neonatal respiratory syncytial virus vaccine development\", \"Development of an Edible Vaccine for Shipping Fever Using Transgenic Forage Crops\", \"Selection of the optimal CpG as an adjuvant for S. aureus Vaccine\", \"Reverse vaccinology, a genomics approach to vaccine development for A. pleuropneumoniae\", \"Recombinant bovine viral diarrhea virus gp53 as subunit vaccine and diagnostic tool\", \"Development of bovine adenovirus vector and its use for the engineering of viral vaccines\", \"Control of the bovine respiratory disease complex: The development of novel vaccine alternatives\", \"Development of novel depot-based vaccine formulations for therapeutic cancer and infectious diseases\", \"A new method to create conjugate vaccine with fine control of T-cell epitopes\", \"Development of a vaccine against Myxobolus cerebralis, the causative agent of whirling disease in fr\", \"Development of STb-fimbrial vaccine for enterotoxigenic Escherichia coli post-weaning diarrhea in pigs\", \"Testing the Efficacy of Novel Pandemic Influenza and Hepatitis B Vaccine Formulations\", \"Development of transgenic alfalfa expressing the P. haemolytica leukotoxin as an oral vaccine in cattle\", \"Developing vaccines using lambda phage particle display and dna technology\", \"Identification of novel mucosal adjuvants and immune biomarkers for neonatal respiratory syncytial virus vaccine development\", \"Identification of novel mucosal adjuvants and immune biomarkers for neonatal respiratory syncytial virus vaccine development\", \"Bioencapsulation of HIV gag secreting myoblasts in alginate microparticles as an HIV vaccine strategy\", \"Design of a viral vector for the development of ployvalent vaccines for cattle\", \"A proteomics approach to the development of a recombinant \\\"Aeromonas salmonicida\\\" vaccine\", \"Engineering of recombinant bovine respiratory syncytial virus vaccine using bovine adenovirus vector\", \"Evaluation of alternative vaccine delivery routes and assessment of their mode of action\", \"Exploring the use of peptide-lipid conjugates in novel depot-based vaccine formulations.\", \"Development of a Vaccine for Atlantic Salmon against Aeromonas sp.\", \"Structural characterization of new bacterial polysaccharides and their use in vaccine design\", \"Bioencapsulation of HIV gag secreting myoblasts in alginate microparticles as an HIV vaccine strategy\", \"Mathematical approaches for controlling emerging and re-emerging diseases using vaccines\", \"Monitoring and diagnosis of a vaccine manufacturing process using spectro-fluorescence\", \"Evaluation of alternative vaccine delivery routes and assessment of their mode of action\", \"Development of a Prion vaccine using a unique PrP-Sc epitope\", \"D\\u00e9veloppement de proc\\u00e9d\\u00e9 pour la production d'un vaccin influenza en culture cellulaire\", \"Evaluation of alternative vaccine delivery routes and assessment of their mode of action\", \"Development of novel depot-based vaccine formulations for therapeutic cancer and infectious diseases\", \"Development of a vaccine against Myxobolus cerebralis, the causative agent of whirling disease in fr\", \"Development of an Edible Vaccine for Shipping Fever Using Transgenic Forage Crops\", \"Design and evaluation of DNA vaccines using cell-targeting polymeric vectors\", \"Bio-Warfare Agent detection and development of a third-generation plague vaccine\", \"Support Vaccine Safety Task Force through HHS\", \"NIAID/MRMC Comprehensive HIV/AIDS Therapeutic and Non-Vaccine Prev Clin, Research\", \"New Scientific Approaches to Facilitate Development of Vaccines\", \"Development of Live Oral Vaccine for Protection against Bacillus Anthracis\", \"Assessing Safety of Cell Substrates and Vaccine Components\", \"THE IMMUNIZATION PROGRAM WAS CREATED TO REDUCE THE INCIDENCE OF VACCINE-PREVENTAB\", \"INTRODUCING THE USE OF SEASONAL INFLUENZA VACCINE IN PUBLIC HEALTH\", \"Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs in Chi\", \"EVALUATE THE LONG-TERM PROTECTION FROM HEPATITIS A AND B VACCINE AMONG\", \"A RATIONAL APPROACH TO DEVELOPING A KILLED HIV-1 VACCINE\", \"Statistical Center for Rotavirus Vaccine in India\", \"CLINICAL TRIAL OF MELANOMA VACCINE AND IL-2 IN LIPOSOME\", \"THERAPORE-HIV AS A VACCINE TO ELICIT T CELL RESPONSE\", \"DEVELOPMENT OF A CONTRACEPTIVE VACCINE\", \"HIV Vaccine Design and Development, Part A-Preventative Vaccines\", \"PRODUCTION OF A RECOMBINANT H5 N1 VACCINE FOR PHASE 1\", \"HLA TYPING AND EPITOPE MAPPING RELATIVE TO HIV VACCINE DESIGN-266030024\", \"Development and Testing of a Modified Vaccinia Ankara /MVA/ Vaccine-266030016\", \"PHASE III PNEUMOCOCCAL CONJUGATE VACCINE STIDY IN THE GAMBIA-266025477\", \"Expanded Phase II and IV Vaccine Trials in Humans-26625455\", \"EXPANDED PHASE II AND IV VACCINE TRIALS IN HUMANS-266025454\", \"Expanded Phase II and IV Vaccine Trials in Humans-26625453\", \"Expanded Phase II and IV Vaccine Trials in Humans-26625452\", \"HLA TYPING AND EPITOPE MAPPING GUIDE TO HIV VACCINE DESIGN-266015442\", \"PRODUCTION AND TESTING OF A MODIFIED VACCINIA ANKARA /MVA/ VACCINE.-266000072\", \"PRODUCTION OF TESTING OF A MODIFIED VACCINIA ANKARA /MVA/ VACCINE-266000071\", \"DEVELOPMENT TESTING AND EVALUATION OF CANDIDATE VACCINES AGAINST PLAGU-266000034\", \"MALARIA VACCINES: CLINICAL RESEARCH AND TRIAL SITES IN ENDEMIC AREAS-2-266000016\", \"HIV VACCINES DESIGN AND DEVELOPMENT TEAMS PART A - PREVENTATIVE VACCIN-266000008\", \"TO SUPPORT IMMUNIZATIONS & THE VACCINES FOR CHILDREN PROG STATEWIDE IN NEW MEXICO\", \"CDC-RFA-IP13-1301, Virgin Islands Immunizations and Vaccines for Children Grants\", \"PROVIDE FUNDING FOR OKLAHOMA STATE DOH TO PROVIDE VACCINE SERVICES TO THE STATE\", \"PREVENT DISEASE, DISABILITY & DEATH FROM VACCINE PREVENTABLE DISEASE IN CHILDREN.\", \"2013 COOPERATIVE AGREEMENT APPLICATION FOR THE IMMUNIZATION, VACCINE FOR CHILDREN\", \"IMMUNIZATION VACCINES FOR CHILDREN GRANT FOR INFRASTRUCTURE TO STATE OF MICHIGAN\", \"PROVIDE IMMUNIZATION SVCS FOR TO CONTROL VACCINE PREVENTABLE DISEASE TRANSMISSION\", \"PUERTO RICO'S IMMUNIZATION & VACCINES FOR CHILDREN 2013-2017 PROGRAM PLAN\", \"Improve Vaccine Management, Storage and Handling in the Republic of the Marshall\", \"Improve vaccine management, storage and handling at provider and grantee level\", \"Nevada State Immunization Program: to improve vaccine management, storage and han\", \"Program Area 5 - Improve Vaccine management, storage and handling at provider\", \"Improve Vaccine Management, Storage and Handling at the Provider and Grantee\", \"Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV\", \"Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV\", \"Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV\", \"Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV\", \"Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV\", \"Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV\", \"Development of Mutivalent Filovirus (Ebola and Marburg) Vaccines\", \"Development of an Anthrax Vaccine\", \"Development of a Third Generation Anthrax Vaccine\", \"SBIR TOPIC 241 LIPID NANO-PARTICLE THERAPEUTIC CERVICAL CANCER VACCINE\", \"The development of hypertension vaccine toward clinical application.\", \"Development of RNA vaccine with fish retrovirus, a substitution of DNA vaccine, for fish viral diseases\", \"\\u57fa\\u56e0\\u91cd\\u7ec4\\u9175\\u6bcdPSMA\\u75ab\\u82d7\\u6297\\u524d\\u5217\\u817a\\u764c\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"MOUSE SYSTEM FOR EVALUATION OF CHOLERA VACCINE\", \"\\u7cd6\\u80bd\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u3001\\u5408\\u6210\\u4e0e\\u6027\\u8d28\\u7814\\u7a76\", \"SVEU - Maintenance of NHPs\", \"SVEU - Maintenance of Nonhuman Primates\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"Evaluation of Immune Responses to a Trimerically Stabilized gp120 Immunogen\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"SVEU - Core Activities - Administrative and Technical Support\", \"SVEU - Maintenance of NHPs\", \"SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"TIER 2 SHIV-C CHALLENAGE OF NONHUMAN PRIMATES PREVIOUSLY PROTECTED FROM TIER 1 SHIV-C CHALLENGE\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"Conduct of Virus In Vivo Titration Study (P196): ?In Vivo SHIV Titration via Intrarectal Route in Indian-origin Rhesus Macaques?\", \"SVEU - Core Activities - Administrative and Technical Support\", \"SVEU - Maintenance of Nonhuman Primates\", \"DEVELOPMENTS IN UPPER AIRWAY MUCOSAL INFLUENZA VIRUS VACCINES\", \"SVEU - Maintenance of NHPs\", \"SVEU - Core Activities - Administrative and Technical Support\", \"SVEU - Maintenance of Nonhuman Primates\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"SVEU - IMMUNOGENICITY OF A NONINTEGRATING INTEGRASE-DEFECTIVE LENTIVIRAL VECTOR\", \"IN VIVO SHIV TITRATION VIA INTRATECTAL ROUTE IN INDIAN-ORIGIN RHESUS MACAQUES\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"Conduct Study P189\", \"SVEU - Prime Boost Efficacy, Boosting Immunization, and Virus Challenge Studies\", \"SVEU - CONDUCT OF STUDIES IN NONHUMAN PRIMATES: REIMMUNIZATION AND CHALLENG\", \"SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"TIER 2 SHIV-C CHALLENAGE OF NONHUMAN PRIMATES PREVIOUSLY PROTECTED FROM TIER 1 SHIV-C CHALLENGE\", \"PREPARATION OF SHIV VIRUS STOCK\", \"Conduct of Virus In Vivo Titration Study (P196): ?In Vivo SHIV Titration via Intrarectal Route in Indian-origin Rhesus Macaques?\", \"\\u80f0\\u817a\\u764cMUC4\\u6297\\u539f\\u591a\\u8868\\u4f4d\\u5d4c\\u5408DNA\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u548c\\u514d\\u75ab\\u7814\\u7a76\", \"SVEU - Maintenance of NHPs\", \"SVEU - Core Activities - Administrative and Technical Support\", \"SVEU - Evaluation of Prime-Boost Regimen Emplyoing Clade C Proteins\", \"SVEU - Maintenance of Nonhuman Primates\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"IN VIVO SHIV TITRATION VIA INTRATECTAL ROUTE IN INDIAN-ORIGIN RHESUS MACAQUES\", \"SVEU - Prime Boost Efficacy, Boosting Immunization, and Virus Challenge Studies\", \"SVEU - CONDUCT OF STUDIES IN NONHUMAN PRIMATES: REIMMUNIZATION AND CHALLENG\", \"SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"IN VIVO SHIV TITRATION VIS INTRARECTAL ROUTE IN INDIAN-ORIGIN REHESUS MACAQUES\", \"TIER 2 SHIV-C CHALLENAGE OF NONHUMAN PRIMATES PREVIOUSLY PROTECTED FROM TIER 1 SHIV-C CHALLENGE\", \"PREPARATION OF SHIV VIRUS STOCK\", \"European network for vaccine evaluation in primates: combined vector immunisations for aids vaccine development\", \"SVEU - Maintenance of NHPs\", \"SVEU - Core Activities - Administrative and Technical Support\", \"SVEU - IMMUNOGENICITY OF A NONINTEGRATING INTEGRASE-DEFECTIVE LENTIVIRAL VECTOR\", \"SVEU - Evaluation of Prime-Boost Regimen Emplyoing Clade C Proteins\", \"SVEU - Reimmunization and Challenge Studies\", \"SVEU - Maintenance of Nonhuman Primates\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"SVEU - Prime Boost Efficacy, Boosting Immunization, and Virus Challenge Studies\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - CONDUCT OF STUDIES IN NONHUMAN PRIMATES: REIMMUNIZATION AND CHALLENG\", \"SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - MAINTENANCE OF NONHUMAN PRIMATES\", \"SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT\", \"Polymeric microparticulate vaccine formulations based on hydrogen bonding\", \"Enhancing the efficacy of poultry vaccines using innate immune adjuvants\", \"How do cross-reactive memory B cells affect influenza vaccine titers?\", \"Understanding Bacille Calmette Guerin's immune-defenses to generate a truly protective TB vaccine.\", \"Dengue fever vaccine: Towards low cost production and delivery\", \"To inform members of Congress that 1) U.S. investments in vaccine research and development are working, 2) that there are some exciting new directions in vaccine research that could lead to new or improved vaccines for many of the most intractable infectious diseases, for which we do not have vaccines or only partially effective vaccines, and 3) to provide an outline of the resources needed that could dramatically accelerate these advances\", \"Development of multi-peptide tumor vaccine for renal cell carcinoma\", \"Jadalna szczepionka przeciwko wirusowi grypy dla drobiu (Oral vaccine against influenza virus for poultry).\", \"MANNHEIMIA HAEMOLYTICA CHIMERIC PROTEIN VACCINE FOR DELIVERY OF MULTIPLE OUTER MEMBRANE PROTEIN AND LEUKOTOXIN ANTIGENS\", \"EVALUATION OF LIVE, ATTENUATED BRUCELLA VACCINE CANDIDATES\", \"IMMUNOINFORMATICS DRIVEN, GENOME DERIVED FISH VACCINE AGAINST THE BACTERIAL PATHOGEN V. ANGUILLARUM\", \"Market assessment and feasibility study on fowl adenovirus (FAdV) vaccine in chicken\", \"Dissection of protective responses to heterologous Campylobacter vaccines\", \"IMMUNOGENICITY OF ROUTINE CHILDHOOD VACCINES IN HIV POSITIVE CHILDREN\", \"Influenza Vaccine Development\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV Vaccine Design and Development Teams, Part A- Preventative Vaccines\", \"GENETICS OF BOVINE VACCINE RESPONSE\", \"FLSC - Vaccine Branch HIV Vaccine Primate Study\", \"Biodefense/Emerging Infection Vaccine Studies\", \"Understanding the publics' response to the H1N1 vaccine\", \"Determinants of the clearance of HIV infected cells by successful AIDS vaccines\", \"DETECTION AND CONTROL OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EMERGING VIRAL DISEASES OF SWINE\", \"RESEARCHES ON IMPROVEMENT OF PERTUSSIS VACCINE\", \"Chromatin nanofibre as a therapeutic cancer vaccine\", \"\\u521b\\u4f24\\u5f27\\u83ccDNA\\u75ab\\u82d7\\u514d\\u75ab\\u6b27\\u6d32\\u9cd7\\u9ca1\\u7684\\u7814\\u7a76\", \"Novel Vaccines against Pseudomonas aeruginosa and Other Microorganisms\", \"REGIONAL SYSTEM FOR VACCINES\", \"Seattle Vaccine Trials Unit\", \"Estudo das poss\\u00edveis interfer\\u00eancias dos m\\u00faltiplos componentes na avalia\\u00e7\\u00e3o da pot\\u00eancia do ant\\u00edgeno da hepatite b, nas vacinas combinadas\", \"Contribution to the WHO Global Vaccine Research Forum to be held at Salvador da Bahia, Brazil on the 12 - 15 June 2005.\", \"Immunogenicity and efficacy of vaccines for pneumonic pasteurelllosis in lambs\", \"Better control of Bacterial Cold Water Disease in farmed rainbow trout by the development of an effective Flavobacterium psychrophilum vaccine\", \"Developing a quadrivalent HCV vaccine\", \"Population-level vaccine safety monitoring: risk assessment and policy implications\", \"Use of Streptococcus gordonii as a live oral vector to prevent infectious diseases\", \"Use of Streptococcus gordonii as a live oral vaccine vehicle\", \"Vyu\\u017eit\\u00ed klonovan\\u00e9ho imunoregula\\u010dn\\u00edho IL-2 genu pro p\\u0159\\u00edpravu protin\\u00e1dorov\\u00fdch vakcin\", \"Immunisation practice and policy development in Australia: responding to urgent priorities in prevention of endemic and epidemic infectious diseases in children.\", \"Innate immune effector recruiting potential of HIV-1 human vaccine induced antibodies\", \"Single versus combination pneumococcal conjugate vaccines (13PCV and PHiD-CV) for high-risk Aboriginal children (COMBO)\", \"ORAL VACCINATION OF DOMESTIC SHEEP AGAINST MANNHEIMIA HAEMOLYTICA LEUKOTOXIN UTILIZING A NOVEL RECOMBINANT BACTERIOPHAGE\", \"A New nanoparticle glycogen for development of vaccine against malaria\", \"Spreading immune-reactions in esophageal cancer patients who were given cancer vaccine and whose tumors co-express additional antigens\", \"Lipid immunity in rhesus monkeys and development of a new anti-tuberculosis vaccine\", \"\\u81ea\\u5236\\u53e3\\u670dDNA\\u75ab\\u82d7\\u7684\\u7c98\\u819c\\u8868\\u8fbe\\u90e8\\u4f4d\\u4e0e\\u8bf1\\u5bfc\\u80a0IEL\\u6548\\u5e94\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u9f20\\u900f\\u660e\\u5e26DNA\\u514d\\u75ab\\u4e0d\\u80b2\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"HIV\\u58f3\\u4f53\\u86cb\\u767d\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u539f\\u6027\\u7814\\u7a76\", \"A multi-component high efficacy malaria vaccine.\", \"The development of vaccines to prevent shigella infections\", \"Enhancing immunogenicity of DNA vaccines by targeted delivery to antigen presenting cells\", \"Novel vaccines and serotyping scheme for Haemophilus parasuis\", \"Exploratory Research On Engineering The Service Sector: Collaborative Research: Research on Designing Vaccine Formularies for Childhood Immunization\", \"Exploratory Research On Engineering The Service Sector: Collaborative Research: Research on Designing Vaccine Formularies for Childhood Immunization\", \"Immunology Core\", \"Ebola Vaccine Immune Correlates and Mechanism of Protection\", \"Malaria Vaccine:  BSAM\", \"Testing of Blood Samples for Immune Response and Vaccine\", \"Ebola Vaccine Immune Correlates and Mechanism of Protection\", \"Testing of Blood Samples for Immune Response and Vaccine Research\", \"Vaccine Studies in HIV-infected Subjects\", \"Head-to-head comparison of two H1N1 swine influenza vaccines in children aged 6 months to 12 years\", \"Efficacious vaccine formulation system for prophylactic control of influenza pandemics\", \"ARRA: Process Development and Manufacture of Universal Influenza Vaccine\", \"VLP Vaccine Technology\", \"Immunogenicity and Efficacy of a Bivalent Clade B gp120 Protein Boost for aDNA/MVA Vaccine\", \"EFFICACY OF DNA AND PROTEIN CO-IMMUNIZATION PROTOCOL TO PROTECT MACAQUES FORM SHIV INFECTION\", \"\\u91cd\\u75c7\\u6025\\u6027\\u547c\\u5438\\u5668\\u75c7\\u5019\\u7fa4(SARS)\\u30a6\\u30a4\\u30eb\\u30b9\\u306b\\u5bfe\\u3059\\u308b\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u3068\\u514d\\u75ab\\u9632\\u5fa1\\u6a5f\\u69cb\\u306e\\u7814\\u7a76\", \"EFFICACY OF DNA AND PROTEIN CO-IMMUNIZATION PROTOCOL TO PROTECT MACAQUES FORM SHIV INFECTION\", \"EFFICACY OF DNA AND PROTEIN CO-IMMUNIZATION PROTOCOL TO PROTECT MACAQUES FORM SHIV INFECTION\", \"An evaluation of HIB vaccination and description of risk factors for HIB vaccine failure in Europe\", \"Advancing human and veterinary vaccinology.\", \"Pneumococcal vaccine escape: genome-wide characterisation of recombinants arising after vaccine implementation.\", \"Biodefense/Emerging Infection Vaccine Studies\", \"VACCINE PRODUCTION FACILITY\", \"Development of mass spectrometry methods for the quantification and characterization of antigens during the vaccine development process\", \"Vaccine and diagnostics development against swine dysentery\", \"Development of a vaccine against reproductive failure in pigs\", \"Development and comparative evaluation of three new generation BRSV DIVA vaccines and a corresponding DIVA test\", \"\\u7cbe\\u5b50\\u8868\\u9762\\u86cb\\u767dDNA \\u75ab\\u82d7\\u751f\\u7269\\u63a7\\u5236\\u5bb3\\u9f20\\u7684\\u7814\\u7a76\", \"Verbundprojekt: Development of a hepatitis C vaccine by targeted delivery of nanogel RNA-replicon constructs (HCVAX) - Teilvorhaben: Immunologische funktionelle Assays f\\u00fcr die in vitro Analyse eines Nanogel-basierten Hepatitis C Impfstoffes\", \"CI3: Realisierung von Software, Planungs- und Steuerungsmodulen f\\u00fcr die beschleunigte automatisierte Herstellung individualisierter MUTANOM-Vakzine (IVAC IT) - Teilvorhaben: Einsatz von innovativen Softwarel\\u00f6sungen als Grundlage zur iterativen Verbesserung von IVAC MUTANOME Impfstoffen\", \"Zwanzig20 - InfectControl 2020 - Verbundvorhaben: Molekulare Serologie zur schnellen Bestimmung der Impftiter gegen impf-pr\\u00e4ventable Infektionskrankheiten (STIKO-Liste) bei Migranten und anderen Patientengruppen, Teilvorhaben: STIKO-Serologie - TV4\", \"Zwanzig20 - InfectControl 2020 - Verbundvorhaben: Molekulare Serologie zur schnellen Bestimmung der Impftiter gegen impf-pr\\u00e4ventable Infektionskrankheiten (STIKO-Liste) bei Migranten und anderen Patientengruppen, Teilvorhaben: STIKO-Serologie - TV3\", \"Zwanzig20 - InfectControl 2020 - Verbundvorhaben: Molekulare Serologie zur schnellen Bestimmung der Impftiter gegen impf-pr\\u00e4ventable Infektionskrankheiten (STIKO-Liste) bei Migranten und anderen Patientengruppen, Teilvorhaben: STIKO-Serologie - TV 2 'Mikroarrays'\", \"Zwanzig20 - InfectControl 2020 - Verbundvorhaben: Molekulare Serologie zur schnellen Bestimmung der Impftiter gegen impf-pr\\u00e4ventable Infektionskrankheiten (STIKO-Liste) bei Migranten und anderen Patientengruppen, Teilvorhaben: STIKO-Serologie - TV1\", \"Entwicklung von in vitro Methoden als Ersatz f\\u00fcr Letalchaellengeversuche an Fischen zur Beurteilung von Vakzinen - Phase II - Teilprojekt 2: Optimierung und Standardisierung eines ELISA-Systems f\\u00fcr Furunkulose-Vakzine\", \"Development of Molecular Adjuvants for HIV-1 Canarypox  Vaccines\", \"Construction and studies on vaccine potential of chimeric protein molecules comprising immunodominant regions of outer membrane proteins of enterobacteriacease for application as broad spectrum vaccine against salmonella shigella E Coil and proteus\", \"Associa\\u00e7\\u00e3o entre ant\\u00edgenos tumorais ao v\\u00edrus vacinal da febre amarela yf 17d como vetor vacinal contra o c\\u00e2ncer\", \"Associa\\u00e7\\u00e3o entre ant\\u00edgenos tumorais ao v\\u00edrus vacinal da febre amarela yf 17d como vetor vacinal contra o c\\u00e2ncer\", \"Immunogenno\\u015b\\u0107 szczepienia przypominaj\\u0105cego przeciw krztu\\u015bcowi przy u\\u017cyciu szczepionki typu dTap u dzieci z nowotworami i po transplantacji kom\\u00f3rek hematopoetycznych.\", \"To better track vaccines and improve supply chains in developing countries by using radio-frequency identification tags (RFID) on vaccine packages that can be detected by near field communication (NFC) found on most smartphones\", \"To ensure quality vaccines are available when needed by developing an application along with blockchain technology to monitor the supply chains delivering vaccines from producers to health workers\", \"Cytomegalovirus (CMV) vaccine development: A study of viral tropism, genomic diversity and neutralizing epitopes in CMV positive clinical samples\", \"IGF::OT::IGF:THE SCRIPPS RESEARCH INSTITUTE. TASK ORDER 2 (HHSN275201500006I/HHSN27500002).PRODUCTION AND DISTRIBUTION OF INVESTIGATIONAL GHRELIN VACCINES--GHRELIN VACCINE AGAINST RAT HORMONE. 09/21/\", \"IGF::OT::IGF:The Scripps Research Institute. Task Order 3 (HHSN275201500006I/HHSN27500003).Production and Distribution of Investigational Ghrelin Vaccines--Ghrelin Vaccine Against Rat Hormone. 09/21/\", \"CPCRN Special Project on HPV Vaccine Uptake\", \"Cancer Vaccine (for Continued Development of Molecular Switching Vaccines Using Genetically Modified Listeria for Cancer, Infectious Disease and Bio-Defense)\", \"Odvozen\\u00ed a charakterizace oslaben\\u00e9 linie Eimeria flavescens a v\\u00fdvoj vakc\\u00edny proti kokcidi\\u00f3ze kr\\u00e1l\\u00edk\\u016f.\", \"Optimizing a vaccine for HPV immunotherapy\", \"Developing drugs and vaccines for malaria by undertaking experimental studies in humans\", \"RV3 Rotavirus Vaccine: A human neonatal rotavirus vaccine for the Asia-Pacific region\", \"To improve understanding of how conjugate vaccines impact pneumococcal ecology and to inform how vaccines of higher valences can be most effectively used to reduce the burden of pneumococcal illness\", \"To support the implementation of phase IV clinical trials in adults to evaluate the safety and reactogenicity of monovalent type 2 and trivalent Oral Polio Vaccine for future comparisons with data on new Oral Polio Vaccines\", \"To design, produce and test in preclinical and clinical studies new material forms of drugs and vaccines for improved drug and vaccine delivery to patients in developing countries\", \"To identify biomarkers of correlates of protection against pre-erythrocytic (PE) malaria infection that will enable down selection of vaccine antigens and predict outcomes of trials for anti-infection vaccines against Plasmodium falciparum\", \"To study the pattern and severity of childhood pneumonia before and after pneumococcal vaccination, evaluate the vaccine status of children with severe illnesses, and analyze the cost effectiveness of the pneumococcal vaccine in Malawi\", \"To generate information on the impact of a Japanese encephalitis vaccination program, using a safe, affordable Japanese encephalitis vaccine produced by a developing country manufacturer, and to support expanded use of the vaccine\", \"To test the efficacy of administering two approved vaccines directly under the tongue, which could help improve vaccine delivery, compliance, and enhance immunity against a variety of pathogens.\", \"To assess delivery strategies for tetanus vaccine during pregnancy and to understand how antenatal care and maternal immunization can be strengthened to optimally deliver current and future vaccines to pregnant women\", \"To build imaging capacity (PET-CT scanning) of the Tulane National Primate Research Center for TB vaccine studies as a part of a service component of the Collaboration for TB Vaccine Discovery (CTVD)\", \"To further optimize the immune response to a combined placental malaria and cervical cancer vaccine and investigate the scalability and efficient production of such a vaccine for the developing world.\", \"To use a new vaccine technology to produce non-infectious poliovirus-like particles that can be used in one highly effective, low-cost polio vaccine capable of inducing protective immunity against all circulating serotypes.\", \"To accelerate the development of therapeutics and vaccines by formalizing an experimental medicine model of Cryptosporidium hominis, the most prevalent cause of human cryptosporidiosis, that can be used to test candidate therapeutics and vaccines\", \"To develop a novel vaccine for TB based on existing BCG vaccines modifi ed to express a gene that is specifi c to latent TB in order to generate a robust immune response to a latent infection.\", \"To reduce cholera burden globally and make the case for rational use of oral cholera vaccines by evaluating strategies to most effectively deploy Oral Cholera Vaccines across multiple settings\", \"To develop a blueprint for strengthening global vaccine safety and coordination between different agencies working on vaccine safety issues, identifying core capacities at various levels, and how these activities can be can be funded and sustained\", \"To evaluate the safety of oral polio vaccine (OPV) by monitoring the incidence of vaccine-associated paralytic poliomyelitis (VAPP) in China, and to provide useful genomic & bio-feature information for developing a safer OPV\", \"To develop and update an assessment framework for the long-term viability of vaccine manufacturers for the traditional Expanded Program on Immunization vaccines and insights into factors that influence their success\", \"To catalyze TB vaccine research and development in China and promote collaboration between international and Chinese researchers with the common goal of developing new, more effective TB vaccines\", \"To enable development of the Vaccine Development and Introduction Platforms, which will position PATH to evaluate and progress a robust pipeline of global health vaccine projects from product concept to impact with industry-standard quality, speed, and effectiveness\", \"To examine the etiology of cases of diarrhea at one rotavirus vaccine clinical trial site in India in order to gather data that will help establish priorities for future enteric vaccine development\", \"To test the theory that providing children with antihelminthic and anti-giardiasis drugs prior to administration of an oral typhoid vaccine ill produce a robust immune response to the vaccine.\", \"To identify, evaluate, and apply platform vaccine formulation and stabilization technologies to accelerate the development and introduction of safe, efficacious, and programmatically suitable vaccines in low- to middle-income countries\", \"To translate the History of Vaccines website into Hindi, Urdu and Arabic and increase the reach of the site to audiences that currently have little access to reliable information about vaccines in their native languages\", \"To improve a malaria vaccine by combining it with a monoclonal antibody to increase competition for the vaccine antigen by antibody-producing immune cells, and with a molecule to prolong the survival of those immune cells\", \"To build imaging capacity (PET-CT scanning) of the University of Pittsburgh for TB vaccine studies as a part of a service component of the Collaboration for TB Vaccine Discovery (CTVD)\", \"To maximize impact and accelerate development of new TB vaccines by creating and applying novel mathematical models to estimate the main target product profiles drivers for epidemiological impact of new TB vaccines\", \"To provide capacity building support for International Vaccine Institute to execute its 2015 strategic plan in support of its mission to discover, develop and deliver safe, effective, and affordable vaccines for global health\", \"To assess safety and tolerability of different vaccine regimens with Ad26.Mos4.HIV, Ad26.Mos.HIV and Clade C gp140 and immunogenicity between the different vaccine regimens with Ad26.Mos4.HIV, Ad26.Mos.HIV and Clade C gp140\", \"To establish a program to link new vaccine discoveries with vaccine manufacturers in developing countries while simultaneously evaluating ways to help these manufacturers purchase rights to these innovative candidates.\", \"To develop an effective, stable intranasal nanoemulsion adjuvanted respiratory syncytial virus (RSV) vaccine for the developing world without the hyper-reactivity observed with prior RSV vaccines in clinical trials\", \"To accelerate the successful uptake of human papillomavirus vaccine in Gavi eligible countries and other low-resource settings by providing key information for national decision-making and planning on human papillomavirus vaccine introduction\", \"To determine if live attenuated influenza vaccine (LAIV) or trivalent influenza vaccine (TIV) affects the density and / or duration of pneumococcal colonization in healthy adults using the EHPC (Experimental Human Pneumococcal Carriage) model\", \"To integrate characteristics of heat shock proteins from thermophilic organisms, which live at relatively high temperatures, into attenuated bacterial vaccines to enhance viability and immunogenicity these vaccines during the freeze-drying process\", \"To identify malaria vaccine targets for the liver-stage of infection using novel, parasite cultivation strategies. These newly identified antigens may be used to supplement the existing RTS,S vaccine, improving levels of protection from malaria\", \"To assess the capacity of six China National Biotec Group institutes to meet World Health Organization requirements for priority vaccines, to improve their potential to provide safe, effective, and affordable vaccines\", \"To reduce the burden of dengue in developing countries by accelerating the introduction of safe and broadly protective dengue vaccines into public sector programs, especially for children, and support the development of dengue vaccine candidates\", \"To generate evidence and a prediction model to inform vaccine scheduling and the design of alternative Pneumococcal conjugate vaccine regimens focused on reducing carriage, person-to-person transmission and optimizing herd protection from disease\", \"To sustain and increase political support and financing for HIV vaccine research and development from European Union institutions and key Member States to help accelerate product development by ensuring a robust pipeline of vaccine candidates\", \"To design a mosquito that can produce and secrete a malaria vaccine protein into a host\\u2019s skin. The hope is that such mosquitoes could deliver protective vaccines against other infectious diseases as well.\", \"To reduce the burden of cholera in endemic and epidemic settings with the use of a single dose regimen of the cholera vaccine developed by International Vaccine Institute (IVI) and recently licensed in India by Shantha Biotechnics\", \"To develop a new vaccine technology that accumulates a high number of antigen-specific cells in the lymph nodes at the time of immunization to improve vaccine effectiveness\", \"To explore the value proposition and technical feasibility of blow-fill-seal for oral and injectable vaccines (IPV, Penta, HPV, PCV, Rota and Cholera), including other pipeline vaccines in development\", \"To develop a vaccine for leishmaniasis by focusing on the scientific and practical issues leading to the development of effective vaccines and therapies, initially in Brazil and India\", \"To facilitate the discovery of a safe, effective and practical HIV-1 vaccine by using valid laboratory criteria and Good Clinical Laboratory Practices to monitor antibody responses in the systemic and mucosal compartment in vaccine testing\", \"IGF::OT::IGF:THE SCRIPPS RESEARCH INSTITUTE. TASK ORDER 2 (HHSN275201500006I/HHSN27500002).PRODUCTION AND DISTRIBUTION OF INVESTIGATIONAL GHRELIN VACCINES--GHRELIN VACCINE AGAINST RAT HORMONE. 09/21/\", \"Task X14:  Evaluation of Ebola Vaccines\", \"DEVELOPMENT OF A WEST NILE VIRUS VACCINE\", \"Nonhuman Primate Core Functional Genomics Laboratory for AIDS Vaccines Research a\", \"Basic study on novel vaccine strategy for avian influenza\", \"B\\u7d30\\u80de\\u8868\\u5c64\\u3067\\u306e\\u5206\\u5b50\\u8a8d\\u8b58\\u5236\\u5fa1\\u306b\\u3088\\u308b\\u30e6\\u30cb\\u30d0\\u30fc\\u30b5\\u30eb\\u30ca\\u30ce\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5275\\u88fd\", \"Development of novel pertussis vaccine\", \"PRODUCTION AND TESTING OF A MODIFIED VACCINIA ANKARA (MVA) VACCINE\", \"Nonhuman Primate Core Functional Genomics Laboratory for AIDS Vaccines Research a\", \"Task X14:  Evaluation of Ebola Vaccines\", \"NIHR Health Protection Research Unit in Immunisation\", \"NanoVector Vaccine Potentiation\", \"Konstrukcja szczepionek odporno\\u015bciowych opartych na \\u017cywych szczepach Salmonella enterica Typhimurium zawieraj\\u0105cych rekombinowane fagi nitkowate\", \"Improving the duration of immunity for FMD vaccines\", \"Novas estrat\\u00e9gias vacinas para pat\\u00f3genos ent\\u00e9ricos: vacinas contra diarr\\u00e9ia baseadas no fator de coloniza\\u00e7\\u00e3o I (CFA/I) de Escherichia coli enterotoxig\\u00eanica (ETEC)\", \"Desenvolvimento de vacina celular anti-pneumoc\\u00f3cica: utiliza\\u00e7\\u00e3o de cepa n\\u00e3o capsulada de Streptococcus pneumoniae\", \"Transmission dynamics of live coccidiosis vaccines: Does management have an impact?\", \"Ultrasound mediated delivery of vaccines for aquaculture\", \"Development of a Reverse Genetics System to Produce Live, Attenuated Infectious Salmon Anemia Virus (ISAV) Vaccine Candidates\", \"Surface proteins of Staphylococcus aureus involved in nasal colonization biofilm formation and immune evasion. Potential for vaccine development\", \"Construction & Development of a New Prototype Measles-Mumps-Rubella Vaccine Based on Recombinant RNA\", \"A NUTRITIVE VACCINE ADJUVANT AGAINST INFLUENZA\", \"CHLAMYDIA TRACHOMATIS VACCINE SAFETY AND EFFICACY EVALUATION IN NONHUMAN PRIMATES\", \"Nonhuman Primate Core Functional Genomics Laboratory for AIDS Vaccines Research a\", \"Multi-Antigen Vaccine for Lung Cancer PreventionPOP: 09/18/2014-09/17/2016\", \"New preventative and therapeutic Hepatits C vaccines: from pre-clinical to phase I\", \"The second phase of a european malaria vaccine development consortium\", \"An international Primate Vaccine Evaluation Network (PVEN) for the optimal use of a variety of primate species for the evaluation of vaccines and other tools against the major infectious diseases in developing countries\", \"Evaluation of the safety and immunogenicity of a new tuberculosis vaccine, MVA85A, as a booster vaccine for BCG, in a series of Phase II clinical trials in South Africa.\", \"PRODUCTION AND TESTING OF A MODIFIED VACCINIA ANKARA (MVA) VACCINE\", \"A single vaccine for influenza and pneumonia\", \"Improving the quality of FMD vaccines by understanding the correlation of vaccine-induced protection with immune responses in cattle\", \"ARRA: H1N1 and Other ARRA Equipment\", \"The Determination of Phosphorus in Vaccines\", \"Development of oral vaccine tech for multivalent protection against Shigella\", \"Development of technology for a combination anthrax-plague live oral vaccine\", \"Development of oral vaccine tech for multivalent protection against Shigella\", \"Development of technology for a combination anthrax-plague live oral vaccine\", \"Development of Anti-Ebola MHC Tetramers to Evaluate Vaccines\", \"Development of Anti-Ebola MHC Tetramers to Evaluate Vaccines\", \"Guinea Pig Model for Shigellosis Vaccine Development\", \"Characterization of the Mechanism of Action of Vaccine Adjuvants\", \"Characterization of the Mechanism of Action of Vaccine Adjuvants\", \"Development of New Tools for Influenza Vaccines\", \"Development of Assays and Pre-clinical Evaluation of Francisella Vaccines\", \"Assays for Characterization and Efficacy Evaluation of Anthrax Vaccines\", \"Robust, defined, animal-free cell culture medium for the production of vaccines\", \"Effectiveness of the Influenza Vaccine in the Aging Population\", \"Production/Testing of a MVA Vaccine\", \"HIV Vaccine Production, PreClinical Testing, FDA Submissions\", \"Nonhuman Primate Core Functional Genomics Laboratory for AIDS Vaccines Research a\", \"Use of TERT Vaccine in Prevention of Lung Cancer in Animal Models\", \"Exploratory Center for Vaccinology Research (RMI)\", \"RNA synthetic biology for genetic engineering of a programmable one-shot smart RNA vaccine\", \"An integrated strategy for preclinical development of improved vaccines against dendritrische cell lung cancer\", \"Developing a novel cancer vaccine using IDO2-silenced DCs for breast cancer\", \"VACCINATION AND PROTECTION STUDIES FOR A TARGETED NANOPARTICULATE ORAL VACCINE AGAINST SHIGELLOSIS\", \"Development of Molecular Diagnostics and Immunotherapeutic Vaccines for Prawn and Brinjal Allergy\", \"Development of Nanoparticle or Microparticle Adjuvanted Subunit Oral Vaccine against Poultry Salmonellosis\", \"Development of a novel \\\"broad-spectrum\\\" subunit vaccine for Bluetongue disease in animals\", \"Programming protective humoral responses with novel vaccine formulations against Dengue Virus.\", \"Innate Predictors of Adaptive BCG and HBV Vaccine-induce Responses in Bangalore Adolescents\", \"Development of prophylactic as well as therapeutic DNA vaccine for canine mammary cancer\", \"Evaulation of novel adjuvants for mucosal priming following cutaneous delivery of vaccine\", \"Development of envelope domain III-based Dengue Virus-like particle (VLP) Vaccine candidates\", \"Targeted nanoparticulate oral vaccine against shigellosis: mimicking shigell's strqategy of infection\", \"Development of DNA vaccine to combat Edwardsiella tarda infection in commercially important food fishes.\", \"Immuno-prophylactic evaluation of potential vaccine candidates against Fasciola gigantica in domestic animals.\", \"Development of Calcium Phosphate Nanoparticle based DNA vaccine against FMD(Foot and Mouth Disease)\", \"Karakterisatie en evaluatie van kandidaat vaccin antigenen tegenover de lebmaag-nematode Ostertagia ostertagi bij het rund.\", \"Onderzoek naar het gebruik van mRNA moleculen als alternatief voor een Chlamydophila psittaci DNA vaccin\", \"Development of an mRNA-based vaccine to treat HPV-positive oropharyngeal squamous cell carcinoma: immunogenicity, therapeutic efficacy and safety.\", \"Ontwikkeling van een cellular HIV vaccin gebaseerd op dendritische cellen ge- transfecteerd met mRNA coderend voor HIV antigenen.\", \"Ontwikkeling van een cellulair HIV vaccin gebaseerd op dendritische cellen getransfecteerd met mRNA coderend voor HIV antigenen.\", \"Inductie van een cellulaire immuunrespons tegen idiotype determinanten. Lymfoma vaccinatie : vaccin productie en evaluatie van de immuunrespons.\", \"De ontwikkeling van RSV vaccins op basis van virus like partikels die korte fragmenten van RSV oppervlakte-eiwitten presenteren.\", \"Onderzoek naar de structurele en mechanistische eigenschappen van een nieuwe RSV therapie en een nieuw RSV vaccin.\", \"Ophelderen van het mechanisme van verbeterde protectie door een M. bovis BCG mutant als een vaccin tegen Mycobacterium tuberculosis infectie\", \"Immunobiologie van gastheer-trypanosoom interacties : identificatie van immunopathologische trypanosoom componenten en ontwikkeling van anti-\\\"ziekte\\\" vaccins.\", \"Zuivering en studie van adenylaat cyclase van Bordetella pertussis : met het oogop een eventuele toepassing ervan in een verbeterd acellulair kinkhoest vaccin.\", \"T cel immunogeniciteit van RHAMM en BMI-1: ontwikkeling van een multi-antigenisch dendritisch celvaccin voor hematologische maligniteiten\", \"\\u65b0\\u4e00\\u4ee3HPV16E7\\u6838\\u9178\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u6297\\u764c\\u7684\\u7ec6\\u80de\\u4e0e\\u5206\\u5b50\\u751f\\u7269\\u5b66\", \"DNA Immunization Against Rhodococcus equi pneumonia of Foals using an Attenuated Salmonella Vaccine Vector\", \"Verbundprojekt: Entwicklung innovativer bestandsspezifischer Impfstoffe f\\u00fcr Gefl\\u00fcgel zur vereinfachten Applikation (innoVAK4DART) - Teilprojekt: 5\", \"Verbundprojekt: Entwicklung innovativer bestandsspezifischer Impfstoffe f\\u00fcr Gefl\\u00fcgel zur vereinfachten Applikation (innoVAK4DART) - Teilprojekt: 4\", \"Verbundprojekt: Entwicklung innovativer bestandsspezifischer Impfstoffe f\\u00fcr Gefl\\u00fcgel zur vereinfachten Applikation (innoVAK4DART) - Teilprojekt 3\", \"Verbundprojekt: Entwicklung innovativer bestandsspezifischer Impfstoffe f\\u00fcr Gefl\\u00fcgel zur vereinfachten Applikation (innoVAK4DART) - Teilprojekt 2\", \"Verbundprojekt: Entwicklung innovativer bestandsspezifischer Impfstoffe f\\u00fcr Gefl\\u00fcgel zur vereinfachten Applikation (innoVAK4DART) - Teilprojekt 1\", \"Verbundprojekt: Neuartiger Ansatz zur Entwicklung eines heterosubtypischen Marker-Impfstoffs gegen die avi\\u00e4re Influenza in Gefl\\u00fcgel - Teilprojekt 2\", \"Verbundprojekt: Neuartiger Ansatz zur Entwicklung eines heterosubtypischen Marker-Impfstoffs gegen die avi\\u00e4re Influenza in Gefl\\u00fcgel - Teilprojekt 1\", \"Entwicklung einer Subunit- und inaktivierten Vollvirus-Vakzine zur Immunisierung von Katzen gegen eine Influenza H5N1-Infektion\", \"Verbundprojekt: Topische Vakzinierung mit funktionalen Nanopartikeln - Teilvorhaben: Hautpenetration und immunologische Validierung von funktionalen Nanopartikelvakzinen\", \"EUREKA-Projekt: Malaria-Impfstoff (EU 101) - Teilvorhaben 1 (Zur Anwendung in Entwicklungsl\\u00e4ndern)\", \"Entwicklung eines Malaria-Impfstoffes: Teilvorhaben 2 und 3 - zur Anwendung in Entwicklungsl\\u00e4ndern\", \"Herstellung eines synthetischen, veterin\\u00e4rmedizinisch Verwendbaren Peptid-Impfstoffes Gegen Virusleukaemie mit dem Ziel der Entwicklung Humanmedizinischer Pharmaka\", \"Verbundprojekt: Entwicklung eines Impfstoffs Gegen Herpes Simplex-Virus, Gewonnen mit Hilfe eines Bakteriellen Systems\", \"KMU-innovativ-8: VakMech - Wirkmechanismus von mRNA-Vakzinen als Basis der n\\u00e4chsten Technologiegeneration\", \"Neues Prinzip einer Vermehrungsf\\u00e4higen Totvakzine am Modell der infekti\\u00f6sen Bovinen Rhinotracheitits (Ibr)\", \"Verbundprojekt: Ein Flexibles System zur gezielten Antigen-Variation bei Humanen Influenza-Viren f\\u00fcr die Herstellung von Vakzinen\", \"Verbundprojekt: Molekulargenetische Entwicklung eines Impfstoffes Gegen Herpesviren zum Einsatz in der Tiermedizin\", \"Verbundprojekt: Gentechnologische Bearbeitung des menschenpathogenen Hanta-Virus mit dem Ziel, einen Impfstoff zu entwickeln\", \"Verbundprojekt: Gentechnologische Bearbeitung des menschenpathogenen Hanta-Virus mit dem Ziel, einen Impfstoff zu entwickeln\", \"Verbundprojekt: Gentechnologische Bearbeitung des menschenpathogenen Hanta-Virus mit dem Ziel, einen Impfstoff zu entwickeln\", \"Verbundprojekt: Gentechnologische Bearbeitung des menschenpathogenen Hanta-Virus mit dem Ziel, einen Impfstoff zu entwickeln\", \"Entwicklung von Verfahren zur effizienten Herstellung von Antik\\u00f6rpern und synthetischen Vakzinen mittels neuartiger Antigen-Lipopeptid-Konjugate\", \"Verbundprojekt: Optimierung der industriellen zellbasierten Herstellung von Influenzavakzine (saisonal und pandemisch), TP 4\", \"Verbundprojekt: Optimierung der industriellen zellkulturbasierten Herstellung von Influenza Vakzinen (saisonal und pandemisch), TP 2\", \"ERA Net EuroTransBio-3: Entwicklung einer anti-CETP Vakzine f\\u00fcr die Vorbeugung und Behandlung der Arteriosklerose\", \"ERA Net EuroTransBio-2: Entwicklung von Crossbetas Adjuvanz Technologie. Eine neue Technologie zur Verbesserung von Impfstoffeigenschaften\", \"KMU-innovativ-1: CSC - Entwicklung eines tumorstammzell-spezifischen therapeutischen Impfstoffs zur Behandlung von Tumoren\", \"BioChancePLUS-4: Entwicklung eines effizienten mRNA basierten Impfstoffes gegen schwer konventionell therapierbare Infektionskrankheiten am Beispiel von CMV\", \"BioChancePLUS-4: 'IgE-AAV' Partikel als Vakzine zur Behandlung von Asthma und anderen allergischen Erkrankungen\", \"BioProfile Stuttgart/Neckar-Alb: Verfahren zur Entwicklung eines therapeutischen Impfstoffs zur Anwendung von Pankreaskarzinomen\", \"BioChancePLUS-2: Verbundprojekt: Therapeutische Tumorimpfstoffe auf der Basis von universellen Tumorantigenen und des Polyoma-Tr\\u00e4gersystems\", \"BioProfile Braunschweig/G\\u00f6ttingen/Hannover: Entwicklung einer rekombinanten Vakzine gegen Dictycaulus viviparus, den Lungenwurm der Rinder\", \"Genom-basierte Untersuchungen zur Expression und Produktion von Impfstoffen gegen virale Erkrankungen von Tieren in transgenen Pflanzen.\", \"Modellregion M\\u00fcnchen: Die Entwicklung von Impfstoffen auf molekularbiologischem Wege gegen Erreger menschlicher Infektionskrankheiten\", \"Modellregion M\\u00fcnchen: Entwicklung neuartiger Impfstoffe zur prophylaktischen Bek\\u00e4mpfung bakterieller Infektionen und deren chronischen Folgeerkrankungen\", \"Entwicklung einer Chicken Factor freien H\\u00fchnerherde f\\u00fcr wissenschaftlich experimentelle und diagnostische Zwecke sowie zur Impfstoffherstellung\", \"Phase I/II-Studie zur Verminderung von R\\u00fcckf\\u00e4llen beim Melanom mit einem Vakzin gegen mutierte Tumorantigene.\", \"JPND Verbundprojekt CrossSeeds: Charakterisierung modifizierter Amyloidpeptide zur Ableitung von Impfstoff-Strategien und spezifischen Nachweismethoden\", \"Pilot Studie zur therapeutischen Impfung von Patienten mit einer chronischen HBV Infektion mittels eines neuen Impfstoff aus Kuba\", \"Major Cell Culture Improvements Needed for a Live Attenuated RSV Vaccine to be Economically Feasible\", \"Verbundprojekt: Thermoelektrischer Solark\\u00fchlschrank zur Aufbewahrung von Impfseren in Entlegenen Krankenstationen der Entwicklungsl\\u00e4nder\", \"Investigating the altered landscape of enteric viruses causing severe gastroenteritis in Australian children following rotavirus vaccine introduction\", \"Mechanisms of B cell immunodominance to influenza virus\", \"Generation of a genetically-stable live vaccine candidate against infectious bursal disease virus (IBDV) through mutagen- driven lethal mutagenesis\", \"\\u201cPlasmodium SCOT1 Mutant As Experimental Malaria Vaccine: Implications For Inducing Pre-Erythrocytic And Cross-Stage Immunity\\u2019\\u2019.\", \"Enhancement Of The Immunogenicity And Protective Efficacy Of Lipopeptide Vaccine Against Mycobacterium Tuberculosis Using Peptidomimetics And Conjugation With Isoniazid\", \"Enhancement Of The Immunogenicity And Protective Efficacy Of Lipopeptide Vaccine Against Mycobacterium Tuberculosis Using Peptidomimetics And Conjugation With Isoniazid\", \"Transplastomic chloroplasts as bioreactors for the synthesis of antigen-based vaccines and enzymes for bomass degradation\", \"Development of a Curative Therapeutic Vaccine for the Treatment of Large Established Tumors in Mice\", \"Evaluation of Plasmodium falciparum erythrocyte binding antigens as malaria vaccine candidates\", \"Probiotic lactic acid bacteria as anticholera oral edible vaccine to be used as a functional food\", \"Attenuation and Characterisation of Eimeria spp for Development and Increasing Live Vaccine Product Quality of Avian Coccidiosis\", \"Simulation of the Dynamics of Viral Evolution Aiming at Engineering Effective Vaccines: A Computer-Aided Study on HIV\", \"Evaluation and Development of Some Potent and Safe Plant-Derived Immunostimulants as Adjuvants for Sub-Unit Vaccines\", \"Screening for Critical Genes from Plasmodium Falciparum as Potential Drug Targets/Vaccine Candidates Against Malaria\", \"Development of Vaccine Using Recombinant Protein and Attenuated Mutant Technologies for the Prevention of Mycobacterial and Leptospiral Infection\", \"The Network of Digestive Gut Enzymes in Ticks: Isolation, Characterization and Their Promise as Molecular Vaccines\", \"Development and Use of Attenuated Salmonella as a Vaccine Vector for Expression of Antigen From an Unrelated Organism\", \"BPVacc: Development of a vaccine against meliodosis with Burkholderia pseudomallei antigens\", \"Industrial Supplement - Construction & Development of a new prototype measles-mumps-rubella vaccine based on recombinant RNA\", \"Targeting microRNA to drive a successful host response to Mycobacterium tuberculosis \\u2013 engineering a better vaccine\", \"Construction and development of a new prototype measles-mumps-rubella vaccine based on recombinant RNA\", \"Development of native and recombinant mumps virus subunit nasal vaccines using proteosome technology\", \"Effects of Lipid Virulence Factors (PDIM/PGLs) on Virulence and Immunogenicity of BCG Vaccine Strains\", \"The relationship between socio-political forces and bioethics with respect to future access to HIV vaccines\", \"Science, Controversy, and Genetically Modified Plants: Participant Observation of the Creation of New Genetic Knowledge and Edible Vaccines.\", \"Understanding the communication between gene-modified cells and the immune system:  Development of new gene therapies and vaccines\", \"Travel support to attend the AIDS Vaccine 2008 Parternship Development Forum in Cape Town, South Africa\", \"Development of glycoprotein E1/E2-immunoglobulin (Ig) chaimeric subunit vaccine candidates against chikungunya viru in E.Coil\", \"Application of DNA vaccines to the clinic: a phase II study of idiotypic vaccination for follicle centre lymphoma\", \"IL-12 \\uc720\\ub3c4\\uc131 \\uc0c8\\ub85c\\uc6b4 \\uba74\\uc5ed\\ud65c\\uc131\\uc81c\\ub85c\\uc11c \\uc6d0\\ucda9 \\uc720\\ub798 \\ud504\\ub85c\\ud544\\ub9b0\\uc758 \\uba74\\uc5ed \\uc99d\\uac15 \\ubc0f \\uc790\\uac00\\uc554 \\ubc31\\uc2e0 \\ud6a8\\uacfc \\uaddc\\uba85\", \"\\uc2e0\\ubcc0\\uc885 \\ubc14\\uc774\\ub7ec\\uc2a4\\uc758 \\ubd84\\uc790\\uc9c4\\ud654 \\uc5f0\\uad6c \\ubc0f \\ub2e8\\ubc31\\uc9c8 \\ub098\\ub178\\uc785\\uc790 \\uae30\\ubc18 \\ucc28\\uc138\\ub300 \\ubcf5\\ud569\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uac10\\uc5fc\\uc131 \\uac00\\ucd95\\uc9c8\\ubcd1 \\uc81c\\uc5b4\\ub97c \\uc704\\ud55c \\ubaa8\\ub2c8\\ud130\\ub9c1 \\uae30\\ubc95 \\uac1c\\ubc1c \\ubc0f \\ud6a8\\ubaa8 \\ub514\\uc2a4\\ud50c\\ub808\\uc774 \\uae30\\ubc18\\uc758 \\ucc28\\uc138\\ub300 \\ubc31\\uc2e0 \\uc751\\uc6a9\", \"\\ud654\\ud559\\uc801 \\uc720\\ub3c4 \\ubc15\\ud14c\\ub9ac\\uc544\\uace0\\uc2a4\\ud2b8(BG)\\ub97c \\uc774\\uc6a9\\ud55c \\uadf8\\ub78c\\uc74c\\uc131\\uade0 \\ubc0f \\uadf8\\ub78c\\uc591\\uc131\\uade0 \\ubc31\\uc2e0 \\ubc0f \\uba74\\uc5ed\\uc99d\\uac15\\uc81c \\uac1c\\ubc1c\", \"TM4SF5 \\ud3a9\\ud0c0\\uc774\\ub4dc-CpG-DNA-\\ub9ac\\ud3ec\\uc880 \\ubcf5\\ud569\\uccb4 \\ubc31\\uc2e0\\uc5d0 \\uc758\\ud55c \\ub300\\uc7a5\\uc554 \\uc5b5\\uc81c \\uae30\\uc804 \\uaddc\\uba85\", \"\\uc0b4\\ubaa8\\ub12c\\ub77c \\ubc0f \\ube0c\\ub8e8\\uc140\\ub77c \\uc0dd\\uade0\\ubc31\\uc2e0\\uc758 \\uba74\\uc5ed\\ubc18\\uc751 \\ud5a5\\uc0c1 \\ubc0f \\uba74\\uc5ed\\ubc18\\uc751 \\uae30\\uac04 \\uc7a5\\uae30\\ud654\\ub97c \\uc704\\ud55c \\ub098\\ub178\\ucea1\\uc290\\ud654\\uae30\\uc220 \\uc751\\uc6a9\", \"GSK-3\\u03b2 \\uc758\\uc874\\uc801\\uc778 IDO \\ubc1c\\ud604\\uc870\\uc808\\uae30\\uc791\\uc744 \\ud1b5\\ud55c \\uc218\\uc9c0\\uc0c1\\uc138\\ud3ec \\uae30\\ubc18\\uc758 \\uc554 \\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\ub098\\ub178 \\uc218\\uc1a1\\uccb4\\ub97c \\uc774\\uc6a9\\ud558\\uc5ec \\uc5ec\\ub7ec \\uc720\\uc804\\uc790\\ub97c \\ub3d9\\uc2dc\\uc5d0 \\uc804\\ub2ec\\ud558\\ub294 \\uc790\\uad81\\uacbd\\ubd80\\uc554 \\ub2e4\\uac00 \\ubc31\\uc2e0 \\uc2dc\\uc2a4\\ud15c \\uc5f0\\uad6c\", \"\\uc2e4\\ubb3c\\uc635\\uc158\\uacfc SIS/SIR \\ubaa8\\ud615\\uc744 \\uc774\\uc6a9\\ud55c \\ubc31\\uc2e0\\uc758 \\ucd5c\\uc801\\ube44\\ucd95 \\uad00\\ub9ac\\uc5d0 \\ub300\\ud55c \\uc5f0\\uad6c\", \"High-throughput immunomics \\ubc29\\ubc95\\uc744 \\uc774\\uc6a9\\ud55c \\uc0c8\\ub85c\\uc6b4 \\uc0bc\\uc77c\\uc5f4\\ub9d0\\ub77c\\ub9ac\\uc544 \\ubc31\\uc2e0  \\ud56d\\uc6d0\\uc758 \\ubc1c\\uad74 \\ubc0f \\uc791\\uc6a9 \\uae30\\uc804 \\uaddc\\uba85\", \"Bomb bacteria-type \\uc7ac\\uc870\\ud569 Live Edwardsiella tarda \\uc81c\\uc791 \\ubc0f \\uc774\\ub97c \\uc774\\uc6a9\\ud55c \\ubcf5\\ud569\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc5f0\\uc1c4\\uc0c1\\uad6c\\uade0 (Streptococcus iniae)\\uc758 \\ud45c\\uba74 \\ub2e8\\ubc31\\uc9c8\\uc744 \\ubc1c\\ud604\\ud558\\ub294 \\ub119\\uce58\\uc790\\uc0dd \\uc720\\uc0b0\\uade0\\uc744 \\uc774\\uc6a9\\ud55c \\uae09\\uc5ec\\ud615 \\uc5b4\\ub958\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc758\\ub300\\uc0dd \\ucf54\\ud638\\ud2b8\\uc5d0\\uc11c A\\ud615 \\uac04\\uc5fc \\ubc31\\uc2e0 1\\ud68c \\uc811\\uc885\\uc758 \\ud6a8\\uacfc \\ud3c9\\uac00\", \"\\uc2e0\\uaddc \\uc885\\uc591\\uc778\\uc790 SCP3\\uc758 Jab1\\uc758\\uc874\\uc801 \\ud56d\\uc554\\uba74\\uc5ed\\ub0b4\\uc131 \\ubc0f \\uc554\\uc804\\uc774 \\uae30\\uc804 \\uc5f0\\uad6c \\ubc0f SCP3 \\uc554\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc624\\ubbf9\\uc2a4 \\uae30\\ubc18 \\uc0bc\\uc77c\\uc5f4\\uc6d0\\ucda9 \\uc720\\uc131\\uc0dd\\uc2dd\\uae30 \\ud2b9\\uc774 \\ub2e8\\ubc31\\uc9c8 \\ub300\\ub2e8\\uc704 \\ubc1c\\uad74\\uc744 \\ud1b5\\ud55c\\uc804\\ud30c \\ucc28\\ub2e8 \\ubc31\\uc2e0 \\ud6c4\\ubcf4\\ubb3c\\uc9c8 \\ub3c4\\ucd9c \\uc5f0\\uad6c\", \"\\uc608\\ubc29 \\ubc31\\uc2e0, \\uc9c4\\ub2e8\\ubc95, \\uce58\\ub8cc\\ubc95, \\uc608\\ud6c4 \\ud310\\uc815\\ubc95 \\uac1c\\ubc1c\\uc744 \\uc704\\ud55c MRSA\\uc640 \\uc218\\ud37c\\ubc15\\ud14c\\ub9ac\\uc544\\uc758 \\ud0c0\\uac9f \\ubc1c\\uad74\", \"Identification of Viral Peptide Candidates for the Development of Second Generation Cervical Cancer Vaccines Tailored for Chinese Women\", \"Nowy uniwersalny wektor i jego zastosowanie do konstrukcji szczepionki nowej generacji\", \"To develop an inexpensive, broadly protective (universal) influenza A virus vaccine in pre-clinical animal studies\", \"Vaccine and Treatment Evaluation Unit: Respiratory Syncytial Virus Diagnostic and Vaccine Assays\", \"Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever\", \"A pilot study to determine the appropriate design for a trial of acellular pertussis vaccine given at birth\", \"Magnetic resonance imaging-assisted design of a thermostable and self-administrable tuberculosis vaccine for inhalation\", \"Development of a Staphylococcus aureus Candida sp. Vaccine\", \"Development of a Staphylococcus aureus Candida sp. Vaccine\", \"Plant-Based Expression Systems for New Vaccines and Therapeutics\", \"Development of Novel Vaccines and Therapeutics Using Plant-Based Expression Systems\", \"Development of a Staphylococcus aureus Candida sp. Vaccine\", \"Development of rice plants for the delivery of oral vaccines\", \"SYSTEMS BIOLOGY IN HOST-PATHOGEN INTERACTIONS \\u2013 IMPLICATIONS FOR VACCINE TARGET DISCOVERY\", \"Development of an antidiabetogenic enterovirus vaccine for prevention of type 1 diabetes\", \"DETECTION AND CONTROL OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EMERGING VIRAL DISEASES OF SWINE\", \"Development of in vitro assay to replace the hamster potency test used for evaluating commercial L.hardjo vaccines\", \"Development & evaluation of standard preparations for assessing QC methods for cat and dog vaccines [was VM0101]\", \"Field trial to assess the safety and efficacy of BCG vaccine admininster parenterally (part of project CB0115)\", \"The development of animal models to test candidate vaccines for M. bovis infection in badgers (continuation of SE0130)\", \"Development of vaccines to protect badgers against M. bovis: development of surrogate assays [was part SE0110]\", \"The development of vaccines for the protection of badgers against infection with Mycobacterium bovis [became SE0122/3]\", \"The rational selection of candidate antigens for inclusion in vaccines against bovine mastitis caused by S.uberis\", \"Genetic and immune basis of protection against infectious bursal disease virus (IBDV) by defined molecular vaccines\", \"Multi-valent Hantvirus-Vaccine (MVA SEO-HTN: Vacc) and a ferret model of disease\", \"Vakc\\u00edna proti kokcidi\\u00f3ze koz\", \"*V\\u00fdvoj univerz\\u00e1ln\\u00ed vakc\\u00edny proti ch\\u0159ipce prasat respektuj\\u00edc\\u00ed aktu\\u00e1ln\\u00ed epizootologickou situaci v \\u010cesk\\u00e9 republice a ve sv\\u011bt\\u011b.\", \"\\u6a5f\\u80fd\\u6027\\u30da\\u30d7\\u30c1\\u30c9\\u306e\\u69cb\\u9020\\u6d3b\\u6027\\u76f8\\u95a2\\u306b\\u57fa\\u3065\\u304f\\u6700\\u9069\\u8a2d\\u8a08\\u3068\\u65b0\\u898f\\u304c\\u3093\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"Application of Protein Capsular Matrix Vaccine Technology to the Development of a Novel Form of Killed Whole Cell Vaccines\", \"Glycopolymer-based vaccine nanocarriers\", \"Bacterial DNA and DNA vaccines as regulators of macrophage function and as a therapeutic approach to Leishmani\", \"Development of a self-adjuvanting mucosal vaccine candidate against Group A Streptococcus using lipid core technology\", \"Identifying determinants of mycobacterial pathogenesis and understanding host immunity for devel. of novel anti-TB vaccine\", \"Understanding the mechanisms of action and optimising the ISCOMATRIX\\ufffd adjuvant for the development of human vaccines\", \"The development of a group A streptococcal vaccine and understanding the immunopathogenesis of rheumatic heart disease\", \"Defining the T cell epitopes of vaccinia and ectromelia viruses: exploring immunodominance in recombinant vaccines and r\", \"The impact of a conjugate pneumococcal vaccine on pneumococcal carriage, antibiotic resistance, & otitis media in Aborig\", \"Efficacy and mode of action of a pro-apoptotic, TLR7-specific ligand adjuvant in anti-tumour vaccine immune responses.\", \"Studying the function and mechanism of histone ADP-ribosylation; (ii) Lipo-peptide--protein vaccine development\", \"H1N1 Optimal use of vaccine to mitigate a second wave of H1N1 2009 influenza in Australia\", \"Development of hybrid HPV/HIV VLPs, a novel vaccine to prevent both HIV and HPV infection\", \"H1N1 Estimating the protective effect of seasonal influenza vaccine against medically attended ILI due to novel influenz\", \"To convene a group of experts to discuss the value of vaccines in reducing the impact of antimicrobial resistance\", \"To create a favorable social environment for accelerated ethical research and global delivery of HIV/AIDS vaccines\", \"To create a favorable social environment for accelerated ethical research and global delivery of HIV/AIDS vaccines\", \"To build additional evidence to understand where typhoid vaccine is needed in Africa and accelerate its delivery where needed\", \"To develop and field test solar powered, battery-free icepack freezers to cool vaccines during transport and immunization sessions.\", \"To convene an international symposium to review the potential contribution of new vaccines to improving global health\", \"To support clinic renovations in support of the Center for HIV/AIDS Vaccine Immunology clinical trials in Africa\", \"To identify actions necessary to accelerate introduction and uptake of cholera vaccines in high burden endemic regions in India\", \"To develop and deploy genetic tests useful for monitoring drug resistance, vaccine responses, and disease severity\", \"To provide financial support for participants from developing countries to attend an international conference on AIDS vaccine\", \"To develop and license a low cost booster vaccine to develop immunity against all serotypes of polio virus\", \"To develop a new vaccine for rotavirus that uses low-technology engineering methods suitable for the developing world.\", \"To assess pneumococcal carriage in children 4 -5 years after introduction of PCV10 (Pneumococcal conjugate vaccine) in Kenya\", \"To create a novel DNA vaccine delivery system that targets dendritic cells in GI mucosal tissues.\", \"To develop an inexpensive, safe, and effective oral vaccine against invasive Salmonella disease using gas-filled bacterial vesicles.\", \"To develop a broad-range vaccine, using your knowledge of bioinformatics, biochemistry, and immunology in an interdisciplinary approach\", \"To reduce HIV infections by supporting research addressing the role of mucosal immunology in HIV protection for vaccine development.\", \"To develop a randomized control trial to assess the non-specific effects of oral poliovirus vaccine in Bangladesh\", \"To develop protein chips that encapsulate poliovirus-like particles (PLP) for use as a safe and effective polio vaccine.\", \"To assess the advantage of plant-derived vaccines as an inexpensive technique compared to traditional production methods\", \"To explore alternative cost-effective delivery methods for inactivated poliovirus vaccine based on the Sabin strains (Sabin-IPV)\", \"To develop an IPV vaccine adjuvanted with CAF01 that is able to enhance mucosal immunity and promote dose-sparing\", \"To develop and license a quadrivalent HPV vaccine available to the masses at an affordable cost\", \"To convene global stakeholders to develop consensus with respect to preferred product characteristics for a TB vaccine\", \"To provide preliminary evidence in order to determine the most effective vaccine strategy for Hepatitis E virus (HEV)\", \"To develop receptor blocking malaria vaccines based on a combination of a novel RBL family of Plasmodium merozoite proteins\", \"To test three components from the mosquito\\u2019s innate signaling pathways for possible use in a malaria vaccine\", \"To identify unique immune responses in individuals who resist tuberculosis infection to guide future vaccine design\", \"To develop improved vaccines against HIV/AIDS for use throughout the world, in particular in high disease burden countries\", \"For the analysis of samples and data from Scientific Advisory Board-approved vaccine trials and natural history studies\", \"To test a large scale deployment of 75 passive vaccine storage devices in different rural settings across Ethiopia\", \"To maximize immunization coverage for children across the developing world by reliably providing vaccines at the point-of-care\", \"To conduct a Phase I HIV vaccine study that will compare the immunogenicity of different centralized gene (env) constructs\", \"To develop a vaccine in both developing and developed nations that prevents the transmission of HIV\", \"To bring together worldwide researchers to discuss the latest findings and trends associated with TB vaccines\", \"To design and test self-assembling peptide vaccine materials that are stable in the face of significant temperature fluctuations.\", \"To develop the optimal techniques for cryopreservation of human mucosal tissues for use in assessing HIV vaccines and microbicides.\", \"To evaluate the immunogenicity and impact of a reduced 13 valent pneumococcal conjugate vaccine (PCV13) dosing schedule\", \"To test the ability of a low-cost plant-based synthetic biology method to produce an RNA malaria vaccine.\", \"To change characteristics in gram-negative bacteria to test an innovative approach for new vaccine generation\", \"To identify novel immune targets and studies on mechanisms of protective immunity in order to accelerate rational vaccine development\", \"To better understand if clearance of malaria will improve T cell function and improve immune responses to vaccines\", \"To develop and characterize a naturally infected Guinea Pig model that can be used for vaccine evaluation.\", \"To understand the impact of pneumococcal conjugate vaccine (PCV) to nasopharynx microbiome in Africa and Southeast countries\", \"To discover new mucosal immunity targets for the design of cheap vaccines effective against all serotypes of pneumococci\", \"To accelerate the development of a global pediatric HIV/AIDS vaccine through basic research and Phase I clinical trials\", \"To develop a new vaccine for tuberculosis that uses an arabinomannan-protein conjugate to elicit strong antibody-mediated immunity.\", \"To test whether changes in the bacteria that naturally reside in human bowels affect vaccine responsiveness.\", \"To design recombinant viruses that can generate self-assembling poliovirus-like particles for use in a poliovirus vaccine.\", \"To develop and test a device for rapid detection of freeze-damage in widely used adjuvant-type vaccines.\", \"To develop Unmanned Aerial Vehicles (UAVs) that can be deployed via cell phones to transport vaccines to rural locations\", \"To fund epidemiological and clinical endpoint definition studies in support of adjuvanted purified and inactivated vaccine development\", \"To provide solutions to the problem of HIV and host genetic diversity to HIV vaccine development\", \"To support the development of an attenuated Plasmodium falciparum sporozoite vaccine to reduce malaria infection, morbidity, and mortality\", \"To provide technical assistance to develop a research plan for the impact evaluation of pneumococcal conjugate vaccine in India\", \"To develop a novel method to validate new potential drug and vaccine gene targets in the malaria parasite\", \"To develop a vaccine that elicits durable cellular and humoral immunity to HIV-1 by targeting dendritic cells\", \"To understand the burden of disease for cholera in Africa and build evidence to support cholera vaccine adoption there\", \"To support the development of typhoid conjugate vaccine cost-effectiveness models to inform optimal delivery strategy\", \"To develop and clinically test economically donor-friendly adjuvanted trivalent Inactivated Polio virus (IPV) vaccines with reduced IPV doses\", \"To develop a non-infectious poliovirus vaccine using encapsidated replicons or mature empty capsids that retain full immunogenicity.\", \"To provide research, develop and improve technologies and manufacture vaccines to improve health in developing countries\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"Influence of Parental Concern about Vaccine Safety on Incomplete Immunization of Alberta Pre-School Children\", \"\\u9d8f\\u80ce\\u5150\\u7d30\\u80de\\u306e\\u6d6e\\u904a\\u57f9\\u990a\\u306b\\u3088\\u308b\\u65e5\\u672c\\u8133\\u708e\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u88fd\\u9020(\\u7d992\\u5e74)\", \"\\u30b8\\u30d5\\u30c6\\u30ea\\u30a2(D), \\u767e\\u65e5\\u54b3(D), \\u7834\\u50b7\\u98a8(T), \\u9ebb\\u75b9(M), \\u6df7\\u5408\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5b9f\\u7528\\u5316\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u306e\\u5e38\\u5728\\u3059\\u308b\\u6771\\u5357\\u30a2\\u30b8\\u30a2\\u306e\\u8abf\\u67fb\\u3068\\u4e88\\u9632\\u52b9\\u679c\\u306e\\u9ad8\\u3044\\u30ef\\u30af\\u30c1\\u30f3\\u88fd\\u9020\\u306e\\u7814\\u7a76\", \"\\u7dd1\\u81bf\\u83cc\\u611f\\u67d3\\u75c7\\u306e\\u30ef\\u30af\\u30c1\\u30f3, \\u6cbb\\u7642\\u7528\\u03b3\\u30b0\\u30ed\\u30d6\\u30ea\\u30f3\\u53ca\\u3073\\u8a3a\\u65ad\\u6db2\\u306e\\u81e8\\u5e8a\\u5fdc\\u7528\", \"\\u7dd1\\u81bf\\u83cc\\u4e09\\u7a2e\\u6df7\\u5408\\u30ef\\u30af\\u30c1\\u30f3\\u53ca\\u3073\\u305d\\u306e\\u6297\\u03b3-\\u30b0\\u30ed\\u30d6\\u30ea\\u30f3\\u306e\\u81e8\\u5e8a\\u5fdc\\u7528\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u907a\\u4f1d\\u5b50\\u7d44\\u307f\\u63db\\u3048\\u306b\\u3088\\u308b\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u6e29\\u5ea6\\u611f\\u53d7\\u6027\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u89aa\\u682a\\u306e\\u4f5c\\u88fd\", \"\\u7dd1\\u81bf\\u83cc3\\u7a2e\\u6df7\\u5408\\u30ef\\u30af\\u30c1\\u30f3\\u53ca\\u3073\\u6297\\u83cc\\u4f53\\u6210\\u5206(OEP), \\u83cc\\u4f53\\u5916\\u9175\\u7d20\\u6297\\u4f53\\u306e\\u81e8\\u5e8a\\u5fdc\\u7528\", \"\\u7d44\\u7e54\\u57f9\\u990a\\u72c2\\u72ac\\u75c5\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4eba\\u4f53\\u63a5\\u7a2e\\u52b9\\u679c\\u53ca\\u3073\\u6700\\u9069\\u63a5\\u7a2e\\u6cd5\\u306e\\u7814\\u7a76\", \"\\u9b5a\\u7fa4\\u3092\\u5bfe\\u7167\\u3068\\u3059\\u308b\\u6d78\\u6f2c\\u30ef\\u30af\\u30c1\\u30f3\\u51e6\\u7406\\u65b9\\u6cd5\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u4f1d\\u67d3\\u6027\\u6c17\\u7ba1\\u652f\\u708e\\u30a6\\u30a4\\u30eb\\u30b9\\u30b9\\u30d1\\u30a4\\u30af\\u86cb\\u767d\\u3092\\u767a\\u73fe\\u3059\\u308b\\u30de\\u30ec\\u30c3\\u30af\\u75c5\\u30a6\\u30a4\\u30eb\\u30b9\\u8840\\u6e052\\u578b\\u306e\\u30ea\\u30b3\\u30f3\\u30d3\\u30ca\\u30f3\\u30c8\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u6297\\u816b\\u760d\\u514d\\u75ab\\u306e\\u30e2\\u30c7\\u30eb\\u3068\\u3057\\u3066\\u306e\\u30de\\u30ec\\u30c3\\u30af\\u75c5\\u751f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4f5c\\u7528\\u6a5f\\u5e8f\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u6f5c\\u4f0fHIV-1\\u6d3b\\u6027\\u5316\\u6a5f\\u5e8f\\u306e\\u89e3\\u660e\\u304a\\u3088\\u3073AIDS\\u767a\\u75c7\\u4e88\\u9632\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u5358\\u30af\\u30ed\\u30fc\\u30f3\\u6297\\u4f53\\u306b\\u3088\\u308b\\u75c5\\u539f\\u30ec\\u30d7\\u30c8\\u30b9\\u30d4\\u30e9\\u611f\\u67d3\\u9632\\u5fa1\\u6297\\u539f\\u306e\\u69cb\\u9020\\u89e3\\u6790\\u3068\\u6210\\u5206\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Trypanosoma cruzi \\u7a2e\\u7279\\u7570\\u6297\\u539f\\u306e\\u8a3a\\u65ad\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u30bf\\u30a4\\u56fd\\u5317\\u90e8\\u306b\\u304a\\u3051\\u308b\\u65e5\\u672c\\u8133\\u708e\\u4f1d\\u64ad\\u8981\\u56e0\\u306e\\u751f\\u614b\\u5b66\\u7684\\u7814\\u7a76\\u3068\\u4e88\\u9632\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u52b9\\u679c\\u5224\\u5b9a\", \"\\u6c34\\u75d8\\u30a6\\u30a3\\u30eb\\u30b9\\u30b2\\u30ce\\u30e0\\u306e\\u69cb\\u9020\\u89e3\\u6790\\u304a\\u3088\\u3073\\u6c34\\u75d8\\u30a6\\u30a3\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u306e\\u5206\\u5b50\\u30de\\u30fc\\u30ab\\u30fc\\u306e\\u540c\\u5b9a\", \"\\u30cf\\u30b7\\u30ab\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u91ce\\u751f\\u682a\\u304b\\u3089\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u3078\\u306e\\u99b4\\u5316\\u73fe\\u8c61\\u306e\\u5206\\u5b50\\u751f\\u7269\\u5b66\\u7684\\u89e3\\u6790\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u306e\\u5e38\\u5728\\u3059\\u308b\\u6771\\u5357\\u30a2\\u30b8\\u30a2\\u306e\\u8abf\\u67fb\\u3068\\u4e88\\u9632\\u52b9\\u679c\\u306e\\u9ad8\\u3044\\u30ef\\u30af\\u30c1\\u30f3\\u88fd\\u9020\\u306e\\u7814\\u7a76\", \"\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u306b\\u304a\\u3051\\u308b\\u514d\\u75ab\\u6291\\u5236\\u89e3\\u9664\\u3068\\u514d\\u75ab\\u8ce6\\u6d3b\\u306e\\u5206\\u5b50\\u6a5f\\u69cb\\u306e\\u89e3\\u660e\", \"Parents' preferences for vaccination for their children in Japan\", \"\\u9769\\u65b0\\u7684\\u4eba\\u5de5\\u30ed\\u30f3\\u30b0\\u30da\\u30d7\\u30c1\\u30c9\\u764c\\u30ef\\u30af\\u30c1\\u30f3\\u3001H/K-HELP\\u306e\\u6297\\u816b\\u760d\\u514d\\u75ab\\u6d3b\\u6027\\u5316\\u6a5f\\u5e8f\\u306e\\u89e3\\u660e\", \"Development of transcutaneous vaccine with efficacy and safety for the overcoming infectious diseases\", \"Development of tailor made peptide vaccines for renal cell carcinoma\", \"\\u30d5\\u30a1\\u30fc\\u30b8\\u30c7\\u30a3\\u30b9\\u30d7\\u30ec\\u30a4\\u6cd5\\u3092\\u7528\\u3044\\u305f\\u6297\\u4f53\\u69d8\\u7d20\\u5b50\\u306e\\u958b\\u767a\\u3068\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"Characterization of abortion related factor of intracellular protozoan parasite Neospora caninum and its application for vaccine development\", \"Novel oral vaccine using genetically engineering bifidobacterium displaying antigen on its cell-surface\", \"Development of Novel Oral Vaccine Delivery System for Mucosal Immunization in Gut-Associated Lymphoid Tissue\", \"\\u982d\\u981a\\u90e8\\u60aa\\u6027\\u816b\\u760d\\u306b\\u5bfe\\u3059\\u308bFAK\\u3068EphA2\\u3092\\u6a19\\u7684\\u3068\\u3057\\u305f\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u306e\\u958b\\u767a\", \"Development of a prophylactic vaccine effective against a broader spectrum of HPVs associated with cervical cancer and basic research on therapeutic HPV vaccine for cervical cancer\", \"Attitudes Towards and Acceptance of HPV Vaccine in Japanese Mothers of Adolescents living in the UK and Australia\", \"Development of subunit cocktail vaccine against bovine babesiosis\", \"Development of the toxoid vaccines and neutralizing monoclonal antibodies against Shiga toxins\", \"\\u30b5\\u30a4\\u30c8\\u30e1\\u30ac\\u30ed\\u30a6\\u30a4\\u30eb\\u30b9\\u306b\\u3088\\u308b\\u773c\\u75be\\u60a3\\u306e\\u65b0\\u898f\\u6cbb\\u7642\\u6cd5\\u3068\\u30b2\\u30ce\\u30e0\\u7de8\\u96c6\\u6280\\u8853\\u306b\\u3088\\u308b\\u30ef\\u30af\\u30c1\\u30f3\\u4f5c\\u6210\", \"WT1\\u30da\\u30d7\\u30c1\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u3092\\u4e2d\\u5fc3\\u3068\\u3057\\u305f\\u60aa\\u6027\\u795e\\u7d4c\\u81a0\\u816b\\u5e79\\u7d30\\u80de\\u6a19\\u7684\\u7642\\u6cd5\\u306e\\u63a2\\u7d22\", \"\\u30c0\\u30cb\\u30a2\\u30ec\\u30eb\\u30b2\\u30f3\\u86cb\\u767d\\u8cea\\u306e\\u9ad8\\u6b21\\u69cb\\u9020\\u306b\\u7126\\u70b9\\u3092\\u3042\\u3066\\u305fIgE\\u30a8\\u30d4\\u30c8\\u30fc\\u30d7\\u89e3\\u6790\\u53ca\\u3073\\u30ef\\u30af\\u30c1\\u30f3\\u8a2d\\u8a08\", \"B\\u578b\\u809d\\u708e\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u6297\\u4f53\\u7372\\u5f97\\u4f8b\\u306e\\u3046\\u3061HB_s\\u6297\\u4f53\\u304c\\u9670\\u6027\\u5316\\u3057\\u305f\\u4f8b\\u306e\\u514d\\u75ab\\u5b66\\u7684\\u691c\\u8a0e\", \"\\u75c5\\u539f\\u30ec\\u30d7\\u30c8\\u30b9\\u30d4\\u30e9\\u611f\\u67d3\\u9632\\u5fa1\\u51dd\\u96c6\\u6297\\u539f\\u3092\\u7528\\u3044\\u305f\\u6210\\u5206\\u30ef\\u30af\\u30c1\\u30f3\\u53ca\\u3073\\u8fc5\\u901f\\u8a3a\\u65ad\\u6cd5\\u306e\\u958b\\u767a\", \"\\u65b0\\u3057\\u3044\\u907a\\u4f1d\\u5b50\\u64cd\\u4f5c\\u6280\\u8853\\u3092\\u7528\\u3044\\u305f\\\"\\u534a\\u751f\\\"\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u3068\\u5fdc\\u7528\", \"Engineering Peptide-MHC/co-stimulator-based Nanoparticle Vaccines for the Treatment of Metastatic Cancer\", \"\\u0418\\u0437\\u0443\\u0447\\u0435\\u043d\\u0438\\u0435 \\u0441\\u0432\\u043e\\u0439\\u0441\\u0442\\u0432 \\u0440\\u0435\\u043a\\u043e\\u043c\\u0431\\u0438\\u043d\\u0430\\u043d\\u0442\\u043d\\u044b\\u0445 \\u0441\\u0442\\u0440\\u0435\\u043f\\u0442\\u043e\\u043a\\u043e\\u043a\\u043a\\u043e\\u0432\\u044b\\u0445 \\u043f\\u043e\\u043b\\u0438\\u043f\\u0435\\u043f\\u0442\\u0438\\u0434\\u043e\\u0432  \\u0432 \\u043a\\u0430\\u0447\\u0435\\u0441\\u0442\\u0432\\u0435  \\u043a\\u043e\\u043c\\u043f\\u043e\\u043d\\u0435\\u043d\\u0442\\u043e\\u0432 \\u0432\\u0430\\u043a\\u0446\\u0438\\u043d\\u044b \\u043f\\u0440\\u043e\\u0442\\u0438\\u0432 \\u0441\\u0442\\u0440\\u0435\\u043f\\u0442\\u043e\\u043a\\u043e\\u043a\\u043a\\u043e\\u0432 \\u0433\\u0440\\u0443\\u043f\\u043f\\u044b \\u0412\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Persistence of protection against invasive bacterial disease-Memory B cell responses in infants after meningococcal vaccines\", \"Prophylactic vaccine against Human papillomavirus 16: Mucosal immunity in the genital tract elicited by Salmonella recombinant strains\", \"Inaktivierte Vakzinen gegen das Afrikanische Schweinepest- virus (ASPV) : Molekulare Basis der immunogenen Proteine.\", \"Verminderung der zur Kontrolle von Tollwutimpfstoffen ben\\u00f6- tigten Anzahl M\\u00e4use in der Human- und Veterin\\u00e4rmedizin\", \"Developing a chlamydial vaccine for koalas\", \"\\u57fa\\u4e8eCTL\\u8868\\u4f4d\\u548cTn\\u6297\\u539f\\u7684\\u6cbb\\u7597\\u6027\\u62df\\u80bd\\u80bf\\u7624\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u3001\\u5408\\u6210\\u53ca\\u6784\\u6548\\u5173\\u7cfb\", \"The basis of the irradiated sporozoite vaccine: identification of Plasmodium genes essential for development to liver stages\", \"Generating regional rotavirus vaccine strains through reverse genetics to alleviate viral diarrhoea in Africa (extension: Dr. Hester O'Neill)\", \"Kombinierte CpG-Oligodeoxynukleotid/Lipopeptid Liposomen als neuer immunmodulatorischer Impfstoff gegen Hepatitis C Virus Infektion\", \"Terapia czerniaka u myszy przy pomocy szczepionki zawieraj\\u0105cej kom\\u00f3rki dendrytyczne JAWSII.\", \"Impact of a novel vaccine candidate against Group B Streptococcus-induced neonatal diseases on commensal microbiota\", \"Etudes cliniques en vaccinologie visant en particulier \\u00e0 \\u00e9valuer l impact \\u00e9pid\\u00e9miologique de diff\\u00e9rents vaccins et \\u00e0 am\\u00e9liorer leur impact populationnel\", \"Statistical Methods for Identifying Correlates of Risk and Surrogate Endpoints in Vaccine Trials\", \"Etudes cliniques en vaccinologie visant en particulier \\u00e0 \\u00e9valuer l impact \\u00e9pid\\u00e9miologique de diff\\u00e9rents vaccins et \\u00e0 am\\u00e9liorer leur impact populationnel\", \"D\\u00e9veloppement d'indicateurs novateurs de performance de la couverture vaccinale au Burkina Faso et dans les pays \\u00e0 revenu faible et interm\\u00e9diaire\", \"Development of phase I vaccine against Staphylococcus epidermis infections resulting from implant associated surgery - Avslutning dr.grad\", \"G\\u00e9n\\u00e9ration de nanoparticules dans le but de d\\u00e9velopper un vaccin universel contre la grippe\", \"G\\u00e9n\\u00e9ration de nanoparticules dans le but de d\\u00e9velopper un vaccin universel contre la grippe\", \"Centre de Recherche en Infectiologie Porcine (CRIP)\", \"New cancer vaccines based on Troy-bodies, telomerase as tumor-specific antigen, and CD40-activated B cells as APC\", \"Elucidating the potential of baculovirions as an effective and safe 'DNA vaccine' delivery system.\", \"Vacina brasileira contra a meningite meningoc\\u00f3cica b e c\", \"RNA interference and recombinant protein prodution for identification of antigens to develop an anti-tick vaccine\", \"ENHANCING AN IMMUNIZATION INFORMATION SYSTEM (IIS) TO INTERFACE WITH CDCs VTRACKS VACCINE ORDERING AND MANAGEMENT SYSTEM\", \"BACULOVIRUS RECOMBINANTS THAT EXPRESS HEPATITIS B VIRUS SURFACE AN TIGEN: DEMONSTRATION FOR PRODUCTION OF SUBUNIT VACCINES\", \"Development of diagnostic techniques for detection of pathogens transmitted by ticks and procedures for preparation of vaccines against ticks\", \"Molecular-biological characterisation of selected tick saliva proteins as potential antigens for development of anti-tick vaccine\", \"Protractive activity of anti-rabies vaccines for rabies-like lyssavirus infections; possibility of influencing it by using adjuvant substances.\", \"New technology to improve vaccines for immunotherapy of cancer: antibody-mediated targeting of synthetic peptide constructs\", \"Immune Responses and Regulation in Hepatitis C Virus (HCV) Infection: Implications for Vaccine/Immunotheraphy\", \"Influence of Parental Concern about Vaccine Safety on Incomplete Immunization of Alberta Pre-School Children\", \"Small Molecule Agonists of RIG-I as Adjuvants for Hepatitis C and other Viral Vaccines\", \"Chair in Social Justice, Equity and Diversity\", \"PPHF 2014: IMMUNIZTAION: ENHANCE AN IMMUNIZATION INFORMATIONSYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING AND MANAGEMENT SYSTEM\", \"PPHF 2014: IMMUNIZATION ENHANCE AN IMMUNIZATION INFORMATION SYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING & MGMT SYSTEM\", \"TO ENHANCE THE STATEWIDE IMMUNIZATION REGISTRY (IRIS) TO INTERFACE WITH CDCs NATIONAL VACCINE ORDERING AND INVENTORY MGMT SYSTEM (VTRCKS)\", \"PPHF 2014: IMMUNIZATION-ENHANCE AN IMMUNIZATION INFORMATION SYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING AND MANAGEMENT SYSTEM\", \"PPHF 2014: IMMUNIZATION ENHANCE AN IMMUNIZATION INFORMATION SYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING & MANAGEMENT SYSTEM\", \"IMMUNIZATION ENHANEMENTS OF OUR IMMUNIZATION INFORMATION SYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING & MGMT SYSTEM\", \"BUILDING ON THE EXISTING NYSIIS VTRCKS INTERFACE TO ENHANCE VACCINE INVENTORY , ACCOUNTABILITY AND USABILITY OF THE NYSIIS SYSTEM\", \"ENHANCING IDAHOS IIS IN ELECTRONICALLY COLLECTING FROM PROVIDERS INFORMATION ON WASTED AND RETURNED VACCINES FOR EXPORT TO VTRCKS\", \"NORTH CAROLINA IMMUNIZATION REGISTRY WHICH IS THE STATE IMMUNIZATION INFORMATION SYSTEM WILL IMPROVE INTERFACE CAPACITY WITH CDCs VACCINE ORDERING\", \"PPHF 2014: IMMUNIZATION: ENHANCE AN IMMUNIZATION INFO SYSTEM (IIS) TO INTERFACE WITH CDCs VTRCKS VACCINE ORDERING & MGMT SYSTEM\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"PRESERVING A TENUOUS RESOURCE: MAINTENANCE OF A PROMISING VACCINE STRAIN OF TOXOPLASMA GONDII\", \"NOVEL VACCINES FOR JOHNE'S DISEASE\", \"European Network of Vaccine Development and Research\", \"Recombinant vaccines against tuberculosis challenge in normal as we ll as transgenic, HLADR-expressing, IA-deficient mice\", \"Construction of potential rotavirus vaccines and evaluation of their capacity for inducing both humoral and cellular immunity\", \"IMMUNOLOGICAL PROTECTION MECHANISM AND ASSESSMENT OF CANDIDA TE VACCINE PREPARATIONS IN A NONHUMAN PRIMATE MODEL FOR SCHI STOSOMIASIS\", \"THE PRODUCTION OF A NOVEL VACCINE AGAINST INFECTIOUS BRONCHITIS VIRUS (IBV) BY THE USE OF GENETIC ENGINEERING TECHNIQUES\", \"DEVELOPMENT OF DIAGNOSTICS FOR T. EVANSI IN CAMELS AND WATER BUFFALOES. PERSPECTIVES IN VACCINE DEVELOPMENT\", \"Development of an oral adenovirus-based vaccine against influenza for pandemic protection.\", \"Development of an oral adenovirus-based vaccine against influenza for pandemic protection.\", \"Out of Africa: British trypanosomes as vaccine vehicles against important cattle pathogens.\", \"Analysis of candidate pre-erythrocytic vaccines against malaria in semi-immune Africans.\", \"Investigation of pre-erythrocytic malaria vaccines in a mouse model using transgenic parasites.\", \"Expression of recombinant antigen-antibody fusion complexes for developing new vaccines.\", \"WHO MALVAC 2007 Meeting\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Characterisation and development of adjuvants for new generation veterinary and human vaccines\", \"Establishment of a flexible insect cell platform for fast production of pseudo-typed VLPs for drug and vaccine development\", \"A combination of two gp41 peptides for a new prophylactic vaccine both neutralizing HIV-1 and inhibiting CD4 depletion\", \"Development of a mucosal hepatitis B vaccine: Design and mechanistic studies of a prototypic multi-component polymeric delivery system.\", \"ER_TRANSPROT -\\u201cEhrlichia ruminantium proteome analysis: a complementary approach to transcriptomics towards increased knowledge on heartwater pathogenesis and vaccine development\", \"Development of ultra-sensitive detection methods and plant nano-vaccines for the fungi Fusarium spp. using nanotechnological devices.\", \"Helicobacter pylori diversity in pathogenesis, antibiotic resistance, and evasion from natural and vaccine-induced immune responses (HELDIVPAT)\", \"The Leishmania TDR1 family-related gene: functional studies and evaluation of TDR1 recombinant protein and knockout vaccines against leishmaniasis.\", \"D\\u00e9veloppement d'un vaccin recombinant contre l'infection par le virus du syndrome reproducteur et respiratoire des porcs (SRRP)\", \"D\\u00e9veloppement dun vaccin recombinant contre linfection par le virus du syndrome reproducteur et respiratoire des porcs (SRRP)\", \"Development of caulobacters as a vaccine presentation system for the passive immunization of hatchery salmonids against IHNV virus\", \"Peptide epitopes for the HIV -1 neutralizing antibodies 2F5 and 2G12 as anti HIV-1 vaccine candidates\", \"Plant molecular pharming: application for the development of an experimental recombinant subunit vaccine against human respiratory syncytial virus\", \"Construction and testing of vaccine proteins against pseudomonas infections using the Caulobacter crescentus S-Layer presentation\", \"Vaccins sous-unitaires induisant une immunit\\u00e9 mucosale effectrice contre l'infection par le virus du syndrome reproducteur et respiratoire porcin\", \"The Hu-SCID mouse: An experimental model for the development and testing of candidate TB vaccines\", \"In ovo and mucosal delivery of CpG-ODN in chickens as an immunostimulant and vaccine adjuvant\", \"Immunologie des prot\\u00e9ines structurales du virus du syndrome reproducteur et respiratoire du porc (SRRP) et valeur vaccinale des prot\\u00e9ines recombinantes\", \"Canadian Network for Vaccines and Immunotherapeutics of Cancer and Chronic Viral Diseases (CANVAC)                    (2006 Renewal Competition)\", \"Peptide epitopes for the HIV -1 neutralizing antibodies 2F5 and 2G12 as anti HIV-1 vaccine candidates\", \"Discovering the optimal signals for T cell proliferation and differentiation: the key to effective vaccines and immunotherapy\", \"Canadian plaform for a cell culture based influenza vaccine production network (IVPN)  ( Funding request for full application preparation.)\", \"Developing vaccine and immunotherapeutic strategies for the prevention and treatment of cancer and viral diseases (CANVAC)\", \"Safety of live vaccines that establish life-long, persis\", \"SARS DNA Recombinant Adenoviral Vaccine\", \"Develop /Production Of A SARS DNA Plasmid Vaccine\", \"West Nile Virus DNA Plasmid Vaccine\", \"High Speed Automated Influenza Vaccine Harvester\", \"LIPOSOMAL VACCINE ADJUVANT FOR INFLUENZA IMMUNIZATION\", \"LIPOSOME-BASED VACCINE ADJUVANT SYSTEM FOR HIV\", \"FUNGAL EXPRESSION OF DENGUE PROTEINS FOR VACCINES\", \"PHASE 2 STUDY IF E COLI O157-REPA CONJUGATE VACCINE IN 2-5 YEAR OLD CH-275023337\", \"SARS Vaccine Development\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"]HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"HIV VACCINE PRODUCTION\", \"VACCINE EFFECTS IN PREGNANT MODEL &OFFSPRING\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Efficacy of a Multi-Antigen Vaccine in the Prevention of Methylnitrosourea\", \"Promoting Tolerogenic Dendritic Cell Migration In Vivo As A Potential For Autoimmune Vaccine Therapy\", \"Evaluation of immune responses engendered in CEA transgenic mice by a vaccine formulation composed of a recombinant CEA N domain antigen and GSK AS15 adjuvant\", \"\\u9002\\u7528\\u4e8e\\u9ca4\\u7684\\u201c\\u81ea\\u6740\\u6027\\u201dDNA\\u75ab\\u82d7\\u8f7d\\u4f53\\u6e05\\u9664\\u673a\\u5236\\u3001\\u6e05\\u9664\\u6548\\u679c\\u53ca\\u514d\\u75ab\\u7814\\u7a76\", \"Live avirulent vaccine against E. coli infections in broilers.\", \"OptiMalVax: Optimizing a deployable high efficacy malaria vaccine\", \"Novel Vaccines for Measles\", \"Gave fra Stiftelsen Kristian Gerhard Jebsen til K.G. Jebsen-senter for forskning p\\u00e5 influensavaksiner\", \"Evaluation of the Immunogenicity and Efficacy of a DNA Prime/Protein Boost Vaccine\", \"Identifying correlates of protection afforded by (Delta)GY SIVmac239 attenuated virus vaccine\", \"Development of vaccines & strategy for their use to control ulcer disease in coldwater ornamental fish.\", \"\\u4eba\\u5de5\\u5408\\u6210\\u65b0\\u578b\\u817a\\u75c5\\u6bd2\\u53ca\\u5176\\u4f5c\\u4e3a\\u75ab\\u82d7\\u8f7d\\u4f53\\u7684\\u7814\\u7a76\", \"Oral Amyloid AAV Vaccine for Alzheimer's Disease\", \"Bench top flow cytometer\", \"Building Vaccinology Expertise in South-East Asia.\", \"A Novel Vaccine Platform for Trimeric Envelope Proteins: HIV-1 envelope\", \"To enable participation by vaccine experts from developing countries in a workshop to be held on the MIT campus to improve technology transfer and improve local vaccine development and manufacturing so that vaccines can be provided at an affordable price, which will, in turn, lead to local employment\", \"To develop an economically donor-friendly IPV vaccine with a reduced IPV dose of at least 5 fold. This vaccine will despite the lower dose of IPV show an immunogenicity which equals or surpasses the current full dose IPV vaccine.\", \"Simian Vaccine Evaluation Units\", \"Efficacy of Conserved Element SIV Gag Vaccine in Control of SIVmac239 Viremia\", \"The application  to cancer vaccine of SSF that mimics pulmonary surfactant\", \"Killer T cell inducing peptide vaccine against malaria infection\", \"Establishment of dendritic cell-based vaccine in combination with chemotherapy for oral cancer patients\", \"Development of dendritic cell vaccine modified with a ligand of NKT cells against tuberculosis\", \"Synthesis of Tn and Sialyl Tn Antigen-Lipid A Analog Conjugate for Synthetic Vaccines\", \"Optimizing Vaccine Formulations for Veterinary Vaccines\", \"Simian Vaccine Evaluation Unit (SVEU)\", \"Seasonal influenza vaccine effectiveness in Asthma\", \"\\u51cf\\u6bd2\\u8fdf\\u7f13\\u7231\\u5fb7\\u534e\\u6c0f\\u83cc\\u4f5c\\u4e3a\\u75ab\\u82d7\\u8f7d\\u4f53\\u5448\\u9012\\u5f02\\u6e90\\u6297\\u539f\\u7684\\u7814\\u7a76\", \"\\u8bf1\\u5bfc\\u548c\\u589e\\u5f3a\\u80a0\\u9053\\u7c98\\u819c\\u6297HIV\\u611f\\u67d3\\u514d\\u75ab\\u53cd\\u5e94\\u7684\\u75ab\\u82d7\\u514d\\u75ab\\u5b9e\\u9a8c\\u7814\\u7a76\", \"TLR\\u914d\\u4f53\\u9006\\u8f6cCD4+CD25+\\u8c03\\u8282\\u6027T\\u7ec6\\u80de\\u5bf9\\u65e5\\u672c\\u8840\\u5438\\u866b\\u8868\\u4f4d\\u75ab\\u82d7\\u6548\\u5e94\\u6291\\u5236\\u7684\\u5206\\u5b50\\u673a\\u5236\", \"\\u8f7d\\u4f53\\u9aa8\\u67b6CpG\\u5316\\u4fee\\u9970\\u5bf9\\u65b0\\u578b\\u590d\\u5236\\u5b50DNA\\u75ab\\u82d7\\u514d\\u75ab\\u8c03\\u8282\\u4f5c\\u7528\\u7814\\u7a76\", \"Vacinas de polissacar\\u00eddeos\", \"Desenvolvimento de vacinas para uso humano: da bancada para a produ\\u00e7\\u00e3o\", \"Immunological memory induced by attenuated malaria parasites\", \"Mobile Computer-Assisted Survey Research Laboratory for HIV Vaccine Implementation Science\", \"Towards a science of community engagement in international HIV vaccine research:  an embedded multinational case study of the social impact of a failed HIV vaccine trial\", \"Feasibility of applying an innovative bioprocessing methodology in a novel vaccine approach\", \"IMMUNOSUPPRESSION BY TICK SALIVA AND VACCINE DEVELOPMENT\", \"PREVENTION OF THE IPNV CARRIER STATE WITH DNA AND SUBUNIT VACCINES\", \"Development and Assessment of Chimaeric Feline Caliciviruses as Vaccines\", \"Proteomics and vaccine development in swine dysentery\", \"Designing effective Gram negative bacterial vaccines\", \"Multifunctional biodegradable nanoparticles for enhanced DNA vaccine delivery\", \"Designing new generation adjuvants for allergy and parasite vaccines\", \"Understanding heat shock protein complex vaccines\", \"EVALUATION OF ADVERSE ALLERGIC REACTIONS TO VACCINES\", \"West Nile Virus Vaccine Development\", \"SARS Coronavirus Vaccine Development\", \"Ebola Vaccine Development\", \"Characterization of Y. pestis antigens for the development of a novel vaccine\", \"HIV Vaccine Production\", \"HIV Vaccine Production\", \"HIV Vaccine Production\", \"Evaluation of NIAID's HIV Vaccine Research Education Initiative\", \"Evaluation of NIAID's HIV Vaccine Research Education Initiative\", \"Evaluation of NIAID's HIV Vaccine Research Education Initiative\", \"Evaluation of NIAID's HIV Vaccine Research Education Initiative\", \"Simian Vaccine Evaluation Units\", \"Simian Vaccine Evaluation Unit (SVEU)\", \"Simian Vaccine Evaluation Unit (SVEU)\", \"Simian Vaccine Evaluation Unit (SVEU)\", \"HIV Vaccine Design and Dev. Teams for Preventation and Treatment\", \"Tuberculosis Research Materials and Vaccine Testing\", \"TB VACCINE TESTING\", \"Tuberculosis Research Materials and Vaccine Testing\", \"Development of BSL-2 Neutralization Assays to Evaluate Filovirus Vaccines\", \"HIV/AIDS Therapeutic and Non-vaccine Prevention Clinical Research\", \"HVDDT: HIV-1 Vaccine Candidates Delivered by VSV Vectors\", \"HIV-1 VACCINE CANDIDATES DELIVERED BY VSV VECTORS\", \"HIV-1 VACCINE CANDIDATES DELIVERED BY VSV VECTORS\", \"Advanced Development of Multivalent Filovirus Vaccines\", \"DNA Vaccine Delivery System for Biodefense with dengue\", \"EIAV Envelope Variation and Vaccine Efficacy\", \"Comparison and basis of efficacy in commercial conventional vaccines against the H5N1 influenza virus.\", \"Examination of Side Effects occured after Vaccination\", \"Vaccine Design and Immune Responses\", \"Vaccine Safety:  Neurotoxicity safety test development,\", \"Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans\", \"Influence of maternal antibodies on a Sendai virus-vectored RSV vaccine\", \"MAO/DETECTION OF ANTIBODIES AND PROTEINS\", \"MAO/DETECTION OF ANTIBODIES &PROTEINS--ISOLATION OF VIR\", \"MAO/DETECTION OF ANTIBODIES &PROTEINS--ISOLATION OF VIR\", \"DESIGNING LIVE INFLUENZA UNIVERSAL VACCINE BASED ON NEW GENE\\u2013ENGINEERING AND IMMUNOGENETICS APPROACHES\", \"\\u7ed3\\u6838\\u75c5B7/hsp\\u5d4c\\u5408DNA \\u75ab\\u82d7\\u7814\\u7a76\", \"\\u53cc\\u91cd\\u7ec4\\u75c5\\u6bd2\\u75ab\\u82d7\\u4e2d\\u767d\\u7ec6\\u80de\\u4ecb\\u7d20\\u20142 \\u514d\\u75ab\\u4f50\\u5242\\u6d3b\\u6027\\u7684\\u7814\\u7a76\", \"I\\u578b\\u7cd6\\u5c3f\\u75c5\\u53cd\\u4e49DNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u9776\\u5411\\u878d\\u5408\\u9632\\u9f8bDNA\\u75ab\\u82d7\\u7684\\u7814\\u5236\\u548c\\u7c98\\u819c\\u514d\\u75ab\\u9632\\u9f8b\\u7684\\u4f5c\\u7528\\u673a\\u5236\", \"\\u57fa\\u56e0\\u67aa\\u4ecb\\u5bfc\\u5355\\u7eaf\\u75b1\\u75b9\\u75c5\\u6bd2gD2DNA\\u75ab\\u82d7\\u514d\\u75ab\\u7684\\u7814\\u7a76\", \"\\u7ec6\\u7c92\\u68d8\\u7403\\u7ee6\\u866b\\u91cd\\u7ec4BCG-Eg95\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"Bovine pneumonic pasteurellosis: a model for development of novel vaccine platforms\", \"The STARSS e-Health system for post-marketing safety surveillance of drugs and vaccines.\", \"Novel HIV-1 glycoprotein vaccines with enhanced presentation of broad neutralization epitopes\", \"Formulation of a pan-species, multi-stage vaccine for the malaria eradication agenda\", \"Next generation of targeted dendritic cell vaccines for cancer treatment\", \"Safety and uptake of the Measles, Mumps, Rubella and Varicella (MMR-V) vaccine\", \"Developing more accurate measures of immune response and vaccine efficacy of standard and novel schedules of two new pneumococcal conjugate vaccines (Prevenar13 or Synflorix) in indigenous infants\", \"Use of polylactidecoglycolide microparticles as an oral vaccine delivery system for farmed fish (LINKSAL17)\", \"*Pr\\u016fmyslov\\u00fd v\\u00fdzkum nejkomplexn\\u011bj\\u0161\\u00ed (v 1 vakcina\\u010dn\\u00ed d\\u00e1vce 11 antigen\\u016f) vakc\\u00edny Biocan Max DHPPi+L5CR, chr\\u00e1n\\u00edc\\u00ed celosv\\u011btov\\u011b psy proti z\\u00e1va\\u017en\\u00fdm infek\\u010dn\\u00edm onemocn\\u011bn\\u00edm, kterou m\\u016f\\u017ee veterin\\u00e1rn\\u00ed l\\u00e9ka\\u0159 pou\\u017e\\u00edt kdekoliv na sv\\u011bt\\u011b bez ohledu na lok\\u00e1ln\\u00ed v\\u00fdzkyt kmen\\u016f.\", \"Applying active hospital-based case ascertainment to assess vaccine effectiveness and safety\", \"Vaccine discovery for human mucosal pathogens: identifying novel vaccine antigens that are stably expressed during host interactions, using analysis of cell-contact and phasevarion mediated expression profiles\", \"The influence of HIV on T cell function and application to vaccine design.\", \"Boosting effectiveness of new vaccines for dengue ,HFMD and influenza by targeting vaccine antigens to Clec9A on dendritic cells.\", \"RV3 rotavirus vaccine: Phase I and II clinical trials of a human neonatal rotavirus vaccine for the global community\", \"Regulation of pulmonary immune responses to subunit vaccines against tuberculosis\", \"Prime-Target Vaccination in Malaria\", \"Construction of novel platforms for herpes simplex virus attenuated vaccines\", \"Use of long overlapping peptides for cancer vaccine and Treg control for potentiating immune response\", \"Study on the anti-allergic DNA vaccines with nanoparticle in gut mucosal immune system\", \"Analysis of efficacy of a vaccine inducing confined avirulent virus replication against immunodeficiency virus infection\", \"Development of a new class of lipid-based vaccines against tuberculosis\", \"Development of a novel vaccine platform based on Adeno associated virus.\", \"Identification of Neospora virulence factor and its application for the vaccine development\", \"Alphaherpesvirus vaccination, recombination and latency\", \"HBcAg-DNA\\u590d\\u5408\\u75ab\\u82d7\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"\\u53ef\\u9884\\u9632\\u5a74\\u5e7c\\u513f\\u547c\\u5438\\u9053\\u5408\\u80de\\u75c5\\u6bd2\\u611f\\u67d3\\u7684\\u53e3\\u670dDNA\\u75ab\\u82d7\", \"trpD\\u57fa\\u56e0\\u6572\\u9664\\u8026\\u8054\\u9776\\u5411\\u9012\\u9001GLS/IL-12\\u7684\\u91cd\\u7ec4BCG\\u6cbb\\u7597\\u6027\\u6d3b\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"Developing an RSV vaccine: Investigating possible adjuvants\", \"DETERMINING VIRUS-LIKE PARTICLE (VLP) FEASIBILITY FOR NEW PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VIRUS (PRRSV) VACCINES\", \"European malaria vaccine initiative\", \"Immunological mechanisms underlying the protective immune responses induced by botulinum oil adjuvanted vaccine\", \"Production of Alternate Adenovector Filovirus Vaccines\", \"Development/production of seasonal, pandemic and universa influenza DNA vaccines\", \"TIME COURSE OF LOT UTILIZATION\", \"Production of Alternate Adenovector Filovirus Vaccines\", \"Development/production of H3/H1 influenza DNA plasmid vaccine\", \"Development/production of a Marburg rAd Vaccine\", \"Production/Testing Of A Recombinant Modified Vaccine Ank\", \"Understanding &Estimating Costs of Vaccine Development,Production and Pricing\", \"Nanoemulsions as novel adjuvents for influenza virus vaccines\", \"ENGINEERED OPSONINS FOR WHOLE CELL TUMOR VACCINES\", \"VACCINATION AGAINST S MANSONI WITH STPI AND SM23\", \"Establishing the Human Vaccines Project as a paradigm for accelerating vaccine development against major global diseases\", \"Bescherming tegen influenza A en modulering van antigenpresentatie door matrix eiwit 2 ectodomein-specifieke antistoffen\", \"\\u57fa\\u4e8eMHC-I\\u77ed\\u80bd\\u7684\\u8fd8\\u539f\\u54cd\\u5e94\\u578b\\u5c0f\\u5206\\u5b50\\u6c34\\u51dd\\u80f6\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u7684\\u5236\\u5907\\u53ca\\u5176\\u8bf1\\u5bfc\\u7ec6\\u80de\\u514d\\u75ab\\u53cd\\u5e94\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"Varicella zoster virus as an HIV vaccine vector: Immunogenicity and protective efficacy in the SIV macaque model\", \"Dose-ranging study of safety, reactogenicity and immunogenicity of a human papillomavirus vaccine administered intradermally and intramuscularly to adults aged 20 to 26 years\", \"MagaVax vaccine for Ebola\", \"MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF INFECTIOUS BURSAL DISEASE VIRUSES\", \"Development of DC-vaccine against tuberclulosis\", \"EFFIVAVY OF CONSERVED ELEMENT SIV GAG VACCINCE IN CONTROL OF SIVmac239 VIREMIA\", \"\\u57fa\\u4e8ehTERT T\\u7ec6\\u80de\\u8868\\u4f4d\\u7684\\u591a\\u6297\\u539f\\u80bd(MAP)\\u75ab\\u82d7\\u8bbe\\u8ba1\\u53ca\\u5176\\u6297\\u80bf\\u7624\\u6548\\u5e94\\u7814\\u7a76\", \"\\u65b0\\u7532\\u578bH1N1\\u6d41\\u611f\\u75c5\\u6bd2\\u57fa\\u56e0\\u5de5\\u7a0b\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u5bf9\\u6297\\u75c5\\u6bd2\\u611f\\u67d3\\u7684\\u7814\\u7a76\", \"\\u514d\\u75ab\\u4e3b\\u5bfc\\u6548\\u5e94\\u5728\\u75ab\\u82d7\\u8f7d\\u4f53\\u4e2d\\u7684\\u4f5c\\u7528\\u53ca\\u6d88\\u9664\", \"\\u6162\\u75c5\\u6bd2\\u75ab\\u82d7\\u8bf1\\u5bfc\\u7684\\u514d\\u75ab\\u5e94\\u7b54\\u4e0e\\u514d\\u75ab\\u4fdd\\u62a4\\u5173\\u7cfb\\u7814\\u7a76\", \"\\u4ee5\\u7ec6\\u83cc\\u9b3c\\u5f71\\u4e3a\\u8f7d\\u4f53\\u7684\\u53cc\\u91cd\\u9776\\u5411DNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\\u7b56\\u7565\", \"\\u591a\\u805a\\u4e9a\\u57fa\\u75ab\\u82d7\\u5c42\\u6790\\u4ecb\\u8d28\\u7684\\u8bbe\\u8ba1\\u53ca\\u6027\\u80fd\\u7814\\u7a76\", \"Novel vaccines (vaccibodies) against avian influenza and prostate cancer.\", \"Predictors of rotavirus vaccine virus replication, immune response and clinical protection following oral rotavirus vaccination in Malawian children.\", \"Improved Venezuelan equine encephalitis virus vaccines\", \"EFFIVAVY OF CONSERVED ELEMENT SIV GAG VACCINCE IN CONTROL OF SIVmac239 VIREMIA\", \"BRUCELLOSIS VACCINE, MT\", \"DNA vaccines for aquaculture: Development and testing of plasmid vectors for vaccination against bacterial and viral fish pathogens.\", \"New childhood vaccines for Malawi: Impact of a national pneumococcal and rotavirus vaccine roll-out on child mortality and disease burden, in a region of sub-optimal strain coverage.\", \"New childhood vaccines for Malawi: Impact of a national pneumococcal and rotavirus vaccine roll-out on child mortality and disease burden, in a region of sub-optimal strain coverage.\", \"Development And Production Of Filovirus DNA Plasmid Vaccines\", \"FIELD TRIAL OF KILLED ORAL CHOLERA VACCINES IN VIETNAM\", \"DEVELOPMENT OF AN SRID POTENCY TEST FOR RABIES VACCINE\", \"CONTROL TESTING OF WHOLE CELL AND ACELLULAR PERTUSSIS VACCINES\", \"Development And Production Of Filovirus DNA Plasmid Vaccines\", \"MONOCLONAL ANTIBODY ANTI-IDIOTYPE TUMOR VACCINES\", \"Robust, animal-free cell culture medium for the production of vaccines\", \"OPTIVAX ADJUVANT--IMPROVE INFLUENZA VIRUS VACCINE\", \"Rabies Virus-Based Vectors as an HIV-1 Vaccine\", \"DESIGN AND ANALYSIS OF HIV VACCINE TRIALS\", \"\\u53d1\\u70ed\\u4f34\\u8840\\u5c0f\\u677f\\u51cf\\u5c11\\u7efc\\u5408\\u5f81\\u75c5\\u6bd2\\u65b0\\u578b\\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u5236\\u7684\\u7cfb\\u7edf\\u75ab\\u82d7\\u5b66\\u7814\\u7a76\\u53ca\\u5176\\u5728HIV\\u75ab\\u82d7\\u7814\\u7a76\\u4e2d\\u7684\\u5e94\\u7528\", \"\\u592a\\u7a7a\\u8bf1\\u53d8\\u80bf\\u7624\\u7ec6\\u80de\\u5236\\u5907\\u7624\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"Pan-Provincial Vaccine Enterprise (PREVENT), Saskatoon\", \"CIHR/CHVI Team in HIV Vaccine Design Based on Novel Strategies to Induce Protective Mucosal Cellular and Humoral Immunity\", \"Transcutaneous microsphere vaccine technology\", \"Multiepitopov\\u00e1 syntetick\\u00e1 vakc\\u00edna proti boreli\\u00f3ze pro veterin\\u00e1rn\\u00ed aplikace\", \"Immunization strategies to prevent Zika viral congenital eye and brain disease\", \"The use of inulin-based adjuvants to enhance the effectiveness and population coverage of influenza vaccination\", \"Self Adjuvanting CTL-Based Influenza Vaccines for Human Use\", \"Translational research of therapeutic vaccine to improve the quality of anti-hypertensive therapy\", \"Optimisation of a novel hybrid vaccine for liver fluke disease in cattle\", \"\\u201c\\u6a21\\u62df\\u75c5\\u6bd2\\u201d\\u578b\\u75ab\\u82d7\\u7684\\u4f18\\u5316\\u8bbe\\u8ba1\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"\\u8840\\u5438\\u866b\\u75c5\\u5408\\u6210\\u591a\\u80bd\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u8349\\u539f\\u5154\\u5c3e\\u9f20\\u900f\\u660e\\u5e263\\u57fa\\u56e0\\u75ab\\u82d7\\u514d\\u75ab\\u4e0d\\u80b2\\u7684\\u7814\\u7a76\", \"Novel DNA-Launched Attenuated Vaccine for VEE Virus SBIR Phase II\", \"Avalia\\u00e7\\u00e3o sorol\\u00f3gica de vacina experimental contra a enterotoxemia causada pela toxina \\u00e9psilon do Clostridium perfringens tipo d em caprinos\", \"Development of a Universal Meningococcal Vaccine\", \"Method for manufacture of biodegradable microsphere as matrices for control and stabilisation of aluminium containing vaccine adjuvants\", \"OPTIMIZING THE IMMUNE RESPONSE TO ALUMINUM-CONTAINING VACCINES\", \"IMPROVING THE SAFETY AND EFFICACY OF MAREK`S DISEASE VIRUS VACCINE CANDIDATES EXPRESSING THE MEQ PROTEIN FROM CVI988 VACCINE STRAIN\", \"Development of a Dendritic Cell-targeted Vaccine against AIDS\", \"Study of immunogenicity of DNA HIV-1 env, gag and pol plasmid vaccines boosted with MVA in Tanzania; HIV vaccine immunogenicity study\", \"Novel vaccination strategies and vaccine formulations for epidemic and pandemic influenza control\", \"Food safety screening: synthetic glucocorticoids\", \"Transcutaneous microsphere vaccine technology\", \"Predicting Vaccine escape: Improving strategic vaccine design.\", \"Interaction between live and killed vaccines: effect of DTP combined vaccine on T cell memory after measles vaccination\", \"Production of New Adenovector Constructs with Fiber-Shaft Modifications\", \"Establishment of a Vaccine Pilot Plant\", \"IN VIVO MODELS FOR SUPERANTIGEN VACCINES\", \"Generating Antigen-Specific Immune Memory\", \"Herpes viruses as re-activating Vaccine Vectors: Protective Efficacy of a Varicella Zoster-HIV Vaccine in the SIV Macaque model\\\"\", \"\\u9a6c\\u4f20\\u67d3\\u6027\\u8d2b\\u8840\\u75c5\\u6bd2\\u5f31\\u6bd2\\u75ab\\u82d7\\u682a\\u548c\\u4eb2\\u672c\\u5f3a\\u6bd2\\u682a\\u7684\\u4f53\\u5185\\u8fdb\\u5316\\u53ca\\u5176\\u4e0e\\u514d\\u75ab\\u5e94\\u7b54\\u5173\\u7cfb\\u7814\\u7a76\", \"Role of dendritic cells during vaccine therapy in hepatitis B virus carriers.\", \"Study on the DNA immunization against microbial infection\", \"Development and validation of  delivery technology for  gene based prophylactic vaccines\", \"Development of an outer membrane vesicle vaccine for Africa against serogroup A and W-135 meningococcal disease\", \"Protein thermal stability using amorphous silica\", \"New flexible frameworks for catalysis, energy materials and nanotechnology\", \"Development of A549 cells as a cell substrate for vaccine production\", \"AIDS Vaccine 2005 International Conference.\", \"THE EFFECTS OF DPT VACCINE ON HEPATIC DRUG METABOLISM\", \"Vitrification-stabilized Multivalent Botulinum Vaccines\", \"HIV VACCINE CLINICAL TRIALS UNIT\", \"Development of a non-living subunit rotavirus vaccine\", \"EVALUATION OF LIPOSOME BASED HERPES VACCINES\", \"PEPTIDE SPECIFIC CD8 T CELLS AS MARKER OF VACCINE ACTION\", \"Adenovirus-based Nanoparticle Vaccines\", \"Mechanisms of Mycobacterial Antigen Processing\", \"Augmentation of DNA Vaccine-Elicited Immunity to HIV/SIV\", \"SAPONIN ADJUVANT ENHANCED PNEUMOCOCCAL VACCINE\", \"A concerted european approach towards the development of amalaria vaccine\", \"Prime-boost vaccination using influenza A H5N1 vaccines\", \"Post-trial HIV Vaccines: Receptivity, Risk &Disparities\", \"DEVELOP AND EVALUATE NEW LEPROSY AND TB VACCINES\", \"Attenuated West Nile Virus Live Vaccine for Human Use\", \"Ontology-based Information Network to Support Vaccine Research\", \"Enhancing Australia's pandemic influenza vaccine output by increasing the yeild of vaccine from eggs\", \"Immunopharmacotherapy for Mitigating Opioid Addiction\", \"Pre-Exposure Prophylaxis Against Francisella tularensis\", \"Enhanced Oral Vaccine Delivery Vehicle\", \"Topical Adjuvants to Enhance the Efficacy of Influenza Vaccines\", \"Anthrax DNA vaccine for non-invasive immunization on skin\", \"Pre-Exposure Prophylaxis Against Francisella tularensis\", \"Prophylactic Vaccines for Schistosomiasis\", \"MEASLES VACCINES--IMMUNE RESPONSES AND ATYPICAL MEASLES\", \"Engineering the Lymph Node Environment with Therapeutic Vaccine Depots to Combat Neuroblastoma\", \"Development and evaluation of a knowledge translation strategy to improve influenza immunization rates among pregnant women\", \"Studies on the Development of an Effective Vaccine Against Hepatitis C Virus\", \"\\u57fa\\u4e8e\\u970d\\u4e71\\u6bd2\\u7d20AB5\\u7ed3\\u6784\\u7684\\u4e2a\\u4f53\\u5316\\u81ea\\u7ec4\\u88c5\\u6297\\u764c\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u6c49\\u6ee9\\u75c5\\u6bd2\\u5d4c\\u5408\\u75ab\\u82d7\\uff08VLP/DNA\\uff09\\u7684\\u5236\\u5907\\u53ca\\u5176\\u514d\\u75ab\\u5b66\\u7279\\u6027\\u7684\\u7814\\u7a76\", \"\\u7532\\u809d\\u51cf\\u6bd2\\u6d3b\\u75ab\\u82d7\\u7684\\u6297\\u4f53\\u6301\\u4e45\\u6027\\u4e0e\\u514d\\u75ab\\u8bb0\\u5fc6\\u7814\\u7a76\", \"\\u9a6c\\u7acb\\u514b\\u6c0f\\u75c5\\u2161\\u3001\\u2162\\u578b\\u75c5\\u6bd2(Z4+FC126)\\u514d\\u75ab\\u534f\\u540c\\u673a\\u7406\\u7814\\u7a76\", \"\\u5185\\u8499\\u9521\\u76df\\u4e2d\\u90e8\\u8349\\u539f\\u751f\\u6001\\u7cfb\\u7edf\\u7ed3\\u6784\\u529f\\u80fd\\u751f\\u4ea7\\u529b\\u63d0\\u9ad8\\u9014\\u5f84\\u7814\\u7a76\", \"\\u6c49\\u6ee9\\u75c5\\u6bd2\\u65b0\\u578b\\u75ab\\u82d7--\\u514d\\u75ab\\u589e\\u5f3a\\u578bVLPs\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u3001\\u514d\\u75ab\\u5b66\\u7279\\u6027\\u548c\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u7684\\u7814\\u7a76\", \"\\u4e2d\\u56fd\\u9ad8\\u5371\\u578b\\u4eba\\u4e73\\u5934\\u7624\\u75c5\\u6bd216/58/18\\u5d4c\\u5408\\u75c5\\u6bd2\\u6837\\u9897\\u7c92\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"idMALVAC: Establishing immunological correlates of protection against malaria vaccine candidates using functional bioassays and proteomic deciphering of host-parasite interactions\", \"Development and evaluation of a recombinant porcine adenovirus vaccine for post-exposure protection against Ebolavirus\", \"Immunogenicity of pneumococcal vaccine in liver transplant recipients\", \"\\u9ad8\\u6548\\u8bf1\\u5bfc2\\u578b\\u514d\\u75ab\\u5e94\\u7b54\\u7684\\u964d\\u538b\\u75ab\\u82d7\\u5448\\u9012\\u7cfb\\u7edfCpG ODN-VLP\\u7814\\u7a76\", \"Elicitation of ?4?7-Competitive Antibodies in Rhesus Macaques by a Synthetic V2 Immunogen\", \"Study to investigate the immunogenicity and efficacy of a rVSV-HIVenv Prime, HIV envelope protein boost vaccination regimen and DNA-HIV Prime, rVSV-HIVenv boost vaccination regimen\", \"In Vivo SHIV/SIV Titration via Mucosal Route in Indian-origin Rhesus Macaques\", \"Conduct Study P193: Evaluation of Immune Responses after Priming with Newcastle Disease Virus and Boosting with Trimeric gp145 Proteins from Indian and African Clade C HIV-1 Isolates\", \"\\u57fa\\u4e8e\\u667a\\u80fd\\u5316\\u591a\\u7cd6\\u7eb3\\u7c73\\u51dd\\u80f6\\u7684\\u80bf\\u7624\\u75ab\\u82d7\\u53ca\\u6297\\u80bf\\u7624\\u4f5c\\u7528\\u7814\\u7a76\", \"CEA\\u8054\\u54084-1BBL\\u57fa\\u56e0\\u75ab\\u82d7\\u6297\\u5927\\u80a0\\u764c\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u5e03\\u6c0f\\u83cc\\u51cf\\u6bd2\\u75ab\\u82d7\\u682aM5-90\\u7684bp26\\u86cb\\u767d\\u8868\\u4f4d\\u5206\\u5b50\\u4fee\\u9970\\u4e0e\\u521d\\u6b65\\u514d\\u75ab\\u8bc4\\u4ef7\", \"\\u53cc\\u6297\\u539f\\u53cc\\u9776\\u5411\\u4e73\\u817a\\u764cDNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\\u7b56\\u7565\", \"\\u57fa\\u4e8eBin1b\\u7684\\u96c4\\u6027\\u514d\\u75ab\\u8282\\u80b2DNA\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u5176\\u6548\\u5e94\\u7814\\u7a76\", \"\\u4ee5\\u7ec6\\u83cc\\u83cc\\u5f71\\u4e3a\\u8f7d\\u4f53\\u7684\\u65b0\\u578b\\u6dcb\\u75c5\\u5948\\u745f\\u83cc\\u9776\\u5411\\u9ecf\\u819c\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"Preclinical Crimean Congo Haemorraghic Fever Vaccine Development\", \"Conduct Study P193: Evaluation of Immune Responses after Priming with Newcastle Disease Virus and Boosting with Trimeric gp145 Proteins from Indian and African Clade C HIV-1 Isolates\", \"DISCOVERY OF PROTECTIVE ANTIGENS FOR NOVEL JOHNE'S DISEASES VACCINES\", \"Development of novel Norovirus vaccines using virus vector\", \"Development of adjuvant-combined nasal influenza vaccine\", \"Conduct Study P193: Evaluation of Immune Responses after Priming with Newcastle Disease Virus and Boosting with Trimeric gp145 Proteins from Indian and African Clade C HIV-1 Isolates\", \"Manipulation of particulate vaccine delivery vehicles to target dendritic cells\", \"\\u8349\\u539f\\u5154\\u5c3e\\u9f20\\u5375\\u900f\\u660e\\u5e263DNA\\u75ab\\u82d7\\u7c98\\u819c\\u514d\\u75ab\\u53ca\\u9975\\u6599\\u91ca\\u653e\\u6548\\u679c\\u7684\\u7814\\u7a76\", \"L-rhamnose\\u4fee\\u9970\\u5bf9\\u80bf\\u7624\\u76f8\\u5173\\u7cd6\\u6297\\u539f\\u75ab\\u82d7\\u6548\\u5e94\\u7684\\u5f71\\u54cd\", \"\\u8f6c\\u57fa\\u56e0\\u7403\\u866b\\u6fc0\\u53d1\\u9e21\\u6297\\u79bd\\u6d41\\u611f\\u7684\\u4fdd\\u62a4\\u6027\\u7c98\\u819c\\u514d\\u75ab\\u5e94\\u7b54\\u673a\\u5236\", \"\\u4e59\\u8111\\u75c5\\u6bd2\\u57fa\\u56e0\\u7ec4\\u591a\\u533a\\u6bb5\\u6784\\u5efaDNA\\u75ab\\u82d7\\u589e\\u5f3a\\u6548\\u5e94\\u4e3b\\u8981\\u73af\\u8282\\u7814\\u7a76\", \"\\u5e7d\\u95e8\\u87ba\\u6746\\u83cc\\u76ca\\u751f\\u83cc\\u578b\\u53e3\\u670d\\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u844e\\u8349\\u82b1\\u7c89\\u4e3b\\u8981\\u53d8\\u5e94\\u539f\\u6838\\u9178\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u80a0\\u9053M\\u7ec6\\u80de\\u9776\\u5411\\u53e3\\u670d\\u80bf\\u7624\\u7eb3\\u7c73\\u4e73\\u5242\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u8054\\u5408\\u5e94\\u7528\\u5355\\u78f7\\u9178\\u9170\\u8102\\u8d28\\uff08MPL\\uff09\\u7684WapA\\u9632\\u9f8bDNA\\u75ab\\u82d7\\u589e\\u5f3a\\u7c98\\u819c\\u514d\\u75ab\\u53cd\\u5e94\\u7684\\u6548\\u5e94\\u53ca\\u5176\\u673a\\u5236\\u7814\\u7a76\", \"Vacinas de DNA contra Streptococcus pneumoniae: avalia\\u00e7\\u00e3o do ant\\u00edgeno pneumolisina e de interleucinas\", \"GeMI-Vax as a multi-life stage  malaria vaccine\", \"Optimized second-generation recombinant mycobacteria vaccine vectors against HIV\", \"Market viability of ImmBioVax vaccines against H. Pylori and C. Difficile\", \"DNA VACCINES FOR BRUCELLA\", \"BRUCELLOSIS VACCINE, MT\", \"''BRUCELLOSIS VACCINE, MT''\", \"Methods for Safety Evaluation of Vaccination Schedules\", \"Immunogenicity and protective efficacy of intranasal delNS1(H5N1) influenza vaccine\", \"Developing a novel single dose prime-boost vaccine against malaria\", \"Developing a novel single dose prime-boost vaccine against malaria\", \"Wellcome Trust Clinical PhD Programme, University of Liverpool 'Health Priorities in the Developing World'\", \"SBIR Phase I: A New Vaccine Development Method\", \"Development/production of universal influenza vaccines\", \"Establishment and operation of a Vaccine Pilot Plant\", \"Marburg Vaccine Development\", \"MOLECULAR TEST FOR REVERTANT MUTATIONS IN LIVE VIRUS VAC\", \"DEVELOPMENT OF AN SURID POTENCY TEST FOR RABIES VACCINE\", \"DEVELOPMENT OF TESTS FOR ACELLULAR PERTUSSIS VACCINES\", \"Marburg Vaccine Development\", \"Malaria Vaccine:  AMA1-rEPA\", \"Malaria Vaccine:  AMA1-C1/ISA 720\", \"Malaria Vaccine:  BSAM\", \"Malaria Vaccine: AMA1-C1\", \"Smallpox subunit vaccine in the C-PERL expression system\", \"Alphavirus Replicon Vaccines against Influenza\", \"Chimeric yellow fever 17D/Dengue vaccines\", \"IMMUNE AND BIOLOGICAL STRATEGIES FOR AIDS VACCINES\", \"Generation of bPIV3-vectored PIV and RSV Vaccines\", \"Development of a VEEV, WEEV, EEEV DNA Vaccine Delivered by Electroporation\", \"NEW CONJUGATE VACCINE FOR GRAM NEGATIVE SEPSIS\", \"Vaccine enhancement through antigen targeting\", \"T-Cell Vaccine-A Clinical Trail for Progressive MS\", \"SYSTEMATIC APPROACH TO VACCINES FOR RETROVIRAL DISEASES\", \"\\u58f3\\u805a\\u7cd6-\\u67b8\\u675e\\u591a\\u7cd6\\u5fae\\u7c92\\u5e7d\\u95e8\\u87ba\\u65cb\\u6746\\u83cc\\u75ab\\u82d7Hp-WAE\\u7684\\u6cbb\\u7597\\u4f5c\\u7528\\u53ca\\u673a\\u5236\\u7814\\u7a76\", \"The next generation of vaccines: characterization of virus-like particle (VLP) vaccines made in plants.\", \"Improvement of a cattle vaccine against Escherichia coli serotype O157:H7\", \"\\u60aa\\u6027\\u9ed2\\u8272\\u816b\\u306b\\u5bfe\\u3059\\u308bcalreticulin/TRP-2DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"GENE GUN-MEDIATED INOCULATION OF ORIENTED DNA VACCINES AGAINST AN INTRACELLULAR PATHOGEN\", \"Molecular Assembly and Stability of Human Hepatitis B Virus Surface Antigen Vaccine\", \"\\u56ca\\u5c3e\\u86b4\\u75c5\\u591a\\u671f\\u590d\\u5408\\u57fa\\u56e0\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"Adjuvants and Glucan Particle Vaccines\", \"Study of Monophosphoril lipid A, from Bordetella pertussis LPS, mechanisms as Influenza vaccine adjuvant\", \"Identification of vaccine candidates using reverse vaccinology\", \"Improved vaccines for Bluetongue Disease\", \"The European malaria vaccine development association\", \"Ration design and standardized evaluation of novel genetic vaccines.\", \"Novel antigen-adjuvant vehicle as an effective influenza vaccine\", \"A Game Theoretic Approach to Pediatric Vaccine Pricing\", \"ARRA: Animal Model Support of Universal Influenza Vaccine\", \"Enhanced Surveillance: New Vaccine Preventable Diseases\", \"Preclinical development of a chimeric tetravalent dengue vaccine\", \"Novel nanotechnology based oral influenza vaccines\", \"Vaccine-induced CD8+ T cell memory\", \"Innovative Single-Dose Hepatitis B Vaccine Formulation\", \"A novel vaccine: botulinum neurotoxin subunit on a viral carrier.\", \"Immunotherapy after ASCT for MM Using hTERT Vaccination + Vaccine-primed T cells\", \"Universal T cell targeted influenza vaccine\", \"SPECIFIC IMMUNOTHERPY OF CANCER WITH VACCINES\", \"Developing a Novel Mumps Virus Vaccine\", \"Improved Vaccines for Rift Valley Fever Virus\", \"HIV and SIV Vaccines and Mucosal Immunity\", \"MAO/EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE MOD\", \"MAO/EVALUATION OF AIDS VACCINES\", \"MAO/EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE\", \"EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE MODELS\", \"MAO/EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE\", \"MAO/EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE\", \"EVALUATION OF RECOMBINANT BCG/SIV VACCINES\", \"EVALUATION OF AIDS VACCINES IN NON-HUMAN PRIMATE\", \"Multitarget-Display Viruslike Particle-Based Vaccine to Combat Lyme Disease\", \"Conjugate Vaccines to Prevent Shigellosis\", \"\\u57fa\\u4e8ecDNA\\u8868\\u8fbe\\u5e93\\u68af\\u7ea7\\u7ec4\\u5206\\u514d\\u75ab\\u9ad8\\u901a\\u91cf\\u7b5b\\u9009\\u6297\\u5185\\u810f\\u5229\\u4ec0\\u66fc\\u75c5\\u75ab\\u82d7\\u5019\\u9009\\u5206\\u5b50\", \"\\u9e21\\u7403\\u866b\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u523a\\u6fc0\\u6027\\u6297\\u539f\\u7684\\u786e\\u5b9a\\u53ca\\u5176\\u5e94\\u7528\", \"Enhancing the Immunogenicity of a Dengue-2 DNA Vaccine with Adjuvants and Anti-FC and RI Antibodies\", \"Androgen Deprivation as an Immunomodulatory Therapy in Combination with DNA Vaccines for the Treatment of Prostate Cancer\", \"DEVELOPING A PARAINFLUENZA VIRUS 5 (PIV5)-BASED PRRSV VACCINE\", \"Emerging Viral Vaccine Antigen Insert Consortium (EVAC)\", \"The use of CpG adjuvants, bio-degradable microparticles, and microneedle technology for the design of novel single-dose vaccines\", \"Ultra-low dose Influenza vaccines\", \"Etec Epidemiology And Vaccine Research In Lower Egypt\", \"Assessment of the Immunogenicity and Protective Efficacy of a Multiagent DNA Vacc\", \"THERAPEUTIC TB VACCINE\", \"Ad4 vectored HIV-Env vaccines with improved immunogenicity\", \"Development of Multivalent Vaccines Against Yellow Fever and Arena Viruses\", \"Adjuvants for Agile Vaccine Development\", \"MOLECULAR APPROACHES TO HUMAN VIRAL VACCINES\", \"Vaccine-induced HIV antibody responses in infants\", \"POLYVALENT VACCINE IN IL-2+GM-CSF LIPOSOMES FOR MELANOMA\", \"Cell-based tumor vaccines targeting CD4+ T lymphocytes\", \"Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine\", \"Boosting Flu Vaccination without Adjuvant Injection\", \"DEVELOPMENT OF ROTAVIRUS DNA VACCINES\", \"Genetic Vaccines Against HIV Mutants\", \"CLINICAL EFFICACY OF PNEUMOCOCCAL VACCINE IN THE ELDERLY\", \"Interaction between conventional cancer therapy and gene-based cancer vaccines\", \"Passively Regulated Cryogenic (PaRC) Vial System for Vaccine Distribution and Administration\", \"\\u65b0\\u578b\\u80f6\\u8d28\\u7624\\u590d\\u5408\\u6297\\u539fDC\\u75ab\\u82d7\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u7684\\u529f\\u80fd\\u7814\\u7a76\", \"ATRQ\\u03b2-001\\u75ab\\u82d7\\u901a\\u8fc7AT1R/APJ\\u5f02\\u4e8c\\u805a\\u5316\\u6297\\u8840\\u7ba1\\u91cd\\u6784\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u4e59\\u578b\\u809d\\u708e\\u75c5\\u6bd2\\u8868\\u9762\\u6297\\u539f\\u57fa\\u56e0\\u514d\\u75ab\\u7684\\u7814\\u7a76\", \"\\u589e\\u5f3aHIV\\u75ab\\u82d7\\u8bf1\\u5bfc\\u514d\\u75ab\\u5e94\\u7b54\\u7b56\\u7565\\u7684\\u63a2\\u8ba8\", \"Phase 2 Study of a Live Attenuated Measles Virus-Vectored Chikungunya Vaccine in Previously Exposed Versus Unexposed Adults Ages 51 to 65\", \"Prophylactic HIV Vaccines for Social Networks of Injection Drug Users\", \"\\u9776\\u5411DC\\u7684FSHR\\u975e\\u75c5\\u7406\\u8868\\u4f4d\\u7684\\u65b0\\u578b\\u907f\\u5b55\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u53ca\\u6548\\u5e94\\u7814\\u7a76\", \"O157\\u591a\\u7cd6\\u86cb\\u767d\\u75ab\\u82d7\\u7684\\u7cd6\\u94fe\\u6570\\u76ee\\u53ca\\u957f\\u5ea6\\u6700\\u4f73\\u914d\\u6bd4\\u7814\\u7a76\", \"Can a pneumococcal H. influenzae protein D conjugate vaccine (PHiD-CV) reduce the frequency of NTHi infection in the lower airway (defined by >10E4 cfu/ml bronchoalveolar lavage) and upper airway (nasopharynx) colonisation of children with chronic suppurative lung disease?\", \"Using VacSIM Delivery to Enhance Malaria Vaccine Efficacy\", \"Using VacSIM Delivery to Enhance Malaria Vaccine Efficacy\", \"V\\u00fdvoj unik\\u00e1tn\\u00edch vakc\\u00edn proti z\\u00e1va\\u017en\\u00fdm onemocn\\u011bn\\u00edm zv\\u00ed\\u0159at\", \"Vaccine microencapsulation for single dose delayed release delivery.\", \"Desenvolvimento nacional de vacina para a preven\\u00e7\\u00e3o de doen\\u00e7a reum\\u00e1tica card\\u00edaca\", \"In vivo induced Bacterial Ghosts from live attenuated bacter\", \"Evaluation of hypertension vaccine using pig model\", \"Development of the novel technique intended to the prophylaxis and treatment of neglected tropical diseases\", \"Development of next generation transdermal vaccine for cancer treatment\", \"Development of a novel vaccine to control virulent strains of Marek's disease virus: enhancement of vaccine efficacy by modulating the host immunosuppression pathway\", \"Basic study for development of a novel anti-tuberculosis vaccine using magnetite nanoparticles\", \"Development of safety vaccine using spleen- and dendritice cells-targeted nano device\", \"Comparative study on differences between  polio and vaccine-derived polio\", \"Development of the transcutaneous influenza vaccine formulation using an self-dissolving microneedle patch\", \"Development of a new type of anti-tuberculosis vaccines by the use of lipid immunity\", \"Basic research of the antigen delivery system that it aimed at the optimization of the DNA vaccine for cancer prevention\", \"Superantigen pulsed DCs supports the induction of tumor immunity\", \"The study of the mechanism of therapeutic efficacy of novel vaccines on Tuberculosis-infection and the induction of cytotoxic T cells by the vaccines\", \"Dynamics of circulating rotavirus strains after vaccine introduction in Brazil.\", \"Targeting cancer vaccines to human dendritic cells via CD301\", \"Development of a live vaccine for gut health in poultry\", \"\\u8bc4\\u4ef7\\u9cd7\\u5f27\\u83cc\\u51cf\\u6bd2\\u6d3b\\u75ab\\u82d7\\u4f53\\u5185\\u514d\\u75ab\\u6548\\u529b\\u7684\\u65b0\\u65b9\\u6cd5\", \"\\u95f4\\u65e5\\u759f\\u539f\\u866b\\u4f20\\u64ad\\u963b\\u65ad\\u75ab\\u82d7\\u5019\\u9009\\u86cb\\u767dPvs25\\u548cPvs28\\u75ab\\u82d7\\u6548\\u679c\\u7684\\u7814\\u7a76\", \"\\u72ac\\u6297\\u7ec6\\u7c92\\u68d8\\u7403\\u7ee6\\u866b\\u611f\\u67d3\\u7684\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7814\\u7a76\", \"\\u5149\\u52a8\\u529b\\u5b66\\u80bf\\u7624\\u75ab\\u82d7\\u6cbb\\u7597\\u548c\\u9884\\u9632\\u4e0a\\u76ae\\u6027\\u5375\\u5de2\\u764c\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u65e5\\u672c\\u8840\\u5438\\u866b\\u75c5\\u75ab\\u82d7\\u53d1\\u5c55\\u7b56\\u7565\\u7814\\u7a76\\uff1a\\u8f90\\u7167\\u81f4\\u5f31\\u5c3e\\u86b4\\u8bf1\\u5bfc\\u9ad8\\u4fdd\\u62a4\\u6027\\u6548\\u5e94\\u673a\\u7406\\u7684\\u5206\\u5b50\\u514d\\u75ab\\u5b66\\u8bc4\\u4ef7\", \"\\u58f3\\u805a\\u7cd6\\u7eb3\\u7c73\\u7c92\\u88c5\\u8f7dHP BabA2/UreI\\u57fa\\u56e0\\u53cc\\u4ef7\\u9ecf\\u819cDNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"Use of a Novel Parent-Report Measure to Improve Childhood Vaccine Uptake\", \"Entwicklung eines Impfstoffs gegen Tuberkulose basierend auf Kohlenhydraten\", \"Development of novel vaccine candidates to prevent primary or reactivated tuberculosis\", \"Development of novel vaccine candidates to prevent primary or reactivated tuberculosis\", \"Conjugated vaccines: from the laboratory to pilot scale 3\", \"Use of nanoparticles in vaccines against bacterial meningitis\", \"Malarial Vaccines Utilizing Antigen/Adjuvant Display on Viral-Like Particles\", \"Development of autogenous vaccines for the control of amoebic gill disease in farmed salmon\", \"Development of a defective live virus vaccine against porcine reproductive and respiratory syndrome.\", \"Investigations of polyphosphazenes as adjuvants for mucosal vaccines\", \"EVALUATING EFFICACY OF A NOVEL BVDV MULTI-ANTIGEN VACCINE\", \"HIV Vaccine Trial Preparedness: Socio-behavioural Challenges of HIV Vaccine Development\", \"Tablet Vaccines\", \"Low cost, broadly efficacious Pneumococcal vaccine\", \"RECOMBINANT VACCINES FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME\", \"Vaccination against the viral haemorrhagic septicaemia: comparison between a live attenuated virus, a preparation of killed virus and a genetically engineered subunit vaccine\", \"Flu vaccine for heterosubtypic protection.\", \"Exploiting plant synthetic biology for the production of glycoproteins in plant chloroplasts.\", \"Malaria Vaccine:  AMA1-C1/ISA 720\", \"PEPTIDE POLYMERS AS VACCINE CANDIDATES\", \"San Francisco Vaccine and Prevention Unit\", \"LIVE VIBRIO CHOLERA AS AN ORAL SIV VACCINE VECTOR\", \"MUCOSAL VACCINE DELIVERY SYSTEMS\", \"Novel Prophylactic HIV Vaccines Based on rAAV Vectors\", \"CENTRAL IMMUNOLOGY LAB FOR AIDS VACCINE CLINICAL TRIALS\", \"DEVELOP LIVE ATTENUATED COLD-ADAPTED INFLUENZA VACCINE\", \"PARAGONE: vaccines for animal parasites\", \"Developing a Novel Modular Nanoparticle Vaccine Strategy to Induce Durable Systemic and Mucosal HIV Envelope Specific Antibodies\", \"\\u57fa\\u4e8e\\u8ba1\\u5212\\u884c\\u4e3a\\u7406\\u8bba\\u7684HPV\\u75ab\\u82d7\\u652f\\u4ed8\\u610f\\u613f\\u4e0e\\u9700\\u6c42\\u9884\\u6d4b\\u7814\\u7a76\", \"CART\\u57fa\\u56e0\\u75ab\\u82d7\\u5728\\u5417\\u5561\\u4f9d\\u8d56\\u548c\\u590d\\u5438\\u4e2d\\u7684\\u4f5c\\u7528\\u53ca\\u5176\\u795e\\u7ecf\\u673a\\u5236\", \"Isolation of unique coccidial antigens for coccidial vaccine development\", \"Evaluation and optimisation of paediatric vaccination programs in Australia and the region\", \"Enhancing the immune response to disordered malaria antigens\", \"Mucosal human immunodeficiency virus vaccine late pre-clinical evaluation\", \"Quantifying the effectiveness of pertussis vaccine in older adults\", \"Understanding immune memory diversity\", \"Viral entry and the development of vaccines.\", \"Group A streptococcal human challenge study: accelerating vaccine development\", \"Improving Therapeutic Delivery by Understanding Nanoparticle Interactions with Cells\", \"Strategies to reduce the burden of gastroenteritis in Aboriginal children.\", \"Virus-like-particles for vaccines produced in plants:  immunologic and structural characterization\", \"Long-term preservation of a whole parasite malaria vaccine for storage and delivery in the tropics\", \"Needle-free vaccines for respiratory viruses\", \"Understanding the unusual effectiveness of Virus-Like Particle (VLP) vaccines made in plants\", \"Parents, Daughters, and the HPV Vaccine: Factors Affecting Parental Decision-Making in a Universal Immunization Program\", \"Discovery of new B cell immunogens for HIV vaccines\", \"Community Engagement in HIV Vaccine Research: Advancing HIV Vaccine Trial Preparedness among Men who have Sex with Men in India\", \"Evaluation of viral sensitizer technology in improving egg-based influenza vaccine manufacturing processes\", \"Randomized phase II study of adjuvant WT-1 analog peptide vaccine in patients with malignant pleural mesothelioma after completion of combined modality therapy.\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine Treatment and Evaluation Unit\", \"IGF::OT::IGF TESTING OF COMBINATION IMMUNO AND CHEMOPREVENTION STRATEGIES FOR LYNCH SYNDROME GASTROINTESTINAL CANCER\", \"IGF::OT::IGF A PILOT STUDY OF MUC1 VACCINE IN CURRENT AND FORMER SMOKERS AT HIGH RISK FOR LUNG CANCER\", \"Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever\", \"VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES\", \"Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)\", \"Novel Innate Immune Adjuvant for Avian Influenza. West Nile Virus, and ZIKA Vaccines\", \"Development of Adjuvant with Vaccines for Tuberculosis and Shigellosis\", \"Development of badger vaccines\", \"Novel multivalent vaccines against haemorrhagic fevers\", \"Viral attenuation and pathogenesis\", \"*V\\u00fdvoj vakc\\u00edny k zabr\\u00e1n\\u011bn\\u00ed p\\u0159enosu kl\\u00ed\\u0161\\u0165aty p\\u0159en\\u00e1\\u0161en\\u00fdch n\\u00e1kaz na b\\u00e1zi Ferritinu-2 pro veterin\\u00e1rn\\u00ed a hum\\u00e1nn\\u00ed pou\\u017eit\\u00ed.\", \"Imunoterapie chronick\\u00e9 myeloidn\\u00ed leukemie: v\\u00fdvoj a testov\\u00e1n\\u00ed experiment\\u00e1ln\\u00edch vakc\\u00edm v my\\u0161\\u00edm syst\\u00e9mu a imunologick\\u00e1 studie pacient\\u016f\", \"Kombinovan\\u00e9 vakc\\u00edny s imunomodula\\u010dn\\u00edmi \\u00fa\\u010dinky v prevenci a l\\u00e9\\u010db\\u011b infekc\\u00ed a imunodeficienc\\u00ed\", \"V\\u00fdvoj vektor\\u016f, nosi\\u010d\\u016f a adjuvans pro konstrukci DNA vakc\\u00edn\", \"\\u30ca\\u30c1\\u30e5\\u30e9\\u30eb\\u30da\\u30d7\\u30c1\\u30c9\\u306e\\u7db2\\u7f85\\u7684\\u89e3\\u6790\\u306b\\u3088\\u308b\\u53e3\\u8154\\u304c\\u3093\\u5e79\\u7d30\\u80de\\u7279\\u7570\\u7684\\u518d\\u767a\\u4e88\\u9632\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Formulation of ultrasmall vaccine nanoparticles\", \"Evaluation of highly immunogenic tumor cell vaccines in combination with regulatory T-cell depletion\", \"A phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine.\", \"Molecular characterisation of the dendritic cell receptor Clec9a and its ligand interactions\", \"Assessing vaccine effectiveness of publicly funded vaccination programs in Queensland\", \"Developing a safe vaccine against group A streptococci\", \"Antibody-Dependent Cellular Cytotoxicity based immunity to Influenza\", \"Generating an effective vaccine response against the intrinsically unstructured malaria antigen Merozoite Surface Protein 2\", \"Development of Carbohydrate Based Self-adjuvanting Vaccine Delivery System\", \"Nanoparticle Vaccines for HIV\", \"Preclinical studies of group A streptococcal vaccine candidates\", \"HIV and HCV Vaccines and Immunopathogenesis.\", \"Optimising immunity towards cancers by vaccination.\", \"Pre-clinica evaluation of a novel HIV-1 vaccine statrgy\", \"Comparative effectiveness of vaccine-induced SIV-specific CD8 T cells\", \"Prophylactic vaccine to prevent cytomegalovirus disease\", \"Immunological Prevention of Cysticercosis and Hydatid Disease\", \"Population genomics of Plasmodium falciparum surface antigen genes\", \"A study to investigate alternative regimens for pneumococcal vaccination of infants in a developing country\", \"Entrapment and deletion of melanoma-specific T cells at vaccination sites\", \"VTEU: Phase I Influenza Vaccine Clinical Trial\", \"VTEU: Phase I Malaria Vaccine Clinical Trial\", \"Development of Adjuvant with Vaccines for Tuberculosis and Shigellosis\", \"Novel Innate Immune Adjuvant for Avian Influenza and West Nile Virus Vaccines\", \"VTEU: Shigella Vaccine Trial\", \"VTEU: Phase I Malaria Vaccine Study\", \"Assay Work for Malaria Vaccines - VTEU\", \"VTEU: Assay Work for Influenza Vaccines\", \"VTEU: Assay Work for Yellow Fever Vaccines\", \"Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)\", \"DEVELOPMENT OF AD-VECTORED VACCINES INDUCING BROAD IMMUNITY TO SWINE INFLUENZA\", \"Development of cancer peptide vaccine that can induce tumor-specific CTLs and Th cells.\", \"Development of Nasal Vaccine agaisnt RS virus based on neonatal innate immunity\", \"Identification of the antibody induced by the new vaccine against Alzheimer's diseasese induces\", \"Development of novel vaccine against tuberculosis using recombinant BCG expressing SOCS1 antagonist\", \"Development of macrophage migration inhibitory factor DNA vaccine against inflammatory ocular disease\", \"Development of immunotherapy for hepatocellular carcinoma by peptide vaccine\", \"Development of a tailor-made type of cancer vaccine treatment\", \"Search for immunopotentiating adjuvants in cancer vaccine therapy for gynecologic malignancies\", \"The creation and safety assessment of cytokine adjuvant and nano-carrier for mucosal vaccine\", \"Establishment of a novel vaccine against Mycobacterium tuberculosis employing carbohydrate-coated liposomes\", \"Construction of influenza virosome and its development to preparation of vaccine\", \"The study of DNA vaccine potency against hamster oral papillomavirus-associated oral cancer\", \"\\u30af\\u30ed\\u30b9\\u30c8\\u30ea\\u30b8\\u30a6\\u30e0\\u30fb\\u30c7\\u30a3\\u30d5\\u30a3\\u30b7\\u30eb\\u611f\\u67d3\\u75c7\\u306b\\u5bfe\\u3059\\u308bDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u3068\\u5fdc\\u7528\", \"\\u7d4c\\u9f3b\\u6295\\u4e0e\\u578b\\u30ea\\u30dd\\u30bd\\u30fc\\u30e0\\u30ef\\u30af\\u30c1\\u30f3\\u3092\\u7528\\u3044\\u305f\\u65b0\\u898f\\u975e\\u4fb5\\u8972\\u6027\\u5b50\\u5bae\\u9838\\u304c\\u3093\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Induction of vaccine-elicited T cell responses by non-natural amino acids\", \"\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u7c98\\u819c\\u514d\\u75ab\\u8a98\\u5c0e\\u53ef\\u80fd\\u306aprime/boost\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Fundamental study on delivery system of DNA vaccine-embedded CPH nanoparticles for cancer prevention using oral mucosa\", \"The prophylactic effect of IL-17A DNA vaccine on arthritis\", \"Developmental research of new generation DNA vaccine against microorganism using synthesized DNA\", \"\\u897f\\u30ca\\u30a4\\u30eb\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u30ef\\u30af\\u30c1\\u30f3\\u8a66\\u4f5c\\u3068\\u305d\\u306e\\u8a55\\u4fa1\", \"Development of mucosal vaccines for prevention of prevention of respiratory infectious diseases\", \"\\u514d\\u75ab\\u8abf\\u7bc0\\u907a\\u4f1d\\u5b50\\u3068\\u306e\\u30d5\\u30e5\\u30fc\\u30b8\\u30e7\\u30f3DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u7d30\\u80de\\u5185\\u5bc4\\u751f\\u539f\\u866b\\u611f\\u67d3\\u5236\\u5fa1\\u306e\\u65b0\\u6226\\u7565\", \"\\u4e8c\\u672c\\u9396RNA\\u3092\\u7528\\u3044\\u305f\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u4f75\\u7528\\u7d4c\\u9f3b\\u4e0d\\u6d3b\\u5316\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Immunopotentiation by immunoadjuvants of human viral vaccines\", \"Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)\", \"Assay Work for Influenza Vaccines - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Phase 1 Malaria Vaccine Trial  - VTEU\", \"Assay Work for Yellow Fever Vaccines - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Phase I Malaria Vaccine Clinical Trial - VTEU\", \"Assay Work for Plague Vaccines - VTEU\", \"Assay Work for Herpes Vaccines - VTEU\", \"Assay Work for Influenza Vaccines - VTEU\", \"Assay Work for TB Vaccines - VTEU\", \"Assay Work for Malaria Vaccines - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Phase I Trial of Tuberculosis Vaccine - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Phase I Malaria Vaccine Study - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Respiratory Syncytial Virus: Diagnostic and Vaccine Assays  - VTEU\", \"Assay Work for Yellow Fever Vaccines - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Phase I Trial of Filovirus Vaccine  - VTEU\", \"Assay Work for Malaria Vaccines - VTEU\", \"Vaccine and Treatment Evaluation Unit\", \"Vaccine and Treatment Evaluation Unit\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine Treatment and Evaluation Unit\", \"Vaccine and Treatment Evaluation Unit\", \"IGF::OT::IGF TESTING OF COMBINATION IMMUNO AND CHEMOPREVENTION STRATEGIES FOR LYNCH SYNDROME GASTROINTESTINAL CANCER\", \"Zika: a safe recombinant vaccine with proof of efficacy in rodents\", \"\\u6297\\u52a8\\u8109\\u7ca5\\u6837\\u786c\\u5316DNA\\u75ab\\u82d7/\\u58f3\\u805a\\u7cd6\\u7eb3\\u7c73\\u7c92\\u9f3b\\u8154\\u7ed9\\u836f\\u7684\\u7814\\u7a76\", \"\\u6c49\\u5766\\u75c5\\u6bd2\\u706d\\u6d3b\\u75ab\\u82d7\\u7ecf\\u547c\\u5438\\u9053\\u7c98\\u819c\\u514d\\u75ab\\u7684\\u7814\\u7a76\", \"\\u7eb3\\u7c73\\u7c92\\u5b50\\u4f5c\\u4e3a\\u8840\\u5438\\u866b\\u75c5\\u75ab\\u82d7\\u4f50\\u5242\\u7684\\u5e94\\u7528\\u7814\\u7a76\", \"Yuji Sato | National Institutes of Health - Jap\\u00e3o\", \"Produ\\u00e7\\u00e3o de vacina de DNA recombinante para o v\\u00edrus dengue-3\", \"Vacinas conjugadas: da bancada para escala piloto - 2\", \"Development of an innovative sub-unit vaccine against toxoplasmosis\", \"STAGED VACCINE DEVELOPMENT: IMMUNOPROPHYLAXIS BY GENE TRANSFER\", \"Development of Inulin Acetate-Based Adjuvant\", \"Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)\", \"Vaccine and Treatment Evaluation Units\", \"Respiratory Syncytial Virus: Diagnostic and Vaccine Assays  - VTEU\", \"Vaccine and Treatment Evaluation Units\", \"Phase 1 Malaria Vaccine Trial  - VTEU\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Phase I Trial of Tuberculosis Vaccine - VTEU\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Respiratory Syncytial Virus: Diagnostic and Vaccine Assays  - VTEU\", \"Phase IIb Pneumococcal Conjugate Vaccine Trial - VTEU\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Safety and Immunogenicity of Shigella Vaccines - VTEU\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Unit\", \"PROSTAGLANDIN PRODUCTION DURING ORTHOPOXVIRUS INFECTIONS\", \"DEVELOPMENT OF IMPROVED VACCINES AGAINST AVIAN PATHOGENS AND POULTRY BORNE FOOD SAFETY TARGETS\", \"Establishment, Strategy and Initial activities of the TuBerculosis Vaccine Initiative : Coordination of European efforts with global research initiatives\", \"An Integrated project for the design and testing of vaccine candidates against tuberculosis: Identification, development and clinical studies\", \"A european malaria vaccine development consortium: euromalvac 1\", \"European Vaccine against AIDS: Centralised facility\", \"New methods for the chemical synthesis of a library of glycopeptide-based tri-component cancer vaccines\", \"Targeting neutralizing epitopes in the MPER of HIV Env\", \"DEVELOPMENT OF DETOXIFIED PERTUSSIS TOXIN FOR ACELLULAR WHOOPING COUGH VACCINE\", \"Vaccinia-based Smallpox Vaccine Safety\", \"Malaria Vaccine:  AMA1-C2\", \"HIV Vaccine Research and Development\", \"HIV Vaccine Research and Development\", \"Enhanced Surveillance for New Vaccine Preventable Disease\", \"Enhanced Surveillance-Newly Vaccine Preventable Diseases\", \"Self-administered microneedle patches for influenza vaccines\", \"Pandemic influenza DNA vaccine Development\", \"Comparative Study of Influenza Vaccines in Adults\", \"A Novel Cassette System for the Assembly of VLP Vaccines\", \"An Adenoviral-Based Mucosal Vaccine for AIDS\", \"Combined TNFSF and TLR stimulation of HIV vaccines\", \"Efficacy of soybean-based vaccines using a model antigen\", \"Animal models to design &evaluate improved VZV vaccines\", \"NEW LIVE VIRAL VECTORS AS CANDIDATE AIDS VACCINES\", \"Task 13/C26: Influenza Challenge Models and Assays for Influenza Vaccines\", \"Vaccine and Treatment Evaluation Units (VTEUs)\", \"Human methamphetamine vaccine:  Translational Avante Garde Award\", \"Assessing Safety of Cell Substrates and Vaccine Components\", \"Evaluation of Anti-Poliovirus Drugs and Vaccines\", \"Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)\", \"Development of a Nanoemulsion Adjuvant with a Vaccine for Pandemic Influenza\", \"VACCINE AND TREATMENT EVALUATION UNITS (VTEUS)\", \"Novel Innate Immune Adjuvant for Avian Influenza and West Nile Virus Vaccines\", \"VACCINE AND TREATMENT EVALUATION UNITS (VTEUS)\", \"Development of Adjuvant with Vaccines for Tuberculosis and Shigellosis\", \"VACCINE AND TREATMENT EVALUATION UNITS (VTEU)\", \"VACCINE TREATMENT AND EVALUATION UNITS (VTEU)\", \"VACCINE AND TREATMENT EVALUATION UNITS (VTEU)\", \"Vaccine and Treatment Evaluation Units (VTEUs)\", \"Vaccine and Treatment Evaluation Units (VTEUs)\", \"VACCINE AND TREATMENT EVALUATION UNITS (VTEU)\", \"VACCINE TREATMENT EVALUATION UNITS (VTEUS)\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"Development of Technologies to Facilitate the use and Response of Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"Development of Technologies to Facilitate the Use of and Response to Vaccines\", \"THERAPEUTIC IMMUNIZATION AGAINST HIV WITH ADJUVANT-ENHANCED DNA AND MULTI-EPITOP\", \"THERAPEUTIC IMMUNIZATION AGAINST HIV WITH ADJUVANT-ENHANCED DNA AND MULTI-EPITOP\", \"THERAPEUTIC IMMUNIZATION AGAINST HIV WITH ADJUVANT-ENHANCED DNA AND MULTI-EPITOP\", \"THERAPEUTIC IMMUNIZATION AGAINST HIV WITH ADJUVANT-ENHANCED DNA AND MULTI-EPITOP\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUTION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"VACCINE AND TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"VACCINE AND EVALUATION TREATMENT UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"VACCINE TREATMENT EVALUATION UNITS\", \"VACCINE TREATMENT EVALUATION UNITS\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Unit\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Units\", \"Vaccine and Treatment Evaluation Unit\", \"SBIR TOPIC 255, PHASE II: SYNTHETIC VACCINES AGAINST PROSTATE CANCER\", \"Colloquium on protecting public trust in immunization -- 2007\", \"Development of a Flexible, Live Tetravalent Dengue Vaccine\", \"Imaging Immunotherapy Development of MRI Probes for In Vivo Tracking of Cell-based Therapies\", \"Molecular Epidemiology and Surveillance Network For Human Papillomavirus in Manitoba Women - a Pilot Study\", \"Development of novel recombinant BCG expressing ESAT-6 that activatesNLRP3, to increase vaccine efficacy against pulmonary andlatent TB infection\", \"Development and evaluation of DIVA-based vaccine utilizing an Indian isolate of classical swine fever virus.\", \"Sub viral particle based Infectious bursal disease vaccine: a way forward towards translation from lab to land\", \"Understanding the immune mechanism of host disease and development of marker vaccines and DIVA test for Peste des Petits ruminants\", \"Development of recombinant BCG vaccine and complimentary diagnostics for TB control in cattle\", \"Development of recombinant antigen based diagnostics and chimeric plant virus-like particle based vaccine for infectious bursal disease virus\", \"Development of novel nanoparticle based hepatitis B (HBV) vaccine with enhanced antigen presentation and prolonged immunity\", \"Development of virus-like particle (VLP) of Japanese encephalitis virus as a potential vaccine candidate\", \"Development of recombinant sheep pox vectored Peste des petits ruminants (PPR) vaccine for small ruminants\", \"Proof of concept studies on FMDV genetics vaccines targeted to antigen presenting cells in guinea pigs\", \"Genetic characterisation of variability in immune responses of sheep and goat for PPR and ET vaccine elicited immune response\", \"Develop a receptor blocking malaria vaccine against Plasmodium falciparum based on a novel combination of three blood stage antigens (PfAARP + PfRH2 + PfF2)\", \"\\\"Establishing immunological correlates of protection against malaria vaccine candidate using functional bio-assays and Proteomic deciphering of Host-Parasite Interactions\\\"\", \"Development of nanodelivery system of DNA based RNAi vaccine against WSSV in tiger shrimp, Peneaus monodon\", \"DEVELOPMENT OF SMALL PEPTIDE BASED NANOSTRUCTURES AS VEHICLES FOR TUMOR SPECIFIC DRUG AND THERAPEUTIC VACCINE DELIVERY\", \"Development of Contraceptive Vaccine and Novel Delivery Strategies for Wildlife with Special Reference to Street Dog Population Management\", \"Development and pre-clinical studies on safety and immunogenicity of novel candidate vaccines against Salmonella enterica serovar Typhi and Paratyphi\", \"Chemoenzymatic assembly of defined protein dendrimers for vaccine use: Immunogenicity and protective efficacy of multivalent PspA constructs from Streptococcus pneumoniae\", \"Characterization of Plasmodium falciparum merozoite surface complex for the development of a multicomponent subunit vaccine\", \"\\\"Mapping of the Resource Requirements for Basic Science and Biomedical Research for Development of Drugs, Diagnostics, Vaccines, Implants and Devices\\\"\", \"Experimental studies on therapy of cancers expressing hCG / hCG\\u00df with a recombinant highly immunogenic vaccine against hCG\", \"Generation of an improved Newcastle disease virus vaccine candidate using a novel reverse genetics technology\", \"Functional Characterization of genes in Leishmania Parasites by RNAi Technology for Drug Discovery and Vaccine Development.\", \"Functional characterization of the role of the Plasmodium falciparum reticulocyte homology proteins, in erythrocyte invasion and their evaluation as potential vaccine candidates\", \"Development of Standardization and field evaluation of thermostable newcastlle disease vaccine strains for use in village chicken.\", \"Multiple antigen peptide approach (MAP) incorporating B-T constructs of F1 and V antigens of Y. pestis in nanoparticles for plague vaccine.\", \"Vitamin D supplementation to improve immune responses to vaccines administered in early infancy- The NutriVac - D Trial\", \"Recovery of infectious chandipura Virus Entirely from cDNA clones and its application in vaccine development\", \"Isolation and characterization of animal adenoviruses for development of a novel viral vector for vaccine delivery\", \"rBCG85C- a candidate TB vaccine: Removal of antibiotic resistance marker, modifications for stabilization of antigen expression and efficacy studies\", \"Development and characterization of Autologous NKT cell based dendritic cell Vaccine for Active Specific Immunotherapy of oral squamous cell carcinoma\", \"A Randomise control Trail of recombinant live oral Cholera Vaccine in Estern Kolkata using cGMP grade material\", \"Design and testing of a CD40 ligand adjuvanted HIV virus-like particle (VLP) as a candidate vaccine against HIV/AIDS\", \"Construction of genomic library of Leptospira interrogans serovar Autumnalis for the identification of immunogenic proteins and development DNA Vaccine\", \"Development of liposome-encapsulated recombinant DNA/protein vaccine(s) for H5N1 and other Influenza viruses\", \"Construction and Characterization of Genetically Engineered Chimeric HIV-1 Envelope Protein Modulating Virus Neutralization: Implication and Relevance in Vaccine development.\", \"Improved immunogenecity of enterovirus antigen by use of microparticles carriers- a proof principle study for development of multivalent enterovirus vaccine.\", \"Rational Development of an effective Vaccine for the prevention of Staphylococcal Mastitis in bovines using mouse mastitis as a model system\", \"Development of blood-stage vaccines for Plasmodium falciparum malaria based on the EBA and PfRH proteins\", \"Development of oral vaccine against Clostridium perfringens employing translation fusion of immunodominant epitopes of beta toxin with heat table labile enterotoxin B\", \"Development of a novel marker vaccine for Bovine Herpesvirus-I(BHV-1) and companion diagnostic test.\", \"Designing heat stable lasota vaccine using vacuum foam drying for efficient treatment of new castle disease.\", \"Maximalisatie van het anti-tumoraal potentieel van next-generation dendritische celvaccins door combinatie van interleukine-15 en in situ neutralisatie van geprogrammeerde celdoodliganden\", \"Onderzoek naar het werkingsmechanisme van een nieuw vaccin tegen het respiratoir syncytieel virus op basis van het ectodomein van het \\\"small hydrophobic protein\\\".\", \"Optimalisering van tuberculose DNA vaccins koderend voor een trehalosemycolyl-transferase (Ag85A) en voor een fosfaat transport receptor (PstS-3) van Mycobacterium tuberculosis.\", \"Analyse van de immunogeniciteit en het protektief vermogen van DNA vaccins tegen M. ulcerans infectie (Buruli Ulcer) in muizen en cavia's.\", \"Towards a \\u201cnegative\\u201d cellular vaccine for the treatment of multiple sclerosis: counter-acting epitope spreading for long-lasting tolerance induction using mRNA-electroporated tolerogenic dendritic cells.\", \"Verbetering van de T cel stimulatoire capaciteit van immature dendritische cellen met als doel de ontwikkeling van een potent anti-tumor vaccin: de TriMix methodologie.\", \"Respiratory mucosal immunization with a novel simian adenovirus-based vaccine against tuberculosis: Overcoming pre-existing anti-human adenovirus type 5 immunity\", \"Layer-by-Layer Multiple Antigen Nano-delivery Platform for Malaria Vaccine\", \"To fund participants from LMIC's to attend a three-day workshop that will explore the critical issues at each stage of vaccine development\", \"\\u65b0\\u578b\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u5bf9\\u7ed3\\u6838\\u75c5\\u9884\\u9632\\u4f5c\\u7528\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u75d8\\u82d7\\u75c5\\u6bd2\\u7624\\u82d7\\u514d\\u75ab\\u6709\\u6548\\u6297\\u539f\\u6210\\u5206\\u7684\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"\\u51cf\\u6bd2\\u6c99\\u95e8\\u6c0f\\u83cc\\u4f20\\u9012\\u7684\\u57fa\\u4e8e\\u5fae\\u57fa\\u56e0\\u4e0eAIDA-1\\u81ea\\u8f6c\\u8fd0\\u86cb\\u767d\\u7684\\u65b0\\u578b\\u80bf\\u7624\\u75ab\\u82d7\", \"\\u9c7c\\u7c7b\\u8679\\u5f69\\u75c5\\u6bd2\\u65b0\\u578b\\u75ab\\u82d7\\u7814\\u53d1\\u548c\\u673a\\u5236\\u63a2\\u8ba8\", \"\\u8fdb\\u4e00\\u6b65\\u7814\\u7a76\\u6297\\u6d41\\u611f\\u75c5\\u6bd2TH DDV\\u514d\\u75ab\\u7b56\\u7565\\u7684\\u5e7f\\u8c31\\u6027\\u548c\\u4fdd\\u62a4\\u673a\\u5236\", \"\\u5229\\u7528\\u5e72\\u6270\\u7d20\\u654f\\u611f\\u75ab\\u82d7\\u75c5\\u6bd2\\u91cd\\u7ec4\\u7cfb\\u7edf\\u5bf9A\\u578b\\u6d41\\u611f\\u75c5\\u6bd2H5N1 NS1\\u86cb\\u767d\\u5728\\u9003\\u907f\\u5929\\u7136\\u548c\\u83b7\\u5f97\\u6027\\u514d\\u75ab\\u4e2d\\u4f5c\\u7528\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u4f20\\u67d3\\u6027\\u6cd5\\u6c0f\\u56ca\\u75c5\\u591a\\u8868\\u4f4d\\u75ab\\u82d7\\u5206\\u5b50\\u8bbe\\u8ba1\\u53ca\\u5176\\u514d\\u75ab\\u6548\\u5e94\\u7684\\u7814\\u7a76\", \"\\u4ee5\\u7eb3\\u7c73\\u7c92\\u5b50\\u4e3a\\u4f50\\u5242\\u7684\\u5c4b\\u5c18\\u87a8\\u75ab\\u82d7\\u514d\\u75ab\\u6cbb\\u7597\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u6838\\u9178\\u75ab\\u82d7pcDNA3-\\u03b3anxB1\\u8bf1\\u5bfc\\u732a\\u56ca\\u5c3e\\u86b4\\u7ec6\\u80de\\u51cb\\u4ea1\\u7684\\u673a\\u7406\", \"\\u6d41\\u611f\\u75c5\\u6bd2\\u8840\\u51dd\\u7d20\\u548c\\u795e\\u7ecf\\u6c28\\u9178\\u9176\\u57fa\\u56e0\\u6297\\u6d41\\u611f\\u5173\\u952e\\u5e8f\\u5217\\u89e3\\u6790\", \"\\u91cd\\u7ec4\\u6838\\u5c0f\\u4f53\\u901a\\u7528\\u6027Th\\u7ec6\\u80de\\u8868\\u4f4d\\u8bf1\\u5bfcSLE\\u53e3\\u670d\\u8010\\u53d7\\u7684\\u7814\\u7a76\", \"\\u5e94\\u7528\\u65b0\\u578b\\u80bf\\u7624\\u6d3b\\u75ab\\u82d7\\u6cbb\\u7597\\u5927\\u9f20\\u8bf1\\u53d1\\u6027\\u5375\\u5de2\\u764c\\u5b9e\\u9a8c\\u7814\\u7a76\", \"Vaccination against Rhodococcus equi pneumonia of foals.\", \"Ear Tip Necrosis in Swine\", \"Enhacning immunity to avian influenza viruses\", \"Kooperation mit Brasilien - Entwicklung einer T.Cruzi-Vaccine und deren Pr\\u00fcfung auf Wirksamkeit in Tiermodellen unter besonderer Ber\\u00fccksichtigung sicherheitspharmakologischer Bestimmungen\", \"Entwicklung neuer und Verbesserung bestehender Diagnostik-Methoden zum Nachweis des Koi-Herpesvirus (KHV) sowie Entwicklung und Etablierung eines wirksamen Impfstoffes\", \"Entwicklung neuer und Verbesserung bestehender Diagnostik-Methoden zum Nachweis des Koi-Herpesvirus (KHV) sowie Entwicklung und Etablierung eines wirksamen Impfstoffes\", \"Entwicklung neuer und Verbesserung bestehender Diagnostik-Methoden zum Nachweis des Koi-Herpesvirus (KHV) sowie Entwicklung und Etablierung eines wirksamen Impfstoffes\", \"Untersuchungen zum mukosalen Immunsystem beim Huhn und seine Reaktion auf Koinfektionen als Basis zur Entwicklung neuer Impfstoffstrategien\", \"Verbundprojekt: Neuartiger Ansatz zur Entwicklung eines heterosubtypischen Marker-Impfstoffs gegen die avi\\u00e4re Influenza in Gefl\\u00fcgel - Teilprojekt 1 (Anschlussprojekt)\", \"Entwicklung eines diagnostischen Systems zur Entdeckung von West-Nile-Virus(WNV)- Infektionen und Entwicklung eines gentechnischen Impfstoffes gegen diese Infektion\", \"Verbundprojekt: Integriertes, patientennahes Verfahren zur Herstellung einer therapeutischen zellul\\u00e4ren Vakzine im geschlossenen System, Teilvorhaben: Gewinnung Kultivierung und Charaktisierung von DC\", \"Verbundprojekt: Nadelfreie Injektion von fl\\u00fcssigen oder pulverf\\u00f6rmigen biomolekularen Arzneimitteln (Bio-Injekt) - Teilvorhaben: Pharmazeutische Technologie und Charakterisierung pulverf\\u00f6rmiger Vakzine\", \"CI3: Realisierung von Software, Planungs- und Steuerungsmodulen f\\u00fcr die beschleunigte automatisierte Herstellung individualisierter MUTANOM-Vakzine (IVAC IT) - Teilvorhaben: Software und Steuerungsmodule f\\u00fcr die GMP Produktion\", \"CI3: Entwicklung individualisierter MUTANOM-Vakzine - From Proof of Concept to Proof of Market (IVAC MUTANOM 2.0) - Teilvorhaben: Individualisierte Immundiagnostik und Leitstruktur\", \"CI3: Herstellung und pr\\u00e4klinische Validierung eines auf chim\\u00e4ren virus-like particles (VLPs) basierenden Impfstoffes zur Tumorvakzinierung, Projektteil Tulip\", \"Analyse der Lokalisation, Orientierung und Interaktion von Proteinen durch Mikroskopie, Toponomics und Bioinformatics zur Identifikation von Wirts-Pathogen-Interaktionen, Resistenztransportern in Trophoblasten und Vakzinkandidaten\", \"Entwicklung eines Biomolek\\u00fcl-Kopierers zur Erzeugung neuartiger Next Generation Mikroarrays - erste Anwendungen f\\u00fcr 10.000 Wirkstoffe, Enzyme und Impfstoffe - BioKopierer\", \"Deutsch-israelische Zusammenarbeit auf dem Gebiet der Aquakultur - Teilprojekt ISR-Aq3: Orale Vakzinierung von Nutzfischen: Verbesserung verschiedener Vakzinen und neue Anwendungsmethoden\", \"EXIST-Forschungstransfer: Entwicklung eines Subunit-Impfstoffes (Totimpfstoff) gegen Malaria basierend auf neu identifizierten Parasitenantigenen aus den Leberstadien der Erreger\", \"Entwicklung einer Chicken Factor freien H\\u00fchnerherde f\\u00fcr wissenschaftlich experimentelle und diagnostische Zwecke sowie zur Impfstoffherstellung\", \"ERA Net EuroTransBio-8: Plurivax: Ausbau und Weiterentwicklung der Enten-Hepatitis VLP(virus like particle) Plattformtechnologie zur Herstellung von Vakzinen f\\u00fcr den Veterin\\u00e4rbereich.\", \"KMU-innovativ-9: Entwicklung eines EliSpot-Testsystems zur Impf\\u00fcberwachung von HPV und Ableitung neuer Impfstoff- und Therapieans\\u00e4tze' ('HPV-EliSpot')\", \"Verbundprojekt: Gentechnologische Bearbeitung des menschenpathogenen Hanta-Virus mit dem Ziel, einen Impfstoff zu entwickeln - Teilvorhaben 2\", \"Verbundprojekt: Gentechnologische Bearbeitung des menschenpathogenen Hanta-Virus mit dem Ziel, einen Impfstoff zu entwickeln - Teilvorhaben 1\", \"Entwicklung eines Produktionsverfahrens f\\u00fcr S- und S/L-Partikel f\\u00fcr die Herstellung eines verbesserten Impfstoffs und Empfindlicher Diagnostikverfahren f\\u00fcr Hepatitis B\", \"ERA-NET PathoGenoMics 3: Diversit\\u00e4t von Helicobacter pylori: Rolle in Pathogenese, Antibiotikaresistenz und der Umgehung nat\\u00fcrlicher und impfstoffinduzierter Immunreaktionen (HELDIVPAT), Teilprojekt Magdeburg\", \"ERA-NET PathoGenoMics 3: Diversit\\u00e4t von Helicobacter pylori: Rolle in Pathogenese, Antibiotikaresistenz und der Umgehung nat\\u00fcrlicher und impfstoffinduzierter Immunreaktionen (HELDIVPAT), Teilprojekt M\\u00fcnchen\", \"ERA-NET PathoGenoMics 3: Diversit\\u00e4t von Helicobacter pylori: Rolle in Pathogenese, Antibiotikaresistenz und der Umgehung nat\\u00fcrlicher und impfstoffinduzierter Immunreaktionen (HELDIVPAT), Teilprojekt Hannover, Josenhans\", \"ERA-NET PathoGenoMics 3: Diversit\\u00e4t von Helicobacter pylori: Rolle in Pathogenese, Antibiotikaresistenz und der Umgehung nat\\u00fcrlicher und impfstoffinduzierter Immunreaktionen (HELDIVPAT), Teilprojekt Hannover, Suerbaum\", \"GO-Bio 3: DENOVO - Entwicklung einer Plattformtechnologie f\\u00fcr das Targeting genetischer Vakzine auf der Basis eines nat\\u00fcrlichen Opsonins\", \"Aufreinigungstechnologie-Verbundprojekt: Einsatz synthetischer Liganden zur Aufreinigung sialins\\u00e4urehaltiger, rekombinanter humaner Proteine und Impfstoff-Antigene, TP 3\", \"Aufreinigungstechnologie-Verbundprojekt: Einsatz synthetischer Liganden zur Aufreinigung sialins\\u00e4urehaltiger, rekombinanter humaner Proteine und Impfstoff-Antigene, TP 2\", \"Aufreinigungstechnologie-Verbundprojekt: Einsatz synthetischer Liganden zur Aufreinigung sialins\\u00e4urehaltiger, rekombinanter humaner Proteine und Impfstoff-Antigene, TP 1\", \"BioProfile Stuttgart/Neckar-Alb: Identifizierung, Selektion und Validierung von Tumor-assoziierten Peptiden von Magenkarzinomen zur Definition eines therapeutischen Impfstoffs auf Basis immunogener Peptid-Epitope\", \"BioChancePLUS: DNAShield, ein leicht adaptierbarer Vakzin-Prototyp mit schnellem Wirkeintritt auf der Grundlage von Antigen-exprimierenden (MIDGE-TH1P) und Antigen-gekoppelten (DNABarrier) DNA-Konstrukten\", \"Verbundprojekt: Entwicklung von Methoden zur Herstellung und Anwendung einer Vakzine zur Behandlung von Humanpapillomvirus-assoziiertem Zervixkarzinom\", \"Entwicklung von Alternativmethoden zur Pr\\u00fcfung von Clostridiumimpfstoffen - Teilprojekt 2: Abl\\u00f6sung von Tierversuchen bei der Chargenpr\\u00fcfung (DAB 10)\", \"Verbundprojekt: Ersatz des Neurovirulenztests an S\\u00e4ugetieren zur Sicherheitspr\\u00fcfung von Polioimpfviruschargen. Teilprojekt 2: Etablierung nichtradioaktiver Detektionsmethoden.\", \"Ersatz von Tierversuchen bei der Wirksamkeitspr\\u00fcfung von Clostridien-Immunpr\\u00e4paraten - Teilprojekt 3: Ersatzmethoden zur Pr\\u00fcfung von Rauschbrand-Impfstoffen\", \"Entwicklung von in vitro-Methoden als Ersatz f\\u00fcr Letalchallengeversuche an Fischen zur Beurteilung von Vakzinen - Teilprojekt 2: Epitopspezifischer Enzymimmunoassay\", \"Entwicklung von in vitro-Methoden als Ersatz f\\u00fcr Letalchallengeversuche an Fischen zur Beurteilung von Vakzinen - Teilprojekt 1: Lymphozytenproliferationstest\", \"Verbundprojekt: Entwicklung einer neuartigen Behandlungsstrategie von Allergien: zielgerichtete Glycan-Allergen Immuntherapie, Teilprojekt: Impfstoff-Charakterisierung und bioanalytische Methodenentwicklung\", \"Verbundprojekt: Entwicklung eines kosteneffizienten Impfstoffs gegen Zervixkarzinome - ein prophylaktischer Ansatz, Teilprojekt: Entwicklung von gereinigten Antigenen und Evaluierung der Immunogenit\\u00e4t\", \"Lebend-Impfstoffe f\\u00fcr Schleimhautimmunit\\u00e4t: Vergleichsstudien mit Shigella, Salmonella und Streptokokken als Tr\\u00e4gerst\\u00e4mme f\\u00fcr rekombinante Antigene aus Krankheitserregern.\", \"Entwicklung und Erprobung eines konditionalen Immortalisationssystems prim\\u00e4rer humaner Tumorzellen zur Konstruktion gentechnisch modifizierter Tumorzellvakzine\", \"Entwicklung eines konditionalen Immortalisationssystems prim\\u00e4rer humaner Tumorzellen zur Konstruktion gentechnisch modifizierter autologer Tumorzellvakzine\", \"Verbund: Immuntherapie mit genetisch ver\\u00e4nderten Zellen: Einf\\u00fchrung von kostimulatorischen Molek\\u00fclen in frisch isolierte autologe Tumorzellvakzine mittels rekombinanter bifunktioneller Konjugate und Gentransfer\", \"Komplikationen der Organtransplantationen durch Herpesviren: Cytomegalovirus Latenz in der Lunge und Entwicklung einer Vakzine mit rekombinanten inkompletten Viruspartikeln\", \"AIDS-Verbund G\\u00f6ttingen: Austestung Chimaerer, nicht infekti\\u00f6ser Hiv-1 Virus-\\u00e4hnlicher Partikel als Vakzinekandidat im S-Hiv Makakenmodell\", \"Pseudomembranoese Colitis durch Clostridium Difficile Toxine: Isolierung und Charakterisierung von Liganden- und Wirtsstruktur zur Entwicklung einer Vakzine\", \"Verbundprojekt HIVERA VIHDUAVAX: Entwicklung eines neuen HIV-1 Impfstoffs mit bivalenten Eigenschaften durch Kombination von zwei gp41 Epitopen: Neutralisation von HIV-1 und CD4 Zell-Depletion\", \"EDCTP HIV-Vakzine:TaMoVac II - Evaluierung der Sicherheit und der Immunantwort nach HIV-Impfung mit einem DNA-Prime/MVA/gp140-Boost-Ansatz in Mbeya Tansania\", \"Verbundprojekt: Entwicklung und klinische Anwendung von genetisch hergestellten Vakzinen basierend auf dem Tumorartigen Muzin zur Behandlung von Patienten mit Pankreas- oder Mammakarzinomen\", \"Verbundprojekt: Kirgisisch-Deutsche Hepatitis B Initiative - Bildung einer nachhaltigen binationalen Infrastruktur f\\u00fcr epidemiologische und impfungsbezogene Forschung, Teilvorhaben: Twincore\", \"Otitis media, hearing loss and school readiness of Indigenous children followed from birth in two randomised controlled trials of novel pneumococcal conjugate vaccine schedules (VOICES. Vaccines to prevent Otitis media In Children Entering School)\", \"Low-Cost Portable Inhalation Therapy Platform for Needle-Free DNA-Based Influenza Vaccination\", \"Hepatitis C vaccine\", \"The role of capsid protein nucleolar localisation in chikungunya virus: implications for vaccine development\", \"Sytemic and mucosal functional antibodies in protection against HIV\", \"Comparing pneumococcal vaccines in a high risk population: a randomised controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea\", \"Development of a safe live genetically attenuated blood stage malaria vaccine\", \"Multistage vaccines for the prevention of tuberculosis\", \"Artificial synthesis of the type III secretion system translocon. A new approach to vaccine design\", \"Monitoring the gap between evidence and vaccination behaviour by sampling the location-specific consumption of health information from news and social media\", \"For research on teens' knowledge of & sources for information about abstinence, contraception & STDs & for an article identifying challenges to HPV vaccine rollout, public education & acceptability\", \"Modulation of T effector memory (TEM) vs T Central Memory (TCM) ratio for the immunotherapy and vaccine strategy for Tuberculosis.\", \"HPV Knowledge & HPV Vaccine Update Among US Navy Personnel 18-26 Years Old\", \"Characterization of the GRP 170 Peptide Binding Protein in Murine and Patients' Tumors and Its Use in the Development of New Breast Cancer Vaccines\", \"Layer by Layer Multiple Antigen Nano-delivery Platform for Malaria Vaccine\", \"Antigen and genome characterization of viral nervous necrosis virus (VNNV) of fish for development of diagnostics and vaccine\", \"Development of a Novel Anthrax-Subunit Vaccine Based on Protective Antigens of Bacillus Anthracis and the Innate Immunity Agonist FliC Flagellin of Salmonella\", \"Evaluating the Current Immune Status of Subjects Against Lymphatic Filariasis Infection in India and Assessing the Need for a Prophylactic Vaccine\", \"A Novel Policy to Improve Vaccine Coverage of Health Care Workers in New South Wales, Australia: Process and Impact Evaluation\", \"Sequencing of commercially available MMR vaccine virus strains and attenuation of cloned virus genes by site directed mutagenesis.\", \"H2020 Catalyst Award: Profiling \\u2018immune signatures\\u2019 predictive of outcome in Staphylococcus aureus infection: Advancing next generation vaccine design\", \"Detailed analysis of the \\\"helper\\\" and \\\"effector: function by CD4+ T cells in antitumor immunity: relevance to the design of therapeutic vaccines for cancer\", \"Dendritic cell targeting of antigens for enhanced immune responses: developing a universal adjuvant vector for theraputics and vaccines.\", \"The impact of publicly funded human papillomavirus (HPV) vaccination on cervical dysplasia: The Ontario Grade 8 HPV vaccine cohort study\", \"Can a modified vaccine reduce the rate of large local reactions to the pre-school booster with DTPa-IPV?\", \"Cancer vaccines targeting the ganglioside tumor-marker GD2\", \"Herpes viruses as Re-activating Vaccine Vectors: Protective Efficacy of a Varicella Zoster-HIV Vaccine in the SIV Macaque model\", \"Defining innovating cancer vaccine based on virus-like particles by targeting multiple antigens\", \"Development of an Implementation Guide for Long Term Care Homes Planning to Use the Ottawa Influenza Vaccine Decision Aid\", \"Structural characterization of the HIV-1 Env trimer as a guide for the development of a vaccine immunogen.\", \"Novel transdermal vaccine delivery\", \"Optimizing H1N1 Vaccination Uptake among Health Care Workers\", \"Viral modulators of inflammation and vascular perturbation\", \"Vaccine adjuvant Co-delivery with food allergen via intestinal mucosa as a novel allergen- specific immunotherpy approach to food allergy\", \"Comrehending the role of mucosal-associated immunity during host pathogen following avibacterium paragallinarum infection in poultry (chicken and japanese quail) for development a futristic mucosal vaccine\", \"Investigation and characterization of protective immune responses generated against novel vaccine candidates isolated from non- albicans Candida species in murine systemic candidiasis.\", \"Application of DNA vaccines to the clinic: a phase II study of idiotypic vaccination for follicle centre lymphoma. Pilot studies in myeloma and CLL\", \"APPLICATION OF DNA VACCINES TO THE CLINIC: A PHASE II STUDY OF IDIOTYPIC VACCINATION FOR FOLLICLE CENTRE LYMPHOMA. PRE-PROTOCOL STUDIES IN MYLEOMA AND CLL\", \"Disialyl Neu5Ac\\u02512-3Gal\\u03b21-3[Neu5Ac\\u02512-6]GalNAc-R\\uc758 \\uc554\\ud56d\\uc6d0, \\uc554\\uc9c4\\ub2e8 \\ubc0f \\uc554\\ubc31\\uc2e0 \\ub2f9\\uc0ac\\uc2ac\\ud654\\ud569\\ubb3c \\uac1c\\ubc1c\\uc744 \\uc704\\ud55c \\uc735\\ud569\\uacfc\\ud559\\uc5f0\\uad6c\", \"\\uccb4\\ub0b4 \\uc554\\uc138\\ud3ec \\uc720\\ub3c4\\ub97c \\ud1b5\\ud574 \\uc2e4\\uc2dc\\uac04 \\uc554\\ud2b9\\uc774\\ud56d\\uc6d0\\uc758 \\uc0dd\\uc131\\uc774 \\uac00\\ub2a5\\ud55c 3\\ucc28\\uc6d0 \\uc2a4\\uce90\\ud3f4\\ub4dc \\uae30\\ubc18 All-in-One \\uc554\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc2e0\\uac1c\\ub150 delivery system\\uacfc Secretory \\ubc1c\\ud604 vector\\ub97c \\uc774\\uc6a9\\ud55c \\uc0b4\\ubaa8\\ub12c\\ub77c\\uade0\\uc99d \\ubc0f \\ubcd1\\uc6d0\\uc131 \\ub300\\uc7a5\\uade0\\uc99d \\uc608\\ubc29\\uc758 \\ub3d9\\uc2dc\\ub2e4\\uac00\\uc608\\ubc29\\ubc31\\uc2e0 \\uac1c\\ubc1c\", \"\\uc5ec\\ub4dc\\ub984 \\uce58\\ub8cc\\uc81c \\uac1c\\ubc1c\\uacfc \\uad00\\ub828\\ud558\\uc5ec \\uc5ec\\ub4dc\\ub984 \\uc804 \\uc784\\uc0c1 \\ub9c8\\uc6b0\\uc2a4 \\ubaa8\\ub378 \\uac1c\\ubc1c \\ubc0f \\ub9c8\\uc6b0\\uc2a4\\uc5d0\\uc11c P. acnes \\uae30\\ubc18 \\ubd88\\ud65c\\uc131\\ud654 \\ubc31\\uc2e0 \\ud6a8\\uacfc\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"\\uc6d0\\uc608\\ucc44\\uc18c\\uae30\\ubc18 \\ud56d\\uc6d0 \\uc735\\ud569\\ubc31\\uc2e0\\ub2e8\\ubc31\\uc9c8 \\uac70\\ub300\\ubd84\\uc790 \\uad6c\\uc870\\uac1c\\uc120 \\ubc0f \\ubc1c\\ud604\\uc2dc\\uc2a4\\ud15c \\uad6c\\ucd95\\uc744 \\ud1b5\\ud55c \\uc804\\ub9bd\\uc120 \\uc554 \\uc608\\ubc29 \\ubc0f \\uce58\\ub8cc \\ud6a8\\uacfc \\uadf9\\ub300\\ud654 \\uae30\\uc220\\uac1c\\ubc1c\", \"\\ub385\\uae30 \\uba74\\uc5ed\\ubcf5\\ud569\\uccb4\\uc758 \\uace0\\ubc1c\\ud604 \\uc2dd\\ubb3c\\uccb4 \\ud655\\ubcf4 \\ubc0f \\ub3d9\\ubb3c\\uc2e4\\ud5d8\\uc744 \\ud1b5\\ud55c 4\\uac00 \\ub385\\uae30\\ubc31\\uc2e0 \\ud6c4\\ubcf4\\ubb3c\\uc9c8\\uc758 \\ubc29\\uc5b4\\ub2a5\\ub825 \\uac80\\uc815\", \"\\ub9cc\\uc131 C\\ud615 \\uac04\\uc5fc\\uc5d0 \\ub300\\ud55c HCV DNA vaccine\\uacfc sPD-1-Fc\\uc758 \\uce58\\ub8cc \\ud6a8\\ub2a5 \\ubc0f \\uadf8 \\uc791\\uc6a9 \\uae30\\uc791\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"Metabolomics profiling\\uc744 \\uc774\\uc6a9\\ud55c \\uc5b4\\ub958 \\uba74\\uc5ed\\ubc18\\uc751 \\ud45c\\uc9c0\\uc778\\uc790 \\uac1c\\ubc1c \\ubc0f \\ud574\\uc0b0\\uc2dd\\ubb3c\\uc720\\ub798\\ub85c\\ubd80\\ud130  \\ub119\\uce58 \\ubd88\\ud65c\\ud654 \\ubc31\\uc2e0\\uc758 ajuvant \\uac1c\\ubc1c\\uc5d0 \\uad00\\ud55c \\uc5f0\\uad6c\", \"\\uac00\\ucd95 \\uc218\\uc778\\uc131 \\uc9c8\\ubcd1 \\uc608\\ubc29\\uc744 \\uc704\\ud55c \\ub2e4\\uae30\\ub2a5\\uc131 \\uace0\\ubd84\\uc790 \\ubbf8\\ub9bd\\uc790 \\ubc0f \\uc720\\uc0b0\\uade0\\uccb4\\ub97c \\uc774\\uc6a9\\ud55c \\ubcf5\\ud569 \\uacbd\\uad6c\\ubc31\\uc2e0 \\uc804\\ub2ec \\uc2dc\\uc2a4\\ud15c\\uc758 \\uac1c\\ubc1c \\ubc0f \\ud3c9\\uac00\", \"A comparison study of humoral and cellular immune responses in very young infants after intradermal versus intramuscular injection of influenza vaccine\", \"Efficacy of recombinant Epstein-Barr virus (EBV) vaccine in patients with nasopharyngeal cancer who had residual EBV DNA load after conventional therapy\", \"EFFECTIVENESS OF ROTAVIRUS VACCINE IN HONG KONG CHILDREN\", \"Ocena aktywno\\u015bci przeciwnowotworowej chemioimmunoterapii z udzia\\u0142em nanokoniugat\\u00f3w metotreksatu oraz szczepionek na bazie kom\\u00f3rek dendrytycznych z wyciszon\\u0105 ekspresj\\u0105 receptora IL-10\", \"To use mathematical modelling to evaluate the added-value of a schistosomiasis vaccine to current Mass Drug Administration approaches and identify optimal delivery systems\", \"To support the 2018 Sabin Gold Medal Award which recognizes individuals who have helped to reduce needless human suffering from vaccine-preventable and neglected tropical diseases\", \"To evaluate nasopharyngeal carriage in children with pneumonia 4 years post introduction of pneumococcal conjugate vaccine vaccination to determine herd impact on unimmunized\", \"To convene an international conference to discuss and share broadly the latest HIV vaccine, microbicide, and ARV-based prevention research\", \"\\u65b0\\u578b\\u5e7d\\u95e8\\u87ba\\u6746\\u83cc\\u591a\\u80bd\\u7eb3\\u7c73\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u4fdd\\u62a4\\u6548\\u5e94\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u54ee\\u5598\\u75ab\\u82d7\\u91cd\\u7ec4BCG\\u4e0e\\u80a0\\u9053\\u9ecf\\u819c\\u7ec6\\u80de\\u76f8\\u4e92\\u4f5c\\u7528\\u7684\\u4fe1\\u53f7\\u4f20\\u5bfc\", \"Vaccine and Treatment Evaluation Unit: Phase I Malaria Vaccine Study\", \"Vaccine and Treatment Evaluation Unit: Phase I Trial of Filovirus Vaccine\", \"Vaccine and Treatment Evaluation Unit: Assay Work for Yellow Fever Vaccines\", \"VACCINE AND EVALUTION TREATMENT UNITS:PHASE I CLINICAL TRIAL OF A HPV VACCINE CANDIDATE\", \"VACCINE AND EVALUTION TREATMENT UNITS:PHASE I CLINICAL TRIAL OF A NOROVIRUS VACCINE CANDIDATE\", \"VACCINE AND TREATMENT EVALUATION UNITS: Phase I Clinical Trial to Evaluate an E. Coli Vaccine\", \"Vaccine and Treatment Evaluation Unit: Phase I Trial of a Yellow Fever Virus Vaccine\", \"Vaccine and Treatment Evaluation Unit: Malaria Vaccine Development\", \"Vaccine and Treatment Evaluation Unit: Phase I Trial of a Yellow Fever Virus Vaccine\", \"Development of Infectious Bursal Disease Virus (IBDV) Vaccines for the Poultry Industries in Hong Kong and Southern China\", \"Development of Robust, Scaleable and Cost Effective Technologies for the Large-scale Production of Plasmid DNA for Therapy or Vaccine\", \"Development of Robust, Scaleable and Cost Effective Technologies for the Large-scale Production of Plasmid DNA for Therapy or Vaccine\", \"Development of Robust, Scaleable and Cost Effective Technologies for the Large-scale Production of Plasmid DNA for Therapy or Vaccine\", \"The use of the ex vivo placental perfusion model to study placental malaria vaccine efficacy and the biology of parasite sequestration\", \"Secreted HSP Vaccine for Malaria Prophylaxis\", \"Secreted HSP Vaccine for Malaria Prophylaxis\", \"Malaria Vaccine Development-Rapid T Cell Antigen Discovery Using Human T Cell Screens of a P. falciparum Proteomic Library\", \"Eurostarsproject, New-Vac, 5934, Isconova AB, New vaccines against intracellular pathogens in salmom\", \"Dry formulation of vaccine\", \"RECOMBINANT SUBUNIT VACCINE AGAINST PISCINE FRANCISELLOSIS\", \"The development of an in vitro inactivation test for Rabies vaccine using reverse transcriptase polymerase chain\", \"Social science study to accompany the Badger Vaccine Deployment\", \"The development of animal models to test candidate vaccines for M. bovis infection in badgers\", \"Development of vaccine candidates for protection of badgers against infection with Mycobacterium bovis\", \"Preclinical development of candidate Zika virus vaccines using mouse models\", \"\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u63a5\\u7a2e\\u653f\\u7b56\\u5909\\u66f4\\u306b\\u4f34\\u3046\\u533b\\u7642\\u7d4c\\u6e08\\u5b66\\u7684\\u52b9\\u679c\\u306e\\u89e3\\u660e\", \"\\u674e\\u65af\\u7279\\u83cc\\u8f7d\\u4f53\\u5728\\u589e\\u5f3a\\u4e19\\u578b\\u809d\\u708e\\u75c5\\u6bd2\\u91cd\\u7ec4\\u591a\\u8868\\u4f4d\\u6811\\u7a81\\u7ec6\\u80de\\u75ab\\u82d7\\u4e2d\\u7684\\u4f5c\\u7528\", \"\\u57fa\\u4e8e\\u91cd\\u7ec4MS2\\u566c\\u83cc\\u4f53\\u6837\\u9897\\u7c92\\u7684\\u80bf\\u7624RNA\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"VP22\\u589e\\u5f3a\\u94dc\\u7eff\\u5047\\u5355\\u80de\\u83ccDNA\\u75ab\\u82d7\\u514d\\u75ab\\u6548\\u529b\\u7684\\u8bc4\\u4ef7\", \"\\u77f3\\u6591\\u9c7c\\u7279\\u5f02\\u6027CpG ODN\\u7684\\u7b5b\\u9009\\u53ca\\u5176\\u4f5c\\u4e3aSGIV\\u75ab\\u82d7\\u4f50\\u5242\\u7684\\u7814\\u7a76\", \"\\u6162\\u6027\\u4e59\\u809d\\u65b0\\u578b\\u53ef\\u590d\\u5236\\u578bDNA\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u589e\\u6548\\u7b56\\u7565\\u7814\\u7a76\", \"Characterisation of the Group A Streptococcus M-like proteins and their potential as vaccine antigens\", \"PRECLINICAL PoC OF MULTIVALENT VACCINE AGENTS & TECHNOLOGY PLATFORM\", \"Mykorhizn\\u00ed technologie pro trvale udr\\u017eitelnou zem\\u011bd\\u011blskou produkci ovocn\\u00fdch plodin (MYCOTAGRIF)\", \"Prevalence HPV infekc\\u00ed ve vakcinovan\\u00e9 populaci \\u017een \\u010cR\", \"To develop a measles and rubella vaccine microarray patch that meets the preferred product characteristics and contributes to global measles and rubella elimination\", \"To develop monoclonal antibodies to all pneumococcal serotypes and have a repository so that these can be used in future vaccine development\", \"LA VACCINAZIONE ANTINFLUENZALE IN ETA\\u00e2   PEDIATRICA COPERTURA VACCINALE NEI BAMBINI CON MALATTIA CRONICA E IN QUELLI SANI ED EFFICACIA DEL VACCINO DURANTE IL PERIODO EPIDEMICO\", \"\\u65b0\\u80bf\\u7624\\u6297\\u539f\\u4eba\\u5de5\\u8868\\u4f4d\\u80bdSurvivin\\u5e8f\\u5217\\u7684\\u53d1\\u73b0\\u53ca\\u5176\\u7eb3\\u7c73\\u75ab\\u82d7\\u8054\\u5408IFN-\\u03b3\\u9776\\u5411\\u8111\\u80bf\\u7624\\u5e72\\u7ec6\\u80de\\u6cbb\\u7597\\u7814\\u7a76\", \"Development of customizable attenuated and vector vaccines to protect against porcine reproductive and respiratory syndrome (PRRS), essential for a successful treatment\", \"BIOVACSAFE ? Biomarkers for enhanced vaccine safety\", \"Selection of Mycoplasma mycoides subsp. mycoides candidate vaccine molecules through identification of monoclonal antibodies that inhibit pathogen-host cell adhesion\", \"Pneumococcal conjugate vaccine (PCV) schedules for the Northern Territory (NT): randomised controlled trial of booster vaccines to broaden and strengthen protection from invasive and mucosal infections.\", \"A dual antigen synthetic peptide subunit vaccine approach to prevent streptococcal associated cardiovascular disease\", \"Improving subunit vaccines against tuberculosis for pulmonary delivery\", \"Mucosal vaccine for Hendra virus\", \"New candidate vaccines to prevent tuberculosis: preclinical assessment of efficacy, safety and mechanism of protection\", \"A multi-protein vaccine targeting the oral pathogens associated with chronic periodontitis\", \"RV3 rotavirus vaccine: developing a neonatal rotavirus vaccine formulation for the global community\", \"A novel Hepatitis B virus genotype in Indigenous Australians: impact on vaccine efficacy and clinical outcomes\", \"A novel paradigm for immunity and vaccine development against group A streptococcus\", \"Research Fellowship\", \"Research Fellowship - Grant ID:637303\", \"Apical membrane proteins as targets for a schistosomiasis vaccine\", \"A new approach to the design and evaluation of T cell vaccines for cancer and infectious disease.\", \"Novel vaccine formulation for immunotherapy of adenocarcinomas\", \"Immunity and pathogenesis in Tropical and Infectious Diseases: Implications for Vaccines and\", \"Application of Protein Microarrays to Develop a Cross-Species Malaria Vaccine\", \"Heterosubtypic T cell-inducing vaccines for influenza in humans\", \"Multiple vector vaccine for hepatitis C virus.\", \"H1N1 Ability of H1N1-09 and seasonal influenza vaccines to reduce symptoms and halt spread of H1N1-09 infection in ferre\", \"To generate data to inform country- and global-level decision-making related to fractional dose inactivated poliovirus vaccine (fIPV) introduction\", \"The impact of the intestinal environment on the immunogenicity of oral vaccines in Zimbabwean infants\", \"Evaluation of the technical & commercial viability of developing an accelerated MERS vaccine\", \"To develop compostable vaccine packaging to diminish the environmental impact of mass vaccination campaigns in developing countries lacking adequate disposal infrastructure.\", \"To create a centralized, comprehensive, integrated and publicly accessible bioinformatics platform that will enable TB drug and vaccine discovery missions\", \"To insure that populations at risk of cholera will benefit from receiving oral cholera vaccine (OCV) in an appropriate and effective manner.\", \"To foster the exploration and innovation needed to identify, develop and deliver the right TB vaccines to those most in need\", \"To create awareness about the need for and challenges facing the research and development of HIV/AIDS vaccines for Africa\", \"To develop a broad-spectrum \\u2018universal\\u2019 vaccine effective against infective sporozoites, disease-causing blood-stages and transmissible sexual stages of most species of human malaria\", \"To conduct initial primate studies that can significantly accelerate the clinical development of a safe, effective AIDS vaccine with activity across clades\", \"To discover biomarkers in blood that can be used to identify individuals at risk of developing active tuberculosis (TB) for priority enrollment into TB vaccine trials\", \"To design and evaluate so-called \\u201cinfinite-epitope\\u201d vaccines for their potential to provide simultaneous and broad protective immunity to the many variant forms of HIV.\", \"To examine a new mechanism that may influence rotavirus vaccine take, and improve our understanding of immunological correlates of protection\", \"To support for the 2015 Sabin Gold Medal Award which recognizes individuals who have helped to reduce needless human suffering from vaccine-preventable and neglected tropical diseases\", \"To develop a novel vector for HIV vaccines based on non-integrating lentivirus vectors that directly target the specialized cells that present antigens to the immune system\", \"To develop an oral HIV vaccine based on Clostridium perfringens to deliver large amounts of antigens to gut-associated lymphoid tissue, a major site of HIV activity\", \"To develop high quality master seed viruses and cell lines that are relevant for foot-and-mouth disease virus vaccine production for East Africa\", \"To identify malaria peptide antigens that present themselves on the surface of infected liver cells for use in the development of new malaria vaccines.\", \"To target T-cells against these ERV antigens. If true, new host-directed vaccines could be developed to eliminate HIV infected cells.\", \"To develop and test a low-cost cellular architecture that can track an individual\\u2019s immunization status, disseminate vaccine-related information, and track at-risk populations.\", \"To introduce and monitor the effects of Haemophilus influenzae type b (Hib) conjugate vaccine in high-risk infant populations in Mali, West Africa\", \"To convene global experts to consider the issues around the design and delivery of effectiveness studies for typhoid conjugate vaccines.\", \"To develop a software-based modeling tool that allows vaccine program managers to analyze all clinical and logistical factors that determine the cost per dose administered.\", \"To apply a new liquid stabilizing technology to create thermostable vaccines that can withstand extremes of temperature and eliminate the need for a cold chain.\", \"To develop a microchip to assess the functioning of single T cells to evaluate HIV-specific T cell response in future HIV vaccine trials\", \"To construct and test a vaccine platform that utilizes low-cost, stable surfactant vesicles to deliver antigens for a sustained immune response\", \"To develop and field test a simple inexpensive micro-hydroturbine that can drive a generator to power vaccine refrigerators and other health care facility equipment.\", \"To engineer, produce, and assess target antigens for developing a potent and cost-effective vaccine to control and prevent influenza infections\", \"To study if a bacterial protease inhibitor from Brucella is a new molecular pattern that could be useful for improving mucosal (oral) delivery of anti-infectious vaccines\", \"To test the theory that poor immunity generated by the oral poliovirus vaccine (OPV) may be responsible for persistence of the disease.\", \"To define a shared strategy and related action plan as well as Monitoring and Evaluation framework to enhance sustainable access to vaccines in Middle Income countries (MICs)\", \"To further research the production and immune stimulating effects of multi-antigen and adjuvant formulations that could be used in a low-cost, long-lasting malaria vaccine.\", \"To evaluate the population effectiveness of rotavirus vaccine introduction in the context of a comprehensive diarrhoea control pilot in Zambia\\u2019s Lusaka Province\", \"To develop a non-live polio vaccine using liposomes to entrap and deliver defined poliovirus antigens effectively to the immune system\", \"To identify the potential causal role of antibodies in MTB control in vivo in an effort to guide future vaccine design\", \"To develop a printable label for vaccine vials to indicate when they have been exposed to temperatures below a set threshold, which would compromise activity.\", \"To evaluate the ability of nanoparticle based vaccines to induce Env-specific protective antibody responses against HIV infection in non human primates\", \"To make the first description of specific histo-blood group antigens (HBGAs) in Zambian children and to assess their influence on immunogenicity of rotavirus vaccines.\", \"To convene experts to discuss new information about vibrios in the environment particularly in relation to diarrhea/enteric diseases, diagnostics, and vaccines\", \"To engineer a highly immunogenic virus to express replication-restricted poliovirus proteins for use in a new nasal spray polio vaccine.\", \"To develop a bio-compatible, biodegradable polymer device that can be placed under the skin to introduce vaccines and antigens to the immune system\", \"To test an innovative single vial system (SVS) technology that allows for easier transport, reconstitution, and storage of vaccines with lyophilized components\", \"To develop high-throughput glycan microarrays to identify glycan antigens, determine their chemical structure, and design glycan-peptide vaccines for future testing.\", \"To generate chimeric Plasmodium falciparum that expresses the antigens of another malaria parasite, P. vivax, allowing them to be evaluated as vaccine candidates.\", \"To develop novel vaccines for African trypanosomiasis, a neglected disease of animals and humans in sub-Saharan Africa that is transmitted by an infected tsetse fly bite\", \"To develop an effective, low cost, oral, human neonatal rotavirus vaccine aimed at prevention of rotavirus gastroenteritis from birth, for infants and children worldwide\", \"To apply highly sensitive quantitative molecular diagnostics for pathogens to understand the etiology of severe diarrhea in post-rotavirus vaccine communities\", \"To enhance the impact of immunization on childhood mortality by defining the potential heterologous effects of vaccines, and adjusting immunization policies if deemed appropriate\", \"To provide information on the potential cost-effectiveness of additional investments in several ongoing, vaccine-improvement initiatives aimed at reducing the global disease burden of measles\", \"To develop the knowledge which is needed to develop vaccines and drugs for global infectious diseases including malaria, tuberculosis, HIV/AIDS, and emerging and neglected diseases\", \"To support the planning of a phase I clinical trial in Belgium for the Oral Polio Vaccines being developed by a consortium of researchers\", \"To develop and test a vaccine delivery system that uses Norovirus virus-like particles (VLPs) to deliver desired antigens directly to the gut mucosa\", \"To develop a vaccine for Salmonella that uses a serotype-independent Salmonella antigen combined with an adjuvant to deliver immunity against all serotypes of the bacteria.\", \"To support pre-clinical and early clinical development of a novel TB vaccine for use in high burden countries in the developing world\", \"To optimize and augment methods to identify mucosal immune factors that may contribute to HIV prevention and vaccine-induced protection.\", \"To increase capacity to conduct HIV vaccine clinical trials, including licensure trials, in highly impacted populations in clade C region of southern Africa.\", \"To provide technical assistance for the Institute of Medical Biology\\u2019s pursuit of World Health Organization prequalification for their Sabin Inactivated Poliovirus vaccine (sIPV)\", \"To work to develop a single dose vaccine that can be given as close to birth as possible to protect against multiple diseases.\", \"To develop a vaccine imunogen capable of eliciting broadly neutralizing antibodies to prevent infection with the HIV strains most common in Africa\", \"To study the complex sugar coating that surrounds and protects HIV to see if parts of this shield can serve as targets for a vaccine\", \"To develop a novel vaccine approach that is based on blocking mosquito transmission of these disease agents rather than inducing pathogen-specific immunity.\", \"To establish a program to search for new innovative, potentially high risk, ideas/technologies that may offer promise to the HIV vaccine research and development field\", \"To leverage recent discoveries involving the immunobiology of TLR11 to develop a tractable small animal model for preclinical testing of ETEC vaccine candidates.\", \"To develop an IPV vaccine adjuvanted with CAF01 that is able to promote significant dose-sparing and enhance mucosal immunity.\", \"To support cholera modeling activities using data from endemic and epidemic settings, in order to better understand how to target vaccine use for highest impact\", \"To incorporate engineered frameshifting gene cassettes into vaccine vectors in hopes of eliciting broader T helper and cytotoxic T cell response, leading to better protection against disease.\", \"To develop a novel vaccine against salivary proteins of sand fl ies with the aim to induce a strong immune response against the parasite\", \"To develop a mutable vaccine in which the gene coding for the antigen mutates a million times more frequently than a typical gene to trigger immune response\", \"To produce a multi-stage malaria vaccine using transgenic sporozoites, generating protective immunity against early stages of infection and antibodies to block transmission via mosquitoes\", \"To develop a low-cost, single-dose, oral polio vaccine using a live, safe adenovirus containing protein-encoding genes from poliovirus.\", \"To develop an evidence base for the determinants of maternal vaccine acceptance to inform future maternal vaccination demand creation strategies in low- and middle-income countries\", \"To develop novel pulsed antigen-releasing single-injection vaccine delivery systems to facilitate pediatric immunizations in Developing World circumstances where repeated patient access can be problematic.\", \"To provide a low cost pneumococcal vaccine to reduce morbidity and mortality from pneumococcal diseases of infants and children in developing countries\", \"To target T-cells against ERV antigens. If true, new host-directed vaccines could be developed to eliminate HIV infected cells.\", \"To convene a meeting of experts in meningococcal disease to determine how to monitor the long-term impact of meningococcal vaccines in Africa\", \"To develop a standardized analytical commutability protocol that Developing Country Vaccine Manufacturers may use for evaluating Vi-conjugate ELISA assays and reference standards to support product registration\", \"To better monitor viral infections and vaccine efficacy in populations throughout the world in order to enhance our ability to improve human health and detect emerging epidemics\", \"To disseminate the most up-to-date information on gastric cancer and the development of possible vaccines; and to encourage research and collaboration on gastric cancer worldwide\", \"To test whether a prototype malaria vaccine which targets a newly identifi ed dendritic cell molecule will produce a strong antibody response without the use of adjuvants.\", \"To produce libraries of DNA fragments encoding thousands of peptides from malaria parasite proteins, for use in production and testing of malaria vaccine formulations\", \"To test novel technologies for developing more effective neonatal vaccines to improve infant health and survival, particularly in low income countries and the world's poorest communities\", \"To develop a single-injection delayed-release T-solium (swine tapeworm) vaccine that would require a one-time access to facilitate control programs in the Developing World\", \"To identify why oral poliovirus and rotavirus vaccines are less effective in the developing world, in order to develop new approaches to protect children from enteric diseases\", \"To reduce the burden of cholera through the deployment of the killed whole cell oral cholera vaccine in endemic and epidemic settings\", \"To enhance IDRI\\u2019s capabilities to provide industry quality adjuvants and formulations for the development of vaccines for diseases in the developing world\", \"To analyze paired mother infant sera from HIV positive mothers to determine the effectiveness of trans-placental antibody transfer for vaccine preventable diseases (flu, pneumo, and tetanus)\", \"To enhance global awareness and visibility of AIDS vaccine research and development in developing countries among the general public and decisionmakers\", \"To explore whether green fluorescent protein is endowed with unique immunological properties which could be used to develop a universal fl u vaccine.\", \"To develop an oral vaccine for tuberculosis that uses rice seeds that express proteins that will induce immunity in the gastrointestinal tract and in the respiratory mucosa.\", \"To reduce disability and deaths due to cholera in epidemic and outbreak settings through the introduction of an additional control tool, oral cholera vaccines\", \"To develop a comprehensive framework and tools for a systematic and coordinated approach to rotavirus vaccine implementation evaluation at country, regional, and global levels\", \"To support for the 2016 Sabin Gold Medal Award which recognizes individuals who have helped to reduce needless human suffering from vaccine-preventable and neglected tropical diseases\", \"To develop live bacterial-based contraceptive vaccines that deliver testis- and sperm-specific antigens to sterilize rodent populations that destroy food crops.\", \"To define the relationship between anti-HIV-1 Env antibody specificity and Fc-mediated effector function to guide HIV-1 vaccine development\", \"To develop a library of media compounds needed to optimize in vitro production of infective malaria sporozites needed for use in an effective vaccine\", \"To define the qualities of an HIV vaccine that will make it sufficiently immunogenic to elicit protective responses in humans\", \"To enable and drive the development of improved and appropriate vaccines against invasive pneumococcal disease for use in high burden low income countries\", \"To use a genetic approach to identify cellular targets that mediate adjuvant effects to accelerate the design of vaccines against globally persistent pathogens\", \"To develop a versatile pollen mimetic transcutaneous vaccination platform with built-in adjuvant properties for needle-free transdermal delivery of vaccine antigens via hair follicles\", \"To develop an Animal Health Services Franchising Business for the delivery of vaccines and pharmaceuticals to smallholder farmers in Kenya\", \"To convene experts in HIV virology and vaccinology to examine role of acute and early infections in HIV vaccine development.\", \"To prevent deaths from vaccine-preventable diseases (VPD) by developing an accurate and field-friendly method to assess effective vaccination coverage in young children\", \"To try to improve the immune response to oral poliovirus vaccine among children in India by treating enteric infections before vaccination.\", \"To provide critical evidence about the population impact of a highly promising pneumococcal conjugate vaccine, PCV10, on radiologically and ultrasound confirmed pneumonia in rural Bangladesh\", \"To guide development of broadly effective vaccines against enteric infections by measuring etiology and burden of severe diarrhea among young children in developing countries\", \"To test the hypothesis that immunizing newborns with soluble rather than particulate antigens will overcome maternal-mediated suppression of infant immune responses to vaccines.\", \"To develop a tuberculosis vaccine that uses polyester biobeads produced in mycobacteria that carry a large repertoire of known and undiscovered antigens on their surface.\", \"To test computational design and experimental approaches that could lead to significantly improved next generation vaccine candidates for human immunodeficiency virus/simian immunodeficiency virus (HIV/SIV)\", \"To develop a printable label that can be used on vaccines to indicate when contents have surpassed a set temperature threshold or exceeded a cumulative temperature limit.\", \"To test the Nearest Neighbor immunogen hypothesis and could lead to significantly improved next generation HIV-1 Env vaccine candidates\", \"To convene an international conference to discuss and share broadly the latest HIV vaccine, microbicide, and ARV-based prevention research\", \"To explore the technical and regulatory feasibility of Micropellet technology for the development of cost-effective novel combination vaccines that are thermal stable\", \"To support development of an attenuated Plasmodium falciparum sporozoite vaccine to reduce malaria infection, morbidity, and mortality in infants and children in Africa\", \"To evaluate the capacity of a new intradermal vaccine using polypropylene sulfide nanoparticles to induce immunity against HIV, Tuberculosis, and Cytomegalovirus infections\", \"To develop the concept that a vaccine can prevent HIV transmission by the trapping of virus-antibody complexes in cervical and cervical/vaginal mucus\", \"To fund the activities of the ACO which support the Alliance in their work on developing a safe, effective and globally accessible HIV vaccine\", \"To develop children\\u2019s ankle bands with electrochemical indicators that change color at specified intervals to remind mothers of their childrens\\u2019 vaccine due dates.\", \"To develop and test an aluminum wicking medium that can be used in an evaporative, passive-cooling refrigeration system for vaccine storage and delivery in dry climates.\", \"To plan for clinical and environmental surveillance of enteric fever in India, and to identify sites of vaccine evaluation with or without complementary sanitary interventions\", \"To engineer Salmonella and Shigella vaccine vectors to overproduce an essential antigen to stimulate gamma delta T cells, to boost mucosal immune response against these enteric pathogens\", \"To develop novel vaccines against HIV, with an approach to modify HIV envelope protein to enhance its immunogenic potency for clinical development\", \"To develop a new oral poliovirus type 2 vaccine (OPV-2) to greatly improve the chances of success of the global eradication of all three poliovirus serotypes\", \"To develop a safe, effective and affordable vaccine for the prevention and control of HIV-AIDS, especially in developing countries\", \"To create requirements and engineering specifications to develop new \\u201cnet zero energy\\u201d warehouse and distribution systems for vaccines and drugs in developing countries.\", \"To conduct the Global Health Series of conferences on HIV/AIDS, tuberculosis, malaria, parasitic diseases, and common infectious disease challenges, such as vaccine development\", \"To evaluate the infant response to pneumococcal vaccination in a Belgian cohort of infants whose mothers were previously vaccinated with tetanus, diphtheria, acellular pertussis vaccine (Tdap)\", \"To develop microcapsules that allow vaccines to be released only after bypassing the acidic stomach environment and arriving at the mucosal tissues of the lower gastrointestinal tract\", \"To discover novel pathways of host defense against Mtb that will impact development of vaccines and host-directed therapies for tuberculosis\", \"To understand host factors associated with infection of tuberculosis in order to develop new diagnostic tools, host-directed therapeutics or vaccines\", \"To test a mobile phone short message service (SMS) system that provides texts to parents to improve timely immunizations, increase vaccine acceptance, and report of side effects.\", \"To develop evidence for improving the performance of live, attenuated, orally delivered rotavirus vaccines in infants in the developing world\", \"To develop an efficacious vaccine against malaria using novel nanoparticle-based technologies termed Interbilayer-Crosslinked Multilamellar Vesicles (ICMVs) and malarial antigens\", \"To improve infant vaccine responses and early childhood development by identifying the mechanisms of and solutions to the detrimental impact of maternal parasitic infection.\", \"To determine whether novel synthetic molecules (imidazoquinolines) are able to activate newborns white blood cells as candidate vaccine adjuvants to dramatically enhance immunization of infants.\", \"To develop a customizable Geographical Information System web application platform that integrates existing data in a particular region to maximize delivery of vaccines to target populations.\", \"To reduce disability and deaths due to cholera in epidemic settings through the introduction of oral cholera vaccines, an additional control tool\", \"To develop a mobile-phone based \\u201cbulletin-board\\u201d for capturing and broadcasting availability and demand information for vaccines and medicines.\", \"To support the development of novel vaccine approaches that aim to decrease transmission of the Malaria parasite from mosquito to human\", \"To establish an internet-based global monitoring and rapid alert system for finding, analyzing, and counteracting misinformation communication campaigns regarding vaccines to support global immunization efforts.\", \"To provide foundation grantees with novel and innovative industry quality adjuvants and formulations to enhance the success of pre-clinical and clinical vaccine development\", \"To support a project to develop a public haplotype resource for monitoring drug resistance, vaccine responses, and markers of disease severity in malaria\", \"To expand efforts to identify populations and build capacity in India where future pivotal TB vaccine trials can be conducted\", \"To futher develop \\u201choming factors\\u201d as vaccine adjuvants that induce the development of memory T cells and generate site-specific immunity against pathogens in the gut.\", \"To evaluate the effect of high levels of maternal antibody on the infant's response to pneumococcal conjugate vaccine given in the routine infant schedule\", \"IGF::OT::IGF STAGED VACCINE DEVELOPMENT\", \"IGF::OT::IGF STAGE VACCINE DEVELOPMENT\", \"IGF::OT::IGF PRODUCTION OF PDNA VACCINE EXPRESSING FLSC\", \"Task X10: Ebola Vaccine Immunogenicity and Efficacy Testing\", \"STAGED VACCINE DEVELOPMENT OF ADENIVIRUS-4 VECTORED VACCINE FOR HUMAN IMMUNODEFICIENCY VIRUS\", \"\\u30c7\\u30f3\\u30b0\\u71b1, \\u51fa\\u8840\\u71b1\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u514d\\u75ab\\u5b66\\u7684\\u6027\\u72b6\\u306e\\u691c\\u8a0e\\u306a\\u3089\\u3073\\u306b\\u305d\\u308c\\u306b\\u57fa\\u304f\\u30ef\\u30af\\u30c1\\u30f3\\u8a66\\u4f5c\\u306e\\u7814\\u7a76\", \"\\u30b8\\u30d5\\u30c6\\u30ea\\u30a2(D)\\u767e\\u65e5\\u54b3(P)\\u7834\\u50b7\\u98a8(T)\\u9ebb\\u75b9(M)\\u6df7\\u5408\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5b9f\\u7528\\u5316\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76(\\u7d992\\u5e74)\", \"\\u7d30\\u83cc\\u611f\\u67d3\\u75c7\\u306e\\u65b0\\u3057\\u3044\\u59ff\\u306e\\u628a\\u63e1\\u53ca\\u3073\\u83cc\\u4ea4\\u4ee3\\u75c7\\u306e\\u4e88\\u9632\\u6cbb\\u7642\\u306b\\u95a2\\u3059\\u308b\\u57fa\\u790e\\u7684\\u7814\\u7a76(\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5)\", \"\\u767e\\u65e5\\u54b3\\u8597\\u306e\\u7523\\u751f\\u3059\\u308b\\u8d64\\u8840\\u7403\\u51dd\\u96c6\\u7d20\\u306e\\u7c21\\u6613\\u8fc5\\u901f\\u306a\\u5206\\u96e2\\u7cbe\\u88fd\\u3068\\u6539\\u826f\\u767e\\u65e5\\u54b3\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"\\u6bd2\\u7d20\\u30d5\\u30e9\\u30b0\\u30e1\\u30f3\\u30c8\\u3092\\u5fdc\\u7528\\u3057\\u305f\\u73fe\\u884c\\u306e\\u3082\\u306e\\u306b\\u304b\\u308f\\u308b\\u7834\\u50b7\\u98a8\\u30ef\\u30af\\u30c1\\u30f3\\u3068\\u6297\\u6bd2\\u7d20\\u6a19\\u6e96\\u5316\\u6cd5\\u306e\\u4f5c\\u6210\", \"NDV\\u4e0d\\u6d3b\\u5316\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u5bfe\\u3059\\u308b\\u6297\\u4f53\\u7523\\u751f\\u80fd\\u306e\\u7570\\u306a\\u308b\\u30a6\\u30ba\\u30e9\\u306e\\u80b2\\u7a2e\\u3068\\u9078\\u629c\\u7cfb\\u306e\\u514d\\u75ab\\u5b66\\u7684\\u7279\\u6027\", \"\\u30de\\u30e9\\u30ea\\u30a2\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306e\\u57fa\\u790e\\u7684\\u7814\\u7a76:\\u30de\\u30e9\\u30ea\\u30a2\\u539f\\u866b\\u5f37\\u6bd2\\u682a\\u3068\\u5f31\\u6bd2\\u682a\\u3068\\u306e\\u907a\\u4f1d\\u5b50\\u767a\\u73fe\\u306e\\u6bd4\\u8f03\", \"\\u30de\\u30e9\\u30ea\\u30a2\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306e\\u57fa\\u790e\\u7684\\u7814\\u7a76:\\u30de\\u30e9\\u30ea\\u30a2\\u539f\\u866b\\u5f37\\u6bd2\\u682a\\u3068\\u5f31\\u6bd2\\u682a\\u3068\\u306e\\u907a\\u4f1d\\u5b50\\u767a\\u73fe\\u306e\\u6bd4\\u8f03\", \"\\u30de\\u30e9\\u30ea\\u30a2\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u306e\\u57fa\\u790e\\u7684\\u7814\\u7a76:\\u30de\\u30e9\\u30ea\\u30a2\\u539f\\u866b\\u5f37\\u6bd2\\u682a\\u3068\\u5f31\\u6bd2\\u682a\\u3068\\u306e\\u907a\\u4f1d\\u5b50\\u767a\\u73fe\\u306e\\u6bd4\\u8f03\", \"Structural characterization of major timothy grass pollen allergens: Basis for the rational development of vaccines against grass pollen allergy\", \"Structural characterization of the major timothy grass pollen allergen, Phl p: Basis for the rationale development of vaccines against grass pollen allergy\", \"A Phase I Study of a Bcr-abl peptide based Vaccine with GM-CSF as an Adjuvant in Patients with Chronic Myleogenous Leikemia\", \"A Phase I Study of a Bcr-abl peptide based Vaccine with GM-CSF as an Adjuvant in Patients with Chronic Myleogenous Leukemia\", \"Rescue of Infectious Newcastle Disease Virus (NDV) from Cloned cDNA for the development of a Novel Vaccine against AIDS\", \"IL-27\\u306b\\u3088\\u308a\\u5206\\u5316\\u8a98\\u5c0e\\u3057\\u305fDC\\u524d\\u99c6\\u7d30\\u80de\\u3092\\u7528\\u3044\\u305f\\u65b0\\u3057\\u3044\\u764cDC\\u30ef\\u30af\\u30c1\\u30f3\\u7642\\u6cd5\\u306e\\u958b\\u767a\", \"NKT\\u7d30\\u80de\\u3068\\u6a39\\u72b6\\u7d30\\u80de\\u306b\\u3088\\u308b\\u4e0a\\u6c17\\u9053\\u7c98\\u819c\\u514d\\u75ab\\u5fdc\\u7b54\\u306e\\u89e3\\u6790\\u3068\\u7d4c\\u9f3b\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5c55\\u958b\", \"Dynamics of Pneumococcal carriage and emergence of high virulence clone after introduction of vaccine in Japan\", \"Development of vaccines against leishmaniasis using polyvalent CDV vaccine and cytokine adjuvant.\", \"DNA macromolecule as a vaccine antigen scaffold for organization of the antigens into repetitively ordered arrays\", \"Malaria vaccine platform technology\", \"Development of an oral delivery vehicle for HIV-1 DNA vaccines to stimulate mucosal immune responses\", \"Vaccine development against hepatitis virus by transcutaneous peptide immunization with TLR7 ligand.\", \"Development of vaccine therapy for pulmonary arterial hypertension\", \"\\u767e\\u65e5\\u54b3\\u83cc\\u306e\\u611f\\u67d3\\u6210\\u7acb\\u6a5f\\u69cb\\u306e\\u89e3\\u660e\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u3078\\u306e\\u5fdc\\u7528\", \"M13\\u30d5\\u30a1\\u30fc\\u30b8\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308bB\\u7d30\\u80de\\u6d3b\\u6027\\u5316\\u6a5f\\u69cb\\u306e\\u89e3\\u660e\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u52b9\\u679c\\u306e\\u691c\\u8a0e\", \"Development of the noninvasive nasal spray vaccine for prevention of cervical cancer using the next generation type virus vector.\", \"Analysis of mechanisms related to the induction of mucosal immunity in Peyer's patches against oral vaccine\", \"Basic research for \\\"RSV pregnant women vaccine\\\" by clinical isolates aimed at overcoming RSV infection\", \"\\u6297\\u7d50\\u6838\\u30ef\\u30af\\u30c1\\u30f3\\u52b9\\u679c\\u306e\\u5897\\u5f37\\u3092\\u76ee\\u6307\\u3057\\u305f\\u7d50\\u6838\\u83cc/BCG\\u306b\\u3088\\u308b\\u9632\\u5fa1\\u514d\\u75ab\\u5236\\u5fa1\\u6a5f\\u5e8f\\u306e\\u89e3\\u660e\", \"\\u907a\\u4f1d\\u5b50\\u7d44\\u63db\\u3048\\u30cb\\u30ef\\u30c8\\u30ea\\u3092\\u7528\\u3044\\u305f\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u88fd\\u9020\\u306e\\u52b9\\u7387\\u5316\\u306b\\u5411\\u3051\\u305f\\u7814\\u7a76\", \"\\u30d8\\u30d1\\u30c8\\u30be\\u30fc\\u30f3\\u306b\\u5bfe\\u3059\\u308b\\u514d\\u75ab\\u5fdc\\u7b54\\u306b\\u95a2\\u4e0e\\u3059\\u308b\\u6297\\u539f\\u86cb\\u767d\\u306e\\u540c\\u5b9a\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5fdc\\u7528\", \"Vaccines against periodontitis using DNA ORIGAMI and imidazoquinolines\", \"\\u4e0b\\u75e2\\u75c7\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u5206\\u5b50\\u75ab\\u5b66\\u3001\\u69cb\\u9020\\u306e\\u7279\\u5fb4\\u3001\\u9032\\u5316\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u8a2d\\u8a08\", \"Development of a new influenza vaccine of global standard.\", \"\\u5fc3\\u7b4b\\u6897\\u585e\\u306b\\u5bfe\\u3059\\u308b\\u30a2\\u30f3\\u30b8\\u30aa\\u30c6\\u30f3\\u30b7\\u30f3\\uff12\\u30ef\\u30af\\u30c1\\u30f3\\u3092\\u7528\\u3044\\u305f\\u65b0\\u898f\\u6cbb\\u7642\\u6cd5\\u306e\\u958b\\u767a\", \"\\u30aa\\u30ea\\u30b4\\uff24\\uff2e\\uff21\\u30ab\\u30d7\\u30bb\\u30eb\\u3092\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u3068\\u3059\\u308b\\u4e73\\u9178\\u83cc\\u7d4c\\u53e3\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5275\\u88fd\", \"\\u7d44\\u63db\\u3048\\u30ef\\u30af\\u30b7\\u30cb\\u30a2\\u30a6\\u30a4\\u30eb\\u30b9\\u3092\\u7528\\u3044\\u305f\\u6297\\uff28\\uff34\\uff2c\\uff36\\uff0d\\uff11\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u72c2\\u72ac\\u75c5\\u30a6\\u30a4\\u30eb\\u30b9\\u306e\\u4f1d\\u64ad\\u30c0\\u30a4\\u30ca\\u30df\\u30af\\u30b9\\u53ca\\u3073\\u30ef\\u30af\\u30c1\\u30f3\\u6226\\u7565\\u7814\\u7a76\", \"\\u30d8\\u30ea\\u30b3\\u30d0\\u30af\\u30bf\\u30fc\\u30d4\\u30ed\\u30ea\\u306e\\u75c5\\u539f\\u6027\\u56e0\\u5b50\\u3068\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"\\u7cd6\\u9396\\u6297\\u539f\\u306e\\u5316\\u5b66\\u5408\\u6210\\u3068\\u8907\\u5408\\u578b\\u5408\\u6210\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u5c55\\u958b\", \"\\u30ef\\u30af\\u30c1\\u30f3\\u30cf\\u30b6\\u30fc\\u30c9\\u306e\\u514b\\u670d\\u3092\\u76ee\\u6307\\u3057\\u305f\\u65b0\\u898f\\u7d4c\\u76ae\\u30ca\\u30ce\\u30ad\\u30e3\\u30ea\\u30a2\\u306e\\u8a2d\\u8a08\", \"Enhancement of protection against various microbial infection by the modification of dominance of Thl or Th2 immune responses\", \"\\u043d\\u0430\\u0443\\u0447\\u043d\\u043e\\u0439 \\u043a\\u043e\\u043d\\u0444\\u0435\\u0440\\u0435\\u043d\\u0446\\u0438\\u0438-14 \\u0432\\u0441\\u0442p\\u0435\\u0447\\u0430 \\u0415\\u0432p\\u043e\\u043f\\u0435\\u0439\\u0441\\u043a\\u043e\\u0433\\u043e \\u043e\\u0431\\u0449\\u0435\\u0441\\u0442\\u0432\\u0430 \\u043f\\u043e \\u0442\\u0435\\u0445\\u043d\\u043e\\u043b\\u043e\\u0433\\u0438\\u0438 \\u043a\\u043b\\u0435\\u0442\\u043e\\u043a \\u0436\\u0438\\u0432\\u043e\\u0442\\u043d\\u044b\\u0445 \\\"\\u0422\\u0435\\u0445\\u043d\\u043e\\u043b\\u043e\\u0433\\u0438\\u044f \\u043a\\u043b\\u0435\\u0442\\u043e\\u043a \\u0436\\u0438\\u0432\\u043e\\u0442\\u043d\\u044b\\u0445: \\u043e\\u0442 \\u0432\\u0430\\u043a\\u0446\\u0438\\u043d \\u0434\\u043e \\u043c\\u0435\\u0434\\u0438\\u0446\\u0438\\u043d\\u0441\\u043a\\u043e\\u0439 \\u0433\\u0435\\u043d\\u0435\\u0442\\u0438\\u043a\\u0438\", \"\\u043c\\u0435\\u0436\\u0434\\u0443\\u043d\\u0430\\u0440\\u043e\\u0434\\u043d\\u043e\\u0439 \\u043a\\u043e\\u043d\\u0444\\u0435\\u0440\\u0435\\u043d\\u0446\\u0438\\u0438 \\u043f\\u043e\\u0434 \\u044d\\u0433\\u0438\\u0434\\u043e\\u0439 European Society for Animal Cell Technology 14th ESACT Meeting Animal Cell Technology: from Vaccines to Genetic Medicine\", \"A double-blind placebo-controlled trial of an HLA-restricted, allergen-derived T cell peptide vaccine in cat-allergic asthma\", \"Vaccine and Treatment Evaluation Unit - Assay Work for CMV Vaccines\", \"Task X9: Development of Standardized Filovirus Immune Assays and Reagents\", \"Dendritic-cell (DC) based vaccines; influence of DC maturational stage and maturational stimuli on their efficacy to induce a specific anti-tumor T cell response.\", \"Feline leukemia virus infection: Factors that influence the sus- ceptibility of the host, the pathogenesis of the infection, and the efficacy of vaccines\", \"Development of a specific immunotherapy in pollen related food allergy: low IgE binding carrot allergens as potential vaccines. (MHV-Beitrag)\", \"A fine characterization of the T cell response induced by active immunization in melanoma patients: a pivotal step for vaccine development.\", \"Analysis of particular features of the immune responses to vaccine antigens during the neonatal period: importance of antigen presentation systems. (S C O R E A)\", \"Analysis of particular features of the immune responses to vaccine antigens during the neonatal period: importance of anti- gen presentation systems\", \"Studies of the cross-protective antibodies elicited after immunization with E.coli J5 vaccine for the prevention of gram-negative shock and death\", \"A randomised Feasability adjuvant autologous renal carcinoma vaccine (ARCV) comparing ARCV to ARCV/interleukin-2 to control (the ART trial)\", \"Understanding success or failure: evaluating DNA vaccine-induced human CD8+ T-cell responses as a function of peptide-MHC stability\", \"Enhanced dendritic cell recruitment and anti-tumor efficacy in a breast cancer DNA vaccine that includes IRES driven expression of cytokine biological adjuvants\", \"\\u53ef\\u6298\\u53e0\\u56db\\u4ef7A\\u03b215\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u7279\\u5f02\\u6027\\u53ca\\u5b89\\u5168\\u6027\\u7814\\u7a76\", \"\\u65b0\\u578bDC\\u9776\\u5411\\u6027MUC1-VNTRn\\u7eb3\\u7c73\\u6838\\u9178\\u75ab\\u82d7\\u7684\\u4f18\\u5316\\u6784\\u5efa\\u53ca\\u6297\\u80f0\\u817a\\u764c\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u542bHSV-2 gD\\u57fa\\u56e0\\u91cd\\u7ec4\\u817a\\u75c5\\u6bd2\\u4fee\\u9970\\u7684\\u6297II\\u578b\\u5355\\u7eaf\\u75b1\\u75b9\\u75c5\\u6bd2\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"\\u4e73\\u9178\\u4e73\\u7403\\u83cc\\u9012\\u5448\\u7684\\u55dc\\u80ba\\u519b\\u56e2\\u83cc\\u65b0\\u578bFlaA/MompS\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u548c\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"\\u65b0\\u578b\\u53cc\\u529f\\u80fd\\u9776\\u5411\\u6cbb\\u7597\\u6027\\u878d\\u5408\\u86cb\\u767d\\u75ab\\u82d7\\u53ca\\u5176\\u6291\\u7624\\u4f5c\\u7528\\u7814\\u7a76\", \"\\u6297\\u80bf\\u7624\\u8840\\u7ba1\\u751f\\u6210\\u65b0\\u578b\\u4f50\\u5242\\u75ab\\u82d7Hydrolipid-bFGF\\u6297\\u80bf\\u7624\\u4f5c\\u7528\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\", \"\\u6709\\u6548\\u6d3b\\u5316\\u7c98\\u819c\\u514d\\u75ab\\u53cd\\u5e94\\u7684\\u827e\\u6ecb\\u75c5\\u75ab\\u82d7\\u7b56\\u7565\\u7814\\u7a76\", \"\\u4ee5\\u58f3\\u805a\\u7cd6\\u4e3a\\u8f7d\\u4f53\\u7684\\u5c4b\\u5c18\\u87a8\\u4f4e\\u53d8\\u5e94\\u539f\\u6027DNA\\u9ecf\\u819c\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u9f3b\\u8154\\u514d\\u75ab\\u6548\\u679c\\u7814\\u7a76\", \"\\u4eba\\u9ad8\\u81f4\\u75c5\\u6027\\u79bd\\u6d41\\u611fH5N1\\u75c5\\u6bd2\\u901a\\u7528\\u578b\\u75ab\\u82d7\\u57fa\\u7840\\u7814\\u7a76\", \"\\u827e\\u6ecb\\u75c5\\u81ea\\u7136\\u611f\\u67d3\\u4e0e\\u75ab\\u82d7\\u8bf1\\u5bfc\\u4ea7\\u751f\\u6297\\u4f53\\u7684\\u9274\\u522b\\u7814\\u7a76\", \"\\u4ee5\\u53d1\\u5939RNA\\u8868\\u8fbe\\u76d2\\u4f5c\\u4e3a\\u4f50\\u5242\\u7684\\u65b0\\u578bDNA\\u75ab\\u82d7\\u8f7d\\u4f53\\u7814\\u7a76\", \"\\u7ed3\\u6838\\u5206\\u679d\\u6746\\u83cc\\u6301\\u7eed\\u611f\\u67d3\\u671f\\u6297\\u539f(latency antigens)\\u7684\\u91cd\\u7ec4BCG\\u75ab\\u82d7\\u7814\\u7a76\", \"hCGbeta-CTP\\u591a\\u805a\\u4f53\\u548cC3d\\u7247\\u6bb5\\u5d4c\\u5408\\u80bd\\u7684\\u751f\\u7269\\u5408\\u6210\\u53ca\\u5176\\u5728\\u80bf\\u7624\\u6cbb\\u7597\\u4e2d\\u7684\\u5e94\\u7528\", \"\\u566c\\u83cc\\u4f53\\u6d3b\\u8f7d\\u4f53HPV16\\u300118\\u8054\\u5408\\u591a\\u4ef7\\u9884\\u9632\\u6027\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u53cc\\u5206\\u5b50\\u4fee\\u9970\\u7684\\u6297\\u539f\\u9012\\u5448\\u7ec6\\u80de\\u9776\\u5411\\u80bf\\u7624\\u7eb3\\u7c73\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u5375\\u900f\\u660e\\u5e26DNA\\u907f\\u5b55\\u75ab\\u82d7\\u8bf1\\u53d1\\u751f\\u6b96\\u9053\\u7c98\\u819c\\u514d\\u75ab\\u53cd\\u5e94\\u7684\\u7814\\u7a76\", \"\\u901a\\u7528\\u578bDC\\u9776\\u5411\\u8102\\u8d28\\u4f53\\u75ab\\u82d7\\u7684\\u6297\\u80bf\\u7624\\u4f5c\\u7528\\u673a\\u7406\\u7814\\u7a76\", \"\\u75ab\\u82d7\\u591a\\u80bd\\u7eb3\\u7c73\\u8f7d\\u836f\\u65b0\\u5206\\u5b50\\u7684\\u7814\\u7a76\", \"\\u6d3e\\u4f0a\\u5c14\\u96c6\\u5408\\u6dcb\\u5df4\\u7ed3\\u5b9a\\u4f4d\\u53e3\\u670d\\u75ab\\u82d7\\u7eb3\\u7c73\\u7c92\\u7ed9\\u836f\\u7cfb\\u7edf\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u809d\\u7d20\\u9176CTL\\u8868\\u4f4d\\u591a\\u6297\\u539f\\u80bd(MAP)\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u53ca\\u5176\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"PB\\u8f6c\\u5ea7\\u5b50\\u4ecb\\u5bfc\\u7684\\u81ea\\u6740\\u57fa\\u56e0\\u5bf9\\u81ea\\u4f53\\u80bf\\u7624\\u6d3b\\u75ab\\u82d7\\u7684\\u9776\\u5411\\u6740\\u4f24\\u4f5c\\u7528\", \"\\u95f4\\u65e5\\u759f\\u591a\\u8868\\u4f4d\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u5ba4\\u7814\\u7a76\", \"\\u4eba\\u4e73\\u5934\\u7624\\u75c5\\u6bd216\\u578bE7\\u6838\\u9178\\u75ab\\u82d7\\u7684\\u5236\\u5907\\u7814\\u7a76\", \"PSCA\\u9897\\u7c92-DNA\\u590d\\u5408\\u75ab\\u82d7\\u6297\\u80f0\\u817a\\u764c\\u6548\\u5e94\\u7684\\u7814\\u7a76\", \"\\u7518\\u9732\\u7cd6\\u5316\\u58f3\\u805a\\u7cd6\\u4ecb\\u5bfc\\u7684\\u6297\\u52a8\\u8109\\u7ca5\\u6837\\u786c\\u5316DNA\\u75ab\\u82d7\\u7ecf\\u7c98\\u819c\\u514d\\u75ab\", \"Next Generation of Multivalent Adenovirus Vaccines Based on Novel Virus-Like Particle (VLP) Technology\", \"Generating regional rotavirus vaccine strains through reverse genetics to alleviate viral diarrhoea in Africa (Senior Fellowship for Dr. Hester Gertruida O'Neill)\", \"Entwicklung RNS basierter Impfstoffe zur Induktion integrierter T und B-Zellimmunantworten gegen molekular definierte Tumorantigene              (A15)\", \"Evaluierung der Effektivit\\u00e4t der Vakzinebehandlung des Prostatakarzinoms in Kombination mit nicht-myeloablativer Knochenmarktransplantation im Tiermodell\", \"Bestimmung der antigen-Spezifit\\u00e4t der T-Zellantwort gegen eine genmodifizierte, polyvalente Vakzine bei der chronischen lymphatischen Leuk\\u00e4mie (CLL)              (C 4)\", \"Native display of Borrelia antigens on the surface of hepatitis B virus capsids: Improved prophylactic and potential therapeutic vaccines against Lyme disease\", \"Identification of low-molecular mass ligands for targeting of subunit vaccines to Peyer`s patch M cells\", \"Das Merozoitenoberfl\\u00e4chenprotein 1 (MSP-1), ein Kandidat f\\u00fcr einen Impfstoff gegen P.falciparum-Infektionen: Untersuchungen zur zellul\\u00e4ren Immunantwort des Menschen              (A01)\", \"Doustna szczepionka przeciwko endoglinie skojarzona z terapi\\u0105 genow\\u0105 IL-12 polaryzuje mikro\\u015brodowisko nowotworowe z proangiogennego i immunosupresyjnego na \\u015brodowisko antyangiogenne i immunostymuluj\\u0105ce.\", \"Badania nad wielofunkcyjn\\u0105 szczepionk\\u0105 przeciwko C.albicans wykorzystuj\\u0105c\\u0105 kierowanie do kom\\u00f3rek dendrytycznych i aktywacj\\u0119 receptora dektynowego.\", \"Ocena odpowiedzi humoralnej poszczepieniu trzynastowalentn\\u0105 skoniugowan\\u0105 szczepionk\\u0105 pneumokokow\\u0105 u dzieci i m\\u0142odzie\\u017cy z nieswoistymi zapeleniami jeltit.\", \"A multi-pronged approach to find endogenous agRNAs\", \"Development of a proposal on Norwegian engagement and collaborative projects in a phase III trial of oral rotavirus vaccine ORV 116E in Indi\", \"Development of an improved vaccine towards meningococcal disease in sub-Saharan Africa\", \"\\u00c9tude de l immunodominance de type T CD8+ dans un contexte d infection par le Virus de l Immunod\\u00e9ficience Humaine : implications dans l \\u00e9laboration d un nouveau vaccin.\", \"D\\u00e9veloppement de formulations pour vaccins conventionnels suite \\u00e0 l'\\u00e9tude du comportement des particules inject\\u00e9es avec l'injecteur sans aiguille du LOCUS\", \"Development of vaccine concepts that protect farmed fish throughout the entire production cycle\", \"Investigation into the immunological basis for enhancing immunity to Marek's disease by using re-vaccination with Marek's disease vaccines.\", \"The regulation of HIV-1 specific T-cell immune responses: influence of highly active antiretroviral drugs cytokines and vaccines.\", \"For additional refurbishment costs associated with Phase II of the Vaccine Unit of the Division of Infectious Diseases.\", \"Development of a bivalent vaccine against hepatitis B and C viruses\", \"Nisin obtention in milk whey medium, evaluation of antimicrobial application in food biopreservation, pharmaceutics products; and vaccines adjuvant\", \"Recombinant BCG expressing Pasteurella antigens\", \"To enhance the IIS for AFIX assessment functionality so the IIS, IRIS, will serve as a single reference source to ensure consistent vaccine coverage reporting statewide.\", \"Testing of a Novel Skin Electroporation Procedure for Multivalent Alphavirus DNA Vaccine Delivery\", \"Marine Mammal Vaccines\", \"Innovative Manufacturing Techniques for Polysaccharide-Protein Conjugate Vaccines\", \"Genomic-guided discovery of new interventions against neglected parasitic diseases.\", \"A combined early and late HIV-1 protein-specific exosome-targeted T cell vaccine capable of counteracting immune suppressions and stimulating CD8+ CTL responses in absence of\", \"Development of mucosal vaccines against Bordetella pertussis\", \"The role of bacterial outer membrane proteins in the pathogenesis of chronic lung infection: Potential vaccine candidates or novel drug targets\", \"Chemical Biology on Carbohydrates - Approaches Towards Potential Drugs and Vaccines against Infectious Diseases and Cancer\", \"Breaking the cold chain for oral recombinant vaccines\", \"CROSS-PROTECTION EFFICACY AND CUSTOMIZATION OF THE EBEAM SALMONELLA VACCINE FOR THE POULTRY INDUSTRY\", \"NEXT GENERATION VACCINE FOR INFECTIOUS BOVINE KERATOCONJUCTIVITIS\", \"Development of a Vaccine against the Hepatitis C Virus (HCV) and Demonstration of Efficacy in Intravenous Drug Users\", \"Do Current Immunization Delivery and Surveillance Systems Adequately Promote and Measure Uptake of the Measles, Mumps, Rubella and Varicella (MMR-V) Vaccine?\", \"Inuit women's understanding of human papillomavirus:  implications for health education and prevention in Nunavik, Qu\\u00e9bec\", \"Love alone won't protect your daughter:  HPV vaccine and the moral negotiations of Ontario parents\", \"Development of novel attenuated PRRS vaccine and disease model.\", \"IAH Jenner Influenza Fellowship\", \"THE PURPOSE OF THE PROPOSED PROJECT IS TO ENHANCE THE VERMONT IMMUNIZATION REGISTRY BY RESEARCHING, EVALUATING AND IMPLEMENTING A VACCINE\", \"ENHANCING ALASKAS VACCINE ORDERING & MGMT TOOLS IN THE IMMUNIZATION INFORMATION SYSTEMS (IIS) TO IMPROVE THE INTERFACE WITH CDCs VTRCKS SYSTEM\", \"STAGED VACCINE DEVELOPMENT OF ADENIVIRUS-4 VECTORED VACCINE FOR HUMAN IMMUNODEFICIENCY VIRUS\", \"Task X9: Development of Standardized Filovirus Immune Assays and Reagents\", \"SBIR Phase I: Silk: A New Approach to Developing a Heat-stable Rotavirus Vaccine\", \"''BRUCELLOSIS VACCINES FOR LIVESTOCK''\", \"EVALUATION OF THE ROLE OF CELL-MEDIATED IMMUNITY IN EFFICACY OF EXPERIMENTAL ALTERNATIVE SCHEDULE OF LIVE ATTENUATED RB51 VACCINE AGAINST BRUCELLOSIS IN CATTLE\", \"EVALUATION OF A SEROTYPE 1 MAREKS DISEASE VIRUS (MDV) AS VECTOR VACCINE TO CONTROL INFECTIOUS BURSAL DISEASE (IBD) IN CHICKENS\", \"DEVELOPMENT OF HIGHLY EFFECTIVE VACCINE TO PREVENT FISH TUBERCULOSIS FOR AQUACULTURE\", \"LIVE-ATTENUATED INFLUENZA VIRUSES (LAIV) VACCINES FOR THE PREVENTION AND CONTROL OF SWINE INFLUENZA\", \"TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION\", \"Design Molecular Vaccines for Type 1 Diabetes\", \"Support for the organisation of a study entitled \\\"update of the cost/std database on european vaccine research\\\" held in bergen/norway in 1999\", \"Novel \\\"non live\\\" vaccine for animal healthcare enabling southern Europe to overcome a serious isue in sheep/cattle farming\", \"Integrated diagnostic and recombinant vaccinedevelopment for cowdriosis and anaplasmosis\", \"A network for the development, evaluation and testing of anti-paras ite vaccines in experimental non-human primate models\", \"IDENTIFICATION OF IMMUNOREACTIVE POLYPEPTIDES INVOLVED IN THE IMMUNE RESPONS AGAINST HIV & T-CRUZI AS A BASIS FOR DIAGNOSTIC AND VACCINE DEVELOPMENT\", \"Mapping of T & B cell epitopes on the major surface antigen 1 of plasmodium vivax, a candidate for vaccine development\", \"Development of an improved vaccine against Mycobacterum Tubercolosis\", \"A STUDY OF THE EPIDEMIOLOGY OF TROPICAL BOVINE THEILERIOSIS IN TUNISIA WITH RELEVANCE TO THE DEVELOPMENT OF A VACCINE\", \"PRODUCTION OF A VACCINE TO BOVINE LEUKEMIA VIRUS ; A MODEL SYSTEM OF PREVENTION AGAINST A WORLDWIDE SPREAD RETROVIRUS-INDUCED NEOPLASM\", \"CHARACTERIZATION OF SOLUBLE PLASMODIUM FALCIPARUM ANTIGENS BY MEANS OF DNA-RECOMBINANT TECHNIQUE AND IMMUNOCHEMICAL METHODS WITH THE PURPOSE OF DEVELOPING A MALARIA VACCINE\", \"THE DEVELOPMENT OF SEXUAL STAGE VACCINES OF PLASMODIUM FALCIPARUM FOR SUPPLEMENTARY CONTROL OF MALARIA TRANSMISSION A MOLECULAR BIOLOGICAL APPROACH\", \"LABORATORY AND FIELD EVALUATION OF DEFINED ANTIGEN VACCINES AGAINST SCHISTOSOMA BOVIS AND S. JAPONICUM IN ANIMALS AND OF DEFINED ANTIGENS FOR THE IMMUNODIAGNOSIS OF HUMANS\", \"Development and Early Clinical Evaluation of a conjugate vaccine that protects against typhoid fever caused by the Salmonella enterica serovars typhi and paratyphi\", \"Development of a multivalent Shigella bioconjugate vaccine to prevent deadly diarrhea in children\", \"Development of a multivalent Shigella bioconjugate vaccine to prevent deadly diarrhea in children\", \"Investigation of novel vaccines against Japanese encephalitis virus infection by virus-like particle or genetic vaccination approach.\", \"A randomised comparative study of the immunogenicity of modified, multisite, intradermal post-exposure rabies vaccine regimens.\", \"The development of recombiant modified vaccinia virus Ankara vaccine delivery systems of increased immunogenicity by manipulation of immunomodulatory genes.\", \"Carriage of hypervirulent meningococci before and after the introduction of serogroup C conjugate polysaccharide vaccine in the UK.\", \"Schistosoma mansoni proteases involved in haemoglobin digestion: efficacy as vaccine molecules and elucidation of immunological parameters required for protection.\", \"Development of novel vaccine delivery systems for induction of mucosal immunity in a large animal model\", \"Characterisation and Stability of ISCOM Vaccines\", \"Development of an Attenuated Infectious Laryngotracheitis Virus Vaccine\", \"Development of an anti-Chlamydia vaccine for the koala\", \"Novel lipid-based adjuvants for induction of mucosal immunity\", \"Optimising the body's immune response with a Nanopatch that delivers biomolecules to the skin\", \"Implications for therapy and disease presentation of the changes triggered by the use of the pneumococcal 7-valent conjugate vaccine\", \"The Leishmania SIR2 family-related gene: functional studies and evaluation of SIR2 recombinant DNA and knockout vaccine to protect against Leishmnaniasis\", \"New approach on the development of an efficient vaccine against streptococcal infection by modulating the conditions of expression, production, purification and formulation\", \"New approach on the development of an efficient vaccine against streptococcal infection by modulating the conditions of expression, production, purification and formulation\", \"Integration of Spatial and Social Network Analysis in Vaccine Trials\", \"Development of DNA-based vaccines for bovine viral diarrhoea virus. D\\u00e9veloppement des vaccins \\u00e0 base dADN le virus de diarrh\\u00e9e bovine.\", \"Generation of murine tumor cell lines that express human HLA-A2 and over-express genes of interest for pre-clinical evaluation and novel cancer vaccine development\", \"Development of a vaccine for sterile immunity to infectious salmon anaemia (ISA) virus and diagnostic kits for ISA virus and antibodies\", \"Development of fowl adenovirus as a vaccine for Newcastle disease and as a gene delivery system to improve feed utilization in poultry\", \"Developing MUC-1 cancer vaccines with the caulobacter S-layer:  use of whole cells as a platform for cancer therapy\", \"Generation of murine tumor cell lines that express human HLA-A2 and over-express genes of interest for pre-clinical evaluation and novel cancer vaccine development\", \"Development of a sea lice vaccine for farmed salmon; collaborative research at the Dept. of Agriculture and Fisheries, Marine Laboratory, Aberdeen, Scotland, U.K.\", \"Generation of murine tumor cell lines that express human HLA-A2 and over-express genes of interest for pre-clinical evaluation and novel cancer vaccine development\", \"Development of Immunomodulators and Vaccines to Reduce Fish Infections of the Intracellular Parasite Microsporidia Using In vivo and In vitro Research Techniques\", \"Using reverse vaccinology to identify novel antigens for vaccine development against Mannheimia haemolytica as a model for bacterial agents associated with bovine respiratory disease\", \"Towards a carbohydrate vaccine for HIV-1: Exploring the Immunogenicity and Antigenicity of the Glycan Shield on the HIV-1 Envelope Glycoprotein, gp120\", \"Towards a carbohydrate vaccine for HIV-1: Exploring the Immunogenicity and Antigenicity of the Glycan Shield on the HIV-1 Envelope Glycoprotein, gp120\", \"Understanding and manipulating chemokines and their receptors in the context of adjuvants\", \"Molecular Genetics of Influenza haemagglutinin production: Developing a rational basis for optimising vaccine yield\", \"A multivalent vaccine and single platform diagnostic for bacterial respiratory diseases of pigs\", \"Structurally modified master seed viruses to enhance conventional foot-and-mouth disease virus vaccine protection\", \"A multivalent vaccine and single platform diagnostic for bacterial respiratory diseases of pigs\", \"Production , purification and preparation of various candidiate vaccines\", \"Development and Production of alphavirus vaccines\", \"HIV LCMV vaccines\", \"Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine\", \"Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine\", \"Ebola Vaccine Development\", \"Chlamydial Immunity and Vaccine Development\", \"PHASE I-II TRIAL OF A GENETIC VACCINE FOR HIV INFECTION\", \"COMPARISON OF LEDERLE DTPH AND DTP VACCINES\", \"POTENCY TEST FOR JAPANESE ENCEPHALITIS VIRUS VACCINE, INACTIVATED, LYOPHILIZED\", \"VIROLOGICAL STUDIES OF RECIPIENTS OF HIV-1 VACCINES\", \"Development/production of H5 influenza DNA plasmid vaccine\", \"Ebola Vaccine Development\", \"Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine\", \"Multiclade HIV-1 DNA Plasmid Vaccine With Plasmid Cytoki\", \"Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine\", \"HIV/AIDS Vaccine Development\", \"TESTING OF ROTAVIRUS VACCINE CANDIDATES IN VENEZUELA AND PERU\", \"CLINICAL AND EXPERIMENTAL STUDIES OF HEPATITIS B VACCINES\", \"Guinea Pig Model for Shigellosis\", \"Storage of serum samples from a smallpox vaccine-associated myocarditis study\", \"Mucosal Vector with TLR3 agonist for protection against VEE\", \"DNA Vaccine for Seasonal &Pandemic Influenza\", \"A single-dose prophylactic Japanese Encephalitis vaccine\", \"HIV VACCINE TRAILS NETWORK LEADERSHIP GROUP\", \"Evaluation of a CCR5 Vaccine for HIV infection in the SIV/Macaque Model\", \"PRODUCTION OF NON-EGG GROWN INFLUENZA VACCINES\", \"WHOLE CELL TUMOR VACCINES BASED ON GPI LINKED MOLECULE\", \"CHIMERIC CELL-SURFACE CYTOKINE FOR TUMOR VACCINES\", \"A Novel Immune Modulator/ Adjuvant for HIV Vaccines\", \"Development of a Recombinant Subunit Ebola Vaccine\", \"Novel Adenovirus Vectors for Biodefense Vaccines\", \"Evaluation of rotavirus vaccines in a primate model\", \"DNA Vaccines for Anthrax: Targeting Afferent Immunity\", \"Rational Anthrax Vaccine with Structural Epitopes on VLP\", \"Membrane-Stabilized Lymphotoxin As a Vaccine Adjuvant\", \"A Unique AIDS Vaccine Candidate For Multiple HIV Strains\", \"LIVE ORAL BACTERIAL VACCINE EVALUATION\", \"Rational Approach to Optimize Immune Potency of DNA Vaccines\", \"Mucoadhesive Polymers for Sublingual Vaccine Delivery\", \"Novel DNA/VLP Vaccines Against Influenza\", \"DIFFUSION AND ADOPTION OF CHILDREN'S VACCINE GUIDELINES\", \"THERAPEUTIC VACCINES TO REDUCE OCULAR HSV RECURRENCE\", \"HIV Vaccine Trials in Women\", \"Novel Vaccine Technology for Chikungunya\", \"Effect of Helminth Infection on HIV-1 Vaccines\", \"An Adjuvanted Therapeutic DNA Vaccine for AIDS\", \"Preclinical-Clinical Paramyxovirus Vaccine Development\", \"Therapeutics/Vaccine Teams\", \"Therapeutics/Vaccine Teams\", \"Task 09 (C21): Development of a Murine Model for Plague Vaccines\", \"Reagent Research Support\", \"VACCINE PRODUCTION FACILITY\", \"SIMIAN VACCINE EVALUATION UNITS\", \"SIMIAN VACCINE EVALUATION UNITS\", \"SIMIAN VACCINE EVALUATION UNITS\", \"CD40L and GITRL adjuvants for adenoviral vaccines against HIV\", \"STATISTICAL METHODS FOR ANALYSES OF HIV VACCINE TRIALS\", \"Task A12: SMALL ANIMAL MODELS FOR MYCOBACTERIA  VACCINE TESTING\", \"A dual vaccine strategy against filovirus infection\", \"Impact of maternally derived antibodies and infant microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants.\", \"Evaluation of Protein Capsule Matrix Vaccines Against Campylobacter jejuni\", \"Clinical Evaluation of an Improved Adenovirus Vaccine\", \"A Dengue/Zika Vaccine That Avoids Antibody-Dependent Enhancement\", \"Development of a Universal Influenza B Vaccine\", \"Enhanced Surveillance for New Vaccine Preventable Diseases\", \"Development of a tularemia vaccine that is safer and more potent than LVS\", \"HA Surface Presented Yeast Flu Vaccine and Its Enhancement by CD154 Codisplay\", \"Role of PD1-Based Vaccine-Elicited CD8+ T Lymphocytes in Modulating MDSC-associated Immunosuppression\", \"Antibodies to melanoma vaccine peptides\", \"A NEW CLASS OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) AUTOGENOUS VACCINE PRODUCED IN A NOVEL PORCINE MACROPHAGE CELL LINE\", \"Stabilization of Influenza Vaccine by Silica-Coating\", \"Development of autogenous vaccines for the control of amoebic gill disease in farmed Atlantic salmon\", \"Increasing HPV Vaccine Coverage among Young Adult Gay and Bisexual Men\", \"Next Generation sequencing of yellow fever 17D vaccine virus\", \"NEW MOLECULAR APPROACHES FOR IMPROVED VACCINES TO POULTRY DISEASES\", \"An immunomodulatory yeast-derived beta glucan as a component of a conjugate\", \"Chemical Strategies for Developing Improved Vaccines against Phenethylamines\", \"Development and comparative evaluation of three new generation BRSV DIVA vaccines and a corresponding DIVA test\", \"Enhanced Surveillance for New Vaccine Preventable Disease\", \"PiiiTCH Study\", \"Development of stable and rapidly acting adjuvanted vaccines for biodefense\", \"Bivalent Recombinant LHn Botulinum Vaccine (Serotypes A and B)\", \"Development of a Global GBS Vaccine\", \"Topical adjuvants to enhance the efficacy of influenza vaccines\", \"Prophylactic Anthrax Toxin Vaccine\", \"Development of a Novel Her2/neu Expressing Adenovirus for Treatment\", \"Trivalent Arenaviral Vaccine Based on Virus-Like Particle Vectors (VLPVs)\", \"School Mandates for Human Papillomavirus Vaccination: Use of an Agent-Based Model\", \"Laser-based powder vaccine delivery for improved newborn immunization\", \"Addressing Intra-/Inter-Clade Diversity in HIV Vaccine Design by Immune Focusing\", \"Development of live attenuated influenza virus vaccine\", \"Targeted Gene Expression from NL63 Vaccine Vectors\", \"Vaccine Renaissance Conference at the Institute for Immunology and Informatics\", \"Integration of Spatial and Social Network Analysis in Vaccine Trials\", \"Oral Vaccine Platform for Yersinia pestis\", \"Passive-Active Immunization Strategies Against Pediatric AIDS\", \"Poxvirus Immunity and DNA/MVA HIV Vaccines\", \"Directing the Immune System via Polymeric Combinations of Molecular Signals\", \"Understanding the issues surrounding parents'decisions to accept new vaccines for their children: A psychological theory-based approach.\", \"Identification of biomarkers indicative of Respiratory Syncytial Virus (RSV) vaccine-induced immune responses\", \"\\u57fa\\u4e8eDDA/TDB\\u9633\\u79bb\\u5b50\\u8102\\u8d28\\u4f53\\u4e3a\\u4f50\\u5242\\u7684\\u65b0\\u578b\\u6d41\\u611f\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u7ecf\\u9f3b\\u7c98\\u819c\\u514d\\u75ab\\u6548\\u5e94\\u4e0e\\u673a\\u5236\\u7814\\u7a76\", \"\\u8868\\u8fbe\\u9e21\\u4f20\\u67d3\\u6027\\u652f\\u6c14\\u7ba1\\u708e\\u75c5\\u6bd2S1\\u548cN\\u86cb\\u767d\\u91cd\\u7ec4\\u65b0\\u57ce\\u75ab\\u75c5\\u6bd2\\u7684\\u6784\\u5efa\\u53ca\\u514d\\u75ab\\u4fdd\\u62a4\\u8bc4\\u4ef7\", \"Use of the Dual Platform Immunization (DuPI) Approach to Develop a Tetravalent Dengue Vaccine\", \"Controlled Release of Inactivated Chikungunya Virus Vaccine Candidate: A Single Vaccination Approach for Long-Term Immunity\", \"Development of a Single Shot, Neonatal Pertussis Vaccine\", \"Public deliberation on vaccine hesitancy\", \"In vivo evaluation of conventional and experimental avian influenza A (H5N1) virus vaccines\", \"Novel cross-protective (universal) vaccine for influenza infections\", \"Novel tuberculosis vaccine for cattle\", \"ImmuneTrack - for optimisation of vaccine stock management in Uganda\", \"Development of a therapeutic vaccine against genital herpes simplex virus 2 infection\", \"A Novel Vaccine Platform for Preventing Zika Virus Infection\", \"Pre-clinical development of a chemically synthetic anti-toxic vaccine against malaria\", \"Improving efficacy of vaccination against the gut pathogen Helicobacter pylori\", \"Next Generation Vaccines to Augment Anti-PD-1 Immunotherapy for Melanoma\", \"Rapid Development of Vaccines for Emerging Viruses\", \"\\u7d4c\\u76ae\\u514d\\u75ab\\u88fd\\u5264\\u306e\\u5229\\u4fbf\\u6027\\u30fb\\u6c4e\\u7528\\u6027\\u5411\\u4e0a\\u306b\\u9069\\u3046\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u306e\\u540c\\u5b9a\\u3068\\u69cb\\u9020\\u6539\\u5909\\u6297\\u539f\\u5206\\u5b50\\u306e\\u5275\\u88fd\", \"\\u30e6\\u30d3\\u30ad\\u30c1\\u30f3\\u30d7\\u30ed\\u30c6\\u30a2\\u30bd\\u30fc\\u30e0\\u7cfb\\u306e\\u5fdc\\u7528\\u306b\\u3088\\u308b\\u7d30\\u80de\\u5185\\u5bc4\\u751f\\u539f\\u866b\\u306b\\u5bfe\\u3059\\u308bDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Development of effective immunization by DNA vaccine against iron-acquisition protein of periodontopathic bacteria\", \"\\u725b\\u306e\\u30dc\\u30c4\\u30ea\\u30cc\\u30b9C\\u578b\\u3001D\\u578b\\u4e2d\\u6bd2\\u306e\\u4e21\\u65b9\\u306b\\u52b9\\u679c\\u306e\\u3042\\u308b\\u30ea\\u30b3\\u30f3\\u30d3\\u30ca\\u30f3\\u30c8\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4f5c\\u88fd\", \"Deparment of vaccine for new type of Vibrio cholerae O139 Bengal\", \"Ultra-dense peptide array analysis of naturally acquired and vaccine-induced P. falciparum immunity\", \"11th International Symposium on Dendritic Cells in Fundamental and Clinical Immunology / DC2010: Forum on Vaccine Science\", \"CD40L and GITRL adjuvants for anti-HIV Ad5 vector vaccines\", \"Development of photochemical internalisation for enhancement of therapeutic and prophylactic vaccination\", \"The Immunogenicity and Protective Efficacy of Plant-Derived Influenza H5N1 Vaccine in Preclinical Models.\", \"Razvoj avtolognih tumorskih vakcin (basic research project)\", \"Vaccine against Streptococcus pneumoniae based on choline-binding proteins\", \"Needleless Intradermal Vaccine Delivery System Using Ultrasound\", \"Boost-Phase Sub-Unit Vaccine Development for Binary Vaccines Against Infectious Diseases and Biological Warfare Agents\", \"MAnufacturing process for Cold-chain Independent VIrosome-based VAccines\", \"Discovery and preclinical development of new generation tuberculosis vaccines\", \"Improvement of current and development of new vaccines for theileriosis and babesios of small ruminants\", \"Initiative on Optimizing Malaria Vaccine Lab Assays Evaluation\", \"Markov Decision Process Models for Optimizing Vaccine Administration\", \"Parental Decision Making in the Context of New Medical Technologies: The HPV Vaccine and its Potential Challenges\", \"Engineered porcine adenovirus type 3 as a vaccine vector\", \"Engineered porcine adenovirus type 3 as a vaccine vector\", \"IMMUNOPATHOGENESIS OF RUBELLA VIRUS ASSOCIATED AUTOIMMUN\", \"Immune Responses to Vaccinia Virus Vaccination\", \"Development of Alphavirus Replicon Vaccine Against SARS\", \"DNA Based Generation of Avian Influenza virus Vaccines\", \"Leadership Group for a Global HIV Vaccine Clinical Trials Network\", \"COALITION FOR HIV VACCINE DEVELOPMENT\", \"DNA BASED GENERATION OF AVIAN INFLUENZA VIRUS VACCINES\", \"CHIMERIC YELLOW FEVER 17D/DENGUE AND WEST NILE VACCINES\", \"Development of an anti-malaria toxin vaccine candidate\", \"HETEROCONJUGATE VACCINES AGAINST HERPES SIMPLEX VIRUS\", \"Development of a plant-grown subunit vaccine against respiratory syncytial virus\", \"Improved influenza A virus vaccines using alpha-Gal epitope modification\", \"An improved targeted vaccine strategy against anthrax\", \"A GENOME-DERIVED, EPITOPE-DRIVEN TULAREMIA VACCINE\", \"Development of a Plant-based Vaccine aganist HIV\", \"DNA Tolerizing Vaccine Therapy for Multiple Sclerosis\", \"A CMV vaccine with modified immuno-modulatory properties\", \"Multifunctional nanoparticles for targeted DNA vaccine delivery\", \"Passive-Active Vaccine Strategies Against Pediatric AIDS\", \"Recombinant Sendai Virus as a Novel HIV Vaccine Vector\", \"AIDS Prevention: Mucosally-Targeted Plant Based Vaccines\", \"Rabies Virus-Based Vectors as an HIV -1 Vaccine\", \"Conference on Gene-Based Vaccines\", \"HIV Vaccines\", \"EFFECT OF COMMUNITY PHARMACISTS ON ADULT IMMUNIZATION\", \"Multi-component and easily administrated anthrax vaccine\", \"Geographical Analysis in Vaccine Efficacy Trials\", \"Vaccines for Prevention of Experimental Congenital CMV\", \"IMMUNOPREVENTION OF HTLV INFECTION\", \"The Effect of Helminth Infection on HIV-1 Vaccines\", \"TB Vaccine Development in Nonhuman Primate Model\", \"HIV/FIV-cat model: a model to identify vaccine epitopes\", \"Acquisition and Natural History of Genital HPV Infection\", \"Childhood Vaccine Policy in the U.S. Since 1955\", \"Center for Research in Emerging Infections and Vaccines\", \"Lymph Node-Targeted Cancer Vaccines\", \"Improving the quality of FMD vaccines by understanding the correlation of vaccine-induced protection with humoral and cellular immune responses\", \"A Phase I Study of a DNA-Based Vaccine Targeting Prostatic Acid Phosphatase (PAP) in Patients with Stage D0 Prostate Cancer\", \"Risks, Controversies & Vaccinations\", \"Newcastle Disease Virus Vectored Vaccine against Poliomyelitis\", \"Development and Testing of an Oral B Subunit-Whole Cell Cholera Vaccine Protecting Against Both O1 and O139 Cholera\", \"Enhancing protective antibody responses for a GM-CSF adjuvanted HIV vaccine\", \"Clinical Trials of  Biodefense Vaccines (Dengue, West Nile Virus, TBEV)\", \"Evolution of the influenza A virus quasispecies in naive and immune hosts\", \"Development of equine herpesvirus 1 vaccine based on new insights into the pathogenesis of foeto- and neuro virulent equine herpesvirus 1 strains\", \"Development and use of new genetic engineering and testing for BCG-based anti-tuberculosis vaccines\", \"Modulation of NK cells by alpha herpes viruses with the aim of optimizing vaccines and virotherapy\", \"Development of Salmonella live attenuated vaccine strains for various serotypes in layers+ broilers\", \"Clinical Development of RNA Nanoparticle Vaccines Targeting Recurrent Pediatric Brain Cancers\", \"In vivo MR Imaging to assess delivery and efficacy of dendritic cell vaccines\", \"Immunology vaccine\", \"\\u00c9tudiante-chercheuse \\u00e9toile June 2013\", \"Influence of pre-existing HIV cross-reactive CD4 T cells on vaccine responses to new Env immunogens\", \"Immunogenic characterization of plant-specific glyco-epitopes present on influenza virus-like particle vaccines produced in Nicotiana benthamiana\", \"\\u65b0\\u578b\\u591a\\u4ef7\\u53e3\\u670dHPV\\u9884\\u9632\\u6027\\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u57fa\\u4e8eDC\\u7684TLR\\u53ca\\u5176\\u4fe1\\u53f7\\u8f6c\\u5bfc\\u901a\\u8def\\u5728\\u65b0\\u578b\\u4e59\\u809dDNA\\u75ab\\u82d7\\u5f39\\u6027\\u7eb3\\u7c73\\u7c92\\u7ecf\\u76ae\\u514d\\u75ab\\u4e2d\\u7684\\u4f5c\\u7528\\u53ca\\u5176\\u673a\\u5236\\u7814\\u7a76\", \"\\u5229\\u7528\\u8f6c\\u57fa\\u56e0\\u690d\\u7269\\u751f\\u4ea7\\u9e21\\u9a6c\\u7acb\\u514b\\u6c0f\\u75c5\\u75ab\\u82d7\", \"2016\\u5e74\\u5ea6\\u6d77\\u5ce1\\u4e24\\u5cb8\\u6c34\\u751f\\u751f\\u7269\\u8d44\\u6e90\\u9886\\u57df\\u9879\\u76ee\\u4e2d\\u671f\\u5b66\\u672f\\u4ea4\\u6d41\\u7814\\u8ba8\\u4f1a\", \"\\u4eff\\u751f\\u7845\\u77ff\\u5316\\u63d0\\u9ad8\\u75ab\\u82d7\\u70ed\\u7a33\\u5b9a\\u6027\\u7684\\u7814\\u7a76\", \"VLP\\u9897\\u7c92\\u6297\\u539f\\u964d\\u538b\\u75ab\\u82d7\\u514d\\u75ab\\u5e94\\u7b54\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u542b\\u6709GM-CSF\\u6216CD40L\\u7684\\u6c49\\u6ee9\\u75c5\\u6bd2\\u5d4c\\u5408VLPs\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u5b66\\u7279\\u6027\\u7814\\u7a76\", \"\\u75d8\\u82d7\\u75c5\\u6bd2\\u8f7d\\u4f53\\u91cd\\u7ec4AIDS\\u75ab\\u82d7\\u4e0e\\u7c98\\u819c\\u4e0a\\u76ae\\u7ec6\\u80de\\u7684\\u76f8\\u4e92\\u4f5c\\u7528\", \"Avian adenoviruses; molecular bilogy, vaccine, diagnostics\", \"Characterization of and challenge studies with infectious bronchitis virus isolates of Ontario\", \"Control of Salmonella in Market Hogs Using Immunizations\", \"Controlling Salmonellosis in Broiler Chickens Using a Multivalent Attenuated Vaccine That Also Controls Necrotic Enteritis\", \"Verbundprojekt: Development of a hepatitis C vaccine by targeted delivery of nanogel RNA-replicon constructs (HCVAX) - Teilvorhaben: Identifizierung und Generierung synthetischer Adjuvantien f\\u00fcr die Verwendung mit Nanogel-verpackten RNA-Replicon Impfstoffen und deren in vitro und in vivo Validierung\", \"A Novel Influenza Vaccine with Enhanced Immunogenic Hemagglutinin Stalk Domain\", \"A sub-unit based vaccine for Salmonella\", \"Topical enhancement of vaccination\", \"Canadian Immunization Research Network\", \"Use of the Baboon Model of Pertussis to Evaluate Strategies for Next Generation Pertussis Vaccines\", \"WT-1 analog peptide vaccine in patients with malignant mesothelioma\", \"Prototypy szczepionek przeciwko Neisseria gonorrhoeae oparte o \\u017cywe szczepy bakterii zawieraj\\u0105c bia\\u0142ka lub aktywne fagi nitkowate z Neisseria gonorrhoeae\", \"\\u53e3\\u670dAg85A DNA\\u75ab\\u82d7\\u80a0\\u9ecf\\u819c\\u7ec6\\u80de\\u5185\\u4f20\\u611f\\u5668\\u53ca\\u4f20\\u5bfc\\u9014\\u5f84\\u4e0e\\u9002\\u5e94\\u6027\\u514d\\u75ab\\u5e94\\u7b54\\u8bf1\\u5bfc\", \"\\u529f\\u80fd\\u5316\\u6c27\\u5316\\u77f3\\u58a8\\u70ef\\u4f5c\\u4e3a\\u65b0\\u578b\\u7eb3\\u7c73\\u4f50\\u5242\\u5728\\u80bf\\u7624DNA\\u75ab\\u82d7\\u4e2d\\u7684\\u7814\\u7a76\", \"\\u9488\\u5bf9\\u80bf\\u7624\\u5fae\\u73af\\u5883\\u9ad3\\u7cfb\\u6291\\u5236\\u7ec6\\u80de\\u7684\\u65b0\\u578bImC\\u75ab\\u82d7\\u6297\\u80bf\\u7624\\u4f5c\\u7528\\u53ca\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"\\u4ea7\\u751f\\u514d\\u75ab\\u4fdd\\u62a4\\u6027\\u7684\\u706d\\u6d3b\\u8fdf\\u7f13\\u7231\\u5fb7\\u534e\\u6c0f\\u83cc\\u7684\\u4f5c\\u7528\\u673a\\u5236\", \"JEV\\u75ab\\u82d7\\u4ea4\\u53c9\\u4fdd\\u62a4\\u767b\\u9769\\u75c5\\u6bd2\\u611f\\u67d3\\u7684\\u673a\\u7406\\u7814\\u7a76\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"Nonhuman Primate Core Functional Genomics Laboratory for AIDS Vaccines Research a\", \"IGF::OT::IGF  A Phase I Trial of the Safety and Immunogenicity of RG1-VLP, a candidate broadly protective vaccine for the prevention of HPV-associated cancer\", \"Determining the Impact of Semisynthetic Saponin Immunologic Adjuvant Titerquil-1055 on Influenza Vaccine Immunogenicity and Stability\", \"Second-Generation Therapeutic DNA Lymphoma Vaccines\", \"CHOLERA, MUCOSAL VACCINES AND IMMUNOMODULATION\", \"Immunological and histochemical assessment of an Alzheimer\\u00b4s vaccine\", \"Alphavirus replicon vectors as vaccines\", \"Simplexia - development of a vaccine against HSV-2 infection\", \"Do host genetic factors restrict natural rotavirus infection and vaccine performance in Nicaragua?\", \"Therapeutic vaccines for the treatment of severe atopic dermatitis and asthma\", \"Tools to study the effects of rotavirus vaccination in Burkina Faso\", \"Immunogenicity and safety of HPV vaccine in immunosuppressed women due to solid organ transplant and rheumatologic disease. Study 1: Evaluation of primary imune response to vaccination\", \"Development of statistical tools for the analysis of complex data: application to associations between reactogenicity and innate/adaptive answer immune related to the adjuvded vaccines for man.\", \"PKD Control  studies on the immune response in fish and vaccine development.\", \"Development of vaccination methods for the control of bacterial kidney disease (BKD) in salmonids (LINKSAL10)\", \"Baboon Model of Pertussis to Evaluate Strategies for Next Generation Vaccines\", \"MUC1\\u6a21\\u62df\\u8868\\u4f4d\\u591a\\u80bd\\u75ab\\u82d7\\u8bbe\\u8ba1\\u53ca\\u5176\\u6297\\u80bf\\u7624\\u6548\\u5e94\\u7814\\u7a76\", \"\\u4eba3\\u578b\\u30017\\u578b\\u817a\\u75c5\\u6bd2\\u53cc\\u4ef7\\u51cf\\u6bd2\\u91cd\\u7ec4\\u75ab\\u82d7\\u5019\\u9009\\u682a\\u7684\\u6784\\u5efa\\u53ca\\u514d\\u75ab\\u539f\\u6027\\u7814\\u7a76\", \"\\u732a\\u761f\\u75c5\\u6bd2\\u7cd6\\u86cb\\u767dE2\\u9ad8\\u53d8\\u533a\\u5bf9\\u75ab\\u82d7C\\u682a\\u83b7\\u5f97\\u6027\\u514d\\u75ab\\u5e94\\u7b54\\u5f71\\u54cd\\u7684\\u7814\\u7a76\", \"\\u4ee5Her2/neu\\u4e3a\\u9776\\u70b9\\u7684\\u65b0\\u578bVLP\\u75ab\\u82d7\\u514d\\u75ab\\u5e94\\u7b54\\u7814\\u7a76\", \"\\u7ec6\\u7c92\\u68d8\\u7403\\u86b4G1Y162\\u6297\\u539f\\u4f18\\u52bf\\u8868\\u4f4d\\u7684\\u7b5b\\u9009\\u53ca\\u5176\\u514d\\u75ab\\u7279\\u6027\\u7684\\u7814\\u7a76\", \"\\u4ee5\\u756a\\u8304\\u679c\\u5b9e\\u4e3a\\u53d7\\u4f53\\u8868\\u8fbe\\u7ed3\\u6838\\u5206\\u679d\\u6746\\u83ccAg85B-ESAT-6-WbbL\\u878d\\u5408\\u86cb\\u767d\\u53ca\\u514d\\u75ab\\u6548\\u5e94\\u7814\\u7a76\", \"Development of a novel fungal vaccine with glycolipid antigens\", \"Optimalizace vakcina\\u010dn\\u00edho sch\\u00e9matu oslaben\\u00e9 vakc\\u00edny Salmonella Enteritidis vedouc\\u00ed k dlouhodob\\u00e9 ochran\\u011b dr\\u016fbe\\u017ee p\\u0159ed infekc\\u00ed salmonelami\", \"Mo\\u017enosti vakcinace prasat inaktivovanou vakc\\u00ednou pro tlumen\\u00ed v\\u00fdskytu salmonel v chovech prasat\", \"V\\u00fdzkum a v\\u00fdvoj vakc\\u00edny proti onemocn\\u011bn\\u00ed doln\\u00edch cest d\\u00fdchac\\u00edch v ozdraven\\u00fdch chovech prasat\", \"Biodegradabiln\\u00ed syst\\u00e9my s prolongovanou liberac\\u00ed vakc\\u00edn\", \"Vyu\\u017eit\\u00ed dendritick\\u00fdch bun\\u011bk nalo\\u017een\\u00fdch univerz\\u00e1ln\\u00edmi n\\u00e1dorov\\u00fdmi antigeny pro p\\u0159\\u00edpravu protin\\u00e1dorov\\u00fdch vakc\\u00edn\", \"Kombinovan\\u00e1 imunoterapie n\\u00e1dor\\u016f vyvolan\\u00fdch lidsk\\u00fdm papillomavirem\", \"Kombinovan\\u00e1 l\\u00e9\\u010dba zbytkov\\u00e9 n\\u00e1dorov\\u00e9 choroby pomoc\\u00ed IL-2 a GM-CSF vyu\\u017e\\u00edvaj\\u00edc\\u00ed rekombinantn\\u00edch cytokin\\u016f a geneticky modifikovan\\u00fdch vakcin.\", \"V\\u00fdvoj rekombinantn\\u00edch vir\\u016f vakcinie s geny pro cytokiny pro l\\u00e9\\u010dbu n\\u00e1dor\\u016f.\", \"Prevence IDDM BCG vakc\\u00ednou : Lidsk\\u00fd model p\\u0159irozen\\u00e9 vn\\u00edmavosti /rezistence na infekci Mycobacterium bovis BCG.\", \"Protin\\u00e1dorov\\u00e9 vakciny p\\u0159ipraven\\u00e9 f\\u00faz\\u00ed n\\u00e1dorov\\u00fdch a dendritick\\u00fdch bun\\u011bk\", \"FRANCIS - V\\u00fdvoj nov\\u00fdch profylaktick\\u00fdch prost\\u0159edk\\u016f proti infekci Francisella tularensis\", \"KANVAKOL - vakc\\u00edna k l\\u00e9\\u010db\\u011b vlekl\\u00fdch kvasinkov\\u00fdch z\\u00e1n\\u011bt\\u016f pochvy.\", \"Studium mechanismu p\\u016fsoben\\u00ed bakteri\\u00e1ln\\u00edch toxin\\u016f\", \"Biologicky bezpe\\u010dn\\u00fd expresn\\u00ed syst\\u00e9m zalo\\u017een\\u00fd na rostlinn\\u00fdch virech pro transientn\\u00ed expresi papillomavirov\\u00fdch onkoprotein\\u016f a v\\u00fdvoj terapeutick\\u00e9 vakc\\u00edny\", \"*Biotechnologie v\\u00fdroby antigen\\u016f Borrelia burgdorferi sensu lato pro p\\u0159\\u00edpravu prototypu vakc\\u00edny proti Lymesk\\u00e9 boreli\\u00f3ze.\", \"Assessment of vaccine efficacy for Malaria and Tuberculosis in a co-infection setting relevant for disease endemic sub-Saharan African regions.\", \"Analysis of vaccine induced immunity in cattle against the gastrointestinal namatode Ostertagia ostertagi\", \"Evolution of the influenza A virus quasispecies in naive and immune hosts\", \"A \\\"negative\\\" dendritic-cell based vaccine for the treatment of multiple sclerosis: a first-in-man multicenter trial.\", \"A Randomized, Double-Blinded, Controlled with GARDASIL\\u00ae Phase 3 Clinical Trial.\", \"Preclinical development of an optimised dendritic cell-based vaccine against acute myeloid leukemia.\", \"Research Fellowship\", \"A polyvalent group A streptococcal vaccine\", \"Attenuated and recombinant mycobacterial strains as novel vaccines to control tuberculosis\", \"Study of HPV 6 L1 virus like paticles as Therapeutic vaccine for genital warts and recurrent respiratory papillomatosis.\", \"Molecular approaches to developing subunit vaccines with improved efficacy against tuberculosis\", \"To support the 5th Global Forum on TB Vaccines, which brings together stakeholders from around the world and across all areas of research to facilitate dialogue and to promote partnership and collaboration with the goal of accelerating TB vaccine R&D\", \"Pre-clinical development of an affordable, safe and efficacious four-in-one dengue vaccine candidate\", \"To test the theory that a measured dose of vitamin A (retinoic acid) given with an oral vaccine will enhance immunoglobulin secretions in the gut, thus boosting the mucosal immune response. If successful, vitamin A could be used as an effective adjuvant for oral vaccines that target diarrhea, a leading cause of death among children worldwide.\", \"To expand CanSino\\u2019s capability to conduct clinical trials in Africa so that, in the future, CanSino will be able to provide low cost and high quality vaccines to African countries and to help prevent common diseases for poor, low-income or otherwise underserved communities that otherwise would lack access to such vaccines at an affordable price\", \"To evaluate the ability of the BEN-1 vaccine to act as a highly effective and safe Contagious Bovine Pleuropneumonia (CBPP) vaccine that meets target product profile and that is a pivotal enabler for the control and then possibly elimination of the disease in Africa\", \"To develop and deploy a low-cost, easy-to-use remote temperature monitoring system for cold chain monitoring which sends SMS alerts to reduce vaccine spoilage and integrates with existing electronic logistics management systems to improve distribution and management of vaccines at different levels of the supply chain\", \"To develop and deploy a low-cost, easy-to-use remote temperature monitoring (RTM) system for cold chain monitoring, which sends SMS alerts to reduce vaccine spoilage and integrates with existing electronic logistics management systems to improve distribution and management of vaccines at different levels of the supply chain\", \"To assess the safety, reactogenicity, immunogenicity and impact on intestinal shedding of 1 dose of a monovalent type 2 high dose inactivated poliovirus vaccine compared to a licensed trivalent inactivated poliovirus vaccine when given concomitantly with bOPV to infants early in life\", \"To assess the feasibility of a project to establish poliovirus surveillance in Cap Verde following a switch from oral polio vaccine (OPV) to inactivated polio vaccine (IPV) to monitor ongoing viral circulation and to use a challenge study to understand the sensitivity of environmental surveillance and to develop a project protocol based on this feasibility study\", \"To convene an international gathering of professionals from developing countries working in research, development, manufacturing and supply of vaccines, towards the common goal of protecting people against known and emerging viral and bacterial infectious diseases by increasing the availability of high-quality vaccines\", \"To develop a vaccine vector based on a prototype vaccine for herpes simplex virus 2 (HSV-2) that encodes multiple CD8 T cell epitopes from HIV proteins, and test its ability to stimulate a robust CD8 T cell response against HIV\", \"To build consensus among the world\\u2019s immunization costing experts on how best to systematically improve immunization service delivery costs for by donors, national governments, and multilateral agencies to advance vaccine development and health policies and programs aimed at reducing vaccine preventable diseases among children, adolescents and adult populations\", \"To boost the effect of vaccines against rotavirus infection, which causes diarrhea, by developing a pig model to mimic the gut conditions of children in developing countries who do not respond to vaccines, which can be used to test interventions.\", \"To convene an international gathering of professionals working in research, development, manufacturing and supply of vaccines, towards the common goal of protecting people against known and emerging viral and bacterial infectious diseases by increasing the availability of high-quality vaccines produced in developing countries\", \"To help inform evidence-based dialogue and public health policy related to vaccines in India, working closely with the Indian Ministry of Health, local experts, and local partners on including vaccines within comprehensive approaches to protect children from life-threatening diseases - namely diarrhea, pneumonia, and meningitis\", \"To support the 4th Global Forum on Tuberculosis (TB) Vaccines intended to build on the success of the prior three conferences in bringing together researchers from all sectors for an in depth review and discussion of progress and gaps in TB vaccine research and development\", \"To design, produce, characterize and assess the immunogenicity of nanoparticles of multiple, specific symmetries that present the prefusion forms of human respiratory syncytial virus (hRSV) F and human metapneumonia virus (hMPV) F, to potentially generate novel vaccine design concepts for hRSV/hMPV vaccines suitable for maternal immunization\", \"To develop a microneedle patch that can be used for safe, efficacious and cost-effective delivery of inactivated poliovirus vaccine (IPV) as part of the polio Eradication and Endgame strategic plan to stop the use of oral polio vaccine (OPV) worldwide by the end of 2019\", \"To develop a microneedle patch that can be used for safe, efficacious and cost-effective delivery of inactivated poliovirus vaccine (IPV) as part of the polio Eradication and Endgame strategic plan to stop the use of oral polio vaccine (OPV) worldwide by the end of 2019\", \"To cover the expenses for the initial activities which are necessary in order to prepare Intravacc to be ready to start to produce, test and document new Oral Polio Vaccine type 2 (nOPV2) poliovirus Master- and Working seed lots (for two concepts) to ensure future production of live polio vaccines as soon as possible after the Product Development\", \"Task X9:  Agilvax Phage Display for Multiple Vaccine Candidates\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"Task A91: Development of a Murine Model of Subcutaneous (SC) Melioidosis for Use in Vaccine Evaluation\", \"Newton Fund - Development of an oral, thermostable enteric fever vaccine: saving lives and supporting tourism in Mexico\", \"Development new immunotherapy for pediatric cancer using human iPSCs\", \"Development of the Novel Therapeutic Strategy for Cerebral Infarction; The Efficacy of  Angiotensin II DNA Vaccine in Rat Model of Cerebral Infarction.\", \"Development of immunomodulatory  p53-targeted vaccine for mouse model of prostate cancer\", \"Basic Study of orally-delivered vaccine development using a new innate immunity inducer\", \"Development of DNA vaccine against intracellular microbial pathogens by using artificially synthesized genes\", \"Immunogenicity, effectiveness and safety of 2009 A (H1N1) pandemicinfluenza vaccine in high risk population.\", \"Development of novel oncofetal antigen targeting immunotherapy for refractory ovarian carcinoma\", \"Persistent infection of Hepatitis C Virus\", \"Reverse genetics for rotavirus and its applications\", \"The development of the polysomal RNA vaccine to the ovarian cancer\", \"\\u96e3\\u6cbb\\u6027\\u539f\\u866b\\u611f\\u67d3\\u75c7\\u306b\\u5bfe\\u3059\\u308b\\u7d30\\u80de\\u6027\\u514d\\u75ab\\u8a98\\u5c0e\\u578b\\u30ef\\u30af\\u30c1\\u30f3\\u30b7\\u30b9\\u30c6\\u30e0\\u306e\\u8a55\\u4fa1\", \"Inhibition of S.mutans colonization by the DNA vaccine targeted on GTFC and It's anti-cariogenic effects\", \"Reconstitution of a novel recombinant Marek's disease virus as a vector vaccine against poultry red mites\", \"\\u30ec\\u30cb\\u30f3\\u30a2\\u30f3\\u30b8\\u30aa\\u30c6\\u30f3\\u30b7\\u30f3\\u7cfb\\u3092\\u6a19\\u7684\\u3068\\u3057\\u305f\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Preclinical and clinical study of influenza microneedle vaccine and analysis of immunity induction mechanism\", \"\\uff22\\u578b\\u809d\\u708e\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u5bfe\\u3059\\u308b\\u521d\\u671f\\u304a\\u3088\\u3073\\u8a18\\u61b6\\u514d\\u75ab\\u5fdc\\u7b54\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"Virus Like Nano-Particle as the delivery tool of vaccine adjuvant\", \"Analysis of adjuvant action Escherichia coli enterotoxin\", \"Parasite digestive enzymes: targets for new drugs and vaccines\", \"Making a yeast-based candidate vaccine against Porcine Epidemic Diarrhea Virus  (PEDV)\", \"Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases\", \"Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases\", \"Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases\", \"TO X13: Evaluation of an E. coli Vaccine Candidate - Immunogenicity Testing\", \"Task X11:Evaluation of Clinical Samples from a Dengue Vaccine Clinical Trial\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"Expansion of Product Development Capacity\", \"Modelling the impact of vaccination targeted against serogroup B meningococcal disease.\", \"A novel prophylactic vaccine and delivery platform to prevent Clostridium difficile infections\", \"\\u65b0\\u57ce\\u75abDNA\\u75ab\\u82d7\\u4e09\\u7532\\u57fa\\u58f3\\u805a\\u7cd6\\u7eb3\\u7c73\\u7c92\\u9ecf\\u819c\\u514d\\u75ab\\u4f20\\u9012\\u7cfb\\u7edf\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u4f5c\\u7528\\u673a\\u5236\\u7814\\u7a76\", \"IL-28B\\u548cCD25\\u6297\\u4f53\\u6291\\u5236\\u8c03\\u8282\\u6027T\\u7ec6\\u80de\\u589e\\u5f3a\\u7ed3\\u6838\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u514d\\u75ab\\u6d3b\\u6027\\u5b9e\\u9a8c\\u7814\\u7a76\", \"PglB\\u4ecb\\u5bfc\\u7684\\u4e00\\u6b65\\u5408\\u6210\\u591a\\u7cd6\\uff0d\\u86cb\\u767d\\u7f00\\u5408\\u7269\\u75ab\\u82d7\\u5e73\\u53f0\\u6784\\u5efa\", \"\\u5976\\u725b\\u4e73\\u623f\\u708e\\u91d1\\u9ec4\\u8272\\u8461\\u8404\\u7403\\u83cc\\u591a\\u4e9a\\u5355\\u4f4d\\u5d4c\\u5408\\u86cb\\u767d\\u6297\\u539f\\u8868\\u8fbe\\u53ca\\u514d\\u75ab\\u539f\\u6027\\u7814\\u7a76\", \"\\u5d4c\\u5408RSV\\u6297\\u539f\\u8868\\u4f4d\\u7684\\u91cd\\u7ec4\\u6d41\\u611f\\u51cf\\u6bd2\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u514d\\u75ab\\u4fdd\\u62a4\", \"\\u5a74\\u513f\\u4e59\\u809d\\u75ab\\u82d7\\u5e94\\u7b54\\u7684\\u6bcd\\u6e90\\u6027\\u7ec6\\u80de\\u5047\\u8bf4\\u53ca\\u5176\\u9a8c\\u8bc1\", \"\\u8102\\u591a\\u7cd6\\u8868\\u4f4d\\u6a21\\u62df\\u80bd\\u75ab\\u82d7\\u8bf1\\u5bfc\\u518d\\u6b21\\u514d\\u75ab\\u5e94\\u7b54\\u7684\\u7814\\u7a76\", \"MAGE\\u591a\\u8868\\u4f4d\\u80bd\\u80bf\\u7624\\u7eb3\\u7c73\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u5f27\\u83cc\\u5916\\u819c\\u86cb\\u767d\\u5728\\u9175\\u6bcd\\u83cc\\u7ec6\\u80de\\u8868\\u9762\\u4e0a\\u7684\\u5c55\\u793a\\u548c\\u4f5c\\u4e3a\\u591a\\u4ef7\\u6d3b\\u75ab\\u82d7\\u7684\\u6f5c\\u5728\\u5e94\\u7528\", \"\\u57fa\\u4e8e\\u5fae\\u9488\\u7ed9\\u836f\\u7cfb\\u7edf\\u7684DNA\\u805a\\u9633\\u79bb\\u5b50\\u7eb3\\u7c73\\u590d\\u5408\\u7269\\u76ae\\u5185\\u514d\\u75ab\\u6548\\u5e94\\u53ca\\u5176\\u673a\\u7406\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u6297\\u4f53\\u7684\\u9488\\u5bf9\\u767b\\u9769\\u75c5\\u6bd2\\u591a\\u80bd\\u75ab\\u82d7\\u7684\\u6784\\u5efa\", \"\\u7eb3\\u7c73\\u5c42\\u72b6\\u53cc\\u6c22\\u6c27\\u5316\\u7269/\\u4e8c\\u6c27\\u5316\\u7845\\u4f5c\\u4e3aDNA\\u75ab\\u82d7\\u9012\\u9001\\u7cfb\\u7edf\\u7684\\u7814\\u7a76\", \"\\u51cf\\u6bd2\\u6c99\\u95e8\\u6c0f\\u83cc\\u9012\\u5448\\u7684TGEV S/N\\u53cc\\u57fa\\u56e0\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u4e0e\\u514d\\u75ab\\u8bf1\\u5bfc\\u89c4\\u5f8b\\u7814\\u7a76\", \"\\u65b0\\u578bMUC1 DNA\\u75ab\\u82d7\\u7684\\u4f18\\u5316\\u6784\\u5efa\\u53ca\\u6cbb\\u7597\\u80f0\\u817a\\u764c\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u5171\\u8868\\u8fbegB\\u53ca\\u9776\\u5411BAK SiRNA\\u7684\\u65b0\\u578b\\u75ab\\u82d7\\u5728\\u52a8\\u7269\\u6a21\\u578b\\u4e0a\\u6297CMV\\u80ce\\u4ed4\\u611f\\u67d3\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u809d\\u7d20\\u9176\\u4e0d\\u540cCTL\\u8868\\u4f4d\\u6df7\\u5408\\u591a\\u80bd\\u75ab\\u82d7\\u6297\\u80bf\\u7624\\u6548\\u5e94\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"OK-432\\u80bf\\u7624\\u75ab\\u82d7\\u6297\\u80bf\\u7624\\u4f5c\\u7528\\u7684\\u4fe1\\u53f7\\u4f20\\u5bfc\\u673a\\u5236\", \"TRAG-3\\u6297\\u539f\\u4e3a\\u9776\\u6807\\u7684\\u65b0\\u578b\\u80bf\\u7624\\u75ab\\u82d7\\u6cbb\\u7597\\u80ba\\u764c\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u6076\\u6027\\u80bf\\u7624\\u65b0\\u578b\\u6cbb\\u7597\\u6027\\u75ab\\u82d7\\u7684\\u5e94\\u7528\\u57fa\\u7840\\u7814\\u7a76\", \"\\u7c98\\u819c\\u4f50\\u5242LTB\\u4f18\\u5316\\u6dcb\\u75c5\\u7eb3\\u7c73\\u6838\\u9178\\u75ab\\u82d7\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u514d\\u75ab\\u5171\\u523a\\u6fc0\\u56e0\\u5b504-1BBL\\u589e\\u5f3aDNA\\u75ab\\u82d7\\u7ec6\\u80de\\u514d\\u75ab\\u53cd\\u5e94\\u7684\\u673a\\u7406\\u7814\\u7a76\", \"\\u526f\\u7ed3\\u6838\\u5206\\u679d\\u6746\\u83cc\\u975e\\u53d8\\u6001\\u53cd\\u5e94\\u6027\\u514d\\u75ab\\u4fdd\\u62a4\\u57fa\\u56e0\\u7684\\u7814\\u7a76\", \"\\u9a6c\\u4f20\\u67d3\\u6027\\u8d2b\\u8840\\u75c5\\u6bd2\\u51cf\\u6bd2\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"L\\u578b\\u9499\\u901a\\u9053\\u6cbb\\u7597\\u6027\\u964d\\u538b\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u9776\\u5411\\u7259\\u5468\\u708eDNA\\u75ab\\u82d7\\u7684\\u7814\\u5236\\u548c\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"IDO\\u57fa\\u56e0\\u4fee\\u9970\\u7684T\\u7ec6\\u80de\\u8868\\u4f4d\\u75ab\\u82d7\\u8bf1\\u5bfc\\u6297-GBM\\u80be\\u708e\\u514d\\u75ab\\u8010\\u53d7\\u7684\\u6548\\u5e94\\u673a\\u5236\\u7814\\u7a76\", \"Novel vaccine candidates against meningococcal disease\", \"Development of a food-grade Lactobacillus-based oral vaccine delivery system\", \"Joining forces to produce next-generation vaccines against enterotoxigenic Escherichia coli\", \"Protection against intracellular pathogens - T-cell based immunity and vaccines\", \"A strategic vision to drive the control of enteric fever through vaccination\", \"Desenvolvimento de uma nova estrat\\u00e9gia vacinal com propriedades profil\\u00e1ticas e terap\\u00eauticas contra a s\\u00edndrome hemol\\u00edtica ur\\u00eamica (SHU) associada a Linhagens de Escherichia coli enterohemorr\\u00e1gica (EHEC) produtorass da toxina Shiga-like (Stx)\", \"Yuji Sato | National Institute of Health - Jap\\u00e3o\", \"Parasite digestive enzymes: targets for new drugs and vaccines\", \"GeMI-Vax as a multi-life stage  malaria vaccine\", \"Orally Administered Bioadherent Sustained Release Microencapsulated Vaccines\", \"Nanoparticle Technology for Minimally-invasive Delivery of DNA Vaccines\", \"Biodegradable Bioadherent Microcapsules for Orally Administered Sustained Release Vaccines\", \"Absorbable Gels for Modulated Bioavailability of Vaccines\", \"Selection versus mutation: reducing the risk of vaccine reversion\", \"DEVELOPMENT OF IMMUNOPROPHYLAXIS FOR RESPIRATORY DISEASE\", \"Chemical Immunology to modulate cross-presentation for improved vaccines\", \"VLP-based Vaccines for Targeting Staphylococcus aureus Secreted Virulence Factors\", \"Novel Oral Vaccine for Infectious Salmon Anemia\", \"Whole Killed ISA Virus Vaccine\", \"IMPROVED HERPESVIRUS OF TURKEY (HVT) VECTOR VACCINE TO CONTROL INFECTIOUS BURSAL DISEASE (IBD) IN CHICKENS\", \"Investigating a novel, physical adjuvant for improving immune responses of vaccines\", \"Development of a novel vaccine targeting parasite tegument proteins for liver fluke disease in livestock\", \"Establishment of a national GLP Core Facility to Monitor Immune Responses in Humans to Prophylactic and or Therapeutic Vaccines Against Infectious Diseases, Cancer and Autoimmunity\", \"Enhancing potency and efficacy of herpesvirus of turkeys-based multivalent vaccines against avian influenza viruses\", \"Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases\", \"Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases\", \"Task X7: Preparedness for Testing NIAID Priority Vaccines for Infectious Diseases\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"IGF::OT::IGF  Base Contract Title:  Preclinical In Vitro and In Vivo Agent Development Assays, Task Order Title:  A Polyvalent Vaccine Against Fusion Proteins Observed in Solid Tumors, Period of Perfo\", \"Optimisation of bacteriophage M13-based DNA and chimeric (DNA/ protein) vaccines\", \"VACCINOLOGY AND IMMUNITY OF AQUATIC ANIMALS\", \"LIVE ATTENUATED EDWARDSIELLA ICTALURI VACCINES FOR PREVENTION OF ENTERIC SEPTICEMIA OF CATFISH\", \"INTEGRATIVE APPROACHES FOR ILTV VACCINES\", \"BATH/ORAL LIVE RECOMBINANT EDWARDSIELLA VACCINE FOR THE AQUACULTURE INDUSTRY\", \"IDENTIFICATION OF COMMON ANTIGENS TO CREATE A UNIVERSAL PORCINE ETEC VACCINE\", \"Baboon Model of Pertussis to Evaluate Strategies for Next Generation Vaccines\", \"Generation of recombinant yellow fever virus (strain 17d) vaccine vectors to deliver heterologous antigens\", \"Generation of mumps virus vaccine vectors for heterologous antigens.\", \"Identification of new bradyzoite surface antigens for use in toxoplasma gondii vaccines and diagnostics\", \"Artificial chimeric proteins as diagnostic, vaccine, and gene therapy carriers\", \"High throughput vaccine evaluation\", \"Fourth advanced vaccinology course (ADVAC-4)\", \"Third advanced vaccinology course (ADVAC-3)\", \"T Cell Inducing Vaccines.\", \"Clinical evaluation of innovative tuberculosis vaccination strategies.\", \"Pneumococcal Conjugate Vaccine Trian in Adults: Blantyre, Malawi.\", \"Development of an attenuated vaccine to control the emerging bovine respiratory pathogen Mycoplasma bovis\", \"Vaccine against leptospirosis\", \"Development of dense gas technology platforms for the formulation of oral vaccines\", \"Development of a safe and immunogenic anti-chlamydia vaccine for the koala\", \"Mathematical modelling of breast cancer immunity: guiding the development of preventative breast cancer vaccines\", \"Mathematical modelling can provide vital information on the effectiveness and practical implementation of microbicides and vaccines against HIV\", \"Dissecting virus neutralizing determinants to guide HCV vaccine development\", \"Development of novel immune stimulators for poultry\", \"Pre-clinical development of a simian adenovirus vectored respiratory syncytial virus (RSV) vaccine\", \"Pre-clinical Development of an Adenovirus Vectored Universal Influenza Vaccine\", \"The characterisation of vaccine protection: models of AIDS vaccine development\", \"Development and testing of novel recombinant pnemococcal glyconjugate vaccines\", \"Differentiation of Infection in Vaccinated Animals for PPR and FMD\", \"ARRA: Development of Universal Influenza Assays\", \"DEVELOPMENT OF FIV RECOMBINANT VACCINE\", \"LOT SPECIFIC CLUSTERING OF SIDS\", \"STABILITY OF TETANUS AND DIPHTHERIA TOXINS\", \"RABIES IMMUNIZATION ANTIBODY DETECTION IN AT RISK PERSON\", \"REACTIONS FOLLOWING IMMUNIZATION WITH JAPANESE ENCEPHALITIS VIRUS VACCINE\", \"DEVELOPMENT OF AN ELISA FOR RABIES VACCINE POTENCY\", \"RABIES IMMUNIZATION ANTIBODY DETECTION IN AT-RISK PERSONNEL\", \"QUANTITATION OF POLYSACCHARIDE (PS) CONTENT IN HIB CONJUGATE VACCINES BY HPLC\", \"The T Cell Response to Hepatitis B Vaccine in Healthy Ad\", \"Novel Therapies For Herpes Simplex Virus Infections\", \"DEVELOPMENT OF NOVEL MUCOSAL VACCINE STRATEGIES\", \"ROTAVIRUS VACCINE TRIAL IN UMEA, SWEDEN\", \"Development of a Combination HIV-1 and Heroin Vaccine for NIDA\", \"New Scientific Approaches to Facilitate Development of Vaccines\", \"In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense\", \"In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense\", \"In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense\", \"Development of clinical correlates of efficacy for vaccines against Francisella\", \"Development of Assays to Assess Novel Cell Substrates\", \"Capsule conjugate vaccines against Campylobacter jejuni\", \"LIVE ATTENUATED VACCINES FOR PANDEMIC PREPAREDNESS\", \"NOVEL TECHNOLOGIES APPLIED TO A DENQUE DNA VACCINE\", \"Dissecting virus neutralizing determinants to guide HCV vaccine development\", \"Development of Influenza Virus-Like Particle (VLP) Vaccines\", \"Vaccination Against Ixodes scapularis Tick Bites\", \"BIODEGRADABLE MINERAL MICROSPHERE ADJUVANTS FOR VACCINES\", \"JAPANESE ENCEPHALITIS VACCINE FROM MUTATED CDNA CLONE\", \"VACCINE DELIVERY SYSTEM FOR LIVE ROTAVIRUS VACCINES\", \"RECOMBINANT CONTRACEPTIVE VACCINES\", \"DEVELOPMENT OF A REPLICATION-DEFECTIVE HSV-2 VACCINE\", \"ATTENUATED LIVE VIBRIO CHOLERAE-VECTORED ETEC VACCINE\", \"SYNTHETIC PEPTIDES AS CARRIERS FOR CONJUGATE VACCINES\", \"PRODUCTION AND PRESERVATION OF AN ORAL CHOLERA VACCINE\", \"CLINICAL TRIAL OF AN IMPROVED MELANOMA VACCINE\", \"Development of needle-free, vectorless, RNA-based vaccines for HIV\", \"Lactobacilli: A Vaccine Delivery Vehicle for Women\", \"Rational design and targeted selection of DNA-scaffolded nicotine vaccines\", \"IDIOTYPE VACCINES FOR CANCER PATIENTS\", \"Oral Vaccine to Inhalation Rabies\", \"Vaccine-enhanced respiratory syncytial virus disease\", \"LIVE, ATTENUATED, RECOMBINANT VACCINE - WEST NILE VIRUS\", \"Human T Cell Antigens of Mycobacterium tuberculosis\", \"ENHANCED SAFETY &EFFICACY OF AIDS VACCINES BY IFN DELTA\", \"HAEMOPHILUS INFLUENZAE B CONJUGATE VACCINE EFFICACY\", \"Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development\", \"RECOMBINANT DNA-DERIVED PERTUSSIS SUBUNIT VACCINE   13.\", \"IMMUNOGENICITY OF PERTUSSIS TOXOID\", \"EPIDEMIOLOGY OF SHIGELLA INFECTION IN CHILDREN\", \"ASSESSING THE SAFETY OF CELL SUBSTRATES AND VACCINE COMPONENTS\", \"ASSESSING THE SAFETY OF CELL SUBSTRATES AND VACCINE COMPONENTS\", \"MASTER CONTRACT FOR PRECLINICAL DEVELOPMENT AIDS RESEARCH (BASIC)\", \"MASTER CONTRACT FOR PRECLINICAL DEVELOPMENT AIDS RESEARCH (BASIC)\", \"AN EFFICACY TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES\", \"PNEUMOCOCCAL REFERENCE LABORATORY\", \"OPERATION OF &EXPERIMENTAL VIRUS VACCINE PRODUCTION LAB\", \"PERTUSSIS CLINICAL TRIAL (PART 2)\", \"RECOMBINANT SALMONELLA AS AN ORAL HIV VACCINE\", \"Propagation Enhancement of Chimeric Lentiviral Vaccines\", \"Development of clinical correlates of efficacy for vaccines against Francisella\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"Reagent Resource Support Program for AIDS Vaccine Development\", \"Task C11 NHP Model for Filovirus Vaccine: Efficacy and Immunogenecity Testing\", \"Advanced Development of Multivalent Filovirus Vaccines\", \"Development of Muc1 Vaccine for the Prevention of Pancreatic Cancer\", \"Testing The True Potential of CD8 T cells to Protect against Immunodefinciency Virus Infection via Novel Vaccination\", \"Development of Salmonella-based MYCN vaccine for immunotherapy of neuroblastoma\", \"Genetic Vaccines Eliciting Lymphoma-specific T-cell Immunity\", \"The study of efficacy and immune correlates to an inactivated H5N1 vaccine in non-human primates\", \"Trivalent Lassa, Ebola and Marburg viral vaccine (Tri-LEMvac)\", \"Engineering an intranasal universal influenza vaccine\", \"DESIGNING LIVE INFLUENZA UNIVERSAL VACCINE BASED ON NEW GENE\\u2013ENGINEERING AND IMMUNOGENETICS APPROACHES\", \"Development of an Innovative, Effective RNA-based Vaccine for Chikungunya Virus\", \"The Interplay of Oral Vaccines, Oral Immunity and the Oral Microbiome in Infants\", \"\\u30de\\u30e9\\u30ea\\u30a2\\u4f1d\\u642c\\u963b\\u6b62\\u7c98\\u819c\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"LIMPII\\u3001\\u30e6\\u30d3\\u30ad\\u30c1\\u30f3\\u878d\\u5408\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u514d\\u75ab\\u5fdc\\u7b54\\u3068\\u611f\\u67d3\\u9632\\u5fa1\", \"\\u514d\\u75ab\\u8abf\\u7bc0\\u907a\\u4f1d\\u5b50\\u3068\\u306e\\u30d5\\u30e5\\u30fc\\u30b8\\u30e7\\u30f3DNA\\u30ef\\u30af\\u30c1\\u30f3\\u306b\\u3088\\u308b\\u7d30\\u80de\\u5185\\u5bc4\\u751f\\u539f\\u866b\\u611f\\u67d3\\u5236\\u5fa1\\u306e\\u65b0\\u6226\\u7565\", \"Phase II Double-blind, randomized, Placebo-controlled Study to evaluate the Safety and Immunogenicity of H1, an adjuvanted TB subunit vaccine (AG85B-ESAT-6 plus IC31), in HIV-infected, BCG vaccinated Adults with CD4 Lymphocyte Counts greater than 350\", \"HIV EPIDEMIOLOGY AND PREVENTION / International AIDS Vaccine Initiative\", \"IMPROVED INFECTIOUS LARYNGOTRACHEITIS VIRUS VACCINES AGAINST NEWCASTLE DISEASE VIRUS WORKSHOP\", \"A Comprehensive Pre-Natal Intervention to Increase Vaccine Coverage\", \"A cluster for tuberculosis vaccine development\", \"Whooping cough vaccine and vaccination in the Netherlands since 1950.\", \"Development of VPL Vaccine for RSV\", \"SBIR Phase I: Development of Polymer Gel-Based Indicators to Monitor the Exposure of Individual Vaccine Vials to Harmful Temperatures\", \"Immune correlates to an inactivated H5N1 vaccine in humans\", \"Safety, immunogenicity and mechanism of action of DNA va\", \"Improving Vaccination Coverage Among Adolescents\", \"INDO-US Collaboration to Develop Rotavirus Vaccines\", \"(HVTN) HIV VACCINE TRIAL UNITS\", \"PULSED ELECTRIC FIELD DELIVERED DENGUE VACCINE\", \"LYME VACCINE BASED ON BORRELIA DECORIN ADHESIN\", \"Novel Protein Adjuvant for Flu Vaccines\", \"HETEROCONJUGATE VACCINES AGAINST HERPES SIMPLEX VIRUS\", \"Pro-Apoptotic BCG as an HCV vaccine vector\", \"Vaccines to Generate Neutralizing Anti-HIV Antibodies\", \"Chimeric Adenovirus Vaccine Vectors for HIV/SIV\", \"Enhancing HIV-1 vaccine immunogenicity using hsp70\", \"EXPRESSION OF SIVmac239 GP120 IN TRANSGENIC MAIZE\", \"Annual Sabin Colloquium on Cancer Vaccines and Immunotherapy\", \"A novel DNA-launched live attenuated Chikungunya vaccine\", \"CANCER VACCINES TO HPV-16 ASSOCIATED TUMOR\", \"Advancing a Lead Candidate Hantavirus Pulmonary Syndrome DNA Vaccine\", \"Functional genomic analysis of the CD8 T cell response to HIV vaccines in\", \"A Small Animal Model for Viscerotropic Disease to Improve Yellow Fever Vaccine\", \"Appropriate Pneumococcal Vaccination in Infants in Fiji\", \"DOMAIN-SPECIFIC SEROLOGY FOR SIV/SHIV VACCINE EVALUATION\", \"DETERMINANTS OF VACCINE PROTECTION IN A SIV MODEL\", \"Development and Testing of New Tuberculosis Vaccines\", \"Protective CMI mechanisms of a dual-subtype FIV vaccine\", \"Multiscale Modeling Tools for Structural Biology\", \"\\u5e94\\u7528\\u591a\\u4ef7\\u75ab\\u82d7\\u514d\\u75abhuCD4/CCR5\\u8f6c\\u57fa\\u56e0\\u5c0f\\u9f20\\u7b5b\\u9009\\u5e7f\\u8c31\\u6297HIV-1\\u4e2d\\u548c\\u6027\\u6297\\u4f53\", \"T\\u7ec6\\u80de\\u75ab\\u82d7\\u53ca\\u5176\\u8bf1\\u5bfc\\u7684\\u6297\\u514b\\u9686\\u578bT\\u7ec6\\u80de\\u7684\\u7814\\u7a76\", \"HIV\\u58f3\\u4f53\\u86cb\\u767d\\u75ab\\u82d7\\u5728\\u8f6c\\u57fa\\u56e0\\u67b8\\u675e\\u6839\\u7cfb\\u4e2d\\u7684\\u5206\\u6ccc\\u8868\\u8fbe\", \"\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u9776\\u5411\\u6027DNA\\u75ab\\u82d7\\u6cbb\\u7597\\u54ee\\u5598\\u7684\\u8bd5\\u9a8c\\u7814\\u7a76\", \"\\u57fa\\u56e0\\u4fee\\u9970\\u7684\\u80ba\\u764c\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u75ab\\u82d7\\u53ca\\u5176\\u6297\\u764c\\u673a\\u5236\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"A New Approach to Immunization Against E. coli Infections in Broilers\", \"Peut-on pr\\u00e9venir la r\\u00e9ponse d\\u00e9l\\u00e9t\\u00e8re du d\\u00e9oxynival\\u00e9nol (DON) sur la r\\u00e9ponse vaccinale chez le poulet?\", \"Development of Novel Vaccine strategies against HIV-1 infection\", \"Research on the social and cultural aspects of implementing HIV vaccine programs among MSM and FSWs in Asia and Africa\", \"CIHR/CHVI Team in the soci-cultural aspects of implementing HIV vaccine programs among MSM and FSWs in Asia and Africa\", \"Enhancing Care and Prevention in HIV Vaccine Trials: An International, Interdisciplinary Collaboration\", \"Preventing Respiratory Syncytial Virus (RSV) infection with a novel antigen-adjuvant platform\", \"Social, Behavioral and Ethical Challenges of HIV Vaccine Development\", \"The immunobiology of recombinant adenovirus vaccines\", \"Understanding H1N1 Immunization Knowledge, Attitudes and Behavior in Pregnant Women in British Columbia\", \"Collaborative vaccine development - SSI (Denmark) and VIDO (Canada)\", \"\\u6d77\\u85fb\\u9178\\u94a0\\u6c34\\u51dd\\u80f6\\u5305\\u88c5\\u4ee5\\u63d0\\u5347\\u817a\\u75c5\\u6bd2\\u8f7d\\u4f53\\u6d41\\u611f\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u6548\\u7387\\u7684\\u673a\\u5236\\u7814\\u7a76\", \"Clinical trial of duration of immunity of the yellow fever vaccine in army recruits, participants of the study \\u201c17DD yellow fever vaccine. A double blind, randomized clinical trial of immunogenicity and safety on a dose-response study\\u201d, done in 2009\", \"PilVax: a novel peptide delivery strategy for the development of vaccines\", \"Mucosal Single-Cycle Vaccines against Zika Virus\", \"\\u540c\\u6e90\\u6a21\\u5efaHSV2\\u514d\\u75ab\\u4fdd\\u62a4\\u53ca\\u514d\\u75ab\\u9003\\u907f\\u86cb\\u767d\\u7684\\u591a\\u8868\\u4f4d\\u878d\\u5408\\u75ab\\u82d7\", \"\\u514d\\u75ab\\u539f\\u6027\\u6c28\\u57fa\\u9178\\u5728\\u80bf\\u7624\\u75ab\\u82d7HER-2/neu\\u8bbe\\u8ba1\\u4e2d\\u7684\\u5e94\\u7528\\u53ca\\u5176\\u514d\\u75ab\\u5e94\\u7b54\\u673a\\u5236\\u7814\\u7a76\", \"\\u6c49\\u5766\\u75c5\\u6bd2\\u65b0\\u578bVLPs\\u75ab\\u82d7\\u53ca\\u5176\\u5728\\u5c0f\\u9f20\\u4e2d\\u8bf1\\u5bfc\\u7684\\u514d\\u75ab\\u53cd\\u5e94\\u7814\\u7a76\", \"\\u8679\\u5f69\\u75c5\\u6bd2\\u7eb3\\u7c73\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u8f7d\\u4f53\\u6784\\u5efa\\u4e0e\\u8de8\\u819c\\u673a\\u7406\\u7814\\u7a76\", \"V\\u00fdvoj vakc\\u00edn nam\\u00ed\\u0159en\\u00fdch proti znak\\u016fm n\\u00e1dorov\\u00fdch kmenov\\u00fdch bun\\u011bk\", \"\\u5fd7\\u8cc0\\u6bd2\\u7d20\\u306b\\u5bfe\\u3059\\u308bB\\u9396\\u6a19\\u7684\\u578b\\u7d44\\u63db\\u3048\\u30c8\\u30ad\\u30bd\\u30a4\\u30c9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u5206\\u5b50\\u69cb\\u7bc9\", \"Feasibility and safety of a WT1-targeted cancer vaccine in patients with malignant mesothelioma and locally advanced breast cancer: an open label phase I trial.\", \"Australia Fellowship\", \"Child and Adolescent Immunisation\", \"Therapeutic Cancer Vaccines\", \"Kunjin replicon based vaccines for HIV\", \"HIV Infection: Immunology and Vaccine Design\", \"A new scrambled antigen vaccine (SAVINE) approach: Proof-of-concept in non-human primates for HIV-1\", \"Global HIV/AIDS Vaccine Enterprise\", \"DETECTION AND CONTROL OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EMERGING VIRAL DISEASES OF SWINE\", \"NATURE`S ADJUVANT: THE EVOLUTIONARY CONSERVED ROLE OF COMPLEMENT COMPONENT 3D (C3D) IN ENHANCING B-CELL RESPONSES\", \"PATHOGENOMICS OF INFECTIOUS LARYNGOTRACHEITIS VIRUS\", \"Development study of next generation therapeutic vaccine for clinical application\", \"A molecular mechanism of cancer vaccine enhancement\", \"Establishment of near infrared laser adjuvants: An exploration of new mechanisms in light reception\", \"Long-Term Reduction of High Blood Pressure by Angiotensin II DNA Vaccine in Spontaneously Hypertensive Rats\", \"Statistical analysis of an influenza infection system\", \"Evaluation of novel transmission blocking vaccine antigen using infected patient's blood from endemic area\", \"The development of new angiotensin II receptor vaccine\", \"Analysis of the factor of low immune responses to pneumococcal conjugate vaccine and Hemophilus influenzae type b conjugate vaccine in immunocompromised children\", \"Study of oral vaccine prevent from neosporosis\", \"Synergistic enhancement of tumor vaccine efficacy mediated by herbal medicines\", \"Development of MIF vaccine therapy against inflammation-related colon carcinogenesis\", \"Generation of new DNA vaccine plasmid for the therapy of Alzheimer's disease\", \"Development of recombinant vaccine for lassa fever using replication-incompetent rabies viral vector.\", \"receptor\", \"Development of a novel vaccine carrier for the next-generation influenza universal vaccine\", \"The prevention of MRSA prosthetic vascular graft infection by using a DNA vaccine\", \"Development of cancer peptide vaccine therapy for oral cancer\", \"Attitudes Towards and Acceptance of HPV Vaccine in Mothers of Adolescent Girls: Maximizing the Impact of HPV Vaccine in Japan\", \"Analysis of dendritic cells in gynecologic cancer patients during WT1 peptide vaccine\", \"Elucidation of immunological mechanism in malignant brain tumor of HUVEC vaccine and expansion of adaptation to hemangioblastoma\", \"Functional Vaccine Carriers by using Chemically Modified Fullerene Nanostructures\", \"Improved safety and immunogenicity of rabies live vaccine by a reverse genetics approach\", \"Studies on the route of pertussis vaccination and immune response : a fundamental study of intranasaly immunization\", \"Optimising the efficacy of mycoplasma vaccines in the field\", \"Improved conjugate vaccines derived from a bacterial immunomodulatory protein\", \"\\u9ad8\\u5206\\u5b50\\u907f\\u5b55\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u8fd0\\u7528\\u86cb\\u767d\\u8d28\\u7ec4\\u5b66\\u65b9\\u6cd5\\u7b5b\\u9009\\u7259\\u5468\\u75c5\\u75ab\\u82d7\\u5019\\u9009p.g\\u6297\\u539f\\u7684\\u53cd\\u5411\\u75ab\\u82d7\\u5b66\\u7814\\u7a76\", \"\\u591a\\u623f\\u68d8\\u7403\\u7ee6\\u866b\\u91cd\\u7ec4Bb-EmII/3-10-Em14-3-3\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"\\u5b9e\\u65f6\\u5b9a\\u91cfPCR\\u5728\\u6838\\u9178\\u75ab\\u82d7\\u751f\\u7269\\u5206\\u5e03\\u4e0e\\u751f\\u7269\\u5b89\\u5168\\u6027\\u7814\\u7a76\\u4e2d\\u7684\\u5e94\\u7528\", \"N-\\u7532\\u57fa-D-\\u5929\\u95e8\\u51ac\\u6c28\\u9178\\u53d7\\u4f532B\\u4e9a\\u57fa\\u8868\\u4f4d\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u9547\\u75db\\u6548\\u5e94\\u7684\\u7814\\u7a76\", \"\\u7ec6\\u7c92\\u68d8\\u7403\\u7ee6\\u866b\\u7ec8\\u672b\\u5bbf\\u4e3b\\u91cd\\u7ec4\\u86cb\\u767d\\u591a\\u4ef7\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u548c\\u514d\\u75ab\\u4fdd\\u62a4\\u6027\\u7814\\u7a76\", \"PfCP-2.9\\u759f\\u75be\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u56ca\\u866bDNA\\u75ab\\u82d7\\u8bf1\\u5bfc\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u5236\\u7684\\u86cb\\u767d\\u8d28\\u7ec4\\u5b66\\u57fa\\u7840\", \"CD4+\\u8c03\\u8282T\\u7ec6\\u80de\\u5728T\\u7ec6\\u80de\\u75ab\\u82d7\\u6cbb\\u7597\\u7c7b\\u98ce\\u5173\\u4e2d\\u7684\\u4f5c\\u7528\", \"Protein lipidation in plants: requirements and potential for the production of lipoprotein vaccines\", \"China, bilateral cooperation on fish vaccine development\", \"Desenvolvimento de vacina de subunidade para a profilaxia da leptospirose su\\u00edna, padroniza\\u00e7\\u00e3o em hamster e avalia\\u00e7\\u00e3o da imunidade ativa e passiva em su\\u00ednos\", \"Caridad Zayas Vignier | Inst. Finlay - Cuba\", \"Desenvolvimento de vacina contra o estreptococo beta hemol\\u00edtico do grupo A\", \"Synthesis and characterization of conjugates obtained from Streptococcus pneumoniae capsular polysaccharide and PspA as vaccines candidates\", \"Multiagent Synthetic DNA Vaccines Delivered by Noninvasive Electroporation\", \"Innovative Manufacturing Techniques for Polysaccharide-Protein Conjugate Vaccines\", \"Dendritic cell targeted adenovirus vaccine vector\", \"Understanding cellular immunity to Staphylococcus aureus is required for novel anti-S. aureus vaccine design\", \"Modulation of innate and adaptive immunity by particulate adjuvants for improved parenteral and mucosal vaccination\", \"Development of a BRSV-ISCOM DIVA vaccine and corresponding DIVA test for future creation, identification and protection of BRSV free zones\", \"Technical development of a novel vaccine vehicle for cattle pathogens\", \"Development of a novel VLP based vaccine for malaria\", \"Staphylococcus aureus Infections - Development of A Novel, Effective Vaccine\", \"Formulation of VZV to protect virus during manufacture and generate a thermo-stable vaccine to ensure market supply\", \"A NOVEL VACCINE AGAINST STREPTOCOCCUS EQUI SUBSP. EQUI FOR HORSES\", \"FOOT-AND-MOUTH DISEASE VIRUS (FMDV) COUNTERMEASURES DISCOVERY\", \"GENERATION AND ANALYSIS OF A RECOMBINANT MAREK'S DISEASE VIRUS WITH MUTATION IN THE MEQ AND RIBONUCLEOTIDE REDUCTASE GENES FOR POTENTIAL USE AS VACCINE.\", \"GENERATION OF A DOUBLE DELETION MUTANT VIRUS TO IMPROVE SAFETY AND EFFICACY OF A MAREK'S DISEASE VACCINE.\", \"Enhancement of nasal vaccination - improved immune protection, safety and cost-effectivness through optimisation of mucosal and nasal delivery system.\", \"Identification of efficacious delivery systems for recombinant and nucleic acid construct vaccines (EFFICACIOUS DELIVERY)\", \"Novel strategies for a safe rotavirus vaccine\", \"Workshop / training courses on vaccine quality control with three rs methods (VAC-TRAIN)\", \"Phase 1/2 clinical testing of clade C-based HIV-1 candidate vaccines in China\", \"European research programme for improved vaccine safety surveillance\", \"Towards a vaccine against helicobacter pylori\", \"DNA vaccination of aquaculture fish with emphasis on VHSV in rainbow trout as a model\", \"Development of an improved vaccine against contagious bovine pleuropneumonia\", \"AN AROMATIC DEPENDENT MUTANT OF AEROMONAS SALMONICIDA AS A LIVE VACCINE FOR FURUNCULOSIS IN SALMONID FISH. STUDIES ON THE IMMUNE RESPONSE OF VACCINATED FISH AND ON THE FATE OF BACTERIA AFTER VACCINATION, IN THE HOST AND IN THE ENVIRONMENT\", \"Development of an effective inactivated rotavirus vaccine (IRV) for developing countries: definition of rationale, business case, technical feasibility and overall development plan.\", \"Parasite evolution in response toblood stage candidate malaria vaccines.\", \"Parasite evolution in response toblood stage candidate malaria vaccines.\", \"Development and introduction of vaccines against infectious diseases: MMR in the Netherlands, 1973-85  .\", \"Stable Vaccines Delivered on Oral Thin Films\", \"Improving immune response to vaccines by selective targeting of epithelial regions with the Nanopatch\", \"Genomic sequencing and comparative genomic analysis for animal bacterial vaccine discovery\", \"Investigation of the resilience of immune memory to manipulation by pathogens\", \"Development of a prime-boost anti-cancer vaccine\", \"Using transgenic plant-based production and delivery systems to develop an avian influenza vaccine\", \"Engineering Creativity Award: Development of Small Scale Facilities for Vaccine\", \"Vectored Blood Stage Malaria Vaccine\", \"Towards improved vaccines for control of avian pathogenic Escherichia coli in poultry\", \"The development of a blood-stage vectored vaccine against Plasmodium falciparum malaria\", \"Imaging Viral Immunity\", \"TRIAL OF A NEW HEMOPHILUS INFLUENZAE TYPE B VACCINE\", \"ADVERSE ALLERGIC REACTIONS TO VACCINES\", \"A Phase I Clinical Trial of a Multiclade HIV-1 Vaccine\", \"Evaluating a Multicomponent Ebola Vaccine In Adult Volun\", \"Imaging Viral Immunity\", \"Chlamydial Immunity and Vaccine Development\", \"SECOND AND THIRD-GENERATION HEPATITIS B VACCINES\", \"Malaria Vaccines: Clinical Research and Trial Sites in Endemic Areas\", \"Plant-derived vaccines against hepatitis C Cooperative *\", \"Infectious DNA (i-DNA) Vaccine for Yellow Fever\", \"Adjuvant-containing chimeric virus-like particles as improved influenza vaccines\", \"BOVINE RESPIRATORY SYNCYTIAL VIRUS AS A HUMAN VACCINE\", \"Novel Formulation of Flu Vaccine for the Aged\", \"A Novel Vaccine for Cancer\", \"Mucosal Immunization Against P. aeruginosa by Modified Adenovirus Vectors\", \"Capsule conjugate vaccines against ETEC and Campylobacter\", \"Novel Vaccine Strategies Against Ebola Virus\", \"Chracteristics of An M. Tuberculosis Derived Vaccine\", \"Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine\", \"GENETIC DETERMINANTS MEDIATING VIRUS INDUCED LUNG INJURY\", \"Improved meningococcal vesicle vaccines\", \"Predoctoral Fellowship for Minority Students\", \"Targeting CD137 to enhance RSV peptide vaccine efficacy in aged mice\", \"Clinical Translation of a Mammaglobin cDNA Vaccine for Breast Cancer Prevention and Therapy\", \"Stabilisation of Newcastle Disease vaccine formulated in sugar-glass on polypropylene membranes\", \"Clinical assessment of a novel simian adenovirus-vectored influenza vaccine designed to induce broadly protective immunity\", \"Translational Immunology Research and Accelerated [vaccine] Development (TRIAD)\", \"Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development\", \"Eliciting and identifying broad anti-HIV immune response with a Polyvalent Anti-HIV Vaccine\", \"\\u8fd0\\u7528\\u65b0\\u578b\\u7edf\\u8ba1\\u5b66\\u4e34\\u5e8a\\u8bd5\\u9a8c\\u8bbe\\u8ba1\\u65b9\\u6cd5\\u8bbe\\u8ba1\\u4e2d\\u56fd\\u9996\\u6b21\\u827e\\u6ecb\\u75c5\\u75ab\\u82d7\\u6709\\u6548\\u6027\\u548c\\u514d\\u75ab\\u539f\\u6027\\u7684IIb\\u671f\\u4e34\\u5e8a\\u8bd5\\u9a8c(\\u4e2d\\u7f8e\\u751f\\u7269\\u533b\\u5b66\\u5408\\u4f5c\\u8bd5\\u70b9\\u9879\\u76ee)\", \"\\u6ee4\\u6ce1\\u8f85\\u52a9T\\u7ec6\\u80de\\u5728\\u4e59\\u809d\\u75ab\\u82d7\\u514d\\u75ab\\u5e94\\u7b54\\u4e2d\\u7684\\u8868\\u578b\\u548c\\u529f\\u80fd\\u5206\\u6790\\u53ca\\u8c03\\u63a7\\u673a\\u5236\\u7814\\u7a76\", \"\\u7ed3\\u6838\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u8bf1\\u5bfc\\u7684\\u8bb0\\u5fc6\\u6027T\\u7ec6\\u80de\\u4e9a\\u578b\\u7279\\u5f81\\u3001\\u5206\\u5316\\u8c03\\u63a7\\u53ca\\u4fdd\\u62a4\\u6548\\u5e94\\u7814\\u7a76\", \"Notch\\u4fe1\\u53f7\\u5728\\u547c\\u5438\\u9053\\u75c5\\u6bd2\\u75ab\\u82d7\\u589e\\u5f3a\\u6027\\u80ba\\u90e8\\u514d\\u75ab\\u75c5\\u7406\\u4e2d\\u7684\\u4f5c\\u7528\\u53ca\\u673a\\u5236\\u7814\\u7a76\", \"RNA particles for Preparedness against Infectious Diseases\", \"Targeted Dendritic Cell Vaccines for Influenza: Providing a vaccine to all 33M Canadians\", \"Planning and development of a Sexually Transmitted Infections Vaccine Consortium in British Columbia (STRIVE-BC)\", \"A DNA-Based Universal Seasonal Influenza Vaccine Phase I Safety and Immunogenicity Study\", \"Development of small molecule viral sensitizers to boost vaccine manufacturing\", \"\\u65b0\\u578bGM-CSF\\u951a\\u5b9a\\u7684\\u8180\\u80f1\\u764c\\u80bf\\u7624\\u5e72\\u7ec6\\u80de\\u75ab\\u82d7\\u7684\\u6cbb\\u7597\\u4f5c\\u7528\\u53ca\\u76f8\\u5173\\u673a\\u5236\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u83cc\\u5f71\\u9012\\u9001\\u7cfb\\u7edf\\u7684\\u6885\\u6bd2\\u87ba\\u65cb\\u4f53\\u65b0\\u578b\\u591a\\u8868\\u4f4d\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u4fdd\\u62a4\\u6548\\u5e94\\u53ca\\u673a\\u5236\", \"The identification of breast tumor antigens targeted by the immune response during tumor rejection\", \"Sociocultural acceptability of a future HIV vaccine: Perspectives of frontline health care workers in Karnataka, India\", \"Development of an oral BCG vaccine bait formulation for badgers\", \"Protective immune responses induced by FMDV vaccine in target species and their epidemiological significance\", \"Matching the antigenic properties of footandmouth disease vaccine virus strains with those of field strains\", \"\\u4f2a\\u72c2\\u72ac\\u75c5\\u75c5\\u6bd2/\\u65e5\\u672c\\u8111\\u708e\\u75c5\\u6bd2\\u590d\\u5236\\u5b50\\u5d4c\\u5408\\u75ab\\u82d7\\u8f7d\\u4f53\\u7684\\u6784\\u5efa\\u53ca\\u8bc4\\u4ef7\", \"Formulation and optimization studies of spray-drying to prepare a thermally stabilized vaccine model\", \"Development of a murine model of oral adenovirus vectored vaccine.\", \"Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems\", \"Improved vaccines against tuberculosis based on dendritic cell manipulation\", \"Understanding Immune Control of HIV\", \"Manufacturing and Development for Rapid Access Ebola Vaccine (EBOMAN) \\u2013 Sofia ref.: 115850\", \"Self-Administered Vaccines Directed Against Plague and MERS\", \"\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u3068\\u3057\\u3066\\u7570\\u7a2e\\u6297\\u539f\\u3092\\u4ed8\\u52a0\\u3057\\u305f\\u30a4\\u30f3\\u30d5\\u30eb\\u30a8\\u30f3\\u30b6\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"The burden of rotavirus diarrhea : Estimating the cumulative incidence among children less than 3 years of age\", \"Antitumor immunity by OK-432-conjugated tumor vaccine in mice cancer model\", \"\\u9020\\u8840\\u7d30\\u80de\\u79fb\\u690d\\u60a3\\u8005\\u306b\\u5bfe\\u3059\\u308b\\u3001\\u514d\\u75ab\\u6291\\u5236\\u3092\\u60f9\\u8d77\\u3057\\u306a\\u3044\\u9ebb\\u75b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"Development of heterologous vaccines using MPT51, a novel secretory protein of Mycobacterium tubeiculosis\", \"\\u30af\\u30eb\\u30de\\u30a8\\u30d3\\u306e\\u691c\\u75ab\\u95a2\\u9023\\u907a\\u4f1d\\u5b50\\u306e\\u6a5f\\u80fd\\u89e3\\u6790\", \"\\u7d30\\u80de\\u5185\\u5bc4\\u751f\\u6027\\u75c5\\u539f\\u4f53\\u306e\\u514d\\u75ab\\u56de\\u907f\\u6a5f\\u69cb\\u306b\\u5bfe\\u5fdc\\u3057\\u305fDNA\\u30ef\\u30af\\u30c1\\u30f3\\u30fb\\u907a\\u4f1d\\u5b50\\u6cbb\\u7642\\u306e\\u6226\\u7565\\u7684\\u57fa\\u76e4\", \"P187 - MULTIPLY EXPOSED VAGINALLY, UNINFECTED MACAQUE MODEL\", \"Mucosal vaccine strategies against human papillomavirus and cervical cancer\", \"\\u65b0\\u578b\\u4e73\\u9178\\u83cc\\u8868\\u9762\\u5c55\\u793a\\u7cfb\\u7edf\\u53ca\\u5176\\u4f5c\\u4e3a\\u75ab\\u82d7\\u8f7d\\u4f53\\u7684\\u524d\\u671f\\u57fa\\u7840\\u7814\\u7a76\", \"Dendritic Cell-Directed Vaccine Against HIV\", \"Application of Open Source Licensing to Vaccine and Medicine Discovery and Development\", \"Fish Virus Vaccines (ViVaFish)\", \"Developing vaccines against diarrhea caused by Enterotoxigenic Escherichia coli and Shigella (EntVac)\", \"TRUKKET XXXXXXXXXXXElectroporation enhanced technology for delivery of DNA vaccines against brucellosis .........\", \"Escalonamento do processo de produ\\u00e7\\u00e3o de vacina recombinante contra Rhodococcus equi\", \"Prediction of Hyperbaric Oxygen Toxicity\", \"Pre-clinical Development of a Vaccine for the Treatment of Heroin Addiction\", \"TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development\", \"P187 - MULTIPLY EXPOSED VAGINALLY, UNINFECTED MACAQUE MODEL\", \"POLYVALENT T CELL MOSAIC VACCINE TO CROSS-PROTECT SWINE AGAINST HETEROLOGOUS PRRSSV STRAINS\", \"Developing and Testing a novel, low-cost, effective HOOKworm VACcine to Control Human Hookworm Infection in endemic countries\", \"Development of an oral Helicobacter Pylori vaccine\", \"A \\u201cUniversal\\u201d Influenza Vaccine through Synthetic, Dendritic Cell-Targeted, Self-Replicating RNA Vaccines\", \"Innovation Partnership for a Roadmap on Vaccines in Europe\", \"Combinatorial immunization strategy to educate the immune system towards cross recognition and coverage against antigenic drift in seasonal influenza virus exposure\", \"ARCAS: Analysis of the Route to Commercialisation of MVA based influenza  vaccines\", \"Development of Vaccines for bTV, EHDV and AHSV\", \"Mucosal Vaccines for Poverty Related Diseases\", \"UK HIV Vaccine Consortium report.\", \"Development of effective live vaccines for prevention of anaplasmosis and babesiosis.\", \"Development of effective live vaccines for prevention of anaplasmosis and babesiosis.\", \"Adapting recombinant anti-tick vaccines to livestock in Africa.\", \"Adapting recombinant anti-tick vaccines to livestock in Africa.\", \"Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infections\", \"Development of small molecule viral sensitizers to boost vaccine manufacturing\", \"Combating highly pathogenic avian influenza: novel vaccination strategies\", \"AEROSOL INFECTION OF MICE AS A MODEL FOR PERTUSSIS INFEC\", \"IMMUNOGENICITY OF TWO DIFFERENT MEASLES VACCINES IN HAITIAN INFANTS\", \"Development of a Vaccine for HIVAIDS: Cellular Immunity\", \"South-West European HIV Vaccine Clinical Trial Unit\", \"Development of an VEE Replicon Vaccine Against Smallpox\", \"Development of ProtollinTM Plague Vaccine\", \"An Inactivated Influenza Nasal Powder Vaccine\", \"Optimizing the Immunogenicity of MVA-Based AIDS Vaccines\", \"Development of a Next Generation Anthrax Vaccine, dmPA7909\", \"Dose Optimization, Production &Tox Testing of Replicon-Vaccines for Smallpox\", \"Development of HIV Vaccine Clinical Trials Phase I-II-III in Dominican Republic\", \"South-West European HIV Vaccine Clinical Trial Unit\", \"Development of Recombinant SARS VLP Vaccines\", \"Preclinical Development of a Recombinant Dengue Vaccine\", \"GENERATION OF NOVEL RECOMBINANT RABIES VIRUS VACCINES\", \"Protective CMI mechanisms of a dual-subtype FIV vaccine\", \"TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION\", \"Potent Vaccine Adjuvant Therapeutic\", \"Novel Smallpox Vaccine Derived from VV/VAR Immunome\", \"Development of an Oral Anthrax Vaccine\", \"Non-invasive delivery of skin-targeted tetanus vaccines\", \"A novel vaccine: botulinum neurotoxin subunit on a viral carrier.\", \"A Novel Therapy for Staphyloccocal Enterotoxin B poisoning\", \"DELETED PHOP/PHOQ S TYPHI AS A LIVE ORAL VACCINE VECTOR\", \"Stress management and vaccine response among women at risk for breast cancer\", \"Increasing efficacy of an Adenovirus vaccine targeting Clostridium difficile usin\", \"Mast Cell Activator as Adjuvant for Biodefense Vaccines\", \"Transdermal vaccine delivery platform technology\", \"HIV Vaccines\", \"HIV Vaccine Development\", \"Epitope Driven HIV Vaccine Development AI50528-01A1\", \"HIV 1 VACCINE AND IMMUNITY STUDY\", \"Randomized Intervention Trial to Evaluate a Vaccine Social Media Website\", \"Optimization of Peptide Based Vaccines for Cancer\", \"Generation and Evaluation of Pro-Apoptotic rBCG and Viral Vectors as TB Vaccine C\", \"Novel vaccines for broad protection against avian influenza\", \"VACCINE APPROACHES TO PREVENT HIV/AIDS IN CHILDREN\", \"DEVELOPMENTAL ASPECTS OF AN IDIOTYPE VACCINE\", \"CLINICALLY RELEVANT MODELS FOR IDIOTYPE HBSAG VACCINE\", \"HUMAN IMMUNE RESPONSES TO HPV VACCINES\", \"DEVELOPMENT OF A NOVEL MULTIENVELOPE AIDS VACCINE\", \"Tuberculosis Vaccine Strategy Using Salmonella Vectors\", \"Gene Variation and Responsiveness to Influenza Vaccines\", \"Development of a Practical Heroin-HIV Vaccine\", \"Development of a Modified mRNA-Based Vaccine for Lassa Virus\", \"Global mapping of HPV vaccine hesitancy: determinants, monitoring and identification of strategies for effective implementation\", \"Ocena potencja\\u0142u epidemicznego szczep\\u00f3w Bordetella pertussis w warunkach obni\\u017conej odpowiedzi poszczepiennej jako element poszukiwania przyczyn obni\\u017conej efektywno\\u015bci szczepie\\u0144 przeciw krztu\\u015bcowi\", \"Clec9A Targeting Antibodies as a New Immunotherapy for Prostate Cancer\", \"Vaccine Immunotherapy for Prostate Cancer\", \"Xenoantigens as Tumor Antigens for the Development of Prostate Cancer Vaccines\", \"Continuation of the development for vaccines against bovine TB in cattle\", \"Generation of Vaccine Candidates Against Mycobacterium bovis\", \"\\\"Strategie combinate basate sulla vaccinazione a DNA per curare i carcinomi ErbB-2/neu positivi e le loro recidive\\\"\", \"Scotia Scholar Award 2014\", \"Development of polyvalent inactivated rhinovirus vaccine\", \"Development of Dendritic Cell-based prophylactic and therapeutic Ebola vaccines\", \"COMMERCIALIZATION OF A SYNTHETIC, LIVE-ATTENUATED FMDV VACCINE\", \"Development of second generation vaccines against parvoviruses\", \"13TSB_SynBio: Engineering immune-cell-targeting bacteria to express vaccines from within the body\", \"ARRA: Clinical Support for Universal Influenza Development\", \"Human Rabies Virus Vaccine Development\", \"Geographic access to care and HPV vaccine uptake among ethnic minority girls\", \"Development of a Sublingual Measles Vaccine\", \"A tri-antigen nasal anthrax vaccine against toxins and vegetative bacilli\", \"Cellular Immune Responses Induced by SIVdelta-vif plus IL-15 DNA Vaccine\", \"The safety of pneumococcal polysaccharide vaccine in children - a followup study.\", \"Vaccine Strategies for Tularemia\", \"Preclinical Evaluation of Antigen-Specific DNA Vaccines as a Treatment for Prostate Cancer\", \"Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metastatic Breast Cancer\", \"EML-VAC: Multivalent replicon vaccine against Ebola, Marburg and Lassa viruses\", \"COMMERCIALIZATION OF A SYNTHETIC, LIVE-ATTENUATED FMDV VACCINE\", \"I-Corps: Enhancing Vaccine Performance\", \"Vacina oral recombinante contra raiva\", \"Development of a Non-adjuvanted VLP Vaccine against Stealth H7N9 Influenza\", \"Development of Structurally Defined QS-17/18-Based Vaccine Adjuvants\", \"leveraging On t-cell immune resPonse To Improve influenza VACcines.\", \"Novel vaccine to enhance breadth of influenza immunity by skin vaccination\", \"Improving the therapeutic efficacy of a lead vaccine against plague using a novel adjuvant system\", \"CONTROL OF INFECTIOUS BRONCHITIS IN POULTRY\", \"New generation vaccines based on recombinant self-replicating alphavirus rna\", \"Diversity of Immune Responses Elicited by HIV Vaccines\", \"Development of a vaccine against HIV and AIDS\", \"DEVELOPMENT AND EVALUATION OF QUALITY CONTROL METHODS FO\", \"DEVELOPMENT OF AN AIDS PROTOTYPE VACCINE USING SIV\", \"Development of a Next Generation Anthrax Vaccine, AV7909\", \"Adjuvant Enhanced Antiviral Immunity\", \"Developing recombinant coronavirus vaccines for SARS\", \"Ontogeny of Measles Immunity in Infants\", \"Targeting vaccine vectors and antigens to dendritic cells using protein L.\", \"Non-peptidic HIV vaccine\", \"Humoral Immune Responses to Virus-like Particle Vaccine Candidates for RSV\", \"Enhancement of mucosal antibody responses to HIV vaccine\", \"Rapid deployment DNA vaccine for pandemic influenza\", \"Mucosal modified vaccinina Ankara-based plaque vaccines\", \"Delivery system development for a reservoir targeted Lyme disease vaccine\", \"A Peptide-Based Vaccine to Nicotine\", \"Acne Vaccines Targeting a Surface Sialidase and a Secreted CAMP Factor Toxin\", \"Rational Design of Live Attenuated Influenza A Vaccine Candidates\", \"Evaluation of Flavivirus Live Attenuated Vaccine Recombination Potential\", \"Controlled Trial of Live Attenuated Influenza Vaccine in Very Premature Infants\", \"POTENTIATION OF CD8+ T CELL RESPONSE TO MELANOMA VACCINE\", \"Laser treatment to enhance therapeutic HPV DNA vaccine potency\", \"Development and Evaluation of a Dual-Antigen Nasal Brucella Vaccine\", \"T. cruzi immune evasion factors and vaccine design\", \"HIV Vaccines in Th2 Biased Recipients\", \"Vaccine-enhanced respiratory syncytial virus disease\", \"Evaluation of Anti-endotoxin Vaccine for Human Use\", \"Nanocarriers for transcutaneous delivery of vaccines\", \"An HB Vaccine Model For HIV Vaccine Trials in Drug Users\", \"Polypeptide Vaccine In IL-2 Liposomes For Prostate Ca\", \"rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses\", \"Building novel vaccines on a borrowed coat\", \"Subunit Vaccines for Brucella Pathogens\", \"New Vaccine against Influenza\", \"Collaborative Development of a Vaccine against Cutaneous and Visceral Leishmanias\", \"New Approaches to Schistosome vaccine antigen discovery\", \"An Envelope Containing HIV Pseudovirion Vaccine\", \"Poly-functional analyses of vaccine-induced T cell responses\", \"VACCINE TRIALS USING INDIVIDUAL AND ECOLOGICAL UNITS\", \"Evaluation of Anti-endotoxin Vaccine for Human Use\", \"FIVDELTAVIF DNA Vaccines with Cytokine Adjuvants\", \"Ontogeny of Measles Immunity in Infants\", \"CONTROLLED RELEASE SYSTEMS AS VACCINE ADJUVANTS\", \"PATHOGENIC ROLE OF H. INFLUENZAE SURFACE PROTEINS\", \"LIVE VIRUS VACCINES AS DOMINANT NEGATIVE MUTANTS\", \"Survivin &Interferon-alpha as Cancer Vaccine Therapy in Pancreatic Cancer\", \"Molecular profiling consortium: biomarker identification and interaction analysis of EPI vaccines\", \"Viral Latency and Virus Detection\", \"Influenza: making vaccines in plants\", \"GMP Production of Candidate Pan-Group 2 Influenza A Virus Vaccines\", \"Universal Influenza T Cell-Targeted Mucosal Vaccines\", \"Combining oncolytic vaccines (OVax) with surgery and immune modulation to prevent postoperative cancer recurrence and metastases\", \"Evaluation of the protection efficacy of vaccines against bovine TB in a natural transmission setting.\", \"Transmission and VaccineInduced Protection of Marek's Disease\", \"Genetically determined susceptibility to rotavirus and rotavirus vaccine failure in sub-Saharan Africa\", \"Addresing Efficacy of a Dengue vaccine candidate in a macaque challenge model\", \"Multivalent Oral Vaccine against Enterotoxigenic Escherichia coli and Enteric Fevers\", \"EUROPEAN VACCINE AGAINST AIDS\", \"Clinical Trials of  Biodefense Vaccines (Dengue)\", \"Laboratory And Preclinical Studies Of Flaviviruses\", \"Vaccine Clinical Trials\", \"Rapid  Response Vaccines for Botulinum Neurotoxins\", \"Adenovirus-vectored RSV vaccine not inhibited by maternal immunity\", \"Synthetic Nanoparticle based Universal Influenza Vaccine\", \"Surrogate endpoints for correlating protective immunity in response to influenza\", \"Adjuvanted Influenza Vaccine\", \"Lyophilization of Plasmodium falciparum sporozoite vaccine\", \"Enhancing TB vaccine with gene silencing\", \"A Lassa Vaccine in primates with AIDS\", \"Immunological Mechanisms of Vaccination\", \"Development of a Recombinant Tetravalent Dengue Vaccine Based on a Subunit Envelo\", \"A novel anti-spore nasal vaccine for protection from anthrax\", \"Novel Bioconjugate Vaccines to Prevent Staphylococcus aureus Infection\", \"Continuing an education campaign on vaccines and immunization\", \"Rationeel ontwerp van een therapeutisch vaccin tegen HIV-1 gebaseerd op een nieuwe formulering van nanopartikel\", \"Clinical optimization of an autologous tumour vaccine strategy for the treatment of Chronic Lymphocytic Leukemia\", \"Highly stable trimerization of HIV-1 envelope based antigens will improve their immunogenicity and capacity to elicit a neutralizing antibody responses\", \"Augmentation of a Canine Melanoma Vaccine with Immunomodulatory Antibodies\", \"Ad-NK4\\u4fee\\u9970\\u7684\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u75ab\\u82d7\\u6297\\u9aa8\\u9ad3\\u7624\\u514d\\u75ab\\u4f5c\\u7528\\u7814\\u7a76\", \"\\u80ba\\u52a8\\u8109\\u9ad8\\u538b\\u5185\\u76ae\\u7d20ETA\\u53d7\\u4f53\\u6cbb\\u7597\\u6027\\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u6059\\u866b\\u75c5\\u4e1c\\u65b9\\u4f53Karp\\u682a\\u878d\\u5408\\u6297\\u539f\\u7684\\u83b4\\u82e3\\u53f6\\u7eff\\u4f53\\u751f\\u7269\\u5c01\\u88c5\\u8868\\u8fbe\\u3001\\u80f6\\u56ca\\u5316\\u53ca\\u514d\\u75ab\\u6548\\u5e94\\u8bc4\\u4ef7\", \"\\u798f\\u6c0f\\u5fd7\\u8d3a\\u6c0f\\u83cc\\u591a\\u7cd6\\u7ed3\\u5408\\u75ab\\u82d7\\u7684\\u4f53\\u5185\\u751f\\u7269\\u5408\\u6210\\u7814\\u7a76\", \"\\u4e19\\u578b\\u809d\\u708e\\u75c5\\u6bd2\\u65b0\\u578b\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"DEC-205/PLGA-\\u809d\\u7d20\\u9176CD4+\\u3001CD8+T\\u7ec6\\u80de\\u8054\\u5408\\u8868\\u4f4d\\u80bd\\u7eb3\\u7c73\\u9897\\u7c92\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u6548\\u5e94\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u4e91\\u5357\\u7701\\u72c2\\u72ac\\u75c5\\u6bd2\\u7cd6\\u86cb\\u767d\\u57fa\\u56e0\\u5206\\u6790\\u53ca\\u6297\\u539f\\u6027\\u7814\\u7a76\", \"\\u9776\\u5411\\u90ce\\u683c\\u7f55\\u6c0f\\u7ec6\\u80de\\u7684Eppin\\u4f18\\u52bf\\u8868\\u4f4d\\u907f\\u5b55\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u4e0e\\u7814\\u7a76\", \"\\u4eba\\u4e73\\u5934\\u7624\\u75c5\\u6bd216\\u578b\\u9884\\u9632\\u6027\\u75ab\\u82d7\\u7684\\u53ef\\u884c\\u6027\\u7814\\u7a76\", \"\\u620a\\u578b\\u809d\\u708e\\u75c5\\u6bd2CDNA\\u57fa\\u56e0\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u53e3\\u670d\\u7f13\\u91ca\\u957f\\u6548\\u970d\\u4e71\\u5fae\\u7403\\u83cc\\u82d7\\u7684\\u52a8\\u7269\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u4e2d\\u56fd\\u4e0e\\u4e16\\u754c\\u6c14\\u5019\\u53ca\\u519c\\u4e1a\\u6c14\\u5019\\u76f8\\u4f3c\\u7814\\u7a76*3\", \"EV71 VP1\\\"\\u98df\\u54c1\\u7ea7\\\"\\u4e73\\u9178\\u83cc\\u6d3b\\u8f7d\\u4f53\\u75ab\\u82d7\\u53ca\\u5f02\\u6e90\\u6297\\u539f\\u8054\\u5408\\u514d\\u75ab\\u8bf1\\u5bfc\\u9ecf\\u819c\\u548c\\u7cfb\\u7edf\\u514d\\u75ab\\u7684\\u7814\\u7a76\", \"MSP2\\u7684\\u6297\\u759f\\u75be\\u75ab\\u82d7\\u6f5c\\u80fd\\u76f8\\u5173\\u6027\\u8d28\\u7684\\u5206\\u5b50\\u673a\\u5236\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u4e73\\u817a\\u4e0a\\u76ae\\u7ec6\\u80deFcRn\\u80de\\u541e\\u8f6c\\u8fd0\\u9014\\u5f84\\u7684\\u91d1\\u9ec4\\u8272\\u8461\\u8404\\u7403\\u83cc\\u591a\\u4ef7\\u6bd2\\u529b\\u56e0\\u5b50\\u75ab\\u82d7\\u8bbe\\u8ba1\\u53ca\\u5176\\u8bf1\\u5bfc\\u514d\\u75ab\\u5e94\\u7b54\\u6548\\u679c\\u7684\\u7814\\u7a76\", \"\\u9e45\\u7ec6\\u5c0f\\u75c5\\u6bd2VP3\\u57fa\\u56e0\\u4e0e\\u9e45\\u03b3\\u5e72\\u6270\\u7d20\\u57fa\\u56e0\\u91cd\\u7ec4\\u79bd\\u75d8\\u75c5\\u6bd2\\u7684\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u53ca\\u5176\\u673a\\u5236\\u7814\\u7a76\", \"FcRn\\u4ecb\\u5bfc\\u7684\\u6297\\u7ec6\\u7c92\\u68d8\\u7403\\u86b4\\u9776\\u5411\\u9ecf\\u819c\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u589e\\u5f3a\\u4f53\\u6db2\\u514d\\u75ab\\u5e94\\u7b54\\u7684\\u673a\\u5236\\u7814\\u7a76\", \"\\u9f3b\\u9ecf\\u819c\\u63a5\\u79cdA\\u03b2\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u9884\\u9632AD\\u7684\\u7597\\u6548\\u8bc4\\u4ef7\\u53ca\\u514d\\u75ab\\u673a\\u5236\\u5206\\u6790\", \"\\u65b0\\u578b\\u53e3\\u670dHIV-1\\u7c98\\u819c\\u514d\\u75ab\\u75ab\\u82d7\\u7684\\u7814\\u5236\", \"\\u6c1f\\u4ee3\\u80bf\\u7624\\u76f8\\u5173\\u7cd6\\u6297\\u539f\\u7684\\u5316\\u5b66\\u9176\\u6cd5\\u5408\\u6210\\u53ca\\u5176\\u5728\\u80bf\\u7624\\u7cd6\\u75ab\\u82d7\\u4e2d\\u7684\\u5e94\\u7528\", \"Enhanced HIV Vaccine by CNT-enabled Mucosal Delivery\", \"Production of Inactivated Vaccines Using Supralethal Irradiation\", \"Passively Regulated Cryogenic (PaRC) Vial System for Vaccine Distribution and Administration\", \"Surfactant-vesicle based gonorrhea vaccine\", \"Developing a Chlamydia trachomatis vaccine by optomizing dendritic cell responses.\", \"Development of Novel Molecular Adjuvants for Genetic Vaccination\", \"Influenza Vaccine Effectiveness Against Serious Outcomes\", \"Short Term Travel Grant to Attend AIDS Vaccine 2008 Partner Development Forum\", \"A Study of an HPV VLP Vaccine in a Cohort of HIV Positive Girls and Women\", \"Vaccination during pregnancy: issues in translational ethics and research ethics\", \"Towards a Broad-Spectrum Meningococcal Vaccine:  Preparation and validation of modified outer membrane vesicle vaccines.\", \"Development of a Salmonella Poultry and Human Vaccine based on  Secreted Bacterial Products\", \"CHVI Team in Social and Behavioral Research on HIV Vaccines\", \"Understanding recent influenza drifts and efficacy of new mucosal vaccines\", \"\\u80ba\\u9012\\u9001\\u70ad\\u75bd\\u75ab\\u82d7\\u5e72\\u7c89\\u6c14\\u6eb6\\u80f6\\u7528\\u4ee5\\u9884\\u9632\\u5438\\u5165\\u6027\\u70ad\\u75bd\\u7684\\u7814\\u7a76\", \"\\\"\\u82b3\\u9999\\u8f9f\\u79fd\\\"\\u4e2d\\u836f\\u4f5c\\u4e3a\\u6d41\\u611f\\u75ab\\u82d7\\u7c98\\u819c\\u4f50\\u5242\\u7684\\u6d3b\\u6027\\u53ca\\u5176\\u9f3b\\u7c98\\u819c\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"\\u4e73\\u9178\\u83cc\\u83cc\\u5f71\\u4f5c\\u4e3aDNA\\u75ab\\u82d7\\u5305\\u88c5\\u8f7d\\u4f53\\u8bf1\\u5bfc\\u514d\\u75ab\\u5e94\\u7b54\\u7684\\u7814\\u7a76\", \"\\u970d\\u4e71\\u6bd2\\u7d20A\\u3001B\\u4e9a\\u5355\\u4f4d\\u589e\\u5f3aDNA\\u75ab\\u82d7\\u514d\\u75ab\\u6548\\u679c\\u7684\\u4f50\\u5242\\u6d3b\\u6027\\u548c\\u673a\\u5236\\u7814\\u7a76\", \"\\u643a\\u5e26Her2/neu\\u7684\\u7ea2\\u7ec6\\u80de\\u4f5c\\u4e3a\\u6297\\u4e73\\u817a\\u764c\\u75ab\\u82d7\\u7684\\u4f5c\\u7528\\u548c\\u514d\\u75ab\\u673a\\u5236\", \"GnIH\\u548cINH\\u57fa\\u56e0\\u75ab\\u82d7\\u8054\\u5408\\u514d\\u75ab\\u5927\\u9f20\\u548c\\u725b\\u7684\\u6548\\u679c\\u53ca\\u4f5c\\u7528\\u673a\\u5236\\u63a2\\u8ba8\", \"\\u57fa\\u4e8e\\u51b7\\u80c1\\u8feb\\u8bf1\\u5bfc\\u4e0b\\u76f8\\u5bb9\\u6027\\u6eb6\\u8d28\\u80de\\u5185\\u79ef\\u7d2f\\u7684\\u9cd7\\u5f27\\u83cc\\u6d3b\\u75ab\\u82d7\\u51bb\\u5e72\\u8010\\u53d7\\u5206\\u5b50\\u673a\\u5236\", \"Progress and Pathways Toward an Effective HIV Vaccine\", \"Development of a Recombinant Listeria Monocytogenes Booster Vaccine against Tuberculosis\", \"Synthesis of Clustered ST-Antigens for the Development of Novel Breast Cancer Vaccines\", \"Antibody affinity maturation and protective effect of B cell responses elicited by HIV-1 Env vaccination of non-human primates\", \"BUILDING BETTER VACCINES; LEARNING FROM VIRUSES\", \"Preparation for a phase I/II study of a new TB vaccine candidate\", \"Gastrointestinal viral infections and novel mucosal vaccines\", \"A cooperative platform for development of Asian and European diagnostics and vaccines for autoimmune diseases\", \"Viral Vectors as Recombinant Vaccines\", \"Improved selection methods for emergency FMD vaccines\", \"Development of strategies for control of classical swine fever by emergency vaccination with live attenuated vaccine\", \"\\u57fa\\u4e8e\\u5927\\u89c4\\u6a21PCR\\u6280\\u672f\\u9ad8\\u901a\\u91cf\\u5236\\u5907DNA\\u75ab\\u82d7\\u65b9\\u6cd5\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u8bf1\\u5bfc\\u548c\\u589e\\u5f3a\\u9ecf\\u819c\\u514d\\u75ab\\u6548\\u5e94\\u7684B\\u7fa4\\u6d41\\u8111\\u75ab\\u82d7\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u725bUK\\u682a\\u8f6e\\u72b6\\u75c5\\u6bd2\\u62ee\\u6297\\u2160\\u578bIFN\\u4fe1\\u53f7\\u8f6c\\u5bfc\\u901a\\u8def\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u8fd1\\u7ea2\\u5916\\u8367\\u5149/\\u6fc0\\u5149\\u62c9\\u66fc\\u53cc\\u6a21\\u5f0f\\u6210\\u50cf\\u6280\\u672f\\u7528\\u4e8e\\u80bf\\u7624\\u9776\\u5411\\u7ec6\\u83cc\\u75ab\\u82d7\\u7684\\u4f53\\u5185\\u5206\\u5e03\\u7814\\u7a76\", \"\\u8d1f\\u8f7dgp96-Ki67\\u80bd\\u590d\\u5408\\u7269\\u7684DC\\u75ab\\u82d7\\u5bf9\\u80be\\u764c\\u7684\\u6297\\u80bf\\u7624\\u6548\\u5e94\\u7814\\u7a76\", \"HIV-1 gp120\\u4e0e\\u6709\\u6548\\u75c5\\u6bd2\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u8bf1\\u5bfcTfh\\u7ec6\\u80de\\u6d3b\\u5316\\u53ca\\u6297\\u4f53\\u751f\\u6210\\u80fd\\u529b\\u7684\\u6bd4\\u8f83\\u7814\\u7a76\", \"TLR3\\u914d\\u4f53\\u63d0\\u9ad8H9\\u4e9a\\u578b\\u79bd\\u6d41\\u611f\\u75ab\\u82d7\\u5bf9\\u9e21\\u7684\\u7ec6\\u80de\\u514d\\u75ab\\u673a\\u7406\\u7814\\u7a76\", \"\\u65b0\\u578b\\u53ef\\u964d\\u89e3\\u7684HPEI-YS\\u9776\\u5411\\u57fa\\u56e0\\u75ab\\u82d7\\u8f7d\\u4f53\\u7528\\u4e8e\\u80bf\\u7624\\u514d\\u75ab\\u57fa\\u56e0\\u6cbb\\u7597\\u7684\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u8d1f\\u6027\\u8c03\\u63a7\\u9aa8\\u9ad3\\u95f4\\u5145\\u8d28\\u5e72\\u7ec6\\u80de\\u7684FAP\\u03b1- - \\u589e\\u5f3a\\u591a\\u53d1\\u6027\\u9aa8\\u9ad3\\u7624\\u75ab\\u82d7\\u6297\\u7624\\u6548\\u5e94\\u7684\\u65b0\\u7b56\\u7565\", \"\\u7f8a\\u4f20\\u67d3\\u6027\\u8113\\u75b1\\u75c5\\u6bd2\\u4fdd\\u62a4\\u6027\\u6297\\u539f\\u8868\\u4f4d\\u7b5b\\u9009\\u53ca\\u8868\\u4f4d\\u4f5c\\u56fe\\u7814\\u7a76\", \"MMSA-1\\u4e0eDKK1\\u8054\\u5408\\u591a\\u8868\\u4f4d\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u53ca\\u6297\\u9aa8\\u9ad3\\u7624\\u7814\\u7a76\", \"\\u732a\\u5e26\\u7ee6\\u866b\\u91cd\\u7ec4Bb-TSO45W-4B-TSOL18\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"\\u725b\\u6e90\\u72ac\\u65b0\\u5b62\\u5b50\\u866bNcSRS2-NcGRA7\\u590d\\u5408\\u57fa\\u56e0\\u6838\\u9178\\u75ab\\u82d7\\u4e0e\\u91cd\\u7ec4\\u817a\\u75c5\\u6bd2\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u53ca\\u5176\\u673a\\u5236\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u917f\\u9152\\u9175\\u6bcd\\u9776\\u5411\\u6027\\u9012\\u5448\\u548c\\u8868\\u8fbe\\u7684DNA\\u75ab\\u82d7\\u7814\\u7a76\", \"T\\u7ec6\\u80de\\u53d7\\u4f53\\u8bc6\\u522b\\u80bf\\u7624\\u591a\\u80bd\\u75ab\\u82d7\\u7684\\u7ed3\\u6784\\u548c\\u529f\\u80fd\\u7814\\u7a76\", \"I-Corps: Nanotechnology for Boosting Vaccine Efficacy and Longevity\", \"V\\u00fdvoj nov\\u00fdch vakcin pro genovou l\\u00e9\\u010dbu zhoubn\\u00fdch n\\u00e1dor\\u016f, zalo\\u017een\\u00fd na kooperaci APC a TH bun\\u011bk\", \"Nanoliposomy pro v\\u00fdvoj rekombinantn\\u00edch vakc\\u00edn a c\\u00edlen\\u00fdch imunoterapeutik\", \"2nd Generation Vaccine for the Treatment of Glioblastoma\", \"Next-Generation Adenovirus Vaccine\", \"\\u0418\\u043d\\u0444\\u043e\\u0440\\u043c\\u0430\\u0446\\u0438\\u043e\\u043d\\u043d\\u044b\\u0435 \\u0442\\u0435\\u0445\\u043d\\u043e\\u043b\\u043e\\u0433\\u0438\\u0438 \\u043e\\u0442\\u0431\\u043e\\u0440\\u0430 \\u043f\\u0430\\u0446\\u0438\\u0435\\u043d\\u0442\\u043e\\u0432 \\u043e\\u043d\\u043a\\u043e\\u043b\\u043e\\u0433\\u0438\\u0447\\u0435\\u0441\\u043a\\u043e\\u0433\\u043e \\u043f\\u0440\\u043e\\u0444\\u0438\\u043b\\u044f \\u0434\\u043b\\u044f \\u043f\\u0440\\u0438\\u043c\\u0435\\u043d\\u0435\\u043d\\u0438\\u044f \\u0434\\u0435\\u043d\\u0434\\u0440\\u0438\\u0442\\u043d\\u043e\\u043a\\u043b\\u0435\\u0442\\u043e\\u0447\\u043d\\u044b\\u0445 \\u0432\\u0430\\u043a\\u0446\\u0438\\u043d.\", \"Immune-complex mimetics (ICMs): an adjuvant free approach to controlling the major diseases for which no vaccines are available\", \"Improving cancer vaccines with agonistic antibodies to CD40 and CD27\", \"Equipment to Support Prophylactic Antibacterial Vaccine Development\", \"Cost effectiveness of poultry vaccination for control of H9N2 avian influenza in Pakistan\", \"Room temperature stable MVA-GP pox vectored vaccine against CCHF\", \"Basic Research on the Development of Recombinant Vaccines for Animals by Genetic Engineering\", \"Establishment of the screening system of vaccine candidate genes against cysticercosis using Nod-scid mice.\", \"Basic study of gene therapy to hepatitis C virus infection by using virus-like particle.\", \"Development of therapeutic RANKL vaccination approach against inflammatory alveolar-bone-destruction\", \"\\u7c98\\u819c\\u30ef\\u30af\\u30c1\\u30f3\\u3078\\u306e\\u57fa\\u790e\\u7814\\u7a76:HIV\\u7279\\u7570\\u7684\\u5206\\u6ccc\\u578bIgA\\u8a98\\u5c0e\\u30b7\\u30b9\\u30c6\\u30e0\\u306e\\u958b\\u767a\", \"Basic and clinical studies for development of peptide vaccine for colorectal cancer\", \"Comparison of DNA sequences on VZV glycoproteins of the Oka vaccine and parental Oka strains\", \"Study on efficacy and improvement of diphtheria and tetanus toxoids and pertussis (DPT) vaccine\", \"Development of orally administrable pertussis vaccine\", \"Studies on the development of mucosal vaccine adjuvant\", \"\\u7dd1\\u81bf\\u83cc\\u611f\\u67d3\\u30de\\u30a6\\u30b9\\u306b\\u304a\\u3051\\u308b\\u907a\\u4f1d\\u5b50\\u64cd\\u4f5c\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u6709\\u52b9\\u6027\\u304a\\u3088\\u3073\\u514d\\u75ab\\u5b66\\u7684\\u6a5f\\u5e8f\\u306e\\u691c\\u8a0e\", \"Antigenic diversity and gene sequences of measles virus in the presence of antibodies\", \"Improving a plant vaccine platform modulation of the plant defence system\", \"DNA fusion gene vaccines against prostate cancer\", \"EV71\\u75c5\\u6bd2\\u8863\\u58f3\\u86cb\\u767dVP1\\u57fa\\u56e0\\u7684\\u4f18\\u5316\\u548c\\u514d\\u75ab\\u539f\\u6027\\u7684\\u7814\\u7a76\", \"\\u534f\\u540c\\u6d3b\\u5316TLR4\\u548cTLR9\\u7684\\u9776\\u5411DC\\u759f\\u75be\\u7ea2\\u5916\\u671f\\u8102\\u8d28\\u4f53\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u643a\\u5e26TGEV S\\u548cPEDV S\\u53cc\\u57fa\\u56e0\\u7684\\u51cf\\u6bd2\\u6c99\\u95e8\\u6c0f\\u83cc\\u53e3\\u670d\\u75ab\\u82d7\\u7684\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"DNA-\\u75d8\\u75c5\\u6bd2\\u75ab\\u82d7\\u521d\\u514d\\u52a0\\u5f3a\\u65b9\\u6848\\u6240\\u8bf1\\u5bfc\\u7684\\u9ad8\\u529f\\u80fd\\u4eb2\\u548c\\u529b\\u7684CD8+T\\u7ec6\\u80de\\u7684\\u5206\\u5b50\\u7279\\u5f81\", \"\\u7ec6\\u7c92\\u68d8\\u7403\\u7ee6\\u866bBCG-egG1Y162\\u91cd\\u7ec4\\u75ab\\u82d7\\u7684\\u6784\\u5efa\\u548c\\u4fdd\\u62a4\\u673a\\u5236\\u7814\\u7a76\", \"\\u80bf\\u7624\\u75ab\\u82d7\\u65b0\\u578b\\u6c22\\u6c27\\u5316\\u94dd\\u51dd\\u80f6/\\u591a\\u7cd6\\u590d\\u5408\\u4f50\\u5242\\uff08Al-PS\\uff09\\u7684\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"SVCV\\u53cd\\u5411\\u9057\\u4f20\\u7cfb\\u7edf\\u7684\\u6784\\u5efa\\u53ca\\u5176\\u4f20\\u9001\\u5206\\u5b50\\u75ab\\u82d7\\u673a\\u5236\\u7814\\u7a76\", \"\\u591a\\u57fa\\u56e0\\u8868\\u8fbe\\u5bb6\\u8695\\u751f\\u7269\\u53cd\\u5e94\\u5668\\u7ecf\\u6d4e\\u9ad8\\u6548\\u7ec4\\u88c5\\u7532\\u578bH1N1\\u6d41\\u611f\\u75c5\\u6bd2\\u6837\\u9897\\u7c92\\u53ca\\u5176\\u514d\\u75ab\\u539f\\u6027\\u7814\\u7a76\", \"TLR3\\u5728HBsAg\\u9633\\u6027\\u6bcd\\u4eb2\\u5a74\\u513f\\u4e59\\u809d\\u75ab\\u82d7\\u65e0\\u5f31\\u5e94\\u7b54\\u4e2d\\u7684\\u4f5c\\u7528\", \"D39\\u25b31672\\u7f3a\\u9677\\u83cc\\u682a\\u7c98\\u819c\\u63a5\\u79cd\\u5bf9\\u80ba\\u708e\\u94fe\\u7403\\u83cc\\u611f\\u67d3\\u7684\\u4fdd\\u62a4\\u4f5c\\u7528\\u53ca\\u673a\\u5236\\u7814\\u7a76\", \"\\u4e19\\u578b\\u809d\\u708e\\u75c5\\u6bd2\\u6297\\u539f\\u8868\\u4f4d\\u7684\\u9897\\u7c92\\u5316\\u5bf9\\u5176\\u514d\\u75ab\\u539f\\u6027\\u7684\\u5f71\\u54cd\", \"\\u8868\\u89c2\\u9057\\u4f20\\u4fee\\u9970\\u7684MHC-II\\u57fa\\u56e0\\u7ec6\\u80de\\u75ab\\u82d7\\u6cbb\\u7597\\u80f0\\u817a\\u764c\\u7684\\u673a\\u7406\\u7814\\u7a76\", \"\\u7ec6\\u7c92\\u68d8\\u7403\\u7ee6\\u866b\\u91cd\\u7ec4Bb-Eg95-EgA31\\u878d\\u5408\\u57fa\\u56e0\\u75ab\\u82d7\\u6784\\u5efa\\u53ca\\u5176\\u514d\\u75ab\\u673a\\u5236\\u7814\\u7a76\", \"\\u9776\\u5411\\u80bf\\u7624\\u5e72\\u7ec6\\u80de\\u7684\\u6811\\u7a81\\u7ec6\\u80de\\u75ab\\u82d7\\u6cbb\\u7597\\u6076\\u6027\\u8111\\u80f6\\u8d28\\u7624\\u7684\\u5b9e\\u9a8c\\u53ca\\u4f5c\\u7528\\u673a\\u5236\\u7814\\u7a76\", \"\\u8868\\u8fbeAg85B\\u3001ESAT-6\\u548cMPT64\\u57fa\\u56e0\\u6838\\u9178\\u75ab\\u82d7\\u514d\\u75ab\\u5e94\\u7b54\\u53ca\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u57fa\\u4e8e\\u86cb\\u767d\\u82af\\u7247\\u6280\\u672f\\u7684\\u65b0\\u578b\\u4e59\\u809d\\u75c5\\u6bd2\\u4f18\\u52bf\\u8868\\u4f4d\\u80bd\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u5c0f\\u53cd\\u520d\\u517d\\u75ab\\u75c5\\u6bd2\\u53cd\\u5411\\u9057\\u4f20\\u64cd\\u4f5c\\u5e73\\u53f0\\u5efa\\u7acb\\u53ca\\u6807\\u8bb0\\u75ab\\u82d7\\u6784\\u5efa\", \"\\u6291\\u5236\\u80be\\u7d20\\u6d3b\\u6027\\u7684\\u77ed\\u80bd\\u7eb3\\u7c73\\u75ab\\u82d7\\u7814\\u7a76\", \"\\u732a\\u7e41\\u6b96\\u4e0e\\u547c\\u5438\\u7efc\\u5408\\u5f81\\u201c\\u81ea\\u6740\\u6027\\u201dDNA\\u75ab\\u82d7\\u7814\\u7a76\", \"\\u91cd\\u7ec4\\u5c3f\\u7d20\\u9176-BCG\\u9884\\u9632\\u5e7d\\u95e8\\u87ba\\u6746\\u83cc\\u611f\\u67d3\\u7684\\u514d\\u75ab\\u673a\\u5236\", \"\\u6211\\u56fd\\u513f\\u7ae5\\u80ba\\u708e\\u94fe\\u7403\\u83cc\\u5206\\u79bb\\u682a\\u86cb\\u767d\\u8d28\\u6297\\u539f\\u7684\\u5206\\u5b50\\u6d41\\u884c\\u75c5\\u5b66\\u7814\\u7a76\", \"\\u53bb\\u9664Treg\\u7ec6\\u80de\\u8054\\u5408IL-15\\u589e\\u5f3aDC\\u75ab\\u82d7\\u7684\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u6cbb\\u7597\\u7814\\u7a76\", \"\\u8c03\\u8282\\u6027T\\u7ec6\\u80de\\u5bf9\\u8840\\u5438\\u866b\\u75ab\\u82d7\\u4fdd\\u62a4\\u6027\\u6548\\u679c\\u7684\\u5f71\\u54cd\\u53ca\\u673a\\u5236\\u7814\\u7a76\", \"\\u6297\\u6d88\\u5316\\u7cfb\\u6076\\u6027\\u80bf\\u7624hTERT\\u5e7f\\u8c31\\u75ab\\u82d7\\u7684\\u5206\\u5b50\\u8bbe\\u8ba1\\u53ca\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u4ee5\\u6c99\\u95e8\\u83cc\\u7684\\u83cc\\u6bdb\\u4e3a\\u8f7d\\u4f53\\u7684\\u591a\\u4ef7HIV-1\\u75ab\\u82d7\", \"\\u57fa\\u4e8e\\u53cc\\u6b67\\u6746\\u83cc\\u8868\\u8fbe\\u7cfb\\u7edf\\u7684EV71 VP1\\u4e9a\\u5355\\u4f4d\\u53e3\\u670d\\u6d3b\\u75ab\\u82d7\\u7814\\u7a76\", \"\\u6162\\u75c5\\u6bd2\\u8f7d\\u4f53\\u7ed3\\u6838\\u75c5\\u6cbb\\u7597\\u6027\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u809d\\u764c\\u5e72\\u7ec6\\u80de/DC\\u75ab\\u82d7\\u589e\\u5f3a\\u6297\\u809d\\u764c\\u514d\\u75ab\\u5e94\\u7b54\\u53ca\\u673a\\u5236\\u7814\\u7a76\", \"\\u65b0\\u578b\\u4f50\\u5242\\u5bf9\\u547c\\u5438\\u9053\\u5408\\u80de\\u75c5\\u6bd2\\u4e9a\\u5355\\u4f4d\\u75ab\\u82d7\\u589e\\u5f3a\\u7684\\u80ba\\u90e8\\u514d\\u75ab\\u75c5\\u7406\\u7684\\u514d\\u75ab\\u8c03\\u8282\\u4f5c\\u7528\\u53ca\\u673a\\u5236\\u7814\\u7a76\", \"\\u53e3\\u670d\\u9776\\u5411\\u75ab\\u82d7\\u63a7\\u5236\\u91ca\\u653e\\u7684\\u57fa\\u7840\\u7814\\u7a76\", \"\\u4ee5\\u75c5\\u6bd2\\u6837\\u9897\\u7c92(VLP)\\u4e3a\\u5bf9\\u7167\\u7814\\u7a76\\u91cd\\u7ec4\\u817a\\u75c5\\u6bd2\\u75ab\\u82d7\\u5bf9\\u8bfa\\u5982\\u75c5\\u6bd2(NV)\\u7684\\u514d\\u75ab\\u4fdd\\u62a4\\u4f5c\\u7528\", \"\\u65b0\\u578b\\u6811\\u7a81\\u72b6\\u7ec6\\u80de\\u75ab\\u82d7\\u6cbb\\u7597\\u524d\\u5217\\u817a\\u764c\\u53ca\\u5176\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u9526\\u706f\\u7b3c\\u591a\\u7cd6\\u5728\\u6838\\u9178\\u75ab\\u82d7\\u4e2d\\u514d\\u75ab\\u589e\\u5f3a\\u4f5c\\u7528\\u7684\\u7814\\u7a76\", \"\\u80a0\\u9053\\u75c5\\u6bd271\\u578bDNA\\u75ab\\u82d7\\u5236\\u5907\\u53ca\\u5176\\u514d\\u75ab\\u6548\\u679c\\u7684\\u4f18\\u5316\", \"\\u6297\\u5bab\\u9888\\u764c\\u7a7f\\u819c\\u80bd\\u878d\\u5408\\u6027\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u53ca\\u4f5c\\u7528\\u7814\\u7a76\", \"\\u75ab\\u82d7\\u7684\\u65b0\\u578b\\u9776\\u5411\\u8f93\\u9001\\u4f53\\u7cfb\\u53ca\\u5176\\u673a\\u5236\\u7814\\u7a76\", \"Enhanced HIV Vaccine by CNT-enabled Mucosal Delivery\", \"E! 5934 Improved vaccines against intracellular pathogens in aquaculture - combining PHARMAQ and Isconova technology\", \"Clinical development of DB Fusion, a serotype-independent vaccine to prevent Shigella dysentery\", \"Generating and improving novel vaccine candidates targeting multiple stages of Malaria\", \"Imuniza\\u00e7\\u00e3o com a vacina pneumoc\\u00f3cica durante a gesta\\u00e7\\u00e3o em mulheres infecctadas pelo v\\u00edrus da imunodefici\\u00eancia humana (HIV): resposta vacinal materna e transmiss\\u00e3o placent\\u00e1ria de anticorpos espec\\u00edficos\", \"Study of the necessary immunological effector mechanisms for the development of vaccine against tuberculosis\", \"Pneumococcal conjugate vaccine: capsular polysaccharide - pneumococcal surface protein A\", \"Control of diarrhea induced by enterotoxigenic Escherichia coli (ETEC) strains: vaccine formulations based on the CFA/I fimbriae, CfaE adhesin, heat-labile toxin (LT), and a new vaccine protection experimental model\", \"Vaccine efficiency test in type 1 bovine Herpesvirus and in types 1 and 2 bovine pestevirus in experimental guinea pig and caprine experimental models\", \"Vacinas para o controle da dengue administradas pelas vias intra-d\\u00e9rmica e transcut\\u00e2nea\", \"THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP A VACCINE DELIVERY SYSTEM WHICH WILL STIMULATE, RAPIDLY, A STATE OF NON-SPECIFIC PROTECTION WHILE IT ENHANCES THE SPECIFIC IMMUNE RESPONSE TO THE VACCINE AND SHORTENS THE INDUCTION PERIOD FOR DEVELOPMENT OF\", \"Development of a Recombinant Vaccine Against Streptococcus Pyogenes Infection and Disease\", \"Developing a Chlamydia trachomatis vaccine by optimizing dendritic cell responses\", \"Targeted disabled infectious single cycle (DISC) Bovine Adenovirus (BAdV)-3 as vaccine delivery vector\", \"Feasibility assessment of a novel vaccine platform for the stratified therapeutic vaccine intervention in non-small cell lung cancer.\", \"POLYVALENT VACCINE TO PROTECT POULTRY FROM AVIAN INFLUENZA\", \"DEVELOPMENT OF A SIMPLE KILLED ENTEROTOXIGENIC E. COLI VACCINE FOR WEANED PIGS\", \"DESIGN OF LIVE ATTENUATED VACCINIA VIRUS VACCINE VECTORS FOR THE DEVELOPMENT OF POLYVALENT VACCINES\", \"ANTIGEN DELIVERY SYSTEM FOR ELICITATION OF PROTECTIVE IMMUNITY AGAINST JOHNE?S DISEASE\", \"DEVELOPMENT OF VIRAL VECTORS FOR POLYVALENT ANIMAL VACCINES\", \"EVALUATION OF B. THURENGIENSIS SPORE-BASED VACCINES EXPRESSING ORF-4 AND ORF-5 OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS\", \"COUNTERMEASURES TO PREVENT AND CONTROL BRUCELLOSIS IN LIVESTOCK AND WILDLIFE RESERVOIRS\", \"An unconventional, effector memory T cell vaccine for influenza\", \"Investigation of influenza immune responses and vaccine efficacy correlates by global expression profiling and immunological analyses in the ferret model of influenza\", \"Development of an efficacious vaccine against animal brucellosis that is harmless for humans\", \"A new vaccine strategy against serogroup b meningococcal infection: from antigen discovery to clinical trials\", \"New mycobacterial tuberculosis antigens for diagnosis and vaccines\", \"Community Engagement and Ethical Practice in Vaccine Research.\", \"Generating and improving novel vaccine candidates targeting multiple stages of Malaria\", \"Statistical analysis and modelling of the effect of conjugate vaccine and systemic capsular antibody on carriage and transmission of Streptococcus pneumoniae in Kenyan children.\", \"Novel vaccine against haemorrhagic septicaemia in cattle and buffalo for use by resource poor farmers.\", \"Anaplasmosis vaccine development for west Africa: genetic and immunologic analysis of endemic strains\", \"Towards the development of a universal influenza vaccine: Investigation of heterosubtypic humoral and cellular immune responses to influenza induced by vaccination with viral\", \"An effectiveness study of 7-valent Pneumococcal Conjugate Vaccine administered through EPI in the Kilifi Demographic Surveillance Survey Area.\", \"Synthesis of bacterial polysaccharide vaccines in plants.\", \"Longitudinal characterization of immunity induced by a novel TB vaccine, MVA85A, in humans.\", \"Synthetic Toll-like Receptor 4 Agonists as Potential Adjuvants for Use in Animal Vaccines\", \"Two Dose E-Z Measles Vaccine Trial: Boosting Of Immune Responses In Bissau\", \"Development of rationally attenuated live vaccines for effective control of infectious bronchitis\", \"IAH Jenner Fellowship: Assessing the efficacy of recombinant viral vaccines to induce heterosubtypic immunity to influenza in birds\", \"VACCINE POTENCY:  DEVELOPMENT AND VALIDATION OF IPV ELIS\", \"Aerosol Infection of Mice as a Model for Pertussis Infec\", \"IN VIVO POTENCY OF INACTIVATED POLIOVIRUS VACCINE\", \"QUANTITATIVE ANALYSIS OF HIB PS IN DTP-HIB CONJUGATE COMBINED VACCINE\", \"Malaria Vaccine Development Branch (MVDB)\", \"Development &Manufacture of an MDR Tuberculosis Vaccine\", \"Bastyr/UW Oncomycology Translational Research Center\", \"Malaria Vaccine Trials in Mali\", \"Multivalent Vaccine for Viral Hemorrhagic Fever\", \"Recombinant Subunit West Nile Virus Vaccine Development\", \"VACCINE DEVELOPMENT FOR IMMUNODEFICIENCY VIRUSES\", \"Development of Chimeric Vesiculo/Alphaviruses as an Alphavirus Vaccine\", \"SELECTION OF RSV SUBGROUP A &B VACCINE CANDIDATES\", \"ORAL MALARIA VACCINE DEVELOPMENT IN A P. BERGHEI MODEL\", \"VACCINE/HEALTH ECONOMICS LINEAR PROGRAMMING SOFTWARE\", \"EFFICACY OF E COLI PILUS VACCINE FOR URINARY INFECTION\", \"A NEW CANDIDATE VACCINE FOR LEUKEMIA AND CANCER\", \"Development of a Bacterial Ghost DNA vaccine for Influenza using antibody epitope\", \"Development of a DNA Vaccine Against Influenza Virus\", \"Synthesis and Optimization of a Malaria Vaccine\", \"Oral Smallpox Vaccine Development\", \"Needle-Free Delivery of Subunit Rotavirus Vaccines\", \"CD1 PRESENTED VACCINES TO PREVENT CHLAMYDIA INFECTION\", \"IMPROVING DNA VACCINES FOR HIV1\", \"EXPRESSION OF MALARIA MSP-1 P42 C-TERMINAL FRAGMENT\", \"VAGINAL IMMUNIZATION AGAINST URINARY TRACT INFECTIONS\", \"VACCINE FOR MYCOBACTERIUM TUBERCULOSIS\", \"WATER SOLUBLE POLYMER MICROSPHERES AS VACCINE VEHICLES\", \"SYNTHETIC GLYCO-CONJUGATE VACCINE AGAINST MENINGOCOCCI\", \"ORAL MALARIA VACCINE DEVELOPMENT INA P BERGHEI MODEL\", \"A novel vaccine against vaginal Chlamydia trachomatis\", \"A novel recombinant vaccine against Cryptococcus.\", \"Identification of protective pneumococcal antigens from a surface protein library\", \"TARGETED DELIVERY OF MUSCOSAL HIV1 RNA VACCINE\", \"HIV VACCINE VOLUNTEERS--PERSONALITY, MOTIVATION, AND RIS\", \"CORRELATION OF ANTIBODY RESPONSE TO MELANOMA VACCINE...\", \"NASAL ANTHRAX VACCINE DELIVERY FORMULATIONS\", \"Diindolylmethane enhances the efficacy of preventive vaccines in an HPV transgeni\", \"IMMUNOGENICITY OF A POLYVALENT MELANOMA ANTIGEN VACCINE\", \"Alphavirus-based Vaccine for Prevention of MPV Infection\", \"Tools for Testing HIV Immune-Control and Vaccine Models\", \"ORAL MALARIA VACCINE DEVELOPMENT--P. BERGHEI MODEL\", \"PROTEIN-POLYSACCHARIDE PNEUMOCOCCAL CONJUGATE VACCINES\", \"HIV Vaccines via 2G12 Carbohydrate Epitope Mimicry\", \"PnuBioVax\\u2122: next-generation vaccine for a personalised and effective immune response against Streptococcus pneumoniae.\", \"Novel Live Vaccines with Modified Lipid A for the Prevention of Shigella Diarrheal Disease\", \"Novel Live Vaccines with Modified Lipid A for the Prevention of Shigella Diarrheal Disease\", \"Generation and characterization of a bivalent replication-competent vaccine against Ebola virus and human immunodeficiency virus\", \"Unpacking Vaccine Hesitancy among Perinatal Healthcare Providers: Influences on Beliefs and Practices\", \"\\u767b\\u9769\\u75c5\\u6bd2\\u56db\\u4ef7\\u75ab\\u82d7\\u514d\\u75ab\\u65b0\\u7b56\\u7565\\u7684\\u7814\\u7a76\", \"\\u6784\\u5efa\\u65b0\\u9896\\u7684\\u51cf\\u6bd2\\u6c99\\u95e8\\u8f7d\\u4f53\\u9012\\u9001\\u9e2d\\u761fDNA\\u75ab\\u82d7\", \"\\u57fa\\u4e8e\\u591a\\u57fa\\u56e0\\u5171\\u8868\\u8fbe\\u8f7d\\u4f53\\u7684\\u901a\\u7528\\u578b\\u6d41\\u611f\\u75ab\\u82d7\\u7814\\u7a76\", \"Investigating tropical enteropathy as a cause of oral rotavirus vaccine failure in the developing world\", \"The examination of a novel viral vector and immunogens for HIV/SIV vaccine development in a non-human primate model\", \"Uptake of The Human Papillomavirus Vaccine in Canada: Barriers and Facilitators.\", \"Dissecting the mechanisms of protection by attenuated Nef-deleted HIV vaccine\", \"Qualitative and quantitative parameters of correlates of protection in HIV-1 vaccines\", \"Accelerated Chlamydia trachomatis Immunoproteomic Vaccine Enterprise\", \"Increasing HPV vaccine uptake in the school-based program in rural and remote British Columbia\", \"Vaccine Development Against Novel Breast Cancer Antigens\", \"Development of a mucosal vaccine against Helicobacter pylori infection including Phase I clinical testing in India\", \"POTENT VACCINE FORMULAS FOR JOHNE`S DISEASE\", \"New strategies for vaccines against infectious bronchitis and the elucidation of pathogenicity and immunity\", \"\\u9a6c\\u4f20\\u67d3\\u6027\\u8d2b\\u8840\\u75c5\\u6bd2\\u5f31\\u6bd2\\u75ab\\u82d7\\u682a\\u4e0e\\u5f3a\\u6bd2\\u682a\\u611f\\u67d3\\u5bf9\\u9776\\u7ec6\\u80de\\u4f5c\\u7528\\u5dee\\u5f02\\u7684\\u7814\\u7a76\", \"Long-term immunogenicity and clinical efficacy of the quadrivalent HPV vaccine in HIV positive girls and women\", \"PROBIOTICS AS TOOLS TO IMPROVE IMMUNE RESPONSE TO VACCINE AGENTS DELIVERED THROUGH THE RESPIRATORY MUCOSAL SURFACE IN FARM ANIMALS\", \"Preventive measurement for vaccine brak of Marek's Disease, Divelopment of the vaccine in particular\", \"\\u6297\\u4f53\\u4f9d\\u5b58\\u6027\\u611f\\u67d3\\u5897\\u5f37\\u73fe\\u8c61\\u3092\\u5229\\u7528\\u3057\\u305f\\u30a2\\u30b8\\u30e5\\u30d0\\u30f3\\u30c8\\u306e\\u958b\\u767a\", \"\\u30cd\\u30aa\\u30b9\\u30dd\\u30e9\\u75c7\\u3092\\u30e2\\u30c7\\u30eb\\u3068\\u3057\\u305f\\u7d4c\\u53e3\\u6295\\u4e0e\\u578b\\u85fb\\u985e\\u30af\\u30e9\\u30df\\u30c9\\u30e2\\u30ca\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u4f5c\\u51fa\", \"HCV\\u611f\\u67d3\\u30c1\\u30f3\\u30d1\\u30f3\\u30b8\\u30fc\\u306b\\u5bfe\\u3059\\u308bHCVDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u52b9\\u679c\\u306b\\u95a2\\u3059\\u308b\\u7814\\u7a76\", \"Active specific immunotherapy with MN\\\\CA IX antigen peptide vaccines for renal cell carcinoma\", \"\\u6b6f\\u5468\\u75c5\\u539f\\u6027\\u83cc\\u306e\\u30b7\\u30b9\\u30c6\\u30a4\\u30f3\\u30d7\\u30ed\\u30c6\\u30a2\\u30fc\\u30bc\\u3092\\u6a19\\u7684\\u3068\\u3057\\u305fDNA\\u30ef\\u30af\\u30c1\\u30f3\\u306e\\u958b\\u767a\", \"\\u30ca\\u30ce\\u30c6\\u30af\\u30ce\\u30ed\\u30b8\\u30fc\\u3092\\u7528\\u3044\\u305f\\u6b21\\u4e16\\u4ee3\\u7d4c\\u9f3b\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\\u3068\\u3001\\u305d\\u308c\\u306b\\u3088\\u308b\\u514d\\u75ab\\u8a98\\u5c0e\\u6a5f\\u5e8f\\u306e\\u89e3\\u660e\", \"Molecular and immunological analysis of periodontopathic bacterial attachment factors\", \"\\u81ea\\u7136\\u514d\\u75ab\\u5236\\u5fa1\\u306b\\u3088\\u308b\\u547c\\u5438\\u5668\\u75be\\u60a3\\u306e\\u4e88\\u9632\\u304a\\u3088\\u3073\\u30ef\\u30af\\u30c1\\u30f3\\u958b\\u767a\", \"\\u30ed\\u30bf\\u30a6\\u30a4\\u30eb\\u30b9\\u30ef\\u30af\\u30c1\\u30f3\\u682a\\u306e\\u91ce\\u751f\\u682a\\u3068\\u306e\\u907a\\u4f1d\\u5b50\\u4ea4\\u96d1\\u4f53\\u306e\\u89e3\\u6790\", \"Development of Immune-Modulated HIV Vaccines\", \"\\u0420\\u0430\\u0437\\u0440\\u0430\\u0431\\u043e\\u0442\\u043a\\u0430 \\u0438 \\u043f\\u0440\\u0438\\u043c\\u0435\\u043d\\u0435\\u043d\\u0438\\u0435 \\u043d\\u043e\\u0432\\u044b\\u0445 \\u0442\\u0435\\u0445\\u043d\\u043e\\u043b\\u043e\\u0433\\u0438\\u0439 \\u043f\\u0440\\u0438 \\u043a\\u043e\\u043d\\u0441\\u0442\\u0440\\u0443\\u0438\\u0440\\u043e\\u0432\\u0430\\u043d\\u0438\\u0438 \\u0434\\u0438\\u0430\\u0433\\u043d\\u043e\\u0441\\u0442\\u0438\\u0447\\u0435\\u0441\\u043a\\u0438\\u0445 \\u0438 \\u0432\\u0430\\u043a\\u0446\\u0438\\u043d\\u043d\\u044b\\u0445 \\u043f\\u0440\\u0435\\u043f\\u0430\\u0440\\u0430\\u0442\\u043e\\u0432 \\u043f\\u0440\\u043e\\u0442\\u0438\\u0432 \\u043b\\u0438\\u0445\\u043e\\u0440\\u0430\\u0434\\u043a\\u0438 \\u0434\\u043e\\u043b\\u0438\\u043d\\u044b \\u0420\\u0438\\u0444\\u0442\", \"Improving the efficacy of hepatitis B prophylactic vaccines\", \"Veien til vellykket DNA-vaksinering av laks mot virussykdommer\", \"Development of methods for enhancement of nucleic acids-based antiviral vaccines immunogenicity\", \"DENDRITIC CELL ARRAYS FOR T1D NANOPARTICLE-BASED VACCINE DEVELOPMENT\", \"EFFEKTIVE VAKSINER OG VAKSINESTRATEGIER FOR TORSK, FOKUS P\\u00c5 BAKTERIELLE AGENS\", \"Vibriosis and furunculosis vaccines for Atlantic cod: efficacy, protective antigens and specific immune responses\", \"Meningococcal vaccines for Africa: Impact of MenAfriVac on serogroup A transmission and clinical evaluation of a new protein-based vaccine\", \"Novel strategies for immunisation against intracellular pathogens of Atlantic salmon\", \"Project establishment: Development of vaccine(s) against infections with diarrheagenic Escherichia coli and Shigella\", \"Immunisation strategies against viral pathogens of Atlantic salmon\", \"Efeito modulador de estrat\\u00e9gias vacinais para tuberculose na encefalite autoimune experimental (EAE)\", \"Genomic characterization of the Bordetella pertussis strain used to produce the anti-pertussis vaccine at Butantan Institute\", \"Studies of the immunogenic and protective properties of third generation vaccines against american tegumentar leishmaniasis\", \"Commercialisation of a world changing invention for the stabilisation and delivery of vaccines\", \"Structural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy\", \"INNOVATIVE STRATEGIES TO ENHANCE PRRSV SPECIFIC INNATE AND MUCOSAL IMMUNITY: IMPLICATION FOR DEVELOPMENT OF BROADLY PROTECTIVE PRRS VACCINE\", \"ROLE OF M-PROTEIN IN PROTECTION AND VIRULENCE OF STREPTOCOCCUS EQUI SUBSP. EQUI\", \"Eliciting Mucosal Immunity to Tuberculosis\", \"Star ID (Star Intradermal)\", \"Developing Stable Liquid Pandemic Influenza Vaccines to Improve Shelf Life, Facilitate Distribution, and Increase Pandemic Preparedness\", \"UNIVERSAL FLU VACCINE BY A NOROVIRUS P PARTICLE PLATFORM\", \"PEPTIDE NANOPARTICLES AS NOVEL IMMUNOGENS: DESIGN AND ANALYSIS OF AVIAN INFLUENZA VACCINE\", \"COMPETITION FOR ANTERIOR PLASMA CELL NICHES DETERMINES THE SUCCESS OF VACCINES\", \"Development of a universal influenza vaccine based on tandem core technology\", \"Reach  \\u03b1-synuclein-dependent neurodegeneration: clinical development of therapeutic AFFITOPE vaccines for Parkinson\\u2019s disease and multisystem atrophy\", \"Clinical development of a VAR2CSA-based placental malaria vaccine\", \"Universal Flu Vaccine\", \"Universal Influenza Vaccines Secured\", \"Mucosal nano vaccine candidate for HIV\", \"Use of CpG oligodeoxynucleotides to improve the immunogenicity of vaccines\", \"Optimisation of the development of Poverty-Related-Diseases (PRD) vaccines by a transversal approach, addressing common gaps and challenges\", \"Plant Production of Vaccines\", \"Vaccine Strategies for Combined Targeting of Innate and Adaptive Immune Pathways\", \"An investigation into the incorporation and release of vaccines from polylactid acid microspheres\", \"Development of tuberculosis vaccine with consistent efficacy in differentregions of the world\", \"Evaluation of respiratory vaccines for children in South East Asia. Streptococcus pneumoniae (and Hib) conjugate vaccincs in prevention of childhood pneumonia in developing countries\", \"I-Corps: SwiftVax - A Green Manufacturing Platform for Faster, Cheaper, and Scalable Vaccine Manufacturing\", \"Two Dose E-Z Measles Vaccine Trial: Boosting of Immune Responses\", \"Plant Production of Vaccines\", \"Production of a Broadly Neutralizing HIV Antibodies\", \"IMMUNOPATHOGENESIS OF RUBELLA VIRUS ASSOCIATED AUTOIMMUN\", \"IMMUNIZATION OF SIX AND NINE MONTH OLD INFANTS AGAINST MEASLES\", \"Novel cell-culture derived split influenza vaccine\", \"Production of Non-Egg grown Influenza Vaccines\", \"Core_Prospective population-based estimation of influenza vaccine effectiveness a\", \"Avian Flu A/H5N1 Vaccine Development in Vietnam\", \"Multi-gene Subunit Vaccine Platform Against Y. pestis\", \"Production of an NP-ISS conjugate vaccine to combat pandemic influenza.\", \"Non-Viral Pandemic Influenza Vaccine Development\", \"Development of a vaccine for Ebola virus in plant system\", \"Influenza DNA Vaccine for Biodefense/Pandemic Readiness\", \"Multi-gene plague vaccine with expanded protection\", \"Evaluation and Production of a Multivalent Adenoviral Plague Vaccine\", \"Transcriptionally Active PCR to Improve DNA Vaccines\", \"MALARIA VACCINE\", \"DEVELOPMENT OF LIPID VACCINES FOR TUBERCULOSIS\", \"Use of Spray-Drying as a Manufacturing Process for Oral Adenovirus Vaccine\", \"Multivalent HPV Capsomere Vaccines\", \"THERAPEUTIC DNA VACCINES TO TREAT B CELL LYMPHOMA\", \"Influenza Virus-like Particles As Vaccines\", \"A Mucosal Vaccine for HSV-2\", \"Novel Delivery of a New Vaccine for Tuberculosis\", \"Development of an Intranasal Rotavirus Subunit Vaccine\", \"A Max-Ad Vaccine for Mucosal Immunity to HIV\", \"DESIGN &DEVELOPMENT OF A MULTIEPITOPE VACCINE: MALARIA\", \"Noninvasive delivery of skin-targeted anthrax vaccines\", \"EXPRESSION OF P FALCIPARUM LSA-1 SUBUNITS\", \"NONINVASIVE DELIVERY OF SKIN-TARGETED RABIES VACCINES\", \"POLYMERS FOR AUGMENTING R BOTULINUM VACCINE EFFICACY\", \"New attenuated anthrax vaccine\", \"Recombinant hPIV3 and RSV Sendai Virus Vaccine Phase I Clinical Trial Development\", \"BCG as an HIV vaccine vector\", \"Exploiting the Unique T Cell Response to CMV for a Cancer Vaccine\", \"Rabbit model to assess reactogenicity and immunogenicity of Salmonella vaccines\", \"E. coli O157:  H7 Vaccine Development\", \"BCG as an HIV vaccine vector\", \"Avian Influenza Virus Vaccines Bearing Immunomodulators\", \"Vaccine potential of promiscuous mycobacterial peptides\", \"Novel Adjuvant Formulations for Genetic Vaccines\", \"Development of a New Tularemia Vaccine\", \"New genetic vaccine to protect aganist botulism\", \"Immunodominant epitopes of a smallpox vaccine in humans\", \"TNFSF APC activators for HIV Vaccines\", \"Pro-Apoptotic Tuberculosis Vaccine\", \"TRANSCRIPTION-REGULATING VECTORS FOR ANTIVIRAL VACCINES\", \"NOVEL, LIVE, RECOMBINANT YEAST BASED HIV VACCINE\", \"Oral Vaccine-Induced Cellular Immunity Against HIV-1\", \"Annual Conference on Vaccine Research\", \"Conference HIV Vaccine Development Progress &Prospects\", \"CONFERENCE ON HIV VACCINE DEVELOPMENT\", \"Host SNPs and Altered Responses to Influenza Vaccine\", \"GANGLIOSIDE MEDIATED IMMUNOTHERAPY OF CANCER\", \"NKT cells as modulators of AIDS vaccine efficacy\", \"Development of Enabling Vector/Antigen Expression Technology for an Orally-Delive\", \"Novel Adjuvant Discovery in Vaccine Therapy\", \"QUALITATIVE NATURE OF ANTIBODIES TO HCV GLYCOPROTEIN SUBUNIT VACCINE IN HUMANS\", \"Vaccine Development in Leishmaniasis\", \"The Immunobiology of the Hemoglobin Receptor of H. ducreyi\", \"SALMONELLA VECTORED MULTIVALENT VACCINES\", \"Correlates of protection against SIV/SHIV challenge\", \"LIVE ATTENUATED MULTIPLY DELETED HIV1 VACCINE FOR AIDS\", \"STATISTICAL &CLINICAL COORDINATING CENTER (SC)\", \"CORE IMMUN. LAB FOR ASSESS. OF AIDS VACCINES IN PRIMATES\", \"MIDCAREER INVESTIGATOR AWARD IN PATIENT ORIENTED RESEARC\", \"Induction of Mucosal Cellular Immunity by HIV-1 Vaccine Vectors\", \"A novel polyvalent vaccine against EBV+ lymphoma\", \"BIOVACSAFE \\u2013 Biomarkers for enhanced vaccine safety\", \"Innovation Mandate Phase 1 Sebastiaan Theuns 150269 (resubmission 140777): Development of a roaal attenuated rotavirus vaccines for gilts, sows and piglets to prevent farrowing and weaning diarrhea\", \"Development of a Recombinant VSV-Based Vaccine for Lassa Fever\", \"Development of a Recombinant VSV-Based Vaccine for Nipah Virus\", \"Vaccines for Pseudomonas aeruginosa\", \"The Road Ahead: HIV Vaccines\", \"HIV Vaccines: Progress, Failures and New Directions\", \"HIV Vaccines: Where do we go next?\", \"\\u8868\\u8fbe\\u4eba\\u7cbe\\u5b50\\u819c\\u86cb\\u767d\\u7684\\u6c99\\u95e8\\u6c0f\\u83cc\\u7684\\u5236\\u5907\\u53ca\\u514d\\u75ab\\u5e94\\u7b54\\u7684\\u7814\\u7a76\", \"\\u732a\\u4f2a\\u72c2\\u72ac\\u75c5\\u548c\\u7ec6\\u5c0f\\u75c5\\u6bd2\\u57fa\\u56e0\\u5de5\\u7a0b\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u732a\\u5706\\u73af\\u75c5\\u6bd2\\u6d3b\\u75ab\\u82d7\\u8f7d\\u4f53\\u7684\\u6784\\u5efa\\u53ca\\u514d\\u75ab\\u539f\\u6027\\u5206\\u6790\", \"\\u5229\\u7528\\u4eba\\u4f53\\u5929\\u7136\\u6297\\u4f53\\u6cbb\\u7597\\u80bf\\u7624\", \"\\u4eba\\u7ed3\\u6838\\u6746\\u83cc\\u591a\\u6297\\u539f\\u57fa\\u56e0\\u91cd\\u7ec4BCG\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"IL-15cDNA\\u534f\\u540cHPV16E6E7\\u65b0\\u578brAAV\\u75ab\\u82d7\\u7684\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u7814\\u7a76\", \"\\u624b\\u6027\\u591a\\u91cd\\u6297\\u539f\\u80bd\\u75ab\\u82d7\\u7684\\u5236\\u5907\\u53ca\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u53e3\\u8e44\\u75abDNA\\u75ab\\u82d7\\u7c98\\u819c\\u514d\\u75ab\\u6548\\u679c\\u7684\\u7814\\u7a76\", \"\\u9c7c\\u7c7b\\u6dcb\\u5df4\\u56ca\\u80bf\\u75c5\\u6bd2\\u4e2d\\u548c\\u5355\\u514b\\u9686\\u6297\\u4f53\\u7814\\u5236\\u53ca\\u5176\\u6d41\\u884c\\u75c5\\u5b66\\u7814\\u7a76\", \"\\u4f0a\\u6c0f\\u9525\\u866bVSG\\u6297\\u539f\\u5e93\\u5efa\\u7acb\\u53ca\\u5176\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u7406\", \"\\u9a6c\\u7acb\\u514b\\u6c0f\\u75c5\\u75ab\\u82d7\\u4e8c\\u6b21\\u514d\\u75ab\\u589e\\u5f3a\\u6297\\u80bf\\u7624\\u514d\\u75ab\\u673a\\u7406\\u7684\\u7814\\u7a76\", \"\\u5e7d\\u95e8\\u87ba\\u6746\\u83cc\\u75ab\\u82d7\\u514d\\u75ab\\u4fdd\\u62a4\\u673a\\u5236\\u7684\\u7814\\u7a76\", \"\\u57fa\\u4e8eIi\\u5206\\u5b50\\u7684HCV-NS3 Th1\\u8868\\u4f4d\\u57fa\\u56e0\\u75ab\\u82d7\\u7684\\u8bbe\\u8ba1\\u53ca\\u529f\\u80fd\\u7814\\u7a76\", \"\\u5229\\u7528\\u751f\\u7269\\u964d\\u89e3\\u5fae\\u7403\\u5236\\u505a\\u6297\\u764c\\u75c7\\u53cc\\u529f\\u80fd\\u878d\\u5408\\u86cb\\u767d\\u514d\\u75ab\\u75ab\\u82d7\", \"\\u4ee5\\u51cf\\u6bd2\\u6c99\\u95e8\\u6c0f\\u83cc\\u4e3a\\u8f7d\\u4f53\\u4e8c\\u4ef7\\u9632\\u9f8bDNA\\u75ab\\u82d7\\u5b9e\\u9a8c\\u7814\\u7a76\", \"\\u8c37\\u6c28\\u9178\\u8131\\u7fa7\\u9176DNA\\u75ab\\u82d7\\u9884\\u9632\\u80f0\\u5c9b\\u708e\\u7814\\u7a76\", \"\\u8f6c\\u57fa\\u56e0\\u690d\\u7269\\u53ef\\u98df\\u5d4c\\u5408\\u4f53\\u9632\\u9f8b\\u75ab\\u82d7\\u7684\\u7814\\u7a76\", \"\\u95f4\\u65e5\\u759f\\u539f\\u866b\\u4f20\\u64ad\\u963b\\u65ad\\u75ab\\u82d7\\u5019\\u9009\\u86cb\\u767dPvs25\\u548cPvs28\\u57fa\\u56e0\\u7684\\u514b\\u9686\\u548c\\u8868\\u8fbe\", \"CpG\\u5be1\\u6838\\u82f7\\u9178\\u4f5c\\u4e3a\\u4eba\\u7528\\u75ab\\u82d7\\u4f50\\u5242\\u7684\\u7814\\u7a76\", \"Investigation of porcine reproductive and respiratory syndrome: chronic losses, vaccine use and export markets.\", \"PRRS Virus:  The Implications for the Breeding Herd\", \"Subunit vaccines directed against Salmonella Enteritidis in poultry\", \"Avalia\\u00e7\\u00e3o das estrat\\u00e9gias de vacina\\u00e7\\u00e3o para a gripe: impacto da muta\\u00e7\\u00e3o viral\", \"Hepatitis C vaccines\"], \"legendgroup\": \"\", \"marker\": {\"color\": [1208, 26956, 26403, 442366, 236067, 130890, 27386, 0, 46000, 7138, 13447, 23051, 24761, 4363, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 61313, 0, 1136603, 29617, 0, 0, 22635, 67917, 6767, 70976, 447769, 63197, 1750550, 36032, 50000, 86356, 20686, 259061, 178772, 38760, 4498, 31616, 3230548, 49951, 4184, 4498, 4546, 4184, 15247, 3455122, 0, 0, 0, 485633, 838646, 0, 0, 52371, 113783, 378543, 113000, 534630, 39000, 0, 0, 8807296, 1265722, 183534, 120798, 1901, 5854, 1691, 1086, 512009, 200000, 0, 0, 295003, 101459, 9841, 67329, 1514, 81841, 182350, 0, 66584, 638466, 579532, 88992, 23691, 230794, 74889, 552165, 3391, 3391, 3391, 71382, 229287, 46740, 78134, 5147415, 84188, 136593, 33003, 120675, 133297, 68538, 116900, 64693, 298213, 96548, 158968, 148678, 109364, 40000, 5523, 5523, 6907, 6907, 8978, 11050, 6907, 0, 6559, 12430, 6934, 3518, 3578777, 126906, 5519281, 0, 0, 50929, 8860, 4071, 0, 0, 0, 4364, 6536, 19106, 96926, 10998, 21960, 64288, 45902, 23952, 66739, 193054, 4998, 79436, 105178, 4216, 72085, 102599, 52765, 4216, 580948, 16102, 4216, 1634, 15000, 752462, 7497149, 0, 0, 0, 310000, 247200, 100000, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 160465, 130785, 239250, 0, 0, 0, 0, 0, 0, 0, 409875, 0, 0, 0, 858983, 1709592, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 740515, 0, 0, 0, 0, 0, 229246, 0, 0, 0, 0, 6077974, 0, 0, 12176449, 28595532, 4359668, 3559620, 12787854, 132483632, 4848248, 2354105, 1027633, 3370321, 22485676, 5545506, 6238876, 4581647, 13332202, 5265499, 9078858, 19171620, 13750234, 12782071, 84654136, 9773650, 18633488, 11954660, 13452676, 9133450, 27272696, 19894560, 20886180, 36897780, 23057106, 30695332, 14725251, 32415946, 20465260, 18486918, 16958976, 14506256, 13074784, 35935876, 58067576, 7377398, 19605318, 6612114, 6472027, 36378536, 11256214, 22522020, 25629016, 51502832, 39530888, 5346605, 13795530, 11807857, 7599557, 24289670, 7587053, 6787449, 16585636, 7824550, 18607916, 31860150, 9059135, 10058390, 14692051, 5550667, 4430576, 19247618, 10479382, 41633856, 15583782, 21286744, 14626625, 8323787, 22845980, 9981773, 16824272, 14710428, 0, 0, 0, 9100510, 447887, 377233, 93832, 766222, 36686, 0, 0, 0, 0, 454005, 526155, 15896, 3391, 56978, 449984, 18068, 36058, 9665, 17502, 3352012, 3352012, 5042594, 3418543, 3200598, 7976947, 1700000, 0, 149989, 294474, 0, 12432, 0, 0, 0, 0, 12042, 845, 2053, 6039, 21740, 14488, 17863, 11414, 5168, 8618, 6024, 2103, 27526, 37887, 3262, 16909, 365392, 357548, 1172455, 2215626, 131436, 569700, 571409, 3935142, 146344, 15864, 43096, 248741, 4424845, 3463, 3463, 3463, 3463, 16174, 154056, 0, 0, 0, 0, 0, 0, 0, 15347, 14769, 3184, 346628, 63651, 235501, 7556, 71400, 27317, 28049, 64572, 66623, 0, 107932, 63697, 3017, 35506, 68775, 103437, 32616, 332091, 56581, 60383, 1514, 29817, 113067, 746244, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 60000, 26697, 179388, 881665, 385160, 449644, 292991, 105796, 810873, 652432, 256438, 232602, 185946, 653455, 150889, 3391, 3391, 3391, 3391, 37718, 0, 37533, 441609, 72348, 70796, 111817, 69224, 197208, 123855, 29704, 203274, 99460, 171630, 111784, 37292, 170570, 8896, 160408, 414742, 60047, 199095, 106640, 109212, 149976, 100000, 440000, 6294086, 2871805, 3543549, 1847820, 25293370, 6376130, 7782675, 385144, 18000000, 807080, 804741, 5178, 8287, 11740, 6768, 6906, 6906, 8978, 17265, 17956, 10360, 12914, 24172, 9323, 31546, 16256, 6213, 42130, 11740, 22102, 14803, 183583, 11034, 7104, 6688, 7597, 4833, 13118, 156508, 3518, 3518, 39124, 927884, 90826, 435809, 0, 2685906, 4388000, 2090968, 3464000, 6720850, 6369000, 4640567, 0, 6978780, 4000000, 5042594, 515844, 4270280, 0, 1300000, 2600000, 791496, 17271, 5293544, 4312612, 149592, 0, 29019, 142572, 307034, 0, 0, 0, 0, 0, 51865, 54650, 127444, 212413, 117981, 8965963, 0, 355035, 272177, 8529, 0, 0, 0, 70000, 233401, 55902, 4071, 90554, 45275, 2736860, 67080, 72594, 37264, 9080219, 0, 0, 0, 0, 0, 0, 0, 0, 0, 75190, 145174, 217382, 163587, 83746, 32656, 66351, 116280, 208503, 148018, 142445, 9540, 52358, 15503, 78576, 22291, 129424, 129905, 43628, 128223, 23745, 161733, 116966, 4090, 14278, 373818, 15247, 4216, 16102, 351165, 298383, 3939, 243286, 206369, 59485, 3654, 408329, 17520, 292, 8812, 216848, 27926, 4090, 4363, 22598, 18511, 19546, 17498, 29109, 14442, 30328, 0, 22663000, 696000, 0, 299525, 0, 1492900, 1373500, 0, 0, 0, 0, 0, 0, 284375, 0, 0, 0, 0, 0, 0, 0, 0, 552946, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 163941, 164000, 150000, 237750, 368846, 181850, 0, 0, 0, 0, 0, 0, 100000, 142814, 0, 0, 0, 1010353, 1273968, 0, 0, 0, 0, 11606890, 14490691, 0, 0, 0, 217249, 0, 0, 0, 0, 0, 0, 0, 0, 411574, 0, 750000, 0, 979767, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3773578, 7545418, 3213894, 2527964, 0, 0, 0, 0, 0, 0, 0, 0, 0, 12239874, 24666320, 23776040, 6919041, 3954801, 26897364, 3732639, 10030916, 13007636, 9628383, 835028, 0, 0, 0, 0, 0, 113650, 0, 0, 2723435, 371377, 13496364, 13072863, 2809421, 383103, 2729831, 372250, 2628793, 358447, 2746553, 374527, 2634897, 359304, 337232, 2758811, 376202, 1735409, 1735409, 6250000, 20000, 2247441, 79683, 211751, 1102716, 0, 0, 0, 46858, 100000, 99632, 357500, 98231, 896490, 449620, 4956, 322481, 1000, 0, 0, 9265633, 327096, 16141, 25831, 1644104, 152343, 170773, 0, 1200000, 2560239, 23024, 0, 39940, 3320228, 12078, 514201, 33782, 0, 3081165, 100000, 428770, 100000, 100000, 98212, 16141, 234957, 336464, 0, 0, 0, 1790, 1777, 1159, 2328, 142191, 654734, 174044, 277036, 69213, 1443557, 541177, 873846, 932, 2129, 1954, 957, 1433, 86605, 7168, 0, 0, 1494972, 328953, 333428, 51269, 247887, 449950, 0, 1299500, 501069, 510006, 100000, 54970, 100000, 487273, 100000, 8958936, 33736704, 222411, 100000, 100000, 800000, 382750, 100000, 100000, 2325773, 100000, 19901076, 100000, 100000, 11631, 438932, 441905, 444428, 34797, 155419, 20711, 272219, 11666, 10079, 17503, 4374, 190050, 294426, 104331, 2318236, 1323948, 196323, 30458, 243699, 99667, 261000, 261000, 165000, 88000, 263474, 10718, 1077813, 1270842, 517816, 1060037, 985801, 31104, 233204, 23078, 1576546, 157372, 1624996, 1369907, 223386, 1286013, 7281277, 1685828, 13116, 31631, 30049, 17500, 51355, 7421, 63483, 36587, 46728, 117550, 49584, 43453, 62245, 17397, 39505, 68810, 73800, 41174, 327733, 1073308, 311686, 56582, 39299, 51907, 156211, 54452, 81445, 870473, 157697, 480900, 63231, 93480, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 11191, 15698, 16906, 16906, 16909, 14488, 16907, 14488, 14483, 6150, 5380, 5168, 4303, 5168, 3442, 5169, 5168, 5164, 5169, 3094, 2103, 976, 604, 84702, 548392, 118430, 234734, 1294061, 279496, 299989, 747533, 155782, 2581731, 806049, 18539, 136301, 915606, 281182, 6792983, 38579, 696583, 71909, 775776, 549251, 5681136, 897548, 373761, 91725, 786127, 3854579, 123733, 718296, 1745503, 324227, 330698, 593649, 561875, 519040, 376405, 339022, 164629, 394723, 32871900, 544826, 1039442, 210836, 31240, 14023, 120251, 1575648, 0, 0, 45224, 105000, 200000, 150000, 40000, 2387117, 2204022, 8388, 154056, 13477, 3030, 13477, 26956, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 8757, 26734, 143822, 118381, 75264, 140407, 407088, 8135774, 116837, 52134, 26446, 395105, 13261, 36949, 291086, 30684, 34445, 13762, 31616, 16338, 100615, 225876, 15330, 1418041, 1266966, 59322, 22798, 410418, 11370, 86733, 36257, 2500, 4818, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 121627, 113300, 120540, 4684442, 386100, 743073, 40362, 40620, 124074, 128841, 202342, 177902, 446022, 38448, 629535, 1007992, 1251342, 22020, 376648, 372787, 205046, 3495000, 1328340, 1788000, 70000, 375000, 74767, 641817, 79486, 511097, 66051, 425772, 172317, 150186, 105840, 332693, 351204, 409410, 252737, 416405, 793905, 420331, 194121, 960309, 3391, 3391, 13200, 26403, 1563412, 0, 507796, 643644, 642366, 493002, 643391, 1238633, 30692, 20757, 682359, 109023, 155631, 150234, 98359, 173588, 101922, 34250, 86172, 106134, 355284, 348763, 64748, 314526, 137939, 128758, 56550, 101151, 84345, 107886, 139249, 214282, 127081, 400427, 174132, 67638, 2000000, 535445, 1515000, 257314, 4510133, 20360592, 49680144, 463650, 1547782, 406436, 7730969, 3018257, 40000, 5988943, 200665216, 2182670, 6455989, 399912, 105000, 198725, 785326, 10628405, 125000, 49720, 400000, 1169363, 1672400, 697763, 999385, 2595505, 121000, 100000, 50000, 25536, 100000, 8000000, 587998, 100000, 15178461, 45795, 181868, 52382, 65707, 323499, 100000, 100000, 997235, 1300000, 17405098, 8097894, 8998623, 100000, 3298464, 695413, 6885862, 82906200, 3692385, 979908, 17121364, 2032736, 100000, 13791587, 622196, 38500, 5935024, 100000, 10390332, 294422, 100000, 38750000, 341619, 100000, 5504889, 2610892, 3940062, 14998390, 25000, 738589, 2626088, 100000, 917380, 12840000, 98734, 100000, 100000, 4631720, 3211791, 9185813, 9858, 12118, 4142, 5178, 4039, 6076, 5454, 33564, 33151, 5662, 17266, 12430, 11740, 40061, 29008, 41439, 2932, 2900, 4833, 29698, 16256, 11128, 13814, 16625, 30844, 9169, 6214, 30844, 23133, 5523, 6213, 5523, 6907, 6907, 6213, 5524, 3452, 19338, 0, 5868, 5523, 41442, 5523, 22792, 216196, 50422, 13814, 15194, 16574, 58704, 41803, 47274, 16333, 35586, 38848, 29431, 12942, 26755, 15521, 1972, 4113, 15633, 11568, 9915, 9190, 4734, 6314, 6688, 5944, 5523, 7597, 6907, 6213, 9873, 4692, 3518, 27386, 3518, 368354, 759468, 368354, 391043, 220699, 139427, 222135, 0, 0, 0, 0, 3893007, 2475253, 300244, 300132, 2605933, 4504514, 1807525, 1700000, 0, 1063489, 4850824, 1136659, 833523, 2095686, 970149, 895126, 2426364, 2426364, 0, 3945003, 0, 2415964, 0, 38000000, 1300000, 2600000, 1136715, 1136715, 127482, 127482, 3090667, 515907, 176449, 526055, 0, 202761, 99374, 1373, 175294, 254095, 104559, 134026, 0, 234160, 99201, 94392, 762005, 73705, 274848, 474793, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 103806, 225085, 105232, 44984, 40870, 180196, 0, 0, 0, 0, 58881, 2292, 3832, 1335832, 190944, 109024, 255214, 17503, 14889, 310096, 16543, 281330, 15555, 194992, 0, 0, 128341, 153852, 0, 100000, 70000, 70000, 59777, 30375, 11729, 4071, 4071, 750, 4750, 119000, 30000, 133517, 2211404, 1234210, 4798781, 700000, 470729, 284625, 0, 176424, 94601, 0, 202402, 703596, 1697952, 0, 0, 0, 805186, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 14558, 33977, 11631, 190580, 287882, 551253, 61059, 62685, 244027, 224199, 207917, 53609, 161223, 110065, 225739, 134336, 246507, 238736, 213304, 93927, 26000, 190644, 130306, 105367, 156547, 5974, 41373, 197648, 250751, 129479, 124344, 195552, 410374, 269851, 221659, 5801500, 13676, 104370, 4184, 25052, 47372, 231657, 13447, 19690, 197992, 24761, 7138, 483, 8757, 8812, 37236, 42383, 151008, 35614, 124232, 425964, 335043, 18753, 4124, 40522, 383574, 149806, 61877, 249348, 20216, 14278, 23560, 211157, 3939, 223462, 3939, 17630, 37236, 15328, 43922, 12913, 40000, 20216, 3939, 15368, 74256, 2042, 11945, 14997, 8757, 18396, 4216, 29109, 29109, 23569, 11525, 35262, 312700, 5000, 1240957, 2796534, 166666, 2254678, 1079999, 719883, 725000, 0, 189000, 77142, 0, 1371344, 0, 12988052, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 12912147, 4962999, 12743213, 23722558, 6081296, 26740972, 8376947, 11099589, 200000, 832647, 836253, 307405, 900000, 1312685, 2529017, 3342566, 5258144, 6573776, 4663588, 5818745, 11351920, 10000000, 149291, 46798, 129672, 24545, 0, 463753, 209612, 255699, 307005, 2265914, 533784, 368553, 632260, 259942, 204988, 2166265, 299702, 611569, 127190, 518332, 129943, 279086, 250136, 47027, 200527, 247522, 342398, 590969, 61940, 39631, 260807, 115753, 127065, 332996, 2163717, 259157, 438924, 503347, 110840, 93756, 219135, 33389, 196137, 243744, 121834, 237885, 570443, 154229, 352580, 438713, 2069231, 247531, 285645, 488790, 242453, 449958, 90032, 2860561, 191821, 239730, 276309, 335623, 1436214, 232415, 549981, 625247, 89448, 734103, 2066824, 269544, 278866, 474656, 0, 0, 600108, 0, 467820, 23165, 166811, 331358, 374989, 0, 0, 9705, 591008, 0, 2673357, 110985, 78512, 0, 0, 2186845, 0, 9808478, 31219180, 94733, 122302, 0, 56901, 105485, 32164, 127290, 0, 3004113, 0, 18180, 0, 0, 494472, 63052, 218826, 115696, 88299, 394665, 286490, 2927343, 0, 44079, 55375, 156568, 36061, 14488, 30306, 2760093, 1342449, 64655, 111991, 110477, 39522, 6394689, 10050972, 5305432, 0, 1149705, 2627641, 723267, 957312, 4626733, 13400000, 3743620, 746628, 1347763, 115466, 609583, 1879802, 0, 2101817, 486798, 2543724, 0, 0, 0, 0, 424610, 13284, 457876, 1051770, 214536, 251869, 281392, 364448, 375122, 61388, 49831, 0, 0, 7603, 100000, 100000, 209056, 24333, 122391, 61006, 4927000, 417016, 187878, 330375, 2288617, 131330, 3095548, 8322236, 6671738, 2164081, 3266919, 100000, 2155957, 1999982, 813050, 100000, 3283816, 100000, 662094, 1091584, 1068783, 405750, 50000, 10928780, 77256, 100000, 600000, 249261, 100000, 1600000, 129913, 4982891, 4472467, 99991, 5930094, 1326233, 2597817, 100000, 455878, 1782978, 10044535, 2047398, 1199081, 100000, 13430939, 100000, 715789, 15000000, 31925352, 93963, 157455, 440933, 2737556, 218199, 176607, 32060, 1421912, 2969205, 8942639, 5837308, 100000, 129485, 270289, 0, 0, 31693, 150079, 252834, 1884051, 964737, 224981, 1113776, 3183629, 884531, 12112367, 4392553, 0, 2951225, 6072797, 252019, 687443, 3314695, 0, 115000, 85000, 115000, 85000, 200000, 250000, 106000, 162000, 114000, 165000, 76000, 85000, 1516871, 953844, 243579, 89573, 2564723, 443988, 1799453, 0, 0, 0, 46163, 70075, 118059, 65794, 106699, 255862, 85433, 132827, 779042, 80696, 133985, 81001, 56670, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 12048, 0, 513128, 268146, 203123, 261659, 552013, 836661, 635484, 252680, 1272513, 2241990, 659051, 1214576, 1049542, 402705, 76164, 174288, 877427, 455829, 254784, 549424, 348852, 718672, 271024, 677935, 108627, 104249, 881036, 436313, 836093, 680681, 282847, 426764, 888499, 1852226, 625588, 93269, 66346, 464221, 10536, 0, 765044, 236595, 467142, 68713, 103111, 66379, 27064, 19300, 0, 79197, 12004, 0, 0, 0, 0, 0, 0, 0, 3870, 261289, 593483, 17119, 16338, 15957, 29214, 3836, 135408, 8908, 51561, 50804, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 53609, 618330, 2700800, 284831, 6964520, 97911, 682841, 5594000, 3502000, 3634039, 1698000, 2540478, 35233, 257058, 175648, 0, 109560, 97254, 882018, 333436, 598339, 334652, 564519, 304563, 612888, 4927, 2434208, 37232, 120593, 0, 157549, 238071, 392357, 194218, 325419, 144001, 68282, 61486, 469297, 72436, 106387, 135190, 136700, 19323722, 701129, 11203452, 100000, 89000, 134282, 1093389, 603646, 305325, 757785, 100000, 778266, 100000, 100000, 100000, 2902288, 100561, 100000, 48391, 1299811, 326293, 1892006, 340202, 169739, 100000, 100000, 2984509, 8029763, 2387938, 868090, 2047166, 7473711, 15000000, 10000, 100000, 1469628, 1197569, 100000, 100000, 2050341, 353295, 1745409, 3550000, 100000, 2697613, 100000, 99550, 100000, 100000, 93882, 6000000, 9792730, 1429611, 906539, 100000, 23034708, 9184036, 609150, 34717072, 100000, 2503510, 593314, 60820, 3106, 4349, 34536, 14780, 17957, 33842, 33153, 27626, 22792, 9169, 8403, 6876, 5524, 4833, 60091, 4833, 5523, 11050, 34512, 46798, 61401, 47262, 232270, 18055, 50211, 49504, 34312, 14430, 177460, 32960, 156594, 35497, 43742, 42879, 31559, 6213, 6213, 17502, 126489, 0, 698949, 700000, 0, 143595, 76035, 57822, 254924, 0, 0, 0, 0, 48474, 0, 8990, 6065, 40481, 6741, 172901, 4962, 4962, 5762, 394683, 92200, 0, 0, 962494, 92550, 1254206, 17542, 27041, 1653087, 1083754, 32352, 158210, 478014, 495914, 700000, 700000, 693022, 700000, 530337, 675415, 668888, 250000, 698272, 651370, 0, 99682, 13227582, 0, 0, 0, 0, 0, 3108448, 8005393, 220394, 393024, 183912, 358668, 10004, 10928292, 276317, 61237, 149116, 162809, 207485, 162328, 133010, 234142, 174671, 87628, 12016, 26896, 112209, 258754, 297553, 170948, 136977, 233654, 3525888, 24988, 14442, 23272, 18051, 0, 0, 0, 0, 0, 0, 0, 0, 0, 245150, 158846, 0, 0, 0, 277934, 541959, 0, 514485, 0, 145000, 10792404, 2045144, 669243, 150000, 0, 35187, 0, 369799, 85975, 151024, 715267, 1593039, 163368, 104502, 130794, 0, 0, 127719, 30000, 551049, 23204, 53067, 54024, 45632, 53717, 40126, 16583, 3264, 182163, 159934, 60106, 44874, 29916, 30715, 0, 0, 0, 28151, 69179, 39572, 0, 0, 53005, 225064, 242564, 444710, 304637, 246609, 0, 0, 0, 0, 99508, 3691, 1029, 16181, 60000, 321632, 1310836, 2993798, 2435221, 1413590, 3283375, 6297694, 1793396, 1000000, 426223, 3836004, 257740, 821096, 242736, 2740852, 1792234, 4000000, 4326403, 7055360, 1320390, 58478, 1443106, 0, 17002768, 2964667, 0, 0, 0, 0, 12074, 14488, 20863, 24240, 9664, 24240, 0, 341368, 562499, 567934, 56751, 91578, 154242, 62303, 2827097, 227450, 345343, 420770, 345750, 979747, 430039, 264513, 32478, 158006, 43646, 210414, 157856, 37595, 149659, 603515, 26517, 26517, 25253, 83088, 150000, 830704, 58004, 14695725, 6031409, 0, 3710279, 5300620, 5300619, 0, 0, 2985700, 204019, 774884, 377815, 0, 38248, 236905, 66995, 225000, 0, 26753, 77788, 52197, 50616, 11815, 35324, 44874, 30715, 703494, 532417, 749999, 610218, 284348, 922365, 1306122, 2273034, 5931410, 0, 0, 0, 3725819, 0, 158820, 0, 3075652, 0, 35187, 318635, 12080, 8439847, 1198845, 265892, 1577020, 2355304, 199021, 170763, 156568, 291775, 24545, 24545, 22090, 1624180, 0, 776428, 39572, 0, 375000, 4625863, 1340958, 1976817, 904115, 278198, 551080, 5968686, 2733246, 65974672, 0, 144262, 7067, 34737, 24644, 22179, 28879, 1145452, 132039, 870706, 3122237, 9091, 0, 5388306, 12074176, 117500, 0, 0, 1871266, 2158469, 2022231, 0, 0, 1806275, 1970145, 461348, 3686016, 1068034, 199915, 1589558, 709102, 2779602, 587238, 144811, 2666650, 2028150, 719493, 0, 104363, 132940, 26974, 26974, 50616, 24142, 5166, 129661, 42327, 1119651, 104345, 292514, 111158, 303353, 465058, 149505, 129321, 93247, 88425, 36990, 35383, 36990, 36990, 451559, 445044, 0, 32113, 175162, 867569, 211084, 27730, 31631, 59836, 26517, 29916, 37948, 24809, 32252, 0, 119607, 193700, 38301, 0, 283854, 302799, 1558344, 3741548, 81007, 240389, 123199, 99937, 87090464, 191620736, 6816766, 0, 0, 0, 1149705, 1594234, 1691450, 4571373, 4388414, 4118394, 6490848, 1827779, 0, 750000, 299495, 0, 104000, 3977843, 0, 73047, 297212, 69741, 41531, 25464, 21507, 0, 460625, 0, 116147, 1168526, 18602506, 11072727, 1472178, 368000, 3600000, 1101809, 2873420, 421237, 308000, 96565, 2509160, 709842, 412500, 0, 1833975, 1403333, 3875811, 0, 0, 0, 0, 0, 40000, 0, 0, 385631, 1003866, 25828, 372089, 439850, 545616, 450000, 673197, 113556, 399808, 0, 1406421, 26000, 300000, 599895, 886845, 0, 152997, 1048913, 2595114, 5020398, 2759672, 995610, 1368221, 0, 0, 999997, 106780, 35187, 9640, 12079, 2750059, 8759, 111158, 127034, 160625, 729996, 1017724, 948927, 130504, 0, 0, 34512, 149649, 45237, 41188, 36196, 56727, 46273, 190456, 186402, 48130, 41305, 163227, 137114, 832820, 338400, 30049, 22090, 18118, 25253, 200748, 25253, 453725, 0, 13205, 1041432, 0, 0, 120000, 484301, 886827, 82030, 0, 133254, 235362, 229805, 0, 0, 952830, 189866, 1637386, 0, 7333610, 0, 99938, 2203357, 0, 0, 0, 192572, 25476, 23024, 0, 220641, 486905, 429523, 338615, 315205, 540720, 1518048, 418384, 94296, 100005, 125204, 646101, 503006, 87612, 86956, 231230, 258005, 100000, 5590, 82586, 151260, 390096, 2639002, 6412369, 763534, 3307969, 1546239, 560648, 622353, 0, 3237783, 1018196, 50712, 460354, 36362, 0, 0, 0, 630350, 87126, 601061, 591421, 592147, 284575, 376035, 529757, 17733272, 135800, 385879, 604672, 441027, 752052, 325412, 1160801, 300000, 4825191, 845285, 2814783, 2901850, 75154, 138132, 48753, 30442, 38524, 1933277, 0, 23645, 32478, 45791, 36084, 48978, 53717, 49025, 294118, 214523, 50880, 50880, 32374, 36496, 44737, 35497, 93473, 42591, 43742, 137604, 23284, 44847, 51914, 16227, 151152, 2823243, 236233, 280264, 1555265, 2767600, 363918, 90057, 299974, 274978, 52261, 89053, 1056336, 277593, 954161, 323706, 137248, 375778, 1022794, 1213064, 277215, 4098006, 2549706, 336281, 307228, 343826, 171226, 84504, 251317, 501265, 315741, 36669, 649581, 104980, 867107, 743576, 3506, 305211, 679964, 74555, 26709, 27730, 25364, 0, 0, 0, 343114, 223056, 225000, 3529059, 335005, 57339, 344492, 67121, 344940, 339191, 35983, 411019, 290933, 59634, 356164, 285964, 363731, 600083, 333338, 301498, 4402, 300000, 374688, 300000, 300000, 1681983, 123745, 300000, 230381, 300000, 379243, 52453, 383846, 300000, 275912, 76157, 90157, 300000, 176652, 300000, 0, 0, 603289, 22562190, 3294831, 0, 406185, 2551532, 0, 0, 3010820, 17222880, 52000000, 2710474, 1341560, 7662077, 5613677, 4311175, 296731, 586500, 428110, 806160, 1492314, 6670070, 845992, 154474, 4033446, 696600, 99992, 2244621, 5516166, 328127, 6770054, 371344, 5490179, 466955, 332887, 348579, 349613, 297960, 328061, 390743, 1651037, 1869229, 3804245, 14455413, 9113435, 3183629, 4654902, 1358731, 1833080, 25800, 1306067, 292954, 12110276, 1000000, 1000000, 1000000, 1000000, 1100000, 165729, 50000, 135867, 300025, 500000, 50000, 794044, 500000, 548024, 300000, 600000, 1000000, 500000, 500000, 500000, 500000, 2000000, 500000, 650000, 1414886, 1914885, 300000, 50000, 500000, 1000000, 600000, 1100000, 500000, 500000, 300000, 500000, 1200000, 500000, 1500000, 500000, 1018554, 500000, 600000, 600000, 1721918, 650000, 300000, 500000, 500000, 50000, 300000, 476679, 600000, 1100000, 500000, 1000000, 1000000, 1500000, 500014, 250000, 1363051, 600000, 462625, 50000, 1701238, 300000, 600000, 500000, 600000, 500000, 1100000, 1002259, 300000, 256667, 600000, 500000, 1100000, 500000, 500000, 629614, 500000, 300000, 250000, 600000, 1000000, 500000, 1000000, 1000000, 475886, 1225886, 540544, 50000, 300000, 500000, 600000, 500000, 300000, 500000, 1000000, 712157, 2000000, 1000000, 50000, 744662, 300000, 573540, 100000, 600000, 500000, 1200000, 1000000, 55000, 1000000, 577778, 250000, 100000, 300000, 600000, 600000, 500000, 500000, 229626, 300000, 1000000, 500000, 1650000, 500000, 333309, 300000, 500000, 50000, 600000, 668081, 500000, 300000, 1483094, 50000, 451256, 0, 0, 18235, 105670, 26242, 333837, 785613, 81055, 181553, 59295, 80687, 29689, 85043, 543790, 855517, 108416, 347282, 190183, 102142, 133431, 218645, 62225, 84499, 132923, 122643, 53181, 28412, 87972, 291644, 40482, 191060, 387537, 51163, 2095674, 168072, 84115, 206470, 105876, 109695, 209795, 137705, 162423, 79855, 69033, 0, 0, 0, 0, 0, 0, 15845, 149998, 35000, 12074, 5282, 35966, 229517, 38248, 65685, 32055, 21815, 21815, 21815, 24240, 21744, 0, 0, 0, 231609, 371817, 451992, 336879, 258716, 886943, 1806623, 364829, 570102, 155119, 2210362, 1774396, 4990726, 1924083, 150244, 198548, 170442, 389872, 552029, 192626, 731315, 342510, 281403, 326450, 280075, 310364, 2218550, 169987, 364405, 941022, 526467, 330858, 918448, 248687, 166655, 471743, 396818, 425601, 4476, 169357, 242139, 225358, 223823, 411901, 374966, 395762, 287568, 169854, 946302, 701792, 173865, 1009125, 389948, 361225, 393705, 423186, 759019, 667743, 664963, 505814, 360521, 275000, 38426, 14708, 200000, 499999, 4976, 0, 0, 0, 13916, 27895, 5349, 20132, 2409, 231386, 157625, 428361, 92324, 15957, 149074, 87338, 93285, 651400, 59290, 59784, 66530, 95752, 70103, 0, 0, 0, 0, 0, 0, 0, 0, 0, 86160, 122599, 66982, 40062, 337459, 40000, 496438, 749999, 36318, 87335, 3218382, 327462, 1360130, 3039, 194950, 312232, 485555, 767273, 311677, 125479, 257434, 16249, 16249, 19861, 295138, 573749, 2725993, 404888, 75383, 0, 199259, 65464, 286567, 239079, 433250, 24704, 96462, 96462, 40207, 36990, 36990, 0, 577937, 326819, 155737, 2313835, 1662279, 64636, 0, 0, 0, 0, 1715612, 596372, 554242, 174934, 499073, 694093, 105455, 842370, 380529, 633567, 769096, 477988, 287893, 139279, 14651668, 425320, 297529, 467887, 251556, 942923, 503022, 217169, 100000, 8280212, 4995354, 1500000, 44078, 1758440, 1854359, 430153, 100000, 265696, 20000, 1954441, 100000, 1494536, 100000, 100000, 98455, 4222128, 132130, 100000, 100000, 100000, 100000, 100000, 2663930, 100000, 100000, 497671, 826426, 2530317, 84554, 3239928, 100000, 7810252, 78522, 30459, 99115, 98427, 99996, 100000, 100000, 880000, 3902497, 2475646, 1117685, 550470, 3559859, 105417, 100000, 100000, 1303692, 2840871, 6938504, 1038645, 100000, 3969624, 99972, 100000, 5000000, 317693, 158739, 471557, 100000, 100000, 100000, 100000, 100000, 998300, 300000, 1530000, 999998, 229861, 50025, 2020533, 15000, 100000, 100000, 2511087, 970344, 16207773, 3553004, 4349073, 103985, 73750, 100000, 100000, 544773, 878292, 20000, 100000, 6965308, 100000, 9990782, 1499862, 7502819, 100000, 5188438, 40000, 1732980, 100000, 2381694, 30319836, 100000, 100000, 2358606, 100000, 7416108, 749216, 1795242, 8339709, 848000, 6886056, 100137, 98047, 100000, 236785, 100000, 7699399, 1325223, 5761970, 100000, 3745079, 63258, 100000, 2000000, 998090, 100000, 9588867, 1588114, 2000134, 100000, 100000, 2680283, 100000, 839483, 100000, 1376376, 2831215, 68696, 990225, 349159, 199797, 199442, 75289, 344576, 3239039, 7597, 5732, 3106, 3038, 15885, 12430, 6214, 6213, 6907, 0, 0, 0, 0, 0, 32132, 35272, 45598, 47999, 48654, 61221, 28038, 32954, 30544, 37673, 43558, 32060, 41440, 41440, 41954, 14998, 7941, 153114, 17828, 20711, 17601, 28513, 39874, 27692, 21226, 21226, 17281, 134092, 0, 0, 173800, 200000, 1222829, 0, 147331, 49994, 132123, 477171, 588647, 5388, 0, 0, 50000, 63269, 31631, 52197, 36375, 44874, 11815, 43790, 49152, 27644, 44874, 10031, 28418, 26517, 24545, 29916, 34725, 33389, 34725, 28046, 49152, 27730, 21815, 12074, 23024, 46080, 100000, 0, 0, 0, 0, 0, 0, 0, 161521, 254516, 64829, 27538, 189461, 35442, 40469, 13440, 25594, 122341, 634779, 131301, 366806, 0, 133320, 450000, 69997, 100000, 1825370, 20372, 116907, 63810, 240432, 2037317, 163802, 0, 99333, 4134427, 195389, 37092, 36596, 291264, 27882, 489169, 614072, 195082, 1761782, 150000, 500000, 0, 0, 80000, 375000, 3321832, 475752, 56834, 1687336, 12553, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7170458, 3146567, 2037393, 3473, 203834, 309556, 1250019, 366958, 279064, 131974, 152218, 272985, 77692, 843112, 242438, 119761, 33466, 18368, 301183, 81237, 20216, 562956, 133838, 211520, 29109, 4300, 8757, 17498, 14997, 19546, 18511, 676283, 1112489, 932571, 54193, 1793362, 1934424, 11022684, 5822186, 27046474, 8736822, 17873060, 6777742, 0, 0, 0, 0, 5400619, 1149705, 7322441, 0, 6232846, 3530037, 0, 0, 70000, 13680, 1246796, 5771762, 6505821, 124686256, 1000000, 26000, 0, 0, 599314, 951338, 433476, 298422, 148163, 98000, 95872, 497617, 0, 393210, 413875, 415204, 0, 1542675, 1653241, 3167056, 1885691, 2869421, 3691362, 6027830, 15067360, 358137, 3164485, 1025578, 0, 715315, 0, 270000, 0, 1219723, 5135559, 1307957, 225284, 6507730, 675386, 600000, 1067820, 670197, 1323632, 125500, 161250, 99948, 224993, 260785, 382920, 426250, 1205314, 149450, 59796, 639632, 3294116, 0, 9054372, 1805738, 2606237, 1287837, 5819399, 123567, 222146, 375910, 432439, 448015, 423500, 489914, 61000, 147260, 1233215, 1818457, 2064580, 2254727, 16980, 13692, 68640, 38248, 812000, 267964, 16980, 75443, 137729, 160015, 1605046, 33628, 58417, 449875, 118061, 395117, 270000, 41801392, 33025, 44843, 108801, 14311, 493431, 360695, 19803, 100000, 1637114, 851858, 0, 0, 69540, 69997, 6036395, 15978946, 3994998, 1360148, 336957, 8234, 58580, 243993, 0, 863263, 4839367, 1400000, 181539904, 10254597, 26000, 26000, 3320986, 764116, 581068, 578784, 408908, 831922, 144408, 100000, 99999, 408485, 209719, 450000, 446025, 378503, 8000, 15000, 0, 157500, 116212, 2198212, 0, 743208, 3327766, 1087229, 5970977, 215235, 4000000, 600000, 1399240, 736307, 396651, 418000, 0, 566331, 2041400, 0, 0, 0, 0, 0, 0, 0, 0, 0, 192569, 13692, 47452, 31631, 12673, 7225, 38248, 124340, 24213, 42166, 0, 0, 0, 0, 676455, 259621, 151332, 23274, 5588065, 280000, 100000, 112638, 127034, 39477, 36318, 46658, 125449, 1871237, 2796093, 95414, 223002, 962500, 689385, 59100, 376024, 301904, 392169, 179873, 84223, 0, 0, 80476, 589441, 350000, 91641, 33773, 35383, 88425, 73955, 88425, 57569, 880111, 456077, 743184, 626037, 445348, 542256, 77128, 220158, 265480, 104407, 507379, 43739, 155930, 257888, 1233845, 0, 0, 0, 0, 0, 0, 701047, 580953, 265112, 483026, 360670, 150000, 1023577, 988742, 150000, 1521491, 999550, 732257, 1475832, 88669, 60375, 100000, 39742, 99772, 34721, 9786362, 35000, 2697432, 1124690, 1696952, 99921, 29589, 2646088, 134680, 505635, 45237, 44571, 55375, 47262, 48889, 240173, 52496, 42324, 44970, 39214, 30050, 124637, 37595, 43558, 161300, 44034, 26755, 25131, 81205, 209730, 737737, 29014, 550747, 255693, 700445, 2585724, 4568697, 399600, 140426, 52197, 47452, 55361, 55361, 29885, 29916, 26517, 30715, 51088, 42327, 32252, 15842, 30715, 26920, 29916, 31409, 15842, 25772, 43790, 0, 43790, 25253, 29455, 23353, 21892, 24809, 694349, 532177, 51032, 590797, 586530, 0, 0, 81205, 627143, 100000, 99999, 597630, 69828, 12604, 0, 0, 415875, 190400, 157591, 0, 500382, 219185, 101097, 208696, 13706, 302399, 380129, 2530213, 458635, 148517, 0, 374770, 234125, 372000, 0, 370000, 197169, 224182, 149561, 196143, 132939, 53353, 92845, 2190696, 2499219, 34320, 382193, 406424, 324494, 424619, 362663, 248622, 1532436, 21900, 116150, 1041867, 17597300, 882908, 680854, 851102, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 320000, 1406814, 193426, 420061, 204023, 172000, 217000, 1632408, 26000, 26000, 792744, 2947514, 748024, 0, 0, 0, 0, 218442, 0, 0, 0, 0, 470025, 467610, 3328489, 0, 1063222, 1740596, 2951659, 3700771, 0, 0, 11354158, 0, 0, 0, 500000, 621848, 1886200, 13830000, 0, 0, 0, 0, 0, 145200, 100000, 2474435, 2420050, 2368328, 1769568, 20885824, 398919, 300000, 600000, 600000, 932246, 895497, 584330, 0, 224998, 400001, 27577, 17021, 0, 271609, 4407307, 503000, 3956523, 4812732, 47678, 225000, 149999, 198866, 0, 1600000, 1130283, 10162663, 26000, 0, 600000, 0, 438917, 378517, 510000, 491313, 300000, 9000, 174300, 490920, 3279471, 4852474, 1719828, 1168026, 1322281, 2392170, 6338002, 4213791, 10351716, 48429, 6808, 8455, 23024, 19322, 0, 19254, 1875, 8759, 745315, 8759, 177122, 25276, 1035844, 56206, 21775, 36318, 203600, 574284, 437250, 26031, 32309, 38599, 40207, 489858, 37533, 0, 3734634, 1587390, 135486, 257980, 5816677, 86359, 958333, 0, 149861, 0, 25531, 34407, 33260, 42919, 41789, 145009, 38399, 46798, 47999, 45922, 52840, 55375, 53781, 62753, 58158, 48220, 55299, 55299, 34312, 34532, 37785, 42591, 64641, 418113, 258135, 28229, 33389, 30719, 29382, 26517, 30719, 182975, 191490, 9761, 0, 25186, 0, 0, 0, 0, 69670, 120000, 82810, 462857, 2142816, 66784, 502470, 237220, 3315873, 234501, 0, 0, 0, 0, 20961, 1282553, 1934701, 94338, 1910593, 1384883, 609220, 544766, 767710, 777730, 159617, 226773, 20935, 50208, 566303, 820763, 500176, 358142, 195078, 434961, 90000, 1374450, 316051, 294333, 4418753, 0, 0, 0, 0, 616870, 1394166, 0, 558430, 3561650, 117986, 599998, 0, 298738, 100000, 1669379, 2886225, 1222614, 3442578, 544748, 72612, 152188, 159864, 100000, 2314243, 215254, 1257462, 12965744, 0, 78252, 47528, 25476, 122035, 24213, 58998, 140064, 7712, 317208, 379009, 95274, 63515, 113700, 26772, 2763721, 326574, 309965, 40386, 18857, 0, 56360, 146466, 186576, 1146241, 668634, 19970, 29044, 31819, 13255, 131014, 20877, 16608, 245277, 382433, 52354, 208017, 451756, 3098696, 2591738, 342470, 0, 69700, 320176, 20608244, 57154, 495000, 7056595, 1723265, 7064241, 600782, 5464655, 198381, 3996185, 20580348, 164608, 1721382, 124287, 183003, 1812122, 1859892, 387251, 1011749, 0, 0, 1266575, 743738, 3300000, 7992403, 6061068, 14315660, 5351252, 1000000, 2384636, 1749940, 1040921, 3269254, 312821, 98672, 600000, 577222, 1027407, 203609, 565250, 669400, 200970, 0, 425920, 396546, 608762, 711903, 20000, 12000, 120012, 144500, 495470, 1249045, 845161, 1634395, 2198199, 0, 0, 3289767, 7044139, 328849, 97206, 7159204, 3033132, 0, 126259, 530862, 99053, 329137, 14104144, 2502254, 323895, 16322, 216388, 740216, 99811, 0, 273897, 8654779, 829600, 36593, 439758, 286525, 76000, 935655, 1850112, 976673, 2039956, 634097, 1195400, 50000, 0, 590546, 396647, 671795, 2444922, 224999, 0, 0, 817620, 3540942, 0, 0, 2794326, 8475960, 3699069, 1177779, 318375, 997723, 411250, 600000, 207016, 667079, 3000000, 99510, 100000, 600000, 31834, 276534, 0, 462228, 418502, 356675, 491375, 367875, 398399, 1982832, 3349338, 1199353, 5335752, 2093325, 2188091, 1115984, 2189690, 1437732, 770436, 3520665, 870326, 1911423, 1353871, 1984483, 0, 0, 0, 136080, 979552, 0, 0, 5085001, 276606, 346000, 12005060, 1355228, 64154, 660003, 591329, 0, 31443522, 9883449, 0, 587806, 589058, 598005, 599994, 600000, 500464, 452375, 487500, 10000, 2183992, 3295345, 3489967, 749630, 0, 0, 16987, 13199, 26974, 111357, 73217, 124340, 108798, 108798, 88425, 31631, 13283, 10240, 6604, 8616, 122035, 129661, 79321, 80846, 79321, 13172, 25772, 124340, 999998, 990021, 149999, 268434, 38403, 91634, 87129, 8045, 1306502, 13140, 187131, 129410, 1113619, 103291, 36318, 46658, 39477, 36318, 111158, 127034, 127034, 20400, 1155000, 80000, 258340, 87603, 66064, 3775742, 81836, 220237, 609070, 1564750, 99678, 83600, 38770, 40207, 37155, 37155, 37155, 37155, 37155, 80386, 80386, 80386, 83600, 24405, 22777, 50000, 97981, 574390, 3241524, 1999175, 0, 183896, 300000, 61147, 0, 579002, 192015, 27816, 26803, 94681, 47922, 28974, 29755, 12265, 10207, 22456, 6297, 53343, 223348, 0, 31631, 31631, 44288, 30049, 30049, 56942, 52197, 47452, 55361, 52197, 23993, 15468, 28418, 43790, 50858, 52225, 30715, 49152, 25772, 25772, 26920, 40870, 46710, 26517, 10514, 46080, 33789, 43790, 49152, 20529, 24809, 37946, 46080, 27644, 33389, 303623, 100000, 800810, 3320711, 77464, 0, 0, 0, 0, 0, 0, 50000, 749505, 10307, 93816, 234506, 99892, 100000, 0, 111497, 140000, 0, 0, 489963, 322294, 1504226, 2472345, 0, 47683, 234092, 143360, 1674934, 1132822, 64139, 2547521, 225600, 275834, 25272, 18153, 666369, 341100, 0, 0, 0, 0, 0, 4095564, 4038890, 4748457, 1854702, 3615940, 0, 1156616, 750200, 0, 0, 0, 0, 578126, 500000, 130750, 428289, 125499, 127989, 0, 0, 0, 0, 0, 0, 0, 600000, 99999, 412619, 0, 0, 0, 96846, 1754766, 0, 1568348, 1029043, 0, 0, 143200, 57206, 446437, 1112464, 13692, 121458, 108798, 134242, 124340, 122118, 54344, 98354, 87612, 118700, 139649, 153787, 315000, 514197, 99846, 1563521, 37155, 887063, 0, 174057, 34590, 44737, 16214, 29185, 17021, 25518, 92901, 32997, 18587, 270000, 0, 146776, 399400, 0, 110000, 176680, 1278115, 2359049, 1083337, 48986, 1167454, 0, 0, 0, 55489, 187122, 61812, 0, 9051385, 292456, 150083, 2200000, 499943, 375000, 3766138, 7080653, 7178411, 4833804, 7030446, 2101788, 106995, 1273485, 2735563, 1269603, 0, 0, 0, 50000, 502767, 612654, 70558096, 0, 0, 3489073, 848254, 4101223, 0, 1653159, 3216687, 2388206, 2876373, 818377, 1089169, 2923479, 1848292, 856254, 420908, 298464, 373315, 281484, 1010042, 583103, 189617, 100000, 400000, 302335, 100000, 177172, 100000, 0, 865145, 126000, 960732, 369570, 423938, 420750, 294015, 392593, 363766, 399165, 616668, 630000, 412295, 422100, 305965, 458313, 0, 371250, 50000, 20000, 0, 151000, 0, 3203238, 5754468, 3423141, 1282020, 1179438, 1514433, 0, 5581859, 8458070, 852857, 0, 570888, 253260, 200000, 0, 0, 1864897, 1864897, 1883749, 11311, 14657, 15405, 14488, 10844, 34725, 24980, 9664, 23024, 24240, 21815, 21815, 27267, 21815, 23024, 25451, 21740, 21740, 20536, 23006, 18114, 19322, 0, 0, 0, 0, 353299], \"coloraxis\": \"coloraxis\"}, \"name\": \"\", \"offsetgroup\": \"\", \"orientation\": \"v\", \"showlegend\": false, \"textposition\": \"auto\", \"type\": \"bar\", \"x\": [2004, 2018, 2017, 2007, 2009, 1993, 2016, 2000, 1980, 2004, 2005, 2005, 2006, 2011, 2002, 1996, 1997, 1996, 1993, 1993, 1993, 1996, 1993, 1996, 2006, 1996, 2010, 2011, 1991, 1986, 2008, 1993, 1993, 1995, 2002, 2004, 1998, 1993, 1986, 2010, 1993, 2000, 2009, 1994, 2013, 2011, 2008, 2005, 2008, 2013, 2012, 2008, 2007, 2017, 1997, 1997, 1997, 2004, 2001, 1990, 1999, 2000, 2000, 2000, 2000, 2000, 2000, 1996, 1995, 2017, 2015, 1999, 2000, 2012, 2009, 2004, 2000, 2007, 2001, 2006, 2011, 2005, 2003, 2001, 2001, 2017, 2003, 2007, 2011, 2010, 1999, 2014, 2014, 1993, 1999, 1993, 1993, 2017, 2017, 2017, 2004, 1991, 1991, 1998, 2017, 1992, 1994, 2001, 1998, 1994, 1993, 1993, 2007, 2013, 1997, 1990, 1992, 1999, 2001, 1971, 1970, 1969, 1966, 1976, 1977, 1986, 2002, 1981, 1981, 2004, 2016, 2015, 2008, 2008, 2010, 2013, 2001, 2008, 2015, 2000, 1987, 1993, 2014, 1981, 2003, 2006, 1997, 1995, 2000, 1999, 1996, 1999, 2011, 2013, 2006, 2001, 2009, 2004, 2010, 2002, 2009, 2006, 2008, 2009, 2004, 2013, 2011, 2009, 1996, 1996, 1990, 2007, 2008, 2003, 1996, 1997, 1997, 1997, 1997, 1997, 1997, 1997, 1998, 1987, 1997, 1997, 1996, 1997, 2002, 2002, 2002, 1997, 1993, 1994, 1993, 1993, 1993, 2003, 2002, 1997, 1998, 1997, 2004, 2004, 1998, 1998, 1997, 1991, 1985, 1989, 1985, 1986, 1998, 1998, 2002, 1999, 1996, 1992, 1991, 1990, 1999, 1985, 1986, 1995, 1994, 2007, 1985, 1997, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2012, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 1988, 1991, 1995, 2017, 2015, 2014, 2014, 2011, 2017, 2016, 2016, 2016, 2015, 2000, 2014, 2017, 2017, 2012, 2018, 1999, 2004, 1999, 2001, 2011, 2011, 2010, 2010, 2008, 2010, 2010, 2007, 2016, 2003, 2004, 1976, 2014, 2017, 2014, 2011, 2015, 2000, 2004, 1999, 2001, 2000, 1999, 1997, 1993, 1993, 1993, 2007, 2008, 2007, 2002, 2003, 2012, 2013, 2019, 2016, 2009, 2010, 2016, 2018, 2008, 2015, 2018, 2002, 2015, 2018, 2018, 2018, 2018, 2018, 2018, 2012, 2017, 2012, 2008, 2012, 2012, 2007, 2005, 2006, 2002, 2004, 2003, 2007, 2006, 2004, 2001, 2000, 2002, 2008, 2001, 2006, 2003, 2016, 2001, 2005, 2004, 2003, 2005, 2002, 2017, 2017, 2017, 2003, 1999, 2016, 2016, 2014, 2013, 2013, 2014, 2015, 2011, 2012, 2012, 2011, 2011, 2017, 2016, 2016, 2013, 2016, 2017, 1996, 2011, 2000, 1996, 1999, 1996, 1998, 1997, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2019, 1998, 1991, 1990, 1995, 1997, 1992, 1994, 2001, 1992, 1995, 1998, 2001, 2001, 2008, 2004, 2011, 2011, 1993, 2000, 1999, 1991, 1995, 2012, 2015, 2012, 2016, 2013, 2018, 2013, 2019, 2009, 2017, 2006, 2005, 2014, 1971, 1971, 1971, 1967, 1968, 1972, 1972, 1973, 1979, 1976, 1975, 1980, 1973, 2001, 2000, 1983, 1984, 1981, 1982, 2010, 2010, 2007, 1992, 1991, 1990, 1990, 1990, 2016, 2016, 2016, 2016, 2013, 2011, 2006, 2008, 2008, 2008, 2013, 2008, 2013, 2008, 2013, 2010, 2010, 2010, 2010, 2008, 2011, 2007, 2008, 2008, 2008, 2006, 2008, 2014, 2000, 2002, 1995, 1997, 1995, 2008, 2013, 2012, 2016, 2009, 2000, 1998, 2002, 2000, 2006, 2014, 2018, 2012, 2013, 2007, 2007, 2000, 1996, 1999, 2010, 2011, 2015, 2015, 2015, 2010, 2007, 2006, 2005, 2005, 2000, 2001, 1997, 1994, 1997, 1986, 1988, 1993, 1992, 2015, 2013, 2013, 2013, 2007, 2009, 2014, 2014, 2012, 2011, 2000, 1993, 1998, 1994, 1993, 2003, 2007, 2001, 1992, 1994, 2003, 1993, 1997, 2011, 2006, 2004, 2007, 2009, 2008, 1994, 2004, 2010, 1994, 1994, 2000, 2013, 2008, 2010, 2004, 2007, 1997, 2008, 2011, 2011, 2002, 2007, 2008, 2013, 2011, 2006, 2012, 1994, 2008, 2016, 2007, 2014, 2007, 2017, 2017, 1997, 1997, 1997, 1998, 1998, 1998, 2008, 1997, 1996, 1997, 1997, 1993, 1996, 1999, 1996, 2004, 2000, 2001, 1997, 1996, 1996, 1997, 1996, 1997, 1997, 1997, 1988, 1989, 2002, 2002, 2002, 2002, 2005, 2002, 1997, 1998, 1999, 1997, 1996, 1997, 2005, 2003, 1995, 1997, 2007, 2003, 2006, 1998, 1997, 1997, 1987, 2009, 2009, 1997, 1986, 2004, 2000, 2001, 1988, 1997, 1995, 1995, 1993, 1997, 1991, 2003, 2003, 2005, 2000, 2004, 1992, 1992, 1998, 1999, 1997, 1999, 1997, 2000, 2005, 2006, 2006, 2006, 2006, 1986, 2004, 2003, 2004, 2004, 2005, 2005, 1985, 1996, 1996, 1996, 1985, 1985, 2005, 2005, 2005, 2005, 1993, 1985, 2005, 2005, 2006, 2005, 1996, 1998, 1997, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2015, 1993, 1996, 1999, 1995, 1994, 2002, 1991, 1985, 2014, 2014, 2013, 2011, 2008, 2008, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2009, 2009, 2012, 2011, 1991, 2014, 2012, 2011, 2016, 2014, 2011, 2005, 2009, 2012, 2007, 2013, 2015, 2018, 1997, 2011, 2012, 2014, 2012, 2006, 2009, 2009, 2012, 2016, 2010, 1998, 1990, 2010, 2001, 2005, 2015, 2015, 2008, 2004, 2014, 2009, 2010, 2018, 2011, 2016, 2014, 2012, 2014, 2009, 2005, 2012, 2017, 2017, 2018, 2017, 2017, 2017, 2017, 2006, 2006, 1988, 2010, 2018, 2013, 2012, 2011, 2015, 2015, 2015, 2015, 2015, 2017, 2018, 2016, 2015, 2019, 2019, 2019, 2007, 2015, 2014, 2014, 2016, 2014, 2016, 2010, 2014, 2013, 2012, 2014, 2018, 2012, 2013, 2013, 2009, 2017, 2015, 2014, 2013, 2017, 2013, 2018, 2013, 2010, 2016, 2018, 2018, 2018, 2016, 2018, 2018, 2018, 2015, 2012, 2015, 2015, 2004, 2012, 2008, 2008, 2018, 2014, 2014, 2014, 2009, 2011, 2010, 2011, 2010, 2007, 2012, 2014, 2013, 2014, 2014, 2014, 2016, 2018, 2016, 2019, 2017, 2018, 2018, 2017, 2018, 2018, 2015, 1989, 2013, 2013, 2007, 2019, 2019, 2018, 2017, 2019, 2017, 2016, 2016, 2016, 2015, 2016, 2017, 2014, 2014, 2013, 2015, 2015, 2013, 2012, 2015, 2013, 2013, 2011, 2013, 2012, 2011, 2013, 2011, 2008, 2006, 2014, 1998, 2010, 2005, 2005, 2003, 1993, 2007, 2004, 2000, 2011, 2009, 2017, 2009, 2016, 2015, 2008, 2006, 2000, 2018, 2007, 2005, 2006, 2019, 2002, 2002, 2002, 2000, 2000, 2000, 2000, 1999, 1994, 1994, 1993, 1993, 1992, 1992, 1991, 1990, 1990, 1979, 2011, 2007, 2005, 2004, 2005, 2012, 2012, 2010, 2008, 2009, 2010, 2016, 2016, 2016, 2016, 2010, 2008, 1987, 2017, 2018, 2015, 2014, 1989, 1989, 1989, 2014, 2012, 2012, 2016, 2016, 2013, 2009, 2009, 2010, 2007, 2006, 2006, 2004, 2013, 2004, 1999, 1997, 1993, 2011, 2015, 2015, 2012, 2002, 2013, 2014, 2017, 2018, 2018, 2018, 1999, 2001, 1999, 2003, 2018, 2016, 2008, 2018, 2018, 2018, 2018, 2018, 2013, 2013, 2016, 2014, 2018, 2017, 2008, 2009, 2009, 2009, 2007, 2011, 2016, 2003, 2001, 2003, 2017, 2006, 2002, 2002, 2000, 2017, 1999, 2007, 2006, 2002, 2008, 1999, 2002, 2008, 2007, 2004, 2010, 2006, 2010, 2017, 2018, 2018, 2017, 2003, 1989, 1986, 2019, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2015, 2015, 2015, 2015, 2015, 2015, 2014, 2014, 2013, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2015, 2015, 2015, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2012, 2011, 2010, 2011, 2011, 2012, 2010, 2011, 2011, 2010, 2011, 2010, 2012, 2010, 2012, 2018, 2007, 1999, 2000, 2000, 2016, 2016, 2010, 2016, 2010, 2012, 2013, 2013, 2014, 2014, 2014, 2014, 2015, 2017, 2017, 2010, 2009, 2006, 2003, 2008, 1998, 2014, 1999, 1999, 1996, 1997, 1995, 1995, 1994, 1995, 1995, 1999, 1996, 1995, 1994, 1997, 1999, 2009, 2017, 2017, 2017, 2017, 2019, 2011, 2018, 2018, 2018, 2018, 2018, 2019, 2017, 2019, 2017, 1991, 1995, 1993, 2002, 1992, 2013, 2007, 2010, 1997, 2008, 2008, 2010, 2010, 2008, 1998, 1990, 2001, 1991, 1997, 1997, 1998, 1995, 2000, 2001, 1994, 2019, 2018, 2019, 2016, 2011, 2005, 2012, 2010, 2019, 2015, 2019, 2017, 2005, 2016, 2012, 2008, 2015, 2019, 2017, 2015, 2010, 2013, 2015, 2007, 2010, 2019, 2017, 2019, 2013, 2017, 2018, 2010, 2007, 2011, 2010, 2019, 2014, 2011, 2012, 2005, 2017, 2007, 2006, 2014, 2011, 2013, 2014, 2019, 2011, 2012, 2014, 2010, 2016, 2013, 2011, 2009, 2012, 2012, 2012, 2018, 2010, 2011, 2016, 2006, 2017, 2014, 2006, 2007, 2013, 2015, 2006, 2011, 2012, 2019, 2018, 2019, 2013, 2015, 2019, 2009, 2014, 2010, 2011, 2010, 2009, 2019, 2009, 2013, 2016, 2015, 1969, 1970, 1965, 1980, 1980, 1975, 1980, 1975, 1977, 1977, 1975, 1981, 1979, 1980, 1977, 1977, 1975, 1979, 2000, 2000, 1973, 2001, 2000, 1998, 1988, 2000, 2000, 1987, 1987, 1986, 1986, 1986, 1985, 1984, 1984, 1984, 1999, 1982, 1982, 1983, 1982, 1982, 1984, 1982, 1981, 1982, 1982, 1983, 2014, 2012, 2006, 2017, 2019, 2019, 2004, 2017, 2003, 2001, 2001, 2001, 1997, 1997, 1996, 1992, 1992, 1991, 1991, 1990, 1990, 1990, 1989, 2001, 2016, 2016, 2016, 2016, 2013, 2010, 2013, 2009, 2011, 2011, 2018, 1999, 2012, 2012, 2011, 2011, 2008, 2008, 2008, 2008, 2011, 2008, 2010, 2009, 2009, 2008, 2009, 2009, 2009, 2008, 2009, 2008, 2009, 2011, 2011, 2010, 2007, 2013, 2013, 2008, 2008, 2008, 2008, 2008, 2008, 2010, 2009, 2010, 2006, 2007, 2007, 2006, 2005, 2000, 2003, 2002, 2002, 2001, 2002, 2001, 2000, 2004, 2002, 1998, 2002, 2016, 2012, 2015, 2008, 2014, 2014, 2012, 2015, 2009, 2015, 2014, 2013, 2011, 2010, 2011, 2011, 2007, 2011, 2016, 2013, 2000, 2009, 2006, 1997, 2010, 2009, 2012, 2011, 2010, 2001, 2012, 2011, 2011, 2012, 2002, 2005, 2009, 2015, 2013, 2010, 2010, 2006, 2006, 2009, 2010, 2012, 2003, 2003, 2010, 1999, 1995, 1995, 1989, 2009, 2007, 2015, 2015, 1988, 1993, 1998, 1995, 2015, 2019, 2015, 2014, 2016, 2016, 2016, 2016, 2003, 2004, 2002, 2002, 2003, 2003, 2000, 2002, 2003, 2000, 2001, 1994, 1998, 1999, 1997, 1998, 1997, 1992, 1996, 1999, 1997, 1994, 2000, 1987, 1986, 1986, 1986, 1986, 1992, 1992, 2014, 2014, 2001, 2005, 2015, 2014, 2015, 2015, 2015, 2014, 2013, 2004, 2015, 2008, 2010, 2016, 2012, 2013, 2014, 2006, 1972, 2006, 1999, 2005, 2007, 1992, 1997, 2007, 2010, 2006, 1992, 2005, 2010, 2003, 1999, 2006, 2003, 1996, 2008, 2012, 1992, 2010, 2005, 2009, 2002, 2006, 2004, 2013, 2010, 2007, 2008, 2005, 2003, 1999, 2002, 2005, 1994, 2009, 2006, 2004, 2007, 1998, 1994, 1995, 2012, 2006, 2000, 1994, 2010, 2001, 2010, 2007, 2008, 2010, 1995, 2002, 1997, 2012, 2010, 2005, 2007, 2010, 2007, 2013, 2010, 2010, 2009, 2011, 2011, 2001, 2005, 2007, 2008, 2008, 2008, 2008, 2008, 2008, 2012, 2016, 2016, 2008, 2002, 2003, 1997, 2003, 2000, 2013, 1998, 2005, 2005, 2005, 2004, 2004, 2004, 2004, 2005, 2006, 2005, 2005, 2006, 2005, 2012, 2017, 2017, 2017, 2017, 2017, 2017, 2017, 2015, 2015, 2015, 2014, 2015, 2014, 2015, 2013, 2012, 2015, 2015, 2012, 2012, 2011, 2008, 2016, 2008, 2006, 1992, 2018, 2018, 2018, 2018, 2018, 2018, 2019, 2018, 2018, 2017, 2017, 2017, 2017, 2016, 2017, 2017, 2017, 2017, 1993, 2016, 2016, 2016, 2016, 2015, 2014, 2015, 2015, 2015, 2015, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2008, 2015, 2015, 2015, 2015, 2015, 2014, 2014, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2003, 2014, 2014, 2015, 2014, 2015, 2014, 2014, 2014, 2013, 2015, 2014, 2014, 2014, 2014, 2017, 2016, 2019, 2016, 2017, 2015, 2016, 2017, 2014, 2019, 2012, 2014, 2009, 1994, 2008, 2006, 2006, 2006, 2006, 2015, 2014, 2012, 2018, 2011, 2003, 2019, 1994, 2018, 2014, 2006, 1992, 2013, 2016, 2005, 2005, 2016, 2019, 2019, 2006, 2009, 1997, 2014, 2017, 2014, 2017, 2017, 2015, 2018, 2008, 2002, 2007, 2019, 2004, 2009, 2004, 2005, 2005, 2016, 2018, 2012, 2006, 2008, 2008, 2008, 2010, 2011, 2010, 2018, 2019, 2018, 2005, 2016, 2016, 1999, 2017, 2010, 2008, 1997, 2016, 2018, 2017, 2010, 2001, 2014, 2017, 2019, 2019, 2019, 2019, 2000, 2006, 2017, 2017, 2017, 2016, 2019, 2019, 2018, 2017, 2018, 2017, 2005, 2005, 2015, 2017, 2013, 2016, 2019, 2010, 2014, 2014, 2019, 2012, 2019, 2019, 2015, 2013, 2019, 2010, 2017, 2011, 2014, 2017, 2011, 2019, 2014, 2011, 2019, 2017, 2018, 2019, 2018, 2018, 2019, 2010, 2013, 2018, 2019, 2012, 2018, 2015, 2018, 2019, 2018, 2009, 2018, 2014, 2019, 2005, 2017, 2017, 2018, 2018, 2017, 2014, 2019, 2017, 2015, 2016, 2018, 2019, 2015, 2018, 2017, 2004, 2007, 2015, 2005, 2005, 2013, 2008, 2015, 2015, 2015, 2016, 2012, 2006, 1995, 2008, 2015, 2015, 2014, 2010, 2001, 2010, 2010, 2009, 2009, 2011, 2010, 2011, 2011, 2010, 2010, 2010, 2010, 2015, 2017, 2009, 2008, 2014, 2015, 2007, 2018, 2019, 2010, 2019, 2019, 2019, 2019, 2017, 2015, 2015, 2013, 2015, 2014, 2012, 2010, 2011, 2005, 2014, 2017, 2005, 2003, 2000, 2009, 2015, 2014, 1998, 1987, 2015, 1998, 2004, 2017, 2017, 2017, 2017, 2017, 2010, 2008, 2007, 2010, 1988, 1989, 1988, 1984, 2014, 1991, 1992, 1992, 1995, 1991, 1995, 1991, 1989, 2016, 2016, 2012, 2010, 2009, 2009, 2009, 2008, 2007, 2005, 2005, 2002, 2001, 1977, 2014, 2018, 2012, 2019, 1990, 2019, 2019, 2018, 2018, 2018, 2018, 2010, 2019, 2014, 2009, 2013, 2016, 2013, 2014, 2016, 2009, 2012, 2016, 2008, 2018, 2006, 2008, 2009, 2003, 2003, 2006, 2008, 2017, 2004, 2016, 2016, 2016, 2016, 2013, 2014, 2013, 2011, 2010, 2012, 2011, 2011, 2011, 2010, 2012, 2010, 2008, 2013, 2019, 2019, 2018, 2006, 2015, 2010, 2009, 2009, 2008, 2007, 2012, 2012, 2016, 2019, 1998, 1996, 2009, 1999, 1997, 1995, 2007, 2000, 2018, 2000, 2014, 2018, 2017, 2018, 2003, 2018, 2010, 2009, 2007, 2005, 2005, 2009, 2013, 2011, 2001, 2010, 2017, 2014, 2008, 2017, 2013, 2010, 2007, 2013, 2011, 2005, 2016, 2013, 2019, 2011, 2014, 2010, 2019, 2017, 2012, 2005, 2017, 2013, 2016, 2018, 2016, 2011, 2012, 2019, 2018, 2017, 2019, 2017, 2018, 2013, 2004, 2013, 2016, 2019, 2013, 2010, 2019, 2018, 2015, 2017, 2011, 2013, 2014, 2010, 2012, 2013, 2014, 2017, 2010, 2005, 2015, 2011, 2012, 2016, 2019, 2019, 2012, 2017, 2016, 2011, 1965, 1965, 1980, 1976, 1977, 1981, 1978, 1981, 1977, 1998, 1998, 1998, 1988, 1985, 1986, 1983, 1982, 1981, 2015, 2016, 2014, 2012, 2012, 2009, 2010, 2010, 2008, 2007, 2009, 2019, 2019, 2017, 2018, 2019, 2003, 1990, 1989, 2001, 2018, 2006, 2016, 2015, 2008, 1998, 1991, 1987, 2018, 2012, 2005, 2014, 2003, 2012, 2018, 2010, 2010, 2010, 2010, 2005, 2013, 2013, 2013, 2004, 2002, 1996, 2011, 2016, 1985, 2013, 2009, 2009, 2017, 2014, 2011, 2014, 2013, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2019, 2008, 2012, 2013, 2001, 1995, 1991, 1986, 1992, 2011, 2012, 2005, 2003, 2004, 2005, 2007, 2015, 2011, 2015, 2016, 2014, 2014, 2012, 2014, 2010, 2000, 1999, 1994, 2005, 1995, 1998, 2003, 2000, 2009, 1997, 2007, 2004, 2006, 2008, 1998, 2002, 2005, 2005, 2005, 2002, 2000, 2000, 1992, 2003, 2009, 2006, 2000, 2000, 2001, 2006, 2006, 2006, 2006, 2006, 2001, 2015, 2014, 2014, 2011, 2015, 2017, 1998, 2019, 2010, 2017, 2018, 2018, 2004, 2015, 2009, 2014, 2014, 2010, 2015, 2014, 2013, 2016, 2015, 2012, 2012, 2008, 1997, 2016, 2013, 2018, 2013, 2011, 2011, 2012, 2001, 1998, 2013, 2018, 2009, 2012, 2012, 2010, 2006, 2006, 2013, 2013, 2014, 2014, 1992, 2006, 2005, 2006, 2009, 2009, 2006, 2006, 2012, 2012, 2010, 2011, 2013, 2013, 2013, 2013, 2010, 2011, 2012, 2012, 2013, 2013, 2014, 2012, 2012, 2015, 2009, 2015, 2011, 1997, 2016, 2002, 2017, 2016, 2000, 1998, 1999, 2016, 2001, 2001, 2006, 2005, 2003, 2005, 2007, 2017, 2019, 2018, 2019, 2016, 2014, 2001, 2012, 2016, 2017, 2014, 2015, 2011, 2010, 2017, 2017, 2012, 2009, 2010, 2008, 2018, 2018, 2018, 2007, 2007, 2007, 2010, 2014, 2006, 2007, 2016, 2012, 1995, 2008, 2008, 2008, 2004, 2009, 2013, 2001, 2002, 2015, 2018, 2017, 2007, 2015, 2017, 2019, 2002, 2016, 2013, 2013, 2010, 2012, 2011, 2012, 2011, 2017, 2009, 2016, 2011, 2001, 2015, 2017, 2012, 2000, 1992, 1992, 2008, 1990, 2012, 1998, 2010, 2001, 2017, 2014, 2003, 2017, 2015, 2016, 2014, 2016, 2007, 2007, 2018, 2018, 2006, 2006, 2006, 2019, 2005, 2014, 2012, 2017, 2010, 2010, 2006, 2005, 2003, 2015, 2011, 2011, 2008, 2008, 1999, 2012, 2008, 2016, 1999, 1999, 2008, 2013, 2019, 2015, 2012, 2005, 1992, 2009, 2007, 2002, 1999, 2000, 2014, 2015, 2010, 1995, 1998, 2013, 2009, 2005, 2009, 2014, 2007, 2017, 2013, 2013, 2010, 2010, 2018, 2014, 2002, 2016, 2014, 2016, 2018, 2018, 2013, 1999, 1991, 2018, 2010, 2017, 2013, 2009, 2016, 2018, 2018, 2018, 2018, 2015, 2015, 2014, 2014, 2014, 2014, 2018, 2017, 2017, 2016, 1994, 2017, 2012, 2010, 2013, 2011, 2007, 2011, 2010, 2010, 2012, 2007, 2009, 2017, 2013, 2014, 2013, 2013, 2019, 2010, 2017, 2017, 2014, 2006, 2018, 2018, 2018, 1999, 1993, 1992, 2008, 2008, 2008, 2008, 2008, 2008, 2009, 2004, 1998, 2003, 2011, 1999, 2007, 2006, 1990, 2017, 2012, 2011, 2002, 1999, 1991, 2009, 2018, 2017, 2018, 2010, 2012, 2009, 2007, 2017, 2010, 2011, 2010, 2013, 2010, 2004, 2016, 2010, 2016, 1993, 2017, 2012, 2007, 2000, 1998, 2000, 1999, 1999, 2000, 1998, 1998, 2016, 2005, 2013, 2019, 2000, 2005, 2019, 2017, 2014, 2017, 2002, 2013, 2000, 2012, 2013, 2008, 2000, 2015, 2004, 2014, 2019, 2018, 2004, 2006, 1990, 2008, 2018, 2018, 2017, 1998, 2004, 2017, 2010, 2016, 2016, 2012, 2015, 2015, 2016, 2017, 2017, 2012, 2015, 2017, 2017, 2015, 2015, 2015, 2018, 2015, 2015, 2010, 2008, 2009, 2009, 2019, 2018, 2013, 2006, 2004, 2007, 2009, 2007, 2019, 2006, 2010, 2012, 2009, 2014, 2009, 2019, 2014, 2009, 2016, 2012, 2015, 2014, 2017, 1993, 2010, 2013, 2011, 1991, 2013, 1995, 2002, 2007, 2003, 1989, 2019, 2018, 2018, 2005, 2007, 2019, 2019, 2019, 2018, 2019, 2018, 2019, 2019, 2019, 2012, 2016, 2007, 2016, 2009, 2010, 2013, 2015, 2016, 2017, 2017, 2017, 2018, 2017, 2017, 2018, 2018, 2018, 2002, 2018, 2018, 2014, 2008, 1998, 2007, 2019, 2014, 2013, 2015, 2014, 2015, 2016, 2015, 2015, 2015, 2015, 2012, 2013, 2004, 2017, 2012, 2013, 2015, 2010, 2005, 2013, 2018, 2017, 2017, 2017, 2017, 2016, 2018, 2016, 2017, 2017, 2015, 2016, 2017, 2014, 2011, 2012, 2012, 2012, 2010, 2012, 2010, 2010, 2007, 2019, 2019, 2017, 2005, 2018, 2018, 2004, 2003, 2003, 2002, 2007, 1994, 2016, 2016, 2018, 2017, 2018, 2018, 2017, 2017, 2017, 2016, 2016, 2016, 2018, 2017, 2018, 2016, 2018, 2018, 2016, 2018, 2018, 2017, 2018, 2018, 2016, 2016, 2016, 2016, 2017, 2017, 2017, 2017, 2016, 2019, 2017, 2017, 2017, 2017, 2017, 2008, 2010, 2004, 1997, 2005, 2007, 2014, 2016, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2016, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2013, 2017, 2010, 2009, 2003, 2000, 2014, 2019, 1997, 2002, 2008, 2011, 2010, 2017, 2011, 2013, 2011, 2008, 2014, 2007, 2007, 2010, 2010, 2005, 2012, 2010, 2017, 2014, 2013, 2014, 2016, 2014, 2016, 2014, 2016, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2015, 2015, 2015, 2014, 2014, 2016, 2014, 2012, 2015, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2014, 2012, 2012, 2013, 2013, 2013, 2013, 2014, 2014, 2014, 2014, 2014, 2014, 2013, 2008, 2019, 2013, 2007, 2018, 2019, 2017, 2018, 2017, 2017, 2018, 2016, 2017, 2014, 2016, 2017, 2017, 2015, 2014, 2015, 2015, 2015, 2016, 2013, 2014, 2014, 2014, 2013, 2013, 2012, 2015, 2013, 2013, 2012, 2012, 2012, 2013, 2013, 2010, 2013, 2010, 2013, 2012, 2014, 2012, 2010, 2018, 2012, 2003, 2006, 2017, 2014, 2015, 2016, 2019, 2001, 1996, 2018, 2017, 2017, 2010, 2008, 2005, 2005, 2005, 2005, 2003, 2005, 2011, 2018, 1985, 2019, 2019, 2019, 2018, 2010, 2009, 2006, 2014, 2017, 2017, 2017, 2010, 2019, 1996, 2012, 1979, 2017, 2016, 1989, 1989, 1993, 2014, 2014, 2014, 2014, 2015, 2012, 2012, 2012, 2007, 2006, 1999, 2000, 1999, 1997, 1996, 1996, 2017, 2018, 1997, 2002, 1999, 1999, 2000, 1998, 1993, 2016, 2017, 2001, 2019, 2018, 2017, 2017, 2019, 2019, 2018, 2018, 2019, 2019, 2019, 2009, 2018, 2016, 2001, 2018, 2012, 2014, 2015, 2009, 2004, 2017, 2006, 2008, 2013, 2003, 2013, 2011, 2010, 2009, 2013, 2010, 2011, 2011, 2017, 2016, 2017, 2004, 2002, 2016, 2016, 2013, 2013, 2015, 2014, 2010, 2010, 2012, 2009, 2011, 2016, 2019, 2019, 2018, 2019, 2019, 2016, 2016, 2017, 2019, 2017, 2017, 2017, 2017, 2018, 2018, 2018, 1998, 2010, 2010, 2010, 2014, 2012, 2012, 2008, 2013, 2013, 2017, 2001, 2015, 1998, 1998, 2019, 2019, 2015, 2015, 2014, 2014, 2014, 2018, 2018, 2007, 2014, 2019, 2019, 2007, 2017, 2015, 2017, 2016, 2017, 2013, 2015, 2015, 2016, 2014, 2009, 2017, 2016, 2014, 2014, 2012, 2017, 2009, 2013, 2012, 2010, 2012, 2010, 2019, 2019, 2018, 2014, 2014, 2016, 2018, 2005, 2018, 2017, 2018, 2010, 2017, 2015, 2011, 2010, 2018, 2014, 2011, 2013, 2009, 2017, 2014, 2013, 2012, 2012, 2015, 2009, 2014, 2014, 2017, 2015, 2013, 2014, 2019, 2014, 2018, 2018, 2011, 2014, 2012, 2014, 2010, 2013, 2019, 2015, 2019, 2018, 2008, 2014, 2015, 2011, 2014, 2019, 2016, 2018, 2019, 2011, 2014, 2010, 2010, 2012, 2015, 2015, 2015, 2010, 2010, 2010, 2011, 2012, 2018, 2014, 2019, 2016, 2016, 2017, 2019, 2004, 2009, 2014, 2014, 2018, 2018, 2014, 2019, 2009, 2008, 2010, 2013, 2013, 2018, 2016, 2014, 2017, 2010, 2011, 2015, 2014, 2011, 2015, 2006, 2018, 2013, 2019, 2012, 2014, 2014, 2018, 2014, 2019, 2017, 2018, 2010, 2015, 2015, 2017, 2015, 2014, 2018, 2011, 2016, 2016, 2009, 2014, 2010, 2017, 2014, 2019, 2018, 2014, 2016, 2017, 2016, 2011, 2013, 2017, 2013, 2019, 2013, 2019, 2008, 2015, 2016, 2008, 2017, 2017, 2017, 2018, 2018, 1971, 1966, 1965, 1978, 1977, 1979, 1988, 1987, 1986, 2002, 2001, 1998, 1998, 2001, 2015, 2014, 2016, 2016, 2014, 2013, 2009, 2008, 2018, 2019, 2019, 2017, 2018, 2018, 2016, 2017, 2017, 2018, 2017, 2018, 2016, 2017, 2016, 2016, 2016, 2016, 2015, 2001, 1996, 1996, 2001, 2017, 2017, 2003, 2005, 2003, 2005, 2000, 1999, 1989, 2010, 2015, 2002, 2013, 2013, 2013, 2013, 2011, 2010, 2010, 2012, 2012, 2011, 2006, 2011, 2007, 2006, 2011, 2008, 2008, 2008, 2008, 2012, 2010, 2005, 2002, 2005, 2012, 2015, 2011, 2008, 2006, 2004, 2010, 2003, 2006, 2017, 2018, 2014, 2010, 2010, 2008, 2010, 2012, 2007, 2004, 2004, 2001, 2013, 2011, 2016, 2017, 2011, 2005, 2004, 2015, 2011, 2005, 2015, 2016, 2016, 2014, 2016, 2018, 2016, 2009, 2015, 2016, 2013, 2016, 2016, 2016, 2017, 2015, 2014, 2014, 2016, 2012, 2013, 2018, 2016, 2000, 2006, 2002, 1997, 1991, 1997, 1998, 1994, 1986, 1991, 1987, 1992, 2018, 2016, 2016, 2002, 2003, 2005, 2005, 2005, 2005, 2004, 2006, 2012, 2007, 2013, 2012, 2008, 2006, 2008, 2013, 1999, 2012, 2006, 1997, 2005, 2011, 1993, 2010, 2013, 2013, 2008, 2007, 2014, 2009, 2015, 2013, 2017, 2016, 2016, 2012, 2016, 2012, 2018, 2016, 2000, 1995, 1991, 1991, 2008, 2008, 2008, 2005, 2008, 2008, 1992, 1987, 2010, 2010, 2012, 2013, 2010, 2008, 2012, 2000, 2000, 1999, 2010, 2009, 2009, 2006, 2005, 2003, 2003, 2005, 1994, 2017, 2015, 2009, 1996, 2005, 2007, 2016, 2014, 2007, 2010, 2013, 2013, 2012, 2011, 2001, 2001, 2001, 2001, 2010, 1998, 2013, 2018, 2018, 2017, 2016, 2017, 2017, 2011, 2012, 2015, 2018, 2019, 2016, 2018, 2018, 2018, 2018, 2000, 2016, 2016, 2015, 2017, 2008, 2014, 2012, 2008, 2013, 2007, 2010, 2013, 2013, 2017, 2013, 2012, 2011, 2019, 2012, 2013, 2010, 2008, 2018, 2011, 2016, 2018, 2017, 2013, 2017, 2011, 2017, 2009, 2013, 2008, 2016, 2018, 2019, 2005, 2007, 2016, 2018, 2010, 2003, 2003, 1998, 1997, 2019, 2011, 2007, 2017, 2012, 2001, 2013, 2005, 2003, 2018, 2014, 2014, 2012, 2015, 2008, 2009, 2008, 1998, 2008, 2009, 2005, 2013, 2007, 2000, 2000, 2010, 2004, 2015, 2011, 2006, 2007, 2004, 2003, 2002, 2009, 2006, 2005, 2006, 2005, 2003, 2011, 2000, 2005, 2005, 2013, 1992, 2011, 2012, 2010, 2012, 2007, 2010, 2018, 2015, 2005, 2018, 2017, 1998, 2015, 2008, 2017, 2018, 2018, 2018, 2017, 2013, 2010, 2011, 2014, 2018, 2016, 2013, 2013, 1999, 2016, 2017, 2017, 2013, 2009, 2007, 2006, 2009, 2010, 2014, 2017, 2012, 2008, 2017, 2018, 2008, 2014, 2016, 2016, 2016, 2016, 2016, 2018, 2018, 2018, 2018, 2006, 2015, 2016, 2015, 2013, 2016, 2014, 2016, 2019, 2017, 2001, 2001, 2017, 2015, 2014, 2014, 2015, 2015, 2015, 2019, 2017, 2016, 2015, 2001, 2011, 2006, 2001, 1999, 1998, 2004, 2011, 1997, 2002, 2011, 2005, 2013, 2015, 2015, 2019, 2015, 2013, 2017, 2015, 2005, 2008, 2006, 2018, 2016, 2014, 2016, 2017, 2016, 2016, 2016, 2015, 2015, 2010, 2015, 2015, 2013, 2017, 2015, 2018, 2019, 2019, 2014, 2016, 2017, 2018, 2019, 2017, 2015, 2015, 2012, 2012, 2012, 2011, 2009, 2009, 2010, 2006, 2006, 2018, 2019, 2019, 2019, 2017, 2002, 2018, 2018, 2018, 2018, 2018, 2016, 2017, 2016, 2018, 2010, 2017, 2013, 2013, 2013, 2013, 2011, 2011, 2007, 2012, 2010, 2010, 2012, 2012, 2012, 2011, 2011, 2011, 2012, 2006, 2010, 2010, 2010, 2007, 2006, 2010, 2010, 2010, 2013, 2013, 2013, 2017, 2019, 2009, 1996, 2018, 2010, 1995, 2011, 1996, 1996, 2017, 2018, 2017, 2018, 2006, 2005, 2016, 2016, 2016, 2009, 2015, 2018, 2018, 2018, 2015, 2016, 2014, 2009, 2011, 2011, 2012, 2016, 2016, 2004, 2006, 2003, 2005, 2006, 2003, 2002, 2014, 2011, 2008, 2011, 2008, 2014, 2015, 2014, 2015, 2018, 2010, 2015, 2012, 2006, 2016, 2017, 2010, 1996, 1995, 1999, 1998, 1992, 1992, 1992, 1992, 2003, 2005, 1999, 1985, 2010, 2009, 2009, 2010, 2009, 2011, 2010, 2013, 2000, 2000, 2014, 2013, 2004, 2001, 1998, 1993, 1986, 2002, 1994, 1988, 1998, 1999, 2012, 2004, 2018, 1990, 2008, 2010, 2003, 2012, 2000, 1995, 2018, 1989, 1995, 1997, 2010, 2010, 2012, 2011, 1988, 1998, 1998, 2003, 1998, 2009, 2012, 2014, 2013, 2012, 2013, 2013, 2013, 2012, 2019, 2009, 2012, 2018, 2019, 2018, 2018, 2018, 2004, 2002, 2001, 2013, 2018, 2017, 2019, 2004, 2004, 2016, 2013, 2008, 2002, 2015, 2008, 2006, 2000, 1999, 2013, 1999, 2011, 2009, 2007, 2006, 2003, 2006, 2014, 2003, 2018, 2017, 2016, 2005, 2005, 2007, 2012, 2015, 2012, 2013, 1995, 2003, 2005, 2003, 2005, 2018, 2008, 2010, 2013, 2010, 2015, 2012, 2011, 2011, 2006, 2016, 2018, 2019, 2019, 2014, 2015, 2014, 2014, 2013, 2019, 2013, 2015, 2009, 2005, 2006, 2008, 2005, 2018, 2016, 2018, 2019, 2018, 2016, 2016, 2017, 2018, 2017, 2016, 2016, 2016, 2015, 2016, 2015, 2012, 2013, 2013, 2011, 2012, 2012, 2008, 2018, 2017, 2018, 2004, 2018, 2018, 2006, 2008, 2008, 2008, 2007, 2008, 2008, 2009, 2005, 2011, 2008, 2005, 2007, 2006, 2017, 2011, 2004, 2008, 2017, 2018, 2015, 2017, 2014, 2017, 2014, 2016, 2011, 2012, 2016, 2002, 2005, 2006, 2004, 2008, 2003, 2003, 2001, 2004, 1996, 2015, 2008, 2008, 2007, 2016, 2012, 2006, 2012, 2010, 2008, 1991, 2010, 2012, 2009, 2015, 1989, 1992, 2004, 2002, 2008, 2008, 1987, 2009, 2012, 2012, 2011, 1994, 2014, 2003, 2018, 2017, 2012, 2014, 2015, 2001, 2006, 2007, 2014, 2005, 2016, 2016, 2015, 2018, 2016, 2012, 2018, 2018, 2013, 2018, 2009, 2019, 2013, 2015, 2016, 2016, 2002, 2014, 2008, 2002, 2002, 2015, 2017, 2016, 2017, 2003, 2007, 2017, 2017, 2008, 2007, 2006, 2006, 2007, 2008, 2003, 2015, 2009, 2011, 2012, 2013, 2018, 2013, 2011, 2010, 2001, 2017, 2019, 2015, 2012, 2019, 2014, 2018, 2016, 2017, 2013, 2014, 2009, 2006, 2012, 2012, 2009, 2010, 2019, 2014, 2012, 1999, 1990, 2008, 2014, 2009, 2007, 2009, 2009, 2012, 2011, 2012, 2014, 2010, 2008, 2011, 2008, 2014, 2012, 2009, 2005, 2004, 2010, 2009, 1999, 2012, 2016, 2007, 2007, 2013, 2004, 2008, 2003, 2017, 2010, 2014, 2015, 2005, 1993, 1989, 2005, 2006, 2004, 2011, 2019, 2018, 2018, 2019, 2014, 2004, 2002, 2012, 2005, 2010, 2016, 2018, 2018, 2016, 1994, 2014, 2010, 2015, 2012, 2013, 2010, 2010, 2012, 2002, 2007, 2002, 2018, 2018, 2018, 2016, 2019, 2019, 2017, 2019, 2017, 2015, 1999, 2019, 2010, 1998, 1998, 2013, 2013, 2010, 2011, 2010, 2012, 2013, 2010, 2009, 2008, 2017, 2006, 2010, 2014, 2010, 2011, 1999, 2012, 2011, 2010, 2006, 2005, 2003, 2011, 2009, 2006, 2019, 2017, 2017, 2014, 2013, 2009, 2006, 2012, 2004, 2009, 2006, 2010, 1996, 1989, 1996, 2009, 2011, 2003, 2014, 2017, 2017, 2018, 2012, 2016, 2017, 2017, 2019, 1992, 2018, 2018, 2005, 2015, 2014, 2013, 2011, 2010, 2009, 2015, 2010, 2011, 2016, 2018, 2016, 2003, 2018, 2006, 2014, 2017, 2018, 2018, 2018, 2017, 2017, 2017, 2015, 2013, 2000, 1998, 1997, 1991, 2018, 2018, 2018, 2018, 2018, 2009, 2006, 2017, 2017, 2017, 2017, 2019, 2006, 2010, 2008, 2008, 2013, 2009, 2011, 2008, 2016, 2011, 2016, 2016, 2016, 2016, 2016, 2016, 2016, 2018, 2011, 1997, 2013, 2010, 2012, 2018, 2017, 2012, 2003, 2010, 2015, 2015, 2015, 2014, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2015, 2014, 2014, 2018, 2000, 2013, 2016, 2016, 2013, 2018, 2018, 2017, 2019, 2017, 1990, 2006, 2004, 2003, 2002, 2003, 2001, 2001, 1995, 1995, 1993, 1994, 2018, 2008, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2013, 2007, 2011, 2011, 2010, 2011, 2012, 2012, 2012, 2006, 2006, 2011, 2010, 2010, 2007, 2007, 2012, 2012, 2010, 2012, 2000, 2010, 2009, 2012, 2012, 2008, 2012, 2015, 2014, 2018, 2017, 2005, 2002, 2014, 2013, 2012, 2015, 1986, 2013, 2007, 2014, 2014, 2012, 2013, 2013, 2013, 2016, 2008, 2011, 2016, 2012, 2004, 2003, 2000, 2011, 2017, 2013, 2014, 2017, 2015, 2012, 2006, 2010, 2012, 2008, 2014, 2012, 1999, 2002, 1992, 1992, 2006, 2010, 2015, 2010, 2012, 2009, 1994, 2015, 2002, 1991, 1999, 1990, 2000, 2010, 2006, 2005, 2005, 2005, 2001, 1999, 1998, 1999, 1996, 1994, 1989, 1988, 2015, 2006, 2016, 1999, 1999, 1993, 2007, 2014, 1988, 2010, 2010, 1991, 1992, 2007, 2019, 2018, 2018, 2016, 2019, 2017, 2018, 2017, 2017, 2013, 2011, 2010, 2008, 2007, 2018, 1998, 2018, 2017, 2003, 2015, 2018, 2019, 1987, 2009, 2019, 2002, 2002, 2002, 2012, 2001, 2012, 1994, 2018, 2011, 2017, 2018, 2016, 2010, 2009, 2012, 2017, 2010, 2007, 2011, 2009, 2015, 2014, 2015, 2017, 2015, 2015, 2019, 2015, 2014, 2015, 2014, 2012, 2017, 2017, 2017, 2018, 2018, 2010, 2008, 2012, 2011, 2007, 1999, 2000, 1997, 2013, 2008, 2011, 2018, 1998, 1991, 2006, 2005, 2016, 2009, 2013, 2009, 2010, 2010, 2004, 2006, 2016, 2007, 2002, 2001, 2014, 2010, 2001, 2007, 2008, 2003, 2003, 2003, 2002, 2003, 2003, 2003, 1999, 2010, 2010, 2012, 2011, 2016, 2014, 2009, 2009, 2009, 2009, 2009, 2007, 2004, 2005, 2003, 2004, 2000, 2003, 2018, 2005, 2000, 2006, 1996, 2018, 2018, 2015, 2012, 2008, 2011, 1999, 2012, 2005, 2000, 1998, 2005, 2014, 2018, 2018, 2017, 2018, 2018, 2018, 2017, 2019, 2018, 2002, 1998, 2008, 2007, 2004, 2005, 2005, 2005, 2005, 2005, 2005, 2005, 2005, 2004, 2004, 2004, 2005, 2003, 2003, 1999, 2006, 2014, 2019, 2018], \"xaxis\": \"x\", \"y\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0], \"yaxis\": \"y\"}],\n","                        {\"barmode\": \"relative\", \"coloraxis\": {\"colorbar\": {\"title\": {\"text\": \"Funding Amount in USD\"}}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"height\": 600, \"legend\": {\"tracegroupgap\": 0}, \"template\": {\"data\": {\"bar\": [{\"error_x\": {\"color\": \"#2a3f5f\"}, \"error_y\": {\"color\": \"#2a3f5f\"}, \"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"bar\"}], \"barpolar\": [{\"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"barpolar\"}], \"carpet\": [{\"aaxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"baxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"type\": \"carpet\"}], \"choropleth\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"choropleth\"}], \"contour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"contour\"}], \"contourcarpet\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"contourcarpet\"}], \"heatmap\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmap\"}], \"heatmapgl\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmapgl\"}], \"histogram\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"histogram\"}], \"histogram2d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2d\"}], \"histogram2dcontour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2dcontour\"}], \"mesh3d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"mesh3d\"}], \"parcoords\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"parcoords\"}], \"scatter\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter\"}], \"scatter3d\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter3d\"}], \"scattercarpet\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattercarpet\"}], \"scattergeo\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergeo\"}], \"scattergl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergl\"}], \"scattermapbox\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattermapbox\"}], \"scatterpolar\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolar\"}], \"scatterpolargl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolargl\"}], \"scatterternary\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterternary\"}], \"surface\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"surface\"}], \"table\": [{\"cells\": {\"fill\": {\"color\": \"#EBF0F8\"}, \"line\": {\"color\": \"white\"}}, \"header\": {\"fill\": {\"color\": \"#C8D4E3\"}, \"line\": {\"color\": \"white\"}}, \"type\": \"table\"}]}, \"layout\": {\"annotationdefaults\": {\"arrowcolor\": \"#2a3f5f\", \"arrowhead\": 0, \"arrowwidth\": 1}, \"colorscale\": {\"diverging\": [[0, \"#8e0152\"], [0.1, \"#c51b7d\"], [0.2, \"#de77ae\"], [0.3, \"#f1b6da\"], [0.4, \"#fde0ef\"], [0.5, \"#f7f7f7\"], [0.6, \"#e6f5d0\"], [0.7, \"#b8e186\"], [0.8, \"#7fbc41\"], [0.9, \"#4d9221\"], [1, \"#276419\"]], \"sequential\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"sequentialminus\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"colorway\": [\"#636efa\", \"#EF553B\", \"#00cc96\", \"#ab63fa\", \"#FFA15A\", \"#19d3f3\", \"#FF6692\", \"#B6E880\", \"#FF97FF\", \"#FECB52\"], \"font\": {\"color\": \"#2a3f5f\"}, \"geo\": {\"bgcolor\": \"white\", \"lakecolor\": \"white\", \"landcolor\": \"#E5ECF6\", \"showlakes\": true, \"showland\": true, \"subunitcolor\": \"white\"}, \"hoverlabel\": {\"align\": \"left\"}, \"hovermode\": \"closest\", \"mapbox\": {\"style\": \"light\"}, \"paper_bgcolor\": \"white\", \"plot_bgcolor\": \"#E5ECF6\", \"polar\": {\"angularaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"radialaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"scene\": {\"xaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"yaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"zaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}}, \"shapedefaults\": {\"line\": {\"color\": \"#2a3f5f\"}}, \"ternary\": {\"aaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"baxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"caxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"title\": {\"x\": 0.05}, \"xaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}, \"yaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}}}, \"title\": {\"text\": \"Clinical Trials per grant\"}, \"xaxis\": {\"anchor\": \"y\", \"domain\": [0.0, 0.98], \"title\": {\"text\": \"End Year\"}}, \"yaxis\": {\"anchor\": \"x\", \"domain\": [0.0, 1.0], \"title\": {\"text\": \"clinical_trials\"}}},\n","                        {\"responsive\": true}\n","                    ).then(function(){\n","                            \n","var gd = document.getElementById('91945063-1f92-4c13-a7e7-375179a7cf89');\n","var x = new MutationObserver(function (mutations, observer) {{\n","        var display = window.getComputedStyle(gd).display;\n","        if (!display || display === 'none') {{\n","            console.log([gd, 'removed!']);\n","            Plotly.purge(gd);\n","            observer.disconnect();\n","        }}\n","}});\n","\n","// Listen for the removal of the full notebook cells\n","var notebookContainer = gd.closest('#notebook-container');\n","if (notebookContainer) {{\n","    x.observe(notebookContainer, {childList: true});\n","}}\n","\n","// Listen for the clearing of the current output cell\n","var outputEl = gd.closest('.output');\n","if (outputEl) {{\n","    x.observe(outputEl, {childList: true});\n","}}\n","\n","                        })\n","                };\n","                \n","            </script>\n","        </div>\n","</body>\n","</html>"]},"metadata":{"tags":[]}}]},{"cell_type":"markdown","metadata":{"id":"jPXeqn8R4PcX","colab_type":"text"},"source":["### Patents and Clinical Trials by Grant Funder"]},{"cell_type":"code","metadata":{"id":"Oqpkjlov4Puj","colab_type":"code","colab":{}},"source":["funders_patents = grants.query('patents > 0').groupby(['Funder', 'Funder Country'], as_index=False).sum().sort_values(by=[\"patents\"], ascending=False)\n","funders_trials = grants.query('clinical_trials > 0').groupby(['Funder', 'Funder Country'], as_index=False).sum().sort_values(by=[\"clinical_trials\"], ascending=False)"],"execution_count":0,"outputs":[]},{"cell_type":"code","metadata":{"id":"KlAghjWn6daw","colab_type":"code","outputId":"55adf37e-1b66-45e4-f280-29937c5477b0","executionInfo":{"status":"ok","timestamp":1573589515649,"user_tz":0,"elapsed":1051,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"colab":{"base_uri":"https://localhost:8080/","height":617}},"source":["px.bar(funders_patents,  y=\"patents\", x=\"Funder\", color=\"Funder Country\",\n","       hover_name=\"Funder\", \n","       hover_data=['Funder', 'Funder Country'], \n","       title=f\"Patents by Funders\")"],"execution_count":0,"outputs":[{"output_type":"display_data","data":{"text/html":["<html>\n","<head><meta charset=\"utf-8\" /></head>\n","<body>\n","    <div>\n","            <script src=\"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_SVG\"></script><script type=\"text/javascript\">if (window.MathJax) {MathJax.Hub.Config({SVG: {font: \"STIX-Web\"}});}</script>\n","                <script type=\"text/javascript\">window.PlotlyConfig = {MathJaxConfig: 'local'};</script>\n","        <script src=\"https://cdn.plot.ly/plotly-latest.min.js\"></script>    \n","            <div id=\"e8bda739-3c57-4d72-849e-cb48a8f53fcf\" class=\"plotly-graph-div\" style=\"height:600px; width:100%;\"></div>\n","            <script type=\"text/javascript\">\n","                \n","                    window.PLOTLYENV=window.PLOTLYENV || {};\n","                    \n","                if (document.getElementById(\"e8bda739-3c57-4d72-849e-cb48a8f53fcf\")) {\n","                    Plotly.newPlot(\n","                        'e8bda739-3c57-4d72-849e-cb48a8f53fcf',\n","                        [{\"alignmentgroup\": \"True\", \"customdata\": [[\"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"National Cancer Institute\", \"United States\"], [\"Congressionally Directed Medical Research Programs\", \"United States\"], [\"National Institute of Food and Agriculture\", \"United States\"], [\"National Institute on Drug Abuse\", \"United States\"], [\"National Institute of Dental and Craniofacial Research\", \"United States\"], [\"National Institute of Child Health and Human Development\", \"United States\"], [\"United States Department of the Navy\", \"United States\"], [\"National Institute of Diabetes and Digestive and Kidney Diseases\", \"United States\"]], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"<b>%{hovertext}</b><br><br>Funder Country=%{customdata[1]}<br>Funder=%{customdata[0]}<br>patents=%{y}\", \"hovertext\": [\"National Institute of Allergy and Infectious Diseases\", \"National Cancer Institute\", \"Congressionally Directed Medical Research Programs\", \"National Institute of Food and Agriculture\", \"National Institute on Drug Abuse\", \"National Institute of Dental and Craniofacial Research\", \"National Institute of Child Health and Human Development\", \"United States Department of the Navy\", \"National Institute of Diabetes and Digestive and Kidney Diseases\"], \"legendgroup\": \"Funder Country=United States\", \"marker\": {\"color\": \"#636efa\"}, \"name\": \"Funder Country=United States\", \"offsetgroup\": \"Funder Country=United States\", \"orientation\": \"v\", \"showlegend\": true, \"textposition\": \"auto\", \"type\": \"bar\", \"x\": [\"National Institute of Allergy and Infectious Diseases\", \"National Cancer Institute\", \"Congressionally Directed Medical Research Programs\", \"National Institute of Food and Agriculture\", \"National Institute on Drug Abuse\", \"National Institute of Dental and Craniofacial Research\", \"National Institute of Child Health and Human Development\", \"United States Department of the Navy\", \"National Institute of Diabetes and Digestive and Kidney Diseases\"], \"xaxis\": \"x\", \"y\": [326, 47, 14, 12, 11, 4, 2, 2, 1], \"yaxis\": \"y\"}],\n","                        {\"barmode\": \"relative\", \"height\": 600, \"legend\": {\"tracegroupgap\": 0}, \"template\": {\"data\": {\"bar\": [{\"error_x\": {\"color\": \"#2a3f5f\"}, \"error_y\": {\"color\": \"#2a3f5f\"}, \"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"bar\"}], \"barpolar\": [{\"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"barpolar\"}], \"carpet\": [{\"aaxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"baxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"type\": \"carpet\"}], \"choropleth\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"choropleth\"}], \"contour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"contour\"}], \"contourcarpet\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"contourcarpet\"}], \"heatmap\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmap\"}], \"heatmapgl\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmapgl\"}], \"histogram\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"histogram\"}], \"histogram2d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2d\"}], \"histogram2dcontour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2dcontour\"}], \"mesh3d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"mesh3d\"}], \"parcoords\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"parcoords\"}], \"scatter\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter\"}], \"scatter3d\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter3d\"}], \"scattercarpet\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattercarpet\"}], \"scattergeo\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergeo\"}], \"scattergl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergl\"}], \"scattermapbox\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattermapbox\"}], \"scatterpolar\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolar\"}], \"scatterpolargl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolargl\"}], \"scatterternary\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterternary\"}], \"surface\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"surface\"}], \"table\": [{\"cells\": {\"fill\": {\"color\": \"#EBF0F8\"}, \"line\": {\"color\": \"white\"}}, \"header\": {\"fill\": {\"color\": \"#C8D4E3\"}, \"line\": {\"color\": \"white\"}}, \"type\": \"table\"}]}, \"layout\": {\"annotationdefaults\": {\"arrowcolor\": \"#2a3f5f\", \"arrowhead\": 0, \"arrowwidth\": 1}, \"colorscale\": {\"diverging\": [[0, \"#8e0152\"], [0.1, \"#c51b7d\"], [0.2, \"#de77ae\"], [0.3, \"#f1b6da\"], [0.4, \"#fde0ef\"], [0.5, \"#f7f7f7\"], [0.6, \"#e6f5d0\"], [0.7, \"#b8e186\"], [0.8, \"#7fbc41\"], [0.9, \"#4d9221\"], [1, \"#276419\"]], \"sequential\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"sequentialminus\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"colorway\": [\"#636efa\", \"#EF553B\", \"#00cc96\", \"#ab63fa\", \"#FFA15A\", \"#19d3f3\", \"#FF6692\", \"#B6E880\", \"#FF97FF\", \"#FECB52\"], \"font\": {\"color\": \"#2a3f5f\"}, \"geo\": {\"bgcolor\": \"white\", \"lakecolor\": \"white\", \"landcolor\": \"#E5ECF6\", \"showlakes\": true, \"showland\": true, \"subunitcolor\": \"white\"}, \"hoverlabel\": {\"align\": \"left\"}, \"hovermode\": \"closest\", \"mapbox\": {\"style\": \"light\"}, \"paper_bgcolor\": \"white\", \"plot_bgcolor\": \"#E5ECF6\", \"polar\": {\"angularaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"radialaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"scene\": {\"xaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"yaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"zaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}}, \"shapedefaults\": {\"line\": {\"color\": \"#2a3f5f\"}}, \"ternary\": {\"aaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"baxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"caxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"title\": {\"x\": 0.05}, \"xaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}, \"yaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}}}, \"title\": {\"text\": \"Patents by Funders\"}, \"xaxis\": {\"anchor\": \"y\", \"domain\": [0.0, 0.98], \"title\": {\"text\": \"Funder\"}}, \"yaxis\": {\"anchor\": \"x\", \"domain\": [0.0, 1.0], \"title\": {\"text\": \"patents\"}}},\n","                        {\"responsive\": true}\n","                    ).then(function(){\n","                            \n","var gd = document.getElementById('e8bda739-3c57-4d72-849e-cb48a8f53fcf');\n","var x = new MutationObserver(function (mutations, observer) {{\n","        var display = window.getComputedStyle(gd).display;\n","        if (!display || display === 'none') {{\n","            console.log([gd, 'removed!']);\n","            Plotly.purge(gd);\n","            observer.disconnect();\n","        }}\n","}});\n","\n","// Listen for the removal of the full notebook cells\n","var notebookContainer = gd.closest('#notebook-container');\n","if (notebookContainer) {{\n","    x.observe(notebookContainer, {childList: true});\n","}}\n","\n","// Listen for the clearing of the current output cell\n","var outputEl = gd.closest('.output');\n","if (outputEl) {{\n","    x.observe(outputEl, {childList: true});\n","}}\n","\n","                        })\n","                };\n","                \n","            </script>\n","        </div>\n","</body>\n","</html>"]},"metadata":{"tags":[]}}]},{"cell_type":"code","metadata":{"id":"tQ8B4QknO-3b","colab_type":"code","outputId":"ba32655d-5e68-4503-e1d6-641eb195dde7","executionInfo":{"status":"ok","timestamp":1573589525707,"user_tz":0,"elapsed":832,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"colab":{"base_uri":"https://localhost:8080/","height":617}},"source":["px.bar(funders_trials,  y=\"clinical_trials\", x=\"Funder\", color=\"Funder Country\",\n","       hover_name=\"Funder\", \n","       hover_data=['Funder', 'Funder Country'], \n","       title=f\"Clinical Trials by Funders\")"],"execution_count":0,"outputs":[{"output_type":"display_data","data":{"text/html":["<html>\n","<head><meta charset=\"utf-8\" /></head>\n","<body>\n","    <div>\n","            <script src=\"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_SVG\"></script><script type=\"text/javascript\">if (window.MathJax) {MathJax.Hub.Config({SVG: {font: \"STIX-Web\"}});}</script>\n","                <script type=\"text/javascript\">window.PlotlyConfig = {MathJaxConfig: 'local'};</script>\n","        <script src=\"https://cdn.plot.ly/plotly-latest.min.js\"></script>    \n","            <div id=\"1e91701e-5fe1-4c7c-bf8b-bcb3fca42528\" class=\"plotly-graph-div\" style=\"height:600px; width:100%;\"></div>\n","            <script type=\"text/javascript\">\n","                \n","                    window.PLOTLYENV=window.PLOTLYENV || {};\n","                    \n","                if (document.getElementById(\"1e91701e-5fe1-4c7c-bf8b-bcb3fca42528\")) {\n","                    Plotly.newPlot(\n","                        '1e91701e-5fe1-4c7c-bf8b-bcb3fca42528',\n","                        [{\"alignmentgroup\": \"True\", \"customdata\": [[\"National Institute of Allergy and Infectious Diseases\", \"United States\"], [\"National Cancer Institute\", \"United States\"], [\"Centers for Disease Control and Prevention\", \"United States\"], [\"National Center for Complementary and Integrative Health\", \"United States\"], [\"National Institute on Drug Abuse\", \"United States\"]], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"<b>%{hovertext}</b><br><br>Funder Country=%{customdata[1]}<br>Funder=%{customdata[0]}<br>clinical_trials=%{y}\", \"hovertext\": [\"National Institute of Allergy and Infectious Diseases\", \"National Cancer Institute\", \"Centers for Disease Control and Prevention\", \"National Center for Complementary and Integrative Health\", \"National Institute on Drug Abuse\"], \"legendgroup\": \"Funder Country=United States\", \"marker\": {\"color\": \"#636efa\"}, \"name\": \"Funder Country=United States\", \"offsetgroup\": \"Funder Country=United States\", \"orientation\": \"v\", \"showlegend\": true, \"textposition\": \"auto\", \"type\": \"bar\", \"x\": [\"National Institute of Allergy and Infectious Diseases\", \"National Cancer Institute\", \"Centers for Disease Control and Prevention\", \"National Center for Complementary and Integrative Health\", \"National Institute on Drug Abuse\"], \"xaxis\": \"x\", \"y\": [6, 2, 1, 1, 1], \"yaxis\": \"y\"}],\n","                        {\"barmode\": \"relative\", \"height\": 600, \"legend\": {\"tracegroupgap\": 0}, \"template\": {\"data\": {\"bar\": [{\"error_x\": {\"color\": \"#2a3f5f\"}, \"error_y\": {\"color\": \"#2a3f5f\"}, \"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"bar\"}], \"barpolar\": [{\"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"barpolar\"}], \"carpet\": [{\"aaxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"baxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"type\": \"carpet\"}], \"choropleth\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"choropleth\"}], \"contour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"contour\"}], \"contourcarpet\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"contourcarpet\"}], \"heatmap\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmap\"}], \"heatmapgl\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmapgl\"}], \"histogram\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"histogram\"}], \"histogram2d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2d\"}], \"histogram2dcontour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2dcontour\"}], \"mesh3d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"mesh3d\"}], \"parcoords\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"parcoords\"}], \"scatter\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter\"}], \"scatter3d\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter3d\"}], \"scattercarpet\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattercarpet\"}], \"scattergeo\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergeo\"}], \"scattergl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergl\"}], \"scattermapbox\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattermapbox\"}], \"scatterpolar\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolar\"}], \"scatterpolargl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolargl\"}], \"scatterternary\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterternary\"}], \"surface\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"surface\"}], \"table\": [{\"cells\": {\"fill\": {\"color\": \"#EBF0F8\"}, \"line\": {\"color\": \"white\"}}, \"header\": {\"fill\": {\"color\": \"#C8D4E3\"}, \"line\": {\"color\": \"white\"}}, \"type\": \"table\"}]}, \"layout\": {\"annotationdefaults\": {\"arrowcolor\": \"#2a3f5f\", \"arrowhead\": 0, \"arrowwidth\": 1}, \"colorscale\": {\"diverging\": [[0, \"#8e0152\"], [0.1, \"#c51b7d\"], [0.2, \"#de77ae\"], [0.3, \"#f1b6da\"], [0.4, \"#fde0ef\"], [0.5, \"#f7f7f7\"], [0.6, \"#e6f5d0\"], [0.7, \"#b8e186\"], [0.8, \"#7fbc41\"], [0.9, \"#4d9221\"], [1, \"#276419\"]], \"sequential\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"sequentialminus\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"colorway\": [\"#636efa\", \"#EF553B\", \"#00cc96\", \"#ab63fa\", \"#FFA15A\", \"#19d3f3\", \"#FF6692\", \"#B6E880\", \"#FF97FF\", \"#FECB52\"], \"font\": {\"color\": \"#2a3f5f\"}, \"geo\": {\"bgcolor\": \"white\", \"lakecolor\": \"white\", \"landcolor\": \"#E5ECF6\", \"showlakes\": true, \"showland\": true, \"subunitcolor\": \"white\"}, \"hoverlabel\": {\"align\": \"left\"}, \"hovermode\": \"closest\", \"mapbox\": {\"style\": \"light\"}, \"paper_bgcolor\": \"white\", \"plot_bgcolor\": \"#E5ECF6\", \"polar\": {\"angularaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"radialaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"scene\": {\"xaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"yaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"zaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}}, \"shapedefaults\": {\"line\": {\"color\": \"#2a3f5f\"}}, \"ternary\": {\"aaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"baxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"caxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"title\": {\"x\": 0.05}, \"xaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}, \"yaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}}}, \"title\": {\"text\": \"Clinical Trials by Funders\"}, \"xaxis\": {\"anchor\": \"y\", \"domain\": [0.0, 0.98], \"title\": {\"text\": \"Funder\"}}, \"yaxis\": {\"anchor\": \"x\", \"domain\": [0.0, 1.0], \"title\": {\"text\": \"clinical_trials\"}}},\n","                        {\"responsive\": true}\n","                    ).then(function(){\n","                            \n","var gd = document.getElementById('1e91701e-5fe1-4c7c-bf8b-bcb3fca42528');\n","var x = new MutationObserver(function (mutations, observer) {{\n","        var display = window.getComputedStyle(gd).display;\n","        if (!display || display === 'none') {{\n","            console.log([gd, 'removed!']);\n","            Plotly.purge(gd);\n","            observer.disconnect();\n","        }}\n","}});\n","\n","// Listen for the removal of the full notebook cells\n","var notebookContainer = gd.closest('#notebook-container');\n","if (notebookContainer) {{\n","    x.observe(notebookContainer, {childList: true});\n","}}\n","\n","// Listen for the clearing of the current output cell\n","var outputEl = gd.closest('.output');\n","if (outputEl) {{\n","    x.observe(outputEl, {childList: true});\n","}}\n","\n","                        })\n","                };\n","                \n","            </script>\n","        </div>\n","</body>\n","</html>"]},"metadata":{"tags":[]}}]},{"cell_type":"markdown","metadata":{"id":"idF8ETxeQZ7B","colab_type":"text"},"source":["### Exploring Correlations between dimensions\n","\n","Tip: a straight diagonal indicates a strong correlation, while a 90 degree angle indicates no correlation. "]},{"cell_type":"code","metadata":{"id":"BAeGfB-_ShvW","colab_type":"code","outputId":"a3f350f1-9b9d-4670-ddc0-002d451bfced","executionInfo":{"status":"ok","timestamp":1573590368092,"user_tz":0,"elapsed":1668,"user":{"displayName":"Michele Pasin","photoUrl":"https://lh3.googleusercontent.com/a-/AAuE7mBu8LVjIGgontF2Wax51BoL5KFx8esezX3bUmaa0g=s64","userId":"10309320684375994511"}},"colab":{"base_uri":"https://localhost:8080/","height":617}},"source":["px.scatter_matrix(grants, dimensions=[\"patents\", \"clinical_trials\", \"pubs\"], color=\"Funder Country\")"],"execution_count":0,"outputs":[{"output_type":"display_data","data":{"text/html":["<html>\n","<head><meta charset=\"utf-8\" /></head>\n","<body>\n","    <div>\n","            <script src=\"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-AMS-MML_SVG\"></script><script type=\"text/javascript\">if (window.MathJax) {MathJax.Hub.Config({SVG: {font: \"STIX-Web\"}});}</script>\n","                <script type=\"text/javascript\">window.PlotlyConfig = {MathJaxConfig: 'local'};</script>\n","        <script src=\"https://cdn.plot.ly/plotly-latest.min.js\"></script>    \n","            <div id=\"d5ce6da6-f4ec-404b-8b82-f4346176fc87\" class=\"plotly-graph-div\" style=\"height:600px; width:100%;\"></div>\n","            <script type=\"text/javascript\">\n","                \n","                    window.PLOTLYENV=window.PLOTLYENV || {};\n","                    \n","                if (document.getElementById(\"d5ce6da6-f4ec-404b-8b82-f4346176fc87\")) {\n","                    Plotly.newPlot(\n","                        'd5ce6da6-f4ec-404b-8b82-f4346176fc87',\n","                        [{\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 2, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 10, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 6, 3, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 1, 18, 2, 0, 2, 0, 1, 0, 0, 0, 0, 1, 16, 5, 0, 3, 7, 0, 0, 0, 1, 0, 0, 5, 2, 1, 4, 0, 2, 13, 1, 7, 1, 5, 7, 15, 0, 2, 1, 2, 7, 1, 1, 2, 0, 0, 4, 2, 2, 30, 3, 4, 0, 0, 4, 3, 2, 8, 2, 3, 0, 2, 2, 4, 1, 0, 3, 1, 3, 0, 0, 1, 11, 8, 0, 0, 0, 6, 2, 3, 0, 8, 1, 0, 0, 0, 3, 16, 2, 0, 3, 4, 5, 0, 0, 1, 2, 0, 0, 3, 0, 0, 0, 0, 0, 3, 2, 4, 8, 2, 0, 3, 11, 1, 4, 2, 2, 1, 2, 4, 1, 1, 1, 0, 1, 0, 0, 0, 19, 1, 1, 3, 0, 0, 2, 5, 3, 2, 0, 1, 0, 0, 0, 4, 3, 2, 1, 4, 15, 2, 1, 14, 6, 3, 1, 2, 13, 2, 8, 6, 7, 5, 6, 4, 1, 0, 18, 0, 0, 10, 1, 1, 1, 4, 0, 1, 3, 0, 3, 1, 3, 2, 2, 0, 1, 0, 4, 4, 0, 1, 1, 4, 0, 4, 0, 1, 0, 0, 1, 1, 6, 26, 0, 1, 5, 7, 1, 14, 4, 10, 4, 1, 2, 3, 2, 5, 1, 4, 1, 0, 0, 0, 0, 3, 6, 0, 0, 0, 1, 0, 10, 3, 4, 3, 3, 2, 8, 2, 3, 3, 2, 6, 6, 2, 3, 7, 1, 2, 8, 0, 1, 2, 1, 2, 1, 3, 5, 10, 4, 0, 1, 3, 4, 0, 2, 0, 2, 3, 2, 2, 1, 5, 2, 2, 0, 3, 1, 0, 4, 3, 6, 3, 5, 3, 9, 5, 0, 2, 15, 9, 12, 6, 3, 0, 0, 3, 1, 0, 1, 0, 1, 9, 5, 1, 1, 1, 0, 3, 0, 0, 1, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=China<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=China\", \"marker\": {\"color\": \"#636efa\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=China\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Canada<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Canada\", \"marker\": {\"color\": \"#EF553B\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Canada\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 1, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 4, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 9, 0, 0, 0, 0, 0, 0, 5, 3, 11, 0, 0, 0, 0, 0, 3, 6, 0, 0, 0, 0, 0, 6, 0, 0, 0, 1, 0, 1, 4, 2, 0, 0, 0, 0, 4, 1, 0, 3, 0, 0, 0, 20, 5, 3, 0, 3, 0, 5, 1, 0, 0, 0, 0, 0, 2, 0, 0, 0, 3, 0, 0, 15, 1, 0, 2, 1, 1, 0, 0, 0, 0, 3, 0, 0, 3, 0, 1, 0, 0, 2, 16, 0, 1, 3, 1, 10, 0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 4, 0, 2, 2, 8, 5, 6, 3, 61, 2, 6, 5, 0, 6, 4, 4, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 8, 0, 0, 3, 4, 3, 3, 0, 6, 0, 72, 0, 0, 9, 0, 3, 0, 0, 10, 0, 3, 1, 4, 1, 1, 0, 0, 0, 6, 4, 2, 0, 0, 6, 7, 5, 1, 0, 0, 0, 25, 0, 0, 9, 1, 0, 0, 0, 0, 3, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Australia<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Australia\", \"marker\": {\"color\": \"#00cc96\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Australia\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 27, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 81, 9, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 4, 14, 1, 0, 0, 0, 2, 28, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 19, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 3, 3, 1, 6, 4, 0, 6, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 3, 29, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 49, 42, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 5, 0, 0, 32, 0, 0, 5, 4, 0, 0, 1, 16, 8, 6, 0, 0, 0, 0, 0, 0, 129, 0, 0, 35, 2, 5, 4, 39, 2, 0, 0, 0, 0, 0, 13, 0, 0, 0, 0, 3, 17, 2, 4, 11, 5, 15, 1, 5, 2, 17, 0, 1, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Belgium<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Belgium\", \"marker\": {\"color\": \"#ab63fa\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Belgium\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 1, 0, 8, 0, 0, 0, 0, 0, 0, 5, 1, 5, 1, 0, 4, 10, 2, 0, 1, 8, 8, 19, 27, 22, 17, 20, 15, 15, 0, 16, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 1, 0, 13, 14, 20, 0, 9, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 9, 1, 0, 2, 1, 0, 1, 2, 2, 0, 32, 7, 7, 11, 4, 12, 23, 6, 2, 3, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 8, 0, 1, 2, 0, 1, 9, 4, 9, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 7, 1, 0, 0, 17, 3, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 9, 0, 3, 0, 2, 1, 7, 17, 12, 1, 1, 4, 0, 0, 1, 0, 0, 0, 0, 3, 8, 0, 0, 0, 1, 1, 0, 0, 3, 0, 0, 1, 3, 0, 2, 8, 3, 3, 2, 0, 4, 1, 0, 0, 0, 3, 0, 2, 0, 1, 2, 0, 4, 3, 0, 11, 22, 28, 0, 0, 0, 1, 0, 1, 0, 2, 0, 0, 2, 44, 7, 5, 0, 174, 7, 30, 0, 2, 0, 0, 21, 17, 5, 7, 13, 5, 0, 8, 1, 15, 1, 3, 3, 13, 1, 6, 4, 0, 0, 26, 17, 29, 65, 9, 3, 39, 15, 0, 0, 0, 6, 18, 8, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 2, 1, 1, 1, 0, 12, 3, 4, 0, 21, 0, 14, 0, 21, 0, 19, 0, 19, 29, 0, 22, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, 2, 63, 0, 7, 0, 0, 0, 0, 2, 0, 0, 0, 2, 1, 0, 1, 1, 1, 0, 0, 10, 67, 0, 0, 0, 2, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 81, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 6, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 1, 3, 0, 1, 3, 0, 8, 0, 0, 2, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 8, 0, 2, 0, 0, 1, 0, 0, 1, 33, 0, 3, 0, 0, 0, 0, 1, 2, 13, 0, 7, 7, 0, 1, 0, 19, 0, 25, 0, 15, 0, 0, 3, 1, 0, 16, 2, 15, 0, 0, 3, 0, 0, 0, 3, 3, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 2, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 61, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 25, 3, 15, 0, 0, 6, 0, 3, 0, 6, 3, 2, 3, 0, 13, 3, 11, 0, 0, 0, 0, 8, 3, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 15, 5, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 41, 0, 0, 29, 0, 3, 2, 17, 14, 15, 0, 8, 18, 0, 2, 84, 0, 0, 0, 0, 4, 0, 0, 1, 0, 0, 0, 6, 1, 0, 0, 8, 3, 1, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 10, 0, 0, 0, 2, 5, 10, 0, 0, 0, 3, 0, 0, 2, 3, 0, 0, 0, 28, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 6, 0, 0, 5, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 4, 3, 5, 0, 0, 0, 0, 1, 0, 0, 13, 0, 0, 0, 1, 1, 0, 15, 4, 0, 1, 9, 0, 0, 0, 0, 0, 1, 1, 0, 2, 2, 3, 0, 3, 1, 0, 0, 0, 1, 4, 0, 3, 4, 0, 0, 0, 4, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 11, 5, 12, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 8, 0, 0, 0, 0, 5, 0, 0, 0, 14, 6, 13, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 2, 3, 16, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 67, 0, 11, 0, 0, 0, 0, 3, 0, 1, 48, 0, 66, 33, 2, 29, 3, 2, 0, 3, 0, 0, 0, 0, 0, 0, 3, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 20, 6, 1, 3, 0, 5, 72, 1, 0, 0, 0, 13, 3, 1, 2, 9, 13, 19, 3, 20, 4, 2, 61, 3, 4, 1, 0, 4, 5, 5, 17, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 10, 0, 4, 2, 10, 0, 0, 0, 5, 4, 1, 8, 10, 1, 1, 6, 21, 3, 0, 0, 1, 1, 1, 2, 1, 1, 27, 3, 22, 4, 0, 5, 3, 2, 0, 10, 2, 6, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 3, 0, 3, 4, 2, 0, 1, 0, 2, 0, 5, 3, 65, 16, 24, 2, 9, 2, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 41, 0, 0, 3, 8, 10, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 1, 17, 40, 0, 9, 0, 0, 5, 2, 15, 21, 0, 0, 15, 0, 0, 3, 1, 0, 9, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 4, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1, 0, 0, 9, 0, 0, 0, 0, 2, 0, 1, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 0, 0, 1, 0, 0, 0, 0, 5, 1, 11, 0, 0, 1, 0, 0, 2, 0, 0, 0, 0, 1, 1, 0, 0, 1, 24, 0, 25, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 20, 0, 2, 8, 0, 2, 0, 0, 0, 0, 4, 29, 0, 1, 2, 0, 6, 0, 1, 0, 0, 7, 0, 0, 1, 0, 1, 20, 0, 3, 2, 0, 0, 3, 2, 5, 1, 2, 0, 2, 0, 0, 0, 1, 1, 0, 10, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 6, 0, 5, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 3, 6, 11, 2, 0, 2, 3, 15, 38, 0, 0, 0, 0, 1, 8, 3, 0, 4, 31, 0, 0, 0, 0, 0, 8, 0, 27, 3, 0, 0, 0, 0, 2, 1, 3, 0, 0, 0, 0, 0, 3, 0, 1, 5, 8, 5, 21, 5, 7, 19, 0, 4, 0, 0, 6, 2, 18, 7, 9, 0, 0, 7, 0, 0, 0, 13, 1, 2, 0, 0, 1, 3, 5, 0, 5, 4, 2, 13, 0, 11, 0, 2, 1, 3, 0, 4, 1, 0, 3, 2, 5, 8, 4, 15, 14, 0, 0, 0, 0, 8, 1, 0, 2, 0, 1, 1, 0, 3, 1, 1, 64, 3, 0, 0, 0, 6, 0, 0, 0, 3, 0, 0, 0, 2, 2, 14, 3, 13, 0, 0, 3, 4, 5, 57, 9, 5, 0, 10, 28, 1, 0, 0, 8, 4, 2, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 1, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 2, 0, 0, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 30, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 1, 29, 0, 0, 0, 1, 2, 0, 1, 0, 0, 0, 0, 6, 2, 1, 2, 1, 17, 5, 37, 5, 4, 11, 3, 1, 0, 0, 0, 0, 0, 0, 6, 2, 14, 1, 1, 0, 0, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 6, 5, 0, 0, 4, 2, 5, 0, 1, 2, 4, 0, 8, 6, 1, 0, 0, 3, 1, 5, 13, 9, 6, 9, 2, 31, 31, 193, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 0, 0, 0, 1, 2, 31, 0, 0, 4, 2, 8, 1, 2, 0, 4, 1, 2, 17, 0, 2, 4, 2, 0, 7, 44, 1, 0, 0, 0, 1, 0, 2, 5, 0, 0, 9, 1, 2, 1, 1, 9, 0, 1, 3, 1, 1, 2, 10, 4, 3, 0, 3, 0, 3, 2, 3, 0, 3, 5, 5, 0, 0, 3, 1, 1, 5, 27, 1, 5, 9, 1, 2, 10, 34, 1, 5, 14, 0, 1, 0, 4, 1, 0, 0, 1, 2, 0, 8, 1, 3, 5, 7, 1, 0, 0, 0, 2, 16, 2, 0, 3, 0, 14, 0, 9, 9, 8, 0, 0, 4, 1, 2, 1, 3, 1, 20, 0, 0, 0, 2, 3, 2, 2, 1, 16, 3, 20, 6, 0, 5, 5, 4, 6, 34, 9, 3, 15, 7, 12, 7, 10, 11, 6, 36, 2, 0, 0, 0, 0, 0, 26, 48, 8, 1, 0, 2, 1, 0, 0, 3, 5, 0, 0, 5, 8, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 60, 9, 10, 32, 6, 2, 1, 1, 2, 0, 0, 0, 0, 0, 3, 0, 0, 2, 0, 0, 2, 0, 0, 0, 0, 0, 3, 0, 3, 3, 3, 5, 0, 2, 11, 4, 2, 0, 0, 2, 0, 0, 1, 0, 0, 10, 0, 0, 0, 0, 11, 0, 0, 0, 1, 0, 0, 0, 1, 24, 0, 13, 0, 1, 6, 0, 8, 1, 2, 1, 3, 0, 0, 0, 1, 2, 0, 0, 0, 2, 6, 1, 2, 0, 0, 0, 4, 2, 2, 3, 0, 4, 2, 1, 2, 5, 2, 2, 1, 13, 1, 8, 0, 0, 0, 1, 6, 0, 1, 10, 11, 5, 1, 0, 8, 28, 121, 7, 27, 2, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 6, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 1, 9, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 6, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 2, 13, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 5, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 6, 0, 6, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 11, 1, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 10, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 4, 0, 0, 0, 0, 1, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 2, 0, 6, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 6, 28, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 0, 0, 0, 2, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 3, 0, 0, 0, 6, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 2, 3, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 20, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 1, 0, 0, 1, 0, 0, 2, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 7, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 7, 0, 0, 0, 0, 0, 5, 0, 0, 1, 0, 0, 0, 0, 4, 0, 0, 0, 4, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=United States<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=United States\", \"marker\": {\"color\": \"#FFA15A\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=United States\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 1, 0, 0, 2, 0, 0, 0, 0, 0, 6, 0, 1, 1, 0, 0, 0, 1, 3, 0, 0, 0, 1, 0, 0, 0, 0, 14, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 1, 0, 0, 0, 3, 0, 1, 0, 1, 0, 0, 3, 0, 1, 3, 0, 1, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 7, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 3, 8, 0, 0, 1, 0, 0, 0, 1, 1, 4, 1, 3, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 3, 0, 0, 1, 11, 0, 0, 0, 0, 0, 0, 0, 0, 0, 10, 0, 0, 2, 5, 0, 0, 2, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Germany<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Germany\", \"marker\": {\"color\": \"#19d3f3\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Germany\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 5, 0, 1, 0, 0, 0, 0, 0, 0, 4]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Sweden<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Sweden\", \"marker\": {\"color\": \"#FF6692\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Sweden\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=New Zealand<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=New Zealand\", \"marker\": {\"color\": \"#B6E880\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=New Zealand\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 3, 0, 0, 38, 1, 2, 1, 0, 3, 5, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 2, 0, 1, 2, 0, 0, 0, 2, 0, 16, 0, 0, 0, 5, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 3, 0, 1, 0, 4, 0, 0, 0, 0, 0, 15, 0, 0, 0, 0, 3, 0, 2, 1, 1, 0, 5, 0, 3, 7, 24, 10, 30, 7, 0, 2, 7, 20, 0, 0, 0, 0, 0, 2, 0, 5, 0, 0, 32, 0, 62, 43, 0, 2, 1, 34, 6, 19, 4, 0, 0, 0, 2, 2, 4, 0, 1, 0, 1, 0, 0, 0, 0, 0, 19, 0, 12, 0, 2, 0, 1, 0, 1, 0, 1, 4, 0, 10, 0, 5, 1, 6, 0, 52, 7, 3, 0, 0, 1, 5, 2, 0, 0, 0, 1, 0, 0, 0, 0, 0, 4, 0, 3, 1, 79, 1, 17, 1, 0, 2, 5, 0, 0, 5, 7]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=United Kingdom<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=United Kingdom\", \"marker\": {\"color\": \"#FF97FF\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=United Kingdom\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [7, 0, 2, 0, 0, 4, 1, 5, 6, 17, 1, 4, 0, 2, 0, 0, 0, 1, 1, 0, 0, 11, 4, 6, 7, 27, 0, 6, 6, 3, 3, 12, 28, 7, 1, 1, 1, 5, 0, 0, 0, 1, 0, 5, 4, 2, 1, 14, 3, 1, 1, 3, 1, 0, 0, 4, 1, 0, 0, 0, 0, 0, 1, 2, 3, 0, 0, 3, 5, 1, 1, 1, 0, 0, 0, 0, 3, 0, 0, 11, 5, 3, 1, 1, 8, 4, 9, 12, 8, 9, 7, 3, 0, 1, 9]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=South Korea<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=South Korea\", \"marker\": {\"color\": \"#FECB52\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=South Korea\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Denmark<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Denmark\", \"marker\": {\"color\": \"#636efa\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Denmark\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 4, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 5, 0, 1, 9, 4, 1, 0, 12, 2, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 4, 0, 2, 4, 0, 1, 1, 0, 0, 2, 0, 14, 1, 0, 10, 0, 0, 0, 0, 8, 0, 8, 0, 0, 0, 4, 18, 1, 0, 0, 1, 12, 3, 3, 1, 0, 1, 0, 0, 0, 0, 0, 7, 22, 18, 0, 2, 0, 9, 3, 0, 0, 0, 2, 0, 1, 3, 1, 0, 2, 8, 1, 0, 2, 1, 0, 0, 1, 5, 1, 0, 4, 0, 1, 0, 2, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 5, 0, 0, 0, 8, 0, 2, 2, 1, 0, 2, 1, 1, 8, 0, 1, 3, 3, 8, 0, 2, 0, 1, 1, 6, 4, 1, 0, 0, 1, 0, 4, 0, 2, 3, 1, 0, 0, 0, 0, 0, 16, 0, 0, 0, 0, 0, 2, 0, 0, 0, 1, 0, 3, 1, 9, 1, 2, 3, 4, 3, 4, 1, 2, 0, 6, 0, 2, 2, 0, 2, 9, 3, 0, 11, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Japan<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Japan\", \"marker\": {\"color\": \"#EF553B\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Japan\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 1, 1, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Austria<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Austria\", \"marker\": {\"color\": \"#00cc96\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Austria\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0, 1, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 6, 0, 1, 0, 0, 0, 1, 2, 1, 3, 0, 0, 0, 3, 25, 11, 0, 0, 2, 0, 4, 11, 7, 0, 11]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Norway<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Norway\", \"marker\": {\"color\": \"#ab63fa\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Norway\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=India<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=India\", \"marker\": {\"color\": \"#FFA15A\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=India\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Slovenia<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Slovenia\", \"marker\": {\"color\": \"#19d3f3\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Slovenia\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 8, 0, 6, 0, 0, 0, 1, 17, 8, 0, 0, 0, 3, 0, 0, 0, 3, 13, 9, 27]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Ireland<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Ireland\", \"marker\": {\"color\": \"#FF6692\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Ireland\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Israel<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Israel\", \"marker\": {\"color\": \"#B6E880\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Israel\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [4, 0, 0, 3, 0, 0, 0, 5, 1, 0, 1, 0, 2, 10, 0, 4, 5, 0, 0, 0, 6, 2, 1, 1, 0, 0, 0, 0, 0, 0, 9, 1, 0, 0, 0, 0, 0, 0, 5, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Switzerland<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Switzerland\", \"marker\": {\"color\": \"#FF97FF\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Switzerland\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 4, 0, 0, 0, 0, 4, 3, 0, 0, 0, 0, 0, 0, 1, 2, 1, 0, 16, 0, 1, 6, 0, 0, 0, 0, 9, 0, 0, 4, 0, 6, 6, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Portugal<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Portugal\", \"marker\": {\"color\": \"#FECB52\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Portugal\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 0, 5, 1, 0, 0, 1, 0, 2, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Brazil<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Brazil\", \"marker\": {\"color\": \"#636efa\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Brazil\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Slovakia<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Slovakia\", \"marker\": {\"color\": \"#EF553B\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Slovakia\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [1]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Hungary<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Hungary\", \"marker\": {\"color\": \"#00cc96\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Hungary\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0, 15, 0, 0, 0, 1, 0, 2]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Russia<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Russia\", \"marker\": {\"color\": \"#ab63fa\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Russia\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 1, 4, 1, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Netherlands<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Netherlands\", \"marker\": {\"color\": \"#FFA15A\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Netherlands\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 2, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Poland<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Poland\", \"marker\": {\"color\": \"#19d3f3\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Poland\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [1, 0, 0, 0, 0, 8, 0, 0, 0, 0, 4, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 7, 4, 0, 3, 0, 22]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Czechia<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Czechia\", \"marker\": {\"color\": \"#FF6692\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Czechia\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0, 0, 0, 0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0, 0, 0, 0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=France<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=France\", \"marker\": {\"color\": \"#B6E880\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=France\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0, 0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0, 0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Italy<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Italy\", \"marker\": {\"color\": \"#FF97FF\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Italy\", \"showlegend\": true, \"type\": \"splom\"}, {\"dimensions\": [{\"axis\": {\"matches\": true}, \"label\": \"pubs\", \"values\": [0]}, {\"axis\": {\"matches\": true}, \"label\": \"patents\", \"values\": [0]}, {\"axis\": {\"matches\": true}, \"label\": \"clinical_trials\", \"values\": [0]}], \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Funder Country=Iceland<br>%{xaxis.title.text}=%{x}<br>%{yaxis.title.text}=%{y}\", \"legendgroup\": \"Funder Country=Iceland\", \"marker\": {\"color\": \"#FECB52\", \"symbol\": \"circle\"}, \"name\": \"Funder Country=Iceland\", \"showlegend\": true, \"type\": \"splom\"}],\n","                        {\"dragmode\": \"select\", \"height\": 600, \"legend\": {\"tracegroupgap\": 0}, \"margin\": {\"t\": 60}, \"template\": {\"data\": {\"bar\": [{\"error_x\": {\"color\": \"#2a3f5f\"}, \"error_y\": {\"color\": \"#2a3f5f\"}, \"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"bar\"}], \"barpolar\": [{\"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"barpolar\"}], \"carpet\": [{\"aaxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"baxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"type\": \"carpet\"}], \"choropleth\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"choropleth\"}], \"contour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"contour\"}], \"contourcarpet\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"contourcarpet\"}], \"heatmap\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmap\"}], \"heatmapgl\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmapgl\"}], \"histogram\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"histogram\"}], \"histogram2d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2d\"}], \"histogram2dcontour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2dcontour\"}], \"mesh3d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"mesh3d\"}], \"parcoords\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"parcoords\"}], \"scatter\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter\"}], \"scatter3d\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter3d\"}], \"scattercarpet\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattercarpet\"}], \"scattergeo\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergeo\"}], \"scattergl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergl\"}], \"scattermapbox\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattermapbox\"}], \"scatterpolar\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolar\"}], \"scatterpolargl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolargl\"}], \"scatterternary\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterternary\"}], \"surface\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"surface\"}], \"table\": [{\"cells\": {\"fill\": {\"color\": \"#EBF0F8\"}, \"line\": {\"color\": \"white\"}}, \"header\": {\"fill\": {\"color\": \"#C8D4E3\"}, \"line\": {\"color\": \"white\"}}, \"type\": \"table\"}]}, \"layout\": {\"annotationdefaults\": {\"arrowcolor\": \"#2a3f5f\", \"arrowhead\": 0, \"arrowwidth\": 1}, \"colorscale\": {\"diverging\": [[0, \"#8e0152\"], [0.1, \"#c51b7d\"], [0.2, \"#de77ae\"], [0.3, \"#f1b6da\"], [0.4, \"#fde0ef\"], [0.5, \"#f7f7f7\"], [0.6, \"#e6f5d0\"], [0.7, \"#b8e186\"], [0.8, \"#7fbc41\"], [0.9, \"#4d9221\"], [1, \"#276419\"]], \"sequential\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"sequentialminus\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"colorway\": [\"#636efa\", \"#EF553B\", \"#00cc96\", \"#ab63fa\", \"#FFA15A\", \"#19d3f3\", \"#FF6692\", \"#B6E880\", \"#FF97FF\", \"#FECB52\"], \"font\": {\"color\": \"#2a3f5f\"}, \"geo\": {\"bgcolor\": \"white\", \"lakecolor\": \"white\", \"landcolor\": \"#E5ECF6\", \"showlakes\": true, \"showland\": true, \"subunitcolor\": \"white\"}, \"hoverlabel\": {\"align\": \"left\"}, \"hovermode\": \"closest\", \"mapbox\": {\"style\": \"light\"}, \"paper_bgcolor\": \"white\", \"plot_bgcolor\": \"#E5ECF6\", \"polar\": {\"angularaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"radialaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"scene\": {\"xaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"yaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"zaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}}, \"shapedefaults\": {\"line\": {\"color\": \"#2a3f5f\"}}, \"ternary\": {\"aaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"baxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"caxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"title\": {\"x\": 0.05}, \"xaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}, \"yaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}}}},\n","                        {\"responsive\": true}\n","                    ).then(function(){\n","                            \n","var gd = document.getElementById('d5ce6da6-f4ec-404b-8b82-f4346176fc87');\n","var x = new MutationObserver(function (mutations, observer) {{\n","        var display = window.getComputedStyle(gd).display;\n","        if (!display || display === 'none') {{\n","            console.log([gd, 'removed!']);\n","            Plotly.purge(gd);\n","            observer.disconnect();\n","        }}\n","}});\n","\n","// Listen for the removal of the full notebook cells\n","var notebookContainer = gd.closest('#notebook-container');\n","if (notebookContainer) {{\n","    x.observe(notebookContainer, {childList: true});\n","}}\n","\n","// Listen for the clearing of the current output cell\n","var outputEl = gd.closest('.output');\n","if (outputEl) {{\n","    x.observe(outputEl, {childList: true});\n","}}\n","\n","                        })\n","                };\n","                \n","            </script>\n","        </div>\n","</body>\n","</html>"]},"metadata":{"tags":[]}}]},{"cell_type":"markdown","metadata":{"id":"_thkJtfjiP9I","colab_type":"text"},"source":["--- \n","\n","## Conclusion\n","\n","In this tutorial we have enriched a grants dataset on the topic of 'vaccines' by adding information about patent and clinical trials.\n"]}]}